{
 "cells": [
  {
   "cell_type": "code",
   "execution_count": 1,
   "metadata": {},
   "outputs": [],
   "source": [
    "from xlrd import open_workbook\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 2,
   "metadata": {},
   "outputs": [],
   "source": [
    "wb = open_workbook('Firms to combine topics.xlsx')"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 3,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "{u'': set([u'Coley Pharmaceutical Group Inc', u'National Comprehensive Cancer Network', u'Connetics Corp', u'Paladin Labs Inc', u'InterMune Inc', u'Ligand Pharmaceuticals Inc', u'Alfa Wassermann SpA', u'UCB Celltech', u'VGX Pharmaceuticals LLC', u'SciClone Pharmaceuticals Inc', u'Boehringer Ingelheim International GmbH', u'Eli Lilly & Co', u'CJ Corp', u'University of Pennsylvania', u'ScinoPharm Taiwan Ltd', u'RegeneRx Biopharmaceuticals Inc', u'Allergan Inc', u'Boehringer Ingelheim Austria GmbH', u'Pfizer Inc', u'Corthera Inc', u'Merckle GmbH', u'Defense Advanced Research Projects Agency', u'F H Faulding & Co Ltd', u'Horizon Pharma plc']), u'Norwalkvirusinfection': set([u'University of Tampere', u'Takeda Vaccines Inc', u'Baylor College of Medicine', u'Archimedes Pharma Ltd', u'Arizona State University', u'US Department of Defense', u'National Institute of Allergy and Infectious Diseases', u'Nanotherapeutics Inc', u'PacificGMP', u'VAXX Inc', u'UMN Pharma Inc', u'GlaxoSmithKline plc']), u'Alagillesyndrome': set([u'Lumena Pharmaceuticals', u'Pfizer Inc']), u'Attentiondeficithyperactivitydisorder': set([u'US Government', u'BioMarin Pharmaceutical Inc', u'Solvay SA', u'University of Florida', u'MSD OSS BV', u'Knoll Pharmaceuticals Co', u'DSG Inc', u'Pharsight Corp', u'Medical and Pharmaceutical Industry Technology and Development Center', u'GlaxoSmithKline plc', u'Shire Richwood', u'Neos Therapeutics Inc', u'DURECT Corp', u'Novartis Pharma AG', u'Scios Inc', u'MonoSol Rx Inc', u'University of South Florida', u'KemPharm Inc', u'Massachusetts College of Pharmacy and Health Sciences', u'Dompe SpA', u'Shire plc', u'Addrenex Pharmaceuticals Inc', u'Aptalis Pharma Srl', u'The National Institute of Mental Health', u'Layton Bioscience Inc', u'Catalent Inc', u'Merckle GmbH', u'Catalyst Biosciences Inc', u'NeuroSearch A/S', u'American BriVision Corporation', u'Taiwan Biotech Co Ltd', u'Premier Research Group Ltd', u'Recro Pharma Inc', u'Targacept Inc', u'Advinus Therapeutics Ltd', u'SmithKline Beecham Pharmaceuticals', u'RespireRx Pharmaceuticals Inc', u'The European Union', u'Abbott Laboratories', u'Alcobra Ltd', u'Somerset Pharmaceuticals Inc', u'PsychoGenics Inc', u'DreamPharma Corp', u'Teva Pharmaceutical Industries Ltd', u'Outlook Pharmaceuticals Inc', u'Tanabe Seiyaku Co Ltd', u'McLean Hospital Corp', u'Astellas Pharma Inc', u'Concordia Pharmaceuticals Inc', u'ALZA Corp', u'Janssen Pharmaceutical KK', u'Gliatech Inc', u'UCB SA', u'Albany Molecular Research Inc', u'Alfresa Pharma Corp', u'Prasco Laboratories', u'Janssen Pharmaceutica NV', u'Camargo Pharmaceutical Services', u'Duramed Pharmaceuticals Inc', u'H Lundbeck A/S', u'Chugai Pharmaceutical Co Ltd', u'National Institute of Neurological Disorders and Stroke', u'ReqMed Co Ltd', u'Osprey Pharmaceutical Co', u'Allergan plc', u'Actavis Inc', u'Medivir AB', u'Undisclosed', u'National Institute on Drug Abuse', u'Altus Formulation', u'University of California', u'Molecular Insight Pharmaceuticals Inc', u'Alkermes plc', u'Eli Lilly & Co', u'Biolite Inc', u'Laboratoire L Lafon SA', u'Orient Pharma Co Ltd', u'Swedish Orphan AB', u'DNAPrint genomics Inc', u'Auriga Laboratories Inc', u'Capsugel Inc', u'Hannover Medical School', u'Proteome Sciences plc', u'AstraZeneca plc', u'Pfizer Inc', u'EMERpharma Ltd', u'Yale University', u'Sandoz Inc', u'Johnson & Johnson', u'Shionogi Inc', u'Mylan Pharmaceuticals Inc', u'Armstrong Laboratories Inc', u'DevCo Pharmaceuticals Ltd', u'UCB Celltech', u'Cingulate Therapeutics LLC', u'Ceptaris Therapeutics Inc', u'National Institutes of Health', u'Afecta Pharmaceuticals', u'Bristol-Myers Squibb Co', u'Elan Corp plc', u'Shire Pharmaceuticals Ltd', u'Neurovance Inc', u'New River Pharmaceuticals Inc', u'Cephalon Inc', u'Celgene Corp', u'Janssen Pharmaceutica BV', u'Crescendo Pharmaceuticals Corp', u'Phytera Inc', u'Therapix Biosciences Ltd', u'Par Pharmaceutical Co Inc', u'Vince and Associates Clinical Research', u'Biovail Corp', u'Bio-Images Drug Delivery Ltd', u'Cepa Schwarz Pharma Sl', u'Genizon BioSciences Inc', u'P2D Biosciences', u'Noven Pharmaceuticals Inc', u'Supernus Pharmaceuticals Inc', u'Attenua Inc', u'MENSIA Technologies', u'Mylan Specialty']), u'Bipolardisorder': set([u'US Government', u'Solvay SA', u'BioLink Life Sciences Inc', u'Galenica AG', u'AOP Orphan Pharmaceuticals AG', u'Breckenridge Pharmaceutical Inc', u'GlaxoSmithKline plc', u'ChemRx Advanced Technologies Inc', u'Novartis Pharma AG', u'Scil Technology GmbH', u'Instytut Psychiatrii i Neurologii', u'Scios Inc', u'ANI Pharmaceuticals Inc', u'University of South Florida', u'Vanda Pharmaceuticals Inc', u'IMPAX Laboratories Inc', u'Apotex Inc', u'Sumitomo Pharmaceuticals Co Ltd', u'Cerca Insights Sdn Bhd', u'UCB Pharma SA', u'MSD OSS BV', u'Ajanta Pharma Ltd', u'Alvogen Korea', u'The National Institute of Mental Health', u'Sun Pharmaceutical Industries Ltd', u'Celera South San Francisco', u'Layton Bioscience Inc', u'Teikoku Seiyaku KK', u'Catalent Inc', u'NeuroSearch A/S', u'23andMe Inc', u'Nelson Pharmaceuticals LLC', u'Biotie Therapies AG', u'University of Oxford', u'SmithKline Beecham Pharmaceuticals', u'Affymetrix Inc', u'Marinus Pharmaceuticals Inc', u'Memory Pharmaceuticals Corp', u'Abbott Laboratories', u'Repligen Corp', u'Forest Laboratories Inc', u'Fujisawa Pharmaceutical Co Ltd', u'InterLab Pharmaceutica', u'Sound Pharmaceuticals Inc', u'Banner Pharmacaps Inc', u'NeuroRx Inc', u'Siegfried Holding Ltd', u'McLean Hospital Corp', u'JDS Pharmaceuticals LLC', u'WuXi PharmaTech (Cayman) Inc', u'Scarista Ltd', u'Janssen Pharmaceutical KK', u'Wellcome Trust', u'Titan Pharmaceuticals Inc', u'Astrazeneca Korea', u'Jazz Pharmaceuticals plc', u'Jiangsu Nhwa Pharmaceutical Group Co Ltd', u'Janssen Pharmaceutica NV', u'Johns Hopkins University', u'Genset SA', u'Parke-Davis & Co', u'Recordati SpA', u'SK Biopharmaceuticals', u'H Lundbeck A/S', u'Galenea Corp', u'Saniona ApS', u'Otsuka Pharmaceutical Co Ltd', u'Transdermal Research Pharm Laboratories LLC', u'Intra-Cellular Therapies Inc', u'Ore Pharmaceuticals Inc', u'American Biogenetic Sciences Inc', u'University of California San Diego', u'Allergan plc', u'Alexza Pharmaceuticals Inc', u'Mediti Pharma Inc', u'KYOWA Pharmaceutical Industry Co Ltd', u'Sumitomo Dainippon Pharma Co Ltd', u'Merck & Co Inc', u'Perlegen Sciences Inc', u'Lundbeck Canada Inc', u'RIMSA Laboratorios', u'Sanofi', u'Eli Lilly & Co', u'Bayer AG', u'Handa Pharmaceuticals', u'Adamed Group', u'Eurand America Inc', u'AstraZeneca plc', u'Pfizer Inc', u'Neurocrine Biosciences Inc', u'The Stanley Medical Research Institute', u'Yale University', u'Hutchison Whampoa Sinopharm Pharmaceuticals Ltd', u'Ferrer Internacional SA', u'Desitin Arzneimittel GmbH', u'Dermatrends Inc', u'Milken Institute', u'Zysis Ltd', u'Shanghai Medicilon Inc', u'Cracow University of Technology', u'Targacept Inc', u'Takeda Pharmaceutical Co Ltd', u'Tikvah Therapeutics Inc', u'National Institutes of Health', u'Bristol-Myers Squibb Co', u'Laxdale Ltd', u'Aequus Pharmaceuticals Inc', u'Bukwang Pharmaceutical Co Ltd', u'Janssen Pharmaceutica BV', u'Tecnifar-Ind\\xfastria T\\xe9cnica Farmac\\xeautica Sa', u'Astellas Pharma Inc', u'NuPathe Inc', u'Scotia Holdings plc', u'Noven Pharmaceuticals Inc', u'Hebrew University of Jerusalem', u'Supernus Pharmaceuticals Inc', u'Novartis AG', u'Gedeon Richter Ltd', u'Sequana Therapeutics', u'University at Buffalo', u'Jagiellonian University']), u'Andrology': set([u'Double Bond Pharmaceutical AB', u'Research Institute of Physical and Chemical Problems']), u'MarginalzoneB-celllymphoma': set([u'University of Iowa', u'Coley Pharmaceutical Group Inc', u'Ludwig Institute for Cancer Research', u'Defense Advanced Research Projects Agency']), u'Klebsiellapneumoniaeinfection': set([u'Theravance Biopharma Inc', u'Wellcome Trust', u'Southern Methodist University', u'Shanghai Institute of Pharmaceutical Industry', u'University of Maryland Baltimore County', u'Takeda Pharmaceutical Co Ltd', u'Phico Therapeutics Ltd', u'National Natural Science Foundation of China', u'Defense Advanced Research Projects Agency', u'Sumitomo Dainippon Pharma Co Ltd', u'National Institute of Allergy and Infectious Diseases', u'US Department of Defense', u'European Eurostars Programme', u'Arsanis Biosciences GmbH', u'Texas A&M AgriLife Research', u'Spero Therapeutics LLC', u'University of Massachusetts Medical School', u'AbCellera Biologics Inc', u'Pro Bono Bio']), u'Acutecoronarysyndrome': set([u'Roche Holding AG', u'DalCor Pharmaceuticals Canada Inc', u\"Xi'an Jiaotong University\", u'Momenta Pharmaceuticals Inc', u'Molecular Targeting Technologies Inc', u'AOP Orphan Pharmaceuticals AG', u'Myriad RBM', u'Harvard Pilgrim Health Care', u'Daiichi Sankyo Co Ltd', u'Il Dong Pharmaceutical Co Ltd', u'Arena Pharmaceuticals Inc', u'Montreal Heart Institute', u'4P Therapeutics', u'Cardiome Pharma Corp', u'The TIMI Study Group', u'Singulex Inc', u'Medical College of Wisconsin', u'Global Atherothrombotic Investigative Network', u'Cerenis Therapeutics SA', u'The Medicines Company', u'Merck & Co Inc', u'MedImmune LLC', u'Sanofi', u'MGI Pharma Inc', u'USpharma Windlas LLC', u'bioCSL PTY Ltd', u'CSL Ltd', u'University of Manchester', u'Chiesi USA Inc', u'Granules India Ltd', u'Athera Biotechnologies AB', u'Sun Pharmaceutical Industries Ltd', u'Fonds de solidarit\\xe9 FTQ', u'Lonza Group AG', u\"St. George's University\", u'AstraZeneca plc', u'SciClone Pharmaceuticals Inc', u'AlphaCore Pharma LLC', u'National Heart Lung and Blood Institute', u'Shaanxi Maike Aote Technology Co Ltd', u'Shionogi & Co Ltd', u'Sandoz Inc', u'Medicure International Inc', u'Patheon Pharmaceuticals Inc']), u'Salmonellatyphimuriuminfection': set([u'Wellcome Trust', u'Emergent Europe Ltd', u'Zeneca Life Science Molecules']), u'Reperfusioninjury': set([u'Clinical Data Inc', u'LeukoSite Inc', u'Quest Diagnostics Inc', u'US Government', u'BioMarin Pharmaceutical Inc', u'Schwarz Pharma Ltd', u'IDM Pharma Inc', u'Bio-Discovery Ltd', u'Aeolus Pharmaceuticals Inc', u'Savient Pharmaceuticals Inc', u'Zhejiang Hisun Pharmaceutical Co Ltd', u'Trophos SA', u'Radikal Therapeutics Inc', u'Celldex Therapeutics Inc', u'Walter Reed Army Institute of Research', u'Sumitomo Pharmaceuticals Co Ltd', u'CarboMed Inc', u'Vasogen Inc', u'Medicure Inc', u'National Heart Lung and Blood Institute', u'Theralogics Inc', u'US Department of Defense', u'Duke Clinical Research Institute', u'Inflabloc Pharmaceuticals Inc', u'EndoProtech Inc', u'Fujifilm Diosynth Biotechnologies', u'Israeli Government', u'Nventa Biopharmaceuticals Corp', u'SCYNEXIS Inc', u'UCB Pharma GmbH', u'Prothix Bv', u'The European Union', u'Bioceros BV', u'National Cancer Institute', u'ZymoGenetics Inc', u'Bolder BioTechnology Inc', u'University of Maryland', u'PresSura Neuro Ltd', u'Inflazyme Pharmaceuticals', u'JCR Pharmaceuticals Co Ltd', u'Pharmacopeia Inc', u'Roche Diagnostics', u'Tioma Therapeutics Inc', u'University of Colorado System', u'LG Chem Ltd', u'Encysive Pharmaceuticals Inc', u'Boston University', u'Fibrex Medical R&D GmbH', u'Oslo University Hospital', u'Compugen Ltd', u'F Hoffmann-La Roche AG', u'University of Bern', u'Molecules for Health Inc', u'APT Therapeutics Inc', u'Revotar Biopharmaceuticals AG', u'LifeArc', u'Seikagaku Corp', u'Undisclosed', u'Melacure Therapeutics AB', u'UBE Industries Ltd', u'Cleveland BioLabs Inc', u'University of Miami', u'Epimmune Inc', u'University of Virginia', u'RegeneRx Biopharmaceuticals Inc', u'Maroon Biotech Corp', u'Hannover Medical School', u'AstraZeneca plc', u'Columbia University', u'Mipharm SpA', u'National Institute of Allergy and Infectious Diseases', u'NeuroVive Pharmaceutical AB', u'Sihuan Pharmaceutical Holdings Group Ltd', u'National Institutes of Health', u'Bristol-Myers Squibb Co', u'IBEX Technologies Inc', u'KAI Pharmaceuticals Inc', u'Ikaria Inc', u'Thomas Jefferson University', u'MGI Pharma Inc', u'University of Chicago', u'Agence Nationale de Valorisation de la Recherche', u'Medical University of South Carolina', u'William Harvey Research Ltd', u'Metaphore Pharmaceuticals Inc', u'Weizmann Institute of Science', u'AcurePharma AB', u'Taligen Therapeutics Inc', u'TikoMed AB', u'Berlex Laboratories Inc', u'Defense Threat Reduction Agency']), u'Fattyliverdisease': set([u'Endra Inc', u'BioLineRx Ltd', u'National Institute of Diabetes, Digestive and Kidney Diseases', u'Weill Cornell Medical College, USA', u'Galmed Pharmaceuticals Ltd', u'Jenken Bioscience Inc', u'Soochow University', u'National Institutes of Health', u'Samil Pharmaceutical Co Ltd', u'Chinese Government', u'CohBar Inc', u'University of Southern California', u'Daewon Pharm Co Ltd', u'Galmed International Ltd', u'Metabolic Solutions Development Co', u'Yonsei University', u'Korean Ministry of Knowledge Economy', u'Hyundai Pharmaceutical', u'GE Healthcare', u'Washington University in St Louis', u'Daegu Hanny University', u'Sveikatal Inc', u'North Carolina Biotechnology Center']), u'Non-Hodgkinlymphoma': set([u'Daiichi Seiyaku Co Ltd', u'Biovest International Inc', u'Vitruvian Networks Inc', u'MENTRIK Biotech LLC', u'Astellas Pharma GmbH', u'The Leukemia & Lymphoma Society', u'Transcept Pharmaceuticals Inc', u'Dynavax Technologies Corp', u'Koken Co Ltd', u'Allos Therapeutics Inc', u'IDEC Pharmaceuticals Corp', u'Hercules Capital Inc', u'Symphony Capital LLC', u'Biogen Inc', u'US Health and Human Services Department', u'Pharmacyclics Inc', u'Yakult Honsha Co Ltd', u'GlaxoSmithKline plc', u'NantKwest Inc', u'BTG plc', u'Quintiles Transnational Corp', u'Bayer Schering Pharma AG', u'Australian Nuclear Science & Technology Organization', u'Chiron Corp', u'Duke University Medical Center', u'Cascadian Therapeutics Inc', u'VGX Pharmaceuticals LLC', u'Seattle Genetics Inc', u'Ionis Pharmaceuticals Inc', u'The Dow Chemical Co', u'Immunex Corp', u'Choice Pharmaceuticals', u'Ortho Biotech Products LP', u'MedImmune LLC', u'Xynomic Pharmaceuticals', u'OSI Pharmaceuticals Inc', u'Fred Hutchinson Cancer Research Center', u'City of Hope', u'Praecis Pharmaceuticals Inc', u'Takeda Oncology', u'Roche Holding AG', u'Halozyme Therapeutics Inc', u'University of British Columbia', u'Neon Therapeutics', u'Biovector Therapeutics SA', u'Stellar Biotechnologies Inc', u'Kite Pharma Inc', u'Ludwig Institute for Cancer Research', u'KuDOS Pharmaceuticals Ltd', u'Spectrum Pharmaceuticals Inc', u'Netherlands Cancer Institute', u'Massachusetts General Hospital', u'Nordic Nanovector ASA', u'Defense Advanced Research Projects Agency', u'Theralogics Inc', u'NantCell Inc', u'Oxis Biotech Inc', u'Scripps Research Institute', u'Tamir Biotechnology Inc', u'University of Nebraska Medical Center', u'Parilis Biopharmaceuticals', u'International Biotechnology Center Generium LLC', u'West German Cancer Center', u'Apexigen Inc', u'Fujifilm Diosynth Biotechnologies', u'Pharsight Corp', u'Wyeth Research', u'Amgen Inc', u'Medarex Inc', u'Cambridge Antibody Technology Group plc', u'Daiichi Sankyo Co Ltd', u'Nippon Kayaku Co Ltd', u'Eisai Co Ltd', u'Boehringer Mannheim GmbH', u'Immune Design Corp', u'Teva Pharmaceutical Industries Ltd', u'National Cancer Institute', u'Novartis AG', u'Sirna Therapeutics Inc', u'ZIOPHARM Oncology Inc', u'Carigent Therapeutics Inc', u'Korea Research Institute of Bioscience and Biotechnology', u'SRI International', u'Fujisawa Pharmaceutical Co Ltd', u'HUYA Bioscience International LLC', u'Dutch Cancer Society', u'Medac GmbH', u'Christie Hospital NHS Foundation Trust', u'Bigmar Inc', u'Medical Research Council', u'Affimed NV', u'Eagle Pharmaceuticals Inc', u'University of Minnesota', u'CryoPort Inc', u'Xeme Biopharma Inc', u'Enzon Pharmaceuticals Inc', u'Oncoceutics Inc', u'Celltrion Inc', u'Goodwin Biotechnology Inc', u'University of Manchester', u'Immunomedics Inc', u'Janssen Pharmaceutical KK', u'SymBio Pharmaceuticals Ltd', u'Sutro Biopharma Inc', u'ImmunoGen Inc', u'Forskningsstiftelsen Norske Radium-Hospital', u'Verenium Corp', u'Kosan Biosciences Inc', u'Millennium Pharmaceuticals Ltd', u'Midatech Pharma US Inc', u'Altor BioScience Corp', u'Micromet Inc', u'Leidos Biomedical Research Inc', u'SHAL Technologies Inc', u'University of California San Diego', u'Infinity Pharmaceuticals Inc', u'Juno Therapeutics Inc', u'BioInvent International AB', u'Oncobiologics Inc', u'Innovent Biologics Inc', u'Royalty Pharma', u'Debiopharm SA', u'Rosetta Genomics Ltd', u'Talon Therapeutics Inc', u'Dovetail Technologies Inc', u'Chugai Pharmaceutical Co Ltd', u'Cancer Research UK', u'MethylGene Inc', u'Genentech Inc', u'AERES Biomedical Ltd', u'PJSC Pharmsynthez', u'IDIS Ltd', u'Strata Oncology', u'Southern Research Institute', u'Inex Pharmaceuticals Corp', u'Oxford BioMedica plc', u'Sumitomo Dainippon Pharma Co Ltd', u'Epizyme Inc', u'ViaCell Inc', u'CMC Biologics Inc', u'Xenetic Biosciences Inc', u'Verastem Inc', u'Tufts University School of Medicine', u'US Government', u'Novuspharma SpA', u'Emergent BioSolutions Inc', u'Sierra Oncology Inc', u'Diosynth Biotechnology', u'Merck & Co Inc', u'Ascentage Pharma Group Corporation Ltd', u'Sanofi', u'University College London', u'CTI BioPharma Corp', u'Eli Lilly & Co', u'Supratek Pharma Inc', u'Bayer AG', u'University of California Davis', u'ScinoPharm Taiwan Ltd', u'Pharmacia Corp', u'Immune Therapeutics Inc', u'Biotec Pharmacon ASA', u'InNexus Biotechnology Inc', u'Torii Pharmaceutical Co Ltd', u'UCSF Helen Diller Family Comprehensive Cancer Center', u'University of Iowa', u'Janssen Biotech Inc', u'rEVO Biologics Inc', u'Leukaemia and Lymphoma Research', u'Almirall Prodesfarma SA', u'AstraZeneca plc', u'Pfizer Inc', u'The Research Council of Norway', u'Human Genome Sciences Inc', u'Corixa Corp', u'Cancer Research Technology Ltd', u'Undisclosed', u'Wyeth', u'University of Maryland', u'Genta Inc', u'Columbia University', u'Memorial Sloan-Kettering Cancer Center', u'Syncor International Corp', u'Celltrion Healthcare Co Ltd', u'Coley Pharmaceutical Group Inc', u'Valor Biotherapeutics LLC', u'AbbVie Inc', u'Apogenix GmbH', u'Genmab A/S', u'Japanese National Cancer Center', u'ASTA Medica AG', u\"St Bartholomew's Hospital\", u'National Institute of Allergy and Infectious Diseases', u'myTomorrows', u'Biolex Therapeutics Inc', u'Pfanstiehl Laboratories Inc', u'National Comprehensive Cancer Network', u'Mundipharma International Corp Ltd', u'UCB Celltech', u'LifeTime Pharmaceuticals Inc', u'Lonza Group AG', u'Viventia Bio Inc', u'Takeda Pharmaceutical Co Ltd', u'Cancer Prevention and Research Institute of Texas', u'SmithKline Beecham plc', u'Servier', u'National Institutes of Health', u'Salmedix Inc', u'University of Tokyo', u'MMRGlobal', u'Bristol-Myers Squibb Co', u'Elan Corp plc', u'Nerviano Medical Sciences Srl', u'Aventis SA', u'Opus Bio Inc', u'Sanofi Genzyme', u'US Oncology Inc', u'Foundation Medicine Inc', u'Aronex Pharmaceuticals Inc', u'University Of Southampton', u'Cephalon Inc', u'Celgene Corp', u'Cornell University', u'Adria Laboratories Inc', u'Educational and Scientific LLC', u'Ascenta Therapeutics Inc', u'Lawrence Livermore National Laboratory', u'Yale University', u'Antisoma plc', u'Relgen LLC', u'Coulter Pharmaceutical Inc', u'Merck Serono SA', u'Meda AB', u'GE Healthcare', u'Takara Bio Inc', u'Tragen Pharmaceuticals', u'ProBioGen AG', u'Hayashibara Co Ltd', u'Repligen Corp', u'BioCryst Pharmaceuticals Inc', u'Serono Inc', u'Bioenvision Inc', u'Rhone-Poulenc Rorer Inc', u'Molecular Templates Inc', u'ILEX Oncology Inc', u'Biomira USA Inc', u'University of Cambridge', u'Jichi Medical University, Japan']), u'Fibroepithelialneoplasm': set([u'Arisaph Pharmaceuticals Inc', u'National Cancer Institute']), u'StevensJohnsonsyndrome': set([u'Foundation for Biomedical Research and Innovation', u'Allergan Inc', u'Regience KK', u'University of North Carolina', u'Inspire Pharmaceuticals Inc']), u'Nethertonsyndrome': set([u'Panorama Research Inc', u'National Institute of Arthritis and Musculoskeletal and Skin Diseases']), u'Chronicleukemia': set([u'ElsaLys Biotech', u'Deutsches Krebsforschungszentrum', u'European Eurostars Programme']), u'Dyspepsia': set([u'Nippon Shinyaku Co Ltd', u'Daejeon University', u'Abbott Laboratories', u'Zeria Pharmaceutical Co Ltd', u'Eisai Co Ltd', u'Astra AB', u'Forest Laboratories Inc', u'Dainippon Pharmaceutical Co Ltd', u'Hokuriku Seiyaku KK', u'Novartis AG', u'Sumitomo Dainippon Pharma Co Ltd', u'Daewoong Pharmaceutical Co Ltd', u'PsiOxus Therapeutics Ltd', u'AGI Therapeutics plc', u'Sanofi', u'Rottapharm Madaus', u'Eli Lilly & Co', u'CJ Corp', u'The Procter & Gamble Co', u'Mitsubishi-Tokyo Pharmaceuticals Inc', u'Rose Pharma A/S', u'Astellas Pharma Inc', u'RaQualia Pharma Inc', u'Bristol-Myers Squibb Co', u'Dynogen Pharmaceuticals Inc', u'Dong-A ST Co Ltd', u'Fujisawa Synthelabo Co Ltd', u'Glaxo Group Ltd', u'Janssen Pharmaceutica NV', u'Aptalis Pharma Inc', u'Pfizer Inc', u'Boehringer Ingelheim Corp', u'Lupin Ltd', u'Takeda Pharmaceutical Co Ltd', u'Sungkyunkwan University', u'Edusa Pharmaceuticals Inc', u'Sigma-Tau Ind Farm Riunite SpA']), u'Hemophilia': set([u'AgResearch Ltd', u'US Government', u'Novo Nordisk A/S', u'Asahi Kasei Corp', u'University of Florida', u'Baxter International Inc', u'Intronn Inc', u'Aevi Genomic Medicine Inc', u'Archemix Corp', u'Biogen Inc', u'Biotest AG', u'Chimera BioTechnology Inc', u'BTG plc', u'Vical Inc', u'MultiCell Technologies Inc', u'Neose Technologies Inc', u'EpiVax Inc', u'Ionis Pharmaceuticals Inc', u'Ipsen', u'Wyeth Pharmaceuticals', u'Sangamo Therapeutics Inc', u'University of Pennsylvania', u'Bioverativ Inc', u'Advanced BioScience Laboratories Inc', u'MorphoSys AG', u'Mitsubishi Tanabe Pharma Corp', u'Cellectis SA', u'ANI Pharmaceuticals Inc', u'VIB', u'Handok Inc', u'Shire Orphan Therapies GmbH', u'Emory University', u'National Heart Lung and Blood Institute', u'Alnylam Pharmaceuticals Inc', u'Poetic Genetics LLC', u'National Research Council of Canada', u'PTC Therapeutics Inc', u'Sanquin Blood Supply Foundation', u'Bayer Corp', u'Symbiosis Corp', u'Catalyst Biosciences Inc', u'Glycotope GmbH', u'ValiGen Inc', u'Somatix Therapy Corp', u'LFB SA', u'Maxygen Inc', u'REGiMMUNE Corp', u'University of Nebraska', u'PAION AG', u'Sernova Corp', u'Georgia Institute of Technology', u'University of Minnesota', u'Academisch Medisch Centrum, Meibergdreef', u'Washington University in St Louis', u'University of California San Diego', u'Swedish Orphan Biovitrum AB', u'Octapharma AG', u'AmpliPhi Biosciences Corp', u'PROLOR Biotech Inc', u'University of North Carolina', u'Genentech Inc', u'Kedrion Biopharma Inc', u'Benesis Corp', u'Flamel Technologies SA', u'Emergent BioSolutions Inc', u'Zilip-Pharma BV', u'CMC Biologics Inc', u'Republic of Korea Government', u'Baxter Healthcare Corp', u'Xenetic Biosciences Inc', u'Alteogen Inc', u'Selecta Biosciences Inc', u'Avid Bioservices', u'Chia Tai Tianqing Pharmaceutical Group Co Ltd', u'Henry M Jackson Foundation for the Advancement of Military Medicine', u'Scripps Research Institute', u'rEVO Biologics Inc', u'Bayer AG', u'InviCRO Llc', u'CSL Ltd', u'Camurus AB', u'Eagle Biologics Inc', u'Kyowa Hakko Kirin Co Ltd', u'Pain Therapeutics Inc', u'Avigen Inc', u'Pfizer Inc', u'Boston VA Research Institute, Inc.', u'Expression Therapeutics LLC', u'Living Cell Technologies Ltd', u'Spark Therapeutics LLC', u'Wyeth', u'Genexine Co Ltd', u'CSL Behring GmbH', u'University of Michigan', u'CSL Behring LLC', u'Genmab A/S', u'Uniformed Services University of the Health Sciences', u'Progenetics LLC', u'Suzhou Alphamab Co Ltd', u'MediVas LLC', u'Opus Bio Inc', u'INSERM', u'Sanofi Genzyme', u'Inspiration Biopharmaceuticals Inc', u'Thomas Jefferson University', u'Dr Rentschler Biotechnologie GmbH', u'Wistar Institute of Anatomy & Biology', u'NanoCarrier Co Ltd', u'Shire plc', u'The Green Cross Corp', u'C2X Pharma', u'GE Healthcare', u'CEVEC Pharmaceuticals GmbH', u'Crucell NV', u'BAC BV', u'Octagen Corp', u'Novozymes A/S', u'German Federal Ministry of Education and Research']), u'Boneinjury': set([u'SMC Biotechnology Inc', u'Luitpold Pharmaceuticals Inc', u'US Government', u'Scil Technology GmbH', u'Baxter International Inc', u'Kalytera Therapeutics Inc', u'Netherlands Government', u'Institute of Pharmacology and Toxicology Academy of Military Medical Sciences PLA', u'BioMimetic Therapeutics Inc', u'California Institute of Regenerative Medicine', u'Unigene Laboratories Inc', u'Locate Therapeutics Ltd', u'University of North Carolina', u'Quintiles Transnational Corp', u'Stryker Spine', u'Premier Inc', u'Aventis Pharma AG', u'TissueGene Inc', u'ZymoGenetics Inc', u'Apotex Inc', u'Eos Imaging', u'Shandong Weigao Group Medical Polymer Co Ltd', u'Kolon Life Science Inc', u'CelgenTek Innovations', u'Agency For Science Technology & Research', u'Accelalox Inc', u'Orthocell Pty Ltd', u'Innovata plc', u\"Boston Children's Hospital\", u'UCB SA', u'Charite Universitaetsmedizin Berlin', u'National Institute of General Medical Sciences', u'Osteogenix', u'National Institute of Arthritis and Musculoskeletal and Skin Diseases', u'Pioneer Surgical Orthobiologics', u'Amgen Inc', u'The European Union', u'Compass Biomedical', u'Innovative Cellular Therapeutics Co Ltd', u'Ohio Development Services Agency', u'Orquest Inc', u'Orthovita Inc', u'Vanderbilt University', u'Haitai Medicine Co Ltd', u'Bone Therapeutics SA', u'Bone Support AB', u'United States Army Institute of Surgical Research', u'National Aeronautics & Space Administration', u'Biopharm GmbH', u'Agenta Biotechnologies Inc', u'Vericel Corp', u'Boehringer Ingelheim Corp', u'Chrysalis BioTechnology Inc', u'Radius Health Inc', u'Juventas Therapeutics Inc', u'Medtronic Inc', u'GliaMed Inc', u'RheoGene Inc', u'Angioblast Systems Inc', u'Mesoblast Ltd', u'National Institute of Diabetes, Digestive and Kidney Diseases', u'Cangene Corp', u'Centerpulse', u'Synedgen Inc', u'Capstone Therapeutics Corp', u'Sakai Chemical Industry Co Ltd', u'Merck & Co Inc', u'Australian Research Council', u'Affinergy Inc', u'University of Southern California', u'Eli Lilly & Co', u'La Jolla Pharmaceutical Co', u'University of California Davis', u'Vetter Pharma International', u'SironRX Therapeutics Inc', u'Kuros Biosurgery AG', u'Theratechnologies Inc', u'Case Western Reserve University', u'Biomet Orthopedics, LLC', u'Medvet Science Pty Ltd', u'Teijin Ltd', u'Synthes (USA)', u'BioGeneriX AG', u'Elk OrthoBiologics Ltd', u'Yale University', u'Novartis Vaccines & Diagnostics', u'Yissum Research Development Co', u'Ferrer Internacional SA', u'Wyeth BioPharma', u'Wyss Institute for Biologically Inspired Engineering', u'UK Government', u'OrgaNext Research BV', u'Solgene Therapeutics LLC', u'Rivanna Medical Llc', u'Northeast Ohio Medical University', u'Lonza Group AG', u'Ramot at Tel Aviv University Ltd', u'National Institutes of Health', u'Curis Inc', u'aap Implantate AG', u'Rush University Medical Center', u'Cedars-Sinai Medical Center', u'MGI Pharma Inc', u'Unilife', u'Integra LifeSciences Holdings Corp', u'Henkel KGaA', u'National Institute of Biomedical Imaging and Bioengineering', u'University of New South Wales', u'Zimmer Biomet Holdings Inc', u'Orthopediatrics Corp', u'Lotus Tissue Repair Inc', u'Walloon Region of Belgium Government', u'National Institute of Dental and Craniofacial Research', u'Novartis AG', u'CuraGen Corp']), u'Granulomatosis': set([u'Nordic Group', u'Boehringer Ingelheim Austria GmbH', u'Maxygen Holdings Ltd', u'Boehringer Ingelheim Corp', u'Genentech Inc', u'Connetics Corp', u'InterMune Inc', u'Nippon Kayaku Co Ltd', u'Horizon Pharma plc', u'Boehringer Ingelheim International GmbH']), u'Complicatedskinandskinstructureinfection': set([u'Atox Bio Inc', u'Theravance Biopharma Inc', u'US Health and Human Services Department', u'SciClone Pharmaceuticals Inc', u'Melinta Therapeutics Inc', u'Ligand Pharmaceuticals Inc']), u'VonWillebrandsdisease': set([u'LFB SA', u'Erasmus University Medical Center Rotterdam', u'Grifols SA', u'CSL Ltd', u'University of Colorado at Denver and Health Sciences Center', u'Jiangxi Boya Bio-pharmaceutical Co Ltd', u'Cardinal Health Inc', u'Ferring Pharmaceuticals SA', u'Kyowa Hakko Kirin Co Ltd', u'Swedish Orphan Biovitrum AB', u'Octapharma AG', u'Alpha Therapeutic Corp']), u'Duodenalulcer': set([u'Takeda GmbH', u'Mitsubishi Pharma Corp', u'Aptalis Pharma Inc', u'Daiichi Sankyo Co Ltd', u'Abbott Laboratories', u'GlaxoSmithKline plc', u'Salix Pharmaceuticals Inc', u'Santarus Inc', u'Astra Merck Inc', u'Yuhan Corp', u'Laboratorios Andromaco SA (Chile)', u'Daewoong Pharmaceutical Co Ltd', u'Merck & Co Inc', u'Otsuka America Pharmaceutical Inc', u'Sanofi', u'Zydus-Cadila Group', u'The Procter & Gamble Co', u'Shenzhen Zhijun Pharmaceutical Co Ltd', u'PLIVA dd', u'Taiho Pharmaceutical Co Ltd', u'Fujirebio KK', u'University of Zagreb', u'GE Healthcare', u'AstraZeneca plc', u'Pfizer Inc', u'Boehringer Ingelheim Corp', u'Exomed Australia Pty Ltd', u'Takeda Pharmaceutical Co Ltd', u'Norgine BV', u'Sigma-Tau Ind Farm Riunite SpA']), u'Fistula': set([u'TiGenix NV', u'Symic Biomedical Inc', u'National Institute of Diabetes, Digestive and Kidney Diseases', u'Takeda Pharmaceutical Co Ltd']), u'Vertebralfracture': set([u'BD Technologies', u'Stryker Corp']), u'Infantcolic': set([u'Noventure', u'Pierre Fabre Pharma GmbHWebsiteDirections']), u'Renalcellcarcinoma': set([u'Immunicum AB', u'Pro Concepta Zug Ag', u'US Government', u'Acceleron Pharma Inc', u'Regeneron Pharmaceuticals Inc', u'SillaJen Inc', u'Ion Beam Applications SA', u'Archemix Corp', u'Netherlands Government', u'Incyte Corp', u'OncoMax LLC', u'Biogen Inc', u'GlaxoSmithKline plc', u'Cell Genesys Inc', u'Biotecnol SA', u'Bayer Schering Pharma AG', u'Chiron Corp', u'NeoTX Therapeutics Ltd', u'MethylGene Inc', u'Cytheris SA', u'Ipsen', u'Immunex Corp', u'Cleveland BioLabs Inc', u'University of Florida', u'MedImmune LLC', u'Xynomic Pharmaceuticals', u'Intracel Corp', u'University of Pittsburgh', u'OSI Pharmaceuticals Inc', u'Roche Holding AG', u'Biocompatibles International plc', u'Kite Pharma Inc', u'Ludwig Institute for Cancer Research', u'Sanofi Genzyme', u'Fox Chase Cancer Center', u'Gloucester Pharmaceuticals Inc', u'Personalis Inc', u'BioSignal Inc', u'Incuron LLC', u'Atreca Inc', u'LipoNova AG', u'Mayo Clinic Foundation', u'Dana-Farber Cancer Institute Inc', u'Rexgene Biotech Co Ltd', u'Philogen SpA', u'Pharminox Ltd', u'Cell Pathways Inc', u'Exelixis Inc', u'Active Biotech AB', u'Adaptive Biotechnologies Corp', u'Medarex Inc', u'University of California San Francisco', u'Cancer Genetics Inc', u'EUSA Pharma USA', u'Lynx Therapeutics GmbH', u'Accelovance Inc', u'National Cancer Institute', u'Novartis AG', u'Ministry of Health & Welfare, Korea', u'German Consortium for Translational Cancer Research', u'Wilex AG', u'NeoPharm Inc', u'Fujisawa Pharmaceutical Co Ltd', u'InteRNA Technologies BV', u'Agennix AG', u'Hopitaux Universitaires de Strasbourg', u'National Comprehensive Cancer Network', u'Abgenix Inc', u'Transgene SA', u'TenX Biopharma Inc', u'Goodwin Biotechnology Inc', u'Protein Sciences Corp', u'Aptose Biosciences Inc', u'Cleveland Clinic Foundation', u'EpiCept Corp', u'Carrus Capital Corp', u'ImmunoGen Inc', u'MegaPharm Ltd', u'Genomic Health Inc', u'Altor BioScience Corp', u'Hoffmann-La Roche Inc', u'Asan Medical Center', u'Curacel International Pty Ltd', u'Biostatin Gyogyszerkutato-Fejleszto Kft', u'Objectif Recherche VACcin Sida', u'F H Faulding & Co Ltd', u'Oncorena AB', u'Prometheus Laboratories Inc', u'University of North Carolina', u'Freedom Eye Ltd', u'Green Cross Corp', u'Genentech Inc', u'DCPrime BV', u'IDIS Ltd', u'Symphony Evolution Inc', u'Stada Arzneimittel AG', u'Schering-Plough Corp', u'Oxford BioMedica plc', u'Somantix BV', u'Undisclosed', u'JW CreaGene Inc', u'Argos Therapeutics Inc', u'Emergent BioSolutions Inc', u'PDL BioPharma Inc', u'Diosynth Biotechnology', u'Merck & Co Inc', u'GenKyoTex SA', u'Wyeth-Ayerst Pharmaceuticals Inc', u'Japan Tobacco Inc', u'Eisai Inc', u'Bayer AG', u'HyupiJin Corporation', u'Calithera Biosciences', u'SIRO ClinPharm USA LLC', u'Rexahn Pharmaceuticals Inc', u'University of Iowa', u'Janssen Biotech Inc', u'University of California Los Angeles', u'BioInvent International AB', u'Pfizer Inc', u'Sanofi', u'Universit\\xe9 De Strasbourg', u'Northwest Biotherapeutics Inc', u'Advanced Cancer Therapeutics', u'Cancer Research Technology Ltd', u'FCB-Pharmicell Co Ltd', u'Vernalis plc', u'Horizon Pharma plc', u'Wyeth BioPharma', u'Immatics Biotechnologies GmbH', u'Maxim Pharmaceuticals Inc', u'Coley Pharmaceutical Group Inc', u'Australian Government', u'Hoffmann-La Roche AG', u'Innovation Pharmaceuticals Inc', u'IDT Australia Ltd', u'Aptamera Inc', u'Yamanouchi Pharmaceutical Co Ltd', u'National Institutes of Health', u'AVEO Oncology', u'Bristol-Myers Squibb Co', u'Medinet Co Ltd', u'Vaccinogen Inc', u'INSERM', u'Kirin Pharma Co Ltd', u'ICOS Corp', u'Aronex Pharmaceuticals Inc', u'Telix Pharmaceuticals Ltd', u'VINNOVA', u'Duke University', u'Antisoma plc', u'Rijksuniversiteit te Leiden', u'BruCells', u'Eberhard-Karls-Universitaet Tuebingen', u'Biologics Inc', u'Dyax Corp', u'Bayer HealthCare Pharmaceuticals Inc', u'Takeda Pharmaceutical Co Ltd', u'University of Gothenburg', u'Beth Israel Deaconess Medical Center', u'SFJ Pharma Ltd']), u'Non-insulindependentdiabetes': set([u'Solvay SA', u'Soci\\xe9t\\xe9 Delpharm SAS', u'InhibeX LLC', u'Nutrition 21 Inc', u'InteKrin Therapeutics Inc', u'Koebenhavns Universitet', u'University of Lille', u'DayTwo Ltd', u'Novartis Institutes for BioMedical Research Inc', u'Shenzhen Chipscreen Biosciences Ltd', u'Technical University of Munich', u'Il Dong Pharmaceutical Co Ltd', u'Verily Life Sciences LLC', u'International Diabetes Institute', u'Ionis Pharmaceuticals Inc', u'Novartis Pharma AG', u'Versartis Inc', u'Intercept Pharmaceuticals Inc', u'Spherix Inc', u'Bridge BioResearch International Ltd', u'Chongqing Fochon Pharmaceutical Co Ltd', u'Northwest Neurologic Inc', u'CohBar Inc', u'University of California Los Angeles', u'CymaBay Therapeutics Inc', u'Ambrx Inc', u'Merck Sharp & Dohme Corp', u'Shanghai Fosun Pharmaceutical (Group) Co Ltd', u'Polyphor Ltd', u'Handok Inc', u'Zhejiang University', u'Cleobrothers & Co Inc', u'Cengent Therapeutics Inc', u'Baker IDI Heart & Diabetes Institute Holdings Ltd', u'Perrigo Co plc', u'Casper Pharma LLC', u'National Research Council of Canada', u'Medical University of Vienna', u'Centre International de Developpement Pharmaceutique Pte. Ltd', u'Redoxis AB', u'National Health and Medical Research Council', u'Entelos Inc', u'PDL BioPharma Inc', u'Centre National de la Recherche Scientifique (CNRS)', u'Acino Holding AG', u'Ergo Science Corp', u'Jiangsu Union Biopharm Co Ltd', u'Melior Pharmaceuticals Inc', u'CASiGEN Pharma Ltd', u'Glenmark Pharmaceuticals Ltd', u'Amarna Therapeutics BV', u'Aarhus University Hospital', u'Weill Cornell Medical College, USA', u'OOO Geropharm', u'Jiangsu Hansoh Pharmaceutical Group Co Ltd', u'Janssen Human Microbiome Institute', u'University of Nebraska', u'Cerep SA', u'Vanderbilt University', u'Tonghua Dongbao Pharmaceutical Co Ltd', u'iNovacia AB', u'Hanmi Pharmaceutical Co Ltd', u'Asembia', u'Metafold Therapeutics Inc', u'Boston Therapeutics Inc', u'Ogeda SA', u'Thermo Fisher Scientific Inc', u'TFChem SAS', u'VeroScience LLC', u'Pharmacopeia Inc', u'Les Laboratoires Servier', u'Wellcome Trust', u'Kyorin Pharmaceutical Co Ltd', u'Cilag AG', u'Starpharma Holdings Ltd', u'Celera Group', u'Probiodrug AG', u'ViaCyte Inc', u'Dance Biopharm Inc', u'Janssen Pharmaceutica NV', u'Proven Process Medical Devices Inc', u'Strathclyde Institute for Drug Research', u'Insight Diagnostics Inc', u'University of Toledo', u'Generex Biotechnology Corp', u'Diamyd Medical AB', u'Genfit SA', u'Swedish Orphan Biovitrum AB', u'Medtronic Inc', u'Patheon Pharmaceuticals Inc', u'University of Queensland', u'Tianjin University of Science and Technology', u'Institut de Recherches Cliniques de Montreal', u'Ajinomoto Co Inc', u'Zen-Bio Inc', u'Sygnature Discovery Ltd', u'Flamel Technologies SA', u'Argonne National Laboratory', u'MaRS Innovation', u'Beijing Sun Novo Pharmaceutical Research Co Ltd', u'Undisclosed', u'Uppsala University', u'JW CreaGene Inc', u'Google Inc', u'Chia Tai Tianqing Pharmaceutical Group Co Ltd', u'Daewoong Pharmaceutical Co Ltd', u'AmorChem LP', u'Cisen Pharmaceutical Co Ltd', u'Sprint Bioscience', u'CTI BioPharma Corp', u'Bilim Pharmaceuticals', u'NOBEL ILAC Sanayii ve Ticaret AS', u'DiAthegen LLC', u'ProMining Therapeutics Ltd', u'Phyton Biotech Inc', u'CSL Ltd', u'reMYND NV', u'Qualcomm Inc', u'Gubra Aps', u'Weizmann Institute of Science', u'Canadian Diabetes Association', u'Metabasis Therapeutics Inc', u'FDS Pharma', u'Erasmus University Medical Center Rotterdam', u'Fournier Pharma', u'State University of New York', u'Exelgen Ltd', u'Genomics Collaborative Inc', u'Sungkyunkwan University', u'Abide Therapeutics Inc', u'Sanwa Kagaku Kenkyusho Co Ltd', u'Johnson & Johnson', u'Merrion Pharmaceuticals Inc', u'Merck SA', u'BELLUS Health Inc', u'Nordic Bioscience A/S', u'SmithKline Beecham plc', u'Samsung Bioepis', u'Servier', u'East China University of Science & Technology', u'Taisho Pharmaceutical Co Ltd', u'Sumitomo Pharmaceuticals Co Ltd', u'Bristol-Myers Squibb Co', u'Myungin Pharm Co Ltd', u'OSEO', u'Bayer Pharmaceuticals Corp', u'University of Gothenburg', u'Seoul National University', u'VINNOVA', u'Astellas Pharma Inc', u'PhaseBio Pharmaceuticals Inc', u'Ortho-McNeil Inc', u'Insmed Inc', u'F Hoffmann-La Roche AG', u'Agouron Pharmaceuticals Inc', u'Universite Denis Diderot', u'Depomed Inc', u'Thermalin Diabetes LLC', u'GI Dynamics Inc', u'One Drop US', u'Astellas Pharma Korea, Inc', u'Uni-Bio Science Group Ltd', u'Karolinska Institutet', u'Yamanouchi Pharmaceutical Co Ltd', u'Ipsen Biopharmaceuticals Inc', u'Southeast TechInventures Inc', u'Phenomix Corp', u'Eli Lilly & Co', u'Anaclim LLC', u'Incyte Corp', u'AdipoGenix Inc', u'iPierian Inc', u'University of North Carolina', u'KineMed Inc', u'Celladon Corp', u'University of Turin', u'Chiesi Farmaceutici SpA', u'Sirona Biochem Corp', u'Dharmacon Inc', u'DiaMedica Inc', u'Chinese Government', u'Astex Pharmaceuticals Inc', u'Angioblast Systems Inc', u'SatRx Llc', u'Enteris BioPharma Inc', u'Mitsubishi-Tokyo Pharmaceuticals Inc', u'Universita Degli Studi Di Perugia', u'Ono Pharmaceutical Co Ltd', u'Garvan Institute of Medical Research', u'Roche Holding AG', u'Merck Sante SA', u'Genzyme Molecular Oncology', u'University of British Columbia', u'Mitsubishi Tanabe Pharma Corp', u'MiNA Therapeutics Ltd', u'Wenzhou Medical College', u'Nodthera Ltd', u'Sanofi Genzyme', u'Selvita SA', u'Tenax Therapeutics Inc', u'Biocon Ltd', u'MSD Japan', u'Duke Clinical Research Institute', u'Korea Drug Development Fund', u'Dana-Farber Cancer Institute Inc', u'Orient Europharma', u'Rinat-Pfizer Inc', u'University of Massachusetts Medical School', u'Charles River Laboratories International Inc', u'Amarantus BioScience Holdings Inc', u'Amgen Inc', u'Karo Pharma AB', u\"Dr Reddy's Research Foundation\", u'Harvard Pilgrim Health Care', u'Hospital Clinicas de Caracas', u'Galena Biopharma Inc', u'REMD Biotherapeutics Inc', u'Hexagen plc', u\"Chongqing Chen'an Biopharmaceutical Co Ltd\", u'Consejo Superior De Investigaciones Cientificas', u'Inflazome Ltd', u'Kotobuki Pharmaceutical Co Ltd', u'Johns Hopkins University School of Medicine', u'Eunice Kennedy Shriver National Institute of Child Health & Human Development', u'Cropsolution Inc', u'Haitai Medicine Co Ltd', u'Massachusetts General Hospital', u'Tanabe Seiyaku Co Ltd', u'Guangdong Zhongsheng Pharmaceutical Co Ltd', u'Plexxikon Inc', u'Mercury Therapeutics Inc', u'Novapeutics LLc', u'OptiKira', u'Dong-A ST Co Ltd', u'Hikma Pharmaceuticals plc', u'Synterys Inc', u'National Human Genome Research Institute', u'Yuhan Corp', u'PegBio Co Ltd', u'University of California San Diego', u'Mellitus SL', u'Sanford Health', u'Joslin Diabetes Center Inc', u'Prosidion Ltd', u'Medivir AB', u'Ranbaxy Laboratories Ltd', u'Glucox Biotech AB', u'University of Oxford', u'Bar-Ilan Research & Development Co Ltd', u'Rockefeller University', u'SICOR Inc', u'Genentech Inc', u'Saniona ApS', u'Mitsubishi Pharma Corp', u'Andrx Corp', u'Mayo Clinic Foundation', u'Alizyme Therapeutics Ltd', u'Harbin Gloria Pharmaceuticals Co Ltd', u'Shionogi USA Inc', u'Xenetic Biosciences Inc', u'Polychip Pharmaceuticals Pty Ltd', u'Amphastar Pharmaceuticals Inc', u'Sumitomo Dainippon Pharma Co Ltd', u'Aerogen Inc', u'Scripps Research Institute', u'Ahn-Gook Pharmaceuticals Co Ltd', u'University of Southern California', u'Giddi Pharma Co Ltd', u'Yabao Pharmaceutical Group Co Ltd', u'Alkermes plc', u'Dartmouth-Hitchcock Medical Center', u'Provalis plc', u'Japan Tobacco Inc', u'Nisshin Flour Milling Co Ltd', u'LION bioscience Inc', u'CEPTYR Inc', u'Diapin Therapeutics LLC', u'Theratechnologies Inc', u'Kadmon Pharmaceuticals LLC', u'R-Pharm', u'Hyundai Pharmaceutical', u'Minster Pharmaceuticals plc', u'Cambrex Karlskoga AB', u'AstraZeneca plc', u'South-Central University For Nationalities', u'Eli Lilly Japan KK', u'SUGEN Inc', u'University of Utah', u'Adenosine Therapeutics LLC', u'Micrometrix SA de CV', u'Array BioPharma Inc', u'Sirtris Pharmaceuticals Inc', u'Australian Government', u'Santhera Pharmaceuticals AG', u'KeyBioScience AG', u'Gilead Palo Alto Inc', u'Zosano Pharma Corp', u'Phylogica Ltd', u'Amylin Pharmaceuticals Inc', u'Mochida Pharmaceutical Co Ltd', u'King Pharmaceuticals Inc', u'Altea Therapeutics', u'Sanofi KK', u'CSIR (South Africa)', u'Peptron Co Ltd', u'University of Alberta', u'Discovery BioMed Inc', u'Theracos Inc', u'Ario Pharma Ltd', u'Zealand Pharma A/S', u'Universidad Aut\\xf3noma del Estado de Morelos', u'Kyoto University', u'Cedars-Sinai Medical Center', u'Polyvalor LP', u'Fujifilm Diosynth Biotechnologies', u'VG Life Sciences Inc', u'Aventis SA', u'Kobe University', u'Valeant Pharmaceuticals International Inc', u'IXICO Plc', u'South African San Council', u'Spencer Pharmaceutical Inc', u'Osteometer BioTech AS', u'NeoPharm Co Ltd', u'Indiana University', u'Pharmacia & Upjohn Ltd', u'Biologix FZ Co', u'PharmaRoth Labs Inc', u'CuraGen Corp', u'Biotech Holdings Ltd', u'Sanofi-Aventis US LLC', u'Elixir Pharmaceuticals Inc', u'Sellas Life Sciences Group', u'Forest Laboratories Inc', u'Korea Research Institute of Chemical Technology', u'Kowa Co Ltd', u'Quintiles Transnational Corp', u'Chongqing Peg-Bio BioTechnology Co Ltd', u'Premier Inc', u'Ureka Sarl', u'Kareus Therapeutics SA', u'NanoAxis', u'Progenra Inc', u'Egret Pharma (Shanghai) Ltd', u'Aventis Pharma AG', u'Accelrys Inc', u'Universite Pierre et Marie Curie', u'MedImmune LLC', u'OSI Pharmaceuticals Inc', u'Reset Therapeutics Inc', u'GW Pharmaceuticals plc', u'Welldoc Communications Inc', u'Hybrigenics SA', u'Scotia Pharmaceuticals', u'ARIAD Pharmaceuticals Inc', u'Biokier Inc', u'ARIUS Research Inc', u'Sun Pharmaceutical Industries Ltd', u'TissueInformatics', u'S2 Therapeutics', u'Harvard TH Chan School of Public Health', u'Helmholtz Zentrum M\\xfcnchen', u'National Center For Advancing Translational Sciences', u'VIVUS Inc', u'LAPID Pharmaceuticals Ltd', u'Ascendis Pharma A/S', u'Tufts University', u'Theraly Pharmaceuticals Inc', u'Japan Science and Technology Agency', u'Solexa Inc', u'Innovation and Technology Commission', u'Institute for the Promotion of Innovation by Science and Technology in Flanders', u'Santarus Inc', u'The European Union', u'Teva Pharmaceutical Industries Ltd', u'Hannam University', u'Purdue Pharma LP', u'University of California San Francisco', u'Lilly China Research & Development Co Ltd', u'Caldan Therapeutics Ltd', u'Emisphere Technologies Inc', u'Victory Square Health', u'Affymetrix Inc', u'National Public Health Institute Finland', u'Gelesis Inc', u'Tobira Therapeutics Inc', u'Ferring Pharmaceuticals SA', u'Prognomix', u'Plex Pharmaceuticals', u'Yissum Research Development Co', u'Glaxo Group Ltd', u'SystemsX', u'Boehringer Ingelheim Corp', u'Protext Mobility Inc', u'Connexios Life Sciences Pvt Ltd', u'Genset SA', u'Scottish Biomedical Ltd', u'PNP Pharmaceuticals Inc', u'Beta Therapeutics Pty Ltd', u'Universite Laval', u'University of Sydney', u'Debiopharm SA', u'Behestan Behdasht', u'Arisaph Pharmaceuticals Inc', u'Guangzhou Institutes of Biomedicine and Health', u'Novo Nordisk A/S', u'Wyeth Pharmaceuticals', u'Renova Therapeutics Inc', u'Advanced Life Sciences Holdings Inc', u'Harvard Medical School', u'IDIS Ltd', u'National Institute of Diabetes, Digestive and Kidney Diseases', u'Akesis Pharmaceuticals Inc', u'The Affiliated Hospital of Guiyang Medical University', u'Schering-Plough Corp', u'Pharmix Corp', u'TBG Diagnostics Ltd', u'Shanghai Institute of Materia Medica of the Chinese Academy of Sciences', u'Alteogen Inc', u'Medical College of Wisconsin', u'Genstruct Inc', u'XOMA Corp', u'University of California', u'Merck & Co Inc', u'Perlegen Sciences Inc', u'Sanofi', u'Chong Kun Dang Pharmaceutical Corp', u'Samyang Genex Co Ltd', u'Bayer AG', u'Ember Therapeutics Inc (pre-merger)', u'BioSerenTach Co Ltd', u'Macrozyme BV', u'Almirall Prodesfarma SA', u'Neurocrine Biosciences Inc', u'Swiss Federal Office of the Commission for Technology and Innovation', u'Intarcia Therapeutics Inc', u'Synthetic Biologics Inc', u'Bioton SA', u'Cortendo AB', u'International Stem Cell Corp', u'Adcock Ingram Ltd', u'Aix-Marseille Universit\\xe9', u'Acambis plc', u'Antares Pharma Inc', u'Ypsomed Holding AG', u'Tularik Inc', u'Pila Pharma AB', u'Massachusetts Institute of Technology', u'Intrexon Corp', u'The University Of Buckingham', u'University of Miyazaki', u'Griffith University', u'Productos Medix, S.A. de C.V.', u'Stevia ApS', u'Novartis Pharma KK', u'Juvenile Diabetes Research Foundation', u'Adocia SAS', u'Wellstat Therapeutics Corp', u'PharmaIN Ltd', u'Gvest Inc', u'Elan Corp plc', u'City of Hope', u'INSERM', u'Ligand Pharmaceuticals Inc', u'Diartis Pharmaceuticals Inc', u'Parke-Davis & Co', u'Malin Corp plc', u'CJ Corp', u'NPS Allelix Corp', u'Research Development Foundation', u'Imperial College London', u'Therapix Biosciences Ltd', u'Catalytica Inc', u'Eurofarma', u'Transition Therapeutics Inc', u'Whitehead Institute for Biomedical Research', u'Duke University', u'Avanir Pharmaceuticals Inc', u'SemBioSys Genetics Inc', u'Salix Pharmaceuticals Ltd', u'vTv Therapeutics LLC', u'FDA Office of Orphan Products Development', u'Janssen Pharmaceuticals Inc', u'Monash University', u'PGC Solutions', u'PXBioVision GmbH', u'Crucell NV', u'Sveikatal Inc', u'Naia Limited', u'South China Center for Innovative Pharmaceuticals', u'California Institute for Biomedical Research', u'Chemex Pharmaceuticals Inc', u'USV Ltd', u'NGM Biopharmaceuticals Inc', u\"Dr Reddy's Laboratories Ltd\", u'US Government', u'European Foundation for the Study of Diabetes', u'Baxter International Inc', u'MDS Pharma Services', u'Fudan University', u'University of Lund', u'Unigene Laboratories Inc', u'GlaxoSmithKline plc', u'Pallane Medical Ltd', u'Covance Inc', u'Bayer Schering Pharma AG', u'Makoto Life Sciences Inc', u'Allegheny-Singer Research Inst', u'Ipsen', u'Massachusetts Life Sciences Center', u'Marina Biotech Inc', u'ActivX Biosciences Inc', u'Synvista Therapeutics Inc', u'Ozstar Therapeutics Pty Ltd', u'University of Michigan', u'Coremed Inc', u'Center for Biomarker Research in Medicine', u'Takeda Oncology', u'Stanford University', u'Halozyme Therapeutics Inc', u'Cold Spring Harbor Laboratory', u'Gleneagles Hospital', u'Temple University', u'Sankyo Co Ltd', u'Canadian Institutes of Health Research', u'Waratah Pharmaceuticals Inc', u'Shionogi & Co Ltd', u'Ontogen Corp', u'Emory University', u'National Heart Lung and Blood Institute', u'GlaxoSmithKline Inc', u'Roussel Morishita Pharmaceutical Co Ltd', u'Morphochem AG', u'Alnylam Pharmaceuticals Inc', u'UCB SA', u'Suntory Ltd', u'Sequenom Inc', u'NovaTarg Therapeutics Inc', u'Deakin University', u'Medarex Inc', u'ConjuChem LLC', u'DiObex Inc', u'Daiichi Sankyo Co Ltd', u'Abbott Laboratories', u'University of Cincinnati', u'3SBio Inc', u'National Cancer Institute', u'Novartis AG', u'Merck KGaA', u'Aradigm Corp', u'Scripps Florida', u'Panorama Research Inc', u'Krish Biotech Research Pvt Ltd', u'Bayer Yakuhin Ltd', u'ParAllele Bioscience Inc', u'Vernalis Research Ltd', u'Arbutus Biopharma Corp', u'Novo Nordisk Farmaceutica do Brasil Ltda', u'Mitogenetics LLC', u'Metabolic Solutions Development Co', u'Teva Takeda Yakuhin Ltd', u'ALZA Corp', u'Amunix Inc', u'Shanghai Jiao Tong University', u'Piramal Enterprises Ltd', u'Meda Pharma Gmbh & Co Kg', u'Cardia Bioplastics Ltd', u'Neurimmune Holding AG', u'University of Colorado System', u'Midatech Pharma US Inc', u'ProSciento Inc', u'University of Barcelona', u'Univalor', u'Washington University in St Louis', u'CytRx Corp', u'Lupin Ltd', u'Avaxia Biologics Inc', u'Hebei Changshan Biochemical Pharmaceutical Co Ltd', u'Glucometrics Inc', u'Watson Laboratories Inc', u'Red Glead Discovery AB', u'Benitec Biopharma Ltd', u'Lexicon Pharmaceuticals Inc', u'Chugai Pharmaceutical Co Ltd', u'Jubilant Life Sciences Ltd', u'Takeda Pharmaceuticals International Inc', u'Otsuka Pharmaceutical Co Ltd', u'Corium International Inc', u'Universiteit Utrecht', u'Shionogi Pharma Inc', u'Nuclea Biotechnologies LLC', u'Republic of Korea Government', u'The Moscow Institute of Physics and Technology', u'Jeil Pharmaceutical Co Ltd', u'Yield10 Bioscience Inc', u'Nanolek LLC', u'Medtronic plc', u'Inalco SpA', u'PLIVA dd', u'ChemGenex Pharmaceuticals Ltd', u'Kyowa Hakko Kirin Co Ltd', u'NicOx SA', u'Kissei Pharmaceutical Co Ltd', u'Korean Ministry of Knowledge Economy', u'Genaera Corp', u'Shaman Pharmaceuticals Inc', u'Nobex Corp', u'Teijin Ltd', u'Pfizer Inc', u'Satiogen Pharmaceuticals Inc', u'Human Genome Sciences Inc', u'Mertiva AB', u'deCODE genetics ehf', u'AFFiRiS AG', u'Dr Reddy\\u2019s Research and Development BV', u'Mount Sinai Medical Center', u'High Point Pharmaceuticals Llc', u'Block Drug Co Inc', u'BioLineRx Ltd', u'LG Life Sciences Ltd', u'CureDM Inc', u'Viking Therapeutics Inc', u'Sichuan University', u'Institut Pasteur de Lille', u'Takeda Pharmaceutical Co Ltd', u'Arena Pharmaceuticals Inc', u'University of Liege', u'Numerate Inc', u'Albumedix A/S', u'Cinvestav', u'National Institutes of Health', u'Alizyme plc', u'Oxford GlycoSciences plc', u'Food and Drug Administration', u'Scios Inc', u'NeoBiocon', u'Furiex Pharmaceuticals Inc', u'Vitae Pharmaceuticals Inc', u'Asahi Kasei Pharma Corp', u'Quark Pharmaceuticals Inc', u'University at Buffalo', u'Marcadia Biotech Inc', u'The Menarini Group', u'ChemDiv Inc', u'ALS Association', u'Axxam SpA', u'Verva Pharmaceuticals Ltd', u'JW Pharmaceutical Corp', u'Quantum Materials Corp', u'Italian Ministry of Economic Development', u'Novozymes A/S', u'Biovail Laboratories International Srl', u'Ventac Partners CH', u'MannKind Corp', u'Jenesis Biosciences LLC', u'Alize Pharma SAS', u'Sequana Therapeutics', u'Tripos Inc', u'Wren Therapeutics Limited', u'MetaMorphix Inc']), u'Leishmaniabraziliensisinfection': set([u'World Health Organization', u'National Institute on Drug Abuse', u'Nagasaki University', u'Humax Pharmaceutical', u'Osaka University', u'Astellas Pharma Inc', u'Infectious Disease Research Institute', u'Universidad de Antioquia', u'Immtech Pharmaceuticals Inc', u'Ruta-N', u'Mologen Ag', u'European Commission', u'Aventis SA', u'Drugs for Neglected Diseases Initiative', u'Abbott Laboratories', u'GlaxoSmithKline plc', u'Fundacao Oswaldo Cruz (Fiocruz)', u'Savant HWP Inc', u'Georgia State University']), u'HyperlipoproteinemiatypeI': set([u'Amryt Pharmaceuticals DAC', u'Ionis Pharmaceuticals Inc', u'Aegerion Pharmaceuticals Inc', u'TRC Capital Corporation']), u'Uvealmelanoma': set([u'Eli Lilly & Co', u'Celldex Therapeutics Inc', u'US Government', u'National Cancer Institute', u'Falk Foundation', u'Columbia University Medical Center', u'Immunocore Ltd', u'Navigen Inc', u'University of Utah', u'Melanoma Research Alliance', u'Mount Sinai Medical Center']), u'Precancer': set([u'Anthra Pharmaceuticals Inc', u'GenoLac BL Corp', u'Biofrontera AG', u'DUSA Pharmaceuticals Inc', u'Nycomed Pharma AS', u'Valera Pharmaceuticals Inc', u'Alfa Wassermann SpA', u'National Cancer Institute', u'Bayer Schering Pharma AG', u'National Institutes of Health', u'Food and Drug Administration', u'Acretia Inc', u'UCB Pharma GmbH', u'Bioleaders Corp', u'Medeva plc', u'Paladin Labs Inc', u'Parabolic Drugs Ltd', u'AnGes MG Inc', u'Stiefel', u'Boston University', u'Aptalis Pharma Inc', u'University of Arkansas']), u'Chronicobstructivepulmonarydisease': set([u'Traffick Therapeutics Inc', u'Italian Government', u'Avita Medical Ltd', u'Pharmaxis Ltd', u'Kunming Medical University', u'GT Biopharma Inc', u'National Institutes of Health', u'Matrix Pharma (Pvt) Ltd', u'Prosonix Ltd', u'Medical Developments International Ltd', u'Dynavax Technologies Corp', u'InterMune Inc', u'Stony Brook University Hospital', u'TOPIGEN Pharmaceuticals Inc', u'Genaera Corp', u'Orion Corporation', u'US Government', u'Mount Sinai School of Medicine', u'UNC School of Medicine', u'Polydex Pharmaceuticals Ltd', u'Forest Laboratories Inc', u'GlaxoSmithKline plc', u\"Cincinnati Children's Hospital Medical Center\", u'Kissei Pharmaceutical Co Ltd', u'InMed Pharmaceuticals Inc', u'Chiesi Farmaceutici SpA', u'Mir SrL', u'Green Cross Corp', u'Kirin Holdings Co Ltd', u'Pulmagen Therapeutics', u'North Carolina State University', u'Janssen Biotech Inc', u'Ipsen', u'Novartis Pharma AG', u'Aventis Pharma AG', u'Korean Ministry of Knowledge Economy', u'Arch Biopartners Inc', u'US Department of Veterans Affairs', u'Vanderbilt University', u'Circassia Pharmaceuticals plc', u'SATT CONECTUS ALSACE', u'Astex Pharmaceuticals Inc', u'TBG Diagnostics Ltd', u'The Austrian Research Promotion Agency FFG', u'Synvista Therapeutics Inc', u'University of Pennsylvania', u'Seoul National University Hospital', u'Cortech Inc', u'Ono Pharmaceutical Co Ltd', u'Sungjee IBPharm', u'Adherium', u'Roche Holding AG', u'Afimmune', u'University of British Columbia', u'Grifols Inc', u'Mitsubishi Tanabe Pharma Corp', u'Galapagos NV', u'University of North Carolina', u'Cachet Pharmaceutical Co Ltd', u'RespiVert Ltd', u'Beijing Jiashilianbo Pharm Sci & Tech Co Ltd', u'Nodthera Ltd', u'Weill Medical College of Cornell University', u'Polyphor Ltd', u'Handok Inc', u'Selvita SA', u'elbion AG', u'Zendex Bio Strategy Inc', u'Catalent Inc', u'Inspire Pharmaceuticals Inc', u'Optimer Pharmaceuticals Inc', u'National Heart Lung and Blood Institute', u'ANUTECH Pty Ltd', u'Orexo AB', u'Amneal Pharmaceuticals Company GmbH', u'Korea Drug Development Fund', u'Fujifilm Finechemicals Co Ltd', u'Teijin Pharma Ltd', u'UCB SA', u'Consort Medical PLC', u'Hikma Pharmaceuticals plc', u'University of Newcastle', u'ECI Inc', u'Etiologics Ltd', u'Overpharma Produtos Medicos e Farmaceuticos Lda', u'Meiji Seika Pharma Co Ltd', u'National Health and Medical Research Council', u'Propeller Health', u'Teijin Ltd', u'Mylan Inc', u'Medarex Inc', u'BioCure Pharma LLC', u'Cystic Fibrosis Foundation Therapeutics Inc', u'Cambridge Antibody Technology Group plc', u'Kunming Pharmaceutical Corp', u'Arrow International Ltd', u'Glenmark Pharmaceuticals Ltd', u'Endo Pharmaceuticals Solutions Inc', u'Sunovion Respiratory Development Inc', u'Laboratorios Bago SA', u'Enzon Pharmaceuticals Inc', u'Innoviva Inc', u'ElsaLys Biotech', u'geneRx+ Inc', u'ICON plc', u'Novartis AG', u'Aradigm Corp', u'Devgen NV', u'Invion Ltd', u'Kos Pharmaceuticals Inc', u'Korea Research Institute of Bioscience and Biotechnology', u'Nostrum Pharmaceuticals Inc', u'Parion Sciences Inc', u'SkyePharma plc', u'Teva Pharmaceutical Industries Ltd', u'Jiangsu Hengrui Medicine Co Ltd', u'Boston University School of Medicine', u'Hanmi Pharmaceutical Co Ltd', u'Laboratorios SALVAT SA', u'Massachusetts General Hospital', u'Medical Research Council', u'Synairgen plc', u'NiKem Research Srl', u'Ethris GmbH', u'Adams Respiratory Therapeutics Inc', u'SuppreMol GmbH', u'Mundipharma EDO GmbH', u'Dotmatics Limited', u'Quintiles Transnational Corp', u'Kyorin Pharmaceutical Co Ltd', u'Axikin Pharmaceuticals Inc', u'Cilag AG', u'Biovail Corp', u'Dong-A ST Co Ltd', u'Hunter Immunology Pty Ltd', u'Tianjin KingYork Group', u'Dermira Inc', u'Takeda GmbH', u'Universitair Medisch Centrum Utrecht', u'LG Chem Ltd', u'Theron Pharmaceuticals Inc', u'Encysive Pharmaceuticals Inc', u'Boehringer Ingelheim Corp', u'Lupin Ltd', u'Yungjin Pharmaceutical Co Ltd', u'Chonbuk National University', u'airPharma', u'Edmond Pharma', u'Shasun Pharmaceuticals Ltd', u'University of Melbourne', u'Sanofi', u'Windtree Therapeutics Inc', u'Pulmagen Therapeutics (Synergy) Ltd', u'Patheon Pharmaceuticals Inc', u'CollaGenex Pharmaceuticals Inc', u'Mallinckrodt plc', u'University Hospital Birmingham NHS Foundation Trust', u'Domantis Ltd', u'Aptar Pharma SAS', u'Genentech Inc', u'Sandoz AG', u'ZAI Laboratory Inc', u'Mereo BioPharma Group Ltd', u'Revotar Biopharmaceuticals AG', u'IDIS Ltd', u'Verona Pharma plc', u'Rigel Pharmaceuticals Inc', u'Oxford GlycoSciences plc', u'Pahang Pharmacy Sdn Bhd', u'Celon Pharma SP', u'MicroDose Therapeutx Inc', u'Lantibio Inc', u'UCB Pharma GmbH', u'Nycomed Canada Inc', u'CMC Biologics Inc', u'Actavis Inc', u'Sakai Chemical Industry Co Ltd', u'Medivir AB', u'Theratrophix Llc', u'Undisclosed', u'Alteogen Inc', u'Pfizer Inc', u'Daewoong Pharmaceutical Co Ltd', u'Aerogen Inc', u'Cantex Pharmaceuticals Inc', u'Macropharma Corp', u'Merck & Co Inc', u'Domainex Ltd', u'NuChem Therapeutics Inc', u'Medtronic plc', u'Alkermes plc', u'Theravance Biopharma Inc', u'Proteros Biostructures GmbH', u'Chiroscience R&D Ltd', u'Bayer AG', u'Syntrix Biosystems Inc', u'Amerisourcebergen Drug Corp', u'Bellerophon Therapeutics LLC', u'Kolon Pharmaceuticals Inc', u'Technology Strategy Board', u'Pulmatrix Inc', u'The Linde Group', u'United Therapeutics Corp', u'Tanabe Seiyaku Co Ltd', u'Carolus Therapeutics Inc', u'Theratechnologies Inc', u'NicOx SA', u'Disease Interception Accelerator', u'BioSeek Plc', u'Argenta Discovery Ltd', u'Arriva Pharmaceuticals Inc', u'Actient Pharmaceuticals LLC', u'Jagotec AG', u'Almirall Prodesfarma SA', u'Therapure Biopharma Inc', u'AstraZeneca plc', u'CoTherix Inc', u'BCY LifeSciences Inc', u'Sandoz GmbH', u'Boehringer Ingelheim Pharmaceuticals Inc', u'Gilead Sciences Inc', u'Synedgen Inc', u'Cytopia Ltd', u'Sosei R&D Ltd', u'Sandoz Inc', u'Institute for the Promotion of Innovation by Science and Technology in Flanders', u'BioFocus DPI', u'DS Biopharma', u'Ziarco Pharma Ltd', u'AusIndustry', u'Janssen-Cilag Ltd', u'Vectura Group plc', u'Apellis Pharmaceuticals Inc', u'Laboratorios Farmaceuticos Rovi SA', u'Takeda Pharmaceuticals International GmbH', u'Intel-Ge Care Innovations Llc', u'Britannia Pharmaceuticals Ltd', u'Abbott Laboratories', u'Schering-Plough Corp', u'Zambon Co SpA', u'Sunovion Pharmaceuticals Inc', u'Quantum Pharmaceuticals LLC', u'Laboratorios Dr Esteve SA', u'Genset SA', u'Astra AB', u'NYU Langone Medical Center', u'Cempra Inc', u'Ligand Pharmaceuticals Inc', u'UCB Celltech', u'Merck Frosst Canada & Co', u'Hyland Immuno', u'Takeda Pharmaceutical Co Ltd', u'Bioneer Corp', u'University of Pittsburgh', u'FAES Farma SA', u'EnBiotix Inc', u'Abeona Therapeutics Inc', u'Synthetic Biologics Inc', u'ProtAffin Biotechnologie AG', u'Menarini Asia-Pacific', u'Chinese Government', u'LifeArc', u'Laborat\\xf3rio Qu\\xedmico Farmac\\xeautico Bergamo Ltda', u'Takeda Oncology', u'Pharmacopeia Inc', u'Shanghai Institute of Pharmaceutical Industry', u'University of Cincinnati', u'ICOS Corp', u'The Menarini Group', u'Five Prime Therapeutics Inc', u'Glenmark Pharmaceuticals SA', u'Critical Therapeutics Inc', u'3M Drug Delivery Systems', u'Imperial College London', u'Astellas Pharma Inc', u'CyDex Pharmaceuticals Inc', u'Dong Wha Pharmaceutical Co Ltd', u'AstraZeneca AB', u'Qualcomm Inc', u'Axxam SpA', u'Procaps SA', u'Covis Pharma Sarl', u'Novartis Oncology', u'Iconovo Ab', u'Cureveda LLC', u'Insmed Inc', u'P2D Biosciences', u'MediciNova Inc', u'Janssen Pharmaceuticals Inc', u'Cook Pharmaceutical Solutions', u'Yuhan Corp', u'Walter and Eliza Hall Institute of Medical Research', u'Crucell NV', u'Synspira', u'Amakem Therapeutics', u'Adamis Pharmaceuticals Corp', u'Quotient Clinical Ltd', u'3M Co', u'Medical College of Zhejiang University', u'Mylan Specialty', u'PARI Pharma GmbH', u'German Federal Ministry of Education and Research', u'BioMarck Pharmaceuticals Ltd', u'Scientific Research Institute of Pulmonology of Roszdrav']), u'SARScoronavirusinfection': set([u'US Government', u'GenVec Inc', u'Oncovir Inc', u'Massachusetts Biologic Laboratories', u'Industrial Technology Research Institute', u'Inovio Pharmaceuticals Inc', u'ViroPharma Inc', u'Sabin Vaccine Institute', u'Vical Inc', u'CombiMatrix Corp', u'Interferon Sciences Inc', u'Genesis Technology Group Inc', u'Centers for Disease Control and Prevention', u'Ionis Pharmaceuticals Inc', u'TaiGen Biotechnology Co Ltd', u'AVIR Green Hills Biotechnology AG', u'Sigma-Aldrich Corp', u'Walter Reed Army Institute of Research', u'Takeda Oncology', u'Roche Holding AG', u'The National Institute of Mental Health', u'Kuhnil Pharmaceutical Co Ltd', u'Tamir Biotechnology Inc', u'University of Massachusetts Medical School', u'Cell Pharm GmbH', u'Medarex Inc', u'CEL-SCI Corp', u'The European Union', u'Immune Design Corp', u'National Cancer Institute', u'Onepharm', u'Aphios Corp', u'SRI International', u'Fresenius Medical Care AG', u'Asembia', u'GeneOne Life Science Inc', u'Protein Sciences Corp', u'Aplicare Inc', u'Genius Biotherapeutics', u'MegaPharm Ltd', u'Leidos Biomedical Research Inc', u'Johns Hopkins University', u'Generex Biotechnology Corp', u'Vybion Inc', u'Orphan Australia', u'Shenzhen Weiguang Biological Products Co Ltd', u'GENESIS Pharma SA', u'Defyrus Inc', u'Kemin Pharma Europe', u'Cangene Corp', u'Southern Research Institute', u'AlphaVax Inc', u'Arriani Pharmaceuticals SA', u'Undisclosed', u'XOMA Corp', u'ResApp Health Ltd', u'Johann Wolfgang Goethe-Universitat Frankfurt am Main', u'Sanofi', u'Isotechnika Pharma Inc', u'GlaxoSmithKline Biologicals', u'Esteve', u'Sinovac Biotech Ltd', u'US Army Medical Research Institute of Infectious Diseases', u'Canadian Department of National Defence', u'Brighton Biotech Inc', u'Pfizer Inc', u'Northeastern University', u'Metdem Healthcare Ltd', u'Advanced Plant Pharmaceuticals Inc', u'University of Illinois', u'Purdue University', u'Baylor College of Medicine', u'Antigen Express Inc', u'Cancer Vaccine Acceleration Fund', u'Academia Sinica', u'National Institute of Allergy and Infectious Diseases', u'Organix Inc', u'Viragen Inc', u'Guangdong Medicine Group Corp', u'National Institutes of Health', u'Novavax Inc', u'Chinese Government', u'Fulcrum Pharmaceuticals Inc', u'GenoMed Inc', u'Chinese Academy of Sciences', u'Intradigm Corp', u'CJ Corp', u'Qiagen NV', u'Institut Pasteur', u'Crucell Switzerland AG', u'The Executive Yuan, Republic of China', u'PiSA Farmaceutica', u'Hemispherx Biopharma Inc', u'Immunology Clinic of New York', u'Advantek Biologics Ltd', u'BioCryst Pharmaceuticals Inc']), u'Compulsivegambling': set([u'IVAX Corp', u'Britannia Pharmaceuticals Ltd', u'Takeda Pharmaceuticals International GmbH', u'Eczacibasi Ilac Pazarlama AS', u'WhanIn Pharmaceutical Co Ltd', u'BioTie Therapies Corp', u'Somaxon Pharmaceuticals Inc']), u'Hematocele': set([u'Leidos Biomedical Research Inc', u'National Institutes of Health', u'Fox Chase Cancer Center']), u'Aplasticanemia': set([u'BioLineRx Ltd', u'US Government', u'Pan Am Cancer Treatment center', u'MD Anderson Cancer Center', u'Amgen Inc', u'US Renal Care Inc', u'Gryphon Therapeutics Inc', u'Boehringer Mannheim GmbH', u'Univ Massachusetts', u'ViaCell Inc', u'Biologics Resources LLC', u'Institute of Biotechnology the Academy of Military Medical Sciences PLA', u'Accentia BioPharmaceuticals Inc', u'Astex Pharmaceuticals Inc', u'DNA Pharmaceuticals Inc', u'HemoGenyx', u'Cornell University', u'Roche Holding AG', u'Scotia Pharmaceuticals', u'Chengdu Diao Group', u'University of Western Ontario', u'Regen BioPharma Inc', u'Johns Hopkins University', u'Takeda Pharmaceutical Co Ltd', u'Chong Kun Dang Pharmaceutical Corp', u'Wyeth BioPharma', u'Affymax Inc']), u'Vitreoushemorrhage': set([u'Allergan Inc', u'Otsuka Pharmaceutical Co Ltd', u'ISTA Pharmaceuticals Inc']), u'Meningitis': set([u\"Tianjin Municipal People's Government\", u'US Government', u'BioVeris Corp', u'Childrens Hospital Oakland Research Institute', u'Bio-Manguinhos/Fiocruz', u'Lanzhou Institute of Biological Products', u'Pasteur Merieux Connaught Canada', u'EndoBiologics Inc', u'Serum Institute of India Ltd', u'Fiotec- Fundacao para o Desenvolvimento Cientifico e Tecnologico em Saude', u'Program for Appropriate Technology in Health', u'Alkermes plc', u'Ribi ImmunoChem Research Inc', u'diaDexus Inc', u'BiosYnth srl', u'Roche Holding AG', u'ALZA Corp', u'North American Vaccine Inc', u'CanSino Biologics Inc', u'Midatech Pharma PLC', u'Emergex Vaccines Limited', u'Human Genome Sciences Inc', u'Pfizer Vaccines', u'National Research Council of Canada', u'13Therapeutics Inc']), u'Transitionalcellcarcinoma': set([u'Eli Lilly & Co', u'National Cancer Institute', u'ScinoPharm Taiwan Ltd', u'Changchun BCHT Biotechnology Co', u'FKD Therapies OY', u'Yale University', u'Merck & Co Inc', u'National Institute of Diabetes, Digestive and Kidney Diseases', u'YuanSci Bio-Tech (Tianjin) Co Ltd', u'Chinese PLA General Hospital', u'Vertex Pharmaceuticals Inc']), u'Vasculitis': set([u'DecImmune Therapeutics', u'Vifor Pharma', u'US Government', u'Lonza Group AG', u'Teijin Ltd', u'Resverlogix Corp', u'NAEJA Pharmaceuticals Inc', u'Food and Drug Administration', u'Genfit SA', u'Human Genome Sciences Inc', u'Kaketsuken', u'Aventis SA', u'ChemoCentryx Inc', u'Kissei Pharmaceutical Co Ltd', u'Cedars-Sinai Medical Center']), u'GroupAStreptococcusinfection': set([u'ID Vaccine Corp', u'Rockefeller University', u'BioVeris Corp', u'Intercell AG', u'Baxter Healthcare Corp', u'Pan-Provincial Vaccine Enterprise Inc', u'National Institute on Drug Abuse', u'University of Missouri', u'Merck & Co Inc', u'Vaxent', u'National Institute of Allergy and Infectious Diseases', u'University of Tennessee']), u'Hypercalcemia': set([u'Chugai Pharmaceutical Co Ltd', u'Genentech Inc', u'Amgen Inc', u'Mylan Inc', u'Istituto Gentili SpA', u'Grunenthal GmbH', u'IDIS Ltd', u'Unigene Laboratories Inc', u'Sebela Pharmaceuticals Inc', u'GlaxoSmithKline plc', u'Rhone-Poulenc SA', u'Abiogen Pharma SpA', u'Novartis AG', u'Leiras Oy', u'Fujisawa Pharmaceutical Co Ltd', u'Merck & Co Inc', u'FFF Enterprises', u'Immunovo BV', u'Asahi Kasei Pharma Corp', u'Abgenix Inc', u'MGI Pharma Inc', u'The Procter & Gamble Co', u'Henkel KGaA', u'Roche Holding AG', u'Pepscan Systems BV', u'Penwest Pharmaceuticals Co', u'Relgen LLC', u'Kissei Pharmaceutical Co Ltd', u'NovaPharm Therapeutics', u'CSPC Pharmaceuticals Group Limited', u'Teijin Ltd', u'Swedish Orphan Biovitrum AB', u'Genta Inc', u'Memorial Sloan-Kettering Cancer Center']), u'Dyskeratosiscongenita': set([u'Elixirgen Llc', u'National Institute of Arthritis and Musculoskeletal and Skin Diseases']), u'Prostatetu': set([u'Sakai Chemical Industry Co Ltd', u'Silence Therapeutics plc']), u'Achromatopsia': set([u'Ludwig-Maximilians University of Munich', u'Icagen Inc (pre-merger)', u'National Neurovision Research Institute', u'University of Florida', u'Athena Vision Ltd', u'AGTC', u'MeiraGTx', u'University Hospital Tubingen', u'BCM Families Foundation', u'National Eye Institute']), u'CutaneousT-celllymphoma': set([u\"Dr Reddy's Laboratories Ltd\", u'Neumedicines Inc', u'Coley Pharmaceutical Group Inc', u'National Comprehensive Cancer Network', u'The Leukemia & Lymphoma Society', u'Merck & Co Inc', u'Yamanouchi Pharmaceutical Co Ltd', u'Genmab A/S', u'OncoSec Medical Inc', u'Allos Therapeutics Inc', u'Hercules Capital Inc', u'TSD Japan', u'Eisai Co Ltd', u'Southern Research Institute', u'National Organization for Rare Disorders', u'GlaxoSmithKline plc', u'Shape Pharmaceuticals Inc', u'Inovio Pharmaceuticals Inc', u'Minophagen Pharm Co', u'National Cancer Institute', u'Duke Cancer Institute', u'Medivir AB', u'Verastem Inc', u'National Institutes of Health', u'Merck Serono SA', u'Emergent BioSolutions Inc', u'Yeda Research and Development Co Ltd', u'Ewopharma AG', u'Choice Pharmaceuticals', u'Elan Corp plc', u'Ligand Pharmaceuticals Inc', u'University of South Florida', u'MSD Japan', u'Wyeth-Ayerst Pharmaceuticals Inc', u'Columbia University', u'Eli Lilly & Co', u'Aronex Pharmaceuticals Inc', u'University of Pennsylvania', u'Galderma Spirig', u'Hy BioPharma Inc', u'University of Rochester', u'Mundipharma EDO GmbH', u'Roche Holding AG', u'Quintiles Transnational Corp', u'Valeant Pharmaceuticals International Inc', u'Taiho Pharmaceutical Co Ltd', u'Zeneus Pharma Ltd', u'Soligenix Inc', u'Medarex Inc', u'Ludwig Institute for Cancer Research', u'Cutaneous Lymphoma Foundation', u'University of Iowa', u'Sanofi Genzyme', u'SRI International', u'Gloucester Pharmaceuticals Inc', u'TetraLogic Pharmaceuticals Corp', u'Defense Advanced Research Projects Agency', u'HUYA Bioscience International LLC', u'Celdara Medical LLC', u'TenX Biopharma Inc', u'BioCryst Pharmaceuticals Inc', u'Memorial Sloan-Kettering Cancer Center', u'Wyeth BioPharma']), u'Fetalgrowthrestriction': set([u'Magnus Life Science', u'University of London', u'The European Union', u'Ark Therapeutics Group plc']), u'Bulimianervosa': set([u'Eli Lilly & Co', u'Meiji Seika Pharma Co Ltd', u'University of North Carolina', u'FAES Farma SA', u'Solvay Meiji Yakuhin KK', u'Opiant Pharmaceuticals Inc', u'The National Institute of Mental Health', u\"King's College London\"]), u'Retinalarteryocclusion': set([u'Catalent Inc', u'Amarantus BioScience Holdings Inc']), u'Heparininducedthrombocytopenia': set([u'Daiichi Seiyaku Co Ltd', u'SciDose LLC', u'BioMarin Pharmaceutical Inc', u'Massachusetts Institute of Technology', u'Genentech Inc', u'Mitsubishi Pharma Corp', u'IDIS Ltd', u'SmithKline Beecham plc', u'NovoTek Pharmaceuticals Ltd', u'Diosynth Inc', u'Akers Biosciences Inc', u'Synthelabo SA', u'IBEX Technologies Inc', u'The Medicines Company', u'University of Pennsylvania', u'Mitsubishi-Tokyo Pharmaceuticals Inc', u'Chiesi USA Inc', u'Mitsubishi Tanabe Pharma Europe Ltd', u'Hyundai Pharmaceutical', u'Encysive Pharmaceuticals Inc', u'MannKind Corp', u'Fox Chase Chemical Diversity Center Inc', u'National Heart Lung and Blood Institute', u'Medicure Inc', u'Loyola University Stritch School of Medicine', u'BASF AG']), u'StageIIImelanoma': set([u'University of Pennsylvania', u'CHU De Nantes', u'Prescient Therapeutics Ltd', u'Novavax Inc', u'ImmunID', u'Scancell Ltd', u'Cadila Pharmaceuticals Ltd', u'Adaptimmune Therapeutics plc']), u'Bronchitis': set([u'CollaGenex Pharmaceuticals Inc', u'Daiichi Seiyaku Co Ltd', u'Auspharm Institute for Mucosal Immunology (AIMI)', u'Johnson & Johnson', u'Oscient Pharmaceuticals Corp', u'TBG Diagnostics Ltd', u'Recordati Espana', u'Mylan Inc', u'Cystic Fibrosis Foundation Therapeutics Inc', u'Daiichi Sankyo Co Ltd', u'Abbott Laboratories', u'Laboratorios Dr Esteve SA', u'Polydex Pharmaceuticals Ltd', u'Forest Laboratories Inc', u'Dainippon Pharmaceutical Co Ltd', u'GlaxoSmithKline plc', u'Bayer Korea Ltd', u'Eddingpharm Inc', u'Teva Pharmaceutical Industries Ltd', u'LTL Pharma Co Ltd', u'PPL Therapeutics plc', u'Innothera', u'Daewoong Pharmaceutical Co Ltd', u'Aerogen Inc', u\"Dr Reddy's Laboratories Ltd\", u'Aventis Pharma AG', u'SS Pharmaceutical - ethical drug division', u'Sanofi', u'Chong Kun Dang Pharmaceutical Corp', u'Merus Labs International Inc', u'Leiden University Medical Center', u'Angelini Pharmaceuticals SpA', u'Adams Respiratory Therapeutics Inc', u'Bayer AG', u'ISM Therapeutics', u'Astellas Pharma Inc', u'Chiesi USA Inc', u'ALZA Corp', u'Biovail Corp', u'Ranbaxy Laboratories Ltd', u'MegaPharm Ltd', u'Rhone-Poulenc SA', u'Hunter Immunology Pty Ltd', u'Cook Pharmaceutical Solutions', u'Hisamitsu Pharmaceutical Co Inc', u'Chiron PathoGenesis', u'BCY LifeSciences Inc', u'Edmond Pharma', u'Lilly China Research & Development Co Ltd', u'Cardiovascular Systems Inc', u'Windtree Therapeutics Inc', u'Dompe Group', u'Dr Reddy\\u2019s Research and Development BV', u'Sigma-Tau Ind Farm Riunite SpA']), u'Livertumor': set([u'Immunicum AB', u'University of Newcastle', u'Singapore Technologies Pte Ltd', u'National Comprehensive Cancer Network', u'Korea Institute of Science and Technology', u'Toronto General Research Institute', u'Cerus Corp', u'Nanobiotix', u'Colorado Office of Economic Development and International Trade', u'Jennerex Inc', u'Koken Co Ltd', u'Sanofi Pasteur', u'GenVec Inc', u'Synteract Inc', u'Oncolys BioPharma Inc', u'Yakult Honsha Co Ltd', u'BTG plc', u'Centelion SAS', u'Intensity Therapeutics Inc', u'Surefire Medical Inc', u'Bayer Schering Pharma AG', u'MultiCell Technologies Inc', u'Green Cross Corp', u'Ludwig Institute for Cancer Research', u'Ionis Pharmaceuticals Inc', u'Ascletis Inc', u'European Eurostars Programme', u'Astex Pharmaceuticals Inc', u'Quirem Medical', u'OSI Pharmaceuticals Inc', u'The University Health Network', u'OSEO', u'Samsung Medical Center (SMC)', u'Aduro BioTech Inc', u'Canadian Liver Foundation', u'University of Manitoba', u'Biocompatibles International plc', u'MiNA Therapeutics Ltd', u'Bavarian Research Foundation', u'Peregrine Pharmaceuticals Inc', u'Microbio Co Ltd', u'Samjin Pharmaceutical Co Ltd', u'Jinan University (Guangdong)', u'Faron Pharmaceuticals Ltd', u'National Health and Medical Research Council of Australia', u'Hangzhou Tianlong Pharmaceutical Co Ltd', u'TTY Biopharm Co Ltd', u'GOT Entwicklungs GmbH', u'Alnylam Pharmaceuticals Inc', u'Transgene SA', u'TNK Therapeutics Inc', u'Reyon Pharmaceuticals Co Ltd', u'Rosetta Genomics Ltd', u'Terumo Corp', u'Maxim Biotech Inc', u'Q BioMed Inc', u'ViRexx Medical Corp', u'Ranbaxy Laboratories Ltd', u'Amgen Inc', u'Clearbridge BioMedics Pte Ltd', u'Daiichi Sankyo Co Ltd', u'Nippon Kayaku Co Ltd', u'Hubei Qianjiang Pharmaceutical Co Ltd', u'3SBio Inc', u'Onxeo SA', u'The University of Birmingham', u'National Cancer Institute', u'MediGene AG', u'Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd', u'Wayne State University', u'DAE HWA Pharm Co Ltd', u'Seoul National University', u'Center for Translational Molecular Medicine', u'Korea Research Institute of Bioscience and Biotechnology', u'Diatos SA', u'Jewim Pharmaceutical Inc', u'Massachusetts General Hospital', u'Tanabe Seiyaku Co Ltd', u'Peking University', u'Guangdong Zhongsheng Pharmaceutical Co Ltd', u'YM BioSciences Inc', u'WuXi PharmaTech (Cayman) Inc', u'Oncolytics Biotech Inc', u'Mallinckrodt Inc', u'Microbial Chemistry Research Foundation', u'Tessa Therapeutics Pte Ltd', u'Anza Therapeutics Inc', u'Nagoya University', u'Can-Fite BioPharma Ltd', u'Eiken Chemical Co Ltd', u'Upstate Medical University', u'ABL Europe', u'Biogazelle NV', u'Institut Pasteur Korea', u'CSPC Pharmaceuticals Group Limited', u'Mirada Medical', u'Boehringer Ingelheim Corp', u'Shaanxi University of Chinese Medicine', u'OnCore Biopharma Inc', u'Fuso Pharmaceutical Industries Ltd', u'University of Southern California', u'Duke University', u'Biomics Biotechnologies (Nantong) Co Ltd', u'Varian Inc', u'Cancer Research UK', u'Undisclosed', u'National Natural Science Foundation of China', u'Medigen Biotechnology Corp', u'GeneNews Ltd', u'Oklahoma Medical Research Foundation', u'Stason Pharmaceuticals Inc', u'Somantix BV', u'China Pharmaceutical University', u'Tufts University School of Medicine', u'XOMA Corp', u'US Government', u'Argos Therapeutics Inc', u'Sumitomo Dainippon Pharma Co Ltd', u'Cancer Research Campaign (UK)', u'MiReven Pty Ltd', u'Protherics Salt Lake City Inc', u'biolitec AG', u'Royal Philips Electronics', u'HepaVec AG fuer Gentherapie', u'Sanofi', u'Eli Lilly & Co', u'Celsion Corp', u'Marina Biotech Inc', u'PharmAbcine', u'Commissariat a l`Energie Atomique', u'Zhejiang University', u'Immune Therapeutics Inc', u'University of Bradford', u'University of Kansas Medical Center', u'Almirall Prodesfarma SA', u'AstraZeneca plc', u'Pfizer Inc', u'ArQule Inc', u'Paul Scherrer Institut', u'SIRTeX Medical Ltd', u'AMAG Pharmaceuticals Inc', u'Oncormed Inc', u'Guerbet', u'EPIX Pharmaceuticals Inc', u'Lonza Biologics plc', u'Genisphere LLC', u'The Institute of Radiation Medicine Academy of Military Medical Sciences PLA', u'Introgen Therapeutics Inc', u'Advanced Medical Isotope Corp', u'Mast Therapeutics Inc', u'Guangzhou Shunjian Biomedical Technology Co Ltd', u'Imclone LLC', u'Kambridge Life Science Technology Co Ltd', u'Chongqing LUMMY Pharmaceutical Co Ltd', u'ASTA Medica AG', u'UniQuest Pty Ltd', u'Somanta Pharmaceuticals Inc', u'Institute of Materia Medica Chinese Academy of Medical Sciences & Peking Union Medical College', u'Jiangsu Sihuan Bioengineering Co Ltd', u'Medipharm Biotech Co Ltd', u'Eureka Therapeutics Inc', u'Lonza Group AG', u'Provectus Biopharmaceuticals Inc', u'Bioneer Corp', u'University of Wisconsin-Madison', u'SillaJen Inc', u'University of Tokyo', u'Commonwealth Scientific and Industrial Research Organization', u'Bristol-Myers Squibb Co', u'Elan Corp plc', u'City of Hope', u'Shenzhen BGI Genomics Techonology Co Ltd', u'Sanofi Genzyme', u'Regulus Therapeutics Inc', u'PharmaSynth Pty Ltd', u'Medical College of Georgia', u'Onyx Pharmaceuticals Inc', u'University of Chicago', u'Colorado State University', u'Imperial College London', u'Baruch S Blumberg Institute', u'Oakwood Laboratories LLC', u'Max Delbruck Centrum Fur Molekulare Medizin', u'Sosei Group Corp', u'PhaseBio Pharmaceuticals Inc', u'Baylor College of Medicine', u'FeRx Inc', u'Merck Serono SA', u'Meda AB', u'GE Healthcare', u'Munich Biotech AG', u'Dyax Corp', u'Cancer Therapy & Research Center', u'Alberta Heritage Foundation For Medical Research', u'Merck KGaA', u'Serono Inc', u'Sahlgrenska University Hospital', u'Biostar Pharmaceuticals Inc', u'Aphton Corp', u'German Federal Ministry of Education and Research', u'Theragence Inc', u'Ministry of Health, Malaysia']), u'Xlinkeddominanthypophosphatemicrickets': set([u'Ultragenyx Pharmaceutical Inc', u'Kyowa Hakko Kirin Co Ltd']), u'Leukopeniadruginduced': set([u'Harbor Therapeutics Inc', u'Chugai Pharmaceutical Co Ltd', u'AMRAD Pharmaceuticals Pty Ltd', u'Medimmune Oncology Inc', u'ASTA Medica AG', u'SmithKline Beecham Corp', u'Cangene Corp', u'Ligand Pharmaceuticals Inc', u'National Cancer Institute', u'Walter Reed Army Institute of Research', u'GlaxoSmithKline plc', u'Thomas Jefferson University', u'CJ Corp', u'Apotex Inc', u'ALZA Corp', u'HealthCare Asia Pharmaceuticals Inc', u'Virginia Commonwealth University', u'Tego BioSciences Corp', u'Rhone-Poulenc Rorer Ltd', u'Takeda Pharmaceutical Co Ltd', u'US Department of Defense', u'Human Genome Sciences Inc', u'Rhone-Poulenc Rorer Inc']), u'Venezuelanequineencephalitisvirusinfection': set([u'University of Texas Medical Branch at Galveston', u'Ichor Medical Systems Inc', u'DynPort Vaccine Company LLC', u'Profectus BioSciences Inc', u'Defyrus Inc', u'National Center for Research Resources', u'National Institute of Allergy and Infectious Diseases', u'US Government', u'Tulane University', u'SRI International', u'University of North Carolina', u'Encorium Group Inc', u'Institute of Human Virology', u'ImmuneRegen BioSciences Inc', u'Texas Biomedical Research Institute', u'Vaxart Inc', u'University of Pittsburgh', u'University of Louisville', u'United States Army', u'GeneSegues Therapeutics', u'Medigen Inc', u'The National Institute of Mental Health', u'Canadian Department of National Defence', u'Emory University', u'US Department of Defense', u'Defense Threat Reduction Agency']), u'Thrombocytopenia': set([u\"King's College London\", u'New York Blood Center', u'Haemostatix Ltd', u'BioMarin Pharmaceutical Inc', u'Pharmagenesis Inc', u'Green Cross Corp', u'Genentech Inc', u'Yakult Honsha Co Ltd', u'ViroMed Co Ltd', u'SmithKline Beecham Corp', u'Scottsdale Scientific DBA Allergy Research Group/Nutricology, INC.', u'Alexion Pharmaceuticals Inc', u'National Institute of Allergy and Infectious Diseases', u'PhytoHealth Corp', u'US Health and Human Services Department', u'3SBio Inc', u'GlaxoSmithKline plc', u'Diosynth Inc', u'Sanquin Blood Supply Foundation', u'National Cancer Institute', u'Bayer Schering Pharma AG', u'Massachusetts Institute of Technology', u'National Institutes of Health', u'Schering-Plough Corp', u'Bolder BioTechnology Inc', u'University of Maryland', u'XOMA Corp', u'Immunex Corp', u'Chinese Government', u'IBEX Technologies Inc', u'US Biotest Inc', u'MabVax Therapeutics Holdings Inc', u'Catholic University of Leuven', u'Ligand Pharmaceuticals Inc', u'Sanofi', u'Wyeth Pharmaceuticals', u'Dragon Pharmaceutical Inc', u'University of Pennsylvania', u'National Endowment for Science, Technology and the Arts', u'Nektar Therapeutics', u'Ono Pharmaceutical Co Ltd', u'ThromboGenics NV', u'Nissan Chemical Industries Ltd', u'PLIVA dd', u'3-Dimensional Pharmaceuticals Inc', u'Receptron Inc', u'Weizmann Institute of Science', u'Pharmacia & Upjohn Co', u'Rockefeller University', u'Plasticell Ltd', u'Tarix Pharmaceuticals LLC', u'Merck Serono SA', u'ZymoGenetics Inc', u'Kirin-Amgen Inc', u'Cellerant Therapeutics Inc', u'Wyeth BioPharma', u'Teijin Ltd', u\"Brigham & Women's Hospital\", u'University of South Florida', u'Terumo BCT', u'Novartis AG', u'Cypress Bioscience Inc', u'IXICO Plc', u'Pfizer Inc', u'University of Southern California', u'Kelong Industrial Co Ltd', u'Institute for the Promotion of Innovation by Science and Technology in Flanders', u'GD Searle & Co', u'Yamanouchi Pharmaceutical Co Ltd', u'BASF AG']), u'Acquiredimmunedeficiencysyndrome': set([u'ID Vaccine Corp', u'Immunicum AB', u'Jiangzhong Pharmaceutical Co Ltd', u'Sanofi Pasteur', u'California Institute of Regenerative Medicine', u'Lynx Therapeutics GmbH', u'Emory University', u'GlaxoSmithKline plc', u'Mylan Laboratories Ltd', u'World Health Organization', u'Cascadian Therapeutics Inc', u'Frederick National Laboratory for Cancer Research', u'Sangamo Therapeutics Inc', u'University of Washington', u'Fred Hutchinson Cancer Research Center', u'GlycoMimetics Inc', u'T.J. Martell Foundation', u'Kunming Institute of Zoology The Chinese Academy of Sciences', u'Omnia Biologics Inc', u'Panaxia Pharmaceutical Industries Ltd', u'Department of Health, South Africa', u'ECI Inc', u'National Center for Research Resources', u'Harvard TH Chan School of Public Health', u'Dana-Farber Cancer Institute Inc', u'Alexis Biotech Ltd', u'Academic Medical Center, University of Amsterdam', u'CEL-SCI Corp', u'International AIDS Vaccine Initiative', u'Atreca Inc', u'Harvard University', u'Numerate Inc', u'Commonwealth Scientific and Industrial Research Organization', u'National Cancer Institute', u'Aphios Corp', u'Normaco Inc', u'SRI International', u'Center for Infectious Disease Research', u'Catholic University of Leuven', u'Transgene SA', u'University of Rochester Medical Center', u\"Ministry of Health of the People's Republic of China\", u'Protein Sciences Corp', u'Immunomedics Inc', u'French National Agency for Research on AIDS and Viral Hepatitis', u'The Foundation for AIDS Research', u'Dong-A ST Co Ltd', u'Midatech Pharma US Inc', u'University of Melbourne', u'San Raffaele Hospital', u'University of Oxford', u'Benitec Biopharma Ltd', u'Rockefeller University', u'University of North Carolina', u'Undisclosed', u'Zeon Corp', u'Medimmune Oncology Inc', u'Harvard Medical School', u'Drugs for Neglected Diseases Initiative', u'Cipla Ltd', u'Baylor Research Institute', u'Ore Pharmaceuticals Inc', u'Arkray Inc', u'Areva Med LLC', u'Pharmix Corp', u'Prescient Therapeutics Ltd', u'Tufts University School of Medicine', u'Sequella Inc', u'University of California', u'Merck & Co Inc', u'Scripps Research Institute', u'University College London', u'BioFocus DPI', u'Japan Tobacco Inc', u'National Institute on Minority Health and Health Disparities', u'Yunnan University', u'Epimmune Inc', u'Takara Bio Inc', u'LION bioscience Inc', u'University of Virginia', u'Cumberland Emerging Technologies Inc', u'Immune Therapeutics Inc', u'MolMed SpA', u'Cyclacel Pharmaceuticals Inc', u'Florida International University', u'Genecure LLC', u'Hannover Medical School', u'University of California Los Angeles', u'University of Kansas Medical Center', u'Pfizer Inc', u'National Institute on Aging', u'Frontier Biotechnologies Co Ltd', u'ToolGen Inc', u'Clinton HIV/AIDS Initiative', u'Janssen Diagnostics BVBA', u'Yunnan Institute of Materia Medica', u'Vaccine Research Institute of San Diego', u'Australian Government', u'University of Missouri', u'University of Regensburg', u'National Institute of Allergy and Infectious Diseases', u'Allegiance Equity Corp', u'University of Mississippi', u'Welfide Corp', u'Haikou VTI Biological Institute', u'Albert Einstein College of Medicine', u'Allegro Biologics Inc', u'National Institutes of Health', u'Bill & Melinda Gates Foundation', u'Fresenius SE & Co KGaA', u'Bristol-Myers Squibb Co', u'City of Hope', u'INSERM', u'Sumagen Co Ltd', u'Teewinot Life Sciences Corp', u'Institut Pasteur', u'University of Western Ontario', u'ChronTech Pharma AB', u'RNL Bio Co Ltd', u'The Institute of Radiation Medicine Academy of Military Medical Sciences PLA', u'Antitope Ltd', u'Bacilligen Inc', u'Thallia Pharmaceuticals SA']), u'Centralnervoussystemtumor': set([u'Eli Lilly & Co', u'GTx Inc', u'National Comprehensive Cancer Network', u'National Cancer Institute', u'AstraZeneca plc', u'Pfizer Inc', u'AstraZeneca Pharmaceuticals LP', u'Biologics Inc', u'National Institute of Neurological Disorders and Stroke', u'NABTT CNS Consortium', u'Oregon Health Sciences University', u'Takeda Pharmaceutical Co Ltd', u\"Nationwide Children's Hospital\", u'University of California San Francisco', u'MD Anderson Cancer Center', u'Southern Research Institute', u'Princeton University']), u'Metastaticbladdercancer': set([u'Ventana Medical Systems Inc', u'Cancer Genetics Inc']), u'Scabiesinfection': set([u'Neo Pharma-Innovations Ltd', u'Eden Research PLC', u'Foamix Pharmaceuticals Ltd', u'Stiefel']), u'Secondaryhyperparathyroidism': set([u'Vifor-Fresenius Medical Care Renal Pharma Ltd', u'University College London', u'Cardinal Health Inc', u'NPS Pharmaceuticals Inc', u'University of Wisconsin-Madison', u'Roche Holding AG', u'Amgen Inc', u'Bone Care International Inc', u'Acologix Inc', u'Canadian Medical Discoveries Fund Inc', u'Galapagos NV', u'Kyowa Hakko Kirin Co Ltd', u'Mitsubishi Tanabe Pharma Corp', u'Cytochroma Inc', u'Abbott Laboratories', u'OPKO Health Inc', u'Swedish Orphan Biovitrum AB', u'BioXell SpA']), u'Primarysclerosingcholangitis': set([u'Alfa Wassermann SpA', u'Prasco Laboratories', u'UCB Pharma GmbH', u'The University of Birmingham', u'Aptalis Pharma Inc', u'Universita degli Studi di Roma La Sapienza', u'Texas A&M University System', u'Shenzhen Municipal Government', u'National Institute for Health Research (NIHR)', u'Mayo Clinic Foundation', u'BioTie Therapies Corp', u'Shenzhen Hepalink Pharmaceutical Group Co Ltd', u'Dong-A ST Co Ltd', u'Seres Therapeutics Inc', u'Aventis Pharma SA', u'Tobira Therapeutics Inc']), u'Hyperacusis': set([u'Oklahoma Center for the Advancement of Science and Technology', u'Hough Ear Institute']), u'Proctitis': set([u'Applied Protein Sciences LLC', u'Anabolic Inc', u'Pharmatel Pty Ltd', u'The Menarini Group', u'National Cancer Institute', u'Biomodels LLC', u'AstraZeneca plc', u'Salix Pharmaceuticals Inc', u'Synedgen Inc', u'Diosynth Ltd', u'Rimaco Inc', u'Panaxia Pharmaceutical Industries Ltd', u'Allegiance Equity Corp', u'Shire plc', u'Salix Pharmaceuticals Ltd', u'Chong Kun Dang Pharmaceutical Corp']), u'Uterinefibroids': set([u'Meiji Seika Pharma Co Ltd', u\"The General Hospital of the People's Liberation Army\", u'Solvay SA', u'ICON Clinical plc', u'Undisclosed', u'Myovant Sciences Ltd', u'HRA Pharma UK Ltd', u'Nippon Kayaku Co Ltd', u'ASTA Medica AG', u'PregLem Holding SA', u'Abbott Laboratories', u'Mochida Pharmaceutical Co Ltd', u'Takeda Pharmaceutical Co Ltd', u'ASKA Pharmaceutical Co Ltd', u'Ligand Pharmaceuticals Inc', u'Meditrina Pharmaceuticals Inc', u'Bayer Schering Pharma AG', u'Ardana Bioscience Ltd', u'Wayne State University', u'National Institutes of Health', u'Xbrane Biopharma AB', u'HRA Pharma', u'Zentaris GmbH', u'Innothera', u'Shin Poong Pharmaceutical Co Ltd', u'TerSera Therapeutics', u'Jenapharm GmbH & Co KG', u'AEterna Zentaris Inc', u'Repros Therapeutics Inc', u'BioSphere Medical Inc', u'Handok Inc', u'Actavis Inc', u'Orion Corporation', u'AstraZeneca plc', u'Pfizer Inc', u'Bayer HealthCare AG', u'Gedeon Richter Ltd', u'Shionogi & Co Ltd', u'Watson Laboratories Inc', u'Neurocrine Biosciences Inc', u'Orient Europharma', u'Novus Therapeutics Inc', u'University of Oxford', u'BioAvenir']), u'HIV-2infection': set([u'Fujirebio Europe NV', u'Medivir AB', u'Medicines Patent Pool', u'Bio-Rad Laboratories Inc', u'Merck & Co Inc', u'Presidio Pharmaceuticals Inc']), u'Lewybodydementia': set([u'Nordion Inc', u'University of Pennsylvania', u'Navidea Biopharmaceuticals Inc', u'Novartis AG', u'Pfizer Inc', u'National Institute on Aging', u'Catalytica Inc', u'Undisclosed', u'Qaam Pharmaceuticals LLC', u'Georgetown University', u'Nihon Medi-Physics Co Ltd', u'Weston Brain Institute', u'University of California San Diego', u'Arizona State University', u'University of Michigan', u'Axovant Sciences Ltd', u'Avid Radiopharmaceuticals Inc', u'Eisai Co Ltd', u'NeuroTransit Inc', u'Ottawa Hospital Research Institute']), u'Leishmaniatropicainfection': set([u'Yamanouchi Pharmaceutical Co Ltd', u'Genentech Inc', u'Connetics Corp', u'InterMune Inc', u'Drugs for Neglected Diseases Initiative', u'LICA Pharmaceuticals A/S', u'Knight Therapeutics Inc', u'CombiMatrix Corp', u'Walter Reed Army Institute of Research', u'Universidade Federal do Rio de Janeiro', u'Center for Infectious Disease Research', u'Elan Corp plc', u'NeXstar Pharmaceuticals Inc', u'University of Sao Paulo', u'GlobeImmune Inc', u'Enzon Pharmaceuticals Inc', u'MycoLogics Inc', u'Sumitomo Pharmaceuticals Co Ltd', u'Astellas Pharma Inc', u'Roche Holding AG', u'Georgia State University', u'AstraZeneca plc', u'Osaka University', u'Boehringer Ingelheim Corp', u'Gilead Sciences Inc', u'Immtech Pharmaceuticals Inc', u'Wyeth-Ayerst Pharmaceuticals Inc', u'Maxygen Holdings Ltd', u'Wyeth BioPharma']), u'Diabeticmacularedema': set([u'Alcon Inc', u'Charlesson LLC', u'iCo Therapeutics Inc', u'R-Tech Ueno Ltd', u'National Institutes of Health', u'Genentech Inc', u'XOMA Corp', u'Intrexon Corp', u'ORA Inc', u'ThromboGenics NV', u'Eyemedix Inc', u'EyeMedics LLC', u'Abbott Laboratories', u'University of New South Wales', u'Knight Therapeutics Inc', u'Brill Pharma SL', u'Nuvue Technologies Inc', u'Molecular Partners AG', u'Juvenile Diabetes Research Foundation', u'Quintiles Transnational Corp', u'Diagnos Inc', u'CMC Biologics Inc', u'Regeneron Pharmaceuticals Inc', u'Johns Hopkins University School of Medicine', u'Sun Pharmaceutical Industries Ltd', u'Alimera Sciences Inc', u'AntriaBio Inc', u'Texas A&M University System', u'Bicycle Therapeutics Ltd', u'MacuSight Inc', u'Senju Pharmaceutical Co Ltd', u'pSivida Corp', u'Sanofi', u'Merck & Co Inc', u'AmorChem LP', u'Advanced Ocular Systems Ltd', u'PhiloGene Inc', u'National Eye Institute', u'ActiveSite Pharmaceuticals Inc', u'MacuCLEAR Inc', u'KalVista Pharmaceuticals Inc (Pre-merger)', u'River Vision Development Corp', u'Universite De Montreal', u'Fujifilm Diosynth Biotechnologies', u'Cephalon Inc', u'Bayer AG', u'OPKO Health Inc', u'SurModics Inc', u'MINU LLC', u'Hanmi Pharmaceutical Co Ltd', u'SemaThera Inc', u'Ampio Pharmaceuticals Inc', u'St Michaels Hospital', u'Technology Strategy Board', u'Santen Pharmaceutical Co Ltd', u'Oakwood Laboratories LLC', u'Undisclosed', u'Hokkaido University', u'The Leona M. and Harry B. Helmsley Charitable Trust', u'Acucela Inc', u'Specialised Therapeutics Australia Pty Ltd', u'National Health Service', u'Vantia Therapeutics', u'Allergan Inc', u'AstraZeneca plc', u'Pfizer Inc', u'pSivida Inc', u'Johns Hopkins University', u'Wakamoto Pharmaceutical Co Ltd', u'Quark Pharmaceuticals Inc', u'Allegro Ophthalmics LLC', u'SIFI Societa Industria Farmaceutica Italiana SpA', u'CoMentis Inc', u'BioInvent International AB', u'Adverum Biotechnologies Inc', u'Eleven Biotherapeutics Inc', u'Institute for the Promotion of Innovation by Science and Technology in Flanders', u'F Hoffmann-La Roche AG', u'Bausch & Lomb Inc', u'University of Nottingham']), u'Organtransplantrejection': set([u'TxCell SA', u'Thermo Fisher Scientific Inc', u'US Government', u'Transcriptome Sciences Inc', u'Undisclosed', u'University of British Columbia', u'Aspen Japan', u'Emergent BioSolutions Inc', u'Caladrius Biosciences Inc', u'Opus Bio Inc', u'Aequus Pharmaceuticals Inc', u'Kissei Pharmaceutical Co Ltd', u'University of California San Francisco']), u'Merkelcellcarcinoma': set([u'Inovio Pharmaceuticals Inc', u'Immune Design Corp', u'Fred Hutchinson Cancer Research Center', u'Life Sciences Discovery Fund', u'National Cancer Institute', u'Roche Holding AG', u'Seattle Cancer Care Alliance', u'OncoSec Medical Inc', u'University of Washington', u'University of South Florida']), u'Shigellainfection': set([u'US Government', u'Antex Biologics Inc', u'McMaster University', u'Advanced BioScience Laboratories Inc', u'DelSite Biotechnologies Inc', u'The Institute for OneWorld Health', u'Ceragenix Pharmaceuticals Inc', u'National Institute of Allergy and Infectious Diseases', u'US Army Medical Research Institute of Infectious Diseases', u'SRI International', u'VBI Vaccines', u'Program for Appropriate Technology in Health', u'National Institutes of Health', u'Immuron Ltd', u'National Institute of Cholera and Enteric Diseases', u'Protein Potential LLC', u'Southwest Research Institute (SwRI)', u'Walter Reed Army Institute of Research', u'Department for International Development', u'Aridis Pharmaceuticals Inc', u'EndoBiologics Inc', u'MSD Wellcome Trust Hilleman Laboratories', u'Anacor Pharmaceuticals Inc', u'Institut Pasteur', u'US Department of Defense', u'St Louis University', u'Acambis plc']), u'Squamouscellcarcinoma': set([u'Johns Hopkins University', u'National Comprehensive Cancer Network', u'MD Anderson Cancer Center', u'Kura Oncology Inc', u'Amgen Inc', u'Advaxis Inc', u'University of Queensland', u'Biothera Pharmaceuticals Inc', u'Veristat, Inc.', u'Incyte Corp', u'University of California Los Angeles', u'OncoTherapy Science Inc', u'CBR International Corp', u'Azanta A/S', u'Inovio Pharmaceuticals Inc', u'National Cancer Institute', u'Sidney Kimmel Comprehensive Cancer Center', u'Clinuvel Pharmaceuticals Ltd', u'Australian Nuclear Science & Technology Organization', u'SurModics Pharmaceuticals', u'Merck KGaA', u'Cascadian Therapeutics Inc', u'Cannabis Science Inc', u'Bristol-Myers Squibb Co', u'Merck & Co Inc', u'Galderma Laboratories LP', u'MedPharm Ltd', u'LEO Pharma A/S', u'MedImmune LLC', u'Foundation Medicine Inc', u'Galderma SA', u'University of Manchester', u'Navidea Biopharmaceuticals Inc', u'Oncolytics Biotech Inc', u'Roche Holding AG', u'PhotoMedex Inc', u'PhotoCure ASA', u'National Institute of Dental and Craniofacial Research', u'UC San Diego Moores Cancer Center', u'Qrono Inc', u'ImmunoGen Inc', u'Sayre Therapeutics Private Ltd', u'Aurobindo Pharma Ltd', u'Allergan Inc', u'Teikoku Pharma USA Inc', u'Peplin Inc', u'Idera Pharmaceuticals Inc', u'Shionogi & Co Ltd', u'Boehringer Ingelheim Corp', u'Boehringer Ingelheim Pharmaceuticals Inc', u'Tapestry Pharmaceuticals Inc', u'Emory University', u'Cancer Therapy & Research Center', u'Shandong Luoxin Pharmaceutical Group Stock Co Ltd', u'Lung Cancer Research Foundation', u'TL Biopharmaceutical Ltd', u'Karyopharm Therapeutics Inc', u'Hikma Pharmaceuticals plc', u'AmpliPhi Biosciences Corp', u'Fournier Pharma', u'Memorial Sloan-Kettering Cancer Center']), u'Urinaryincontinence': set([u'Afferon Corp', u'Solvay SA', u'Mount Cook BioSciences', u'Orion Corporation', u'Forest Laboratories Inc', u'GlaxoSmithKline plc', u'Quintiles Transnational Corp', u'Renovis Inc', u'Ono Pharmaceutical Co Ltd', u'Takeda Oncology', u'KeyNeurotek Pharmaceuticals AG', u'Bridge Pharmaceuticals Inc', u'Neurogen Corp', u'Arachnova Ltd', u'Vivax Pharmaceuticals SRO', u'Handok Inc', u'Hisamitsu Pharmaceutical Co Inc', u'Shionogi & Co Ltd', u'Signal Research Division', u'Frazier Healthcare Partners', u'Innovus Pharmaceuticals Inc', u'Abbott Laboratories', u'Endo Pharmaceuticals Solutions Inc', u'Eisai Co Ltd', u'Innoviva Inc', u'SLA Pharma UK Ltd', u'Novartis AG', u'Tanabe Seiyaku Co Ltd', u'Merus Labs International Inc', u'UCB Pharma GmbH', u'The Procter & Gamble Co', u'Apogepha Arzneimittel GmbH', u'UCB Pharma Inc', u'Mundipharma EDO GmbH', u'ALZA Corp', u'Samsung Electronics Co Ltd', u'Kyorin Pharmaceutical Co Ltd', u'Ferring Pharmaceuticals SA', u'Madaus AG', u'Duchesnay Inc', u'Pharmacia & Upjohn AB', u'Taiho Pharmaceutical Co Ltd', u'Boehringer Ingelheim Corp', u'Plethora Solutions Holdings plc', u'Roche Palo Alto', u'Recordati SpA', u'H Lundbeck A/S', u'Mitsubishi Pharma Corp', u'Grunenthal GmbH', u'Actavis Inc', u'BMP Sunstone Corp', u'Undisclosed', u'Nippon Chemiphar Co Ltd', u'Daewoong Pharmaceutical Co Ltd', u'Merck & Co Inc', u'Jeilmedix Pharmaceutical Co', u'Eli Lilly & Co', u'Bayer AG', u'Valeant Pharmaceuticals International Inc', u'Allergan Inc', u'PLIVA dd', u'Enhance Biotech Inc', u'Kissei Pharmaceutical Co Ltd', u'Laboratorios Inibsa SA', u'Pfizer Inc', u'National Institute on Aging', u'Medtronic plc', u'EuroCept International BV', u'Antares Pharma Inc', u'Nippon Shinyaku Co Ltd', u'Seipel Group Pty Ltd', u'Ferring Canada', u'Dainippon Pharmaceutical Co Ltd', u'Hokuriku Seiyaku KK', u'Yamanouchi Pharmaceutical Co Ltd', u'National Institutes of Health', u'Elan Corp plc', u'Esprit Pharma Inc', u'Asahi Kasei Pharma Corp', u'ICOS Corp', u'UCB Japan Co Ltd', u'Takeda Cambridge Ltd', u'Crescendo Pharmaceuticals Corp', u'Sosei Group Corp', u'Arachnova Therapeutics Ltd', u'Ranbaxy Laboratories Ltd', u'Arriani Pharmaceuticals SA', u'Janssen Pharmaceuticals Inc', u'GLSynthesis Inc', u'Tribute Pharmaceuticals Canada Inc', u'Takeda Pharmaceutical Co Ltd']), u'Ocularinflammation': set([u'US Government', u'Portage Biotech Inc', u'Novartis Ophthalmics Inc', u'Ocular Therapeutix Inc', u'4SC Discovery GmbH', u'Tonghua Dongbao Pharmaceutical Co Ltd', u'Advanced Ocular Systems Ltd', u'ISTA Pharmaceuticals Inc', u'RPS Diagnostics', u'MINU LLC', u'Roche Holding AG', u'Shire plc', u'University of British Columbia', u'A H Robins Co Ltd', u'RespiVert Ltd', u'Hain Diagnostika GmbH', u'Kuhnil Pharmaceutical Co Ltd', u'Handok Inc', u'Binational Industrial Research and Development Foundation', u'Taro International Ltd', u'S. Fyodorov Eye Microsurgery Complex', u'Reata Pharmaceuticals Inc', u'KalVista Pharmaceuticals Inc (Pre-merger)', u'CollaGenex International Ltd', u'NovaMedica', u'CrystalGenomics Inc', u'Bioconcept Laboratories', u'Amgen Inc', u'Topivert Pharma Ltd', u'The European Union', u'Portola Pharmaceuticals Inc', u'Croma Pharma GmbH', u'University of Aberdeen', u'The New Energy and Industrial Technology Development Organization', u'SIFI Societa Industria Farmaceutica Italiana SpA', u'CIS Pharma AG', u'Parion Sciences Inc', u'Novelion Therapeutics Inc', u'Laboratorios Sophia', u'Alliance Pharma plc', u'ISDIN SA', u'Incept LLC', u'EyGen Ltd', u'Sirion Therapeutics Inc', u'Kyorin Pharmaceutical Co Ltd', u'Panoptes Pharma Ges.m.b.H', u'MegaPharm Ltd', u'Alfresa Pharma Corp', u'Pharmacia & Upjohn Inc', u'Allergan Inc', u'Boehringer Ingelheim Corp', u'AcSentient Inc', u'Oculex Pharmaceuticals Inc', u'Swedish Orphan Biovitrum AB', u'Bausch & Lomb Inc', u'Activus Pharma Co Ltd', u'CollaGenex Pharmaceuticals Inc', u'University of Houston', u'iVeena LLC', u'Quidel Corp', u'ITR Laboratories Canada Inc', u'Syntex (USA) LLC', u'Aciont Inc', u'Shenzhen Relin Medicine', u'Karr Dental AG', u'Undisclosed', u'Merck & Co Inc', u'Laboratorio EDOL Produtos Farmaceuticos S.A', u'InSite Vision Inc', u'Taejoon Pharm Co Ltd', u'Nicox Ophthalmics Inc', u'OphthalmoPharma Ltd', u'Pfizer Inc', u'Portage Pharmaceuticals Ltd', u'University of Utah', u'A H Robins Co Inc', u'Alcon Inc', u'AbbVie Inc', u'University of Missouri', u'Biocydex', u'Pharmos Corp', u'Knight Therapeutics Inc', u'PharmaNova Inc', u'Lux Biosciences Inc', u'Shenyang Pharmtech Pharmaceutical R & D Ltd', u'Senju Pharmaceutical Co Ltd', u'ORA Inc', u'Altacor Ltd', u'AmbioPharm Inc', u'ProtoKinetix Inc', u'Willvonseder & Marchesani GmbH & Co KG', u'Bri Biopharmaceuticals Research Inc', u'Pharma Med Inc', u'Laboratories Leurquin-Mediolanum SA']), u'Streptococcuspneumoniaeinf': set([u'Merus Labs International Inc', u'Iroko Pharmaceuticals LLC']), u'VitaminB12deficiency': set([u'US Government', u'Marina Biotech Inc', u'Hawthorn Pharmaceuticals Inc', u'Questcor Pharmaceuticals Inc', u'TG Therapeutics Inc', u'OnSite Diagnostic Labs India Pvt Ltd', u'Fleming Pharmaceuticals', u'Biohit OYJ', u'Par Specialty Pharmaceuticals', u'Swedish Orphan Biovitrum AB', u'QOL Medical']), u'Chroniclymphocyticleukemia': set([u'Quest Diagnostics Inc', u'MENTRIK Biotech LLC', u'The Leukemia & Lymphoma Society', u'Transcept Pharmaceuticals Inc', u'IDEC Pharmaceuticals Corp', u'Hercules Capital Inc', u'US Government', u'Biogen Inc', u'Eutropics Pharmaceuticals Inc', u'Pharmacyclics Inc', u'GlaxoSmithKline plc', u'KineMed Inc', u'BTG plc', u'Quintiles Transnational Corp', u'Windtree Therapeutics Inc', u'Bayer Schering Pharma AG', u'Idun Pharmaceuticals Inc', u'Australian Nuclear Science & Technology Organization', u'MethylGene Inc', u'Seattle Genetics Inc', u'MedImmune LLC', u'University of Michigan', u'Veristat, Inc.', u'University of Pennsylvania', u'Fred Hutchinson Cancer Research Center', u'The Medicines Company', u'Dutch-Belgian Cooperative Trial Group for Hematology Oncology', u'Aegera Therapeutics Inc', u'Takeda Oncology', u'Hybrigenics SA', u'Roche Holding AG', u'NantHealth Inc', u'Neon Therapeutics', u'BioSavita Inc', u'GLG Pharma LLC', u'Kite Pharma Inc', u'Medac GmbH', u'Vasogen Inc', u'KuDOS Pharmaceuticals Ltd', u'TESARO Inc', u'Nordic Nanovector ASA', u'Loxo Oncology Inc', u'TG Therapeutics Inc', u'American BriVision Corporation', u'Dana-Farber Cancer Institute Inc', u'University Of Southampton', u'Nanjing Yoko Pharmaceutical Co Ltd', u'Sprint Bioscience', u'International Biotechnology Center Generium LLC', u'Alexis Biotech Ltd', u'Trubion Pharmaceuticals Inc', u'Apexigen Inc', u'MD Anderson Cancer Center', u'The University of Aston In Birmingham', u'Medarex Inc', u'Cancer Genetics Inc', u'Daiichi Sankyo Co Ltd', u'Abbott Laboratories', u'Eisai Co Ltd', u'Lynx Therapeutics GmbH', u'Presage Biosciences', u'Boehringer Mannheim GmbH', u'US Health and Human Services Department', u'National Cancer Institute', u'MediGene AG', u'Korea Research Institute of Bioscience and Biotechnology', u'Teva Pharmaceutical Industries Ltd', u'I N C Research LLC', u'Pharmacopeia Inc', u'Eagle Pharmaceuticals Inc', u'CryoPort Inc', u'WuXi PharmaTech (Cayman) Inc', u'Enzon Pharmaceuticals Inc', u'Laureate Biopharmaceutical Services Inc', u'Kancera AB', u'Goodwin Biotechnology Inc', u'Immunomedics Inc', u'Janssen Pharmaceutical KK', u'SymBio Pharmaceuticals Ltd', u'Piramal Enterprises Ltd', u'BlackSwan Pharma GmbH', u'Fougera Pharmaceuticals Inc', u'Millennium Pharmaceuticals Ltd', u'LifeArc', u'Midatech Pharma US Inc', u'Micromet Inc', u'Titan Pharmaceuticals Inc', u'CytRx Corp', u'Boehringer Ingelheim Corp', u'Myriad Genetics Inc', u'University of California San Diego', u'Infinity Pharmaceuticals Inc', u'Juno Therapeutics Inc', u'BioInvent International AB', u'Innovent Biologics Inc', u'Royalty Pharma', u'Rosetta Genomics Ltd', u'Bar-Ilan Research & Development Co Ltd', u'ILEX Oncology Inc', u'Cell Pathways Inc', u'Verastem Inc', u'Chugai Pharmaceutical Co Ltd', u'Duke University Medical Center', u'Ortho Biotech Products LP', u'Genentech Inc', u'IDIS Ltd', u'Southern Research Institute', u'Oncternal Therapeutics Inc', u'Oxford BioMedica plc', u'Boots Hoechst Celanese', u'Bradley Pharmaceuticals Inc', u'Areva Med LLC', u'Meditrina Pharmaceuticals Inc', u'Seikagaku Corp', u'Massachusetts Institute of Technology', u'Tufts University School of Medicine', u'Cellectar Biosciences Inc', u'Emergent BioSolutions Inc', u'ImmunoCellular Therapeutics Ltd', u'XOMA Corp', u'Burroughs Wellcome International Ltd', u'Merck & Co Inc', u'Zenyaku Kogyo Co Ltd', u'Scripps Research Institute', u'Redx Oncology Ltd', u'Ascentage Pharma Group Corporation Ltd', u'Sanofi', u'Vion Pharmaceuticals Inc', u'CTI BioPharma Corp', u'Eli Lilly & Co', u'Biolite Inc', u'CASI Pharmaceuticals Inc', u'Bayer AG', u'Pharsight Corp', u'Institut Necker', u'Kyowa Hakko Kirin Co Ltd', u'Immune Therapeutics Inc', u'Astellas Pharma GmbH', u'InNexus Biotechnology Inc', u'Janssen Biotech Inc', u'University of California Los Angeles', u'University of Kansas Medical Center', u'Leukaemia and Lymphoma Research', u'AstraZeneca plc', u'Pfizer Inc', u'Gilead Sciences Inc', u'Corixa Corp', u'Cancer Research Technology Ltd', u'Undisclosed', u'Genta Inc', u'Columbia University', u'Genor Biopharma Co Ltd', u'Celltrion Healthcare Co Ltd', u'AnorMED Inc', u'Innate Pharma SA', u'AbbVie Inc', u'Genmab A/S', u'Paul Scherrer Institut', u'University of Utah', u'Pfanstiehl Laboratories Inc', u'Taisho Pharmaceutical Co Ltd', u'Nerviano Medical Sciences Srl', u'Ligand Pharmaceuticals Inc', u'GeneGo Inc', u'Lonza Group AG', u'SmithKline Beecham plc', u'Servier', u'National Institutes of Health', u'Salmedix Inc', u'Food and Drug Administration', u'Bristol-Myers Squibb Co', u'Tolero Pharmaceuticals Inc', u'Aventis SA', u'MorphoSys AG', u'Evotec (UK) Ltd', u'Ohio State University', u'US Oncology Inc', u'Fujifilm Diosynth Biotechnologies', u'Columbia University Medical Center', u'Celgene Corp', u'Memgen LLC', u'Transgenomic Inc', u'Ascenta Therapeutics Inc', u'Antisoma plc', u'Avella', u'Coulter Pharmaceutical Inc', u\"Brigham & Women's Hospital\", u'BeiGene Co Ltd', u'Biologics Inc', u'Novartis AG', u'Accelis Pharma', u'Bioenvision Inc', u'University of Cambridge', u'DRI Capital', u'Tragen Pharmaceuticals', u'Prospect Therapeutics Inc']), u'HSV-2infection': set([u'US Government', u'Profectus BioSciences Inc', u'University of Gothenburg', u'Henderson Morley plc', u'Wyeth Pharmaceuticals', u'Upsher-Smith Laboratories Inc', u'Vaccibody AS', u'CEL-SCI Corp', u'Harvard Medical School', u'Genocea Biosciences Inc', u'Molecular Express Inc', u'Admedus Immunotherapies', u'GenVec Inc', u'National Institute of Allergy and Infectious Diseases', u'SmithKline Beecham plc', u'SRI International', u\"Cincinnati Children's Hospital Medical Center\", u'Novartis AG', u'Vical Inc', u'Sealy Center for Vaccine Development', u'California State Polytechnic University', u'University of California', u'Amistad Pharma SAS', u'Okamoto Industries', u'University of Washington', u'Fred Hutchinson Cancer Research Center', u'VINNOVA', u'AiCuris Anti-infective Cures GmbH', u'Simplexia', u'Starpharma Holdings Ltd', u'NanoBio Corp', u'Southern Illinois University', u'Washington University in St Louis', u'Indiana University', u'Nereus Pharmaceuticals Inc', u'Isconova AB', u'University of California San Diego', u'Biomedical Research Models Inc', u'Alnylam Pharmaceuticals Inc', u'Novactyl Inc']), u'Livertransplantrejection': set([u'SatRx Llc', u'Janssen-Cilag Ltd', u'Dompe Group', u'Chiesi Farmaceutici SpA', u'Isogenis Inc', u'Astellas Pharma Inc', u'Novartis AG', u'Fujisawa Pharmaceutical Co Ltd', u'Bristol-Myers Squibb Co', u'National Institute of Diabetes, Digestive and Kidney Diseases', u'Veloxis Pharmaceuticals A/S', u'National Institute of Allergy and Infectious Diseases', u'Hikma Pharmaceuticals plc', u'Taiba Pharma LLC', u'Massachusetts General Hospital', u'University of Pittsburgh Medical Center']), u'Glycogenstoragedisease1a': set([u'Viking Therapeutics Inc', u'Dimension Therapeutics Inc', u'REGENXBIO Inc', u'Duke University', u'PoC Capital LLC', u'Ligand Pharmaceuticals Inc']), u'Boneresorption': set([u'Novartis AG', u'Mylan Inc', u'Scripps Florida', u'Korea Research Institute of Chemical Technology', u'The National Institute of Mental Health', u'Ewha Womans University', u'Sebela Pharmaceuticals Inc']), u'Dermatologicaldisease': set([u'INTEGA Skin Sciences Inc', u'University of Bristol', u'Signum Biosciences Inc', u'ICTV Brands', u'Cato BioVentures', u'Ultimark Products', u'Altropus Gmbh', u'Ceragenix Pharmaceuticals Inc', u'TRM Korea', u'Artes Medical', u'Igeneon GmbH', u'MedPharm Ltd', u'Fluence Therapeutics Inc', u'Oclassen Pharmaceuticals Inc', u'Xycrobe Therapeutics Inc', u'Dermavant Sciences', u'Erasmus University Medical Center Rotterdam', u'Merck Sharp & Dohme Corp', u'Avidas Pharmaceuticals LLC', u'Johnson & Johnson Consumer Cos Inc', u'Botulinum Toxin Research Associates Inc', u'Intendis GmbH', u'Foamix Pharmaceuticals Ltd', u'National Hellenic Research Foundation', u'Jurox Pty Ltd', u'New York University', u'Biomedica Life Sciences SA', u'Portola Pharmaceuticals Inc', u'Glenmark Pharmaceuticals Ltd', u'Croma Pharma GmbH', u'PIQUR Therapeutics Ltd', u'Barrier Therapeutics Inc', u'Agennix AG', u'Solvay Pharmaceuticals Inc', u'PharmaDerm', u'ISDIN SA', u'University of Manchester', u'MedCision LLC', u'Nuvo Pharmaceuticals Inc', u'Cilag AG', u'Starpharma Holdings Ltd', u'Comvita New Zealand Ltd', u'Access Business Group International', u'INDEE Medical', u'Genfit SA', u'Nestle SA', u'Thermigen Llc', u'DS Healthcare Group Inc', u'AmorePacific Corp', u'Biotech Lab Singapore Pte Ltd', u'Nuevolution A/S', u'Revance Therapeutics Inc', u'Protea Biosciences Inc', u'Daewoong Pharmaceutical Co Ltd', u'LEO Pharma A/S', u'Demegen Inc', u'Ferndale Laboratories Inc', u'Eli Lilly & Co', u'Thesan Pharmaceuticals Inc', u'Prodermiq', u'PAZ Arzneimittelentwicklungsgesellschaft GmbH', u'PharmaEssentia Corp', u'Stiefel', u'National Institute on Aging', u'Xgene Corp', u'Crescita Therapeutics Inc', u'Akorn Inc', u'Johnson & Johnson', u'GlycoMar Ltd', u'AbbVie Inc', u'Colour Collective', u'Vixen Pharmaceuticals Inc', u'Midwood Distributors Inc', u'University of Strathclyde', u'Knight Therapeutics Inc', u'OSEO', u'AmDerma Pharmaceuticals', u'Obagi System', u'Fourth Military Medical University PLA', u'Cutanea Life Sciences Inc', u'Leo Pharma Inc', u'Beijing Northland Biotech Co Ltd', u'Innovative Pharmaceutical Concepts (IPC) Inc', u'Toray Industries Inc', u'Paramount BioSciences LLC', u'EGeen International Corp', u'Hayashibara Co Ltd', u'Suneva Medical Inc', u'Laboratorios Ojer Pharma SL', u'Hexal AG', u'Promius Pharma LLC', u'Merz North America', u'Uni-Bio Science Group Ltd', u'Avita Medical Ltd', u\"Sookmyung Women's University\", u'Mayne Pharma Group Ltd', u'Phagelux Inc', u'Sanofi Consumer Health Inc', u'Stanford University', u'Pharma Cosmetics Laboratories Ltd', u'Fidia Farmaceutici SpA', u'University of Pennsylvania', u'OncoTech LLC', u'Reckitt Benckiser plc', u'TOLMAR Therapeutics Inc', u'RepliCel Life Sciences Inc', u'ANI Pharmaceuticals Inc', u'Ember Therapeutics', u'Tenax Therapeutics Inc', u'Eukarion Inc', u'Alliance Pharma plc', u'OptiBiotix Health plc', u'Primus Pharmaceuticals Inc', u'HanAll Biopharma Co Ltd', u'Maruho Co Ltd', u'Alberta Research Council', u'Endo Health Solutions Inc', u'Galena Biopharma Inc', u'Bionpharma Inc', u'Laguna Blends Inc', u'Repair-A Ltd', u'NC3Rs', u'Newcells Biotech', u'Dermata Therapeutics LLC', u'SkyePharma plc', u'Massachusetts General Hospital', u'Tanabe Seiyaku Co Ltd', u'Astellas Pharma Inc', u'Basilea Pharmaceutica International Ltd', u'Biotoxtech Co Ltd', u'Topokine Therapeutics', u'Echo Therapeutics Inc', u'Parabolic Drugs Ltd', u'Prasco Laboratories', u'Allergan Inc', u'Particle Sciences Inc', u'AlphaMed Pharmaceuticals Corp', u'Genentech Inc', u'TransDerm Inc', u'Kemin Pharma Europe', u'Rigel Pharmaceuticals Inc', u'Sinclair Pharma plc', u'Institut Biochimique SA', u'Ansata Therapeutics Inc', u'Scripps Research Institute', u'University of Southern California', u'Sonoma Pharmaceuticals Inc', u'AiVita Biomedical', u'Japan Tobacco Inc', u'Pierre Fabre SA', u'Bioglan Pharmaceuticals Co', u'Cubist Pharmaceuticals Inc', u'AstraZeneca plc', u'Dermik Laboratories Inc', u'Intercytex Ltd', u'SUGEN Inc', u'Horizon Pharma plc', u'Carrington Laboratories Inc', u'Nobel Biocare Ab (Publ)', u'Academia Sinica', u'Technical University of Lodz', u'PPD Dermatology Inc', u'Medy-Tox Inc', u'Mochida Pharmaceutical Co Ltd', u'MatTek Corp', u'Ligand Pharmaceuticals Inc', u'Alfa Wassermann SpA', u'Valeant Canada', u'Abeona Therapeutics Inc', u'ProMetic Life Sciences Inc', u'ZARS Pharma Inc', u'Pulse Biosciences Inc', u'Valeant Pharmaceuticals International Inc', u'Coapt Systems Inc', u\"Brigham & Women's Hospital\", u'BIOMEDX Group', u'Takeda Pharmaceutical Co Ltd', u'TopoTarget A/S', u'Medimetriks Pharmaceuticals Inc', u'Zen-Bio Inc', u'Biostar Pharmaceuticals Inc', u'Prestige Brands Holdings Inc', u'Merck Sharp & Dohme BV', u'Anika Therapeutics Inc', u'US Government', u'Il-Yang Pharmaceutical Co', u'Microbion Corp', u'Cosmo Pharmaceuticals SpA', u'Meyer Pharmaceuticals LLC', u'Moberg Pharma AB', u'ALPHAEON Corp', u'Acologix Inc', u'OSI Pharmaceuticals Inc', u'Arriva Pharmaceuticals Inc', u'Cipher Pharmaceuticals Inc', u'SkinMedica Inc', u'Symbollon Pharmaceuticals Inc', u'Biomatrix Inc', u'Senetek plc', u'leon-nanodrugs GmbH', u'Villani inc', u'Wroc\\u0142aw University Of Technology', u'Zelmic Technologies AB', u'Angion Biomedica Corp', u'Stratford Pharmaceuticals', u'Mylan Inc', u'Pediapharm Inc', u'Dow Pharmaceutical Sciences', u'University of Dundee', u'IGI Inc', u'Athenex Inc', u'Clinuvel Pharmaceuticals Ltd', u'Briggs Medical Service Co', u'Amarillo Biosciences Inc', u'Boehringer Ingelheim International GmbH', u'DRAXIS Pharma Inc', u'Cellastra Inc', u'Helix BioMedix Inc', u'Carrus Capital Corp', u'Exeltis USA Dermatology Llc', u'AnGes MG Inc', u'Boehringer Ingelheim Corp', u'EPI Health LLC', u'Florida Gulf Coast University', u'Graceway Pharmaceuticals Inc', u'Dura Pharmaceuticals Inc', u'G-treeBNT Co Ltd', u'American Skin Association', u'Connetics Corp', u'Biofrontera AG', u'Miravant Medical Technologies', u'Microa As', u'Histogen Inc', u'Cipla Ltd', u'Dermadis SAS', u\"L'Oreal SA\", u'Kythera Biopharmaceuticals Inc', u'Merck & Co Inc', u'OAO \"Akrikhin\"', u'Montana Department of Commerce', u'Bicosome', u'Sanofi', u'Johnson & Johnson Consumer Products Inc', u'University of Patras', u'Columbia University', u'DERMACYTE Switzerland', u'Bayer AG', u'Pharmacia Corp', u'Beacon Pharmaceuticals', u'GeNOsys Inc', u'BioChemics Inc', u'Case Western Reserve University', u'Almirall Prodesfarma SA', u'LaRon Pharma Inc', u'Gilead Sciences Inc', u'Caladrius Biosciences Inc', u'4SC AG', u'Antares Pharma Inc', u'Q-Med AB', u'Geneva Pharmaceuticals Technology Corp', u'TEC-PHARMA SA', u'Science to Consumers Inc', u'DUSA Pharmaceuticals Inc', u'Cynosure Inc', u'Smith & Nephew Biotherapeutics', u'Nihon Nohyaku Co Ltd', u'BMG Pharma LLC', u'Aventis SA', u'MorphoSys AG', u'HRA Pharma', u'Mundipharma Korea Ltd', u'Teb Sanaat Lotus', u'Ethicor Pharma Ltd', u'Interleukin Genetics Inc', u'Ranbaxy Laboratories Ltd', u'Boehringer Ingelheim Austria GmbH', u'Med Discovery SA', u'Digna Biotech SL', u'Pernix Therapeutics Holdings Inc', u'Chemex Pharmaceuticals Inc', u'Quest PharmaTech Inc', u'Berlex Laboratories Inc', u'Peroxychem Llc', u\"Dr Reddy's Laboratories Ltd\", u'Perrigo Co Ltd', u'Baxter International Inc', u'InterMune Inc', u'Biogen Inc', u'UMeWorld Ltd', u'Renaissance Acquisition Holdings LLC', u'GlaxoSmithKline plc', u'Afecta Pharmaceuticals', u'Bayer Schering Pharma AG', u'Universkin', u'Ipsen', u'Riso Pharma Tech', u'Protein Mechanics Inc', u'Nextcell Medical', u'Halozyme Therapeutics Inc', u'Abbott Healthcare Products BV', u'Cytochroma Inc', u'Laboratoires Biocodex', u'Key Organics Ltd', u'Reata Pharmaceuticals Inc', u'GlaxoSmithKline Inc', u'Aclaris Therapeutics Inc', u'Shionogi & Co Ltd', u'UCB SA', u'Lipogrid', u'Spanish Ministry of Science and Innovation', u'York Pharma plc', u'Crown Laboratories Inc', u'Ducere Pharma LLC', u'MIKA Pharma GmbH', u'Micreos BV', u'Daiichi Sankyo Co Ltd', u'Derma Sciences Inc', u'GlaxoSmithKline Consumer Healthcare Ltd', u'National Cancer Institute', u'Combinature Biopharm AG', u'Fujisawa Pharmaceutical Co Ltd', u'Molecular Design International Inc', u'SonoLight Pharmaceuticals Corp', u'BioScience Laboratories Inc', u'Astellas Institute for Regenerative Medicine', u'PhotoMedex Inc', u'Adolor Corp', u'JAKPharm LLC', u'Dermira Inc', u'Ferrer Internacional SA', u'Laboratorios Dermatologicos Darier SA', u'Sol-Gel Technologies Ltd', u'SWITCH Biotech AG', u'Chugai Pharmaceutical Co Ltd', u'Undisclosed', u'Samsung Medical Center (SMC)', u'Fibercell Systems Inc', u'Medicis Pharmaceutical Corp', u'Otsuka Pharmaceutical Co Ltd', u'GALENpharma GmbH', u'Avadim Technologies Inc', u'Allergan plc', u'Protein Genomics Inc', u'Medx Health Corp', u'Maxygen Holdings Ltd', u'Promore Pharma', u'Yield10 Bioscience Inc', u'Organogenesis Inc', u'ISO International LLC', u'Galderma SA', u'PharmaMar SA', u'Cellmid Ltd', u'NovaBiotics Ltd', u'Hygeia Therapeutics Inc', u'The University of Newcastle Upon Tyne', u'RegeneRx Biopharmaceuticals Inc', u'Peptaderm Sp zoo', u'Shaman Pharmaceuticals Inc', u'Biosolution Co Ltd', u'Pfizer Inc', u'Collegium Pharmaceutical Inc', u'Melinta Therapeutics Inc', u'Yale University', u'Tsumura & Co', u'Avontec GmbH', u'Sandoz Inc', u'Block Drug Co Inc', u'BioLineRx Ltd', u'Malvern Cosmeceutics Ltd', u'Luqa Pharmaceuticals', u'Genus Pharmaceuticals Ltd', u'Ochoa Laboratories Ltd', u'General Biologicals Corp', u'PhotoCure ASA', u'National Institutes of Health', u'Visualant Inc', u'Grannus BioSciences Ltd', u'Vitae Pharmaceuticals Inc', u'The Menarini Group', u'Dompe Group', u'Brickell Biotech Inc', u'Maruishi Pharmaceutical Co Ltd', u'Cca Industries Inc', u'University of California Irvine', u'Equity Labs Inc', u'Pacgen Life Science Corp', u'RXi Pharmaceuticals Corp']), u'Cushingssyndrome': set([u'GyeongGi Bio Center', u'William Harvey Research Ltd', u'Temple University', u'LifeArc', u'US Department of the Treasury', u'HRA Pharma', u'Incheon National University', u'Yonsei University', u'Queen Mary University of London', u'IDIS Ltd', u'Cortendo AB', u'Formulation Technologies LLC', u'CEOLIA Pharma Co Ltd', u'Corcept Therapeutics Inc']), u'Lassafever': set([u'ViroPharma Inc', u'US Government', u'University of Maryland Baltimore County', u'Tulane University', u'NOWDiagnostics Inc', u'SIGA Technologies Inc', u'National Institutes of Health', u'GeoVax Labs Inc', u'Wellcome Trust', u'National Institute of Allergy and Infectious Diseases', u'Kineta Inc', u'United States Army Medical Research Institute of Chemical Defense', u'Chembio Diagnostic Systems Inc', u'Scripps Research Institute', u'Zalgen Labs LLC', u'The Paul G. Allen Family Foundation', u'National Center For Advancing Translational Sciences']), u'Thromboembolism': set([u'Daiichi Seiyaku Co Ltd', u'Oscient Pharmaceuticals Corp', u'Speedel Holding AG', u'Korea Institute of Science and Technology', u'Peptisyntha Inc', u'Mount Sinai School of Medicine', u'Yuhan SP Corp', u'Apeloa Pharmaceutical Co Ltd', u'Warner-Lambert Co', u'Inovio Pharmaceuticals Inc', u'Telios Pharmaceuticals Inc', u'Bayer Schering Pharma AG', u'Uppsala University', u'Russian Federation', u'Variagenics Inc', u'Vernalis plc', u'TMS Co Ltd', u'Boehringer Ingelheim Pharma KG', u'Mitsubishi-Tokyo Pharmaceuticals Inc', u'Boehringer Ingelheim Korea Ltd', u'Takeda Oncology', u'Roche Holding AG', u'Sandoz Ltd', u'Kaketsuken', u'Hovione Inter Ltd', u'Sankyo Co Ltd', u'Asahi Kasei Pharma Corp', u'Toray Industries Inc', u'Trigen GmbH', u'HanAll Biopharma Co Ltd', u'National Heart Lung and Blood Institute', u'Esteve', u\"Fundacio Privada I Institut De Recerca De L'Hospital De La Santa Creu I Sant Pau\", u'Southeast University', u'Shire BioChem Inc', u'Meiji Seika Pharma Co Ltd', u'Aralez Pharmaceuticals Inc', u'Biopharm (UK) Ltd', u'Kanebo KK', u'Daiichi Sankyo Co Ltd', u'Abbott Laboratories', u'Boehringer Mannheim GmbH', u'Novartis AG', u'Merck KGaA', u'PAION AG', u'Vanderbilt University', u'Sanofi-Synthelabo', u'GlaxoSmithKline plc', u'Astellas Pharma Inc', u'Pharmacia KK', u'Universit\\xe4ts-Herzzentrum Freiburg Bad KrozingenKlinik f\\xfcr Kardiologie und Angiologie II', u'Adolor Corp', u'Kyorin Pharmaceutical Co Ltd', u'LG Chem Ltd', u'Encysive Pharmaceuticals Inc', u'Hoffmann-La Roche Inc', u'DuPont Pharmaceuticals Ltd', u'United Therapeutics Corp', u'F Hoffmann-La Roche AG', u'Showa Pharmaceutical University', u'Terumo Corp', u'Genentech Inc', u'Mitsubishi Pharma Corp', u'CVPath Institute', u'TeaRx LLC', u'Bayer Yakuhin Ltd', u'Synthelabo SA', u'Shanghai Institute of Materia Medica of the Chinese Academy of Sciences', u'Diosynth Biotechnology', u'Merck & Co Inc', u'LEO Pharma A/S', u'COR Therapeutics Inc', u'Sanofi', u'UBE Industries Ltd', u'Tokyo University of Agriculture & Technology Co Ltd', u'Eli Lilly & Co', u'Berlex Biosciences', u'Japan Tobacco Inc', u'Bayer AG', u'Thrombosis Research Institute', u'Navigo Proteins GmbH', u'Torii Pharmaceutical Co Ltd', u'Hepar Industries Inc', u'University of Tennessee', u'Hyundai Pharmaceutical', u'Janssen Biotech Inc', u'Teijin Ltd', u'Pfizer Inc', u'Kaken Pharmaceutical Co Ltd', u'Japan Energy Corp', u'Wyeth-Ayerst Pharmaceuticals Inc', u'Sandoz Inc', u'Wyeth', u'Kitasato Institute', u'Research Corporation Technologies', u'Nippon Shinyaku Co Ltd', u'Baylor College of Medicine', u'Portola Pharmaceuticals Inc', u'Daiichi Sankyo Inc', u'DevCo Pharmaceuticals Ltd', u'SmithKline Beecham plc', u'Dendreon San Diego LLC', u'Yamanouchi Pharmaceutical Co Ltd', u'Grupo Uriach', u'Organon A/S', u'Bristol-Myers Squibb Co', u'Myungin Pharm Co Ltd', u'The Medicines Company', u'Nanogen Inc', u'Takata Seiyaku', u'ESP Pharma Inc', u'European Society of Cardiology', u'Canyon Pharmaceuticals Inc', u'Biovail Corp', u'Janssen Pharmaceuticals Inc', u'Nanjing Zhongrui Pharmaceutical Co Ltd', u'MannKind Corp', u'Bristol-Myers Squibb Pharma Co', u'Gedeon Richter Ltd', u'Beth Israel Deaconess Medical Center', u'Universite Pierre et Marie Curie', u'Thallia Pharmaceuticals SA']), u'Cornealdisease': set([u'Sankyo Co Ltd', u'Scope Ophthalmics', u'US Government', u'JCR Pharmaceuticals Co Ltd', u'Japan Innovative Therapeutics Inc', u'Gene Signal SAS', u'The Doshisha', u'Mobius Therapeutics Inc', u'Medical Need Europe AB', u'Emmaus Medical Inc', u'CellSeed Inc', u'Bio-Tissue Inc', u'R-Tech Ueno Ltd', u'National Eye Institute', u'Santen Pharmaceutical Co Ltd', u'Yamaguchi University', u'Cedars-Sinai Medical Center']), u'Alcoholicliverdisease': set([u'Metabolic Technologies Inc', u'Extend Biosciences Inc', u'National Institute on Alcohol Abuse and Alcoholism', u'Immuron Ltd', u'Vanderbilt University', u'RTI International', u'Immune Biologics Pty Ltd']), u'Skintumor': set([u'AusIndustry', u'Terumo Corp', u'Singapore Technologies Pte Ltd', u'Diomed Ltd', u'CadheRx Therapeutics Inc', u'Xenova Ltd', u'Australian Government', u'University of Florida', u'ASAT AG Applied Science & Technology', u'Maruho Co Ltd', u'Biofrontera AG', u'Cancer Research Campaign Technology Ltd', u'Otsuka Pharmaceutical Co Ltd', u'DUSA Pharmaceuticals Inc', u'MEI Pharma Inc', u'Mochida Pharmaceutical Co Ltd', u'Commonwealth Scientific and Industrial Research Organization', u'Inovio Pharmaceuticals Inc', u'National Cancer Institute', u'Bayer Schering Pharma AG', u'Yamanouchi Pharmaceutical Co Ltd', u'National Institutes of Health', u'Daewoong Pharmaceutical Co Ltd', u'biolitec AG', u'Efamol', u'Astex Pharmaceuticals Inc', u'Inflazyme Pharmaceuticals', u'Novogen Ltd', u'Biosceptre International Ltd', u'Miravant Medical Technologies', u'Pharma Patch plc', u'Parabolic Drugs Ltd', u'Stony Brook University Hospital', u'Medicis Pharmaceutical Corp', u'Biofrontera Bioscience GmbH', u'Niadyne Pharma Inc', u'Stiefel', u'Hayashibara Co Ltd', u'Boehringer Ingelheim Corp', u'DPT Laboratories', u'Kyowa Hakko Kogyo Co Ltd', u'National Heart Lung and Blood Institute', u'Vectorite Biomedica Inc', u'Radient Pharmaceuticals Corp', u'Suntory Ltd', u'Scotia Holdings plc']), u'Papillomavirusinfection': set([u'Daiichi Seiyaku Co Ltd', u'Solvay Arzneimittel GmbH', u'Etubics Corp', u'US Government', u'Texas Emerging Technology Fund', u'Henderson Morley plc', u'Intronn Inc', u'Advaxis Inc', u'Cancer Research Campaign Technology Ltd', u'Roche Molecular Systems Inc', u'Netherlands Government', u'Oncovir Inc', u'Xiamen University', u'Polydex Pharmaceuticals Ltd', u'GlaxoSmithKline plc', u'Zhejiang Academy Of Medical Sciences', u'Novavax Inc', u'Inovio Pharmaceuticals Inc', u'Cosmo Pharmaceuticals SpA', u'US Civilian Research and Development Foundation', u'Bayer Schering Pharma AG', u'Vical Inc', u'Valentis Inc', u'Chiron Corp', u'University of Queensland', u'Interferon Sciences Inc', u'University Of Southampton', u'Ionis Pharmaceuticals Inc', u'Strand Life Sciences', u'Xenova Group plc', u'Helix BioPharma Corp', u'Sagentia Ltd', u'Chinese Government', u'MedImmune LLC', u'Wyeth Pharmaceuticals', u'Fujian provincial government', u'Leiden University Medical Center', u'Imaxio', u'ShigaMediX', u'Clarity Imaging International', u'Contraceptive Research and Development Organization', u'Kaketsuken', u'Pharmacia & Upjohn Co', u'Jiangsu Ruike Biotechnology Co Ltd', u'Kite Pharma Inc', u'Genecor International Inc', u'Dynavax Technologies Corp', u'South Dakota State University', u'US Department of the Treasury', u'3M Pharmaceuticals', u'Emory University', u'Biomas Inc', u'The Althea Foundation', u'Genticel', u'JS Bio Pharm Co Ltd', u'Hospital de Cancer de Barretos - Fundacao Pio XII', u'Transgene SA', u'TrovaGene Inc', u'Sequenom Inc', u'Regina Elena Cancer Institute', u'National Health and Medical Research Council', u'Inex Pharmaceuticals Corp', u'Quantovir AB', u'Nventa Biopharmaceuticals Corp', u'Cell Pharm GmbH', u'GenoLac BL Corp', u'Chinese Academy of Medical Sciences', u'National Center for Research Resources', u'Rega Institute for Medical Research', u'Mast Therapeutics Inc', u'Artes Biotechnology', u'UniQuest Pty Ltd', u'Tulane University', u'University of Aberdeen', u'ApolloBio Corp', u'National Cancer Institute', u'MediGene AG', u'bioCSL PTY Ltd', u'Amarillo Biosciences Inc', u'Center for Translational Molecular Medicine', u'Georgetown University', u'MerLion Pharmaceuticals Pte Ltd', u'Teva Pharmaceutical Industries Ltd', u'Cantab Biopharmaceuticals Ltd', u'Italfarmaco SpA', u'TFS Corp', u'Agennix AG', u'Asembia', u'Indian Council of Medical Research', u'SciClone Pharmaceuticals Inc', u'SensiGen LLC', u'Verta Ltd', u'Taurus Pharma Gmbh', u'Vyriad', u'Pennsylvania State University', u'Graceway Pharmaceuticals Inc', u'Starpharma Holdings Ltd', u'Loyola University of Chicago', u'Fougera Pharmaceuticals Inc', u'Tessa Therapeutics Pte Ltd', u'AnGes MG Inc', u'Meditrina Pharmaceuticals Inc', u'Fujirebio Europe NV', u'Boehringer Ingelheim Corp', u'Santalis Healthcare Corporation', u'University of Bristol', u'Generex Biotechnology Corp', u'Carrus Capital Corp', u'F Hoffmann-La Roche AG', u'University of Oxford', u'KMS Therapeutics', u'Virionics Corp', u'FunPep Co Ltd', u'KuDOS Pharmaceuticals Ltd', u'Fraunhofer USA Inc', u'Stanford University', u'Agilvax Inc', u'Merck & Cie Schaffhausen', u'DelSite Biotechnologies Inc', u'Profectus BioSciences Inc', u'Bradley Pharmaceuticals Inc', u'Avesthagen Ltd', u'Papivax LLC', u'Global BioPharma Inc', u'NanoVir Llc', u'Zhejiang Pukang Biotechnology Co Ltd', u'Sinopharm', u'Xisle Pharma Ventures Trust', u'IncellDx Inc', u'Merck & Co Inc', u'Abivax', u'MRIGlobal', u'Virometix AG', u'Australian Research Council', u'Okamoto Industries', u'Isotechnika Pharma Inc', u'Touchlight Genetics Ltd', u'Cocrystal Pharma Inc', u'Tianjin Genstar Vaccine LLC', u'Bio-Bridge Science Inc', u'CSL Ltd', u'Deutsches Krebsforschungszentrum', u'Epimmune Inc', u'ViroPan Inc', u'Weizmann Institute of Science', u'FUJIFILM Holdings Corp', u'Disease Interception Accelerator', u'Genetic Immunity Kft', u'Canadian Department of National Defence', u'University of Missouri', u'Pharmatek Laboratories Inc', u'Gilead Sciences Inc', u'Advanced Cancer Therapeutics', u'Queensland University of Technology', u'Genencor International Inc', u'European Organization for Research and Treatment of Cancer', u'Undisclosed', u'Genexine Co Ltd', u'Unihart Corp', u'Johns Hopkins University', u'Memorial Sloan-Kettering Cancer Center', u'Johnson & Johnson', u'Ichor Medical Systems Inc', u'Qualia Clinical Service Inc', u'OriGenix Technologies Inc', u'PDS Biotechnology Corp', u'GeneCell Diagnostics Pvt. Ltd', u'Mojave Therapeutics Inc', u'PowderMed Ltd', u'Prima BioMed Ltd', u'National Institute of Allergy and Infectious Diseases', u'Takeda Pharmaceutical Co Ltd', u'Abzymo Biosciences Co Ltd', u'Bavarian Nordic A/S', u'Xiamen Innovax Biotech Co Ltd', u'King Pharmaceuticals Inc', u'Azanta A/S', u'Redbiotec AG', u'Morishita Jintan Co Ltd', u'Agency for Healthcare Research and Quality', u'Guangdong Medicine Group Corp', u'SmithKline Beecham plc', u'PhotoCure ASA', u'National Institutes of Health', u'Bill & Melinda Gates Foundation', u'University of Tokyo', u'Knight Therapeutics Inc', u'Japan Health Science Foundation', u'New Zealand government', u'Eczacibasi Ilac Pazarlama AS', u'University of Rochester', u'ISA Pharmaceuticals BV', u'Rush University Medical Center', u'JSC Binnopharm', u'ValiRx plc', u'Kentucky BioProcessing LLC', u'Bioleaders Corp', u'Roche Holding AG', u'Cutanea Life Sciences Inc', u'Ciba-Geigy AG', u'BC Cancer Agency', u'Duke University', u'Wistar Institute of Anatomy & Biology', u'Cancer Research UK Manchester Institute', u'Institut Pasteur', u'Merck Serono SA', u'BioSun Pharmed Co', u'Janssen Pharmaceuticals Inc', u'GC-Rise Pharmaceutical Co Ltd', u'Cepheid', u'Crucell NV', u'Idera Pharmaceuticals Inc', u'Hemispherx Biopharma Inc', u'Accelis Pharma', u'Kyowa Kirin', u'Epitome Pharmaceuticals Ltd', u'American Red Cross', u'University of Wales College of Medicine', u'BIAL Group', u'University of Cambridge', u'University of Louisville', u'University of Arkansas', u'NeoImmuneTech Inc', u'Enact Pharma plc', u'SK Chemicals Co Ltd', u'TOLMAR Therapeutics Inc']), u'Femaleinfertility': set([u'Biopasgroup', u'US Government', u'Amgen Inc', u'Ferring Research Ltd', u\"Teva Women's Health Inc\", u'ASKA Pharmaceutical Co Ltd', u'Allergan plc', u'Cell Genesys Inc', u'Suzhou Shengji Pharmaceutical Co Ltd', u'Actavis Inc', u'Metris Therapeutics Ltd', u'Ardana Bioscience Ltd', u'Healthcare Royalty Partners', u'PowderJect Pharmaceuticals plc', u'Pharmasure Ltd', u'Juniper Pharmaceuticals Inc', u'Myovant Sciences Ltd', u'Protalix BioTherapeutics Inc', u'Vyteris Inc', u'JCR Pharmaceuticals Co Ltd', u'Crescendo Pharmaceuticals Corp', u'Hafslund Nycomed Innovation AB', u'Roche Holding AG', u'ALZA Corp', u'MSD OSS BV', u'Ferring Pharmaceuticals SA', u'Astrazeneca Korea', u'Celmatix Inc', u'Itero Biopharmaceuticals LLC', u'AEterna Zentaris Inc', u'Merck Serono SA', u'Laboratoires Genevrier SA', u'Molecular Biosystems Inc', u'Washington University in St Louis', u\"Prince Henry's Institute of Medical Research\", u'Akzo Nobel NV', u'Shionogi & Co Ltd', u'Suzhou Kangju Biological Technology Co Ltd', u'Takeda Pharmaceutical Co Ltd', u'Johns Hopkins University School of Medicine', u'Alvogen Korea', u'Compugen Ltd', u'Zentaris GmbH', u'23andMe Inc', u'MetaMorphix Inc']), u'TaySachsdisease': set([u'National Tay-Sachs & Allied Diseases Association', u'Hospital for Sick Children', u'Actelion Ltd', u'National Institutes of Health', u'Food and Drug Administration', u'UCB SA', u'Teva Pharmaceutical Industries Ltd', u'ExSAR Corp', u'Oxford GlycoSciences plc', u'GD Searle & Co']), u'Fetalalcoholsyndrome': set([u'University of Louisville', u'National Institute on Alcohol Abuse and Alcoholism', u'University of Illinois']), u'MetabolicsyndromeX': set([u'Rockefeller University', u'New York University', u'InhibeX LLC', u'Wenzhou Medical College', u'DayTwo Ltd', u'University of Dundee', u'University of Nebraska', u'Maryland Technology Development Corp', u'Hadassah Medical Organization', u'Immuron Ltd', u'GlobalAcorn', u'Indian Institute of Chemical Technology', u'Regulus Therapeutics Inc', u'Bionovo Inc', u'National Center for Complementary and Alternative Medicine', u'Ontario Institute for Cancer Research', u'Sphaera Pharma', u'4Cyte Therapeutics Inc', u'Nano Terra Inc', u'Kadmon Pharmaceuticals LLC', u'Seres Therapeutics Inc', u'Canadian Institutes of Health Research', u'Netherlands Cancer Institute', u'Leiden University (NL)', u'Massachusetts General Hospital', u'University of California San Diego', u'Janssen Human Microbiome Institute', u'Cardero Therapeutics Inc', u'Ritter Pharmaceuticals Inc']), u'Hookworminfection': set([u'Brazilian Government', u'Sabin Vaccine Institute', u'Fraunhofer USA Inc', u'Bill & Melinda Gates Foundation', u'iBio Inc', u'National Institute of Allergy and Infectious Diseases', u'George Washington University', u'Dutch Ministry of Foreign Affairs', u'Fundacao Oswaldo Cruz (Fiocruz)']), u'Infectiouskeratoconjunctivitis': set([u'OPKO Health Inc', u'Redox Pharmaceutical Corp', u'Adenovir Pharma AB', u'VINNOVA', u'Umea University']), u'Renalsarcoma': set([u'Nottingham Trent University', u'The University of Birmingham', u'Cantab Biopharmaceuticals Ltd']), u'Jansky-Bielschowskydisease': set([u'University of Medicine and Dentistry of New Jersey', u'Weill Medical College of Cornell University', u'BioMarin Pharmaceutical Inc', u'REGENXBIO Inc', u'US Government', u'Microbot Medical Inc']), u'Encephalitis': set([u'AlphaVax Inc', u'US Government', u'American Federation for Aging Research', u'US Army Medical Research Institute of Infectious Diseases', u'National Institutes of Health', u'Sumitomo Dainippon Pharma Co Ltd', u'Koken Co Ltd', u'Alpha Cancer Technologies Inc', u'Merrimack Pharmaceuticals Inc', u'Metaphore Pharmaceuticals Inc', u'St Louis University', u'Acambis plc', u'Cedars-Sinai Medical Center']), u'Psychiatricdisorder': set([u'Biopasgroup', u'Karolinska Institutet', u'NovAliX', u'Brown University', u'Krenitsky Pharmaceuticals Inc', u'Turing Pharmaceuticals LLC', u'Luc Therapeutics Inc', u'MSD OSS BV', u'Prodotti Formenti Srl', u'Centre for Drug Research and Development', u'Psychiatric Genomics Inc', u'Alliance for Lupus Research', u'Swiss Federal Office of the Commission for Technology and Innovation', u'Mount Sinai School of Medicine', u'Palau Pharma SA', u'Forest Laboratories Inc', u'Ambit Biosciences Corp', u'GlaxoSmithKline plc', u'Vanda Pharmaceuticals Inc', u'Michigan Small Business and Technology Development Center', u'The EDI Institute', u'Senju Pharmaceutical Co Ltd', u'BioHaven Pharmaceutical Holding Co Ltd', u'Biotech Precision Berhad', u'Caraco Pharmaceutical Laboratories Ltd', u'Novartis Pharma AG', u'Aspire Capital Fund LLC', u'Hoechst-Roussel Pharmaceuticals Inc', u'Par Pharmaceutical Co Inc', u'Domain Therapeutics SA', u'Aestus Therapeutics Inc', u'University of Bonn', u'University of Pennsylvania', u'IMPAX Laboratories Inc', u'Takeda Oncology', u'Aurora Biosciences Corp', u'Advanced Targeting Systems Inc', u'INSERM', u'The National Institute of Mental Health', u'Orphagen Pharmaceuticals Inc', u'Virion Systems Inc', u'ANI Pharmaceuticals Inc', u'Ranbaxy Pharmaceuticals Inc', u'Embera NeuroTherapeutics Inc', u'Yale University', u'Shionogi & Co Ltd', u'Stony Brook Medicine', u'Sunovion Pharmaceuticals Inc', u'SAGE Therapeutics Inc', u'Emory University', u'Tanabe Seiyaku Co Ltd', u'NeuroSearch A/S', u'Avineuro Pharmaceuticals Inc', u'Sigma-Tau Ind Farm Riunite SpA', u'Evotec AG', u'National Health and Medical Research Council', u'Johnson & Johnson Pharmaceutical Research & Development LLC', u'NPS Allelix Corp', u'ConverGene LLC', u'International Business Machines Corp', u'Amgen Inc', u'RespireRx Pharmaceuticals Inc', u'Marinus Pharmaceuticals Inc', u'Harvard University', u'Abbott Laboratories', u'Mochida Pharmaceutical Co Ltd', u'NPS Pharmaceuticals Inc', u'Novartis AG', u'Merck KGaA', u'PsychoGenics Inc', u'Ex scientia Ltd', u'ACADIA Pharmaceuticals Inc', u'Louisiana State University Medical Center Foundation', u'Fujisawa Pharmaceutical Co Ltd', u'Ntz Lab Ltd', u'AfaSci Inc', u'SK Corp', u'Medical Research Council', u'moksha8 Pharmaceuticals Inc', u'McLean Hospital Corp', u'Astellas Pharma Inc', u'JCR Pharmaceuticals Co Ltd', u'Xceleron Ltd', u'Pentech Pharmaceuticals Inc', u'Affectis Pharmaceuticals AG', u'Pharmacopeia Inc', u'NeurOp Inc', u'Janssen-Ortho Inc (Canada)', u'Tetra Discovery Partners LLC', u'Anesta Corp', u'CeNeRx BioPharma Inc', u'Corcept Therapeutics Inc', u'McGill University', u'Janssen Pharmaceutica NV', u'Washington University in St Louis', u'Maruishi Pharmaceutical Co Ltd', u'Osaka University', u'Genaissance Pharmaceuticals Inc', u'PreveCeutical Medical Inc', u'Britannia Pharmaceuticals Ltd', u'University of California San Diego', u'Laboratoires Houde SA', u'Lonza Ltd', u'Camargo Pharmaceutical Services', u'Parke-Davis & Co', u'PKU International Healthcare Group Co Ltd', u'NovaMed Pharmaceuticals Inc', u'F Hoffmann-La Roche AG', u'H Lundbeck A/S', u'Prestwick Chemical Inc', u'National Institute of Neurological Disorders and Stroke', u'Active Pass Pharmaceuticals Inc', u'Galenea Corp', u'Wyeth Pharmaceuticals', u'Otsuka Pharmaceutical Co Ltd', u'Djavad Mowafaghian Centre for Brain Health', u'Wisconsin Department of Commerce', u'Circuit Therapeutics Inc', u'Bago', u'Academic Drug Discovery Consortium', u'Sumitomo Dainippon Pharma Co Ltd', u'Hamilton Pharmaceuticals Ltd', u'University of California', u'French Government', u'Amarin Corp plc', u'SK Biopharmaceuticals', u'Scripps Research Institute', u'Glaxo Group Ltd', u'Sanofi', u'Columbia University', u'Eli Lilly & Co', u'Tranzyme Pharma Inc', u'Addex Therapeutics Ltd', u'Eisai Inc', u'CoNCERT Pharmaceuticals Inc', u'Seaside Therapeutics Inc', u'Pierre Fabre SA', u'University of Maryland Baltimore County', u'ThioPharma Inc', u'IBM Watson Health Life Sciences', u'BioSeek Plc', u'Argenta Discovery Ltd', u'Hannover Medical School', u'SRI International', u'ReNeuron Group plc', u'AstraZeneca plc', u'Pfizer Inc', u'Neurocrine Biosciences Inc', u'EMERpharma Ltd', u'Universit\\xe9 De Strasbourg', u'BioProjet, Societe Civile de Recherche', u'The Stanley Medical Research Institute', u'Applied StemCell Inc', u'Promentis Pharmaceuticals Inc', u'Wyeth', u'Pherin Pharmaceuticals Inc', u'Yissum Research Development Co', u'SIBIA Neurosciences Inc', u'Boehringer Ingelheim Corp', u'Broad Institute Inc', u'Scotia Holdings plc', u'Ore Pharmaceuticals Inc', u'Memory Pharmaceuticals Corp', u'Sigma-Aldrich Corp', u'Scarista Ltd', u'Hoffmann-La Roche AG', u'University of Western Australia', u'Rigel Pharmaceuticals Inc', u'SmithKline Beecham Corp', u'Cenomed BioSciences LLC', u'Amylin Pharmaceuticals Inc', u'Korea National Enterprise for Clinical Trials', u'Takeda Pharmaceutical Co Ltd', u'Taisho Pharmaceutical Co Ltd', u'Cerecor Inc', u'XCell Science Inc', u'Northwestern University', u'UniQuest Pty Ltd', u'Chronos Therapeutics', u'National Institutes of Health', u'Southern Home Medical Inc', u'Sanford-Burnham Medical Research Institute', u'Bristol-Myers Squibb Co', u'deCODE chemistry', u'Arena Pharmaceuticals Inc', u'Aequus Pharmaceuticals Inc', u'Solvay Seiyaku KK', u'Spectrum Pharmaceuticals Inc', u'Bukwang Pharmaceutical Co Ltd', u'Janssen Research & Development LLC', u'Cephalon Inc', u'Takata Seiyaku', u'ChemDiv Inc', u'Therapix Biosciences Ltd', u'BioMed X GmbH', u'CyDex Pharmaceuticals Inc', u'Phytecs Inc', u'Retrophin Inc', u'Daiichi Pharmaceutical Corp', u'BioTie Therapies Corp', u'Avanir Pharmaceuticals Inc', u'Jubilant Life Sciences Ltd', u'Shire plc', u'Childrens Hospital of Philadelphia', u'Noven Pharmaceuticals Inc', u'University of Western Ontario', u'Janssen Pharmaceuticals Inc', u'Icagen Inc (pre-merger)', u'Roussel Uclaf Corp', u'Cypress Bioscience Inc', u'Gedeon Richter Ltd', u'Canadian Government', u'PAREXEL International', u'Nobilis Therapeutics LLC']), u'Hemolyticuremicsyndrome': set([u'Vifor Pharma', u'Tramedico International', u'PDL BioPharma Inc', u'Almac Group', u'Alexion Pharmaceuticals Inc', u'Pharmascience Inc', u'Uniformed Services University of the Health Sciences', u'Sunol Molecular Corp', u'National Institutes of Health', u'Greenovation Biotech GmbH', u'ChemoCentryx Inc', u'Sanofi Genzyme', u'Collegium Pharmaceutical Inc', u'Hawker Resources Inc', u'Goodwin Biotechnology Inc', u'Lakewood-Amedex Inc', u'Medical University of South Carolina', u'Tufts University', u'Caprion Pharmaceuticals Inc', u'Kissei Pharmaceutical Co Ltd', u'University of Colorado System', u'Teijin Ltd', u'Takeda Pharmaceutical Co Ltd', u'Taligen Therapeutics Inc', u'Alnylam Pharmaceuticals Inc', u'Albert-Ludwigs-Universit\\xe4t Freiburg']), u'Nicotinedependence': set([u'US Government', u'Dent Neuroscience Research Center', u'Recovery Pharmaceuticals Inc', u'Louisiana State University Medical Center Foundation', u'GlaxoSmithKline plc', u'University of Connecticut', u'Advanced Therapeutic Products, Inc', u'Marina Biotech Inc', u'Brookhaven National Laboratory', u'European Community', u'University of Pittsburgh', u'University of Pennsylvania', u'WhanIn Pharmaceutical Co Ltd', u'CeNeS Pharmaceuticals plc', u'Aviragen Therapeutics Inc', u'Somaxon Pharmaceuticals Inc', u'VaxLogic LLC', u'Vrije Universiteit van Amsterdam', u'Virginia Commonwealth University', u'Embera NeuroTherapeutics Inc', u'Netherlands Cancer Institute', u'ImmuLogic Pharmaceutical Corp', u'Sound Affects Life', u'AstraZeneca plc', u'Molecular Express Inc', u'Eolas Therapeutics Inc', u'European Molecular Biology Laboratory', u'Wake Forest University', u'Riemser Pharma GmbH', u'Cary Pharmaceuticals Inc', u'Chrono Therapeutics Inc', u'Catalyst Pharmaceutical Partners Inc', u'Achieve Life Science Inc', u'University of Dundee', u'Diosynth Inc', u'Promiliad Biopharma Inc', u'National Cancer Institute', u'Novartis AG', u'TRIA Bioscience Corp', u'Aradigm Corp', u'Invion Ltd', u'Georgetown University', u'22nd Century Group Inc', u'University of Minnesota', u'Lohmann Therapie-Systeme GmbH & Co KG', u'Hager Biosciences LLC', u'ALZA Corp', u'Biovail Corp', u'Numoda Corp', u'Pharmacia & Upjohn AB', u'Leiden University (NL)', u'Britannia Pharmaceuticals Ltd', u'Duke University', u'National Center for Complementary and Integrative Health', u'Duke University Medical Center', u'Harvard Medical School', u'Assuage Pharmaceuticals Inc', u'Able Laboratories Inc', u'Astellas Pharma Inc', u'Actavis Inc', u'Medivir AB', u'Alexza Pharmaceuticals Inc', u'Undisclosed', u'National Institute on Drug Abuse', u'Queen Mary University of London', u'Scripps Research Institute', u'Antidote Therapeutics Inc', u'Sanofi', u'Eli Lilly & Co', u'GlaxoSmithKline Biologicals', u'Addex Therapeutics Ltd', u'University of Miami', u'Agenus Inc', u'Pierre Fabre SA', u'IVAX Corp', u'Aktiv-Dry LLC', u'Pfizer Inc', u'Ciba-Geigy Corp', u'Yale University', u'University of Illinois', u'Beactica AB', u'Celtic Pharmaceutical Holdings LP', u'Massachusetts Institute of Technology', u'Takeda Pharmaceuticals International GmbH', u'Multimeric Biotherapeutics Inc', u'SmithKline Beecham plc', u'Cerecor Inc', u'Ceptaris Therapeutics Inc', u'IntelGenx Technologies Corp', u'National Institutes of Health', u'Eczacibasi Ilac Pazarlama AS', u'Janssen LP', u'Kuros Biosciences Ltd', u'Minneapolis Medical Research Foundation', u'Kentucky Science and Technology Corp', u'Cornell University', u'Dong Wha Pharmaceutical Co Ltd', u'Ciba-Geigy AG', u'BioTie Therapies Corp', u'RTI International', u'Institut Pasteur', u'Selecta Biosciences Inc', u\"Brigham & Women's Hospital\", u'Cypress Bioscience Inc', u'PsychoGenics Inc', u'OncoGenex Pharmaceuticals Inc', u'University of Cambridge']), u'Herpesvirustype8infection': set([u'University of North Carolina', u'National Cancer Institute', u'Microbiotix Inc', u'University of Virginia', u'Wistar Institute of Anatomy & Biology', u'National Institute of Allergy and Infectious Diseases', u'University of Southern California']), u'Pityriasiscapitisinfection': set([u'Moberg Pharma AB', u'Gebro Pharma GmbH']), u'Osteogenesisimperfecta': set([u'NovaPharm Therapeutics', u\"Lee's Pharmaceutical Holdings Limited\", u'Delivra Corp', u'ICON plc', u'Acceleron Pharma Inc', u'National Institute of Arthritis and Musculoskeletal and Skin Diseases', u'Mereo BioPharma Group Ltd', u'University of Sheffield', u'Novartis AG', u'Kalytera Therapeutics Inc', u'University of Missouri', u'Grunenthal GmbH', u'University of Washington', u'University of Michigan', u'Warner Chilcott plc', u'MorphoSys AG', u'Abiogen Pharma SpA', u'Ramot at Tel Aviv University Ltd', u'Asahi Kasei Pharma Corp']), u'Lebershereditaryopticatrophy': set([u'Pharmathen SA', u'Genethon', u'Santhera Pharmaceuticals AG', u'GenSight Biologics SA', u'Ewopharma AG', u'European Vision Institute Clinical Research Network (EVICR)', u'Institut de la Vision']), u'Riftvalleyfever': set([u'The Vaccine and Gene Therapy Institute of Florida', u'University of Texas Medical Branch at Galveston', u'National Institutes of Health', u'Defyrus Inc', u'Vanderbilt University', u'National Institute of Allergy and Infectious Diseases', u'US Government', u'University of Pittsburgh']), u'Ectopicpregnancy': set([u'Wayne State University', u'Meditrina Pharmaceuticals Inc']), u'Acutepromyelocyticleukemia': set([u'Nippon Shinyaku Co Ltd', u'Chugai Pharmaceutical Co Ltd', u'JW Pharmaceutical Corp', u'TMRC Co Ltd', u'PDL BioPharma Inc', u'Kanebo KK', u'Procaps Sas', u'Phebra Pty Ltd', u'OncBioMune Pharmaceuticals Inc', u'Eisai Co Ltd', u'Ligand Pharmaceuticals Inc', u'Stragen Group', u'Innovive Pharmaceuticals Inc', u'University of Tokyo', u'Sanofi Genzyme', u'Aronex Pharmaceuticals Inc', u'Heron Therapeutics Inc', u'Cephalon Inc', u'LOTUS Pharmaceutical Co Ltd (JAPAN)', u'US Government', u'ChemGenex Pharmaceuticals Ltd', u\"Children's Hospital of Los Angeles\", u'DKSH Business Unit Healthcare', u'F Hoffmann-La Roche AG', u'Janssen Pharmaceuticals Inc', u'Allergan Inc', u'Innovir Laboratories Inc', u'CytRx Corp', u'EPS Co Ltd', u'CHEPLAPHARM Arzneimittel GmbH', u'Fuji Pharma Co Ltd', u'Memorial Sloan-Kettering Cancer Center']), u'Amnesia': set([u'Eli Lilly & Co', u'Helicon Therapeutics Inc', u'Weston Brain Institute', u'Aptinyx Inc', u'Yunnan Spirin Biotechnology Co Ltd', u'Translational Genomics Research Institute', u'Amarantus BioScience Holdings Inc', u'BTG plc', u'Abiogen Pharma SpA', u'National Institutes of Health', u'Georgetown University', u'Chinese Government', u'Scripps Research Institute', u'MediProPharma Inc', u'Axonyx Inc', u'Chinese Academy of Sciences', u'Thomas Jefferson University', u'University of Wisconsin-Milwaukee', u'Kunming Institute of Botany The Chinese Academy of Sciences', u'Phytera Inc', u'IXICO Plc', u'Mitsubishi Tanabe Pharma Corp', u'Pharmacia & Upjohn Co', u'The National Institute of Mental Health', u'University of Western Ontario', u\"Arizona Alzheimer's Consortium\", u'National Institute on Aging', u'Boehringer Ingelheim Corp', u'The Institute of Radiation Medicine Academy of Military Medical Sciences PLA', u'Institute for the Study of Aging (ISOA), Ltd', u'Takeda Pharmaceutical Co Ltd', u'NeuroSearch A/S', u'Merck Sharp & Dohme Ltd']), u'Bacterialpneumonia': set([u'Daiichi Seiyaku Co Ltd', u\"Dr Reddy's Laboratories Ltd\", u'University of Texas Medical Branch at Galveston', u'EnBiotix Inc', u'Sanofi Pasteur', u'US Government', u'Iroko Pharmaceuticals LLC', u'US Health and Human Services Department', u'Forest Laboratories Inc', u'GlaxoSmithKline plc', u'Eddingpharm Inc', u'ZAI Laboratory Inc', u'Aventis Pharma AG', u'Clinigen Group plc', u'Peninsula Pharmaceuticals Inc', u'Sumitomo Pharmaceuticals Co Ltd', u'Dompe Group', u'Paratek Pharmaceuticals Inc', u'Polyphor Ltd', u'Purdue Pharma LP', u'Fujifilm Finechemicals Co Ltd', u'National Research Council of Canada', u'Meiji Seika Pharma Co Ltd', u'Wockhardt Ltd', u'Nventa Biopharmaceuticals Corp', u'Mylan Inc', u'Cystic Fibrosis Foundation Therapeutics Inc', u'Daiichi Sankyo Co Ltd', u'Abbott Laboratories', u'Lepetit International Inc', u'Innoviva Inc', u'ICON plc', u'Pendopharm', u'Teva Pharmaceutical Industries Ltd', u'Zeneca Group plc', u'Biovista Inc', u'SciClone Pharmaceuticals Inc', u'Lilly China Research & Development Co Ltd', u'Merus Labs International Inc', u'Astellas Pharma Inc', u'Concordia Pharmaceuticals Inc', u'ALZA Corp', u'Basilea Pharmaceutica International Ltd', u'Wellcome Trust', u'Taiho Pharmaceutical Co Ltd', u'Windtree Therapeutics Inc', u'MegaPharm Ltd', u'Janssen Pharmaceutica NV', u'Chiron PathoGenesis', u'Boehringer Ingelheim Corp', u'Royalty Pharma', u'Chugai Pharmaceutical Co Ltd', u'AMP-Therapeutics GmbH & Co KG', u'Macrolide Pharmaceuticals Inc', u'Advanced Life Sciences Holdings Inc', u'Bayer Korea Ltd', u'Unimedic AB', u'LTL Pharma Co Ltd', u'Yuhan Corp', u'Undisclosed', u'Sumitomo Dainippon Pharma Co Ltd', u'CUBRC', u'Sanofi', u'Melinta Therapeutics Inc', u'Chong Kun Dang Pharmaceutical Corp', u'Theravance Biopharma Inc', u'Bayer AG', u'US Army Medical Research Institute of Infectious Diseases', u'Cubist Pharmaceuticals Inc', u'AstraZeneca plc', u'Pfizer Inc', u'Midatech Pharma PLC', u'Emergex Vaccines Limited', u'Corixa Corp', u'Foundation for the National Institutes of Health', u'Toyama Chemical Co Ltd', u'Johnson & Johnson', u'Avir Pharma Inc', u'Tetraphase Pharmaceuticals Inc', u'National Institute of Allergy and Infectious Diseases', u'Cempra Inc', u'Abcombi Biosciences Inc', u'National Institutes of Health', u'Food and Drug Administration', u'Dainippon Pharmaceutical Co Ltd', u'The Medicines Company', u'Furiex Pharmaceuticals Inc', u'The Menarini Group', u'Kyowa Hakko Bio Co Ltd', u'TAP Pharmaceuticals Inc', u'Catalytica Inc', u'Ranbaxy Laboratories Ltd', u'Rhone-Poulenc SA', u'Takeda Pharmaceutical Co Ltd', u'Teligent Inc', u'Defense Threat Reduction Agency']), u'Streptococcusagalactiaeinfection': set([u'Tzamal Medical Group Ltd', u'Cardiome Pharma Corp', u'Intercell AG', u'Novartis AG']), u'Sexualdysfunction': set([u'VIVUS Inc', u'Medline Industries Inc', u'Henry Schein Inc', u'Oz Biogenics Ltd', u'Harvard Scientific Corp', u'Astra AB', u'GlaxoSmithKline plc', u'Bayer Schering Pharma AG', u'Perelman School of Medicine', u'Futura Medical plc', u'GeneOne Life Science Inc', u'CJ Corp', u'University of Pennsylvania', u'Corridor Pharmaceuticals Inc', u'Theragen ETEX', u'Senetek plc', u'Sae Han Pharmaceuticals', u'Actient Pharmaceuticals LLC', u'Cepheid', u'National Institute on Aging', u'Plethora Solutions Holdings plc', u'UCB SA', u'Apricus Biosciences Inc', u'Innovus Pharmaceuticals Inc']), u'Pharyngitis': set([u'SK Chemicals Life Science', u'Clonmel Healthcare', u'MiddleBrook Pharmaceuticals Inc', u'Innothera', u'Fourth Military Medical University PLA', u'Ilsung Pharmaceutical Co Ltd', u'Victory Pharma Inc', u'Biostar Pharmaceuticals Inc', u'DoctorDirectory', u'Sigma-Tau Ind Farm Riunite SpA', u'GlaxoSmithKline plc']), u'Opiatedependence': set([u'US Government', u'Indivior plc', u'Molecular Express Inc', u'Institute of Pharmacology and Toxicology Academy of Military Medical Sciences PLA', u'TheraKine Ltd', u'New York State Psychiatric Institute', u'Quintiles Transnational Corp', u'Maine Technology Institute', u'AntiOp Inc', u'Uppsala University', u'GeneAlign Inc', u'MonoSol Rx Inc', u'Vernalis plc', u'Virginia Commonwealth University', u'University of Bath', u'Beijing Wellso Pharmaceutical Co Ltd', u'Reckitt Benckiser plc', u'Somaxon Pharmaceuticals Inc', u'University of Kentucky', u'Catalent Inc', u'SWK Holdings Corporation', u'Omeros Corp', u'Scripps Research Institute', u'Panos Therapeutics Ltd', u'Purdue Pharma Canada', u'Acella Pharmaceuticals LLC', u'Catalyst Pharmaceutical Partners Inc', u'BioCorRx Inc', u'Innovata plc', u'Montefiore Health System', u'National Institute on Alcohol Abuse and Alcoholism', u'Zynerba Pharmaceuticals Inc', u'Goodwin Biotechnology Inc', u'Avista Pharma Solutions', u'Titan Pharmaceuticals Inc', u'Cilag AG', u'Kyorin Pharmaceutical Co Ltd', u'Opiant Pharmaceuticals Inc', u'DrugAbuse Sciences Inc', u'Britannia Pharmaceuticals Ltd', u'Klaria Pharma Holding Ab', u'Camargo Pharmaceutical Services', u'CVS Caremark', u'Martindale Pharma', u'Adapt Pharma Ltd', u'Pacira Pharmaceuticals Inc', u'Medical College of Wisconsin', u'Braeburn Pharmaceuticals Inc', u'Undisclosed', u'Pear Therapeutics Inc', u'National Institute on Drug Abuse', u'Melacure Therapeutics AB', u'Merck & Co Inc', u'Nanotherapeutics Inc', u'Reckitt Benckiser Healthcare (UK) Ltd', u'Columbia University', u'Camurus AB', u'AIKO Biotechnology Inc', u'Fannin Ltd', u'Florida International University', u'University of California Los Angeles', u'IVAX Corp', u'US Department of Defense', u'Orexo US Inc', u'Alkermes plc', u'Takeda Pharmaceuticals International GmbH', u'Evonik Industries AG', u'Endo Health Solutions Inc', u'Quivive Pharma LLC', u'Addiction Therapeutix Inc', u'Mundipharma International Corp Ltd', u'Walter Reed Army Institute of Research', u'National Institutes of Health', u'Noramco Inc', u'Knight Therapeutics Inc', u'Eczacibasi Ilac Pazarlama AS', u'WhanIn Pharmaceutical Co Ltd', u'West Pharmaceutical Services Inc', u'Minneapolis Medical Research Foundation', u'Columbia University Medical Center', u'Research Foundation for Mental Hygiene Inc', u'University of Chicago', u'Orexigen Therapeutics Inc', u'VINNOVA', u'BioDelivery Sciences International Inc', u'BioTie Therapies Corp', u'US WorldMeds LLC', u'MediciNova Inc', u'Avigen Inc', u\"King's College London\"]), u'Nephrotoxicity': set([u'HemoGenix Inc', u'Vitro Diagnostics Inc']), u'Bronchusdisease': set([u'Allergan Inc', u'Eisai Co Ltd', u'Ligand Pharmaceuticals Inc']), u'FragileXsyndrome': set([u'The Fragile X Research Foundation', u'National Institute of Neurological Disorders and Stroke', u'Stanford University', u'AOP Orphan Pharmaceuticals AG', u'RespireRx Pharmaceuticals Inc', u'SAGE Therapeutics Inc', u'Marinus Pharmaceuticals Inc', u'University of Michigan', u'BELLUS Health Inc', u'GlaxoSmithKline plc', u'Neurotrope BioScience Inc', u\"Cincinnati Children's Hospital Medical Center\", u'Sentinel Oncology Ltd', u'US Department of Defense', u'SMaRT Therapeutics Inc', u'University of California', u'University of Chile', u'National Institutes of Health', u'Confluence Pharmaceuticals LLC', u'Agilis Biotherapeutics LLC', u'Merck & Co Inc', u'European Eurostars Programme', u'Scripps Research Institute', u'Neuron Bio SA', u'Neurotrope Inc', u'Vanderbilt University', u'Ovid Therapeutics Inc', u'University of California Davis', u'Seaside Therapeutics Inc', u'Roche Holding AG', u'NMI TT Pharmaservices', u'AMO Pharma Ltd', u'Technology Strategy Board', u'University of South Florida', u'Emory University', u'Afraxis Inc', u'Neuropharm Group plc', u'Sention Inc', u'H Lundbeck A/S']), u'Transplantrejecti': set([u'Sumitomo Pharmaceuticals Co Ltd', u'Epimmune Inc']), u'Thrombosis': set([u\"Dr Reddy's Laboratories Ltd\", u'D Western Therapeutics Institute', u'University of Delaware', u'Nuvelo Inc', u'Asahi Kasei Corp', u'InhibeX LLC', u'Archemix Corp', u'Southwest University', u'Capricor Therapeutics Inc', u'US Health and Human Services Department', u'Pharmacyclics Inc', u'Nostrum Pharmaceuticals Inc', u'Shandong University', u'GlaxoSmithKline plc', u'Univ Massachusetts', u'Merck Research Laboratories', u'PhenoTech Inc', u'Bayer Schering Pharma AG', u'ARYx Therapeutics Inc', u'Cerevast Therapeutics Inc', u'National Institute of Neurological Disorders and Stroke', u'University of Minnesota', u'Vascular Solutions Inc', u'SurroMed Inc', u'Ionis Pharmaceuticals Inc', u'Blau Pharmaceuticals', u'Immunex Corp', u'Arizona State University', u'Daiichi Seiyaku Co Ltd', u'LegoChem Bioscience Inc', u'Adimmune Corp', u'Cosmic Discoveries', u'Western Michigan University', u'ArQule Inc', u'ProFibrix BV', u'BioVascular Inc', u'MorphoSys AG', u'PAION AG', u'Mitsubishi-Tokyo Pharmaceuticals Inc', u'Aspen PharmaCare Holdings Ltd', u'Chiesi USA Inc', u'Alchemia Ltd', u'MSD OSS BV', u'Shanghai Yalian Antibody Pharmaceutical Co Ltd', u'Grifols Inc', u'Aptalis Pharma Srl', u'Virtual Drug Development Inc', u'Trigen GmbH', u'Celera South San Francisco', u'Sankyo Co Ltd', u'Avacta Ltd', u'TechnoPhage SA', u'Toray Industries Inc', u'Asahi Kasei Pharma America Corp', u'Medicure Inc', u'Bayer HealthCare AG', u'Catalent Inc', u'Inspire Pharmaceuticals Inc', u'HanAll Biopharma Co Ltd', u'Armetheon Inc', u'National Heart Lung and Blood Institute', u'Morphochem AG', u'Gen Ilac', u'Alnylam Pharmaceuticals Inc', u'Pharmaniaga Bhd', u'Wuhan Guanggu Humanwell Biomedical Pharmaceutical Co Ltd', u'National Center For Advancing Translational Sciences', u'SciDose LLC', u'Roche Holding AG', u'Meiji Seika Pharma Co Ltd', u'Evolutec Group plc', u'Israeli Government', u'Suzhou Dixing Biomedical Technology Co Ltd', u'Behringwerke AG', u'China Nuokang Bio-Pharmaceutical Inc', u'ZymoGenetics Inc', u'Daiichi Sankyo Co Ltd', u'Abbott Laboratories', u'Regado Biosciences Inc', u'Mitsui Pharmaceuticals Inc', u'University of Utah', u'Hamamatsu University School of Medicine', u'Teva Pharmaceutical Industries Ltd', u'Novartis AG', u'Merck KGaA', u'Sirna Therapeutics Inc', u'Jilin Yuhua', u'Kyushu University', u'Brandeis University', u'Vanderbilt University', u'Rambam Med-Tech Ltd', u'Shifa Biomedical Corp', u'Sanofi-Synthelabo', u'Wyss Institute for Biologically Inspired Engineering', u'Hefei Industrial Pharmaceutical Institute Co Ltd', u'University of California San Francisco', u'Eagle Pharmaceuticals Inc', u'Emisphere Technologies Inc', u'Monash University', u'Immunomedics Inc', u'TBG Diagnostics Ltd', u'Dendreon Corp', u'Sunovion Pharmaceuticals Canada Inc', u'PepTx Inc', u'United States Army Institute of Surgical Research', u'AstraZeneca AB', u'Celera Group', u'Albany Molecular Research Inc', u'Cardiobene SA', u'Pharmacia & Upjohn Inc', u'Imperial Cancer Research Technology Ltd', u'HealthLinx Ltd', u'Encysive Pharmaceuticals Inc', u'Ferrer Internacional SA', u'Tenax Therapeutics Inc', u'Funda\\xe7\\xe3o Universidade Federal De S\\xe3o Carlos', u'Tomen Corp', u'Sumitomo Metal Industries Ltd', u'Synthelabo SA', u'Infinity Pharmaceuticals Inc', u'Octapharma AG', u'Loyola University Stritch School of Medicine', u'Dispositivos Medicos EIRL', u'Cigalah', u'Abo Akademi University', u'Shenzhen Techdow Pharmaceutical Co Ltd', u'Zedira GmbH', u'Green Cross Corp', u'Undisclosed', u'Genentech Inc', u'University of Milan', u'APT Therapeutics Inc', u'Mitsubishi Pharma Corp', u'University of Jyvaskyla', u'Andrx Corp', u'Otsuka Pharmaceutical Co Ltd', u'Korea Drug Development Fund', u'EVAS Therapeutics', u'University of Leeds', u'Wyeth Pharmaceuticals', u'Thios Pharmaceuticals Inc', u'TeaRx LLC', u'University of California San Diego', u'Cerylid Biosciences Ltd', u'Hooke Laboratories Inc', u'Changzhou Qianhong Biopharma Co Ltd', u'Lundbeck Inc', u'Celestar Lexico-Sciences Inc', u'Finnish Funding Agency for Technology and Innovation', u'Amphastar Pharmaceuticals Inc', u'Anhui University of Chinese Medicine', u'US Government', u'Diosynth Biotechnology', u'Tecnogen SCpA', u'Genzyme General', u'Merck & Co Inc', u'ImaRx Therapeutics Inc', u'COR Therapeutics Inc', u'Sanofi', u'Nanjing University', u'The Institute of Radiation Medicine Academy of Military Medical Sciences PLA', u'Eli Lilly & Co', u\"Lee's Pharmaceutical Holdings Limited\", u'Berlex Biosciences', u'Bayer AG', u'Valeant Pharmaceuticals International Inc', u'Pharmacia Corp', u'Inalco SpA', u'Thrombosis Research Institute', u'Mylan Inc', u'MediciNova Inc', u'Mayo Clinic, Minnesota', u'NicOx SA', u'Matrix Pharmaceuticals Ltd', u'LEO Pharma A/S', u'Hyundai Pharmaceutical', u'Janssen Biotech Inc', u'rEVO Biologics Inc', u'Biosidus SA', u'AstraZeneca plc', u'Pfizer Inc', u'Fournier Pharma', u'ConjuChem LLC', u'Seattle Life Sciences', u'Zydus-Cadila Group', u'Knoll GmbH', u'Hadasit Bio-Holdings Ltd', u'Central Drug Research Institute', u'Sandoz Inc', u'Wyeth', u'Boehringer Ingelheim Corp', u'Emosis Ltd', u'Endotis Pharma', u'AusIndustry', u'University of Turku', u'Johnson & Johnson', u'Momenta Pharmaceuticals Inc', u'Australian Government', u'Takeda Pharmaceuticals International GmbH', u'Portola Pharmaceuticals Inc', u'Volution Immuno Pharmaceuticals', u'University of Pennsylvania', u'Nippon Soda Co Ltd', u'Curacyte AG', u'Biolex Therapeutics Inc', u'SmithKline Beecham plc', u'Yamanouchi Pharmaceutical Co Ltd', u'King Pharmaceuticals Inc', u'Vascular Laboratory Inc', u'Dendreon San Diego LLC', u'Protherics plc', u'The Australian National University', u'Thromgen Inc', u'XO1 Ltd', u'National Institutes of Health', u'Patient Centered Outcome Research Institute', u'University of Tokyo', u'ProMetic Life Sciences Inc', u'Bristol-Myers Squibb Co', u'Chinese Government', u'The Medicines Company', u'Takeda Oncology', u'INSERM', u'Hamamatsu Photonics', u'Ligand Pharmaceuticals Inc', u'MSD Japan', u'The Menarini Group', u'Aronora Inc', u'Almirall Prodesfarma SA', u'InspireMD Inc', u'Louisiana State University', u'Adria Laboratories Inc', u'Aptahem AB', u'3-Dimensional Pharmaceuticals Inc', u'BioTie Therapies Corp', u'Tufts University', u'Institute of Microbial Technology', u'Gentium SpA', u'Tabuk Pharmaceutical Manufacturing Co', u'The Green Cross Corp', u'Meda AB', u'Janssen Pharmaceuticals Inc', u'GLSynthesis Inc', u'Crucell NV', u'Thrombolytic Science International LLC', u\"Brigham & Women's Hospital\", u'Qu\\xedmica Ariston Ecuador LLC', u'Oriens Life Sciences Ltd', u'MannKind Corp', u'Synthon BV', u'Translational Sciences Inc', u'Tripos Inc', u'Ajinomoto Medica', u'Microbix Biosystems Inc', u'GD Searle & Co', u'German Federal Ministry of Education and Research', u'University of Lausanne', u'University of Cambridge']), u'Schizoaffectivedisorder': set([u'H Lundbeck A/S', u'Solvay SA']), u'Mouthulcer': set([u'Block Drug Co Inc', u'Wockhardt Ltd', u'Zambon Co SpA', u'Clinuvel Pharmaceuticals Ltd', u'National Institute of Dental and Craniofacial Research', u'Abeona Therapeutics Inc', u'Paladin Labs Inc', u'Sinclair Pharma plc', u'Post Oak Pharmaceuticals Inc', u'BMG Pharma LLC', u'Luqa Pharmaceuticals', u'Laboratorios Dr Esteve SA', u'Meda AB']), u'Thyroidtumor': set([u'Quest Diagnostics Inc', u'National Health and Medical Research Council', u'National Comprehensive Cancer Network', u'DRAXIMAGE', u'Stanford University', u'Beartown Pharma Inc', u'Palacky University', u'National Institute of Diabetes, Digestive and Kidney Diseases', u'Eisai Co Ltd', u'Ambrilia Biopharma Inc', u'Ministry of Health, Welfare and Family Affairs', u'National Cancer Institute', u'Kolltan Pharmaceuticals Inc', u'University of Colorado at Denver and Health Sciences Center', u'AkaRx Inc', u'Bristol-Myers Squibb Co', u'MaxCyte Inc', u'Albert Einstein Medical Center', u'Aqualis ASA', u'Translational Therapeutics Inc', u'Genzyme General', u'Interpace Diagnostics Group Inc', u'Best Med Opinion Ltd', u'Sanofi Genzyme', u'Cedars-Sinai Medical Center', u'Veracyte Inc', u'Bayer AG', u'Mateon Therapeutics Inc', u'Garvan Institute of Medical Research', u'Knoll GmbH', u'EpiCept Corp', u'Ewha Womans University', u'Translational Genomics Research Institute', u'Novacell Technology Inc', u'Aetna Inc', u'Rhenium Ltd', u'AstraZeneca plc', u'Pfizer Inc', u'Biologics Inc', u'Trophogen Inc', u'FNApath.com', u'New York State Department Of Health', u'SFJ Pharma Ltd', u'Guerbet', u'Memorial Sloan-Kettering Cancer Center', u'Rosetta Genomics Ltd']), u'Cerebralhypoxia': set([u'Sankyo Co Ltd', u'Daiichi Fine Chemicals Co Ltt', u'Bioresearch SpA', u'Knoll Farmaceutici SpA']), u'Majordepressivedisorder': set([u'Angelini Labopharm', u'Turing Pharmaceuticals LLC', u'Undisclosed', u'Cennerv Pharmaceuticals Pte Ltd', u'Zysis Ltd', u'Intra-Cellular Therapies Inc', u'Mount Sinai School of Medicine', u'VistaGen Therapeutics Inc', u'Cerecor Inc', u'Targacept Inc', u'Apotex Inc', u'National Institutes of Health', u'ACADIA Pharmaceuticals Inc', u'KYOWA Pharmaceutical Industry Co Ltd', u'University of Maryland', u'Vanda Pharmaceuticals Inc', u'Marina Biotech Inc', u'Siegfried Holding Ltd', u'Jiangsu Nhwa Pharmaceutical Group Co Ltd', u'Sanofi', u'Medical Research Council', u'Janssen Research & Development LLC', u'Ontario Brain Institute', u'CoNCERT Pharmaceuticals Inc', u'Astellas Pharma Inc', u'Biovail Corp', u'Alvogen Korea', u'Astrazeneca Korea', u'Avanir Pharmaceuticals Inc', u'The National Institute of Mental Health', u'Tetra Discovery Partners LLC', u'Janssen Pharmaceuticals Inc', u'AstraZeneca plc', u'Gedeon Richter Ltd', u'Pernix Therapeutics Holdings Inc', u'Recordati SpA', u'Osmotica Pharmaceutical Corp']), u'Musculardystrophy': set([u'Swiss Foundation for Research on Muscle Diseases', u'Banyan Biomarkers Inc', u'University of Washington', u'Association Francaise Contre Les Myopathies', u'Sphaera Pharma', u'National Institute of Arthritis and Musculoskeletal and Skin Diseases', u'Amerinet Inc', u'Santhera Pharmaceuticals AG', u'Jain Foundation', u'French Muscular Dystrophy Association', u'BioMarin Nederland BV', u'University of Nevada', u'Harvard Medical School', u'Cellular Dynamics International Inc', u'Duchenne Research Fund', u'European Commission', u'Alexion Pharmaceuticals Inc', u'Novation', u'University of Arizona', u'iPierian Inc', u'Genea Ltd', u'Lantheus Medical Imaging Inc', u'Amarin Corp plc', u'Novogen Ltd', u'Rhenovia Pharma SAS', u'CepTor Corp', u'Parke-Davis & Co', u'Northwestern University', u'Pharnext SAS', u'Bayer Schering Pharma AG', u'IDIS Ltd', u'Solid Biosciences LLC', u'Trim-edicine Inc', u'National Institute of Neurological Disorders and Stroke', u'Food and Drug Administration', u'Parent Project Muscular Dystrophy', u'Ionis Pharmaceuticals Inc', u'University of Pennsylvania', u'Sarepta Therapeutics Inc', u'MRIGlobal', u'Cure CMD', u'Sanofi Genzyme', u'Kyoto University', u'Medical Research Council', u'Columbia University', u'OSI Pharmaceuticals Inc', u'Leiden University Medical Center', u'JCR Pharmaceuticals Co Ltd', u'Phyton Biotech Inc', u'Tivorsan Pharmaceuticals Inc', u'Hybrigenics SA', u'Novartis AG', u'Bioblast Pharma Ltd', u'Cold Spring Harbor Laboratory', u'University of Rochester', u'Teva Pharmaceutical Industries Ltd', u'Insmed Inc', u'UMN Pharma Inc', u'Roche Madison Inc', u'Muscular Dystrophy Association', u'Transgene SA', u'Senju Pharmaceutical Co Ltd', u'Genovo Inc', u'Genethon', u'AstraZeneca plc', u'Royal DSM NV', u'FUJIFILM RI Pharma Co', u'Royal Holloway University Of London', u'Montreal Neurological Institute and Hospital', u'Hadassah University Hospital', u'Fate Therapeutics Inc', u'Cardero Therapeutics Inc', u'Ottawa Health Research Institute', u'Yissum Research Development Co', u'Selecta Biosciences Inc', u'Benitec Biopharma Ltd', u'Prothelia Inc', u'EPIX Pharmaceuticals Inc']), u'Musclespasm': set([u'Neurana Pharmaceuticals Inc', u'LG Life Sciences Ltd', u'Orion Corporation', u'Eisai Co Ltd', u'Hokuriku Seiyaku KK', u'Quintiles Transnational Corp', u'Novartis AG', u'Shionogi USA Inc', u'Yamanouchi Pharmaceutical Co Ltd', u'DRAXIS Health Inc', u'Daewoong Pharmaceutical Co Ltd', u'Elan Corp plc', u'Eczacibasi Ilac Pazarlama AS', u'Zambon Italia Srl', u'Cephalon Inc', u'Sanochemia Pharmazeutika AG', u'Pennsylvania State University', u'Aptalis Pharma Srl', u'Bracco Eisai', u'Cognitive Research Corp', u'Flex Pharma Inc', u'NOBEL ILAC Sanayii ve Ticaret AS', u'Wellcome Trust', u'Elan Pharmaceuticals Inc', u'ECR Pharmaceuticals', u'PharmaSwiss SA', u'Canbex Therapeutics Ltd', u'Adcock Ingram Ltd', u'Casper Pharma LLC']), u'Escherichiacoliinfectio': set([u'Eddingpharm Inc', u'Lilly China Research & Development Co Ltd']), u'Thymoma': set([u'Bristol-Myers Squibb Co', u'Memorial Sloan-Kettering Cancer Center']), u'Pregnancydisorder': set([u'Thomas Jefferson University', u'UCB Celltech', u'F H Faulding & Co Ltd', u'Australian Government', u'ESP Pharma Inc', u'Corthera Inc', u'Inflammatics Inc', u'Novozymes GroPep Ltd', u'Connetics Corp', u'Paladin Labs Inc', u'Sinclair Pharma plc', u'BMG Pharma LLC', u'Barbeau Pharma Inc']), u'Metalintoxication': set([u'Synthetic Biologics Inc', u'National Institutes of Health']), u'Chronicliverfailure': set([u'Clinica Universidad de Navarra', u'Shanghai Science and Technique Committee', u'Hospital Clinic of Barcelona', u'Shanghai Genomics Inc']), u'Hermansky-Pudlaksyndrome': set([u'Marnac Inc', u'Bayer Schering Pharma AG']), u'Birthcomplication': set([u'University of Calgary', u'Carmentix Private Ltd', u'Northeast Pharmaceutical Group Co Ltd', u'Henry Schein Inc', u'International Business Machines Corp', u'Chinese Government', u'University of Melbourne', u'Atlas Genomics']), u'Hepatotoxicitydrug-induced': set([u'Optivia Biotechnology', u'KaLy-Cell', u'National Institutes of Health', u'CiToxLAB Group', u'Vitro Diagnostics Inc', u'HemoGenix Inc', u'University of California San Francisco']), u'Congenitalheartdefect': set([u'Clinical Data Inc', u'B. Braun Interventional Systems Inc', u\"Cincinnati Children's Hospital Medical Center\", u'Bayer AG', u'Albert Einstein College of Medicine', u'Transgenomic Inc', u'Numed Inc', u'National Institutes of Health', u'Mezzion Pharma Co Ltd', u'CRISPR Therapeutics', u'New England Research Institutes']), u'Vesicoureteralreflux': set([u\"Dr Reddy's Laboratories Ltd\", u'Oceana Therapeutics Inc']), u'T-celllymphoma': set([u'US Government', u'National Comprehensive Cancer Network', u'The Leukemia & Lymphoma Society', u'Inje University', u'AOP Orphan Pharmaceuticals AG', u'Genmab A/S', u'Korea Drug Development Fund', u'TenX Biopharma Inc', u'SangStat Medical Corp', u'Yale Cancer Center', u'Verastem Inc', u'National Institutes of Health', u'Boryung Pharm Co Ltd', u'Emergent BioSolutions Inc', u'Poniard Pharmaceuticals Inc', u'Eczacibasi Ozgun Kimyasal Urunler Sanayi ve Ticaret AS', u'Therapeutic Human Polyclonals Inc', u'PharmaMar SA', u'Mundipharma EDO GmbH', u'Vigencell Co Ltd', u'Ascalon International Inc', u'Medarex Inc', u'Merck Serono SA', u'Angimmune LLC', u'Biocon Ltd', u'The Center of Molecular Immunology', u'Infinity Pharmaceuticals Inc', u'Victoria Link Ltd', u'Dana-Farber Cancer Institute Inc', u'Pieris Pharmaceuticals Inc', u'Wacker Biotech GmbH', u'BioCryst Pharmaceuticals Inc', u'Memorial Sloan-Kettering Cancer Center']), u'Maroteaux-Lamysyndrome': set([u'Fondazione Telethon', u'AnGes MG Inc', u'BioMarin Pharmaceutical Inc', u'Inventiva', u'University of Pretoria', u'REGENXBIO Inc', u'European Commission', u'SA Pathology']), u'Carcinoma': set([u'Daiichi Seiyaku Co Ltd', u'LeukoSite Inc', u'US Government', u'National Comprehensive Cancer Network', u'Silence Therapeutics plc', u'Cancer Research Campaign Technology Ltd', u'InterMune Inc', u'IDEC Pharmaceuticals Corp', u'Yakult Honsha Co Ltd', u'GlaxoSmithKline plc', u'Warner-Lambert Co', u'BTG plc', u'Australian Nuclear Science & Technology Organization', u'Cascadian Therapeutics Inc', u'Seattle Genetics Inc', u'Sanofi Winthrop France SA', u'Ipsen', u'Immunex Corp', u'ArQule Inc', u'Stanford University', u'Onyvax Ltd', u'Navidea Biopharmaceuticals Inc', u'Genaera Corp', u'UbiVac', u'Oncodesign Biotechnology SA', u'Biovector Therapeutics SA', u'Nihon Medi-Physics Co Ltd', u'Sandoz Ltd', u'Stanford Rook Ltd', u'Sanford-Burnham Medical Research Institute', u'Dana-Farber Cancer Institute Inc', u'Microbial Chemistry Research Foundation', u'University of Nebraska Medical Center', u'Xenova Ltd', u'Light Sciences Corp', u'Inex Pharmaceuticals Corp', u'Amgen Inc', u'Medarex Inc', u'Daiichi Sankyo Co Ltd', u'Abbott Laboratories', u'Roswell Park Cancer Institute', u'Eisai Co Ltd', u'Celgene Corp', u'Lytix Biopharma AS', u'Teva Pharmaceutical Industries Ltd', u'National Cancer Institute', u'Novartis AG', u'SRI International', u'Fujisawa Pharmaceutical Co Ltd', u'Novelion Therapeutics Inc', u'Georgetown University Medical Center', u'CytoCore Inc', u'Boehringer Ingelheim International GmbH', u'YM BioSciences Inc', u'Immunomedics Inc', u'ALZA Corp', u'Kyorin Pharmaceutical Co Ltd', u'Janssen Korea Ltd', u'ImmunoGen Inc', u'Pharmacia & Upjohn Inc', u'Allergan Inc', u'Boehringer Ingelheim Corp', u'Kyowa Hakko Kogyo Co Ltd', u'Swedish Orphan Biovitrum AB', u'American Skin Association', u'Ortho Biotech Products LP', u'Genentech Inc', u'Connetics Corp', u'Medimmune Oncology Inc', u'Harvard Medical School', u'Schering-Plough Corp', u'ViaCell Inc', u'LifeArc', u'Maxygen Holdings Ltd', u'Sakai Chemical Industry Co Ltd', u'Merck & Co Inc', u'Zenyaku Kogyo Co Ltd', u'Schering Overseas Ltd', u'LEO Pharma A/S', u'rEVO Biologics Inc', u'Sanofi', u'Sagami Chemical Research Center', u'Eli Lilly & Co', u'PharmaMar SA', u'ScinoPharm Taiwan Ltd', u'Pharmacia Corp', u'Janssen Biotech Inc', u'Almirall Prodesfarma SA', u'AstraZeneca plc', u'Pfizer Inc', u'University of Southern California', u'Corixa Corp', u'Wyeth', u'Horizon Pharma plc', u'Johnson & Johnson', u'Tularik Inc', u'GPC Biotech AG', u'NuChem Pharmaceuticals Inc', u'Imclone LLC', u'ASTA Medica AG', u'SmithKline Beecham plc', u'Ligand Pharmaceuticals Inc', u'Viventia Bio Inc', u'Bristol-Myers Squibb Co', u'American Cyanamid Co', u'ICOS Corp', u'Cephalon Inc', u'Integra LifeSciences Holdings Corp', u'Antisoma plc', u'Boehringer Ingelheim Austria GmbH', u'Cyanamid Benelux NV', u'TopoTarget A/S', u'Rhone-Poulenc Rorer Inc', u'DRI Capital', u'Biomira USA Inc', u'Berlex Laboratories Inc']), u'Metapneumovirusinfection': set([u'Johnson & Johnson', u'InGen Biosciences', u'Quidel Corp', u'Vanderbilt University', u'National Institute of Allergy and Infectious Diseases', u'MedImmune LLC']), u'Hodgkinsdisease': set([u'MENTRIK Biotech LLC', u'Inex Pharmaceuticals Corp', u'The Leukemia & Lymphoma Society', u'Cancer Research UK', u'MD Anderson Cancer Center', u'Genentech Inc', u'Genmab A/S', u'Allos Therapeutics Inc', u'OncBioMune Pharmaceuticals Inc', u'Eisai Co Ltd', u'GlaxoSmithKline plc', u'University of Texas Southwestern Medical Center', u'National Cancer Institute', u'Australian Nuclear Science & Technology Organization', u'MethylGene Inc', u'Salmedix Inc', u'University College London', u'Seattle Genetics Inc', u'University of Maryland', u'Bristol-Myers Squibb Co', u'Elan Corp plc', u'Choice Pharmaceuticals', u'Merck & Co Inc', u'Medac GmbH', u'National Comprehensive Cancer Network', u'Dr Willmar Schwabe GmbH & Co', u'Affimed NV', u'Eli Lilly & Co', u\"Lee's Pharmaceutical Holdings Limited\", u'Undisclosed', u'Celgene Corp', u'Takeda Oncology', u'Richard L. Chang Holdings', u'Roche Holding AG', u'Theradex Systems Inc', u'University of British Columbia', u'SymBio Pharmaceuticals Ltd', u'Immune Therapeutics Inc', u'Astellas Pharma GmbH', u'Kosan Biosciences Inc', u'Medarex Inc', u'Dermira Inc', u'University of Cologne', u'Gedeon Richter Ltd', u'Corixa Corp', u'Lipomed AG', u'Leadiant Biosciences', u'Rich Pharmaceuticals Inc', u'Talon Therapeutics Inc']), u'Paraganglioma': set([u'Advanced Accelerator Applications SA', u'Centre for Probe Development and Commercialization', u'National Cancer Institute', u'Progenics Pharmaceuticals Inc']), u'Autosomaldominantpolycystickidneydisease': set([u'University of Maryland School of Medicine', u'AstraZeneca plc', u'Garvan Institute of Medical Research', u'Discovery BioMed Inc', u'Shanghai Institute of Materia Medica of the Chinese Academy of Sciences', u'National Institute of Diabetes, Digestive and Kidney Diseases', u'Kadmon Pharmaceuticals LLC', u'Symphony Evolution Inc', u'3SBio Inc', u'PKD Foundation Australia', u'Alvogen Inc']), u'Alkaptonuria': set([u'DevelopAKUre Consortium', u'The European Union']), u'Biliarycancer': set([u'Exelixis Inc', u'Genentech Inc', u'Imclone LLC', u'Japanese National Cancer Center', u'Otsuka Pharmaceutical Co Ltd', u'H Lee Moffitt Cancer Center and Research Institute', u'Wilex AG', u'Institut Gustave Roussy', u'National Cancer Institute', u'Merck KGaA', u'JW CreaGene Inc', u'Ludwig Institute for Cancer Research', u'South Texas Accelerated Research Therapeutics', u'Bristol-Myers Squibb Co', u'Merck & Co Inc', u'Eli Lilly & Co', u'OSI Pharmaceuticals Inc', u'Bayer AG', u'Halozyme Therapeutics Inc', u'OncoVista Innovative Therapies Inc', u'Rijksuniversiteit te Leiden', u'tella Inc', u'Merck Serono SA', u'Princeton University', u'Janssen Biotech Inc', u'Jikei University', u'AstraZeneca plc', u'Takeda Pharmaceutical Co Ltd', u'Fuso Pharmaceutical Industries Ltd', u'BioInvent International AB', u'Lonza Biologics plc']), u'Connectivetissuedisease': set([u'Wyss Institute for Biologically Inspired Engineering', u'Connetics Corp', u'Paladin Labs Inc', u'Taisho Pharmaceutical Co Ltd', u'UCB Celltech', u'National Institutes of Health', u'University of California', u'Osiris Therapeutics Inc', u'Bio3 Research Srl', u'University of Miami', u'FibroGen Inc', u'Universita Degli Studi di Genova', u'BioSpecifics Technologies Corp', u'Institute of Cancer Research UK', u'Olympus Corp', u'Protelica Inc', u'Innova Onlus', u'Medarex Inc', u'Cytori Therapeutics Inc', u'Charite Universitaetsmedizin Berlin', u'Boehringer Ingelheim Corp', u'RecipharmCobra Biologics', u'F H Faulding & Co Ltd', u'Corthera Inc']), u'Lymphaticsystemdisease': set([u'Ark Therapeutics Group plc', u'Nycomed AS', u'Stanford University', u'Food and Drug Administration', u'Laurantis Pharma Oy', u'Sanofi', u'twoXar Inc']), u'Centralnervoussysteminjury': set([u'KineMed Inc', u'Neuronax', u'Neureva', u'Universite d Auvergne', u'Cyberkinetics Neurotechnology Systems Inc', u'Oxeia Biopharmaceuticals Inc', u'The European Union', u'Undisclosed', u'Acorda Therapeutics Inc', u'NeuroMetrix Inc', u'University of California', u'Vyrex Corp', u'Perrigo Co plc', u'Immune Response BioPharma Inc', u'Medtronic Inc', u'Geron Corp', u'Imago Pharmaceuticals Inc']), u'Braintumor': set([u'Bradmer Pharmaceuticals Inc', u'Daiichi Seiyaku Co Ltd', u'University of Calgary', u'US Government', u'Translational Genomics Research Institute', u'Regeneron Pharmaceuticals Inc', u'University of Northern Colorado', u'Transcept Pharmaceuticals Inc', u'Medical University of Graz', u'Voices Against Brain Cancer', u'Ion Beam Applications SA', u'Silence Therapeutics plc', u'Cancer Research Campaign Technology Ltd', u'Nexstim Oy', u'Netherlands Government', u'Allos Therapeutics Inc', u'Ben and Catherine Ivy Foundation', u'California Institute of Regenerative Medicine', u'Rockefeller University', u'Pharmacyclics Inc', u'Yakult Honsha Co Ltd', u'GlaxoSmithKline plc', u'BTG plc', u'Inovio Pharmaceuticals Inc', u'Centelion SAS', u'Bayer Schering Pharma AG', u'Oncobiologics Inc', u'DURECT Corp', u'Biotoscana International', u'Uppsala University', u'Vion Pharmaceuticals Inc', u'Morphotek Inc', u'Arch Biopartners Inc', u'Vernalis plc', u'Astex Pharmaceuticals Inc', u'Genentech Inc', u'University of Pittsburgh', u'University of Michigan', u'Celldex Therapeutics Inc', u'University of Pennsylvania', u'The University Health Network', u'Loma Linda University', u'Dutch-Belgian Cooperative Trial Group for Hematology Oncology', u'EGEN Inc', u'Stanford University', u'Korea Institute of Radiological and Medical Sciences', u'Threshold Pharmaceuticals Inc', u'PlantForm Corp', u'Bio-Path Holdings Inc', u'Thomas Jefferson University', u'National Brain Tumor Society', u'Nihon Medi-Physics Co Ltd', u'Peregrine Pharmaceuticals Inc', u'Kite Pharma Inc', u'Sun Pharmaceutical Industries Ltd', u'Nascent Biotech Inc', u'Agency For Science Technology & Research', u'KuDOS Pharmaceuticals Ltd', u'Innovate Pharmaceuticals Ltd', u'Diffusion Pharmaceuticals LLC', u'Accurexa Inc', u'Radient Pharmaceuticals Corp', u'Memorial Sloan-Kettering Cancer Center', u'Stiefel', u'Agios Pharmaceuticals Inc', u'Emory University', u'MSD Japan', u'Pfizer Inc', u'Morvus Technology Ltd', u'University of Florida', u'GOT Entwicklungs GmbH', u'Dana-Farber Cancer Institute Inc', u'Theralase Technologies Inc', u'Aposense Ltd', u'Discovery Genomics Inc', u'Department of Pathology at Rigshospitalet', u'University of Nebraska Medical Center', u'National Research Council of Canada', u'Reyon Pharmaceuticals Co Ltd', u'SS Pharmaceutical - ethical drug division', u'Xenova Ltd', u'National Health and Medical Research Council', u'Oncology Sciences Corp', u'MGI GP Inc', u'Inex Pharmaceuticals Corp', u'AngioChem Inc', u\"Children's Cancer Institute Australia for Medical Research\", u'Centre National de la Recherche Scientifique (CNRS)', u'National Center for Research Resources', u'National Institute of Neurological Disorders and Stroke', u'Medimmune Vaccines Inc', u'Blackfynn', u'Accelerate Brain Cancer Cure', u'Greenland Resources Inc', u'Baxter Oncology GmbH', u'e-Therapeutics Plc', u'Synaptive Medical (Barbados) Inc', u'Eisai Co Ltd', u'Tulane University', u'Geron Corp', u'Boehringer Mannheim GmbH', u'Athenex Inc', u'National Cancer Institute', u'Novartis AG', u'Merck KGaA', u'Telix Pharmaceuticals Ltd', u'University of Heidelberg', u'SRI International', u'NeoPharm Inc', u'MediBIC', u'Affibody AB', u'Teva Pharmaceutical Industries Ltd', u'Siemens Healthcare Diagnostics GmbH', u'Diatos SA', u'Italfarmaco SpA', u'Mapp Biopharmaceutical Inc', u'Medac GmbH', u'University of Alabama', u'Massachusetts General Hospital', u'Centre For Imaging Technology Commercialization', u'University of Minnesota', u'Fraunhofer-Institute fur Zelltherapy und Immunologie', u'Virium Pharmaceuticals Inc', u'Healthquest Pharma Ltd', u'Mallinckrodt Inc', u'ALZA Corp', u'Cleveland Clinic Foundation', u'Advantagene Inc', u'University of Guelph', u'Premier Research Group Ltd', u'Guangzhou Xiangxue Pharmaceutical Co Ltd', u'Copharos Inc', u'Arbor Pharmaceuticals Inc', u'Immune Response BioPharma Inc', u'Dong-A ST Co Ltd', u'Targepeutics Inc', u'Kyungwon University', u'Janssen Pharmaceutica NV', u'Ethypharm SA', u'Helsinn Healthcare SA', u'Therabiologics Inc', u'University of California San Francisco', u'Johns Hopkins University', u'Shenzhen BGI Genomics Techonology Co Ltd', u'Kyowa Hakko Kogyo Co Ltd', u'University of California San Diego', u'North Shore University Hospital Research Corp', u'Therapeia GmbH & Co KG', u'PhaseBio Pharmaceuticals Inc', u'Tetra Bio-Pharma Inc', u'BioInvent International AB', u'Lixte Biotechnology Holdings Inc', u'Swedish Orphan Biovitrum AB', u'Oakwood Laboratories LLC', u'Medtronic Inc', u'Carthera', u'ILEX Oncology Inc', u'Chugai Pharmaceutical Co Ltd', u'Sidney Kimmel Cancer Center', u'Duke University Medical Center', u'Ampac Fine Chemicals Llc', u'Scottsdale Healthcare', u'Medipharm Biotech Co Ltd', u'Mitsubishi Pharma Corp', u'Cobra Biologics Holding AB', u'Centre for the Commercialization of Antibodies and Biologics', u'Mayo Clinic Foundation', u'Stemline Therapeutics Inc', u'University of Maryland', u'MediGene Inc', u'Burzynski Research Institute Inc', u'Protherics Salt Lake City Inc', u'Blaze Bioscience Inc', u'Schering-Plough Corp', u'Stason Pharmaceuticals Inc', u'Lin Bioscience Inc', u'Boots Hoechst Celanese', u'Intradigm Corp', u'PCT, a Caladrius company', u'CMC Biologics Inc', u'Hospital for Sick Children', u'University of Washington', u'Accelerating Combination Therapies LLC', u'Massachusetts Institute of Technology', u'Undisclosed', u'Zhejiang Hisun Pharmaceutical Co Ltd', u'photonamic GmbH & Co KG', u'ImmunoCellular Therapeutics Ltd', u'University of California', u'Diosynth Biotechnology', u'National Cancer Center of Korea', u'MD Anderson Cancer Center', u'Merck & Co Inc', u'BioChem Pharma (International ) Inc', u'Sunnybrook Health Sciences Centre', u'Sanofi', u'Medison Pharma Ltd', u'Alkermes plc', u'Eli Lilly & Co', u'Celsion Corp', u'Novogen Ltd', u'Tocagen Inc', u'Calibrant Biosystems Inc', u'IntelliSyn Pharma', u'Pharmacia Corp', u'Pierre Fabre SA', u'Breitling Energy Corp', u'Weizmann Institute of Science', u'Quadriga BioSciences Inc', u'Constance Therapeutics', u'SIRO ClinPharm USA LLC', u'BBB Therapeutics BV', u'RegeneRx Biopharmaceuticals Inc', u'Nederlands Kanker Instituut-Antoni van Leeuwenhoek Ziekenhuis', u'University of Sydney', u'Kalgene Pharma Inc', u'University of Geneva', u'The UK Imperial Cancer Research Fund', u'Dutch Ministry of Health, Welfare and Sport', u'MDS Nordion', u'IVAX Corp', u'Almirall Prodesfarma SA', u'AstraZeneca plc', u'Nvidia Corp', u'Neurocrine Biosciences Inc', u'Midatech Pharma PLC', u'Universit\\xe9 De Strasbourg', u'Northwest Biotherapeutics Inc', u'Morex Development Partners', u'Luna Innovations Inc', u'Aarhus University Hospital', u\"Brigham & Women's Hospital\", u'Triangle Pharmaceuticals Inc', u'Gendux Molecular Ltd', u'University of Texas Southwestern Medical Center', u'US Department of Defense', u'BC Cancer Agency Research Centre', u'Feinstein Institute for Medical Research', u'Health Research Institute of Santiago de Compostela', u'EPIX Pharmaceuticals Inc', u'Japan Pharmaceutical Development Co Ltd', u'Beactica AB', u'Immatics Biotechnologies GmbH', u'SciClone Pharmaceuticals Inc', u'Nuo Therapeutics Inc', u'Introgen Therapeutics Inc', u'Baylor College of Medicine', u'Australian Government', u'PharmaCyte Biotech Inc', u'Eleison Pharmaceuticals Inc', u'Somanta Pharmaceuticals Inc', u'Solexa Inc', u'ASTA Medica AG', u'DUSA Pharmaceuticals Inc', u'Averion International Corp', u'BrainLAB Inc', u'TTY Biopharm Co Ltd', u'Stanford Cancer Institute', u'Kennedy Krieger Institute', u'Magnetic Insight Inc', u'Stemergie Biotechnology SA', u'Ontario Cancer Biomarker Network', u'American Brain Tumor Association', u'University of Miami', u'BL&H Co Ltd', u'Double Bond Pharmaceutical AB', u'Vectorite Biomedica Inc', u'Hovione SA', u'OSEO', u'Albert Einstein College of Medicine', u'Sophiris Bio Inc', u'Specialized Medical Services-oncology BV', u'National Institutes of Health', u'Upjohn Inc', u'Food and Drug Administration', u'BioCancell Therapeutics Ltd', u'Swiss Government', u'Lauren Sciences Llc', u'City of Hope', u'Moleculin Biotech Inc', u'Laureate Biopharmaceutical Services Inc', u'Cedars-Sinai Medical Center', u'Aronex Pharmaceuticals Inc', u'CJ Corp', u'Roswell Park Cancer Institute', u'Celgene Corp', u'University of Chicago', u'Colorado State University', u'Memgen LLC', u'Dompe Group', u'Zalicus Inc', u'Max Delbruck Centrum Fur Molekulare Medizin', u'Biovail Corp', u'Nobelpharma Co Ltd', u'National Institute of Biomedical Imaging and Bioengineering', u'National University of Singapore', u'Duke University', u'Antisoma plc', u\"Seattle Children's Hospital\", u'University of Alabama at Birmingham', u'UC San Diego Moores Cancer Center', u'Childrens Hospital of Philadelphia', u'Oncormed Inc', u'Paul Scherrer Institut', u'Lonza Group AG', u'Viralytics Ltd', u'The Menarini Group', u'University of California Irvine', u'Neuralstem Inc', u'Avigen Inc', u'biOasis Technologies Inc', u'Orphan Australia', u'Biologics Inc', u'ArmaGen Technologies Inc', u'Alberta Heritage Foundation For Medical Research', u'Dartmouth College', u'Zhejiang Huahai Pharmaceutical Group Co Ltd', u'University of Portsmouth', u'SIRTeX Medical Ltd', u'Rhone-Poulenc Rorer Inc', u'LI-COR Biosciences']), u'Braindisease': set([u'Karolinska Institutet', u'RadNet Inc', u'Netherlands Government', u'California Institute of Regenerative Medicine', u'Mount Sinai School of Medicine', u'Amsterdam Molecular Therapeutics BV', u'Bayer Schering Pharma AG', u'SGX Pharmaceuticals Inc', u'European Community', u'Promentis Pharmaceuticals Inc', u'University of Bonn', u'University of Pennsylvania', u'City University of New York', u'University of British Columbia', u'Nortis Inc', u'apceth GmbH & Co KG', u'The National Institute of Mental Health', u'Zhejiang Xianju Pharmaceutical Corp Ltd', u'WaVe Life Sciences Ltd', u'VIB', u'Shionogi & Co Ltd', u'Centre for Addiction and Mental Health', u'University of Nebraska Medical Center', u'Brain Canada', u'Evotec AG', u'Centre National de la Recherche Scientifique (CNRS)', u'Biota Holdings Ltd', u'Montana University', u'Intelligence Advanced Research Projects Activity', u'Rhenovia Pharma SAS', u'Alzeca Biosciences Inc', u'Mount Sinai Hospital', u'Vanderbilt University', u'Clarity Pharmaceuticals Pty Ltd', u'Orpheris Inc', u'Nansen Neuroscience Network', u'Uteron Pharma S.A.', u'Biomedical Translational Imaging Centre', u'Celera Group', u'Dart NeuroScience LLC', u'York Instruments', u'Complete Genomics Inc', u'University of Melbourne', u'Lixte Biotechnology Holdings Inc', u'University of Sydney', u'Fuji Pharma Co Ltd', u'University of Houston', u'National Institute of Neurological Disorders and Stroke', u'Wellcome Trust Sanger Institute', u'Natural Sciences and Engineering Research Council of Canada', u'Elekta AB', u'Howard Florey Institute of Experimental Physiology and Medicine', u'Squibb Diagnostics', u'European Research Council (ERC)', u'The Knut and Alice Wallenberg Foundation', u'Undisclosed', u'Rosalind Franklin University of Medicine & Science', u'Scripps Research Institute', u'Australian Research Council', u'MD Anderson Cancer Center', u'ReadCoor', u'University of Southern California', u'Proteus Sciences', u'BioFocus DPI', u'KCNQ2 Cure Alliance Foundation', u'Bayer AG', u'University of York', u'Seaside Therapeutics Inc', u'Thuris Corp', u'BBB Therapeutics BV', u'University of Geneva', u'Proteome Sciences plc', u'Sanford-Burnham Medical Research Institute', u'Yale University', u'Memorial Sloan-Kettering Cancer Center', u'Beactica AB', u'Wyss Institute for Biologically Inspired Engineering', u'Vect-Horus', u'Max Planck Institute of Neurobiology', u'Pairnomix LLC', u'Praecis Pharmaceuticals Inc', u'Advanced Accelerator Applications SA', u'National Institutes of Health', u'Scios Inc', u'INSERM', u'Kyoto University', u'bluebird bio Inc', u'Florida Atlantic University', u'European Bioinformatics Institute', u'Mithra Pharmaceuticals', u'Samus Therapeutics Inc', u'GE Healthcare', u'PNO Resources Ltd', u'Medic Vision - Brain Technologies Ltd']), u'Pseudohypoaldosteronism': set([u'Wellcome Trust', u'Mediolanum Farmaceutici SpA', u'Apeptico Forschung und Entwicklung GmbH']), u'Leberscongentialamaurosis': set([u'Allergan plc', u'Editas Medicine Inc', u'University Medical Centre St Radboud', u'University of Florida', u'Athena Vision Ltd', u'INSERM', u'University of Pennsylvania', u'Spark Therapeutics LLC', u'MeiraGTx', u'Genzyme General', u'University of Massachusetts Medical School', u'Universite de Nantes', u'Foundation Fighting Blindness']), u'Depression': set([u'Unimed Pharmaceuticals Inc', u'Scil Technology GmbH', u'Koebenhavns Universitet', u'Soochow University', u'Rexahn Pharmaceuticals Inc', u'Novartis Pharma AG', u'VU University Medical Center', u'POZEN Inc', u'University of South Florida', u'IMPAX Laboratories Inc', u'University of Bath', u'Inventiv Health Clinical Inc', u'Gabriel Sciences', u'Mount Cook BioSciences', u'Dompe SpA', u'Handok Inc', u'Catalent Inc', u'Merckle GmbH', u'Tanabe Seiyaku Co Ltd', u'NeuroSearch A/S', u'American BriVision Corporation', u'Taiwan Biotech Co Ltd', u'Wake Forest University', u'23andMe Inc', u'National Health and Medical Research Council', u'New York University', u'Universidad Autonoma de Madrid', u'Xtrexa Bio Inc', u'Mochida Pharmaceutical Co Ltd', u'Wayne State University', u'Xymogen', u'Egret Pharma (Shanghai) Ltd', u'Santen Pharmaceutical Co Ltd', u'Wellcome Trust', u'Cleveland Clinic Foundation', u'Probiodrug AG', u'CSPC Zhongqi Pharmaceutical Technology (Shijiazhuang) Co Ltd', u'William Beaumont Army Medical Center', u'CeNeRx BioPharma Inc', u'Pharmacia & Upjohn AB', u'Janssen Pharmaceutica NV', u'CSPC Pharmaceuticals Group Limited', u'NorthStar R&D Ltd', u'SK Biopharmaceuticals', u'Patheon Pharmaceuticals Inc', u'Denovo Biopharma LLC', u'NPS Pharmaceuticals Inc', u'Curidium Medica plc', u'Forenap Pharma', u'MaRS Innovation', u'Juvantia Pharma Ltd', u'Trevena Inc', u'Undisclosed', u'RIMSA Laboratorios', u'Eli Lilly & Co', u'Tikvah Therapeutics Inc', u'BioHaven Pharmaceutical Holding Co Ltd', u'Eurand America Inc', u'NeuroNova AB', u'Algae Dynamics Corp', u'Armstrong Laboratories Inc', u'SIBIA Neurosciences Inc', u'Neuro3d SA', u'Johnson & Johnson', u'Helsinki University', u'Angelini Labopharm', u'Taisho Pharmaceutical Co Ltd', u'Cerecor Inc', u'Servier', u'Bristol-Myers Squibb Co', u'Myungin Pharm Co Ltd', u'Epic Pharma LLC', u'Rush University Medical Center', u'Astellas Pharma Inc', u'Lundbeck Research USA Inc', u'Premier Biomedical Inc', u'Fabre Kramer Pharmaceuticals Inc', u'University of Cambridge', u'Karolinska Institutet', u'Brown University', u'Phase 2 Discovery Inc', u'Institute of Pharmacology and Toxicology Academy of Military Medical Sciences PLA', u'Orion Corporation', u'Medical and Pharmaceutical Industry Technology and Development Center', u'BTG plc', u'Texas A&M University System', u'US Department of Veterans Affairs', u'Chinese Government', u'Vernalis plc', u'University of Pennsylvania', u'Mikah Pharma', u'Mitsubishi-Tokyo Pharmaceuticals Inc', u'Chongqing Pharmaceutical Research Institute Co Ltd', u'Roche Holding AG', u'Mitsubishi Tanabe Pharma Corp', u'The National Institute of Mental Health', u'Temple University', u'Mindsense Biosystems Ltd', u'Catalyst Biosciences Inc', u'Korea Drug Development Fund', u'Neurologix Inc', u'Brain Canada', u'Evotec AG', u'Meiji Seika Pharma Co Ltd', u'Impel NeuroPharma', u'Bukwang Pharmaceutical Co Ltd', u'Sanofi (pre-1999)', u'e-Therapeutics Plc', u'Endo Health Solutions Inc', u'VistaGen Therapeutics Inc', u'Consejo Superior De Investigaciones Cientificas', u'SWK Holdings Corporation', u'Imperial College London', u'Sanofi-Synthelabo', u'Massachusetts General Hospital', u'Medical Research Council', u'PN Gerolymatos SA', u'Scarista Ltd', u'Janssen Pharmaceutical KK', u\"M's Science Corp\", u'YuanSci Bio-Tech (Tianjin) Co Ltd', u'Marco Polo Pharmaceuticals SA', u'Tetra Discovery Partners LLC', u'Albany Molecular Research Inc', u'Zhejiang Huahai Pharmaceutical Group Co Ltd', u'LG Chem Ltd', u'Daiichi Fine Chemicals Co Ltt', u'University of California San Diego', u'DuPont Pharmaceuticals Ltd', u'Jeil Pharmaceutical Co Ltd', u'Cepa Schwarz Pharma Sl', u'F Hoffmann-La Roche AG', u'Green Cross Corp', u'Mitsubishi Pharma Corp', u'Xian-Janssen Pharmaceutical Ltd', u'Mayo Clinic Foundation', u'Intra-Cellular Therapies Inc', u'Ore Pharmaceuticals Inc', u'Altus Formulation', u'Ardent Pharmaceuticals Inc', u'Actavis Inc', u'Sumitomo Dainippon Pharma Co Ltd', u'Molecular Insight Pharmaceuticals Inc', u'University of Texas Southwestern Medical Center', u'ScinoPharm Taiwan Ltd', u'Pierre Fabre SA', u'Shanghai Institute of Pharmaceutical Industry', u'AstraZeneca plc', u'The Stanley Medical Research Institute', u'Lacer SA', u'Scotia Holdings plc', u'University of Turku', u'Array BioPharma Inc', u'Mylan Pharmaceuticals Inc', u'Euthymics Bioscience Inc', u'Pherin Pharmaceuticals Inc', u'Shanghai Medicilon Inc', u'A Carlsson Research AB', u'Abiogen Pharma SpA', u'Organon A/S', u'Summit Pharmaceuticals International Corp', u'Medavante Inc', u'Cornell University', u'Affectis Pharmaceuticals AG', u'Virginia Polytechnic Institute and State University', u'Covis Pharma Sarl', u'Admera Health', u'ChemGenex Pharmaceuticals Ltd', u'Concordia International Corp', u'University of Western Ontario', u'Neuralstem Inc', u'Meta-IQ', u'Takeda Pharmaceutical Co Ltd', u'Rising Pharmaceuticals Inc', u'Quantum Materials Corp', u'Clinical Data Inc', u'Krenitsky Pharmaceuticals Inc', u'Turing Pharmaceuticals LLC', u'Edgemont Pharmaceuticals LLC', u'Ridge Diagnostics Inc', u'Mount Sinai School of Medicine', u'Onxeo SA', u'Forest Laboratories Inc', u'Korea Research Institute of Chemical Technology', u'Quintiles Transnational Corp', u'University of Queensland', u'NanoAxis', u'Biocortech', u'Revaax Pharmaceuticals LLC', u'nLife Therapeutics SL', u'Hybrigenics SA', u'Massachusetts College of Pharmacy and Health Sciences', u'Novartis Pharmaceuticals Corp', u'Orexigen Therapeutics Inc', u'CogState Ltd', u'Defense Advanced Research Projects Agency', u'Knoll Farmaceutici SpA', u'Bioresearch SpA', u'Centre for Addiction and Mental Health', u'Azevan Pharmaceuticals Inc', u'SunGen Pharma LLC', u'Cary Pharmaceuticals Inc', u'Blackfynn', u'Memory Pharmaceuticals Corp', u'Reckitt & Colman plc', u'Michigan Economic Development Corp', u'Gnosis Srl', u'Repligen Corp', u'PsychoGenics Inc', u'InterLab Pharmaceutica', u'Bionomics Ltd', u'Maryland Department of Business and Economic Development', u'Angelini Pharmaceuticals SpA', u'Avera Pharmaceuticals Inc', u'Trovis Pharmaceuticals LLC', u'Glaxo Group Ltd', u'Boehringer Ingelheim Corp', u'Neuro Bioscience Inc', u'Patient Centered Outcome Research Institute', u'University of Arizona', u'Duke University Medical Center', u'Neurolixis Inc', u'Health Policy and Research Foundation', u'Shanghai Institute of Materia Medica of the Chinese Academy of Sciences', u'KYOWA Pharmaceutical Industry Co Ltd', u'Amorsa Therapeutics Inc', u'Merck & Co Inc', u'Sanofi', u'The Salk Institute for Biological Studies', u'Wyeth-Ayerst Pharmaceuticals Inc', u'Columbia University', u'Bayer AG', u'Pharmacia Corp', u'Handa Pharmaceuticals', u'Phytera Inc', u'University of Zagreb', u'Neurocrine Biosciences Inc', u'Wyeth', u'Cervel Neurotech Inc', u'NeuroNascent Inc', u'Wuhan Yuanzheng Century Pharmaceutical Co Ltd', u'Gaia Ag', u'University of Kansas', u'VIA Pharmaceuticals Inc', u'GlaxoSmithKline KK', u'Elan Corp plc', u'WhanIn Pharmaceutical Co Ltd', u'INSERM', u'Alte Biosciences', u'Columbia University Medical Center', u'Cephalon Inc', u'Khandelwal Laboratories Ltd', u'Agence Nationale de Valorisation de la Recherche', u'Par Pharmaceutical Co Inc', u'IDT Australia Ltd', u'Biovail Corp', u'Stegram Pharmaceuticals Ltd', u'Ranbaxy Laboratories Ltd', u'Janssen Pharmaceuticals Inc', u'GenuPro Inc', u\"Dr Reddy's Laboratories Ltd\", u'US Government', u'Korea Institute of Science and Technology', u'Luc Therapeutics Inc', u'MSD OSS BV', u'Alliance for Lupus Research', u'Fudan University', u'GlaxoSmithKline plc', u'moksha8 Pharmaceuticals Inc', u'Marina Biotech Inc', u'Scios Inc', u'Elite Pharmaceuticals Inc', u'Ameritox Ltd', u'FAES Farma SA', u'Cerca Insights Sdn Bhd', u'Neurogen Corp', u'Sankyo Co Ltd', u'Layton Bioscience Inc', u'Pohang University of Science & Technology', u'Shionogi & Co Ltd', u'Emory University', u'Morphochem AG', u'Akhu Therapeutics Inc', u'Universiteit Maastricht', u'Wockhardt Ltd', u'Johnson & Johnson Pharmaceutical Research & Development LLC', u'RespireRx Pharmaceuticals Inc', u'Abbott Laboratories', u'Eisai Co Ltd', u'Novartis AG', u'Merck KGaA', u'Avanti Therapeutics', u'NanoOptics Ltd', u'McLean Hospital Corp', u'Beech Tree Labs Inc', u'NeurOp Inc', u'Prestwick Chemical Inc', u'Alfresa Pharma Corp', u'Pharmacia & Upjohn Inc', u'Rio Grande Neurosciences Inc', u'Washington University in St Louis', u'Sonkei Pharmaceuticals Inc', u'Johns Hopkins University', u'Myriad Genetics Inc', u'Kyowa Hakko Kogyo Co Ltd', u'Recordati SpA', u'H Lundbeck A/S', u'Vela Pharmaceuticals Inc', u'Mallinckrodt plc', u'Chugai Pharmaceutical Co Ltd', u'University of North Carolina', u'National Institute of Neurological Disorders and Stroke', u'Otsuka Pharmaceutical Co Ltd', u'Transdermal Research Pharm Laboratories LLC', u'SRI International', u'Medivir AB', u'National Institute on Drug Abuse', u'Medtronic plc', u'Biolite Inc', u'Addex Therapeutics Ltd', u'Laboratoire L Lafon SA', u'PLIVA dd', u'Adamed Group', u'Alembic Ltd', u'Enhance Biotech Inc', u'R-Biopharm Ag', u'DNAPrint genomics Inc', u'Western Michigan University', u'Sunovion Pharmaceuticals Inc', u'Pfizer Inc', u'Tetragenex Pharmaceuticals Inc', u'Sandoz Inc', u'University of Illinois', u'Osmotica Pharmaceutical Corp', u'Milken Institute', u'Baylor College of Medicine', u'Laboratorios Farmaceuticos Rovi SA', u'University of Western Australia', u'Somerset Pharmaceuticals Inc', u'Arena Pharmaceuticals Inc', u'Targacept Inc', u'Pillar5 Pharma', u'Aarhus University', u'IntelGenx Technologies Corp', u'National Institutes of Health', u'Solvay Meiji Yakuhin KK', u'Laxdale Ltd', u'Janssen LP', u'Aequus Pharmaceuticals Inc', u'Asahi Kasei Pharma Corp', u'HolsboerMaschmeyer NeuroChemie GmbH', u'Kunming Institute of Botany The Chinese Academy of Sciences', u\"Institut d'Investigacions Biomediques August Pi I Sunyer\", u'Childrens Hospital of Philadelphia', u'Attenua Inc', u'Chengdu Institute Of Organic Chemistry Chinese Academy Of Sciences', u'Cypress Bioscience Inc', u'Ministry of Science and Higher Education, Poland', u'Tripos Inc', u'Mylan Specialty']), u'MuckleWellssyndrome': set([u'Novartis Pharma AG', u'Medarex Inc']), u'Ocularhypertension': set([u'D Western Therapeutics Institute', u'Aerie Pharmaceuticals Inc', u'Novartis Ophthalmics Inc', u'Undisclosed', u'SamChunDang Pharm Co Ltd', u'Otsuka Pharmaceutical Co Ltd', u'Ocular Therapeutix Inc', u'Daiichi Sankyo Co Ltd', u'Sucampo Pharmaceuticals Inc', u'Eisai Co Ltd', u'Neurobiological Technologies Inc', u'Forest Laboratories Inc', u'Kowa Co Ltd', u'Boehringer Mannheim GmbH', u'Graybug Vision Inc', u'Senju Pharmaceutical Co Ltd', u'Asahi Glass Co Ltd', u'ACADIA Pharmaceuticals Inc', u'NicOx SA', u'Fujisawa Pharmaceutical Co Ltd', u'Novelion Therapeutics Inc', u'Aton Pharma Inc', u'pSivida Corp', u'Hanmi Pharmaceutical Co Ltd', u'Ueno Fine Chemicals Industry Ltd', u'Merck & Co Inc', u'Asahi Kasei Pharma Corp', u'Santen Pharmaceutical Co Ltd', u'MSD Japan', u'Chong Kun Dang Pharmaceutical Corp', u'Othera Pharmaceuticals Inc', u'Ono Pharmaceutical Co Ltd', u'InSite Vision Inc', u'Incept LLC', u'Sinphar Pharmaceutical Co Ltd', u'Kyorin Pharmaceutical Co Ltd', u'Wakamoto Pharmaceutical Co Ltd', u'Sandoz Ltd', u'Zuellig Pharma Ltd', u'Dong-A ST Co Ltd', u'Mundipharma Pte Ltd', u'Allergan Inc', u'H Lundbeck A/S', u'Altheos Inc', u'Pfizer Inc', u'Childrens Medical Center Corp', u'Sylentis SAU', u'University of Florida', u'UBE Industries Ltd', u\"Boston Children's Hospital\", u'Alnylam Pharmaceuticals Inc', u'R-Tech Ueno Ltd', u'Bausch & Lomb Inc', u'Merz & Co GmbH', u'Samil Pharmaceutical Co Ltd']), u'HIVinfec': set([u'Eisai Co Ltd', u'Ligand Pharmaceuticals Inc']), u'Hypersensitivity': set([u'Stanford University', u'Benchmark Animal Health Ltd', u'Evax AG', u'ImmuLogic Pharmaceutical Corp']), u'Hirsutism': set([u'Follicum AB', u'Clinical Research Center for Hair and Skin Science']), u'Degenerativediscdisease': set([u'Rainbow Medical', u'AnGes MG Inc', u'National Institute of Arthritis and Musculoskeletal and Skin Diseases', u'Ferring Pharmaceuticals SA', u'Ensol Biosciences Inc', u'Seikagaku Corp', u'Yuhan Corp', u'Korea Drug Development Fund', u'Medos SA', u'Nippon Zoki Pharmaceutical Co Ltd', u'Feinstein Institute for Medical Research']), u'Lymphaticsystemtumor': set([u'Helmholtz Zentrum M\\xfcnchen', u'Sirion Gmbh']), u'Cornealtransplantrejection': set([u'Ribomic Inc', u'Juntendo University', u'Gene Signal SAS', u'Medical Need Europe AB']), u'Tendondisease': set([u'Depuy', u'Collplant Ltd', u'Orthocell Pty Ltd', u'Arthrex Inc', u'Novartis Vaccines & Diagnostics', u'BioMimetic Therapeutics Inc']), u'HIV-1infection': set([u'Karolinska Institutet', u'National University of Colombia', u'Etubics Corp', u'US Government', u'University of Cologne', u'University of Medicine and Dentistry of New Jersey', u'The Chinese Centre for Disease Control and Prevention', u'Sanofi Pasteur', u'IDM Pharma Inc', u'GenVec Inc', u'Fudan University', u'Lynx Therapeutics GmbH', u'Oncolys BioPharma Inc', u'Maxygen Inc', u'Commonwealth Government', u'GlaxoSmithKline plc', u'Howard Hughes Medical Institute', u'CombiMatrix Corp', u'The Ragon Institute', u'Indiana University School of Medicine', u'University Of Southampton', u'Ionis Pharmaceuticals Inc', u'Sangamo Therapeutics Inc', u'University of Pennsylvania', u'Shandong University', u'Apotex Inc', u'Shanghai Desano Pharmaceuticals Co Ltd', u'Chinese Academy of Medical Sciences & Peking Union Medical College', u'Roche Holding AG', u'Hospital Clinic of Barcelona', u'Shire plc', u'TransGenex Nanobiotech Inc', u'Emcure Pharmaceuticals Ltd', u'The National Institute of Mental Health', u'Aviragen Therapeutics Inc', u'Virion Systems Inc', u'Aurobindo Pharma Ltd', u'UCB Pharma SA', u'Wilex Inc', u'Vironova AB', u'3M Pharmaceuticals', u'ReiThera Srl', u'National Center for Research Resources', u'Ministry of Health, Thailand', u'Pfizer Inc', u'ImQuest Life Sciences Inc', u'Peking University', u'Dana-Farber Cancer Institute Inc', u'AltraVax Inc', u'Helmholtz Zentrum M\\xfcnchen', u'University of Nebraska Medical Center', u'National Research Council of Canada', u'RecipharmCobra Biologics', u'National Institute of General Medical Sciences', u'Academic Medical Center, University of Amsterdam', u'University of Messina', u'National Health and Medical Research Council', u'Receptome', u'GenPhar Inc', u'Frontier Biotechnologies Co Ltd', u'Global Solutions for Infectious Diseases', u'Hetero Drugs Ltd', u'Janssen Diagnostics BVBA', u'Harvard University', u'Samjin Pharmaceutical Co Ltd', u'Ohio State University', u'Tulane University', u'South China Sea Institute of Oceanology Chinese Academy of Sciences', u'LBR Regulatory & Clinical Consulting Services Inc', u'Immune Design Corp', u'National Cancer Institute', u'RetroVirox Inc', u'Technical University of Munich', u'Aphios Corp', u'Southern Research Institute', u'Center for Infectious Disease Research', u'Istituto Richerche Immunobiologiche di Siena', u'Nairobi University', u'CiVentiChem LLC', u'Istituto Scientifico H San Raffaele', u'Virus Research Institute Inc', u'Madam Therapeutics BV', u'Pharmexa-Epimmune Inc', u'Universita degli Studi di Napoli Federico II', u'Massachusetts General Hospital', u'Chimerix Inc', u'NanoSystems LLC', u'Mylan Laboratories Ltd', u'Trustees Of Stevens Institute Of Technology', u'EirGenix Inc', u'Mallinckrodt Inc', u'Trimeris Inc', u'AUM LifeTech', u'Cytokine PharmaSciences Inc', u'Carrus Capital Corp', u'Mbeya Medical Research Programme', u'International Partnership for Microbicides', u'Dong-A ST Co Ltd', u'bioMONTR Labs', u'Pharmacia & Upjohn Inc', u'McGill University', u'Janssen Pharmaceutica NV', u'Iowa State University', u'TeneoBio Inc', u'DFH Pharma Inc', u'Leidos Biomedical Research Inc', u'National Institute of Biomedical Innovation', u'Boehringer Ingelheim Corp', u'Hoffmann-La Roche Inc', u'University of California San Diego', u'University of Southern California', u'Taiga Biotechnologies Inc', u'Vyrex Corp', u'Hebei General Hospital', u'Janssen Research Foundation Worldwide', u'Presidio Pharmaceuticals Inc', u'Rockefeller University', u'University of Maryland Baltimore County', u'National Institute of Neurological Disorders and Stroke', u'Biotron Ltd', u'Wyeth Pharmaceuticals', u'Hospital Universitario Ramon y Cajal', u'The Macfarlane Burnet Institute For Medical Research & Public Health Ltd', u'Aaron Diamond AIDS Research Center', u'Harvard Medical School', u'Korea Drug Development Fund', u'International Therapeutics Inc', u'irsiCaixa Foundation', u'Cipla Ltd', u'Weill Medical College of Cornell University', u'Schering-Plough Corp', u'California Institute of Technology', u'Universidade Federal Fluminense', u'Panacos Pharmaceuticals Inc', u'RFS Pharma LLC', u'Kumamoto University', u'Medivir AB', u'University of California San Francisco', u'University of California', u'Merck & Co Inc', u'Australian Research Council', u'Scripps Research Institute', u'Sanofi', u'The Salk Institute for Biological Studies', u'Frederick Research Center', u'Monogram Biosciences Inc', u'Centers for Disease Control and Prevention', u'Shanghai LF Asia Healthcare Co Ltd', u'University of Miami', u'Bayer AG', u'Avaris AB', u'Beijing Institute of Pharmacology and Toxicology', u'Epimmune Inc', u'Novasep', u'VivaCell Biotechnology Espana SL', u'MSD Japan', u'R-Pharm', u'ViiV Healthcare Ltd', u'Aspen South Africa', u'Esteve', u'Sedia Biosciences Corp', u'Gilead Sciences Inc', u'Medicines Patent Pool', u\"Brigham & Women's Hospital\", u'International AIDS Vaccine Initiative', u'Novartis Vaccines & Diagnostics', u'Novita Healthcare Ltd', u'Tobira Therapeutics Inc', u'ProSci Inc', u'MatTek Corp', u'University of Washington', u'Picower Institute for Medical Research', u'Rega Institute for Medical Research', u'Purdue University', u'Vaccine Research Institute of San Diego', u'Australian Government', u'Janssen R&D (Ireland)', u'AbbVie Inc', u'Sarawak MediChem Pharmaceuticals Inc', u'University of Oklahoma', u'Janssen Pharmaceuticals Inc', u'Kureha Corp', u'National Institute of Allergy and Infectious Diseases', u'Bavarian Nordic A/S', u'The Australian National University', u'Hubei Academy of Agricultural Sciences', u'Walter Reed Army Institute of Research', u'National Institutes of Health', u'Bill & Melinda Gates Foundation', u'Janssen Sciences Ireland Uc', u'US Army Office of the Surgeon General', u'Bristol-Myers Squibb Co', u'City of Hope', u'University of Rochester', u'INSERM', u'Solon Eiendom ASA', u'Integrated Diagnostics Inc', u'Chiron Viagene Inc', u'Seoul National University', u'The Research Council of Norway', u'University of Hawaii', u'Duke University', u'Kagoshima University', u'Institut Pasteur', u'Agouron Pharmaceuticals Inc', u'diaDexus Inc', u'Takara Bio Inc', u'University of Oxford', u'Crucell NV', u'Indiana University', u'Ciclofilin Pharmaceuticals Inc', u'ChronTech Pharma AB', u'Beth Israel Deaconess Medical Center', u'TaiMed Biologics Inc', u'Sanfer']), u'Mitochondrialdisease': set([u'Sphaera Pharma', u'Mitobridge Inc', u\"Alzheimer's Drug Discovery Foundation\", u'Isomerase Therapeutics Ltd', u'ElexoPharm GmbH', u'The European Union', u'Courtagen Life Sciences Inc', u'NeuroVive Pharmaceutical AB', u'BTG plc', u'Horizon Orphan LLC', u'Undisclosed', u'Food and Drug Administration', u'Georgetown University', u'Aventis SA', u'European Eurostars Programme', u'Samaritan Pharmaceuticals Inc', u'Radboud University', u'Mitogenetics LLC', u'Virginia Commonwealth University', u'Yungjin Pharmaceutical Co Ltd', u'VINNOVA', u'Astellas Pharma Inc', u'Transgenomic Inc', u'Khondrion BV', u'United Mitochondrial Disease Foundation', u'Foundation for Mitochondrial Medicine', u'Childrens Hospital of Philadelphia', u'Janssen Biotech Inc', u'Biologics Inc', u'State University of New York', u'Genfit SA', u'Bioelectron Technology Corp', u'University of Florida', u'Dana-Farber Cancer Institute Inc', u'Pharmacelsus', u'German Federal Ministry of Education and Research', u'National Human Genome Research Institute', u'Sumitomo Dainippon Pharma Co Ltd']), u'Autosomalrecessivepolycystickidneydisease': set([u'Kadmon Pharmaceuticals LLC', u'Symphony Evolution Inc', u'University of Texas Southwestern Medical Center', u'National Institute of Diabetes, Digestive and Kidney Diseases']), u'Jaundice': set([u'IXICO Plc', u'Soleno Therapeutics Inc', u'Shanghai CiiC Science and Technology Development Company', u'University of Madras']), u'Osteoarthritis': set([u'Deltagen Research Laboratories', u'NovAliX', u'Servier', u'US Government', u'C&O Pharmaceutical Technology (Holdings) Ltd', u'Aratana Therapeutics Inc', u'University of Vienna', u'NAEJA Pharmaceuticals Inc', u'NovelMed Therapeutics Inc', u'Eupraxia Pharmaceuticals Inc', u'Regeneus Pty Ltd', u'Sunovion Pharmaceuticals Canada Inc', u'Netherlands Government', u'Gel-Del Technologies Inc', u'Anika Therapeutics Inc', u'Advance Pharma Sdn Bhd', u'Chugai Pharmaceutical Co Ltd', u'Iroko Pharmaceuticals LLC', u'Unigene Laboratories Inc', u'Forest Laboratories Inc', u'Tonghua Dongbao Pharmaceutical Co Ltd', u'GlaxoSmithKline plc', u'BioLife Solutions Inc', u'Chiesi Farmaceutici SpA', u'Johns Hopkins University', u'Asahi Kasei Corp', u'pSivida Corp', u'TR-Pharm', u'Novartis Pharma AG', u'Aventis Pharma AG', u'Elan Pharmaceutical Technologies', u'Marina Biotech Inc', u'Helix BioPharma Corp', u'Archimica SpA', u'Osteologix Holdings PLC', u'Procter & Gamble Pharmaceuticals Inc', u'TissueGene Inc', u'Italchimici SpA', u'Vernalis plc', u'Symic Biomedical Inc', u'Medical Innovators Pty Ltd', u'Fidia Farmaceutici SpA', u'Navidea Biopharmaceuticals Inc', u'Zeneca Group plc', u'Biomodels LLC', u'Apotex Inc', u'Ono Pharmaceutical Co Ltd', u'bene Corp', u'Five Prime Therapeutics Inc', u'Massachusetts College of Pharmacy and Health Sciences', u'Dompe SpA', u'UCB Celltech', u'Inventiv Health Clinical Inc', u'Mitsubishi Tanabe Pharma Corp', u'Galapagos NV', u'Biomatrix Inc', u'Kolon Life Science Inc', u'Auritec Pharmaceuticals Inc', u'Mesoblast Ltd', u'Sun Pharmaceutical Industries Ltd', u'Fidia Group', u'Sayre Therapeutics Private Ltd', u'Medservice', u'Sankyo Co Ltd', u'University of Kentucky', u'Ember Therapeutics', u'Laboratorios Rubio SA', u'IntelliCell BioSciences Inc', u'St Marianna University School of Medicine', u'Shionogi & Co Ltd', u'Eukarion Inc', u'Merckle GmbH', u'Optimer Pharmaceuticals Inc', u'Melacure Therapeutics AB', u'Knoll Farmaceutici SpA', u'Evgen Pharma plc', u'Bioresearch SpA', u'Teijin Pharma Ltd', u'PLIVA Pharma Ltd', u'PetVivo Holdings Inc', u'Marinova Pty Ltd', u'PRA International', u'CrystalGenomics Inc', u'XTL Biopharmaceuticals Ltd', u'Phytochemindo', u'PRIM Group', u'Bioiberica SA', u'Bioventus LLC', u'National Institute of Arthritis and Musculoskeletal and Skin Diseases', u'University of Oxford', u'MD Anderson Cancer Center', u'Mitsubishi Corp', u'Medarex Inc', u'The University Health Network', u'California Institute of Regenerative Medicine', u'LocomoGene Inc', u'Maryland Stem Cell Research Fund', u'Squire Pharmaceuticals', u'Abbott Laboratories', u'Endo Health Solutions Inc', u'The Royal Veterinary College', u'Queen Mary University of London', u'UMeWorld Ltd', u'Geron Corp', u'Santarus Inc', u'Harris FRC Corp', u'Calimmune Inc', u'Novartis AG', u'Arcarios', u'Ferrer Internacional SA', u'Sirna Therapeutics Inc', u'Ministry of Health & Welfare, Korea', u'Kos Pharmaceuticals Inc', u'Palau Pharma SA', u'VOCATE Pharmaceuticals S.A', u'PLx Pharma Inc (pre-merger)', u'Pendopharm', u'NovaMedica', u'Parkway Holdings Ltd', u'Brane Discovery Srl', u'Agennix AG', u'Osiris Therapeutics Inc', u'A.S. Bryden and Sons Ltd', u'Cocoon Biotech Inc', u'Medical Research Council', u'BioSystems International SAS', u'Emisphere Technologies Inc', u'UCB Pharma GmbH', u'Mallinckrodt Inc', u'TiGenix NV', u'Pharmacopeia Inc', u'Dendreon Corp', u'Cleveland Clinic Foundation', u'Lubris BioPharma', u'Taisho Pharmaceutical Co Ltd', u'University of California San Diego', u'Celera Group', u'Dong-A ST Co Ltd', u'Biopharm GmbH', u'Surgicraft Ltd', u'Swedish Orphan Biovitrum AB', u'Alvogen Inc', u'KS Biomedix Holdings plc', u'AnGes MG Inc', u'Mor Research Applications Ltd', u'Landsteiner Scientific Sa De Cv', u'Boehringer Ingelheim Corp', u'Nuvo Pharmaceuticals Inc', u'National Institutes of Health', u'Tokuhon Co Ltd', u'Horizon Pharma plc', u'Camargo Pharmaceutical Services', u'BioInvent International AB', u'Recordati SpA', u'Hospital for Special Surgery NY', u'Royal DSM NV', u'Vianex SA', u'F Hoffmann-La Roche AG', u'Medvet Science Pty Ltd', u'Orphan Australia', u'Epitech Group Srl', u'Nordic Bioscience A/S', u'Roche Holding AG', u'SS Pharmaceutical - ethical drug division', u'Tiantan Puhua Neurological Hospital', u'AmorePacific Corp', u'Duke University Medical Center', u'JARI Pharmaceuticals BV', u'Angioblast Systems Inc', u'Olympus Corp', u'ReqMed Co Ltd', u'Mitsubishi Pharma Corp', u'Istituto Gentili SpA', u'Grunenthal GmbH', u'Covidien plc', u'MegaPharm Ltd', u'M.Fast Technologies Ltd', u'Stryker Corp', u'GeneNews Ltd', u'Shire Orphan Therapies GmbH', u'Apogee Biotechnology Corp', u'Sanova Pharma GesmbH', u'Ultrafine Chemicals Ltd', u'Asklepios Biopharmaceutical Inc', u'Allergan plc', u'Windlas Healthcare Private Limited', u'Hi-Tech Pharmacal Co Inc', u'Institut Biochimique SA', u'Aquilus Pharmaceuticals Inc', u'Merck KGaA', u'NicOx SA', u'Santa Farma', u'National Institute on Drug Abuse', u'Altus Formulation', u'Pfizer Inc', u'XOMA Corp', u'Daewoong Pharmaceutical Co Ltd', u'Scripps Research Institute', u'Winston Pharmaceuticals Inc', u'Andrews Research and Educational Institute', u'Logical Therapeutics Inc', u'Merck Sharp & Dohme de Espana SA', u'Neurotune AG', u'Daewon Pharm Co Ltd', u'Vertex Pharmaceuticals Inc', u'Feinstein Institute for Medical Research', u'Eli Lilly & Co', u'Sinil Pharmaceutical', u'Provalis plc', u'Japan Tobacco Inc', u'Blansett Pharmacal Co Inc', u'Bayer AG', u'University of California Davis', u'Laboratoire L Lafon SA', u'Selexis SA', u'Medinox Inc', u'AKL International Inc', u'United Therapeutics Corp', u'University of Edinburgh', u'Shanghai Rebone Biomaterials Co Ltd', u'McNeil Consumer Products Co', u'Pediapharm Inc', u'University of Tennessee', u'University of Iowa', u'MEDS Medikal Ltd', u'Janssen Biotech Inc', u'Medovex Corp', u'Almirall Prodesfarma SA', u'Therapure Biopharma Inc', u'AstraZeneca plc', u'Esteve', u'National Institute on Aging', u'Cerimon Pharmaceuticals Inc', u'University of Cincinnati', u'Modi Mundipharma Pvt Ltd', u'Sosei R&D Ltd', u'MitoKor', u'Denki Kagaku Kogyo Kabushiki Kaisha', u'Lacer SA', u'Wyeth', u'Institute for the Promotion of Innovation by Science and Technology in Flanders', u'Unity Biotechnology', u'Cartela AB', u'CollaGenex Pharmaceuticals Inc', u'Han Seo Pharm Co Ltd', u'LG Life Sciences Ltd', u'Traverse Biosciences Inc', u'Australian Government', u'Genmab A/S', u'Euthymics Bioscience Inc', u'Kureha Corp', u'Solvay Pharmaceuticals Inc', u'Glenmark Pharmaceuticals Ltd', u'Pharmos Corp', u'Harvester Trading Co Ltd', u'Elanco Animal Health', u'Kyowa Kirin', u'SmithKline Beecham plc', u'Dojin Iyaku-Kako Co Ltd', u'Victory Pharma Inc', u'Alfa Wassermann SpA', u'Novartis Pharma KK', u'Juvenile Diabetes Research Foundation', u'VistaGen Therapeutics Inc', u'Laboratorio Medinfar - Productos Farmaceuticos Lda', u'Proteomika SL', u'Albert Einstein College of Medicine', u'RNL Bio Co Ltd', u'FAES Farma SA', u'Asahi Glass Co Ltd', u'Pharmalink AB', u'Zimmer Inc', u'Ablynx NV', u'Sumitomo Pharmaceuticals Co Ltd', u'Samil Pharmaceutical Co Ltd', u'Sanofi', u'Elan Corp plc', u'University of Valencia', u'Aventis SA', u'MorphoSys AG', u'Roche Palo Alto', u'Prismic Pharmaceuticals Inc', u'Asahi Kasei Pharma Corp', u'Rush University Medical Center', u'Quark Pharmaceuticals Inc', u'The Arthritis Society, Canada', u'Parke-Davis & Co', u'Mundipharma International Corp Ltd', u'Green Cross Corp', u'Cephalon Inc', u'Array BioPharma Inc', u'Par Pharmaceutical Co Inc', u'University of Toronto', u'Dong Wha Pharmaceutical Co Ltd', u'Synartro AB', u'IXICO Plc', u'Daiichi Fine Chemicals Co Ltt', u'Interpace BioPharma LLC', u'Seikagaku Corp', u'Undisclosed', u'Moebius Medical Ltd', u'Merck Serono SA', u'Jaba Farmaceutica, SA', u'Meda AB', u'University of Western Ontario', u'Arthritis Foundation', u'Hebrew University of Jerusalem', u'Rheumco LLC', u'Flexion Therapeutics Inc', u'Cypress Bioscience Inc', u'Cellular Biomedicine Group Inc', u'Tribute Pharmaceuticals Canada Inc', u'Fera Pharmaceuticals LLC', u'AcurePharma AB', u'Telesta Therapeutics Inc', u'CuraGen Corp', u'Teligent Inc', u'GD Searle & Co', u'The Global Alliance for Innovation in Neuroscience Inc', u'Pacific Pharmaceuticals Co Ltd', u'SK Chemicals Co Ltd']), u'DNAvirusinfection': set([u'Beijing Wellso Pharmaceutical Co Ltd', u'Therapeutic Systems Research Laboratories', u'University of California', u'Institute of Microbiology and Epidemiology Academy of Military Medical Sciences PLA', u'National Institute of Allergy and Infectious Diseases', u'Chimerix Inc']), u'CMVretinitis': set([u'Boehringer Mannheim GmbH', u'Roche Holding AG', u'Galena Biopharma Inc', u'University of Massachusetts Medical School', u'Rega Institute for Medical Research', u'University of Kentucky', u'CytRx Corp', u'pSivida Inc', u'Gilead Sciences Inc', u'Ionis Pharmaceuticals Inc', u'pSivida Corp', u'Sandoz Ltd', u'Pharmacia & Upjohn Co', u'Recordati SpA', u'CIBA Vision Corp', u'PDL BioPharma Inc', u'Bausch & Lomb Inc', u'Chiron Vision', u'Tanabe Seiyaku Co Ltd', u'Pacira Pharmaceuticals Inc']), u'Facialnervedisease': set([u'Mount Sinai School of Medicine', u'National Institutes of Health', u'Moebius Syndrome Foundation', u'Swiss National Science Foundation']), u'Gramnegativebacteriuminfection': set([u'Daiichi Seiyaku Co Ltd', u'Oscient Pharmaceuticals Corp', u'University of South Australia', u'University of Connecticut', u'NEOMED Institute', u'Wesleyan University', u'Bill & Melinda Gates Foundation', u'Koebenhavns Universitet', u'US Health and Human Services Department', u'GlaxoSmithKline plc', u'Univ Massachusetts', u'T2 Biosystems Inc', u'King Saud University', u'Cantab Anti-Infectives Ltd', u'Ionis Pharmaceuticals Inc', u'Los Angeles Biomedical Research Institute', u'Aventis Pharma AG', u'PolyMedix Inc', u'European Eurostars Programme', u'Forge Therapeutics Inc', u'Vernalis plc', u'University of Leipzig', u'Leiden University Medical Center', u'Trius Therapeutics Inc', u'New Anti Infectives Consortium', u'Roche Holding AG', u'Microcide Pharmaceuticals Inc', u'St Petersburg Institute of Experimental Medicine', u'Combating Antibiotic-Resistant Bacteria Biopharmaceutical Accelerator', u'Torrey Pines Institute for Molecular Studies', u'Polyphor Ltd', u'Grunenthal GmbH', u'Shionogi & Co Ltd', u'US Department of Defense', u'Statens Serum Institut', u'Aptuit LLC', u'Hans Knoell Institute of Natural Products Research', u'National Research Council of Canada', u'Pro Bono Bio', u'International Health Management Associates Inc', u'Cystic Fibrosis Foundation Therapeutics Inc', u'Affibody AB', u'The European Union', u'Abbott Laboratories', u'Trine Pharmaceuticals Inc', u'Innoviva Inc', u'Avance Pharma Inc', u'Lawrence Livermore National Laboratory', u'Merck KGaA', u'Aradigm Corp', u'Cantab Biopharmaceuticals Ltd', u'The Medicines Company', u'Massachusetts General Hospital', u'Curza Global LLC', u'Warp Drive Bio', u'Monash University', u'Denmark Technical University', u'University of Manchester', u'ANTABIO', u'Basilea Pharmaceutica International Ltd', u'Wellcome Trust', u'Arsanis Biosciences GmbH', u'Oxford Drug Design', u'University of Colorado System', u'SINTEF Group', u'Omm Scientific Inc', u'The Research Council of Norway', u'University of California San Diego', u'University of Melbourne', u'Xellia Pharmaceuticals AS', u'F Hoffmann-La Roche AG', u'Biotechnology and Biological Sciences Research Council (BBSRC)', u'Crocus Laboratories Inc', u'Mansoura University', u'Innovative Medicines Initiative', u'Harvard Medical School', u'Novacta Biosystems Ltd', u'BioVersys AG', u'BioDiem Ltd', u'Allergan plc', u'Roussel Uclaf SA', u'Microbiotix Inc', u'Synedgen Inc', u'XOMA Corp', u'Crystal Bioscience Inc', u'Redx Pharma Plc', u'Sanofi', u'Melinta Therapeutics Inc', u'University College London', u'University of Wisconsin-Madison', u'AiCuris Anti-infective Cures GmbH', u'Peptor Ltd', u'Adimab LLC', u'Canadian Department of National Defence', u'The University of Liverpool', u'Cubist Pharmaceuticals Inc', u'AstraZeneca plc', u'Technology Strategy Board', u'State University of New York', u'Mpex Pharmaceuticals Inc', u'The Austrian Research Promotion Agency FFG', u'Toyama Chemical Co Ltd', u'Spero Therapeutics LLC', u'NUBAD LLC', u'Baylor College of Medicine', u'Euprotec', u'Blueberry Therapeutics Ltd', u'National Institute of Allergy and Infectious Diseases', u'Demuris Ltd', u'University of Texas Southwestern Medical Center', u'Appili Therapeutics Inc', u'University of Strathclyde', u'National Institutes of Health', u'Boston University School of Law', u'Achaogen Inc', u'OSEO', u'Synspira', u'PanTherix Ltd', u'X-Biotix Therapeutics Inc', u'Creative Antibiotics Sweden AB', u'Promiliad Biopharma Inc', u'Ortho-McNeil Inc', u'MGB Biopharma Ltd', u'Newton Fund', u'Novexel SA', u'Atterx Biotherapeutics', u'Rempex Pharmaceuticals Inc', u'NAEJA Pharmaceuticals Inc', u'Discuva Ltd', u'Iterum Therapeutics Ltd', u'John Innes Centre', u'Defense Threat Reduction Agency']), u'Parkinsonism': set([u'Nordion Inc', u'Navidea Biopharmaceuticals Inc']), u'Malehypogonadism': set([u'Solvay SA', u'Lipocine Inc', u'Paladin Labs Inc', u'Acerus Pharmaceuticals Corp', u'TesoRx Pharma', u'ASKA Pharmaceutical Co Ltd', u'Teva Pharmaceutical Industries Ltd', u'Ardana Bioscience Ltd', u'Ipsen', u'IASO Biomed Inc', u'Juniper Pharmaceuticals Inc', u'Solvay Pharmaceuticals Inc', u'ANI Pharmaceuticals Inc', u'CoreRx Inc', u'Aytu BioScience Inc', u'Bayer AG', u'Myovant Sciences Ltd', u'Therios Healthcare', u'Medac GmbH', u'Hyundai Pharmaceutical', u'McGill University', u'Laboratoires Besins International', u'Auxilium Pharmaceuticals Inc', u'Takeda Pharmaceutical Co Ltd', u'GlaxoSmithKline Inc', u'Orient Europharma']), u'Nephroticsyndrome': set([u'Pfizer Inc', u'CHEPLAPHARM Arzneimittel GmbH', u'Mallinckrodt plc', u'West Therapeutic Development LLC']), u'Metastaticpancreascancer': set([u'BioLineRx Ltd', u'Momenta Pharmaceuticals Inc', u'Duke University Medical Center', u'MD Anderson Cancer Center', u'Baxter International Inc', u'In Ovations Holdings Inc', u'Biothera Pharmaceuticals Inc', u'H Lee Moffitt Cancer Center and Research Institute', u'GlaxoSmithKline plc', u'MabVax Therapeutics Inc', u'National Cancer Institute', u'Albert Einstein College of Medicine', u'Ipsen', u'MabVax Therapeutics Holdings Inc', u'IDT Biologika GmbH', u'Massachusetts General Hospital', u'Ontario Institute for Cancer Research', u'University of Texas Southwestern Medical Center', u'The University Health Network', u'University of Miami', u'FibroGen Inc', u'Aduro BioTech Inc', u'Astellas Pharma Inc', u'Immunomedics Inc', u'Regulon Inc', u'Precision Biologics Inc', u'Rockefeller University', u'Hebrew University of Jerusalem', u'Nationales Centrum fur Tumorerkrankungen', u'HonorHealth Research Institute', u'AstraZeneca plc', u'University of Illinois', u'Johns Hopkins University', u'Myriad Genetics Inc', u'US Oncology Inc', u'Merrimack Pharmaceuticals Inc', u'Dana-Farber Cancer Institute Inc', u'Johns Hopkins Hospital', u'NOXXON Pharma AG', u'TrovaGene Inc', u'Boehringer Ingelheim Corp', u'Merck & Co Inc']), u'Trachoma': set([u'M.J. Murdock Charitable Trust', u'Massachusetts Institute of Technology', u'Infectious Disease Research Institute', u'BIO Ventures for Global Health', u'Alnylam Pharmaceuticals Inc', u'Medicines for Malaria Venture', u'GlaxoSmithKline plc']), u'Methylmalonicacidemia': set([u'Lonza Group AG', u'Selecta Biosciences Inc']), u'Anaplasmainfection': set([u'Virginia Commonwealth University', u'US Government']), u'Cranialnervetumor': set([u'Brainlabs BV', u'Dalhousie University']), u'Neurogenicbladder': set([u'Yamanouchi Pharmaceutical Co Ltd', u'GlaxoSmithKline plc']), u'Contusion': set([u'Eisai Co Ltd', u'Teikoku Seiyaku KK']), u'Dyslexia': set([u'Eunice Kennedy Shriver National Institute of Child Health & Human Development', u'University of California Los Angeles']), u'Metachromaticleukodystrophy': set([u'Fondazione Telethon', u'Istituto Scientifico H San Raffaele', u'Copenhagen Hospital Corp', u'bluebird bio Inc', u'University of North Carolina', u'Shire Human Genetic Therapies Inc', u'MolMed SpA', u'Zymenex A/S', u'GlaxoSmithKline plc']), u'Pruritus': set([u'Daiichi Seiyaku Co Ltd', u'Nippon Shinyaku Co Ltd', u'Johnson & Johnson', u'Chugai Pharmaceutical Co Ltd', u'Pharmacare Ltd', u'China Pharmaceutical University', u'MD Anderson Cancer Center', u'Laboratorios Elmor SA', u'Toray Industries Inc', u'Maruho Co Ltd', u'Rhone-Poulenc Rorer Pharm Inc', u'Cara Therapeutics Inc', u'Grunenthal GmbH', u'SoleRx LLC', u'Daiichi Sankyo Co Ltd', u'Abbott Laboratories', u'SK Chemicals Co Ltd', u'Eisai Co Ltd', u'GlaxoSmithKline plc', u'Takeda Pharmaceuticals International GmbH', u'Allergan plc', u'Quintiles Transnational Corp', u'Chiesi Farmaceutici SpA', u'Merck KGaA', u'Orient Europharma', u'UBE Industries Ltd', u'National Institute of Neurological Disorders and Stroke', u'Food and Drug Administration', u'Sumitomo Dainippon Pharma Co Ltd', u'Fujisawa Pharmaceutical Co Ltd', u'Moberg Pharma AB', u'Bristol-Myers Squibb Co', u'Eczacibasi Ilac Pazarlama AS', u'Italfarmaco SpA', u'Fresenius Medical Care AG', u'Merck & Co Inc', u'Taiho Pharmaceutical Co Ltd', u'Chong Kun Dang Pharmaceutical Corp', u'UCB Japan Co Ltd', u'Galderma SA', u'Japan Tobacco Inc', u'UCB SA', u'Hanmi Pharmaceutical Co Ltd', u'Roche Holding AG', u'Eurofarma', u'TOLMAR Therapeutics Inc', u'Synthelabo', u'Adolor Corp', u'Maruishi Pharmaceutical Co Ltd', u'Mitsubishi Tanabe Pharma Corp', u'Epigen Biosciences Inc', u'Ranbaxy Laboratories Ltd', u'Novis Pharmaceuticals Llc', u'Enhance Biotech Inc', u'Torii Pharmaceutical Co Ltd', u'Kissei Pharmaceutical Co Ltd', u'Helsinn Healthcare SA', u'Sankyo Co Ltd', u'Menlo Therapeutics Inc', u'Allergan Inc', u'IVAX Corp', u'Almirall Prodesfarma SA', u'Inspire Pharmaceuticals Inc', u'Pfizer Inc', u'Shionogi & Co Ltd', u'Boehringer Ingelheim Corp', u'Tenax Therapeutics Inc', u'GlaxoSmithKline KK', u'Boryung Pharm Co Ltd', u'Nippon Boehringer Ingelheim Co Ltd', u'Laboratorios Servimedic', u'Elorac Inc', u'Highnoon Laboratories Ltd', u'Sarasota Medical Products Inc', u'Sanwa Kagaku Kenkyusho Co Ltd', u'Prestige Brands Holdings Inc']), u'Multiplemyeloma': set([u'Biovest International Inc', u'Quest Diagnostics Inc', u'Spectrum Health Hospitals', u'Attenuon LLC', u'Novartis Institutes for BioMedical Research Inc', u'Chimeric Technologies Inc', u'US Health and Human Services Department', u'Technical University of Munich', u'Synergy Pharmaceuticals Inc', u'Hackensack University Medical Center', u'The Dow Chemical Co', u'Transcept Pharmaceuticals Inc', u'Pharmaceutical Product Development LLC', u'University of Pittsburgh', u'Eczacibasi Ozgun Kimyasal Urunler Sanayi ve Ticaret AS', u'Multiple Myeloma Research Consortium', u'Vaccibody AS', u'Neon Therapeutics', u'Cellectis SA', u'Fortis Therapeutics Inc', u'ElsaLys Biotech', u'One World Cannabis Ltd', u'European Commission', u'Weill Medical College of Cornell University', u'Israeli Government', u'Osteros Biomedica', u'Tel Aviv University', u'Cambridge Antibody Technology Group plc', u'Multiple Myeloma Opportunities for Research & Education', u'Bio-Gal Advanced Biotechnology', u'Mount Sinai School of Medicine', u'Vivolux AB', u'Acetylon Pharmaceuticals Inc', u'MediGene AG', u'Beijing Kawin Technology Share-Holding Co Ltd', u'Poniard Pharmaceuticals Inc', u'Winship Cancer Institute', u'Lipomed AG', u'Poseida Therapeutics Inc', u'Kancera AB', u'ImmunoGen Inc', u'Altor BioScience Corp', u'MBC Pharma Inc', u'Tragara Pharmaceuticals Inc', u'Infinity Pharmaceuticals Inc', u'Talon Therapeutics Inc', u'AERES Biomedical Ltd', u'Progenra Inc', u'Unum Therapeutics Inc', u'Sevion Therapeutics Inc', u'New Jersey Medical School', u'AnorMED Inc', u'Undisclosed', u'Chroma Therapeutics Ltd', u'LEO Pharma A/S', u'Eli Lilly & Co', u'University of Wisconsin-Madison', u'Seattle Cancer Care Alliance', u'Astellas Pharma GmbH', u'Madrigal Pharmaceuticals Inc', u'Sunesis Pharmaceuticals Inc', u'Seattle Genetics Inc', u'AbbVie Biotherapeutics Inc', u'University of South Florida', u'Cancer Research Technology Ltd', u'Patrys Ltd', u'Zalicus Inc', u'Innate Pharma SA', u'Peter MacCallum Cancer Centre', u'Pfanstiehl Laboratories Inc', u'AltaRex Medical Corp', u'Northwestern University', u'Servier', u'Salmedix Inc', u'Bristol-Myers Squibb Co', u'OSEO', u'US Oncology Inc', u'Skylinedx Bv', u'Astellas Pharma Inc', u'CyDex Pharmaceuticals Inc', u'Federal Ministry of Education and Research Service', u'Pretoria East Hospital', u'Institute of Cancer Research UK', u'University of Milan', u'LifeTime Pharmaceuticals Inc', u'PPD Discovery Inc', u'Intellikine Inc', u'University of Cambridge', u'Karolinska Institutet', u'Prostate Cancer Foundation', u'Astellas Pharma Global Development Inc', u'The Cancer Council Victoria', u'Adaptive Biotechnologies Corp', u'Eutropics Pharmaceuticals Inc', u'Pharmacyclics Inc', u'BCN Peptides SA', u'VA Greater Los Angeles Healthcare System (GLA)', u'Immune System Therapeutics Ltd', u'University Of Southampton', u'Selexis SA', u'US Department of Veterans Affairs', u'Elan Corp plc', u'Sellas Life Sciences Group', u'Genentech Inc', u'Onyvax Ltd', u'University of Pennsylvania', u'City of Hope', u'Ono Pharmaceutical Co Ltd', u'ViaCell Inc', u'Roche Holding AG', u'University of British Columbia', u'ANI Pharmaceuticals Inc', u'ProChon Biotech Ltd', u'Texas Tech University', u'OncoArendi Therapeutics Sp Z Oo', u'Dana-Farber Cancer Institute Inc', u'Beike Biotechnology Co Ltd', u'Charite Universitaetsmedizin Berlin', u'Biokine Therapeutics Ltd', u'Evotec AG', u'Regenacy Pharmaceuticals LLC', u'Amgen Inc', u'Janssen Research & Development LLC', u'Affibody AB', u'Ohio State University', u'MI Bioresearch', u'ZIOPHARM Oncology Inc', u'RedHill Biopharma Ltd', u'Georgetown University', u'University of Alabama at Birmingham', u'Array BioPharma Inc', u'University of Texas Health Science Center San Antonio', u'Massachusetts General Hospital', u'Medical Research Council', u'Callisto Pharmaceuticals Inc', u'TBG Diagnostics Ltd', u'Immunomedics Inc', u'Janssen Pharmaceutical KK', u'Astex Therapeutics Ltd', u'TeneoBio Inc', u'Xencor Inc', u'University of California San Diego', u'DuPont Pharmaceuticals Ltd', u'Lynx Therapeutics GmbH', u'NOXXON Pharma AG', u'Rockefeller University', u'Medidata Solutions Worldwide', u'Cancer Research UK', u'VGXI Inc', u'Stanford University', u'Mustang Bio Inc', u'Paladin Labs Inc', u'CellProtect Nordic Pharmaceuticals AB', u'Korea Drug Development Fund', u'Actavis Inc', u'Eden Biodesign Ltd', u'Novuspharma SpA', u'Kiromic LLC', u'Australian Research Council', u'Inflection Biosciences Ltd', u'Celonic AG', u'Dartmouth-Hitchcock Medical Center', u'CASI Pharmaceuticals Inc', u'SEBIA', u'ScinoPharm Taiwan Ltd', u'Pierre Fabre SA', u'YOUAI', u'MolMed SpA', u'West Virginia University', u'AstraZeneca plc', u'University of Utah', u'Genta Inc', u'University of Arkansas for Medical Sciences', u'Nippon Shinyaku Co Ltd', u'Advanced Medical Isotope Corp', u'Reprixys Pharmaceuticals Corp', u'NCIC Clinical Trials Group', u'Translational Genomics Research Institute', u'Genmab A/S', u'ASTA Medica AG', u'Axogen Ltd', u'H Lee Moffitt Cancer Center and Research Institute', u'Ligand Pharmaceuticals Inc', u'Innovation Pharmaceuticals Inc', u'HaemaLogiX', u'University of Wurzburg', u'Leap Therapeutics Inc', u'Bioenvision Inc', u'Spectrum Pharmaceuticals Inc', u'Fujifilm Diosynth Biotechnologies', u'AABB', u'Karyopharm Therapeutics Inc', u'Ohio State University Comprehensive Cancer Center', u'Indiana University', u'Dyax Corp', u'Takeda Pharmaceutical Co Ltd', u'International Myeloma Foundation', u'TopoTarget A/S', u'CuraGen Corp', u'Modulation Therapeutics Inc', u'German Federal Ministry of Education and Research', u'Clinical Data Inc', u'Aldevron', u'Acceleron Pharma Inc', u'Royal DSM NV', u'Kirin Brewery Co Ltd', u'MandalMed Inc', u'Mologen Ag', u'Centre for Probe Development and Commercialization', u'Biotest AG', u'Hadassah Medical Organization', u'Cytogen Corp', u'TKsignal Ltd', u'Triphase Accelerator Corp', u'MedImmune LLC', u'TMRC Co Ltd', u'DNA BioPharma', u'Fred Hutchinson Cancer Research Center', u'Pharmacia & Upjohn Co', u'Specialised Therapeutics Australia Pty Ltd', u'University of Kentucky', u'Ontario Institute for Cancer Research', u'Inventiva', u'Allosterix Ltd', u'Visterra Inc', u'Constellation Pharmaceuticals Inc', u'Melanoma Research Alliance', u'Diaclone SA', u'Harvard University', u'Yale University', u'University of Heidelberg', u'NeoPharm Inc', u'I N C Research LLC', u'Purdue Pharma LP', u'University of California San Francisco', u'CryoPort Inc', u'Oncolytics Biotech Inc', u'Mundipharma EDO GmbH', u'MultiCell ImmunoTherapeutics Inc', u'Dendreon Corp', u'Dovetail Technologies Inc', u'Micromet Inc', u'Boehringer Ingelheim Corp', u'Groote Schuur Hospital', u'Juno Therapeutics Inc', u'BioInvent International AB', u'GNS Healthcare', u'ILEX Oncology Inc', u'Engmab Ag', u'Duke University Medical Center', u'MiNeueT Therapeutics Ltd', u'Van Andel Institute', u'Proteolix Inc', u'Harvard Medical School', u'IDIS Ltd', u'Mayo Clinic Foundation', u'Oxford BioMedica plc', u'Epizyme Inc', u'PCT, a Caladrius company', u'CMC Biologics Inc', u'Cellectar Biosciences Inc', u'Nextbio', u'XOMA Corp', u'Merck & Co Inc', u'Gemin X Pharmaceuticals Inc', u'rEVO Biologics Inc', u'Sanofi', u'Columbia University', u'University of Oslo', u'Avaris AB', u'Fluorinov Pharma Inc', u'The National Centre for Research and Development', u'Janssen Pharmaceutica NV', u'T.J. Martell Foundation', u'CIS Bio International SAS', u'Merrimack Pharmaceuticals Inc', u'SymBio Pharmaceuticals Ltd', u'Vernalis plc', u'Broad Institute Inc', u'Massachusetts Institute of Technology', u'Miragen Therapeutics, Inc.', u'University of Missouri', u'Australian Government', u\"St Bartholomew's Hospital\", u'Cancer Research Ventures Ltd', u'University of Kansas', u'Juvenile Diabetes Research Foundation', u'The Australian National University', u'University of Tokyo', u'AVEO Oncology', u'Penn State Hershey Medical Center', u'MaxCyte Inc', u'Aventis SA', u'Takeda Oncology', u'MorphoSys AG', u'Stendhal International', u'Cephalon Inc', u'Celgene Corp', u'Imperial College London', u'Max Delbruck Centrum Fur Molekulare Medizin', u'Ascenta Therapeutics Inc', u'Adaptimmune Therapeutics plc', u'IATROS Bio/Pharma Inc', u'OPi SA', u'Beth Israel Deaconess Medical Center', u'XTL Biopharmaceuticals Ltd', u'Quest PharmaTech Inc', u'New Jersey Health Foundation Inc', u'US Government', u'University of Cologne', u'The Leukemia & Lymphoma Society', u'Baxter International Inc', u'Pharsight Corp', u'Biogen Inc', u'Leukogene Therapeutics Inc', u'Polyplus Transfection SAS', u'GlaxoSmithKline plc', u'Cell Genesys Inc', u'Sahar International Trading Inc', u'Innovive Pharmaceuticals Inc', u'Biotoscana International', u'Ipsen', u'Oklahoma Center for the Advancement of Science and Technology', u'European Eurostars Programme', u'Dragonfly Therapeutics Inc', u'Institut Curie', u'University of Michigan', u'University of Texas Health Science Center Houston', u'Myeloma UK', u'Aduro BioTech Inc', u'Sheba Medical Center', u'Westmead Institute for Medical Research', u'Fox Chase Cancer Center', u'Nordic Nanovector ASA', u'Emory University', u'Oxis Biotech Inc', u'Apexigen Inc', u'MD Anderson Cancer Center', u'Medarex Inc', u'Eisai Co Ltd', u'Empire Genomics Llc', u'Macquarie University', u'National Cancer Institute', u'Novartis AG', u'University of Maryland', u'Novab Inc', u'Affimed NV', u'Multiple Myeloma Research Foundation', u'Oncoceutics Inc', u'TRACON Pharmaceuticals Inc', u'Diplomat Pharmacy Inc', u'Sutro Biopharma Inc', u'Immune Response BioPharma Inc', u'Kosan Biosciences Inc', u'Vericel Corp', u'Janssen Biotech NV', u'Johns Hopkins University', u'Myriad Genetics Inc', u'Kyowa Hakko Kogyo Co Ltd', u'Vaxil BioTherapeutics Ltd', u'Royalty Pharma', u'Wacker Biotech GmbH', u'Chugai Pharmaceutical Co Ltd', u'Southern Research Institute', u'Boots Hoechst Celanese', u'Heidelberg Pharma Holding Ltd', u'ImmunoCellular Therapeutics Ltd', u'University College London', u'PharmaMar SA', u\"Children's Hospital of Los Angeles\", u'University of Virginia', u'Janssen Biotech Inc', u'Ascentage Pharma Group Corporation Ltd', u'Pfizer Inc', u'Norwegian Research Council', u'Human Genome Sciences Inc', u'Memorial Sloan-Kettering Cancer Center', u'OncoPep Inc', u'Synex Consulting Korea Limited', u'Eureka Therapeutics Inc', u'Selected Value Therapeutics', u'Semafore Pharmaceuticals Inc', u'University of Liege', u'National Institutes of Health', u'Natco Pharma Ltd', u'Food and Drug Administration', u'Medinet Co Ltd', u'Curis Inc', u'Oncology Venture ApS', u'Asahi Kasei Pharma Corp', u'Onyx Pharmaceuticals Inc', u'Colorado State University', u'Transgenomic Inc', u'Takara Bio Inc', u'Cytopia Ltd', u'Biologics Inc', u'Sidney Kimmel Comprehensive Cancer Center', u'MannKind Corp', u'Boryung Pharm Co Ltd', u'Tragen Pharmaceuticals', u'Prospect Therapeutics Inc']), u'Streptococcaceaeinfection': set([u'Callisto Pharmaceuticals Inc', u'Institute For Hepatitis & Virus Research', u'Ribi ImmunoChem Research Inc', u'Pfizer Vaccines', u'National Institute of Allergy and Infectious Diseases', u'US Army Research Office']), u'Myotonicdystrophytype1': set([u'Radboud University', u'Univalor', u'National Institute of Neurological Disorders and Stroke', u'University of Rochester', u'BioMarin Nederland BV', u'Valerion Therapeutics LLC', u'Ionis Pharmaceuticals Inc', u'Netherlands Government', u'AmorChem LP', u'Scripps Florida', u'US Government', u'F Hoffmann-La Roche AG', u'US Health and Human Services Department', u'Biogen Inc', u'University College London', u'Senter']), u'Myotonicdystrophytype2': set([u'VLT Biopharma', u'National Institute of Neurological Disorders and Stroke', u'MD Anderson Cancer Center', u'National Institutes of Health', u'Scripps Research Institute', u'Scripps Florida', u'Muscular Dystrophy Association']), u'Emphysema': set([u'Etiologics Ltd', u'University of Connecticut', u'Royal College of Surgeons in Ireland', u'Mount Sinai School of Medicine', u'Takeda Pharmaceutical Co Ltd', u'Astra AB', u'ASKA Pharmaceutical Co Ltd', u'Alpha-1 Foundation', u'Juntendo University', u'geneRx+ Inc', u'Hyland Immuno', u'Vanderbilt University', u'Circassia Pharmaceuticals plc', u'Broncus Medical Inc', u'University of Pittsburgh', u'Eli Lilly & Co', u'Thomas Jefferson University', u'Bio-Techne Corp', u'Covenant Therapeutics LLC', u'Bayer AG', u'Ono Pharmaceutical Co Ltd', u'Takeda Oncology', u'Zambon Co SpA', u'Aeris Therapeutics Inc', u'Kuros Biosurgery AG', u'Dong-A ST Co Ltd', u'COPD Foundation', u'Arriva Pharmaceuticals Inc', u'Uptake Medical Corp', u'Theron Pharmaceuticals Inc', u'AstraZeneca plc', u'CoTherix Inc', u'Sandoz GmbH', u'National Heart Lung and Blood Institute', u'Synthetic Biologics Inc', u'Angion Biomedica Corp']), u'InfluenzavirusAinfection': set([u'Response Biomedical Corp', u'Johnson & Johnson', u'Arisan Therapeutics Inc', u'Profectus BioSciences Inc', u'Guangzhou Nanxin Pharmaceutical Co Ltd', u'Quidel Corp', u'National Center for Research Resources', u'Defyrus Inc', u'Institute of Pharmacology and Toxicology Academy of Military Medical Sciences PLA', u'Guangzhou Chest Hospital', u'Rega Institute for Medical Research', u'Codagenix Inc', u'National Institute of Allergy and Infectious Diseases', u'iBio Inc', u'US Health and Human Services Department', u'Pascal Biosciences Inc', u'Life Technologies Corp', u'University of Maryland Baltimore County', u'Pomona Ricerca Srl', u'Novartis AG', u'Novici Biotech LLC', u'Abcombi Biosciences Inc', u'Bill & Melinda Gates Foundation', u'Georgetown University', u'Viroclinics BV', u'Mount Sinai Hospital', u'South Dakota State University', u'MedImmune LLC', u'Vertex Pharmaceuticals Inc', u'Trellis Bioscience Inc', u'Guangdong Zhongsheng Pharmaceutical Co Ltd', u'Centers for Disease Control and Prevention', u'Vizient Inc', u'University of Washington', u'WuXi PharmaTech (Cayman) Inc', u'Samaritan Pharmaceuticals Inc', u'Milstein Medical Asian American Partnership Foundation', u'Medigen Biotechnology Corp', u'Vivaldi Biosciences Inc', u'NanoViricides Inc', u'Gemmus Pharma Inc', u'University of British Columbia', u'University of California Irvine', u'Georgia State University', u'Humabs BioMed SA', u'Janssen Pharmaceuticals Inc', u'University of Barcelona', u'National Health Research Institutes', u'Crucell NV', u'InGen Biosciences', u'Visterra Inc', u'Alere Inc', u'Fides Pharma Spa', u'Abzyme Therapeutics LLC', u'Changsheng Bio-technology Co Ltd', u'Kineta Inc', u\"St Jude Children's Research Hospital\", u'National Institute of General Medical Sciences']), u'Gastrointestinalmotilitydisorder': set([u'Theravance Biopharma Inc', u'Queen Mary University of London', u'Takeda Pharmaceutical Co Ltd', u'ENTEROME Bioscience SA', u'MabVax Therapeutics Holdings Inc', u'BioSeek Plc']), u'Tineacorporis': set([u'MedPharm Ltd', u'Sinclair Pharma plc', u'Dong Wha Pharmaceutical Co Ltd', u'Novartis AG']), u'Bacteroidesinfection': set([u'Pfizer Inc', u'AstraZeneca plc']), u'HepatitisGvirusinfection': set([u'Chiron Corp', u'Genelabs Technologies Inc', u'University of Iowa']), u'Autoinflammatorydisease': set([u'TechnoPhage SA', u'Takeda Pharmaceutical Co Ltd', u'UCB SA', u'GammaDelta Therapeutics Ltd', u'Biogen Inc', u'Kiniksa Pharmaceuticals']), u'Sialorrhea': set([u'The Michael J. Fox Foundation', u'Shionogi Pharma Inc', u'NeuroHealing Pharmaceuticals Inc', u'Summit Therapeutics plc', u'Orient Pharma Co Ltd', u'Merz Inc', u'Elan Corp plc', u'Eisai Co Ltd']), u'Cryopyrinassociatedperiodicsyndrome': set([u'Selvita SA', u'National Institute of Arthritis and Musculoskeletal and Skin Diseases', u'Amgen Inc', u'Swedish Orphan Biovitrum AB', u'US Government', u'Confluence Life Sciences Inc', u'Nodthera Ltd']), u'Urinaryin': set([u'ALZA Corp', u'Bayer AG']), u'Cervicaldysplasia': set([u'PharmaJet Inc', u'Fujimoto Diagnostics Inc', u'Nventa Biopharmaceuticals Corp', u'FusionVax', u'Vaccibody AS', u'Advaxis Inc', u'CEL-SCI Corp', u'Netherlands Government', u'Oncovir Inc', u'National Cancer Institute', u'Jeil Pharmaceutical Co Ltd', u'PhotoCure ASA', u'Interferon Sciences Inc', u'Kirax Corp', u'Novavax Inc', u'University of Maryland', u'Cantab Biopharmaceuticals Ltd', u'Xenova Group plc', u'Galderma Laboratories LP', u'Helix BioPharma Corp', u'Sagentia Ltd', u'Merck & Co Inc', u'ISA Pharmaceuticals BV', u'Transgene SA', u'Galderma SA', u'Erimos Pharmaceutical LLC', u'Bioleaders Corp', u'PhotoMedex Inc', u'Roche Holding AG', u'tella Inc', u'Allermed Laboratories, Inc', u'Xisle Pharma Ventures Trust', u'Cancer Research Campaign Technology Ltd', u'AnGes MG Inc', u'Ergomed PLC', u'3M Pharmaceuticals', u'Johns Hopkins University', u'Hemispherx Biopharma Inc', u'Takeda Pharmaceutical Co Ltd', u'The Althea Foundation', u'University of Oxford', u'University of Cambridge', u'University of Arkansas']), u'Nausea': set([u\"Dr Reddy's Laboratories Ltd\", u'Sanofi-Aventis US LLC', u'Chugai Pharmaceutical Co Ltd', u'MD Anderson Cancer Center', u'Validus Pharmaceuticals', u'CSC Pharmaceuticals Handels GmbH', u'Daiichi Sankyo Inc', u'Abbott Laboratories', u'US Government', u'Galena Biopharma Inc', u'ULURU Inc', u'Ligand Pharmaceuticals Inc', u'Mundipharma International Corp Ltd', u'Specialised Therapeutics Australia Pty Ltd', u'Therabel Pharma NV', u'Braeburn Pharmaceuticals Inc', u'University of Tokyo', u'Merck & Co Inc', u'Pedipharm Oy', u'Hanmi Pharmaceutical Co Ltd', u'Accentia BioPharmaceuticals Inc', u'Sanofi', u'Reckitt Benckiser Healthcare (UK) Ltd', u'CJ Corp', u'Angelini Pharmaceuticals SpA', u'IntelGenx Technologies Corp', u'Ono Pharmaceutical Co Ltd', u'Camurus AB', u'PT Kalbe Farma Tbk', u'Melmed Holding AG', u'Cambridge Laboratories Ltd', u'Ribosepharm GmbH', u'R&R Inc', u'Galenica SA (Greece)', u'Cynapsus Therapeutics Inc', u'Helsinn Healthcare SA', u'MonoSol Rx Inc', u'Arius Pharmaceuticals Inc', u'Pfizer Inc', u'Purdue Pharma Canada', u'Rafa Laboratories Ltd', u'Mitsubishi Tanabe Pharma Factory Ltd', u'PharmaSwiss SA', u'SCOLR Pharma Inc', u'Locl Pharma Inc', u'GlaxoSmithKline plc', u'Helsinn Group']), u'Nasopharyngealcarcinoma': set([u'Chugai Pharmaceutical Co Ltd', u'Baylor College of Medicine', u'CEL-SCI Corp', u'Cancer Research UK', u'IDIS Ltd', u'Harvard University', u'GeneNews Ltd', u'Pharmacyclics Inc', u'Nimura Genetic Solutions Co Ltd', u'QIMR Berghofer Medical Research Institute', u'National Cancer Centre of Singapore', u'National Cancer Institute', u'Cancer Research Initiatives Foundation', u'Chinese Government', u'Aventis SA', u'Atara Biotherapeutics Inc', u'Merck & Co Inc', u'Xynomic Pharmaceuticals', u'Fujifilm Diosynth Biotechnologies', u'YM BioSciences Inc', u'Cell Medica Ltd', u'Biotech Pharmaceutical Co Ltd', u'Tessa Therapeutics Pte Ltd', u'Haikou VTI Biological Institute', u'Ministry of Health, Malaysia', u'Ferozsons Laboratories Ltd', u'Therapure Biopharma Inc', u'Yabao Pharmaceutical Group Co Ltd', u'Biocon Ltd', u'PiSA Farmaceutica', u'The Center of Molecular Immunology', u'Chinese University of Hong Kong', u'University of Toronto', u'Orient Europharma', u'Genta Inc']), u'Renalarteryobstruction': set([u'SurModics Inc', u'Nexeon MedSystems Inc']), u'Hypertrichosis': set([u'Follicum AB', u'Clinical Research Center for Hair and Skin Science']), u'Globoidcellleukodystrophy': set([u'Fondazione Telethon', u'Istituto Scientifico H San Raffaele', u\"Children's Hospital of Pittsburgh\", u'MolMed SpA', u'GlaxoSmithKline plc', u'The Legacy of Angels Foundation']), u'Scoliosis': set([u'Eos Imaging', u\"Centre hospitalier de l'Universit\\xe9 de Montr\\xe9al (CHUM)\", u'Axial Biotech Inc', u'Undisclosed', u'Transgenomic Inc', u'Li Ka Shing Faculty of Medicine']), u'Synovitis': set([u'Leiden University Medical Center', u'Ignyta Inc']), u'Cornealdystrophy': set([u'Florida State University', u'Trefoil Therapeutics Llc']), u'Endocrinetumor': set([u'Navidea Biopharmaceuticals Inc', u'Medical University of Lodz', u'Optimer Pharmaceuticals Inc', u'Tulane University', u'Debiovision Inc', u'Debiopharm SA', u'Ohio State University', u'Salix Pharmaceuticals Ltd', u'Evestra Onkologia Sp. z.o.o.', u'Cempra Inc']), u'Postherpeticneuralgia': set([u'Johnson & Johnson', u'National Institute of Neurological Disorders and Stroke', u'Grunenthal GmbH', u'Endo Health Solutions Inc', u'Mochida Pharmaceutical Co Ltd', u'ZARS Pharma Inc', u'GlaxoSmithKline plc', u'Elan Corp plc', u'Winston Pharmaceuticals Inc', u'Nippon Zoki Pharmaceutical Co Ltd', u'Aestus Therapeutics Inc', u'SK Chemicals Life Science', u'Valeant Pharmaceuticals International Inc', u'Ipsen Bioinnovation', u'Inventiv Health Clinical Inc', u'Maruishi Pharmaceutical Co Ltd', u'Meda Pharma Gmbh & Co Kg', u'XenoPort Inc', u'Allergan Inc', u'Depomed Inc', u'Teikoku Pharma USA Inc', u'Teikoku Seiyaku KK', u'Hikma Pharmaceuticals plc', u'Depomed Development Ltd']), u'Hemangioma': set([u'Wilmington PharmaTech', u'Pierre Fabre Dermatologie', u'BioAxone Biosciences Inc', u'Gilead Sciences Inc', u'Maruho Co Ltd', u'Pierre Fabre SA', u'Universite de Bordeaux', u'Pharmacia & Upjohn Co', u'Rega Institute for Medical Research', u'Hanmi Pharmaceutical Co Ltd']), u'Eatingdisorder': set([u'Eli Lilly & Co', u'Research Corporation Technologies', u'CSIR (South Africa)', u'Theravance Biopharma Inc', u'NPS Allelix Corp', u'Takeda Pharmaceutical Co Ltd', u'AstraZeneca plc', u'Pfizer Inc', u'National Institute of Neurological Disorders and Stroke', u'Louisiana State University', u'MSD OSS BV', u'Gliatech Inc', u'IXICO Plc', u'Lundbeck Research USA Inc', u'Human Genome Sciences Inc', u'Pherin Pharmaceuticals Inc', u'South African San Council', u'Neurogen Corp', u'Novartis AG', u'Sanofi', u'GlaxoSmithKline plc']), u'Dyspnea': set([u'Monaghan Medical Corporation', u'Mayne Pharma Group Ltd', u'Electromed Inc', u'Flinders University of South Australia']), u'Mouthtumor': set([u'Introgen Therapeutics Inc', u'Dentamed', u'Navidea Biopharmaceuticals Inc', u'European Organisation for Research and Treatment of Cancer (EORTC)', u'Weill Cornell Medical College, USA', u'Northwestern University', u'Rice University', u'National Cancer Institute', u'Cancer Prevention and Research Institute of Texas', u'National Institutes of Health', u'S.I.R.A.M. Ltd', u'Novomix Meditech', u'XOMA Corp', u'Republic of Korea Government', u'The Netherlands Organisation for Health Research and Development', u'Ahn-Gook Pharmaceuticals Co Ltd', u'Isla Lab Products LLC', u'Onyx Pharmaceuticals Inc', u'Diamedica OU Group', u'MDxHealth SA', u'UbiVac', u'Colgate-Palmolive Co', u'Sayre Therapeutics Private Ltd', u'Netherlands Cancer Institute', u'Janssen Biotech Inc', u'National Institute of Dental and Craniofacial Research', u'Vigilant Biosciences', u'Bio-Connect Diagnostics B.V.', u'Pfizer Inc', u'Sveikatal Inc', u'Privo Technologies Inc', u'Concile GmbH', u'Queensland University of Technology', u'Moldionics SL', u'Lagitre S.R.L', u'Debiopharm SA']), u'Paraproteinemia': set([u'Miragen Therapeutics, Inc.', u'H Lee Moffitt Cancer Center and Research Institute']), u'Gingivadisease': set([u'University of Toronto', u'Evolva Holding SA', u'Oragenics Inc', u'Garden Of Life Inc']), u'Neonatalrespiratorydistresssyndrome': set([u'CollaGenex Pharmaceuticals Inc', u'Karolinska Institutet', u'Johnson & Johnson', u'US Government', u'Azargen Biotechnologies (Pty) Ltd', u'Massachusetts Institute of Technology', u'Acorda Therapeutics Inc', u'iBio Inc', u'Dr Rentschler Biotechnologie GmbH', u'Laboratorios Dr Esteve SA', u\"Cincinnati Children's Hospital Medical Center\", u'Chiesi Farmaceutici SpA', u'Wayne State University', u'National Institutes of Health', u'Bill & Melinda Gates Foundation', u'Food and Drug Administration', u'Aerogen Inc', u'Scripps Research Institute', u\"Lee's Pharmaceutical Holdings Limited\", u'Dompe Farmaceutici SpA', u'Swedish Research Council', u'Quintiles Transnational Corp', u'Maruishi Pharmaceutical Co Ltd', u'Airway Therapeutics LLC', u'Faron Pharmaceuticals Ltd', u'Windtree Therapeutics Inc', u'Ortho Pharmaceutical Corp']), u'Tachycardia': set([u'Abbott Laboratories', u'Selectus Pharmaceuticals Inc', u'Bristol-Myers Squibb Pharma Co', u'Mitsui Pharmaceuticals Inc']), u'Gastrointestinalstromaltumor': set([u'Immunicum AB', u'US Government', u'National Cancer Institute', u'Bayer AG', u'PDL BioPharma Inc', u'Array BioPharma Inc', u'Biologics Inc', u'Clovis Oncology Inc', u'Arog Pharmaceuticals Inc', u'Karolinska University Hospital', u'Pfizer Inc', u'ARIAD Pharmaceuticals Inc', u'Qiagen NV', u'Incyte Corp', u'Infinity Pharmaceuticals Inc', u'University of California San Diego', u'Blueprint Medicines Corp']), u'NiemannPickdiseasetypeC1': set([u'National Institutes of Health', u'RRD International']), u'Ocularneovasculardisorder': set([u'US Government', u'EyeCyte Inc', u'EyeMedics LLC', u'Eyemedix Inc', u'National Eye Institute', u'Acucela Inc']), u'T-cellacutelymphoblasticleukemia': set([u'Angimmune LLC', u'National Cancer Institute', u\"Children's Cancer Institute Australia for Medical Research\", u'Technology Strategy Board', u'MD Anderson Cancer Center', u'AOP Orphan Pharmaceuticals AG', u'Threshold Pharmaceuticals Inc', u'Sareum Holdings plc', u'Merck & Co Inc', u'Cellectis SA']), u'Bladdercancer': set([u'PhotoCure ASA', u'US Government', u'National Comprehensive Cancer Network', u'Centre for Drug Research and Development', u'Incyte Corp', u'China Medicine Inc', u'Lynx Therapeutics GmbH', u'Oryzon Genomics SA', u'GlaxoSmithKline plc', u'Genome British Columbia', u'Inovio Pharmaceuticals Inc', u'Universitat Ulm', u'Scion Cardio-Vascular Inc', u'Medivation Inc', u'Minomic International Ltd', u'University Of Southampton', u'University of Sheffield', u'Ipsen', u'Marina Biotech Inc', u'Polypeptide Laboratories AB (SWEDEN)', u'Institut Curie', u'University of Pittsburgh', u'Novavax Inc', u'JSS Medical Research Inc', u'University of Texas Health Science Center Houston', u'Farmabrasilis', u'Roche Holding AG', u'Almac Diagnostics', u'Immunocore Ltd', u'University of British Columbia', u'University of Surrey', u'Merck Sharp & Dohme Corp', u'Vaccinex Inc', u'Ludwig Institute for Cancer Research', u'Handok Inc', u'Fox Chase Cancer Center', u'Chengdu Institute of Biological Products', u'Shionogi & Co Ltd', u'Emory University', u'University of California San Francisco', u'ElsaLys Biotech', u'Beike Biotechnology Co Ltd', u'Optimum Therapeutics LLC', u'Alkopharma', u'National Institute of General Medical Sciences', u'European Commission', u'Exelixis Inc', u'Iovance Biotherapeutics Inc', u'Lipac Oncology LLC', u'MD Anderson Cancer Center', u'Adaptive Biotechnologies Corp', u'AADi LLC', u'Mylan Inc', u'National Institute for Health Research (NIHR)', u'Sichuan University', u'Affibody AB', u'OncoTherapy Science Inc', u'Abbott Laboratories', u'TesoRx Pharma', u'Ohio State University', u'Tulane University', u'Geron Corp', u'MGI Pharma Biologics', u'Macquarie University', u'National Cancer Institute', u'MediGene AG', u'Medicenna Therapeutics Pte Ltd', u'VAR2 Pharmaceuticals ApS', u'Xcell Biosciences Inc', u'Cougar Biotechnology Inc', u'Arquer Diagnostics', u'Axella Solutions Llc', u'Fluxion Biosciences Inc', u'Transgene SA', u'Affymetrix Inc', u'WuXi PharmaTech (Cayman) Inc', u'SBI Pharmaceuticals', u'Florida Biologix', u\"Queen's University at Kingston\", u'PharmaGap Inc', u'Speciality European Pharma Ltd', u'Rubicon Genomics Inc', u'Fougera Pharmaceuticals Inc', u'SAFC Pharma', u'LifeArc', u'Hamlet Pharma AB', u'Altor BioScience Corp', u'University of Lausanne', u'Johns Hopkins University', u'University of California San Diego', u'Curasan AG', u'Spectrum Pharmaceuticals Inc', u'University of Ghent', u'Rosetta Genomics Ltd', u'Med Discovery SA', u'Kairos Therapeutics Inc', u'University of South Carolina', u'Asieris Pharmaceuticals Co Ltd', u'Chugai Pharmaceutical Co Ltd', u'Medidata Solutions Worldwide', u'Florida Department of Health', u'MethylGene Inc', u'Genentech Inc', u'ITR Laboratories Canada Inc', u'Shenzhen Main Luck Pharmaceuticals Inc', u'Morvus Technology Ltd', u'UroGen Pharma Ltd', u'Pacific Edge Biotechnology Ltd', u'Bradley Pharmaceuticals Inc', u'CMC Biologics Inc', u'Meditrina Pharmaceuticals Inc', u'Tolero Pharmaceuticals Inc', u'Undisclosed', u'ImmunoCellular Therapeutics Ltd', u'Telormedix SA', u'iOx Therapeutics Ltd', u'Merck & Co Inc', u'Orphan Canada Inc', u'Theravance Biopharma Inc', u'University of Hawaii Cancer Center', u'University of California Davis', u'Sienna Cancer Diagnostics Ltd', u'University of Sunderland', u'Cellmid Ltd', u'Pierre Fabre SA', u'Arcis Biotechnology Ltd', u'FKD Therapies OY', u'AEterna Zentaris Inc', u'Nektar Therapeutics', u'Universidade Estadual de Campinas', u'American Urological Association', u'AstraZeneca plc', u'Technology Strategy Board', u'Theralase Technologies Inc', u'Ymir Genomics Llc', u'University of Utah', u'Cadila Pharmaceuticals Ltd', u'Pasteur Merieux Connaught Canada', u'Horizon Pharma plc', u'Charles University', u'Micromedic Technologies Ltd', u'Vancouver Prostate Centre', u'Baylor College of Medicine', u'Translational Genomics Research Institute', u'Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - CNPq', u'OncoCyte Corp', u'Vaxiion Therapeutics Inc', u'Celek Pharmaceuticals LLC', u'The University Health Network', u'Bavarian Nordic A/S', u'UroGene SA', u'Fundacao de Amparo a Pesquisa do Estado Sao Paulo', u'Centre Hospitalier Universitaire Vaudois', u'PapGene Inc', u'National Institutes of Health', u'University of Tokyo', u'Food and Drug Administration', u'Euro-Diagnostica AB', u'Bristol-Myers Squibb Co', u'Heat Biologics Inc', u'Shanghai Shyndec Pharmaceutical Co Ltd', u'Ascend Biopharmaceuticals Ltd', u'Cedars-Sinai Medical Center', u'TARIS Biomedical Inc', u'Celgene Corp', u'Colorado State University', u'MDxHealth SA', u'Memgen LLC', u'Astellas Pharma Inc', u'Pinnacle Biologics Inc', u'Medical University of South Carolina', u'Ferring Research Ltd', u'Juno Pharmaceuticals Inc', u'Imagin Medical', u'Adaptimmune Therapeutics plc', u'University of Rochester Laboratory of Laser Energetics', u'Viralytics Ltd', u'University of Oxford', u'The Princess Margaret Cancer Centre', u'SIGA Technologies Inc', u'Accelis Pharma', u'Takeda Pharmaceutical Co Ltd', u'BeneVir Biopharm Inc', u'DRI Capital', u'Synthego']), u'Aneuploidy': set([u'Harvard Medical School', u'Sequenom Center For Molecular Medicine', u'National Institute Of Environmental Health Sciences', u'Laboratoire Pasteur-Cerba']), u'Chemotherapyinducednauseaandvomiting': set([u\"The Chris O'Brien Lifehouse\", u'Vifor Pharma', u'Chugai Pharmaceutical Co Ltd', u'Merck & Co Inc', u'Undisclosed', u'Baxter International Inc', u'Riemser Pharma GmbH', u'Mylan Inc', u'Tilray Canada', u'Grunenthal GmbH', u'VioQuest Pharmaceuticals Inc', u'Cancer Genetics Inc', u'Institute of Pharmacology and Toxicology Academy of Military Medical Sciences PLA', u'Albany Molecular Research Inc', u'H Lee Moffitt Cancer Center and Research Institute', u'NovaDel Pharma Inc', u'Galena Biopharma Inc', u'Mundipharma International Corp Ltd', u'Onxeo SA', u'Purdue Pharma Canada', u'Novartis AG', u'Therabel Pharma NV', u'Pen Pharmaceutical Services Ltd', u'RedHill Biopharma Ltd', u'Normaco Inc', u'Jiangsu Hengrui Medicine Co Ltd', u'Italfarmaco SpA', u'Isofol Medical AB', u'Taiho Pharmaceutical Co Ltd', u'MonoSol Rx Inc', u'Stendhal International', u'Nemus Bioscience Inc', u'Yunfeng Pharmaceutical Co Ltd', u'Heron Therapeutics Inc', u'Clinigen Group plc', u'OPKO Health Inc', u'ScinoPharm Taiwan Ltd', u'Insys Therapeutics Inc', u'RHEI Pharmaceuticals Inc', u'Teewinot Life Sciences Corp', u'University of British Columbia', u'SymBio Pharmaceuticals Ltd', u'Recipharm AB', u'NSW Government', u'SpePharm Holding BV', u'Axim Biotechnologies Inc', u'Kissei Pharmaceutical Co Ltd', u'Specialised Therapeutics Australia Pty Ltd', u'TESARO Inc', u'Helsinn Healthcare SA', u'AstraZeneca plc', u'Vestiq Pharmaceuticals Inc', u'Catalent Inc', u'Inform Genomics Inc', u'Abeille Pharmaceuticals Inc', u'Kyowa Kirin', u'National Cheng Kung University', u'Soligenix Inc', u'Sandoz Inc', u'Swedish Orphan Biovitrum AB', u'Asymmetric Therapeutics LLC', u'SCOLR Pharma Inc', u'SpePharm AG', u'Biologics Inc', u'Solasia Pharma KK', u'Helsinn Group']), u'Congestiveheartfailure': set([u'US Government', u'Universitaire Ziekenhuizen Leuven', u'Takeda GmbH', u'Regenerative Medicine Institute of Tijuana', u'CareDx Inc', u'Biogen Inc', u'Aeolus Pharmaceuticals Inc', u'GlaxoSmithKline plc', u'Celladon Corp', u'Cardioxyl Pharmaceuticals Inc', u'AstraZeneca Pharmaceuticals LP', u'Chiron Corp', u'University of Queensland', u'Taxus Cardium Pharmaceuticals Group', u'Cardiokine Inc', u'US Department of Veterans Affairs', u'Genentech Inc', u'The Medicines Company', u'Revita Life Sciences', u'Serodus ASA', u'Takeda Oncology', u'Roche Holding AG', u'Mitsubishi Tanabe Pharma Corp', u'TOLMAR Therapeutics Inc', u'Elacor Pty Ltd', u'Bio-Medisinsk Innovasjon AS', u'Paladin Labs Inc', u'Sun Pharmaceutical Industries Ltd', u'Vasogen Inc', u'Theregen Inc', u'Shionogi & Co Ltd', u'National Heart Lung and Blood Institute', u'Neurocrine Biosciences Inc', u'Theragene Pharmaceuticals', u'Evotec AG', u'Aralez Pharmaceuticals Inc', u'Collateral Therapeutics Inc', u'Daiichi Sankyo Co Ltd', u'Abbott Laboratories', u'Kansas Bioscience Authority', u'Geron Corp', u'MediGene AG', u'Merck KGaA', u'RedHill Biopharma Ltd', u'Egalet Corp', u'University of Maryland', u'SkyePharma plc', u'Guidant Corp', u'Massachusetts General Hospital', u'Biomedical Research and Commercialization Program (BRCP)', u'GenPharm International Inc', u'Pharmacopeia Inc', u'Cholestech Corp', u'Cleveland Clinic Foundation', u'Cytokine PharmaSciences Inc', u'Swedish Orphan Biovitrum AB', u'Alvogen Inc', u'Tissue Genesis Inc', u'University of Edinburgh', u'LG Chem Ltd', u'Haemopep Pharma GmbH', u'Titan Pharmaceuticals Inc', u'Encysive Pharmaceuticals Inc', u'Boehringer Ingelheim Corp', u'Schering AG', u'Celogos', u'Genfit SA', u'Recordati SpA', u'Juventas Therapeutics Inc', u'Ranbaxy Laboratories Ltd', u'Medtronic Inc', u'F H Faulding & Co Ltd', u'AmpliPhi Biosciences Corp', u'Artesian Therapeutics Inc', u'University of North Carolina', u'T3 Therapeutics LLC', u'Angioblast Systems Inc', u'Renova Therapeutics Inc', u'Connetics Corp', u'Mesoblast Ltd', u'Picower Institute for Medical Research', u'Flamel Technologies SA', u'Nanolek LLC', u'British Heart Foundation', u'Molecular Insight Pharmaceuticals Inc', u'Lotus Pharmaceutical Co Ltd', u'Eli Lilly & Co', u'CardioPep Pharma GmbH', u'Vasogenix Pharmaceuticals Inc', u'Novasep', u'Kyowa Hakko Kirin Co Ltd', u'Palatin Technologies Inc', u'Janssen Biotech Inc', u'AstraZeneca plc', u'Pfizer Inc', u'NanoCor Therapeutics Inc', u'Corthera Inc', u'University of Cincinnati', u'BioProjet, Societe Civile de Recherche', u'The Salk Institute for Biological Studies', u'PharmaSwiss SA', u'National Taiwan University', u'Johns Hopkins University', u'Canadian Network for Vaccines and Immunotherapeutics', u'Merck & Co Inc', u'Rubicon Biotechnology Inc', u'US Stem Cell Inc', u'Innovation Norway', u'King Pharmaceuticals Inc', u'Yatharth Wellness Hospital', u'UCB Celltech', u'Baker Heart Research Institute', u'Astra Merck Inc', u'Actelion Ltd', u'National Institutes of Health', u'Bristol-Myers Squibb Co', u'Scios Inc', u'Aventis SA', u'NEBU-TEC', u'INSERM', u'Evotec (UK) Ltd', u'ICOS Corp', u'The Menarini Group', u'Cephalon Inc', u'Pharma Pass LLC', u'bioCSL PTY Ltd', u'ESP Pharma Inc', u'Knoll GmbH', u'Eiger BioPharmaceuticals Inc', u'Archimedes Pharma Ltd', u'Central Adelaide Local Health Network Inc', u'JW Pharmaceutical Corp', u'HenKan Pharmaceutical Co Ltd', u'CHEPLAPHARM Arzneimittel GmbH', u'Lonza Group AG', u'Biovail Laboratories International Srl', u'Novartis AG', u'Madeleine Pharmaceuticals Pty Ltd', u'United Therapeutics Corp']), u'Tremor': set([u'Oxford Natural Products', u'University of Mississippi', u'National Institutes of Health', u'Ariston Pharmaceuticals Inc']), u'Atrophicvaginitis': set([u'Orion Corporation Fermion', u'Amneal Pharmaceutical LLC', u'Novo Nordisk A/S', u'Pear Tree Pharmaceuticals', u'Pfizer Inc', u'National Institute on Aging', u'Endoceutics Inc', u'QUATRx Pharmaceuticals Co', u'Acerus Pharmaceuticals Corp', u'IDIS Ltd', u'Merck & Co Inc', u'MediNova Ltd', u'Shionogi & Co Ltd', u'AMAG Pharmaceuticals Inc']), u'Leighdisease': set([u'Courtagen Life Sciences Inc', u'Horizon Orphan LLC']), u'Non-small-celll': set([u'Human Genome Sciences Inc', u'GlaxoSmithKline plc']), u'Enterococcusfaecalisinfection': set([u'Royalty Pharma', u'Undisclosed']), u'Non-small-celllungcancer': set([u'Quest Diagnostics Inc', u\"Hospital Vall D'Hebron\", u'Transcept Pharmaceuticals Inc', u'Altropus Gmbh', u'OSE Immunotherapeutics', u'University of Turin', u'Shenzhen Chipscreen Biosciences Ltd', u'Champions Oncology Inc', u'MethylGene Inc', u'Seattle Genetics Inc', u'Ionis Pharmaceuticals Inc', u'Choice Pharmaceuticals', u'Ventana Medical Systems Inc', u'University of Pittsburgh', u'Palobiofarma SL', u'UbiVac', u'Merck Sharp & Dohme Corp', u'Neon Therapeutics', u'Kuhnil Pharmaceutical Co Ltd', u'Shanghai Fosun Pharmaceutical (Group) Co Ltd', u'US Department of the Treasury', u'Bigmar Inc', u'NantCell Inc', u'Peking University', u'OxOnc Development LP', u'Sanofi Pasteur', u'Transgene SA', u'National Research Council of Canada', u'Xcovery Inc', u'Symphogen A/S', u'PDL BioPharma Inc', u'Cambridge Antibody Technology Group plc', u'Sirnaomics Inc', u'Nippon Kayaku Co Ltd', u'Turgut \\u0130laclari As', u'Fem CadeT Taxol LLC', u'Corixa Corp', u'Agennix AG', u'Gen-Probe Inc', u'Thermo Fisher Scientific Inc', u'Puma Biotechnology Inc', u'Regulon Inc', u'Kyung Hee University', u'ALZA Corp', u'Wellcome Trust', u'Titan Pharmaceuticals Inc', u'Checkpoint Therapeutics Inc', u'Janssen Korea Ltd', u'ImmunoGen Inc', u'MegaPharm Ltd', u'DelMar Pharmaceuticals Inc', u'Altor BioScience Corp', u'Helsinn Healthcare SA', u'Taiho Pharmaceutical Co Ltd', u'Tragara Pharmaceuticals Inc', u'Ministry of Science and Technology of the People\\xb4s Republic of China', u'Infinity Pharmaceuticals Inc', u'Oslo University Hospital', u'Swedish Orphan Biovitrum AB', u'Biochemie GmbH', u'Talon Therapeutics Inc', u'Vaxon Biotech SA', u'Almac Group', u'Mirati Therapeutics Inc', u'Medimmune Oncology Inc', u'Biothera Pharmaceuticals Inc', u'Vernalis Group plc', u'Undisclosed', u'Domainex Ltd', u'Vion Pharmaceuticals Inc', u'Igeneon GmbH', u'Eli Lilly & Co', u'Med Biogene Inc', u'Simbec-Orion Group Ltd', u'Phyton Biotech Inc', u'AbbVie Inc', u'University of Victoria', u'Madrigal Pharmaceuticals Inc', u'XBiotech Inc', u'University of California Los Angeles', u'Rhizen Pharmaceuticals SA', u'Hangzhou Gmax Biopharm Biomedical Engineering Co Ltd', u'Technomark Life Sciences', u'Immatics Biotechnologies GmbH', u'Johnson & Johnson', u'Coley Pharmaceutical Group Inc', u'Stehlin Foundation For Cancer Research', u'OSI Pharmaceuticals Inc', u'SmithKline Beecham plc', u'Bavarian Nordic A/S', u'UCB Celltech', u'Salmedix Inc', u'BioCancell Therapeutics Ltd', u'A&G Pharmaceutical Inc', u'Bristol-Myers Squibb Co', u'Addario Lung Cancer Medical Institute', u'Technical University of Munich', u'Institute of Cancer Research UK', u'Royalty Pharma', u'American Society of Clinical Oncology', u'YM BioSciences Inc', u'Shandong Luoxin Pharmaceutical Group Stock Co Ltd', u'Aphton Corp', u'Biomira USA Inc', u'Institute of Pharmacology and Toxicology Academy of Military Medical Sciences PLA', u'IDM Pharma Inc', u'Adaptive Biotechnologies Corp', u'Kanagawa Prefectural Hospital Organization', u'Neupharma Inc', u'Xenova Group plc', u'Morphotek Inc', u'US Department of Veterans Affairs', u'Chinese Government', u'ArQule Inc', u'TBG Diagnostics Ltd', u'Syndax Pharmaceuticals Inc', u'Hovione SA', u'Mateon Therapeutics Inc', u'Biotech Synergy', u'Roche Holding AG', u'Immunocore Ltd', u'Biocompatibles International plc', u'Vaccinex Inc', u'Gradalis Inc', u'TESARO Inc', u'Selvita SA', u'Exosome Diagnostics', u'Biocon Ltd', u'Atreca Inc', u'Mayo Clinic Foundation', u'Dana-Farber Cancer Institute Inc', u'Cell>Point LLC', u'National Institute of General Medical Sciences', u'Exelixis Inc', u'Immunicon Corp', u'Amgen Inc', u'Gatekeeper Pharmaceuticals Inc', u'Baxter Oncology GmbH', u'Lonza Walkersville Inc', u'Mitsui Pharmaceuticals Inc', u'LSK Biopartners Inc', u'Guangzhou Weimei Investment Co Ltd', u'Gritstone Oncology', u'Italfarmaco SpA', u'Shanghai Yizhong Biotechnology Co Ltd', u'Massachusetts General Hospital', u'Abgenix Inc', u'Samyang Corp', u'Immune Cell Therapy Inc', u'Guangdong Zhongsheng Pharmaceutical Co Ltd', u'Biodesix Inc', u'Yunnan Green-Field Biological & Medicinal Co Ltd', u'Immunomedics Inc', u'Merck Millipore', u'Imperial Cancer Research Technology Ltd', u'University of Hawaii', u'University of California San Diego', u'Shanghai Kaibao Pharmaceutical Co Ltd', u'Sclavo SpA', u'Innovent Biologics Inc', u'Bar-Ilan Research & Development Co Ltd', u'SICOR Inc', u'Cancer Research UK', u'Genentech Inc', u'Antisoma plc', u'Cobra Biologics Holding AB', u'StemSynergy Therapeutics Inc', u'Korea Drug Development Fund', u'Novuspharma SpA', u'Sumitomo Dainippon Pharma Co Ltd', u'Scripps Research Institute', u'Avila Therapeutics Inc', u'Genosco', u'University of Texas Southwestern Medical Center', u'Monogram Biosciences Inc', u'Hutchison Medipharma Enterprises Ltd', u'Japan Tobacco Inc', u'ScinoPharm Taiwan Ltd', u'Debiopharm Research & Manufacturing SA', u'Pierre Fabre SA', u'Kadmon Pharmaceuticals LLC', u'University of Iowa', u'AstraZeneca plc', u'Boehringer Ingelheim Pharmaceuticals Inc', u'Jiangsu Aidea Pharmaceutical Co Ltd', u'Genta Inc', u'Beijing Pason Pharmaceuticals Inc', u'Lonza Biologics plc', u'Introgen Therapeutics Inc', u'NCIC Clinical Trials Group', u'Academia Sinica', u'Translational Genomics Research Institute', u'ASTA Medica AG', u'Serenex Inc', u'H Lee Moffitt Cancer Center and Research Institute', u'Ligand Pharmaceuticals Inc', u'Mundipharma International Corp Ltd', u'IDT Australia Ltd', u'Shandong Simcere Medgenn Bio-Pharmaceutical Co Ltd', u'Novavax Inc', u'Activate Immunotherapy', u'Aqualis ASA', u'Heat Biologics Inc', u'Leap Therapeutics Inc', u'Proacta Inc', u'Fujifilm Diosynth Biotechnologies', u'Shandong Chengchuang Pharmaceutical R&D Co Ltd', u'MediGene Ltd', u'Karyopharm Therapeutics Inc', u'Institut Pasteur', u'Mersana Therapeutics Inc', u'NeoPharm Co Ltd', u'PiSA Farmaceutica', u'Dyax Corp', u'Laboratory Corporation of America Holdings', u'OncoGenex Pharmaceuticals Inc', u'Weill Cornell Medical College, USA', u'University of Toronto', u'National Comprehensive Cancer Network', u'University of Florida', u'Sarah Cannon Research Institute', u'Binex Co Ltd', u'EMD Serono Inc', u'Caprion Pharmaceuticals Inc', u'Lynx Therapeutics GmbH', u'Yakult Honsha Co Ltd', u'Quintiles Transnational Corp', u'Idun Pharmaceuticals Inc', u'TL Biopharmaceutical Ltd', u'Uppsala University', u'CIMYM BioSciences', u'MedImmune LLC', u'Maria Sklodowska-Curie Memorial Cancer Center', u'TMRC Co Ltd', u'Eleison Pharmaceuticals Inc', u'CureVac GmbH', u'Five Prime Therapeutics Inc', u'Cell Signaling Technology Inc', u'ARIAD Pharmaceuticals Inc', u'LIDDS AB', u'Specialised Therapeutics Australia Pty Ltd', u'Ludwig Institute for Cancer Research', u'Pharmatech Oncology', u'Axis Genetics plc', u'University of California San Francisco', u'multimmune GmbH', u'Nereus Pharmaceuticals Inc', u'MedStar Georgetown University Hospital', u'Inex Pharmaceuticals Corp', u'Active Biotech AB', u'Incyte Corp', u'Cancer Genetics Inc', u'Mast Therapeutics Inc', u'Clovis Oncology Inc', u'Purdue Pharma LP', u'BerGenBio AS', u'GlobeImmune Inc', u'WuXi PharmaTech (Cayman) Inc', u'MediBIC', u'Threshold Pharmaceuticals Inc', u'Azaya Therapeutics Inc', u'Micromet Inc', u'University of Illinois', u'Boehringer Ingelheim Corp', u'National Cheng Kung University', u'Windtree Therapeutics Inc', u'ILEX Oncology Inc', u'Wyeth Pharmaceuticals', u'Scottsdale Healthcare', u'Van Andel Institute', u'Guardant Health Inc', u'Universita di Bologna', u'University of Texas at El Paso', u'Insight Genetics Inc', u'CMC Biologics Inc', u'Dalian Wanchun Biotech', u'Cellectar Biosciences Inc', u'Australian Government', u'XOMA Corp', u'Merck & Co Inc', u'Vancouver General Hospital', u'Ascentage Pharma Group Corporation Ltd', u'Sanofi', u'The Salk Institute for Biological Studies', u'Columbia University', u'Beta Pharma Inc', u'MolecularMD Corp', u'University of California Davis', u'Pharmacia Corp', u'Phytera Inc', u'SignaBlok Inc', u'Beijing Xingda Science System Co Ltd', u'Nektar Therapeutics', u'Biomarker Strategies Llc', u'Almirall Prodesfarma SA', u'Therapure Biopharma Inc', u'Tamir Biotechnology Inc', u'Astex Pharmaceuticals Inc', u'Gilead Sciences Inc', u'Triangle Pharmaceuticals Inc', u'Axelar AB', u'Merrimack Pharmaceuticals Inc', u'X-BODY BioSciences', u'GeneKor SA', u'Tularik Inc', u'Guangzhou Shunjian Biomedical Technology Co Ltd', u'Imclone LLC', u'Eli Lilly Group Ltd (UK)', u'Hope Biosciences Inc', u'Lonza Group AG', u'The Australian National University', u'Sophiris Bio Inc', u'AVEO Oncology', u'Ono Pharmaceutical Co Ltd', u'MaxCyte Inc', u'Aventis SA', u'Sanofi Genzyme', u'MSD Japan', u'Bukwang Pharmaceutical Co Ltd', u'CJ Corp', u'Celgene Corp', u'BrightPath Biotherapeutics Co Ltd', u'BC Cancer Agency', u'Ascenta Therapeutics Inc', u'BeyondSpring Pharmaceuticals Inc', u'Viralytics Ltd', u'Queens University of Belfast', u'Bayer HealthCare Pharmaceuticals Inc', u'OncoGenex Technologies Inc', u'University of Alberta', u'Rhone-Poulenc Rorer Inc', u'Pique Therapeutics Inc', u'Daiichi Seiyaku Co Ltd', u'US Government', u'Ultimovacs AS', u'Roche Molecular Systems Inc', u'Allos Therapeutics Inc', u'Biogen Inc', u'GlaxoSmithKline plc', u'NantKwest Inc', u'Innovive Pharmaceuticals Inc', u'Biotoscana International', u'Cascadian Therapeutics Inc', u'Novotech (Australia) Pty Ltd', u'University of Basel', u'Progenetics Ltd', u'Immunex Corp', u'SRI International', u'University of Michigan', u'Halozyme Therapeutics Inc', u'Peregrine Pharmaceuticals Inc', u'Aurobindo Pharma Ltd', u'Reata Pharmaceuticals Inc', u'GlaxoSmithKline Inc', u'US Department of Defense', u'Asterias Biotherapeutics Inc', u\"Boston Children's Hospital\", u'ICOS Corp', u'Rosetta Genomics Ltd', u'Apexigen Inc', u'MD Anderson Cancer Center', u'Medarex Inc', u'Daiichi Sankyo Co Ltd', u'Abbott Laboratories', u'Eisai Co Ltd', u'3SBio Inc', u'Chosun Nursing College', u'Immune Design Corp', u'National Cancer Institute', u'Novartis AG', u'Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd', u'Intelgen (HK) Limited', u'Novelion Therapeutics Inc', u'Simcere Pharmaceutical Group', u'SciClone Pharmaceuticals Inc', u'CANbridge Life Sciences Ltd', u'University of Minnesota', u'Chung-Ang University', u'Concordia Pharmaceuticals Inc', u'Aptose Biosciences Inc', u'Gold Nanotech Inc', u'Dako Diagnostics Ltd', u'Kosan Biosciences Inc', u'BASF Pharma', u'Midatech Pharma US Inc', u'Medical University of South Carolina', u'Princess Margaret Hospital', u'The Center of Molecular Immunology', u'Kyowa Hakko Kogyo Co Ltd', u'US Health and Human Services Department', u'Biocept Inc', u'Benitec Biopharma Ltd', u'OncoMed Pharmaceuticals Inc', u'Chugai Pharmaceutical Co Ltd', u'University of North Carolina', u'Ortho Biotech Products LP', u'GENESIS Pharma SA', u'Symphony Evolution Inc', u'Argos Therapeutics Inc', u'Southern Research Institute', u'DSM Pharmaceutical Products', u'Teligene Inc', u'iTherX Pharmaceuticals Inc', u'Yuhan Corp', u'Tufts University School of Medicine', u'Dongguk University', u'Positive Biosciences Ltd', u'Helomics Corp', u'Oxford BioDynamics Ltd', u'University of Miami', u'PharmaMar SA', u'Epimmune Inc', u'Strathmann Biotec AG', u'UC San Diego Moores Cancer Center', u\"Children's Hospital of Los Angeles\", u'RegeneRx Biopharmaceuticals Inc', u'Janssen Biotech Inc', u'Pfizer Inc', u'Human Genome Sciences Inc', u'Bioyong Technologies Inc', u'Cadila Pharmaceuticals Ltd', u'CTI BioPharma Corp', u'GenQuest Inc', u'Memorial Sloan-Kettering Cancer Center', u'Mount Sinai Medical Center', u'Baylor College of Medicine', u'In Ovations Holdings Inc', u'National Institute of Allergy and Infectious Diseases', u'Takeda Pharmaceutical Co Ltd', u'Zambon Co SpA', u'University of New South Wales', u'Lantern Pharma', u'Lung Cancer Research Foundation', u'National Institutes of Health', u'Suzhou Alphamab Co Ltd', u'Food and Drug Administration', u'South Texas Accelerated Research Therapeutics', u'DxS Genotyping Ltd', u'Medinet Co Ltd', u'Foundation Medicine Inc', u'Onyx Pharmaceuticals Inc', u'University of Milano-Bicocca', u'Transgenomic Inc', u'Taxolog Inc', u'Qiagen NV', u'Ferozsons Laboratories Ltd', u'Merck Serono SA', u'Incozen Therapeutics Pvt Ltd', u'Teikoku Pharma USA Inc', u'Biologics Inc', u'Rafa Laboratories Ltd', u'Merck KGaA', u'Biocure Inc', u'Scancell Ltd', u'Helsinn Group']), u'Nocturia': set([u'Merus Labs International Inc', u'Allergan Inc', u'US Government', u'Ion Channel Innovations LLC', u'Pharmaplan GmbH', u'Ferring Canada', u'Recordati SpA', u'Serenity Pharmaceuticals']), u'Epidermolysisbullosa': set([u'US Government', u'Organogenesis Inc', u'Stanford University', u'Intrexon Corp', u'Genetrix Inc', u'Epidermolysis Bullosa Research Partnership', u'University of Modena and Reggio Emilia', u'San Raffaele Telethon Institute for Gene Therapy', u'University of Dundee', u'twoXar Inc', u'JCR Pharmaceuticals Co Ltd', u'Castle Creek Pharmaceuticals LLC', u'InMed Pharmaceuticals Inc', u'National Institutes of Health', u'Abeona Therapeutics Inc', u'Food and Drug Administration', u'WaVe Life Sciences Ltd', u'GlaxoSmithKline plc', u'University of Southern California', u'Sangamo Therapeutics Inc', u'Fibrocell Science Inc', u'Defiante Farmaceutica Lda', u'Advanced Biotherapy Inc', u'PharmaSeed Ltd', u'TWi Pharmaceuticals Inc', u'Osaka University Hospital', u'RegeneRx Biopharmaceuticals Inc', u'GroupMed (Holding)', u'Lotus Tissue Repair Inc', u'Advancell', u'Ember Therapeutics', u'ATERA SAS', u'Technology Strategy Board', u'Intercytex Ltd', u'PacificGMP', u'Scioderm Inc', u'Sandoz Inc', u'G-treeBNT Co Ltd']), u'Cardiacfailure': set([u'Quest Diagnostics Inc', u'Solvay SA', u'Stony Brook University Hospital', u\"Cincinnati Children's Hospital Medical Center\", u'AstraZeneca Pharmaceuticals LP', u'McNeil Pharmaceuticals Inc', u'European Community', u'Drexel University College of Medicine', u'Sumitomo Pharmaceuticals Co Ltd', u'CVie Therapeutics Co Ltd', u'Ambrx Inc', u'Restoragen Inc', u'Cuorips Inc', u'Handok Inc', u'North Carolina Biotechnology Center', u'Insulet Corp', u'Sigma-Tau Ind Farm Riunite SpA', u'Ludwig Boltzmann Institute', u'Tensha Therapeutics Inc', u'Arizona Biomedical Research Commission', u'Zeria Pharmaceutical Co Ltd', u'Innoviva Inc', u'Glotecx Inc', u'Kindstar Diagnostics Co. Ltd', u'Allosteros Therapeutics Inc', u'Silvergate Pharmaceuticals Inc', u'Vanderbilt University', u'University of Rochester Medical Center', u'Thermo Fisher Scientific Inc', u'Cardioxyl Pharmaceuticals Inc', u'Merck Sharp & Dohme Ltd', u'Lavipharm SA', u'Janssen Pharmaceutica NV', u'Aventis Pharmaceuticals Inc', u'Biochemie GmbH', u'Medtronic Inc', u'Phrixus Pharmaceuticals Inc', u'RPI Finance Trust', u'Bakoulev Center for Cardiovascular Surgery of Russian Academy of Sciences', u'Monsanto Co', u'Undisclosed', u'Eli Lilly & Co', u'University of Wisconsin-Madison', u'Navigo Proteins GmbH', u'Knoll Pharmaceutical Co (US)', u'Gilead Colorado Inc', u'Erasmus University Medical Center Rotterdam', u'CeNeS Pharmaceuticals Inc', u'Asubio Pharma Co Ltd', u'Cell Signals Inc', u'Guangzhou Municipal Zhongwei Biotechnology Co Ltd', u'Toyama Chemical Co Ltd', u'The Gladstone Institute of Cardiovascular Disease', u'Johns Hopkins University', u'Mitsubishi Tanabe Pharma Factory Ltd', u'Boston Scientific Corp', u'Taisho Pharmaceutical Co Ltd', u'UCB Celltech', u'Actelion Ltd', u'Yamanouchi Pharmaceutical Co Ltd', u'Bristol-Myers Squibb Co', u'Versant Ventures', u'Recordati SpA', u'Astellas Pharma Inc', u'CyDex Pharmaceuticals Inc', u'Chungnam National University', u'Novartis Farmaceutica SA', u'Medisun International Limited', u'University of Cambridge', u'SPS Cardio LLC', u'Servier', u'Knoll Pharmaceuticals Co', u'Vicor Technologies Inc', u'University of Tokyo', u'Orion Corporation', u'CPEC LLC', u'JHP Pharmaceuticals LLC', u'BTG plc', u'Cardiome Pharma Corp', u'DRAXIS Health Inc', u'Mylan Bertek Pharmaceuticals Inc', u'US Department of Veterans Affairs', u'Genentech Inc', u'Sangamo Therapeutics Inc', u'Mitsubishi-Tokyo Pharmaceuticals Inc', u'Grindeks, Publiska Akciju Sabiedriba', u'Ono Pharmaceutical Co Ltd', u'Shire-Movetis NV', u'Angioblast Systems Inc', u'Roche Holding AG', u'Merck Sante SA', u'Shire plc', u'Sandoz Ltd', u'Vasogen Inc', u'Procter & Gamble Pharmaceuticals Inc', u'Bayer HealthCare AG', u'Duke Clinical Research Institute', u'Korea Drug Development Fund', u'Evotec AG', u'Meiji Seika Pharma Co Ltd', u'Amgen Inc', u'Endacea Inc', u'Hemovent GmbH', u'Eunice Kennedy Shriver National Institute of Child Health & Human Development', u'Stiefel Laboratories (UK) Ltd', u'SkyePharma plc', u'Anchored Rsk3 Inhibitors Llc', u'Catalytica Inc', u'TBG Diagnostics Ltd', u'Gambro UF Solutions, Inc', u'Sunshine Heart Inc.', u'OXO', u'Roche Diagnostics', u'Alvogen Inc', u'Armgo Pharma Inc', u'University of California San Diego', u'DuPont Pharmaceuticals Ltd', u'China Pharma Holdings Inc', u'Univ Massachusetts', u'Rockefeller University', u'SICOR Inc', u'Green Cross Corp', u'Biotron Ltd', u'Astellas Institute for Regenerative Medicine', u'Mitsubishi Pharma Corp', u'Mayo Clinic Foundation', u'Ore Pharmaceuticals Inc', u'Alere Medical Inc', u'Molecular Insight Pharmaceuticals Inc', u'University of Texas Southwestern Medical Center', u'Alkermes plc', u'Research Corporation Technologies', u'AIT Austrian Institute Of Technology Gmbh', u'ScinoPharm Taiwan Ltd', u'Mytogen Inc', u'Celixir Ltd', u'Pierre Fabre SA', u'United Therapeutics Corp', u'MDS Nordion', u'AstraZeneca plc', u'Makai Biotechnology LLC', u'Pharmstandard OJSC', u'Terumo Corp', u'Introgen Therapeutics Inc', u'Australian Government', u'Gilead Palo Alto Inc', u'Bioject Medical Technologies Inc', u'Amylin Pharmaceuticals Inc', u'US Stem Cell Inc', u'King Pharmaceuticals Inc', u'Top Institute Pharma', u'Maryland Innovation Initiative', u'Critical Diagnostics', u'Kyoto University', u'Cedars-Sinai Medical Center', u'ICOS Corp', u'Ligand Pharmaceuticals Inc', u'ESP Pharma Inc', u'Invetech Pty Ltd', u'Artelis SA', u'Medichem SA', u'Covis Pharma Sarl', u'Avery Therapeutics Inc', u'University of California San Diego Medical Center', u'Walloon Region of Belgium Government', u'Institute of Medicinal Molecular Design Inc', u'Nycomed Christiaens BV', u'Takeda Pharmaceutical Co Ltd', u'Madeleine Pharmaceuticals Pty Ltd', u'University of Graz', u'Sanofi-Aventis US LLC', u'University of Florida', u'Agennix USA Inc', u'Mount Sinai School of Medicine', u'Forest Laboratories Inc', u'Quintiles Transnational Corp', u'Myogen GmbH', u'Aventis Pharma AG', u'scPharmaceuticals', u'OSI Pharmaceuticals Inc', u'University of Washington', u'Bio-Medisinsk Innovasjon AS', u'Agency For Science Technology & Research', u'ARCA Biopharma Inc', u'National Center For Advancing Translational Sciences', u'Aralez Pharmaceuticals Inc', u'Mylan Inc', u'Mast Therapeutics Inc', u'Arrow International Ltd', u'Jouveinal Laboratories Inc', u'Speedel Pharma AG', u'Boehringer Mannheim GmbH', u'University of California San Francisco', u'Celladon Corp', u'German Government', u'Les Laboratoires Servier', u'Glaxo Group Ltd', u'Encysive Pharmaceuticals Inc', u'Boehringer Ingelheim Corp', u'Cilag AG', u'Debiopharm SA', u'ILEX Oncology Inc', u'Duke University Medical Center', u'Renova Therapeutics Inc', u'Aspen PharmaCare Holdings Ltd', u'University of South Alabama', u'Biogen Inc (FL)', u'Sensile Medical Ag', u'Millar Inc', u'LTL Pharma Co Ltd', u'Baxter Healthcare Corp', u'XOMA Corp', u'Belupo', u'Merck & Co Inc', u'Edwards Lifesciences Corp', u'National Eye Institute', u'Sanofi', u'The Salk Institute for Biological Studies', u'Columbia University', u'XO1 Ltd', u'Ageless Regenerative Institute', u'University of Zagreb', u'Florida International University', u'Hannover Medical School', u'Neurocrine Biosciences Inc', u'BioProjet, Societe Civile de Recherche', u'Fox Chase Chemical Diversity Center Inc', u'Caladrius Biosciences Inc', u'TSH Biopharm Corporation Limited', u'Wyeth', u'Institute for the Promotion of Innovation by Science and Technology in Flanders', u'Response Biomedical Corp', u'Celyad', u'Lonza Group AG', u'The Australian National University', u'Meditronic Inc', u'PharmaIN Ltd', u'Elan Corp plc', u'Takeda Oncology', u'Sanofi Genzyme', u'MSD Japan', u'Par Pharmaceutical Co Inc', u'Biovail Corp', u'Duke University', u'Apollo Endosurgery Inc', u'Janssen Pharmaceuticals Inc', u'Bayer HealthCare Pharmaceuticals Inc', u'North Shore Long Island Jewish Health System', u'Laboratoires Negma', u'Medistem Inc', u'Daiichi Seiyaku Co Ltd', u'US Government', u'Acorda Therapeutics Inc', u'Heart Failure Clinical Research Network', u'California Institute of Regenerative Medicine', u'Capricor Therapeutics Inc', u'Califia Bio Inc', u'King Pharmaceuticals R&D Inc', u'GlaxoSmithKline plc', u'EZRA Innovations LLC', u'Cell Genesys Inc', u'Berg Pharma LLC', u'Bayer Schering Pharma AG', u'Ipsen', u'University of Michigan', u'Hadar Training and Medical Services', u'Hainan Sihuan Cardio-cerebral Vascular Drugs Research Institute Co Ltd', u'Azur Pharma Ltd', u'Sankyo Co Ltd', u'Aderis Pharmaceuticals Inc', u'Shionogi & Co Ltd', u'National Heart Lung and Blood Institute', u'US Department of Defense', u'UCB SA', u'Universiteit Maastricht', u'Suntory Ltd', u'Recro Pharma Inc', u'Vasade Biosciences Inc', u'Cytokinetics Inc', u'Knoll AG', u'Collateral Therapeutics Inc', u'Cordex Pharma Inc', u'Abbott Laboratories', u'Eisai Co Ltd', u'Novartis AG', u'Merck KGaA', u'Kos Pharmaceuticals Inc', u'NitroMed Inc', u'BEAT BioTherapeutics Corp', u'BG Medicine Inc', u'SciClone Pharmaceuticals Inc', u'University of Minnesota', u'The Procter & Gamble Co', u'Zensun (Shanghai) Sci-Tech Co Ltd', u'ALZA Corp', u'University of Texas System', u'Trevena Inc', u'Numoda Corp', u'Styrian Hospital mbH', u'Ferrer Internacional SA', u'LXR Biotechnology Inc', u'Pluristem Therapeutics Inc', u'Cordis Corp', u'Growblox Sciences Inc', u'Chugai Pharmaceutical Co Ltd', u'University of North Carolina', u'National Institute of Neurological Disorders and Stroke', u'Mesoblast Ltd', u'Health Sciences Research Institute Germans Trias i Pujol Foundation (IGTP)', u'Innopharmax Inc', u'Royal Philips Electronics', u'Medtronic plc', u'University of Miami', u'diaDexus Inc', u'Cellmid Ltd', u'PLIVA dd', u'University of Virginia', u'Janssen Biotech Inc', u'Pfizer Hellas AE', u'Pfizer Inc', u'Sinobiopharma Inc', u'deCODE genetics ehf', u'University of Arizona', u'Wyeth BioPharma', u'Rubicon Research Private Ltd', u'Laboratorios Farmaceuticos Rovi SA', u'Daiichi Sankyo Co Ltd', u'Jiangsu Lianhuan Pharmaceutical Co Ltd', u'Innovation Norway', u'CardioCell LLC', u'California Institute for Biomedical Research', u'Bayer AG', u'National Institutes of Health', u'National University Health System', u'Scios Inc', u'Synvista Therapeutics Inc', u'Yuyu Inc', u'Exscien Corp', u'The Menarini Group', u'University of Chicago', u\"Universita' Della Calabria\", u'The Green Cross Corp', u'Merck Serono SA', u'Ercopharm A/S']), u'Abdominalabscess': set([u\"Dr Reddy's Laboratories Ltd\", u'Pfizer Inc', u'GlaxoSmithKline plc', u'AstraZeneca plc']), u'Albuminuria': set([u'Par Pharmaceutical Co Inc', u'BioMarin Pharmaceutical Inc']), u'Pediculosiscapitisinfestation': set([u\"Dr Reddy's Laboratories Ltd\", u'Eli Lilly & Co', u'Eden Research PLC', u'BTG plc', u'Neo Pharma-Innovations Ltd', u'TerpeneTech Ltd', u'Homedics Inc', u'State of Indiana', u'Sanofi-Topaz', u'Hatchtech Pty Ltd', u'TG Therapeutics Inc', u'Pernix Therapeutics Holdings Inc', u'Nordic Biotech Venture Fund II K/S', u'Undisclosed', u'TechCare Corp', u'Arbor Pharmaceuticals Inc', u'SePRO Corp', u'ParaPRO LLC']), u'Insectinfection': set([u'Evogene Ltd', u'Marrone Organic Innovations']), u'Intracranialaneurysm': set([u'Bicetre Hospital', u'Sequent Medical Inc']), u'Hypertrophicskindisease': set([u'Velius', u'Rockefeller University']), u'Dilatedcardiomyopathy': set([u'Vericel Corp', u'Qingdao University of Science and Technology', u'National Institutes of Health', u'Chinese Academy of Medical Sciences & Peking Union Medical College', u'MyoKardia Inc', u'Max Delbruck Centrum Fur Molekulare Medizin', u'Sanofi', u'California Institute of Regenerative Medicine', u'AptaRes Ag', u'Charite Universitaetsmedizin Berlin', u'Phrixus Pharmaceuticals Inc', u'ATEK Medical', u'Cedars-Sinai Medical Center']), u'Retinaldystrophy': set([u'GP Pharm SA', u'Undisclosed', u'ProRetina Therapeutics SL', u'BCN Peptides SA', u'NSW Government', u'University of Sydney', u'NightstaRx Ltd']), u'Huntingtonschorea': set([u'Taiwan Specialty Pharma Corp', u'University of Delaware', u'Regeneron Pharmaceuticals Inc', u'Elixir Pharmaceuticals Inc', u'Vaccinex Inc', u'Japanese Ministry of Health, Labor and Welfare', u'Structural Genomics Consortium', u'Centre for Drug Research and Development', u'GenVec Inc', u'California Institute of Regenerative Medicine', u'Mount Sinai School of Medicine', u'Neurobiological Technologies Inc', u'Buck Institute', u'GlaxoSmithKline plc', u'KineMed Inc', u'BTG plc', u'Icogenex Corp', u'Horizon Orphan LLC', u'National Institute of Neurological Disorders and Stroke', u'Medivation Inc', u'Neose Technologies Inc', u'MethylGene Inc', u'Ionis Pharmaceuticals Inc', u'Trophos SA', u'European Eurostars Programme', u'US Department of Veterans Affairs', u'Laxdale Ltd', u'University of Iowa', u'Scil Technology GmbH', u'Stanford University', u'Microbot Medical Inc', u'University of Pittsburgh', u'INSERM Transfert', u'OSI Pharmaceuticals Inc', u'University of Washington', u'University of Lyon', u'Aegera Therapeutics Inc', u'Voyager Therapeutics', u'Roche Holding AG', u'Shire plc', u'University of British Columbia', u'INSERM', u'Galapagos NV', u'The National Institute of Mental Health', u'Ludwig Institute for Cancer Research', u'WaVe Life Sciences Ltd', u'Intellect Neurosciences Inc', u'University of Kentucky', u'Relief Therapeutics Holding AG', u'NeuroSpheres Ltd', u'National Center for Research Resources', u'NeuroSearch A/S', u'Vertex Pharmaceuticals Inc', u'Neurologix Inc', u'Institut du Cerveau et de la Moelle epiniere', u'Alnylam Pharmaceuticals Inc', u'UCB SA', u'Ultragenyx Pharmaceutical Inc', u'University of Massachusetts Medical School', u'European Commission', u'Evotec AG', u'Link Medicine Corp', u'Charles River Laboratories International Inc', u'New York University', u'Azevan Pharmaceuticals Inc', u'Medimmune Vaccines Inc', u'SMA Foundation', u'Tel Aviv University', u'Harvard University', u'Prana Biotechnology Ltd', u'EUSA Pharma USA', u'Institute for Neurodegenerative Disorders', u'Mitochon Pharmaceuticals', u'Cloud Pharmaceuticals Inc', u'National Cancer Institute', u'Repligen Corp', u'Oryzon Genomics SA', u'Sirna Therapeutics Inc', u'Seneb BioSciences Inc', u'University of Maryland', u'Teva Pharmaceutical Industries Ltd', u'Cantab Biopharmaceuticals Ltd', u'California Institute of Technology', u'Scripps Florida', u'REGENXBIO Inc', u\"Universite d'Angers\", u'Scarista Ltd', u'Sention Inc', u'Scripps Research Institute', u'Albany Molecular Research Inc', u'Alfresa Pharma Corp', u'Ministerio de Economia y Competitividad', u'University of Barcelona', u'Washington University in St Louis', u'Tapestry Pharmaceuticals Inc', u'Niigata University', u'uniQure BV', u'Vybion Inc', u'Medtronic Inc', u'AmpliPhi Biosciences Corp', u'GNS Healthcare', u'Translational Laboratory in Genetic Medicine', u'Neurocrine Biosciences Inc', u'Rockefeller University', u'Duke University Medical Center', u'Galenea Corp', u'Genentech Inc', u'Progenra Inc', u'Lifehealth Ltd', u'Prolexys Pharmaceuticals Inc', u'QR Pharma Inc', u'MediGene Inc', u'Cambrex Corp', u'AFT Pharmaceuticals Ltd', u'Mindset BioPharmaceuticals (USA) Inc', u'European Research Council (ERC)', u'Lundbeck Inc', u'Ben Franklin Technology Partners of Southeastern Pennsylvania', u'ProTrials Research, Inc', u'Oregon Health Sciences University', u'Provid Pharmaceuticals Inc', u'National Institute on Drug Abuse', u'Encore Pharmaceuticals Inc', u'ENKAM Pharmaceuticals A/S', u'University of California', u'French Government', u'Merck & Co Inc', u'Varinel Inc', u'Hereditary Disease Foundation', u'Giddi Pharma Co Ltd', u'University College London', u'BioFocus DPI', u'Addex Therapeutics Ltd', u'CARBOGEN AMCIS AG', u'Weizmann Institute of Science', u'University of California Irvine', u\"The Huntington's Disease Society of America\", u'CHDI Inc', u'Harvard NeuroDiscovery Center', u'FORUM Pharmaceuticals Inc', u'National Institute on Aging', u'Orphan Australia', u'Proteome Sciences plc', u'ReNeuron Group plc', u'RespireRx Pharmaceuticals Inc', u'Pfizer Inc', u'MediFront Ltd', u'University of Toulouse', u'Bioelectron Technology Corp', u'UK Department of Trade & Industry', u'University of Texas Southwestern Medical Center', u'Undisclosed', u'Aptuit Inc', u'Zalicus Inc', u'Scotia Holdings plc', u'Mitoconix Bio Ltd', u'VistaGen Therapeutics Inc', u'Sirtris Pharmaceuticals Inc', u'Massachusetts Institute of Technology', u'Australian Government', u'Boston Biomedical Research Inst', u'Serenex Inc', u'Patheon Pharmaceuticals Inc', u'University of California San Diego', u'CHDI Foundation Inc', u'Amarin Corp plc', u'Numerate Inc', u'Molecular Neuroimaging LLC', u'National Institutes of Health', u'Synthetic Biologics Inc', u'Elan Corp plc', u'Aequus Pharmaceuticals Inc', u'Sanofi Genzyme', u'Siena Biotech SpA', u'Proteostasis Therapeutics Inc', u'Thomas Jefferson University', u'Sangamo Therapeutics Inc', u'Samaritan Pharmaceuticals Inc', u'Imperial College London', u'High Q Foundation Inc', u'Biovail Corp', u'IXICO Plc', u'Cambridge Laboratories Ltd', u'Duke University', u\"European Huntington's Disease Network\", u'Childrens Hospital of Philadelphia', u'Ruhr Universitat Bochum', u'GE Healthcare', u'Albert-Ludwigs-Universit\\xe4t Freiburg', u'Neuralstem Inc', u'Solano Pharmaceuticals Inc', u'Biovail Laboratories International Srl', u'biOasis Technologies Inc', u'Benitec Biopharma Ltd', u'Global Stem Cell Solutions LLC', u'Viva Biotech', u'BrainVectis', u'J David Gladstone Institutes', u'ESI BIO', u'University of Cambridge']), u'Veindisease': set([u'NicOx SA', u'Angiodynamics Inc', u'Merz North America', u'Bayer AG']), u'Vitamindeficiency': set([u'Ibn Cina Drug Stores', u'Hangzhou Minsheng Pharmaceutical Group Company Ltd', u'Daewoong Pharmaceutical Co Ltd', u'Sanofi']), u'Presbycusis': set([u'Royal National Institute for Deaf People', u'University of South Florida', u'Pragma Therapeutics']), u'Rectaltumor': set([u'Aurobindo Pharma Ltd', u'Janssen Biotech Inc', u'US Government', u'University of Chicago', u'National Cancer Institute', u'Shuttle Pharmaceuticals LLC', u'Immunicon Corp', u'Hoffmann-La Roche AG', u'Altropus Gmbh', u'National Institutes of Health', u'Aptose Biosciences Inc', u'Varian Medical System Inc', u'Igeneon GmbH', u'GenVec Inc', u'Sanofi-Synthelabo', u'Bionix Radiation Therapy', u'AmpliPhi Biosciences Corp', u'RecipharmCobra Biologics', u'TL Biopharmaceutical Ltd', u'GlaxoSmithKline plc']), u'Hyperthermia': set([u'Mallinckrodt Inc', u'AAIPharma Services Corp', u'Palatin Technologies Inc', u'National Institute on Drug Abuse', u'Eagle Pharmaceuticals Inc']), u'Leishmaniainfection': set([u'iCo Therapeutics Inc', u'Mercachem Holding BV', u'The Consortium for Parasitic Drug Development', u'Nagasaki University', u'University of Antwerp', u'GlaxoSmithKline plc', u'World Health Organization', u'Sabin Vaccine Institute', u'VU University Medical Center', u'Fraunhofer Institut Molekularbiologie Und Angewandte Oekologie', u'Walter Reed Army Institute of Research', u'National Institute of Advanced Industrial Science and Technology', u'University of Tokyo', u'Vrije Universiteit van Amsterdam', u'Medicines for Malaria Venture', u'Medium-Tech Medizinger\\xe4te GmbH', u'Global Health Innovative Technology Fund', u'Microbial Chemistry Research Foundation', u'Dutch Ministry of Foreign Affairs', u'Grand Challenges Canada', u'GeneDesign Inc', u'Koninklijk Instituut voor de Tropen', u'Advinus Therapeutics Ltd', u'Ministry of Health of Uganda', u'Upstream Biosciences Inc', u'The European Union', u'Eisai Co Ltd', u'University of Dundee', u'University of Pune', u'University of Bristol', u'Wellcome Trust', u'MV Lomonosov Moscow State University', u'London School of Hygiene and Tropical Medicine', u'Gennova Biopharmaceuticals', u'MycoLogics Inc', u'Kancera AB', u'Alnylam Pharmaceuticals Inc', u'Infectious Disease Research Institute', u'Profounda Inc', u'University of Porto', u'Instituto de Parasitologia y Biomedicina Lopez-Neyra', u'Glaxo Group Ltd', u'McGill University', u'Johns Hopkins University', u'University of Bern', u'Ohio State University', u'LifePharms Inc', u'Dr Babasaheb Ambedkar Marathwada University', u'Dafra Pharma R&D', u'Paladin Labs Inc', u'Savant HWP Inc', u'Drugs for Neglected Diseases Initiative', u'Banaras Hindu University', u'Max Planck Innovation GmbH', u'High Energy Accelerator Research Organization', u'Undisclosed', u'US Army Medical Research and Materiel Command', u'Instituto Butantan', u'Sanofi', u'Columbia University', u'Y B Chavan College of Pharmacy', u'BIO Ventures for Global Health', u'Anacor Pharmaceuticals Inc', u'AEterna Zentaris Inc', u'Institut de Recherche pour le Developpement (IRD)', u'Pfizer Inc', u'Gilead Sciences Inc', u'Central Drug Research Institute', u'Institute for the Promotion of Innovation by Science and Technology in Flanders', u'Kitasato Institute', u'Massachusetts Institute of Technology', u'Rakta Therapeutics Inc', u'University of London School of Pharmacy', u'Takeda Pharmaceuticals International GmbH', u'Makerere University', u'National Institute of Allergy and Infectious Diseases', u'University of Mississippi', u'Knight Therapeutics Inc', u'Top Institute Pharma', u'Universidade Federal de Minas Gerais', u'National Institutes of Health', u'Bill & Melinda Gates Foundation', u'Universidade Federal do Rio de Janeiro', u'SVKMs NMIMS', u'Aventis SA', u'JADO Technologies GmbH', u'Celgene Corp', u'Astellas Pharma Inc', u'BioDelivery Sciences International Inc', u'Mycosynthetix Inc', u'RTI International', u'Vindico Pharmaceuticals Inc', u'Institut Pasteur', u'InvitroCue', u'IOTA Pharmaceuticals Ltd', u'Photeomix', u'Takeda Pharmaceutical Co Ltd', u'NanoPass Technologies Ltd', u'AmVac AG']), u'Nasopharynxtumor': set([u'Eli Lilly & Co', u'Sanofi', u'SRI International', u'AstraZeneca plc']), u'Familialamyloidneuropathy': set([u'SOM Biotech SL', u'Sanofi Genzyme', u\"Hospital Vall D'Hebron\", u'Regeneron Pharmaceuticals Inc', u'Corino Therapeutics Inc', u'Invitae', u'Universitat Autonoma de Barcelona', u'Ionis Pharmaceuticals Inc', u'Scripps Research Institute', u'Alnylam Pharmaceuticals Inc', u'Intellia Therapeutics Inc', u'FoldRx Pharmaceuticals Inc', u'TRC Capital Corporation', u'GlaxoSmithKline plc']), u'Hyperemia': set([u'Eye Therapies, LLC', u'Bausch & Lomb Inc', u'ORA Inc']), u'Alcoholism': set([u'Karolinska Institutet', u'US Government', u'Novo Nordisk A/S', u'TheraKine Ltd', u'Forest Laboratories Inc', u'Natural Pharmacia International Inc', u'AEterna Zentaris Inc', u'Brookhaven National Laboratory', u'Sintegal', u'Zentaris GmbH', u'University of Pennsylvania', u'Swedish Brain Foundation', u'Millennium Research Institute', u'Medications Discovery Texas Inc', u'CeNeS Pharmaceuticals plc', u'Somaxon Pharmaceuticals Inc', u'Torrey Pines Institute for Molecular Studies', u'US Department of Defense', u'Alnylam Pharmaceuticals Inc', u'Aptuit LLC', u'Eva and Oscar Ahr\\xe9ns Foundation', u'National Center For Advancing Translational Sciences', u'Lohmann Therapie-Systeme GmbH & Co KG', u'Abbott Laboratories', u'Catalyst Pharmaceutical Partners Inc', u'BioCorRx Inc', u'Howard University', u'Assistance Publique Hopitaux de Paris', u'Merck KGaA', u'University of Chile', u'HF Arzneimittelforschung GmbH & Co KG', u'Universite De Montreal', u'McLean Hospital Corp', u'Arbutus Biopharma Corp', u'Swedish Research Council', u'Opiant Pharmaceuticals Inc', u'Cilag AG', u'Les Laboratoires Meram', u'CFR Pharmaceuticals SA', u'Ethypharm SA', u'DrugAbuse Sciences Inc', u'Britannia Pharmaceuticals Ltd', u'Renaissance Pharma Inc', u'Rutgers University', u'SK Biopharmaceuticals', u'BioTie Therapies Corp', u'H Lundbeck A/S', u'University of Houston', u'University of California San Diego School of Medicine', u'Assuage Pharmaceuticals Inc', u'KYOWA Pharmaceutical Industry Co Ltd', u'Southern Research Institute', u'The Swedish National Board of Health and Welfare', u'National Institute on Drug Abuse', u'Zynerba Pharmaceuticals Inc', u'Alkermes plc', u'Eli Lilly & Co', u'Addex Therapeutics Ltd', u'Systembolaget', u'UWM Research Foundation Inc', u'elbion NV', u'R-Pharm', u'University of California Los Angeles', u'IVAX Corp', u'Almirall Prodesfarma SA', u'Pfizer Inc', u'Soberlink Healthcare LLC', u'Ambrosia Treatment Center', u'Merck Sharp & Dohme Ltd', u'Nippon Shinyaku Co Ltd', u'Baylor College of Medicine', u'University of Gothenburg', u'Takeda Pharmaceuticals International GmbH', u'Addiction Therapeutix Inc', u'Cerecor Inc', u'University of Rhode Island', u'MAP Health Management LLC', u'Chronos Therapeutics', u'University of Wisconsin-Milwaukee', u'Eczacibasi Ilac Pazarlama AS', u'WhanIn Pharmaceutical Co Ltd', u'Siberian State Medical University', u'Recalcine Pharmaceutical Corp', u'Millennium Laboratories', u'National Institute on Alcohol Abuse and Alcoholism', u'Astellas Pharma Inc', u'Medical University of South Carolina', u'Oakwood Laboratories LLC', u'Tufts University', u'University of Milan', u'MediciNova Inc', u'XenoPort Inc', u'Indiana University', u'Olle Engkvist Foundation', u'VM Discovery Inc', u'Merz & Co GmbH']), u'Staphylococcus': set([u'Sumitomo Dainippon Pharma Co Ltd', u'Takeda Pharmaceutical Co Ltd']), u'Tickborneencephalitisvirusinfection': set([u'Voyager Therapeutics', u'Hawaii Biotech Inc', u'Kirin Holdings Co Ltd', u'Merck & Co Inc', u'Bird Rock Bio Inc', u'National Institute of Allergy and Infectious Diseases']), u'Insomnia': set([u'DKSH Holding Ltd', u'US Government', u'Plantex', u'Cennerv Pharmaceuticals Pte Ltd', u'MedPointe Pharmaceuticals Inc', u'ProCom One Inc', u'Fudan University', u'ASKA Pharmaceutical Co Ltd', u'GlaxoSmithKline plc', u'Eddingpharm Inc', u'Actelion Ltd', u'Soochow University', u'Aspen PharmaCare Australia Pty Ltd', u'Questcor Pharmaceuticals Inc', u'Suda Ltd', u'Marina Biotech Inc', u'Elan Corp plc', u'Zydus-Cadila Group', u'FAES Farma SA', u'NRC Research Institute', u'Roche Holding AG', u'TOLMAR Therapeutics Inc', u'Neurogen Corp', u'Novartis Pharmaceuticals Corp', u'Laboratoires Biocodex', u'Kuhnil Pharmaceutical Co Ltd', u'Hisamitsu Pharmaceutical Co Inc', u'Ergomed PLC', u'Orexo AB', u'Purdue Pharma LP', u'Sunovion Pharmaceuticals Inc', u'SS Pharmaceutical - ethical drug division', u'Evotec AG', u'Meiji Seika Pharma Co Ltd', u'CJ Corp', u'The Procter & Gamble Co', u'Abbott Laboratories', u'NovaDel Pharma Inc', u'Eisai Co Ltd', u'Novartis AG', u'ACADIA Pharmaceuticals Inc', u'Il Dong Pharmaceutical Co Ltd', u'SkyePharma plc', u'Teva Pharmaceutical Industries Ltd', u'Italfarmaco SpA', u'Sanofi-Synthelabo', u'Siegfried Holding Ltd', u'Neuron Bio SA', u'University of California San Francisco', u'Neurim Pharmaceuticals', u'Astellas Pharma Inc', u'Zhejiang Jingxin Pharmaceutical Co Ltd', u'Janssen Pharmaceutica NV', u'Somnus Therapeutics Inc', u'Ferrer Internacional SA', u'Lupin Ltd', u'Growblox Sciences Inc', u'H Lundbeck A/S', u'Blake Insomnia Therapeutics Inc', u'Mallinckrodt plc', u'Chugai Pharmaceutical Co Ltd', u'Mitsubishi Pharma Corp', u'Paladin Labs Inc', u'Schering-Plough Corp', u'Actavis Inc', u'Somaxon Pharmaceuticals Inc', u'Shanghai Institute of Materia Medica of the Chinese Academy of Sciences', u'Undisclosed', u'KYOWA Pharmaceutical Industry Co Ltd', u'Sumitomo Dainippon Pharma Co Ltd', u'Merck & Co Inc', u'Sanofi', u'M et P Pharma AG', u'Eli Lilly & Co', u'Eisai Inc', u'CHEPLAPHARM Arzneimittel GmbH', u'Columbia-Presbyterian Medical Center', u'AstraZeneca plc', u'Pfizer Inc', u'Neurocrine Biosciences Inc', u'Wyeth', u'Kinexis Inc', u'Hoechst Marion Roussel Inc', u'LG Life Sciences Ltd', u'Amherst Pharmaceuticals', u'Euthymics Bioscience Inc', u'Takeda Pharmaceutical Co Ltd', u'Ligand Pharmaceuticals Inc', u'Sanofi KK', u'Aurigene Discovery Technologies Ltd', u'Max-Planck-Gesellschaft', u'Chinese Government', u'Myungin Pharm Co Ltd', u'King Pharmaceuticals Inc', u'The Menarini Group', u'Rechon Life Science AB', u'Cephalon Inc', u'Par Pharmaceutical Co Inc', u'BioDelivery Sciences International Inc', u'Valeant Pharmaceuticals International Inc', u'F Hoffmann-La Roche AG', u'Meda AB', u'Fabre Kramer Pharmaceuticals Inc', u'Sajo Consulting LLC', u'Minerva Neurosciences Inc', u'ECR Pharmaceuticals', u'Rhone-Poulenc Rorer Inc', u'GD Searle & Co', u'Sigma Pharmaceuticals Ltd']), u'Appetiteloss': set([u'Chugai Pharmaceutical Co Ltd', u'Unimed Pharmaceuticals Inc', u'MD Anderson Cancer Center', u'CSC Pharmaceuticals Handels GmbH', u'Allegiance Equity Corp', u'Mundipharma International Corp Ltd', u'Elan Drug Technologies', u'Advanced Viral Research Corp', u'Undisclosed', u'Bial-Portela & Ca Sa', u'Italfarmaco SpA', u'IntelGenx Technologies Corp', u'Par Pharmaceutical Co Inc', u'Ohr Pharmaceutical Inc', u'Panaxia Pharmaceutical Industries Ltd', u'Axim Biotechnologies Inc', u'Specialised Therapeutics Australia Pty Ltd', u'Helsinn Healthcare SA', u'Tetra Bio-Pharma Inc', u'Gen Ilac', u'Lacer SA', u'Helsinn Group']), u'Bronchiolitis': set([u'CollaGenex Pharmaceuticals Inc', u'CJ Corp', u'Windtree Therapeutics Inc', u'AIT Therapeutics Inc', u'Soroka University Medical Center', u'Kyorin Pharmaceutical Co Ltd', u'Aerogen Inc', u'PARI Pharma GmbH', u'National Institute of Allergy and Infectious Diseases', u'Merck & Co Inc', u'Laboratorios Dr Esteve SA', u'Virion Systems Inc', u'MSD Japan', u'Breath Therapeutics Holding BV']), u'Spinaldisease': set([u'Promimic Ab', u'Baxter International Inc', u'Mitsubishi Corp', u'Mesoblast Ltd', u'Kinetic Concepts Inc', u'Synaptive Medical (Barbados) Inc', u'LDR Holding Corp', u'National Institute of Arthritis and Musculoskeletal and Skin Diseases', u'Undisclosed', u'Scripps Research Institute', u'Angioblast Systems Inc', u'Feinstein Institute for Medical Research', u'Progenerative Medical Inc', u'Poly-Shape SAS', u'LifeHealthcare Group', u'Theracell Inc', u'Kuros Biosurgery AG', u'Medvet Science Pty Ltd', u'National Institute on Aging', u'North Shore University Hospital Research Corp', u'Amendia Inc', u'Yissum Research Development Co', u'K2M Group Holdings Inc']), u'Cough': set([u\"Dr Reddy's Laboratories Ltd\", u'Vifor Pharma', u'PhytoHealth Corp', u'Lumara Health Inc', u'NEOMED Institute', u'Galen Ltd', u'Lipocine Inc', u'Ducere Pharma LLC', u'Verona Pharma plc', u'Abbott Laboratories', u'Medical and Pharmaceutical Industry Technology and Development Center', u'BELLUS Health Inc', u'SEEK', u'Dinamika Ltd Co', u'Cerecor Inc', u'Cardiome Pharma Corp', u'Johns Hopkins University School of Medicine', u'Tris Pharma Inc', u'Undisclosed', u'Moberg Pharma AB', u'US Government', u'Nexgen Pharma Inc', u'Ipsen', u'Merck & Co Inc', u'Biocopea Ltd', u'Piramal Enterprises Ltd', u'Ahn-Gook Pharmaceuticals Co Ltd', u'Sanofi', u'Medical Research Council', u'Vernalis plc', u'Guangdong Zhongsheng Pharmaceutical Co Ltd', u'Spriaso LLC', u'SunTen Phytotech Co Ltd', u'Sun Yat-Sen University', u'Chiesi USA Inc', u'Melmed Holding AG', u'South China Center for Innovative Pharmaceuticals', u'Coating Place Inc', u'Prestige Brands Holdings Inc', u'Neurogen Corp', u'Alitair Pharmaceuticals Inc', u'ULURU Inc', u'Alvogen Inc', u'Monaghan Medical Corporation', u'Attenua Inc', u'AstraZeneca plc', u'Pfizer Inc', u'Electromed Inc', u'Pfizer Canada Inc', u'Catalyst Biosciences Inc', u'Soho Flordis International', u'Strides Shasun Ltd', u'Pernix Therapeutics Holdings Inc', u'Fells Laboratories LLC', u'UCB SA', u'Edmond Pharma']), u'Ironmetabolismdisorder': set([u'St Louis University', u'National Institute of Diabetes, Digestive and Kidney Diseases']), u'Lupuserythematosuspanniculitis': set([u'Merrimack Pharmaceuticals Inc', u'Alpha Cancer Technologies Inc', u'Eisai Co Ltd', u'Oklahoma Medical Research Foundation']), u'Vasculareyedisease': set([u'ElsaLys Biotech', u'MABLife', u'Undisclosed', u'Allegro Ophthalmics LLC', u'Senju Pharmaceutical Co Ltd', u'Georgia State University', u'ProDa BioTech LLC']), u'Metastaticcoloncancer': set([u'Aurobindo Pharma Ltd', u'Bukwang Pharmaceutical Co Ltd', u'Leaders in Oncology Care', u'TL Biopharmaceutical Ltd', u'LSK Biopartners Inc', u'Northwest Biotherapeutics Inc', u'Greenville Health System', u'Sarah Cannon Research Institute', u'Selah Genomics Inc']), u'Pseudomembranouscolitis': set([u'Merus Labs International Inc', u'Iroko Pharmaceuticals LLC', u'Hawker Resources Inc', u'Pharmascience Inc', u'Tramedico International']), u'Otitism': set([u'Concordia Pharmaceuticals Inc', u'Teligent Inc']), u'CharcotMarieToothdisease': set([u'VIB', u'Cyprus Institute of Neurology and Genetics', u'Acetylon Pharmaceuticals Inc', u'University of Sheffield', u'Allosterix Ltd', u'Hereditary Neuropathy Foundation', u'Food and Drug Administration', u'Ipsen', u'Pharnext SAS', u'IRCCS San Raffaele', u'OSEO', u'California Institute of Regenerative Medicine', u'BioPontis Alliance LLC', u'Neurorecovery Inc', u'Cedars-Sinai Medical Center', u'Muscular Dystrophy Association']), u'Epidermophytoninfection': set([u'Sun Pharmaceutical Industries Ltd', u'Johnson & Johnson', u'Barrier Therapeutics Inc', u'Dong Wha Pharmaceutical Co Ltd', u'Novartis AG']), u'Lichen': set([u'Ministry of Science, Education, and Sports', u'University of Zagreb', u'Mipharm SpA', u'Abeona Therapeutics Inc']), u'Hypertension': set([u'Speedel Holding AG', u'Knoll Pharmaceutical Co (US)', u'Solvay SA', u'InhibeX LLC', u'Life Technologies Corp', u'Engevity Inc', u'AstraZeneca Pharmaceuticals LP', u'Novartis Pharma AG', u'McNeil Pharmaceuticals Inc', u'Italchimici SpA', u'University of Sao Paulo', u'Pharmathen SA', u'Sumitomo Pharmaceuticals Co Ltd', u'Hospira Inc', u'Chiesi USA Inc', u'Kuhnil Pharmaceutical Co Ltd', u'Sandoz Ltd', u'Toray Industries Inc', u'Catalent Inc', u'HanAll Biopharma Co Ltd', u'Dalton Cardiovascular Research Center', u'Agence nationale de la recherche (ANR)', u'Cobalt Pharmaceuticals', u'Reliant Pharmaceuticals Inc', u'Fournier Pharma', u'Sigma-Tau Ind Farm Riunite SpA', u'iCarbonX', u'Glenmark Pharmaceuticals Ltd', u'Innoviva Inc', u'Serenus Biotherapeutics Inc', u'Egalet Corp', u'Silvergate Pharmaceuticals Inc', u'Hanmi Pharmaceutical Co Ltd', u'Santen Pharmaceutical Co Ltd', u'Pharmacopeia Inc', u'Toyama Chemical Co Ltd', u'Wellcome Trust', u'Wyeth', u'Cilag AG', u'Nano Terra Inc', u'Arbor Pharmaceuticals Inc', u'Ryogen LLC', u'Janssen Pharmaceutica NV', u'Torrent Pharmaceuticals Ltd', u'Laboratoires Delagrange', u'Lusochimica SpA', u'Nippon Boehringer Ingelheim Co Ltd', u'Long-E International', u'Aventis Pharmaceuticals Inc', u'Swedish Orphan Biovitrum AB', u'CHEPLAPHARM Arzneimittel GmbH', u'F H Faulding & Co Ltd', u'Patheon Pharmaceuticals Inc', u'Synthelabo-Lavipharm AE', u'Ajinomoto Co Inc', u'Monsanto Co', u'Dong-A ST Co Ltd', u'Flamel Technologies SA', u'Neopharma', u'Undisclosed', u'Daewoong Pharmaceutical Co Ltd', u'Bernofarm Pharmaceutical Co', u'Eli Lilly & Co', u'Isotechnika Pharma Inc', u'Pen Pharmaceutical Services Ltd', u'Penwest Pharmaceuticals Co', u'Bracco Eisai', u'Gilead Colorado Inc', u'Erasmus University Medical Center Rotterdam', u'Asubio Pharma Co Ltd', u'State University of New York', u'National Taiwan University', u'Solvay Biosciences (China) Ltd', u'Amerigen Pharmaceuticals Ltd', u'Hybio Pharmaceutical Co Ltd', u'InVasc Therapeutics Inc', u'Sanwa Kagaku Kenkyusho Co Ltd', u'Noden Pharma', u'Merck SA', u'University of California San Diego', u'SmithKline Beecham plc', u'Taisho Pharmaceutical Co Ltd', u'Global Damon Pharm', u'UCB Celltech', u'Actelion Ltd', u'Servier', u'Bristol-Myers Squibb Co', u'The Medicines Company', u'Pronova BioPharma ASA', u'Takata Seiyaku', u'Sidec Technologies Ab', u'Astellas Pharma Inc', u'Knoll GmbH', u'Lundbeck Research USA Inc', u'PhaseBio Pharmaceuticals Inc', u'Fujirebio KK', u'Meda AB', u'Tribute Pharmaceuticals Canada Inc', u'Procaps SA', u'Locus Pharmaceuticals Inc', u'Nichi-iko Pharma Factory Co Ltd', u'Yamanouchi Pharmaceutical Co Ltd', u'Universitat des Saarlandes', u'ASKA Pharmaceutical Co Ltd', u'Knoll Pharmaceuticals Co', u'Kyungpook National University', u'Boehringer Ingelheim GmbH', u'IDM Pharma Inc', u'Paul Graham Pharma Consulting Ltd', u'Chiesi Farmaceutici SpA', u'Sankyo Pharma Inc', u'Mylan Bertek Pharmaceuticals Inc', u'US Department of Veterans Affairs', u'The Austrian Research Promotion Agency FFG', u'Veristat, Inc.', u'LTT Bio-Pharma Co Ltd', u'Mikah Pharma', u'Ono Pharmaceutical Co Ltd', u'Shire-Movetis NV', u'Roche Holding AG', u'Merck Sante SA', u'Shire plc', u'Mitsubishi Tanabe Pharma Corp', u'Handok Inc', u'ANI Pharmaceuticals Inc', u'Tensive Controls Inc', u'Population Health Research Institute', u'UCB Pharma SA', u'Elan Pharmaceuticals Inc', u'OptiBiotix Health plc', u'Aveva Drug Delivery Systems', u'Evotec AG', u'Meiji Seika Pharma Co Ltd', u'WellSpring Pharmaceutical Corp', u'Stocosil', u'Berlin-Chemie AG', u'Zeneus Pharma Ltd', u'Kotobuki Pharmaceutical Co Ltd', u'RedHill Biopharma Ltd', u'Georgetown University', u'SkyePharma plc', u'Italfarmaco SpA', u'Tanabe Seiyaku Co Ltd', u'RIKEN', u'Prism Pharmaceuticals Inc', u'Chevron Phillips Chemical Co Lp', u'Plexxikon Inc', u'Yeda Research and Development Co Ltd', u'Cleveland Clinic Foundation', u'Rotta Research Lab SpA', u'Biovail Corp', u'Albany Molecular Research Inc', u'Galenica SA (Greece)', u'Sterling Pharmaceutical Services LLC', u'Alvogen Inc', u'Prasco Laboratories', u'Ibn Cina Drug Stores', u'Osaka University', u'Mitsubishi Tanabe Pharma Factory Ltd', u'Wakunaga Pharmaceutical Co Ltd', u'Seikagaku Corp', u'F Hoffmann-La Roche AG', u'Tsumura & Co', u'China Pharma Holdings Inc', u'Wyeth AG', u'Sanofi-Aventis US LLC', u'Green Cross Corp', u'Genentech Inc', u'Mitsubishi Pharma Corp', u'Paladin Labs Inc', u'Andrx Corp', u'Toa Eiyo KK', u'Harbin Gloria Pharmaceuticals Co Ltd', u'Actavis Inc', u'Nutrilinea Ltd', u'Hutchison Medipharma Enterprises Ltd', u'Barr Pharmaceuticals Inc', u'United Therapeutics Corp', u'Kadmon Pharmaceuticals LLC', u'Foxhollow Technologies Inc', u'Serodus ASA', u'Actient Pharmaceuticals LLC', u'AstraZeneca plc', u'Corthera Inc', u'PharmaSwiss SA', u'Genta Inc', u'Sandoz AG', u'Zynaxis Inc', u'Australian Government', u'Quantum Genomics Corp', u'Euthymics Bioscience Inc', u'PCAS Pharma Synthesis', u'Mochida Pharmaceutical Co Ltd', u'Navitas Pharma Inc', u'Dainippon Pharmaceutical Co Ltd', u'King Pharmaceuticals Inc', u'Innovation Pharmaceuticals Inc', u'IDT Australia Ltd', u'Dexcel Ltd', u'Valeant Canada', u'Discovery BioMed Inc', u'Asahi Glass Co Ltd', u'Zealand Pharma A/S', u'ICOS Corp', u'ESP Pharma Inc', u'PT Kalbe Farma Tbk', u'Valeant Pharmaceuticals International Inc', u'Medichem SA', u'Par Pharmaceutical Inc', u'Inotek Pharmaceuticals Corp', u'Nycomed Christiaens BV', u'Takeda Pharmaceutical Co Ltd', u'Zambon Italia Srl', u'Pharmabiota NZ Ltd', u\"Dr Reddy's Laboratories Ltd\", u'Matrix Pharma (Pvt) Ltd', u'Turing Pharmaceuticals LLC', u'University of Florida', u'Schwarz Pharma Ltd', u'EMD Serono Inc', u'Digital Gene Technologies Inc', u'Sanofi Canada', u'Hetero Drugs Ltd', u'Forest Laboratories Inc', u'Korea Research Institute of Chemical Technology', u'Kowa Co Ltd', u'Quintiles Transnational Corp', u'Healthcare Royalty Partners', u'Tris Pharma Inc', u'SCOHIA PHARMA Inc', u'Aventis Pharma AG', u'Cranford Pharmaceuticals LLC', u'UCB SA', u'Nissan Chemical Industries Ltd', u'Addrenex Pharmaceuticals Inc', u'Aptalis Pharma Srl', u'Novartis Pharmaceuticals Corp', u'National Center for Research Resources', u'Beijing CoSci Med-Tech Co Ltd', u'Hikma Pharmaceuticals plc', u'University of Nebraska Medical Center', u'Cas Medical Systems Inc', u'Aralez Pharmaceuticals Inc', u'Validus Pharmaceuticals', u'SunGen Pharma LLC', u'Mylan Inc', u'Allist Pharmaceuticals Inc', u'Cary Pharmaceuticals Inc', u'Arrow International Ltd', u'Jouveinal Laboratories Inc', u'Speedel Pharma AG', u'Boehringer Mannheim GmbH', u'GTx Inc', u'Shanghai Sine Wanxiang Pharmaceutical Co Ltd', u'AOBiome LLC', u'Teva Pharmaceutical Industries Ltd', u'Veloxis Pharmaceuticals A/S', u'UCB Pharma GmbH', u'Affymetrix Inc', u'WuXi PharmaTech (Cayman) Inc', u'Lannett Co Inc', u'Glaxo Group Ltd', u'AnGes MG Inc', u'Encysive Pharmaceuticals Inc', u'Boehringer Ingelheim Corp', u'Hoffmann-La Roche Inc', u'EA Pharma Co Ltd', u'Holmdel Pharmaceuticals LP', u'Java Clinical Research Ltd', u'Lavipharm SA', u'Nippon Shinyaku Co Ltd', u'Connetics Corp', u'Laborat\\xf3rio Qu\\xedmico Farmac\\xeautico Bergamo Ltda', u'SteadyMed Therapeutics Inc', u'Baxter Healthcare Corp', u'SK Pharmaceutical Co Ltd', u'XOMA Corp', u'Belupo', u'Merck & Co Inc', u'NextWave Pharmaceuticals Inc', u'Sanofi', u'Blue Note Pharmaceuticals BV', u'FSC Laboratories Inc', u'Novogen Ltd', u'Bayer AG', u'Almirall Prodesfarma SA', u'BioProjet, Societe Civile de Recherche', u'Kaken Pharmaceutical Co Ltd', u'TSH Biopharm Corporation Limited', u'Merck Sharp & Dohme Ltd', u'Institute for the Promotion of Innovation by Science and Technology in Flanders', u'Macropharma Corp', u'Zydus Cadila Healthcare Ltd', u'Takeda Pharmaceuticals International GmbH', u'Vita-Invest SA', u'Astra AB', u'Napp Pharmaceutical Group Ltd', u'Protherics plc', u'Meditronic Inc', u'Elan Corp plc', u'INSERM', u'Ligand Pharmaceuticals Inc', u'MSD Japan', u'CJ Corp', u'Pharma Pass LLC', u'Bioleaders Corp', u'Kyoto Pharmaceutical Industries Ltd', u'Par Pharmaceutical Co Inc', u'RHEI Pharmaceuticals Inc', u'Retrophin Inc', u'Top Institute Pharma', u'Ranbaxy Laboratories Ltd', u'Sanofi GmbH', u'Kitov Pharmaceuticals Ltd', u'National Defense Medical Center', u'Supernus Pharmaceuticals Inc', u'Instituto Invest y Desarrollo Quimico-Biologico SA', u'North Shore Long Island Jewish Health System', u'Laboratoires Negma', u'University of Alberta', u'Berlex Laboratories Inc', u'Purzer Pharmaceutical Co Ltd', u'Daiichi Seiyaku Co Ltd', u'DKSH Holding Ltd', u'US Government', u'BioMarin Pharmaceutical Inc', u'SamChunDang Pharm Co Ltd', u'CoVaccine BV', u'SunTech Medical Group Ltd', u'Symplmed Pharmaceuticals LLC', u'Breckenridge Pharmaceutical Inc', u'GlaxoSmithKline plc', u'EZRA Innovations LLC', u'Bayer Schering Pharma AG', u'Ipsen', u'Marina Biotech Inc', u'Zeria Pharmaceutical Co Ltd', u'Ranbaxy Pharmaceuticals Inc', u'Elite Pharmaceuticals Inc', u'FAES Farma SA', u'Yuyu Inc', u'Sankyo Co Ltd', u'Shionogi & Co Ltd', u'Pharmaniaga Bhd', u'Consort Medical PLC', u'Universiteit Maastricht', u'Austin Shasun LLC', u'Pahang Pharmacy Sdn Bhd', u'Windlas Healthcare Private Limited', u'Speedel Development AG', u'Daiichi Sankyo Co Ltd', u'Abbott Laboratories', u'Eisai Co Ltd', u'Schwarz Pharma Inc', u'BioRestorative Therapies Inc', u'geneRx+ Inc', u'Novartis AG', u'Merck KGaA', u'Kos Pharmaceuticals Inc', u'Innopharmax Inc', u'Fujisawa Pharmaceutical Co Ltd', u'SciClone Pharmaceuticals Inc', u'Concordia Pharmaceuticals Inc', u'Teva Takeda Yakuhin Ltd', u'ALZA Corp', u'National Institute Of Environmental Health Sciences', u'Taiho Pharmaceutical Co Ltd', u'Ethypharm SA', u'Health Care Logistics Inc', u'Ferrer Internacional SA', u'Yungjin Pharmaceutical Co Ltd', u'Innovative Pharma Developments Ltd', u'Watson Laboratories Inc', u'Recordati SpA', u'Lexicon Pharmaceuticals Inc', u'Chugai Pharmaceutical Co Ltd', u'Helopharm', u'Hanwha Corp', u'Allergan plc', u'Shionogi Pharma Inc', u'Yuhan Corp', u'Jeil Pharmaceutical Co Ltd', u'Nanolek LLC', u'University of California', u'Medtronic plc', u'UBE Industries Ltd', u'Perlegen Sciences Inc', u'Dr Falk Pharma GmbH', u'Epimmune Inc', u'Kyowa Hakko Kirin Co Ltd', u'NicOx SA', u'Kissei Pharmaceutical Co Ltd', u'Korean Ministry of Knowledge Economy', u'Janssen Biotech Inc', u'Aptalis Pharma Inc', u'Pfizer Inc', u'Sinobiopharma Inc', u'deCODE genetics ehf', u'AFFiRiS AG', u'Kitasato Institute', u'Osmotica Pharmaceutical Corp', u'DABL LIMITED', u'Rubicon Research Private Ltd', u'BioLineRx Ltd', u'LG Life Sciences Ltd', u'Laboratorios Farmaceuticos Rovi SA', u'Jiangsu Lianhuan Pharmaceutical Co Ltd', u'Stendhal International', u'Zambon Co SpA', u'Pfizer Ltd', u'National Institutes of Health', u'Menarini Asia-Pacific', u'Scios Inc', u'Synvista Therapeutics Inc', u'Vitae Pharmaceuticals Inc', u'The Menarini Group', u'Nippon Shoji Co Ltd', u'Cytopia Inc', u'JW Pharmaceutical Corp', u'The Green Cross Corp', u'Merck Serono SA', u'Takara Bio Inc', u'Biovail Laboratories International Srl', u'Gedeon Richter Ltd', u'Boryung Pharm Co Ltd', u'Ercopharm A/S']), u'Hyperglycemia': set([u'FUJIFILM Pharma Co Ltd', u'New Jersey Medical School', u'AstraZeneca plc', u'American Diabetes Association', u'Discovery BioMed Inc', u'Beijing Sun Novo Pharmaceutical Research Co Ltd', u'Mitsubishi Tanabe Pharma Corp', u'Teva Pharmaceutical Industries Ltd', u'Uni-Bio Science Group Ltd', u'National Institute of Diabetes, Digestive and Kidney Diseases', u'Bayer Yakuhin Ltd']), u'Angleclosureglaucoma': set([u'Amakem Therapeutics', u'pH Pharma']), u'Pagetsbonedisease': set([u'Meiji Seika Pharma Co Ltd', u'Mylan Inc', u'Grunenthal GmbH', u'Sanofi (pre-1999)', u'Unigene Laboratories Inc', u'Sebela Pharmaceuticals Inc', u'Abiogen Pharma SpA', u'Novartis AG', u'National Institutes of Health', u'Teva Pharmaceutical Industries Ltd', u'Merck & Co Inc', u'FFF Enterprises', u'Asahi Kasei Pharma Corp', u'Sanofi', u'Henkel KGaA', u'Glaxo Group Ltd', u'Osteometer BioTech AS', u'Procter & Gamble Pharmaceuticals Inc', u'NovaPharm Therapeutics', u'University of California Los Angeles', u'CSPC Pharmaceuticals Group Limited', u'Teijin Ltd', u'Ferrer Internacional SA', u'Provalis plc', u'Towa Pharmaceutical Co Ltd']), u'Huntersyndrome': set([u'University of North Carolina', u'Green Cross Corp', u'McMaster University', u'Isaac Foundation', u'Paladin Labs Inc', u'ViroMed Co Ltd', u'National Center for Child Health & Development', u'Shire Human Genetic Therapies Inc', u'ASKA Pharmaceutical Co Ltd', u'GlaxoSmithKline plc', u'National Institutes of Health', u'Zacharon Pharmaceuticals Inc', u'Opus Bio Inc', u'Sanofi Genzyme', u'University of Minnesota', u'Samaritan Pharmaceuticals Inc', u'JCR Pharmaceuticals Co Ltd', u'National MPS Society', u'University of Manchester', u'Shire plc', u\"Nationwide Children's Hospital\", u'University of Pretoria', u'Team Sanfilippo Foundation', u'Cardiff University', u'Genethon', u'Inventiva', u'biOasis Technologies Inc', u'Fondazione Brains for Brain ONLUS', u'Universitat Autonoma de Barcelona', u'ArmaGen Technologies Inc', u'Esteve', u'REGENXBIO Inc']), u'Macrocyticanemia': set([u'Merus Labs International Inc', u'Sanofi']), u'Bloodproteindisorder': set([u\"Brigham & Women's Hospital\", u'GLYCODesign Inc']), u'Vitiligo': set([u\"Dr Reddy's Laboratories Ltd\", u'BTG plc', u'Laboratoires Genevrier SA', u'AdPharma Inc', u'American Skin Association', u'National Institute of Arthritis and Musculoskeletal and Skin Diseases', u'Issar Pharmaceuticals Pvt Ltd', u'Clinuvel Pharmaceuticals Ltd', u'Oregon Health Sciences University', u'SurModics Pharmaceuticals', u'Advanced Biotherapy Inc', u'Radikal Therapeutics Inc', u'Zydus-Cadila Group', u'New York University School of Medicine, US', u'Luqa Pharmaceuticals', u'Loyola University of Chicago', u'University of Massachusetts Medical School', u'GroupMed (Holding)', u\"King's College London\"]), u'Intestinedisease': set([u'US Government', u'Wyeth Pharmaceuticals', u'Taisho Pharmaceutical Co Ltd', u'Consejo Superior De Investigaciones Cientificas', u'EpiBiome Inc', u'Eunice Kennedy Shriver National Institute of Child Health & Human Development', u'RedHill Biopharma Ltd', u'Bill & Melinda Gates Foundation', u'Accinov', u'MaaT Pharma', u'Eli Lilly & Co', u'Roche Holding AG', u'Valeant Pharmaceuticals International Inc', u'Adolor Corp', u'MIMETAS', u'Entera Health', u'University of British Columbia', u'University of Barcelona', u'Dignify Therapeutics Inc', u'North Carolina Biotechnology Center', u'Takeda Pharmaceutical Co Ltd', u'Institut National de la Recherche Agronomique', u'Norgine BV', u'Progenics Pharmaceuticals Inc', u'Ritter Pharmaceuticals Inc']), u'Endocarditis': set([u'Biosynexus Inc', u'NuvOx Pharma LLC', u'Eunice Kennedy Shriver National Institute of Child Health & Human Development', u'Catalytica Inc', u'Nutrition 21 Inc', u'IHM Labs', u'Taiho Pharmaceutical Co Ltd', u'Toyama Chemical Co Ltd', u'Wayne State University', u'Sanofi']), u'Autosomalrecessivedisorder': set([u'Leadiant Biosciences Inc', u'Dr Falk Pharma GmbH', u'Aldeyra Therapeutics Inc', u'National Organization for Rare Disorders', u'Solvay Pharmaceuticals Inc', u'University of Nebraska Medical Center']), u'Laryngopharyngitis': set([u'Abbott Laboratories', u'Toyama Chemical Co Ltd']), u'Hyperuricemia': set([u'LG Life Sciences Ltd', u'Polaris Pharmaceuticals Inc', u'Kunming Pharmaceutical Corp', u'Grunenthal GmbH', u'Ardea Biosciences Inc', u'Mochida Pharmaceutical Co Ltd', u'3SBio Inc', u'Chungnam National University', u'SK Group', u'Ipsen', u'Ironwood Pharmaceuticals Inc', u'The Menarini Group', u'Astellas Pharma Inc', u'Kunming Medical University', u'Kissei Pharmaceutical Co Ltd', u'EnzymeRx LLC', u'Fuji Yakuhin Co Ltd', u'AstraZeneca plc', u'Pfizer Inc', u'Teijin Ltd', u'Takeda Pharmaceutical Co Ltd', u'Teijin Pharma Ltd']), u'Skinulcer': set([u'Lifecore Biomedical Inc', u'Scios Inc', u'US Government', u'Organogenesis Inc', u'Regeneron Pharmaceuticals Inc', u'Glycotex Inc', u'Merck KGaA', u'Defiante Farmaceutica Lda', u'Eukarion Inc', u'Obagi System', u'National Institutes of Health', u'Kaken Pharmaceutical Co Ltd', u'US Army Medical Research and Materiel Command', u'Sandoz Inc', u'Duke University', u'Hanmi Pharmaceutical Co Ltd', u'National Science Foundation', u'RegeneRx Biopharmaceuticals Inc', u'LifeCell Corp', u'IsoTis SA']), u'Coronaryarterydisease': set([u\"Dr Reddy's Laboratories Ltd\", u'US Government', u'BioMarin Pharmaceutical Inc', u'Sonic Healthcare Ltd', u'Angiotech Pharmaceuticals Inc', u'SurModics Inc', u'Peptisyntha Inc', u'Cardinal Health Inc', u'TPG-Axon Capital', u'GenVec Inc', u'Endovasc Inc', u'Pharmacyclics Inc', u'Breckenridge Pharmaceutical Inc', u'GlaxoSmithKline plc', u'KineMed Inc', u'Frontage Laboratories Inc', u'Ministry of Health, Welfare and Family Affairs', u'Bayer Schering Pharma AG', u'DURECT Corp', u'Poniard Pharmaceuticals Inc', u'Taxus Cardium Pharmaceuticals Group', u'Hain Diagnostika GmbH', u'Medix Innovators LLC', u'Chulalongkorn University', u'Novartis Pharma AG', u'Cerenis Therapeutics SA', u'Anesiva Inc', u'Stanford University', u'Vernalis plc', u'Mallinckrodt Group Inc', u'Academy of Traditional Chinese Medical Science & Medicine of Jilin Province', u'Nexeon MedSystems Inc', u'Defiante Farmaceutica Lda', u'Millennium HealthCare', u'Alchemia Ltd', u'PYRAMID Laboratories, Inc', u'University of Miami', u'Atrium Medical Corp', u'Shandong Disha Pharmaceutical Co Ltd', u'Heartflow Inc', u'Procter & Gamble Pharmaceuticals Inc', u'Sankyo Co Ltd', u'Hatch Medical Llc', u'Aderis Pharmaceuticals Inc', u'Taro International Ltd', u'CollaGenex International Ltd', u'AstraZeneca plc', u'Alliance Pharma plc', u'National Heart Lung and Blood Institute', u'St Elizabeths Medical Center of Boston Inc', u'Rapidscan Pharma Solutions Inc', u'Cambridge Theranostics Ltd', u'Hainan Sinotau Pharmaceutical Co Ltd', u'Pfizer Hellas AE', u'Amerinet Inc', u'PPD Discovery Inc', u'Berlin-Chemie AG', u'Collateral Therapeutics Inc', u'Daiichi Sankyo Co Ltd', u'Abbott Laboratories', u'Regado Biosciences Inc', u'Eisai Co Ltd', u'King Pharmaceuticals R&D Inc', u'FUJIFILM RI Pharma Co', u'Johns Hopkins University School of Medicine', u'Symplmed Pharmaceuticals LLC', u'University Of Eastern Finland', u'Lantheus Medical Imaging Inc', u'Novelion Therapeutics Inc', u'Teva Pharmaceutical Industries Ltd', u'University of Alabama at Birmingham', u'Sanofi-Synthelabo', u'Roxwood Medical Inc', u'Montreal Heart Institute', u'Massachusetts General Hospital', u'Abgenix Inc', u'ParAllele Bioscience Inc', u'ISDIN SA', u'UCB Pharma GmbH', u'Par Pharmaceutical Co Inc', u'LocalMed Inc', u'Yeda Research and Development Co Ltd', u'ALZA Corp', u'Insys Therapeutics Inc', u'FluoroPharma Inc', u'Celera Group', u'Alfresa Pharma Corp', u'Global Genomics Group LLC', u'AnGes MG Inc', u'Johns Hopkins University', u'Schering AG', u'DuPont Pharmaceuticals Ltd', u'Aventis Pharmaceuticals Inc', u'Recordati SpA', u'Cordis Corp', u'Lavipharm SA', u'CardioVascular BioTherapeutics Inc', u'Nestle SA', u'Lexicon Pharmaceuticals Inc', u'Viron Therapeutics Inc', u'Biosense Webster', u'National Natural Science Foundation of China', u'NOF Corp', u'Transgene SA', u'Oxford BioMedica plc', u'Boots Hoechst Celanese', u'Karr Dental AG', u'Undisclosed', u'XOMA Corp', u'7TM Pharma A/S', u'ViroMed Co Ltd', u'Global Atherothrombotic Investigative Network', u'Perlegen Sciences Inc', u'Merck & Co Inc', u'Sanofi', u'UBE Industries Ltd', u'Columbia University', u'Berlex Biosciences', u'Royal Philips Electronics', u'Willvonseder & Marchesani GmbH & Co KG', u'Strathmann Biotec AG', u'Zhejiang University', u'University of Virginia', u'Molecular Insight Pharmaceuticals Inc', u'RegeneRx Biopharmaceuticals Inc', u'Gilead Colorado Inc', u'Janssen Biotech Inc', u'MDS Nordion', u'Almirall Prodesfarma SA', u'Therapure Biopharma Inc', u'Aptalis Pharma Inc', u'Pfizer Inc', u'Cardiovascular Systems Inc', u'Asubio Pharma Co Ltd', u'Gilead Sciences Inc', u'Luna Innovations Inc', u'Shanghai No 1 Biochemical & Pharmaceutical Co Ltd', u'Human Genome Sciences Inc', u'Adenosine Therapeutics LLC', u'Merck Sharp & Dohme Ltd', u'Genta Inc', u'Biscayne Pharmaceuticals Inc', u'EPIX Pharmaceuticals Inc', u'CollaGenex Pharmaceuticals Inc', u'Cardio Neo-Genesis LP', u'BioLineRx Ltd', u'Momenta Pharmaceuticals Inc', u'Massachusetts Institute of Technology', u'Laboratorios Farmaceuticos Rovi SA', u'Gilead Palo Alto Inc', u'Takeda Pharmaceuticals International GmbH', u'Medikit Co Ltd', u'Kobayashi Medical Co Ltd', u'Novation', u'LipimetiX LLC', u'DevCo Pharmaceuticals Ltd', u'Kuopio University Hospital', u'Protein Mechanics Inc', u'VIA Pharmaceuticals Inc', u'Corindus Ltd', u'National Institutes of Health', u'Molecular Medicine BioServices Inc', u'AtheroNova Inc', u'Maryland Innovation Initiative', u'Bristol-Myers Squibb Co', u'Aventis SA', u'Takeda Oncology', u'Sanofi Genzyme', u'American Heart Association', u'Astellas Pharma Inc', u'Tryton Medical Inc', u'Qiagen NV', u'Tufts University', u'GE Healthcare', u'diaDexus Inc', u'Boehringer Ingelheim Austria GmbH', u'Crucell NV', u\"Brigham & Women's Hospital\", u'Jiangsu Kefeiping Medicine Co Ltd', u'Novartis AG', u'Acusphere Inc', u'Beth Israel Deaconess Medical Center', u'Health Diagnostic Laboratory Inc', u'Pharma Med Inc']), u'Cockaynesyndrome': set([u'Dutch Ministry of Health, Welfare and Sport', u'National Institute on Aging', u'ChromaDex Corp', u'DNage BV']), u'Fungalmeningitis': set([u'Dong-A ST Co Ltd', u'Janssen Korea Ltd', u'Barrier Therapeutics Inc', u'Johnson & Johnson']), u'Herpesvirusinfection': set([u'KINAXO Biotechnologies GmbH', u'IRX Therapeutics Inc', u'Maxim Pharmaceuticals Inc', u'National Institute of Neurological Disorders and Stroke', u'Centre National de la Recherche Scientifique (CNRS)', u'Hoffmann-La Roche AG', u'Genomic Vision', u'Bavarian Research Foundation', u'IDIS Ltd', u'Shogoo Pharmaceuticals KK', u'National Institute of Allergy and Infectious Diseases', u'Institut de la Vision', u'GlaxoSmithKline plc', u'Redbiotec AG', u'Chiron Corp', u'Osaka University', u'Bristol-Myers Squibb Co', u'OSEO', u'Henderson Morley plc', u'Amistad Pharma SAS', u'BioSphings AG', u'Isotechnika Pharma Inc', u'POLA Pharma Inc', u'IC-MedTech Inc', u'VG Life Sciences Inc', u'US Army Medical Research Institute of Infectious Diseases', u'EpiCept Corp', u'University of Virginia', u'Avanir Pharmaceuticals Inc', u'Starpharma Holdings Ltd', u'N & N Scientific Inc', u'Cellectis SA', u'MegaPharm Ltd', u'NanoBio Corp', u'University of Colorado System', u'Friedrich-Alexander-Universitaet Erlangen-Nuernberg', u'TeselaGen Biotechnology Inc', u'4SC AG', u'University of California San Diego', u'Biomolecular Research Institute Ltd', u'Kent State University', u'National Institute of Biomedical Innovation', u'F H Faulding & Co Ltd', u'Estero-Anstalt', u'Cold Spring Harbor Laboratory']), u'Penileinduration': set([u'Actelion Pharmaceuticals Ltd', u'Imprimis Pharmaceuticals Inc', u'Asahi Kasei Corp', u'Pfizer Inc', u'Auxilium Pharmaceuticals Inc', u'Eton Pharmaceuticals Inc', u'BioSpecifics Technologies Corp', u'Swedish Orphan Biovitrum AB', u'RecipharmCobra Biologics']), u'Hypoxia': set([u'US Government', u'Diffusion Pharmaceuticals LLC', u'National Cancer Institute', u'CytRx Corp', u'Omniox Inc', u'ALS Association', u'Threshold Pharmaceuticals Inc', u'National Heart Lung and Blood Institute', u'Allos Therapeutics Inc', u'Hanmi Pharmaceutical Co Ltd', u'Molecular Insight Pharmaceuticals Inc', u'Siemens Medical Solutions Molecular Imaging', u'Cell>Point LLC']), u'Genitalherpes': set([u'Eli Lilly & Co', u'University of Washington', u'3M Pharmaceuticals', u'Undisclosed', u'Vical Inc', u'Immune Therapeutics Inc', u'National Institute of Allergy and Infectious Diseases', u'NanoBio Corp']), u'PrimarymediastinallargeB-cell': set([u'Kite Pharma Inc', u'Daiichi Sankyo Co Ltd']), u'Viralmeningitis': set([u'ViroPharma Inc', u'Sanofi']), u'Bingeeatingdisorder': set([u'US Government', u'LCS Therapeutics', u'Catalyst Pharmaceutical Partners Inc', u'Eisai Co Ltd', u'Neurobiological Technologies Inc', u'Forest Laboratories Inc', u'Chronos Therapeutics', u'Undisclosed', u'National Institute on Drug Abuse', u'Ewopharma AG', u'Olfactory Biosciences Corp', u'Alkermes plc', u'University of Chicago', u'Brookhaven National Laboratory', u'Jazz Pharmaceuticals plc', u'Allergan Inc', u'Childrens Medical Center Corp', u'Takeda Pharmaceutical Co Ltd', u\"Boston Children's Hospital\", u'Aptuit LLC', u'Hikma Pharmaceuticals plc', u'H Lundbeck A/S', u'Lucerne Biosciences LLC', u'Merz & Co GmbH']), u'EhlersDanlossyndrome': set([u'Greater Paris University Hospitals, AP-HP', u'Intrexon Corp', u'Acer Therapeutics Inc', u'Fibrocell Science Inc']), u'Peritonealt': set([u'TESARO Inc', u'WuXi PharmaTech (Cayman) Inc', u'Millennium Pharmaceuticals Ltd']), u'Battendisease': set([u'Evotec AG', u'University College London', u'US Government', u'University of North Carolina', u'Horizon Orphan LLC', u'Patheon Pharmaceuticals Inc', u'The European Union', u'National Institutes of Health', u'Ciba-Geigy AG', u'University of Missouri', u'French Government', u'Abeona Therapeutics Inc', u'NeuroSpheres Ltd', u'Cambrex Corp', u'Microbot Medical Inc', u'Childrens Hospital of Philadelphia', u'Beyond Batten Disease Foundation']), u'Ovarytumor': set([u'Ottawa Health Research Institute', u'Quest Diagnostics Inc', u'INEX Innovations Exchange', u'Advanced BioScience Laboratories Inc', u'Atlantic Cancer Research Institute', u'European Commission', u'US Health and Human Services Department', u'Hackensack University Medical Center', u'Ionis Pharmaceuticals Inc', u'Novartis Pharma AG', u'University of Florida', u'Pharmaceutical Product Development LLC', u'Intracel Corp', u'University of Pittsburgh', u'Hong Kong University of Science & Technology', u'Celldex Therapeutics Inc', u'Ontario Cancer Institute', u'NantHealth Inc', u'Stellar Biotechnologies Inc', u'Dompe SpA', u'Handok Inc', u'TTY Biopharm Co Ltd', u'North Carolina Biotechnology Center', u'NantCell Inc', u'Georgia Research Alliance', u'Glasgow University', u'National Research Council of Canada', u'CanTx Inc', u'National Health and Medical Research Council', u'Israeli Government', u'Cambridge Antibody Technology Group plc', u'The European Union', u'Nippon Kayaku Co Ltd', u'Tallikut Pharmaceuticals Inc', u'Valera Pharmaceuticals Inc', u'Predictive Therapeutics', u'The University of Hong Kong', u'MediGene AG', u'BioOutsource Ltd', u'Tempus Inc', u'Targepeutics Inc', u'Poniard Pharmaceuticals Inc', u'Cantab Biopharmaceuticals Ltd', u'Rgenix Inc', u'Medac GmbH', u'University of Gottingen', u'Ajinomoto Althea Inc', u'YM BioSciences Inc', u'OncoQuest Inc', u'JCR Pharmaceuticals Co Ltd', u'Dendritic Nanotechnologies Inc', u'RuiYi Inc', u'BioMoti Ltd', u'Wellcome Trust', u'Nottingham Trent University', u'FASgen Inc', u'Janssen Korea Ltd', u'ImmunoGen Inc', u'Oxford BioTherapeutics', u'Starpharma Holdings Ltd', u'Novacell Technology Inc', u'RayBiotech Inc', u'Altor BioScience Corp', u'Inverness Medical Switzerland GmbH', u'Cancer Therapeutics Ltd', u'Generex Biotechnology Corp', u'Australian Nuclear Science & Technology Organization', u'Swedish Orphan Biovitrum AB', u'Biochemie GmbH', u'Ludwig-Maximilians University of Munich', u'Pressure BioSciences Inc', u'Atani KK', u'Triton Biosystems Inc', u'Genomic Vision', u'Medimmune Oncology Inc', u'Protherics Salt Lake City Inc', u'Quest PharmaTech Inc', u'Regis Technologies Inc', u'Cellcor Inc', u'Sentinel Oncology Ltd', u'Verastem Inc', u'Undisclosed', u'Nemucore Medical Innovations Inc', u'VaxOnco Inc', u'Queen Mary University of London', u'Centro para el Desarrollo Tecnologico Industrial', u'Genewiz Inc', u'Ewha Womans University', u'IDT Biologika GmbH', u'LEO Pharma A/S', u'Helsinki University', u'CTI BioPharma Corp', u'Eli Lilly & Co', u'Celsion Corp', u'GlaxoSmithKline Biologicals', u'Immune Pharmaceuticals Inc', u'US Surgical Corp', u'University of Wisconsin-Madison', u'Phyton Biotech Inc', u'Rubicon Biotechnology Inc', u'Weizmann Institute of Science', u'Guangdong Jiaying Pharmaceutical Co Ltd', u'Madrigal Pharmaceuticals Inc', u'Busto Arsizio Hospital', u'University of California Los Angeles', u'OSI Pharmaceuticals Inc', u'NanoString Technologies Inc', u'Spire Healthcare Limited', u'Fournier Pharma', u'Hyaluron Inc', u'Strakan Europe', u'Corixa Corp', u'Cancer Research Technology Ltd', u'Pharmion Corp', u'FCB-Pharmicell Co Ltd', u'Zentaris GmbH', u'Cytran Inc', u'Johnson & Johnson', u'Coley Pharmaceutical Group Inc', u'Innate Pharma SA', u'Eleison Pharmaceuticals Inc', u'Japanese National Cancer Center', u'Peter MacCallum Cancer Centre', u'East of England Development Agency', u'BL&H Co Ltd', u'AltaRex Medical Corp', u'Cancer Prevention and Research Institute of Texas', u'PapGene Inc', u'Epic Sciences Inc', u'Fresenius SE & Co KGaA', u'BioCancell Therapeutics Ltd', u'US Oncology Inc', u'Janssen Research & Development LLC', u'Victorian Cancer Agency', u'MDxHealth SA', u'NERx Biosciences Inc', u'Astellas Pharma Inc', u'UCB Celltech', u'Vanderbilt-Ingram Cancer Center', u'Institute of Cancer Research UK', u'Antisoma plc', u'Avella', u'United Biotech Corp', u'Oncormed Inc', u'Meda AB', u'Hayashibara Co Ltd', u'Hemispherx Biopharma Inc', u'MabVax Therapeutics Inc', u'University of Gothenburg', u'INRS - Institut Armand-Frappier', u'Stehlin Foundation For Cancer Research', u'Karolinska Institutet', u'CPC Clinical Research', u'AltheaDx Inc', u'CytogenDx Co Ltd', u'Orion Corporation', u'Sermonix Pharmaceuticals LLC', u'BTG plc', u'Centelion SAS', u'Specialised Therapeutics Australia Pty Ltd', u'Chiron Corp', u'Target Discovery Inc', u'AlphaMed Inc', u'Zhejiang Hisun Pharmaceutical Co Ltd', u'Bristol-Myers Squibb Co', u'Xenova Group plc', u'Morphotek Inc', u'Astex Pharmaceuticals Inc', u'Onyvax Ltd', u'Syndax Pharmaceuticals Inc', u'Veristat, Inc.', u'University of Pennsylvania', u'Navidea Biopharmaceuticals Inc', u'City of Hope', u'Mateon Therapeutics Inc', u'Garvan Institute of Medical Research', u'Roche Holding AG', u'Felicitex Therapeutics Inc', u'Immunocore Ltd', u'Medeva plc', u'Sandoz Ltd', u'Biocompatibles International plc', u'Nihon Medi-Physics Co Ltd', u'Gradalis Inc', u'Jinan University (Guangdong)', u'TESARO Inc', u'Selvita SA', u'Integrated DNA Technologies Inc', u'Wisconsin Department of Commerce', u'Dana-Farber Cancer Institute Inc', u'Terry Fox Foundation', u'Guangzhou Doublle Bioproducts Co Ltd', u'Exelixis Inc', u'University of Florida College of Medicine', u'Amgen Inc', u'Baxter Oncology GmbH', u'LFB SA', u'MGI Pharma Biologics', u'The University of Birmingham', u'Johns Hopkins University School of Medicine', u'ZIOPHARM Oncology Inc', u'University Hospitals Seidman Cancer Center', u'Georgetown University', u'Georgetown University Medical Center', u'Array BioPharma Inc', u'PsiOxus Therapeutics Ltd', u'Massachusetts General Hospital', u'Medical Research Council', u'Samyang Corp', u'Pevion Biotech Ltd', u'Enzon Pharmaceuticals Inc', u'Goodwin Biotechnology Inc', u'Immunomedics Inc', u'Nycomed Pharma AS', u'Adler School of Professional Psychology', u'Cytovance Biologics LLC', u'Imperial Cancer Research Technology Ltd', u'HealthLinx Ltd', u'CellSight Technology, Inc.', u'Dubai Healthcare City', u'National Institute of Biomedical Innovation', u'Cancer Treatment Centers of America', u'TetraLogic Pharmaceuticals Corp', u'Mater Hospitals', u'F Hoffmann-La Roche AG', u'Sigma-Tau Ind Farm Riunite SpA', u'SICOR Inc', u'Cancer Research UK', u'Genentech Inc', u'Paladin Labs Inc', u'Cobra Biologics Holding AB', u'Mayo Clinic Foundation', u'Novuspharma SpA', u'Cellumen Inc ( now a service mark of Apredica)', u'ImmunoCellular Therapeutics Ltd', u'Eden Biodesign Ltd', u'NanoSmart Pharmaceuticals Inc', u'Adaptimmune Therapeutics plc', u'PDL BioPharma Inc', u'Kiromic LLC', u'iOx Therapeutics Ltd', u'Organon Teknika BV', u'Science and Industry Endowment Fund', u'University of Southern California', u'Medison Pharma Ltd', u'Bionovo Inc', u'AiVita Biomedical', u'Dompe Farmaceutici SpA', u'Avera Medical Group', u'ScinoPharm Taiwan Ltd', u'Deutsches Krebsforschungszentrum', u'Johns Hopkins Medicine', u'Pierre Fabre SA', u'Neovii Biotech GmbH', u'GamaMabs Pharma', u'AEterna Zentaris Inc', u'CJ Corp', u'IVAX Corp', u'AstraZeneca plc', u'Technology Strategy Board', u'SUGEN Inc', u'University of Utah', u'University of Texas Southwestern Medical Center', u'Kent State University', u'diaDexus LLC', u'Lonza Biologics plc', u'Introgen Therapeutics Inc', u'Singapore General Hospital Pte Ltd', u'Australian Government', u'CASI Pharmaceuticals Inc', u'Translational Genomics Research Institute', u'Universidad Complutense de Madrid', u'ASTA Medica AG', u'BC Cancer Agency', u'Multimeric Biotherapeutics Inc', u'Sophia Genetics Sa', u'H Lee Moffitt Cancer Center and Research Institute', u'BioChem Therapeutic Inc', u'Ligand Pharmaceuticals Inc', u'Mundipharma International Corp Ltd', u'Alberta Heritage Foundation For Medical Research', u'National Cancer Centre of Singapore', u'Critical Outcome Technologies Inc', u'Tulane University', u'University of Wurzburg', u'Aqualis ASA', u'ICOS Corp', u'Aronex Pharmaceuticals Inc', u'MicroVAX LLC', u'IC-MedTech Inc', u'VG Life Sciences Inc', u'Calando Pharmaceuticals Inc', u'ADT Pharmaceuticals', u'The Princess Margaret Cancer Centre', u'ThromboGenics NV', u'Melmotte Inc', u'Adria Laboratories Inc', u'Medical University of South Carolina', u'National University of Singapore', u'NanoCarrier Co Ltd', u'Selecta Biosciences Inc', u'The Vaccine and Gene Therapy Institute of Florida', u'Walter and Eliza Hall Institute of Medical Research', u'Ottawa Regional Cancer Foundation', u\"Brigham & Women's Hospital\", u'Dyax Corp', u'Janssen Products Inc', u'Laboratory Corporation of America Holdings', u'3M Co', u'Serono Inc', u'CuraGen Corp', u'German Federal Ministry of Education and Research', u'National Comprehensive Cancer Network', u'Cancer Immunotherapy Trials Network', u'Royal DSM NV', u'DRAXIMAGE', u'Cerus Corp', u'Silence Therapeutics plc', u'Sarah Cannon Research Institute', u'Case Comprehensive Cancer Center', u'Yakult Honsha Co Ltd', u'Kowa Co Ltd', u'NeoPharm Inc', u'VolitionRX Ltd', u'Ministry of Health, Welfare and Family Affairs', u'Cytogen Corp', u'Abnova (Taiwan) Corp', u'Aventis Pharma AG', u'MedImmune LLC', u'CellControl Biomedical Laboratories AG', u'Amaran Biotechnology Inc', u'University of Washington', u'Southend Hospital', u'City University of New York', u'Pharmacia & Upjohn Co', u\"Queen's University\", u'ARIUS Research Inc', u'Implicit Bioscience Ltd', u'Aravive Biologics Inc', u'Ludwig Institute for Cancer Research', u'KuDOS Pharmaceuticals Ltd', u'Lankenau Institute for Medical Research', u'Axis Genetics plc', u'Biosite Inc', u'National Center for Research Resources', u'Xenova Ltd', u'Inex Pharmaceuticals Corp', u'ViRexx Medical Corp', u'Incyte Corp', u'Mylan Inc', u'OncoSurg Inc', u'Harvard University', u'Novonco Therapeutics Inc', u'TransGenex Nanobiotech Inc', u'Boehringer Mannheim GmbH', u'Clovis Oncology Inc', u'Oncolytics Biotech Inc', u'Bolder BioTechnology Inc', u'Diatos SA', u'Catholic University of Leuven', u'Purdue Pharma LP', u'CryoPort Inc', u'Florida Hospital', u'WuXi PharmaTech (Cayman) Inc', u'Fraunhofer-Institute fur Zelltherapy und Immunologie', u'Leo Pharmaceuticals', u'MediBIC', u'Dendreon Corp', u'Threshold Pharmaceuticals Inc', u'Ferring Pharmaceuticals SA', u'Foligo Therapeutics Inc', u'Viventia Bio Inc', u'Skolkovo', u'Genta Inc', u'Millennium Pharmaceuticals Ltd', u'Boehringer Ingelheim Corp', u'Asan Medical Center', u'Vermillion Inc', u'Juno Therapeutics Inc', u'BioInvent International AB', u'Neopharm Ltd', u'Splash Pharmaceuticals Inc', u'Debiopharm SA', u'Vancouver Coastal Health Research Institute', u'Fujirebio Diagnostics Inc', u'LI-COR Biosciences', u'Tikcro Technologies Ltd', u'Anthra Pharmaceuticals Inc', u'Oncovir Inc', u'Medivation Inc', u'MabCure Inc', u'Van Andel Institute', u'University of South Alabama', u'Schering-Plough Corp', u'Case Western Reserve University School of Medicine', u'PCT, a Caladrius company', u'Solixia Inc', u'CMC Biologics Inc', u'OncoTartis Inc', u'Cellectar Biosciences Inc', u'NCIC Clinical Trials Group', u'XOMA Corp', u'Merck & Co Inc', u'Ingenex Inc', u'Morphisto GmbH', u'CFD Therapeutics Inc', u'Sanofi', u'Vertex Pharmaceuticals Inc', u'Novogen Ltd', u'Calibrant Biosystems Inc', u'Pharmacia Corp', u'BD Diagnostics', u'The Mary Kay Foundation', u'Voluntis', u'T.J. Martell Foundation', u'Almirall Prodesfarma SA', u'Sellas Life Sciences Group', u'Pharmaceutics International Inc', u'University of Cologne', u'Saint Savas Cancer Hospital', u'Summa Health System', u'Caladrius Biosciences Inc', u'Merrimack Pharmaceuticals Inc', u'Arrien Pharmaceuticals LLC', u'Vernalis plc', u'Baxter Healthcare Ltd', u'Genisphere LLC', u'Purdue University', u'AnorMED Inc', u'Antigen Express Inc', u'Yale School of Medicine', u'Imclone LLC', u'PharmaGap Inc', u'Hainan Tianwang International Pharmaceutical', u'The University Health Network', u'NYU Langone Medical Center', u'Clinigen Group plc', u'Neovacs SA', u'Novartis Pharma KK', u'Lonza Group AG', u'AviPep Pty Ltd', u'Soricimed Biopharma Inc', u'CQDM', u'Kiyatec Llc', u'Chinese Government', u'Aventis SA', u'INSERM', u'Sanofi Genzyme', u'HRA Pharma', u'MGI Pharma Inc', u'Celgene Corp', u'Research Development Foundation', u'Helmholtz Institute for Pharmaceutical Research Saarland', u'Raven Biotechnologies Inc', u'Octamer Inc', u'Staatsministerium fur Wissenschaft und Kunst', u'KS Biomedix Holdings plc', u'Duke University', u'Apollo Endosurgery Inc', u'MISSION Therapeutics Ltd', u'University of Georgia', u'Endocyte Inc', u'Alethia Biotherapeutics Inc', u'Abeome Corp', u'Sydys Corp', u'SIGA Technologies Inc', u'Bayer HealthCare Pharmaceuticals Inc', u'Abraxis BioScience Inc', u'University of Alberta', u'ProMIS Neurosciences Inc', u'Rhone-Poulenc Rorer Inc', u'Universitair Ziekenhuis Brussel', u'Pantarhei Bioscience BV', u'OncoGenex Pharmaceuticals Inc', u'Defense Threat Reduction Agency', u'Daiichi Seiyaku Co Ltd', u'US Government', u'BioMarin Pharmaceutical Inc', u'Rice University', u'Pharmexa A/S', u'Cancer Research Campaign Technology Ltd', u'W C Heraeus GmbH & Co KG', u'Gynecologic Oncology Group', u'Esperance Pharmaceuticals Inc', u'Recepta biopharma', u'Woodland Pharmaceuticals LLC', u'Biogen Inc', u'Xiamen University', u'GlaxoSmithKline plc', u'NantKwest Inc', u'Cytran Ltd', u'Cell Genesys Inc', u'Johnson Matthey plc', u'BayPoint Biosystems', u'Cascadian Therapeutics Inc', u'Novotech (Australia) Pty Ltd', u'Ipsen', u'Massachusetts Life Sciences Center', u'Frantz Biomarkers Llc', u'Institut Curie', u'University of Michigan', u'Immunotope Inc', u'Genelux Corp', u'FAES Farma SA', u'European Network of Gynaecological Oncological Trial Groups', u'EGEN Inc', u'Aduro BioTech Inc', u'Almac Diagnostics', u'The Honorable Tina Brozman Foundation Inc', u'Seoul Clinical Laboratories', u'Temple University', u\"Wuxi Maternal and Children's Hospital\", u'PNP Research Corporation LLC', u'Fox Chase Cancer Center', u'3M Pharmaceuticals', u'Shionogi & Co Ltd', u'Stanford Rook Ltd', u'Taiwan Liposome Co', u'Nanovalent Pharmaceuticals Inc', u'Johnson & Johnson Pharmaceutical Research & Development LLC', u'Cancer Therapy Evaluation Program', u'MD Anderson Cancer Center', u'Swedish Orphan AB', u'Medarex Inc', u'Immunovaccine Inc', u'Abbott Laboratories', u'UniQuest Pty Ltd', u'Eisai Co Ltd', u'Cloud Pharmaceuticals Inc', u'National Cancer Institute', u'Novartis AG', u'Merck KGaA', u'Almac Discovery Ltd', u'Syngene International Ltd', u'Fujisawa Pharmaceutical Co Ltd', u'Novelion Therapeutics Inc', u'Bigmar Inc', u'Universite De Montreal', u'University of Minnesota', u'Cornell University', u'Galectin Therapeutics Inc', u'ALZA Corp', u'University of South Florida', u'University of Colorado System', u'Sunnybrook Health Sciences Centre', u'CytRx Corp', u'University of Massachusetts Medical School', u'Johns Hopkins University', u'Tapestry Pharmaceuticals Inc', u'Myriad Genetics Inc', u'Compugen Ltd', u'TRION Pharma GmbH', u'Biocept Inc', u'AmpliPhi Biosciences Corp', u'OncoMed Pharmaceuticals Inc', u'Chugai Pharmaceutical Co Ltd', u'University of North Carolina', u'Ortho Biotech Products LP', u'GENESIS Pharma SA', u'Intus Healthcare Ltd', u'Symphony Evolution Inc', u'SRI International', u'Iovance Biotherapeutics Inc', u'Sakai Chemical Industry Co Ltd', u'Medivir AB', u'Yale Cancer Center', u'Massey Cancer Center', u'Indiana University Purdue University Indianapolis', u'PharmaMar Inc', u'US Bioservices', u'BBI Holdings PLC', u'University College London', u'BiPar Sciences Inc', u'PharmaMar SA', u'Kobe University', u'University of Virginia', u'The University of Newcastle Upon Tyne', u'Pharmasyntez', u'The University of Liverpool', u'Pfizer Inc', u'Midatech Pharma PLC', u'Yale University', u'Provista Diagnostics LLC', u'Northeastern University', u'Yissum Research Development Co', u'Genor Biopharma Co Ltd', u'Memorial Sloan-Kettering Cancer Center', u'Mount Sinai Medical Center', u'Therion Biologics Corp', u'Cato Research Ltd', u'Baylor College of Medicine', u'GPC Biotech AG', u'UK Government', u'NanOlogy LLC', u'CritiTech Inc', u'VentiRx Pharmaceuticals Inc', u'MEI Pharma Inc', u'Prima BioMed Ltd', u'National Institute of Allergy and Infectious Diseases', u'The Ovarian Cancer Research Fund', u'Spectros Corp', u'Takeda Pharmaceutical Co Ltd', u'Selected Value Therapeutics', u'TapImmune Inc', u'Oasmia Pharmaceutical AB', u'Cinvestav', u'Universidad Nacional Autonoma De Mexico', u'National Institutes of Health', u'TopoTarget A/S', u'Food and Drug Administration', u'Vaccinogen Inc', u'Curis Inc', u'Oncology Venture ApS', u'American Cyanamid Co', u'Select Therapeutics Inc', u'Thomas Jefferson University', u'Onyx Pharmaceuticals Inc', u'Roswell Park Cancer Institute', u'Merck Serono SA', u'Fuda Cancer Hospital', u'H2Biologics, Inc', u'AVAX Technologies Inc', u'Biologics Inc', u'Mayne Pharma Pty Ltd', u'NanoOncology', u'Dare Bioscience Inc']), u'Poxvirusinfection': set([u'Santalis Healthcare Corporation', u'Texas Emerging Technology Fund', u'Sanofi Pasteur', u'Rega Institute for Medical Research', u'National Institute of Allergy and Infectious Diseases', u'Universit\\xe9 De Strasbourg', u'Southern Research Institute', u'GlaxoSmithKline plc', u'Oxford BioMedica plc', u'US Health and Human Services Department', u'Valneva SE', u'Bavarian Nordic A/S', u'Emergent BioSolutions Inc', u'TFS Corp', u'N & N Scientific Inc', u'Universite De Reims Champagne Ardenne', u'Sanofi', u'Abgenix Inc', u'Isotechnika Pharma Inc', u'US Army Medical Research Institute of Infectious Diseases', u'Epimmune Inc', u'UFR Sciences Pharmaceuticals', u'Pharmacia & Upjohn Co', u'AstraZeneca plc', u'SIGA Technologies Inc', u'Gilead Sciences Inc', u'Czech Academy of Sciences', u'Chimerix Inc']), u'ALamyloidosis': set([u'Dr Rentschler Biotechnologie GmbH', u'Prothena Corp plc', u'National Cancer Institute', u'Patheon Inc', u'Food and Drug Administration', u'Caelum Biosciences Inc', u'AmorChem LP', u'BELLUS Health Inc', u'Columbia University']), u'Microalbuminuria': set([u'Sankyo Co Ltd', u'The Menarini Group', u'Sankyo Pharma Inc', u'Ranbaxy Laboratories Ltd', u'Recordati SpA', u'Daiichi Sankyo Co Ltd', u'Forest Laboratories Inc', u'GlaxoSmithKline plc']), u'Aorticvalvestenosis': set([u'Mayo Clinic Foundation', u'Cerenis Therapeutics SA', u'Cranford Pharmaceuticals LLC', u'ANI Pharmaceuticals Inc', u'Sanofi', u'Montreal Heart Institute']), u'Agitation': set([u'Cures Within Reach', u'Biovail Laboratories International Srl', u\"Alzheimer's Drug Discovery Foundation\", u'Ferrer Internacional SA', u'Alexza Pharmaceuticals Inc', u'ACADIA Pharmaceuticals Inc', u'University of California San Diego', u'Medivir AB', u'Siegfried Holding Ltd', u'Sunnybrook Health Sciences Centre', u'Teva Pharmaceuticals USA Inc', u'National Institute on Aging']), u'Hepatobiliarydisease': set([u'Cytokinetics Inc', u'Perrigo Co Ltd', u'4D Molecular Therapeutics LLC', u'Dicerna Pharmaceuticals Inc', u'Orphan Europe SARL', u'Cumberland Pharmaceuticals Inc', u'ASKA Pharmaceutical Co Ltd', u'Emerge Health Pty Ltd', u'Alfa Wassermann SpA', u'Solana Therapeutics Inc', u'Interferon Sciences Inc', u'Ionis Pharmaceuticals Inc', u'Synpromics Ltd', u'Sanofi', u'Therapix Biosciences Ltd', u'uniQure BV', u'KineMed Inc', u'La Jolla Pharmaceutical Co', u'Arbutus Biopharma Corp', u'Kyorin Pharmaceutical Co Ltd', u'Vesta Therapeutics Inc', u'Grifols Inc', u'Axcella Health Inc', u'Gentium SpA', u'R-Pharm', u'Swedish Orphan Biovitrum AB', u'Ranbaxy Pharmaceuticals Inc', u'IPCA Laboratories Ltd', u'Crucell NV', u'AstraZeneca plc', u'Biologix FZ Co', u'PharmaSwiss SA', u'Cytonet LLC', u'Gen Ilac', u'Alnylam Pharmaceuticals Inc', u'AMAG Pharmaceuticals Inc', u'Link Pharmaceuticals Ltd', u'H Lundbeck A/S', u'Guerbet', u'Nanjing BioSciKin Co', u'Lumena Pharmaceuticals']), u'Mycoplasmainfection': set([u'Novexel SA', u'Galderma SA', u'Cepheid', u'Novartis AG', u'Aventis Pharma AG', u'SpeeDx Pty Ltd']), u'Bronchospasm': set([u'Zhejiang Medicine Co Ltd', u'MediciNova Inc']), u'Schizophrenia': set([u'University of Newcastle', u'DKSH Holding Ltd', u'US Government', u'Novo Nordisk A/S', u'Solvay SA', u'Turing Pharmaceuticals LLC', u'Galenica AG', u'AOP Orphan Pharmaceuticals AG', u'DarPharma Inc', u'Suzhou Vigonvita Life Sciences Co Ltd', u'Max Planck Institut fur Experimentelle Medizin', u'Fudan University', u'Reckitt & Colman plc', u'Envoy Therapeutics Inc', u'Tel Aviv University', u'Breckenridge Pharmaceutical Inc', u'GlaxoSmithKline plc', u'Takeda Pharmaceutical Co Ltd', u'ChemRx Advanced Technologies Inc', u'Tikvah Therapeutics Inc', u'University of Maryland', u'ARYx Therapeutics Inc', u'IBM Watson Health Life Sciences', u'Biotoscana International', u'Cascadian Therapeutics Inc', u'University of Colorado at Denver and Health Sciences Center', u'Potomac Pharma Inc', u'Novartis Pharma AG', u'University of Queensland', u'NewBridge Pharmaceuticals Ltd', u'Scil Technology GmbH', u'Anvyl LLC', u'Hoechst-Roussel Pharmaceuticals Inc', u'European Community', u'Omeros Corp', u'Promentis Pharmaceuticals Inc', u'Domain Therapeutics SA', u'Sigma-Aldrich Corp', u'University of Pennsylvania', u'Lead Discovery Center GmbH', u'Apotex Inc', u'Sumitomo Pharmaceuticals Co Ltd', u'Saniona ApS', u\"People's Government of Jiangsu Province\", u'Cerca Insights Sdn Bhd', u'CeNeS Pharmaceuticals plc', u'MSD OSS BV', u'Azur Pharma Ltd', u'Ajanta Pharma Ltd', u'Mitsubishi Tanabe Pharma Corp', u'University of North Carolina', u'Auritec Pharmaceuticals Inc', u'The National Institute of Mental Health', u'Neurogen Corp', u'Laxdale Ltd', u'Solvay Pharmaceuticals Inc', u'Vrije Universiteit van Amsterdam', u'Celera South San Francisco', u'University of Cambridge', u'Taiho Pharmaceutical Co Ltd', u'Teikoku Seiyaku KK', u'Titan Pharmaceuticals Inc', u'CogState Ltd', u'Shionogi & Co Ltd', u'Catalent Inc', u'Sunovion Pharmaceuticals Inc', u'Concordia University', u'Emory University', u'NeuroSearch A/S', u'CoMentis Inc', u'Transdermal Research Pharm Laboratories LLC', u'University of Florida', u'HLS Therapeutics Inc', u'European Molecular Biology Laboratory', u'Neurocrine Biosciences Inc', u'Centre for Addiction and Mental Health', u'Avineuro Pharmaceuticals Inc', u'Brain Canada', u'Centre for Human Drug Research', u'Universidad del Pais Vasco', u'Meiji Seika Pharma Co Ltd', u'Vanda Pharmaceuticals Inc', u'Impel NeuroPharma', u'Israeli Government', u'Pierrel SpA', u'Amgen Inc', u'Rottapharm Madaus', u'Orion Corporation', u'AviMed Pharmaceuticals', u'National Center for Research Resources', u'Harvard University', u'Daiichi Sankyo Co Ltd', u'Abbott Laboratories', u'Intelligence Advanced Research Projects Activity', u'Endo Pharmaceuticals Solutions Inc', u'EUSA Pharma USA', u'Lynx Therapeutics GmbH', u'Institute for Neurodegenerative Disorders', u'Consejo Superior De Investigaciones Cientificas', u'Marquette University', u'Novartis AG', u'Johns Hopkins University School of Medicine', u'PsychoGenics Inc', u'Scottish Biomedical Ltd', u'Wellcome Trust', u'ACADIA Pharmaceuticals Inc', u'Wyss Institute for Biologically Inspired Engineering', u'Forest Laboratories Inc', u'Fujisawa Pharmaceutical Co Ltd', u'Mount Sinai School of Medicine', u'Vanderbilt University', u'Shanghai Institute of Materia Medica of the Chinese Academy of Sciences', u'Alla Chem LLC', u'Scripps Florida', u'Siegfried Holding Ltd', u'University at Buffalo', u'Massachusetts General Hospital', u'Fluxion Biosciences Inc', u'Boehringer Ingelheim International GmbH', u'McLean Hospital Corp', u'Northeastern University', u'Hager Biosciences LLC', u'Karuna Pharmaceuticals', u'Scarista Ltd', u'University of Manchester', u'BioTie Therapies Corp', u'Avera Pharmaceuticals Inc', u'Gliatech Inc', u'Qrono Inc', u'NeurOp Inc', u'Halimed Pharmaceuticals Inc', u'Janssen Pharmaceutical KK', u'Prestwick Chemical Inc', u'Tetra Discovery Partners LLC', u'MegaPharm Ltd', u'Otsuka Pharmaceutical Co Ltd', u'XCell Science Inc', u'University of Colorado System', u'Jiangsu Nhwa Pharmaceutical Group Co Ltd', u'Janssen Pharmaceutica NV', u'Lifelike Biomatic Inc', u'Florida A & M University', u'Boehringer Ingelheim Corp', u'Sunovion Pharmaceuticals Europe Ltd', u'Genset SA', u'SmithKline Beecham Pharmaceuticals', u'Johns Hopkins University', u'National Center For Advancing Translational Sciences', u'Recordati SpA', u'Sanofi', u'Duke University', u'F Hoffmann-La Roche AG', u'H Lundbeck A/S', u'Lexicon Pharmaceuticals Inc', u'The Bronx Project Inc', u'Denovo Biopharma LLC', u'Dermatrends Inc', u'Alexza Pharmaceuticals Inc', u'Rockefeller University', u'University of Maryland Baltimore County', u'National Institute of Neurological Disorders and Stroke', u'Galenea Corp', u'Genentech Inc', u'Mind-NRG', u'Tego BioSciences Corp', u'Mitsubishi Pharma Corp', u'Osprey Pharmaceutical Co', u'Argolyn Bioscience Inc', u'Johnson & Johnson', u'Delpor Inc', u'National Institute on Drug Abuse', u'NeuroScience Pharmaceuticals Inc', u'Intra-Cellular Therapies Inc', u'Wyeth Pharmaceuticals', u'Ore Pharmaceuticals Inc', u'University of California San Diego', u'The Lieber Institute For Brain Development', u'CHU Sainte Justine', u'Knoll AG', u'VA Boston Healthcare System', u'AgeneBio Inc', u'University of Leige', u'Braeburn Pharmaceuticals Inc', u'Mediti Pharma Inc', u'TheraSci Ltd', u'KYOWA Pharmaceutical Industry Co Ltd', u'Sumitomo Dainippon Pharma Co Ltd', u'Pfizer Inc', u'French Government', u'tesa Labtec GmbH', u'Perlegen Sciences Inc', u'Merck & Co Inc', u'Universidad Autonoma de Madrid', u'APR Applied Pharma Research SA', u'University of Fukui', u'Columbia University', u'Eli Lilly & Co', u'Addex Therapeutics Ltd', u'Queensland Government', u'USpharma Windlas LLC', u'McGill University', u'Pharmacia Corp', u'Handa Pharmaceuticals', u'National Institute of General Medical Sciences', u'Pierre Fabre SA', u'Adamed Group', u'ComGenex Inc', u'Instytut Psychiatrii i Neurologii', u'Granules India Ltd', u'Wisconsin Department of Commerce', u'FORUM Pharmaceuticals Inc', u'Eurand America Inc', u'Minster Pharmaceuticals plc', u'Cognitive Pharmaceuticals Ltd', u'SRI International', u'Institut de Genetique et de Biologie Moleculaire et Cellulaire', u'AstraZeneca plc', u'Esteve', u'Algae Dynamics Corp', u'Universit\\xe9 De Strasbourg', u'Childrens Medical Center Corp', u'The Stanley Medical Research Institute', u'London Genetics Ltd', u'GW Pharmaceuticals plc', u'Allelix Neuroscience Inc', u'deCODE genetics ehf', u'Knoll Ltd', u'Marinus Pharmaceuticals Inc', u'Feinstein Institute for Medical Research', u'Hutchison Whampoa Sinopharm Pharmaceuticals Ltd', u'Ferrer Internacional SA', u'Broad Institute Inc', u'Scotia Holdings plc', u'Beactica AB', u'University of Wales', u'BioLineRx Ltd', u'Daya Drug Discoveries Inc', u'Memory Pharmaceuticals Corp', u'Purdue University', u'UK Government', u'Autifony Therapeutics Ltd', u'Xytis Inc', u'Servier Laboratories (Australia) Pty Ltd', u'Probiomed S.A. de C.V', u'Phebra Pty Ltd', u'Schering-Plough Corp', u'BrainCells Inc', u'Zysis Ltd', u'DevCo Pharmaceuticals Ltd', u'Gedeon Richter Ltd', u'SmithKline Beecham plc', u'Taisho Pharmaceutical Co Ltd', u'Arena Pharmaceuticals Inc', u'Glytech Inc', u'A Carlsson Research AB', u'VistaGen Therapeutics Inc', u'Genizon BioSciences Inc', u'Taro Pharmaceutical Industries Ltd', u'Molecular Neuroimaging LLC', u'Minerva Neurosciences Inc', u'Ramot at Tel Aviv University Ltd', u'National Institutes of Health', u'ProteoSys AG', u'Teva Pharmaceuticals USA Inc', u'University of Wisconsin-Milwaukee', u'Bristol-Myers Squibb Co', u'Elan Corp plc', u'Takeda Oncology', u'Aequus Pharmaceuticals Inc', u'Kyoto University', u'Parke-Davis & Co', u'Yale University', u'Bukwang Pharmaceutical Co Ltd', u'NPS Allelix Corp', u'Topharman Shanghai Co Ltd', u'Janssen Pharmaceutica BV', u'Roche Holding AG', u'Astellas Pharma Inc', u'Vernalis Research Ltd', u'Biovail Corp', u'Retrophin Inc', u'Technology Strategy Board', u'Russian Academy of Sciences', u'Scripps Research Institute', u'Douglas Pharmaceuticals', u'Avanir Pharmaceuticals Inc', u'Undisclosed', u'NuPathe Inc', u'Targacept Inc', u'BRAINCo Biopharma S.L', u'Institut Pasteur', u'Coronis NeuroSciences', u'Standard Chemical & Pharmaceutical Co Ltd', u'University of Western Ontario', u'Janssen Pharmaceuticals Inc', u'Proximagen Group plc', u'Icagen Inc (pre-merger)', u'Indiana University', u'Trillium Therapeutics Inc', u'Cypress Bioscience Inc', u'Scios Inc', u'Cracow University of Technology', u'Merck KGaA', u'Ministry of Science and Higher Education, Poland', u'Sequana Therapeutics', u'Tripos Inc', u'Soochow University', u'RespireRx Pharmaceuticals Inc', u'CuraGen Corp', u'Solexa Inc', u'Jagiellonian University', u'Merz & Co GmbH', u\"King's College London\"]), u'Medullarythyroidcancer': set([u'Exelixis Inc', u'PDL BioPharma Inc', u'Ipsen', u'Biomedica Life Sciences SA', u'ARIAD Pharmaceuticals Inc', u'Erasmus University Rotterdam', u'National Centre For Scientific Research \"Demokritos\"', u'Incyte Corp', u'Swedish Orphan Biovitrum AB']), u'Progestogendeficiency': set([u'AMAG Pharmaceuticals Inc', u'Juniper Pharmaceuticals Inc', u'Boston University School of Medicine', u'ASCEND Therapeutics Inc']), u'Candidatropicalisinfection': set([u'QIMR Berghofer Medical Research Institute', u'National Health and Medical Research Council']), u'Drugwithdrawalsyndrome': set([u'CHEPLAPHARM Arzneimittel GmbH', u'National Institutes of Health', u'SUNY Downstate Medical Center', u'AstraZeneca plc']), u'Nauseadrug-induced': set([u'Oxford Natural Products', u'Ono Pharmaceutical Co Ltd', u'Merck & Co Inc', u'Sofgen Pharmaceuticals', u'Akorn Inc', u'University of Mississippi']), u'Polycysticliverdisease': set([u'Mayo Clinic Foundation', u'Summa Health System', u'IC-MedTech Inc']), u'Skininfection': set([u'Avita Medical Ltd', u'BioAtla Llc', u'Amgen Inc', u'Luqa Pharmaceuticals', u'Eisai Co Ltd', u'GlaxoSmithKline plc', u'NovaBay Pharmaceuticals Inc', u'Barrier Therapeutics Inc', u'Novartis Consumer Health Inc', u'BMG Pharma LLC', u'Smith & Nephew plc', u'LEO Pharma A/S', u'Mintcare', u'Demegen Inc', u'Galderma SA', u'Angelini Pharmaceuticals SpA', u'Cutanea Life Sciences Inc', u'Durata Therapeutics Inc', u'Helix BioMedix Inc', u'Carrus Capital Corp', u'Shire plc', u'Halozyme Therapeutics Inc', u'SK Chemicals Life Science', u'Almirall Prodesfarma SA', u'AstraZeneca plc', u'Pfizer Inc', u'Sanofi', u'Ferrer Internacional SA', u'Ilsung Pharmaceutical Co Ltd', u'Pacgen Life Science Corp', u'Piramal Enterprises Ltd', u'Warner Chilcott plc', u'Neopharm Ltd']), u'Periventricularleukomalacia': set([u'JS Genetics Inc', u'National Institute of Neurological Disorders and Stroke']), u'Gastrointestinalulcer': set([u'Allergan Inc', u'ALTANA AG', u'Bayer AG', u'Winston Pharmaceuticals LLC', u'Antibe Therapeutics Inc', u'Laboratories Acbel SA']), u'Spinalinjury': set([u'Cook Medical Inc', u'Stryker Corp', u'TFS AB', u'Spinologics Inc', u'Axerion Therapeutics Inc', u'SonoSpine LLC', u'Titan Spine Llc', u'National Institutes of Health', u'Oxford Performance Materials Inc', u'Rosalind Franklin University of Medicine & Science', u'RTI Surgical Inc', u'Eos Imaging', u'Institute for Applied Neurosciences', u'Medtronic plc', u'University of Bonn', u'Izi Medical Products Llc', u'Shandong Weigao Group Medical Polymer Co Ltd', u'Celling Biosciences LLC', u'Implanet', u'Safe Wire Holding Llc', u'Amedica Corp', u'MBA Inc SL', u'Mazor Surgical Technologies Ltd', u'Misonix Inc', u'Amendia Inc', u'National Center For Advancing Translational Sciences']), u'PeutzJeghersyndrome': set([u\"Brigham & Women's Hospital\", u'National Cancer Institute']), u'Membranousglomerulonephritis': set([u'Sanofi Genzyme', u'Alnylam Pharmaceuticals Inc']), u'Myeloidleukemia': set([u'Fujifilm Diosynth Biotechnologies', u'CCL Pharmaceuticals', u'Chugai Pharmaceutical Co Ltd', u'National Cancer Institute', u'Novartis AG', u'University of Pittsburgh', u'Hoffmann-La Roche AG', u'Hoffmann-La Roche Inc', u'Interferon Sciences Inc', u'Sumitomo Dainippon Pharma Co Ltd', u'Koken Co Ltd', u'IDIS Ltd', u'Merck & Co Inc', u'Aventis SA', u'Abbott Laboratories', u'Genta Inc', u'rEVO Biologics Inc', u'Maxim Pharmaceuticals Inc', u'Hualida Biotech']), u'Paraplegia': set([u'University of Pennsylvania', u'Neuralstem Inc']), u'Minimalchangedisease': set([u'Imperial College London', u'Achillion Pharmaceuticals Inc', u'Kissei Pharmaceutical Co Ltd', u'Vifor Pharma']), u'Immunethrombocytopenicpurpura': set([u'Symphogen A/S', u'Protalex Inc', u'Rockefeller University', u'AstraZeneca plc', u'SuppreMol GmbH', u'Immunomedics Inc', u'US Government', u'Food and Drug Administration', u'OncBioMune Mexico SA de CV', u'Rigel Pharmaceuticals Inc', u'Takeda GmbH', u'Swedish Orphan Biovitrum AB', u'Aviragen Therapeutics Inc', u'Cangene Corp', u'German Federal Ministry of Education and Research', u'Kamada Ltd', u'Ligand Pharmaceuticals Inc']), u'Woundhealing': set([u'Innovacyn Inc', u'US Health and Human Services Department', u'TRM Korea', u'ProDerm Limited Partnership', u'Hackensack University Medical Center', u'OPK Biotech', u'Oclassen Pharmaceuticals Inc', u'SomaGenics Inc', u'University of Rochester', u'Hospira Inc', u'Morulaa HealthTech', u'General Research Laboratory Inc', u'Microbio Co Ltd', u'Audax Medical Inc', u'Taiwan Major Chemical & Pharmaceutical Corp', u'Biophage Pharma Inc', u'Curative Health Services', u'National Research Council of Canada', u'New York University', u'Israeli Government', u'Kaken Pharmaceutical Co Ltd', u'Rega Institute for Medical Research', u'Zeria Pharmaceutical Co Ltd', u'Compass Biomedical', u'Agile Sciences Inc', u'Aoti Inc', u'Barrier Therapeutics Inc', u'Caladrius Biosciences Inc', u'Vanderbilt University', u'Boston University School of Medicine', u'Hanmi Pharmaceutical Co Ltd', u'Solvay Pharmaceuticals Inc', u'Mintcare', u'Quintiles Transnational Corp', u'CytoSolv Inc', u'Nuvo Pharmaceuticals Inc', u'Olympus Corp', u'Agenta Biotechnologies Inc', u'Crosslink Genetics Corp', u'INDEE Medical', u'PolyNovo Ltd', u'Recalcine Pharmaceutical Corp', u'Nestle SA', u'GliaMed Inc', u'Biorex Research and Development Co', u'Bacterin International Inc', u'FunPep Co Ltd', u'Forticell Bioscience', u'Fidia Advanced Biopolymers SrL', u'Almalco', u'Sinopharm', u'Chi Sheng Chemical Corp', u'Napa Biosciences Inc', u'Daewoong Pharmaceutical Co Ltd', u'Worcester Polytechnic Institute', u'Nanotherapeutics Inc', u'Factor Therapeutics Ltd', u'APR Applied Pharma Research SA', u'Eli Lilly & Co', u'Sarasota Medical Products Inc', u'University of Wisconsin-Madison', u'Waisman Clinical Biomanufacturing Facility', u'Bioatrix Pty Ltd', u'Ophtimed Instrument', u'University of Edinburgh', u'GlycoBioSciences Inc', u'Johns Hopkins University', u'Vatea Fund', u'US Biotest Inc', u'Novan Inc', u'Mipharm SpA', u'CogENT Therapeutics LLC', u'Nano3D Biosciences, Inc', u'Kinetic Concepts Inc', u'Abazali Bio Ventures', u'SmithKline Beecham plc', u'Taisho Pharmaceutical Co Ltd', u'TAP Biosystems', u'Lifecore Biomedical Inc', u'Walter Reed Army Institute of Research', u'Renovo Group plc', u'Endovasc Inc', u'AmDerma Pharmaceuticals', u'Pontificia Universidad Catolica De Chile', u'University of London', u'Integra LifeSciences Holdings Corp', u'Obagi System', u'Archimedes Pharma Ltd', u'Cardio Derma Clinical Partners', u'W R Grace & Co', u'Lotus Tissue Repair Inc', u'Meda AB', u'ChronTech Pharma AB', u'Transwell Biotech Co., Ltd', u'Advanced Medical Solutions Ltd', u'Avita Medical Ltd', u'Ipsen Biopharmaceuticals Inc', u'Regeneron Pharmaceuticals Inc', u'Angiotech Pharmaceuticals Inc', u'Knoll Pharmaceuticals Co', u'BTG plc', u'Universitat Ulm', u'Chiron Corp', u'Arizona State University', u'Genentech Inc', u'The GI Company Inc', u'Absorption Systems Group Llc', u'Molnlycke Health Care AB', u'Acrux Ltd', u'Shire plc', u'Mitsubishi Tanabe Pharma Corp', u'DelSiTech Ltd', u'GSK Consumer Healthcare Schweiz AG', u'Tenax Therapeutics Inc', u'Biopure Corp', u'RenovaCare Inc', u'Orient Europharma', u'Inflabloc Pharmaceuticals Inc', u'National Institute of General Medical Sciences', u'Hemcon Inc', u'Amerinet Inc', u'E-QURE', u'Organogenesis Inc', u'Maruho Co Ltd', u'ULURU Inc', u\"Women's Dermatologic Society\", u'Diosynth Inc', u'University of Bristol', u'New Life Scientific Inc', u'Amniox Medical', u'Massachusetts General Hospital', u'Medical Research Council', u'msm medical gmbh', u'Biora Ab', u'American Registry of Pathology', u'North Florida/South Georgia Veterans Health System', u'United States Army Institute of Surgical Research', u'CorMedix Inc', u'National Tissue Engineering Center', u'Alvogen Inc', u'Wake Forest University', u'iFyber Llc', u'Ark Therapeutics Group plc', u'WaferGen Biosystems Inc', u'Duke University', u'Medline Industries Inc', u'Stanford University', u'Eurogentec SA', u'Benesis Corp', u'Hi-Tech Pharmacal Co Inc', u'Eden Biodesign Ltd', u'HansMeical Company Ltd', u'Roji Ltd', u'Sinclair Pharma plc', u'Scripps Research Institute', u'Australian Research Council', u'Smith & Nephew plc', u'Theratechnologies Inc', u'University of Southern California', u'Giddi Pharma Co Ltd', u'University of Texas Southwestern Medical Center', u'La Jolla Pharmaceutical Co', u'MEDICAL Z', u'Advanced Bio-Technologies Inc', u'AEterna Zentaris Inc', u'AstraZeneca plc', u'Technology Strategy Board', u'Research Center for Medical Polymers and Biomaterials', u'Intercytex Ltd', u'Sonoma Pharmaceuticals Inc', u'Berlin-Brandenburg Center for Regenerative Therapies', u'Topical Therapeutic Agent Ltd', u'Carrington Laboratories Inc', u'Sirnaomics Inc', u'Australian Government', u'CSL Behring LLC', u'Globe Laboratories Inc', u'King Pharmaceuticals Inc', u'AndroScience Corp', u'Arizona Burn Center', u'University of Dundee', u'Slater Technology Fund', u'PharmaResearch Products Co Ltd', u'Ministry of Health Saudi Arabia', u'National Science Foundation', u'CoDa Therapeutics Inc (US)', u'AlloSource', u'Collplant Ltd', u'SBH Sciences', u'Valeant Pharmaceuticals International Inc', u'National Institute of Biomedical Imaging and Bioengineering', u'Karyopharm Therapeutics Inc', u'Alliqua BioMedical Inc', u'Protelica Inc', u'NephRx Corp', u'SironRX Therapeutics Inc', u'Alat Medika Indonesia', u'Biologix FZ Co', u'University of Toronto', u'Zen-Bio Inc', u'Avipero Ltd', u'ESI BIO', u'SANUWAVE Health Inc', u'Texas Emerging Technology Fund', u'University of Florida', u'Silence Therapeutics plc', u'Torii Pharmaceutical Co Ltd', u'Microbion Corp', u'NovaBay Pharmaceuticals Inc', u'Aghraas-Cigalah', u'Moberg Pharma AB', u'Vomaris Wound Care Inc', u'OSI Pharmaceuticals Inc', u'BSN Medical Inc', u'Fred Hutchinson Cancer Research Center', u'NuvOx Pharma LLC', u'Defiante Farmaceutica Lda', u'Newsummit Biopharma Co Ltd', u'TFS Corp', u'Valitor Inc', u'Azopharma Inc', u'Astellas Pharma Europe BV', u'CTS Chemical Industries', u'Kiadis Pharma Netherlands BV', u'Hikma Pharmaceuticals plc', u'Zydus Cadila Healthcare Ltd', u'ProThera Biologics LLC', u'Angel Biotechnology Holdings plc', u'Queensland University of Technology', u'Michigan Economic Development Corp', u'ZymoGenetics Inc', u'DFB Pharmaceuticals Inc', u'Guangzhou Xiangxue Pharmaceutical Co Ltd', u'Taiga Biotechnologies Inc', u'Keneric Healthcare', u'GHD GesundHeits GmbH', u'Fusion Antibodies Ltd', u'Roger Williams Medical Center', u'CFR Pharmaceuticals SA', u'Amneal Pharmaceutical LLC', u'Santalis Healthcare Corporation', u'University of Melbourne', u'Juventas Therapeutics Inc', u'University of Sydney', u'CardioVascular BioTherapeutics Inc', u'G-treeBNT Co Ltd', u'Washburn Therapeutics Inc', u'Intralytix Inc', u'National Institute of Diabetes, Digestive and Kidney Diseases', u'Histogen Inc', u'Cangene Corp', u'Oxford BioMedica plc', u'Hospital for Sick Children', u'Humeca', u'PPL Therapeutics plc', u'Capstone Therapeutics Corp', u'US Army Medical Research and Materiel Command', u'Synedgen Inc', u'Auxagen Inc', u'Covalon Technologies Ltd', u'Montana Department of Commerce', u'Sanofi', u'Bayer AG', u'University Of Huddersfield', u'Kuros Biosurgery AG', u'University of Zagreb', u'BioSeek Plc', u'Anhui Anke Biotechnology (Group) Co Ltd', u'Luna Innovations Inc', u'Walter Reed Army Medical Center', u'Sofregen Medical Inc', u'International Stem Cell Corp', u'Gemstone Biotherapeutics', u'LifeCell Corp', u'EGIS Gyogyszergyar RT', u'CollaGenex Pharmaceuticals Inc', u'Bachem Holding AG', u'Nuo Therapeutics Inc', u'Massachusetts Institute of Technology', u'Chrysalis BioTechnology Inc', u'Smith & Nephew Biotherapeutics', u'Lonza Group AG', u'Elis Pharmaceuticals Ltd', u'Advanced Tissue', u'Elanix Biotechnologies SA', u'IBEX Technologies Inc', u'MGI Pharma Inc', u'Glycotex Inc', u'Novolytics Ltd', u'CellTran Ltd', u'Transition Therapeutics Inc', u'Ranbaxy Laboratories Ltd', u'Avanir Pharmaceuticals Inc', u'Janssen Pharmaceuticals Inc', u'Vifor Consumer Health Ltd', u'Linkoping University', u'Acelity LP Inc', u'University of Medicine and Dentistry of New Jersey', u'US Government', u'BioMarin Pharmaceutical Inc', u'Asahi Kasei Corp', u'Baxter International Inc', u'Ancor Capital Partners', u'China State Institute of Pharmaceutical Industry', u'GTM-V gGmbH', u'Genedrive plc', u'UMeWorld Ltd', u'ProMetic Life Sciences Inc', u'Cell Genesys Inc', u'Bayer Schering Pharma AG', u'Hyseq Inc', u'National Pharmaceuticals Corp', u'Taxus Cardium Pharmaceuticals Group', u'Clinipace', u'Bio3 Research Srl', u'Riso Pharma Tech', u'Kringle Pharma Inc', u'Ortop\\xe9dicos Futuro', u'Abbott Healthcare Products BV', u'PYRAMID Laboratories, Inc', u'CarboMed Inc', u'Lipopeptide AB', u'Derma Life Clinical Partners LP', u'Arch Therapeutics', u'Shionogi & Co Ltd', u'US Department of Defense', u'York Pharma plc', u'National Institute of Arthritis and Musculoskeletal and Skin Diseases', u'Pioneer Surgical Orthobiologics', u'Stratatech Corp', u'Angelini Pharma Inc', u'Abbott Laboratories', u'Derma Sciences Inc', u'Goldfarb Corporation', u'Jiangxi Aiqilin Pharmaceuticals Group', u'National Cancer Institute', u'Novartis AG', u'Merck KGaA', u'ACell Inc', u'Scarless Laboratories Inc', u'University of Maryland', u'Panorama Research Inc', u'Monash University', u'Haisco Pharmaceutical Group Co Ltd', u'Southmedic Inc', u'University of Manchester', u'Sankara Nethralaya', u'BioSpecifics Technologies Corp', u'University of Texas System', u'Sunnybrook Health Sciences Centre', u'Montana State University', u'BioPhage Therapeutics Ltd', u'Ferrer Internacional SA', u'ProCyte Corp', u'Jadran Galenski laboratorij', u'Misonix Inc', u'UDL Laboratories Inc', u'Undisclosed', u'Fibercell Systems Inc', u'Kerecis Ehf', u'Primus Pharmaceuticals Inc', u'Journey Medical Corp', u'Clinquest Group', u'Allergan plc', u'Devro plc', u'ImmuneRegen BioSciences Inc', u'Merck & Co Inc', u'Regenicin Inc', u'US Naval Medical Research Center', u'PLIVA dd', u'Rademacher Group Ltd', u'Kyowa Hakko Kirin Co Ltd', u'Prestige Brands Holdings Inc', u'RegeneRx Biopharmaceuticals Inc', u'Kissei Pharmaceutical Co Ltd', u'Enox Biopharma Inc', u'Arriva Pharmaceuticals Inc', u'Tech-Medica Equipos Medicos SAS', u'Pfizer Inc', u'Marinova Pty Ltd', u'Norwegian Research Council', u'Seattle Life Sciences', u'O2 RegenTech LLC', u'Trim-edicine Inc', u'Living Cell Technologies Ltd', u'Haemacure Corp', u'Northeastern University', u'Sandoz Inc', u'MediWound Ltd', u'Apricus Biosciences Inc', u'University of Gothenburg', u'National Shanghai Center for Drug Safety Evaluation and Research (NCDSER)', u'AVACEN Medical', u'AlgiPharma AS', u'Phoenicia Biosciences Inc', u'National Institute of Allergy and Infectious Diseases', u'Omnio Healer AB', u'ATG Allied Technologies', u'MPI Research', u'Albert Einstein College of Medicine', u'Development Center for Biotechnology', u'National Institutes of Health', u'Boryung Pharm Co Ltd', u'Food and Drug Administration', u'Sanford-Burnham Medical Research Institute', u'Scios Inc', u'Tissue Regenix Group Plc', u'Cardiff University', u'Advanced Tissue Sciences Inc', u'Aridis Pharmaceuticals Inc', u'TNO', u'The Green Cross Corp', u'Exsal Ltda', u'Entellus Medical Inc', u'Biocure Inc', u'Nycomed Inc', u'BASF AG']), u'Ewingsarcoma': set([u'Tube Pharmaceuticals GmbH', u'Van Andel Institute', u'University of Missouri', u'OntoChem GmbH', u'Veristat, Inc.', u'Schering-Plough Corp', u'Leo Pharmaceuticals', u'Gradalis Inc', u'National Cancer Institute', u'Advanced Accelerator Applications SA', u\"St Jude Children's Research Hospital\", u'National Institutes of Health', u'TDP Biotechnology LLC', u'NanoSmart Pharmaceuticals Inc', u\"Children's Oncology Group\", u'Georgetown University', u'Poniard Pharmaceuticals Inc', u'Merck & Co Inc', u'CryoPort Inc', u'WuXi PharmaTech (Cayman) Inc', u\"Children's Hospital of Los Angeles\", u'Cytheris SA', u'Lombardi Comprehensive Cancer Center at Georgetown University Hospital', u'Millennium Pharmaceuticals Ltd', u'University of Iowa', u'TESARO Inc', u'The Dow Chemical Co', u'University Hospital Halle', u'NantCell Inc', u'Dana-Farber Cancer Institute Inc', u'PPD Discovery Inc', u'Nanovalent Pharmaceuticals Inc', u'Mount Sinai Medical Center']), u'Hormonemetabolismdisorder': set([u'SCYNEXIS Inc', u'GlaxoSmithKline plc']), u'Exophthalmos': set([u'NovaMedica', u'Neothetics Inc']), u'Hypophosphatasia': set([u'Handok Inc', u'ICON plc', u'Novartis AG', u'Enobia Pharma Inc', u'Food and Drug Administration', u'Mereo BioPharma Group Ltd', u'Vanderbilt University', u'University of Georgia', u'Alexion Pharmaceuticals Inc', u'MorphoSys AG', u'Ohio State University', u'Soft Bones Inc']), u'Cardiovascularinflammation': set([u'VIA Pharmaceuticals Inc', u'NovelMed Therapeutics Inc', u'Cardax Pharmaceuticals Inc', u'National Heart Lung and Blood Institute', u'Genome Quebec', u'Abbott Laboratories', u'BASF AG']), u'FragileX-associatedtremorataxiasyndrome': set([u'Scripps Florida', u'National Institute of Neurological Disorders and Stroke']), u'Diabeticeyedisease': set([u'Shenzhen Relin Medicine', u'ThromboGenics NV', u'Jenesis Biosciences LLC', u'MingSight Pharmaceuticals', u'Galapagos NV', u'BioInvent International AB', u'Eleven Biotherapeutics Inc', u'National Eye Institute', u'Cedars-Sinai Medical Center', u'Joslin Diabetes Center Inc']), u'Uterustumor': set([u'Daiichi Seiyaku Co Ltd', u'University of Medicine and Dentistry of New Jersey', u'Octamer Inc', u'BiPar Sciences Inc', u'Chugai Pharmaceutical Co Ltd', u'Almirall Prodesfarma SA', u'AstraZeneca plc', u'3M Pharmaceuticals', u'Genentech Inc', u'Syntrix Biosystems Inc', u'Yakult Honsha Co Ltd', u'Mylan Inc', u'3M Co', u'University of Minnesota', u'TerSera Therapeutics', u'Kobold Medical', u'Coley Pharmaceutical Group Inc', u'Elekta AB', u'Gradalis Inc', u'Sanofi', u'Pharmacia Corp']), u'Erythromelalgia': set([u'Pfizer Inc', u'Icagen Inc (pre-merger)', u'Yale School of Medicine']), u'AdultT-celllymphoma': set([u'Takara Bio Inc', u'Hayashibara Co Ltd', u'University of Tokyo', u'Japanese National Cancer Center', u'Otsuka Pharmaceutical Co Ltd', u'Daiichi Sankyo Co Ltd']), u'Vacciniavirusinfection': set([u'PharmaJet Inc', u'Stanford University', u'National Center for Research Resources', u'CEL-SCI Corp', u'National Institute of Allergy and Infectious Diseases', u'US Army Medical Research Institute of Infectious Diseases']), u'Respiratorycongestion': set([u'SS Pharmaceutical - ethical drug division', u'GlaxoSmithKline plc', u'HanAll Biopharma Co Ltd', u'Hisamitsu Pharmaceutical Co Inc', u'AstraZeneca plc']), u'Embolismandthrombosis': set([u'InspireMD Inc', u'be Medical', u'Comesa Gmbh']), u'Methemoglobinemia': set([u'Dr Franz Kohler Chemie GmbH', u'Provepharm SAS']), u'Mycobacteriuminfection': set([u'Transave Inc', u'Quest Diagnostics Inc', u'Health Protection Agency', u'Tramedico International', u'Centre for Digestive Diseases', u'Prague Clinical Services', u'Universita Cattolica del Sacro Cuore', u'Silence Therapeutics plc', u'e-Therapeutics Plc', u'Cystic Fibrosis Foundation Therapeutics Inc', u'National Institute of Allergy and Infectious Diseases', u'US Government', u'SmithKline Beecham plc', u'Forest Laboratories Inc', u'Aradigm Corp', u'RedHill Biopharma Ltd', u'Sequella Inc', u'Sakai Chemical Industry Co Ltd', u'GeneThera Inc', u'Ajinomoto Althea Inc', u'Onyvax Ltd', u'YM BioSciences Inc', u'Universita degli Studi di Roma La Sapienza', u'Pharmacia Corp', u'Roche Diagnostics', u'Matinas BioPharma Inc', u'Insmed Inc', u'Pharmacia & Upjohn AB', u'Crestone Inc', u'Giaconda Ltd', u'Stanford Rook Ltd', u'Corixa Corp', u'National Institute of General Medical Sciences', u'Universidad Nacional Autonoma De Mexico', u'Orphan Australia', u'Oregon State University']), u'Alzheimersdisease': set([u'NovAliX', u'Gismo Therapeutics Inc', u'Panacea Pharmaceuticals Inc', u'Renishaw plc', u'Jiangzhong Pharmaceutical Co Ltd', u'NeuroSolutions Ltd', u'Care Camp Inc', u'BBB Therapeutics BV', u'R J Reynolds Tobacco Co', u'B&C Biopharm', u'Nagasaki University', u'Novartis Institutes for BioMedical Research Inc', u'RadNet Inc', u'Neurobiological Technologies Inc', u'Pain Therapeutics Inc', u'Buck Institute', u'XCell Science Inc', u'Warner-Lambert Co', u'Genome British Columbia', u'Inovio Pharmaceuticals Inc', u'Biotecnol SA', u'Transdermal Delivery Solutions Corp', u'CoCo Therapeutics Ltd', u'MethylGene Inc', u'Ionis Pharmaceuticals Inc', u'Georgetown University Medical Center', u'VU University Medical Center', u'European Community', u'MonoSol Rx Inc', u'University of South Florida', u'Snow Brand Milk Products Co Ltd', u'Adlyfe Inc', u'Hong Kong University of Science & Technology', u'Sigma-Aldrich Corp', u'University of Leipzig', u'University of Arizona', u'Carna Biosciences Inc', u'Sumitomo Pharmaceuticals Co Ltd', u'Shiga University of Medical Science', u'Resverlogix Corp', u'Alla Chem LLC', u'University of California Los Angeles', u'Universidad de Zaragoza', u'Galapagos NV', u'Caprion Biosciences Inc', u'Relevare Pharmaceuticals Ltd', u'Zhejiang Xianju Pharmaceutical Corp Ltd', u'McLaughlin Research Institute', u'Rudman Foundation', u'Orion Corporation', u'Banner Sun Health Research Institute', u'NeuroSpheres Ltd', u'Catalent Inc', u'AutoImmune Inc', u'University of Lille', u'Tanabe Seiyaku Co Ltd', u'NeuroSearch A/S', u'Glasgow University', u'Imago Pharmaceuticals Inc', u'Capo Therapeutics Inc', u'Aquapharm Biodiscovery Ltd', u'Yantai University', u'National Research Council of Canada', u'European Commission', u'BioAdvance', u'MGI GP Inc', u'New York University', u'PDL BioPharma Inc', u'Muses Labs Inc', u'Ranbaxy Laboratories Ltd', u'Universitat Autonoma de Barcelona', u'Longeveron LLC', u'University of California San Francisco', u'Eli Lilly Japan KK', u'Institut National Des Sciences Appliquees de Rouen (INSA)', u'Tel Aviv University', u'Cambridge Antibody Technology Group plc', u'Nitto Denko Corp', u'Nippon Kayaku Co Ltd', u'Zeria Pharmaceutical Co Ltd', u'Worldwide Clinical Trials', u'Abmaxis Inc', u'U-Protein Express Bv', u'Essex Bio-Technology Ltd', u'Universite du Droit et de la Sante de Lille II', u'Oryzon Genomics SA', u'Devgen NV', u'Nanjing University of Chinese Medicine', u'Wellcome Trust', u'Linda Crnic Institute for Down Syndrome', u'Curaxis Pharmaceutical Corp', u'Nymox Pharmaceutical Corp', u'MV Lomonosov Moscow State University', u'Cantab Biopharmaceuticals Ltd', u'Siemens Medical Systems Inc', u'Boston University School of Medicine', u'Clino Corp', u'St Vincents Hospital (Melbourne) Ltd', u'Siegfried Holding Ltd', u'University of Gottingen', u'Neuron Bio SA', u'Alzhyme Pty Ltd', u'BioSystems International SAS', u'Digital Biotech Co Ltd', u'Gladstone Institute of Neurological Disease', u'Newron Pharmaceuticals SpA', u'Friedrich Schiller University of Jena', u'Karuna Pharmaceuticals', u'Ceregene Inc', u'National Center Of Neurology & Psychiatry', u'Taisho Pharmaceutical Co Ltd', u'Janssen Pharmaceutical KK', u'Probiodrug AG', u'QR Pharma Inc', u'Lumos Labs', u'Gliatech Inc', u'Austin Health', u'NeuroNascent Inc', u'RayBiotech Inc', u'Mitsubishi-Tokyo Pharmaceuticals Inc', u'Universitat Pompeu Fabra', u'Janssen Pharmaceutica NV', u'Lifelike Biomatic Inc', u'Cortice Biosciences Inc', u'ESBATech AG', u'NeurOp Inc', u'James J. Peters VA Medical Center', u'Cambridge Isotope Laboratories Inc', u'Kinexis Inc', u'Neuro-Hitech Inc', u'Archer Pharmaceuticals Inc', u'Qaam Pharmaceuticals LLC', u'Genfit SA', u'Rutgers University', u'Mitochon Pharmaceuticals', u'Medtronic Inc', u'Stellar Biotechnologies Inc', u'Equis & Zaroo Co Ltd', u'Yamanouchi Pharmaceutical Co Ltd', u'C2N Diagnostics', u'Ludwig-Maximilians University of Munich', u'AnC Bio Group', u'Crc For Mental Health Ltd', u'LifeLabs Medical Laboratory Services', u'SIRENADE Pharmaceuticals AG', u'Picower Institute for Medical Research', u'University of Texas System', u'ReXceptor Inc', u'The Gladstone Institute of Cardiovascular Disease', u'Oligomerix Inc', u'Mylan Pharmaceuticals Inc', u'Argonne National Laboratory', u'Sentinel Oncology Ltd', u'Forenap Pharma', u'BioFarmind', u'Protea Biosciences Inc', u'Uppsala University', u'Emergent BioSolutions Inc', u'Sumitomo Heavy Industries Ltd', u'Daewoong Pharmaceutical Co Ltd', u'Ewha Womans University', u'Nanotherapeutics Inc', u'LEO Pharma A/S', u'York Instruments', u'APR Applied Pharma Research SA', u'Eli Lilly & Co', u'GlaxoSmithKline Biologicals', u'Amydis Diagnostics', u'ID Pharma Co Ltd', u'DNage BV', u'WE Biosciences Llc', u'McGill University', u'CSL Ltd', u'reMYND NV', u'Teijin Pharma Ltd', u'Weizmann Institute of Science', u'Monash University', u'AC Immune SA', u'NsGene A/S', u'Horizon Orphan LLC', u\"Alzheimer's Association\", u'Alzheon Inc', u'ISOLOGIC Innovative Radiopharmaceuticals', u'FDS Pharma', u'Sunesis Pharmaceuticals Inc', u'EIP Pharma LLC', u'National Institute on Aging', u'Exelgen Ltd', u'IBL international GmbH', u'National Taiwan University', u'Abide Therapeutics Inc', u'ADispell Inc', u'ALZYN', u'Center for Applied Medical Research', u'Johns Hopkins University', u'Mapp Biopharmaceutical Inc', u'Beactica AB', u'Johnson & Johnson', u'Coley Pharmaceutical Group Inc', u'Merrion Pharmaceuticals Inc', u'China Pharmaceutical University', u'Universite Victor Segalen Bordeaux 2', u'Raphas Co Ltd', u'Boston Biomedical Research Inst', u'AbbVie Inc', u'Mercachem Holding BV', u\"Wisconsin Alzheimer's Disease Research Center\", u'Siemens Healthcare GmbH', u'Synaging', u'University of Washington', u'BrainLAB Inc', u'Rodin Therapeutics Inc', u'Metabolon Inc', u'JSW-Research Forschungslabor Gmbh', u'BELLUS Health Inc', u'University of California San Diego', u'SmithKline Beecham plc', u'Sun Health Research Institute', u'Snowdon Inc', u'Neurotrope BioScience Inc', u\"Alzheimer's Disease Cooperative Study\", u'University of Texas Southwestern Medical Center', u'Northwestern University', u'Pharnext SAS', u'Takeda Pharmaceutical Co Ltd', u'Nestle Health Science', u'University of Pittsburgh', u'NeuroQuest Ltd', u'Anavex Life Sciences Corp', u'Crossbeta Biosciences BV', u'Bristol-Myers Squibb Co', u'PeopleBio Inc', u'Life Science Research Israel', u'OSEO', u'Pharmacopeia Inc', u'Rush University Medical Center', u'Chinese Academy of Sciences', u'Janssen Research & Development LLC', u'Dr Rentschler Biotechnologie GmbH', u'Laboratorios Indas SA', u'Good Biomarker Sciences Bv', u'Astellas Pharma Inc', u'Daiichi Fine Chemicals Co Ltt', u'Hospital de Sant Pau', u'Amylon LLC', u'Genizon BioSciences Inc', u'Rhone-Poulenc SA', u'Premier Biomedical Inc', u'Universite Denis Diderot', u'Hebrew University of Jerusalem', u'SS Pharmaceutical Co Ltd', u'Simon Fraser University', u'Pre Diagnostics AS', u'GenOmind LLC', u'Hoechst Marion Roussel Inc', u'National Institute for Biological Standards and Control', u'University of Tasmania', u'Power3 Medical Products Inc', u'Siemens Medical Solutions Molecular Imaging', u'Palo Alto Institute for Research & Education, Inc', u'Altimmune Inc (pre-merger)', u'Banner Health', u'University of Cambridge', u\"King's College London\", u\"Alzheimer's Disease Research Foundation\", u'Karolinska Institutet', u'Weill Medical College of Cornell University', u'Servier', u'Brown University', u'Novo Nordisk A/S', u'Regeneron Pharmaceuticals Inc', u'Herantis Pharma Plc', u\"Alzheimer's Drug Discovery Foundation\", u'SmithKline Beecham Corp', u'Angiotech Pharmaceuticals Inc', u'Opthea Ltd', u'Universidad de Antioquia', u'LamdaGen Llc', u'Siemens AG', u'Neurologic Inc', u'Taiho Pharmaceutical Co Ltd', u'Araclon Biotech Sl', u'SciGenics Inc', u'Axovant Sciences Ltd', u'Rockefeller University', u'Microlin Bio Inc', u\"M's Science Corp\", u'KineMed Inc', u'BTG plc', u'University of Bonn', u'Dementia Consortium', u'Chiesi Farmaceutici SpA', u'Shasun Pharmaceuticals Ltd', u'DURECT Corp', u'National Institute of Neurological Disorders and Stroke', u'DRAXIS Health Inc', u'Fidia Group', u'University Of Southampton', u'Arizona State University', u'Erimos Pharmaceutical LLC', u'Anvyl LLC', u'Chinese Government', u'KU Leuven R&D', u'Walter and Eliza Hall Institute of Medical Research', u'ArQule Inc', u'IsoTis SA', u'Microbot Medical Inc', u'Toyo Jozo Co Ltd', u'Accera Inc', u'University of Pennsylvania', u'Navidea Biopharmaceuticals Inc', u'Aventis SA', u'Amicus Therapeutics Inc', u'Shionogi & Co Ltd', u'Ono Pharmaceutical Co Ltd', u'Garvan Institute of Medical Research', u'Sanochemia Pharmazeutika AG', u'Roche Holding AG', u'Procypra Therapeutics LLC', u'Shire plc', u'University of British Columbia', u'MorphoSys AG', u'Mitsubishi Tanabe Pharma Corp', u'Epigen Biosciences Inc', u'TOLMAR Therapeutics Inc', u'Panaxia Pharmaceutical Industries Ltd', u'The National Institute of Mental Health', u'Sanomune Inc', u'Wren Therapeutics Limited', u'Rosalind Franklin University of Medicine & Science', u'Cerveau Technologies Inc', u'Perrigo Co plc', u'Seoul University', u'Asceneuron SA', u'Selvita SA', u'Teikoku Seiyaku KK', u'Osprey Pharmaceutical Co', u'Elan Pharmaceuticals Inc', u'Catalyst Biosciences Inc', u'Medivators Inc', u'Mayo Clinic Foundation', u'Neurologix Inc', u'Accenture', u'European Molecular Biology Laboratory', u'Avid Radiopharmaceuticals Inc', u'Medical College of Georgia', u'ChemRar High Tech Center', u'Brain Canada', u'Asclepios Bioresearch', u'The European Union', u'Exelixis Inc', u'WhanIn Pharmaceutical Co Ltd', u'Genesis Biopharma', u'Macrogen Inc', u'Diaxonhit', u'Amarantus BioScience Holdings Inc', u'AB Science SA', u'Amgen Inc', u'Oxford GlycoSciences plc', u'Sanofi (pre-1999)', u'Queens University of Belfast', u'EuroTransBio', u'Anagen Therapeutics Inc', u'Endo Pharmaceuticals Solutions Inc', u'EUSA Pharma USA', u'Sinova Inc', u'Geron Corp', u'TauRx Pharmaceuticals Ltd', u'Consejo Superior De Investigaciones Cientificas', u'University of California Merced', u'Solano Pharmaceuticals Inc', u'Johns Hopkins University School of Medicine', u'Seoul National University', u'DiaGenic ASA', u'Neurolab', u'Southern Research Institute', u'Georgetown University', u\"Texas Children's Hospital\", u'BioPharmaceuticals Australia', u'AfaSci Inc', u'Italfarmaco SpA', u'CohBar Inc', u'Signal Research Division', u'Massachusetts General Hospital', u'Medical Research Council', u'eemagine GmbH', u'Polichem SA', u'PN Gerolymatos SA', u'Howard Florey Institute of Experimental Physiology and Medicine', u\"Queen's University at Kingston\", u'Avraham Pharmaceuticals Ltd', u'Medeia Therapeutics Ltd', u'Cytox Ltd', u'Cleveland Clinic Foundation', u'Allon Therapeutics Inc', u\"Cure Alzheimer's Fund\", u'Merck Millipore', u'FluoroPharma Inc', u'Biovail Corp', u'Tetra Discovery Partners LLC', u'Dong-A ST Co Ltd', u'Numoda Corp', u'Bio-Link Australia Pty Ltd', u'SunPharm Corp', u'Astex Therapeutics Ltd', u'Human Metabolome Technologies Inc', u'Allergan Inc', u'RemeGenix Inc', u'Sangamo Therapeutics Inc', u'Lundbeck Research USA Inc', u'Instituto De Medicina Molecular', u'Shandong International Biotechnology Park Development Co Ltd', u'SurroMed Inc', u'Klinge Pharma GmbH', u'AgeneBio Inc', u'Lixte Biotechnology Holdings Inc', u'SeneXta Therapeutics SA', u'Stemedica Cell Technologies Inc', u'Denali Therapeutics Inc', u'F Hoffmann-La Roche AG', u'Fujifilm\\xa0Corp', u'Carthera', u'The Open University', u'Jefferson Corner Group', u'Inflame Therapeutics Inc', u'Warwick University', u'Ohio State University', u'Active Pass Pharmaceuticals Inc', u'Genentech Inc', u'Mind-NRG', u'Yissum Research Development Co', u'NeuroGenetic Pharmaceuticals Inc', u'Andrx Corp', u'Synaptic Dynamics Inc', u'Korea Drug Development Fund', u'DelSite Biotechnologies Inc', u'Djavad Mowafaghian Centre for Brain Health', u'Intra-Cellular Therapies Inc', u'National Health and Medical Research Council', u'Xel Pharmaceuticals Inc', u'Ore Pharmaceuticals Inc', u'Parke-Davis & Co', u'LifeArc', u'Actavis Inc', u'DuChemBio Co Ltd', u'Hamilton Pharmaceuticals Ltd', u'DiamiR LLC', u'Universidad Autonoma de Madrid', u'Nippon Chemiphar Co Ltd', u'Scripps Research Institute', u'Samus Therapeutics Inc', u'Douglas Mental Health University Institute', u'MediProPharma Inc', u'University of Southern California', u'Medison Pharma Ltd', u'Tranzyme Pharma Inc', u'Altimmune Inc', u'GinkgoPharma Co Ltd', u'CoNCERT Pharmaceuticals Inc', u'Yunnan Spirin Biotechnology Co Ltd', u'CARBOGEN AMCIS AG', u'VFP Therapies SAS', u'Dermaxon', u'Teva Pharmaceutical Industries Ltd', u'Tokyo Metropolitan Institute of Gerontology', u'Harvard NeuroDiscovery Center', u'Alector LLC', u'FORUM Pharmaceuticals Inc', u'Adimab LLC', u'MDS Nordion', u'Galapagos Genomics BV', u'Proteome Sciences plc', u'Crucell NV', u'ReNeuron Group plc', u'AstraZeneca plc', u'Technology Strategy Board', u'Uppsala Imanet AB', u'The Stanley Medical Research Institute', u'Immuno-Biological Laboratories Co Ltd', u'University of Utah', u'UK Department of Trade & Industry', u'Cognition Therapeutics Inc', u'Lacer SA', u'Socratech LLC', u'MassGeneral Institute for Neurodegenerative Disorders', u'Elegene AG', u'Synaptech', u'Janssen-Cilag Ltd', u'Mitoconix Bio Ltd', u'Tasly Pharmaceutical Group Co Ltd', u'Harvard University', u'Australian Government', u'Oxygen Healthcare', u'Merz North America', u'Prana Biotechnology Ltd', u'bioMerieux SA', u'Academia Sinica', u'Cognoptix Inc', u'Icogenex Corp', u'Cenomed BioSciences LLC', u'Acumen Pharmaceuticals Inc', u'Yale School of Medicine', u'Pharmos Corp', u'NYU Langone Medical Center', u'ArmaGen Technologies Inc', u'Ligand Pharmaceuticals Inc', u'Abiogen Pharma SpA', u'National Center for Complementary and Alternative Medicine', u'Molecular Neuroimaging LLC', u'Cenna Biosciences Inc', u'Advanced Accelerator Applications SA', u'ProMIS Neurosciences Inc', u'Abeona Therapeutics Inc', u'Senju Pharmaceutical Co Ltd', u'Noscira SA', u'deCODE chemistry', u'Proclara Biosciences', u'PharmatrophiX', u'MeiraGTx', u'T3D Therapeutics Inc', u'Kyoto University', u'Cedars-Sinai Medical Center', u'Rainbow BioScience LLC', u'Gnome Diagnostics LLC', u'American Heart Association', u'Cambridge NeuroScience Partners', u'Medavante Inc', u'Cornell University', u'Engineering and Physical Sciences Research Council', u'Fenwal Inc', u'Asset Realisation Co plc', u'AdProTech Ltd', u'Russian Academy of Sciences', u'The Michael J. Fox Foundation', u'CIEN Foundation', u'Senexis Ltd', u'P2D Biosciences', u'Institut Pasteur', u'Adamas Pharmaceuticals Inc', u'Coronis NeuroSciences', u'Rhenovia Pharma SAS', u'GE Healthcare', u'Walloon Region of Belgium Government', u'J David Gladstone Institutes', u'Neuralstem Inc', u'Meta-IQ', u\"Brigham & Women's Hospital\", u'Dyax Corp', u'Bristol-Myers Squibb Pharma Co', u'Emerald Logic', u'University of Toronto', u'ProteoSys AG', u'CuraGen Corp', u'German Federal Ministry of Education and Research', u'Roussel Uclaf Corp', u'Sanofi-Aventis US LLC', u'Medical University of South Carolina', u'Royal DSM NV', u'University of Florida', u'Protein Mechanics Inc', u'Prodotti Formenti Srl', u'Cardinal Health Inc', u'Humanetics Corp', u'Centre for Drug Research and Development', u'Digital Gene Technologies Inc', u'Neuracle Science', u'Knight Therapeutics Inc', u'The Genetics Co Inc', u'Mount Sinai School of Medicine', u'Medical Research Commercialization Fund', u'Forest Laboratories Inc', u'AlzProtect', u'Meso Scale Technologies', u'Quintiles Transnational Corp', u'Universite de Caen Basse-Normandie', u'TG United', u'University of Queensland', u'King Saud University', u'Ntz Lab Ltd', u'ProteoTech Inc', u'Kareus Therapeutics SA', u'NanoAxis', u'Centro De Investigaci\\xf3n Biom\\xe9dica En Red De Enfermedades Neurodegenerativas', u'Roskamp Institute', u'Aventis Pharma AG', u'KinoPharma Inc', u'Ecole Polytechnique Federale de Lausanne', u'Allergan Pharmaceuticals Ireland', u'OSI Pharmaceuticals Inc', u'SIBIA Neurosciences Inc', u'Nanomerics Ltd', u'Atherotech Inc', u'Hanmi Pharmaceutical Co Ltd', u'Minster Pharmaceuticals plc', u'MSD OSS BV', u'Yonsei University', u'University of Science and Technology, Korea', u'University of Manitoba', u'Pharmacia & Upjohn Co', u'Jacobus Pharmaceutical Co Inc', u'Immune Network Ltd', u'Bionomics Ltd', u'Aquila Biopharmaceuticals Inc', u'Applied NeuroSolutions Inc', u'Two Cells Co Ltd', u'3D Signatures Inc', u'CogState Ltd', u'Santen Pharmaceutical Co Ltd', u'Siemens Healthineers Inc', u'National Center for Research Resources', u'Keio University', u'Knoll Farmaceutici SpA', u'Vertex Pharmaceuticals Inc', u'Bioresearch SpA', u'Ogeda SA', u'Universite Libre de Bruxelles', u'Loyola University of Chicago', u'Institute for Molecular Medicine', u'University of Hawaii', u'Avineuro Pharmaceuticals Inc', u'National Center For Advancing Translational Sciences', u'Chinese Academy of Medical Military Sciences', u'Mylan Inc', u'Biota Holdings Ltd', u'Fudan University', u'sGC Pharma Inc', u'Lohmann Therapie-Systeme GmbH & Co KG', u'Alzinova AB', u'Genomics Institute of the Novartis Research Foundation', u'Intelligence Advanced Research Projects Activity', u'VLP Biotech Inc', u'University of Dundee', u'Vasix Corp', u'PsychoGenics Inc', u'Aphios Corp', u'Pharmexa A/S', u'University of Heidelberg', u'Alzeca Biosciences Inc', u'Meldex International plc', u'IASO Biomed Inc', u'Neuroscience Campus Amsterdam', u'Yantai Yenepharma Biomedical Co Ltd', u'Catholic University of Leuven', u'Kwang Dong Pharmaceutical Co Ltd', u'ProMediTech Inc', u'Axonyx Inc', u'Signum Biosciences Inc', u'Medisan Pharmaceutical Co Ltd Harbin', u'CryoPort Inc', u'Affymetrix Inc', u'University of Wurzburg', u'OPKO Health Inc', u'University of Texas Medical Branch at Galveston', u'ALS Biopharma LLC', u'Eiken Chemical Co Ltd', u'PET Pharm Biotech Ltd', u'Glaxo Group Ltd', u'Southern Illinois University', u'Piramal Imaging GmbH', u'University of Western Ontario', u'Fujirebio Europe NV', u'Boehringer Ingelheim Corp', u'Ministerio de Educacion y Ciencia', u'Connexios Life Sciences Pvt Ltd', u'Genset SA', u'Universidad De Le Republica - Uruguay', u'Camargo Pharmaceutical Services', u'Memorial Sloan-Kettering Cancer Center', u'Unimed Pharmaceuticals Inc', u'Debiopharm SA', u'Mount Sinai Medical Center', u'Elan Pharma International Ltd', u'Saegis Pharmaceuticals Inc', u'Weston Brain Institute', u'Medifron DBT Co Ltd', u'University of Houston', u'Duke University Medical Center', u'Fudan University Shanghai Medical College', u'Wyeth Pharmaceuticals', u'VITRUVIAN BioMedical', u'Novartis Pharma AG', u'Biofrontera AG', u'Advanced Life Sciences Holdings Inc', u'Harvard Medical School', u'North Carolina Biotechnology Center', u'Wyss Institute for Biologically Inspired Engineering', u'National Institute of Diabetes, Digestive and Kidney Diseases', u'NeoGenesis Pharmaceuticals Inc', u'Universita di Bologna', u'Cangene Corp', u'Schering-Plough Corp', u'Neurokorr', u'Sirtris Pharmaceuticals Inc', u'Mindset BioPharmaceuticals (USA) Inc', u'Jiangsu Simcere Pharmaceutical Co Ltd', u'Shanghai Institute of Materia Medica of the Chinese Academy of Sciences', u'New York University School of Medicine, US', u'University of California', u'Merck & Co Inc', u'Zenyaku Kogyo Co Ltd', u'National Eye Institute', u'Sanofi', u'Alectos Therapeutics Inc', u'Feinstein Institute for Medical Research', u'State Science and Technology Commission', u'Clinical Imaging Research Centre', u'Acobiom', u'Novogen Ltd', u'Bayer AG', u\"Alzheimer's Foundation of America\", u'Pharmacia Corp', u'Renovis Inc', u'Advectus Life Sciences Inc', u'Max-Planck-Institut f\\xfcr Biophysikalische Chemie', u'Institute for the Study of Aging (ISOA), Ltd', u'FUJIFILM Holdings Corp', u'Translational Genomics Research Institute', u'Beijing SL Pharmaceutical Co Ltd', u'Klogene Therapeutics Inc', u'Kalgene Pharma Inc', u'Case Western Reserve University', u'University of California Irvine', u'Kyowa Hakko Kogyo Co Ltd', u'Roivant Sciences Ltd', u'Almirall Prodesfarma SA', u'Imanova Ltd', u'WisTa Laboratories Ltd', u'Alzheimer\\u2019s disease Cooperative Study', u'Neurocrine Biosciences Inc', u'Alzamend Neuro Inc', u'Swiss Federal Office of the Commission for Technology and Innovation', u'Childrens Medical Center Corp', u'Foundation for Mitochondrial Medicine', u'Synthetic Biologics Inc', u'Harrington Discovery Institute', u'Roche Diagnostics', u'International Stem Cell Corp', u'Wyeth', u'Tri-Institutional Therapeutics Discovery Institute Inc', u'Aptuit Inc', u'Leandro P. Rizzuto Foundation ALS Finding A Cure', u'Instituto de Quimica Medica-CSIC', u'Neuro Bioscience Inc', u'Ichor Medical Systems Inc', u'Purdue University', u'Massachusetts Institute of Technology', u'Wuhan Yuanzheng Century Pharmaceutical Co Ltd', u'Hoffmann-La Roche AG', u'VINNOVA', u'GliaCure Inc', u'Shanghai Jiao Tong University', u'Walter Reed Army Institute of Research', u'Axerion Therapeutics Inc', u'NJ Commission on Science and Technology', u'Institut Pasteur de Lille', u'Neuralab Ltd', u'AGP Therapeutics LLC', u'CANTABio Pharmaceuticals Inc', u'Vrije Universiteit van Amsterdam', u'China Medical University (Taiwan)', u'SignalGene Inc', u'Ablynx NV', u'IGC Inc', u'University of Texas Austin', u'Elan Corp plc', u'Praecis Pharmaceuticals Inc', u'City of Hope', u'Takeda Oncology', u'INSERM', u'Kuros Biosciences Ltd', u'MSD Japan', u'Centaur Pharmaceuticals Inc', u'Malin Corp plc', u'University of Calgary', u'MGI Pharma Inc', u'University College London', u'Cephalon Inc', u'Celgene Corp', u'Samaritan Pharmaceuticals Inc', u'University of Kentucky', u'Array BioPharma Inc', u'Therapix Biosciences Ltd', u'Catalytica Inc', u'Vernalis Research Ltd', u'Ciba-Geigy AG', u'Transition Therapeutics Inc', u'Whitehead Institute for Biomedical Research', u'Daiichi Pharmaceutical Corp', u'Stegram Pharmaceuticals Ltd', u'Duke University', u'Avanir Pharmaceuticals Inc', u'RIKEN', u'Warren Pharmaceuticals Inc', u'Sequenom Inc', u'CoPlex Therapeutics LLC', u'BioSolveIT Gmbh', u'Queensland Institute of Medical Research', u'vTv Therapeutics LLC', u'Janssen Pharmaceuticals Inc', u\"Arizona Alzheimer's Consortium\", u'Ester Neurosciences Ltd', u'Stemedica International SA', u'Mabtech AB', u'Avid Bioservices', u'Sihuan Pharmaceutical Holdings Group Ltd', u'International Medical Center of Japan', u'Universite de Bordeaux', u'PAREXEL International', u'Rhone-Poulenc Rorer Inc', u'Shionogi-GlaxoSmithKline Pharmaceuticals LLC', u'Io Therapeutics Inc', u'Janssen Research Foundation Worldwide', u'Daiichi Seiyaku Co Ltd', u'Gachon University', u'US Government', u'BioMarin Pharmaceutical Inc', u'Korea Institute of Science and Technology', u'Hunter-Fleming Ltd', u'National Institutes of Health', u'Baxter International Inc', u'Medisyn Technologies Inc', u'MDS Pharma Services', u'Jupiter Orphan Therapeutics Inc', u'Palumed SA', u'GenVec Inc', u'California Institute of Regenerative Medicine', u'Biogen Inc', u'GlaxoSmithKline plc', u\"Ataxia Telangiectasia Children's Project Inc\", u'Xuanwu Hospital Of Capital Medical University', u'Bayer Schering Pharma AG', u'University of Kuopio', u'Immunas Pharma Inc', u'Medivation Inc', u'ABX-CRO', u'Treventis Corp', u'University of Illinois at Urbana-Champaign', u'SRI International', u'Marina Biotech Inc', u\"L'Universita Degli Studi di Trieste\", u'Enigma Biomedical Group Inc', u'Agahan Ayandeye Pars Inc', u'Intellect Neurosciences Inc', u'SeD Biomedical Inc', u'University of Michigan', u'Phenomenome Discoveries Inc', u'Vanderbilt University', u'Far East University', u'Virginia Commonwealth University', u\"St Vincent's Institute Medical Research\", u'Stanford University', u'University of Kentucky college of Medicine', u'MitoKor', u'Almac Diagnostics', u'Halozyme Therapeutics Inc', u'Abbott Healthcare Products BV', u'Nortis Inc', u'Xcellsyz Ltd', u'Edunn Biotechnology Inc', u'Vishnevsky Central Military Hospital', u'Neurogen Corp', u'Neurotech Pharmaceuticals Inc', u'Cognosci Inc', u'Sankyo Co Ltd', u'JSW Life Sciences Gmbh', u'Layton Bioscience Inc', u'Canadian Institutes of Health Research', u'VIB', u'BrightFocus Foundation', u'PhoreMost Ltd', u'Emory University', u'Ariana Pharmaceuticals', u'CoMentis Inc', u'Morphochem AG', u'Edith Cowan University', u\"Boston Children's Hospital\", u'Alnylam Pharmaceuticals Inc', u'St Louis University', u'Suntory Ltd', u'Memory Pharmaceuticals Corp', u'Rosetta Genomics Ltd', u'Allele Biotechnology & Pharmaceuticals Inc', u'Link Medicine Corp', u'IXICO Plc', u'Advinus Therapeutics Ltd', u'Sigma-Tau Ind Farm Riunite SpA', u'Xenetic Biosciences Inc', u'Proteostasis Therapeutics Inc', u'RespireRx Pharmaceuticals Inc', u'CereSpir Inc', u'Tularik Inc', u'Daiichi Sankyo Co Ltd', u'Abbott Laboratories', u'Eisai Co Ltd', u'Commonwealth Scientific and Industrial Research Organization', u'CallistoGen AG', u'Montreal Neurological Institute and Hospital', u'Neuroem Therapeutics Inc', u'University of Texas at El Paso', u'Cloud Pharmaceuticals Inc', u'University of Chicago', u'National Cancer Institute', u'Institute for Memory Impairments and Neurological Disorders', u'Jiangsu Kanion Pharmaceutical Co Ltd', u'Nathan Kline Institute for Psychiatric Research', u'ALSP Inc', u'Macquarie University', u'Recombinetics', u'Revalesio Corp', u'Torrey Pines Pharmaceuticals Inc', u'BenevolentAI Ltd', u'Panorama Research Inc', u'Avanti Therapeutics', u'QPS LLC', u'Imaging Research Solutions Ltd', u'University of Minnesota', u'Neurotrope Inc', u'Abiant', u\"Banner Alzheimer's Institute\", u'Metabolic Solutions Development Co', u'University of Manchester', u'Hawthorn Pharmaceuticals Inc', u'Piramal Enterprises Ltd', u'Funakoshi Corp', u'Neurimmune Holding AG', u'Ramot at Tel Aviv University Ltd', u'Pharmacia & Upjohn Inc', u'Neurimmune Therapeutics AG', u'University of Colorado System', u'Sunnybrook Health Sciences Centre', u'Midatech Pharma US Inc', u'Alion Pharmaceuticals Inc', u'Lay Line Genomics SpA', u'University of Barcelona', u'Warner Lambert Pty Ltd', u'Washington University in St Louis', u'Universite Laval', u'Ocean University of China', u'Ferrer Internacional SA', u'Myriad Genetics Inc', u'Immtech Pharmaceuticals Inc', u'Laboratoires Houde SA', u'National Institute of General Medical Sciences', u'Neuronetrix Inc', u'National Center For Geriatrics & Gerontology', u'H Lundbeck A/S', u'Genea Ltd', u'GCA Therapeutics Ltd', u'Chugai Pharmaceutical Co Ltd', u'University of North Carolina', u'Evotec AG', u'Undisclosed', u'University of California San Diego School of Medicine', u'The Charles Evans Foundation', u'Bioventix Inc', u'Shanghai Institutes for Biological Sciences CAS', u'Mesoblast Ltd', u'Otsuka Pharmaceutical Co Ltd', u'AmideBio LLC', u'Thuris Corp', u'New York Genome Center', u'Bago', u'Amylyx Pharmaceuticals Inc', u'Asklepios Biopharmaceutical Inc', u'Actelion Pharmaceuticals Ltd', u'Cellzome', u'Shionogi Pharma Inc', u'Impel NeuroPharma', u'Republic of Korea Government', u'Ben Franklin Technology Partners of Southeastern Pennsylvania', u'Jeil Pharmaceutical Co Ltd', u'Pharmasum Therapeutics', u'Merck Serono SA', u'Onyx Scientific Ltd', u'ENKAM Pharmaceuticals A/S', u'tesa Labtec GmbH', u'MRIGlobal', u'MD Anderson Cancer Center', u'Jiangsu Simovay Pharmaceutical Co Ltd', u'TorreyPines Therapeutics Inc', u'Foundation for the National Institutes of Health', u'Hopital Saint-Antoine', u'Addex Therapeutics Ltd', u'Eisai Inc', u'Epimmune Inc', u'Transparency Life Sciences LLC', u'Zhejiang University', u'Acelot Inc', u'Nuron Biotech Inc', u'Kyowa Hakko Kirin Co Ltd', u'Vaccine Research Institute of San Diego', u'NicOx SA', u'Varinel Inc', u'American Federation for Aging Research', u'Epigenetix Inc', u'Cognitive Pharmaceuticals Ltd', u'Pfizer Inc', u'Saladax Biomedical Inc', u'Immunome Inc', u'Norwegian Research Council', u'Synaptica Ltd', u'Yale University', u'HealthPartners Research Foundation', u'BACE Therapeutics Pty Ltd', u'deCODE genetics ehf', u'AFFiRiS AG', u'Columbia University', u'University of Illinois', u'EPIX Pharmaceuticals Inc', u'Hopital Universitaire de la Pitie Salpetriere', u'High Point Pharmaceuticals Llc', u'Illumina Inc', u'LG Life Sciences Ltd', u'Compass Research', u'Mercia Pharma Inc', u'Molecular Sensing Plc', u'Somerset Pharmaceuticals Inc', u'Neuraltus Pharmaceuticals Inc', u'Cita NeuroPharmaceuticals Inc', u'Laboratory Corporation of America Holdings', u'Prima BioMed Ltd', u'Allegiance Equity Corp', u'Endogenous Stem Cells Activators Inc', u'University of Dresden', u'Arena Pharmaceuticals Inc', u'Vitae Pharmaceuticals Inc', u'AdAlta Pty Ltd', u'Numerate Inc', u'Targacept Inc', u'University of Melbourne', u'Albert Einstein College of Medicine', u'Aarhus University', u'Heptares Therapeutics Ltd', u'Development Center for Biotechnology', u'NAEJA Pharmaceuticals Inc', u'Aquinnah Pharmaceuticals Inc', u'Immunobrain Checkpoint Inc', u'Sanford-Burnham Medical Research Institute', u'Eisai Ltd', u'Scios Inc', u'Synvista Therapeutics Inc', u'IntelliSyn Pharma', u'Blanchette Rockefeller Neurosciences Institute (BRNI)', u'Neurotez Inc', u'University of Aberdeen', u'American Cyanamid Co', u'Siena Biotech SpA', u'Select Therapeutics Inc', u'Thomas Jefferson University', u'Kentucky Science and Technology Corp', u'Pentraxin Therapeutics Ltd', u'Kunming Institute of Botany The Chinese Academy of Sciences', u'Plandai Biotechnology Inc', u'Cognito Therapeutics', u'FB Health', u'Osta Biotechnologies Inc', u'Axxam SpA', u'Quantum Materials Corp', u'Clinical Research Services Turku Oy', u'Grifols SA', u'Fonds Unique Interministeriel', u'ProTrials Research, Inc', u'AlzeCure Foundation', u'Purdue Neuroscience Corp', u'GemVax & Kael Co Ltd', u'Celera Diagnostics', u'BioArctic Neuroscience AB', u'Icagen Inc (pre-merger)', u'Attenua Inc', u'Idera Pharmaceuticals Inc', u'The Mental Health Research Institute of Victoria', u'Novartis AG', u'Mindset Biopharmaceuticals Ltd', u'Zenyth Therapeutics Ltd', u'University of New Mexico', u'Sonexa Therapeutics', u'Boryung Pharm Co Ltd', u'BrainVectis', u'Ortho-Clinical Diagnostics Inc', u'Mylan Specialty', u'China Pharmaceutical University Pharmaceutical Co Ltd', u'Genoma Espa\\xf1a', u'Technion - Israel Institute of Technology', u'Merz & Co GmbH', u'BASF AG']), u'Postnataldepression': set([u'SAGE Therapeutics Inc', u'University of California', u'Marinus Pharmaceuticals Inc', u'Ligand Pharmaceuticals Inc']), u'Hyperbilirubinemia': set([u'InfaCare Pharmaceutical Corp', u'WellSpring Pharmaceutical Corp', u'Rockefeller University']), u'Periodontaldisease': set([u'Medtronic Sofamor Danek', u'Luitpold Pharmaceuticals Inc', u'US Government', u'Scil Technology GmbH', u'Sanofi Pasteur', u'BioMimetic Therapeutics Inc', u'Ministry of Health, Welfare and Family Affairs', u'Universitat Ulm', u'Protein Mechanics Inc', u'Biolase Technology Inc', u'University of London', u'Hain Diagnostika GmbH', u'Taro International Ltd', u'CollaGenex International Ltd', u'Taiwan Major Chemical & Pharmaceutical Corp', u'Alliance Pharma plc', u'Ambalal Sarabhai Enterprises', u'Stryker Corp', u'Bioventus LLC', u'Harvard University', u'The European Union', u'MediGene AG', u'Orquest Inc', u'Novelion Therapeutics Inc', u'ISDIN SA', u'Biora Ab', u'Colgate-Palmolive Co', u'University of Texas System', u'Alfresa Pharma Corp', u'SK Chemicals Life Science', u'The McGuire Institute', u'University of Melbourne', u'Medtronic Inc', u'Genmedix Ltd', u'University of North Carolina', u'Collagenesis Inc', u'Centerpulse', u'CLL Pharma', u'Republic of Korea Government', u'PPL Therapeutics plc', u'Medivir AB', u'Karr Dental AG', u'US Army Medical Research and Materiel Command', u'HansMeical Company Ltd', u'Ortho Dental Solutions Ltd', u'Johnson & Johnson Consumer Products Inc', u'Synt:em', u'CSL Ltd', u'Ophtimed Instrument', u'Enox Biopharma Inc', u'Genetics Institute LLC', u'Genaera Corp', u'Pfizer Inc', u'Novartis Vaccines & Diagnostics', u'Toyama Chemical Co Ltd', u'FCB-Pharmicell Co Ltd', u'LifeCell Corp', u'4SC AG', u'Wyeth BioPharma', u'CollaGenex Pharmaceuticals Inc', u'Block Drug Co Inc', u'Traverse Biosciences Inc', u'Purdue University', u'University of Gothenburg', u'Pharmascience Inc', u'University of Miami', u'Lifecore Biomedical Inc', u'Yamanouchi Pharmaceutical Co Ltd', u'Meditronic Inc', u'Oscotec Inc', u'Aventis SA', u'Curis Inc', u'National Science Foundation', u'Obagi System', u'Therapix Biosciences Ltd', u'BioMed X GmbH', u'Periodontix Inc', u'Child Health Corporation of America (CHCA)', u'Willvonseder & Marchesani GmbH & Co KG', u'National Institute of Dental and Craniofacial Research', u'Exsal Ltda', u'ZymoGenetics Inc', u'Sidus', u'Rafa Laboratories Ltd', u'Millennium Dental Technologies Inc', u'Pharma Med Inc']), u'Liverfibrosis': set([u'Karolinska Institutet', u'Universidad del Pais Vasco', u'BioLineRx Ltd', u'Tokai University', u'Minophagen Pharm Co', u'Intercept Pharmaceuticals Inc', u'Collgard Biopharmaceuticals Ltd', u'Stelic Institute & Co', u'Shanghai Sundise Traditional Chinese Medicine Co Ltd', u'InterMune Inc', u'University of Regensburg', u'National Institute of Diabetes, Digestive and Kidney Diseases', u'ProDa BioTech LLC', u'US Government', u'Mount Sinai School of Medicine', u'Shanghai Municipal Government', u'ProMetic Life Sciences Inc', u'European Research Council (ERC)', u'Assistance Publique Hopitaux de Paris', u'University of Wurzburg', u'Undisclosed', u'Intervet International BV', u'Novartis Pharma AG', u'CTI Clinical Trial and Consulting Services', u'Shanghai University of Traditional Chinese Medicine', u'Shanghai Genomics Inc', u'INSERM', u'French Government', u'Sanofi Genzyme', u'Pharmaceutical Product Development LLC', u'Allysta Pharmaceuticals Inc', u'La Jolla Pharmaceutical Co', u'Bio-Rad Pasteur', u'University of Miami', u'Takeda Oncology', u'Bayer AG', u'FibroGen Inc', u'Galectin Therapeutics Inc', u'Shenzhen Royal Asset Management Co Ltd', u'National Institute of Biomedical Imaging and Bioengineering', u'Metabasis Therapeutics Inc', u'University of Navarra', u'Navigo Proteins GmbH', u'Georgia State University', u'Xfibra LLC', u'University of Tennessee', u'Hadasit Medical Research Services and Development Ltd', u'GE Healthcare', u'Universita Degli Studi Di Perugia', u'Biotherapix SLU', u'Temple University', u'Tianjin International Joint Academy of Biotechnology and Medicine', u'Angion Biomedica Corp', u'Boehringer Ingelheim Corp', u'Takeda Pharmaceutical Co Ltd', u'Ariana Pharmaceuticals', u'ChemWerth USA', u'Sankyo Co Ltd', u'Marnac Inc', u'Regulus Therapeutics Inc', u'German Federal Ministry of Education and Research', u'Digna Biotech SL']), u'Acuteintermittentporphyria': set([u'Digna Biotech SL', u'Protein Sciences Corp', u'uniQure BV', u'The European Union', u'University of Navarra', u'Aventis Pharmaceuticals Inc', u'Alnylam Pharmaceuticals Inc', u'Sanofi Genzyme', u'Amsterdam Molecular Therapeutics BV']), u'Thrombocythemia': set([u'Novartis AG', u'Yuhan Corp', u'Amarillo Biosciences Inc', u'Swedish Orphan AB', u'Shire plc', u'Kyowa Hakko Kirin Co Ltd', u'Cytopharm Inc', u'Incyte Corp']), u'Aspergillusinfection': set([u'Johnson & Johnson', u'US Government', u'SICOR Inc', u'MD Anderson Cancer Center', u'UK Government', u'Molecular Express Inc', u'Avir Pharma Inc', u'RegeneRx Biopharmaceuticals Inc', u'National Institute of Allergy and Infectious Diseases', u'University of Strathclyde', u'Bayer (Canada) Inc', u'Universita Degli Studi Di Roma \"Tor Vergata\"', u'Unimedic AB', u'Astellas Pharma Canada Inc', u'SEQUUS Pharmaceuticals Inc', u'Vical Inc', u'University of Texas System', u'Biotoscana International', u'Barrier Therapeutics Inc', u'Vicuron Pharmaceuticals Inc', u'Fujisawa Pharmaceutical Co Ltd', u'The Dow Chemical Co', u'Elan Corp plc', u'Zeneca Group plc', u'Lypro Biosciences Inc', u'Asahi Kasei Pharma Corp', u'SciClone Pharmaceuticals Inc', u'Samyang Corp', u'GlobeImmune Inc', u'Eli Lilly & Co', u'Aronex Pharmaceuticals Inc', u'CJ Corp', u'Enzon Pharmaceuticals Inc', u'MycoLogics Inc', u'Astellas Pharma Inc', u'Basilea Pharmaceutica International Ltd', u'Takis Biotech', u'University of Texas Health Science Center San Antonio', u'Janssen Korea Ltd', u'NovaBiotics Ltd', u'Zeneus Pharma Ltd', u'Dong-A ST Co Ltd', u'Hikma Pharmaceuticals plc', u'Sankyo Co Ltd', u'Janssen Pharmaceutica NV', u'Almirall Prodesfarma SA', u'Pfizer Inc', u'Ferrer Internacional SA', u'Kyowa Hakko Kogyo Co Ltd', u'Valley Fever Solutions Inc', u'F Hoffmann-La Roche AG', u'Universite De Montreal', u'Torrex Pharma Ges mbH']), u'Gravesdisease': set([u'European Commission', u'Apitope International NV']), u'Respiratorydisease': set([u\"Dr Reddy's Laboratories Ltd\", u'University of Medicine and Dentistry of New Jersey', u'DKSH Holding Ltd', u'US Government', u'The Menarini Group', u'Texas Emerging Technology Fund', u'Genus plc', u'Baxter International Inc', u'Schwarz Pharma Ltd', u'Advanced BioScience Laboratories Inc', u'Prosonix Ltd', u'Medical Developments International Ltd', u'4d pharma plc', u'InterMune Inc', u'Merck Sharp & Dohme BV', u'Washington State University', u'IDM Pharma Inc', u'GenVec Inc', u'Inflazyme Pharmaceuticals', u'Indiso Ltd', u'Mount Sinai School of Medicine', u'Kereos Inc', u'GlaxoSmithKline plc', u'Zydus-Cadila Group', u'Celltrion Inc', u'Quintiles Transnational Corp', u'Newcastle Innovation Ltd', u'Vegenics Ltd', u'Bayer Schering Pharma AG', u'Meyer Pharmaceuticals LLC', u'Advanced Therapies Inc', u'Kirin Holdings Co Ltd', u'Pulmagen Therapeutics', u'EvoRx Technologies', u'Janssen Biotech Inc', u'University Of Southampton', u'Ionis Pharmaceuticals Inc', u'Aventis Pharma AG', u'Radikal Therapeutics Inc', u'S&D Pharma', u'MedImmune LLC', u'ArQule Inc', u'Santen SAS', u'The Austrian Research Promotion Agency FFG', u'BioFocus DPI', u'Fred Hutchinson Cancer Research Center', u'Lead Discovery Center GmbH', u'Cenix BioScience GmbH', u'Brighton Biotech Inc', u'Sumitomo Pharmaceuticals Co Ltd', u'Primagen Holding BV', u'Newsummit Biopharma Co Ltd', u'Five Prime Therapeutics Inc', u'Chiesi USA Inc', u'Resmed Ltd', u'Alchemia Ltd', u'Rosa & Co LLC', u'Owlstone Medical Ltd', u'Grifols Inc', u'Azopharma Inc', u'Galapagos NV', u'Altair Therapeutics Inc', u'Serendex Pharmaceuticals A/S', u'SenzaGen AB', u'RespiVert Ltd', u'Lovelace Respiratory Research Institute', u'ANI Pharmaceuticals Inc', u'Monaghan Medical Corporation', u'Polyphor Ltd', u'TESARO Inc', u'Relief Therapeutics Holding AG', u'Selvita SA', u'The Doctors Healthcare company plc', u'Orion Corporation', u'Orexo AB', u'Shionogi & Co Ltd', u'Catalent Inc', u'AstraZeneca plc', u'Optimer Pharmaceuticals Inc', u'Audeo Oncology Inc', u'Gravity Bio Inc', u'Laboratorios SALVAT SA', u'Esteve', u'NitroMed Inc', u'Inspire Pharmaceuticals Inc', u'Peking University', u'Alnylam Pharmaceuticals Inc', u'Pharmaniaga Bhd', u'Hikma Pharmaceuticals plc', u'Videregen Ltd', u'ZAI Laboratory Inc', u'Sigma-Tau Ind Farm Riunite SpA', u'Evotec AG', u'Overpharma Produtos Medicos e Farmaceuticos Lda', u'INO Therapeutics Inc', u'Charles River Laboratories International Inc', u'Pharmagene', u'Evolutec Group plc', u'Propeller Health', u'Alpine Immune Sciences Inc', u'Amgen Inc', u'Mylan Inc', u'Cipla Ltd', u'Cambridge Antibody Technology Group plc', u'Sunovion Pharmaceuticals Inc', u'Abbott Laboratories', u'UniQuest Pty Ltd', u'Tianjin KingYork Group', u'National Heart Lung and Blood Institute', u'Innoviva Inc', u'University of Rochester', u'CepTor Corp', u'Reata Pharmaceuticals Inc', u'Cloud Pharmaceuticals Inc', u'National Cancer Institute', u'Novartis AG', u'Anthera Pharmaceuticals Inc', u'Aradigm Corp', u'BioMarck Pharmaceuticals Ltd', u'Invion Ltd', u'Yale University', u'Bicycle Therapeutics Ltd', u'PediaMed Pharmaceuticals Inc', u'Stiefel', u'University of Maryland', u'Modern Healthcare Solutions Co Ltd', u'Teva Pharmaceutical Industries Ltd', u'Osiris Therapeutics Inc', u'Juvenescence Limited', u'Amira Pharmaceuticals Inc', u'Zendex Bio Strategy Inc', u'Tanabe Seiyaku Co Ltd', u'Synairgen plc', u'UCB SA', u'NanoSystems LLC', u'The Cho Group', u'Ethris GmbH', u'Astellas Pharma Inc', u'Ventaira Pharmaceuticals Inc', u'Adams Respiratory Therapeutics Inc', u'OPKO Health Inc', u'Sterling Srl', u'Pharmacopeia Inc', u'University of Manchester', u'EpiGenesis Pharmaceuticals Inc', u'Nektar Therapeutics', u'Kyorin Pharmaceutical Co Ltd', u'Ferring Pharmaceuticals SA', u'Windtree Therapeutics Inc', u'Scripps Research Institute', u'Alitair Pharmaceuticals Inc', u'Activaero GmbH', u'Glaxo Group Ltd', u'Tarix Pharmaceuticals LLC', u'AnGes MG Inc', u'Washington University in St Louis', u'Peakdale Molecular', u'University of California San Francisco', u'Boehringer Ingelheim Corp', u'Chiesi Farmaceutici SpA', u'Genfit SA', u'Florida Gulf Coast University', u'Accolade Pharmaceuticals Pte Ltd', u'UCB Pharma SA', u'Selventa', u'Innothera', u'Cigalah', u'Ortho Pharmaceutical Corp', u'University of Queensland', u'Chugai Pharmaceutical Co Ltd', u'University of North Carolina', u'Medidata Solutions Worldwide', u'Aptar Pharma SAS', u'Genentech Inc', u'Mitsubishi Pharma Corp', u'Mesoblast Ltd', u'Silence Therapeutics plc', u'Mediolanum Farmaceutici SpA', u'Lanthio Pharma', u'New Alliance Pharmaceuticals Inc', u'North Carolina State University', u'Rigel Pharmaceuticals Inc', u'Tabuk Pharmaceutical Manufacturing Co', u'BioTrove Inc', u'ORS Nasco', u'MicroDose Therapeutx Inc', u'DSM Pharmaceutical Products', u'Bayer Yakuhin Ltd', u'Allergan plc', u'The Linde Group', u'CMC Biologics Inc', u'AlphaMed Pharmaceuticals Corp', u'Care Fusion', u'sterna biologicals GmbH and Co KG', u'Pathway Therapeutics Ltd', u'Cornell University', u'Sumitomo Dainippon Pharma Co Ltd', u'Pfizer Inc', u'ImmuneRegen BioSciences Inc', u'Aerogen Inc', u'Grelan Pharmaceutical Co Ltd', u'MAP Pharmaceuticals Inc', u'Merck & Co Inc', u'Ahn-Gook Pharmaceuticals Co Ltd', u'Sanofi', u'QoL Devices', u'UBE Industries Ltd', u'Alkermes plc', u'Theravance Biopharma Inc', u\"Lee's Pharmaceutical Holdings Limited\", u'Dompe Farmaceutici SpA', u'Bayer AG', u'Amerisourcebergen Drug Corp', u'Epimmune Inc', u'Lipocine Inc', u'Pulmatrix Inc', u'Chrysalis Technologies Inc', u'BD Technologies', u'Oxysure Systems Inc', u'Savara Inc', u'Alembic Ltd', u'Paranta Biosciences Ltd', u'Meridica Ltd', u'TOPIGEN Pharmaceuticals Inc', u'Kissei Pharmaceutical Co Ltd', u'Air Water Inc', u'BioSeek Plc', u'Argenta Discovery Ltd', u'BioRx', u'MonoSol Rx Inc', u'Almirall Prodesfarma SA', u'BioDuro LLC', u'Apeptico Forschung und Entwicklung GmbH', u'CoTherix Inc', u'The Pharmaceutical Institute', u'Verona Pharma plc', u'Caladrius Biosciences Inc', u'Avontec GmbH', u'WuXi PharmaTech (Cayman) Inc', u'deCODE genetics ehf', u'US Department of Defense', u'Vertical Pharmaceuticals Inc', u'Akorn Inc', u'Aptuit Inc', u'Poly Pharmaceuticals Inc', u'ADM Tronics Unlimitd Inc', u'Nichi-Iko Pharmaceutical Co Ltd', u'Nippon Shinyaku Co Ltd', u'Johnson & Johnson', u'Baylor College of Medicine', u'Arriva Pharmaceuticals Inc', u'Insilico Medicine Inc', u'CSL Behring LLC', u'Intel-Ge Care Innovations Llc', u'US Health and Human Services Department', u'Schering-Plough Corp', u'MEI Pharma Inc', u'Tetraphase Pharmaceuticals Inc', u'University of Adelaide', u'National Institute of Allergy and Infectious Diseases', u'Laboratorios Dr Esteve SA', u'Takeda Pharmaceutical Co Ltd', u'Ligand Pharmaceuticals Inc', u'Alfa Wassermann SpA', u'Zambon Co SpA', u'Mundipharma International Corp Ltd', u'MPI Research', u'Direct-Haler AS', u'Orphan Pacific, Inc', u'Agenus Inc', u'National Institutes of Health', u'Teijin Ltd', u'Oxford GlycoSciences plc', u'Ablynx NV', u'ProtAffin Biotechnologie AG', u'Elan Corp plc', u'LifeArc', u'Takeda Oncology', u'Sumitomo Seika Chemicals Co Ltd', u'VaxLogic LLC', u'Pneuma Partners LLC', u'Apax Partners LLP', u'Dr Rentschler Biotechnologie GmbH', u'3M Drug Delivery Systems', u'Roche Holding AG', u'Galera Therapeutics Inc', u'Bristol-Myers Squibb Pharma Co', u'AstraZeneca AB', u'Touchstone Innovations Plc', u'Axxam SpA', u'Archimedes Pharma Ltd', u'Technology Strategy Board', u'Salus Pharma Inc', u'Ranbaxy Laboratories Ltd', u'Cureveda LLC', u'Wellcome Trust Sanger Institute', u'Grifols SA', u'Cambrex Corp', u'Salix Pharmaceuticals Ltd', u'Metaphore Pharmaceuticals Inc', u'GE Healthcare', u'Janssen Pharmaceuticals Inc', u'ActivBiotics Inc', u'Incozen Therapeutics Pvt Ltd', u'Crucell NV', u'New bioMerieux Alliance', u'Idera Pharmaceuticals Inc', u'AAM Healthcare', u'Vectura Group plc', u'Electromed Inc', u'Innovative Genomics Initiative', u'Aerovance Inc', u'Cooper pharma', u'Johns Hopkins University School of Medicine', u'Rhone-Poulenc Rorer Inc', u'SkyePharma plc', u'PARI Pharma GmbH', u'Altimmune Inc (pre-merger)', u'OncoGenex Pharmaceuticals Inc', u'Proteologics Inc', u'Merck Sharp & Dohme Corp']), u'HSV-1infection': set([u'Henderson Morley plc', u'OriGenix Technologies Inc', u'Upsher-Smith Laboratories Inc', u'CEL-SCI Corp', u'National Institute of Allergy and Infectious Diseases', u'Onxeo SA', u'SmithKline Beecham plc', u'University of Alabama', u'Novartis AG', u'Bruno Farmaceutici', u'Food and Drug Administration', u'University of California', u'Amistad Pharma SAS', u'GlaxoSmithKline plc', u'University of Michigan', u'University of Washington', u'Louisiana State University', u'Carrus Capital Corp', u'NanoBio Corp', u'Erasmus University Medical Center Rotterdam', u'Nereus Pharmaceuticals Inc', u'Nerium Biotechnology Inc', u'Novactyl Inc']), u'Hypophosphatemia': set([u'Laureate Biopharmaceutical Services Inc', u'Enobia Pharma Inc', u'Canadian Institutes of Health Research', u'McGill University']), u'Cardiacarrest': set([u'AmKor Pharma Inc', u'Quintiles Transnational Corp', u'Merck & Co Inc', u'Republic of Korea Government', u'GNT Pharma Co Ltd']), u'MELASsyndrome': set([u'Sirtris Pharmaceuticals Inc', u'National Cancer Institute', u'Massachusetts Institute of Technology', u'Santhera Pharmaceuticals AG', u'Yungjin Pharmaceutical Co Ltd', u'Washington University in St Louis', u'NeuroVive Pharmaceutical AB', u'Columbia University']), u'Friedreichataxia': set([u'Warren Pharmaceuticals Inc', u'Santhera Pharmaceuticals AG', u'Intrexon Corp', u\"Go Friedreich's Ataxia Research\", u'National Ataxia Foundation', u'University of Oklahoma', u'Catabasis Pharmaceuticals Inc', u'IDIS Ltd', u'Weill Cornell Medical College, USA', u'Sanofi Genzyme', u'ViroPharma Inc', u'Repligen Corp', u'Ixchel Pharma LLC', u'STATegics Inc', u'University of California Davis', u'Agilis Biotherapeutics LLC', u'Scripps Research Institute', u'AmorChem LP', u'Annapurna Therapeutics SAS', u'Muscular Dystrophy Association', u'American Cyanamid Co', u'Therapeutics for Rare and Neglected Diseases', u'Boehringer Ingelheim International GmbH', u\"Friedreich's Ataxia Research Alliance\", u'Chondrial Therapeutics LLC', u'Murdoch Childrens Research Institute', u'Voyager Therapeutics', u'Jupiter Orphan Therapeutics Inc', u'Penwest Pharmaceuticals Co', u'Intellect Neurosciences Inc', u'Wake Forest University', u'Boehringer Ingelheim Austria GmbH', u'Indiana University', u'University of South Florida', u'Catalent Inc', u'InterMune Inc', u'Takeda Pharmaceutical Co Ltd', u'Bioelectron Technology Corp', u'REGENXBIO Inc', u'Universite Laval', u'Undisclosed', u'H Lundbeck A/S', u'Waisman Clinical Biomanufacturing Facility', u'Horizon Pharma plc', u'Sigma-Tau Ind Farm Riunite SpA']), u'Osteopenia': set([u'UCB Celltech', u'Shaare Zedek Medical Center', u'Amgen Inc', u'Suzhou Alphamab Co Ltd', u'Kalytera Therapeutics Inc', u'Beth Israel Deaconess Medical Center', u'Feiyang Biotech (Jilin) Co Ltd', u'ArQule Inc', u'GlaxoSmithKline plc']), u'Diabeticneuropathy': set([u'Roussel Uclaf Corp', u'US Government', u'Novo Nordisk A/S', u'Relief Therapeutics SA', u'Prodotti Formenti Srl', u'Dalhousie University', u'Califia Bio Inc', u'Endovasc Inc', u'Warner-Lambert Co', u\"Ataxia Telangiectasia Children's Project Inc\", u'Ministry of Health, Welfare and Family Affairs', u'Cervelo Pharmaceuticals Ltd', u'ASTA Medica Inc', u'Aventis Pharma AG', u'US Department of Veterans Affairs', u'Microbot Medical Inc', u'University of Pittsburgh', u'Sangamo Therapeutics Inc', u'Merck Sante SA', u'IriSys LLC', u'University of Manitoba', u'PYRAMID Laboratories, Inc', u'NK Curex KK', u'Fidia Group', u'Sankyo Co Ltd', u'Dompe SpA', u'Handok Inc', u'Toray Industries Inc', u'St Elizabeths Medical Center of Boston Inc', u'Shionogi & Co Ltd', u'North Carolina Biotechnology Center', u'Esteve', u'Sigma-Tau Ind Farm Riunite SpA', u'MGI GP Inc', u'Nagasaki University', u'Genesis Biopharma', u'China Nuokang Bio-Pharmaceutical Inc', u'SmithKline Beecham Corp', u'Endo Pharmaceuticals Solutions Inc', u'Eisai Co Ltd', u'Boehringer Mannheim GmbH', u'Universite de Sherbrooke', u'University of Bristol', u'ACADIA Pharmaceuticals Inc', u'Fujisawa Pharmaceutical Co Ltd', u'Brane Discovery Srl', u'Solvay Pharmaceuticals Inc', u'Tanabe Seiyaku Co Ltd', u'University of Rochester Medical Center', u'Quintiles Transnational Corp', u'Meda Pharma Gmbh & Co Kg', u'Dong-A ST Co Ltd', u'Neurorecovery Inc', u'Allergan Inc', u'Boehringer Ingelheim Corp', u'Nanjing Military Command Center for Disease Control and Prevention', u'University of California San Diego', u'Laboratoires Houde SA', u'Parke-Davis & Co', u'Recordati SpA', u'Depomed Development Ltd', u'Epitech Group Srl', u'University of North Carolina', u'Neurotune AG', u'Genentech Inc', u'Mitsubishi Pharma Corp', u'Grunenthal GmbH', u'Prismic Pharmaceuticals Inc', u'Biogen Inc (FL)', u'UCB Pharma SA', u'National Institute of Diabetes, Digestive and Kidney Diseases', u'Bago', u'Oxford BioMedica plc', u'Republic of Korea Government', u'Sumitomo Dainippon Pharma Co Ltd', u'Daewoong Pharmaceutical Co Ltd', u'Lundbeck Canada Inc', u'Edwards Lifesciences Corp', u'Glaxo Group Ltd', u'Sanofi', u'Medison Pharma Ltd', u'BioFocus DPI', u'Eli Lilly & Co', u'Strathmann Biotec AG', u'The Institute for Diabetes Discovery LLC', u'Boehringer Ingelheim Austria GmbH', u'United Therapeutics Corp', u'SciMeDent Health Corp', u'ReNeuron Group plc', u'Stiefel', u'Pfizer Inc', u'Stada Arzneimittel AG', u'Kaken Pharmaceutical Co Ltd', u'Winsantor Inc', u'Wyeth', u'Sanwa Kagaku Kenkyusho Co Ltd', u'Scotia Holdings plc', u'Hoffmann-La Roche AG', u'ViroMed Co Ltd', u'Euthymics Bioscience Inc', u'Takeda Pharmaceutical Co Ltd', u'Juvenile Diabetes Research Foundation', u'VIA Pharmaceuticals Inc', u'National Institutes of Health', u'Food and Drug Administration', u'Senju Pharmaceutical Co Ltd', u'Elan Corp plc', u'Arcion Therapeutics Inc', u'Curis Inc', u'Rinat-Pfizer Inc', u'Cephalon Inc', u'Diamyd Inc', u'FirstString Research Inc', u'BioDelivery Sciences International Inc', u'Shandong Qidu Pharmaceutical Co Ltd', u'Qiagen NV', u'Avanir Pharmaceuticals Inc', u'Apollo Endosurgery Inc', u'Depomed Inc', u'Neuralstem Inc', u'Hua Han Health Industry Holdings Limited', u'Epitome Pharmaceuticals Ltd', u'PPD Discovery Inc', u\"King's College London\"]), u'Enterovirusinfection': set([u'Sinovac Biotech Ltd', u'Malaysian Technology Development Corp', u'The Chinese Centre for Disease Control and Prevention', u'Sentinext Therapeutics Sdn Bhd']), u'Pyelonephritis': set([u'Taiho Pharmaceutical Co Ltd', u'Toyama Chemical Co Ltd']), u'Ataxiatelangiectasia': set([u'Recursion Pharmaceuticals LLC', u'National Institute on Aging', u\"Ataxia Telangiectasia Children's Project Inc\", u'ChromaDex Corp']), u'Heartvalvedisease': set([u'Admedus Ltd', u'Coroneo Inc', u'Venus MedTech (HangZhou) Inc', u'Colibri Heart Valve Llc', u'Transcatheter Technologies GmbH']), u'Growthdisorder': set([u'Biopasgroup', u'Emisphere Technologies Inc', u'PROLOR Biotech Inc', u'Giddi Pharma Co Ltd', u'University of Sheffield', u'Novo Nordisk A/S', u'Baxter International Inc', u'CSL Behring LLC', u'Sumitomo Pharmaceuticals Co Ltd', u'Cobra Biologics Holding AB', u'National Institute of Allergy and Infectious Diseases', u'Ferring Pharmaceuticals Inc', u'IDIS Ltd', u'Amylin Pharmaceuticals Inc', u'Abbott Laboratories', u'US Government', u'Cangene Corp', u'D&A Pharma', u'Pharmacia & Upjohn Co', u'Ipsen Biopharmaceuticals Inc', u'US Department of Veterans Affairs', u'Sumitomo Dainippon Pharma Co Ltd', u'CMC Biologics Inc', u'Republic of Korea Government', u'Novartis AG', u'Ardana Bioscience Ltd', u'Tulane University', u'Imaxio', u'Nautilus Biotech SA', u'Alteogen Inc', u'Savient Pharmaceuticals Inc', u'Bolder BioTechnology Inc', u'Fujisawa Pharmaceutical Co Ltd', u'Altus Pharmaceuticals Inc', u'Sumitomo Chemical Co Ltd', u'TOLMAR Therapeutics Inc', u'Valeant Pharmaceuticals International Inc', u'INSERM', u'Theratechnologies Inc', u'ArQule Inc', u'Genentech Inc', u'Alkermes plc', u'Eli Lilly & Co', u'Fujifilm Diosynth Biotechnologies', u'UCB Pharma GmbH', u'JCR Pharmaceuticals Co Ltd', u'Apotex Inc', u'Phyton Biotech Inc', u'CSL Ltd', u'Quantum Health Resources Inc', u'CeNeS Pharmaceuticals plc', u'Universidad de Oviedo', u'Ambrx Inc', u'DSM Pharmaceuticals Inc', u'Teva Pharmaceutical Industries Ltd', u'Insmed Inc', u'Soligenix Inc', u'Washington University in St Louis', u'Merck Serono SA', u'Celera South San Francisco', u'Celera Diagnostics', u'SUGEN Inc', u'TransPharma Medical Ltd', u'Biologix FZ Co', u'Menarini Asia-Pacific', u'Vidara Therapeutics LLC', u'Ontogen Corp', u'Repligen Corp', u'InterMune Inc', u'ProChon Biotech Ltd', u'BioGeneriX AG', u'Pfizer Inc', u'Human Genome Sciences Inc', u'Ferring Pharmaceuticals SA', u'Xcellerex LLC', u'TPG Biotech', u'InfiMed Therapeutics Inc', u'Sandoz GmbH', u'Ipsen', u'Grandis Biotech GmbH', u'Antares Pharma Inc']), u'Viralskininfection': set([u'Sakai Chemical Industry Co Ltd', u'Bioglan Pharmaceuticals Co']), u'Kidneytransplantation': set([u'Astellas Pharma Canada Inc', u'Paragonix Technologies Inc', u'VINNOVA', u'MBA Medical', u'Paladin Labs Inc', u'Transplant Genomics', u'University of Alberta', u'Mayo Clinic Foundation', u'Hansa Medical AB', u'US Government', u'Veloxis Pharmaceuticals A/S', u'Tioma Therapeutics Inc', u'NephRx Corp', u'Essential Pharmaceuticals, LLC']), u'Osteoporosis': set([u'Michigan Technological University', u'Oscient Pharmaceuticals Corp', u'QS Pharma', u'Therapeutic Systems Research Laboratories', u'B&C Biopharm', u'Oxagen Ltd', u'Sekisui Chemical Co Ltd', u'Eddingpharm Inc', u'Novartis Pharma AG', u'Osteologix Holdings PLC', u'Sumitomo Pharmaceuticals Co Ltd', u'Galapagos NV', u'Critical Pharmaceuticals Ltd', u'International Discovery Sourcing Consultants, LLC', u'Daiichi Sankyo Europe GmbH', u'Institute Of Life Sciences', u'University of Valencia', u'Abgenix Inc', u'NeuroSearch A/S', u'Evgen Pharma plc', u'Samyang Corp', u'National Institute on Aging', u'National Research Council of Canada', u'Asubio Pharma Co Ltd', u'National Health and Medical Research Council', u'University of Nottingham', u'Eli Lilly Japan KK', u'Nitto Denko Corp', u'Mochida Pharmaceutical Co Ltd', u'ICON plc', u'Arcarios', u'Leiras Oy', u'TransPharma Medical Ltd', u'Hanmi Pharmaceutical Co Ltd', u'Solvay Pharmaceuticals Inc', u'Newron Pharmaceuticals SpA', u'Windtree Therapeutics Inc', u'Celera Group', u'CSPC Pharmaceuticals Group Limited', u'Access Business Group International', u'Medesis Pharma SA', u'DSM Nutritional Products AG', u'Rutgers University', u'Duramed Pharmaceuticals Inc', u'NPS Pharmaceuticals Inc', u'Progenra Inc', u'Grunenthal GmbH', u'Teikoku Hormone Manufacturing Co Ltd', u'Velcura Therapeutics Inc', u'Provalis plc', u'Richter-Helm BioTec GmbH & Co KG', u'Undisclosed', u'Azure Biotech Inc', u'Cytovance Biologics LLC', u'Daewoong Pharmaceutical Co Ltd', u'Eli Lilly & Co', u'Cygnus Inc', u'University of Wisconsin-Madison', u'Phyton Biotech Inc', u'Penwest Pharmaceuticals Co', u'Horizon Orphan LLC', u'University of California Los Angeles', u'Synthes (USA)', u'Fournier Pharma', u'National Taiwan University', u'Cancer Research Technology Ltd', u'Deltanoid Pharmaceuticals', u'Genexine Co Ltd', u'Ferrer Internacional SA', u'Shaare Zedek Medical Center', u'Mitsubishi Tanabe Pharma Factory Ltd', u'SmithKline Beecham plc', u'Taisho Pharmaceutical Co Ltd', u'Sebela Pharmaceuticals Inc', u'UCB Celltech', u'Servier', u'Bristol-Myers Squibb Co', u'Roche Palo Alto', u'Astellas Pharma Inc', u'Oramed Pharmaceuticals Inc', u'Insmed Inc', u'Rhone-Poulenc SA', u'Tarsa Therapeutics Inc', u'Hoechst Marion Roussel Inc', u'DRI Capital', u'UPM Pharmaceuticals Inc', u'EffRx Pharmaceuticals SA', u'Ciblex Corp', u'Incyte Corp', u'Orion Corporation', u'Sermonix Pharmaceuticals LLC', u'GalPharma Co Ltd', u'Chiesi Farmaceutici SpA', u'Auckland UniServices Ltd', u'Evolva Biotech A/S', u'ArQule Inc', u'Vernalis plc', u'Garvan Institute of Medical Research', u'Roche Holding AG', u'Shire plc', u'Procter & Gamble Pharmaceuticals Inc', u'Mayo Clinic Foundation', u'Teijin Pharma Ltd', u'Ribomic Inc', u'Novus Therapeutics Inc', u'National Institute of General Medical Sciences', u'Evotec AG', u'Meiji Seika Pharma Co Ltd', u'Amgen Inc', u'Karo Pharma AB', u'Center for Clinical and Basic Research AS', u'Sanofi (pre-1999)', u'Feiyang Biotech (Jilin) Co Ltd', u'NovaDx International Inc', u'Sandoz Korea Ltd', u'ProSkelia Pharmaceuticals SAS', u'Gemini Genomics plc', u'Tanabe Seiyaku Co Ltd', u'BioXell SpA', u'Proteos Inc', u'Ethicor Pharma Ltd', u'Yeda Research and Development Co Ltd', u'Shin Poong Pharmaceutical Co Ltd', u'BiologicsMD Inc', u'Ciba-Geigy AG', u'Dong-A ST Co Ltd', u'Biopharm GmbH', u'Hikma Pharmaceuticals plc', u'Prasco Laboratories', u'Osaka University', u'Emerillon Therapeutics Inc', u'University of California San Diego', u'Columbia University Health Sciences', u'Radius Health Inc', u'New Paradigm Therapeutics', u'University of Oxford', u'Green Cross Corp', u'Genentech Inc', u'Upsher-Smith Laboratories Inc', u'Mereo BioPharma Group Ltd', u'Korea Drug Development Fund', u'Aegis Therapeutics LLC', u'Osteopro A/S', u'Faran Laboratories SA', u'Ore Pharmaceuticals Inc', u'Dishman Pharmaceuticals & Chemicals Ltd', u'Actavis Inc', u'BDD/CCDRD Group', u'Nippon Chemiphar Co Ltd', u'Scripps Research Institute', u'Theratechnologies Inc', u'Ahn-Gook Pharmaceuticals Co Ltd', u'Stada Arzneimittel AG', u'Giddi Pharma Co Ltd', u'Alkermes plc', u'Bionovo Inc', u'CASI Pharmaceuticals Inc', u'Japan Tobacco Inc', u'Janssen Pharmaceuticals Inc', u'LION bioscience Inc', u'Kangwon National University', u'BioLineRx Ltd', u'Glide Pharmaceutical Technologies Ltd', u'Hyundai Pharmaceutical', u'Technology Strategy Board', u'Pharmatest', u'University of Utah', u'Vectura Group plc', u'Virchow Biotech Pvt Ltd', u'Genmab A/S', u'Harlan, Inc', u'Ligand Pharmaceuticals Inc', u'Altea Therapeutics', u'Abiogen Pharma SpA', u'A-Strong Co Ltd', u'Discovery BioMed Inc', u'Tzamal Bio-Pharma Ltd', u'Selective Genetics Inc', u'Henkel KGaA', u'3M Drug Delivery Systems', u'Dong Wha Pharmaceutical Co Ltd', u'Engineering and Physical Sciences Research Council', u'Hospira Adelaide Pty Ltd', u'Fontus Pharmaceuticals Inc', u'Mithra Pharmaceuticals', u'Osteometer BioTech AS', u'Par Pharmaceutical Inc', u'Cimphoni Life Sciences LLC', u'Takeda Pharmaceutical Co Ltd', u'CuraGen Corp', u'Novozymes A/S', u'Aventis Pharma SA', u'Roussel Uclaf Corp', u\"Dr Reddy's Laboratories Ltd\", u'Acceleron Pharma Inc', u'Telios Pharmaceuticals Inc', u'Binex Co Ltd', u'Zosano Pharma Corp', u'Yakult Honsha Co Ltd', u'Korea Research Institute of Chemical Technology', u'Ipsen Biopharmaceuticals Inc', u'Ministry of Health, Welfare and Family Affairs', u'Premier Inc', u'Aventis Pharma AG', u'OSI Pharmaceuticals Inc', u'University of Washington', u'Yonsei University', u'ARIAD Pharmaceuticals Inc', u'Chiva Pharmaceuticals Inc', u'Creighton University', u'Signal Research Division', u'SCOLR Pharma Inc', u'Klinge Pharma GmbH', u'Zydus Cadila Healthcare Ltd', u'Bioiberica SA', u'Bayer Corp', u'DNA Biomedical Solutions Ltd', u'Validus Pharmaceuticals', u'Mylan Inc', u'Harvard University', u'Boehringer Mannheim GmbH', u'BIOCND', u'GTx Inc', u'ZymoGenetics Inc', u'Teva Pharmaceutical Industries Ltd', u'Zeneca Group plc', u'Emisphere Technologies Inc', u'Lohmann Therapie-Systeme GmbH & Co KG', u'University of Louisville', u'MultiCell ImmunoTherapeutics Inc', u'Ferring Pharmaceuticals SA', u'Affilogic Laboratories', u'Glaxo Group Ltd', u'UAB Research Foundation', u'Amneal Pharmaceutical LLC', u'Parke-Davis & Co', u'Novo Nordisk A/S', u'Wyeth Pharmaceuticals', u'Donesta Bioscience Bv', u'Harvard Medical School', u'IDIS Ltd', u'National Institute of Diabetes, Digestive and Kidney Diseases', u'Integrated Oncology Solutions Inc', u'Medical College of Wisconsin', u'Merck & Co Inc', u'Sanofi', u'Daewon Pharm Co Ltd', u'Bayer AG', u'Amdipharm', u'Florida International University', u'Nektar Therapeutics', u'TissueGene Inc', u'Wyeth', u'Institute for the Promotion of Innovation by Science and Technology in Flanders', u'Aptuit Inc', u'Takeda Pharmaceuticals International GmbH', u'PolyNovo Ltd', u'Astra AB', u'DanioLabs Ltd', u'Welfide Corp', u'China Medical University (Taiwan)', u'Ablynx NV', u'Oscotec Inc', u'Elan Corp plc', u'FFF Enterprises', u'Enteris BioPharma Inc', u'MorphoSys AG', u'NPS Allelix Corp', u'Celgene Corp', u'Takeda Cambridge Ltd', u'Par Pharmaceutical Co Inc', u'Sosei Group Corp', u'Interleukin Genetics Inc', u'Ranbaxy Laboratories Ltd', u'Noven Pharmaceuticals Inc', u'NovaPharm Therapeutics', u'Delivra Corp', u'Alethia Biotherapeutics Inc', u'Kyowa Kirin', u'Beth Israel Deaconess Medical Center', u'Rhone-Poulenc Rorer Inc', u'GD Searle & Co', u'Kolon Life Science Inc', u'Daiichi Seiyaku Co Ltd', u'US Government', u'Hunter-Fleming Ltd', u'QUATRx Pharmaceuticals Co', u'National Institutes of Health', u'Kalytera Therapeutics Inc', u'Unigene Laboratories Inc', u'GlaxoSmithKline plc', u'Ipsen', u'Immunex Corp', u'Marina Biotech Inc', u'Takeda Oncology', u'Teysan Pharmaceutical Co Ltd', u'Ajinomoto Co Inc', u'Cytochroma Inc', u'Huons Co Ltd', u'Ranbaxy Pharmaceuticals Inc', u'Q-Pharm Pty Ltd', u'St Marianna University School of Medicine', u'Shionogi & Co Ltd', u'Ontogen Corp', u'Paras Biopharmaceuticals Finland Oy', u'US Department of Defense', u'Oxis Biotech Inc', u\"Boston Children's Hospital\", u'Sequenom Inc', u'Wockhardt Ltd', u'National Institute of Arthritis and Musculoskeletal and Skin Diseases', u'Botanix Pharmaceuticals Ltd', u'Eisai Co Ltd', u'Tanox Inc', u'Novartis AG', u'Indian Government Department of Biotechnology', u'Osiris Therapeutics Inc', u'The Procter & Gamble Co', u'ALZA Corp', u'Pharmacia & Upjohn Inc', u'Towa Pharmaceutical Co Ltd', u'Alize Pharma III SAS', u'Vericel Corp', u'Azelon Pharmaceuticals Inc', u'Johns Hopkins University', u'Myriad Genetics Inc', u'Nordic Bioscience A/S', u'Watson Laboratories Inc', u'Royalty Pharma', u'Aursos Inc', u'Chugai Pharmaceutical Co Ltd', u'Istituto Gentili SpA', u'Korea Research Institute of Bioscience and Biotechnology', u'Yuhan Corp', u'Jeil Pharmaceutical Co Ltd', u'Arris Pharmaceutical Corp', u'Indiana University Purdue University Indianapolis', u'Torii Pharmaceutical Co Ltd', u'Kissei Pharmaceutical Co Ltd', u'IMGENEX India Pvt Ltd', u'Nobex Corp', u'Teijin Ltd', u'Pfizer Inc', u'deCODE genetics ehf', u'Hanlim Pharmaceutical Co Ltd', u'Wyeth BioPharma', u'Shire Pharmaceutical Development Ltd', u'Laboratorios Farmaceuticos Rovi SA', u'MAX BioPharma', u'UK Government', u'Medivir AB', u'Biologix FZ Co', u'Vidasym LLC', u'Italian Government', u'NAEJA Pharmaceuticals Inc', u'Suzhou Alphamab Co Ltd', u'Food and Drug Administration', u'Gene Logic', u'Curis Inc', u'Yuyu Inc', u'Asahi Kasei Pharma Corp', u'Axxam SpA', u'Azign Bioscience A/S', u'The Green Cross Corp', u'Gedeon Richter Ltd', u'Sequana Therapeutics']), u'Helminthinfection': set([u'World Health Organization', u'Program for Appropriate Technology in Health', u'Massachusetts Institute of Technology', u'California Institute for Biomedical Research', u'Global Health Innovative Technology Fund', u'Novartis AG', u'Alnylam Pharmaceuticals Inc', u'Bill & Melinda Gates Foundation', u'Johns Hopkins Bloomberg School of Public Health', u'BIO Ventures for Global Health', u'National Institute of Allergy and Infectious Diseases', u'Sanofi', u'Drugs for Neglected Diseases Initiative', u'Abbott Laboratories', u'Thallia Pharmaceuticals SA', u'Medicines for Malaria Venture', u'Pharmacia & Upjohn Inc', u'GlaxoSmithKline plc']), u'Pancreastumor': set([u'RESprotect GmbH', u'Synteract Inc', u'University of Northern Colorado', u'Phoenix Pharmacologics Inc', u'Wilex AG', u'Advanced BioScience Laboratories Inc', u'COARE Biotechnology Inc', u'Panacea Pharmaceuticals Inc', u'NYU School of Medicine', u'Tyme Technologies Inc', u'US Health and Human Services Department', u'Champions Oncology Inc', u'National Comprehensive Cancer Network', u'Asuragen Inc', u'Inovio Pharmaceuticals Inc', u'Aura Biosciences Inc', u'Samsung Pharmaceuticals', u'MethylGene Inc', u'Oncomatryx SL', u'Rexbio Inc', u'Ventana Medical Systems Inc', u'European Community', u'Vericel Corp', u'University of Pittsburgh', u'University of Arizona', u'tella Inc', u'Bio-Path Holdings Inc', u'Minomic International Ltd', u'Almirall Prodesfarma SA', u'Sandoz Ltd', u'Catalent Inc', u'Abgenix Inc', u'NantCell Inc', u'Centre Hospitalier Universitaire de Toulouse', u'Sanofi Pasteur', u'London Genetics Ltd', u'CrystalGenomics Inc', u'University of Minnesota', u'National Health and Medical Research Council', u'Polaris Pharmaceuticals Inc', u'University of Nottingham', u'Israeli Government', u'Centre National de la Recherche Scientifique (CNRS)', u'Zor Pharmaceuticals', u'MediGene AG', u'Apptec Inc', u'Theragence Inc', u'Tempus Inc', u'Yakult Honsha Co Ltd', u'Sunshine Biopharma Inc', u'Vanderbilt University', u'Concordia Pharmaceuticals Inc', u'CytomX Therapeutics Inc', u'Ajinomoto Althea Inc', u'Rottapharm Madaus', u'Resarci Therapeutics LLC', u'YM BioSciences Inc', u'National Jewish Health', u'Indivumed GmbH', u'Kancera AB', u'Immunomedics Inc', u'Regulon Inc', u'Titan Pharmaceuticals Inc', u'Centro Nacional de Investigaciones Oncologicas', u'ImmunoGen Inc', u'MegaPharm Ltd', u'Altor BioScience Corp', u'Cortice Biosciences Inc', u'National Health Research Institutes', u'Kura Oncology Inc', u'Ohio University', u'Infinity Pharmaceuticals Inc', u'Oslo University Hospital', u'Bexion Pharmaceuticals LLC', u'Rutgers University', u'Raven Biotechnologies Inc', u'Astrimmune', u'Shanghai Jingfeng Pharmaceutical Co Ltd', u'D Western Therapeutics Institute', u'Ajinomoto Co Inc', u'Biothera Pharmaceuticals Inc', u'Protherics Salt Lake City Inc', u'Apogee Biotechnology Corp', u'Morehouse School Of Medicine', u'Sentinel Oncology Ltd', u'Purdue University', u'Onconova Therapeutics Inc', u'Oregon Health Sciences University', u'JW CreaGene Inc', u'Centro para el Desarrollo Tecnologico Industrial', u'Daewoong Pharmaceutical Co Ltd', u'biolitec AG', u'4P Pharma', u'Quay Pharmaceuticals Ltd', u'Vion Pharmaceuticals Inc', u'Eli Lilly & Co', u'Celsion Corp', u'US Surgical Corp', u'OncoMab GmbH', u'Weizmann Institute of Science', u'University of Barcelona', u'Rexahn Pharmaceuticals Inc', u'University of California Los Angeles', u'Algae Dynamics Corp', u'Universit\\xe9 De Strasbourg', u'Corixa Corp', u'Cancer Research Technology Ltd', u'Patrys Ltd', u'Sanwa Kagaku Kenkyusho Co Ltd', u'Kansas State University', u'Innate Pharma SA', u'OSI Pharmaceuticals Inc', u'Myriad Genetics Inc', u'Dalton Pharma Services', u'Peking University Health Science Center', u'SmithKline Beecham plc', u'Taisho Pharmaceutical Co Ltd', u'Northwestern University', u'Cancer Prevention and Research Institute of Texas', u'Epic Sciences Inc', u'Fresenius SE & Co KGaA', u'GeneSense Technologies', u'BioCancell Therapeutics Ltd', u'University City Science Center', u'Astellas Pharma Inc', u'Institute of Cancer Research UK', u'Hokkaido University', u'PureTech Health Plc', u'Oncormed Inc', u'Agouron Pharmaceuticals Inc', u'Hollister-Stier Laboratories LLC', u'Taivex Therapeutics Inc', u'Munich Biotech AG', u'ImaginAb Inc', u'Karolinska Institutet', u'Hospital Universitario Central de Asturias', u'Barbara Ann Karmanos Cancer Institute', u'Salmedix Inc', u'Sun BioPharma Inc', u'Ardea Biosciences Inc', u'Lustgarten Foundation', u'Pharmacyclics Inc', u'Cell Culture Company LLC', u'BTG plc', u'Centelion SAS', u'Chiron Corp', u'Ludwig Institute for Cancer Research', u'Zhejiang Hisun Pharmaceutical Co Ltd', u'Bristol-Myers Squibb Co', u'Xenova Group plc', u'Morphotek Inc', u'Chinese Government', u'Astex Pharmaceuticals Inc', u'Vernalis plc', u'University of Pennsylvania', u'Navidea Biopharmaceuticals Inc', u'Ono Pharmaceutical Co Ltd', u'Garvan Institute of Medical Research', u'Roche Holding AG', u'Lankenau Institute for Medical Research', u'University of British Columbia', u'Biocompatibles International plc', u'Gradalis Inc', u'ANI Pharmaceuticals Inc', u'Virginia Commonwealth University', u'Selvita SA', u'Binational Industrial Research and Development Foundation', u'Biocon Ltd', u'Bayer HealthCare AG', u'Texas Tech University', u'Dana-Farber Cancer Institute Inc', u'Orient Europharma', u'Diomed Ltd', u'Aspyrian Therapeutics Inc', u'University of Florida College of Medicine', u'Amgen Inc', u'State University of New York at Stony Brook', u'Baxter Oncology GmbH', u'Ohio State University', u'Lonza Walkersville Inc', u'RedHill Biopharma Ltd', u'Southern Research Institute', u'Georgetown University', u'AlgoNomics NV', u'Georgetown University Medical Center', u'MabVax Therapeutics Holdings Inc', u'University of Alabama at Birmingham', u'Immunovo BV', u'Confluence Life Sciences Inc', u'Samyang Corp', u'OncoQR OG', u'Biodesix Inc', u'Enzon Pharmaceuticals Inc', u'Goodwin Biotechnology Inc', u'Indian Institute Of Technology Madras', u'Advantagene Inc', u'Pennsylvania State University', u'Pharma Patch plc', u'Pancreatic Cancer Action Network', u'Cytovance Biologics LLC', u'Pangaea Biotech SA', u'Osaka University', u'University of Waterloo', u'University of California San Diego', u'SG Austria', u'NOXXON Pharma AG', u'TrovaGene Inc', u'Cancer Research UK', u'National Foundation For Cancer Research', u'Genentech Inc', u'Mayo Clinic Foundation', u'Rigel Pharmaceuticals Inc', u'Oxford GlycoSciences plc', u'Weill Medical College of Cornell University', u'Reino de Espana', u'Garden State Cancer Center', u'Laureate Biopharmaceutical Services Inc', u'Pennsylvania Department of Health', u'Universitaet Stuttgart', u'PDL BioPharma Inc', u'Scripps Research Institute', u'Redx Pharma Plc', u'Efamol', u'Shenzhen Hepalink Pharmaceutical Group Co Ltd', u'University of Southern California', u'Medison Pharma Ltd', u'Bionovo Inc', u'DiaCarta LLC', u'AIT Austrian Institute Of Technology Gmbh', u'ScinoPharm Taiwan Ltd', u'Immunovia AB', u'Karolinska University Hospital', u'Fundacion Marques de Valdecilla', u'MRI Interventions Inc', u'Wuhan University', u'AEterna Zentaris Inc', u'IVAX Corp', u'CivaTech Oncology', u'AstraZeneca plc', u'Caprion Proteomics Inc', u'University of Texas Southwestern Medical Center', u'Undisclosed', u'diaDexus LLC', u'Do-Coop Technologies Ltd', u'Beijing Pason Pharmaceuticals Inc', u'Lonza Biologics plc', u'Carrington Laboratories Inc', u'Nippon Shinyaku Co Ltd', u'Introgen Therapeutics Inc', u'Hemispherx Biopharma Inc', u'PharmaCyte Biotech Inc', u'Translational Genomics Research Institute', u'Genmab A/S', u'H Lee Moffitt Cancer Center and Research Institute', u'Biolex Therapeutics Inc', u'Tikcro Technologies Ltd', u'Medipharm Biotech Co Ltd', u'IDT Australia Ltd', u'Proteomika SL', u'Axlr Satt Du Languedoc Roussillon', u'Maryland Innovation Initiative', u'Aqualis ASA', u'Early Diagnosis Consortium', u'Moleculin Biotech Inc', u'ICOS Corp', u'Shandong Chengchuang Pharmaceutical R&D Co Ltd', u'Florida Atlantic University', u'Cambridge University Hospitals NHS Foundation Trust', u'Adria Laboratories Inc', u'National Institute of Biomedical Imaging and Bioengineering', u'Pepscan Systems BV', u'NanoCarrier Co Ltd', u'Selecta Biosciences Inc', u'GE Healthcare', u'Aphton Corp', u'PiSA Farmaceutica', u'Interthyr Corp', u'University of Toronto', u'University of Cambridge', u'German Federal Ministry of Education and Research', u'Viatar LLC', u'Acceleron Pharma Inc', u'Tara Immuno-Oncology LLC', u'University of Florida', u'Cerus Corp', u'Arana Therapeutics Ltd', u'Cellcor Inc', u'EMD Serono Inc', u'TGen Drug Development', u'OncoTherapy Science Inc', u'Forest Laboratories Inc', u'NeoPharm Inc', u'Quintiles Transnational Corp', u'Intensity Therapeutics Inc', u'Vernalis Group plc', u'Uppsala University', u'IDT Biologika GmbH', u'AvantGen Inc', u'MedImmune LLC', u'Eleison Pharmaceuticals Inc', u'University of Washington', u'Fred Hutchinson Cancer Research Center', u'Five Prime Therapeutics Inc', u'ARIUS Research Inc', u'Bavarian Research Foundation', u'Debiovision Inc', u'Aravive Biologics Inc', u'Best Med Opinion Ltd', u'Felicitex Therapeutics Inc', u'National Institute of Public Health, Japan', u'Sanford-Burnham Medical Research Institute', u'Microbial Chemistry Research Foundation', u'Rexgene Biotech Co Ltd', u'Amcure GmbH', u'University of Nebraska Medical Center', u'OncoTherics', u'International Biotechnology Center Generium LLC', u'Singapore Technologies Pte Ltd', u'Inex Pharmaceuticals Corp', u'Intas Pharmaceuticals Ltd', u'Incyte Corp', u'Mylan Inc', u'Affitech A/S', u'Harvard University', u'Mast Therapeutics Inc', u'Hubei Qianjiang Pharmaceutical Co Ltd', u'Selective Genetics Inc', u'VAXIMM AG', u'Clovis Oncology Inc', u'PsychoGenics Inc', u'Aphios Corp', u'Acuvax Ltd', u'MediBIC', u'Diatos SA', u'Syros Pharmaceuticals', u'Cancer Advances Inc', u'Kwang Dong Pharmaceutical Co Ltd', u'RTP Pharma Corp', u'University of California San Francisco', u'GlobeImmune Inc', u'Fraunhofer-Institute fur Zelltherapy und Immunologie', u'Oncolytics Biotech Inc', u'FibroGen Inc', u'Evestra Inc', u'Threshold Pharmaceuticals Inc', u'MabVax Therapeutics Inc', u'Precision Biologics Inc', u'ProlX Pharmaceuticals LP', u'Boehringer Ingelheim Corp', u'Personalized Cancer Therapy Inc', u'Debiopharm SA', u'Scotia Holdings plc', u'CureFAKtor Pharmaceuticals LLC', u'Duke University Medical Center', u'Abramson Cancer Center of the University of Pennsylvania', u'Harvard Medical School', u'Histogen Inc', u'Universita di Bologna', u'Schering-Plough Corp', u'CMC Biologics Inc', u'Shanghai Institute of Materia Medica of the Chinese Academy of Sciences', u'Argos Therapeutics Inc', u'XOMA Corp', u'University of California', u'Merck & Co Inc', u'3B Pharmaceuticals Gmbh', u'University Hospital Heidelberg', u'CFD Therapeutics Inc', u'Sanofi', u'Tauriga Sciences Inc', u'Novogen Ltd', u'Pharmacia Corp', u'Cambridge Biomedical Inc', u'SignaBlok Inc', u'Case Western Reserve University', u'The UK Imperial Cancer Research Fund', u'Acoustic Medsystems Inc', u'Nektar Therapeutics', u'Jikei University', u'Link Health Group', u'Therapure Biopharma Inc', u'Tamir Biotechnology Inc', u'ArQule Inc', u'NeoGenix Oncology Inc', u'Gilead Sciences Inc', u'Triangle Pharmaceuticals Inc', u'Merrimack Pharmaceuticals Inc', u'NEC Corp', u'ChemRegen Inc', u'Aix-Marseille Universit\\xe9', u'Baxter Healthcare Ltd', u'Genisphere LLC', u'Keaise Medicine Corp', u'Massachusetts Institute of Technology', u'Imclone LLC', u'Chongqing LUMMY Pharmaceutical Co Ltd', u'Knight Cancer Institute', u'The University Health Network', u'Western University Of Health Sciences', u'University of Mississippi', u'Lonza Group AG', u'Sophiris Bio Inc', u'Elan Corp plc', u'City of Hope', u'INSERM', u'Sanofi Genzyme', u'CJ Corp', u'OriBase Pharma', u'Celgene Corp', u'Research Development Foundation', u'National Institute on Alcohol Abuse and Alcoholism', u'Robert H Lurie Cancer Center', u'Oakwood Laboratories LLC', u'Clinical Network Services', u'Inno Biologics Sdn Bhd', u'Alethia Biotherapeutics Inc', u'Sydys Corp', u'Bayer HealthCare Pharmaceuticals Inc', u'North Shore Long Island Jewish Health System', u'Talon Therapeutics Inc', u'Abraxis BioScience Inc', u'Provectus Biopharmaceuticals Inc', u'Epeius Biotechnologies Corp', u'Rhone-Poulenc Rorer Inc', u'Quest PharmaTech Inc', u'Daiichi Seiyaku Co Ltd', u'Acceptys Inc', u'Wylde LLC', u'US Government', u'Cancer Research Technology Pioneer Fund', u'The Leukemia & Lymphoma Society', u'Baxter International Inc', u'Jupiter Orphan Therapeutics Inc', u'InvivoGen Therapeutics', u'GenVec Inc', u'OncoVent Co Ltd', u'Biogen Inc', u'GlaxoSmithKline plc', u'NantKwest Inc', u'Cell Genesys Inc', u'ITI Health Inc', u'Berg Pharma LLC', u'Caris Life Sciences', u'Cascadian Therapeutics Inc', u'Novotech (Australia) Pty Ltd', u'Ipsen', u'Immunex Corp', u'Cavion LLC', u'University of Michigan', u'Lokon Pharma AB', u'Kringle Pharma Inc', u'Aduro BioTech Inc', u'Almac Diagnostics', u'Halozyme Therapeutics Inc', u'Bionaut Pharmaceuticals Inc', u'Cold Spring Harbor Laboratory', u'Peregrine Pharmaceuticals Inc', u'Nascent Biotech Inc', u'Davos Life Science Pte Ltd', u'Kochi University', u'ERYtech Pharma', u'Emory University', u'National Heart Lung and Blood Institute', u\"Boston Children's Hospital\", u'Ambry Genetics Corp', u'RecipharmCobra Biologics', u'Focused Ultrasound Surgery Foundation', u'Cell Pathways Inc', u'Iovance Biotherapeutics Inc', u'MD Anderson Cancer Center', u'Medarex Inc', u'Reata Pharmaceuticals Inc', u'Daiichi Sankyo Co Ltd', u'Abbott Laboratories', u'ClearLight Diagnostics', u'3SBio Inc', u'Cloud Pharmaceuticals Inc', u'University of Chicago', u'National Cancer Institute', u'Novartis AG', u'Merck KGaA', u'Korea Research Institute of Bioscience and Biotechnology', u'University of Maryland', u'National Brain Tumor Society', u'SciClone Pharmaceuticals Inc', u'Stehlin Foundation For Cancer Research', u'Galectin Therapeutics Inc', u'Aptose Biosciences Inc', u'Taiho Pharmaceutical Co Ltd', u'University of Colorado System', u'Midatech Pharma US Inc', u'Universitair Medisch Centrum Utrecht', u'Washington University in St Louis', u'Leidos Biomedical Research Inc', u'Health Care Logistics Inc', u'Johns Hopkins University', u'The Center of Molecular Immunology', u'Tapestry Pharmaceuticals Inc', u'Lazarex Cancer Foundation', u'Kyowa Hakko Kogyo Co Ltd', u'Fuso Pharmaceutical Industries Ltd', u'AmpliPhi Biosciences Corp', u'OncoMed Pharmaceuticals Inc', u'Chugai Pharmaceutical Co Ltd', u'Sinopharm', u'GENESIS Pharma SA', u'Andrus Reo Ltd', u'Station X Inc', u'Quimatryx', u'Otsuka Pharmaceutical Co Ltd', u'Primus Pharmaceuticals Inc', u'CendR Inc', u'Montefiore Medical Center', u'Stason Pharmaceuticals Inc', u'Medivir AB', u'Heidelberg Pharma Holding Ltd', u'Tufts University School of Medicine', u'Ability Pharmaceuticals SL', u'ImmunoCellular Therapeutics Ltd', u'Royal Philips Electronics', u'BiPar Sciences Inc', u'OncoQuest Inc', u'University of Miami', u'UC San Diego Moores Cancer Center', u'University of Virginia', u'Kyowa Hakko Kirin Co Ltd', u'Immune Therapeutics Inc', u'Zetiq Technologies Ltd', u'Janssen Biotech Inc', u'The University of Liverpool', u'BioVectra DCL', u'Pfizer Inc', u'Polybiocept Ab', u'The Royal Marsden NHS Trust', u'Yissum Research Development Co', u'Memorial Sloan-Kettering Cancer Center', u'Mount Sinai Medical Center', u'Therion Biologics Corp', u'LG Life Sciences Ltd', u'Baylor College of Medicine', u'UK Government', u'Norsk Hydro AS', u'In Ovations Holdings Inc', u'Mirna Therapeutics Inc', u'Paul Scherrer Institut', u'MEI Pharma Inc', u'University of New Mexico', u'Prima BioMed Ltd', u'National Institute of Allergy and Infectious Diseases', u'Miltenyi Biotec GmbH', u'Takeda Pharmaceutical Co Ltd', u'Innovation Norway', u'TYG Oncology Ltd', u'Octamer Inc', u'Eisai Co Ltd', u'NuView Life Sciences', u'Albert Einstein College of Medicine', u'Aarhus University', u'Targovax AS', u'National Institutes of Health', u'Food and Drug Administration', u'South Texas Accelerated Research Therapeutics', u'Interpace Diagnostics Group Inc', u'Onyx Pharmaceuticals Inc', u'Roswell Park Cancer Institute', u'Seena Magowitz Foundation', u'Transgenomic Inc', u'Beth Israel Deaconess Medical Center', u'YM BioSciences USA', u'Educational and Scientific LLC', u'Araxes Pharma LLC', u'Ferozsons Laboratories Ltd', u'Macquarie University', u'Merck Serono SA', u'GemVax & Kael Co Ltd', u'Takara Bio Inc', u'H2Biologics, Inc', u'Riptide Bioscience Inc', u'Idera Pharmaceuticals Inc', u'Sidney Kimmel Comprehensive Cancer Center', u'NCI Alliance for Nanotechnology in Cancer', u'Cancer Therapy & Research Center', u'University of Michigan Comprehensive Cancer Center', u'Mayne Pharma Pty Ltd', u'Immunovative Therapies Ltd', u'Prospect Therapeutics Inc']), u'Allergicrhinitis': set([u'Afferon Corp', u'Perrigo Co Ltd', u'iCo Therapeutics Inc', u'Hunter-Fleming Ltd', u'Galenica AG', u'Nippon Chemiphar Co Ltd', u'Rhone-Poulenc Rorer Pharm Inc', u'Silence Therapeutics plc', u'Arana Therapeutics Ltd', u'Sanofi Canada', u'US Government', u'Biogen Inc', u'Pharmacyclics Inc', u'GlaxoSmithKline plc', u'Quintiles Transnational Corp', u'Chiesi Farmaceutici SpA', u'Tris Pharma Inc', u'Solvay SA', u'Pulmagen Therapeutics', u'Torii Pharmaceutical Co Ltd', u'Ionis Pharmaceuticals Inc', u'ORA Inc', u'Virtici LLC', u'University of Iowa', u'ZymoGenetics Inc', u'ISTA Pharmaceuticals Inc', u'Stanford Rook Ltd', u'IMPAX Laboratories Inc', u'FAES Farma SA', u'Ono Pharmaceutical Co Ltd', u'Allergopharma GmbH & Co KG', u'Hanmi Pharmaceutical Co Ltd', u'Pharmacia & Upjohn Diagnostics AB', u'SBI Biotech Co Ltd', u'Novis Pharmaceuticals Llc', u'Aptalis Pharma Srl', u'Sun Pharmaceutical Industries Ltd', u'RIKEN', u'Sankyo Co Ltd', u'Vianex SA', u'Allergy Therapeutics plc', u'Nicox Ophthalmics Inc', u'Grunenthal GmbH', u'elbion AG', u'Amalyte Pharmaceuticals LLC', u'Catalent Inc', u'Inspire Pharmaceuticals Inc', u'Defense Advanced Research Projects Agency', u'Orexo AB', u'Cobalt Pharmaceuticals', u'3E Therapeutics Corp', u'Orient Europharma', u'Hikma Pharmaceuticals plc', u'Fountain BioPharma Inc', u'J Uriach & Cia SA', u'Innovus Pharmaceuticals Inc', u'Centre for Human Drug Research', u'Pharmacare Ltd', u'Laboratorios Servimedic', u'Charles River Laboratories International Inc', u'University of Nottingham', u'Evolutec Group plc', u'SCYNEXIS Inc', u'Mylan Inc', u'Pediapharm Inc', u'Daiichi Sankyo Co Ltd', u'Portola Pharmaceuticals Inc', u'Eisai Co Ltd', u'University of Aberdeen', u'Tanox Inc', u'Biosintetica Farmaceutica Ltda', u'Novartis AG', u'Akari Therapeutics Plc', u'University of Bristol', u'Teamm Pharmaceuticals', u'Pendopharm', u'Teva Pharmaceutical Industries Ltd', u'Inflamax Research Inc', u'Agence Nationale de Valorisation de la Recherche', u'Swiss Institute of Allergy & Asthma Research', u'Sanofi-Synthelabo', u'Tanabe Seiyaku Co Ltd', u'Boehringer Ingelheim International GmbH', u'UCB SA', u'Inflazyme Pharmaceuticals', u'YM BioSciences Inc', u'Fraunhofer-Institute fur Zelltherapy und Immunologie', u'Concordia Pharmaceuticals Inc', u'Mundipharma EDO GmbH', u'Mitsubishi-Tokyo Pharmaceuticals Inc', u'Janssen Pharmaceutical KK', u'Eurofarma', u'Biovail Technologies Ltd', u'Kyorin Pharmaceutical Co Ltd', u'Harrison Clinical Research', u'Cilag AG', u'Sosei Group Corp', u'Greer Laboratories Inc', u'Immunomic Therapeutics Inc', u'Dong-A ST Co Ltd', u'Prasco Laboratories', u'Nuvo Pharmaceuticals Inc', u'Janssen Pharmaceutica NV', u'Taiho Pharmaceutical Co Ltd', u'Lupin Ltd', u'Shionogi & Co Ltd', u'Accolade Pharmaceuticals Pte Ltd', u'Recordati SpA', u'Seikagaku Corp', u'Highnoon Laboratories Ltd', u'Chugai Pharmaceutical Co Ltd', u'Meda Pharma Gmbh & Co Kg', u'Green Cross Corp', u'Genentech Inc', u'University of Montpellier', u'Hyphens Pharma Pte Ltd', u'Paladin Labs Inc', u'Hayashibara Biochemical Laboratories Inc', u'Andrx Corp', u'Mayo Clinic Foundation', u'Verona Pharma plc', u'Suzhou Connect Biopharmaceuticals Ltd', u'Cipla Ltd', u'Shionogi Inc', u'Schering-Plough Corp', u'Bayer Yakuhin Ltd', u'Shionogi Pharma Inc', u'CMC Biologics Inc', u'NTC srl', u'Innovata Biomed Ltd', u'Undisclosed', u'Dongguk University', u'Biomay AG', u'Altus Formulation', u'Sakai Chemical Industry Co Ltd', u'Biolipox AB', u'Merck & Co Inc', u'Muro Pharmaceutical Inc', u'Ahn-Gook Pharmaceuticals Co Ltd', u'Collegium Pharmaceutical Inc', u'Chong Kun Dang Pharmaceutical Corp', u'Curalogic A/S', u'FSC Laboratories Inc', u'CRC For Biopharmaceutical Research Pty Ltd', u'Pierre Fabre SA', u'Ovamed GmbH', u'Barr Pharmaceuticals Inc', u'Meiji Co Ltd', u'Kyowa Hakko Kirin Co Ltd', u'University of Salzburg', u'NicOx SA', u'Kissei Pharmaceutical Co Ltd', u'Argenta Discovery Ltd', u'Actient Pharmaceuticals LLC', u'Almirall Prodesfarma SA', u'The Doctors Healthcare company plc', u'AstraZeneca plc', u'Pfizer Inc', u'Sanofi', u'Kaken Pharmaceutical Co Ltd', u'Corixa Corp', u'Meiji Seika Pharma Co Ltd', u'UBE Industries Ltd', u'Onyvax Ltd', u'Acambis plc', u'Ziarco Pharma Ltd', u'Alcon Inc', u'Nippon Shinyaku Co Ltd', u'Coley Pharmaceutical Group Inc', u'Laboratorios Elmor SA', u'West-Ward Pharmaceutical Corp', u'Takeda Pharmaceuticals International GmbH', u'Asphelia Pharmaceuticals Inc', u'National Institute of Allergy and Infectious Diseases', u'Astra AB', u'Sunovion Pharmaceuticals Inc', u'Arena Pharmaceuticals Inc', u'Helixir Co Ltd', u'Lonza Group AG', u'Stallergenes SA', u'Phylogica Ltd', u'National Institutes of Health', u'Grupo Uriach', u'ALK-Abello', u'Bristol-Myers Squibb Co', u'Eczacibasi Ilac Pazarlama AS', u'bene Corp', u'Taisho Pharmaceutical Co Ltd', u'MSD Japan', u'ICOS Corp', u'The Menarini Group', u'CJ Corp', u'University College London', u'Takeda Oncology', u'Universite de Rouen', u'DBV Technologies SA', u'Astellas Pharma Inc', u'Laboratorios Leti SL', u'Dong Wha Pharmaceutical Co Ltd', u'Paradigm Biopharmaceuticals Ltd', u'University of Ghent', u'Covis Pharma Sarl', u'Program for Appropriate Technology in Health', u'Ranbaxy Laboratories Ltd', u'PLIVA dd', u'Fujirebio KK', u'Tabuk Pharmaceutical Manufacturing Co', u'Cambrex Corp', u'Merck Serono SA', u'Meda AB', u'YooYoung Pharmaceuticals Co Ltd', u'DIC Corp', u'Hayashibara Co Ltd', u'Stallergenes Greer plc', u'Sanofi-Aventis US LLC', u'Tribute Pharmaceuticals Canada Inc', u'Takeda Pharmaceutical Co Ltd', u'Merck KGaA', u'Boryung Pharm Co Ltd', u'BIAL Group', u'SkyePharma plc', u'Roxall Medizin GmbH', u'S-TARget therapeutics']), u'Transplantrejection': set([u'Biovest International Inc', u'US Government', u'Baxter International Inc', u'Schwarz Pharma Ltd', u'Proteo Biotech AG', u'National Institute of Allergy and Infectious Diseases', u'Netherlands Government', u'IDM Pharma Inc', u'Industrial Technology Research Institute', u'Biogen Inc', u'Maxygen Inc', u'Nostrum Pharmaceuticals Inc', u'Breath Therapeutics Holding BV', u'BTG plc', u'Bayer Schering Pharma AG', u'Chiron Corp', u'Ionis Pharmaceuticals Inc', u'Merck Serono SA', u'Teva Pharmaceutical Industries Ltd', u'Theratase plc', u'Circassia Pharmaceuticals plc', u'MedImmune LLC', u'Pacific Therapeutics Ltd', u'Stanford University', u'The Austrian Research Promotion Agency FFG', u'INSERM Transfert', u'Celldex Therapeutics Inc', u'Leiden University Medical Center', u'Zeneca Group plc', u'Hammersmith Hospital', u'Stromedix Inc', u'Takeda Oncology', u'Roche Holding AG', u'Pharma Pacific Pty Ltd', u'University of British Columbia', u'Mycosearch Inc', u'Sandoz Ltd', u'Coral Therapeutics, Inc', u'Auritec Pharmaceuticals Inc', u'Atrium Medical Corp', u'Ludwig Institute for Cancer Research', u'University of Kentucky', u'Canadian Institutes of Health Research', u'PanGenetics BV', u'BioTransplant Inc', u'Medical Research Council', u'Innovata plc', u'Agence nationale de la recherche (ANR)', u'Glasgow University', u'Dana-Farber Cancer Institute Inc', u'Orient Europharma', u'National Research Council of Canada', u'RecipharmCobra Biologics', u'Medical University of Vienna', u'TxCell SA', u'Weill Medical College of Cornell University', u'Inex Pharmaceuticals Corp', u'Beckman Coulter Inc', u'Active Biotech AB', u'Tohoku University', u'Amgen Inc', u'Medarex Inc', u'Chelsea Therapeutics International Ltd', u'SangStat Medical Corp', u'Emory University', u'Abbott Laboratories', u'Mochida Pharmaceutical Co Ltd', u'Aspreva International Ltd', u'National Center for Research Resources', u'Boehringer Mannheim GmbH', u'The University of Birmingham', u'Novartis AG', u'Aphios Corp', u'Fujisawa Pharmaceutical Co Ltd', u'Keryx Biopharmaceuticals Inc', u'Cantab Biopharmaceuticals Ltd', u'CytoCore Inc', u'Vertex Pharmaceuticals Inc', u'Veloxis Pharmaceuticals A/S', u'Massachusetts General Hospital', u'Abgenix Inc', u'BioXell SpA', u'GlobeImmune Inc', u'Inflazyme Pharmaceuticals', u'Monash University', u'Celltrion Inc', u'Tolerx Inc', u'Universite Catholique de Louvain', u'Kyorin Pharmaceutical Co Ltd', u'University of Navarra', u'ImmunoGen Inc', u'AtheroGenics Inc', u'Albany Molecular Research Inc', u'Millennium Pharmaceuticals Ltd', u'Primatope Therapeutics', u'University of Auckland', u'Transplant Genomics', u'University of Edinburgh', u'Fujirebio Europe NV', u'ImmuNext Inc', u'Johns Hopkins University', u'Baxter Healthcare Corp', u'Golden Jubilee National Hospital', u'Kyowa Hakko Kogyo Co Ltd', u'Tokai University School of Medicine, Japan', u'Lynx Therapeutics GmbH', u'Debiopharm SA', u'Kamada Ltd', u'ILEX Oncology Inc', u'University of Colorado System', u'Chugai Pharmaceutical Co Ltd', u'Viron Therapeutics Inc', u'Tolera Therapeutics Inc', u'Genentech Inc', u'Paladin Labs Inc', u'Hayashibara Biochemical Laboratories Inc', u'Harvard Medical School', u'Mayo Clinic Foundation', u'Rigel Pharmaceuticals Inc', u'Cipla Ltd', u'Baylor Research Institute', u'Taiba Pharma LLC', u'Thios Pharmaceuticals Inc', u'CLL Pharma', u'Laureate Biopharmaceutical Services Inc', u'Diabetogen BioSciences Inc', u'Ark Therapeutics Group plc', u'Undisclosed', u'Argos Therapeutics Inc', u'Emergent BioSolutions Inc', u'PDL BioPharma Inc', u'XOMA Corp', u'British Heart Foundation', u'TcLand SA', u'ChemoCentryx Inc', u'Celonic AG', u'Sanofi', u'DNA Pharmaceuticals Inc', u'Eli Lilly & Co', u'Isotechnika Pharma Inc', u'Medexus Inc', u'Synt:em', u'Symmetrix Pharmaceuticals LLC', u'Bayer AG', u'Isogenis Inc', u'Louisiana State University', u'Medinox Inc', u'Kyowa Hakko Kirin Co Ltd', u'Peptor Ltd', u'Trillium Therapeutics', u'GroupMed (Holding)', u'Inotek Pharmaceuticals Corp', u'rEVO Biologics Inc', u'Effimune SA', u'Therapure Biopharma Inc', u'Apeptico Forschung und Entwicklung GmbH', u'Pfizer Inc', u'University of Southern California', u'Idera Pharmaceuticals Inc', u'Corixa Corp', u'Chong Kun Dang Pharmaceutical Corp', u'Wyeth', u'Elevant BioPharma', u'Akorn Inc', u'Nordic Group', u'Janssen-Cilag Ltd', u'LG Life Sciences Ltd', u'Tularik Inc', u'Lorantis Ltd', u'Artes Biotechnology', u'Patch International Inc', u'Emory University Technology Transfer Office', u'myTomorrows', u'Nippon Kayaku Co Ltd', u'Taisho Pharmaceutical Co Ltd', u'Organix Inc', u'PowderJect Pharmaceuticals plc', u'Lonza Group AG', u'The Australian National University', u'Walter Reed Army Institute of Research', u'National Institutes of Health', u'Pharmalink AB', u'3SBio Inc', u'Bristol-Myers Squibb Co', u'Elan Corp plc', u'OSEO', u'Asahi Kasei Pharma Corp', u'Fujifilm Diosynth Biotechnologies', u'American Heart Association', u'VG Life Sciences Inc', u'Imperial College School of Medicine', u'Astellas Pharma Inc', u'Advanced Biotherapy Inc', u'Medical University of South Carolina', u'Institute of Microbial Technology', u'Coulter Pharmaceutical Inc', u'F Hoffmann-La Roche AG', u'University of Western Ontario', u'Hebrew University of Jerusalem', u'University of California Irvine', u'AVAX Technologies Inc', u'Cytopia Ltd', u'Digna Biotech SL', u'Repligen Corp', u'Cypress Bioscience Inc', u'Cardion AG', u'OPi SA', u'University of Alberta', u'Beth Israel Deaconess Medical Center', u'Taligen Therapeutics Inc', u'APT Pharmaceuticals Inc', u'PARI Pharma GmbH', u'BioCryst Pharmaceuticals Inc', u'University of Cambridge']), u'Condyloma': set([u'Xiamen Innovax Biotech Co Ltd', u'Hemispherx Biopharma Inc', u'OriGenix Technologies Inc', u'Biofrontera AG', u'CEL-SCI Corp', u'Mochida Pharmaceutical Co Ltd', u'Engitech Inc', u'Azanta A/S', u'Beijing Zhifei Luzhu Biopharmaceutical Co Ltd', u'Bradley Pharmaceuticals Inc', u'Royal Gist-Brocades NV', u'Meditrina Pharmaceuticals Inc', u'MediGene AG', u'Emergent Health Corp', u'Interferon Sciences Inc', u'Xiamen University', u'Sinclair Pharma plc', u'Pharmanova Doo', u'Telormedix SA', u'University of California', u'BMG Pharma LLC', u'Idera Pharmaceuticals Inc', u'European Eurostars Programme', u'Merck & Co Inc', u'Parabolic Drugs Ltd', u'Hafslund Nycomed Innovation AB', u'Hong Kong University of Science & Technology', u'Oclassen Pharmaceuticals Inc', u'Kora Healthcare', u'Deutsches Krebsforschungszentrum', u'Helix BioPharma Corp', u'Pierre Fabre SA', u'Difa Cooper SPA', u'Nycomed Pharma AS', u'Carrus Capital Corp', u'Nordic Pharma', u'Fougera Pharmaceuticals Inc', u'Will-Pharma', u'Grupo JUSTE', u'Hualida Biotech', u'Center for Genetic Engineering and Biotechnology', u'CCL Pharmaceuticals', u'Intendis GmbH', u'Ergomed PLC', u'3M Pharmaceuticals', u'SynCore Biotechnology Co Ltd', u'Foamix Pharmaceuticals Ltd', u'Accelis Pharma', u'University of California San Diego', u'Epitome Pharmaceuticals Ltd', u'American Red Cross', u'F Hoffmann-La Roche AG', u'Charite Universitaetsmedizin Berlin', u'Laboratorio Elea']), u'Helicobacterpyloriinfection': set([u'Oscient Pharmaceuticals Corp', u'RedHill Biopharma Ltd', u'OnSite Diagnostic Labs India Pvt Ltd', u'GLYCODesign Inc', u'Sanofi Pasteur', u'Pasteur Merieux-OraVax', u'Technical University of Munich', u'GlaxoSmithKline plc', u'Howard Hughes Medical Institute', u'Il-Yang Pharmaceutical Co', u'Vical Inc', u'EpiVax Inc', u'Immuron Ltd', u'University of Illinois at Urbana-Champaign', u'NewBridge Pharmaceuticals Ltd', u'MedImmune LLC', u'BioPort Corp', u'Walter Reed Army Institute of Research', u'University of London', u'Chaperone Technologies Inc', u'Recipharm AB', u'Teikoku Chemical Industries Co Ltd', u\"Let's Talk Recovery Inc\", u'AB ANALITICA', u'Wuhu Kang Wei Biotechnology Co Ltd', u'Sydney Compounding Chemist', u'Vianex SA', u'Exomed Australia Pty Ltd', u'Pasteur Merieux', u'Emergent Europe Ltd', u'AstraZeneca plc', u'National Research Council of Canada', u'Sigma-Tau Ind Farm Riunite SpA', u'Merckle GmbH', u'Antex Biologics Inc', u'Chinese Academy of Medical Military Sciences', u'Romark Laboratories LC', u'Priaxon AG', u'Biohit OYJ', u'Abbott Laboratories', u'Zeria Pharmaceutical Co Ltd', u'Ohio State University', u'Amarillo Biosciences Inc', u'Rhode Island Hospital', u'DiaSorin Inc', u'MerLion Pharmaceuticals Pte Ltd', u'Hanmi Pharmaceutical Co Ltd', u'The Procter & Gamble Co', u'Shenzhen Zhijun Pharmaceutical Co Ltd', u'Taiho Pharmaceutical Co Ltd', u'Acambis Inc', u'Amneal Pharmaceutical LLC', u'Chiron PathoGenesis', u'Boehringer Ingelheim Corp', u'Third Military Medical University of the Chinese PLA', u'R2 Pharma LLC', u'University of Melbourne', u'TransChem Inc', u'ImevaX GmbH', u'Mitsubishi Pharma Corp', u'Paladin Labs Inc', u'National Institute of Diabetes, Digestive and Kidney Diseases', u'Eurocine Vaccines AB', u'Dainabot KK', u'Yuhan Corp', u'Medivir AB', u'Sequella Inc', u'Daewoong Pharmaceutical Co Ltd', u'bioMerieux Vitek Inc', u'Laboratorios Columbia SA de CV', u'Sanofi', u'Nanjing University', u'ParaPRO LLC', u'Isotechnika Pharma Inc', u'Virus Research Institute Inc', u'CSL Ltd', u'Istituto Pirri Srl', u'University of Virginia', u'Chiron Vaccines Co', u'Biomerica Inc', u'Meridian Bioscience Inc', u'Aptalis Pharma Inc', u'Pfizer Inc', u'aRigen Pharmaceuticals Inc', u'Mobidiag Oy', u'Human Genome Sciences Inc', u'University of Rhode Island', u'Acambis plc', u'Giaconda Ltd', u'Immunobiology Ltd', u'Wyeth Laboratories Inc', u'Shanghai East Best Biopharmaceutical Enterprises Co Ltd', u'Arietis Corp', u'Pasteur Merieux Serums et Vaccins SA', u'Pooyandegan Pezeshki Pardis', u'National Institute of Allergy and Infectious Diseases', u'Astra AB', u'Taisho Pharmaceutical Co Ltd', u'ProJect Pharmaceutics GmbH', u'Eisai Co Ltd', u'Astra Merck Inc', u'National Institutes of Health', u'Alfa Wassermann SpA', u'CJ Corp', u'Virginia Polytechnic Institute and State University', u'Shanxi Kangbao Biological Products Co Ltd', u'Novosanis Nv', u'AzurRx BioPharma Inc', u'Institut Pasteur', u'ActivBiotics Inc', u'Depomed Inc', u'Takeda Pharmaceutical Co Ltd', u'SK Chemicals Co Ltd', u'Helicure AB', u'German Federal Ministry of Education and Research', u'Kaneka Corp']), u'HIVassociateddementia': set([u'MGI GP Inc', u'Centaur Pharmaceuticals Inc', u'DevCo Pharmaceuticals Ltd', u'US Government', u'Califia Bio Inc', u'Neurobiological Technologies Inc', u'Forest Laboratories Inc', u'Undisclosed', u'Renovis Inc', u'Vernalis plc', u'University of Rochester Medical Center', u'Dong-A ST Co Ltd', u'Symphony Neuro Development Co', u'Allergan Inc', u'H Lundbeck A/S', u'National Institute on Aging', u'Childrens Medical Center Corp', u'University of California San Diego', u\"Boston Children's Hospital\", u'University of Nebraska Medical Center', u'Tobira Therapeutics Inc', u'Merz & Co GmbH']), u'Diabeticcataract': set([u'Sankyo Co Ltd', u'Warner-Lambert Co', u'University of Colorado at Denver and Health Sciences Center', u'Merck KGaA', u'Astellas Pharma Inc', u'Pfizer Inc', u'Fujisawa Pharmaceutical Co Ltd', u'Scios Inc', u'NK Curex KK', u'Recordati SpA', u'R-Tech Ueno Ltd', u'National Eye Institute', u'Sanwa Kagaku Kenkyusho Co Ltd']), u'Ventricularfibrillation': set([u'Life-Assist Inc', u'Philips Medical Systems Technologies Ltd', u'Wyeth-Ayerst Pharmaceuticals Inc', u'Sanofi-Synthelabo']), u'Spinalcordtumor': set([u'Eli Lilly & Co', u'AstraZeneca plc', u'Mallinckrodt Inc', u'CarboMed Inc', u'Horizon Orphan LLC', u'Reyon Pharmaceuticals Co Ltd']), u'Varicellazostervirusinfection': set([u'Norwegian Institute of Public Health', u'US Government', u'Green Cross Corp', u'Quidel Corp', u'POLA Pharma Inc', u'Affitech A/S', u'IMZ Inc', u'Sanofi Pasteur', u'Rega Institute for Medical Research', u'Vical Inc', u'Nippon Kayaku Co Ltd', u'NYU Langone Medical Center', u'Marine Biotechnology Australia Pty Ltd', u'SmithKline Beecham plc', u'Flamel Technologies SA', u'Kaketsuken', u'World Health Organization', u'Sahar International Trading Inc', u'Novartis AG', u'Sang-A Pharmaceutical Co Ltd', u'National Institute of Neurological Disorders and Stroke', u'Beijing Kawin Technology Share-Holding Co Ltd', u'Yale University', u'Novotech (Australia) Pty Ltd', u'Sakai Chemical Industry Co Ltd', u'SkyePharma plc', u'Bristol-Myers Squibb Co', u'Cantab Biopharmaceuticals Ltd', u'Australian Research Council', u'Italfarmaco SpA', u'Merck & Co Inc', u'National Eye Institute', u'GlaxoSmithKline plc', u'Welsh School of Pharmacy', u'Research Corporation Technologies', u'Bukwang Pharmaceutical Co Ltd', u'Galderma SA', u'bioCSL PTY Ltd', u'Inhibitex Inc', u'Biovail Corp', u'MedImmune LLC', u'Bioglan Pharmaceuticals Co', u'Avanir Pharmaceuticals Inc', u'University of Sydney', u'Yamasa Shoyu Co Ltd', u'Merck Serono SA', u'University of Georgia', u'Astellas Pharma Europe BV', u'Asahi Kasei Pharma Corp', u'InGen Biosciences', u'Takeda Pharmaceutical Co Ltd', u'CTS Chemical Industries', u'Boryung Pharm Co Ltd', u'AltraVax Inc', u'VABIOTECH', u'Cristalia', u'BIKEN Foundation', u'University of Illinois']), u'Gallstones': set([u'Solvay Pharmaceuticals Inc', u'Leadiant Biosciences Inc', u'Dr Falk Pharma GmbH']), u'Hypernatremia': set([u'Ardelyx Inc', u'AstraZeneca plc']), u'Gastrointestinaldisease': set([u\"Dr Reddy's Laboratories Ltd\", u'FIT-BioCeuticals Pty Ltd', u'DKSH Holding Ltd', u'Perrigo Co Ltd', u'Solvay SA', u'Nycomed AS', u'OnSite Diagnostic Labs India Pvt Ltd', u'Alizyme plc', u'4d pharma plc', u'Cancer Prevention Pharmaceuticals Inc', u'The GI Company Inc', u'Entrinsic Health Solutions Llc', u'Amsterdam Molecular Therapeutics BV', u'ASKA Pharmaceutical Co Ltd', u'GlaxoSmithKline plc', u'BTG plc', u\"Cincinnati Children's Hospital Medical Center\", u'Cosmo Pharmaceuticals SpA', u'Vivelix Pharmaceuticals Ltd', u'Chiesi Farmaceutici SpA', u'University of Zagreb', u'Green Cross Corp', u'Ionis Pharmaceuticals Inc', u'Altus Pharmaceuticals Inc', u'Bio-Rad Laboratories Inc', u'SRI International', u'European Eurostars Programme', u'BioSyent Inc', u'Procter & Gamble Pharmaceuticals Inc', u'AGI Therapeutics plc', u'The European Union', u'Wyeth Pharmaceuticals', u'Par Pharmaceutical Co Inc', u'Synergy Pharmaceuticals Inc', u'University of Michigan', u'Lead Discovery Center GmbH', u'IMPAX Laboratories Inc', u'Origin Sciences Ltd', u'UCB SA', u'AzurRx BioPharma Inc', u'Abbott Healthcare Products BV', u'Recipharm AB', u'Biosurfaces Inc', u'Resolution Chemicals Ltd', u'Quality Brands International Direct', u'The Charles Stark Draper Laboratory Inc', u'Phenex Pharmaceuticals AG', u'ANI Pharmaceuticals Inc', u'Cytori Therapeutics Inc', u'Molecular Biosystems Inc', u'Cour Pharmaceutical Development Co Inc', u'Shionogi & Co Ltd', u'AstraZeneca plc', u'Anchen Pharmaceuticals Inc', u'Alliance Pharma plc', u'University of California San Francisco', u'Soho Flordis International', u'Beijing CoSci Med-Tech Co Ltd', u'NovaMedica', u'Norgine BV', u'Poetic Genetics LLC', u'Alkopharma', u'Oxiquant Inc', u'Unigene Laboratories Inc', u'Rosetta Genomics Ltd', u'Evotec AG', u'Merckle GmbH', u'Santarus Inc', u'Nextrast Inc', u'UCB Pharma GmbH', u'Ocera Therapeutics Inc', u'Genetic Analysis AS', u'Monash University', u'US Government', u'Biohit OYJ', u'Prana Biotechnology Ltd', u'Zeria Pharmaceutical Co Ltd', u'Eisai Co Ltd', u'Tulane University', u'Symphony Capital LLC', u'Takata Seiyaku', u'Innoviva Inc', u'Lexicon Pharmaceuticals Inc', u'MediGene AG', u'ActoGeniX NV', u'Pharmacyclics Inc', u'Nubiyota LLC', u'RedHill Biopharma Ltd', u'Zydus-Cadila Group', u'Forest Laboratories Inc', u'Otsuka America Pharmaceutical Inc', u'Newron Pharmaceuticals SpA', u'Agennix AG', u'Bracco Research SA', u'Prometheus Laboratories Inc', u'Massachusetts General Hospital', u'Lyric Pharmaceuticals Inc', u'NuMedii Inc', u'Fourth Military Medical University PLA', u'AvidBiotics Corp', u'Il-Yang Pharmaceutical Co', u'Mallinckrodt Inc', u'Concordia Pharmaceuticals Inc', u'Cadus Corp', u'RaQualia Pharma Inc', u'Laboratoires Mayoly Spindler', u'Honolulu Pharmacy', u'Reliant Pharmaceuticals Inc', u'Ferring Pharmaceuticals SA', u'Institute for the Promotion of Innovation by Science and Technology in Flanders', u'Dong-A ST Co Ltd', u'Kosan Biosciences Inc', u'Glaxo Group Ltd', u'EndoLogic LLC', u'Janssen Pharmaceutica NV', u'Ethypharm SA', u'LG Chem Ltd', u'Taiho Pharmaceutical Co Ltd', u'Boehringer Ingelheim Corp', u'Shire Holdings AG', u'EA Pharma Co Ltd', u'LXR Biotechnology Inc', u'Piramal Enterprises Ltd', u'Albert David Ltd', u'BioInvent International AB', u'Pernix Therapeutics Holdings Inc', u'Neopharm Ltd', u'Kinexis Inc', u'CIMA Labs Inc', u'TransChem Inc', u'Ipsen', u'Solasia Pharma KK', u'Owlstone Medical Ltd', u'Hyseq Inc', u'Chugai Pharmaceutical Co Ltd', u'CDInvestments Srl', u'Takeda Pharmaceuticals International Inc', u'Exact Corp', u'NPS Pharmaceuticals Inc', u'AIMM Therapeutics BV', u'PBM Pharmaceuticals Inc', u'Olympus Corp', u'Oceana Therapeutics Inc', u'Ajinomoto Co Inc', u'Grunenthal GmbH', u'Otsuka Pharmaceutical Co Ltd', u'Mayo Clinic Foundation', u'Alizyme Therapeutics Ltd', u'National Institute of Diabetes, Digestive and Kidney Diseases', u'University of Texas System', u'Cipla Ltd', u'Ore Pharmaceuticals Inc', u'Sigmoid Pharma Ltd', u'CLL Pharma', u'Allergan plc', u'Novel Laboratories LLC', u'SangStat Medical Corp', u'Oregon Health Sciences University', u'Immuron Ltd', u'SFJ Pharmaceuticals Inc', u'Queen Mary University of London', u'University of California', u'Merck & Co Inc', u'Arcturus Therapeutics Inc', u'Reckitt Benckiser plc', u'ChemoCentryx Inc', u'ImaRx Therapeutics Inc', u'Ironwood Pharmaceuticals Inc', u'Sanofi', u'Landson', u'Alkermes plc', u'Eli Lilly & Co', u'Alimentary Health Ltd', u'Akkadeas Pharma', u'Japan Tobacco Inc', u'Synt:em', u'DiaCarta LLC', u'Vifor Pharma', u'PLIVA dd', u'Dynogen Pharmaceuticals Inc', u'Meiji Co Ltd', u'Global Alliance for Vaccines and Immunization', u'Kyowa Hakko Kirin Co Ltd', u'Organon (India) Ltd', u'enGene Inc', u'Quintiles Transnational Corp', u'TAP Pharmaceutical Products Inc', u'Auriga Laboratories Inc', u'Janssen Biotech Inc', u'Bracco SpA', u'Assembly Biosciences Inc', u'LICONSA Liberacion Controlada de Sustancias Activas SA', u'Almirall Prodesfarma SA', u'Aptalis Pharma Inc', u'Pfizer Inc', u'Tillotts Pharma AG', u'Intract pharma Ltd', u'Cumberland Pharmaceuticals Inc', u'Altos Therapeutics LLC', u'University of Toledo', u'Progenics Pharmaceuticals Inc', u'Takeda Pharmaceuticals International GmbH', u'Hybio Pharmaceutical Co Ltd', u'Undisclosed', u'Horizon Pharma plc', u'EGIS Gyogyszergyar RT', u'Beekley Corp', u'Nippon Shinyaku Co Ltd', u'Moberg Pharma AB', u'Q-Med AB', u'CTC Bio Inc', u'Marathon Pharmaceuticals LLC', u'Interpharma Praha AS', u'E-Z-EM Inc', u'Evonik Degussa GmbH', u'University of Missouri', u'Nichi-Iko Pharmaceutical Co Ltd', u'Valeant Pharmaceuticals North America LLC', u'Kureha Corp', u'National Institute of Allergy and Infectious Diseases', u'Natural Partners Inc', u'Medeva Inc', u'Takeda Pharmaceutical Co Ltd', u'Sunovion Pharmaceuticals Inc', u'Amarin Corp plc', u'Alfa Wassermann SpA', u'Numerate Inc', u'Dr Falk Pharma GmbH', u'Metabiomics Corporate', u'Nogra Pharma Ltd', u'National Institutes of Health', u'Bill & Melinda Gates Foundation', u'Taisho Pharmaceutical Co Ltd', u'Bristol-Myers Squibb Co', u'Zealand Pharma A/S', u'Pharmacopeia Inc', u'Sanofi Genzyme', u'PharmaVigilant', u'NPS Allelix Corp', u'Celgene Corp', u'Seoul National University', u'ThromboGenics NV', u'Astellas Pharma Inc', u'EndoBiologics Inc', u'Biovail Corp', u'MedImmune LLC', u'Program for Appropriate Technology in Health', u'Pepscan Systems BV', u'Jubilant Life Sciences Ltd', u'Finch Therapeutics', u'Salix Pharmaceuticals Ltd', u'AAIPharma Inc', u'Concordia International Corp', u'Shire plc', u'Azur Pharma Ltd', u'Kolon Pharmaceuticals Inc', u'Depomed Inc', u'Jaguar Health Inc', u'Napo Pharmaceuticals Inc', u'Idera Pharmaceuticals Inc', u'Novartis AG', u'Kyowa Kirin', u'Caret Pharma', u'Teligent Inc', u'Canadian Government', u'Williamsburg Holdings', u'Biostar Pharmaceuticals Inc', u'StemCell Technologies', u'InDex Pharmaceuticals AB', u'German Federal Ministry of Education and Research', u'Kaneka Corp']), u'Mucopolysaccharidosis': set([u'University of Pretoria', u'JCR Pharmaceuticals Co Ltd', u'National Institute of Neurological Disorders and Stroke', u'National Institutes of Health', u'Inventiva', u'Isaac Foundation', u'Zacharon Pharmaceuticals Inc', u'University of British Columbia', u'Mayo Clinic Foundation', u'ASKA Pharmaceutical Co Ltd']), u'Peripheralneuropathy': set([u'Roussel Uclaf Corp', u'Warren Pharmaceuticals Inc', u'Wockhardt Ltd', u'MGI GP Inc', u'The Leukemia & Lymphoma Society', u'Cyberkinetics Neurotechnology Systems Inc', u'McMaster University', u'Genentech Inc', u'Winsantor Inc', u'YD Life Science Inc', u'Prodotti Formenti Srl', u'Rinat-Pfizer Inc', u'RespireRx Pharmaceuticals Inc', u'Croda International plc', u'Nanyang Technological University', u'Dalhousie University', u'Nippon Kayaku Co Ltd', u'US Government', u'Eisai Co Ltd', u'Circuit Therapeutics Inc', u'Bago', u'University of California San Diego', u'University of Pittsburgh', u'University of Mississippi', u'Hallym University', u'National Cancer Institute', u'Novartis AG', u'Amsterdam Molecular Therapeutics BV', u'National Institutes of Health', u'Aptinyx Inc', u'CQDM', u'Fidia Group', u'PolyNovo Ltd', u'Merck Serono SA', u'Daewoong Pharmaceutical Co Ltd', u'NeuroMetrix Inc', u'Neuren Pharmaceuticals Ltd', u'Relief Therapeutics SA', u'Hanyang University', u'Hoffmann-La Roche AG', u'Parke-Davis & Co', u'Nemus Bioscience Inc', u'Tanabe Seiyaku Co Ltd', u\"Lee's Pharmaceutical Holdings Limited\", u'Cephalon Inc', u'SmithKline Beecham Corp', u'Zenyth Therapeutics Ltd', u'Allon Therapeutics Inc', u'EpiCept Corp', u'Nuraging Biotech Srl', u'Dong-A ST Co Ltd', u'Case Western Reserve University', u'Glaxo Group Ltd', u'National Institute of Nursing Research', u'Dompe SpA', u'Galapagos Genomics BV', u'University of Michigan', u'Pfizer Inc', u'Allosterix Ltd', u'Johns Hopkins University', u'University of Manitoba', u'Kyowa Hakko Kogyo Co Ltd', u'Defense Advanced Research Projects Agency', u'Epitome Pharmaceuticals Ltd', u'Laboratoires Houde SA', u'IRCCS San Raffaele', u'Netherlands Government', u'Signal Research Division', u'Mertiva AB', u'Diamyd Inc', u'St Louis University', u'AxoTect Inc', u'H Lundbeck A/S', u'Sigma-Tau Ind Farm Riunite SpA']), u'Lipoma': set([u'BioSpecifics Technologies Corp', u'Auxilium Pharmaceuticals Inc', u'US Government', u'RecipharmCobra Biologics']), u'Neisseriagonorrhoeaeinfection': set([u'VINNOVA', u'US Government', u'Yaso Biotechnology Inc', u'Undisclosed', u'Imclone LLC', u'Mylan Inc', u'Advanced Life Sciences Holdings Inc', u'National Institute of Allergy and Infectious Diseases', u'Genocea Biosciences Inc', u'Abbott Laboratories', u'Polydex Pharmaceuticals Ltd', u'Global Antibiotic Research and Development Partnership', u'GlaxoSmithKline plc', u'GlaxoSmithkline Pharmaceuticals (India) Ltd', u'SK Chemicals Life Science', u\"St Jude Children's Research Hospital\", u'National Institutes of Health', u'Bill & Melinda Gates Foundation', u'Microbiotix Inc', u'University of California', u'Dainippon Pharmaceutical Co Ltd', u'Nobelex Biotech Inc', u'Rush University Medical Center', u'Melinta Therapeutics Inc', u'The Menarini Group', u'TherapyX Inc', u'Concordia Pharmaceuticals Inc', u'Debiopharm Research & Manufacturing SA', u'Contraceptive Research and Development Organization', u'Creative Antibiotics Sweden AB', u'Combating Antibiotic-Resistant Bacteria Biopharmaceutical Accelerator', u'Rhone-Poulenc SA', u'Teligent Inc', u'University of Tennessee', u'Entasis Therapeutics', u'Ilsung Pharmaceutical Co Ltd', u'Isconova AB', u'Fujifilm Finechemicals Co Ltd', u'Cempra Inc', u'Wyeth', u'Debiopharm SA', u'SPA Societa Prodotti Antibiotici SpA']), u'Decompressionsickness': set([u'Virginia Commonwealth University', u'Vatea Fund', u'US Naval Medical Research Center', u'Tenax Therapeutics Inc', u'Chi Sheng Chemical Corp', u'US Department of Defense', u'Office of Naval Research (ONR)']), u'Hyponatremia': set([u'Pfizer Inc', u'Shire-Movetis NV', u'Alliance Pharm Pte Ltd', u'Cumberland Pharmaceuticals Inc', u'Piramal Enterprises Ltd', u'Cardiokine Inc', u'Institute for the Promotion of Innovation by Science and Technology in Flanders', u'Biogen Inc']), u'Prematureejaculation': set([u'FBM Industria Farmaceutica Ltda', u'Johnson & Johnson', u'CTC Bio Inc', u'Elis Pharmaceuticals Ltd', u'Techno Venture Management', u'Jeil Pharmaceutical Co Ltd', u'Inyx Inc', u'Oz Biogenics Ltd', u'Endo Pharmaceuticals Solutions Inc', u'Shionogi Pharma Inc', u'Bayer Schering Pharma AG', u'Ixchelsis Ltd', u'Syngene International Ltd', u'Teva Pharmaceutical Industries Ltd', u'Paul Capital Healthcare', u'BroadMed', u'Furiex Pharmaceuticals Inc', u'Dong Kook Pharmaceutical Co Ltd', u'The Menarini Group', u'CJ Corp', u'Khandelwal Laboratories Ltd', u'Ampio Pharmaceuticals Inc', u'DMI BioSciences Inc', u'Undisclosed', u'Enhance Biotech Inc', u'Huons Co Ltd', u'YooYoung Pharmaceuticals Co Ltd', u'Pfizer Inc', u'Jin Yang Pharm Co Ltd', u'Plethora Solutions Holdings plc', u'Recordati SpA', u'GenuPro Inc', u'Neopharm Ltd', u'Apricus Biosciences Inc', u'Innovus Pharmaceuticals Inc']), u'Acuteexternalotitis': set([u\"Lee's Pharmaceutical Holdings Limited\", u'Guangzhou Boji Medical & Biotechnological Co Ltd', u'Pediapharm Inc', u'Laboratorios SALVAT SA', u'Zhaoke Pharmaceutical (Hefei) Co Ltd', u'Arbor Pharmaceuticals Inc']), u'Plasmacytoma': set([u'SymBio Pharmaceuticals Ltd', u'Eisai Co Ltd', u'Salmedix Inc', u'Astellas Pharma GmbH']), u'Shigellaflexneriinfection': set([u'Program for Appropriate Technology in Health', u'GlycoVaxyn AG', u'Wellcome Trust', u'University of Maryland', u'Agence nationale de la recherche (ANR)', u'Institut Pasteur']), u'Hyperhidrosis': set([u'China Meheco Co Ltd', u'Bodor Laboratories Inc', u'Miramar Labs Inc', u'Undisclosed', u'Maruho Co Ltd', u'Kaken Pharmaceutical Co Ltd', u'Brickell Biotech Inc', u'Dermira Inc']), u'Nevus': set([u'Harvard Medical School', u'Undisclosed', u'American Skin Association', u'EpiPharm AG']), u'Clusterheadache': set([u'GlaxoSmithKline KK', u'Clinvest', u'Eisai Co Ltd', u'Soleno Therapeutics Inc']), u'Gastroenteritis': set([u\"Cincinnati Children's Hospital Medical Center\", u'Angelini Pharmaceuticals SpA', u'Yuhan Corp', u'University of Tampere', u\"Lee's Pharmaceutical Holdings Limited\", u'Mobidiag Oy', u'Janssen Research & Development LLC', u'Unilabs SA', u'National Institute of Allergy and Infectious Diseases', u'US Naval Medical Research Center', u'Virginia Polytechnic Institute and State University', u'UMN Pharma Inc', u'Nippon Shinyaku Co Ltd']), u'CharcotMarieToothtype1disease': set([u'Charcot-Marie-Tooth Association', u'Addex Therapeutics Ltd', u'Affectis Pharmaceuticals AG']), u'Telangiectasis': set([u'Genentech Inc', u'XOMA Corp']), u'Cocaineaddiction': set([u'Celtic Pharmaceutical Holdings LP', u'Royal Gist-Brocades NV', u'Rockefeller University', u'Vybion Inc', u'Bioprojet Pharma', u'US Government', u'Stanford University', u'TheraKine Ltd', u'Saniona ApS', u'Xytis Inc', u'Harvard Medical School', u'Recovery Pharmaceuticals Inc', u'Sanofi Pasteur', u'Mercer University', u'Abbott Laboratories', u'Catalyst Pharmaceutical Partners Inc', u'Universite d`Orleans', u'University of Cincinnati', u'Louisiana State University Medical Center Foundation', u'Cerecor Inc', u'Organix Inc', u'BioCorRx Inc', u'NeuroSearch A/S', u'University of Texas System', u'National Institutes of Health', u'National Institute on Drug Abuse', u'University of Pennsylvania', u'Bristol-Myers Squibb Co', u'Merck & Co Inc', u'CytoCore Inc', u'Brookhaven National Laboratory', u'Georgia Institute of Technology', u'MedImmune LLC', u'Massachusetts General Hospital', u'Columbia University', u'Immunovaccine Inc', u'University of Miami', u'Beijing Institute of Pharmacology and Toxicology', u'University of Bath', u'Novartis AG', u'University of Texas Medical Branch at Galveston', u'Perelman School of Medicine', u'Opiant Pharmaceuticals Inc', u'BioTie Therapies Corp', u'Georgetown University Medical Center', u'RTI International', u'Molecular Insight Pharmaceuticals Inc', u'Albany Molecular Research Inc', u'P2D Biosciences', u'Weill Medical College of Cornell University', u'Orexigen Therapeutics Inc', u'Wake Forest University', u'Supernus Pharmaceuticals Inc', u'Embera NeuroTherapeutics Inc', u'ImmuLogic Pharmaceutical Corp', u'Sanofi', u'DrugAbuse Sciences Inc', u'Innovata plc', u'Yale University', u'Scripps Research Institute', u'Panos Therapeutics Ltd', u'Alkermes plc', u'University of Cambridge', u'The Dana Foundation']), u'Muscleweakness': set([u'Karolinska Institutet', u'Cytokinetics Inc', u'Grifols SA', u'National Institute of Arthritis and Musculoskeletal and Skin Diseases', u'Emmyon Inc', u'Astellas Pharma Inc', u'Pharmalink AB', u'Halozyme Therapeutics Inc', u'Avid Bioservices', u'Nutrabolt', u'Natural Alternatives International']), u'Systemiclupu': set([u'Johns Hopkins University', u'Accentia BioPharmaceuticals Inc']), u'Cutaneouslupuserythematosus': set([u'Genentech Inc', u'Sequenom Inc', u'Tolerx Inc', u'SensiGen LLC']), u'Spielmeyer-Vogtdisease': set([u'Abeona Therapeutics Inc', u'UneMed Corp']), u'Dysmenorrhea': set([u'Nippon Shinyaku Co Ltd', u'Hi-Tech Pharmacal Co Inc', u'Nautilus Neurosciences Inc', u'Kowa Pharmaceuticals America Inc', u'Abbott Laboratories', u'ASKA Pharmaceutical Co Ltd', u'Victory Pharma Inc', u'Santarus Inc', u'Bayer Schering Pharma AG', u'Metris Therapeutics Ltd', u'Undisclosed', u'ObsEva SA', u'Aoxing Pharmaceutical Co Inc', u'Elan Corp plc', u'Juniper Pharmaceuticals Inc', u'Theratechnologies Inc', u'Merck Sharp & Dohme de Espana SA', u'APR Applied Pharma Research SA', u'PDC Biotech GmbH', u'UCB Pharma GmbH', u'FAES Farma SA', u'Roche Holding AG', u'Novartis AG', u'Biovail Corp', u'Nobelpharma Co Ltd', u'Sunovion Pharmaceuticals Canada Inc', u'Janssen Pharmaceutical KK', u'Mithra Pharmaceuticals', u'Merck Serono SA', u'Boehringer Ingelheim Corp', u'Chiesi Farmaceutici SpA', u'Plethora Solutions Holdings plc', u'Ardana Bioscience Ltd', u'Recordati SpA', u'Japan Medical Association', u'Fuji Pharma Co Ltd']), u'Respiratorytractallergy': set([u'Program for Appropriate Technology in Health', u'Stallergenes SA', u'DBV Technologies SA', u'West-Ward Pharmaceutical Corp', u'GlaxoSmithKline plc', u'Innovus Pharmaceuticals Inc']), u'VitaminDdeficiency': set([u'OPKO Health Inc', u'Catalent Inc']), u'Pharynxtumor': set([u'Singapore Technologies Pte Ltd', u'Diomed Ltd', u'Baylor College of Medicine', u'MD Anderson Cancer Center', u'Boehringer Ingelheim Corp', u'National Institutes of Health', u'Kyowa Hakko Kogyo Co Ltd', u'Tessa Therapeutics Pte Ltd', u'Vigilant Biosciences', u'Daewoong Pharmaceutical Co Ltd', u'biolitec AG', u'Queensland University of Technology', u'Efamol', u'Hitachi Chemical Co America Ltd', u'Disease Interception Accelerator', u'Scotia Holdings plc']), u'Nephroblastoma': set([u'Memorial Sloan-Kettering Cancer Center', u'Atara Biotherapeutics Inc']), u'Familialdysautonomia': set([u'American Gene Technologies International Inc', u'New York University School of Medicine, US', u'National Institutes of Health', u'Food and Drug Administration', u'National Eye Institute', u'Massachusetts General Hospital', u'PTC Therapeutics Inc', u'Dysautonomia Foundation Inc']), u'Peritonealtumor': set([u'National Comprehensive Cancer Network', u'Cancer Immunotherapy Trials Network', u'PDL BioPharma Inc', u'Amgen Inc', u'Gynecologic Oncology Group', u'University of Pennsylvania', u'Biogen Inc', u'Ohio State University', u'University of Cologne', u'US Health and Human Services Department', u'National Cancer Institute', u'IDT Biologika GmbH', u'City of Hope', u'Juno Therapeutics Inc', u'ICOS Corp', u'Janssen Research & Development LLC', u'Cephalon Inc', u'Oncolytics Biotech Inc', u'Aduro BioTech Inc', u'University of Hawaii', u'Madrigal Pharmaceuticals Inc', u'Walter and Eliza Hall Institute of Medical Research', u'NanoString Technologies Inc', u'TetraLogic Pharmaceuticals Corp', u'Hemispherx Biopharma Inc', u'Myriad Genetics Inc', u'TopoTarget A/S', u'University of Utah', u'Merrimack Pharmaceuticals Inc', u'Memorial Sloan-Kettering Cancer Center', u'Optimum Therapeutics LLC', u'National Center For Advancing Translational Sciences']), u'Streptococcusanginosusinfection': set([u'Cardiome Pharma Corp', u'Tzamal Medical Group Ltd']), u'Arthritis': set([u'Deltagen Research Laboratories', u'Daiichi Seiyaku Co Ltd', u'US Government', u'Novo Nordisk A/S', u'Regeneron Pharmaceuticals Inc', u'CellAct Pharma GmbH', u'ANANDA Scientific Inc', u'Eupraxia Pharmaceuticals Inc', u'American Osteopathic Association', u'PharmaIN Ltd', u'Qiagen NV', u'Lantheus Medical Imaging Inc', u'BTG plc', u'Hadasit Medical Research Services and Development Ltd', u'Bayer Schering Pharma AG', u'Meyer Pharmaceuticals LLC', u'Laboratoires Bouchara Recordati SAS', u'Oscotec Inc', u'Aventis Pharma AG', u'Radikal Therapeutics Inc', u'LegoChem Bioscience Inc', u'PainCeptor Pharma Corp', u'Chinese Government', u'ArQule Inc', u'OSI Pharmaceuticals Inc', u'University of Washington', u'Fibrocell Science Inc', u'Mateon Therapeutics Inc', u'Sanochemia Pharmazeutika AG', u'Shire plc', u'University of British Columbia', u'ARIAD Pharmaceuticals Inc', u'Auritec Pharmaceuticals Inc', u'Hisamitsu Pharmaceutical Co Inc', u'3M Pharmaceuticals', u'Schein Pharmaceutical Inc', u'Dana-Farber Cancer Institute Inc', u'Sichuan BoXin LaiTe Biotechnology Inc', u'UCB SA', u'CrystalGenomics Inc', u'Amerinet Inc', u\"Tianjin Municipal People's Government\", u'National Institute of Arthritis and Musculoskeletal and Skin Diseases', u'Ensol Biosciences Inc', u'MD Anderson Cancer Center', u'Abbott Laboratories', u'Mochida Pharmaceutical Co Ltd', u'Cytoguide ApS', u'Boehringer Mannheim GmbH', u'The University of Birmingham', u'FUJIFILM RI Pharma Co', u'Korea Research Institute of Bioscience and Biotechnology', u'Massachusetts General Hospital', u'Medical Research Council', u'Transgene SA', u'Midwestern University', u'The Procter & Gamble Co', u'Kangwon University Pharmaceutical College', u'Mathilda and Terrence Kennedy Institute of Rheumatology Trust', u'Macrophage Pharma Limited', u'ImmunoGen Inc', u'Dong-A ST Co Ltd', u'Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd', u'Janssen Pharmaceutica NV', u'Helsinn Healthcare SA', u'Boehringer Ingelheim Corp', u'Takara Bio USA Inc', u'Horizon Pharma plc', u'Nippon Boehringer Ingelheim Co Ltd', u'Roche Palo Alto', u'Seikagaku Corp', u'Sinil Pharmaceutical', u'Oakwood Laboratories LLC', u'University of Oxford', u'Chiron Corp', u'AmorePacific Corp', u'YD Life Science Inc', u'Momenta Pharmaceuticals Inc', u'Beijing Orbiepharmacy Technology Co Ltd', u'Ultrafine Chemicals Ltd', u'Oxford BioMedica plc', u'Cellzome', u'Republic of Korea Government', u'Yuhan Corp', u'Jeil Pharmaceutical Co Ltd', u'Altus Formulation', u'Orygen Biotecnologia Ltda', u'Chroma Therapeutics Ltd', u'Daewoong Pharmaceutical Co Ltd', u'Merck & Co Inc', u'Ewha Womans University', u'Theratechnologies Inc', u'Sanofi', u'UBE Industries Ltd', u'Shanghai Pharmaceuticals Holding Co Ltd', u'Eli Lilly & Co', u'CASI Pharmaceuticals Inc', u'Alter SA', u'CSL Ltd', u'bluebird bio Inc', u'University of California Irvine', u'Case Western Reserve University', u'Argenta Discovery Ltd', u'Centre for Applied Microbiology & Research', u'Mungyeong City', u'ReNeuron Group plc', u'Stiefel', u'Pfizer Inc', u'University of Southern California', u'Caladrius Biosciences Inc', u'Yissum Research Development Co', u'Acambis plc', u'Macrogen Inc', u'EPIX Pharmaceuticals Inc', u'Nattermann & Cie GmbH', u'Johnson & Johnson', u'LG Life Sciences Ltd', u'Intrexon Corp', u'Sawai Pharmaceutical Co Ltd', u'Novation', u'ASTA Medica AG', u'Griffith University', u'Korea Materials & Components Industry Agency', u'SmithKline Beecham plc', u'National Institutes of Health', u'AnaptysBio Inc', u'Ono Pharmaceutical Co Ltd', u'Samil Pharmaceutical Co Ltd', u'Bristol-Myers Squibb Co', u'Elan Corp plc', u'MuriGen Pty Ltd', u'MSD Japan', u'Intradigm Corp', u'Paradigm Biopharmaceuticals Ltd', u'Russian Academy of Sciences', u'Gyeonggi Institute Of Science & Technology Promotion', u'JW Pharmaceutical Corp', u'LPB Istituto Farmaceutico SpA', u'Therabel Pharma NV', u'Metaphore Pharmaceuticals Inc', u'RNL Bio Co Ltd', u'Icagen Inc (pre-merger)', u'Inotek Pharmaceuticals Corp', u'Tianjin Nankai Hospital', u'Helsinn Group']), u'Essentialtremor': set([u'University of Washington', u'Medtronic plc', u'SAGE Therapeutics Inc', u'University of California', u'Aleva Neurotherapeutics Sa', u'Greatbatch Ltd']), u'Testistumor': set([u'US Government', u'Predictive Therapeutics', u'ZIOPHARM Oncology Inc', u'Immunomedics Inc', u'Adria Laboratories Inc', u'Daiichi Sankyo Co Ltd', u'diaDexus LLC', u'ArQule Inc', u'Queensland Institute of Medical Research']), u'Lymphoma': set([u'Veeda Clinical Research', u'Biovest International Inc', u'Quest Diagnostics Inc', u'US Government', u'MolMed SpA', u'The Leukemia & Lymphoma Society', u'Immunicum AB', u\"The International Waldenstrom's Macroglobulinemia Foundation\", u'Baxter International Inc', u'Rutgers Cancer Institute of New Jersey', u'Advaxis Inc', u'Allos Therapeutics Inc', u'Attenuon LLC', u'The Cancer Council Victoria', u'Adaptive Biotechnologies Corp', u'California Institute of Regenerative Medicine', u'Rockefeller University', u'Biogen Inc', u'US Health and Human Services Department', u'Pharmacyclics Inc', u'Il Dong Pharmaceutical Co Ltd', u'Korea Research Institute of Chemical Technology', u'GlaxoSmithKline plc', u'Molecular Templates Inc', u'Quintiles Transnational Corp', u'Intensity Therapeutics Inc', u'Bayer Schering Pharma AG', u'Idun Pharmaceuticals Inc', u'Oncobiologics Inc', u'Royal DSM NV', u'Cascadian Therapeutics Inc', u'Seattle Genetics Inc', u'MLL Munich Leukemia Laboratory', u'Coherus BioSciences Inc', u'Sigma-Aldrich Corp', u'Selexis SA', u'Redx Oncology Ltd', u'University of Iowa', u'Astex Pharmaceuticals Inc', u'Stanford University', u'Institut Curie', u'Sangamo Therapeutics Inc', u'HemoGenyx', u'Fred Hutchinson Cancer Research Center', u'Dutch-Belgian Cooperative Trial Group for Hematology Oncology', u'Takeda Oncology', u'Ontario Institute for Cancer Research', u'Roche Holding AG', u'Second Military Medical University PLA', u'ARIAD Pharmaceuticals Inc', u'Pharmacia & Upjohn Co', u'Biovector Therapeutics SA', u'Cellectis SA', u'Aviragen Therapeutics Inc', u'Peregrine Pharmaceuticals Inc', u'Genecor International Inc', u'Spectrum Pharmaceuticals Inc', u'Bayer HealthCare AG', u'Catalent Inc', u'Loxo Oncology Inc', u'TG Therapeutics Inc', u'Emory University', u'ElsaLys Biotech', u'LipoCure', u'Mayo Clinic Foundation', u'Dana-Farber Cancer Institute Inc', u'Zhejiang Huahai Pharmaceutical Group Co Ltd', u'Terry Fox Foundation', u'Nordic Nanovector ASA', u'Diaclone SA', u'Evotec AG', u'Touro University', u'Weill Medical College of Cornell University', u'Inex Pharmaceuticals Corp', u'Roche GlycArt Ag', u'MD Anderson Cancer Center', u'Hercules Capital Inc', u'Amgen Inc', u'Mylan Inc', u'Medarex Inc', u'Seragen Inc', u'Cancer Genetics Inc', u'Cambridge Antibody Technology Group plc', u'University of Michigan', u'Daiichi Sankyo Co Ltd', u'Abbott Laboratories', u'OncBioMune Pharmaceuticals Inc', u'Eisai Co Ltd', u'Empire Genomics Llc', u'Predictive Therapeutics', u'Lytix Biopharma AS', u'LFB SA', u'Acetylon Pharmaceuticals Inc', u'National Cancer Institute', u'Znomics Inc', u'LEO Pharma A/S', u'ZIOPHARM Oncology Inc', u'Cyteir Therapeutics Inc', u'Korea Research Institute of Bioscience and Biotechnology', u'S*BIO Pte Ltd', u'Triphase Accelerator Corp', u'KRS Global Biotechnology Inc', u'Jiangsu Hengrui Medicine Co Ltd', u'Diatec Monoclonals AS', u'Shanghai Wanxing Bio-Pharmaceutical Co Ltd', u'Medac GmbH', u'Nycomed Imaging A/S', u'University of California San Francisco', u'Lipomed AG', u'Inflazyme Pharmaceuticals', u'Astellas Pharma Inc', u'Cell Medica Ltd', u'Enzon Pharmaceuticals Inc', u'Jichi Medical University, Japan', u'Strategia Therapeutics Inc', u'Biotech Pharmaceutical Co Ltd', u'Mundipharma EDO GmbH', u'Dendreon Corp', u'SymBio Pharmaceuticals Ltd', u'ImmunoGen Inc', u'Celera Group', u'Immune Response BioPharma Inc', u'Dong-A ST Co Ltd', u'Hualida Biotech', u'WuXi PharmaTech (Cayman) Inc', u'Republic of Korea Government', u'Micromet Inc', u'The Center of Molecular Immunology', u'CerRx Inc', u'Infinity Pharmaceuticals Inc', u'SIOGEN Biotech', u'Pluristem Therapeutics Inc', u'Neopharm Ltd', u'Royalty Pharma', u'Debiopharm SA', u'Fujifilm\\xa0Corp', u'Benitec Biopharma Ltd', u'Denovo Biopharma LLC', u'CureTech Ltd', u'Chugai Pharmaceutical Co Ltd', u'VGXI Inc', u'Louisiana State University Health Sciences Center New Orleans', u'Genentech Inc', u'Nippon Shinyaku Co Ltd', u'Ajinomoto Co Inc', u'IDIS Ltd', u'International Therapeutics Inc', u'Rigel Pharmaceuticals Inc', u'Compliment Corp', u'Apogee Biotechnology Corp', u'Southern Research Institute', u'Pacira Pharmaceuticals Inc', u'Kocak Farma Ilac Ve Kimya San AS', u'Epizyme Inc', u'ViaCell Inc', u'Lundbeck Inc', u'Massachusetts Institute of Technology', u'Oregon Health Sciences University', u'Verastem Inc', u'Immunex Corp', u'Merck & Co Inc', u'Gemin X Pharmaceuticals Inc', u'Regenacy Pharmaceuticals LLC', u'Synthon BV', u'BioChem Pharma (International ) Inc', u'rEVO Biologics Inc', u'Sanofi', u'Vion Pharmaceuticals Inc', u'CTI BioPharma Corp', u'Eli Lilly & Co', u'FORMA Therapeutics Inc', u'Eisai Inc', u'Teva Pharmaceutical Industries Ltd', u'Fluorinov Pharma Inc', u'Takara Bio Inc', u'eFFECTOR Therapeutics Inc', u'Universita Degli Studi di Genova', u\"Children's Hospital of Los Angeles\", u'University of Virginia', u'Kyowa Hakko Kirin Co Ltd', u'Dare Bioscience Inc', u'Ascalon International Inc', u'Alligator Bioscience AB', u'University of Jena', u'Cyclacel Pharmaceuticals Inc', u'Case Western Reserve University', u'TeneoBio Inc', u'Nektar Therapeutics', u'SRI International', u'AstraZeneca plc', u'Pfizer Inc', u'University of Southern California', u'Corixa Corp', u'Sandoz Inc', u'AMAG Pharmaceuticals Inc', u'OPi SA', u'NanoScan Imaging LLC', u'Memorial Sloan-Kettering Cancer Center', u'Xynomic Pharmaceuticals', u'Celltrion Healthcare Co Ltd', u'Illumina Inc', u'Baylor College of Medicine', u'Biocad Ltd', u'Innate Pharma SA', u'Mabion SA', u'Ministero per l Universita e la Ricerca Scientifica e Tecnologica', u'Genmab A/S', u'Nippon Kayaku Co Ltd', u'OncoSec Medical Inc', u'University of Washington', u'Stanford Cancer Institute', u'Biolex Therapeutics Inc', u'Nerviano Medical Sciences Srl', u'Ligand Pharmaceuticals Inc', u'Mundipharma International Corp Ltd', u'Innovation Pharmaceuticals Inc', u'Karus Therapeutics Ltd', u'Northwestern University', u'Lonza Group AG', u'MacroGenics Inc', u\"St Jude Children's Research Hospital\", u'National Institutes of Health', u'ProMIS Neurosciences Inc', u'Axxiom Inc', u'Immunomedics Inc', u'OJSC Farmak', u'City of Hope', u'Curis Inc', u'Ascend Biopharmaceuticals Ltd', u'Trellis Bioscience Inc', u'NuView Life Sciences', u'Onyx Pharmaceuticals Inc', u'Cephalon Inc', u'Celgene Corp', u'Calando Pharmaceuticals Inc', u'Cornell University', u'Valeant Pharmaceuticals International Inc', u'Live Like Bella Childhood Cancer Foundation', u'BC Cancer Agency', u'IMCOR Pharmaceutical Co', u'Qiagen NV', u'Undisclosed', u'Antisoma plc', u'Bioniche Teoranta', u'Bio-Ker Srl', u'Childrens Hospital of Philadelphia', u'Accelera Srl', u'Hebrew University of Jerusalem', u'CCL Pharmaceuticals', u'Walter and Eliza Hall Institute of Medical Research', u'Johnson & Johnson', u'University of New Mexico', u'Takeda Pharmaceutical Co Ltd', u'Oncoceutics Inc', u'Boryung Pharm Co Ltd', u'Jackson Laboratory', u'Solexa Inc', u'Biomira USA Inc', u'Immune Therapeutics Inc']), u'Vaginalcancer': set([u'Elekta AB', u'Kobold Medical']), u'Myotonicdystrophy': set([u'VLT Biopharma', u'Sanofi Genzyme', u'University of North Carolina', u'National Institute of Arthritis and Musculoskeletal and Skin Diseases', u'Neuron Bio SA', u'Undisclosed', u'Ionis Pharmaceuticals Inc', u'University at Buffalo', u'Marina Biotech Inc', u'New York State Office of Science, Technology and Academic Research', u'Rosetta Genomics Ltd', u'Massachusetts General Hospital', u'Camille & Henry Dreyfus Foundation', u'Muscular Dystrophy Association']), u'Blister': set([u'HRA Pharma', u'Cilag AG']), u'Pulmonaryarteryhypertension': set([u'PH Therapeutics Ltd', u'Nippon Shinyaku Co Ltd', u'Mallinckrodt plc', u'US Government', u'Ascendis Pharma A/S', u'DEKA Research & Development Corp', u'University of Sheffield', u'University of Florida', u'Stanford University', u'Beijing Tide Pharmaceutical Co Ltd', u'AADi LLC', u'VIVUS Inc', u'miRagen Therapeutics Inc', u'Nippon Kayaku Co Ltd', u'University of South Alabama', u'YM BioSciences Inc', u'Mast Therapeutics Inc', u'California Institute of Regenerative Medicine', u'Mochida Pharmaceutical Co Ltd', u'Mount Sinai School of Medicine', u'GlaxoSmithKline plc', u'Celladon Corp', u'Cardiome Pharma Corp', u'GeneraMedix Inc', u'Actelion Ltd', u'Selten Pharma Inc', u'Bayer AG', u'HTaPFrance', u'Nippon Chemiphar Co Ltd', u'British Heart Foundation', u'AmorChem LP', u'Royal Philips Electronics', u'INSERM', u'Merck & Co Inc', u'Medical Research Council', u'Cedars-Sinai Medical Center', u\"Lee's Pharmaceutical Holdings Limited\", u'LTT Bio-Pharma Co Ltd', u'Celgene Corp', u'bioCSL PTY Ltd', u'Bellerophon Therapeutics LLC', u'Pulmokine Inc', u'German Government', u'Eiger BioPharmaceuticals Inc', u'Mitsubishi Tanabe Pharma Corp', u'Nagoya University', u'New York Medical College', u'Theragene Pharmaceuticals', u'Activaero GmbH', u'SteadyMed Therapeutics Inc', u'GenThera Inc', u'Proteo Biotech AG', u'Supernus Pharmaceuticals Inc', u'Encysive Pharmaceuticals Inc', u'Bayer HealthCare AG', u'Bayer Schering Pharma AG', u'Gilead Sciences Inc', u'National Heart Lung and Blood Institute', u'Mifcare', u'Hangzhou Gmax Biopharm Biomedical Engineering Co Ltd', u'Glasgow University', u'United Therapeutics Corp', u'INRS - Institut Armand-Frappier', u'Medtronic Inc', u'National Center For Global Health & Medicine', u'University of Cambridge']), u'Vascularocclusivedisease': set([u'Australian Government', u'NewSouth Innovations']), u'Diabeticretinopathy': set([u'US Government', u'Charlesson LLC', u'iCo Therapeutics Inc', u'Aqua Therapeutics Co Ltd', u'University of Florida', u'AGTC', u'Experimentica Ltd', u'GenVec Inc', u'Warner-Lambert Co', u'BTG plc', u'Univ Massachusetts', u'Regeneron Pharmaceuticals Inc', u'University of Colorado at Denver and Health Sciences Center', u'Indiana University School of Medicine', u'MacuSight Inc', u'Ionis Pharmaceuticals Inc', u'Ipsen', u'LegoChem Bioscience Inc', u'ActiveSite Pharmaceuticals Inc', u'Radical Biotechnology Pty Ltd', u'Microbot Medical Inc', u'ISTA Pharmaceuticals Inc', u'Neuro Kinetics Inc', u'Mystic Pharmaceuticals Inc', u'Sankyo Co Ltd', u'Eyetech Inc', u'Regulus Therapeutics Inc', u'Teijin Ltd', u'Emory University', u'Allegro Ophthalmics LLC', u'NeuMedics Inc', u'Alnylam Pharmaceuticals Inc', u'R-Tech Ueno Ltd', u'Targazyme Inc', u'SciDose LLC', u'Weill Medical College of Cornell University', u'Thomas Jefferson University', u'Sirnaomics Inc', u'Abbott Laboratories', u'Compass Biomedical', u'National Cancer Institute', u'Antisense Therapeutics Ltd', u'Johns Hopkins University School of Medicine', u'Alimera Sciences Inc', u'Fujisawa Pharmaceutical Co Ltd', u'St Vincents Hospital (Melbourne) Ltd', u'Santen Pharmaceutical Co Ltd', u'Guangdong Zhongsheng Pharmaceutical Co Ltd', u'Monash University', u'Lions Eye Institute of Western Australia Inc', u'EZRA Innovations LLC', u'FibroGen Inc', u'Kangwon University Pharmaceutical College', u'Pennsylvania State University', u'Institute of Ophthalmology', u'Allergan Inc', u'pSivida Inc', u'University of California San Diego', u'Joslin Diabetes Center Inc', u'Recordati SpA', u'Bausch & Lomb Inc', u'China Pharma Holdings Inc', u'NOXXON Pharma AG', u'Green Cross Corp', u'Genentech Inc', u'Kato Pharmaceuticals Inc', u'Agilent Technologies Inc', u'Harvard Medical School', u'Otsuka Pharmaceutical Co Ltd', u'Korea Drug Development Fund', u'Aciont Inc', u'Molecular Design International Inc', u'Oxford BioMedica plc', u'Diagnos Inc', u'Genzyme Pharmaceuticals', u'Undisclosed', u'EyeCyte Inc', u'Scripps Research Institute', u'National Eye Institute', u'The Leona M. and Harry B. Helmsley Charitable Trust', u'Vascular Pharmaceuticals Inc', u'University College London', u'Eli Lilly & Co', u\"Lee's Pharmaceutical Holdings Limited\", u'University of Miami', u'Bayer AG', u'University of Virginia', u'IBM Watson Health Life Sciences', u'University of Tennessee', u'University of California Los Angeles', u'Erasmus University Medical Center Rotterdam', u'AstraZeneca plc', u'Pfizer Inc', u'Gilead Sciences Inc', u'SUGEN Inc', u'Zalicus Inc', u'Alcon Inc', u'Ajou University', u'Johnson & Johnson', u'Australian Government', u'American Diabetes Association', u'Texas Emerging Technology Fund', u'Juvenile Diabetes Research Foundation', u'Northwestern University', u'Idx Llc', u'Crinetics Pharmaceuticals Inc', u'National Institutes of Health', u'Senju Pharmaceutical Co Ltd', u'Sanofi Genzyme', u'MacuCLEAR Inc', u'Quark Pharmaceuticals Inc', u'University of Melbourne', u'Intradigm Corp', u'Astellas Pharma Inc', u'UCB Celltech', u'Fovea Pharmaceuticals SA', u'Duke University', u'Hokkaido University', u'Apollo Endosurgery Inc', u'BioDiem Ltd', u'Life Sciences Discovery Fund', u'Idera Pharmaceuticals Inc', u'Takeda Pharmaceutical Co Ltd', u'BetaStem Therapeutics Inc', u'German Federal Ministry of Education and Research', u\"King's College London\"]), u'Gaspoisoning': set([u'Ryerson University', u'Altimmune Inc', u'National Institute of Neurological Disorders and Stroke', u'Countervail Corp', u'Defense Advanced Research Projects Agency', u'Percivia LLC', u'PlantForm Corp', u'University of Maryland', u'Nanotherapeutics Inc']), u'Bonemarrowdisease': set([u'Thomas Jefferson University', u'Editas Medicine Inc', u'Zhejiang Hisun Pharmaceutical Co Ltd', u'Bar-Ilan University', u'National Cancer Institute', u'Tego BioSciences Corp', u'Cure Medical Manufacturing', u'Biothera Pharmaceuticals Inc', u'ALZA Corp', u'Biomas Inc', u'Alpha-Beta Technology Inc', u'Teva Pharmaceutical Industries Ltd', u'The Collaborative Group', u'Cleveland BioLabs Inc', u'San Raffaele Telethon Institute for Gene Therapy', u'Russian Federation', u'Medimmune Oncology Inc', u'GlaxoSmithKline plc']), u'Macroglobulinemia': set([u'Chugai Pharmaceutical Co Ltd', u'National Comprehensive Cancer Network', u'The Leukemia & Lymphoma Society', u'Genentech Inc', u'Genmab A/S', u'Harvard Medical School', u'IDIS Ltd', u'IDEC Pharmaceuticals Corp', u'MENTRIK Biotech LLC', u'arGEN-X NV', u'Lonza Group AG', u'National Cancer Institute', u'XOMA Corp', u'Aventis SA', u'Eli Lilly & Co', u'Fujifilm Diosynth Biotechnologies', u'CASI Pharmaceuticals Inc', u'Fred Hutchinson Cancer Research Center', u'Zenyaku Kogyo Co Ltd', u'Takeda Oncology', u'Pharsight Corp', u'Roche Holding AG', u'Janssen Pharmaceutical KK', u'Medarex Inc', u'Micromet Inc', u'BeiGene Co Ltd', u'siRNAx Inc', u'Human Genome Sciences Inc', u'Cancer Genetics Inc', u'Royalty Pharma', u'Genta Inc']), u'Yersiniapestisinfection': set([u'University of Washington', u'University of Texas Medical Branch at Galveston', u'University of Maryland Baltimore County', u'Protein Potential LLC', u'DynPort Vaccine Company LLC', u'Advanced BioScience Laboratories Inc', u'Advanced Life Sciences Holdings Inc', u'Biothera Pharmaceuticals Inc', u'FasCure Therapeutics LLC', u'Tetraphase Pharmaceuticals Inc', u'National Institute of Allergy and Infectious Diseases', u'iBio Inc', u'Endacea Inc', u'US Army Medical Research and Materiel Command', u'UK Ministry of Defence', u'Mount Sinai School of Medicine', u'Prokarium', u'Greffex Inc', u'US Health and Human Services Department', u'InViragen LLC', u'National Institutes of Health', u'Texas A&M University System', u'US Government', u'UMeWorld Ltd', u'Achaogen Inc', u'Syntiron LLC', u'Chinese Government', u'CUBRC', u'Nanotherapeutics Inc', u'ANI Pharmaceuticals Inc', u'US Army Medical Research Institute of Infectious Diseases', u'Medison Pharma Ltd', u'Fujifilm Diosynth Biotechnologies', u'Celldex Therapeutics Inc', u'Altimmune Inc', u'AvidBiotics Corp', u'University of Chicago', u'University of Kentucky', u'UK Government', u'Aridis Pharmaceuticals Inc', u'Advanced Biotherapy Inc', u'Basilea Pharmaceutica International Ltd', u'Creative Antibiotics Sweden AB', u'Federal government of Mexico', u'Trudeau Institute', u'Battelle', u'BioDiem Ltd', u'Canadian Department of National Defence', u'Lanzhou Institute of Biological Products', u'US Naval Medical Research Center', u'Crucell NV', u'University of Massachusetts Medical School', u'SIGA Technologies Inc', u'Biophage Pharma Inc', u'Norwell Inc', u'University of California San Diego', u'US Department of Defense', u'Kineta Inc', u'Undisclosed', u'ID Biomedical Corp', u'University of Illinois', u'Defense Threat Reduction Agency']), u'Leptospiraceaeinfection': set([u'Finlay Institute', u'Korean Ministry of Knowledge Economy', u'Abivax', u'ImmuneMed Inc']), u'Unclassifiedvirusinfection': set([u'Gilead Sciences Inc', u'Rega Institute for Medical Research']), u'Inflammatorybreastcancer': set([u'Milburn Foundation', u'Erasmus University Medical Center Rotterdam', u'Mount Sinai Medical Center']), u'Osteosarcoma': set([u'Onyx Pharmaceuticals Inc', u'Apricity Therapeutics Inc', u'US Government', u'Baylor College of Medicine', u'Aurora Biopharma Inc', u'GENESIS Pharma SA', u'Celldex Therapeutics Inc', u'Advaxis Inc', u'Jenner Biotherapies Inc', u'IDM Pharma Inc', u'US Health and Human Services Department', u'Pediatric Oncology Experimental Therapeutics Investigation Consortium', u'National Cancer Institute', u'Novartis AG', u'Cancer Prevention and Research Institute of Texas', u'National Institutes of Health', u'Salmedix Inc', u'Allosteros Therapeutics Inc', u'Cancer Research Campaign (UK)', u'XOMA Corp', u'Karolinska Institutet', u'Medison Pharma Ltd', u'Onyvax Ltd', u'Eli Lilly & Co', u'Cancer Council New South Wales', u'Bellicum Pharmaceuticals Inc', u'Kancera AB', u'Garvan Institute of Medical Research', u'Triangle Pharmaceuticals Inc', u'Imclone LLC', u'Inventiv Health Clinical Inc', u'MBC Pharma Inc', u'Cambridge Laboratories Ltd', u'CorMedix Inc', u'Live Like Bella Childhood Cancer Foundation', u'University of California San Diego', u'Takeda Development Centre Europe Ltd', u'Epeius Biotechnologies Corp', u'University of Oxford']), u'Filovirusinfection': set([u'National Health and Medical Research Council', u'BioProtection Systems Corp', u'GenPhar Inc', u'Agilvax Inc', u'The Macfarlane Burnet Institute For Medical Research & Public Health Ltd', u'Janssen Vaccines & Prevention BV', u'University of Washington', u'National Institute of Allergy and Infectious Diseases', u'University of Texas Medical Branch at Galveston', u'Cangene Corp', u'Texas Biomedical Research Institute', u'Albert Einstein College of Medicine', u'Microbiotix Inc', u'Scripps Research Institute', u'Merck & Co Inc', u'Candian Chemical, Biological, Radiological or Nuclear (CBRN) Research and Technology Initiative', u'Abgenix Inc', u'Paragon Bioservices Inc', u'Immunovaccine Inc', u'NewLink Genetics Corp', u'US Army Medical Research Institute of Infectious Diseases', u'US Government', u'Battelle', u'Integrated BioTherapeutics Inc', u'Public Health Agency of Canada', u'US Department of Defense', u'Kineta Inc', u'Trellis Bioscience Inc', u'BioCryst Pharmaceuticals Inc', u'Defense Threat Reduction Agency']), u'GauchersdiseasetypeI': set([u'Oxford GlycoSciences plc', u'UCB SA', u'Teva Pharmaceutical Industries Ltd', u'Actelion Ltd']), u'Vitreoushumordisease': set([u'BioFirst Corporation', u'American BriVision Corporation']), u'Moraxellacatarr': set([u'Abbott Laboratories', u'Toyama Chemical Co Ltd']), u'Sicklecell': set([u'Par Pharmaceutical Co Inc', u'BioMarin Pharmaceutical Inc']), u'Patentductusarteriosus': set([u'Eunice Kennedy Shriver National Institute of Child Health & Human Development', u'Orphan Europe SARL', u'PLx Pharma Inc (pre-merger)', u'Medunik Canada']), u'Biliarytumor': set([u'Gilead Sciences Inc', u'GlaxoSmithKline plc']), u'Centralnervoussysteminfection': set([u'Cangene Corp', u'Sanofi Genzyme']), u'Kidneydialysis': set([u'Chugai Pharmaceutical Co Ltd', u'Mitsui & Co Ltd', u'Asahi Kasei Corp', u'NovelMed Therapeutics Inc', u'Myriad RBM', u'Otsuka Pharmaceutical Co Ltd', u'Sandoz International GmbH', u'CorMedix Inc', u'US Government', u'Advanced Renal Technologies', u'Gambro AB', u'Hemotech SAS', u'Rockwell Medical Inc', u'Fresenius Medical Care AG', u'Rex Medical LP', u'Japan Tobacco Inc', u'DaVita Inc', u'Bluegrass Vascular Technologies', u'Merit Medical Systems Inc', u'CryoLife Inc', u'Toray Industries Inc', u'Argon Medical Devices Inc', u'NxStage Medical Inc']), u'Viralencephalitis': set([u'Akonni Biosystems', u'Ichor Medical Systems Inc', u'US Army Medical Research Institute of Infectious Diseases', u'Hawaii Biotech Inc', u'National Institutes of Health', u'Acuvax Ltd', u'US Department of Defense', u'Frost & Sullivan', u'CytoGenix Inc']), u'Dermatophytosis': set([u'Janssen Pharmaceutica NV', u'Barrier Therapeutics Inc', u'Kyowa Hakko Kogyo Co Ltd', u'Johnson & Johnson']), u'Jointdisease': set([u'Stryker Corp', u'William Harvey Research Ltd', u'Medarex Inc', u'Wright Medical Technology Inc', u'Netherlands Government', u'Silipos Inc', u'Mochida Pharmaceutical Co Ltd', u'Geron Corp', u'LifeArc', u'ZymoGenetics Inc', u'Restore Surgical LLC dba Instratek', u'National Institutes of Health', u'Fidia Group', u'Sumitomo Pharmaceuticals Co Ltd', u'Novartis Pharma AG', u'MorphoSys AG', u'Vericel Corp', u\"Lee's Pharmaceutical Holdings Limited\", u'Navidea Biopharmaceuticals Inc', u'Mitsubishi-Tokyo Pharmaceuticals Inc', u'InviCRO Llc', u'Bioverativ Inc', u'Sosei Group Corp', u'Algeos', u'Galapagos NV', u'Corin Group PlC', u'Hokkaido University', u'Zimmer Biomet Holdings Inc', u'Merck Serono SA', u'Nextremity Solutions Llc', u'University Campus Suffolk', u'Nordic Bioscience A/S', u'Azign Bioscience A/S', u'Rheumco LLC']), u'Oralmucositis': set([u'GliaMed Inc', u'Maxim Pharmaceuticals Inc', u'US Government', u'Australian Government', u'University of California San Diego School of Medicine', u'Intrexon Corp', u'Amgen Inc', u'National Research Council of Canada', u'Meiji Seika Pharma Co Ltd', u'Oragenics Inc', u'Luqa Pharmaceuticals', u'Ardea Biosciences Inc', u'OraPharma Inc', u'Kyowa Kirin', u'Pharmacia & Upjohn SpA', u'R-Pharm US LLC', u'Jian An Pharmaceuticals', u'GlycoMira Therapeutics Inc', u'ActoGeniX NV', u'Amarillo Biosciences Inc', u'Abeona Therapeutics Inc', u'Kereos Inc', u'Synedgen Inc', u'BMG Pharma LLC', u'PolyMedix Inc', u'Hanmi Pharmaceutical Co Ltd', u'Massachusetts Life Sciences Center', u'SciClone Pharmaceuticals Inc', u'Samyang Corp', u'IS Pharma plc', u'La Jolla Pharmaceutical Co', u'Biomodels LLC', u'Verta Ltd', u'Galera Therapeutics Inc', u'Camurus AB', u'National Institute of Dental and Craniofacial Research', u'RHEI Pharmaceuticals Inc', u'EKR Therapeutics Inc', u'TGR BioSciences Pty Ltd', u'Taiga Biotechnologies Inc', u'US Department of Energy', u'Soligenix Inc', u'ActivBiotics Inc', u'National Cancer Institute', u'Vestiq Pharmaceuticals Inc', u'Hayashibara Co Ltd', u'Novozymes GroPep Ltd', u'Avaxia Biologics Inc', u'Swedish Orphan Biovitrum AB', u'Institute for the Promotion of Innovation by Science and Technology in Flanders', u'Estero-Anstalt', u'Targazyme Inc', u'Solasia Pharma KK']), u'Papularskindisease': set([u'Allergan Inc', u'BioAdvance', u'SkyePharma plc', u'Bioglan Pharmaceuticals Co', u'TOLMAR Therapeutics Inc', u'SansRosa Pharmaceutical Development Inc']), u'Hypotension': set([u'Cork University Hospital', u'La Jolla Pharmaceutical Co', u'Apex Bioscience Inc', u'Astellas Pharma Inc', u'LFB SA', u'Cleveland Clinic Foundation', u'Medinox Inc', u'Yabao Pharmaceutical Group Co Ltd', u'Ajinomoto Co Inc', u'George Washington University', u'Orient Europharma', u'BCO Pharma Ltd', u'Sanofi', u'European Commission']), u'Arthralgia': set([u'Vifor Pharma', u'Obj Ltd', u'Advanced Medical Isotope Corp', u'Anika Therapeutics Inc', u'Griffith University', u'Undisclosed', u'National Institute on Drug Abuse', u'Elan Corp plc', u'Sanofi Genzyme', u'TTY Biopharm Co Ltd', u'Eli Lilly & Co', u'Colorado State University', u'BioDelivery Sciences International Inc', u'Paradigm Biopharmaceuticals Ltd', u'Transition Therapeutics Inc', u'Professional Compounding Centers Of America Ltd', u'Galapagos NV', u'Aureus Medical', u'Calchan Ltd', u'Modi Mundipharma Pvt Ltd', u'Medovex Corp', u'Handok Inc', u'Imprimis Pharmaceuticals Inc', u'Technology Strategy Board', u'Shionogi & Co Ltd', u'Boehringer Ingelheim Corp', u'PDI Inc', u'Soho Flordis International', u'Antibe Therapeutics Inc', u'Teijin Pharma Ltd', u'University of Kentucky', u'Laboratories Acbel SA']), u'Hendravirusinfection': set([u'University of Texas Medical Branch at Galveston', u'Profectus BioSciences Inc', u'National Cancer Institute', u'Royal DSM NV', u'University of Queensland', u'Uniformed Services University of the Health Sciences', u'Queensland Government', u'NSW Government', u'National Institute of Allergy and Infectious Diseases', u'Commonwealth Scientific and Industrial Research Organization', u'Commonwealth Government']), u'Alopeciaareata': set([u'University of Minnesota', u'Medivir AB', u'TetraLogic Pharmaceuticals Corp', u'Bristol-Myers Squibb Co', u'Aclaris Therapeutics Inc', u'Vixen Pharmaceuticals Inc', u'Rigel Pharmaceuticals Inc', u'Hapten Pharmaceuticals Llc', u'RXi Pharmaceuticals Corp', u'Columbia University']), u'Astrocytoma': set([u'Double Bond Pharmaceutical AB', u'National Cancer Institute', u'AstraZeneca plc', u'Emory University', u'Axelar AB', u'Merck & Co Inc', u'Activate Immunotherapy', u'Research Institute of Physical and Chemical Problems', u'Rush University Medical Center', u'American Brain Tumor Association']), u'Acutechestsyndrome': set([u'NuvOx Pharma LLC', u'University of Pittsburgh']), u'Streptococcusmutansinfection': set([u'Planet Biotechnology Inc', u'Large Scale Biology Corp', u'National Institute of Dental and Craniofacial Research', u'University of Alabama at Birmingham']), u'Hematopoieticstemcelltransplantation': set([u'National Cancer Institute', u'Medidata Solutions Worldwide', u'Bellicum Pharmaceuticals Inc', u'Baylor College of Medicine', u'Novartis AG', u\"Children's Oncology Group\", u'Magenta Therapeutics Inc', u'Otsuka Pharmaceutical Co Ltd', u'Kyowa Hakko Kirin Co Ltd', u'Pluristem Therapeutics Inc', u'Bioforum']), u'Cerebrovasculardisease': set([u'National Health and Medical Research Council', u'MGI GP Inc', u'SICOR Inc', u'University of Western Australia', u'Synthelabo', u'Boehringer Ingelheim GmbH', u'Kunming Pharmaceutical Corp', u'Chugai Pharmaceutical Co Ltd', u'BELLUS Health Inc', u'Institute of Materia Medica Chinese Academy of Medical Sciences & Peking Union Medical College', u'GlaxoSmithKline plc', u'Medisan Pharmaceutical Co Ltd Harbin', u'Merck KGaA', u'NeoCytex Biopharma Inc', u'National Institutes of Health', u'University of Oregon', u'Hamilton Pharmaceuticals Ltd', u'Chinese Government', u'Zeria Pharmaceutical Co Ltd', u'Agahan Ayandeye Pars Inc', u'Sanofi', u'Astellas Pharma Inc', u'Kentucky Science and Technology Corp', u'FB Health', u'Nissan Chemical Industries Ltd', u'Daiichi Pharmaceutical Corp', u'Zhejiang Huahai Pharmaceutical Group Co Ltd', u'CeNeS Pharmaceuticals Inc', u'AstraZeneca plc', u'Sihuan Pharmaceutical Holdings Group Ltd', u'Roche Palo Alto', u'Tripos Inc', u'Dali University', u'H Lundbeck A/S']), u'Metastaticrenalcancer': set([u'Wuhan Maidesen Pharmaceutical Technology Co Ltd', u'Chinese Government']), u'Fabrydisease': set([u'Evotec AG', u'Green Cross Corp', u'Israeli Government', u'Almac Group', u'State Of Israel The Ministry Of Industry & Trade The National Physical Laboratory', u'Paladin Labs Inc', u'Mayo Clinic Foundation', u'Shire Human Genetic Therapies Inc', u'Oxford GlycoSciences plc', u'iBio Inc', u'Baylor Research Institute', u'Mount Sinai School of Medicine', u'GlaxoSmithKline plc', u'Ozmosis Research Inc.', u'National Institutes of Health', u'Greenovation Biotech GmbH', u'Teva Pharmaceutical Industries Ltd', u'Sanofi Genzyme', u'Kentucky BioProcessing LLC', u'Sangamo Therapeutics Inc', u'Protalix BioTherapeutics Inc', u'The University Health Network', u'JCR Pharmaceuticals Co Ltd', u'Amicus Therapeutics Inc', u'Sumitomo Pharmaceuticals Co Ltd', u'Zacharon Pharmaceuticals Inc', u'Shire plc', u'Research Corporation Technologies', u'Transkaryotic Therapies', u'Orphan Medical Inc', u'GD Searle & Co', u'SK Chemicals Co Ltd', u'Isu Abxis Inc']), u'Pancreasdisease': set([u'National Institute of Diabetes, Digestive and Kidney Diseases', u'Lonza Group AG', u'Dr Falk Pharma GmbH', u'Aegera Therapeutics Inc', u'Salix Pharmaceuticals Ltd', u'Seoul National University', u'Protea Biosciences Inc', u'Laboratoires Mayoly Spindler', u'Tulane University', u'Altus Pharmaceuticals Inc', u'Cystic Fibrosis Foundation Therapeutics Inc', u'Aptalis Pharma Srl', u'Curis Inc', u'AMAG Pharmaceuticals Inc', u'Dong-A ST Co Ltd', u'Debiopharm SA', u'Alnara Pharmaceuticals Inc', u'Massachusetts General Hospital', u'Debiovision Inc', u'Samil Pharmaceutical Co Ltd']), u'Trypanosomacruziinfection': set([u'Nagasaki University', u'University of Antwerp', u'GlaxoSmithKline plc', u'World Health Organization', u'Sabin Vaccine Institute', u'Bayer Schering Pharma AG', u'CombiMatrix Corp', u'Lafepe', u'University of Basel', u'VU University Medical Center', u'Federal University of Ouro Preto', u'Celera South San Francisco', u'ArQule Inc', u'Isla Lab Products LLC', u'University of Pittsburgh', u'Swiss Agency for Development and Cooperation', u'National Institute of Advanced Industrial Science and Technology', u'Sandexis LLP', u'Medicines for Malaria Venture', u'Global Health Innovative Technology Fund', u'Aeras Global TB Vaccine Foundation', u'Murdoch University', u'Microbial Chemistry Research Foundation', u'St Louis University', u'Dutch Ministry of Foreign Affairs', u'National Center For Advancing Translational Sciences', u'Advinus Therapeutics Ltd', u'Fundacion Mundo Sano', u'SCYNEXIS Inc', u'Gador SA', u'Medecins Sans Frontieres', u'The European Union', u'Abbott Laboratories', u'Eisai Co Ltd', u'University of Dundee', u'Center for Infectious Disease Research', u\"Texas Children's Hospital\", u'University of California San Francisco', u'WuXi PharmaTech (Cayman) Inc', u'La Agencia Espa\\xf1ola de Cooperaci\\xf3n Internacional para el Desarrollo', u'Kancera AB', u'Infectious Disease Research Institute', u'Wellcome Trust', u'Vanderbilt University School of Medicine', u'Institut Pasteur Korea', u'Swiss Tropical & Public Health Institute', u'University of California San Diego', u'Drugs for Neglected Diseases Initiative', u'High Energy Accelerator Research Organization', u'Scripps Research Institute', u'Sanofi', u'Pen Pharmaceutical Services Ltd', u'Department for International Development', u'Humanigen Inc', u'Anacor Pharmaceuticals Inc', u'The University of Liverpool', u'Epichem Pty Ltd', u'AstraZeneca plc', u'Pfizer Inc', u'Fundacao Oswaldo Cruz (Fiocruz)', u'Centre for Drug Candidate Optimisation', u'Kitasato Institute', u'Broad Institute Inc', u'Baylor College of Medicine', u'Savant Neglected Diseases LLC', u'University of London School of Pharmacy', u'Center for Discovery and Innovation in Parasitic Diseases', u'Universidad Complutense de Madrid', u'Centro Nacional de Diagnostico e Investigacion de Endemo-epidemias', u'Universidad Industrial De Santander', u'The Institute for OneWorld Health', u'National Institute of Allergy and Infectious Diseases', u'SEEK', u'Phylogica Ltd', u'National Institutes of Health', u'Bill & Melinda Gates Foundation', u'University of Tokyo', u'M.J. Murdock Charitable Trust', u'Aventis SA', u'Sanofi Genzyme', u'Janssen Research & Development LLC', u'Celgene Corp', u'Astellas Pharma Inc', u'BioDelivery Sciences International Inc', u'Chembio Diagnostic Systems Inc', u'Institut Pasteur', u'CEI Campus Moncloa', u'Takeda Pharmaceutical Co Ltd', u'German Federal Ministry of Education and Research']), u'Juvenilerheumatoidarthritis': set([u'Celltrion Inc', u'UCB Celltech', u'Santarus Inc', u'Novartis AG', u'Wyeth', u'Boehringer Ingelheim Corp', u'Novartis Pharma AG', u'Amgen Inc', u'Knoll GmbH', u'Cumberland Pharmaceuticals Inc', u'Stiefel Laboratories (UK) Ltd', u'Samil Pharmaceutical Co Ltd', u'Bristol-Myers Squibb Co', u'Abbott Laboratories', u'Biochemie GmbH', u'Eisai Co Ltd', u'Medarex Inc', u'Nordic Group', u'Victory Pharma Inc']), u'Rotavirusi': set([u'AB ANALITICA', u'Mobidiag Oy']), u'Spinalcordinjury': set([u'US Government', u'BioMarin Pharmaceutical Inc', u'Hunter-Fleming Ltd', u'University of Zurich', u'Remedy Pharmaceuticals Inc', u'MandalMed Inc', u'Cardinal Health Inc', u'Netherlands Government', u'Q Therapeutics Inc', u'Scholar Rock Inc', u'California Institute of Regenerative Medicine', u'Amsterdam Molecular Therapeutics BV', u'Heriot-Watt University', u'The Ohio State University Wexner Medical Center', u\"Cincinnati Children's Hospital Medical Center\", u'DaVinci Biosciences LLC', u'Bayer Schering Pharma AG', u'QSV Biologics', u'Ohio Third Frontier', u'Tiantan Puhua Neurological Hospital', u'Radikal Therapeutics Inc', u'Medipost Co Ltd', u'Center for Stem Cell and Regenerative Medicine', u'Cell Design, LLC', u'Renew Spinal Care Inc', u'Stanford University', u'Microbot Medical Inc', u'University of Pittsburgh', u'NeuroFix Therapeutics Inc', u'Sangamo Therapeutics Inc', u'Kringle Pharma Inc', u'Walter Reed Army Institute of Research', u'MirImmune LLC', u'Hospira Inc', u'Shandong Weigao Group Medical Polymer Co Ltd', u'University of Miami Miller School of Medicine', u'BrainStorm Cell Therapeutics Inc', u'Acorda Therapeutics Inc', u'StemCyte Inc', u'Cognosci Inc', u'Tenax Therapeutics Inc', u'NeuroSpheres Ltd', u'Keio University', u'Sanford-Burnham Medical Research Institute', u'Asterias Biotherapeutics Inc', u'Alseres Pharmaceuticals Inc', u'LeadPhysician', u'Loyola University of Chicago', u'National Research Council of Canada', u'Warren Pharmaceuticals Inc', u'MGI GP Inc', u'Shirley Ryan AbilityLab', u'CuroNZ Ltd', u'Japan Science and Technology Agency', u'Neurosciences Victoria Ltd', u'Geron Corp', u'SonoSpine LLC', u'Lipopharma Therapeutics SL', u'Migragen AG', u'Eunice Kennedy Shriver National Institute of Child Health & Human Development', u'Morphochem AG', u'Neuren Pharmaceuticals Ltd', u'Sernova Corp', u'Maryland Stem Cell Research Fund', u'Santen Pharmaceutical Co Ltd', u'Medical Research Council', u'Monash University', u'Yeda Research and Development Co Ltd', u'Newron Pharmaceuticals SpA', u'Alnylam Pharmaceuticals Inc', u\"Ataxia Telangiectasia Children's Project Inc\", u'Cleveland Clinic Foundation', u'BioVex Inc', u'Wellcome Trust', u'Innovascreen Inc', u'Case Western Reserve University', u'National Aeronautics & Space Administration', u\"M's Science Corp\", u'HeadNorth Foundation', u'Nanotope Inc', u'University of California San Francisco', u'Ferrer Internacional SA', u'Asan Medical Center', u'GNT Pharma Co Ltd', u'Christopher and Dana Reeve Foundation', u'McGill University Health Center', u'Rutgers University', u'BioAxone Therapeutic Inc', u'Stemedica Cell Technologies Inc', u'Medtronic Inc', u'H Lundbeck A/S', u'Nano Terra Inc', u'National Institute of Neurological Disorders and Stroke', u'Novoron Bioscience Inc', u'Zacharon Pharmaceuticals Inc', u'Alexion Pharmaceuticals Inc', u'AmKor Pharma Inc', u'Wyeth Pharmaceuticals', u'Mc10 Inc', u'Merrion Pharmaceuticals Inc', u'Oxford BioMedica plc', u'Sumitomo Dainippon Pharma Co Ltd', u\"O'Brien Institute\", u'Squibb Diagnostics', u'Republic of Korea Government', u'Seikagaku Corp', u'Undisclosed', u'Chi Sheng Chemical Corp', u'US Army Medical Research and Materiel Command', u'Histocell Sl', u'University of California', u'Merck & Co Inc', u'Vertex Pharmaceuticals Inc', u'Feinstein Institute for Medical Research', u'University of Western Ontario', u'US Naval Medical Research Center', u'University of Miami', u'Deutsches Krebsforschungszentrum', u'St Andrews University', u'University of California Irvine', u'Swenora Biotech AB', u'BBB Therapeutics BV', u'Kadmon Pharmaceuticals LLC', u'Maroon Biotech Corp', u'Galapagos Genomics BV', u'ReNeuron Group plc', u'AstraZeneca plc', u'Pfizer Inc', u'Nordic Life Science Pipeline Inc', u'Kaken Pharmaceutical Co Ltd', u'Epiomed Therapeutics Inc', u'InVivo Therapeutics Holdings Corp', u'Adenosine Therapeutics LLC', u'US Department of Defense', u'FCB-Pharmicell Co Ltd', u'Genexine Co Ltd', u'Johns Hopkins University', u'Vatea Fund', u'InCube Laboratories LLC', u'Apogenix GmbH', u'RhinoCyte Inc', u'Axogen Ltd', u'Advirna LLC', u'NeuroVive Pharmaceutical AB', u'University of California San Diego', u'BioTime Inc', u'Juvenile Diabetes Research Foundation', u'Quintiles Transnational Corp', u'Centro De Biologia Molecular Severo Ochoa', u'TCA Cellular Therapy LLC', u'National Institutes of Health', u'Abeona Therapeutics Inc', u'Proneuron Biotechnologies Inc', u'University of Oregon', u'Noscira SA', u'Elan Corp plc', u'IBEX Technologies Inc', u'OSEO', u'Curis Inc', u'Shepherd Center', u'Kyoto University', u'Medical College of Georgia', u'Neuronax', u'AGY Therapeutics Inc', u'University of Chicago', u'US Department of Commerce', u'BioAxone Biosciences Inc', u'Ciba-Geigy AG', u'Tianjin Pharmaceutical Holdings Ltd', u'Apollo Endosurgery Inc', u'FDA Office of Orphan Products Development', u'BioArctic Neuroscience AB', u'RNL Bio Co Ltd', u'Athersys Inc', u'Neuralstem Inc', u'Aventis Pharma SA', u'Junta de Beneficencia de Guayaquil', u'Novartis AG', u'University of Tasmania', u'University of Louisville', u'German Federal Ministry of Education and Research', u'Synthego', u\"King's College London\"]), u'Anticoagulantoverdose': set([u'Perosphere Inc', u'Daiichi Sankyo Co Ltd']), u'Enterococcaceaeinfection': set([u'Dyax Corp', u'Inhibitex Inc']), u'Bacteroidesfragilisinfection': set([u'Pfizer Inc', u'Bayer AG', u'Chong Kun Dang Pharmaceutical Corp', u'AstraZeneca plc']), u'Systemicmastocytosis': set([u'Biologics Inc', u'Novartis AG']), u'Ren': set([u'Silence Therapeutics plc', u'Corixa Corp', u'Stanford Rook Ltd', u'YM BioSciences Inc', u'Onyvax Ltd']), u'Turnerssyndrome': set([u'Biopasgroup', u'Eli Lilly & Co', u'UCB Pharma GmbH', u'JCR Pharmaceuticals Co Ltd', u'Pfizer Inc', u'CSL Ltd', u'Genentech Inc', u'Quantum Health Resources Inc', u'TPG Biotech', u'Savient Pharmaceuticals Inc', u'Sumitomo Dainippon Pharma Co Ltd', u'US Department of Veterans Affairs', u'Ipsen', u'Ferring Pharmaceuticals SA', u'Amylin Pharmaceuticals Inc', u'Sumitomo Chemical Co Ltd', u'Abbott Laboratories', u'Grandis Biotech GmbH', u'InfiMed Therapeutics Inc']), u'AIDSrelatedcomplex': set([u'CASI Pharmaceuticals Inc', u'Athersys Inc', u'Celgene Corp', u'National Cancer Institute', u'Undisclosed', u'Immunex Corp', u'Elan Corp plc', u'Immune Therapeutics Inc', u'Wyeth', u'Royalty Pharma', u'Ore Pharmaceuticals Inc', u'Lipomed AG']), u'Hereditaryhemorrhagictelangiectasia': set([u'Fondazione Telethon', u'Fondazione IRCCS Policlinico San Matteo']), u'Menorrhagia': set([u'Bordoloi Biotech Llc', u'Washington University in St Louis', u'Meditrina Pharmaceuticals Inc', u'Wayne State University', u'Ferring Pharmaceuticals SA', u'Xanodyne Pharmaceuticals Inc']), u'Pachyonychiacongenita': set([u'BioAdvance', u'Pachyonychia Congenita Project', u'National Institute of Arthritis and Musculoskeletal and Skin Diseases', u'Food and Drug Administration', u'TransDerm Inc', u'Palvella Therapeutics Llc']), u'Ocularinfection': set([u'Alcon Inc', u'Clinical Data Inc', u'University of Lund', u'Acuity Pharmaceuticals', u'SCYNEXIS Inc', u'Atlantic Technology Ventures Inc', u'Jamjoom Pharmaceuticals', u'US Government', u'NYU Langone Medical Center', u'Pathogenics Inc', u'PharmaNova Inc', u'Innovation Pharmaceuticals Inc', u'Dr Mann Pharma GmbH', u'Senju Pharmaceutical Co Ltd', u'CLS Pharmaceuticals Inc', u'Adenovir Pharma AB', u'Undisclosed', u'Ionis Pharmaceuticals Inc', u\"Dr Reddy's Laboratories Ltd\", u'National Eye Institute', u'Demegen Inc', u'Altacor Ltd', u'Biem Pharmaceuticals', u'Laboratoires Thea', u'InSite Vision Inc', u'NanoViricides Inc', u'Sirion Therapeutics Inc', u'Mitsubishi Tanabe Pharma Corp', u'Dong-A ST Co Ltd', u'Purdue Neuroscience Corp', u'Universitat Innsbruck', u'Inspire Pharmaceuticals Inc', u'Santen Pharmaceutical Co Ltd', u'Gilead Sciences Inc', u'General Biologicals Corp', u'Pacgen Life Science Corp', u'Parke-Davis & Co', u'DRI Capital', u'Bausch & Lomb Inc', u'Foresight Biotherapeutics Inc']), u'HumanTcellleukemiavirusinfection': set([u'THERAVECTYS', u'OSEO']), u'Retinitispigmentosa': set([u'Precision BioSciences Inc', u'US Government', u'Ocugen Inc', u'Baylor College of Medicine', u'University of Florida', u'Astellas Institute for Regenerative Medicine', u'UK Government', u'AGTC', u'Beijing SoloBio Gene Technology Co Ltd', u'Harvard Medical School', u'University of Pennsylvania', u'Forsight Labs, LLC', u'Amarantus BioScience Holdings Inc', u'California Institute of Regenerative Medicine', u'ID Pharma Co Ltd', u'Biogen Inc', u'Bascom Palmer Eye Institute', u'Wellstat Ophthalmics Corp', u'S. Fyodorov Eye Microsurgery Complex', u'Asklepios Biopharmaceutical Inc', u'Sumitomo Dainippon Pharma Co Ltd', u'Orphagen Pharmaceuticals Inc', u'Novartis AG', u'University of Washington', u'MeiraGTx', u'Athena Vision Ltd', u'Oregon Health Sciences University', u'Stemedica Cell Technologies Inc', u'BCN Peptides SA', u'University of California', u'University of Colorado System', u'Clino Corp', u'Universite Pierre et Marie Curie', u'National Eye Institute', u'Santen Pharmaceutical Co Ltd', u'Therapeutics for Rare and Neglected Diseases', u'RIKEN', u'Sancilio & Company Inc', u'Sangamo Therapeutics Inc', u'AiVita Biomedical', u'University of Manchester', u'Florida Atlantic University', u'University of Miami', u'National Neurovision Research Institute', u'Astellas Pharma Inc', u'MitoKor', u'ProRetina Therapeutics SL', u'Shire plc', u'Ceregene Inc', u'Orient Europharma', u'Fovea Pharmaceuticals SA', u'University of North Carolina', u'Zuellig Pharma Ltd', u'OptiKira', u'Arshia Gostar Darman Co', u'Dong-A ST Co Ltd', u'BioDiem Ltd', u'Acucela Inc', u'Foundation Fighting Blindness', u'Mimotopes Pty Ltd', u'FDA Office of Orphan Products Development', u'University of California Irvine', u'ReNeuron Group plc', u'GP Pharm SA', u'Japan Science and Technology Agency', u'BioMotiv LLC', u'University of California San Francisco', u'Catalent Inc', u'Second Sight LLC', u'Sinphar Pharmaceutical Co Ltd', u'BIKAM Pharmaceuticals Inc', u'Synthetic Biologics Inc', u'Caladrius Biosciences Inc', u'Spark Therapeutics LLC', u'REGENXBIO Inc', u'Genable Technologies Ltd', u'R-Tech Ueno Ltd', u'Sucampo Pharmaceuticals Inc', u'Benitec Biopharma Ltd', u'National Center For Advancing Translational Sciences']), u'Schistosomiasis': set([u'Yamanouchi Pharmaceutical Co Ltd', u'University of California Santa Barbara', u'Massachusetts Institute of Technology', u'The European Union', u'Eurogentec SA', u'The Institute for OneWorld Health', u'Drugs for Neglected Diseases Initiative', u'National Institute of Allergy and Infectious Diseases', u'Texas Biomedical Research Institute', u'GlaxoSmithKline plc', u'Top Institute Pharma', u'Sabin Vaccine Institute', u'Merck KGaA', u'Illinois State University', u'University of Texas System', u'Baylor College of Medicine', u'National Institutes of Health', u'Bill & Melinda Gates Foundation', u\"Texas Children's Hospital\", u'Sanofi', u'VU University Medical Center', u'INSERM', u'Pediatric Praziquantel Consortium', u'Fundacao Oswaldo Cruz (Fiocruz)', u'University of California San Francisco', u'Wyeth-Ayerst Pharmaceuticals Inc', u'CoNCERT Pharmaceuticals Inc', u'Kancera AB', u'Astellas Pharma Inc', u'Roche Holding AG', u'Financiadora de Estudos e Projetos', u'BIO Ventures for Global Health', u'Merck Millipore', u'George Washington University', u'BioDiem Ltd', u'Queensland Institute of Medical Research', u'Medicines for Malaria Venture', u'Global Health Innovative Technology Fund', u'Swiss Tropical & Public Health Institute', u'National Center for Research Resources', u'Texas Tech University', u'Alnylam Pharmaceuticals Inc', u'Wyeth BioPharma']), u'Metastaticbreastcancer': set([u'BioMarin Pharmaceutical Inc', u'Sarah Cannon Research Institute', u'Sermonix Pharmaceuticals LLC', u'National Comprehensive Cancer Network', u'Eddingpharm Inc', u'Biotoscana International', u'Seattle Genetics Inc', u'Ionis Pharmaceuticals Inc', u'Ipsen', u'Stanford University', u'Syndax Pharmaceuticals Inc', u'Amaran Biotechnology Inc', u'University of Washington', u'Halozyme Therapeutics Inc', u'Oncodesign Biotechnology SA', u'Alvogen Korea', u'Cold Spring Harbor Laboratory', u'Stellar Biotechnologies Inc', u'Analytical Biochemistry Laboratories Inc', u'Specialised Therapeutics Australia Pty Ltd', u'TESARO Inc', u'Wilex Inc', u'Emory University', u'BriaCell Therapeutics Corp', u'Universita di Bari', u'Dana-Farber Cancer Institute Inc', u'University of Nebraska Medical Center', u'National Research Council of Canada', u'NT Pharma (Group) Co Ltd', u'MD Anderson Cancer Center', u'Equity Pharmaceuticals Pty Ltd', u'Mylan Inc', u'Daiichi Sankyo Co Ltd', u'Abbott Laboratories', u'Eisai Co Ltd', u'PIQUR Therapeutics Ltd', u'R-Pharm US LLC', u'National Cancer Institute', u'Clovis Oncology Inc', u'ZIOPHARM Oncology Inc', u'University of Alabama at Birmingham', u'Paul I Terasaki Foundation Laboratory', u'Japanese Society for the Promotion of Science', u'GlaxoSmithKline plc', u'Massachusetts General Hospital', u'WuXi PharmaTech (Cayman) Inc', u'Predictive Therapeutics', u'Oncolytics Biotech Inc', u'Puma Biotechnology Inc', u'Immunomedics Inc', u'Astrazeneca Korea', u'Millennium Pharmaceuticals Ltd', u'Nuclea Biotechnologies LLC', u'Astex Therapeutics Ltd', u'Link Health Group', u'Boehringer Ingelheim Corp', u'Myriad Genetics Inc', u'F Hoffmann-La Roche AG', u'NCIC Clinical Trials Group', u'Spotlight Innovation Inc', u'Green Cross Corp', u'Genentech Inc', u'Arizona Cancer Therapeutics LLC', u'Biothera Pharmaceuticals Inc', u'Wilex AG', u'CMC Biologics Inc', u'Queen Mary University of London', u'Cancer InSight, LLC', u'Immunophotonics Inc', u'Eastern Cooperative Oncology Group', u'Merck & Co Inc', u'Mayo Clinic Arizona', u'Eli Lilly & Co', u'PharmaMar SA', u'Pierre Fabre SA', u'SEVA Therapeutics', u'The Mary Kay Foundation', u'Mayo Clinic, Minnesota', u'Lombardi Comprehensive Cancer Center at Georgetown University Hospital', u'Hefei Everlife Pharmaceutical Co Ltd', u'Nektar Therapeutics', u'University of California Los Angeles', u'AstraZeneca plc', u'Pfizer Inc', u'Immutep SA', u'Merrimack Pharmaceuticals Inc', u'University of Illinois', u'University of Arizona', u\"Dana-Farber/Brigham and Women's Cancer Center\", u'Janssen Diagnostics LLC', u'Veristat, Inc.', u'Caligor Opco Llc', u'H Lee Moffitt Cancer Center and Research Institute', u'Ligand Pharmaceuticals Inc', u'Northwestern University', u'MacroGenics Inc', u'Bristol-Myers Squibb Co', u'Kurume University School of Medicine', u'QuantumLeap Healthcare', u'University of Central Florida', u'NewLink Genetics Corp', u'Silicon Biosystems SRL', u'GTx Inc', u'Abilita Bio Inc', u'Biologics Inc', u'Novartis AG', u'Kyowa Kirin', u'Quest PharmaTech Inc']), u'Vasospasm': set([u'Handok Inc', u'Actelion Ltd']), u'Umbilicalcordstemcelltransplantation': set([u'Cephalon Inc', u'Binational Industrial Research and Development Foundation', u'New York Blood Center', u'Mesoblast Ltd', u'Hadassah Medical Organization', u'Pluristem Therapeutics Inc']), u'Cystinosis': set([u\"Seattle Children's Hospital\", u'Leadiant Biosciences Inc', u'Cystinosis Research Foundation', u'Baylor College of Medicine', u\"Universite d'Angers\", u\"Montreal Children's Hospital\", u'Stanford University', u'National Institutes of Health', u'University of California San Diego', u'Bambino Ges\\xf9 Hospital and Research Institute', u'French Government', u'Patheon Pharmaceuticals Inc', u'Scripps Research Institute', u'Cambrex Corp', u'Horizon Orphan LLC', u'National Eye Institute']), u'Periph': set([u'Merck & Co Inc', u'Memorial Sloan-Kettering Cancer Center', u'Columbia University']), u'Cornealtransplantation': set([u'Oxford BioMedica plc', u'Technology Strategy Board', u'TAP Biosystems', u'Clayton Foundation For Research', u'International Stem Cell Corp']), u'Primarybiliarycirrhosis': set([u'Intercept Pharmaceuticals Inc', u'AbbVie Inc', u'National Institute of Allergy and Infectious Diseases', u'Alfa Wassermann SpA', u'MediGene AG', u'National Institutes of Health', u'AmberGen Inc', u'Sumitomo Dainippon Pharma Co Ltd', u'Massachusetts General Hospital', u'Prasco Laboratories', u'UCB Pharma GmbH', u'Dr Falk Pharma GmbH', u'Retrophin Inc', u'FDA Office of Orphan Products Development', u'Universita Degli Studi Di Perugia', u'Asklepion Pharmaceuticals LLC', u'Aptalis Pharma Inc', u'Pfizer Inc', u'Sanofi', u'Medicines Patent Pool', u'Synthetic Biologics Inc', u'INOVA Diagnostics Inc', u'Aventis Pharma SA', u'Lumena Pharmaceuticals']), u'Juvenilemyoclonicepilepsy': set([u'Emerge Health Pty Ltd', u'Meiji Seika Pharma Co Ltd', u'Laboratoires Biocodex', u'Desitin Arzneimittel GmbH']), u'Metrorrhagia': set([u'Medtronic plc', u'Smith & Nephew plc']), u'Cervixinfection': set([u'Azanta A/S', u'Haemologic Ltd']), u'Japaneseencephalitisvirusinfection': set([u'Center For Disease Control Department Of Health Taiwan Roc', u'University of Texas Medical Branch at Galveston', u'Rhein Biotech NV', u'Undisclosed', u'Baxter International Inc', u'Indian Immunologicals Ltd', u'Defyrus Inc', u'Sanofi Pasteur', u'VaxServe Inc', u'The European Union', u'National Institute of Allergy and Infectious Diseases', u'Walter Reed Army Institute of Research', u'Malaysian Technology Development Corp', u'Valneva SE', u'BioNet-Asia Co Ltd', u'The Korea National Institute of Health', u'Sabin Vaccine Institute', u'InViragen LLC', u'Vaxine Pty Ltd', u\"St Jude Children's Research Hospital\", u'Oregon Health Sciences University', u'Biological E Ltd', u'Mount Sinai Hospital', u'Liaoning Cheng Da Co Ltd', u'Sanofi', u'Sentinext Therapeutics Sdn Bhd', u'VABIOTECH', u'University of Washington', u'VaccGen International LLC', u'US Army Medical Research Institute of Infectious Diseases', u'Astellas Pharma Inc', u'Mitsubishi Tanabe Pharma Corp', u'Kaketsuken', u'Adimmune Corp', u'Institut Pasteur', u'The Vaccine and Gene Therapy Institute of Florida', u'Crucell NV', u'Intercell AG', u'Novartis AG', u'US Department of Defense', u'Boryung Pharm Co Ltd', u'Kineta Inc', u'SK Chemicals Co Ltd', u'St Louis University', u'SingVax Pte Ltd', u'BIKEN Foundation', u'Acambis plc', u'Dr Reddy\\u2019s Research and Development BV', u'Bharat Biotech International Ltd', u'International Vaccine Institute']), u'NiemannPickdisease': set([u'Brazilian Government', u'CTD Holdings Inc', u'Oxford GlycoSciences plc', u'Maryland Innovation Initiative', u'Medical Need Europe AB', u'Teva Pharmaceutical Industries Ltd', u'Accenture', u'Genzyme General', u'Mount Sinai School of Medicine', u'GD Searle & Co', u'Institute for Bioscience and Biotechnology Research']), u'Mycob': set([u'Maxygen Holdings Ltd', u'Boehringer Ingelheim Corp', u'InterMune Inc', u'Genentech Inc', u'Connetics Corp']), u'Femalegenitaltractinfection': set([u'Centers for Disease Control and Prevention', u'Ciba-Geigy (Japan) Ltd', u'Chugai Pharmaceutical Co Ltd', u'Gynelogix Inc', u'The Medicines Company', u'National Institutes of Health', u'Contraceptive Research and Development Organization', u'Bill & Melinda Gates Foundation', u'Osel Inc', u'JW Pharmaceutical Corp', u'Undisclosed', u'National Institute of Allergy and Infectious Diseases', u'Rush University Medical Center', u'Polydex Pharmaceuticals Ltd']), u'Cardiotoxicitydrug-induced': set([u'Pink Ribbon Foundation', u'Novoheart Holdings Ltd', u'VistaGen Therapeutics Inc', u'Fred Hutchinson Cancer Research Center', u'Clinigen Group plc', u'The Leukemia & Lymphoma Society', u'Roche Holding AG', u'National Institutes of Health', u'Neostem Oncology', u'Cumberland Pharmaceuticals Inc', u'Synthetic Biologics Inc', u'Cellular Dynamics International Inc', u'Duke University', u'Undisclosed', u'Vitro Diagnostics Inc', u'Stemina Biomarker Discovery', u'HemoGenix Inc', u'Netherlands Cancer Institute']), u'Backpain': set([u'Eli Lilly & Co', u'Quintiles Transnational Corp', u'Handok Inc', u'bioRASI LLC', u'MAC Clinical Research', u'ICTV Brands', u'Esteve', u'PhotoMedex Inc', u'BioDelivery Sciences International Inc', u'Grunenthal GmbH', u'Relevium Technologies', u'GlobalAcorn', u'Back-A-Line Inc', u'CardioVascular BioTherapeutics Inc', u'TTY Biopharm Co Ltd']), u'Pheochromocytoma': set([u'National Cancer Institute', u'Advanced Accelerator Applications SA', u'Covis Pharma Sarl', u'Progenics Pharmaceuticals Inc', u'Centre for Probe Development and Commercialization', u'GlaxoSmithKline plc']), u'Crigler-Najjarsyndrome': set([u'REGENXBIO Inc', u'Audentes Therapeutics Inc', u'University of Pennsylvania', u'Perelman School of Medicine']), u'Esophagustumor': set([u'Ignyta Inc', u'Transcept Pharmaceuticals Inc', u'Sanofi Pasteur', u'GenVec Inc', u'OncoTherapy Science Inc', u'US Health and Human Services Department', u'GlaxoSmithKline plc', u'Asuragen Inc', u'BTG plc', u'Centelion SAS', u'Cancer Research UK', u'Sanofi Winthrop France SA', u'Ipsen', u'Immunex Corp', u'IDT Biologika GmbH', u'Arizona State University', u'ArQule Inc', u'Vernalis plc', u'OSI Pharmaceuticals Inc', u'Konica Minolta Camera Inc', u'Aduro BioTech Inc', u'Roche Holding AG', u'Immunocore Ltd', u'Mie University School of Medicine', u'Neon Therapeutics', u'KuDOS Pharmaceuticals Ltd', u'Fox Chase Cancer Center', u'Biocon Ltd', u'Shionogi & Co Ltd', u'CANbridge Life Sciences Ltd', u'Technology Strategy Board', u'RecipharmCobra Biologics', u'Light Sciences Corp', u'Apexigen Inc', u'MD Anderson Cancer Center', u'Okayama University Hospital', u'Mylan Inc', u'Institut Armand-Frappier', u'Daiichi Sankyo Co Ltd', u'Ohio State University', u'National Cancer Institute', u'Merck KGaA', u'Novelion Therapeutics Inc', u'Diatos SA', u'Agennix AG', u'Abgenix Inc', u'YM BioSciences Inc', u'Nagoya University', u'Guided Therapeutics Inc', u'PhotoBiotics Ltd', u'Boehringer Ingelheim Corp', u'Oncormed Inc', u'University of Oxford', u'AmpliPhi Biosciences Corp', u'Chugai Pharmaceutical Co Ltd', u'Atani KK', u'Genentech Inc', u'Protherics Salt Lake City Inc', u'Schering-Plough Corp', u'Undisclosed', u'US Government', u'Argos Therapeutics Inc', u'XOMA Corp', u'Merck & Co Inc', u'Ascentage Pharma Group Corporation Ltd', u'Sanofi', u'University College London', u'CTI BioPharma Corp', u'Eli Lilly & Co', u'Supratek Pharma Inc', u'AIT Austrian Institute Of Technology Gmbh', u'AEterna Zentaris Inc', u'Case Western Reserve University', u'Therapure Biopharma Inc', u'AstraZeneca plc', u'Pfizer Inc', u'Caprion Proteomics Inc', u'Merrimack Pharmaceuticals Inc', u'Cadila Pharmaceuticals Ltd', u'Lonza Biologics plc', u'Introgen Therapeutics Inc', u'Imclone LLC', u'Chongqing LUMMY Pharmaceutical Co Ltd', u'Japanese National Cancer Center', u'ASTA Medica AG', u'Hainan Tianwang International Pharmaceutical', u'Peter MacCallum Cancer Centre', u'University of Tokyo', u'Oncolys BioPharma Inc', u'AVEO Oncology', u'Bristol-Myers Squibb Co', u'Early Diagnosis Consortium', u'Leap Therapeutics Inc', u'Oncology Venture ApS', u'American Cyanamid Co', u'Onyx Pharmaceuticals Inc', u'Roswell Park Cancer Institute', u'Victorian Cancer Agency', u'University of Chicago', u'Imperial College London', u'Cornell University', u'Ascenta Therapeutics Inc', u'Ferozsons Laboratories Ltd', u'Adaptimmune Therapeutics plc', u'Takara Bio Inc', u'Cyanamid Benelux NV', u'University of Toronto', u'Rhone-Poulenc Rorer Inc', u'Aphton Corp']), u'Prostatehyperplasia': set([u'Daiichi Seiyaku Co Ltd', u'Matrix Pharma (Pvt) Ltd', u'US Government', u'Antev Ltd', u'Unimed Pharmaceuticals Inc', u'Phase 2 Discovery Inc', u'Orion Corporation', u'Lynx Therapeutics GmbH', u'GlaxoSmithKline plc', u'Bayer Schering Pharma AG', u'AndroBioSys Inc', u'Pharmaplan GmbH', u'Sanofi Winthrop France SA', u'Ipsen', u'Italchimici SpA', u'Zentaris GmbH', u'Ono Pharmaceutical Co Ltd', u'Takeda Oncology', u'Roche Holding AG', u'Abbott Healthcare Products BV', u'Astellas Pharma Europe BV', u'Sankyo Co Ltd', u'Handok Inc', u'Laboratoires Besins International', u'Shionogi & Co Ltd', u'Catalent Inc', u'Sigma-Tau Ind Farm Riunite SpA', u'Meiji Seika Pharma Co Ltd', u'Light Sciences Corp', u'Johnson & Johnson Pharmaceutical Research & Development LLC', u'Kanebo KK', u'Nippon Petrochem Co Ltd', u'WellSpring Pharmaceutical Corp', u'Angelini Pharmaceuticals SpA', u'Baxter Oncology GmbH', u'Milkhaus Laboratory Inc', u'Eisai Co Ltd', u'GTx Inc', u'Ardana Bioscience Ltd', u'Leiras Oy', u'Mediwin Limited', u'Aphios Corp', u'Tanaka Kapec Design Group Inc', u'Sunshine Biopharma Inc', u'Nymox Pharmaceutical Corp', u'Novelion Therapeutics Inc', u'Hanmi Pharmaceutical Co Ltd', u'Sanofi-Synthelabo', u'BioXell SpA', u'Schering SpA', u'UCB Pharma GmbH', u'Chevron Phillips Chemical Co Lp', u'Shanghai Academy of Science and Technology', u'ALZA Corp', u'Beech Tree Labs Inc', u'Shanghai Aoqi Pharmaceutical and Technology Co Ltd', u'Dong-A ST Co Ltd', u'BalOnco GmbH', u'Glaxo Group Ltd', u'Prasco Laboratories', u'Allergan Inc', u'Johns Hopkins University', u'Medifocus Inc', u'Recordati SpA', u'NovaMed Pharmaceuticals Inc', u'Mayne Pharma Group Ltd', u'ClinTrials BioResearch Ltd', u'PharmaPrint Inc', u'Andrx Corp', u'Valocor Therapeutics Ltd', u'National Institute of Diabetes, Digestive and Kidney Diseases', u'Teikoku Hormone Manufacturing Co Ltd', u'Pahang Pharmacy Sdn Bhd', u'Laborat\\xf3rio Qu\\xedmico Farmac\\xeautico Bergamo Ltda', u'Astellas Pharma Inc', u'Bayer Korea Ltd', u'Actavis Inc', u'Jeil Pharmaceutical Co Ltd', u'Undisclosed', u'Merck & Co Inc', u'Paracelsian Inc', u'Sanofi', u'Chong Kun Dang Pharmaceutical Corp', u'Eli Lilly & Co', u'Celsion Corp', u'Novogen Ltd', u'Bayer AG', u'CSL Ltd', u'Warner Chilcott plc', u'University of Victoria', u'Kissei Pharmaceutical Co Ltd', u'AEterna Zentaris Inc', u'Otechestvennie Lekarstva OJSC', u'Pfizer Inc', u'University of Southern California', u'Jiangsu Lianhuan Pharmaceutical Co Ltd', u'Intarcia Therapeutics Inc', u'Light Sciences Oncology Inc', u'Nippon Shinyaku Co Ltd', u'China Pharmaceutical University', u'Australian Government', u'Macropharma Corp', u'Synthelabo', u'Nippon Kayaku Co Ltd', u'ASTA Medica AG', u'MEI Pharma Inc', u'Solvay SA', u'Astra AB', u'UroGene SA', u'Zambon Co SpA', u'Pfizer Ltd', u'Boston Scientific Corp', u'University of Wisconsin-Madison', u'National Institutes of Health', u'Asahi Kasei Pharma Corp', u'American Cyanamid Co', u'MSD Japan', u'ICOS Corp', u'Par Pharmaceutical Co Inc', u'Valeant Pharmaceuticals International Inc', u'Lundbeck Research USA Inc', u'Ranbaxy Laboratories Ltd', u'SmithKline Beecham plc', u'Cyanamid Benelux NV', u'Takeda Pharmaceutical Co Ltd', u'Rising Pharmaceuticals Inc', u'Sophiris Bio Inc', u'Procaps SA', u'Berlex Laboratories Inc']), u'Cerebralinfarction': set([u'Daiichi Seiyaku Co Ltd', u'Roussel Uclaf Corp', u'Ciba-Geigy (Japan) Ltd', u'Zhejiang Ausun Pharmaceutical Co Ltd', u'Chugai Pharmaceutical Co Ltd', u\"The General Hospital of the People's Liberation Army\", u'Merck & Co Inc', u'Genentech Inc', u'Beijing Tide Pharmaceutical Co Ltd', u'Zhengzhou University', u'Nattermann & Cie GmbH', u'Mitsubishi Pharma Corp', u'Prodotti Formenti Srl', u'RespireRx Pharmaceuticals Inc', u'Otsuka Pharmaceutical Co Ltd', u'Nagasaki University', u'Daiichi Sankyo Co Ltd', u'Abbott Laboratories', u'SmithKline Beecham plc', u'Bago', u'Korea Research Institute of Chemical Technology', u'Korea Advanced Institute of Science and Technology', u'Novartis AG', u'Synthelabo SA', u'Horizon Orphan LLC', u'Seoul National University', u'Shenyang Pharmtech Pharmaceutical R & D Ltd', u'Senju Pharmaceutical Co Ltd', u'Chinese Government', u'Italfarmaco SpA', u'Taisho Pharmaceutical Co Ltd', u'Aventis Pharma AG', u'Hyundai Pharmaceutical', u'Purdue Pharma LP', u'Hoffmann-La Roche AG', u'Vertex Pharmaceuticals Inc', u'Suntory Ltd', u'Tanabe Seiyaku Co Ltd', u'LTT Bio-Pharma Co Ltd', u'Empire Pharmaceuticals Inc', u'JCR Pharmaceuticals Co Ltd', u'Mitsubishi-Tokyo Pharmaceuticals Inc', u'Bayer AG', u'Ono Pharmaceutical Co Ltd', u'SmithKline Beecham Corp', u'Shin Poong Pharmaceutical Co Ltd', u'Cellmid Ltd', u'Yuhan Corp', u'Teijin Ltd', u'R-Tech Ueno Ltd', u'BioHaven Pharmaceutical Holding Co Ltd', u'Merck Serono SA', u'Glaxo Group Ltd', u'Two Cells Co Ltd', u'University of Barcelona', u'AstraZeneca plc', u'Encysive Pharmaceuticals Inc', u'Johns Hopkins University', u'Cell Signals Inc', u'Shenyang Pharmaceutical University', u'MannKind Corp', u'Endogenous Stem Cells Activators Inc', u'Laboratoires Houde SA', u'Parke-Davis & Co', u'Sanofi (pre-1999)', u'Toyama Chemical Co Ltd', u'AxoTect Inc', u'Sigma-Tau Ind Farm Riunite SpA', u'Shin Nippon Biomedical Laboratories Ltd', u'Cecoura Therapeutics Inc']), u'Porphyria': set([u'University of Texas Medical Branch at Galveston', u'Clinuvel Pharmaceuticals Ltd', u'SurModics Pharmaceuticals', u'Food and Drug Administration', u'University of Navarra', u'Amsterdam Molecular Therapeutics BV']), u'Temporomandibularjointsyndrome': set([u'National Institute on Drug Abuse', u'Trigemina Inc']), u'Picornavirusinfection': set([u'ViroPharma Inc', u'Sanofi']), u'Speechdisorder': set([u'Voiceitt', u'ASDERA LLC', u'Binational Industrial Research and Development Foundation', u'Q BioMed Inc']), u'Rheumatoidarthri': set([u'Biochemie GmbH', u'UCB Celltech']), u'Urinarytractdisease': set([u'Promepla', u'Afferon Corp', u'Nippon Shinyaku Co Ltd', u'Medline Industries Inc', u'Evotec AG', u'National Institutes of Health', u'Trendlines Group Ltd', u'WellSpring Pharmaceutical Corp', u'FSC Laboratories Inc', u'National Institute of Diabetes, Digestive and Kidney Diseases', u'National Institute of Allergy and Infectious Diseases', u'Rockefeller University', u'Eisai Co Ltd', u'Yale University', u'Dainippon Pharmaceutical Co Ltd', u'GlaxoSmithKline plc', u'Boehringer Mannheim GmbH', u'Covance Inc', u'Forendo Pharma Oy', u'Sihuan Pharmaceutical Holdings Group Ltd', u'Makoto Life Sciences Inc', u'Potrero Medical Inc', u'Takeda Pharmaceutical Co Ltd', u'Sumitomo Dainippon Pharma Co Ltd', u'Syntiron LLC', u'Roche Palo Alto', u'Bioderm Inc', u'ICOS Corp', u'Signal Research Division', u'Evestra Inc', u'Recordati SpA', u'Aytu BioScience Inc', u'Ono Pharmaceutical Co Ltd', u'Mundipharma EDO GmbH', u'Astellas Pharma Inc', u'Degania Silicone', u'CellMark AB', u'Titan Medical Inc', u'Fougera Pharmaceuticals Inc', u'Cogentix Medical Inc', u'Serenity Pharmaceuticals', u'Icagen Inc (pre-merger)', u'Florida Hospital Nicholson Center', u'Taiho Pharmaceutical Co Ltd', u'Women\\u2019s Choice Pharmaceuticals LLC', u'Sandoz Ltd', u'Endo International plc', u'Gedeon Richter Ltd', u'Boryung Pharm Co Ltd', u'CPEX Pharmaceuticals Inc', u'Frazier Healthcare Partners', u'Apricus Biosciences Inc', u'Control Flo Medical LLC']), u'Pemphigus': set([u'Peptimmune Inc', u'Novartis AG', u'Orphan Europe SARL', u'Johns Hopkins University', u'Advanced Biotherapy Inc', u'GroupMed (Holding)', u'F Hoffmann-La Roche AG', u'Accentia BioPharmaceuticals Inc', u'Aspreva International Ltd', u'GlaxoSmithKline plc']), u'Habitualabortion': set([u'Nora Therapeutics Inc', u'Maryland Technology Development Corp']), u'Mitochondrialencephalomyopathy': set([u'United Mitochondrial Disease Foundation', u'Medical Research Council', u'St Georges University of London', u'Orphan Technologies Ltd']), u'Salivaryglanddisease': set([u'University of Rochester', u'EUSA Pharma', u'Arcoral Pharma As', u'National Institute of Dental and Craniofacial Research']), u'Epilepsy': set([u'University of Newcastle', u'1st Order Pharmaceuticals', u'Sintegal', u'Novo Nordisk A/S', u'BioLink Life Sciences Inc', u'University of Reading', u'The National Institute of Mental Health', u'Acorda Therapeutics Inc', u'Auralis Ltd', u'MedPointe Pharmaceuticals Inc', u'Institute of Pharmacology and Toxicology Academy of Military Medical Sciences PLA', u'Centre for Drug Research and Development', u'Teva Pharmaceutical Industries Ltd', u'Ardea Biosciences Inc', u'SciGen Ltd', u'Lynx Therapeutics GmbH', u'Aeolus Pharmaceuticals Inc', u'GlaxoSmithKline plc', u'BTG plc', u\"Cincinnati Children's Hospital Medical Center\", u'Knopp Biosciences LLC', u'Bayer Schering Pharma AG', u'DRAXIS Health Inc', u'SICOR Inc', u'Otsuka Holdings Co Ltd', u'NanoAxis', u'Novartis Pharma AG', u'Citizens United for Research in Epilepsy', u'Vrije Universiteit van Amsterdam', u'NewBridge Pharmaceuticals Ltd', u'InterLab Pharmaceutica', u'European Community', u'StemoniX Inc', u'CURx Pharmaceuticals Inc', u'Stanford University', u'Pacific Therapeutics Ltd', u'University of Washington', u'Vanderbilt University', u'WITA Proteomics AG', u'IMPAX Laboratories Inc', u'Ikano Therapeutics Inc', u'Garvan Institute of Medical Research', u'Hanmi Pharmaceutical Co Ltd', u'Martindale Pharma', u'Addrenex Pharmaceuticals Inc', u'University of North Carolina', u'Aptalis Pharma Srl', u'Q-State Biosciences Inc', u'Neurogen Corp', u'Sun Pharmaceutical Industries Ltd', u'Neurotech Pharmaceuticals Inc', u'SynapCell SAS', u'University of Kentucky', u'UCB Pharma SA', u'Sandoz Ltd', u'Elan Pharmaceuticals Inc', u'North Carolina Biotechnology Center', u'Emory University', u'National Heart Lung and Blood Institute', u'Medivators Inc', u'elbion AG', u'Transdermal Research Pharm Laboratories LLC', u'Neurologix Inc', u'Cascade Therapeutics Inc', u'European Molecular Biology Laboratory', u'Neurocrine Biosciences Inc', u'Orient Europharma', u'Hikma Pharmaceuticals plc', u'Ultragenyx Pharmaceutical Inc', u'MedGenesis Therapeutix Inc', u'National Institute of General Medical Sciences', u'European Commission', u\"Texas Children's Hospital\", u'Annovis Inc', u'The European Union', u'Meiji Seika Pharma Co Ltd', u'Nelson Pharmaceuticals LLC', u'NPS Pharmaceuticals Inc', u'Midwestern University', u'Wyeth Research', u'Vodis Pharmaceuticals Inc', u'Alliance Healthcare (Distribution) Ltd', u'University of California San Francisco', u'US Government', u'Royal College of Surgeons in Ireland', u'Harvard University', u'Daiichi Sankyo Co Ltd', u'Abbott Laboratories', u'Catalyst Pharmaceutical Partners Inc', u'Eisai Co Ltd', u'Mount Sinai School of Medicine', u'Harris FRC Corp', u'H Lundbeck A/S', u'Harbin Pharmaceutical Group Co Ltd', u'InvaGen Pharmaceuticals Inc', u'Georgetown University', u'Tecnifar-Ind\\xfastria T\\xe9cnica Farmac\\xeautica Sa', u'NeuroGenomeX Inc', u'AfaSci Inc', u'Ewopharma AG', u'University of Alabama at Birmingham', u'Banner Pharmacaps Inc', u'NsGene A/S', u'Bionomics Ltd', u'Avanti Therapeutics', u'Purdue Pharma LP', u'Tanabe Seiyaku Co Ltd', u'eemagine GmbH', u'UCB SA', u'University of Minnesota', u'Istituto di Ricerche Farmacologiche Mario Negri', u'UCB Pharma GmbH', u'JDS Pharmaceuticals LLC', u'WuXi PharmaTech (Cayman) Inc', u'AurimMed Pharma Inc', u'Novartis AG', u'Southern Cross University', u'Tansna Therapeutics Inc', u'Insero Health Inc', u'Valeant Pharmaceuticals International Inc', u'Jazz Pharmaceuticals plc', u'Alfresa Pharma Corp', u'Eiken Chemical Co Ltd', u'Bio-Link Australia Pty Ltd', u'York Instruments', u'Jiangsu Nhwa Pharmaceutical Group Co Ltd', u'NRC Research Institute', u'Evogen Inc', u'Aventis Pharmaceuticals Inc', u'SK Biopharmaceuticals', u'NovaMed Pharmaceuticals Inc', u'Growblox Sciences Inc', u'Athena Diagnostics Inc', u'Depomed Development Ltd', u'Bionevia Pharmaceuticals Inc', u'Xenon Pharmaceuticals Inc', u'VG Life Sciences Inc', u'Meda Pharma Gmbh & Co Kg', u'National Institute of Neurological Disorders and Stroke', u'moksha8 Pharmaceuticals Inc', u'Louisiana State University Health Sciences Center New Orleans', u'IsoTis SA', u'Supernus Pharmaceuticals Inc', u'Cognetix Inc', u'LifeSplice Pharma LLC', u'Otsuka Pharmaceutical Co Ltd', u'Korea Drug Development Fund', u'EndogenX Inc', u'University of London', u'University of Maryland', u'Genetic Technologies Ltd', u'Wyeth Pharmaceuticals', u'University of Melbourne', u'American Biogenetic Sciences Inc', u'Asklepios Biopharmaceutical Inc', u'Allergan plc', u'Faraday Pharmaceuticals Inc', u'Lundbeck Inc', u'Onconova Therapeutics Inc', u'Undisclosed', u'National Institute on Drug Abuse', u'Sumitomo Dainippon Pharma Co Ltd', u'Pfizer Inc', u'Daewoong Pharmaceutical Co Ltd', u'Merck & Co Inc', u'University of Colorado System', u'MRIGlobal', u'Lundbeck Canada Inc', u'Scripps Research Institute', u'University of Saskatchewan', u'RIMSA Laboratorios', u'Sanofi', u'Gelpell AG', u'Columbia University', u'Eli Lilly & Co', u'Addex Therapeutics Ltd', u'NeuroSearch A/S', u'CoNCERT Pharmaceuticals Inc', u'Fluorinov Pharma Inc', u'Universidad De Le Republica - Uruguay', u'reMYND NV', u'Proximagen Group plc', u'Xcel Pharmaceuticals', u'Epilepsy Foundation', u'University of Virginia', u'Icagen Inc (pre-merger)', u'Kyowa Hakko Kirin Co Ltd', u'Alembic Ltd', u'NSW Government', u'BBB Therapeutics BV', u'Kissei Pharmaceutical Co Ltd', u'Rexahn Pharmaceuticals Inc', u'Childrens Medical Research Institute', u'GW Pharmaceuticals plc', u'University of California Los Angeles', u'The University of Liverpool', u'CeNeS Pharmaceuticals Inc', u'Esteve', u'ArQule Inc', u'Panaxia Pharmaceutical Industries Ltd', u'Fox Chase Chemical Diversity Center Inc', u'NeuroAdjuvants Inc', u'Yale University', u'Northwest A&F University', u'A H Robins Co Inc', u'Wyeth', u'Institute for the Promotion of Innovation by Science and Technology in Flanders', u'SIBIA Neurosciences Inc', u'Advicenne Pharma', u'Neuroene Therapeutics', u'D-Pharm Ltd', u'Desitin Arzneimittel GmbH', u'Beactica AB', u'Harbor Therapeutics Inc', u'Wyss Institute for Biologically Inspired Engineering', u'VistaGen Therapeutics Inc', u'Nobelpharma Co Ltd', u'Baylor College of Medicine', u'Australian Government', u'Pairnomix LLC', u'Sawai Pharmaceutical Co Ltd', u'BrainLAB Inc', u'Intelligence Advanced Research Projects Activity', u'Shire BioChem Inc', u'Allegiance Equity Corp', u'Takeda Pharmaceutical Co Ltd', u'Cerecor Inc', u'Ligand Pharmaceuticals Inc', u'DanioLabs Ltd', u'Sanofi KK', u'Scientus Pharma Inc', u'Janssen-Cilag Ltd', u'Northwestern University', u'Ovid Therapeutics Inc', u'Molecular Neuroimaging LLC', u'UniQuest Pty Ltd', u'XERIS Pharmaceuticals Inc', u'University of Wisconsin-Madison', u'National Institutes of Health', u'Walter Reed Army Institute of Research', u'BioQuest Innovations Inc', u'Elan Corp plc', u'Dainippon Pharmaceutical Co Ltd', u'MuriGen Pty Ltd', u'Aequus Pharmaceuticals Inc', u'Camargo Pharmaceutical Services', u'Nanogen Inc', u'Siberian State Medical University', u'Stendhal International', u'Auburn University', u'Parke-Davis & Co', u'Advanced Neural Dynamics', u'Cephalon Inc', u'Takeda Oncology', u'Sydney Childrens Hospital', u'Plandai Biotechnology Inc', u'CyDex Pharmaceuticals Inc', u'Vernalis Research Ltd', u'Sosei Group Corp', u'MMJ PhytoTech Ltd', u'Asset Realisation Co plc', u'Ranbaxy Laboratories Ltd', u'Yichang Humanwell Pharmaceutical Co Ltd', u'Therakind Ltd', u'Shire plc', u'Institut Pasteur', u'Medtronic Inc', u'Purdue Neuroscience Corp', u'Meda AB', u'Hebrew University of Jerusalem', u'Depomed Inc', u'Upsher-Smith Laboratories Inc', u'Walter and Eliza Hall Institute of Medical Research', u'University of Utah', u'NantHealth Inc', u'SCM Pharma Ltd', u'PerkinElmer Inc', u'Hoechst Marion Roussel Inc', u'University of Tasmania', u'Questcor Pharmaceuticals Inc', u'BIAL Group', u'PAREXEL International', u'University of Cambridge', u'Sun Pharmaceutical Advanced Research Co Ltd', u'Neurogate Therapeutics Inc', u'Neuronex Inc', u'BASF AG']), u'Genitaltractinfection': set([u'Umea University', u'National Institutes of Health', u'Advanced Life Sciences Holdings Inc', u'National Institute of Allergy and Infectious Diseases', u\"St Jude Children's Research Hospital\", u'Interferon Sciences Inc', u'Microbiotix Inc', u'Uppsala University', u'Biosyn Inc', u'Shenyang Sky and Land Latex', u'TherapyX Inc', u'Contraceptive Research and Development Organization', u'Creative Antibiotics Sweden AB', u'SpeeDx Pty Ltd', u'Starpharma Holdings Ltd', u'University of Pittsburgh Medical Center', u'University of Tennessee', u'Genaera Corp', u'University of California Irvine', u'Cepheid', u'American Red Cross', u'Ambalal Sarabhai Enterprises', u'AusAm Biotechnologies Inc']), u'Autoimmuneencephalomyelitis': set([u'National Institute of Allergy and Infectious Diseases', u'University of Medicine and Dentistry of New Jersey', u'University of Pennsylvania', u'National Institute of Neurological Disorders and Stroke']), u'Snoring': set([u'Zelegent Inc', u'ALPHAEON Corp']), u'Constipationpredominantirritablebowelsyndrome': set([u'Allergan plc', u'EndoLogic LLC', u'Ironwood Pharmaceuticals Inc', u'Almirall Prodesfarma SA', u'Alizyme plc', u'Ferring Pharmaceuticals SA', u'Albireo Ltd', u'Assembly Biosciences Inc', u'Forest Laboratories Inc']), u'Norovirusinfection': set([u'Astellas Pharma Inc', u'University of Tokyo', u'Icon Genetics AG', u'National Vaccine and Serum Institute', u'Denki Kagaku Kogyo Kabushiki Kaisha', u'Lanzhou Institute Of Chemical Physics Chinese Academy Of Sciences', u'Daiichi Sankyo Co Ltd', u'National Institute of Allergy and Infectious Diseases', u'Ohio State University', u'UMN Pharma Inc']), u'Klebsiellainfection': set([u'Australian Government', u'Oxford Drug Design', u'Westmead Millennium Institute for Medical Research', u'Takeda Pharmaceutical Co Ltd', u'Sumitomo Dainippon Pharma Co Ltd', u'Technology Strategy Board', u'Toyama Chemical Co Ltd', u'Abbott Laboratories', u'AmpliPhi Biosciences Corp']), u'Chromosomeaberration': set([u'Sigma-Aldrich Corp', u'Elixirgen Llc', u'BioNano Genomics Inc', u'Repligen Corp', u'AGTC', u'Sumitomo Dainippon Pharma Co Ltd', u'Pluristem Therapeutics Inc', u'Berry Genomics Co Ltd', u'Translate Bio', u'Case Western Reserve University', u'Roche Innovation Center Copenhagen A/S', u'BioMarin Pharmaceutical Inc']), u'Thymusneoplasm': set([u'Georgetown University', u'Merck Sharp & Dohme Corp', u'Nerviano Medical Sciences Srl', u'Tiziana Life Sciences PLC']), u'Bloodclottingdisorder': set([u'Daiichi Seiyaku Co Ltd', u'Daejeon University', u'BioMarin Pharmaceutical Inc', u'Korea Institute of Science and Technology', u'Massachusetts Institute of Technology', u'Bayer Corp', u'Baxter International Inc', u'Mitsubishi Pharma Corp', u'Institute of Hematology and Blood Transfusion, Czech Republic', u'Korea Drug Development Fund', u'LegoChem Bioscience Inc', u'SmithKline Beecham plc', u'CSL Behring GmbH', u'Abzena plc', u'Diosynth Inc', u'Zilip-Pharma BV', u'Dendreon San Diego LLC', u'Sanquin Blood Supply Foundation', u'Hemosonics Llc', u'Synthelabo SA', u'Xenetic Biosciences Inc', u'Novo Nordisk A/S', u'US Government', u'Diakron Pharmaceuticals Inc', u'Ionis Pharmaceuticals Inc', u'Ipsen', u'Merck & Co Inc', u'IBEX Technologies Inc', u'PolyMedix Inc', u'European Eurostars Programme', u'Siemens Healthcare Diagnostics GmbH', u'Asahi Kasei Pharma Corp', u'Genentech Inc', u'Altea Therapeutics', u'Hopitaux Universitaires De Geneve', u'Molecumetics Ltd', u'Mitsubishi-Tokyo Pharmaceuticals Inc', u'Bayer AG', u'CSL Ltd', u'Hanmi Pharmaceutical Co Ltd', u'Aptahem AB', u'ST Pharm Co Ltd', u'Universal Biosensors Pty Ltd', u'Japan Blood Products Organization', u'Undisclosed', u'PolyMASC Pharmaceuticals plc', u'Childrens Hospital of Philadelphia', u'ZymoGenetics Inc', u'Janssen Biotech Inc', u'Encysive Pharmaceuticals Inc', u'Bayer HealthCare AG', u'Dyax Corp', u'HanAll Biopharma Co Ltd', u'MannKind Corp', u'National Heart Lung and Blood Institute', u'Pfizer Inc', u'Rambam Med-Tech Ltd', u'Okklo Life Sciences BV', u'Kyowa Hakko Kirin Co Ltd', u'Emosis Ltd', u'BASF AG']), u'Otitis': set([u\"Dr Reddy's Laboratories Ltd\", u'Innovation Pharmaceuticals Inc', u'Guangzhou Boji Medical & Biotechnological Co Ltd', u'Phage Biotech Ltd', u'SamChunDang Pharm Co Ltd', u'Hadassah Medical Organization', u'Zhaoke Pharmaceutical (Hefei) Co Ltd', u'Breckenridge Pharmaceutical Inc']), u'NiemannPickdiseasetypeB': set([u'Sanofi Genzyme', u'Gallus BioPharmaceuticals']), u'NiemannPickdiseasetypeC': set([u'Neurotrope BioScience Inc', u'Neurotrope Inc', u'US Government', u'AMO Pharma Ltd', u'Novartis AG', u'RaNeDis Pharmaceuticals', u'Stanford University', u'Actelion Ltd', u'Wellcome Trust', u'NP-C Therapeutics LLC', u'Vtesse Inc', u'UCB SA', u'Teva Pharmaceutical Industries Ltd', u'Perlara PBC', u'Oxford GlycoSciences plc', u'Mount Sinai School of Medicine', u'University of Oxford', u'Orphazyme ApS', u'The University of Notre Dame du Lac']), u'Myoclonicseizure': set([u'Dravet Syndrome Foundation', u'National Institute of Neurological Disorders and Stroke', u'OPKO Health Inc', u'Epygenix Therapeutics Inc', u'LifeSplice Pharma LLC', u'Bionomics Ltd', u'University of California San Francisco', u'Athena Diagnostics Inc']), u'Conjunctivadisease': set([u'Sankyo Co Ltd', u'Kissei Pharmaceutical Co Ltd', u'Santen Pharmaceutical Co Ltd', u'Teika Seiyaku KK']), u'Acuteliverfailure': set([u'Clinica Universidad de Navarra', u'Hospital Clinic of Barcelona']), u'Footulcer': set([u'Ibn Cina Drug Stores', u'Dong-A ST Co Ltd', u'ViroMed Co Ltd', u'Daewoong Pharmaceutical Co Ltd', u'Seoul National University']), u'Contactdermatitis': set([u'ElSohly Laboratories Inc', u'Galderma SA', u'National Institute of Arthritis and Musculoskeletal and Skin Diseases', u'Novartis AG', u'Hapten Sciences Inc', u'Gideon Pharmaceuticals Inc', u'Gamida Cell Ltd', u'Synvista Therapeutics Inc', u'Elorac Inc', u'Ceragenix Pharmaceuticals Inc', u'Clinquest Group', u'Particle Sciences Inc', u'BioPro Pharmaceutical Inc', u'Universiteit Utrecht']), u'Metastaticnonsmallcelll': set([u'ImmunoCellular Therapeutics Ltd', u'Memgen LLC']), u'Myocardialdisease': set([u'Daiichi Seiyaku Co Ltd', u'Karolinska Institutet', u'University of North Carolina', u'The Leukemia & Lymphoma Society', u'DRAXIMAGE', u'Cheminpharma LLC', u'University of Missouri', u'University of California San Francisco', u'Vericel Corp', u'National Heart Lung and Blood Institute', u'Tulane University', u'Lantheus Medical Imaging Inc', u'University of California San Diego', u'Quintiles Transnational Corp', u'Ohio State University', u'European Research Council (ERC)', u'Johns Hopkins University School of Medicine', u'National Institutes of Health', u'Parent Project Muscular Dystrophy', u'Bristol-Myers Squibb Co', u'University of Florida', u'Osiris Therapeutics Inc', u'TBG Diagnostics Ltd', u'Columbia University', u'University of Minnesota', u'National Institutes of Standards and Technology', u'Fred Hutchinson Cancer Research Center', u'Mallinckrodt Inc', u'Zensun (Shanghai) Sci-Tech Co Ltd', u'TOLMAR Therapeutics Inc', u'Capstone Therapeutics Corp', u'GE Healthcare', u'Novopyxis Inc', u'Phrixus Pharmaceuticals Inc', u'Chrysalis BioTechnology Inc', u'MicroMed Technology Inc', u'Pluristem Therapeutics Inc', u'Stemedica Cell Technologies Inc', u'Charite Universitaetsmedizin Berlin', u'Coalition Duchenne', u'Guerbet', u'National Center For Advancing Translational Sciences']), u'Non-alcoholicsteatohepatitis': set([u'Pharmaxis Ltd', u'Intercept Pharmaceuticals Inc', u'Catabasis Pharmaceuticals Inc', u'Hadasit Medical Research Services and Development Ltd', u'DURECT Corp', u'Immuron Ltd', u'Novartis Pharma AG', u'Cerenis Therapeutics SA', u'Allysta Pharmaceuticals Inc', u'University of California San Diego School of Medicine', u'Universita Degli Studi Di Perugia', u'Afimmune', u'LifeLiver Co Ltd', u'Exalenz Bioscience Ltd', u'Jenrin Discovery Inc', u'Phenex Pharmaceuticals AG', u'Harvard Stem Cell Institute', u'Enzo Biochem Inc', u'Temple University', u'Binational Industrial Research and Development Foundation', u'Tobira Therapeutics Inc', u'OWL Metabolomics', u'Antwerp University Hospital', u'Mayo Clinic Foundation', u'Fujifilm Finechemicals Co Ltd', u'Perrigo Co plc', u'BGN Technologies', u'BioAdvance', u'Sanyal Biotechnology', u'Israeli Government', u'Conatus Pharmaceuticals Inc', u'KeyBioScience AG', u'Novartis AG', u'Hadassah Medical Organization', u'Guangdong Zhongsheng Pharmaceutical Co Ltd', u'UCB Pharma GmbH', u'WuXi PharmaTech (Cayman) Inc', u\"Universite d'Angers\", u'Galectin Therapeutics Inc', u'Mercury Therapeutics Inc', u'Zora Biosciences Oy', u'Gelesis Inc', u'Dong-A ST Co Ltd', u'DS Biopharma', u'Asan Medical Center', u'Nordic Bioscience A/S', u'Genfit SA', u'Patheon Pharmaceuticals Inc', u'NuSirt Sciences Inc', u'Stanford University', u'Isomerase Therapeutics Ltd', u'Korea Drug Development Fund', u'National Institute of Diabetes, Digestive and Kidney Diseases', u'Promethera Biosciences SA/NV', u'Cambrex Corp', u'University of California San Diego', u'Allergan plc', u'Sumitomo Dainippon Pharma Co Ltd', u'French Government', u'Arcturus Therapeutics Inc', u'Sanofi', u'University of Texas Southwestern Medical Center', u'Eli Lilly & Co', u'La Jolla Pharmaceutical Co', u'Weizmann Institute of Science', u'NicOx SA', u'Seres Therapeutics Inc', u'Horizon Orphan LLC', u'Oasis Pharmaceuticals', u'Aptalis Pharma Inc', u'Gilead Sciences Inc', u'Virginia Commonwealth University', u'Itamar Medical (Cm) 1997 Ltd', u'Boehringer Ingelheim Corp', u'BioLineRx Ltd', u'Viking Therapeutics Inc', u'Nitto Denko Corp', u'University of Pennsylvania', u'Fujian Cosunter Pharmaceutical Co Ltd', u'NeuroVive Pharmaceutical AB', u'Takeda Pharmaceutical Co Ltd', u'Cempra Inc', u'Ligand Pharmaceuticals Inc', u'Alfa Wassermann SpA', u'Shenzhen HighTide Biopharmaceutical Ltd', u'National Institutes of Health', u'Wellstat Therapeutics Corp', u'Samil Pharmaceutical Co Ltd', u'Bristol-Myers Squibb Co', u'CTI Clinical Trial and Consulting Services', u'Galmed Pharmaceuticals Ltd', u'OSEO', u'Therapix Biosciences Ltd', u'Eurofarma', u'ProSciento Inc', u'Duke University', u'Tufts University', u'Italian Ministry of Economic Development', u'Janssen Pharmaceuticals Inc', u'TARGET PharmaSolutions, Inc', u'Engitix Ltd']), u'Femalecontraception': set([u'Roussel Uclaf Corp', u'Johnson & Johnson', u'Mayne Pharma Group Ltd', u'Agile Therapeutics Inc', u'CG Therapeutics Inc', u'Merck & Co Inc', u'Elan Corp plc', u'Galen Ltd', u'Hyphens Pharma Pte Ltd', u'HLL Lifecare Ltd', u'Grunenthal GmbH', u'Teva Pharmaceutical Industries Ltd', u'Cipla Ltd', u'Glenmark Pharmaceuticals Ltd', u'Takeda Pharmaceutical Co Ltd', u'Polydex Pharmaceuticals Ltd', u'ASKA Pharmaceutical Co Ltd', u'Ligand Pharmaceuticals Inc', u'Paladin Labs Inc', u'Allergan plc', u'Gynial', u'Actavis Inc', u'Bayer Schering Pharma AG', u'Teikoku Seiyaku KK', u'Eunice Kennedy Shriver National Institute of Child Health & Human Development', u'FAES Farma SA', u'Undisclosed', u'Bill & Melinda Gates Foundation', u'US Government', u'Eastern Virginia Medical School', u'RW Johnson Pharmaceutical Research Institute', u'Aventis Pharma AG', u'Shin Poong Pharmaceutical Co Ltd', u'Afaxys Inc', u'BIOQUAL Inc', u'Procter & Gamble Pharmaceuticals Inc', u'Hyundai Pharmaceutical', u'HRA Pharma', u'Contraceptive Research and Development Organization', u'Lohmann Therapie-Systeme GmbH & Co KG', u'Cygnus Inc', u'Apexus', u'Bayer AG', u'Chemo Group', u'Evestra Inc', u'Acrux Ltd', u'Rush University Medical Center', u'MSD OSS BV', u'Barr Pharmaceuticals Inc', u'Piramal Enterprises Ltd', u'Dare Bioscience Inc', u'RTI International', u'Pfizer Vaccines', u'Mithra Pharmaceuticals', u'Shire plc', u'HRA Pharma UK Ltd', u'Repros Therapeutics Inc', u'Alvogen Inc', u'Janssen Pharmaceuticals Inc', u'Warner Chilcott plc', u'Intendis GmbH', u'Torrent Pharmaceuticals Ltd', u'Akzo Nobel NV', u'Bayer HealthCare AG', u'Bayer HealthCare Pharmaceuticals Inc', u'Medicines360', u'Population Council', u'Gedeon Richter Ltd', u'Pfizer Inc', u'Watson Laboratories Inc', u'Central Drug Research Institute', u'WomanCare Global LLC', u'Wyeth', u'Duramed Pharmaceuticals Inc', u'GD Searle & Co', u'Aventis Pharma SA']), u'Jointinjury': set([u'Medical College of Wisconsin', u'Cimphoni Life Sciences LLC']), u'Arterialocclusivedisease': set([u'Daiichi Seiyaku Co Ltd', u'Mitsubishi-Tokyo Pharmaceuticals Inc', u'Encysive Pharmaceuticals Inc', u'Genentech Inc', u'MannKind Corp', u'Mitsubishi Pharma Corp', u'Synthelabo SA', u'Hyundai Pharmaceutical', u'SmithKline Beecham plc', u'Korean Ministry of Knowledge Economy', u'Korea United Pharm Inc']), u'InfluenzavirusBinfection': set([u'Response Biomedical Corp', u'Samaritan Pharmaceuticals Inc', u'Vizient Inc', u'Crucell NV', u'Guangzhou Nanxin Pharmaceutical Co Ltd', u'Quidel Corp', u'Alere Inc', u'Georgetown University', u'Institute of Pharmacology and Toxicology Academy of Military Medical Sciences PLA', u'National Institute of Allergy and Infectious Diseases', u'Scripps Research Institute', u'US Health and Human Services Department', u'Life Technologies Corp', u'Trellis Bioscience Inc']), u'Malabsorptionsyndrome': set([u'Biohit OYJ', u'OnSite Diagnostic Labs India Pvt Ltd']), u'Chronicmyelomonocyticleukemia': set([u'University of Cologne', u'Medivir AB', u'TetraLogic Pharmaceuticals Corp', u'The Northwestern Mutual Life Insurance Company', u'Cancer Research Technology Ltd', u'Incyte Corp', u'H Lee Moffitt Cancer Center and Research Institute', u'Cardiff University', u'University of California San Francisco', u'Walter and Eliza Hall Institute of Medical Research']), u'Femalegenitaltract': set([u\"Dr Reddy's Laboratories Ltd\", u'GlaxoSmithKline plc']), u'Cryptococcusneoformansinfection': set([u'US Government', u'Zeneus Pharma Ltd', u'Elan Corp plc', u'Amplyx Pharmaceuticals Inc', u'Enzon Pharmaceuticals Inc']), u'Cardiacsurgicalprocedure': set([u\"Dr Reddy's Laboratories Ltd\", u'CytoSorbents Corp', u'Terumo Cardiovascular Group']), u'Keratoconjunctivitis': set([u'Thevac LLC', u'Baylor College of Medicine', u'Henderson Morley plc', u'University of Missouri', u'S. Fyodorov Eye Microsurgery Complex', u'Croma Pharma GmbH', u'Allergan plc', u'Lux Biosciences Inc', u'Fujisawa Pharmaceutical Co Ltd', u'ISTA Pharmaceuticals Inc', u'Johnson & Johnson Vision Products Inc', u'Undisclosed', u'Senju Pharmaceutical Co Ltd', u'Samil Pharmaceutical Co Ltd', u'Santen Pharmaceutical Co Ltd', u'Chong Kun Dang Pharmaceutical Corp', u'University of Pittsburgh', u'TheraCour Pharma Inc', u'NanoViricides Inc', u'Allergan Inc', u'NovaMedica', u'Sucampo Pharmaceuticals Inc']), u'Metastasis': set([u'US Government', u'Penwest Pharmaceuticals Co', u'Colorado Office of Economic Development and International Trade', u'GLYCODesign Inc', u'Allos Therapeutics Inc', u'US Health and Human Services Department', u'Polyplus Transfection SAS', u'GlaxoSmithKline plc', u'University of Wurzburg', u'Quintiles Transnational Corp', u'Surefire Medical Inc', u'Chiron Corp', u'National Institute of Neurological Disorders and Stroke', u'Cascadian Therapeutics Inc', u'Zacharon Pharmaceuticals Inc', u'Ipsen', u'Aventis Pharma AG', u'University of Tokushima', u'Chinese Government', u'Fuzhou University', u'MedImmune LLC', u'Stanford University', u'University of Pennsylvania', u'Hovione SA', u'Aduro BioTech Inc', u'Roche Holding AG', u'University of British Columbia', u'Epigen Biosciences Inc', u'Biocompatibles International plc', u'Bio-Medisinsk Innovasjon AS', u'Kite Pharma Inc', u'Ludwig Institute for Cancer Research', u'Sayre Therapeutics Private Ltd', u'Faron Pharmaceuticals Ltd', u'University of Turin', u'Cardiff University', u'Fox Chase Cancer Center', u'Association for International Cancer research', u'TrovaGene Inc', u'Texas Tech University', u'Technology Partnerships Canada', u'Sichuan BoXin LaiTe Biotechnology Inc', u'Melanoma Research Alliance', u'Terry Fox Foundation', u'Universidad De Jaen', u'GenomeDx Biosciences Inc', u'Inex Pharmaceuticals Corp', u'MD Anderson Cancer Center', u'Deutsche Forschungsgemeinschaft (DFG)', u'The University of Aston In Birmingham', u'Cancer Genetics Inc', u'Emory University', u'Kansas Bioscience Authority', u'Universidad de Valladolid', u'Hamamatsu University School of Medicine', u'National Cancer Institute', u'Novartis AG', u'Johns Hopkins University School of Medicine', u'Leiras Oy', u'RedHill Biopharma Ltd', u'Hadassah Medical Organization', u'Qurient Therapeutics', u'Purdue Pharma LP', u'BerGenBio AS', u'University of Minnesota', u'Aptose Biosciences Inc', u'Providence Cancer Center, Earle A. Chiles Research Institute', u'Wellcome Trust', u'Anza Therapeutics Inc', u'Copharos Inc', u'Tsukuba Research Institute', u'McGill University', u'Washington University in St Louis', u'The Research Council of Norway', u'Osaka University', u'Boehringer Ingelheim Corp', u'Chemokine Therapeutics Corp', u'BioInvent International AB', u'Vaxil BioTherapeutics Ltd', u'Hapten Pharmaceuticals Llc', u'AmpliPhi Biosciences Corp', u'Davis Drug Discovery Group', u'Terpenoid Therapeutics Inc', u'Arisaph Pharmaceuticals Inc', u'Rockefeller University', u'Cancer Research UK', u'Genentech Inc', u'APT Therapeutics Inc', u'Universitaet Stuttgart', u'Mayo Clinic Foundation', u'bioTheranostics Inc', u'Cellectar Biosciences Inc', u'Phoenix Biotechnology Inc', u'Deciphera Pharmaceuticals LLC', u'Society of Nuclear Medicine', u'Oncomatryx SL', u'CureMeta LLC', u'Metastat Inc', u'Scripps Research Institute', u'Stichting Voor De Technische Wetenschappen', u'Sanofi', u'Vertex Pharmaceuticals Inc', u'Therion Biologics Corp', u'University of Oslo', u'Helen F Graham Cancer Center at Christiana Care', u'United Therapeutics Corp', u'Propanc Biopharma Inc', u'BioChain Institute Inc', u'Rowan University', u'Kissei Pharmaceutical Co Ltd', u'Janssen Biotech Inc', u'University of California Los Angeles', u'Novita Pharmaceuticals Inc', u'University Medical Centre St Radboud', u'Syapse Inc', u'University of Cincinnati', u'Kaken Pharmaceutical Co Ltd', u\"Brigham & Women's Hospital\", u'Telesta Therapeutics Inc', u'AMAG Pharmaceuticals Inc', u'Memorial Sloan-Kettering Cancer Center', u'Nippon Shinyaku Co Ltd', u'Momenta Pharmaceuticals Inc', u'Intrexon Corp', u'Rubicon Biotechnology Inc', u'University of Oklahoma', u'Bavarian Nordic A/S', u'Novartis Pharma KK', u'Ohio State University', u'Northwestern University', u'Alliance Discovery Inc', u'Albert Einstein College of Medicine', u'Aarhus University', u'New Jersey Health Foundation Inc', u'National Institutes of Health', u'Splash Pharmaceuticals Inc', u'siRNAsense AS', u'Bristol-Myers Squibb Co', u'Elan Corp plc', u'Sphaera Pharma', u'Beth Israel Deaconess Medical Center', u'Asahi Kasei Pharma Corp', u'University of Bergen', u'ThromboGenics NV', u'National Institute of Biomedical Imaging and Bioengineering', u'Wistar Institute of Anatomy & Biology', u'Institute of Cancer Research UK', u'Toray Industries Inc', u'biOasis Technologies Inc', u'Veana Therapeutics', u'Max-Planck-Gesellschaft', u'University of Virginia', u'Antitope Ltd', u'Biocure Inc', u'Epeius Biotechnologies Corp', u'Tiziana Life Sciences PLC', u'ImaginAb Inc', u'RXi Pharmaceuticals Corp']), u'Histiocytoma': set([u'Crucell NV', u'Sidney Kimmel Comprehensive Cancer Center']), u'Sarcoidosis': set([u'Bachem Holding AG', u'Relief Therapeutics Holding AG', u'Almirall Prodesfarma SA', u'Centurion Pharma', u'Lung Biotechnology Inc', u'Hanmi Pharmaceutical Co Ltd', u'Mount Sinai Medical Center', u'Transparency Life Sciences LLC', u'23andMe Inc', u'Auven Therapeutics', u'GlaxoSmithKline plc']), u'UshersyndromeII': set([u'University of Oklahoma', u'Foundation Fighting Blindness']), u'FactorVIIdeficiency': set([u'Sangamo Therapeutics Inc', u'Handok Inc', u'University of North Carolina', u'Shire plc', u'Ipsen', u'Inspiration Biopharmaceuticals Inc', u'Genexine Co Ltd', u'Cangene Corp', u'Childrens Hospital of Philadelphia']), u'Immunedeficiency': set([u'Harbor Therapeutics Inc', u'Yamanouchi Pharmaceutical Co Ltd', u'Medidata Solutions Worldwide', u'ASD Healthcare', u'Undisclosed', u'Genentech Inc', u'Kedrion Biopharma Inc', u'Amgen Inc', u'Connetics Corp', u'InterMune Inc', u'National Institute of Allergy and Infectious Diseases', u'US Health and Human Services Department', u'Farma Biagini SpA', u'GlaxoSmithKline plc', u'Avid Bioservices', u'PowderJect Pharmaceuticals plc', u'Kaleidos Pharma Inc', u'Maxygen Holdings Ltd', u'Green Cross Corp', u'National Institutes of Health', u'Human Genome Sciences Inc', u'Bavarian Nordic A/S', u'Cytheris SA', u'Immuron Ltd', u'Bristol-Myers Squibb Co', u'FFF Enterprises', u'OSEO', u'OMRIX Biopharmaceuticals SA', u'Sanofi', u'Laureate Biopharmaceutical Services Inc', u'Boehringer Ingelheim International GmbH', u'National University Hospital (Singapore) Pte Ltd', u'ImmuCell Corp', u'Garvan Institute of Medical Research', u'Halozyme Therapeutics Inc', u'National University of Singapore', u'Objectif Recherche VACcin Sida', u'NSW Government', u'Aviragen Therapeutics Inc', u'Virginia Commonwealth University', u'Boehringer Ingelheim Austria GmbH', u'Biotest Pharmaceuticals Corp', u'Agency For Science Technology & Research', u'Boehringer Ingelheim Corp', u'Dyax Corp', u'HanAll Biopharma Co Ltd', u'Caladrius Biosciences Inc', u'GD Searle & Co', u'Horizon Pharma plc', u'Mount Sinai Medical Center']), u'Hyperprolactinemia': set([u'Pharmacia & Upjohn AB', u'University of Maryland Baltimore County', u'Ferring Pharmaceuticals SA', u'Novartis Pharma AG', u'The National Institute of Mental Health', u'Kissei Pharmaceutical Co Ltd']), u'Brainhemorrhage': set([u'Daiichi Seiyaku Co Ltd', u'Ciba-Geigy (Japan) Ltd', u'Chugai Pharmaceutical Co Ltd', u'Asahi Kasei Corp', u'SurModics Inc', u'Nattermann & Cie GmbH', u'Translational Genomics Research Institute', u'Centaur Pharmaceuticals Inc', u'Edge Therapeutics Inc', u'Abbott Laboratories', u'Eisai Co Ltd', u'New Jersey Commission on Science and Technology', u'Bayer Schering Pharma AG', u'Merck KGaA', u'National Institute of Neurological Disorders and Stroke', u'National Institutes of Health', u'PresSura Neuro Ltd', u'Italfarmaco SpA', u'Renovis Inc', u\"Phoenix Children's Hospital\", u'Sanofi', u'ICOS Corp', u'Barrow Neurological Insitute', u'Bayer AG', u'Roche Holding AG', u'NeurOp Inc', u'Oakwood Laboratories LLC', u'Almirall Prodesfarma SA', u'AstraZeneca plc', u'Encysive Pharmaceuticals Inc', u'Takeda Pharmaceutical Co Ltd', u'Vernalis Group plc', u'Axovan AG', u'F Hoffmann-La Roche AG', u'H Lundbeck A/S']), u'Infarction': set([u'Bayer Schering Pharma AG', u'Merck KGaA', u'Boehringer Ingelheim Corp', u'Yamanouchi Pharmaceutical Co Ltd', u'Japan Science and Technology Agency', u'NPO Petrovax Pharm LLC', u'Nagasaki University', u'Sanofi']), u'Mumpsvirusinfection': set([u'Fiotec- Fundacao para o Desenvolvimento Cientifico e Tecnologico em Saude', u'bioCSL PTY Ltd', u'Australian Government', u'Walvax Biotechnology Co Ltd', u'Univec Corp', u'Bio-Manguinhos/Fiocruz', u'Bill & Melinda Gates Foundation', u'Kaketsuken', u'Merck & Co Inc', u'GlaxoSmithKline plc', u'Sanofi Pasteur', u'Chongqing Zhifei Biological Products Co Ltd']), u'Anaplasticthyroidcancer': set([u'Azanta A/S', u'Maxim Pharmaceuticals Inc', u'LifeArc', u'AstraZeneca plc', u\"Brigham & Women's Hospital\", u'Shire plc', u'Mateon Therapeutics Inc', u'Merck & Co Inc', u'University of Texas Southwestern Medical Center', u'DRI Capital', u'Massachusetts General Hospital', u'Haemologic Ltd']), u'Stomachfunctiondisorder': set([u'Meiji Seika Pharma Co Ltd', u'National Institute of Biomedical Innovation', u'Undisclosed', u'University of Tokyo', u'Takeda Pharmaceutical Co Ltd', u'Meldex International plc', u'Daewoong Pharmaceutical Co Ltd', u'R&R Inc', u'Astra AB', u'Dainippon Pharmaceutical Co Ltd']), u'Renalosteodystrophy': set([u'Indiana University', u'Novartis AG']), u'Lungdisease': set([u'University of Texas Medical Branch at Galveston', u'OrPro Therapeutics Inc', u'Kirin Brewery Co Ltd', u'Imbio', u'University of Tokyo', u'US Government', u'Ablynx NV', u'Respiratorius AB', u\"Cincinnati Children's Hospital Medical Center\", u'University of Maryland', u'Advanced Therapies Inc', u'Fetal Health Foundation', u'Toyota Tsusho Corp', u'GeNO LLC', u'DRAXIMAGE', u'MedImmune LLC', u'ArQule Inc', u'University of Pittsburgh', u'University of Michigan', u'University of Pennsylvania', u'EGEN Inc', u'Progenra Inc', u'Serendex Pharmaceuticals A/S', u'UCB Pharma SA', u'Relief Therapeutics Holding AG', u'BioMotiv LLC', u'Bayer HealthCare AG', u'AstraZeneca plc', u'National Heart Lung and Blood Institute', u'Inspire Pharmaceuticals Inc', u'Johnson & Johnson Pharmaceutical Research & Development LLC', u'Tufts Medical Center', u'Alpha-1 Foundation', u'National Cancer Institute', u'Genetic Therapy Inc', u'Parion Sciences Inc', u'Brandeis University', u'Catholic University of Leuven', u'Maryland Stem Cell Research Fund', u'William Harvey Research Ltd', u'National Jewish Health', u'Mallinckrodt Inc', u'Celerion', u'Activaero GmbH', u'Glaxo Group Ltd', u'Washington University in St Louis', u'NTT Data Corp', u'Boehringer Ingelheim Corp', u'University of Sydney', u'F H Faulding & Co Ltd', u'University of North Carolina', u'Interferon Sciences Inc', u'Genentech Inc', u'Connetics Corp', u'Paladin Labs Inc', u'University of South Alabama', u'Biogen Inc (FL)', u'SRI International', u'Grey Innovation Pty Ltd', u'Therabron Therapeutics Inc', u'Aerogen Inc', u'Australian Research Council', u'Vertex Pharmaceuticals Inc', u'BioFocus DPI', u'Eli Lilly & Co', u'Centers for Disease Control and Prevention', u'Bayer AG', u'Northern Therapeutics Inc', u'Indiana University Research and Technology Corp Inc', u'Pulmatrix Inc', u'United Therapeutics Corp', u'NovaBay Pharmaceuticals Inc', u'Palatin Technologies Inc', u'AGI Therapeutics plc', u'Capsugel Inc', u'Nektar Therapeutics', u'Genovo Inc', u'Aktiv-Dry LLC', u'Corthera Inc', u'Gilead Sciences Inc', u\"Brigham & Women's Hospital\", u'Khepri Pharmaceuticals', u'Guerbet', u'Broad Institute Inc', u'National Institute of Allergy and Infectious Diseases', u'UCB Celltech', u'AntexPharma Inc', u'Cynata Therapeutics Ltd', u'National Institutes of Health', u'PharmaIN Ltd', u'Food and Drug Administration', u'MaxCyte Inc', u'NEBU-TEC', u'Sanofi Genzyme', u'ERCell LLC', u'Medizinische Universit\\xe4t Innsbruck', u'P2D Biosciences', u'GE Healthcare', u'Inotek Pharmaceuticals Corp', u'Propagenix Inc', u'Indiana University', u'Quadrant Technologies Ltd', u'Hemispherx Biopharma Inc', u'North Shore Long Island Jewish Health System', u'Medistem Inc', u'American Red Cross']), u'Gastroesophagealreflux': set([u'US Government', u'Takeda GmbH', u'Winston Pharmaceuticals LLC', u'Sanofi Pasteur', u'Forest Laboratories Inc', u'GlaxoSmithKline plc', u'ARYx Therapeutics Inc', u'Caraco Pharmaceutical Laboratories Ltd', u'Mitsubishi-Tokyo Pharmaceuticals Inc', u'Shire-Movetis NV', u'Mitsubishi Tanabe Pharma Corp', u'Mitsubishi Pharma Corp', u'Sun Pharmaceutical Industries Ltd', u'Procter & Gamble Pharmaceuticals Inc', u'Sankyo Co Ltd', u'Orexo AB', u'AstraZeneca plc', u'Optimer Pharmaceuticals Inc', u'National Heart Lung and Blood Institute', u'Norgine BV', u'Wilmington Pharmaceuticals Inc', u'Negma', u'Sigma-Tau Ind Farm Riunite SpA', u'Mylan Inc', u'Admedics AG', u'Medigus Ltd', u'Daiichi Sankyo Co Ltd', u'Abbott Laboratories', u'Eisai Co Ltd', u'Santarus Inc', u'Novartis AG', u'Aradigm Corp', u'RedHill Biopharma Ltd', u'Yale University', u'Meldex International plc', u'Otsuka America Pharmaceutical Inc', u'Hanmi Pharmaceutical Co Ltd', u'University of California San Francisco', u'Rottapharm Madaus', u'The Procter & Gamble Co', u'Edusa Pharmaceuticals Inc', u'RaQualia Pharma Inc', u'Shenzhen Zhijun Pharmaceutical Co Ltd', u'Taiho Pharmaceutical Co Ltd', u'Kosan Biosciences Inc', u'Prasco Laboratories', u'Allergan Inc', u'Janssen Pharmaceutica NV', u'Innovamedica SA de CV', u'Boehringer Ingelheim Corp', u'Yuhan Corp', u'Shire Holdings AG', u'R2 Pharma LLC', u'Undisclosed', u'Ajinomoto Co Inc', u'Andrx Corp', u'Flamel Technologies SA', u'Salix Pharmaceuticals Inc', u'LTL Pharma Co Ltd', u'University of Basel', u'Sinopharm', u'Sumitomo Dainippon Pharma Co Ltd', u'Daewoong Pharmaceutical Co Ltd', u'Merck & Co Inc', u'Sanofi', u'UBE Industries Ltd', u'ParaPRO LLC', u'Eli Lilly & Co', u'FSC Laboratories Inc', u'Dynogen Pharmaceuticals Inc', u'Amneal Pharmaceutical LLC', u'Torii Pharmaceutical Co Ltd', u'Genpharm Inc', u'AGI Therapeutics plc', u'Aptalis Pharma Inc', u'Pfizer Inc', u'Apharm Srl', u'Sandoz Inc', u'Institute for the Promotion of Innovation by Science and Technology in Flanders', u'Kitasato Institute', u'Cinclus Pharma AG', u'CTC Bio Inc', u'Marathon Pharmaceuticals LLC', u'TAP Pharmaceutical Products Inc', u'University of Missouri', u'Valeant Pharmaceuticals North America LLC', u'Swiss National Science Foundation', u'Astra AB', u'Cempra Inc', u'Hokuriku Seiyaku KK', u'Astra Merck Inc', u'Sinorda Biomedicine Ltd', u'CJ HealthCare Corp', u'Bristol-Myers Squibb Co', u'Dainippon Pharmaceutical Co Ltd', u'Shanghai Golden Grand-Medical Instruments Ltd', u'CJ Corp', u'Astellas Pharma Inc', u'TWi Pharmaceuticals Inc', u'JW Pharmaceutical Corp', u'Fujirebio KK', u'Salix Pharmaceuticals Ltd', u'GE Healthcare', u'XenoPort Inc', u'Takeda Pharmaceutical Co Ltd', u'Shandong Luoxin Pharmaceutical Group Stock Co Ltd', u'Aphton Corp']), u'Colontumor': set([u'Daiichi Seiyaku Co Ltd', u'Anabolic Inc', u'Sumitomo Dainippon Pharma Co Ltd', u'Etubics Corp', u'Agence Nationale de Recherches sur le Sida et les hepatites virales (ANRS)', u'Korea Institute of Science and Technology', u'Karolinska Institutet', u'Phoenix Pharmacologics Inc', u'JSS University', u'Cerus Corp', u'Biocartis', u'Cancer Research Campaign Technology Ltd', u'Koebenhavns Universitet', u'Diosynth Ltd', u'Cancer Prevention Pharmaceuticals Inc', u'Recepta biopharma', u'IDM Pharma Inc', u'Chugai Pharmaceutical Co Ltd', u'US Health and Human Services Department', u'Il Dong Pharmaceutical Co Ltd', u'GlaxoSmithKline plc', u'BTG plc', u'Cell Genesys Inc', u'UCB Pharma GmbH', u'Cosmo Pharmaceuticals SpA', u'Ventana Medical Systems Inc', u'Royal DSM NV', u'MethylGene Inc', u'Ludwig Institute for Cancer Research', u'Clinipace', u'Zhejiang Hisun Pharmaceutical Co Ltd', u'Igeneon GmbH', u'NewBridge Pharmaceuticals Ltd', u'European Eurostars Programme', u'MedImmune LLC', u'Astex Pharmaceuticals Inc', u'Intracel Corp', u'University of Pittsburgh', u'University of Michigan', u'Eleison Pharmaceuticals Inc', u'Carna Biosciences Inc', u'Mateon Therapeutics Inc', u'Unigen Pharmaceuticals Inc', u'Biotech Synergy', u'Hybrigenics SA', u'University of California Los Angeles', u'Genzyme Molecular Oncology', u'NantHealth Inc', u'University of Kansas Medical Center', u'Pro Concepta Zug Ag', u'Siamab Therapeutics', u'Loma Linda University Medical Center', u'ANI Pharmaceuticals Inc', u'International Bioimmune Systems Inc', u'Felicitex Therapeutics Inc', u'Sandoz Ltd', u'Selvita SA', u'Inventiva', u'ONCO Life Sciences', u'Integrated DNA Technologies Inc', u'Eukarion Inc', u'CaroGen Corp', u'Fluxion Biosciences Inc', u'AstraZeneca plc', u'Statens Serum Institut', u'MicroVAX LLC', u'Kiadis Pharma Netherlands BV', u'Loyola University of Chicago', u'PhotoCure ASA', u'Pharminox Ltd', u'CrystalGenomics Inc', u'Xenova Ltd', u'Exelixis Inc', u'National Health and Medical Research Council', u'Inex Pharmaceuticals Corp', u'Active Biotech AB', u'Diaxonhit', u'Chem-Master International Inc', u'Deutsche Forschungsgemeinschaft (DFG)', u'Amgen Inc', u'Mylan Inc', u'Medarex Inc', u'CEL-SCI Corp', u'Affitech A/S', u'College Of Nanoscale Science & Engineering', u'Baxter Oncology GmbH', u'OncoTherapy Science Inc', u'Abbott Laboratories', u'Ohio State University', u'Protherics Salt Lake City Inc', u'Selah Genomics Inc', u'Indivumed GmbH', u'Boehringer Mannheim GmbH', u'Cloud Pharmaceuticals Inc', u'National Cancer Institute', u'Janssen Pharmaceutica NV', u'Merck KGaA', u'Ministry of Health & Welfare, Korea', u'Hospital del Mar', u'Panacea Pharmaceuticals Inc', u'Salix Pharmaceuticals Inc', u'Poniard Pharmaceuticals Inc', u'Georgetown University Medical Center', u'Diatos SA', u'CytoCore Inc', u'Vaccinogen Inc', u'CytomX Therapeutics Inc', u'Centre For Imaging Technology Commercialization', u'Cancer Research Technology Ltd', u'Pevion Biotech Ltd', u'Inflazyme Pharmaceuticals', u'Fourth Military Medical University PLA', u'Enzon Pharmaceuticals Inc', u'Biovation Ltd', u'Callisto Pharmaceuticals Inc', u'MediBIC', u'Immunomedics Inc', u'Seconda Universit\\xe0 degli studi di Napoli', u'Protein Sciences Corp', u'Dendreon Corp', u'Synergy Pharmaceuticals Inc', u'EpiGenesis Pharmaceuticals Inc', u'University of Connecticut', u'Yakult Honsha Co Ltd', u'Threshold Pharmaceuticals Inc', u'Rubicon Genomics Inc', u'Immune Response BioPharma Inc', u'Intensity Therapeutics Inc', u'Genomic Health Inc', u'Sidney Kimmel Cancer Center', u'Midatech Pharma US Inc', u'Biogazelle NV', u'Pangaea Biotech SA', u'Micromet Inc', u'University of California Irvine', u'The Research Council of Norway', u'Boehringer Ingelheim Corp', u'Myriad Genetics Inc', u'Generex Biotechnology Corp', u'Fuso Pharmaceutical Industries Ltd', u'Infinity Pharmaceuticals Inc', u'Purdue Pharma LP', u'University of Melbourne', u'Duke University', u'Debiopharm SA', u'21st Century Therapeutics Inc', u'Sanofi Pasteur', u'ILEX Oncology Inc', u'Acceptys Inc', u'University of Queensland', u'AmorePacific Corp', u'University of North Carolina', u'Green Cross Corp', u'AIMM Therapeutics BV', u'Genentech Inc', u'The Genetics Co Inc', u'Otsuka Pharmaceutical Co Ltd', u'NSABP Foundation Inc', u'Mologen Ag', u'Oxford GlycoSciences plc', u'Baylor Research Institute', u'Savient Pharmaceuticals Inc', u'Southern Research Institute', u'Nascent Biotech Inc', u'Johnson & Johnson Pharmaceutical Research & Development LLC', u'PledPharma AB', u'AlphaVax Inc', u'Sophia Genetics Sa', u'Nuclea Biotechnologies LLC', u'Ionis Pharmaceuticals Inc', u'Undisclosed', u'NatImmune A/S', u'US Government', u'Cellectar Biosciences Inc', u'Encore Pharmaceuticals Inc', u'Cancer Research Campaign (UK)', u'Ryhov County Hospital', u'Merck & Co Inc', u'Rimaco Inc', u'University of Florida', u'MD Anderson Cancer Center', u'Pharmasset Inc', u'BioChem Pharma (International ) Inc', u'rEVO Biologics Inc', u'Sanofi', u'Chong Kun Dang Pharmaceutical Corp', u'CTI BioPharma Corp', u'GlaxoSmithKline Biologicals', u'University of Florida College of Medicine', u'Southwest Oncology Group', u'DiaCarta LLC', u'Bayer AG', u'Bio-Bridge Science Inc', u'Foundation Of Biomedical Research Of The Academy Of Athens', u'Pharmacia Corp', u'Epimmune Inc', u'Pierre Fabre SA', u'OncoMab GmbH', u'Helen F Graham Cancer Center at Christiana Care', u'BD Technologies', u'Kyowa Hakko Kirin Co Ltd', u'NicOx SA', u'Kalgene Pharma Inc', u'Zetiq Technologies Ltd', u'Sunnybrook Health Sciences Centre', u'University of Bradford', u'Merus BV', u'Janssen Biotech Inc', u'Pharmatel Pty Ltd', u'IVAX Corp', u'SRI International', u'Almirall Prodesfarma SA', u'Aptalis Pharma Inc', u'Pfizer Inc', u'University of Southern California', u'Genetracer Biotech Sl', u'Northwest Biotherapeutics Inc', u'Saint Savas Cancer Hospital', u'Ludwig Institute for Cancer Research (Australia)', u'Corixa Corp', u'Centre for Drug Candidate Optimisation', u'Vanderbilt-Ingram Cancer Center', u'Netherlands Government', u'Patrys Ltd', u'PDL BioPharma Inc', u'Vernalis plc', u'Johns Hopkins University', u'Memorial Sloan-Kettering Cancer Center', u'Lonza Biologics plc', u'North Central Cancer Treatment Group', u'LG Life Sciences Ltd', u'Harvard University', u'AnorMED Inc', u'VIB', u'Antigen Express Inc', u'Yale School of Medicine', u'bioMerieux SA', u'Imclone LLC', u'Genmab A/S', u'Universidad Complutense de Madrid', u'Japanese National Cancer Center', u'ASTA Medica AG', u'Pierre Fabre Laboratories', u'Stanford Cancer Institute', u'Ontario Cancer Biomarker Network', u'Pacific Meinuoke Biopharmaceutical', u'Bavarian Nordic A/S', u'Alfa Wassermann SpA', u'American Health Foundation', u'National Cancer Centre of Singapore', u'Propep Surgical Llc', u'Research Council of the South East Sweden (FORSS)', u'Cancer Prevention and Research Institute of Texas', u'Sophiris Bio Inc', u'PharmaMar SA', u'National Institutes of Health', u'Anavex Life Sciences Corp', u'Food and Drug Administration', u'Fresenius SE & Co KGaA', u'Bristol-Myers Squibb Co', u'Chinese Government', u'University of Wurzburg', u'Quest Diagnostics Inc', u'MorphoSys AG', u'Sanofi Genzyme', u'MSD OSS BV', u'Aduro BioTech Inc', u'OncoMed Pharmaceuticals Inc', u'The Menarini Group', u'MGI Pharma Inc', u'Decisionq Corp', u'Astellas Pharma Inc', u'YM BioSciences USA', u'T.J. Martell Foundation', u'KS Biomedix Holdings plc', u'Walter and Eliza Hall Institute of Medical Research', u'AlfaGene Biosciences Inc', u'Wistar Institute of Anatomy & Biology', u'JW Pharmaceutical Corp', u'Shire plc', u'Salix Pharmaceuticals Ltd', u'Cognate BioServices Inc', u'Agouron Pharmaceuticals Inc', u'GD Searle & Co', u'Mogam Biotechnology Institute', u'University of Utah', u'NewBiotics Inc', u'Japan Science and Technology Agency', u'John Wayne Cancer Institute', u'Novartis AG', u'Central South University', u'Weizmann Institute of Science', u'Symphony Evolution Inc', u'Linkoping University', u'Chronix Biomedical', u'Rhone-Poulenc Rorer Inc', u'GeneMedicine Inc', u'Medicon Pharmaceuticals Inc', u'Aphton Corp']), u'Coxsackievirusinfection': set([u'Sigma-Aldrich Corp', u'Esteve', u'Hemispherx Biopharma Inc', u'Hollister-Stier Laboratories LLC', u'Korea Research Institute of Bioscience and Biotechnology', u'Guangdong Medicine Group Corp', u'Chinese Government', u'Undisclosed', u'Genius Biotherapeutics', u'Institute of Medical Biology Chinese Academy of Medical Sciences']), u'Haemophilusinfluenzaein': set([u'Astellas Pharma Inc', u'LTL Pharma Co Ltd']), u'Dysgeusia': set([u'Zeria Pharmaceutical Co Ltd', u'SK Chemicals Co Ltd']), u'Suddencardiacdeath': set([u'Glotecx Inc', u'Greenville Health System', u'Vicor Technologies Inc', u'Helix', u'Admera Health', u'Selah Genomics Inc']), u'Rickets': set([u'Laureate Biopharmaceutical Services Inc', u'Enobia Pharma Inc', u'Canadian Institutes of Health Research', u'Lonza Group AG', u'McGill University']), u'Monogenicdisorder': set([u'Sangamo Therapeutics Inc', u'Shire plc', u'Roche Holding AG', u'4D Molecular Therapeutics LLC']), u'Hallucination': set([u'Fudan University', u'Soochow University', u'Shanghai Institute of Materia Medica of the Chinese Academy of Sciences']), u'Paratuberculosis': set([u'University of Minnesota', u'RedHill Biopharma Ltd', u'University of Central Florida']), u'Candidaalbicansinfection': set([u'Sankyo Co Ltd', u'Nankai University', u'Innoprot', u'Michigan State University', u'BioVeris Corp', u'MD Anderson Cancer Center', u'Stanford University', u'Mansoura University', u'Biosearch Italia SpA', u'Takeda Vaccines Inc', u'University of Texas System', u'National Institute of Allergy and Infectious Diseases', u'DermaMed Pharmaceutical Inc', u'Laboratorios Effik SA', u'Enzon Pharmaceuticals Inc', u'Aragen Bioscience Inc', u'Zeneus Pharma Ltd', u'Merck Centre of Fungal Genetics', u'PPL Therapeutics plc', u'King Saud University', u'SRI International', u'Sequella Inc', u'Fujisawa Pharmaceutical Co Ltd', u'Elan Corp plc', u'PolyMedix Inc', u'GlaxoSmithKline plc', u'Eli Lilly & Co', u'Aronex Pharmaceuticals Inc', u'Guild Associates Inc', u'Angelini Pharmaceuticals SpA', u'Buckman Laboratories International, Inc', u'Bayer AG', u'TheraCarb Inc', u'Newsummit Biopharma Co Ltd', u'Periodontix Inc', u'Shaman Pharmaceuticals Inc', u'Virginia Polytechnic Institute and State University', u'University of Minnesota', u'Janssen Korea Ltd', u'Omnia Molecular', u'Verenium Corp', u'Dong-A ST Co Ltd', u'Organon International Inc', u'Child Health Corporation of America (CHCA)', u'Research Corporation Technologies', u'McGill University', u'National Institute of Dental and Craniofacial Research', u'Montana State University', u'Ciba-Geigy Corp', u'BioSynesis Inc', u'Hoechst Marion Roussel Inc', u'Pacgen Life Science Corp', u'Corixa Corp', u'The Global Alliance for TB Drug Development', u'Recordati SpA', u'Inhibitex Inc', u'Vicuron Pharmaceuticals Inc', u'Farmades SpA', u'Southeast University', u'Ferrer Internacional SA', u'University of Arizona']), u'BKvirusinfection': set([u'Cancer Prevention and Research Institute of Texas', u'Viracyte', u'University of California', u'Chimerix Inc']), u'Hypersomnia': set([u'Aerial BioPharma LLC', u'Dompe SpA', u'Cephalon Inc', u'Reset Therapeutics Inc', u'Laboratoire L Lafon SA', u'Merckle GmbH', u'Mylan Inc', u'Teva Pharmaceutical Industries Ltd', u'Armstrong Laboratories Inc', u'Taiwan Biotech Co Ltd', u'Jazz Pharmaceuticals plc', u'Cepa Schwarz Pharma Sl', u'Alfresa Pharma Corp', u'H Lundbeck A/S', u'Tanabe Seiyaku Co Ltd', u'Alkermes plc']), u'Spinalmuscularatrophy': set([u'Spotlight Innovation Inc', u'Cytokinetics Inc', u'Association Francaise Contre Les Myopathies', u'National Institute of Neurological Disorders and Stroke', u'ANDREWS BUDDIES CORPORATION/FightSMA', u'Undisclosed', u'Good Start Genetics Inc', u'Johns Hopkins University School of Medicine', u'Intrexon Corp', u'Academia Sinica', u'Ucyclyd Pharma Inc', u'Jasin Discovery Solutions Inc', u'Pfizer Inc', u'Scholar Rock Inc', u'US Government', u'Ohio State University', u'TRC Capital Corporation', u'Life Technologies Corp', u'Asklepios Biopharmaceutical Inc', u'Oxford BioMedica plc', u'Univ Massachusetts', u'Repligen Corp', u'California Institute for Biomedical Research', u'Eunice Kennedy Shriver National Institute of Child Health & Human Development', u'National Institutes of Health', u'Indiana University School of Medicine', u'US Army Medical Research and Materiel Command', u'Georgetown University', u'Ionis Pharmaceuticals Inc', u'Rosalind Franklin University of Medicine & Science', u'Sarepta Therapeutics Inc', u'Murdoch University', u'BioLife Cell Bank', u'University of California San Francisco', u'Imago Pharmaceuticals Inc', u'Columbia University', u\"Sophia's Cure Inc\", u'AveXis Inc', u'Tikvah Therapeutics Inc', u'Navinta LLC', u'Astellas Pharma Inc', u'Roche Holding AG', u'Indiana University Research and Technology Corp Inc', u\"Nationwide Children's Hospital\", u'University of Miami Miller School of Medicine', u'Cold Spring Harbor Laboratory', u'RTI International', u'Paratek Pharmaceuticals Inc', u'CHDI Inc', u'Albany Molecular Research Inc', u'Trophos SA', u'The National Institute of Mental Health', u'Muscular Dystrophy Association', u'Vivonoetics Inc', u'REGENXBIO Inc', u'Sanofi Genzyme', u'University of Edinburgh', u\"Brigham & Women's Hospital\", u'Johns Hopkins University', u'SMA Foundation', u'Emory University', u'Genome Medical Inc', u'Indiana University', u'Families of Spinal Muscular Atrophy', u'Zalicus Inc', u'deCODE genetics ehf', u'University of Massachusetts Medical School', u'Lexicon Pharmaceuticals Inc', u'PTC Therapeutics Inc']), u'Keratitis': set([u'Aero-Dap LLC', u'Mimetech SRL', u'Allergan Inc', u'Jade Therapeutics', u'Riptide Bioscience Inc', u'Stiefel', u'Phage Biotech Ltd', u'Hadassah Medical Organization', u'National Science Foundation', u'The New Energy and Industrial Technology Development Organization', u'NovaMedica', u'Anabasis Pharma', u'Scope Ophthalmics', u'Recordati SpA', u'Bio-Tissue Inc', u'Navigo Proteins GmbH', u'National Eye Institute', u'S. Fyodorov Eye Microsurgery Complex', u'Activus Pharma Co Ltd']), u'Polyomavirusinfection': set([u'Inhibikase Therapeutics Inc', u'US Government']), u'Neur': set([u'Genentech Inc', u'Roche Holding AG']), u'Acnevulgaris': set([u'Novan Inc', u'National Institute of Arthritis and Musculoskeletal and Skin Diseases', u'Sato Pharmaceutical Co Ltd', u'University of California San Diego School of Medicine', u'Maruho Co Ltd', u'Veterans Medical Research Foundation', u'Medicis Pharmaceutical Corp', u'POLA Pharma Inc', u'Glenmark Pharmaceuticals Ltd', u'GlaxoSmithKline plc', u'Quintiles Transnational Corp', u'Matawan Pharmaceuticals LLC', u'Dermata Therapeutics LLC', u'The Austrian Research Promotion Agency FFG', u'Galderma SA', u'Toyama Chemical Co Ltd', u'SkinMedica Inc', u'Arkin Holdings Ltd', u'Intendis GmbH', u'Villani inc', u'Allergan Inc', u'Almirall Prodesfarma SA', u'Foamix Pharmaceuticals Ltd', u'University of California San Diego', u'Zen-Bio Inc', u'Perrigo Co plc', u'Sanofi Pasteur', u'Altimmune Inc (pre-merger)', u'Origimm Biotechnology GmbH']), u'Skin': set([u'RegeneRx Biopharmaceuticals Inc', u'US Government']), u'Lunginfection': set([u'Transave Inc', u'Bachem Holding AG', u'US Government', u'McMaster University', u'Serendex Pharmaceuticals A/S', u'Intrexon Corp', u'Savara Inc', u'Cystic Fibrosis Foundation Therapeutics Inc', u'National Institute of Allergy and Infectious Diseases', u'National Heart Lung and Blood Institute', u'Qiagen NV', u'University of Aberdeen', u'Agile Sciences Inc', u'Aradigm Corp', u'Undisclosed', u'NHS Grampian', u'Aerogen Inc', u'Cystic Fibrosis Trust', u'Synairgen plc', u'Aridis Pharmaceuticals Inc', u'Creative Antibiotics Sweden AB', u'NovaBiotics Ltd', u'Axentis Pharma AG', u'Celera Group', u'Insmed Inc', u'University of Sydney', u'Horizon Orphan LLC', u'Canadian Department of National Defence', u'Relief Therapeutics Holding AG', u'Tripex Pharmaceuticals', u'Aptalis Pharma Inc', u'Chiron PathoGenesis', u'Chiesi Farmaceutici SpA', u'aRigen Pharmaceuticals Inc', u'Ajinomoto Althea Inc', u'Mpex Pharmaceuticals Inc', u'PARI Pharma GmbH', u'NanoMaterials Technology Pte Ltd', u'AmpliPhi Biosciences Corp', u'Horizon Pharma plc']), u'Westernequineencephalitisvirusinfection': set([u'University of Texas Medical Branch at Galveston', u'Ichor Medical Systems Inc', u'ViRexx Medical Corp', u'University of Pittsburgh', u'Emory University', u'Profectus BioSciences Inc', u'US Department of Defense', u'Defyrus Inc', u'National Center for Research Resources', u'AltraVax Inc', u'National Institute of Allergy and Infectious Diseases', u'US Government', u'Canadian Department of National Defence', u'Tulane University', u'Defense Threat Reduction Agency']), u'Complicatedurinarytractinfection': set([u'Genesoft Inc', u'LG Life Sciences Ltd', u'Northern Antibiotics Ltd', u'EnBiotix Inc', u'Innovative Medicines Initiative', u'AiCuris Anti-infective Cures GmbH', u'Wired Holdings Investment Corp', u'Spero Therapeutics LLC']), u'Xerodermapigmentosum': set([u'INSERM', u'ProGeLife', u'OSEO']), u'Eardisease': set([u'Alcon Inc', u'BioAdvance', u'Luitpold Pharmaceuticals Inc', u'Cystic Fibrosis Foundation Therapeutics Inc', u'Amarantus BioScience Holdings Inc', u'Sound Pharmaceuticals Inc', u'NeuroSystec Corp', u'Otomagnetics LLC', u'Amring Pharmaceuticals Inc', u'DURECT Corp', u'pSivida Corp', u'Auration Biotech Inc', u'Maryland Department of Business and Economic Development', u'Auris Medical Holding AG', u'Astellas Pharma Inc', u'Otifex Therapeutics Pty Ltd', u'Fiagon Gmbh', u'Chiroscience Group plc', u'Alphagen Laboratories Inc', u'St James Associates Llc/Faber Research Series', u'Nobelpharma Co Ltd', u'Entellus Medical Inc', u'Foundation for Biomedical Research and Innovation', u'TalexMedical', u'University of Massachusetts Medical School']), u'Peri': set([u'TESARO Inc', u'Merck & Co Inc', u'Veristat, Inc.']), u'Hepatitis': set([u'Novartis Diagnostics', u'Israeli Government', u'Shanghai Biochemistry Pharmaceutical Co Ltd', u'Cancer Vaccine Acceleration Fund', u'BioMena SA', u'Aevi Genomic Medicine Inc', u'National Institute of Diabetes, Digestive and Kidney Diseases', u'Oncovir Inc', u'National Institute of Allergy and Infectious Diseases', u'SRI International', u'Mundipharma International Corp Ltd', u'Dongguan Biotech Industrial Development Co', u'General Biologicals Corp', u'National Institutes of Health', u'University of Tokyo', u'Cellectar Biosciences Inc', u'ProMetic Life Sciences Inc', u'Merck & Co Inc', u'Australian Research Council', u'Purdue Pharma LP', u'Daewon Pharm Co Ltd', u'Gen-Probe Inc', u'GNI Group Ltd', u'Seoul National University', u'National Natural Science Foundation of China', u'Pharmacopeia Inc', u'EpiCept Corp', u'Galapagos NV', u'Kyowa Hakko Kirin Co Ltd', u'Dong-A ST Co Ltd', u'HealthCare Asia Pharmaceuticals Inc', u'Glaxo Group Ltd', u'Medical University of South Carolina', u'Walter and Eliza Hall Institute of Medical Research', u'Indiana University', u'Sanofi', u'Reata Pharmaceuticals Inc', u'Nanjing University', u'Idenix Pharmaceuticals Inc', u'Chong Kun Dang Pharmaceutical Corp', u'Sigma-Tau Ind Farm Riunite SpA', u'Dongsheng Pharmaceutical International Co Ltd']), u'Sjoegrenssyndrome': set([u'IMMCO Diagnostics Inc', u'US Government', u'University of North Carolina', u'University of Gothenburg', u'Genentech Inc', u'National Institute for Health Research (NIHR)', u'Mithra Pharmaceuticals', u'Biogen Inc', u'The University of Birmingham', u'Lonza Group AG', u'Novartis AG', u'Parion Sciences Inc', u'Hanmi Pharmaceutical Co Ltd', u'Eli Lilly & Co', u'Kainos Medicine Inc', u'NicOx SA', u'Zhejiang Xianju Pharmaceutical Corp Ltd', u'Toleranzia AB', u'Allergan Inc', u'Inspire Pharmaceuticals Inc', u'Sanford-Burnham Medical Research Institute', u'Human Genome Sciences Inc', u'University at Buffalo']), u'Sanfilipposyndrome': set([u'Genea Ltd', u'US Government', u'National Institute of Neurological Disorders and Stroke', u'Sanfilippo Syndrome Medical Research Foundation', u'Team Sanfilippo Foundation', u'Alcyone Lifesciences Inc', u'BioStrategies LC', u'Zacharon Pharmaceuticals Inc', u'Los Angeles Biomedical Research Institute', u'Universite De Montreal', u'Oxford BioMedica plc', u'Novogen Ltd', u'National MPS Society', u'Orchard Therapeutics', u'University of Manchester', u'Abeona Therapeutics LLC', u'Phoenix Nest Inc', u\"Nationwide Children's Hospital\", u'BBB Therapeutics BV', u'LYSOGENE', u'Shire plc', u'Institut Pasteur', u'Genethon', u'Esteve', u'Universitat Autonoma de Barcelona', u'uniQure BV', u'REGENXBIO Inc', u'Jonah\\u2019s Just Begun-Foundation']), u'Ischemia': set([u'Quest Diagnostics Inc', u'US Government', u'Regeneron Pharmaceuticals Inc', u'BioAtla Llc', u'Netherlands Government', u'Allos Therapeutics Inc', u'ArtGen Inc', u'Korea Research Institute of Chemical Technology', u'Dongbu Hannong Chemical Co Ltd', u'Quintiles Transnational Corp', u'CHA Bio & Diostech Co Ltd', u'Cyclis Pharmaceuticals Inc', u'Interferon Sciences Inc', u'Rexgenero Ltd', u'Radikal Therapeutics Inc', u'N-Gene Research Laboratories Inc', u'Human Stem Cells Institute', u'Sangamo Therapeutics Inc', u'University of Pennsylvania', u'Mitsubishi-Tokyo Pharmaceuticals Inc', u'Walter Reed Army Institute of Research', u'Sumitomo Pharmaceuticals Co Ltd', u'St Franziskus Hospital', u'DMI BioSciences Inc', u'PYRAMID Laboratories, Inc', u'Vasogen Inc', u'Faron Pharmaceuticals Ltd', u'Aldagen Inc', u'St Elizabeths Medical Center of Boston Inc', u'Biosite Inc', u'National Heart Lung and Blood Institute', u'US Department of Defense', u'Charite Universitaetsmedizin Berlin', u'Angion Biomedica Corp', u'Annovis Inc', u'SCYNEXIS Inc', u'William Harvey Research Ltd', u'The European Union', u'Abbott Laboratories', u'Compass Biomedical', u'Aronora Inc', u'Pharmicell Europe GmbH', u'Gambro AB', u'Panacea Pharmaceuticals Inc', u'SynBio LLC', u'Vanderbilt University', u'Angiob Ltd', u'Massachusetts General Hospital', u'UCB Pharma GmbH', u'Hemostemix Asia Inc', u'Cypralis Ltd', u'Pathfinder Cell Therapy Inc', u'Roche Diagnostics', u'Sosei Group Corp', u'Innovative Medical Management', u'Tioma Therapeutics Inc', u'Glaxo Group Ltd', u'Vericel Corp', u'AnGes MG Inc', u'Washington University in St Louis', u'Lixte Biotechnology Holdings Inc', u'Qiagen NV', u'Jefferson Corner Group', u'National Institute of Neurological Disorders and Stroke', u'Molecules for Health Inc', u'Genentech Inc', u'Cognetix Inc', u'Mitsubishi Pharma Corp', u'National Institute of Diabetes, Digestive and Kidney Diseases', u'Vector Gene Technology Co Ltd', u'LifeArc', u'Yuhan Corp', u'Xenetic Biosciences Inc', u'Merck & Co Inc', u'Edwards Lifesciences Corp', u'COR Therapeutics Inc', u'Mirrx Therapeutics', u'ID Pharma Co Ltd', u'Alloksys Life Sciences BV', u'University of California Davis', u'Phytera Inc', u'Strathmann Biotec AG', u'Pluristem Therapeutics Inc', u'Galileo Pharmaceuticals Inc', u'Case Western Reserve University', u'Hannover Medical School', u'Technology Strategy Board', u'National Institute on Aging', u'Corixa Corp', u'Adenosine Therapeutics LLC', u'Yissum Research Development Co', u'Danube Pharmaceuticals Inc', u'NeuroNascent Inc', u'Hemostemix Inc', u'Boston Scientific Corp', u'Zambon Co SpA', u'VIA Pharmaceuticals Inc', u'Takeda Pharmaceutical Co Ltd', u'Shanghai Jia Fu Medical Apparatus', u'National Institutes of Health', u'PharmaIN Ltd', u'Endovasc Inc', u'Iniciativa Andaluza en Terapias Avanzadas (IATA)', u'Bristol-Myers Squibb Co', u'Thomas Jefferson University', u'Dr Rentschler Biotechnologie GmbH', u'Celgene Corp', u'Sangart Inc', u'Medizinische Universit\\xe4t Innsbruck', u'Duke University', u'Tufts University', u'ATEK Medical', u'Centenary Institute Cancer Medicine & Cell Biology', u'Boehringer Ingelheim Austria GmbH', u'Gedeon Richter Ltd', u'Medistem Inc', u'PPD Discovery Inc', u'13Therapeutics Inc']), u'Lactoseintolerance': set([u'University of Nebraska', u'US Government', u'Ritter Pharmaceuticals Inc']), u'Chronicthromboembolicpulmonaryhypertension': set([u'Mallinckrodt plc', u'Actelion Ltd', u'Bayer Schering Pharma AG', u'Bellerophon Therapeutics LLC', u'Bayer AG', u'Merck & Co Inc']), u'Ileus': set([u'Eli Lilly & Co', u'Tranzyme Pharma Inc', u'Phynova Group Ltd', u'University of Chicago', u'UR Labs Inc', u'Shire plc', u'Adolor Corp', u'Botanic Century (Beijing) Co Ltd', u'Norgine BV', u'Progenics Pharmaceuticals Inc', u'GlaxoSmithKline plc']), u'Hypercho': set([u'Sun Pharmaceutical Industries Ltd', u'Novartis AG']), u'Tardivedyskinesia': set([u'Taiwan Specialty Pharma Corp', u'Meiji Seika Pharma Co Ltd', u'Novo Nordisk A/S', u'AOP Orphan Pharmaceuticals AG', u'Lifehealth Ltd', u'EUSA Pharma USA', u'Alfresa Pharma Corp', u'AFT Pharmaceuticals Ltd', u'Synchroneuron LLC', u'Lundbeck Inc', u'Bayer Schering Pharma AG', u'Temmler GmbH', u'TheraSci Ltd', u'Lundbeck Canada Inc', u'Giddi Pharma Co Ltd', u'Valeant Pharmaceuticals International Inc', u'Biovail Corp', u'Mitsubishi Tanabe Pharma Corp', u'Cambridge Laboratories Ltd', u'CeNeS Pharmaceuticals plc', u'Somaxon Pharmaceuticals Inc', u'UCB Pharma SA', u'Medicure Inc', u'MediFront Ltd', u'Japanese Ministry of Health, Labor and Welfare', u'Duke Clinical Research Institute', u'Neurocrine Biosciences Inc', u'UCB SA', u'Orphan Australia']), u'Trichomonasinfection': set([u'National Institute of Allergy and Infectious Diseases', u'Adelphi University', u'University of California San Diego', u'AstraZeneca Pharmaceuticals LP']), u'Wegenergranulomatosis': set([u'Celltrion Healthcare Co Ltd', u'Teva Pharmaceutical Industries Ltd']), u'Sandhoffdisease': set([u'Oxford GlycoSciences plc', u'GD Searle & Co', u'Food and Drug Administration', u'Teva Pharmaceutical Industries Ltd', u'ExSAR Corp']), u'Autoimmunehepatitis': set([u'Veloxis Pharmaceuticals A/S', u'Taiba Pharma LLC']), u'Seminoma': set([u'US Government', u'ArQule Inc', u'Daiichi Sankyo Co Ltd']), u'Ocularinjury': set([u'Allergan Inc', u'United States Army Medical Research Institute of Chemical Defense', u'Wayne State University', u'National Institutes of Health', u'AcSentient Inc', u'US Government', u'Syntex (USA) LLC', u'BioSpring Gesellschaft Fur Biotechnologie mbH', u'Amarantus BioScience Holdings Inc', u'RegeneRx Biopharmaceuticals Inc', u'Bascom Palmer Eye Institute', u'Quark Pharmaceuticals Inc', u'ISTA Pharmaceuticals Inc']), u'Respiratorytractinflammation': set([u'MD Biosciences GmbH', u'BioSeek LLC', u'Takeda GmbH', u'Medisyn Technologies Inc', u'GlaxoSmithKline plc', u'Biocrates Life Sciences GmbH', u'Verona Pharma plc', u'MedPharm Ltd', u'Sanofi', u'Inflazyme Pharmaceuticals', u'UCB SA', u'Ranbaxy Laboratories Ltd', u'AMRAD Discovery Technologies Pty Ltd', u'Ludwig Institute for Cancer Research', u'Incozen Therapeutics Pvt Ltd', u'Eurodrug Laboratories', u'AstraZeneca plc', u'Cytopia Ltd', u'Rhizen Pharmaceuticals SA', u'Vectura Group plc', u'Orexo AB', u'LAB Research Inc', u'Dr Lo Zambeletti SpA']), u'Hormonedependentprostatecancer': set([u'Bachem Holding AG', u'Green Cross Corp', u'bioMerieux SA', u'Kirin Brewery Co Ltd', u'United Laboratories Inc.', u'Mayo Clinic Foundation', u'Astellas Pharma Europe Ltd', u'GlaxoSmithKline plc', u'Uppsala University', u'Ipsen', u'Sanpower Group Co Ltd', u'Fujifilm Diosynth Biotechnologies', u'Dendreon Corp', u'Valeant Pharmaceuticals International Inc', u'HemaCare Corp', u'Alvogen Korea', u'Kyowa Hakko Kirin Co Ltd', u'LIDDS AB', u'Immune Response BioPharma Inc', u'AEterna Zentaris Inc', u'TerSera Therapeutics', u'AstraZeneca plc', u'Akzo Nobel NV', u'Shionogi & Co Ltd', u'Orient Europharma', u'Astrazeneca Korea', u'Debiopharm SA', u'TOLMAR Therapeutics Inc']), u'Prostatectomy': set([u'Trendlines Group Ltd', u'National Cancer Institute', u'Endo International plc', u'Emory University', u'Verathon Inc', u'Joule']), u'Polycystickidneydisease': set([u'NovaTarg Therapeutics Inc', u'Laboratorios Farmaceuticos Rovi SA', u'Abbott Laboratories', u'Otsuka Pharmaceutical Co Ltd', u'Mayo Clinic Foundation', u'National Institute of Diabetes, Digestive and Kidney Diseases', u'National Institute of Allergy and Infectious Diseases', u'SRI International', u'Covance Inc', u'Discovery BioMed Inc', u'Plexxikon Inc', u'National Institutes of Health', u'Food and Drug Administration', u'PreClinomics', u'Merck & Co Inc', u'Indiana University Purdue University Indianapolis', u'Cardiokine Inc', u'Akrivis Technologies LLC', u'University of California San Francisco', u'IC-MedTech Inc', u'Metabolic Solutions Development Co', u'Chiesi USA Inc', u'Johns Hopkins Medicine', u'PKD Foundation', u'National Cancer Institute', u'Napo Pharmaceuticals Inc', u'Pfizer Inc', u'Shionogi & Co Ltd', u'Boehringer Ingelheim Corp', u'Palladio Biosciences Inc', u'Summa Health System', u'Merck Sharp & Dohme Ltd', u'F Hoffmann-La Roche AG', u'Intellikine Inc']), u'Hemorrhagicstroke': set([u'National Institutes of Health', u'Translational Genomics Research Institute', u'KAT General Hospital', u'Barrow Neurological Insitute', u\"Phoenix Children's Hospital\", u'Randox Laboratories Ltd']), u'Cerebrovascularischemia': set([u'Guangdong Zhongsheng Pharmaceutical Co Ltd', u'WuXi PharmaTech (Cayman) Inc']), u'Impetigo': set([u'Galderma SA', u'Perrigo Co Ltd', u'Almirall Prodesfarma SA', u'Toyama Chemical Co Ltd', u'Maruho Co Ltd', u'XOMA Corp', u'Medimetriks Pharmaceuticals Inc', u'Incyte Corp', u'US Government', u'NovaBay Pharmaceuticals Inc', u'GlaxoSmithKline plc']), u'Skinallergy': set([u'Sumitomo Pharmaceuticals Co Ltd', u'Genentech Inc', u'IMTM GmbH', u'Japan Energy Corp', u'Gamida Cell Ltd', u'Synvista Therapeutics Inc', u'Clinquest Group', u'Evotec (UK) Ltd', u'Universiteit Utrecht']), u'Suicide': set([u'Karolinska Institutet', u'Johnson & Johnson', u'Premier Biomedical Inc', u'William Beaumont Army Medical Center']), u'Canavandisease': set([u'Thomas Jefferson University', u'University of Medicine and Dentistry of New Jersey', u'Turing Pharmaceuticals LLC', u'Advanced Therapies Inc', u'University of Toledo', u'University of Auckland', u'Yale University', u'Bamboo Therapeutics Inc', u'City of Hope', u'Rowan University', u'California Institute of Regenerative Medicine']), u'Urethritis': set([u'Urigen Pharmaceuticals Inc', u'Kalium Inc']), u'Trypanosomabruceiinfection': set([u'University of Georgia', u'M\\xe9decins Sans Fronti\\xe8res', u'Massachusetts Institute of Technology', u'Advinus Therapeutics Ltd', u'The European Union', u'SCYNEXIS Inc', u'National Institute of Allergy and Infectious Diseases', u'Nagasaki University', u'Drugs for Neglected Diseases Initiative', u'Abbott Laboratories', u'Eisai Co Ltd', u'University of Dundee', u'GlaxoSmithKline plc', u'High Energy Accelerator Research Organization', u'Marine Biological Laboratory', u'Bill & Melinda Gates Foundation', u'University of Tokyo', u'Cleveland BioLabs Inc', u'Selcia Ltd', u'Sanofi', u'Medical Research Council', u'University of Texas Southwestern Medical Center', u'The Center for World Health & Medicine at Saint Louis University', u'Swiss Agency for Development and Cooperation', u'Pen Pharmaceutical Services Ltd', u'WuXi PharmaTech (Cayman) Inc', u'Celgene Corp', u'La Agencia Espa\\xf1ola de Cooperaci\\xf3n Internacional para el Desarrollo', u'Department for International Development', u'National Institute of Advanced Industrial Science and Technology', u'Astellas Pharma Inc', u'BIO Ventures for Global Health', u'Pace University', u'Anacor Pharmaceuticals Inc', u'Microbial Chemistry Research Foundation', u'Norwegian Agency for Development Cooperation', u'Medicines for Malaria Venture', u'Wellcome Trust', u'University of Edinburgh', u'AstraZeneca plc', u'Global Health Innovative Technology Fund', u'Cleveland State University', u'MediSynergics LLC', u'Takeda Pharmaceutical Co Ltd', u'Glasgow University', u'Northeastern University', u'Alnylam Pharmaceuticals Inc', u'University of Antwerp', u'VU University Medical Center', u'German Federal Ministry of Education and Research', u'Kitasato Institute']), u'Pollakiuria': set([u'Hokuriku Seiyaku KK', u'Nippon Shinyaku Co Ltd', u'Enhance Pharmaceuticals Inc', u'Bayer Schering Pharma AG', u'Ono Pharmaceutical Co Ltd', u'Kyorin Pharmaceutical Co Ltd', u'Yamanouchi Pharmaceutical Co Ltd', u'Pfizer Inc', u'Barr Pharmaceuticals Inc', u'Recordati SpA', u'Orion Corporation', u'Tanabe Seiyaku Co Ltd', u'Dainippon Pharmaceutical Co Ltd', u'GlaxoSmithKline plc']), u'TypeIcomplexregionalpainsyndrome': set([u'Grunenthal GmbH', u'Abiogen Pharma SpA', u'NovaPharm Therapeutics']), u'Brainischemia': set([u'Guangdong Zhongke Drug Research & Development Co Ltd', u'University of Calgary', u'National Institute of Neurological Disorders and Stroke', u'NoNO Inc', u'Shionogi & Co Ltd', u'Shizuoka University', u'Anavex Life Sciences Corp', u'l\\u2019Universite Paris Descartes', u'University of California San Francisco', u'NeurOp Inc', u'Shijiazhuang Yiling Pharmaceutical Co Ltd']), u'Uterinece': set([u'Yakult Honsha Co Ltd', u'Rhone-Poulenc Rorer Inc']), u'Protozoalinfection': set([u'Eli Lilly & Co', u'Pfizer Inc', u'Medimmune Oncology Inc', u'Verenium Corp', u'Schering Overseas Ltd', u'Vicuron Pharmaceuticals Inc', u'GlaxoSmithKline plc']), u'Cancerpain': set([u'Javelin Pharmaceuticals Inc', u'Sentynl Therapeutics Inc', u'TTY Biopharm Co Ltd', u'DURECT Corp', u'Ipsen', u'Novartis Pharma AG', u'NewBridge Pharmaceuticals Ltd', u'Advanced Pain Therapeutics LLC', u'University of Michigan', u'IMPAX Laboratories Inc', u'GW Pharmaceuticals plc', u'CeNeS Pharmaceuticals plc', u'TOLMAR Therapeutics Inc', u'Hisamitsu Pharmaceutical Co Inc', u'University of Kentucky', u'Clinical Development Capital Llc', u'Teikoku Seiyaku KK', u'Aptargroup Inc', u'Orexo AB', u'Shionogi & Co Ltd', u'Esteve', u'Aveva Drug Delivery Systems', u'Hamelin Ltd', u'Ribomic Inc', u'New York University', u'CSC Pharmaceuticals Handels GmbH', u'Cancer Genetics Inc', u'Daiichi Sankyo Co Ltd', u'Nippon Kayaku Co Ltd', u'Endo Health Solutions Inc', u'Galena Biopharma Inc', u'Teva Pharmaceuticals USA Inc', u'National Cancer Institute', u'US Department of Defense', u'Acturum Life Science Ab', u'Purdue Pharma LP', u'UCB Pharma GmbH', u'WuXi PharmaTech (Cayman) Inc', u'Kancera AB', u'Mundipharma EDO GmbH', u'RaQualia Pharma Inc', u'ALZA Corp', u'Insys Therapeutics Inc', u'Taiho Pharmaceutical Co Ltd', u'Lavipharm SA', u'Kyukyu Pharmaceutical Co Ltd', u'Nycomed Canada Inc', u'Osaka University', u'Klaria Pharma Holding Ab', u'Tetra Bio-Pharma Inc', u'Diamyd Inc', u'Neopharm Ltd', u'Bionevia Pharmaceuticals Inc', u'Cognetix Inc', u'Paladin Labs Inc', u'Grunenthal GmbH', u'Otsuka Pharmaceutical Co Ltd', u'Pharmasol Ltd', u'KunWha Pharmaceutical Co Ltd', u'Undisclosed', u'Altus Formulation', u'Daewoong Pharmaceutical Co Ltd', u'Metaphore Pharmaceuticals Inc', u'Collegium Pharmaceutical Inc', u'Eli Lilly & Co', u'IntelGenx Technologies Corp', u'Fluorinov Pharma Inc', u'Hebrew University of Jerusalem', u'Bioglan Pharmaceuticals Co', u'Penwest Pharmaceuticals Co', u'NicOx SA', u'Ikano Therapeutics Inc', u'CeNeS Pharmaceuticals Inc', u'Pfizer Hellas AE', u'Pfizer Inc', u'Sosei R&D Ltd', u'Sandoz Inc', u'Terumo Corp', u'Nippon Shinyaku Co Ltd', u'Cato Research Ltd', u'Pharmos Corp', u'H Lee Moffitt Cancer Center and Research Institute', u'Pfizer Japan Inc', u'Bayer AG', u'National Institutes of Health', u'Menarini Asia-Pacific', u'Elan Corp plc', u'WEX Pharmaceuticals Inc', u'Almirall Prodesfarma SA', u'BioDelivery Sciences International Inc', u'Valeant Pharmaceuticals International Inc', u'Uppsalagruppen Medical Ab', u'Maruishi Pharmaceutical Co Ltd', u'tesa Labtec GmbH', u'National Institute of Dental and Craniofacial Research', u'Takeda Pharmaceutical Co Ltd', u'Actavis Group HF', u'Kyowa Hakko Kirin Co Ltd']), u'Atherosclerosis': set([u'Clinical Data Inc', u'Oscient Pharmaceuticals Corp', u'Servier', u'US Government', u'Novo Nordisk A/S', u'Molecular Targeting Technologies Inc', u'National Institutes of Health', u'FAES Farma SA', u'ANANDA Scientific Inc', u'VIRxSYS Corp', u'Shire Human Genetic Therapies Inc', u'Digital Gene Technologies Inc', u'Capricor Therapeutics Inc', u'BIOTRONIK SE & Co', u'National Heart Foundation of Australia', u'SynBio LLC', u'GlaxoSmithKline plc', u'KineMed Inc', u'BTG plc', u\"Cincinnati Children's Hospital Medical Center\", u'Centelion SAS', u'Hadasit Medical Research Services and Development Ltd', u'Maquet Medical Systems USA', u'Cortical Pty Ltd', u'Solvay SA', u'Torrey Pines Pharmaceuticals Inc', u'Taxus Cardium Pharmaceuticals Group', u'Aventis Pharma AG', u'Chinese Government', u'Spherix Inc', u'Synvista Therapeutics Inc', u'Bio3 Research Srl', u'Celldex Therapeutics Inc', u'University of Washington', u'Italfarmaco SpA', u'Center for Biomarker Research in Medicine', u'Atherotech Inc', u'Resverlogix Corp', u'Hybrigenics SA', u'Nissan Chemical Industries Ltd', u'Merck Sante SA', u'MSD OSS BV', u'Mitsubishi Tanabe Pharma Corp', u'AFA Insurance', u'University of Munster', u'Orphagen Pharmaceuticals Inc', u'Sk\\xe5ne University Hospital', u'Sun Pharmaceutical Industries Ltd', u'Sankyo Co Ltd', u'Universita Degli Studi Di Perugia', u'Dompe SpA', u'Canadian Institutes of Health Research', u'Temple University', u'Nycomed Imaging A/S', u'Boston University', u'Synageva BioPharma Corp', u'Trigen GmbH', u'Emory University', u'Advancecor GmbH', u'Sanford-Burnham Medical Research Institute', u'Baker IDI Heart & Diabetes Institute Holdings Ltd', u'Harvard TH Chan School of Public Health', u'Iproteos', u'Alnylam Pharmaceuticals Inc', u'Reliant Pharmaceuticals Inc', u'Universiteit Maastricht', u'University of Massachusetts Medical School', u'Klinge Pharma GmbH', u'CrystalGenomics Inc', u'Oxagen Ltd', u'New York University', u'EMC Microcollections GmbH', u'Karo Pharma AB', u'CardioVax LLC', u'The European Union', u'Abbott Laboratories', u'Amarna Therapeutics BV', u'Mount Sinai School of Medicine', u'Speedel Pharma AG', u'Novartis AG', u'Johns Hopkins University School of Medicine', u'Pharmacyclics Inc', u'Kyushu University', u'Poniard Pharmaceuticals Inc', u'Guidant Corp', u'The Medicines Company', u'Kowa Co Ltd', u'Massachusetts General Hospital', u'Abgenix Inc', u'Boehringer Ingelheim International GmbH', u'Rotta Research Lab SpA', u'FibroGen Inc', u'Friedrich Schiller University of Jena', u'Cholestech Corp', u'Borean Pharma A/S', u'Cleveland Clinic Foundation', u'Mathilda and Terrence Kennedy Institute of Rheumatology Trust', u'Wyeth', u'ZIT', u'AtheroGenics Inc', u'Celera Group', u'Galenica SA (Greece)', u'Global Genomics Group LLC', u'CytoTools AG', u'Bioincept LLC', u'Sandoz Ltd', u'Univalor', u'Washington University in St Louis', u'Chiron PathoGenesis', u'Ocean University of China', u'EnduRx Pharmaceuticals Inc', u'Kyowa Hakko Kogyo Co Ltd', u'Genset SA', u'Genfit SA', u'Compugen Ltd', u'Recordati SpA', u'Ranbaxy Laboratories Ltd', u'Lexicon Pharmaceuticals Inc', u'Yamanouchi Pharmaceutical Co Ltd', u'Arisaph Pharmaceuticals Inc', u'PROLOR Biotech Inc', u'Umea University', u'Shanghai Genomics Inc', u'National Natural Science Foundation of China', u'Artery Therapeutics Inc', u'Miravant Medical Technologies', u'Mayo Clinic Foundation', u'National Institute of Diabetes, Digestive and Kidney Diseases', u'Oxford GlycoSciences plc', u'Reino de Espana', u'Boots Hoechst Celanese', u'Memorial University', u'Pharmacia & Upjohn Inc', u'Xenetic Biosciences Inc', u'Undisclosed', u'Corimmun GmbH', u'Riparian Pharmaceuticals Inc', u'Provid Pharmaceuticals Inc', u'Merck & Co Inc', u'AmorChem LP', u'Napp Pharmaceutical Group Ltd', u'Massachusetts Life Sciences Center', u'COR Therapeutics Inc', u'GenKyoTex SA', u'Vascular Pharmaceuticals Inc', u'Eli Lilly & Co', u'Bayer AG', u'Pierre Fabre SA', u'University of Virginia', u'Inner Mongolia Lantai Industrial Co Ltd', u'Foxhollow Technologies Inc', u'Nanobac Pharmaceuticals Inc', u'Janssen Biotech Inc', u'Concord Biosciences LLC', u'Almirall Prodesfarma SA', u'AstraZeneca plc', u'Pfizer Inc', u'Sanofi', u'Fournier Pharma', u'Indiana University', u'Human Genome Sciences Inc', u'Tsumura & Co', u'Lipigon Pharmaceuticals', u'Northeastern University', u'Pieris Pharmaceuticals Inc', u'AFFiRiS AG', u'IVAX Corp', u'NanoScan Imaging LLC', u'Dr Reddy\\u2019s Research and Development BV', u'LG Life Sciences Ltd', u'Massachusetts Institute of Technology', u'University of Gothenburg', u'Gilead Palo Alto Inc', u'OSI Pharmaceuticals Inc', u'Anagen Therapeutics Inc', u'Amylin Pharmaceuticals Inc', u'Yissum Research Development Co', u'Institute of Materia Medica Chinese Academy of Medical Sciences & Peking Union Medical College', u'Astra AB', u'Taisho Pharmaceutical Co Ltd', u'Arena Pharmaceuticals Inc', u'Ligand Pharmaceuticals Inc', u'Zambon Co SpA', u'Baker Heart Research Institute', u'Aventis Cambridge Genomics Center LLC', u'SmithKline Beecham plc', u'Carna Biosciences Inc', u'NAEJA Pharmaceuticals Inc', u'Molecular Medicine BioServices Inc', u'AtheroNova Inc', u'IMCOR Pharmaceutical Co', u'Bristol-Myers Squibb Co', u'Elan Corp plc', u'Dainippon Pharmaceutical Co Ltd', u'Aventis SA', u'Takeda Oncology', u'INSERM', u'Esperion Therapeutics Inc', u'Sanofi Genzyme', u'Regulus Therapeutics Inc', u'Cedars-Sinai Medical Center', u'Peptor Ltd', u'NPS Allelix Corp', u'SignaBlok Inc', u'University of Chicago', u'University of Kentucky', u'Roche Holding AG', u'Astellas Pharma Inc', u'Cytopia Inc', u'National Institute of Biomedical Imaging and Bioengineering', u'Aterovax', u'Athera Biotechnologies AB', u'Duke University', u'Tufts University', u'University of Milan', u'Protelica Inc', u'Meda AB', u'ActivBiotics Inc', u\"Brigham & Women's Hospital\", u'Calgenex', u'Hoechst Marion Roussel Inc', u'Antitope Ltd', u'Takeda Pharmaceutical Co Ltd', u'Merck KGaA', u'Galapagos NV', u'University of Cambridge', u'twoXar Inc', u'Bio-Quant Inc', u'National Heart Lung and Blood Institute', u'Kaneka Corp']), u'Pulmonaryheartdisease': set([u\"Dr Reddy's Laboratories Ltd\", u'MC3 Inc', u'SCOLR Pharma Inc', u'Terumo Corp']), u'Esophagealdisease': set([u'Cell Pathways Inc', u'Vizient Inc', u'Paladin Labs Inc', u'Ipsen', u'EMD Serono Inc', u'Abbott Laboratories', u'National Cancer Institute', u'Bayer Schering Pharma AG', u'Menarini Asia-Pacific', u'Sanofi Winthrop France SA', u'Novelion Therapeutics Inc', u'Medac GmbH', u'American Cyanamid Co', u'MSD Japan', u'OSI Pharmaceuticals Inc', u'Pharmacia Corp', u'Circa Scientific Llc', u'Stiefel', u'Health Care Logistics Inc', u'Cyanamid Benelux NV', u'Takeda Pharmaceutical Co Ltd', u'DUSA Pharmaceuticals Inc', u'Kitasato Institute', u'photonamic GmbH & Co KG']), u'Aphasia': set([u'Soterix Medical Inc', u'National Institute of Neurological Disorders and Stroke', u'FTLD Consortium', u'Axon Neuroscience SE']), u'Atrophy': set([u'Sanford-Burnham Medical Research Institute', u'Bayer AG', u'Bayer Schering Pharma AG', u'Endorecherche Inc', u'Shionogi & Co Ltd', u'Johns Hopkins University', u'Endoceutics Inc', u'QUATRx Pharmaceuticals Co', u'Royalty Pharma', u'California Institute of Regenerative Medicine', u'National Aeronautics & Space Administration', u'Regenerative Patch Technologies, LLC', u'Ligand Pharmaceuticals Inc']), u'Paroxysmalventriculartachycardia': set([u'Cato BioVentures', u'DSM Pharmaceuticals Inc', u'Cordex Pharma Inc']), u'Sneezing': set([u'Moberg Pharma AB', u'Prestige Brands Holdings Inc']), u'Combinedimmunodeficiency': set([u'Fondazione Telethon', u'Genethon', u'Assistance Publique Hopitaux de Paris', u'ViroMed Co Ltd', u'National Institute of Allergy and Infectious Diseases', u'Istituto Scientifico H San Raffaele', u'INSERM', u'Discovery Genomics Inc', u'Institut Pasteur', u'GlaxoSmithKline plc']), u'Giantcellbonetumor': set([u'Feiyang Biotech (Jilin) Co Ltd', u'Amgen Inc', u'Suzhou Alphamab Co Ltd', u'GlaxoSmithKline plc']), u'Amenorrhea': set([u'Wyeth', u'Actavis Inc', u'Aspen PharmaCare Holdings Ltd', u'Barr Pharmaceuticals Inc', u'Juniper Pharmaceuticals Inc', u'ANI Pharmaceuticals Inc']), u'Spinalandbulbarmuscularatrophy': set([u\"Kennedy's Disease Association\", u'Allianz Pharmascience Ltd', u'Armgo Pharma Inc', u'National Institute of Neurological Disorders and Stroke', u'AndroScience Corp']), u'Visiondisorder': set([u'Johnson & Johnson Vision Products Inc', u'National Institutes of Health', u'Sankara Nethralaya', u'Food and Drug Administration', u'Scripps Research Institute', u'University of Waterloo', u'International Stem Cell Corp', u'AGTC', u'Regulus Therapeutics Inc', u'University of California San Diego']), u'Peripheralvasculardisease': set([u'CPC Clinical Research', u'Telios Pharmaceuticals Inc', u'Mallinckrodt Group Inc', u'Abdi Ibrahim Ilac Sanayi Ve Ticaret Anonim Sirketi', u'Quest Diagnostics Inc', u'GenVec Inc', u'BIOTRONIK SE & Co', u'Unigene Laboratories Inc', u'Il Dong Pharmaceutical Co Ltd', u'Inovio Pharmaceuticals Inc', u'Centelion SAS', u'CHA Bio & Diostech Co Ltd', u'Bayer Schering Pharma AG', u'Vical Inc', u'Chiron Corp', u'University of Queensland', u'Taxus Cardium Pharmaceuticals Group', u'Rexgenero Ltd', u'Aventis Pharma AG', u'Vasogen Inc', u'Advanced Catheter Therapies', u'AngioStem Inc', u'Sangamo Therapeutics Inc', u'LTT Bio-Pharma Co Ltd', u'Servicio Andaluz De Salud', u'Ono Pharmaceutical Co Ltd', u'Nissan Chemical Industries Ltd', u'Mitsubishi Tanabe Pharma Corp', u'Mitsubishi Pharma Corp', u'TheraVasc Inc', u'Procter & Gamble Pharmaceuticals Inc', u'Sankyo Co Ltd', u'Toray Industries Inc', u'Medirista Biotechnologies AB', u'Highmark Inc', u'National Heart Lung and Blood Institute', u'Duke Clinical Research Institute', u'Profusa Inc', u'Charite Universitaetsmedizin Berlin', u'Louisiana State University Medical Center Foundation', u'Amerinet Inc', u'Shanghai Sunway Biotech Co Ltd', u'Benxi Leilong Pharmaceutical Co Ltd', u'Aralez Pharmaceuticals Inc', u'Israeli Government', u'Angel Biotechnology Holdings plc', u'AADi LLC', u'Virtual Drug Development Inc', u'Maryland Industrial Partnerships', u'Daiichi Sankyo Co Ltd', u'Abbott Laboratories', u'Regenerative Medicine Institute of Tijuana', u'FUJIFILM RI Pharma Co', u'Johns Hopkins University School of Medicine', u'University of Bristol', u'ArtGen Inc', u'Vanderbilt University', u'Transgene SA', u'UCB Pharma GmbH', u'Corridor Pharmaceuticals Inc', u'Hemostemix Asia Inc', u'Genentech Inc', u'AnGes MG Inc', u'Biosense Webster', u'Maquet Medical Systems USA', u'Schering AG', u'AngioSoma Inc', u'Vermillion Inc', u'Pluristem Therapeutics Inc', u'F H Faulding & Co Ltd', u'Fundacion Publica Andaluza Progreso y Salud', u'Vizient Inc', u'Human Stem Cells Institute', u'Connetics Corp', u'Paladin Labs Inc', u'Otsuka Pharmaceutical Co Ltd', u'NOF Corp', u'La Jolla Capital Partners LLC', u'US Department of Veterans Affairs', u'Ark Therapeutics Group plc', u'Seikagaku Corp', u'7TM Pharma A/S', u'Merck & Co Inc', u'Edwards Lifesciences Corp', u'Sanofi', u'Medtronic plc', u'Bayer AG', u'Laboratoire L Lafon SA', u'Getinge AB', u'University of Virginia', u'United Therapeutics Corp', u'NicOx SA', u'Western Michigan University', u'Nuvelo Inc', u'ReNeuron Group plc', u'AstraZeneca plc', u'Pfizer Inc', u'Corthera Inc', u'Kaken Pharmaceutical Co Ltd', u'QT Vascular Ltd', u'Human Genome Sciences Inc', u'Boehringer Ingelheim Corp', u'EPIX Pharmaceuticals Inc', u'Nuo Therapeutics Inc', u'NHS Blood & Transplant', u'UK Government', u'Sanofi Biosurgery', u'University of Pennsylvania', u'Novation', u'US Stem Cell Inc', u'Institute of Materia Medica Chinese Academy of Medical Sciences & Peking Union Medical College', u'Taisho Pharmaceutical Co Ltd', u'Arena Pharmaceuticals Inc', u'UCB Celltech', u'Sihuan Pharmaceutical Holdings Group Ltd', u'Asahi Glass Co Ltd', u'Endovasc Inc', u'Bristol-Myers Squibb Co', u'Scios Inc', u'NEBU-TEC', u'Sanofi Genzyme', u'Pharmacia Corp', u'Fujifilm Diosynth Biotechnologies', u'Celgene Corp', u'Athera Biotechnologies AB', u'Tarix Pharmaceuticals LLC', u'Avinger Inc', u'Indigo Pharmaceuticals Inc', u'Lantheus Medical Imaging Inc', u'Hemostemix Inc', u'University of Kuopio', u'GD Searle & Co']), u'Advancedsolidtumor': set([u'UC San Diego Moores Cancer Center', u'National Cancer Center,singapore', u'Ignyta Inc', u'Apexigen Inc', u'Open Monoclonal Technologies Inc', u'Cancer Research UK', u'MD Anderson Cancer Center', u'Guangzhou Shunjian Biomedical Technology Co Ltd', u'Shanghai Serum Bio-Technology Co Ltd', u'Cancer Genetics Inc', u'Eisai Co Ltd', u'Apogee Biotechnology Corp', u'Wilex AG', u'Yisheng Biopharma Co Ltd', u'Applied BioMath LLC', u'LifeArc', u'National Cancer Institute', u'Kotobuki Pharmaceutical Co Ltd', u'Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd', u'Shanghai Institute of Materia Medica of the Chinese Academy of Sciences', u'Shanghai Acebright Pharmaceuticals Group Co Ltd', u'Green Cross Corp', u'Institute of Biotechnology the Academy of Military Medical Sciences PLA', u'Ablynx NV', u'Poniard Pharmaceuticals Inc', u'Bristol-Myers Squibb Co', u'Merck & Co Inc', u'Ventana Medical Systems Inc', u'Jounce Therapeutics Inc', u'Oncology Venture ApS', u'NuCana', u'Sanofi', u'Eli Lilly & Co', u'Mount Vernon Hospital', u'Veristat, Inc.', u'WuXi PharmaTech (Cayman) Inc', u'Predictive Therapeutics', u'Genelux Corp', u'Ono Pharmaceutical Co Ltd', u'Imperial College London', u'Astellas Pharma Inc', u'Theradex Systems Inc', u'Medical University of South Carolina', u'Alvogen Korea', u'Astrazeneca Korea', u'Alligator Bioscience AB', u'Kyowa Hakko Kirin Co Ltd', u'Gradalis Inc', u'Millennium Pharmaceuticals Ltd', u'Mologen Ag', u'TESARO Inc', u'ZIOPHARM Oncology Inc', u'AstraZeneca plc', u'BeiGene Co Ltd', u'Boehringer Ingelheim Corp', u'Loxo Oncology Inc', u'Xcovery Inc', u'Infinity Pharmaceuticals Inc', u'Korea Drug Development Fund', u'Scripps Research Institute', u'DRI Capital', u'ImmunoGen Inc', u'Experimental Cancer Medicine Centre Network', u'Mount Sinai Medical Center']), u'Interstitialcystitis': set([u'Lipella Pharmaceuticals Inc', u'Urigen Pharmaceuticals Inc', u'Galen Ltd', u'Tribute Pharmaceuticals Canada Inc', u'National Institute of Diabetes, Digestive and Kidney Diseases', u'Celek Pharmaceuticals LLC', u'National Institutes of Health', u'Sinclair Pharma plc', u'University of Maryland', u'XOMA Corp', u'BMG Pharma LLC', u'Acologix Inc', u'Jeilmedix Pharmaceutical Co', u'University of Pittsburgh', u'IS Pharma plc', u'TARIS Biomedical Inc', u'Ferring Research Ltd', u'Trillium Therapeutics', u'Allergan Inc', u'Laboratorios Inibsa SA', u'Imprimis Pharmaceuticals Inc', u'Plethora Solutions Holdings plc', u'Yale University']), u'Dentalcaries': set([u'National Institute of Dental and Craniofacial Research', u'Agile Sciences Inc', u'Large Scale Biology Corp', u'National Institutes of Health', u'C3J Therapeutics Inc', u'Planet Biotechnology Inc', u'University of Alabama at Birmingham']), u'Aggression': set([u'PsychoGenics Inc', u'UCB Pharma SA', u'Solvay SA', u'ReqMed Co Ltd', u'Lundbeck Canada Inc']), u'Pleuraldisease': set([u'The University of Texas Health Science Center Tyler', u'National Institutes of Health', u'National Heart Lung and Blood Institute', u'Cumberland Emerging Technologies Inc', u'Vanderbilt University', u'Cumberland Pharmaceuticals Inc']), u'Dermatomyositis': set([u'University of Pennsylvania', u'Zenyaku Kogyo Co Ltd', u'National Institute of Arthritis and Musculoskeletal and Skin Diseases', u'Corbus Pharmaceuticals Holdings Inc', u'BioSense Global LLC', u'Genentech Inc', u'Roche Holding AG', u'XOMA Corp', u'Neovacs SA', u'IDEC Pharmaceuticals Corp', u'Chong Kun Dang Pharmaceutical Corp']), u'Metabol': set([u'Harbor Therapeutics Inc', u'China State Institute of Pharmaceutical Industry']), u'Panicdisorder': set([u'National Institute of Neurological Disorders and Stroke', u'Mitsubishi Pharma Corp', u'Xian-Janssen Pharmaceutical Ltd', u'Abbott Laboratories', u'Mochida Pharmaceutical Co Ltd', u'Endo Pharmaceuticals Solutions Inc', u'Onxeo SA', u'Forest Laboratories Inc', u'GlaxoSmithKline plc', u'Quintiles Transnational Corp', u'IntelGenx Technologies Corp', u'Questcor Pharmaceuticals Inc', u'Teva Pharmaceutical Industries Ltd', u'Scripps Research Institute', u'Myungin Pharm Co Ltd', u'Therapade Technologies LLC', u'Eli Lilly & Co', u'Lohmann Therapie-Systeme GmbH & Co KG', u'FAES Farma SA', u'Mitsubishi Tanabe Pharma Corp', u'Fabre Kramer Pharmaceuticals Inc', u'Pfizer Inc', u'Eolas Therapeutics Inc', u'Recordati SpA', u'Tikvah Therapeutics Inc', u'H Lundbeck A/S']), u'Autoimmunedisease': set([u'Takeda Vaccines Inc', u'C4X Discovery Holdings plc', u'LeukoSight Inc', u'Altropus Gmbh', u'OSE Immunotherapeutics', u'Archemix Corp', u'European Commission', u'Oxagen Ltd', u'US Health and Human Services Department', u'Nostrum Pharmaceuticals Inc', u'Buck Institute', u'Telios Pharmaceuticals Inc', u'University of Maryland', u'Proximagen Group plc', u'EpiVax Inc', u'Seattle Genetics Inc', u'Ionis Pharmaceuticals Inc', u'Coherus BioSciences Inc', u'Igeneon GmbH', u'Takeda GmbH', u'Locus Pharmaceuticals Inc', u'University of Pittsburgh', u'Fidson Healthcare', u'Celldex Therapeutics Inc', u'GDI Integrated Facility Services Inc', u'Hospira Inc', u'SBI Biotech Co Ltd', u'DNX Biopharmaceuticals Inc', u'Mycosearch Inc', u'JHL Biotech', u'Hansa Medical AB', u'Orphagen Pharmaceuticals Inc', u'Aviragen Therapeutics Inc', u'Phenex Pharmaceuticals AG', u'PIKAMAB Inc', u'Daiichi Sankyo Europe GmbH', u'Handok Inc', u'mAbxience SA', u'Toray Industries Inc', u'Catalent Inc', u'HanAll Biopharma Co Ltd', u'Abgenix Inc', u'Agence nationale de la recherche (ANR)', u'Fate Therapeutics Inc', u'Alseres Pharmaceuticals Inc', u'Baxalta Inc', u'Zhejiang Huahai Pharmaceutical Group Co Ltd', u'National Research Council of Canada', u'23andMe Inc', u'Sigma-Tau Ind Farm Riunite SpA', u'Symphogen A/S', u'Polpharma Biologics', u'National Health and Medical Research Council', u'Israeli Government', u'Biomedica Life Sciences SA', u'MABLife', u'Cambridge Antibody Technology Group plc', u'Rega Institute for Medical Research', u'The European Union', u'Portola Pharmaceuticals Inc', u'Mochida Pharmaceutical Co Ltd', u'Protagen AG', u'Amplimmune Inc', u'University of Cambridge', u'Znomics Inc', u'Phillips University', u'Covella Pharmaceuticals Inc', u'MerLion Pharmaceuticals Pte Ltd', u'Hadasit Bio-Holdings Ltd', u'Cantab Biopharmaceuticals Ltd', u'Reset Therapeutics Inc', u'Hanmi Pharmaceutical Co Ltd', u'Agennix AG', u'Merrimack Pharmaceuticals Inc', u'Ionix Pharmaceuticals Ltd', u'Ogeda SA', u'Gardant Pharmaceuticals Inc', u'National Jewish Health', u'University of Adelaide', u'Tolerx Inc', u'RuiYi Inc', u'RaQualia Pharma Inc', u'Cytokine PharmaSciences Inc', u'ImmunoGen Inc', u'Nano Terra Inc', u'Celera Group', u'Probiodrug AG', u'ImmuNext Inc', u'Ohio University', u'Diamyd Medical AB', u'Principia Biopharma Inc', u'Recalcine Pharmaceutical Corp', u'Swedish Orphan Biovitrum AB', u'F H Faulding & Co Ltd', u'Atox Bio Inc', u'University of Queensland', u'Questcor Pharmaceuticals Inc', u'Lung Biotechnology Inc', u'BaroFold Inc', u'CRELUX GmbH', u'Alexion Pharmaceuticals Inc', u'Momenta Pharmaceuticals Inc', u'arGEN-X NV', u'Deciphera Pharmaceuticals LLC', u'Pharmacia & Upjohn Co', u'WuXi Biologics', u'Sevion Therapeutics Inc', u'Biond Biologics Ltd', u'La Jolla Institute of Allergy & Immunology', u'Hospital for Special Surgery NY', u'Abpro Inc', u'Oregon Health Sciences University', u'Emergent BioSolutions Inc', u'Telormedix SA', u'Burroughs Wellcome International Ltd', u'AmorChem LP', u'Cellatope', u'Eli Lilly & Co', u'Isotechnika Pharma Inc', u'University of Wisconsin-Madison', u'CSL Ltd', u'VU University Medical Center', u'Sofie Biosciences', u'AbbVie Inc', u'BD Technologies', u'Alder Biopharmaceuticals Inc', u'Novopharm Biotech (USA)', u'University of Maryland College Park', u'Trillium Therapeutics', u'NextCell Pharma AB', u'Argenta Discovery Ltd', u'Mount Tam Biotechnologies', u'Sunesis Pharmaceuticals Inc', u'Immunic AG', u'Rhizen Pharmaceuticals SA', u'Scienion AG', u'Universitat Autonoma de Barcelona', u'Codon Devices', u'Innovative Targeting Solutions Inc', u'Immutep SA', u'ProdiGene Inc', u'Pharmion Corp', u'Genexine Co Ltd', u'Science Foundation Ireland', u'Baylor Scott & White Research Institute', u'Harbor Therapeutics Inc', u'Johnson & Johnson', u'Coley Pharmaceutical Group Inc', u'Oxford University Innovation', u'Innate Pharma SA', u'Creabilis Therapeutics Srl', u'Changchun Huapu Biotechnology Co Ltd', u'Magenta Therapeutics Inc', u'Serum Institute of India Ltd', u'Poseidon Pharmaceuticals A/S', u'BELLUS Health Inc', u'SmithKline Beecham plc', u'Samsung Bioepis', u'UCB Celltech', u'Northwestern University', u'Sigma-Aldrich Corp', u'Actelion Ltd', u'Spherium Biomed', u'Biographics Laboratory', u'Servier', u'Taisho Pharmaceutical Co Ltd', u'GenQual Corp', u'Bristol-Myers Squibb Co', u'ChemOvation Ltd', u'OSEO', u'Evotec (UK) Ltd', u'Accentia BioPharmaceuticals Inc', u'Pontificia Universidad Catolica De Chile', u'Peptimmune Inc', u'VINNOVA', u'Astellas Pharma Inc', u'Advanced Biotherapy Inc', u'BioDelivery Sciences International Inc', u'Antisoma plc', u'Insmed Inc', u'Singapore Immunology Network', u'Coulter Pharmaceutical Inc', u'Lonza Group AG', u'Hebrew University of Jerusalem', u'Athersys Inc', u'Zander Therapeutics Inc', u'Hoechst Marion Roussel Inc', u'Gamida Cell Ltd', u'Hadassah University Hospital', u'University of Michigan', u'Veloxis Pharmaceuticals A/S', u'Beta Innov SAS', u'ImaginAb Inc', u'Padlock Therapeutics Inc', u'Karolinska Institutet', u'GenPat77 Pharmacogenetics AG', u'Novo Nordisk A/S', u'Cynvenio Biosystems LLC', u'CMIC Holdings Co Ltd', u'Ciblex Corp', u'University of Tokyo', u'IDEC Pharmaceuticals Corp', u'Adaptive Biotechnologies Corp', u'NauchTekhStroy Plus', u'Pharmacyclics Inc', u'BTG plc', u'Cardiome Pharma Corp', u'Lead Pharma Holding BV', u'University of Oregon', u'DiaKine Therapeutics Inc', u'Chiron Corp', u'Tolera Therapeutics Inc', u'Pulmagen Therapeutics', u'Neose Technologies Inc', u'Zhejiang Xianju Pharmaceutical Corp Ltd', u'Xenova Group plc', u'Selexis SA', u'Elan Corp plc', u'Congenica Ltd', u'ArQule Inc', u'Stanford University', u'Vernalis plc', u'Opsona Therapeutics Ltd', u'Lorantis Ltd', u'Lead Discovery Center GmbH', u'Ono Pharmaceutical Co Ltd', u'Garvan Institute of Medical Research', u'Roche Holding AG', u'Shire plc', u'Owlstone Medical Ltd', u'MorphoSys AG', u'Mitsubishi Tanabe Pharma Corp', u'Battelle', u'Vaccinex Inc', u'ANI Pharmaceuticals Inc', u'Selvita SA', u'KAHR Medical Ltd', u'Biocon Ltd', u'Inventiva', u'Agios Pharmaceuticals Inc', u'TG Therapeutics Inc', u'Atreca Inc', u'Biotica Technology Ltd', u'Teijin Pharma Ltd', u'Dana-Farber Cancer Institute Inc', u'Charite Universitaetsmedizin Berlin', u'University of Massachusetts Medical School', u'Sorrento Therapeutics Inc', u'National Institute of General Medical Sciences', u'Evotec AG', u'Trubion Pharmaceuticals Inc', u'Exelixis Inc', u'AutoImmune Inc', u'XOMA Corp', u'Amgen Inc', u'Axela Inc', u'Affibody AB', u'University of California Discovery Fund', u'Consejo Superior De Investigaciones Cientificas', u'LFB SA', u'Airmid Inc', u'Akari Therapeutics Plc', u'University of Kiel', u'University of Bristol', u'Gemini Genomics plc', u'Palau Pharma SA', u'CGI Pharmaceuticals Inc', u'MabVax Therapeutics Holdings Inc', u'Tsinghua University', u'Upjohn Pharmaceuticals Ltd', u'Dartmouth Medical School', u'Massachusetts General Hospital', u'Aurum Ventures MKI', u'Novotectid GmbH', u'Supragen', u'Omeros Corp', u'GenPharm International Inc', u'Yeda Research and Development Co Ltd', u'Orca Pharmaceuticals', u'TBG Diagnostics Ltd', u'Immunomedics Inc', u'Can-Fite BioPharma Ltd', u'Alturas Analytics Inc', u'Primatope Therapeutics', u'Western States Biopharmaceuticals Inc', u'Allergan Inc', u'TeneoBio Inc', u'Actinobac Biomed Inc', u'National Institute of Biomedical Innovation', u'Xencor Inc', u'University of California San Diego', u\"The Children's Hospital at Westmead\", u'NantWorks LLC', u'Wakunaga Pharmaceutical Co Ltd', u'F Hoffmann-La Roche AG', u'University of Oxford', u'Rockefeller University', u'Viron Therapeutics Inc', u'Medidata Solutions Worldwide', u'Domantis Ltd', u'Topas Therapeutics GmbH', u'Genentech Inc', u'The Macfarlane Burnet Institute For Medical Research & Public Health Ltd', u\"Tianjin Municipal People's Government\", u'Eurogentec SA', u'Paladin Labs Inc', u'Agilent Technologies Inc', u'Korea Drug Development Fund', u'Rigel Pharmaceuticals Inc', u'Baylor Research Institute', u'China Biopharma Inc', u'New Jersey Economic Development Authority', u'Oklahoma Medical Research Foundation', u'Ramaciotti Foundation', u'CHU Sainte Justine', u'LifeArc', u'Hi-Tech Pharmacal Co Inc', u'Uman Pharma', u'Nautilus Biotech SA', u'SFJ Pharmaceuticals Inc', u'PDL BioPharma Inc', u'ATGen Co Ltd', u'Henry M Jackson Foundation for the Advancement of Military Medicine', u'Atara Biotherapeutics Inc', u'Avila Therapeutics Inc', u'Crystal Bioscience Inc', u'SuppreMol GmbH', u'Stada Arzneimittel AG', u'BTB Pharma', u'BioFocus DPI', u'Research Corporation Technologies', u'Dompe Farmaceutici SpA', u'Blansett Pharmacal Co Inc', u'Symmetrix Pharmaceuticals LLC', u'Numab AG', u'Immunovia AB', u'Medinox Inc', u'Pierre Fabre SA', u'Genzyme General', u'VLST Corp', u'Caprion Pharmaceuticals Inc', u'Seres Therapeutics Inc', u'R-Pharm', u'University of Iowa', u'Lycera Corp', u'Galapagos Genomics BV', u'Emulate Inc', u'AstraZeneca plc', u'Corthera Inc', u'Knoll AG', u'X-BODY BioSciences', u'ChemomAb Ltd', u'University of Utah', u'Glasgow Caledonian University', u'ZAI Laboratory Inc', u'Janssen-Cilag Ltd', u'XL-Protein GmbH', u'Zynaxis Inc', u'Australian Government', u'Corixa Corp', u'CSL Behring LLC', u'Progentec Diagnostics Inc', u'Genmab A/S', u'Globe Laboratories Inc', u'Japan Tobacco Inc', u'Immunotech Developments Inc', u'Knoll Pharmaceuticals Ltd', u'Ligand Pharmaceuticals Inc', u'MacroGenics Inc', u'Linkoping University', u'New Jersey Health Foundation Inc', u'Sareum Holdings plc', u'Proteomika SL', u'Heat Biologics Inc', u'Pepgen Corp', u'Kirin Pharma Co Ltd', u'ICOS Corp', u'Fujifilm Diosynth Biotechnologies', u'Theranyx', u'The Australian National University', u'VG Life Sciences Inc', u'Critical Therapeutics Inc', u'GMP Companies Inc', u'Bristol-Myers Squibb Pharma Co', u'Medical University of South Carolina', u'Hospira Adelaide Pty Ltd', u'Kennedy Institute of Rheumatology', u'Karyopharm Therapeutics Inc', u'Institute of Microbial Technology', u'Mithra Pharmaceuticals', u'Selecta Biosciences Inc', u'Ohio State University Comprehensive Cancer Center', u'Therakos Inc', u'Indiana University', u'Dyax Corp', u'Antitope Ltd', u'Interthyr Corp', u'Xenome Ltd', u'KBP Biosciences Co Ltd', u'Genesis Research and Development Corp Ltd', u'CuraGen Corp', u'German Federal Ministry of Education and Research', u'AgResearch Ltd', u'MENTRIK Biotech LLC', u'Pharmagenesis Inc', u'Phytomedics Inc', u'Sociedade Beneficente Israelita Brasileira Hospital Albert Einsten', u'Kirin Brewery Co Ltd', u'Agennix USA Inc', u'4d pharma plc', u'Neovacs SA', u'EMD Serono Inc', u\"Brigham & Women's Hospital\", u'Kadmon Pharmaceuticals LLC', u'Industrial Technology Research Institute', u'Lynx Therapeutics GmbH', u'Maxygen Inc', u'Forest Laboratories Inc', u'Tanabe Research Labs USA Inc', u'ProtAb Ltd', u'Kissei Pharmaceutical Co Ltd', u'Vical Inc', u'Oncobiologics Inc', u'jinan tianhe stem cell biotechnology ltd', u'Hunter-Fleming Ltd', u'MGI Pharma Inc', u'Schepens Eye Research Institute', u'Uppsala University', u'Aventis Pharma AG', u'MedImmune LLC', u'University of Washington', u'Molecumetics Ltd', u'Cortech Inc', u'Tyrian Diagnostics Ltd', u'ARIAD Pharmaceuticals Inc', u'IMTM GmbH', u'Atrium Medical Corp', u'Ludwig Institute for Cancer Research', u'New Zealand Foundation for Research, Science and Technology', u'Cytori Therapeutics Inc', u'Dynavax Technologies Corp', u'Relief Therapeutics Holding AG', u'EPIRUS Biopharmaceuticals Inc', u'Fundacao para o Remedio Popular', u'Innate Immunotherapeutics Ltd', u'Defense Advanced Research Projects Agency', u'Pfizer Inc', u'Signal Research Division', u'Kiadis Pharma Netherlands BV', u'Parilis Biopharmaceuticals', u'TxCell SA', u'Mitsubishi Pharma Corp', u'Vifor Pharma', u'Active Biotech AB', u'Elan Pharmaceuticals Inc', u'Walvax Biotechnology Co Ltd', u'Mylan Inc', u'Chelsea Therapeutics International Ltd', u'Affitech A/S', u'Harvard University', u'Hubei Qianjiang Pharmaceutical Co Ltd', u'Third Venture Biopharma', u'ZymoGenetics Inc', u'ActoGeniX NV', u'Pharmexa A/S', u'Ludwig Institute for Cancer Research (Australia)', u'Hadassah Medical Organization', u'Teva Pharmaceutical Industries Ltd', u'Valeo Pharma Inc', u'Zeneca Group plc', u'Biogen Idec Hemophilia Inc', u'Bionomics Ltd', u'University of California San Francisco', u'Boehringer Ingelheim International GmbH', u'Glaxo Group Research Ltd', u'WuXi PharmaTech (Cayman) Inc', u'University of Wurzburg', u'Biotech Pharmaceutical Co Ltd', u'Ferring Pharmaceuticals SA', u'Millennium Pharmaceuticals Ltd', u'Glaxo Group Ltd', u'CFR Pharmaceuticals SA', u'Centre Hospitalier Regional Universitaire de Lille', u'Laboratorios Ramos', u'Boehringer Ingelheim Corp', u'Hoffmann-La Roche Inc', u'Universit\\xe4tsklinikum Hamburg-Eppendorf', u'Medigene Immunotherapies GmbH', u'Juno Therapeutics Inc', u'Beta Therapeutics Pty Ltd', u'Neopharm Ltd', u'University of Sydney', u'Debiopharm SA', u'ILEX Oncology Inc', u'University of Lund', u'Duke University Medical Center', u'Interferon Sciences Inc', u'Wyeth Pharmaceuticals', u'Aspen PharmaCare Holdings Ltd', u'Connetics Corp', u'Tetragenetics Inc', u'Laboratorios Liomont Sa De Cv', u'Harvard Medical School', u'Iluten', u'Cangene Corp', u'Athelos Corp', u'University of Barcelona', u'PCT, a Caladrius company', u'CMC Biologics Inc', u'Baxter Healthcare Corp', u'Keimyung University', u'Shanghai Institute of Materia Medica of the Chinese Academy of Sciences', u'Westmead Millennium Institute for Medical Research', u'Alteogen Inc', u'Shanghai Celgen Biopharmaceuticals', u'Argos Therapeutics Inc', u'Wellstat ImmunoTherapeutics LLC', u'Provid Pharmaceuticals Inc', u'University of California', u'Merck & Co Inc', u'ChemoCentryx Inc', u'rEVO Biologics Inc', u'IMAB China', u'ForHumanTech Co Ltd', u'University of Patras', u'Tanabe Seiyaku Co Ltd', u'CORD:USE Cord Blood Bank', u'University of Oslo', u'Enlivex Therapeutics Ltd', u'Be The Match BioTherapies', u'FUJIFILM Holdings Corp', u'CBio Ltd', u'Princeton University', u'Regen BioPharma Inc', u'Merus BV', u'Nektar Therapeutics', u'SRI International', u'Almirall Prodesfarma SA', u'Therapure Biopharma Inc', u'Kyto Biopharma Inc', u'Intarcia Therapeutics Inc', u'Caladrius Biosciences Inc', u'HUYA Bioscience International LLC', u'Kineta Inc', u'Arrien Pharmaceuticals LLC', u'Institute for the Promotion of Innovation by Science and Technology in Flanders', u'4SC AG', u'Antares Pharma Inc', u'Bachem Holding AG', u'Tularik Inc', u'Massachusetts Institute of Technology', u'Intrexon Corp', u'INSERM U976', u'Emory University Technology Transfer Office', u'Nichi-Iko Pharmaceutical Co Ltd', u'Vedanta Biosciences Inc', u'Clal Biotechnology Industries Ltd', u'Allied Minds', u'Abzena plc', u'PowderJect Pharmaceuticals plc', u'DCAM Pharma Inc', u'Aurigene Discovery Technologies Ltd', u'Roche Products Ltd', u'Zymeworks Inc', u'AnaptysBio Inc', u'Ablynx NV', u'RxMD Inc', u'Chinese Government', u'INSERM', u'Kuros Biosciences Ltd', u'Sanofi Genzyme', u'Beryllium Discovery Corp', u'Kalypsys Inc', u'Celgene Corp', u'Array BioPharma Inc', u'Therapix Biosciences Ltd', u'Max Delbruck Centrum Fur Molekulare Medizin', u'Repugen', u'Duke University', u'Avanir Pharmaceuticals Inc', u'Wellcome Trust Sanger Institute', u'Pinteon Therapeutics', u'Pharma Pacific Pty Ltd', u'Queensland Institute of Medical Research', u'Janssen Pharmaceuticals Inc', u'RNL Bio Co Ltd', u'Flexion Therapeutics Inc', u'MPI Research', u'AbGenomics International Inc', u'Medistem Inc', u'American Red Cross', u'Beth Israel Deaconess Medical Center', u'Io Therapeutics Inc', u'Pfizer Vaccines', u'Tiziana Life Sciences PLC', u'University of Western Ontario', u'LeukoSite Inc', u'US Government', u'The Leukemia & Lymphoma Society', u'Aratana Therapeutics Inc', u'MSD OSS BV', u'Activiomics Ltd', u'Nodality Inc', u'InterMune Inc', u'Netherlands Government', u'China State Institute of Pharmaceutical Industry', u'HTG Molecular Diagnostics Inc', u'Biogen Inc', u'4SC Discovery GmbH', u'GlaxoSmithKline plc', u'QIMR Berghofer Medical Research Institute', u'Bayer Schering Pharma AG', u'Cascadian Therapeutics Inc', u'National Pharmaceuticals Corp', u'Immunex Corp', u'Massachusetts Life Sciences Center', u'Dynamix Pharmaceuticals Ltd', u'Nodthera Ltd', u'Novimmune SA', u'INSERM Transfert', u'Formula Pharmaceuticals Inc', u'Fibrocell Science Inc', u'Takeda Oncology', u'Aduro BioTech Inc', u'Innovative Genomics Initiative', u'Kolon Life Science Inc', u'Resolve Therapeutics LLC', u'Janus Biotherapeutics Inc', u'PanGenetics BV', u'ECI Inc', u'Reata Pharmaceuticals Inc', u'Foundation for Biomedical Research and Innovation', u'Theradiag', u'Quintiles Ltd', u'University of Florida', u'Biomedical Primate Research Centre', u\"Boston Children's Hospital\", u'UCB SA', u'Cristalia', u'Philogen SpA', u'Ontogen Corp', u'Johnson & Johnson Pharmaceutical Research & Development LLC', u'Beckman Coulter Inc', u'Evolutec Group plc', u'Lansen Pharmaceutical Holdings Limited', u'Interprotein Corp', u'Medarex Inc', u'Catalyst Biosciences Inc', u'Daiichi Sankyo Co Ltd', u'Abbott Laboratories', u'UniQuest Pty Ltd', u'Eisai Co Ltd', u'Aspreva International Ltd', u'Sten K Johnson\\u2019s Foundation', u'Tanox Inc', u'Kansas Bioscience Authority', u'National Cancer Institute', u'LipoCure', u'Anthera Pharmaceuticals Inc', u'REGiMMUNE Corp', u'RST Biomedikal Sanayi AS', u'Fujisawa Pharmaceutical Co Ltd', u'Keryx Biopharmaceuticals Inc', u'Simcere Pharmaceutical Group', u'Panorama Research Inc', u'Krish Biotech Research Pvt Ltd', u'Tianjin Hemay Bio-Tech Co Ltd', u'University of Minnesota', u'Novartis Pharma AG', u'Monash University', u'CHU De Nantes', u'Cadus Corp', u'TechnoPhage SA', u'NeuClone Pty Ltd', u'Piramal Enterprises Ltd', u'Trinity College Dublin', u'Complix NV', u'Immune Response BioPharma Inc', u'University of Colorado System', u'MediGene Ltd', u'CSL Behring Recombinant Facility AG', u'Ethypharm SA', u'Effimune SA', u'Johns Hopkins University', u'The Center of Molecular Immunology', u'Smart Assays', u'Kyowa Hakko Kogyo Co Ltd', u'RecipharmCobra Biologics', u'Umea University', u'Compugen Ltd', u'Pluristem Therapeutics Inc', u'Bird Rock Bio Inc', u'Pepscan Systems BV', u'Wacker Biotech GmbH', u'Pharming Group NV', u'Saitama Medical University', u'Chugai Pharmaceutical Co Ltd', u'Undisclosed', u'Integrity Biosolution Llc', u'Acyte Biotec Pty Ltd', u'Hayashibara Biochemical Laboratories Inc', u'Meiji Seika Pharma Co Ltd', u'Clinquest Group', u'Taiba Pharma LLC', u'Universiteit Utrecht', u'Southern Research Institute', u'Ultrafine Chemicals Ltd', u'TenX Biopharma Inc', u'GRI Bio Inc', u'Diabetogen BioSciences Inc', u'Medivir AB', u'Seegene Inc', u'Virobay Inc', u'Selventa', u'MD Anderson Cancer Center', u'University of Technology Sydney', u'TcLand SA', u'Anergix LLC', u'Radboud University', u'Albany Molecular Research Inc', u'Phylogica Ltd', u'Cellmid Ltd', u'Maruho Co Ltd', u'Recoly NV', u'University of Virginia', u'Kyowa Hakko Kirin Co Ltd', u'Immune Therapeutics Inc', u'Gliknik Inc', u'BioRap Technologies Ltd', u'Scholar Rock Inc', u'BD Biosciences', u'Korean Ministry of Knowledge Economy', u'University of Bradford', u'Janssen Biotech Inc', u'Anokion SA', u'Center for Blood Research Inc', u'AHAR Pharma', u'Esteve', u'Sanofi', u'Midatech Pharma PLC', u'University of Leicester', u'Idera Pharmaceuticals Inc', u'Human Genome Sciences Inc', u'Vertex Pharmaceuticals Inc', u'Elevant BioPharma', u'Yissum Research Development Co', u'ABLS II LLC', u'EPIX Pharmaceuticals Inc', u'University of Gothenburg', u'Virdante Pharmaceuticals Inc', u'University of California at Berkeley', u'National Institute of Allergy and Infectious Diseases', u'Quantum Pharmaceuticals LLC', u'Takeda Pharmaceutical Co Ltd', u'ILTOO Pharma', u'Checkpoint Immunology Inc', u'Vernalis Research Ltd', u'GeneGo Inc', u'Albumedix A/S', u'National Institutes of Health', u'Helmedix Pty Ltd', u'Axxiom Inc', u'Sanford-Burnham Medical Research Institute', u'Broteio Pharma BV', u'Verenium Corp', u'Asahi Kasei Pharma Corp', u'AYUMI Pharmaceutical Corp', u'Taligen Therapeutics Inc', u'Onyx Pharmaceuticals Inc', u'ChemDiv Inc', u'Brickell Biotech Inc', u'3-Dimensional Pharmaceuticals Inc', u'Inflammatorx Inc', u'Qiagen NV', u'Yale University', u'Origen Therapeutics', u'Humanigen Inc', u'Merck Serono SA', u'3SBio Inc', u'University of California Irvine', u'Mabtech Holdings Limited', u'Pharmos Corp', u'Cytopia Ltd', u'Novartis AG', u'Cypress Bioscience Inc', u'Cardion AG', u'Paligent Inc', u'MacroChem Corp', u'KT&G Life Sciences Corp', u'BioCryst Pharmaceuticals Inc']), u'Campylobacterjejuniinfection': set([u'ACE BioSciences A/S', u'Nordic Vaccine A/S', u'US Naval Medical Research Center']), u'Foodhypersensitivity': set([u'Leiden University Medical Center', u'Helixir Co Ltd', u'Allergy Therapeutics plc', u'Jaffe Food Allergy Institute', u'Nestle Health Science', u'DBV Technologies SA', u'Astellas Pharma Inc', u'National Institutes of Health', u'SBI Biotech Co Ltd', u'Aimmune Therapeutics Inc', u'Consortium of Food Allergy Research', u'Immune Design Corp', u'Stanford University School of Medicine', u'Second Genome Inc', u'Immunomic Therapeutics Inc', u'Vedanta Biosciences Inc', u'Sanofi', u'Saiba GmbH', u\"King's College London\"]), u'WestNilevirusinfectio': set([u'Roche Holding AG', u'Interferon Sciences Inc', u'Hemispherx Biopharma Inc']), u'Esophagitis': set([u'GE Healthcare', u'Il-Yang Pharmaceutical Co', u'Santarus Inc', u'AstraZeneca plc', u'Merck KGaA', u'Takeda GmbH', u'Boehringer Ingelheim Corp', u'TWi Pharmaceuticals Inc', u'Mitsubishi Pharma Corp', u'Takeda Pharmaceutical Co Ltd', u'Pfizer Inc', u'Daewoong Pharmaceutical Co Ltd', u'Merck & Co Inc', u'Otsuka America Pharmaceutical Inc', u'Daiichi Sankyo Co Ltd', u'Norgine BV', u'Sanofi', u'Sigma-Tau Ind Farm Riunite SpA']), u'Vascularinjury': set([u'Northwestern University', u'Pfizer Inc', u'Pervasis Therapeutics Inc', u'National Heart Lung and Blood Institute', u'United States Army Institute of Surgical Research', u'National Institute of Allergy and Infectious Diseases', u'US Government', u'Compass Biomedical', u'HemoShear Therapeutics LLC', u'Feinstein Institute for Medical Research']), u'Small-celllungcancer': set([u'Ignyta Inc', u'Royal DSM NV', u'Sarah Cannon Research Institute', u'Arana Therapeutics Ltd', u'Recepta biopharma', u'Oryzon Genomics SA', u'GlaxoSmithKline plc', u'MabVax Therapeutics Inc', u'Idun Pharmaceuticals Inc', u'Cancer Research UK', u'Seattle Genetics Inc', u'Ipsen', u'Stanford University', u'Vernalis plc', u'Eleison Pharmaceuticals Inc', u'Dutch-Belgian Cooperative Trial Group for Hematology Oncology', u'Olon SpA', u'Roche Holding AG', u'University of British Columbia', u'Specialised Therapeutics Australia Pty Ltd', u'Ludwig Institute for Cancer Research', u'University of Kentucky', u'W C Heraeus GmbH & Co KG', u'NantCell Inc', u'Dana-Farber Cancer Institute Inc', u'National Research Council of Canada', u'Inex Pharmaceuticals Corp', u'Aronex Pharmaceuticals Inc', u'MD Anderson Cancer Center', u'Woomera Therapeutics Inc', u'Lindis Biotech', u'Baxter Oncology GmbH', u'Nippon Kayaku Co Ltd', u'Tallikut Pharmaceuticals Inc', u'3SBio Inc', u'National Cancer Institute', u'Novartis AG', u'Merck KGaA', u'ZIOPHARM Oncology Inc', u'Pulsalys Inc', u'Poniard Pharmaceuticals Inc', u'MabVax Therapeutics Holdings Inc', u'NuMedii Inc', u'Predictive Therapeutics', u'MediBIC', u'Immunomedics Inc', u'Threshold Pharmaceuticals Inc', u'Taiho Pharmaceutical Co Ltd', u'ImmunoGen Inc', u'Trilex Pharmaceuticals Inc', u'Millennium Pharmaceuticals Ltd', u'McGill University', u'CytRx Corp', u'Boehringer Ingelheim Corp', u'TRION Pharma GmbH', u'Talon Therapeutics Inc', u'Chugai Pharmaceutical Co Ltd', u'Atani KK', u'Genentech Inc', u'Stemcentrx Inc', u'Polaris Pharmaceuticals Inc', u'Callisto Pharmaceuticals Inc', u'Undisclosed', u'Sumitomo Dainippon Pharma Co Ltd', u'ImmunoCellular Therapeutics Ltd', u'4P Pharma', u'Mimetogen Pharmaceuticals Inc', u'Ascentage Pharma Group Corporation Ltd', u'Vertex Pharmaceuticals Inc', u'Supratek Pharma Inc', u'CRC For Biopharmaceutical Research Pty Ltd', u'PharmaMar SA', u'Imclone LLC', u'Kyowa Hakko Kirin Co Ltd', u'Dare Bioscience Inc', u'MolMed SpA', u'AEterna Zentaris Inc', u'The UK Imperial Cancer Research Fund', u'University of California Los Angeles', u'rEVO Biologics Inc', u'OSI Pharmaceuticals Inc', u'AstraZeneca plc', u'G1 Therapeutics Inc', u'Hefei Heyuan Pharmaceutical Co Ltd', u'Hyaluron Inc', u'Vion Pharmaceuticals Inc', u'Memorial Sloan-Kettering Cancer Center', u'NovoTek Pharmaceuticals Ltd', u'Introgen Therapeutics Inc', u'AnorMED Inc', u'AbbVie Inc', u'Abbott Laboratories', u'MEI Pharma Inc', u'Hainan Tianwang International Pharmaceutical', u'Peter MacCallum Cancer Centre', u'BioChem Therapeutic Inc', u'Institut Gustave Roussy', u'Northwestern University', u'Critical Outcome Technologies Inc', u'National Institutes of Health', u'AltheaDx Inc', u'Bristol-Myers Squibb Co', u'Elan Corp plc', u'INSERM', u'Spirogen Ltd', u'Fujifilm Diosynth Biotechnologies', u'Shandong Chengchuang Pharmaceutical R&D Co Ltd', u'Victorian Cancer Agency', u'Adria Laboratories Inc', u'Ascenta Therapeutics Inc', u'DDP Therapeutics Inc', u'Biologics Inc', u'Antitope Ltd', u'Lung Cancer Research Foundation']), u'Parkinsonsdiseasedementia': set([u'The Michael J. Fox Foundation', u'Asceneuron SA', u'Gismo Therapeutics Inc', u'Weston Brain Institute', u'The Parkinson Study Group', u'Wuhan Kangliyuan Medical Science and Technology Co Ltd', u\"St. Joseph's Health Care Foundation\", u'Qingdao University', u'Van Andel Institute', u'Chiltern International Inc.', u'BioTie Therapies Corp', u'Amarantus BioScience Holdings Inc']), u'Cystitis': set([u\"Dr Reddy's Laboratories Ltd\", u'Afferon Corp', u'Nippon Shinyaku Co Ltd', u'Takeda Pharmaceuticals International GmbH', u'UroCor Inc', u'Santa Farma', u'Laboratoire Thea', u'Atlantic Technology Ventures Inc', u'Technopharm', u'National Institute of Diabetes, Digestive and Kidney Diseases', u'Telesta Therapeutics Inc', u'United States Army Medical Research Institute of Chemical Defense', u'Endo Pharmaceuticals Solutions Inc', u'Zambon Italia Srl', u'Sanova Pharma GesmbH', u'GlaxoSmithKline plc', u'Eddingpharm Inc', u'LTL Pharma Co Ltd', u'Seikagaku Corp', u'University of Bristol', u'National Institutes of Health', u'Cytochemia Corp', u'IPC Nordic AS', u'ProMetic Life Sciences Inc', u'The University of Massachussetts', u'Laboratorios Rubio SA', u'Kyoto University', u'BioXell SpA', u'ICOS Corp', u'IS Pharma plc', u'Bayer AG', u'Concordia Pharmaceuticals Inc', u'Mundipharma EDO GmbH', u'Astellas Pharma Inc', u'Roche Holding AG', u'ALZA Corp', u'Taiho Pharmaceutical Co Ltd', u'Janssen Pharmaceuticals Inc', u'University of Sydney', u'Bioniche Teoranta', u'VOCATE Pharmaceuticals S.A', u'Arriva Pharmaceuticals Inc', u'Lipella Pharmaceuticals Inc', u'IVAX Corp', u'ReNeuron Group plc', u'Plethora Solutions Holdings plc', u'Baker Norton Pharmaceuticals Inc', u'Lilly China Research & Development Co Ltd', u'Toyama Chemical Co Ltd', u'PLIVA Pharma Ltd', u'Teligent Inc', u'University of Pittsburgh', u'Genmedix Ltd']), u'Hepaticinsufficiency': set([u'Celerion', u'Merck & Co Inc']), u'Psychoticdisorder': set([u'Dermatrends Inc', u'Weston Brain Institute', u'Organix Inc', u'Novo Nordisk A/S', u'Integrative Research Laboratories Sweden AB', u'Solvay SA', u'Galenea Corp', u'Wyeth Pharmaceuticals', u'Vivione Biosciences Llc', u'Pierrel SpA', u'MSD OSS BV', u'Orion Corporation', u'Zysis Ltd', u'Abbott Laboratories', u'Egis Technology Inc', u'Neurogen Corp', u'Arena Pharmaceuticals Inc', u'GlaxoSmithKline plc', u'Taisho Pharmaceutical Co Ltd', u'University of Maryland', u'Knoll AG', u'Bayer Schering Pharma AG', u'Merck KGaA', u'National Institutes of Health', u'Mediti Pharma Inc', u'ACADIA Pharmaceuticals Inc', u'National Institute on Drug Abuse', u'Schering-Plough Corp', u'Sumitomo Dainippon Pharma Co Ltd', u'Fujisawa Pharmaceutical Co Ltd', u'Novartis Pharma AG', u'Merck & Co Inc', u'Myungin Pharm Co Ltd', u'Scripps Florida', u'Scios Inc', u'Siegfried Holding Ltd', u'Jiangsu Nhwa Pharmaceutical Group Co Ltd', u'Sanofi', u'VINNOVA', u'Feinstein Institute for Medical Research', u'Eli Lilly & Co', u'Elite Pharmaceuticals Inc', u'Angelini Pharmaceuticals SpA', u'Vanderbilt University', u'Janssen Pharmaceutica BV', u'Teikoku Seiyaku KK', u'Saniona ApS', u'Regeneron Pharmaceuticals Inc', u'Astellas Pharma Inc', u'Janssen Pharmaceutical KK', u'SmithKline Beecham Pharmaceuticals', u'University of British Columbia', u'Titan Pharmaceuticals Inc', u'Mitsubishi Tanabe Pharma Corp', u'Janssen Pharmaceutica NV', u'TOLMAR Therapeutics Inc', u'RTI International', u'The National Institute of Mental Health', u'Axim Biotechnologies Inc', u'Lederle Laboratories', u'Universite De Montreal', u'Solvay Pharmaceuticals Inc', u'Purdue Neuroscience Corp', u'Corcept Therapeutics Inc', u'Eurand America Inc', u'H Lundbeck A/S', u'Roivant Sciences Ltd', u'Almirall Prodesfarma SA', u'Biovail Laboratories International Srl', u'AstraZeneca plc', u'Pfizer Inc', u'AriBio', u'Gedeon Richter Ltd', u'NeuroSearch A/S', u'Tripos Inc', u'Northeastern University', u'Knoll Ltd', u'SunGen Pharma LLC', u'Columbia University', u'US Department of the Treasury']), u'Shock': set([u'Harbor Therapeutics Inc', u'Picower Institute for Medical Research', u'Schwarz Pharma Ltd', u'La Jolla Pharmaceutical Co', u'Ajinomoto Co Inc', u'Yabao Pharmaceutical Group Co Ltd', u'IDM Pharma Inc', u'Office of Naval Research (ONR)', u'LFB SA', u'Dendreon San Diego LLC', u'UCB Pharma GmbH', u'National Institutes of Health', u'Food and Drug Administration', u'Immunex Corp', u'Fujifilm Diosynth Biotechnologies', u'Inflazyme Pharmaceuticals', u'Sumitomo Pharmaceuticals Co Ltd', u'Epimmune Inc', u'Takeda Pharmaceuticals International GmbH', u'Cytokine PharmaSciences Inc', u'George Washington University', u'Metaphore Pharmaceuticals Inc', u'Virginia Commonwealth University', u'IVAX Corp', u'Apex Bioscience Inc', u'Pfizer Inc', u'Henry Ford Health Science Center']), u'Gynecologicaldisorder': set([u'Merus Labs International Inc', u'Torrent Pharmaceuticals Ltd', u\"The General Hospital of the People's Liberation Army\", u'MD Anderson Cancer Center', u'Angiotech Pharmaceuticals Inc', u'ASAT AG Applied Science & Technology', u'MSD OSS BV', u'Biofrontera AG', u'Tsinghua University', u'Hologic Inc', u'PregLem Holding SA', u'Bovie Medical Corp', u'Takeda Pharmaceutical Co Ltd', u'ASKA Pharmaceutical Co Ltd', u'Ligand Pharmaceuticals Inc', u'Novacell Technology Inc', u'Ministry of Health, Welfare and Family Affairs', u'Actavis Inc', u'Bayer Schering Pharma AG', u'Oxford MEStar', u'Innothera', u'Pfizer Inc', u'Elanix Biotechnologies SA', u'Sanofi', u'ALPHAEON Corp', u'Ewha Womans University', u'Parabolic Drugs Ltd', u'ArQule Inc', u'Melon Ltd', u'Sirex M\\xe9dica SA', u'Veristat, Inc.', u'TEC-PHARMA SA', u'Vitre-Tech', u'Bayer AG', u'Torregal', u'Cadus Corp', u'Fourth Military Medical University PLA', u'Shin Poong Pharmaceutical Co Ltd', u'Nobelpharma Co Ltd', u'AdnaGen AG', u'Juniper Pharmaceuticals Inc', u'Viveve Inc', u'Karyopharm Therapeutics Inc', u'Titan Medical Inc', u'Sincopharm SA', u'ATT Medikal', u'Coolmed SA', u'HRA Pharma UK Ltd', u'Abbott Healthcare Products BV', u'Biofrontera Bioscience GmbH', u'University of Oxford', u'Florida Hospital Nicholson Center', u'AstraZeneca plc', u'Esteve', u'Bayer HealthCare AG', u'Novartis AG', u'KellBenx Inc', u'Gedeon Richter Ltd', u'MARC Group International LLC', u'Signal Research Division', u'Frazier Healthcare Partners', u'Biostar Pharmaceuticals Inc', u'Adenor SA', u'HRA Pharma', u'Kyoto University', u'Zalicus Inc']), u'Intracranialhemorrhage': set([u'Pfizer Inc', u'Universita di Bologna']), u'Lymphoproliferativedisease': set([u'Zenyaku Kogyo Co Ltd', u'National Cancer Institute', u'Genentech Inc', u'Roche Holding AG', u'Phoenicia Biosciences Inc', u'XOMA Corp', u'IDEC Pharmaceuticals Corp']), u'Anorexianervosa': set([u'Servier', u'BioLineRx Ltd', u'Ipsen Biopharmaceuticals Inc', u'Cannabics Pharmaceuticals Inc', u'Ono Pharmaceutical Co Ltd', u'Santhera Pharmaceuticals AG', u'Genentech Inc', u'Rambam Health Care Campus', u'Menarini Asia-Pacific', u'National Institute on Drug Abuse', u'Biologix FZ Co', u'Ipsen', u'Northeastern University', u'Sapphire Therapeutics Inc', u'Giddi Pharma Co Ltd', u'Wyeth-Ayerst Pharmaceuticals Inc', u'Columbia University']), u'Dysphagia': set([u'Swedish Orphan Biovitrum AB', u'BL&H Co Ltd', u'National Institutes of Health', u'Amgen Inc', u'MegaPharm Ltd']), u'Systemiclupuseryth': set([u'Hikma Pharmaceuticals plc', u'Astellas Pharma Inc']), u'Analfissure': set([u'SLA Pharma UK Ltd', u'Epsilon Pharmaceuticals', u'Perrigo Co Ltd', u'Solvay SA', u'Orexo AB', u'Adamis Pharmaceuticals Corp', u'National Institutes of Health', u'Norgine Ltd', u'CeNeS Pharmaceuticals plc', u'Kyowa Kirin', u'Sinclair Pharma plc', u'Neptune Pharmaceutical Corp', u'Ferring Pharmaceuticals SA', u'BMG Pharma LLC', u'Instituto de Ci\\xeancias Farmac\\xeauticas', u'New Harbor Corp']), u'Cholesterolmetabolismdisorder': set([u'University of Ottawa', u'Medicure Inc', u'Acacia Research Corp', u'Pfizer Inc', u'University of Manitoba', u'Xenon Pharmaceuticals Inc', u'ArQule Inc']), u'Enterocolitis': set([u'Merus Labs International Inc', u'Eddingpharm Inc', u'Dupont Nutrition Biosciences Aps', u'NPS Pharmaceuticals Inc', u'Undisclosed', u'Canadian Government', u'NPS Allelix Corp', u'Iroko Pharmaceuticals LLC', u'Lilly China Research & Development Co Ltd', u'Leadiant Biosciences Inc']), u'Anxietydisorder': set([u'Symphony Capital LLC', u'MSD OSS BV', u'Knoll Pharmaceuticals Co', u'Alliance for Lupus Research', u'Fudan University', u'US Government', u'Onxeo SA', u'Forest Laboratories Inc', u'GlaxoSmithKline plc', u'BTG plc', u'Tikvah Therapeutics Inc', u'Soochow University', u'University of Queensland', u'Texas A&M University System', u'Caraco Pharmaceutical Laboratories Ltd', u'Novartis Pharma AG', u'Instytut Psychiatrii i Neurologii', u'Elan Corp plc', u'POZEN Inc', u'ArQule Inc', u'Par Pharmaceutical Co Inc', u'Myungin Pharm Co Ltd', u'Revaax Pharmaceuticals LLC', u'Elite Pharmaceuticals Inc', u'University of Pennsylvania', u'FAES Farma SA', u'NRC Research Institute', u'Roche Holding AG', u'CeNeS Pharmaceuticals plc', u'Azur Pharma Ltd', u'Mitsubishi Tanabe Pharma Corp', u'TOLMAR Therapeutics Inc', u'UCB SA', u'The National Institute of Mental Health', u'Neurogen Corp', u'Xian-Janssen Pharmaceutical Ltd', u'University of Kentucky', u'Hisamitsu Pharmaceutical Co Inc', u'Pohang University of Science & Technology', u'Innovata plc', u'Morphochem AG', u'Cascade Therapeutics Inc', u'Neurocrine Biosciences Inc', u'Panos Therapeutics Ltd', u'Medipure Holdings Inc', u'Avineuro Pharmaceuticals Inc', u'Medical University of Vienna', u'SS Pharmaceutical - ethical drug division', u'Evotec AG', u'Meiji Seika Pharma Co Ltd', u'National Health and Medical Research Council', u'Biotie Therapies AG', u'Azevan Pharmaceuticals Inc', u'Corealis Pharma Inc', u'Orion Corporation', u'The European Union', u'Abbott Laboratories', u'Mochida Pharmaceutical Co Ltd', u'Endo Pharmaceuticals Solutions Inc', u'Eisai Co Ltd', u'NeuroSearch A/S', u'Merck KGaA', u'Fujisawa Pharmaceutical Co Ltd', u'Teva Pharmaceutical Industries Ltd', u'InterLab Pharmaceutica', u'Therapade Technologies LLC', u'Italfarmaco SpA', u'Bionomics Ltd', u'Akhu Therapeutics Inc', u'Canabo Medical Corporation', u'Pentech Pharmaceuticals Inc', u'Southern Cross University', u'Beech Tree Labs Inc', u'Kedem Pharmaceuticals Inc', u'St Louis University', u'Scios Inc', u'Avera Pharmaceuticals Inc', u'Probiodrug AG', u'Janssen Pharmaceutica NV', u'LG Chem Ltd', u'Wyeth', u'Ferrer Internacional SA', u'DuPont Pharmaceuticals Ltd', u'University of Arizona', u'Recordati SpA', u'Growblox Sciences Inc', u'H Lundbeck A/S', u'Biotechnology and Biological Sciences Research Council (BBSRC)', u'Sai Advantium', u'NeuroNova AB', u'Shanghai Institute of Materia Medica of the Chinese Academy of Sciences', u'Chugai Pharmaceutical Co Ltd', u'University of North Carolina', u'NPS Pharmaceuticals Inc', u'University of British Columbia', u'Mitsubishi Pharma Corp', u'Harvard Medical School', u'Intra-Cellular Therapies Inc', u'Schering-Plough Corp', u'Forenap Pharma', u'LTL Pharma Co Ltd', u'Health Policy and Research Foundation', u'Alexza Pharmaceuticals Inc', u'Undisclosed', u'Sumitomo Dainippon Pharma Co Ltd', u'Pfizer Inc', u'Belupo', u'Merck & Co Inc', u'Scripps Research Institute', u'Upjohn Inc', u'Ironwood Pharmaceuticals Inc', u'Sanofi', u'Columbia University', u'Eli Lilly & Co', u'Addex Therapeutics Ltd', u'Bayer AG', u'IntelliSyn Pharma', u'Pharmacia Corp', u'Adamed Group', u'MedPharm Ltd', u'Delivra Corp', u'UWM Research Foundation Inc', u'CEPA', u'Rexahn Pharmaceuticals Inc', u'Epigenetix Inc', u'Ikano Therapeutics Inc', u'RIMSA Laboratorios', u'Proteome Sciences plc', u'AstraZeneca plc', u'Esteve', u'Algae Dynamics Corp', u'BioProjet, Societe Civile de Recherche', u'Xphase Pharmaceuticals Inc', u'Knoll Ltd', u'Merck Sharp & Dohme Ltd', u'Vernalis plc', u'Boehringer Ingelheim Corp', u'Neuro3d SA', u'University of Turku', u'Helsinki University', u'University of Western Australia', u'Universidad Complutense de Madrid', u'Euthymics Bioscience Inc', u'Pherin Pharmaceuticals Inc', u'Institute of Materia Medica Chinese Academy of Medical Sciences & Peking Union Medical College', u'Addiction Therapeutix Inc', u'Abiogen Pharma SpA', u'VIA Pharmaceuticals Inc', u'Takeda Pharmaceutical Co Ltd', u'Servier', u'TopoTarget A/S', u'Solvay Meiji Yakuhin KK', u'Taisho Pharmaceutical Co Ltd', u'University of Wisconsin-Milwaukee', u'GlaxoSmithKline KK', u'Bristol-Myers Squibb Co', u'deCODE chemistry', u'Biotrial SAS', u'WhanIn Pharmaceutical Co Ltd', u'Takeda Oncology', u'INSERM', u'PN Gerolymatos SA', u'The Menarini Group', u'Cephalon Inc', u'Terra Life Sciences Inc', u'Array BioPharma Inc', u'Astellas Pharma Inc', u'Affectis Pharmaceuticals AG', u'BioDelivery Sciences International Inc', u'Biovail Corp', u'Russian Academy of Sciences', u'Dosecann Inc', u'Childrens Hospital of Philadelphia', u'Selectus Pharmaceuticals Inc', u'Purdue Neuroscience Corp', u'MediciNova Inc', u'University of Western Ontario', u'Janssen Pharmaceuticals Inc', u'Icagen Inc (pre-merger)', u'Walter and Eliza Hall Institute of Medical Research', u'Orit Laboratories LLC', u'PerkinElmer Inc', u'Novartis AG', u'Bristol-Myers Squibb Pharma Co', u'Cracow University of Technology', u'Ministry of Science and Higher Education, Poland', u'RespireRx Pharmaceuticals Inc', u'Jagiellonian University']), u'Rotavirusinfection': set([u'National Health and Medical Research Council', u'Health Research Council of New Zealand', u'Vaxess Technologies Inc', u'Baylor College of Medicine', u'Fraunhofer USA Inc', u'Stanford University', u'Microbiotix Inc', u'Wuhan Institute of Biological Products Co Ltd', u'National Institute of Allergy and Infectious Diseases', u'iBio Inc', u'Royal Childrens Hospital, Melbourne', u'GlaxoSmithKline plc', u\"Cincinnati Children's Hospital Medical Center\", u'Program for Appropriate Technology in Health', u'International Medica Foundation', u'Green Cross Corp', u'National Institutes of Health', u'Bill & Melinda Gates Foundation', u'Bio Farma', u'Serum Institute of India Ltd', u'Medicago Inc', u'Biological E Ltd', u'Chinese Government', u'Sinopharm', u'Global Vaccines Inc', u'CureVac GmbH', u'Zenyth Therapeutics Ltd', u'JSC Binnopharm', u'University of Melbourne', u'University of Otago', u'Centers for Disease Control and Prevention', u'Celldex Therapeutics Inc', u'University of Washington', u'bioCSL PTY Ltd', u'Murdoch Childrens Research Institute', u'Aridis Pharmaceuticals Inc', u'Shantha Biotechnics PVT Ltd', u'US Government', u'World Health Organization', u'Batavia Biosciences', u'Virginia Polytechnic Institute and State University', u'Mitsubishi Tanabe Pharma Corp', u'Global Alliance for Vaccines and Immunization', u'Acambis Inc', u'UMN Pharma Inc', u'Instituto Butantan', u'Paul Capital Healthcare', u'University of Tampere', u'Nissin Foods Holdings Co Ltd', u'Meridian Life Science Inc', u'University of Vermont', u'Pfizer Inc', u'University of Virginia', u'Pasteur Merieux', u'University of Gadjah Mada', u'BIOVIRx Inc', u'Institute of Medical Biology Chinese Academy of Medical Sciences', u'SK Chemicals Co Ltd', u'Royalty Pharma', u\"Children's Hospital Inc\", u'Virus Research Institute Inc', u'Bharat Biotech International Ltd', u'Merck & Co Inc']), u'Histiocytosis': set([u\"Cincinnati Children's Hospital Medical Center\", u'Exelixis Inc', u'Genentech Inc', u'National Heart Lung and Blood Institute']), u'Neuromyelitisoptica': set([u'CryoPort Inc', u'Orion BioScience Inc', u'Novartis AG', u'Genentech Inc', u'Anvil Biosciences LLC', u'Genmab A/S', u'Opexa Therapeutics Inc', u'Alnylam Pharmaceuticals Inc', u'National Institute of Allergy and Infectious Diseases', u'Biogen Inc', u'Sanofi Genzyme', u'National Eye Institute', u'GlaxoSmithKline plc']), u'Renalcell': set([u'Maxim Pharmaceuticals Inc', u'Estero-Anstalt']), u'Rabiesvirusinfection': set([u'Beijing Minhai Biotechnology Co Ltd', u'Royal DSM NV', u'Il-Yang Pharmaceutical Co', u'Massachusetts Institute of Technology', u'Fraunhofer USA Inc', u'The Thai Red Cross Society', u'National Institute of Allergy and Infectious Diseases', u'Immunotech SA (Argentina)', u'Medigen Biotechnology Corp', u'Sanofi Pasteur', u'The European Union', u'Massachusetts Biologic Laboratories', u'iBio Inc', u'Elanco Animal Health', u'US Health and Human Services Department', u'Serum Institute of India Ltd', u'BioNet-Asia Co Ltd', u'ReceptoPharm Inc', u'Celltrion Inc', u'CSIR (South Africa)', u'World Health Organization', u'Novartis AG', u'Xenetic Biosciences Inc', u'Mediclone Biotech Pvt Ltd', u'National Institutes of Health', u'Bill & Melinda Gates Foundation', u'Liaoning Yisheng Biopharmaceutical Co Ltd', u'OncBioMune Mexico SA de CV', u'Viroclinics BV', u'Chinese Government', u'Institute of Medical Biology Chinese Academy of Medical Sciences', u'Transgene SA', u'Guangzhou Yinheyangguang Biological Products Co Ltd', u'Novartis Vaccines & Diagnostics', u'Ventria Bioscience', u'Centers for Disease Control and Prevention', u'University of Maryland School of Medicine', u'bioCSL PTY Ltd', u'NanoViricides Inc', u'Mid-Atlantic Biotherapeutics', u'Department of Science & Technology', u'Grifols Inc', u'Kaketsuken', u'Liaoning Cheng Da Co Ltd', u'Icon Genetics AG', u'Institut Pasteur', u'University of Georgia', u'Takeda Vaccines Inc', u'Kedrion SpA', u'Thomas Jefferson University', u'Crucell NV', u'Rhone-Merieux SA', u'Chinese Ministry of Science and Technology', u'Zydus-Cadila Group', u'North China Pharmaceutical Group Corp (NCPC)', u'Boehringer Ingelheim Vetmedica GmbH', u'Guangzhou Ruibeisi Pharmaceutical Co Ltd', u'Undisclosed', u'Molecular Targeting Technologies Inc', u'Akorn Inc', u'Altimmune Inc (pre-merger)', u'AB (Wuhan) Biotech Co Ltd', u'Kamada Ltd', u'Immunome Inc']), u'Commoncold': set([u\"Dr Reddy's Laboratories Ltd\", u'Evotec AG', u'Vifor Pharma', u'US Government', u'Lumara Health Inc', u'Lipocine Inc', u'Mylan Inc', u'Ducere Pharma LLC', u'Vertical Pharmaceuticals Inc', u'Kanazawa University', u'SEEK', u'Dinamika Ltd Co', u'ULURU Inc', u'ViroPharma Inc', u'ProPhase Labs Inc', u'Tris Pharma Inc', u'National Institutes of Health', u'Horizon Genomics GmbH', u'Moberg Pharma AB', u'Merck & Co Inc', u'Breathtec Biomedical Inc', u'Piramal Enterprises Ltd', u'Marinomed Biotechnologie GmbH', u'Vernalis plc', u'Spriaso LLC', u'Technion Research & Development Foundation Ltd', u'Chiesi USA Inc', u'Melmed Holding AG', u'Maruishi Pharmaceutical Co Ltd', u'Coating Place Inc', u'Nexgen Pharma Inc', u'Avanir Pharmaceuticals Inc', u'Alitair Pharmaceuticals Inc', u'Alvogen Inc', u'Cocrystal Discovery Inc', u'PGC Solutions', u'Pfizer Inc', u'CAM-Global, LLC', u'Boehringer Ingelheim Corp', u'Pfizer Canada Inc', u'Cleobrothers & Co Inc', u'Soho Flordis International', u'SinoFresh Healthcare Inc', u'Pernix Therapeutics Holdings Inc', u'Strides Shasun Ltd', u'Poly Pharmaceuticals Inc']), u'Mitochondrialmyopathy': set([u'Karolinska Institutet', u'University of Pennsylvania', u'Mitobridge Inc', u'NeuroVive Pharmaceutical AB', u'The Salk Institute for Biological Studies', u'Muscular Dystrophy Association']), u'Cholestasis': set([u'Lumena Pharmaceuticals', u'University of Michigan', u\"Cincinnati Children's Hospital Medical Center\", u'Aptalis Pharma Inc', u'Pfizer Inc', u'VINNOVA', u'Food and Drug Administration', u'MetaboGen Ab', u'Ferring Pharmaceuticals SA', u'Albireo Ltd', u'National Institute of Diabetes, Digestive and Kidney Diseases', u'Orphagen Pharmaceuticals Inc']), u'Nervoussysteminjury': set([u'NsGene A/S', u'CeNeS Pharmaceuticals Inc', u'AstraZeneca plc', u'Renovis Inc', u'Genentech Inc', u'ProBioGen AG', u'Undisclosed', u'Human Genome Sciences Inc', u'TheraSci Ltd', u'Senju Pharmaceutical Co Ltd', u'ARIAD Pharmaceuticals Inc', u'Novartis Pharma AG', u'PAION AG', u'Parke-Davis & Co', u'Curis Inc', u'GlaxoSmithKline plc', u'Kuros Biosciences Ltd', u'CarboMed Inc', u'Amsterdam Molecular Therapeutics BV', u'BioFocus DPI']), u'Heartinjury': set([u'FirstString Research Inc', u'Stanford University', u'National Institutes of Health', u'Cleveland Clinic Foundation', u'Virginia Polytechnic Institute and State University', u'Silver Creek Pharmaceuticals Inc', u'University of Virginia', u'US Stem Cell Inc', u'California Institute of Regenerative Medicine', u'RegeneRx Biopharmaceuticals Inc', u'University of Texas Southwestern Medical Center']), u'Cardiovasculardisease': set([u'Bertin Pharma', u'Lumara Health Inc', u'NEOMED Institute', u'ANANDA Scientific Inc', u'Sareum Holdings plc', u'Archemix Corp', u'West Pharmaceutical Services Inc', u'University of Illinois', u'Korea Research Institute of Bioscience and Biotechnology', u'BIOTRONIK SE & Co', u'US Health and Human Services Department', u'ArtGen Inc', u'Life Technologies Corp', u'Montreal Heart Institute', u\"Cincinnati Children's Hospital Medical Center\", u'Eddingpharm Inc', u'Alliance Medical Group', u'University of Maryland', u'Arterys Inc', u'Ionis Pharmaceuticals Inc', u'The Dow Chemical Co', u'Paul Capital Healthcare', u'Scil Technology GmbH', u'BioSyent Inc', u'alphaGEN Co Ltd', u'Zydus-Cadila Group', u'David Geffen School of Medicine at UCLA', u'Metabasis Therapeutics Inc', u'Creabilis Therapeutics Srl', u'Stony Brook Medicine', u'Aegera Therapeutics Inc', u'Sumitomo Pharmaceuticals Co Ltd', u'VIA Pharmaceuticals Inc', u'Resverlogix Corp', u'Chiesi USA Inc', u'University of California Los Angeles', u'Merit Medical Systems Inc', u'CardiNor AS', u'Merck Sharp & Dohme Corp', u'University of Miami', u'Siemens AG', u'Jitsubo Co Ltd', u'Roxwood Medical Inc', u'Celera South San Francisco', u'Mount Cook BioSciences', u'GLYCODesign Inc', u'Theregen Inc', u'HanAll Biopharma Co Ltd', u'Formatech Inc', u'Advancecor GmbH', u'Baker IDI Heart & Diabetes Institute Holdings Ltd', u'Upjohn Pharmaceuticals Ltd', u'Peking University', u'Okklo Life Sciences BV', u'EMD Serono Inc', u'23andMe Inc', u'Quadrant Technologies Ltd', u'Edwards Lifesciences Corp', u'Aurum Ventures MKI', u'University of Cincinnati', u'National Health and Medical Research Council', u'Ludwig Boltzmann Institute', u'CardioGene Therapeutics Inc', u'PDL BioPharma Inc', u'Centre National de la Recherche Scientifique (CNRS)', u'Nventa Biopharmaceuticals Corp', u'AADi LLC', u'Inflazyme Pharmaceuticals', u'Acino Holding AG', u'Longeveron LLC', u'Monash University', u'Kunming Pharmaceutical Corp', u'Natural Partners Inc', u'Glenmark Pharmaceuticals Ltd', u'Tokyo Medical and Dental University', u'Worldwide Clinical Trials', u'Acasti Pharma Inc', u'Beijing Bencao Tianyuan Drug Institute', u'Genetic Therapy Inc', u'Il Dong Pharmaceutical Co Ltd', u'Modern Healthcare Solutions Co Ltd', u'RW Johnson Pharmaceutical Research Institute', u'Vanderbilt University', u'Reset Therapeutics Inc', u'Agennix AG', u'St Vincents Hospital (Melbourne) Ltd', u'ACGT Corp', u'LipoScience Inc', u'Santen Pharmaceutical Co Ltd', u'Boston Therapeutics Inc', u'TransgenRx Inc', u'Cardiovascular Research Institute Maastricht CARIM', u'Pharmacopeia Inc', u'Inovio Pharmaceuticals Inc', u'Centro Nacional de Investigaciones Oncologicas', u'Nano Terra Inc', u'Celera Group', u'Lantheus Medical Imaging Inc', u'The Ruth and Bruce Rappaport Faculty of Medicine', u'Biofrontera Discovery GmbH', u'Arete Therapeutics Inc', u'2bPrecise LLC', u'Haemopep Pharma GmbH', u'Boston University', u'Access Business Group International', u'Ohio University', u'Sanofi Chimie SA', u'Genfit SA', u'Vical Inc', u'Aventis Pharmaceuticals Inc', u'Roche Diagnostics', u'Medtronic Inc', u'F H Faulding & Co Ltd', u'Cigalah', u'Ludwig-Maximilians University of Munich', u'Sistemic Scotland Limited', u'University of Queensland', u'MSN Laboratories Ltd', u'moksha8 Pharmaceuticals Inc', u'Radical Biotechnology Pty Ltd', u'Xcellsyz Ltd', u'Universita degli Studi di Ferrara', u'AC Nova Technologies Inc', u'ElexoPharm GmbH', u'PeptiDream Inc', u'Minapharm Pharmaceuticals', u'Alexion Pharmaceuticals Inc', u'Wyeth Pharmaceuticals', u'Karolinska Development AB', u'Flamel Technologies SA', u'Pharmacia & Upjohn Inc', u'MedAxiom', u'Oregon Health Sciences University', u'Toronto Hospital', u'Melacure Therapeutics AB', u'Queen Mary University of London', u'Daewoong Pharmaceutical Co Ltd', u'AmorChem LP', u'LEO Pharma A/S', u'COR Therapeutics Inc', u'CTI BioPharma Corp', u'Eli Lilly & Co', u'Proteros Biostructures GmbH', u\"Lee's Pharmaceutical Holdings Limited\", u'Marathon Pharmaceuticals LLC', u'AvantGen Inc', u'Medpace Inc', u'Kyosei Seiyaku Co Ltd', u'Pronova BioPharma ASA', u'HealthLinx Ltd', u'RheoGene Inc', u'George Washington University', u'Kedem Pharmaceuticals Inc', u'Argenta Discovery Ltd', u'Gilead Colorado Inc', u'Novopyxis Inc', u'POZEN Inc', u'National Institute on Aging', u'Chiatai Qingchunbao Pharmaceutical Co Ltd', u'Unimark Remedies Ltd', u'Thia Medica AS', u'National Taiwan University', u'Roseman University of Health Sciences', u'The Gladstone Institute of Cardiovascular Disease', u'Johns Hopkins University', u'Forbes Medi-Tech Inc', u'Harbor Therapeutics Inc', u'Johnson & Johnson', u'Momenta Pharmaceuticals Inc', u'The Danish National Advanced Technology Foundation', u'Icagen Inc', u'Stem Cell Theranostics Inc', u'ViroMed Co Ltd', u'Serenics Inc', u'Silence Therapeutics AG', u'Valeant Pharmaceuticals North America LLC', u'China Resources Saike Pharmaceutical Co Ltd', u'Metabolon Inc', u'Horizon Discovery Group plc', u'uniQure BV', u'Boston Scientific Corp', u'Taisho Pharmaceutical Co Ltd', u'Korea Advanced Institute of Science and Technology', u'Proteus Digital Health Inc', u'UCB Celltech', u'Karus Therapeutics Ltd', u'Baker Heart Research Institute', u'Hyland Immuno', u'Actelion Ltd', u\"Shanghai Wan'Te Pharmaceutical Co Ltd\", u'Servier', u'Endovasc Inc', u'Bristol-Myers Squibb Co', u'OSEO', u'Sphaera Pharma', u'AVAC Ltd', u'IntelGenx Technologies Corp', u'Seoul National University', u'Astellas Pharma Inc', u'CyDex Pharmaceuticals Inc', u'BioDelivery Sciences International Inc', u'Knoll GmbH', u'IMCOR Pharmaceutical Co', u'Relypsa Inc', u'Tabuk Pharmaceutical Manufacturing Co', u'Rhone-Poulenc SA', u'Meda AB', u'Oscient Pharmaceuticals Corp', u'Proteo Biotech AG', u'Fujifilm\\xa0Corp', u'Yuhan Corp', u'Enamine Ltd', u'Hollister-Stier Laboratories LLC', u'Galapagos NV', u'Health Diagnostic Laboratory Inc', u'PPD Discovery Inc', u'StemCell Technologies', u'Cell Therapies Pty Ltd', u'ImaginAb Inc', u'SynthRx Inc', u'Karolinska Institutet', u'Yamanouchi Pharmaceutical Co Ltd', u'Global Medical Solutions Ltd', u'Novo Nordisk A/S', u'Regeneron Pharmaceuticals Inc', u'Mera Pharmaceuticals Inc', u'Angiotech Pharmaceuticals Inc', u'Knoll Pharmaceuticals Co', u'IDM Pharma Inc', u'Incyte Corp', u'Orion Corporation', u'Rockefeller University', u'iPierian Inc', u'JHP Pharmaceuticals LLC', u'KineMed Inc', u'Celladon Corp', u'Centelion SAS', u'Frontage Laboratories Inc', u'Cardiome Pharma Corp', u'Chiesi Farmaceutici SpA', u'Johns Hopkins University Office of Technology Transfer', u'DRAXIS Health Inc', u'Torrey Pines Institute for Molecular Studies', u'University of Iowa', u'Xenova Group plc', u'Chinese Government', u'Phosphagenics Ltd', u'ArQule Inc', u'Angioblast Systems Inc', u'Microbot Medical Inc', u'Boehringer Ingelheim Pharma KG', u'Navidea Biopharmaceuticals Inc', u'Lead Discovery Center GmbH', u'Mitsubishi-Tokyo Pharmaceuticals Inc', u'Shionogi & Co Ltd', u'Ono Pharmaceutical Co Ltd', u'Roche Holding AG', u'Solvotrin Therapeutics Ltd', u'Alchemia Ltd', u'Artery Therapeutics Inc', u'University of British Columbia', u'PDI Inc', u'Biocompatibles International plc', u'University of Tokyo', u'Medidata Ft Inc', u'Paladin Labs Inc', u'Vasogen Inc', u'Procter & Gamble Pharmaceuticals Inc', u'VIB', u'Virginia Commonwealth University', u'AFA Insurance', u'Selvita SA', u'Tenax Therapeutics Inc', u'Biocon Ltd', u'Bayer HealthCare AG', u'Eukarion Inc', u'Shire Orphan Therapies GmbH', u'Catalyst Biosciences Inc', u'OptiBiotix Health plc', u'Biotica Technology Ltd', u'Duke Clinical Research Institute', u'Mayo Clinic Foundation', u'Towa Pharmaceutical Co Ltd', u'ChemRar High Tech Center', u'Dongsheng Pharmaceutical International Co Ltd', u'Amerinet Inc', u'Exelixis Inc', u'Charles River Laboratories International Inc', u'Tasly Pharmaceuticals', u'Simcere Pharmaceutical Group', u'Amgen Inc', u'Nippon Petrochem Co Ltd', u'Innovation and Technology Commission', u'Arrowhead Pharmaceuticals Inc', u'EuroTransBio', u'e-Therapeutics Plc', u'Numerate Inc', u'Prism Pharmaceuticals Inc', u'Pcovery ApS', u'FUJIFILM RI Pharma Co', u'Johns Hopkins University School of Medicine', u'Eunice Kennedy Shriver National Institute of Child Health & Human Development', u'Center for Translational Molecular Medicine', u'Gemini Genomics plc', u'Drug Discovery Laboratory AS', u'MabVax Therapeutics Holdings Inc', u'Pivotal Therapeutics Inc', u'iRhythm Technologies Inc', u'Scigenic & Scigen Harvest Co Ltd', u'Massachusetts General Hospital', u'Abgenix Inc', u'Transgene SA', u'Garnet BioTherapeutics Inc', u'DalCor Pharmaceuticals Canada Inc', u'SBI Pharmaceuticals', u'Cryo-Cell International Inc', u'Hemostemix Asia Inc', u'RxGen Inc', u'Cleveland Clinic Foundation', u'Gliatech Inc', u'PepTx Inc', u'Helix', u'AstraZeneca AB', u'AtheroGenics Inc', u'Neptune Technologies & Bioressources Inc', u'Dong-A ST Co Ltd', u'Hikma Pharmaceuticals plc', u'Armgo Pharma Inc', u'FMC Corp', u'The Research Council of Norway', u'Osaka University', u'Shanghai Fosun Pharmaceutical (Group) Co Ltd', u'Chemokine Therapeutics Corp', u'Hadasit Medical Research Services and Development Ltd', u'Vybion Inc', u'Vicore Pharma AB', u'Wyeth-Ayerst Pharmaceuticals Inc', u'Roche Palo Alto', u'Cardero Therapeutics Inc', u'New Haven Pharmaceuticals Inc', u'Nuformix Ltd', u'Dispositivos Medicos EIRL', u'Upstate USA Inc', u'Fuji Pharma Co Ltd', u'Phyxius Pharma LLC', u'Radiation Monitoring Devices Inc', u'SICOR Inc', u'Medidata Solutions Worldwide', u'TriCardia LLC', u'Active Pass Pharmaceuticals Inc', u'Genentech Inc', u'Yissum Research Development Co', u'Comesa Gmbh', u'Axol Bioscience Ltd', u'Electra-Box Diagnostica', u'Aegis Therapeutics LLC', u'WellSpring Pharmaceutical Corp', u'Ore Pharmaceuticals Inc', u'Laureate Biopharmaceutical Services Inc', u'LifeArc', u'Actavis Inc', u'Ark Therapeutics Group plc', u'Nutrilinea Ltd', u'Nautilus Biotech SA', u'Nordion Inc', u'University of Adelaide', u'Nippon Chemiphar Co Ltd', u'be Medical', u'Australian Research Council', u'Genzyme General', u'ImaRx Therapeutics Inc', u'Capella BioScience', u'Lotus Pharmaceutical Co Ltd', u'University of Texas Southwestern Medical Center', u'BioFocus DPI', u'CASI Pharmaceuticals Inc', u'Impedimed Pty Ltd', u'Royal Philips Electronics', u'Janssen Pharmaceuticals Inc', u'Martindale Pharma', u'Alize Pharma Group', u'Pharmasol Corp', u'Hospices Civils De Lyon', u'Evolva SA', u'LION bioscience Inc', u'Athersys Inc', u'United Therapeutics Corp', u'MRI Interventions Inc', u'Kadmon Pharmaceuticals LLC', u'Janssen Biotech Inc', u'Serodus ASA', u'Meridian Bioscience Inc', u'Nuvelo Inc', u'Monsanto Co', u'AstraZeneca plc', u'Technology Strategy Board', u'GenKyoTex SA', u'Arteriae Sp. z o.o. sp.k', u'Benxi Leilong Pharmaceutical Co Ltd', u'Lorem Vascular Co Ltd', u'Adenosine Therapeutics LLC', u'Undisclosed', u'Scotia Holdings plc', u'Pharmix Corp', u'Introgen Therapeutics Inc', u'Zynaxis Inc', u'Australian Government', u'MultiGene Vascular Systems Ltd (MGVS)', u'Insilico Medicine Inc', u'Gilead Palo Alto Inc', u'La Jolla Pharmaceutical Co', u'Genmab A/S', u'US Stem Cell Inc', u'Nippon Kayaku Co Ltd', u'Indiana University', u'Mochida Pharmaceutical Co Ltd', u'H Lee Moffitt Cancer Center and Research Institute', u'Portola Pharmaceuticals Inc', u'Institute of Materia Medica Chinese Academy of Medical Sciences & Peking Union Medical College', u'Ligand Pharmaceuticals Inc', u'Hoechst AG', u'Top Institute Pharma', u'MacroGenics Inc', u'Athpharma Ltd', u'Sihuan Pharmaceutical Holdings Group Ltd', u'TCA Cellular Therapy LLC', u'Zhejiang Xianju Pharmaceutical Corp Ltd', u'Theracos Inc', u'Cardiovascular Institute and Fuwai Hospital', u'Hemostemix Ltd', u'Womens & Childrens Hospital', u'Zealand Pharma A/S', u'Esperion Therapeutics Inc', u'Spectrum Pharmaceuticals Inc', u'Kyoto University', u'Cedars-Sinai Medical Center', u'Icoria Inc', u'Fujifilm Diosynth Biotechnologies', u'Unilife', u'American Heart Association', u'InspireMD Inc', u'ESP Pharma Inc', u'ThromboGenics NV', u'Bristol-Myers Squibb Pharma Co', u'Max-Planck-Institute for Coal Research', u'Covis Pharma Sarl', u'Athera Biotechnologies AB', u'GVK Biosciences Pvt Ltd', u'Pierre Fabre SA', u'Cyclenium Pharma Inc', u'Invitae', u'Mithra Pharmaceuticals', u'Institut Pasteur', u'Ventaira Pharmaceuticals Inc', u'GE Healthcare', u'diaDexus Inc', u'Upperton Ltd', u\"Brigham & Women's Hospital\", u'DGX Pharma', u'Dyax Corp', u'Argon Medical Devices Inc', u'Endogenous Stem Cells Activators Inc', u'Biosensors International Group Ltd', u'Medicure Inc', u'University of Cambridge', u'Biostar Pharmaceuticals Inc', u'CuraGen Corp', u'German Federal Ministry of Education and Research', u'Clinical Data Inc', u\"Dr Reddy's Laboratories Ltd\", u'Telios Pharmaceuticals Inc', u'Royal DSM NV', u'University of Florida', u'Schwarz Pharma Ltd', u'Agennix USA Inc', u'BioRap Technologies Ltd', u'Humanetics Corp', u'Cellular Dynamics International Inc', u'DAVA Pharmaceuticals Inc', u'RegeneRx Biopharmaceuticals Inc', u'Bracco Imaging SpA', u'Dorizoe Lifesciences Ltd', u'Mount Sinai School of Medicine', u'Global Clean Energy Holdings Inc', u'Corvidia Therapeutics', u'Ministry of Health, Welfare and Family Affairs', u'Fondation Nationale de Transfusion Sanguine', u'Idun Pharmaceuticals Inc', u'\\xd6stersj\\xf6stiftelsen', u'SGX Pharmaceuticals Inc', u'Poniard Pharmaceuticals Inc', u'Uppsala University', u'LG Chem Ltd', u'Aventis Pharma AG', u'Cerenis Therapeutics SA', u'Accelrys Inc', u'East Gate Pharmaceuticals', u'MedImmune LLC', u'OSI Pharmaceuticals Inc', u'University of Washington', u'Apotex Inc', u'Atherotech Inc', u'Millennium HealthCare', u'MSD OSS BV', u'University of Manitoba', u'Peptisyntha Inc', u'Proteome Sciences plc', u'Bio-Medisinsk Innovasjon AS', u'Ludwig Institute for Cancer Research', u'Applied NeuroSolutions Inc', u'Maryland Stem Cell Research Fund', u'Peplin Inc', u'ModeRNA Therapeutics', u'Medical University of Vienna', u'Biosite Inc', u'National Center for Research Resources', u'University of California San Francisco', u'Pfizer Inc', u'Signal Research Division', u'Peregrine Renovations LLC', u'ARCA Biopharma Inc', u'University of Nebraska Medical Center', u'Medlogics Device Corp', u'Corthera Inc', u'PTC Therapeutics Inc', u'University of Toronto', u'Aralez Pharmaceuticals Inc', u'Riemser Pharma GmbH', u'Affitech A/S', u'China Nuokang Bio-Pharmaceutical Inc', u'Harvard University', u'OncBioMune Pharmaceuticals Inc', u'University of Dundee', u'Iroko Pharmaceuticals LLC', u'Universidad Aut\\xf3noma del Estado de Morelos', u'Correvio International Sarl', u'Axiogenesis AG', u'Magnesium Elektron Ltd', u'XOMA Corp', u'Xibei (North-West) University', u'The European Union', u'Teva Pharmaceutical Industries Ltd', u'Perlecan Pharma Pvt Ltd', u'The Medicines Company', u'Amira Pharmaceuticals Inc', u'Diosynth BV', u'Boehringer Ingelheim International GmbH', u'Merus Labs International Inc', u'UCB Pharma GmbH', u'Florida Hospital', u'WuXi PharmaTech (Cayman) Inc', u'Fraunhofer-Institute fur Zelltherapy und Immunologie', u'University of Wurzburg', u'Dendreon Corp', u'Mathilda and Terrence Kennedy Institute of Rheumatology Trust', u'Peakdale Molecular', u'Lipid Sciences Inc', u'Global Genomics Group LLC', u'Glaxo Group Ltd', u'AnGes MG Inc', u'Fujirebio Europe NV', u'Encysive Pharmaceuticals Inc', u'NanoScan Imaging LLC', u'Boehringer Ingelheim Corp', u'Schering AG', u'Genset SA', u'Lipomics Technologies Inc', u'BioInvent International AB', u'VistaGen Therapeutics Inc', u'BioAxone Therapeutic Inc', u'NovaMed Pharmaceuticals Inc', u'Mount Sinai Medical Center', u'St Boniface General Hospital', u'Xerion Pharmaceuticals AG', u'Vizient Inc', u'Duke University Medical Center', u'University of Sheffield', u'Quidel Corp', u'Human Stem Cells Institute', u'Renova Therapeutics Inc', u'Espero Pharmaceuticals Inc', u'PeriCor Therapeutics Inc', u'Connetics Corp', u'Hope Heart Institute', u'Harvard Medical School', u'Illumina Inc', u'National Institute of Diabetes, Digestive and Kidney Diseases', u'NeoGenesis Pharmaceuticals Inc', u'Schering-Plough Corp', u'Roche Innovation Center Copenhagen A/S', u'Oxford BioMedica plc', u'Millar Inc', u'Jago Pharma AG', u'ViaCell Inc', u'SQI Diagnostics Systems Inc', u'Hospital for Sick Children', u'Baxter Healthcare Corp', u'Sigma-Tau Ind Farm Riunite SpA', u'KYOWA Pharmaceutical Industry Co Ltd', u'University of Gothenburg', u'Metabolic Modulators Research Ltd', u'University of California', u'British Heart Foundation', u'OAO \"Akrikhin\"', u'Chugai Biopharmaceuticals Inc', u'Texas Heart Institute', u'Sanofi', u'Vertex Pharmaceuticals Inc', u'DNAmicroarray Inc', u'Tanabe Seiyaku Co Ltd', u'Novogen Ltd', u'University of Oslo', u'Bayer AG', u'HedgePath Pharmaceuticals Inc', u'Unigene Laboratories Inc', u'Ra Pharmaceuticals Inc', u'InNexus Biotechnology Inc', u'Institut Pasteur Korea', u'Merck Research Laboratories', u'BioSeek Plc', u'Hannover Medical School', u'Concord Biosciences LLC', u'Almirall Prodesfarma SA', u'Neurocrine Biosciences Inc', u'Applied StemCell Inc', u'HUYA Bioscience International LLC', u'Kineta Inc', u'Multiplicom N.V.', u'TSH Biopharm Corporation Limited', u'Broad Institute Inc', u'Nichi-Iko Pharmaceutical Co Ltd', u'Response Biomedical Corp', u'Bachem Holding AG', u'Celyad', u'Sangamo Therapeutics Inc', u'Ubiquigent Limited', u'Zydus Cadila Healthcare Ltd', u'Takeda Pharmaceuticals International GmbH', u'US Department of Defense', u'University of Missouri', u'United Eastern Pharmaceutica', u'iPS Academia Japan Inc', u'Sunol Molecular Corp', u'The University Health Network', u'NeuroVive Pharmaceutical AB', u'University of Utah', u'Amarin Corp plc', u'Heartlight Systems Limited', u'Dendreon San Diego LLC', u'CoGenesys Inc', u'The Australian National University', u'Bioagency AG', u'PharmaIN Ltd', u'iCardiac Technologies Inc', u'University of Oregon', u'Elan Corp plc', u'Aramed Inc', u'MorphoSys AG', u'Sanofi Genzyme', u'KAI Pharmaceuticals Inc', u'University of Calgary', u'Columbia University Medical Center', u'Celgene Corp', u'Pharma Pass LLC', u'Research Development Foundation', u'Array BioPharma Inc', u'Cambridge Therapeutic Technologies', u'Par Pharmaceutical Co Inc', u'Biovail Corp', u'Regulus Therapeutics Inc', u'University of Lyon', u'Interleukin Genetics Inc', u'Ranbaxy Laboratories Ltd', u'Avanir Pharmaceuticals Inc', u'SemBioSys Genetics Inc', u'Apollo Endosurgery Inc', u'MediciNova Inc', u'Azur Pharma Ltd', u'IPCA Laboratories Ltd', u'Crucell NV', u'AlphaCore Pharma LLC', u'Patheon Pharmaceuticals Inc', u'Kereos Inc', u'Hemostemix Inc', u'Linkoping University', u'Univalor', u'ProTherapeutics Pte Ltd', u'GD Searle & Co', u'NGM Biopharmaceuticals Inc', u'OncoGenex Pharmaceuticals Inc', u'Daiichi Seiyaku Co Ltd', u'FIT-BioCeuticals Pty Ltd', u'DKSH Holding Ltd', u'US Government', u'BioMarin Pharmaceutical Inc', u'Asahi Kasei Corp', u'GT Biopharma Inc', u'Baxter International Inc', u'AOP Orphan Pharmaceuticals AG', u'University of Oxford', u'miRagen Therapeutics Inc', u'CardioWise GmbH', u'GenVec Inc', u'Capricor Therapeutics Inc', u'Biogen Inc', u'King Pharmaceuticals R&D Inc', u'4SC Discovery GmbH', u'Breckenridge Pharmaceutical Inc', u'GlaxoSmithKline plc', u'EZRA Innovations LLC', u'Cell Genesys Inc', u'University of Ottawa', u'Covance Inc', u'Bayer Schering Pharma AG', u'Pharnext SAS', u'Taxus Cardium Pharmaceuticals Group', u'Takeda Pharmaceutical Co Ltd', u'Cipla-Medpro (Pty) Ltd', u'Immunex Corp', u'Perelman School of Medicine', u'European Eurostars Programme', u'Scios Inc', u'Bioadvantex Pharma Inc', u'Sarepta Therapeutics Inc', u'The Cleveland Clinic Research Institute', u'Bio3 Research Srl', u'Sankyo Co Ltd', u'Takeda Oncology', u'Stanford University', u'Fujisawa USA Inc', u'Abbott Healthcare Products BV', u'Vitae Pharmaceuticals Inc', u'Innovative Genomics Initiative', u'Joslin Diabetes Center Inc', u'Temple University', u'Peregrine Pharmaceuticals Inc', u'Davos Life Science Pte Ltd', u'Ranbaxy Pharmaceuticals Inc', u'Aderis Pharmaceuticals Inc', u'Canadian Institutes of Health Research', u'Toyobo Co Ltd', u'BioMotiv LLC', u'Cevidra Laboratories', u'Alere Inc', u'Reata Pharmaceuticals Inc', u'National Heart Lung and Blood Institute', u'Elan Pharmaceuticals Inc', u'NitroMed Inc', u\"Boston Children's Hospital\", u'Alnylam Pharmaceuticals Inc', u'Pharmaniaga Bhd', u'EndogenX Inc', u'HeartGenetics, Genetics & Biotechnology, S.A.', u'New York University', u'Sequenom Inc', u'Terumo Corp', u'Light Sciences Corp', u'National Institute of Arthritis and Musculoskeletal and Skin Diseases', u'Aronex Pharmaceuticals Inc', u'Corealis Pharma Inc', u'ConjuChem LLC', u'Collateral Therapeutics Inc', u'Daiichi Sankyo Co Ltd', u'Abbott Laboratories', u'HaptoGuard Inc', u'NuView Life Sciences', u'Aronora Inc', u'BioRestorative Therapies Inc', u'Solana Therapeutics Inc', u'National Cancer Institute', u'Novartis AG', u'Merck KGaA', u'Repligen Corp', u'Biogal Gyogyszergyar RT', u'Kos Pharmaceuticals Inc', u'Innopharmax Inc', u'Bicycle Therapeutics Ltd', u'Juvenile Diabetes Research Foundation', u'EndGenitor Technologies Inc', u'PLx Pharma Inc (pre-merger)', u'Novelion Therapeutics Inc', u'Apicore LLC', u'Scripps Florida', u'Osiris Therapeutics Inc', u'Juvenescence Limited', u'Nycomed Imaging A/S', u'SciClone Pharmaceuticals Inc', u'Universite De Montreal', u'University of Minnesota', u'Neurotrope Inc', u'Yale University', u'Cornell University', u'Transgenomic Inc', u'Cadus Corp', u'Agena Bioscience Inc', u'UCB SA', u'Bicoll GmbH', u'Xenon Pharmaceuticals Inc', u'Industrifonden', u'St Jude Medical Inc', u'University of Texas System', u'BASF Pharma', u'University of Colorado System', u'PamGene International BV', u'McGill University', u'Novoheart Holdings Ltd', u'Ethypharm SA', u'The Knut and Alice Wallenberg Foundation', u'CytRx Corp', u'Ferrer Internacional SA', u'Lupin Ltd', u'Iverson Genetic Diagnostics Inc', u'Kyowa Hakko Kogyo Co Ltd', u'Cell>Point LLC', u'National University of Singapore', u'Compugen Ltd', u'Recordati SpA', u'Cordis Corp', u'California Initiative to Advance Precision Medicine', u'Royalty Pharma', u'Growblox Sciences Inc', u'Pharming Group NV', u'University of North Carolina', u'The Procter & Gamble Co', u'Evotec AG', u'Protea Biosciences Inc', u'Oxford Cardiac Pharmacology Ltd', u'Bioventix Inc', u'Mesoblast Ltd', u'ImuThes Ltd', u'Dynasty Biotechnology Ltd', u'Meiji Seika Pharma Co Ltd', u'Symphony Evolution Inc', u'Catheter Connections Inc', u'DSM Pharmaceutical Products', u'Molecular Stethoscope Inc', u'Sanquin Blood Supply Foundation', u'Ascendance Biotechnology Inc', u'Seikagaku Corp', u'SurModics Pharmaceuticals', u'Corimmun GmbH', u'Merck Serono SA', u'Kalypsys Inc', u'French Government', u'Latitude Pharmaceuticals', u'Merck & Co Inc', u'University College London', u'Celera Diagnostics', u'Wellcome Trust Sanger Institute', u'Perlegen Sciences Inc', u'Epimmune Inc', u'EKR Therapeutics Inc', u'University of Virginia', u'University of California Irvine', u'Enhance Biotech Inc', u'Chicago Labs Inc', u'NicOx SA', u'Cyclacel Pharmaceuticals Inc', u'Ikano Therapeutics Inc', u'Medvet Science Pty Ltd', u'Nobex Corp', u'Avadel Pharmaceuticals plc', u'Teijin Ltd', u'Esteve', u'Cytori Therapeutics Inc', u'Idera Pharmaceuticals Inc', u'Human Genome Sciences Inc', u'Sinobiopharma Inc', u'Suntory Pharmaceutical Research Laboratories LLC', u'Lipigon Pharmaceuticals', u'deCODE genetics ehf', u'Sandoz Inc', u'Pieris Pharmaceuticals Inc', u'AFFiRiS AG', u'Cardurion Pharmaceuticals', u'Guerbet', u'EPIX Pharmaceuticals Inc', u'Hopital Universitaire de la Pitie Salpetriere', u'Rubicon Research Private Ltd', u'BioLineRx Ltd', u'LG Life Sciences Ltd', u'Scarista Ltd', u'Synthelabo', u'TissueNetix Inc', u'Trigen GmbH', u'Jiangsu Lianhuan Pharmaceutical Co Ltd', u'PhRMA Foundation', u'Solvay Pharmaceuticals Inc', u'UniQuest Pty Ltd', u'Novation', u'Xylocor Therapeutics Inc', u'Acusphere Inc', u'BioMedical Materials Program', u'Arena Pharmaceuticals Inc', u'NormOxys Inc', u'Xenome Ltd', u'Zambon Co SpA', u'ARTMS Products Inc', u'Provid Pharmaceuticals Inc', u'Cinvestav', u'Aarhus University', u'Heptares Therapeutics Ltd', u'CardioPep Pharma GmbH', u'National Institutes of Health', u'Tranzyme Pharma Inc', u'Sanford-Burnham Medical Research Institute', u'MediVas LLC', u'Laxdale Ltd', u'Synvista Therapeutics Inc', u'Curis Inc', u'Chronogen Inc', u'Zenyth Therapeutics Ltd', u'Advanced Tissue Sciences Inc', u'National Institutes of Standards and Technology', u'Taisho Biomed Instruments Co Ltd', u'University of Chicago', u'Cytopia Inc', u'Trinity College Dublin', u'Cardiobene SA', u'3-Dimensional Pharmaceuticals Inc', u'Jubilant Life Sciences Ltd', u'HenKan Pharmaceutical Co Ltd', u'Childrens Hospital of Philadelphia', u'Efarmes SA', u'DecImmune Therapeutics', u'The Menarini Group', u'Icagen Inc (pre-merger)', u'Biovail Laboratories International Srl', u'Genesys Pharma Inc', u'Cytopia Ltd', u'MannKind Corp', u'Gedeon Richter Ltd', u'X-Chem Inc', u'AcurePharma AB', u'Tripos Inc', u'BioCryst Pharmaceuticals Inc', u'TBG Diagnostics Ltd']), u'Reproductivedisorder': set([u'Universite Laval', u'Beijing Novogene Bioinformatics Technology Co Ltd', u'MSD OSS BV', u'Illumina Inc', u'PregLem Holding SA', u'Ore Pharmaceuticals Inc', u'PowderJect Pharmaceuticals plc', u'Faculdade de Medicina do ABC', u'Merck KGaA', u'University of Chile', u'Ipsen', u'Aventis Pharma AG', u'Sanofi Genzyme', u'Universita Degli Studi Di Roma \"Tor Vergata\"', u'University of Rochester', u'Smiths Medical', u'Genzyme Molecular Oncology', u'Ferring Research Ltd', u'Exact Sciences Corp', u'Coopersurgical Inc', u'Merck Serono SA', u'Reprogen Inc', u'Pfizer Inc', u'Nordic Life Science Pipeline Inc', u'Recalcine Pharmaceutical Corp']), u'Drugdependence': set([u\"Dr Reddy's Laboratories Ltd\", u'Karolinska Institutet', u'US Government', u'Novo Nordisk A/S', u'University of Florida', u'Indivior plc', u'DarPharma Inc', u'TheraKine Ltd', u'Forest Laboratories Inc', u'GlaxoSmithKline plc', u'New York State Psychiatric Institute', u'BTG plc', u'National Institute of Neurological Disorders and Stroke', u'NPS Allelix Corp', u'Sandia National Laboratories', u'Elite Pharmaceuticals Inc', u'University of Pennsylvania', u'MakScientific LLC', u'Mikah Pharma', u'Walter Reed Army Institute of Research', u'Takeda Oncology', u'Massachusetts College of Pharmacy and Health Sciences', u'CeNeS Pharmaceuticals plc', u'Inventiv Health Clinical Inc', u'University of Miami', u'The National Institute of Mental Health', u'Somaxon Pharmaceuticals Inc', u'University of Cambridge', u'Embera NeuroTherapeutics Inc', u'Gosnold on Cape Cod', u'Orexo AB', u'Pfizer Inc', u'Eolas Therapeutics Inc', u'Omeros Corp', u'Astraea Therapeutics LLC', u'Universite De Montreal', u'EMERpharma Ltd', u'MGI GP Inc', u'Savant HWP Inc', u'Biophor Diagnostics Inc', u'Large Scale Biology Corp', u'RespireRx Pharmaceuticals Inc', u'Abbott Laboratories', u'Catalyst Pharmaceutical Partners Inc', u'BioCorRx Inc', u'National Cancer Institute', u'Novartis AG', u'Aphios Corp', u'Portland Veterans Administration Research Foundation', u'Louisiana State University Medical Center Foundation', u'Georgetown University', u'Georgetown University Medical Center', u'Vanderbilt University', u'University at Buffalo', u'Santen Pharmaceutical Co Ltd', u'Peking University', u'University of Minnesota', u'Angelini Pharmaceuticals SpA', u'Phoenix PharmaLabs Inc', u'Perrigo Co plc', u'Insys Therapeutics Inc', u\"M's Science Corp\", u'Albany Molecular Research Inc', u'Anesta Corp', u'Xiamen Zhaoyang Biological Engineering Co Ltd', u'Janssen Pharmaceutica NV', u'Southern Research Institute', u'DrugAbuse Sciences Inc', u'Britannia Pharmaceuticals Ltd', u'Publicis Touchpoint Solutions', u'Rutgers University', u'Duke University', u'Sankyo Pharmaceutical', u'kDAC Therapeutics', u'Mallinckrodt plc', u'Bioprojet Pharma', u'Undisclosed', u'The Macfarlane Burnet Institute For Medical Research & Public Health Ltd', u'Amygdala Neurosciences Inc', u'Novartis Consumer Health Inc', u'Djavad Mowafaghian Centre for Brain Health', u'University of Texas System', u'National Health and Medical Research Council', u'InterveXion Therapeutics LLC', u'Laureate Biopharmaceutical Services Inc', u'Ardent Pharmaceuticals Inc', u'Biotie Therapies AG', u'Lundbeck Inc', u'Oregon Health Sciences University', u'TheraSci Ltd', u'National Institute on Drug Abuse', u'Aoxing Pharmaceutical Co Inc', u'Merck & Co Inc', u'Scripps Research Institute', u'The Third Institute of Oceanography State Oceanic Administration', u'Sanofi', u'Wyeth-Ayerst Pharmaceuticals Inc', u'Alkermes plc', u'Eli Lilly & Co', u'Addex Therapeutics Ltd', u'National Institute on Minority Health and Health Disparities', u'XenoPort Inc', u'Camurus AB', u'Ohmeda Inc', u'Amneal Pharmaceutical LLC', u'elbion NV', u'DNAPrint genomics Inc', u'Florida International University', u'IVAX Corp', u'SRI International', u'AstraZeneca plc', u'Esteve', u'Neurocrine Biosciences Inc', u'Asubio Pharma Co Ltd', u'State University of New York', u'Gilead Sciences Inc', u'EncepHeal Therapeutics Inc', u'Ambrosia Treatment Center', u'Northwest A&F University', u'Wyeth', u'Lifeloc Technologies Inc', u'University of Arkansas for Medical Sciences', u'Highland Pharmaceuticals LLC', u'Ore Pharmaceuticals Inc', u'Purdue University', u'Euthymics Bioscience Inc', u'Multimeric Biotherapeutics Inc', u'University of Kansas', u'Addiction Therapeutix Inc', u'Organix Inc', u'Pharm-Eco Laboratories Inc', u'Abiogen Pharma SpA', u'Heptares Therapeutics Ltd', u'Servier', u'National Institutes of Health', u'Medicago Inc', u'Lumiphore', u'WEX Pharmaceuticals Inc', u'New England Research Institutes', u'Cephalon Inc', u'Research Foundation for Mental Hygiene Inc', u'Roche Holding AG', u'VINNOVA', u'Oakwood Laboratories LLC', u'BioTie Therapies Corp', u'US WorldMeds LLC', u'Lederle Laboratories', u'University of British Columbia', u'University of California Irvine', u'Tripos Inc', u'Pisgah Laboratories Inc', u'VM Discovery Inc', u'Merz & Co GmbH', u'University of Arkansas']), u'Aggressivefibromatosis': set([u'BioSpecifics Technologies Corp', u'Auxilium Pharmaceuticals Inc', u'Memorial Sloan-Kettering Cancer Center', u'Food and Drug Administration']), u'Rhinopharyngitis': set([u'Fourth Military Medical University PLA', u'Biostar Pharmaceuticals Inc']), u'Lupusnephritis': set([u'Eli Lilly & Co', u'Vifor Pharma', u'BioMarin Pharmaceutical Inc', u'TxCell SA', u'MD Anderson Cancer Center', u'Astellas Institute for Regenerative Medicine', u'Lupus Research Institute', u'National Institute of Allergy and Infectious Diseases', u'EMD Serono Inc', u'Pertinax Therapeutics Inc', u'IDEC Pharmaceuticals Corp', u'Abbott Laboratories', u'Biogen Inc', u'ARC Ventures', u'Aspreva International Ltd', u\"Seattle Children's Hospital\", u'Lonza Group AG', u'Idun Pharmaceuticals Inc', u'Phytomedics Inc', u'XOMA Corp', u'Worldwide Clinical Trials', u'Oso Biopharmaceuticals Manufacturing LLC', u'Hanmi Pharmaceutical Co Ltd', u'British Canadian Biosciences Corp', u'SuppreMol GmbH', u'Massachusetts General Hospital', u'Genentech Inc', u'AZANO biotech', u'La Jolla Pharmaceutical Co', u'Zenyaku Kogyo Co Ltd', u'University of Alabama at Birmingham', u'Astellas Pharma Inc', u'Roche Holding AG', u'Aurinia Pharmaceuticals Inc', u'Medical University of South Carolina', u'Nippon Kayaku Co Ltd', u'Ospedale San Raffaele', u'Novartis Institutes for BioMedical Research Inc', u'ChemoCentryx Inc', u'Kissei Pharmaceutical Co Ltd', u'Hikma Pharmaceuticals plc', u'University of Colorado System', u'National Institute of Diabetes, Digestive and Kidney Diseases', u'Nordic Group', u'Pfizer Inc', u'Kineta Inc', u'Taligen Therapeutics Inc', u'F Hoffmann-La Roche AG', u'German Federal Ministry of Education and Research', u'Broad Institute Inc']), u'Bladderpain': set([u'Ferring Research Ltd', u'University of Pittsburgh']), u'Myocarditis': set([u'CEL-SCI Corp', u'Johns Hopkins University', u'Chinese Academy of Medical Sciences & Peking Union Medical College', u'Qingdao University of Science and Technology']), u'Exocrinepancreaticinsufficiency': set([u'Eli Lilly & Co', u'Anthera Pharmaceuticals Inc', u'Digestive Care Inc', u'Chiesi USA Inc', u'Laboratoires Mayoly Spindler', u'AzurRx BioPharma Inc', u'Cystic Fibrosis Foundation Therapeutics Inc', u'Tonghua Dongbao Pharmaceutical Co Ltd', u'University of Munster', u'Swedish Orphan Biovitrum AB', u'Cilian AG', u'ProteaBio Europe SAS', u'DSM BioSolutions']), u'Thalassemia': set([u'Crucell NV', u'Boston University', u'National Institutes of Health', u'Phoenicia Biosciences Inc', u'National Heart Lung and Blood Institute', u'Ercole Biotech Inc', u'Sarepta Therapeutics Inc', u'Chinese Government', u'Hangzhou Zede Pharmaceutical Technology Co Ltd', u'Kiadis Pharma Netherlands BV', u'Rijksuniversiteit te Leiden', u'The Thalassaemia International Federation']), u'Vulvovaginitis': set([u'Lumavita AG', u'Shogoo Pharmaceuticals KK']), u'deLangesyndrome': set([u'Recursion Pharmaceuticals LLC', u'Eunice Kennedy Shriver National Institute of Child Health & Human Development']), u'Adhesivecapsulitis': set([u'BioSpecifics Technologies Corp', u'Auxilium Pharmaceuticals Inc']), u'Sensorineuralhearingloss': set([u'Roche Holding AG', u'University of South Florida', u'Pragma Therapeutics', u'Hough Ear Institute', u'Royal National Institute for Deaf People', u'Nippon Boehringer Ingelheim Co Ltd', u'Otologic Pharmaceutics Inc', u'Inception Sciences Inc', u'Advanced Bionics Corp', u'Kyoto University', u'University of Washington Medical Center']), u'Herpesvirustype6infection': set([u'Cancer Prevention and Research Institute of Texas', u'Microbiotix Inc', u'Institute of Human Virology', u'Idera Pharmaceuticals Inc', u'Rega Institute for Medical Research', u'National Institute of Allergy and Infectious Diseases', u'Viracyte', u'Sanofi']), u'Acutedecompensatedheartfailure': set([u'Janssen Pharmaceuticals Inc', u'Renova Therapeutics Inc', u'Roche Holding AG', u'Cardiorentis Ltd']), u'Mycosisfungoides': set([u'Hayashibara Co Ltd', u'Innate Pharma SA', u'Maruho Co Ltd', u'Vivalis', u'Otsuka Pharmaceutical Co Ltd', u'OSEO', u'Mochida Pharmaceutical Co Ltd', u'Suntory Ltd']), u'Obstetrics': set([u'Plethora Solutions Holdings plc', u'HCB Happy Child Birth Holding AG']), u'Decompensatedlivercirrhosis': set([u'Rohto Pharmaceutical Co Ltd', u'Niigata University']), u'Sarcoma': set([u'US Government', u'Cancer Research Campaign Technology Ltd', u'GenVec Inc', u'US Health and Human Services Department', u'Pharmacyclics Inc', u'GlaxoSmithKline plc', u\"Cincinnati Children's Hospital Medical Center\", u'MabVax Therapeutics Inc', u'Pharmatech Inc', u'MedImmune LLC', u'ArQule Inc', u\"Alex's Lemonade Stand Foundation\", u'Eleison Pharmaceuticals Inc', u'Leiden University Medical Center', u'Bellicum Pharmaceuticals Inc', u'Immunocore Ltd', u'Shire plc', u'ARIAD Pharmaceuticals Inc', u'Merck Sharp & Dohme Corp', u'Peregrine Pharmaceuticals Inc', u'Kite Pharma Inc', u'Archerdx Inc', u'Shionogi & Co Ltd', u'Vertex Pharmaceuticals Inc', u'Sarcoma Alliance for Research through Collaboration', u'RecipharmCobra Biologics', u'Xenova Ltd', u'Exelixis Inc', u'Iovance Biotherapeutics Inc', u'Molecular Pathology Laboratory Network Inc', u'MD Anderson Cancer Center', u'Institut Armand-Frappier', u'Baxter Oncology GmbH', u'Daiichi Sankyo Co Ltd', u'Abbott Laboratories', u'Ohio State University', u'JCR Pharmaceuticals Co Ltd', u'National Cancer Institute', u'Merck KGaA', u'ZIOPHARM Oncology Inc', u'SRI International', u'Fujisawa Pharmaceutical Co Ltd', u'Vanderbilt University', u'Y-mAbs Therapeutics Inc', u'Abgenix Inc', u'Transgene SA', u'Predictive Therapeutics', u'MediBIC', u'Threshold Pharmaceuticals Inc', u'Janssen Korea Ltd', u'Boehringer Ingelheim Corp', u'Tapestry Pharmaceuticals Inc', u'University of California San Diego', u'Swedish Orphan Biovitrum AB', u'F Hoffmann-La Roche AG', u'Patheon Pharmaceuticals Inc', u'MD Biosciences GmbH', u'Cancer Research UK', u'Ortho Biotech Products LP', u'StemSynergy Therapeutics Inc', u'North Central Cancer Treatment Group', u'Biogen Inc (FL)', u'Southern Research Institute', u'University of Chieti, Italy', u'Merck & Co Inc', u'Gemin X Pharmaceuticals Inc', u'LEO Pharma A/S', u'Sanofi', u'University of Texas Southwestern Medical Center', u'CTI BioPharma Corp', u'Eli Lilly & Co', u'Supratek Pharma Inc', u'PharmaMar SA', u'Phyton Biotech Inc', u'ScinoPharm Taiwan Ltd', u'Madrigal Pharmaceuticals Inc', u'University of Pittsburgh Medical Center', u'Pfizer Inc', u'Xynomic Pharmaceuticals', u'Triangle Pharmaceuticals Inc', u'Cancer Research Technology Ltd', u'Columbia University', u'Memorial Sloan-Kettering Cancer Center', u'Johnson & Johnson', u'Tularik Inc', u'Baylor College of Medicine', u'Paul Scherrer Institut', u'PharmaGap Inc', u'BioChem Therapeutic Inc', u'Medipharm Biotech Co Ltd', u'National Institutes of Health', u'Salmedix Inc', u'Bristol-Myers Squibb Co', u'INSERM', u'Cedars-Sinai Medical Center', u'University of Chicago', u'Oakwood Laboratories LLC', u'MediaPharma Srl', u'AmpliPhi Biosciences Corp', u'TopoTarget A/S', u'Epeius Biotechnologies Corp', u'Mayne Pharma Pty Ltd', u'CuraGen Corp', u'Systems Medicine Inc']), u'Motionsickness': set([u'Marina Biotech Inc', u'Schwarz Pharma Inc']), u'Polycythemiavera': set([u'University of California Los Angeles', u'PharmaEssentia Corp', u'Novartis AG', u'AOP Orphan Pharmaceuticals AG', u'National Institute of Diabetes, Digestive and Kidney Diseases', u'Incyte Corp']), u'Bonemetastases': set([u'Singapore Technologies Pte Ltd', u'Chugai Pharmaceutical Co Ltd', u'Diatide Inc', u'Pharmatest Services Oy', u'Genentech Inc', u'MetCure Therapeutics LLC', u'Amgen Inc', u'University of Missouri', u'Agamyxis', u'Feiyang Biotech (Jilin) Co Ltd', u'Daiichi Sankyo Co Ltd', u'Diomed Ltd', u'Schering-Plough Corp', u'GlaxoSmithKline plc', u'Algeta ASA', u'Top Institute Pharma', u'Eddingpharm Inc', u'National Cancer Institute', u'Bayer Schering Pharma AG', u'Advanced Accelerator Applications SA', u'Cytogen Corp', u'IASON GmbH', u'CIS Bio International SAS', u'Undisclosed', u'The Dow Chemical Co', u'Suzhou Alphamab Co Ltd', u'Ablynx NV', u'Poniard Pharmaceuticals Inc', u'Daewoong Pharmaceutical Co Ltd', u'biolitec AG', u'Royal Philips Electronics', u'Immunovo BV', u'Brookhaven National Laboratory', u'Vernalis plc', u'Asahi Kasei Pharma Corp', u'Abgenix Inc', u'Jiangsu Laitai Medical Biotechnology Co Ltd', u'BioFocus DPI', u'Taconic Biosciences Inc', u'Isotopen Technologien M\\xfcnchen AG', u'Ono Pharmaceutical Co Ltd', u\"People's Government of Jiangsu Province\", u'Astellas Pharma Inc', u'Roche Holding AG', u'Osteros Biomedica', u'Efamol', u'Profound Medical Inc', u'Galapagos NV', u'Pepscan Systems BV', u'US Department of Energy', u'Rhone-Poulenc SA', u'University of Colorado System', u'Universitair Medisch Centrum Utrecht', u'AstraZeneca plc', u'Boehringer Ingelheim Corp', u'Novartis AG', u'Kyowa Hakko Kogyo Co Ltd', u'Kyowa Kirin', u'DuPont Pharmaceuticals Ltd', u'Human Genome Sciences Inc', u'CisThera Inc', u'PPD Discovery Inc', u'MBC Pharma Inc', u'Shanghai Institute of Applied Physics Chinese Academy of Sciences', u'Scotia Holdings plc']), u'Machado-Josephdisease': set([u'Catalent Inc', u'Jupiter Orphan Therapeutics Inc']), u'Epistaxis': set([u'Fondazione Telethon', u'Fondazione IRCCS Policlinico San Matteo', u'Entellus Medical Inc', u'CogENT Therapeutics LLC']), u'Escherichiacoliinfection': set([u\"Dr Reddy's Laboratories Ltd\", u'ID Vaccine Corp', u'Takeda Vaccines Inc', u'US Government', u'Diatherix Laboratories Inc', u'Vaccine Technologies Inc', u'Sanofi Pasteur', u'GlaxoSmithKline plc', u'ImmuCell Corp', u'Immuron Ltd', u'Hawker Resources Inc', u'Institut Curie', u'Ribi ImmunoChem Research Inc', u'Celldex Therapeutics Inc', u'University of Washington', u'Walter Reed Army Institute of Research', u'University of British Columbia', u\"Let's Talk Recovery Inc\", u'Direct Relief International', u'Etvax AB', u'Intercell AG', u'Merckle GmbH', u'Defense Advanced Research Projects Agency', u'US Department of Defense', u'UCB SA', u'University of Massachusetts Medical School', u'Pro Bono Bio', u'Tramedico International', u'Active Biotech AB', u'The European Union', u'LFB SA', u'Cambridge Biostability Ltd', u'GeneThera Inc', u'AbCellera Biologics Inc', u'AvidBiotics Corp', u'Creative Antibiotics Sweden AB', u'Navigen Inc', u'Wellcome Trust', u'Pherecydes Pharma', u'Oxford Drug Design', u'GlycoVaxyn AG', u'Johns Hopkins University', u'Qotics AS', u'University of California San Diego', u'AmpliPhi Biosciences Corp', u'VINNOVA', u'Almac Group', u'Alexion Pharmaceuticals Inc', u'Sumitomo Dainippon Pharma Co Ltd', u'Westmead Millennium Institute for Medical Research', u'Emergent BioSolutions Inc', u'Antex Biologics Inc', u'Sanofi', u'University of Texas Southwestern Medical Center', u'GlaxoSmithKline Biologicals', u'US Naval Medical Research Center', u'Prokarium', u'Arsanis Biosciences GmbH', u'US Army Medical Research Institute of Infectious Diseases', u'New York University School of Medicine, US', u'Teijin Ltd', u'Technology Strategy Board', u'The Austrian Research Promotion Agency FFG', u'ProdiGene Inc', u'Acambis Research Ltd', u'PDL BioPharma Inc', u'Spero Therapeutics LLC', u'Acambis plc', u'Alcon Inc', u'Inclinix Inc', u'Australian Government', u'Phico Therapeutics Ltd', u'Pharmascience Inc', u'The Institute for OneWorld Health', u'National Institute of Allergy and Infectious Diseases', u'Thallion Pharmaceuticals Inc', u'Alfa Wassermann SpA', u'UCB Celltech', u'EpiBiome Inc', u'Bill & Melinda Gates Foundation', u'University of Tokyo', u'PATH Enteric Vaccine Initiative', u'Novavax Inc', u'A-CUBE Inc', u'INSERM', u'ACE BioSciences A/S', u'Intercell USA', u'Astellas Pharma Inc', u'Janssen Pharmaceuticals Inc', u'Napo Pharmaceuticals Inc', u'University of New Mexico', u'Takeda Pharmaceutical Co Ltd']), u'Hereditaryangioedema': set([u'Pharming NV', u'CVS Caremark', u'Express Scripts Inc', u'Weill Medical College of Cornell University', u'Sanquin Blood Supply Foundation', u'Hyupjin Corp', u'Kos Pharmaceuticals Inc', u'CMIC Holdings Co Ltd', u'CSL Behring LLC', u'Novellus Biopharma AG', u'Accovion GmbH', u'Taiba Pharma LLC', u'ViroPharma Inc', u'Cytobioteck', u'Hyland Immuno', u'University of Colorado at Denver and Health Sciences Center', u'AntriaBio Inc', u'Food and Drug Administration', u'Transmedic Pte Ltd', u'Eczacibasi Ilac Pazarlama AS', u'FFF Enterprises', u'Annapurna Therapeutics SAS', u'Genzyme General', u'Paul Capital Healthcare', u'ActiveSite Pharmaceuticals Inc', u'Sanofi', u'Diosynth BV', u'Lev Pharmaceuticals Inc', u'Fujifilm Diosynth Biotechnologies', u'Dompe Farmaceutici SpA', u'Defiante Farmaceutica Lda', u'Vince and Associates Clinical Research', u'Valeant Pharmaceuticals International Inc', u'Halozyme Therapeutics Inc', u'Swedish Orphan Biovitrum AB', u'CVie Therapeutics Co Ltd', u'Santarus Inc', u'MegaPharm Ltd', u'BioRx', u'Sanofi Genzyme', u'Shire Orphan Therapies GmbH', u'Dyax Corp', u'National Center for Research Resources', u'Neopharm Ltd', u'Pint Pharma', u'Pharming Group NV', u'Sanofi Chimie SA', u'Shire Human Genetic Therapies Inc']), u'Slysyndrome': set([u'St Louis University', u\"Steven and Alexandra Cohen Children's Medical Center of New York\", u'Ultragenyx Pharmaceutical Inc']), u'Pulmonaryedema': set([u'Mediolanum Farmaceutici SpA', u'Apeptico Forschung und Entwicklung GmbH']), u'Intestineinfection': set([u'National Institute of Allergy and Infectious Diseases', u'University of California San Diego']), u'Heterotopicossification': set([u'Io Therapeutics Inc', u'Thomas Jefferson University', u'Childrens Hospital of Philadelphia', u'University of Michigan']), u'Downsyndrome': set([u\"Alzheimer's Disease Research Foundation\", u'NovAliX', u'University of Queensland', u'National Institute of Neurological Disorders and Stroke', u'Stanford University', u'University of California San Diego School of Medicine', u'Balance Therapeutics Inc', u'Elixirgen Llc', u'NeuroNascent Inc', u'National Institutes of Health', u'KinoPharma Inc', u'Queensland Government', u'Global Down Syndrome Foundation', u'Universidade Estadual De Maringa', u'Lumiphore', u'Fondation Jerome Lejeune', u'University of Michigan', u'Thermo Fisher Scientific Inc', u'Vanderbilt University', u'Carna Biosciences Inc', u'The Jerome Lejeune Foundation', u'Maryland Biotechnology Center', u'UFR Sciences Pharmaceuticals', u'Tufts University', u'AC Immune SA', u'Horizon Orphan LLC', u'University of Colorado System', u'ManRos Therapeutics', u'Bracco SpA', u'Technische Universitat Darmsdadt', u'Cortice Biosciences Inc', u'Ikonisys Inc', u'National Institute on Aging', u'Johns Hopkins University', u'University of California San Diego', u'LuMind Research Down Syndrome Foundation', u'Northwest A&F University', u'Kent State University', u'Abide Therapeutics Inc']), u'HepatitisEvirusinfection': set([u'Hong Kong University of Science & Technology', u'Beijing Zhifei Luzhu Biopharmaceutical Co Ltd', u'Select Exploration Ltd', u'Fujian provincial government', u'National Institutes of Health', u'Walter Reed Army Institute of Research', u'MP Biomedicals LLC', u'Changchun Institute of Biological Products', u'Beijing Wantai Biological Pharmacy Enterprise Co Ltd', u'Novavax Inc', u'Genelabs Technologies Inc', u'Chinese Government', u'The European Union', u'Xiamen Innovax Biotech Co Ltd', u'SmithKline Beecham plc', u'Xiamen University', u'Institut Pasteur']), u'Tinnitus': set([u'US Government', u'Sensorion Pharmaceuticals', u'Autifony Therapeutics Ltd', u'Cystic Fibrosis Foundation Therapeutics Inc', u'Endo Health Solutions Inc', u'Oklahoma Medical Research Foundation', u'Sound Pharmaceuticals Inc', u'NeuroSystec Corp', u'Otifleks', u'US Department of Defense', u'DURECT Corp', u'Undisclosed', u'Forest Laboratories Inc', u'Ipsen', u'French Government', u'Oklahoma Center for the Advancement of Science and Technology', u'INSERM', u'University of Pittsburgh', u'Immune Pharmaceuticals Inc', u'Auris Medical Holding AG', u'Hough Ear Institute', u'Kyorin Pharmaceutical Co Ltd', u'Otologic Pharmaceutics Inc', u'Merck Serono SA', u'Flexion Therapeutics Inc', u'Otonomy Inc', u'ADM Tronics Unlimitd Inc', u'Technology Strategy Board', u'Merz North America', u'Merz & Co GmbH', u\"King's College London\"]), u'Streptococcuspyogenesinfection': set([u'Olymvax Biopharmaceuticals Inc', u'Promiliad Biopharma Inc', u'University of Connecticut', u'US Army Medical Research Institute of Infectious Diseases', u'VaxForm LLC', u'National Institute of Allergy and Infectious Diseases', u'Statens Serum Institut', u'Griffith University']), u'Carcinoidtumor': set([u'Roswell Park Cancer Institute', u'National Comprehensive Cancer Network', u'Novartis AG', u'Advanced Accelerator Applications SA', u'Beijing Kawin Technology Share-Holding Co Ltd', u'Eckert & Ziegler Eurotope Gmbh', u'Molecular Insight Pharmaceuticals Inc', u'University of Iowa', u'Sahar International Trading Inc']), u'Clostridiuminfection': set([u'University of California Davis', u'Mapp Biopharmaceutical Inc', u'University of Arizona']), u'Treponemapalliduminfection': set([u'Fiotec- Fundacao para o Desenvolvimento Cientifico e Tecnologico em Saude', u'University of California Los Angeles', u'National Health and Medical Research Council', u'The Macfarlane Burnet Institute For Medical Research & Public Health Ltd', u'Bio-Manguinhos/Fiocruz', u'National Institute of Allergy and Infectious Diseases', u'Chembio Diagnostic Systems Inc', u'Isla Lab Products LLC']), u'Lungtransplantrejection': set([u'Apeptico Forschung und Entwicklung GmbH', u'Baxter International Inc', u'Lung Biotechnology Inc', u'Mediolanum Farmaceutici SpA', u'ImmuneWorks Inc', u'PARI Pharma GmbH', u'Kamada Ltd', u'Breath Therapeutics Holding BV']), u'Decubitusulcer': set([u'US Government', u'Molnlycke Health Care AB', u'Defiante Farmaceutica Lda', u'Smith & Nephew plc', u'National Institutes of Health', u'CellMark AB', u'Leaf Healthcare, Inc', u'RegeneRx Biopharmaceuticals Inc', u'Bioderm Inc', u'Rochal Industries Llp']), u'Tissuetransplantation': set([u'National Institute of General Medical Sciences', u'Nanovalent Pharmaceuticals Inc']), u'Burkittslymphoma': set([u'Altor BioScience Corp', u'Fred Hutchinson Cancer Research Center', u'CMC Biologics Inc', u'University of Gothenburg', u'Arvinas Inc', u'University of British Columbia', u'Yale University', u'University of Washington', u'Elan Corp plc', u'Talon Therapeutics Inc', u'Inex Pharmaceuticals Corp']), u'Yersiniainfection': set([u'US Government', u'Fox Chase Cancer Center', u'Fox Chase Chemical Diversity Center Inc']), u'Angiogenesisdisorder': set([u'TRACON Pharmaceuticals Inc', u'Johnson & Johnson', u'US Government', u'University of North Carolina', u'Regeneron Pharmaceuticals Inc', u'Genentech Inc', u'University of California San Diego School of Medicine', u'Gilead Palo Alto Inc', u'CJ Corp', u'Connetics Corp', u'Kirin Brewery Co Ltd', u'Mayo Clinic Foundation', u'National Center for Research Resources', u'University of California Discovery Fund', u'Vical Inc', u'Roswell Park Cancer Institute', u'BioActa Ltd', u'OmegaGenesis', u'National Cancer Institute', u'Novartis AG', u'Aventis Cambridge Genomics Center LLC', u'SciClone Pharmaceuticals Inc', u'Korea Research Institute of Bioscience and Biotechnology', u'Endovasc Inc', u'Advanced Medical Imaging LLC', u'ZentralKlinik Bad Berka GmbH', u'Imgenex Corp', u'Morphotek Inc', u'Renovis Inc', u'Imclone LLC', u'Bionomics Ltd', u'COR Therapeutics Inc', u'Regulus Therapeutics Inc', u'Stanford University', u'GNI Group Ltd', u'Istituto di Ricerche Farmacologiche Mario Negri', u'CASI Pharmaceuticals Inc', u'Advanced Imaging Projects LLC', u'Integra LifeSciences Holdings Corp', u'University of California Davis', u'Navigen Inc', u'Genzyme Molecular Oncology', u'Duke University', u'JW Pharmaceutical Corp', u'RegeneRx Biopharmaceuticals Inc', u'National Eye Institute', u'Bracco SpA', u'AnGes MG Inc', u'Seattle Life Sciences', u'Eyetech Inc', u'Sanofi', u'Corthera Inc', u'ZymoGenetics Inc', u'Gilead Sciences Inc', u'Kyowa Hakko Kogyo Co Ltd', u'Sanford-Burnham Medical Research Institute', u'Harvard TH Chan School of Public Health', u'University of Cambridge', u'Discovery Genomics Inc', u'University of Nebraska Medical Center', u'Johns Hopkins University', u'Baxter Healthcare Ltd']), u'Diastolicheartfailure': set([u'Par Pharmaceutical Co Inc', u'BioMarin Pharmaceutical Inc']), u'Immunization': set([u'US Government', u'Ichor Medical Systems Inc', u'University of Wisconsin-Madison', u'Ferrer Internacional SA', u'UK Government', u'Emory University', u'Sakai Chemical Industry Co Ltd', u'Global Alliance for Vaccines and Immunization', u'National Center for Research Resources', u'Theratechnologies Inc', u'National Institute of Allergy and Infectious Diseases', u'Cristalia', u'Instituto Butantan']), u'Kaposiss': set([u'Eisai Co Ltd', u'Ewopharma AG']), u'Otorhinolaryngologicaldisease': set([u'Polyganics BV', u'Burton Hospitals NHS Foundation Trust', u'Stryker Corp', u'Martindale Pharma']), u'Behcetsdisease': set([u'NOBEL ILAC Sanayii ve Ticaret AS', u'Janssen Biotech Inc', u'CASI Pharmaceuticals Inc', u'Celgene Corp', u'XOMA Corp', u'Advanced Biotherapy Inc', u'Servier', u'Amarillo Biosciences Inc', u'AbbVie Inc', u'Mitsubishi Tanabe Pharma Corp', u'Lipomed AG', u'Ceragenix Pharmaceuticals Inc', u'Royalty Pharma', u'Eisai Co Ltd', u'GroupMed (Holding)', u'Brigham Young University', u'TOLMAR Therapeutics Inc']), u'Paracetamoloverdose': set([u'PledPharma AB', u'University of Edinburgh']), u'Autosomaldominantdisorder': set([u'Albert-Ludwigs-Universit\\xe4t Freiburg', u'Synthego']), u'Wilsondisease': set([u'Vivet Therapeutics', u'Massachusetts Eye & Ear Infirmary', u'Revive Therapeutics Ltd', u'Valeant Pharmaceuticals North America LLC', u'Orphan Europe SARL', u'Fundacion para la Investigacion Medica Aplicada', u'Dimension Therapeutics Inc', u'Medical Need Europe AB', u'Teva Pharmaceutical Industries Ltd', u'Perelman School of Medicine', u'Undisclosed', u'Tactic Pharma LLC', u'Kadmon Pharmaceuticals LLC']), u'Septicshock': set([u'Atox Bio Inc', u'MGI GP Inc', u'Novo Nordisk A/S', u'Undisclosed', u'Rega Institute for Medical Research', u'RegeneRx Biopharmaceuticals Inc', u'National Institute of Allergy and Infectious Diseases', u'Curacyte AG', u'Lynx Therapeutics GmbH', u'Pathogenex GmbH', u\"Ataxia Telangiectasia Children's Project Inc\", u'Lonza Group AG', u'Chiron Corp', u'National Institutes of Health', u'US Government', u'Keryx Biopharmaceuticals Inc', u'Merck & Co Inc', u'Radikal Therapeutics Inc', u'Fast-Track Drugs and Biologics LLC', u'Sanofi-Synthelabo', u'Sanofi', u'BioXell SpA', u'Warner Lambert Pty Ltd', u'Bayer AG', u'Sumitomo Pharmaceuticals Co Ltd', u'Defiante Farmaceutica Lda', u'Epimmune Inc', u'Medinox Inc', u'UCB Celltech', u'PUMC Pharmaceutical Co Ltd', u'Attogen Inc', u'BRAHMS AG', u'Hebrew University of Jerusalem', u'Immuno-Designed Molecules SA', u'Binational Industrial Research and Development Foundation', u'Fibrex Medical R&D GmbH', u'Biophage Pharma Inc', u'Ikaria Inc', u'Ortho-Clinical Diagnostics Inc', u'Yissum Research Development Co', u'National Institute of General Medical Sciences', u'BASF AG']), u'Gastritis': set([u'Nippon Shinyaku Co Ltd', u'Biohit OYJ', u'Pooyandegan Pezeshki Pardis', u'Abbott Laboratories', u'Zeria Pharmaceutical Co Ltd', u'Eisai Co Ltd', u'Japan Upjohn Ltd', u'Dainippon Pharmaceutical Co Ltd', u'Alfa Wassermann SpA', u'Hamamatsu University School of Medicine', u'Shanghai Pharmaceutical Group Corp', u'Astra AB', u'Sumitomo Dainippon Pharma Co Ltd', u'Daewoong Pharmaceutical Co Ltd', u'Sanofi', u'Daewon Pharm Co Ltd', u'Salix Pharmaceuticals Inc', u\"Lee's Pharmaceutical Holdings Limited\", u'The Procter & Gamble Co', u'Seoul National University', u'Ono Pharmaceutical Co Ltd', u'Taejoon Pharm Co Ltd', u'Taiho Pharmaceutical Co Ltd', u'Fujirebio KK', u'Dong-A ST Co Ltd', u'Glaxo Group Ltd', u'Pfizer Inc', u'Boehringer Ingelheim Corp', u'Merckle GmbH', u'Takeda Pharmaceutical Co Ltd', u'Kitasato Institute', u'SK Chemicals Co Ltd', u'Sigma-Tau Ind Farm Riunite SpA']), u'Thyroiddisease': set([u'Chugai Pharmaceutical Co Ltd', u'NPS Pharmaceuticals Inc', u'Takeda Pharmaceuticals International GmbH', u'Acino Holding AG', u'ASKA Pharmaceutical Co Ltd', u'Altea Therapeutics', u'Theraclion', u'Merck KGaA', u'Inner Mongolia Furui Medical Science Co Ltd', u'Merck & Co Inc', u'Jerome Stevens Pharmaceuticals Inc', u'Sanofi Genzyme', u'KAI Pharmaceuticals Inc', u'Hospira Inc', u'Par Pharmaceutical Co Inc', u'Kyowa Hakko Kirin Co Ltd', u'Merck Serono SA', u'Lannett Co Inc', u'Prasco Laboratories', u'Shire Orphan Therapies GmbH', u'Neopharma', u'Rising Pharmaceuticals Inc', u'DRI Capital']), u'Carotidstenosis': set([u'Clarity Pharmaceuticals Pty Ltd', u'InspireMD Inc', u'Cardiobene SA', u'Baker IDI Heart & Diabetes Institute Holdings Ltd', u'Dispositivos Medicos EIRL', u'Angiocare BV']), u'Rhinitis': set([u'Sanofi-Aventis US LLC', u'Nippon Shinyaku Co Ltd', u'Terumo Corp', u'Galenica AG', u'Mitsubishi Pharma Corp', u'Dynavax Technologies Corp', u'Andrx Corp', u'National Institute of Allergy and Infectious Diseases', u'Bayer Yakuhin Ltd', u'Shionogi Pharma Inc', u'Biosintetica Farmaceutica Ltda', u'Yamanouchi Pharmaceutical Co Ltd', u'Undisclosed', u'Grupo Uriach', u'Nippon Boehringer Ingelheim Co Ltd', u'Merck & Co Inc', u'Italfarmaco SpA', u'ANI Pharmaceuticals Inc', u'Sanofi', u'Sankyo Co Ltd', u'Zeneca Group plc', u'Bayer AG', u'Sumitomo Pharmaceuticals Co Ltd', u'Epimmune Inc', u'Shire plc', u'Biovail Technologies Ltd', u'Kyorin Pharmaceutical Co Ltd', u'Deerfield Management Company LP', u'Tabuk Pharmaceutical Manufacturing Co', u'Celera South San Francisco', u'Prasco Laboratories', u'Par Pharmaceutical Inc', u'Janssen Pharmaceutica NV', u'Hisamitsu Pharmaceutical Co Inc', u'AstraZeneca plc', u'Esteve', u'Shionogi & Co Ltd', u'Sunovion Pharmaceuticals Inc', u'BIAL Group', u'Recordati SpA']), u'Chronicbronchitis': set([u'Oscient Pharmaceuticals Corp', u'US Government', u'University of North Carolina', u'Duke University Medical Center', u'Genentech Inc', u'SmithKline Beecham Corp', u'Rigel Pharmaceuticals Inc', u'RegeneRx Biopharmaceuticals Inc', u'Abbott Laboratories', u'Aeolus Pharmaceuticals Inc', u'Astra AB', u'GlaxoSmithKline plc', u'Bayer Korea Ltd', u'Zambon Co SpA', u'National Cancer Institute', u'National Institutes of Health', u'Defiante Farmaceutica Lda', u'Circassia Pharmaceuticals plc', u'Chong Kun Dang Pharmaceutical Corp', u'Takeda Oncology', u'Bayer AG', u'Concordia Pharmaceuticals Inc', u'ALZA Corp', u'Albany Molecular Research Inc', u'Kissei Pharmaceutical Co Ltd', u'SK Chemicals Life Science', u'LG Chem Ltd', u'Theron Pharmaceuticals Inc', u'AstraZeneca plc', u'Pfizer Inc', u'Inspire Pharmaceuticals Inc', u'Ilsung Pharmaceutical Co Ltd', u'National Heart Lung and Blood Institute', u'Synthetic Biologics Inc', u'Teligent Inc']), u'Scleritis': set([u'FDA Office of Orphan Products Development', u'University of Pennsylvania', u'Johns Hopkins University School of Medicine', u'Eyegate Pharmaceuticals Inc', u'Food and Drug Administration', u'XOMA Corp', u'National Eye Institute']), u'Functionalboweldisorder': set([u'Eli Lilly & Co', u'Takeda Pharmaceutical Co Ltd', u'Mitsubishi Pharma Corp', u'Shire plc', u'Adolor Corp', u'Queen Mary University of London', u'Provid Pharmaceuticals Inc', u'National Institute of Digestive Disorders and Kidney Disease', u'Argenta Discovery Ltd', u'Arachnova Ltd', u'GlaxoSmithKline plc']), u'Urethr': set([u'Fujifilm Finechemicals Co Ltd', u'Cempra Inc']), u'T-ce': set([u'CuraGen Corp', u'TopoTarget A/S']), u'Palpitation': set([u'Shandong Disha Pharmaceutical Co Ltd', u'Academy of Traditional Chinese Medical Science & Medicine of Jilin Province']), u'Qfever': set([u'Australian Government', u'Defense Threat Reduction Agency', u'Massachusetts General Hospital', u'Defence Science and Technology Laboratory', u'bioCSL PTY Ltd']), u'Motorneuronedisease': set([u\"Alzheimer's Disease Research Foundation\", u'Legacy Pharma', u'Weill Medical College of Cornell University', u'Chronos Therapeutics', u'US Government', u'Regeneron Pharmaceuticals Inc', u'Herantis Pharma Plc', u'Reino de Espana', u\"Alzheimer's Drug Discovery Foundation\", u'Ecole Polytechnique Federale de Lausanne', u'ProMIS Neurosciences Inc', u'Weston Brain Institute', u'miRagen Therapeutics Inc', u'SpePharm Holding BV', u'Max Planck Institut fur Experimentelle Medizin', u'European Commission', u'Q Therapeutics Inc', u'Harvard NeuroDiscovery Center', u'California Institute of Regenerative Medicine', u'Rockefeller University', u'Biogen Inc', u'Aeolus Pharmaceuticals Inc', u'JHP Pharmaceuticals LLC', u'Hudson Alpha Institute For Biotechnology', u'Life Technologies Corp', u'University of Gottingen', u'Bruschettini SRL', u'Kadimastem Ltd', u'NsGene A/S', u'Hadasit Medical Research Services and Development Ltd', u'Bayer Schering Pharma AG', u'Universitair Medisch Centrum Utrecht', u'Chiron Corp', u'National Institute of Neurological Disorders and Stroke', u'New Jersey Health Foundation Inc', u'Flinders University of South Australia', u'MGI Pharma Inc', u'Ionis Pharmaceuticals Inc', u'Hermo Pharma Oy Ltd', u'Massachusetts Life Sciences Center', u'GeNeuro SA', u'University of Florida', u'Neugen Pharma Inc', u'European Community', u'Muscular Dystrophy Association', u'Microbot Medical Inc', u'Aestus Therapeutics Inc', u'LTT Bio-Pharma Co Ltd', u'Galena Biopharma Inc', u'Boston University School of Medicine', u'Two Cells Co Ltd', u'Ono Pharmaceutical Co Ltd', u'Houston Methodist Hospital', u'Voyager Therapeutics', u'MeiraGTx', u'Neostem Oncology', u'Abbott Healthcare Products BV', u'NantHealth Inc', u'University of Miami Miller School of Medicine', u'BrainStorm Cell Therapeutics Inc', u'NeuroSense Therapeutics', u'Torrey Pines Institute for Molecular Studies', u'Harvard Stem Cell Institute', u'VIB', u'Phase 2 Discovery Inc', u'Dompe SpA', u'Relief Therapeutics Holding AG', u'Temple University', u'Neurotec Pharma SL', u'University of Michigan', u'California Pacific Medical Center', u'Regulus Therapeutics Inc', u'Emory University', u'University of California San Francisco', u'NeuroNova AB', u'IDIS Ltd', u'REGENXBIO Inc', u'Accenture', u'Institut du Cerveau et de la Moelle epiniere', u'Tego BioSciences Corp', u'UCB SA', u'University of Massachusetts Medical School', u'Reyon Pharmaceuticals Co Ltd', u'Evotec AG', u'Virginia Commonwealth University', u'Bioinova sro', u'Stryker Corp', u\"St. Joseph's Hospital and Medical Center\", u'RXi Pharmaceuticals Corp', u'Israeli Government', u'Diaxonhit', u'Scripps Florida', u'Amgen Inc', u'CuroNZ Ltd', u'RespireRx Pharmaceuticals Inc', u'The Procter & Gamble Co', u'Tel Aviv University', u'Kaken Pharmaceutical Co Ltd', u'Harvard University', u'IriSys LLC', u'Sheffield Institute for Translational Neuroscience', u'Amarna Therapeutics BV', u'Worldwide Clinical Trials', u'iPierian Inc', u'Cloud Pharmaceuticals Inc', u'Rhenovia Pharma SAS', u'National Cancer Institute', u'Novartis AG', u'Johns Hopkins University School of Medicine', u'University of California', u'University of Chile', u'Hadassah Medical Organization', u'Treeway BV', u'Brandeis University', u'Barrow Neurological Insitute', u'Neuren Pharmaceuticals Ltd', u'BenevolentAI Ltd', u'Chaperone Therapeutics Inc', u'Massachusetts General Hospital', u'Medical Research Council', u'Oxford BioMedica plc', u'Seqirus', u'AveXis Inc', u'Congressionally Directed Medical Research Programs', u'Newron Pharmaceuticals SpA', u'Iron Horse Therapeutics', u'Thera Neuropharma Inc', u'Cleveland Clinic Foundation', u'Northern Biomedical Research', u'University of California San Diego', u'Neurimmune Holding AG', u'XCell Science Inc', u'Center for Neurologic Study', u'Leiden/Amsterdam Center for Drug Research', u'Wellcome Trust', u'Allergan Inc', u'Tikvah Therapeutics Inc', u'University of Edinburgh', u'SUNY Upstate Medical University Hospital', u'Corestem Co Ltd', u'CytRx Corp', u'Sfida Biologic Inc', u'Johns Hopkins University', u'Brainstorm Technologies Llc', u'University of Toledo', u'The Angel Fund', u'PolyNovo Ltd', u'uniQure BV', u'Wockhardt Ltd', u'Universite Laval', u'SK Biopharmaceuticals', u'Karyopharm Therapeutics Inc', u'Sanochemia Pharmazeutika AG', u'AmpliPhi Biosciences Corp', u'ALS Therapy Development Institute', u'UC Irvine Medical Center', u'Genea Ltd', u'Biorex Research and Development Co', u'Ohio State University', u'Duke University Medical Center', u'ANDREWS BUDDIES CORPORATION/FightSMA', u'Neurotune AG', u'Genentech Inc', u'Beijing Tide Pharmaceutical Co Ltd', u'French Muscular Dystrophy Association', u'Martindale Pharma', u'LifeSplice Pharma LLC', u'Agilent Technologies Inc', u'IntelliCell BioSciences Inc', u'Otsuka Pharmaceutical Co Ltd', u'Cytokinetics Inc', u'Amarantus BioScience Holdings Inc', u'Mayo Clinic Foundation', u'Carolinas HealthCare System', u'Nanologica Ab', u'Reata Pharmaceuticals Inc', u'Amylyx Pharmaceuticals Inc', u'Asklepios Biopharmaceutical Inc', u'Alcyone Lifesciences Inc', u'Denmark Technical University', u'International Center for Genetic Engineering and Biotechnology (ICGEB)', u'LifeArc', u'Hospital for Sick Children', u'Seikagaku Corp', u'Undisclosed', u'Synthetic Biologics Inc', u'Encore Pharmaceuticals Inc', u'Pfizer Inc', u'Rowan University', u'Daewoong Pharmaceutical Co Ltd', u'Merck & Co Inc', u'Meiji Seika Pharma Co Ltd', u'McMaster University', u'Scripps Research Institute', u'Iron Horse Diagnostics Inc', u'Servier', u'Maas BiolAB LLC', u'Columbia University', u'Eli Lilly & Co', u'GE Healthcare', u\"St Jude Children's Research Hospital\", u'Novogen Ltd', u'Fight for Sight', u'Phyton Biotech Inc', u'Louisiana State University', u'Lay Line Genomics SpA', u'PLIVA dd', u'Synthelabo', u'Fannin Ltd', u'University of Virginia', u'Life Science and Health \\u2013 Topconsortium for Knowledge and Innovation Foundation', u'PRC Clinical', u'MediciNova Inc', u'ExSAR Corp', u'Foundation for Mitochondrial Medicine', u'AC Immune SA', u'Motor Neurone Disease Association', u'Chemigen LLC', u'University of Iowa', u'Hannover Medical School', u'University of Wisconsin-Madison', u'Bar-Ilan University', u'Origent Data Sciences Inc', u'AstraZeneca plc', u'AL-S Pharma AG', u'National Institute on Aging', u'Fox Chase Chemical Diversity Center Inc', u'Italfarmaco SpA', u'Amen Clinics Inc', u'University of Utah', u'Families of Spinal Muscular Atrophy', u'US Department of Defense', u'AxoTect Inc', u'Renishaw plc', u'BioFocus DPI', u'Leandro P. Rizzuto Foundation ALS Finding A Cure', u'Knopp Neurosciences Inc', u'Charles University', u'Wyeth BioPharma', u'Regenesance BV', u'Washington University in St Louis', u'Purdue University', u'Sangamo Therapeutics Inc', u'Helsinki University', u'AbbVie Inc', u'ViroMed Co Ltd', u'Neuraltus Pharmaceuticals Inc', u'RhinoCyte Inc', u'University of Washington', u'YooYoung Pharmaceuticals Co Ltd', u'Yale School of Medicine', u'Emory University Technology Transfer Office', u'The University Health Network', u'NYU Langone Medical Center', u'CRISPR Therapeutics', u'GRI Bio Inc', u'Lauren Sciences Llc', u'University of Miami', u'Eisai Co Ltd', u'Targacept Inc', u'Pan-Provincial Vaccine Enterprise Inc', u'Sigma-Aldrich Corp', u'University of Toronto', u'Northeast ALS Consortium', u'Universitat Ulm', u'TCA Cellular Therapy LLC', u'China Medical University Hospital', u'National Institutes of Health', u'Aquinnah Pharmaceuticals Inc', u'University of Zurich', u'Food and Drug Administration', u'Aptagen LLC', u'Sanford-Burnham Medical Research Institute', u'Elan Corp plc', u'Protein Production Services Ltd', u'City of Hope', u'Curis Inc', u'Sanofi Genzyme', u'Encefa', u'Izumi Biosciences LLC', u'Cedars-Sinai Medical Center', u'Applied Research using OMIC Sciences SL', u'Proteostasis Therapeutics Inc', u'Target ALS Foundation', u'Columbia University Medical Center', u'Project A.L.S.', u'Cephalon Inc', u'Celgene Corp', u'University of Chicago', u'University of Kentucky', u'University City Science Center', u'Agence Nationale de Valorisation de la Recherche', u'Navinta LLC', u'Astellas Pharma Inc', u'ALS Association', u'Wakunaga Pharmaceutical Co Ltd', u'Anida Pharma Inc', u'IXICO Plc', u'Covis Pharma Sarl', u'The Michael J. Fox Foundation', u'Duke University', u'The Salk Institute for Biological Studies', u'University of Louisville', u'Insmed Inc', u'Trophos SA', u'Advancell', u'FDA Office of Orphan Products Development', u'Inventiv Health Clinical Inc', u'Hebrew University of Jerusalem', u'University of Oxford', u'Neuralstem Inc', u'TVM Capital Life Science', u\"Brigham & Women's Hospital\", u'Lascco SA', u'Sanofi-Aventis US LLC', u'Zenyth Therapeutics Ltd', u'Takeda Pharmaceutical Co Ltd', u'EUROIMMUN GmbH', u'Power3 Medical Products Inc', u'Nexgenix Pharmaceuticals Inc', u'The Bronx Project Inc', u'PNA Center for Neurological Research', u'Orphazyme ApS', u'J David Gladstone Institutes', u'Harlan Biotech Israel Ltd', u\"King's College London\"]), u'Empyema': set([u'The University of Texas Health Science Center Tyler', u'National Heart Lung and Blood Institute']), u'Gynecologyandobstetrics': set([u\"Lee's Pharmaceutical Holdings Limited\", u'Depomed Inc', u'Theramex', u'Actavis Inc', u'Mallinckrodt Inc', u'Macrogen Inc', u'Rabin Medical Center', u'Women\\u2019s Choice Pharmaceuticals LLC', u'Dilafor AB', u'Seoul National University Hospital', u'Smith & Nephew plc', u'Fougera Pharmaceuticals Inc', u'Schering SpA', u'Medtronic plc', u'Rosetta Genomics Ltd']), u'Adultvaricellazostervirusinfection': set([u'Janus Pharmaceuticals Inc', u'ContraVir Pharmaceuticals Inc', u'Maxim Pharmaceuticals Inc', u'US Government', u'Texas Emerging Technology Fund', u'Upstate Medical University', u'Australian Government', u'Cambridge Biotechnology Ltd', u'SmithKline Beecham plc', u'GlaxoSmithKline plc', u'Synergy Pharmaceuticals Inc', u'Medivir AB', u'Center Point Clinical Services LLC', u'Novavax Inc', u'Bristol-Myers Squibb Co', u'Merck & Co Inc', u'TFS Corp', u'Pharmaceutical Product Development LLC', u'University of Pittsburgh', u'Research Corporation Technologies', u'bioCSL PTY Ltd', u'CSL Ltd', u'NanoViricides Inc', u'Yamasa Shoyu Co Ltd', u'Santalis Healthcare Corporation', u'aRigen Pharmaceuticals Inc', u'Diamyd Inc', u'Reliant Pharmaceuticals Inc', u'Estero-Anstalt', u'SK Chemicals Co Ltd']), u'Pain': set([u'University of Bristol', u'Unimed Pharmaceuticals Inc', u'Syngene International Ltd', u'Formulation Technologies LLC', u'Eupraxia Pharmaceuticals Inc', u'Nautilus Neurosciences Inc', u'Medosan Industrie Biochimiche Riunite SpA', u'Rinat-Pfizer Inc', u'The Unconventional Foundation for Autism', u'Vapogenix Inc', u'US Health and Human Services Department', u'Alpharma Inc', u'Lantheus Medical Imaging Inc', u'Cadence Pharmaceuticals Inc', u'Melmed Holding AG', u'Tikvah Therapeutics Inc', u'Maine Technology Institute', u'Cervelo Pharmaceuticals Ltd', u'Royal DSM NV', u'Proximagen Group plc', u'Ingenium Pharmaceuticals AG', u'Cannabis Science Inc', u'Sevion Therapeutics Inc', u'Turing Pharmaceuticals LLC', u'The Dow Chemical Co', u'Novartis Pharma AG', u'Paul Capital Healthcare', u'Anesiva Inc', u'PainCeptor Pharma Corp', u'BioSyent Inc', u'Advantis Corp', u'Pain Therapeutics Inc', u'Visterra Inc', u'Hydra Biosciences Inc', u'ISTA Pharmaceuticals Inc', u'Advanced Pain Therapeutics LLC', u'Exodos Life Science Partners', u'Pharmanest AB', u'Midview Drug Health Mart Pharmacy', u'KemPharm Inc', u'IMPAX Laboratories Inc', u'Ramot at Tel Aviv University Ltd', u'Sumitomo Pharmaceuticals Co Ltd', u'Orbis Biosciences Inc', u'Hospira Inc', u'CeNeS Pharmaceuticals plc', u'MainPointe Pharmaceuticals LLC', u'Inventiv Health Clinical Inc', u'AcelRx Pharmaceuticals Inc', u'Bridge Pharmaceuticals Inc', u'Recipharm AB', u'A H Robins Co Ltd', u'Arachnova Ltd', u'Kuhnil Pharmaceutical Co Ltd', u'Celera South San Francisco', u'Botulinum Toxin Research Associates Inc', u'Mount Cook BioSciences', u'Clinical Development Capital Llc', u'Toray Industries Inc', u'US Department of the Treasury', u'Regeneus Pty Ltd', u'Auxilium Pharmaceuticals Inc', u'Merckle GmbH', u'Greater Paris University Hospitals, AP-HP', u'tesa Labtec GmbH', u'NeuroSearch A/S', u'Govsphere Inc', u'ZingoTX Pty Ltdd', u'G Pohl-Boskamp GmbH & Co KG', u'Astraea Therapeutics LLC', u'Biomeks Ilac', u'Medipure Holdings Inc', u'TransForm Pharmaceuticals Inc', u'National Research Council of Canada', u'23andMe Inc', u'Revogenex Inc', u'Sigma-Tau Ind Farm Riunite SpA', u'BioAdvance', u'NutraFuels Inc', u'Biotie Therapies AG', u'Julphar Gulf Pharmaceutical Industries', u'Israeli Government', u'Centre National de la Recherche Scientifique (CNRS)', u'Acino Holding AG', u'Alanex Corp', u'Xsira Pharmaceuticals Inc', u'Syntano Technology Venture', u'Monash University', u'Tel Aviv University', u'Kaken Pharmaceutical Co Ltd', u'Claris Lifesciences Ltd', u'Glenmark Pharmaceuticals Ltd', u'NovaDel Pharma Inc', u'Tulane University', u'Censo Biotechnologies Ltd', u'Croma Pharma GmbH', u'Ciba-Geigy Canada Ltd', u'Tripos Inc', u'Albemarle Corp', u'Organix Inc', u'Atley Pharmaceuticals Inc', u'Devgen NV', u'CIS Pharma AG', u'Wellcome Trust', u'Egalet Corp', u'HUYA Bioscience International LLC', u'SI Group Inc', u'Ionix Pharmaceuticals Ltd', u'Santen Pharmaceutical Co Ltd', u'Ajinomoto Althea Inc', u'Lipomed AG', u'UCB SA', u'RMX Pharmaceutical Technology Co Ltd', u'Digital Biotech Co Ltd', u'Phoenix PharmaLabs Inc', u'Mallinckrodt Inc', u'Newron Pharmaceuticals SpA', u'Pharmacopeia Inc', u'Nectid Inc', u'AurimMed Pharma Inc', u'Insys Therapeutics Inc', u'Navigen Inc', u'EpiCept Corp', u'Cytokine PharmaSciences Inc', u'Janssen Korea Ltd', u'Lavipharm SA', u'Janssen Pharmaceutical KK', u'Halimed Pharmaceuticals Inc', u'Japan Tobacco Inc', u'Shire plc', u'Zhejiang Jianfeng Group Co Ltd', u'CeNeRx BioPharma Inc', u'Pain Relief & Wellness Strategy Center', u'Nycomed Canada Inc', u'Oracain ApS', u'Sunovion Pharmaceuticals Canada Inc', u'Crosslink Genetics Corp', u'Helsinn Healthcare SA', u'SymBio Pharmaceuticals Ltd', u'Wyeth', u'Tragara Pharmaceuticals Inc', u'PreveCeutical Medical Inc', u'Generex Biotechnology Corp', u'NorthStar R&D Ltd', u'Infinity Pharmaceuticals Inc', u'CorePharma LLC', u'Recalcine Pharmaceutical Corp', u'Healthcare Royalty Partners', u'European Pain Federation EFIC', u'Therakind Ltd', u'Medtronic Inc', u'F H Faulding & Co Ltd', u'Patheon Pharmaceuticals Inc', u'NovaSAID AB', u'Solasia Pharma KK', u'CollaGenex Pharmaceuticals Inc', u'Mebias Discovery', u'Sedor Pharmaceuticals LLC', u'moksha8 Pharmaceuticals Inc', u'Questcor Pharmaceuticals Inc', u'MannKind Corp', u'Ajinomoto Co Inc', u'Grunenthal GmbH', u'Picower Institute for Medical Research', u'Merck Sharp & Dohme Ltd', u'Flinders University of South Australia', u'arGEN-X NV', u'NeuroMetrix Inc', u'Pacira Pharmaceuticals Inc', u'Flamel Technologies SA', u'CLL Pharma', u'Apkarian Technologies LLC', u'European Research Council (ERC)', u'DPT Laboratories', u'Finnish Funding Agency for Technology and Innovation', u'Revance Therapeutics Inc', u'KunWha Pharmaceutical Co Ltd', u'Oregon Health Sciences University', u'M.Fast Technologies Ltd', u'Sanofi-Synthelabo', u'Daewoong Pharmaceutical Co Ltd', u'University of Colorado System', u'Knoll GmbH', u'Logical Therapeutics Inc', u'Novartis India', u'APR Applied Pharma Research SA', u'Southwest Research Institute (SwRI)', u'Ferndale Laboratories Inc', u'Eli Lilly & Co', u\"Lee's Pharmaceutical Holdings Limited\", u'Immune Pharmaceuticals Inc', u'Synt:em', u'Kaup Pharmacy', u'CSL Ltd', u'Eyegate Pharmaceuticals Inc', u'Louisiana State University', u'AIKO Biotechnology Inc', u'Takeda Pharmaceuticals International GmbH', u'Ossianix Inc', u'Tecnofarma', u'XenaCare Holdings Inc', u'Penwest Pharmaceuticals Co', u'AstraZeneca Canada Inc', u'Horizon Orphan LLC', u'Medovex Corp', u'Argenta Discovery Ltd', u'Metabasis Therapeutics Inc', u'MINRAD International Inc', u'MedImmune LLC', u'CeNeS Pharmaceuticals Inc', u'Phebra Pty Ltd', u'Schein Pharmaceutical Inc', u'Molteni Farmaceutici', u'Universitat Autonoma de Barcelona', u'Cumberland Pharmaceuticals Inc', u'University of Sao Paulo', u'Toyama Chemical Co Ltd', u'PDL BioPharma Inc', u'Laboratorios Saval S.A.', u'Johns Hopkins University', u'Zalicus Inc', u'Johnson & Johnson', u'Trevena Inc', u'China Pharmaceutical University', u'Quay Pharmaceuticals Ltd', u'Marathon Pharmaceuticals LLC', u'Trendlines Group Ltd', u'US Department of Defense', u'ASCEND Therapeutics Inc', u'Cmxtwenty', u'Valeant Pharmaceuticals North America LLC', u'Inspirion Delivery Sciences', u'Harbor-UCLA Research and Education Institute', u'Organon AG', u'Protect Pharmaceuticals Inc', u'Sunovion Pharmaceuticals Inc', u'Cerecor Inc', u'Snowdon Inc', u'BL&H Co Ltd', u'Northwestern University', u'Searle Canada Inc', u'Hermes Pharma', u'Galephar PR Inc', u'Nanomerics Ltd', u'Noramco Inc', u'GD Searle LLC', u'LIDTKE Technologies', u'Bristol-Myers Squibb Co', u'BioQ Pharma', u'The Medicines Company', u'University of Rochester', u'Watson Laboratories Inc', u'Epic Pharma LLC', u'Victory Pharma Inc', u'Formosa Laboratories Inc', u'Alpharma Ireland Ltd', u'Shanghai Institute of Applied Physics Chinese Academy of Sciences', u'Vyteris Inc', u'Recordati SpA', u'Cambridge Drug Discovery Ltd', u'Nuvectra Corp', u'Galera Therapeutics Inc', u'Astellas Pharma Inc', u'BioDelivery Sciences International Inc', u'CALOX de Costa Rica S.A', u'Chromocell Corp', u'Archimedes Pharma Ltd', u'Gridiron Cannabis Coalition', u'InteRx Biomedical Co Ltd', u'New Haven Pharmaceuticals Inc', u'PharmaNess Neuroscience', u'Zogenix Inc', u'Metaphore Pharmaceuticals Inc', u'Meda AB', u'ActivBiotics Inc', u'Depomed Inc', u'Gedeon Richter Ltd', u'Cellix Bio Pvt Ltd', u'Orphan Australia', u'Algorithme Pharma', u'Hoechst Marion Roussel Inc', u'Akzo Nobel Fraser AG', u'Novum Pharmaceutical Research Services', u'Senju Pharmaceutical Co Ltd', u'BIAL Group', u'Calmare Therapeutics Inc', u'Shanghai Pharmaceutical Group Corp', u'DRI Capital', u'Imprimis Pharmaceuticals Inc', u'NOXXON Pharma AG', u'Nanotherapeutics Inc', u'SK Chemicals Co Ltd', u'Spr Therapeutics Llc', u'Karolinska Institutet', u'Sumitomo Dainippon Pharma Co Ltd', u'Luitpold Pharmaceuticals Inc', u'Chalmers University of Technology', u'Regeneron Pharmaceuticals Inc', u'CMIC Holdings Co Ltd', u'Javelin Pharmaceuticals Inc', u'Opthea Ltd', u'Lunatus', u'Boehringer Ingelheim GmbH', u'Dalhousie University', u'Solvay Pharmaceuticals Inc', u'Orion Corporation', u'Amarin Development AB', u'Paul Graham Pharma Consulting Ltd', u'Ikano Therapeutics Inc', u'Aerial BioPharma LLC', u'BTG plc', u'Stiefel', u'Cambridge Scientific Pty Ltd', u'iNova Pharmaceuticals (Australia) Pty Ltd', u'Chiesi Farmaceutici SpA', u'Shasun Pharmaceuticals Ltd', u'Relevare Pharmaceuticals Ltd', u'DURECT Corp', u'InVivo Therapeutics Holdings Corp', u'Dharmacon Inc', u'ReveraGen BioPharma Inc', u'Altus Pharmaceuticals Inc', u'DSM Chemie Linz GmbH', u'Chinese Government', u'Panacea Biotec Ltd', u'ArQule Inc', u'Shijiazhuang Yiling Pharmaceutical Co Ltd', u'Microbot Medical Inc', u'Vernalis plc', u'Sangamo Therapeutics Inc', u'Fidia Farmaceutici SpA', u'Enteris BioPharma Inc', u'Polyphor Ltd', u'Ono Pharmaceutical Co Ltd', u'Saniona ApS', u'BioElectronics Corp', u'Acrux Ltd', u'Alchemia Ltd', u'Chiroscience Group plc', u'Reckitt Benckiser plc', u'Mitsubishi Tanabe Pharma Corp', u'Epigen Biosciences Inc', u'Biocompatibles International plc', u'TOLMAR Therapeutics Inc', u'Panaxia Pharmaceutical Industries Ltd', u'The National Institute of Mental Health', u'Virginia Commonwealth University', u'Ember Therapeutics', u'Sanofi Genzyme', u'Taiho Pharmaceutical Co Ltd', u'Arius Pharmaceuticals Inc', u'Elan Pharmaceuticals Inc', u'Shire Orphan Therapies GmbH', u'Interprotein Corp', u'Covidien plc', u'Catalyst Biosciences Inc', u'MSD Japan', u'Soho Flordis International', u'Alveda Pharmaceuticals Inc', u'Aveva Drug Delivery Systems', u'Hamelin Ltd', u'Premier Biomedical Pain Management Solutions LLC', u'Charite Universitaetsmedizin Berlin', u'Xuanzhu Pharma Co Ltd', u'Catalent Inc', u'National Institute of General Medical Sciences', u'Evotec AG', u'Meiji Seika Pharma Co Ltd', u'The Wolfson Institute for Biomedical Research', u'Aspyrian Therapeutics Inc', u'Diaxonhit', u'Wyeth Research', u'Akela Pharma Inc', u'Pierrel SpA', u'Amgen Inc', u'Hebrew University of Jerusalem', u'CSC Pharmaceuticals Handels GmbH', u'CytoMed Inc', u'Saudi-Arabian Japanese Pharmaceutical Co', u'e-Therapeutics Plc', u'Endo Health Solutions Inc', u'Endo Pharmaceuticals Solutions Inc', u'EUSA Pharma USA', u'Ancora Medical Technology', u'ULURU Inc', u'Consejo Superior De Investigaciones Cientificas', u'Zeneus Pharma Ltd', u'R-Pharm US LLC', u'Takeda Cambridge Ltd', u'Kotobuki Pharmaceutical Co Ltd', u'Universite de Sherbrooke', u'Janssen Pharmaceutica BV', u'Teva Pharmaceuticals USA Inc', u'ACADIA Pharmaceuticals Inc', u'Normaco Inc', u'Palau Pharma SA', u'Georgetown University', u'Dekel Pharmaceuticals Ltd', u'SkyePharma plc', u'AfaSci Inc', u'Ultrafine Chemicals Ltd', u'Imperial College London', u'Acura Pharmaceuticals Inc', u'Massachusetts General Hospital', u'Tanabe Seiyaku Co Ltd', u'BioXell SpA', u'Peking University', u'Sanofi Winthrop Inc', u'Canabo Medical Corporation', u'Schrodinger Inc', u'Perrigo Co plc', u'BioVex Inc', u'Atlantic Canada Opportunities Agency', u'Max Delbruck Centrum Fur Molekulare Medizin', u'CERSCI Therapeutics', u'Kereos Inc', u'Interpharm Holdings Inc', u'Phenicia Group', u'Dong-A ST Co Ltd', u'Echo Therapeutics Inc', u'SCOLR Pharma Inc', u'Alvogen Inc', u'Prasco Laboratories', u'Jiangsu Nhwa Pharmaceutical Group Co Ltd', u'Allergan Inc', u'Wake Forest University', u'Lundbeck Research USA Inc', u'Landsteiner Scientific Sa De Cv', u'Yuhan Corp', u'University of California San Diego', u'DuPont Pharmaceuticals Ltd', u'Roche Palo Alto', u'Seelos Therapeutics Inc', u'Highnoon Laboratories Ltd', u'Denali Therapeutics Inc', u'F Hoffmann-La Roche AG', u'University of Oxford', u'Depomed Development Ltd', u'Euclises Pharmaceuticals Inc', u'Inversago Pharma', u'Nuon Therapeutics Inc', u'Ohio State University', u'RTI International', u'Shimoda Biotech (Pty) Ltd', u'Genentech Inc', u'Ortho-McNeil Inc', u'Maitland Labs LLC', u'Cognetix Inc', u'Mitsubishi Pharma Corp', u'Paladin Labs Inc', u'Argolyn Bioscience Inc', u'Korea Drug Development Fund', u'Piramal Critical Care Inc', u'Harbin Gloria Pharmaceuticals Co Ltd', u'Yale University', u'Nichiiko', u'Therapeutic Discovery Corp', u'Sinclair Pharma plc', u'Ardent Pharmaceuticals Inc', u'Hyal Pharmaceutical Corp', u'LifeArc', u'Actavis Inc', u'Hi-Tech Pharmacal Co Inc', u'Institut Biochimique SA', u'Mentor Corp', u'Braeburn Pharmaceuticals Inc', u\"Universita' Degli Studi Di Parma\", u'Eastern Virginia Medical School', u'Altus Formulation', u'OptechGroup', u'Crystal Bioscience Inc', u'Australian Research Council', u'Scripps Research Institute', u'Noven Pharmaceuticals Inc', u'Stada Arzneimittel AG', u'Reckitt Benckiser Healthcare (UK) Ltd', u'University of Texas Southwestern Medical Center', u'BioFocus DPI', u'IS Pharma plc', u'CASI Pharmaceuticals Inc', u'Dompe Farmaceutici SpA', u'Latitude Pharmaceuticals', u'CoNCERT Pharmaceuticals Inc', u'VM Pharma LLC', u'ScinoPharm Taiwan Ltd', u'GC-Rise Pharmaceutical Co Ltd', u'Pierre Fabre SA', u'GL PharmTech Corp', u'Barr Pharmaceuticals Inc', u'Supernus Pharmaceuticals Inc', u'Bioglan Pharmaceuticals Co', u'Theratechnologies Inc', u'Caprion Pharmaceuticals Inc', u'R-Pharm', u'Adimab LLC', u'Aros Pharma', u'Actient Pharmaceuticals LLC', u'IVAX Corp', u'Primm SrL', u'Cubist Pharmaceuticals Inc', u'AstraZeneca plc', u'Technology Strategy Board', u'Xanodyne Pharmaceuticals Inc', u'Frontier Biotechnologies Co Ltd', u'Lead Chemical Co Ltd', u'Antibe Therapeutics Inc', u'Solace Pharmaceuticals', u'Universita degli Studi di Sassari', u'Lacer SA', u'Alkermes plc', u'CanniMed Ltd', u'CIMA Labs Inc', u'Terumo Corp', u'Janssen-Cilag Ltd', u'Vectura Group plc', u'Universita Degli Studi G D`Annunzio Chieti', u'Syntrix Biosystems Inc', u'TPI Enterprises Pty Ltd', u'Australian Government', u'QRxPharma Ltd', u'Caretta Therapeutics', u'Physiomics plc', u'Euthymics Bioscience Inc', u'ASTA Medica AG', u'Evonik Industries AG', u'STADA Pharmaceuticals Australia Pty Ltd', u'Mochida Pharmaceutical Co Ltd', u'Globe Laboratories Inc', u'ABIC', u'Nippon Kayaku Co Ltd', u'Panion Ltd', u'Nerviano Medical Sciences Srl', u'King Pharmaceuticals Inc', u'Altea Therapeutics', u'IDT Australia Ltd', u'Abiogen Pharma SpA', u'Proteomika SL', u'Ceptaris Therapeutics Inc', u'Universidade Federal de Minas Gerais', u'Mano Equestrian Services Pte Ltd', u'Universidade Federal do Rio de Janeiro', u'Maryland Innovation Initiative', u'Samil Pharmaceutical Co Ltd', u'Pernix Therapeutics Holdings Inc', u'Womens & Childrens Hospital', u'ZARS Pharma Inc', u'Spectra Medical', u'Hexal AG', u'Futura Medical plc', u'Fujifilm Diosynth Biotechnologies', u'Novalar Pharmaceuticals Inc', u'Epsilon Pharmaceuticals', u'Cambridge NeuroScience Partners', u'3M Drug Delivery Systems', u'Cornell University', u'Dong Wha Pharmaceutical Co Ltd', u'Valeant Pharmaceuticals International Inc', u'Medinox Inc', u'National University of Singapore', u'Douglas Pharmaceuticals', u'Thornton & Ross Ltd', u'Pacific Pharmaceuticals Co Ltd', u'Institut Pasteur', u'Neogen NV', u'Absize Inc', u'Par Pharmaceutical Inc', u'Avigen Inc', u'LION bioscience Inc', u'Dyax Corp', u'Sherrington Pharmaceuticals Inc', u'EMS SA', u'Dipharma Francis Srl', u'Xenome Ltd', u'University of Toronto', u'University of Cambridge', u'University of British Columbia', u'Locl Pharma Inc', u'Aventis Pharma SA', u'Dr Lo Zambeletti SpA', u\"Dr Reddy's Laboratories Ltd\", u'Medservice', u'Novartis Ophthalmics Inc', u'Enhance Biotech Inc', u'MHC Medical Products LLC', u'IDEA AG', u'Cardinal Health Inc', u'Hana Pharm Co Ltd', u'DAVA Pharmaceuticals Inc', u'Amura Therapeutics Ltd', u'Worldwide Clinical Trials', u'ASKA Pharmaceutical Co Ltd', u'Kowa Co Ltd', u'XOMA Corp', u'Handok Inc', u'Korea Institute of Science and Technology', u'Mencuro Therapeutics Inc', u'Cytogen Corp', u'Tris Pharma Inc', u'Aratana Therapeutics Inc', u'Laboratorios Elmor SA', u'Glide Pharmaceutical Technologies Ltd', u'MGI Pharma Inc', u'NanoAxis', u'Moberg Pharma AB', u'PAION AG', u'Aventis Pharma AG', u'Selcia Ltd', u'Brookhaven National Laboratory', u'Shanxi Medical University', u'Hyundai Pharmaceutical', u'Anygen Co Ltd', u'Samaritan Pharmaceuticals Inc', u'University of Bonn', u'SIBIA Neurosciences Inc', u'Apotex Inc', u'Dexcel Pharma', u'University of London', u'Nissan Chemical Industries Ltd', u'Cipher Pharmaceuticals Inc', u'Nippon Zoki Pharmaceutical Co Ltd', u'WEX Pharmaceuticals Inc', u'Auritec Pharmaceuticals Inc', u'Guangdong Zhongke Drug Research & Development Co Ltd', u'State of Queensland', u'Prism Health Care Services, Inc', u'Quartet Medicine', u'Themis Medicare Ltd', u'University of Kentucky', u'Univar Usa Inc', u'Fast Forward LLC', u'Peplin Inc', u'Vistin Pharma', u'Pfizer Hellas AE', u'Receptor Life Sciences', u'National Center for Research Resources', u'Pfizer Inc', u'NovaMedica', u'Norgine BV', u'SiteOne Therapeutics Inc', u'Omeros Corp', u'Panos Therapeutics Ltd', u'Kowa Pharmaceuticals America Inc', u'Hikma Pharmaceuticals plc', u'University of Nebraska Medical Center', u'Annovis Inc', u'University of Mississippi', u'Vifor Pharma', u'WBC Sciences LLC', u'Bioventus LLC', u'Mundipharma International Corp Ltd', u'Aralez Pharmaceuticals Inc', u'Mylan Inc', u'Pediapharm Inc', u'National Institute of Neurological Disorders and Stroke', u'AskAt Inc', u'Lohmann Therapie-Systeme GmbH & Co KG', u'DEG Inc', u'Signal Research Division', u'Gevys Pharmaceuticals Ltd', u'Boehringer Mannheim GmbH', u'Abrika Pharmaceuticals', u'Santarus Inc', u'Stragen Group', u'Galderma Spirig', u'Lawrence Laboratories Ltd', u'PsychoGenics Inc', u'Terra Life Sciences Inc', u'University of Munster', u'Sosei R&D Ltd', u'UMeWorld Ltd', u'RNL Bio Co Ltd', u'Meldex International plc', u'Teva Pharmaceutical Industries Ltd', u'Aphria Inc', u'Pfizer Japan Inc', u'Bionomics Ltd', u'Kwang Dong Pharmaceutical Co Ltd', u'Purdue Pharma LP', u'Scripps Translational Science Institute', u'Bio-Nucleonics Inc', u'Cytogel LLC', u'UCB Pharma GmbH', u'Angelini Pharmaceuticals SpA', u'WuXi PharmaTech (Cayman) Inc', u'Daeyang E&C', u'SingleSeed Payments Inc', u'RaQualia Pharma Inc', u'Mundipharma EDO GmbH', u'Regione Lombardia', u'Universite Catholique de Louvain', u'Neurosciences Victoria Ltd', u'Sirion Therapeutics Inc', u'Ferring Pharmaceuticals SA', u'Yichang Humanwell Pharmaceutical Co Ltd', u'Sante Cannabis', u'Kyukyu Pharmaceutical Co Ltd', u'Avanti Rx Analytics Inc', u'Samsung Electronics Co Ltd', u'Equatorial Coal Ltd', u'CFR Pharmaceuticals SA', u'SK Chemicals Life Science', u'Elegene AG', u\"People's Government of Jiangsu Province\", u'University of Illinois', u'Boehringer Ingelheim Corp', u'Nuvo Pharmaceuticals Inc', u'Plethora Solutions Holdings plc', u'Tokuhon Co Ltd', u'Horizon Pharma plc', u'Custopharm Inc', u'Camargo Pharmaceutical Services', u'Memorial Sloan-Kettering Cancer Center', u'Neopharm Ltd', u'NovaMed Pharmaceuticals Inc', u'Dura Pharmaceuticals Inc', u'St Charles Pharmaceuticals Inc', u'Roche Holding AG', u'Dermatrends Inc', u'Kalyra Pharmaceuticals', u'Guangzhou Institutes of Biomedicine and Health', u'Zydus-Cadila Group', u'Duke University Medical Center', u'Asahi Kasei Corp', u'DRAXIS Health Inc', u'Wyeth Pharmaceuticals', u'Aspen PharmaCare Holdings Ltd', u'Nippon Shinyaku Co Ltd', u'Flynn Pharma Ltd', u'Tetragenetics Inc', u'Harvard Medical School', u'BioLineRx Ltd', u'National Institute of Diabetes, Digestive and Kidney Diseases', u'Cipla Ltd', u'University of Arizona', u'JT Pharmaceuticals Inc', u'Cangene Corp', u'MEDRx Co Ltd', u'AnaBios Corp', u'Wilmington Pharmaceuticals Inc', u'Montavit', u'Faraday Pharmaceuticals Inc', u'Seoul National University', u'Baxter Healthcare Corp', u'Teikoku Seiyaku KK', u'Shanghai Institute of Materia Medica of the Chinese Academy of Sciences', u'NicOx SA', u'US Army Medical Research and Materiel Command', u'Medical College of Wisconsin', u'Western Maryland Health System (WMHS)', u'University of California', u'Erasmus University Rotterdam', u'Instituto Butantan', u'Glaxo Group Ltd', u'Collegium Pharmaceutical Inc', u'Daewon Pharm Co Ltd', u'Chong Kun Dang Pharmaceutical Corp', u'Columbia University', u'Dr Wolff Gruppe GmbH', u'Bayer AG', u'Fluorinov Pharma Inc', u'US Army Medical Research Institute of Infectious Diseases', u'Camurus AB', u'Sandor Medicaids Pvt Ltd', u'Mikart Inc', u'Ohmeda Inc', u'Janssen Pharmaceutica NV', u'Constance Therapeutics', u'VM Discovery Inc', u'McNeil Consumer Products Co', u'Amdipharm', u'Wockhardt UK Ltd', u'Transdermal Delivery Solutions Corp', u'Sandoz AG', u'Nektar Therapeutics', u'Centre for Applied Microbiology & Research', u'National Institute on Aging', u'Almirall Prodesfarma SA', u'Cerimon Pharmaceuticals Inc', u'Pharmaceutics International Inc', u'AIT Laboratories', u'Essen BioScience Inc', u'Corium International Inc', u'POZEN Inc', u'CIS Bio International SAS', u'Kineta Inc', u'A H Robins Co Inc', u'Adcock Ingram Ltd', u'Lumosa Therapeutics Co Ltd', u'Aptuit Inc', u'Antares Pharma Inc', u'Alcon Inc', u'University of Iowa', u'Yale School of Medicine', u'Serina Therapeutics Inc', u'Gwangju Institute of Science & Technology', u'Powder Pharmaceuticals Inc', u'Pharmos Corp', u'Vertical Pharmaceuticals Inc', u'PolyNovo Ltd', u'Daiichi Sankyo Inc', u'MakScientific LLC', u'Elminda Ltd', u'Astra AB', u'Dojin Iyaku-Kako Co Ltd', u'Amarin Corp plc', u'Mikah Pharma', u'DanioLabs Ltd', u'Novartis Pharma KK', u'University of North Carolina', u'Panag Pharma Inc', u'Premier Biomedical Inc', u'Max-Planck-Gesellschaft', u'Anteana Therapeutics Inc', u'Soricimed Biopharma Inc', u\"Universita' Degli Studi Di Urbino\", u'Nippon Boehringer Ingelheim Co Ltd', u'Elan Corp plc', u'Aventis SA', u'Takeda Oncology', u'INSERM', u'Smokefree Innotec Inc', u'Prismic Pharmaceuticals Inc', u'Ligand Pharmaceuticals Inc', u'KAI Pharmaceuticals Inc', u'Actavis LLC', u'Nanovibronix Inc', u'Alfa Wassermann SpA', u'CJ Corp', u'Cephalon Inc', u'Celgene Corp', u'Millennium Laboratories', u'bioCSL PTY Ltd', u'Crescendo Pharmaceuticals Corp', u'Array BioPharma Inc', u'Therapix Biosciences Ltd', u'Par Pharmaceutical Co Inc', u'Eurofarma', u'Biovail Corp', u'Retrophin Inc', u'Swedish Orphan Biovitrum AB', u'Septodont', u'Greatbatch Ltd', u'Ranbaxy Laboratories Ltd', u'Medical Futures Inc', u'University of Sydney', u'Ferring Research Ltd', u'Oxford Natural Products', u'Medos SA', u'Ipsen Bioinnovation', u'Kitov Pharmaceuticals Ltd', u'Geomc Co Ltd', u'Targon Corp', u'Janssen Pharmaceuticals Inc', u'National Institute of Dental and Craniofacial Research', u'Delivra Corp', u'Flexion Therapeutics Inc', u'Controlled Chemicals Inc', u'Adamis Pharmaceuticals Corp', u'Orexo AB', u'Kyowa Kirin', u'Abraxis BioScience Inc', u'Huizhou Raffles Pharmatech Co Ltd', u'Asana BioSciences LLC', u'ProTherapeutics Pte Ltd', u'GD Searle & Co', u'Cyathus Exquirere Pharmaforschungs GmbH', u'Sugentech Inc', u'Daiichi Seiyaku Co Ltd', u'Neura Therapeutik LLC', u'DKSH Holding Ltd', u'US Government', u'Diatide Inc', u'Cooper Maroc Pharmaceuticals', u'Apeiron Biologics GmbH', u'Galenica AG', u'Mercachem Holding BV', u'Yakult Honsha Co Ltd', u'MSD OSS BV', u'University of Milan', u'Medical Developments International Ltd', u'University of Queensland', u'CTT Pharmaceuticals Inc', u'Algynomics Inc', u'CrossLink Bioscience', u'United States Army Medical Research Institute of Chemical Defense', u'Iroko Pharmaceuticals LLC', u'University of Wisconsin-Madison', u'Unigene Laboratories Inc', u'OncoSil Medical Ltd', u'GlaxoSmithKline plc', u'Litha Healthcare Group Ltd', u'Velcera Pharmaceuticals', u'Johnson Matthey plc', u'InMed Pharmaceuticals Inc', u'MedX Holdings Inc', u'Aspen PharmaCare Australia Pty Ltd', u'National Pharmaceuticals Corp', u'Takeda Pharmaceutical Co Ltd', u'Evomed', u'Ipsen', u'SRI International', u'Elan Pharmaceutical Technologies', u'Marina Biotech Inc', u'European Eurostars Programme', u'TWi Pharmaceuticals Inc', u'Pharmaceutical Product Development LLC', u'University of Michigan', u'Elite Pharmaceuticals Inc', u'Sinobioway Bio-medicine Co Ltd', u'Laboratoires Thea', u'Clinigen Group plc', u'FAES Farma SA', u'Xention Ltd', u'NRC Research Institute', u'Stanford University', u'Advanced Targeting Systems Inc', u'Azur Pharma Ltd', u'Sagent Pharmaceuticals Inc', u'Novis Pharmaceuticals Llc', u'Huons Co Ltd', u'Neurogen Corp', u'Lancet', u'Hisamitsu Pharmaceutical Co Inc', u'Sankyo Co Ltd', u'PAZ Arzneimittelentwicklungsgesellschaft GmbH', u'PanGenetics BV', u'3M Pharmaceuticals', u'Shionogi & Co Ltd', u'Purdue Pharma Canada', u'Endo International plc', u'Oroxcell SAS', u'Convergence Pharmaceuticals Ltd', u'Horizon Pharma GmbH', u'Gold Coast Therapeutics', u'DePuy Synthes Companies', u'Nutra Pharma Corp', u'Neuromed Pharmaceuticals Inc', u'Fortress Biotech Inc', u'Zynerba Pharmaceuticals Inc', u'Universidade Federal de Sao Paulo - UNIFESP', u'Biomet Inc', u'SS Pharmaceutical - ethical drug division', u'Shire BioChem Inc', u'Calmar Pain Relief Llc', u'National Institute of Arthritis and Musculoskeletal and Skin Diseases', u'Q BioMed Inc', u'MD Anderson Cancer Center', u'Equity Pharmaceuticals Pty Ltd', u'Swedish Orphan AB', u'Ducere Pharma LLC', u'MIKA Pharma GmbH', u'Emory University', u'Sanofi', u'Daiichi Sankyo Co Ltd', u'Abbott Laboratories', u'Catalyst Pharmaceutical Partners Inc', u'Eisai Co Ltd', u'Commonwealth Scientific and Industrial Research Organization', u'Kentucky Science and Technology Corp', u'Migralex Inc', u'Grifols SA', u'GlaxoSmithKline Consumer Healthcare Ltd', u'National Cancer Institute', u'Innovata plc', u'Aradigm Corp', u'Advanced Technologies Solutions', u'Kos Pharmaceuticals Inc', u'NitroMed Inc', u'PLx Pharma Inc (pre-merger)', u'Novelion Therapeutics Inc', u'Tribute Pharmaceuticals Canada Inc', u'Rx Xpress Health Mart Pharmacy', u'Avanti Therapeutics', u'Algomedix Inc', u'University of Minnesota', u'Hunan Normal University', u'Bristol-Myers Squibb Pharma Co', u'Zenyth Therapeutics Ltd', u'Doxa AB', u'ALZA Corp', u'Teewinot Life Sciences Corp', u'Adolor Corp', u'Shanghai Jiao Tong University', u'Piramal Enterprises Ltd', u'Xenon Pharmaceuticals Inc', u'Medeor Inc', u'Sequence Therapy LLC', u'University of Texas System', u'Anesta Corp', u'Pharmacia & Upjohn Inc', u'Balchem Corp', u'Midatech Pharma US Inc', u'McGill University', u'Lay Line Genomics SpA', u'University of Barcelona', u'Ethypharm SA', u'Zambon Co SpA', u'Leiden University (NL)', u'TCG Lifesciences Ltd', u'Ferrer Internacional SA', u'Lupin Ltd', u'AcSentient Inc', u'Swati Spentose Pvt Ltd', u'Kyowa Hakko Kogyo Co Ltd', u'UniQuest Pty Ltd', u'Jiangsu Laitai Medical Biotechnology Co Ltd', u'Tetra Bio-Pharma Inc', u'Recro Pharma Inc', u'Diamyd Inc', u'GVK Biosciences Pvt Ltd', u'Growblox Sciences Inc', u'H Lundbeck A/S', u'Benitec Biopharma Ltd', u'Epitech Group Srl', u'Afferent Pharmaceuticals', u'CVS Caremark', u'Mallinckrodt plc', u'Mayne Pharma Group Ltd', u'JW Pharmaceutical Corp', u'Innovative Drug Delivery Systems Inc', u'Undisclosed', u'Titan Pharmaceuticals Inc', u'Galen Ltd', u'Cellectricon Ab', u'URIST Regenerative Med Inc', u'Atlantic Technology Ventures Inc', u'Pharmasol Ltd', u'Circ Pharma Ltd', u'Sosei Group Corp', u'Relmada Therapeutics Inc', u'Circuit Therapeutics Inc', u'Southern Research Institute', u'DSM Pharmaceutical Products', u'PRIM Group', u'Rainbow Medical', u'Innocoll AG', u'PainReform Ltd', u'Republic of Korea Government', u'BMP Sunstone Corp', u'Science Council of British Columbia', u'Aquilus Pharmaceuticals Inc', u'Alexza Pharmaceuticals Inc', u'Aspen Global Incorporated', u'National Institute on Drug Abuse', u'Oxford Pharmascience Group Plc', u'DB Pharm Korea', u'Aoxing Pharmaceutical Co Inc', u'French Government', u'Purdue Neuroscience Corp', u'Halo Pharmaceutical Inc', u'Napp Pharmaceutical Group Ltd', u'Merck & Co Inc', u'Merck Sharp & Dohme de Espana SA', u'Novo A/S', u'Medtronic plc', u'Molecular Pharmacology (USA) Ltd', u'Radboud University', u'AlgoRx Pharmaceuticals Inc', u'Alter SA', u'InSite Vision Inc', u'Laboratoire L Lafon SA', u'Theranyx', u'Forest Laboratories Inc', u'Vivozon Inc', u'EKR Therapeutics Inc', u'University of Virginia', u'University of California Irvine', u'Kyowa Hakko Kirin Co Ltd', u'Prestige Brands Holdings Inc', u'Cresset Biomolecular Discovery Ltd', u'Vital Living Inc', u'Axim Biotechnologies Inc', u'Kissei Pharmaceutical Co Ltd', u'Biousian Biosystems Inc', u'Auriga Laboratories Inc', u'GW Pharmaceuticals plc', u'Parke-Davis & Co', u'Nobex Corp', u'Aptalis Pharma Inc', u'Esteve', u'Bioniche Pharma Holdings Ltd', u'Peak Harvest Health', u'Shenyang Pharmaceutical University', u'SmithKline Beecham plc', u'NeurogesX Inc', u'Allelix Neuroscience Inc', u'Mertiva AB', u'deCODE genetics ehf', u'Sandoz Inc', u'Cadila Pharmaceuticals Ltd', u'PDI Inc', u'Yissum Research Development Co', u'Apricus Biosciences Inc', u'Therabel Pharma NV', u'Institute of Advanced Chemistry of Catalonia', u'H.A. Systems Dental Imports Ltd', u'AusIndustry', u'DABL LIMITED', u'Block Drug Co Inc', u'Cato Research Ltd', u'Shionogi Inc', u'Indena SpA', u'Spike Marks Inc', u'Sawai Pharmaceutical Co Ltd', u'Cara Therapeutics Inc', u'Pharmascience Inc', u'Pen Pharmaceutical Services Ltd', u'Incline Therapeutics Inc', u'DevCo Pharmaceuticals Ltd', u'Allegiance Equity Corp', u'3M Co', u'S. Fyodorov Eye Microsurgery Complex', u'Encore Therapeutics Inc', u'Vernalis Research Ltd', u'Galena Biopharma Inc', u'Targacept Inc', u'University of Melbourne', u'PhytoPain Pharma Inc', u'Albert Einstein College of Medicine', u'Heptares Therapeutics Ltd', u'Italian Government', u'National Institutes of Health', u'Actavis Group HF', u'WellSpring Pharmaceutical Corp', u'Food and Drug Administration', u'MediVas LLC', u'Biotrial SAS', u'Lek Pharmaceutical and Chemical Co DD', u'West Pharmaceutical Services Inc', u'Shanghai Shyndec Pharmaceutical Co Ltd', u'Asahi Kasei Pharma Corp', u'Aptalis Pharma Srl', u'Novo Nordisk A/S', u'The Menarini Group', u'Yutoku Pharmaceutical Ind Co Ltd', u'BioXcel Therapeutics Inc', u'Green Vision Company', u'Taejoon Pharm Co Ltd', u'Geisinger Health System', u'MMJ PhytoTech Ltd', u'Axxam SpA', u'Maruishi Pharmaceutical Co Ltd', u'Dosecann Inc', u'ReNeuron Group plc', u'Jubilant Life Sciences Ltd', u'The University of Massachussetts', u'LPB Istituto Farmaceutico SpA', u'AAIPharma Inc', u'AyoxxA Biosystems GmbH', u'Icagen Inc (pre-merger)', u'Teikoku Pharma USA Inc', u'Eurodrug Laboratories', u'University of Utah', u'Strides Shasun Ltd', u'Renovis Inc', u'Phosphagenics Ltd', u'Novartis AG', u'Torcan Chemicals Ltd', u'Cypress Bioscience Inc', u'Acusphere Inc', u'Biocure Inc', u'PT.SOHO Industri Pharmasi', u'Centrexion Therapeutics Corp', u'Bentley Pharmaceuticals Inc', u'Mitacs Inc', u'Merz & Co GmbH', u'Helsinn Group']), u'Pre-eclampsia': set([u'DiabetOmics Llc', u'University of Lund', u'CSL Behring LLC', u'Connetics Corp', u'Paladin Labs Inc', u'Bioniche Teoranta', u'NeuroVive Pharmaceutical AB', u'Samuel Lunenfeld Research Institute', u'GlaxoSmithKline plc', u'Hokuriku Seiyaku KK', u'UCB Celltech', u'Research Toxicology Centre', u'A1M Pharma AB', u'Miraculins Inc', u'Velo Bio LLC', u'Eunice Kennedy Shriver National Institute of Child Health & Human Development', u'Undisclosed', u'Corthera Inc', u'University of Amsterdam', u'Monash University', u'Fred Hutchinson Cancer Research Center', u'Mitsubishi-Tokyo Pharmaceuticals Inc', u'ESP Pharma Inc', u'BD Technologies', u'Kaketsuken', u'LifeCodexx AG', u'Ferring Research Ltd', u'F H Faulding & Co Ltd', u'Adepthera LLC', u'Hospital for Sick Children', u'Protherics plc', u'Barbeau Pharma Inc', u'Alere Inc', u'National Heart Lung and Blood Institute', u'Aggamin Pharmaceuticals LLC', u'Compugen Ltd', u'University of Melbourne', u'Wayne State University', u'AMAG Pharmaceuticals Inc', u'Charite Universitaetsmedizin Berlin', u'Glenveigh Pharmaceuticals Inc']), u'Alopeciadrug-induced': set([u'US Government', u'Sound Pharmaceuticals Inc']), u'Lungtumor': set([u'RESprotect GmbH', u'Innogene Kalbiotech Pte Ltd', u'Quest Diagnostics Inc', u\"Hospital Vall D'Hebron\", u'Oncologix Inc', u'Transcept Pharmaceuticals Inc', u'Formation Biologics', u'Colorado Office of Economic Development and International Trade', u'Stony Brook University Hospital', u'European Commission', u'OncoMax LLC', u'Champions Oncology Inc', u'Asuragen Inc', u'Eddingpharm Inc', u'University of Maryland', u'Koch Institute for Integrative Cancer Research', u'Ionis Pharmaceuticals Inc', u'NueHealth', u'Takeda GmbH', u'European Community', u'Pharmaceutical Product Development LLC', u'Walter Reed Army Institute of Research', u'Palobiofarma SL', u'Silence Therapeutics plc', u'Shanghai Fosun Pharmaceutical (Group) Co Ltd', u'Hayashibara Co Ltd', u'Uptake Medical Corp', u'US Department of the Treasury', u'ONCO Life Sciences', u'Sorrento Therapeutics Inc', u'Epigenomics AG', u'Fluxion Biosciences Inc', u'Theralase Technologies Inc', u'Wake Forest University', u'Alkopharma', u'Michigan State University', u'City of Hope Medical Center', u'National Health and Medical Research Council', u'CadheRx Therapeutics Inc', u\"Children's Cancer Institute Australia for Medical Research\", u'PDL BioPharma Inc', u'Chem-Master International Inc', u'The University Health Network', u'Monash University', u'Sirnaomics Inc', u'The European Union', u'Nippon Kayaku Co Ltd', u'Tallikut Pharmaceuticals Inc', u'Barrier Therapeutics Inc', u'Sunshine Biopharma Inc', u'Poniard Pharmaceuticals Inc', u'Talon Therapeutics Inc', u'Dutch Cancer Society', u'Boston University School of Medicine', u'Hanmi Pharmaceutical Co Ltd', u'Agennix AG', u'RadNet Inc', u'YM BioSciences Inc', u'Indivumed GmbH', u'Indian Institute Of Technology Madras', u'Regulon Inc', u'Titan Pharmaceuticals Inc', u'Celera Group', u'KBI Biopharma Inc', u'MegaPharm Ltd', u'DelMar Pharmaceuticals Inc', u'Janssen Pharmaceutica NV', u'Kura Oncology Inc', u'Swedish Orphan Biovitrum AB', u'Shanghai Jingfeng Pharmaceutical Co Ltd', u'Acceptys Inc', u'Spotlight Innovation Inc', u'Clarient', u'MethylGene Inc', u'Triton Biosystems Inc', u'Cabrellis Pharmaceuticals Corp', u'Protherics Salt Lake City Inc', u'Deciphera Pharmaceuticals LLC', u'Massachusetts Institute of Technology', u'Sinopharm', u'US Government', u'Avid Bioservices', u'Sakai Chemical Industry Co Ltd', u'LEO Pharma A/S', u'Eli Lilly & Co', u'Phyton Biotech Inc', u'OncoMab GmbH', u'TNK Therapeutics Inc', u'Weizmann Institute of Science', u'Guangdong Jiaying Pharmaceutical Co Ltd', u'Dow Biomedica', u'University of Pittsburgh Cancer Institute', u'OSI Pharmaceuticals Inc', u'NanoString Technologies Inc', u'University of South Florida', u'Fournier Pharma', u'GenWay Biotech Inc', u'Hyaluron Inc', u'Corixa Corp', u'Abion Inc', u'Osaka University', u'Patrys Ltd', u'OncoCyte Corp', u'Medical Acoustics', u'EU Horizon 2020', u'Johnson & Johnson', u'Coley Pharmaceutical Group Inc', u'Accu Reference Medical Lab', u'AbbVie Inc', u'Japanese National Cancer Center', u'Dalton Pharma Services', u'UCB Celltech', u'Belgian Volition Pte Ltd', u'Cancer Prevention and Research Institute of Texas', u'Epic Sciences Inc', u'Fresenius SE & Co KGaA', u'Bristol-Myers Squibb Co', u'Stroke Detection Plus', u'VolitionRX Ltd', u'Chinese Academy of Sciences', u'MDxHealth SA', u'Astellas Pharma Inc', u'IMCOR Pharmaceutical Co', u'Northeast Ohio Medical University', u'Vanderbilt-Ingram Cancer Center', u'Institute of Cancer Research UK', u'Antisoma plc', u'Insmed Inc', u'Acecgt', u'Oncormed Inc', u'Agouron Pharmaceuticals Inc', u'Hebrew University of Jerusalem', u'University of Pretoria', u'Benitec Biopharma Ltd', u'Selective Genetics Inc', u'Cellular Biomedicine Group Inc', u'Health Diagnostic Laboratory Inc', u'Biomira USA Inc', u\"PX'Therapeutics SA\", u'Karolinska Institutet', u'Qu Biologics Inc', u'Aspedia LLC', u'Barbara Ann Karmanos Cancer Institute', u'Jenner Biotherapies Inc', u'IDM Pharma Inc', u'Incyte Corp', u'CytoGenix Inc', u'Pharmacyclics Inc', u'Howard Hughes Medical Institute', u'Centelion SAS', u'University of Bonn', u'Chiron Corp', u'AlphaMed Inc', u'Zhejiang Hisun Pharmaceutical Co Ltd', u'Arizona State University', u'Morphotek Inc', u'Walter and Eliza Hall Institute of Medical Research', u'Astex Pharmaceuticals Inc', u'Stanford University', u'Onyvax Ltd', u'Syndax Pharmaceuticals Inc', u'Andarix Pharmaceuticals Inc', u'University of Kentucky', u'Mateon Therapeutics Inc', u'Biotech Synergy', u'Roche Holding AG', u'Pinnacle Biologics Inc', u'Second Military Medical University PLA', u'University of Texas Health Science Center San Antonio', u'Medic Vision - Brain Technologies Ltd', u'Mie University School of Medicine', u'Gradalis Inc', u'Jinan University (Guangdong)', u'Sellas Life Sciences Group', u'TESARO Inc', u'Selvita SA', u'Biocon Ltd', u'Mayo Clinic Foundation', u'Dana-Farber Cancer Institute Inc', u'Ribomic Inc', u'University of Massachusetts Medical School', u'Exelixis Inc', u'McMaster University', u'Amgen Inc', u'Nippon Petrochem Co Ltd', u'State University of New York at Stony Brook', u'Mitsui Pharmaceuticals Inc', u'Shanghai Wanxing Bio-Pharmaceutical Co Ltd', u'Johns Hopkins University School of Medicine', u'ZIOPHARM Oncology Inc', u'RedHill Biopharma Ltd', u'Georgetown University', u'Robert H. Lurie Comprehensive Cancer Center', u'Georgetown University Medical Center', u'Gritstone Oncology', u'University of Alabama at Birmingham', u'Medical Research Council', u'Samyang Corp', u'Transgene SA', u'Guangdong Zhongsheng Pharmaceutical Co Ltd', u'Inflazyme Pharmaceuticals', u'Biovation Ltd', u'Goodwin Biotechnology Inc', u'Immunomedics Inc', u'Cleveland Clinic Foundation', u'Copharos Inc', u'Dong-A ST Co Ltd', u'Sandoz Ltd', u'Pangaea Biotech SA', u'Florida A & M University', u'National Institute of Biomedical Innovation', u'University of California San Diego', u'Biomoda Inc', u'Oakwood Laboratories LLC', u'University of Oxford', u'Cancer Research UK', u'Genentech Inc', u'Paladin Labs Inc', u'Agilent Technologies Inc', u'Korea Drug Development Fund', u'Rigel Pharmaceuticals Inc', u'Oxford GlycoSciences plc', u'GeneNews Ltd', u'Reino de Espana', u'Invision Biotech', u'New York University', u'Sumitomo Dainippon Pharma Co Ltd', u'iOx Therapeutics Ltd', u'Scripps Research Institute', u'Avila Therapeutics Inc', u'University of Southern California', u'Medison Pharma Ltd', u'Japan Tobacco Inc', u'DiaCarta LLC', u'AIT Austrian Institute Of Technology Gmbh', u'ScinoPharm Taiwan Ltd', u'Bio Analytical Research Corp', u'Pierre Fabre SA', u'Intuitive Surgical Inc', u'MolMed SpA', u'Caprion Pharmaceuticals Inc', u'Disease Interception Accelerator', u'CJ Corp', u'Proteome Sciences plc', u'ReNeuron Group plc', u'AstraZeneca plc', u'National Cancer Center Research Institute', u'Boehringer Ingelheim Pharmaceuticals Inc', u'Caprion Proteomics Inc', u'SUGEN Inc', u'University of Texas Southwestern Medical Center', u'John Wayne Cancer Institute', u'diaDexus LLC', u'OncImmune Ltd', u'Personalized Cancer Therapy Inc', u'Lonza Biologics plc', u'Terumo Corp', u'Vectura Group plc', u'Introgen Therapeutics Inc', u'Academia Sinica', u'Savara Inc', u'Genmab A/S', u'Universidad Complutense de Madrid', u'ASTA Medica AG', u'ASLAN Pharmaceuticals Pte Ltd', u'H Lee Moffitt Cancer Center and Research Institute', u'NYU Langone Medical Center', u'Mundipharma International Corp Ltd', u'Medipharm Biotech Co Ltd', u'Ralph Lauren Center for Cancer Care and Prevention', u'Oncolys BioPharma Inc', u'Activate Immunotherapy', u'Early Diagnosis Consortium', u'Nanogen Inc', u'Advanced Medical Imaging and Genetics', u'Aronex Pharmaceuticals Inc', u'ADT Pharmaceuticals', u'Cornell University', u'Adria Laboratories Inc', u'Medical University of South Carolina', u'Jinghua Pharmaceutical Group Co Ltd', u'Wistar Institute of Anatomy & Biology', u'NanoCarrier Co Ltd', u'Selecta Biosciences Inc', u'GE Healthcare', u'NeoPharm Co Ltd', u'PiSA Farmaceutica', u'Cyanamid Benelux NV', u'Dyax Corp', u'Takeda Pharmaceutical Co Ltd', u'University of Toronto', u'Modulation Therapeutics Inc', u'Clinical Data Inc', u'Ignyta Inc', u'National Comprehensive Cancer Network', u'DRAXIMAGE', u'Unigen Pharmaceuticals Inc', u'Advaxis Inc', u'Mologen Ag', u'Sanofi Pasteur', u'OncoTherapy Science Inc', u'Yakult Honsha Co Ltd', u'Kowa Co Ltd', u'NeoPharm Inc', u'Quintiles Transnational Corp', u'Intensity Therapeutics Inc', u'Shenzhen BGI Genomics Techonology Co Ltd', u'QSV Biologics', u'Oncobiologics Inc', u'Abnova (Taiwan) Corp', u'Matrix Pharma (Canada) Inc', u'Vanderbilt University', u'Quirem Medical', u'Eleison Pharmaceuticals Inc', u'University of Washington', u'Fred Hutchinson Cancer Research Center', u'PlantForm Corp', u'ARIAD Pharmaceuticals Inc', u'New Mexico Institue of Mining and Technology', u'Pharmacia & Upjohn Co', u'ARIUS Research Inc', u'Debiovision Inc', u'Kite Pharma Inc', u'Maurice Wilkins Centre', u'Felicitex Therapeutics Inc', u'Inventiva', u'Medicell Co', u'Saccomanno Research Institute', u\"Prince Henry's Institute of Medical Research\", u'National Center for Research Resources', u'Technology Strategy Board', u'Samford University', u'TrovaGene Inc', u'University of Nottingham', u'International Biotechnology Center Generium LLC', u'Xenova Ltd', u'Inex Pharmaceuticals Corp', u'Intas Pharmaceuticals Ltd', u'Response Genetics Inc', u'Radboud University', u'Mylan Inc', u'National Research Council of Canada', u'Cancer Genetics Inc', u'Genome Institute Of Singapore National University', u'JCR Pharmaceuticals Co Ltd', u'Boehringer Mannheim GmbH', u'Clovis Oncology Inc', u'Acuvax Ltd', u'Diatos SA', u'CytoCore Inc', u'University of Louisville', u'BARD1AG SA', u'Purdue Pharma LP', u'University of California San Francisco', u'WuXi PharmaTech (Cayman) Inc', u'Oncolytics Biotech Inc', u'OPKO Health Inc', u'Belfer Institute', u'Precision Biologics Inc', u'Global Discovery Biosciences', u'Micromet Inc', u'Boehringer Ingelheim Corp', u'University of Melbourne', u'Dynavax Technologies Corp', u'Debiopharm SA', u'21st Century Therapeutics Inc', u'Matrix Analytics Inc', u'Duke University Medical Center', u'Miravant Medical Technologies', u'University of South Alabama', u'Harmonic Pharma', u'JoBen Bio-Medical Co Ltd', u'Schering-Plough Corp', u'Insight Genetics Inc', u'Sidney Kimmel Cancer Center', u'The Knut and Alice Wallenberg Foundation', u'Sanofi Winthrop France SA', u'Global BioPharma Inc', u'Shanghai Institute of Materia Medica of the Chinese Academy of Sciences', u'Cellectar Biosciences Inc', u'Cancer Research Campaign (UK)', u'XOMA Corp', u'Merck & Co Inc', u'Gemin X Pharmaceuticals Inc', u'CFD Therapeutics Inc', u'Instituto Butantan', u'Ascentage Pharma Group Corporation Ltd', u'Celtic Biotech Ltd', u'The Salk Institute for Biological Studies', u'Xenova Group plc', u'Tanabe Seiyaku Co Ltd', u'Development Center for Biotechnology', u'HedgePath Pharmaceuticals Inc', u'Pharmacia Corp', u'European Eurostars Programme', u'Maccine Pte Ltd', u'Biogazelle NV', u'University of Geneva', u'T.J. Martell Foundation', u'Almirall Prodesfarma SA', u'Therapure Biopharma Inc', u'Tamir Biotechnology Inc', u'Broncus Medical Inc', u'Genetracer Biotech Sl', u'Saint Savas Cancer Hospital', u'Anhui Fengyuan Pharmaceutical Co Ltd', u'Triangle Pharmaceuticals Inc', u'Recombio', u'US Department of Defense', u'Vernalis plc', u'Advanomics Corp', u'Broad Institute Inc', u'Tularik Inc', u'AnorMED Inc', u'Antigen Express Inc', u'Imclone LLC', u'Chongqing LUMMY Pharmaceutical Co Ltd', u'Pierre Fabre Laboratories', u'University of Kansas', u'Hope Biosciences Inc', u'Knight Therapeutics Inc', u'Pfizer Japan Inc', u'American Health Foundation', u'Lonza Group AG', u'bioAffinity Technologies, Inc.', u'AltheaDx Inc', u'University of Tokyo', u'Chinese Government', u'MorphoSys AG', u'Cancer Australia', u'MGI Pharma Inc', u'Celgene Corp', u'Muskingum University', u'Research Development Foundation', u'Octamer Inc', u'BC Cancer Agency', u'Ascenta Therapeutics Inc', u'Duke University', u'School of Medicine, Keio University', u'Sheba Medical Center', u'Adaptimmune Therapeutics plc', u'Crown Bioscience Inc', u'Alethia Biotherapeutics Inc', u'European Organisation for Research and Treatment of Cancer (EORTC)', u'Abraxis BioScience Inc', u'Provectus Biopharmaceuticals Inc', u'ProMIS Neurosciences Inc', u'Beth Israel Deaconess Medical Center', u'ValiRx plc', u'Rhone-Poulenc Rorer Inc', u'GD Searle & Co', u'Quest PharmaTech Inc', u'Daiichi Seiyaku Co Ltd', u'Agence Nationale de Recherches sur le Sida et les hepatites virales (ANRS)', u'Cancer Research Technology Pioneer Fund', u'BioChain (Beijing) Science and Technology', u'Baxter International Inc', u'Humanwell Healthcare (Group) Co Ltd', u'Cancer Research Campaign Technology Ltd', u'W C Heraeus GmbH & Co KG', u'VioQuest Pharmaceuticals Inc', u'HTG Molecular Diagnostics Inc', u'GlaxoSmithKline plc', u'Axxiom Inc', u'Cell Genesys Inc', u'Johnson Matthey plc', u'Bayer Schering Pharma AG', u'Biotoscana International', u'ZAI Laboratory Inc', u'Florida Department of Health', u'Ipsen', u'Massachusetts Life Sciences Center', u'Institut Quimic De Sarria CETS', u'Queensland Government', u'Helix BioPharma Corp', u'Institut Curie', u'Aduro BioTech Inc', u'Almac Diagnostics', u'Lung Cancer Alliance', u'Bionaut Pharmaceuticals Inc', u'Peregrine Pharmaceuticals Inc', u'Nascent Biotech Inc', u'Davos Life Science Pte Ltd', u'Best Medical Opinion', u'Biosceptre International Ltd', u'PNP Research Corporation LLC', u'Netherlands Cancer Institute', u'BioMotiv LLC', u'Shionogi & Co Ltd', u'Stanford Rook Ltd', u'Emory University', u'LipoCure', u\"Boston Children's Hospital\", u'Radient Pharmaceuticals Corp', u'Rosetta Genomics Ltd', u'Cell Pathways Inc', u'Tangent Reprofiling', u'Light Sciences Corp', u'Iovance Biotherapeutics Inc', u'MD Anderson Cancer Center', u'Onyx Pharmaceuticals Inc', u'Medarex Inc', u'Clearbridge BioMedics Pte Ltd', u'Daiichi Sankyo Co Ltd', u'Abbott Laboratories', u'UniQuest Pty Ltd', u'Eisai Co Ltd', u'3SBio Inc', u'Ganymed Pharmaceuticals AG', u'Immune Design Corp', u'National Cancer Institute', u'Novartis AG', u'Merck KGaA', u'Fujisawa Pharmaceutical Co Ltd', u'Novelion Therapeutics Inc', u'Nycomed Imaging A/S', u'SciClone Pharmaceuticals Inc', u'Anne Arundel Medical Center', u'University of Minnesota', u'Association of Community Cancer', u'Institut National Des Sciences Appliquees de Rouen (INSA)', u'University of Manchester', u'Aptose Biosciences Inc', u'Tessa Therapeutics Pte Ltd', u'Luye Pharma Group Ltd', u'HitGen Ltd', u'Pharmacia & Upjohn Inc', u'University of Colorado System', u'Strike Bio', u'Washington University in St Louis', u'Ferrer Internacional SA', u'The Center of Molecular Immunology', u'Tapestry Pharmaceuticals Inc', u'Kyowa Hakko Kogyo Co Ltd', u'TC BioPharm Ltd', u'Biotecnol Ltd', u'Biocept Inc', u'AmpliPhi Biosciences Corp', u'OncoMed Pharmaceuticals Inc', u'Chugai Pharmaceutical Co Ltd', u'University of North Carolina', u'Undisclosed', u'GENESIS Pharma SA', u'Andrus Reo Ltd', u'Samsung Medical Center (SMC)', u'MabPlex International Ltd', u'Mesoblast Ltd', u'Herrick Foundation', u'Argos Therapeutics Inc', u'SRI International', u'Amgen Research (Munich) GmbH', u'ArQule Inc', u'Boots Hoechst Celanese', u'Republic of Korea Government', u'National Cancer Research Center Japan', u'Genomac International Ltd', u'Ability Pharmaceuticals SL', u'Orphan Canada Inc', u'BBI Holdings PLC', u'University College London', u'Queensland Genomics Health Alliance', u'Cureline Inc', u'BiPar Sciences Inc', u'PharmaMar SA', u'Epimmune Inc', u'Cellmid Ltd', u'UC San Diego Moores Cancer Center', u'Pharmasyntez', u'RegeneRx Biopharmaceuticals Inc', u'Paradigm', u'Canada-Israel Industrial Research and Development Fund', u'University of Bradford', u'Janssen Biotech Inc', u'rEVO Biologics Inc', u'BioVectra DCL', u'Pfizer Inc', u'Sanofi', u'Yale University', u'Sandoz Inc', u'NanoScan Imaging LLC', u'Guerbet', u'Memorial Sloan-Kettering Cancer Center', u'Cures Within Reach', u'Therion Biologics Corp', u'Stason Pharmaceuticals Inc', u'BioLineRx Ltd', u'LG Life Sciences Ltd', u'Baylor College of Medicine', u'GPC Biotech AG', u'Norsk Hydro AS', u'University of Oklahoma', u'Paul Scherrer Institut', u'Guangxi Wuzhou Pharmaceutical Group Co Ltd', u'National Institute of Allergy and Infectious Diseases', u'Somanta Pharmaceuticals Inc', u'Eureka Therapeutics Inc', u'Viragen Inc', u'Oasmia Pharmaceutical AB', u'Albert Einstein College of Medicine', u'MolecularMD Corp', u'National Institutes of Health', u'Metabolomx', u'American Cyanamid Co', u'Okayama University Hospital', u'University of Chicago', u'YM BioSciences USA', u'Educational and Scientific LLC', u'Araxes Pharma LLC', u'IPMD Inc', u'Ferozsons Laboratories Ltd', u'Exact Sciences Corp', u'University of Guelph', u'Merck Serono SA', u'University Of Science & Technology Of China', u'Takara Bio Inc', u'H2Biologics, Inc', u'Biologics Inc', u'PXBioVision GmbH', u'Cancer Therapy & Research Center', u'Lung Cancer Research Foundation', u'Mayne Pharma Pty Ltd', u'NanoOncology']), u'Corynebacteriumdiphtheriaeinfection': set([u\"Tianjin Municipal People's Government\", u'LG Life Sciences Ltd', u'Chiron Behring GmbH & Co', u'Ribi ImmunoChem Research Inc', u'Rhein Biotech NV', u'Walvax Biotechnology Co Ltd', u'Bio-Manguinhos/Fiocruz', u'Massachusetts Biologic Laboratories', u'Sanofi Pasteur', u'Daiichi Sankyo Co Ltd', u'Abbott Laboratories', u'Sanofi Pasteur KK', u'Takeda Pharmaceutical Co Ltd', u'Serum Institute of India Ltd', u'GlaxoSmithKline plc', u'Sanofi KK', u'Chiron Corp', u'Cambridge Biostability Ltd', u'Undisclosed', u'Bio Farma', u\"United Nations International Children's Fund\", u'OptiNose AS', u'Biological E Ltd', u'Chinese Government', u'West Pharmaceutical Services Inc', u'Merck & Co Inc', u'Fundacao Oswaldo Cruz (Fiocruz)', u'Centers for Disease Control and Prevention', u'Funda\\xe7\\xe3o Ezequiel Dias - Funed', u'bioCSL PTY Ltd', u'SmithKline Beecham Corp', u'Astellas Pharma Inc', u'Shantha Biotechnics PVT Ltd', u'Mitsubishi Tanabe Pharma Corp', u'Kaketsuken', u'LG Life Sciences India Pvt Ltd', u'North American Vaccine Inc', u'Chiron Vaccines Co', u'BIKEN Foundation', u'New Zealand government', u'CanSino Biologics Inc', u'Crucell NV', u'Japan Poliomyelitis Research Institute', u'Quadrant Technologies Ltd', u'Panacea Biotec Ltd', u'Statens Serum Institut', u'University of Melbourne', u'Pfizer Vaccines', u'Akorn Inc', u'Kitasato Institute']), u'Aspergillusfumigatusinfection': set([u'ACE BioSciences A/S', u'Innoprot', u'US Government', u'MycoLogics Inc', u'Genmab A/S', u'Omnia Molecular', u'US Health and Human Services Department', u'Amplyx Pharmaceuticals Inc', u'GlobeImmune Inc']), u'Tracheobronchomalacia': set([u'Materialise Dental NV', u'Tissue Regeneration Systems Inc', u'University of Michigan']), u'Staphylococcusaureusinfection': set([u'Oscient Pharmaceuticals Corp', u'Serenta Biotechnology LLC', u'Nutrition 21 Inc', u'Incyte Corp', u'University of Lund', u'Iroko Pharmaceuticals LLC', u'GlaxoSmithKline plc', u'Inovio Pharmaceuticals Inc', u'Cardiome Pharma Corp', u'Biopharmaceutical Manufacturing Technology Center', u'Chiron Corp', u'Novalex Therapeutics', u'Chongqing Yuanlun Biological Technology Co Ltd', u'Uppsala University', u'Aventis Pharma AG', u'Morphotek Inc', u'MedImmune LLC', u'The Austrian Research Promotion Agency FFG', u'Biosynexus Inc', u'University of Pennsylvania', u'Imaxio', u'University of London', u'Microcide Pharmaceuticals Inc', u'SARomics AB', u'Aviragen Therapeutics Inc', u'ANI Pharmaceuticals Inc', u'Hyglos GmbH', u'Intercell AG', u'Biocon Ltd', u'Sorrento Therapeutics Inc', u'Merus Labs International Inc', u'Defense Advanced Research Projects Agency', u'US Department of Defense', u\"Boston Children's Hospital\", u'Arsanis Biosciences GmbH', u'Evotec AG', u'Queen Elizabeth Hospital', u'Ardea Biosciences Inc', u'Priaxon AG', u'The European Union', u'Kenta Biotech Ltd', u'University of Maryland', u'Absynth Biologics Ltd', u'TTY Biopharm Co Ltd', u'Emisphere Technologies Inc', u'Robert Wood Johnson Medical School', u'SoyMeds Inc', u'Toyama Chemical Co Ltd', u'US Government', u'Sunovion Pharmaceuticals Canada Inc', u'Taiho Pharmaceutical Co Ltd', u'Dong-A ST Co Ltd', u'Red Cross Foundation Central Laboratory Blood Transfusion Service SRC', u'Integrated BioTherapeutics Inc', u'Wellcome Trust', u'BioPhage Therapeutics Ltd', u'GlycoVaxyn AG', u'Third Military Medical University of the Chinese PLA', u'Ondine Biomedical Inc', u'AmpliPhi Biosciences Corp', u'Janus Pharmaceuticals Inc', u'Chugai Pharmaceutical Co Ltd', u'AIMM Therapeutics BV', u'Genentech Inc', u'Biosearch Italia SpA', u'Intralytix Inc', u'Clinquest Group', u'Cangene Corp', u'Laureate Biopharmaceutical Services Inc', u'Medivir AB', u'Undisclosed', u'Microbiotix Inc', u'Avid Bioservices', u'XOMA Corp', u'Affinivax Inc', u'Henry M Jackson Foundation for the Advancement of Military Medicine', u'Indiana University Purdue University Indianapolis', u'CUBRC', u'Merck & Co Inc', u'Medison Pharma Ltd', u'Eli Lilly & Co', u'Agenus Inc', u'US Army Medical Research Institute of Infectious Diseases', u'Ancora Pharmaceuticals Inc', u'Humabs BioMed SA', u'Cubist Pharmaceuticals Inc', u'Pfizer Inc', u'aRigen Pharmaceuticals Inc', u'University of Adelaide', u'Inhibitex Inc', u'4SC AG', u'Lonza Biologics plc', u'Alcon Inc', u'Johnson & Johnson', u'NovaDigm Therapeutics Inc', u'Phico Therapeutics Ltd', u'Tzamal Medical Group Ltd', u'Uniformed Services University of the Health Sciences', u'University of New Mexico', u'National Institute of Allergy and Infectious Diseases', u'Harbor-UCLA Research and Education Institute', u'Bayer AG', u'National Institutes of Health', u'PharmaIN Ltd', u'MorphoSys AG', u'OMRIX Biopharmaceuticals SA', u'The New Energy and Industrial Technology Development Organization', u'Dr Rentschler Biotechnologie GmbH', u'Ball State University', u'Seoul National University', u'Aridis Pharmaceuticals Inc', u'Astellas Pharma Inc', u'Elusys Therapeutics Inc', u'Cambrex Corp', u'Destiny Pharma Ltd', u'FDA Office of Orphan Products Development', u'Novexel SA', u'Cepheid', u\"Brigham & Women's Hospital\", u'German Federal Ministry of Education and Research', u'BioResearch Ireland', u'Wakamoto Pharmaceutical Co Ltd', u'Alopexx Pharmaceuticals', u'3M Co', u'Excelimmune Inc', u'ContraFect Corp']), u'Growthhormonedeficiency': set([u'Merck Serono Co Ltd China', u'Ammonett Pharma LLC', u'Ipsen Biopharmaceuticals Inc', u'Undisclosed', u'Genentech Inc', u'ASCEND Therapeutics Inc', u'Versartis Inc', u'Binex Co Ltd', u'EMD Serono Inc', u'BioPartners GmbH', u'IMBcom Pty Ltd', u'LG Life Sciences Ltd', u'Tulane University', u'Novo Nordisk A/S', u'Diosynth Inc', u'Ambrilia Biopharma Inc', u'Teva Pharmaceutical Industries Ltd', u'Ardana Bioscience Ltd', u'Ferrer Internacional SA', u'Nautilus Biotech SA', u'Ipsen', u'Abeona Therapeutics Inc', u'Savient Pharmaceuticals Inc', u'Sumitomo Pharmaceuticals Co Ltd', u'Altus Pharmaceuticals Inc', u'Daewoong Pharmaceutical Co Ltd', u'Merck & Co Inc', u'Auxilium Pharmaceuticals Inc', u'Theratechnologies Inc', u'Massachusetts General Hospital', u'Ajinomoto Althea Inc', u'Zentaris GmbH', u'Sella Pharmaceuticals Inc', u'OPKO Health Inc', u'Nipro Corp', u'Wellcome Trust', u'Critical Pharmaceuticals Ltd', u'AEterna Zentaris Inc', u'FUJIFILM Pharma Co Ltd', u'Ergomed PLC', u'Pfizer Inc', u'Health Care Logistics Inc', u'Caisson Biotech LLC', u'Teijin Ltd', u'HanAll Biopharma Co Ltd', u'Sandoz KK', u'PROLOR Biotech Inc', u'Bentley Pharmaceuticals Inc', u'Boehringer Ingelheim Corp']), u'Bordetellapertussisinfection': set([u'ILiAD Biotechnologies', u'LG Life Sciences Ltd', u'Chiron Behring GmbH & Co', u'Rhein Biotech NV', u'Walvax Biotechnology Co Ltd', u'Intrexon Corp', u'Bio-Manguinhos/Fiocruz', u'National Institute of Allergy and Infectious Diseases', u'Sanofi Pasteur', u'Daiichi Sankyo Co Ltd', u'Abbott Laboratories', u'Sanofi Pasteur KK', u'Institut Pasteur de Lille', u'Takeda Pharmaceutical Co Ltd', u'Mahidol University', u'BioNet-Asia Co Ltd', u'GlaxoSmithKline plc', u\"United Nations International Children's Fund\", u'Sanofi KK', u\"Tianjin Municipal People's Government\", u'Chiron Corp', u'Cambridge Biostability Ltd', u'Undisclosed', u'Bill & Melinda Gates Foundation', u'Bio Farma', u'Serum Institute of India Ltd', u'Biological E Ltd', u'Chinese Government', u'National University Of Ireland Maynooth', u'INSERM', u'Merck & Co Inc', u'Fundacao Oswaldo Cruz (Fiocruz)', u'Genticel', u'Centers for Disease Control and Prevention', u'Funda\\xe7\\xe3o Ezequiel Dias - Funed', u'DBV Technologies SA', u'SmithKline Beecham Corp', u'Astellas Pharma Inc', u'Shantha Biotechnics PVT Ltd', u'University of British Columbia', u'Mitsubishi Tanabe Pharma Corp', u'National University of Singapore', u'Kaketsuken', u'LG Life Sciences India Pvt Ltd', u'North American Vaccine Inc', u'University of Texas System', u'NanoBio Corp', u'University of Geneva', u'CanSino Biologics Inc', u'University of Melbourne', u'Crucell NV', u'Japan Poliomyelitis Research Institute', u'Quadrant Technologies Ltd', u'Panacea Biotec Ltd', u'Synthetic Biologics Inc', u'Statens Serum Institut', u'ALERT B&C Corp', u'Pfizer Vaccines', u'BIKEN Foundation', u'Kitasato Institute']), u'Pneumoconiosis': set([u'Pfizer Inc', u'Sinergium Biotech']), u'Restenosis': set([u'Daiichi Seiyaku Co Ltd', u'US Government', u'BioMarin Pharmaceutical Inc', u'Telios Pharmaceuticals Inc', u'C R Bard Inc', u'Angiotech Pharmaceuticals Inc', u'SurModics Inc', u'Agennix USA Inc', u'Abdi Ibrahim Ilac Sanayi Ve Ticaret Anonim Sirketi', u'EMD Serono Inc', u'GenVec Inc', u'NicOx SA', u'BIOTRONIK SE & Co', u'King Pharmaceuticals R&D Inc', u'GlaxoSmithKline plc', u'Cell Genesys Inc', u'Bayer Schering Pharma AG', u'Valentis Inc', u'Chiron Corp', u'Green Cross Corp', u'Poniard Pharmaceuticals Inc', u'MGI Pharma Inc', u'Ipsen', u'Novartis Pharma AG', u'Advanced Catheter Therapies', u'Sarepta Therapeutics Inc', u'University of Pittsburgh', u'Bio3 Research Srl', u'Creabilis Therapeutics Srl', u'University of Pennsylvania', u'Fred Hutchinson Cancer Research Center', u'Mitsubishi-Tokyo Pharmaceuticals Inc', u'Sumitomo Pharmaceuticals Co Ltd', u'Stanford University', u'Canadian Institutes of Health Research', u'Cold Spring Harbor Laboratory', u'Ludwig Institute for Cancer Research', u'Boehringer Ingelheim Pharma KG', u'Aderis Pharmaceuticals Inc', u'Handok Inc', u'Toray Industries Inc', u'Focal Inc', u'Stiefel', u'Otsuka Pharmaceutical Co Ltd', u'National Heart Lung and Blood Institute', u'West-Ward Columbus', u'NitroMed Inc', u'NOF Corp', u'Inex Pharmaceuticals Corp', u'New York University', u'Thomas Jefferson University', u'MD Anderson Cancer Center', u'Amgen Inc', u'ValiGen Inc', u'Abbott Laboratories', u'Iroko Pharmaceuticals LLC', u'Mitsui Pharmaceuticals Inc', u'The New Energy and Industrial Technology Development Organization', u'Diosynth Inc', u'Intervet International BV', u'Mount Sinai School of Medicine', u'Viron Therapeutics Inc', u'Novation Pharmaceuticals Inc', u'Guidant Corp', u'Tanabe Seiyaku Co Ltd', u'Transgene SA', u'UCB Pharma GmbH', u'JCR Pharmaceuticals Co Ltd', u'TBG Diagnostics Ltd', u'Inovio Pharmaceuticals Inc', u'Cleveland Clinic Foundation', u'Industrifonden', u'Celera Group', u'Channel Therapeutics Inc', u'Encysive Pharmaceuticals Inc', u'Health Care Logistics Inc', u'Boehringer Ingelheim Corp', u'Tapestry Pharmaceuticals Inc', u'Kyowa Hakko Kogyo Co Ltd', u'Lynx Therapeutics GmbH', u'Long-E International', u'Biochemie GmbH', u'Medtronic Inc', u'Aspen PharmaCare Australia Pty Ltd', u'Glaxo Wellcome (formerly The Wellcome Foundation)', u'AtheroGenics Inc', u'Vegenics Ltd', u'Duke University Medical Center', u'Undisclosed', u'Genentech Inc', u'Miravant Medical Technologies', u'AIM Therapeutics Inc', u'Mayo Clinic Foundation', u'Cangene Corp', u'Thios Pharmaceuticals Inc', u'Karolinska Development AB', u'Goodman Co Ltd', u'Hyal Pharmaceutical Corp', u'Ark Therapeutics Group plc', u'Cook Group Inc', u'SkyePharma plc', u'Merck & Co Inc', u'Ciba-Geigy Corp', u'COR Therapeutics Inc', u'Sanofi', u'Bayer AG', u'Phyton Biotech Inc', u'Elixir Medical Corp', u'Epimmune Inc', u'Pervasis Therapeutics Inc', u'Progenitor Inc', u'AnGes MG Inc', u'Kissei Pharmaceutical Co Ltd', u'\\xd6stersj\\xf6stiftelsen', u'The UK Imperial Cancer Research Fund', u'Janssen Biotech Inc', u'Therapure Biopharma Inc', u'AstraZeneca plc', u'Pfizer Inc', u'Gilead Sciences Inc', u'SUGEN Inc', u\"Brigham & Women's Hospital\", u'Human Genome Sciences Inc', u'Gendux Molecular Ltd', u'Avontec GmbH', u'Osaka University', u'Wyeth', u'Genta Inc', u'Zalicus Inc', u'Terumo Corp', u'Hoechst Marion Roussel Inc', u'Introgen Therapeutics Inc', u'Massachusetts Institute of Technology', u'Australian Government', u'Collgard Biopharmaceuticals Ltd', u'Gilead Palo Alto Inc', u'Synthelabo', u'Medikit Co Ltd', u'Solexa Inc', u'DUSA Pharmaceuticals Inc', u'Amylin Pharmaceuticals Inc', u'Molecumetics Ltd', u'Takeda Pharmaceutical Co Ltd', u'Boston Scientific Corp', u'UCB Celltech', u'The Australian National University', u'University of Strathclyde', u'National Institutes of Health', u'Teijin Ltd', u'Endovasc Inc', u'Licentia Ltd', u'Bristol-Myers Squibb Co', u'Zynaxis Inc', u'IBEX Technologies Inc', u'MSD Japan', u'Aronex Pharmaceuticals Inc', u'Columbia University Medical Center', u'Cephalon Inc', u'Hosokawa Micron Corp', u'Astellas Pharma Inc', u'Transition Therapeutics Inc', u'Athera Biotechnologies AB', u'Protelica Inc', u'University of Western Ontario', u'Hebrew University of Jerusalem', u'Indiana University', u'Dyax Corp', u'MannKind Corp', u'Cardion AG', u'China Pharma Holdings Inc', u'Biosensors International Group Ltd', u'University of Toronto', u'Mayne Pharma Pty Ltd', u'Global Therapeutics', u'BASF AG']), u'Indigestion': set([u'Moberg Pharma AB', u'Prestige Brands Holdings Inc']), u'Calciphylaxis': set([u'Sanifit Laboratoris SL', u'Frenova Renal Research']), u'Glucoseintolerance': set([u'Beijing Sun Novo Pharmaceutical Research Co Ltd', u'Merck & Co Inc', u'Uni-Bio Science Group Ltd', u'Probiodrug AG', u'Institute of Diabetes Gerhardt Katsch Karlsburg e.V', u'Chong Kun Dang Pharmaceutical Corp']), u'Dryagerelatedmaculardegeneration': set([u'Aerie Pharmaceuticals Inc', u'US Government', u'Lin Bioscience Inc', u'National Institute of Neurological Disorders and Stroke', u'Israeli Government', u'Tufts University School of Medicine', u'Astellas Institute for Regenerative Medicine', u'University of Bonn', u'Institut de la Vision', u'GlaxoSmithKline plc', u'Lonza Group AG', u'Aldeyra Therapeutics Inc', u'Kodiak Sciences Inc', u'National Institutes of Health', u'Ionis Pharmaceuticals Inc', u'pSivida Corp', u'AmorChem LP', u'Asia Pharm Ind Co Ltd', u'MacuCLEAR Inc', u'Ajinomoto Althea Inc', u'iCura Vision', u'Columbia University', u'NovelMed Therapeutics Inc', u'Ramot at Tel Aviv University Ltd', u'University of Cologne', u'LumiThera Inc', u'University of Wisconsin-Madison', u'Orphagen Pharmaceuticals Inc', u'Cell Cure Neurosciences Ltd', u'Acucela Inc', u'National Eye Institute', u'Foundation Fighting Blindness', u'Ophthotech Corp', u'University of California Los Angeles', u'SynCore Biotechnology Co Ltd', u'BIOPHYTIS', u'Foamix Pharmaceuticals Ltd', u'Patheon Inc', u'Columbia Technology Ventures', u'Mperia Therapeutics Inc', u'Univalor', u'Alkeus Pharmaceuticals Inc']), u'Filariasis': set([u'Liverpool School of Tropical Medicine', u'University of Bonn', u'Massachusetts Institute of Technology', u'Bayer AG', u'Drugs for Neglected Diseases Initiative', u'Astellas Pharma Inc', u'Bill & Melinda Gates Foundation', u'BIO Ventures for Global Health', u'Divergence Inc', u'Alnylam Pharmaceuticals Inc', u'National Institute of Allergy and Infectious Diseases', u'Medicines for Malaria Venture', u'Sanofi', u'Institute For Medical Research (Inc In Malaysia)', u'Molplex Pharmaceuticals', u'GlaxoSmithKline plc']), u'Abdominalaorticaneurysm': set([u'University of Oklahoma', u'National Institute on Aging', u'MicroPort Scientific', u'National Heart Lung and Blood Institute', u'Clemson University', u'Yale University', u'Bristol-Myers Squibb Co', u'Lombard Medical Technologies PLC', u'Lantheus Medical Imaging Inc', u'Georgia State University']), u'Delirium': set([u'Eisai Co Ltd', u'Undisclosed', u'Gaia BioPharma Ltd']), u'Tineacapitis': set([u'Dong Wha Pharmaceutical Co Ltd', u'Novartis AG']), u'Skincancer': set([u'Karolinska Institutet', u'University of Queensland', u'Hexima Ltd', u'American Skin Association', u'Advanced Medical Isotope Corp', u'Australian Government', u'MD Anderson Cancer Center', u'TBG Diagnostics Ltd', u'Stratatech Corp', u'Biomedica Life Sciences SA', u'New Colombia Resources Inc', u'Harvard University', u'US Government', u'Balmoral Australia Pty Ltd', u'PIQUR Therapeutics Ltd', u'Phase Holographic Imaging Phi Ab', u'National Cancer Institute', u'Prescient Therapeutics Ltd', u'Massachusetts Institute of Technology', u'National Institutes of Health', u'Restoration Genetics Inc', u'Telormedix SA', u'Elan Corp plc', u'Redx Pharma Plc', u'European Eurostars Programme', u'MorphoSys AG', u'Oncology Venture ApS', u'LEO Pharma A/S', u'Transgene SA', u'University of Patras', u'ISDIN SA', u'Florida Atlantic University', u'Colorado State University', u'HedgePath Pharmaceuticals Inc', u'Deutsches Krebsforschungszentrum', u'PharmaQest Pty Ltd', u'Acrux Ltd', u'Pierre Fabre SA', u'Melanoma Research Alliance', u'Translational Genomics Research Institute', u'Undisclosed', u'Viventia Bio Inc', u'AGI Dermatics Inc', u'Metaphore Pharmaceuticals Inc', u'University of California Los Angeles', u'The Knut and Alice Wallenberg Foundation', u'Peplin Inc', u'Farmatech SA', u'Digna Biotech SL', u'Foamix Pharmaceuticals Ltd', u'CHS Resources LLC', u'University of California San Francisco', u'Mayne Pharma Pty Ltd', u'Oregon Health Sciences University', u'Cadila Pharmaceuticals Ltd', u'Charite Universitaetsmedizin Berlin', u'Constellation Diagnostics Inc']), u'Chikungunyavirusinfection': set([u'Themis Bioscience GmbH', u'University of Texas Medical Branch at Galveston', u'Quratis Co Ltd', u'Australian Government', u'Baxter International Inc', u'Nobilon International BV', u'Defyrus Inc', u'SingVax Pte Ltd', u'University of Maryland', u'Wageningen University and Research', u'National Institute of Allergy and Infectious Diseases', u'US Government', u'US Health and Human Services Department', u'Integral Molecular Inc', u'Inovio Pharmaceuticals Inc', u'Top Institute Pharma', u'Duke-NUS Graduate Medical School', u'InViragen LLC', u'Sun Pharmaceutical Industries Ltd', u'Walter Reed Army Institute of Research', u'National Institutes of Health', u'VGX Pharmaceuticals LLC', u'Vivalis', u'GenPhar Inc', u'Engility Holdings Inc', u'Nanotherapeutics Inc', u'Catholic University of Leuven', u'Zydus-Cadila Group', u'Isla Lab Products LLC', u'Centers for Disease Control and Prevention', u'University of Pennsylvania', u'University of Wisconsin-Madison', u'US Army Medical Research Institute of Infectious Diseases', u'Infectious Disease Research Institute', u'Evolva SA', u'Medigen Inc', u'MacroGenics Inc', u'Chembio Diagnostic Systems Inc', u'Institut Pasteur', u'Washington University in St Louis', u'PaxVax Inc', u'Erasmus University Medical Center Rotterdam', u'Agency For Science Technology & Research', u'Atomo Diagnostics Pty Ltd', u'Hawaii Biotech Inc', u'Blood Systems Research Institute (BSRI)', u'Takeda Pharmaceutical Co Ltd', u'National Institute of Virology', u'Aix-Marseille Universit\\xe9', u'The Paul G. Allen Family Foundation']), u'Hyperoxaluria': set([u'Hospices Civils De Lyon', u'Q-Med AB', u'Institut f\\xfcr Mikro\\xf6kologie GmbH', u'Galenica AB', u'The University College London Hospitals NHS Trust', u'National Institute of Diabetes, Digestive and Kidney Diseases', u'The European Union', u'Ixion Biotechnology Inc', u'K.A.B.S Laboratories Inc', u'Allena Pharmaceuticals Inc', u'Captozyme LLC', u'University of Florida', u'Sanofi Genzyme', u'Ajinomoto Althea Inc', u'University Hospital, Bonn', u'OxThera AB', u'Bio-Images Drug Delivery Ltd', u'TNO', u'Ergomed PLC', u'SymbioPharm GmbH', u'Alnylam Pharmaceuticals Inc', u'Wake Forest University', u'RecipharmCobra Biologics']), u'Lymedisease': set([u'State University of New York', u'Massachusetts Institute of Technology', u'Time for Lyme Inc', u'OPKO Diagnostics', u'Sanofi Pasteur', u'National Institute of Allergy and Infectious Diseases', u'Elanco Animal Health', u'US Health and Human Services Department', u'Immuno Tech Inc', u'Protagen AG', u'Mikrogen Molekularbiologische Entewicklungs GmbH', u'Agile Sciences Inc', u'Vical Inc', u'Ventria Bioscience', u'National Institutes of Health', u'Texas A&M University System', u'Bay Area Lyme Fund', u'Brandeis University', u'Brookhaven National Laboratory', u'MedImmune LLC', u'Columbia University', u'Boulder Diagnostics Inc', u'Centers for Disease Control and Prevention', u'Celldex Therapeutics Inc', u'VG Life Sciences Inc', u'Concordia Pharmaceuticals Inc', u'Evolva SA', u'Turn the Corner Foundation', u'SK Chemicals Life Science', u'Intercell AG', u'University Medical Centre St Radboud', u'L2 Diagnostics Llc', u'Ilsung Pharmaceutical Co Ltd', u'Abzyme Therapeutics LLC', u'Yale University', u'Boehringer Ingelheim Vetmedica GmbH', u'Novartis Vaccines & Diagnostics', u'University of Rhode Island', u'Teligent Inc', u'GlaxoSmithKline plc']), u'Renalinjury': set([u'University of Cincinnati', u'US Government', u'Stanford University', u'CSL Behring LLC', u'Silence Therapeutics plc', u'Vifor Pharma', u'National Institute of Diabetes, Digestive and Kidney Diseases', u'Alliance for Lupus Research', u'Abbott Laboratories', u'NeuroVive Pharmaceutical AB', u'University of California San Diego', u'Bessor Pharma LLC', u'Innovative BioTherapies', u'Mitohealth Inc', u'A1M Pharma AB', u'Astute Medical Inc', u'DURECT Corp', u'STATegics Inc', u'Food and Drug Administration', u'Ionis Pharmaceuticals Inc', u'Zealand Pharma A/S', u'Sk\\xe5ne University Hospital', u'Massachusetts General Hospital', u'Quark Pharmaceuticals Inc', u'Transplant Genomics', u'Hospira Inc', u'Fred Hutchinson Cancer Research Center', u'Astellas Pharma Inc', u'Medizinische Universit\\xe4t Innsbruck', u'Pathfinder Cell Therapy Inc', u'CorMedix Inc', u'Region Skane', u'University of Colorado System', u'Shanghai Fosun Pharmaceutical (Group) Co Ltd', u'Virginia Commonwealth University', u'Thrasos Therapeutics', u'National Cancer Institute', u'Indiana University', u'Kyoto University', u'Novartis AG', u'Action Pharma A/S', u'Pfizer Inc', u'Alnylam Pharmaceuticals Inc']), u'Bronchiectasis': set([u'Pharmaxis Ltd', u'Undisclosed', u'Savara Inc', u'IDIS Ltd', u'US Government', u'Quintiles Transnational Corp', u'Grifols SA', u'Chiesi Farmaceutici SpA', u'Aradigm Corp', u'EnBiotix Inc', u'Pulmagen Therapeutics', u'Parion Sciences Inc', u'Massachusetts General Hospital', u'Nobelpharma Co Ltd', u'Serendex Pharmaceuticals A/S', u'Insmed Inc', u'University of Sydney', u'Alitair Pharmaceuticals Inc', u'Canadian Department of National Defence', u'AstraZeneca plc', u'Gilead Sciences Inc', u'Kamada Ltd', u'ANUTECH Pty Ltd', u'PARI Pharma GmbH', u'Edmond Pharma']), u'Asthma': set([u'Deltagen Research Laboratories', u'Takeda Vaccines Inc', u'Oscient Pharmaceuticals Corp', u'Oxagen Ltd', u\"Cincinnati Children's Hospital Medical Center\", u'Takara Bio USA Inc', u'National Institutes of Health', u'Verus Pharmaceuticals Inc', u'Ionis Pharmaceuticals Inc', u'Novartis Pharma AG', u'European Community', u'University of South Florida', u'Celldex Therapeutics Inc', u'AzERx Inc', u'Danish National University Hospital', u'Ramot at Tel Aviv University Ltd', u'University of Rochester', u'Hospira Inc', u'SBI Biotech Co Ltd', u'JHL Biotech', u'DSM Pharmaceuticals Inc', u'ZymoGenetics Inc', u'Celera South San Francisco', u'Universita Degli Studi Di Perugia', u'Dompe SpA', u'Handok Inc', u'Shire Orphan Therapies GmbH', u'Catalent Inc', u'Tanabe Seiyaku Co Ltd', u'ElsaLys Biotech', u'NeuroSearch A/S', u'Lotus Pharmaceuticals Inc', u'Sandoz AG', u'Florida Institute of Technology', u'National Health and Medical Research Council', u'Entelos Inc', u'University of Nottingham', u'Julphar Gulf Pharmaceutical Industries', u'PDL BioPharma Inc', u'Propeller Health', u'Nventa Biopharmaceuticals Corp', u'University of California San Francisco', u'Beximco Pharmaceuticals Ltd', u'Cambridge Antibody Technology Group plc', u'Nitto Denko Corp', u'Glenmark Pharmaceuticals Ltd', u'Enzon Pharmaceuticals Inc', u'Innoviva Inc', u'University of Cambridge', u'Antisense Therapeutics Ltd', u'Znomics Inc', u'Devgen NV', u'Genetic Therapy Inc', u'Allosteros Therapeutics Inc', u'Poniard Pharmaceuticals Inc', u'Vanderbilt University', u'Tonghua Dongbao Pharmaceutical Co Ltd', u'SunTen Phytotech Co Ltd', u'Hanmi Pharmaceutical Co Ltd', u'Agennix AG', u'Ethris GmbH', u'YM BioSciences Inc', u'National Jewish Health', u'Friedrich Schiller University of Jena', u'Kyorin Pharmaceutical Co Ltd', u'Mir SrL', u'Cilag AG', u'Celera Group', u'MegaPharm Ltd', u'Prommune Inc', u'Hunter Immunology Pty Ltd', u'East Carolina University', u'Nycomed Canada Inc', u'Haemopep Pharma GmbH', u'Tianjin International Joint Academy of Biotechnology and Medicine', u'airPharma', u'Genfit SA', u'Vernalis Group plc', u'Infinity Pharmaceuticals Inc', u'Nippon Boehringer Ingelheim Co Ltd', u'Laboratorios Servimedic', u'Sanofi', u'Swedish Orphan Biovitrum AB', u'Patheon Pharmaceuticals Inc', u'Ortho Pharmaceutical Corp', u'Hartford Hospital', u'Axiom Biotechnologies Inc', u'Progenra Inc', u'Grunenthal GmbH', u'Dong-A ST Co Ltd', u'Bayer Yakuhin Ltd', u'La Jolla Institute of Allergy & Immunology', u'Alpha Biologics', u'7TM Pharma A/S', u'Sakai Chemical Industry Co Ltd', u'Daewoong Pharmaceutical Co Ltd', u'Novartis International Pharmaceutical Ltd', u'Antigen Express Inc', u'Domainex Ltd', u'Eli Lilly & Co', u'Chiroscience R&D Ltd', u'CSL Ltd', u'Seikagaku Corp', u'Mipharm SpA', u'Cumberland Emerging Technologies Inc', u'Palatin Technologies Inc', u'Argenta Discovery Ltd', u'Hamilton Health Sciences Corp', u'Mimetrix', u'Sandoz GmbH', u'AppTec Laboratory Services', u'Cumberland Pharmaceuticals Inc', u'Corixa Corp', u'National Taiwan University', u'Forbes Medi-Tech Inc', u'Johnson & Johnson', u'Coley Pharmaceutical Group Inc', u'AbbVie Inc', u'BIAL Group', u'University of California San Diego', u'SmithKline Beecham plc', u'Taisho Pharmaceutical Co Ltd', u'UCB Celltech', u'Program for Appropriate Technology in Health', u'Northwestern University', u'Hyland Immuno', u'Takeda Pharmaceutical Co Ltd', u'Yamanouchi Pharmaceutical Co Ltd', u'Bristol-Myers Squibb Co', u'Laborat\\xf3rio Qu\\xedmico Farmac\\xeautico Bergamo Ltda', u'Peptimmune Inc', u'Janssen Research & Development LLC', u'Fourth Military Medical University PLA', u'CyDex Pharmaceuticals Inc', u'Fujirebio KK', u'Insmed Inc', u'Tabuk Pharmaceutical Manufacturing Co', u'Rhone-Poulenc SA', u'Metaphore Pharmaceuticals Inc', u'DIC Corp', u'Cynata Therapeutics Ltd', u'Hoechst Marion Roussel Inc', u'University of Manitoba', u'Bridge Pharmaceuticals Inc', u'Procaps SA', u'Bio-Quant Inc', u'S-TARget therapeutics', u'Intellikine Inc', u'Genesis Research and Development Corp Ltd', u'Cachet Pharmaceutical Co Ltd', u'Avita Medical Ltd', u'Protagonist Therapeutics Inc', u'Dynavax Technologies Corp', u'IDEC Pharmaceuticals Corp', u'Orion Corporation', u'BTG plc', u'RespiVert Ltd', u'Chiesi Farmaceutici SpA', u'Shasun Pharmaceuticals Ltd', u'University of Coimbra', u'Pulmagen Therapeutics', u'Savient Pharmaceuticals Inc', u'University Of Southampton', u'Syngenta AG', u'Arizona State University', u'Chinese Government', u'Astex Pharmaceuticals Inc', u'TBG Diagnostics Ltd', u'The Austrian Research Promotion Agency FFG', u'Onyvax Ltd', u'Lorantis Ltd', u'Mitsubishi-Tokyo Pharmaceuticals Inc', u'Ono Pharmaceutical Co Ltd', u'Roche Holding AG', u'Merck Sante SA', u'Shire plc', u'University of British Columbia', u'Medeva plc', u'Mitsubishi Tanabe Pharma Corp', u'Hovione Scientia Ltd', u'Altair Therapeutics Inc', u'ANI Pharmaceuticals Inc', u'UCB Pharma SA', u'Hisamitsu Pharmaceutical Co Inc', u'Innovata plc', u'Korea Drug Development Fund', u'Teijin Pharma Ltd', u'Orient Europharma', u'Inflabloc Pharmaceuticals Inc', u'University of Massachusetts Medical School', u'Centre for Human Drug Research', u'Evotec AG', u'Meiji Seika Pharma Co Ltd', u'OncoArendi Therapeutics Sp Z Oo', u'Maruho Co Ltd', u'Sanofi (pre-1999)', u'Northern Sydney Area Health Service', u'e-Therapeutics Plc', u'Endacea Inc', u'Galena Biopharma Inc', u'The Menarini Group', u'Biosintetica Farmaceutica Ltda', u'Invion Ltd', u'Stiefel Laboratories (UK) Ltd', u'SkyePharma plc', u'University of Alabama at Birmingham', u'Sanofi-Synthelabo', u'Abgenix Inc', u'NiKem Research Srl', u'Inflazyme Pharmaceuticals', u'Astellas Pharma Inc', u'Alseres Pharmaceuticals Inc', u'Berlin Free University', u'Scarista Ltd', u'TWi Pharmaceuticals Inc', u'AtheroGenics Inc', u'Albany Molecular Research Inc', u'Transition Therapeutics Inc', u'Activaero GmbH', u'LG Chem Ltd', u'Xencor Inc', u'Mimotopes Pty Ltd', u'Roche Palo Alto', u'Accolade Pharmaceuticals Pte Ltd', u'Medivir AB', u'Highnoon Laboratories Ltd', u'Shenzhen Jiaxuan Pharmatech Co Ltd', u'King Pharmaceuticals Inc', u'Medidata Solutions Worldwide', u'Green Cross Corp', u'Genentech Inc', u'Overpharma Produtos Medicos e Farmaceuticos Lda', u'Mitsubishi Pharma Corp', u'Xian-Janssen Pharmaceutical Ltd', u'Mayo Clinic Foundation', u'Rigel Pharmaceuticals Inc', u'Oxford GlycoSciences plc', u'Ore Pharmaceuticals Inc', u'Arriva Pharmaceuticals Inc', u'Sumitomo Dainippon Pharma Co Ltd', u'LifeArc', u'Actavis Inc', u'Merck Frosst Canada & Co', u'Nippon Chemiphar Co Ltd', u'Altus Formulation', u'Biolipox AB', u'Aerogen Inc', u'Australian Research Council', u'Scripps Research Institute', u'Ahn-Gook Pharmaceuticals Co Ltd', u'Surface Therapeutics Ltd', u'Alkermes plc', u'Dompe Farmaceutici SpA', u'Numab AG', u'Commense Inc', u'National Tsing Hua University', u'Tunitas Therapeutics Inc', u'Actient Pharmaceuticals LLC', u'IVAX Corp', u'Zhejiang Medicine Co Ltd', u'AstraZeneca plc', u'Technology Strategy Board', u'Boehringer Ingelheim Pharmaceuticals Inc', u'Ares-Serono Inc', u'Adenosine Therapeutics LLC', u'University College London', u'Undisclosed', u'CardioPep Pharma GmbH', u'Intech Biopharm Ltd', u'BioFocus DPI', u'Horizon Pharma plc', u'Scotia Holdings plc', u'Terumo Corp', u'Janssen-Cilag Ltd', u'Vectura Group plc', u'Australian Government', u'The European Union', u'Savara Inc', u'Genmab A/S', u'Solexa Inc', u'ASLAN Pharmaceuticals Pte Ltd', u'INOXIA Lifesciences GmbH', u'Biocopea Ltd', u'Ben-Gurion University Of The Negev', u'Janssen Sciences Ireland Uc', u'University of Wisconsin-Milwaukee', u'Ario Pharma Ltd', u'Eczacibasi Ilac Pazarlama AS', u'Heat Biologics Inc', u'Horizon Pharma GmbH', u'Critical Therapeutics Inc', u'3M Drug Delivery Systems', u'ESP Pharma Inc', u'Bristol-Myers Squibb Pharma Co', u'IXICO Plc', u'Covis Pharma Sarl', u'P2D Biosciences', u'Yung-Shin Pharmaceutical Industry Co Ltd', u'Institut Pasteur', u'Ventaira Pharmaceuticals Inc', u'diaDexus Inc', u'Par Pharmaceutical Inc', u'Zaiya Inc', u'Walter and Eliza Hall Institute of Medical Research', u'Avigen Inc', u'Resistentia Pharmaceuticals AB', u'Dyax Corp', u'3M Co', u'Atlantic Healthcare plc', u'Proteologics Inc', u'GeneMedicine Inc', u'Clinical Data Inc', u'LeukoSite Inc', u'Matrix Pharma (Pvt) Ltd', u'Royal DSM NV', u'Takeda GmbH', u'Inyx Inc', u'Silence Therapeutics plc', u'Torii Pharmaceutical Co Ltd', u'Aeolus Pharmaceuticals Inc', u'Biotest AG', u'Forest Laboratories Inc', u'Global Clean Energy Holdings Inc', u'Quintiles Transnational Corp', u'Shanghai Institute of Pharmaceutical Industry', u'Orexo AB', u'Meyer Pharmaceuticals LLC', u'University of Queensland', u'Kirin Holdings Co Ltd', u'Verona Pharma plc', u'Aventis Pharma AG', u'University of Tennessee', u'MedImmune LLC', u'Johannes Gutenberg Universitat Mainz', u'Galapagos NV', u'Molecumetics Ltd', u'Zeneca Group plc', u'Janssen Biotech Inc', u'Defiante Farmaceutica Lda', u'Adherium', u'Swiss Institute of Allergy & Asthma Research', u'ARIAD Pharmaceuticals Inc', u'Medical College of Zhejiang University', u'Ancile Pharmaceuticals Inc', u'Immune Network Ltd', u'ReveraGen BioPharma Inc', u'Nippon Shinyaku Co Ltd', u'SATT CONECTUS ALSACE', u'Relief Therapeutics Holding AG', u'Teijin Ltd', u'Defense Advanced Research Projects Agency', u'Pfizer Inc', u'Signal Research Division', u'Synairgen plc', u'Hikma Pharmaceuticals plc', u'Fountain BioPharma Inc', u'Etiologics Ltd', u'Tohoku University', u'Mylan Inc', u'Novozymes GroPep Ltd', u'Laboratorios Elmor SA', u'Arrow International Ltd', u'TransGenex Nanobiotech Inc', u'Repligen Corp', u'Yale University', u'NeoPharm Inc', u'Teva Pharmaceutical Industries Ltd', u'CytoCore Inc', u'Allakos Inc', u'Avontec GmbH', u'Pharmacopeia Inc', u'Boehringer Ingelheim International GmbH', u'UCB Pharma GmbH', u'University of Wurzburg', u'Mundipharma EDO GmbH', u'EpiGenesis Pharmaceuticals Inc', u'Lonn Ryonn Pharma Ltd', u'Glaxo Group Ltd', u'AnGes MG Inc', u'University of Bristol', u'Encysive Pharmaceuticals Inc', u'Boehringer Ingelheim Corp', u'MAP Pharmaceuticals Inc', u'Britannia Pharmaceuticals Ltd', u'Genset SA', u'PrEP Biopharm Limited', u'University of Melbourne', u'Windtree Therapeutics Inc', u'Icure Pharmaceutical Corp', u'Duke University Medical Center', u'Tianjin KingYork Group', u'Allergica Ltd', u'Connetics Corp', u'Revotar Biopharmaceuticals AG', u'National Institute of Diabetes, Digestive and Kidney Diseases', u'Vical Inc', u'Celon Pharma SP', u'Schering-Plough Corp', u'Cureon A/S', u'PCT, a Caladrius company', u'Innovata Biomed Ltd', u'Capstone Therapeutics Corp', u'Ception Therapeutics Inc', u'XOMA Corp', u'PharmEste SRL', u'Merck & Co Inc', u'ChemoCentryx Inc', u'Collegium Pharmaceutical Inc', u'ForHumanTech Co Ltd', u'Columbia University', u'Italian Government', u'Phytera Inc', u'Case Western Reserve University', u'BioSeek Plc', u'Jagotec AG', u'Almirall Prodesfarma SA', u'West-Ward Columbus', u'Gene Smart Health', u'Gilead Sciences Inc', u'Innate Immune Inc', u'Synthetic Biologics Inc', u'Caladrius Biosciences Inc', u'Unimark Remedies Ltd', u'University of Adelaide', u'Copernicus Therapeutics Inc', u'Wyeth', u'Institute for the Promotion of Innovation by Science and Technology in Flanders', u'Eleventa', u'Vernalis plc', u'Acambis plc', u'CollaGenex Pharmaceuticals Inc', u'Tularik Inc', u'Massachusetts Institute of Technology', u'Macropharma Corp', u'Takeda Pharmaceuticals International GmbH', u'National Institute of Allergy and Infectious Diseases', u'Laboratorios Dr Esteve SA', u'Astra AB', u'Pharmacare Ltd', u'Hokuriku Seiyaku KK', u'PowderJect Pharmaceuticals plc', u'Helixir Co Ltd', u'Lonza Group AG', u'Max-Planck-Gesellschaft', u'Ablynx NV', u'GlaxoSmithKline KK', u'Dongguan Kaifa Biomedicine Inc', u'Elan Corp plc', u'Dainippon Pharmaceutical Co Ltd', u'NKT Therapeutics Inc', u'MorphoSys AG', u'Kuros Biosciences Ltd', u'Ligand Pharmaceuticals Inc', u'MSD Japan', u'CJ Corp', u'Cephalon Inc', u'Celgene Corp', u'Khandelwal Laboratories Ltd', u'Imperial College London', u'Eurofarma', u'Sosei Group Corp', u'Corus Pharma Inc', u'Scottsdale Scientific DBA Allergy Research Group/Nutricology, INC.', u'Genelabs Technologies Inc', u'Ranbaxy Laboratories Ltd', u'Tufts University', u'MediciNova Inc', u'Janssen Pharmaceuticals Inc', u'Boehringer Ingelheim Austria GmbH', u'Amakem Therapeutics', u'Adamis Pharmaceuticals Corp', u'Meda Pharmaceuticals Inc', u'PARI Pharma GmbH', u'St Georges University of London', u'Daiichi Seiyaku Co Ltd', u'US Government', u'iCo Therapeutics Inc', u'Hunter-Fleming Ltd', u'GT Biopharma Inc', u'Galenica AG', u'Rhone-Poulenc Rorer Pharm Inc', u'Medical Developments International Ltd', u'InterMune Inc', u'Biogen Inc', u'Grupo Uriach', u'Breckenridge Pharmaceutical Inc', u'GlaxoSmithKline plc', u'Newcastle Innovation Ltd', u'Axxam SpA', u'ZAI Laboratory Inc', u'Firestone Institute for Respiratory Health', u'Five Prime Therapeutics Inc', u'Immunex Corp', u'Queensland Government', u'Helm AG', u'Procter & Gamble Pharmaceuticals Inc', u'Glycobia Inc', u'Wyeth Pharmaceuticals', u'Novimmune SA', u'University of Michigan', u'FAES Farma SA', u'Stemmed Ltd', u'Takeda Oncology', u'Iconovo Ab', u'SnowBrand Pharmaceuticals Inc', u'Novis Pharmaceuticals Llc', u'AMRAD Discovery Technologies Pty Ltd', u'Neurogen Corp', u'Beijing Jiashilianbo Pharm Sci & Tech Co Ltd', u'Cognosci Inc', u'Sankyo Co Ltd', u'Aderis Pharmaceuticals Inc', u'Philipps-Universitat Marburg', u'BioWa Inc', u'3M Pharmaceuticals', u'Amalyte Pharmaceuticals LLC', u'ECI Inc', u'Stanford Rook Ltd', u'National Heart Lung and Blood Institute', u'elbion AG', u'Amneal Pharmaceuticals Company GmbH', u'UCB SA', u'Pahang Pharmacy Sdn Bhd', u'SAJE Pharma', u'Sucampo AG', u'Jinzhou Jiutai Pharmaceutical Co Ltd China', u'Mitsubishi Corp', u'Medarex Inc', u'Cystic Fibrosis Foundation Therapeutics Inc', u'Daiichi Sankyo Co Ltd', u'Abbott Laboratories', u'Eisai Co Ltd', u'Laboratorios Bago SA', u'Tanox Inc', u'geneRx+ Inc', u'National Cancer Institute', u'Novartis AG', u'Merck KGaA', u'Aradigm Corp', u'DreamPharma Corp', u'Kos Pharmaceuticals Inc', u'Korea Research Institute of Bioscience and Biotechnology', u'Fujisawa Pharmaceutical Co Ltd', u'Zendex Bio Strategy Inc', u'Mycenax Biotech Inc', u'Oxford BioMedica plc', u'OSI Pharmaceuticals Inc', u'Monash University', u'Concordia Pharmaceuticals Inc', u'Cadus Corp', u'University of Texas System', u'Kosan Biosciences Inc', u'Dermira Inc', u'McGill University', u'Universitair Medisch Centrum Utrecht', u'PUMC Pharmaceutical Co Ltd', u'Johns Hopkins University', u'Lupin Ltd', u'Myriad Genetics Inc', u'Kyowa Hakko Kogyo Co Ltd', u'Recordati SpA', u'Wacker Biotech GmbH', u'H Lundbeck A/S', u'Orphan Australia', u'Isu Abxis Inc', u'Chugai Pharmaceutical Co Ltd', u'Telesso Technologies Ltd', u'NITTO DENKO Avecia', u'Aptar Pharma SAS', u'Oregon Health Sciences University', u'Otsuka Pharmaceutical Co Ltd', u'Schering-Plough KK', u'Prosonix Ltd', u'Maxygen Holdings Ltd', u'ImmuneRegen BioSciences Inc', u'Sumitomo Chemical Co Ltd', u'Cephalon Australia Pty Ltd', u\"Dr Reddy's Laboratories Ltd\", u'UBE Industries Ltd', u'Amerisourcebergen Drug Corp', u'PLIVA dd', u'Amgen Inc', u'University of Virginia', u'Kyowa Hakko Kirin Co Ltd', u'SIRO ClinPharm USA LLC', u'RegeneRx Biopharmaceuticals Inc', u'Kissei Pharmaceutical Co Ltd', u'Protectimmun GmbH', u'Korean Ministry of Knowledge Economy', u'Genaera Corp', u'Sunovion Pharmaceuticals Inc', u'Esteve', u'Peregrine Renovations LLC', u'Shenyang Pharmaceutical University', u'Daewon Pharm Co Ltd', u'Sosei R&D Ltd', u'Institute of Medical Biology Chinese Academy of Medical Sciences', u'deCODE genetics ehf', u'Sandoz Inc', u'Pieris Pharmaceuticals Inc', u'Khepri Pharmaceuticals', u'Yissum Research Development Co', u'PA Consulting Services Ltd', u'Shinshu University', u'Ziarco Pharma Ltd', u'BioLineRx Ltd', u'Shionogi Inc', u'sterna biologicals GmbH and Co KG', u'Mercia Pharma Inc', u'UK Government', u'Synthelabo', u'Immune Pharmaceuticals Inc', u'DevCo Pharmaceuticals Ltd', u'Aerovance Inc', u'United BioPharma Inc', u'Zambon Co SpA', u'Stallergenes SA', u'Phylogica Ltd', u'Heptares Therapeutics Ltd', u'Bayer AG', u'NAEJA Pharmaceuticals Inc', u'Food and Drug Administration', u'ALK-Abello', u'Sanford-Burnham Medical Research Institute', u'Synvista Therapeutics Inc', u'University of Connecticut', u'Zenyth Therapeutics Ltd', u'Taligen Therapeutics Inc', u'UCB Japan Co Ltd', u'National Institutes of Standards and Technology', u'University of Chicago', u'Biostar Pharmaceuticals Inc', u'Yungjin Pharmaceutical Co Ltd', u'3-Dimensional Pharmaceuticals Inc', u'National Institute of Pharmaceutical Education and Research', u'JW Pharmaceutical Corp', u'Merck Serono SA', u'Kolon Pharmaceuticals Inc', u'Idera Pharmaceuticals Inc', u'Acusphere Inc', u'Boryung Pharm Co Ltd', u'Progenitor Inc', u'Pulmagen Therapeutics (Asthma) Ltd', u'Mylan Specialty']), u'Hepatitisvirusinfection': set([u'Undisclosed', u'Institute of Biotechnology the Academy of Military Medical Sciences PLA', u'Harvard University', u'Abbott Laboratories', u'Haikou VTI Biological Institute', u'MYR GmbH', u'RFS Pharma LLC', u'National Institutes of Health', u'Bill & Melinda Gates Foundation', u'National Center for Complementary and Alternative Medicine', u'Hep C Ltd', u'Deutsches Krebsforschungszentrum', u'VectorLogics Inc', u'Shanxi Kangbao Biological Products Co Ltd', u'Weizmann Institute of Science', u'Merck Serono SA', u'ANI Pharmaceuticals Inc', u'Direct Relief International', u'Pharmacia & Upjohn AB', u'Napo Pharmaceuticals Inc', u'Fujirebio Europe NV', u'Adamis Pharmaceuticals Corp', u'German Federal Ministry of Education and Research']), u'Renalcellca': set([u'Celgene Corp', u'Lipomed AG']), u'Sinusitis': set([u'Daiichi Seiyaku Co Ltd', u'Oscient Pharmaceuticals Corp', u'Johnson & Johnson', u'LG Life Sciences Ltd', u'Green Cross Corp', u'Genentech Inc', u'Entellus Medical Inc', u'Arana Therapeutics Ltd', u'Cystic Fibrosis Foundation Therapeutics Inc', u'Daiichi Sankyo Co Ltd', u'SmithKline Beecham Corp', u'US Government', u'Laboratorios Bago SA', u'GlaxoSmithKline plc', u'Bayer Korea Ltd', u'Medivir AB', u'Innothera', u'OptiNose AS', u'SkyePharma plc', u'Merck & Co Inc', u'Universitat Innsbruck', u'Xoran Technologies Inc', u'Hanmi Pharmaceutical Co Ltd', u'Accentia BioPharmaceuticals Inc', u'Sanofi', u'Chong Kun Dang Pharmaceutical Corp', u'The Menarini Group', u'Leiden University Medical Center', u'CRC For Biopharmaceutical Research Pty Ltd', u'Bayer AG', u'Ono Pharmaceutical Co Ltd', u'Roche Holding AG', u'ISM Therapeutics', u'ALZA Corp', u'BioDelivery Sciences International Inc', u'Cilag AG', u'Dong-A ST Co Ltd', u'LG Chem Ltd', u'Genaera Corp', u'SK Chemicals Life Science', u'Genesoft Inc', u'Almirall Prodesfarma SA', u'AstraZeneca plc', u'Pfizer Inc', u'CAM-Global, LLC', u'Inspire Pharmaceuticals Inc', u'Atlantic Technology Ventures Inc', u'SinoFresh Healthcare Inc', u'Human Genome Sciences Inc', u'Mayo Clinic Foundation', u'Ranbaxy Laboratories Ltd', u'Sigma-Tau Ind Farm Riunite SpA', u'Dr Reddy\\u2019s Research and Development BV', u'Ilsung Pharmaceutical Co Ltd']), u'Narcolepsy': set([u'Wake Up Narcolepsy', u'National Institute of Neurological Disorders and Stroke', u'Stanford University', u'Armstrong Laboratories Inc', u'SRI International', u'Ligand Pharmaceuticals Inc', u'Aerial BioPharma LLC', u'UCB Celltech', u'Hospital for Sick Children', u'PsychoGenics Inc', u'CoNCERT Pharmaceuticals Inc', u'National Institutes of Health', u'OptiNose AS', u'Novartis Pharma AG', u'Reset Therapeutics Inc', u'French National Research Agency', u'Alkermes plc', u'Cephalon Inc', u'Hovione SA', u'bioCSL PTY Ltd', u'Laboratoire L Lafon SA', u'SK Biopharmaceuticals', u'Valeant Pharmaceuticals International Inc', u'Addrenex Pharmaceuticals Inc', u'Nagoya University', u'Jazz Pharmaceuticals plc', u'The National Institute of Mental Health', u'Alfresa Pharma Corp', u'Theranexus SAS', u'The Research Council of Norway', u'Neurocrine Biosciences Inc', u'Beth Israel Deaconess Medical Center', u'Taiwan Biotech Co Ltd', u'Seelos Therapeutics Inc', u'Orphan Medical Inc', u'Hikma Pharmaceuticals plc', u'H Lundbeck A/S']), u'Mastocytosis': set([u'JADO Technologies GmbH', u'Critical Therapeutics Inc', u'Shasun Pharmaceuticals Ltd', u'AEterna Zentaris Inc', u'TG Therapeutics Inc', u'Genset SA', u'Thornton & Ross Ltd', u'Abbott Laboratories', u'Patheon Pharmaceuticals Inc']), u'Focalsegmentalglomerulosclerosis': set([u'University of Miami', u'FibroGen Inc', u'The NephCure Foundation', u'Boehringer Ingelheim Corp', u'University of Bristol', u'L&F Research LLC', u'Medarex Inc', u'Retrophin Inc', u'Variant Pharmaceuticals Inc', u'EspeRare Foundation', u'Merck Serono SA', u'Ligand Pharmaceuticals Inc']), u'B-cellacutelymphoblasticleukemia': set([u'Oxford BioMedica plc', u'CryoPort Inc', u'ProBioGen AG', u'The Leukemia & Lymphoma Society', u'National Cancer Institute', u'AstraZeneca plc', u'NovoMedix Inc', u'Novartis AG', u'National Institutes of Health', u'Takara Bio Inc', u'The European Union', u'University of Pennsylvania', u'University College London', u'Merck & Co Inc', u'Jichi Medical University, Japan', u'Daiichi Sankyo Co Ltd', u'Kite Pharma Inc', u'Childrens Hospital of Philadelphia', u'Department of Health', u'Affimed NV']), u'Herpessimplexvirusinfection': set([u'US Government', u'Yaso Biotechnology Inc', u'Solvay SA', u'Lisoma International Ltd', u'Bill & Melinda Gates Foundation', u'UNC Center for AIDS Research Clinical Pharmacology and Analytical Chemistry Core', u'Sanofi Pasteur', u'CytoGenix Inc', u'Marine Biotechnology Australia Pty Ltd', u'Renaissance Acquisition Holdings LLC', u'GlaxoSmithKline plc', u\"Cincinnati Children's Hospital Medical Center\", u'Virion Systems Inc', u'Vical Inc', u'Chiron Corp', u'Interferon Sciences Inc', u'SkyePharma plc', u'Novotech (Australia) Pty Ltd', u'Afexa Life Sciences Inc', u'NB Therapeutics Inc', u'Xenova Group plc', u'Quidel Corp', u'MedImmune LLC', u'University of Pittsburgh', u'University of Bonn', u'Clinigen Group plc', u'Hospira Inc', u'Roche Holding AG', u'University of British Columbia', u'University of Wisconsin-Madison', u'Pharmacia & Upjohn Co', u'Auritec Pharmaceuticals Inc', u'Aviragen Therapeutics Inc', u'Novartis AG', u'Jinan University (Guangdong)', u'Aquila Biopharmaceuticals Inc', u'Astellas Pharma Europe BV', u'Direct Relief International', u'Sandoz Ltd', u'PLIVA dd', u'3M Pharmaceuticals', u'AstraZeneca plc', u'CTS Chemical Industries', u'Pacific Pharmaceuticals', u'Acambis plc', u'Profectus BioSciences Inc', u'PDL BioPharma Inc', u'CEL-SCI Corp', u'Medimmune Vaccines Inc', u'Rega Institute for Medical Research', u'Nippon Kayaku Co Ltd', u'Sparta Pharmaceuticals Inc', u'Drogsan Ilaclari San. ve Tic. A.S.', u'Mack Molding Company', u'Immune Design Corp', u'The University of Birmingham', u'MediGene AG', u'University of California', u'University of Maryland', u'EPIcyte Pharmaceutical Inc', u'Italfarmaco SpA', u'Virus Research Institute Inc', u'University of Alabama', u'Chimerix Inc', u'Emisphere Technologies Inc', u'Biovation Ltd', u'Creative Antibiotics Sweden AB', u'Beech Tree Labs Inc', u'EpiCept Corp', u'Starpharma Holdings Ltd', u'Japan Tobacco Inc', u'MegaPharm Ltd', u'Iowa State University', u'Landsteiner Scientific Sa De Cv', u'ACO Hud AB', u'Renaissance Pharma Inc', u'Diamyd Inc', u'University of Sydney', u'F H Faulding & Co Ltd', u'Novactyl Inc', u'AuRx Inc', u'Wyeth Pharmaceuticals', u'Ministry of Economic Affairs, ROC', u'Upsher-Smith Laboratories Inc', u'Ajinomoto Co Inc', u'Harvard Medical School', u'IDIS Ltd', u'Phanuel Pursuits LLC', u'Univeristat Duisburg-Essen', u'California Institute of Technology', u'Flamel Technologies SA', u'Cliantha Research Limited', u'Agenus Inc', u'Transport Pharmaceuticals Inc', u'Medivir AB', u'Zynaxis Inc', u'Undisclosed', u'University of Alabama at Birmingham', u'Sakai Chemical Industry Co Ltd', u'Daewoong Pharmaceutical Co Ltd', u'Merck & Co Inc', u'Australian Research Council', u'Repros Therapeutics Inc', u'Scripps Research Institute', u'APR Applied Pharma Research SA', u'New American Therapeutics Inc', u'Eli Lilly & Co', u'Galderma SA', u'DermTech International', u'Deutsches Rote Kreuze', u'Phytera Inc', u'Pierre Fabre SA', u'Weizmann Institute of Science', u'University of California Irvine', u'Bioglan Pharmaceuticals Co', u'Immune Therapeutics Inc', u'University of Zagreb', u'GroupMed (Holding)', u'PaxVax Inc', u'InGen Biosciences', u'Pfizer Inc', u'Norwich Clinical Research Associates Ltd', u'Gilead Sciences Inc', u'KRS Global Biotechnology Inc', u'Vion Pharmaceuticals Inc', u'Luxembourg Pharmaceuticals Ltd', u'Genta Inc', u'Apricus Biosciences Inc', u'Estero-Anstalt', u'Beijing Pason Pharmaceuticals Inc', u'Okamoto Industries', u'Maxim Pharmaceuticals Inc', u'Fujimoto Diagnostics Inc', u'Hoffmann-La Roche AG', u'Norsk Hydro AS', u'Onxeo SA', u'National Institute of Allergy and Infectious Diseases', u'ABIC', u'University of California San Diego', u'SmithKline Beecham plc', u'United BioPharma Inc', u'BL&H Co Ltd', u'Northeast Ohio Medical University', u'Albert Einstein College of Medicine', u'Development Center for Biotechnology', u'National Institutes of Health', u'Bruno Farmaceutici', u'Bristol-Myers Squibb Co', u'Asahi Kasei Pharma Corp', u'University of Chicago', u'Viragen Inc', u'tesa Labtec GmbH', u'NanoViricides Inc', u'Advanced Biotherapy Inc', u'Biovail Corp', u'Avanir Pharmaceuticals Inc', u'Guangdong Province, Department of Science and Technology', u'Merck Serono SA', u'Healthcare Brands International Ltd', u'Meda AB', u'GLSynthesis Inc', u'Sang-A Pharmaceutical Co Ltd', u'Napo Pharmaceuticals Inc', u'Adjuvantys Inc', u'Hemispherx Biopharma Inc', u'EMS SA', u'Innocutis Holdings LLC', u'Boryung Pharm Co Ltd', u'AusAm Biotechnologies Inc', u'Zeneca Group plc']), u'Polypoidalchoroidalvasculopathy': set([u'Ajinomoto Althea Inc', u'Ophthotech Corp']), u'Skinbur': set([u'Allegiance Equity Corp', u'Panaxia Pharmaceutical Industries Ltd']), u'MucopolysaccharidosistypeI': set([u'Fondazione Telethon', u'BioMarin Pharmaceutical Inc', u'The Ryan Foundation for MPS Children', u'Team Sanfilippo Foundation', u'Health Resources and Services Administration', u'Mount Sinai School of Medicine', u'GlaxoSmithKline plc', u'National MPS Society', u'Undisclosed', u'Plexcera Therapeutics LLC', u'Zacharon Pharmaceuticals Inc', u'Istituto Scientifico H San Raffaele', u'Genzyme General', u'University of Pennsylvania', u'Fred Hutchinson Cancer Research Center', u'Amicus Therapeutics Inc', u'OPKO Health Inc', u'bene Corp', u'MolMed SpA', u'The Association of Public Health Laboratories', u'Immusoft Corp', u'University of California Los Angeles', u'University of Pretoria', u'Inventiva', u'REGENXBIO Inc', u'PTC Therapeutics Inc', u'Mount Sinai Medical Center']), u'Esophagealvarices': set([u'Biopasgroup', u'Ferring Pharmaceuticals SA', u'NovaMedica']), u'Mumpsv': set([u'Fundacao Oswaldo Cruz (Fiocruz)', u'GlaxoSmithKline plc']), u'Cataplexy': set([u'PsychoGenics Inc', u'Hikma Pharmaceuticals plc', u'Jazz Pharmaceuticals plc', u'The National Institute of Mental Health']), u'Respiratorysyncytialvirusinfection': set([u'US Government', u'Baxter International Inc', u'Netherlands Government', u'Sanofi Pasteur', u'IDEC Pharmaceuticals Corp', u'US Health and Human Services Department', u'GlaxoSmithKline plc', u'Il-Yang Pharmaceutical Co', u'Inovio Pharmaceuticals Inc', u'ViroPharma Inc', u'Vical Inc', u'Visterra Inc', u'The Dow Chemical Co', u'Oklahoma Center for the Advancement of Science and Technology', u'MedImmune LLC', u'University of South Florida', u'University of Pittsburgh', u'University of Michigan', u'Novavax Inc', u'CureVac GmbH', u'University of Rochester', u'Roche Holding AG', u'Aviragen Therapeutics Inc', u'Virion Systems Inc', u'NanoBio Corp', u'Nissin Foods Holdings Co Ltd', u'VIB', u'Direct Relief International', u'Canadian Institutes of Health Research', u'mAbxience SA', u'Viriom Inc', u'Genesis Bio-Pharmaceuticals', u'National Heart Lung and Blood Institute', u'US Department of Defense', u'Agence nationale de la recherche (ANR)', u'Biomedical Research Models Inc', u'Alnylam Pharmaceuticals Inc', u'Ark Biosciences', u'National Research Council of Canada', u'Weill Medical College of Cornell University', u'GenVec Inc', u'Max-Planck-Institute of Biochemistry', u'PDL BioPharma Inc', u'Changchun BCHT Biotechnology Co', u'Biota Holdings Ltd', u'Medimmune Vaccines Inc', u'Abbott Laboratories', u'Soroka University Medical Center', u'TransGenex Nanobiotech Inc', u'Kenta Biotech Ltd', u'Korea University', u'geneRx+ Inc', u'Novartis AG', u'Eunice Kennedy Shriver National Institute of Child Health & Human Development', u'Meissa Vaccines Inc', u'Johns Hopkins Bloomberg School of Public Health', u'Sigmovir Biosystems Inc', u'AlgoNomics NV', u'Gemini Technologies Inc', u'Teva Pharmaceutical Industries Ltd', u'Vanderbilt University', u'CytoCore Inc', u'Imperial College London', u'VBI Vaccines', u'Boehringer Ingelheim International GmbH', u'University of Rochester Medical Center', u'Pevion Biotech Ltd', u'RSV Corp', u'TechnoVax Inc', u'Trimeris Inc', u'Navigen Inc', u'Wellcome Trust', u'Arsanis Biosciences GmbH', u'Georgia State University', u'Starpharma Holdings Ltd', u'Acambis Inc', u'Activaero GmbH', u'University of Massachusetts Medical School', u'Boehringer Ingelheim Corp', u'Virogen Ltd', u'Biomolecular Research Institute Ltd', u'Avatar Medical LLC', u'Codevax Inc', u'Themis Bioscience GmbH', u'AIMM Therapeutics BV', u'University of Saskatchewan', u'Agilvax Inc', u'University of South Alabama', u'Parallel Solutions Inc', u'Universiteit Utrecht', u'MicroDose Therapeutx Inc', u'AlphaVax Inc', u'CMC Biologics Inc', u'Medivir AB', u'Microbiotix Inc', u'Vivalis', u'Merck & Co Inc', u'Ventaira Pharmaceuticals Inc', u'Alkermes plc', u'Centers for Disease Control and Prevention', u'Mucosis BV', u'CSL Ltd', u'Scotgen Biopharmaceuticals Inc', u'Kyowa Hakko Kirin Co Ltd', u'Medarex Inc', u'Adimab LLC', u'University of Iowa', u'Napo Pharmaceuticals Inc', u'Cubist Pharmaceuticals Inc', u'Aktiv-Dry LLC', u'Pfizer Inc', u'National Institute on Aging', u'Australian government Department of Innovation, Industry, Science and Research', u'Institut National de la Recherche Agronomique', u'Mymetics Corp', u'Institute for the Promotion of Innovation by Science and Technology in Flanders', u'Virosome Biologicals BV', u'University of Sussex', u'Lonza Biologics plc', u'Array BioPharma Inc', u'Johnson & Johnson', u'Baylor College of Medicine', u'AIT Therapeutics Inc', u'Virogenomics Inc', u'Mapp Biopharmaceutical Inc', u'National Institute of Allergy and Infectious Diseases', u'Functional Genetics Inc', u'SmithKline Beecham plc', u'Bavarian Nordic A/S', u'Program for Appropriate Technology in Health', u\"St Jude Children's Research Hospital\", u'National Institutes of Health', u'Bill & Melinda Gates Foundation', u'Ablynx NV', u'Arrow Therapeutics Ltd', u'ZymeTx Inc', u'Trellis Bioscience Inc', u'ReViral Ltd', u'Immunovaccine Inc', u'Sanofi Pasteur Inc', u'DBV Technologies SA', u'Aridis Pharmaceuticals Inc', u'Immune Design Corp', u'Institut Pasteur', u'University of Georgia', u'Crucell NV', u'ProBioGen AG', u'Pan-Provincial Vaccine Enterprise Inc', u'Vectura Group plc', u'MannKind Corp', u'Artificial Cell Technologies Inc', u'AmVac AG', u'PARI Pharma GmbH']), u'Hyperlipidemia': set([u'Jiangsu Shenlong Pharmaceutical Co Ltd', u'Novo Nordisk A/S', u'Solvay SA', u'QUATRx Pharmaceuticals Co', u'Koebenhavns Universitet', u'Catabasis Pharmaceuticals Inc', u'Kowa Pharmaceuticals America Inc', u'Fudan University', u'Il Dong Pharmaceutical Co Ltd', u'GlaxoSmithKline plc', u'SUNY Downstate Medical Center', u'Healthcare Royalty Partners', u'Ionis Pharmaceuticals Inc', u'Elan Corp plc', u'Kyoto Pharmaceutical University', u'Takeda Pharmaceuticals North America Inc', u'Zydus-Cadila Group', u'WhanIn Pharmaceutical Co Ltd', u'Mitsubishi-Tokyo Pharmaceuticals Inc', u'Xention Ltd', u'Defiante Farmaceutica Lda', u'Chinese Academy of Medical Sciences & Peking Union Medical College', u'Nissan Chemical Industries Ltd', u'Cipher Pharmaceuticals Inc', u'Borijihan Medical Co Of Wuhan', u'Gamida Cell Ltd', u'Almirall Prodesfarma SA', u'Sankyo Co Ltd', u'Catalent Inc', u'HanAll Biopharma Co Ltd', u'National Heart Lung and Blood Institute', u'Teijin Pharma Ltd', u'Alnylam Pharmaceuticals Inc', u'Reliant Pharmaceuticals Inc', u'Casper Pharma LLC', u'CiVi Biopharma Inc', u'Klinge Pharma GmbH', u'Johnson & Johnson Pharmaceutical Research & Development LLC', u'Amgen Inc', u'Stocosil', u'Daiichi Sankyo Co Ltd', u'Abbott Laboratories', u'Novartis AG', u'Merck KGaA', u'University of California', u'DAE HWA Pharm Co Ltd', u'Kos Pharmaceuticals Inc', u'SkyePharma plc', u'University of Alabama at Birmingham', u'Hanmi Pharmaceutical Co Ltd', u'Veloxis Pharmaceuticals A/S', u'Kowa Co Ltd', u'Arbutus Biopharma Corp', u'Cholestech Corp', u'Sunovion Pharmaceuticals Canada Inc', u'Kyorin Pharmaceutical Co Ltd', u'Grelan Pharmaceutical Co Ltd', u'Ethypharm SA', u'LG Chem Ltd', u'Daegu Hanny University', u'Ibn Cina Drug Stores', u'Ocean University of China', u'Genfit SA', u'Recordati SpA', u'F Hoffmann-La Roche AG', u'ILEX Oncology Inc', u'Green Cross Corp', u'Genentech Inc', u'National Natural Science Foundation of China', u'Otsuka Pharmaceutical Co Ltd', u'National Institute of Diabetes, Digestive and Kidney Diseases', u'Inner Mongolia University', u'Roche Innovation Center Copenhagen A/S', u'Shionogi Pharma Inc', u'Yuhan Corp', u'Shionogi USA Inc', u'Daewoong Pharmaceutical Co Ltd', u'Merck & Co Inc', u'Bernofarm Pharmaceutical Co', u'Daewon Pharm Co Ltd', u'University of Texas Southwestern Medical Center', u'Eli Lilly & Co', u'Japan Tobacco Inc', u'Bayer AG', u'Pronova BioPharma ASA', u'Barr Pharmaceuticals Inc', u'Korean Ministry of Knowledge Economy', u'Dezima Pharma BV', u'AstraZeneca plc', u'Pfizer Inc', u'Fournier Pharma', u'Satiogen Pharmaceuticals Inc', u'Kaken Pharmaceutical Co Ltd', u'Sandoz Inc', u'China Pharmaceutical University', u'Viking Therapeutics Inc', u'Amylin Pharmaceuticals Inc', u'LipimetiX LLC', u'Institute of Materia Medica Chinese Academy of Medical Sciences & Peking Union Medical College', u'SmithKline Beecham plc', u'Arena Pharmaceuticals Inc', u'Ligand Pharmaceuticals Inc', u'Morishita Jintan Co Ltd', u'Amryt Pharmaceuticals DAC', u'Galephar PR Inc', u'Yamanouchi Pharmaceutical Co Ltd', u'Bristol-Myers Squibb Co', u'Chinese Government', u'Synvista Therapeutics Inc', u'Aventis SA', u'West Pharmaceutical Services Inc', u'Regulus Therapeutics Inc', u'MSD Japan', u'CJ Corp', u'TAP Pharmaceuticals Inc', u'Roche Holding AG', u'Biovail Corp', u'Ranbaxy Laboratories Ltd', u'Avanir Pharmaceuticals Inc', u'Elan Drug Technologies', u'Merck Serono SA', u'SS Pharmaceutical Co Ltd', u'Hoechst Marion Roussel Inc', u'Mitsubishi Tanabe Pharma Corp', u'Takeda Pharmaceutical Co Ltd', u'Zhongzhu Healthcare Holding Co Ltd', u'Aegerion Pharmaceuticals Inc']), u'Bonedisease': set([u'Medtronic Sofamor Danek', u'Oscient Pharmaceuticals Corp', u'Weill Medical College of Cornell University', u'US Government', u'Ipsen Biopharmaceuticals Inc', u'Regeneron Pharmaceuticals Inc', u'EffRx Pharmaceuticals SA', u'DRAXIMAGE', u'Baxter International Inc', u'Angiotech Pharmaceuticals Inc', u'Amend Surgical Inc', u'Samumed LLC', u'Netherlands Government', u'California Institute of Regenerative Medicine', u'Locate Therapeutics Ltd', u'Synergy Pharmaceuticals Inc', u'Hyseq Inc', u'DRAXIS Health Inc', u'Takeda Oncology', u'Savient Pharmaceuticals Inc', u'Ipsen', u'Aventis Pharma AG', u'TissueGene Inc', u'Wyeth Pharmaceuticals', u'University of Pittsburgh', u'Bio3 Research Srl', u'University of Michigan', u'Fibrocell Science Inc', u'Garvan Institute of Medical Research', u'Roche Holding AG', u'Tecnalia Corp', u'ARIAD Pharmaceuticals Inc', u'Galapagos NV', u'OsteoCorp Inc', u'Mesoblast Ltd', u'Agency For Science Technology & Research', u'Teijin Ltd', u'ProChon Biotech Ltd', u'Laboratorios SALVAT SA', u'Pfizer Inc', u'DT MedTech LLC', u\"Boston Children's Hospital\", u'Scripps Research Institute', u'UCB SA', u'Shire BioChem Inc', u'National Health and Medical Research Council', u'Bioventus LLC', u'National Institute of Arthritis and Musculoskeletal and Skin Diseases', u'University of Connecticut Health Center', u'Bayer Corp', u'Amgen Inc', u'The Procter & Gamble Co', u'NovaDx International Inc', u'ASINEX Ltd', u'ProSkelia Pharmaceuticals SAS', u'Novartis AG', u'Leiras Oy', u'Enzo Therapeutics Inc', u'Velcura Therapeutics Inc', u'Helsinn Investment Fund SA', u'Scripps Florida', u'Emisphere Technologies Inc', u'Astellas Pharma Inc', u'Progenerative Medical Inc', u'Sun Yat-Sen University', u'University of Manchester', u'MBC Pharma Inc', u'Olympus Corp', u'National Aeronautics & Space Administration', u'Alize Pharma III SAS', u'EvoGenix Pty Ltd', u'Emerillon Therapeutics Inc', u'Genset SA', u'Heraeus Medical Gmbh', u'Radius Health Inc', u'Wakunaga Pharmaceutical Co Ltd', u'Nordic Bioscience A/S', u'Depuy', u'SANUWAVE Health Inc', u'RheoGene Inc', u'Collagenesis Inc', u'University of Sheffield', u'Evolva Biotech A/S', u'Genentech Inc', u'Endoceutics Inc', u'Immunodiagnostic Systems Ltd', u'Istituto Gentili SpA', u'Grunenthal GmbH', u'Biogen Inc (FL)', u'National Institute of Diabetes, Digestive and Kidney Diseases', u'Osteopro A/S', u'Stryker Corp', u'OraPharma Inc', u'OsteoGeneX Inc', u'Orthocon Llc', u'Tissue Regeneration Systems Inc', u'Callisto Pharmaceuticals Inc', u'Penwest Pharmaceuticals Co', u'LifeArc', u'New Paradigm Therapeutics', u'Baylor College of Medicine', u'Undisclosed', u'Auxeris Therapeutics Inc', u'Ceros Pharmaceuticals Inc', u'Histocell Sl', u'Nippon Chemiphar Co Ltd', u'Merck & Co Inc', u'Smith & Nephew plc', u'Bezwada Biomedical LLC', u'Nanotherapeutics Inc', u'Ahn-Gook Pharmaceuticals Co Ltd', u'Sanofi', u'Giddi Pharma Co Ltd', u'University of Miami', u'Vetter Pharma International', u'Clementia Pharmaceuticals Inc', u'Litho Med Trading Co Ltd', u'OrthoCyte Corp', u'Kyowa Hakko Kirin Co Ltd', u'Kuros Biosurgery AG', u'NSW Government', u'Kissei Pharmaceutical Co Ltd', u'Genetics Institute LLC', u'Nektar Therapeutics', u'University of California Los Angeles', u'University of Melbourne', u'National Institutes of Health', u'Heraeus Holding GmbH', u'Immuno-Biological Laboratories Co Ltd', u'Caladrius Biosciences Inc', u'University of Adelaide', u'Institute for the Promotion of Innovation by Science and Technology in Flanders', u'The Ruth and Bruce Rappaport Faculty of Medicine', u'Guerbet', u'Zalicus Inc', u'Wyeth BioPharma', u'Nuo Therapeutics Inc', u'Purdue University', u'AnorMED Inc', u'Australian Government', u'University of Toledo', u'University of Kansas', u'Sydney Childrens Hospital', u'Kinetic Concepts Inc', u'Biologix FZ Co', u'BioTime Inc', u'OsteoQC', u'Abiogen Pharma SpA', u'Lonza Group AG', u'Max-Planck-Gesellschaft', u'Yamanouchi Pharmaceutical Co Ltd', u'Meditronic Inc', u'Menarini Asia-Pacific', u'Chinese Government', u'Curis Inc', u'MorphoSys AG', u'Asahi Kasei Pharma Corp', u'Siena Biotech SpA', u'Boehringer Mannheim GmbH', u'Collplant Ltd', u'Henkel KGaA', u'Endorecherche Inc', u'Bristol-Myers Squibb Pharma Co', u'TaconicArtemis GmbH', u'Healios KK', u'Azign Bioscience A/S', u'Protelica Inc', u'NovaPharm Therapeutics', u'Athersys Inc', u'Alethia Biotherapeutics Inc', u'Laboratoire Chauvin SA', u'Indiana University', u'Aventis Pharma SA', u'Peptinnovate Ltd', u'Kyowa Kirin', u'Rohto Pharmaceutical Co Ltd', u'GreenBone Ortho srl', u'Cell Therapies Pty Ltd']), u'Stomachtumor': set([u'Daiichi Seiyaku Co Ltd', u\"Dr Reddy's Laboratories Ltd\", u'Agence Nationale de Recherches sur le Sida et les hepatites virales (ANRS)', u'National Comprehensive Cancer Network', u'Korea Institute of Science and Technology', u'Yakult Honsha Co Ltd', u'Cellcor Inc', u'Sanofi Pasteur', u'European Commission', u'Synteract Inc', u'US Health and Human Services Department', u'Il Dong Pharmaceutical Co Ltd', u'GlaxoSmithKline plc', u'QIMR Berghofer Medical Research Institute', u'Bayer Schering Pharma AG', u'Cytogen Corp', u'Chiron Corp', u'Duke University Medical Center', u'Cascadian Therapeutics Inc', u'VGX Pharmaceuticals LLC', u'Sanofi Winthrop France SA', u'Ipsen', u'IDT Biologika GmbH', u'European Eurostars Programme', u'MedImmune LLC', u'Astex Pharmaceuticals Inc', u'Vernalis plc', u'Navidea Biopharmaceuticals Inc', u'Aduro BioTech Inc', u'Roche Holding AG', u'Immunocore Ltd', u'Halozyme Therapeutics Inc', u'Guangzhou Esa Biotech Co Ltd', u'University of Manitoba', u'OncoSynergy Inc', u'Pharmacia & Upjohn Co', u'Debiovision Inc', u'Kite Pharma Inc', u'Ludwig Institute for Cancer Research', u'Fox Chase Cancer Center', u'Inventiva', u'Biocon Ltd', u'Stupid Strong', u'Ariana Pharmaceuticals', u'Dana-Farber Cancer Institute Inc', u'Helmholtz Zentrum M\\xfcnchen', u'Northeast Pharmaceutical Group Co Ltd', u'Intas Pharmaceuticals Ltd', u'MD Anderson Cancer Center', u'University of Oxford', u'Amgen Inc', u'Mylan Inc', u'Affibody AB', u'Biohit OYJ', u'Harvard University', u'Daiichi Sankyo Co Ltd', u'Abbott Laboratories', u'OncBioMune Pharmaceuticals Inc', u'Galena Biopharma Inc', u'Boehringer Mannheim GmbH', u'Konruns Pharmaceutical Co Ltd', u'WIL Research', u'Athenex Inc', u'National Cancer Institute', u'Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd', u'Theragence Inc', u'University of Chile', u'Korea Research Institute of Bioscience and Biotechnology', u'Schering-Plough Corp', u'NeoPharm Inc', u'Novelion Therapeutics Inc', u'Cantab Biopharmaceuticals Ltd', u'Merrimack Pharmaceuticals Inc', u'Shanghai Henlius Biotech Co Ltd', u'Bigmar Inc', u'Tanabe Seiyaku Co Ltd', u'Pevion Biotech Ltd', u'YM BioSciences Inc', u'JCR Pharmaceuticals Co Ltd', u'University of Wurzburg', u'EOC Pharma Ltd', u'Shin Poong Pharmaceutical Co Ltd', u'Tessa Therapeutics Pte Ltd', u'Nottingham Trent University', u'Hefei Co-Source Pharmaceuticals Co Ltd', u'Dong-A ST Co Ltd', u'Wuhan KatyGen Pharmaceuticals Inc', u'Vericel Corp', u'CFR Pharmaceuticals SA', u'Actinium Pharmaceuticals Inc', u'Inverness Medical Switzerland GmbH', u'Boehringer Ingelheim Corp', u'Rhone-Poulenc Rorer Inc', u'Cancer Therapeutics Ltd', u'Generex Biotechnology Corp', u'Med Abome Inc', u'BioInvent International AB', u'Recalcine Pharmaceutical Corp', u'Swedish Orphan Biovitrum AB', u'Debiopharm SA', u'Lonza Biologics plc', u'Swiss Institute Of Bioinformatics', u'Chugai Pharmaceutical Co Ltd', u'Cancer Research UK', u'MethylGene Inc', u'Genentech Inc', u'MabPlex International Ltd', u'Medimmune Oncology Inc', u'Agilent Technologies Inc', u'Korea Drug Development Fund', u'Eurocine Vaccines AB', u'Novuspharma SpA', u'Deciphera Pharmaceuticals LLC', u'Dako Corp', u'Republic of Korea Government', u'Shanghai Institute of Materia Medica of the Chinese Academy of Sciences', u'The Dow Chemical Co', u'US Government', u'Argos Therapeutics Inc', u'Novomix Meditech', u'Diosynth Biotechnology', u'Atara Biotherapeutics Inc', u'Schering Overseas Ltd', u'Merck & Co Inc', u'Ahn-Gook Pharmaceuticals Co Ltd', u'Sanofi', u'CTI BioPharma Corp', u'Eli Lilly & Co', u'US Surgical Corp', u'Imperial Cancer Research Technology Ltd', u'Phyton Biotech Inc', u'Pharmacia Corp', u'Imclone LLC', u'Neovii Biotech GmbH', u'Paradigm', u'R-Pharm', u'Nektar Therapeutics', u'IVAX Corp', u'Almirall Prodesfarma SA', u'Therapure Biopharma Inc', u'AstraZeneca plc', u'Pfizer Inc', u'ArQule Inc', u'Gilead Sciences Inc', u'HUYA Bioscience International LLC', u'Apthera Inc', u'Yunnan Institute of Materia Medica', u'Patrys Ltd', u'Genta Inc', u'Memorial Sloan-Kettering Cancer Center', u'Cambridge Antibody Technology Group plc', u'Immatics Biotechnologies GmbH', u'The Center of Molecular Immunology', u'Tapestry Pharmaceuticals Inc', u'Stehlin Foundation For Cancer Research', u'Mast Therapeutics Inc', u'Guangzhou Shunjian Biomedical Technology Co Ltd', u'Academia Sinica', u'Translational Genomics Research Institute', u'Chongqing LUMMY Pharmaceutical Co Ltd', u'Japanese National Cancer Center', u'ASLAN Pharmaceuticals Pte Ltd', u'Pooyandegan Pezeshki Pardis', u'NantPharma LLC', u'Takeda Pharmaceutical Co Ltd', u'IDT Australia Ltd', u'National Cancer Centre of Singapore', u'MacroGenics Inc', u'University of Toronto', u'National Institutes of Health', u'Fresenius SE & Co KGaA', u'Bristol-Myers Squibb Co', u'Chinese Government', u'Aventis SA', u'TRION Pharma GmbH', u'American Cyanamid Co', u'MSD Japan', u'Aronex Pharmaceuticals Inc', u'AbClon Inc', u'Array BioPharma Inc', u'Baylor Health Care System', u'Kunming Institute of Precious Metals', u'No Stomach For Cancer Inc', u'Institute of Cancer Research UK', u'Antisoma plc', u'Ferozsons Laboratories Ltd', u'The University of Birmingham', u'University of Guelph', u'OncoMab GmbH', u'Adaptimmune Therapeutics plc', u'GE Healthcare', u'Mersana Therapeutics Inc', u'Aphton Corp', u'Teikoku Pharma USA Inc', u'Light Pointe Medical Inc', u'PlantForm Corp', u'PiSA Farmaceutica', u'Cyanamid Benelux NV', u'Dyax Corp', u'Imugene Ltd', u'Shandong Luoxin Pharmaceutical Group Stock Co Ltd', u'Merck KGaA', u'Nexgenix Pharmaceuticals Inc', u'Mayne Pharma Pty Ltd', u'Helicure AB']), u'Dupuytrencontracture': set([u'Actelion Pharmaceuticals Ltd', u'Asahi Kasei Corp', u'Pfizer Inc', u'Auxilium Pharmaceuticals Inc', u'BioSpecifics Technologies Corp', u'State University of New York at Stony Brook', u'Swedish Orphan Biovitrum AB', u'RecipharmCobra Biologics']), u'Papillarythyroidtumor': set([u'Interpace Diagnostics Group Inc', u'Best Med Opinion Ltd']), u'Glioma': set([u'US Government', u'National Comprehensive Cancer Network', u'National Institutes of Health', u'Pharmaco Kinesis Corp', u'Attenuon LLC', u'Oncovir Inc', u'California Institute of Regenerative Medicine', u'Biogen Inc', u'Peregrine Pharmaceuticals Inc', u'Galaxy Biotech LLC', u'NeoPharm Inc', u'Windtree Therapeutics Inc', u'QSV Biologics', u'Texas A&M University System', u'Ipsen', u'Novartis Pharma AG', u'Xenova Group plc', u'Erimos Pharmaceutical LLC', u'Arch Biopartners Inc', u'Johannes Gutenberg Universitat Mainz', u'Cavion LLC', u'University of Pittsburgh', u'Sangamo Therapeutics Inc', u'MGI GP Inc', u'University of Pennsylvania', u'SBI Holdings Inc', u'Ontario Cancer Institute', u'Dutch-Belgian Cooperative Trial Group for Hematology Oncology', u'Five Prime Therapeutics Inc', u'Roche Holding AG', u'University of Texas Health Science Center San Antonio', u'ARIAD Pharmaceuticals Inc', u'Epigen Biosciences Inc', u'Biocompatibles International plc', u'Brentwood Biomedical Research Institute', u'Catherex Inc', u'Specialised Therapeutics Australia Pty Ltd', u'Kochi University', u'Biocon Ltd', u'Prana Therapeutics Inc', u'Agios Pharmaceuticals Inc', u'Emory University', u'University of California San Francisco', u'University of Florida', u'TransMolecular Inc', u'Dana-Farber Cancer Institute Inc', u'Premier Research Group Ltd', u'Ottawa Hospital Research Institute', u'Sigma-Tau Ind Farm Riunite SpA', u'National Health and Medical Research Council', u'Exelixis Inc', u'Light Sciences Corp', u'Inex Pharmaceuticals Corp', u\"Children's Cancer Institute Australia for Medical Research\", u'Centre National de la Recherche Scientifique (CNRS)', u'Ranbaxy Laboratories Ltd', u'The University of Aston In Birmingham', u'Nippon Petrochem Co Ltd', u'Accelerate Brain Cancer Cure', u'Cambridge Antibody Technology Group plc', u'University of Michigan', u'Daiichi Sankyo Co Ltd', u'Ohio State University', u'Centre for Probe Development and Commercialization', u'MI Bioresearch', u'Beckman Research Institute', u'National Cancer Institute', u'MediGene AG', u'Merck KGaA', u'Arog Pharmaceuticals Inc', u'Biostatistics and Bioinformatics Shared Facility (BBSF)', u'Georgetown University', u'National Brain Tumor Society', u'GlaxoSmithKline plc', u'Massachusetts General Hospital', u'Abgenix Inc', u'RIKEN', u'YM BioSciences Inc', u'FibroGen Inc', u'University of Adelaide', u'NABTT CNS Consortium', u'ALZA Corp', u'Advantagene Inc', u'Titan Pharmaceuticals Inc', u'ImmunoGen Inc', u'Northwestern University Feinberg School of Medicine', u'National Institute of Biomedical Imaging and Bioengineering', u'Peking Union Medical College Hospital', u'Pharmion Corp', u'Boehringer Ingelheim Corp', u'The Center of Molecular Immunology', u'Kyowa Hakko Kogyo Co Ltd', u'University of California San Diego', u'National Cheng Kung University', u'Soochow University', u'University of Arizona', u'Diamyd Inc', u'Oakwood Laboratories LLC', u'Bar-Ilan Research & Development Co Ltd', u'photonamic GmbH & Co KG', u'National Institute of Neurological Disorders and Stroke', u'Genentech Inc', u'Everfront Biotech Inc', u'Arrogene Inc', u'Isarna Therapeutics GmbH', u'DCPrime BV', u'Mayo Clinic Foundation', u'Southeastern Brain Tumor Foundation', u'Stemline Therapeutics Inc', u'MediGene Inc', u'Burzynski Research Institute Inc', u'Southern Research Institute', u'Stason Pharmaceuticals Inc', u'GLASS Consortium', u'USC Stevens Institute for Innovation', u'Onconova Therapeutics Inc', u'Massachusetts Institute of Technology', u'Cellectar Biosciences Inc', u'ImmunoCellular Therapeutics Ltd', u'XOMA Corp', u'University of California', u'Merck & Co Inc', u'Arcturus Therapeutics Inc', u'Intsel Chimos SA', u'MD Anderson Cancer Center', u'Tocagen Inc', u'BioChem Pharma (International ) Inc', u'COR Therapeutics Inc', u'Sanofi', u'Medison Pharma Ltd', u'Alkermes plc', u'Eli Lilly & Co', u'University of Miami', u'Deutsches Krebsforschungszentrum', u'University Hospital Heidelberg', u'proActina SA', u'Takeda Pharmaceuticals International GmbH', u'Autotelic Inc', u'Novopharm Biotech (USA)', u'Case Western Reserve University', u'The UK Imperial Cancer Research Fund', u'Ascentage Pharma Group Corporation Ltd', u'OSI Pharmaceuticals Inc', u'Therapure Biopharma Inc', u'AstraZeneca plc', u'Pfizer Inc', u'University of Ioannina', u'Boehringer Ingelheim Pharmaceuticals Inc', u'SUGEN Inc', u'Triangle Pharmaceuticals Inc', u'Gendux Molecular Ltd', u'Merrimack Pharmaceuticals Inc', u'Vion Pharmaceuticals Inc', u'NEC Corp', u'Johns Hopkins University', u'Memorial Sloan-Kettering Cancer Center', u'Lonza Biologics plc', u'Celtic Pharmaceutical Holdings LP', u'Introgen Therapeutics Inc', u'Baylor College of Medicine', u'The European Union', u'Cancer Vaccine Acceleration Fund', u'Imclone LLC', u'Paul Scherrer Institut', u'Eberhard Karls Universit\\xe4t T\\xfcbingen', u'Dalton Pharma Services', u'Kennedy Krieger Institute', u'University of Mississippi', u'American Brain Tumor Association', u'BL&H Co Ltd', u'University of Hamburg', u'Stand Up To Cancer', u'Sophiris Bio Inc', u'Chonnam National University', u'China Medical University (Taiwan)', u'Osaka City University', u'University of Tokyo', u'Food and Drug Administration', u'Bristol-Myers Squibb Co', u'Activate Immunotherapy', u'City of Hope', u'Moleculin Biotech Inc', u'Stendhal International', u'Cedars-Sinai Medical Center', u'Ribomed Inc', u'Select Therapeutics Inc', u'NeOnc Technologies Inc', u'Columbia University Medical Center', u'Celgene Corp', u'University of Chicago', u'Medipharm Biotech Co Ltd', u'National Dong-Hwa University', u'Memgen LLC', u'Sosei Group Corp', u'Nobelpharma Co Ltd', u'KS Biomedix Holdings plc', u'Ascenta Therapeutics Inc', u'Duke University', u'Institute of Cancer Research UK', u'Ferozsons Laboratories Ltd', u'BruCells', u'PiSA Farmaceutica', u'Novartis AG', u'Alberta Heritage Foundation For Medical Research', u'University of Toronto', u'Biocure Inc', u'Nexgenix Pharmaceuticals Inc', u'Annai Systems Inc', u'ImaginAb Inc']), u'Myelofibrosis': set([u'Onyx Pharmaceuticals Inc', u'Takeda Oncology', u'Novartis AG', u'MD Anderson Cancer Center', u'Baxter International Inc', u'S*BIO Pte Ltd', u'Bristol-Myers Squibb Co', u'MEI Pharma Inc', u'Pharsight Corp', u'Incyte Corp', u'Mayo Clinic Foundation', u'CTI BioPharma Corp', u'Geron Corp', u'Helsinn Group']), u'Myositis': set([u'Senexis Ltd', u'Medical Research Council']), u'Alopecia': set([u'University of Medicine and Dentistry of New Jersey', u'US Government', u'Daniel Alain Life Science', u'Organ Technologies Inc', u'GlaxoSmithKline plc', u'RNS Inc', u'Cure Medical Manufacturing', u'Tiantan Puhua Neurological Hospital', u'Arizona State University', u'Kyocera Corp', u'Pineworld Capital', u'University of Pennsylvania', u'Fred Hutchinson Cancer Research Center', u'Defiante Farmaceutica Lda', u'Acrux Ltd', u'Cipher Pharmaceuticals Inc', u'University of British Columbia', u'Azopharma Inc', u'RepliCel Life Sciences Inc', u'Procter & Gamble Pharmaceuticals Inc', u'Follicum AB', u'Key Organics Ltd', u'ECI Inc', u'Biomas Inc', u'Aclaris Therapeutics Inc', u'Orient Europharma', u'Sigma-Tau Ind Farm Riunite SpA', u'Valocor Therapeutics Ltd', u'MGI GP Inc', u'Regience KK', u'Kaken Pharmaceutical Co Ltd', u'Eisai Co Ltd', u'Korea University', u'National Cancer Institute', u'US Department of Defense', u'Caladrius Biosciences Inc', u'Novelion Therapeutics Inc', u'Teva Pharmaceutical Industries Ltd', u'Hanmi Pharmaceutical Co Ltd', u'RIKEN', u'University of Minnesota', u'JAKPharm LLC', u'University of Rochester', u'Applied Biology Inc', u'Prasco Laboratories', u'CFR Pharmaceuticals SA', u'Osaka University', u'ProCyte Corp', u'Interpharma Praha AS', u'Planet Biotechnology Inc', u'Histogen Inc', u\"L'Oreal SA\", u'Clinical Research Center for Hair and Skin Science', u'Kythera Biopharmaceuticals Inc', u'Napa Biosciences Inc', u'ImmuneRegen BioSciences Inc', u'Merck & Co Inc', u'LEO Pharma A/S', u'Johnson & Johnson Consumer Products Inc', u'OsteoScreen Inc', u'RegeneRx Biopharmaceuticals Inc', u'GroupMed (Holding)', u'Novopyxis Inc', u'Bar-Ilan University', u'Luna Innovations Inc', u'Unilever', u'Genta Inc', u'Bachem Holding AG', u'Zynaxis Inc', u'Ligand Pharmaceuticals Inc', u'AndroScience Corp', u'North Park Aesthetics Inc', u'Actelion Ltd', u'Neosil Inc', u'National Institutes of Health', u'University of Tokyo', u'Bristol-Myers Squibb Co', u'Curis Inc', u'Shiseido Co Ltd', u'MSD Japan', u'Pontificia Universidad Catolica De Chile', u'MGI Pharma Inc', u'Almirall Prodesfarma SA', u'Astellas Pharma Inc', u'Advanced Biotherapy Inc', u'Virginia Polytechnic Institute and State University', u'Archimedes Pharma Ltd', u'Biophysica Inc', u'diaDexus Inc', u'RNL Bio Co Ltd', u'MPI Research', u'Rohto Pharmaceutical Co Ltd']), u'Cachexia': set([u'LeukoSite Inc', u'Bertin Pharma', u'Hospices Civils De Lyon', u'Ipsen Biopharmaceuticals Inc', u'Unimed Pharmaceuticals Inc', u'Extend Biosciences Inc', u'MSD OSS BV', u'Neovacs SA', u'EMD Serono Inc', u'US Government', u'GlaxoSmithKline plc', u'Bial-Portela & Ca Sa', u'Savient Pharmaceuticals Inc', u'Ipsen', u'US Department of Veterans Affairs', u'SignaBlok Inc', u'Zentaris GmbH', u'University of Lyon', u'Mercian Corp', u'Ono Pharmaceutical Co Ltd', u'Five Prime Therapeutics Inc', u'DSM Pharmaceuticals Inc', u'Specialised Therapeutics Australia Pty Ltd', u'Tensive Controls Inc', u'Laboratoires Besins International', u'Keio University', u'Baker IDI Heart & Diabetes Institute Holdings Ltd', u'Gen Ilac', u'Dana-Farber Cancer Institute Inc', u'MYOS RENS Technology Inc', u'RecipharmCobra Biologics', u'Innovus Pharmaceuticals Inc', u'Pharmacare Ltd', u'Hearst Communications Inc', u'MD Anderson Cancer Center', u'The University of Aston In Birmingham', u'CSC Pharmaceuticals Handels GmbH', u'The Procter & Gamble Co', u'The European Union', u'Abbott Laboratories', u'Eisai Co Ltd', u'Tulane University', u'Cloud Pharmaceuticals Inc', u'National Cancer Institute', u'Novartis AG', u'Ardana Bioscience Ltd', u'Halsa Pharmaceuticals Inc', u'Theradiag', u'Italfarmaco SpA', u'Simcere Pharmaceutical Group', u'Abgenix Inc', u'Monash University', u'Toyama Chemical Co Ltd', u'Ohr Pharmaceutical Inc', u'Ferring Pharmaceuticals SA', u'Dong-A ST Co Ltd', u'Celliance Bioservices Inc', u'Helsinn Healthcare SA', u'Osaka University', u'Boehringer Ingelheim Corp', u'Watson Laboratories Inc', u'University of Melbourne', u'Debiopharm SA', u'Pharmexa A/S', u'Chugai Pharmaceutical Co Ltd', u'Genentech Inc', u'VGX Pharmaceuticals LLC', u'Sapphire Therapeutics Inc', u'Astellas Pharma Inc', u'Therapeutic Discovery Corp', u'Actavis Inc', u'Ark Therapeutics Group plc', u'Advanced Viral Research Corp', u'St Vincents Hospital Sydney Ltd', u'French Government', u'Merck & Co Inc', u'Sanofi', u'Giddi Pharma Co Ltd', u'University of Texas Southwestern Medical Center', u'Tanabe Seiyaku Co Ltd', u'Alize Pharma Group', u'Theratechnologies Inc', u'AEterna Zentaris Inc', u'University of Iowa', u'Nektar Therapeutics', u'Concord Biosciences LLC', u'Lacer SA', u'Ferrer Internacional SA', u'Scotia Holdings plc', u'BioLineRx Ltd', u'Baylor College of Medicine', u'Santhera Pharmaceuticals AG', u'Translational Genomics Research Institute', u'Bioject Medical Technologies Inc', u'Pherin Pharmaceuticals Inc', u'Motus Therapeutics Inc', u'Biologix FZ Co', u'Mundipharma International Corp Ltd', u'University of Mississippi', u'Oxford Natural Products', u'Cannabics Pharmaceuticals Inc', u'National Institutes of Health', u'AVEO Oncology', u'Menarini Asia-Pacific', u'Par Pharmaceutical Co Inc', u'Quantum Health Resources Inc', u'Anagenesis Biotechnologies', u'Emmaus Medical Inc', u'GTx Inc', u'Elan Drug Technologies', u'Merck Serono SA', u'Gedeon Richter Ltd', u'Rambam Health Care Campus', u'PhytoMedical Technologies Inc', u'Helsinn Group']), u'Proteinuria': set([u'Symphony Evolution Inc', u'Exelixis Inc']), u'Nephritis': set([u'Green Cross Corp', u'Genentech Inc', u'Otsuka Pharmaceutical Co Ltd', u'Mayo Clinic Foundation', u'National Institute of Diabetes, Digestive and Kidney Diseases', u'Abbott Laboratories', u'TAP Pharmaceuticals Inc', u'Tanox Inc', u'Hospital for Sick Children', u'Augusta University Research Institute Inc', u'Osaka Prefecture University', u'Kyoto University', u'DNA Pharmaceuticals Inc', u'The Kidney Foundation of Canada', u'Kinki University', u'AstraZeneca plc', u'Takeda Pharmaceutical Co Ltd', u'Canadian Government', u'Chong Kun Dang Pharmaceutical Corp', u'Takara Shuzo Co Ltd', u'Government of Ontario', u'China Pharma Holdings Inc']), u'Hallervorden-Spatzsyndrome': set([u'Acies Bio doo', u'Retrophin Inc', u\"St Jude Children's Research Hospital\", u'University Medical Center Groningen']), u'Venousocclusivedisease': set([u'Gentium SpA', u'Handok Inc', u'Crinos SpA', u'Leadiant Biosciences Inc', u'Jazz Pharmaceuticals plc']), u'Urinarytractinfection': set([u'Oscient Pharmaceuticals Corp', u'Nippon Shinyaku Co Ltd', u'Vifor Pharma', u'Shionogi Inc', u'Gynelogix Inc', u'Baylor College of Medicine', u'Recordati Espana', u'ASCEND Therapeutics Inc', u'Optimer Pharmaceuticals Inc', u'National Institute of Allergy and Infectious Diseases', u'Noventure', u'National Institute of Diabetes, Digestive and Kidney Diseases', u'Fimbrion Therapeutics Inc', u'US Health and Human Services Department', u'Allegis Pharmaceuticals', u'GlaxoSmithKline plc', u'Actavis Inc', u'Takara Bio USA Inc', u'University of Washington', u'Shionogi USA Inc', u'National Institutes of Health', u'Achaogen Inc', u'Enteris BioPharma Inc', u'Esprit Pharma Inc', u'Massachusetts General Hospital', u'RRD International', u'Vernalis plc', u'Centers for Disease Control and Prevention', u'Sharklet Technologies Llc', u'Angelini Pharmaceuticals SpA', u'The Medicines Company', u'Aytu BioScience Inc', u'Bayer AG', u'Astellas Pharma Inc', u'Q Pharma SL Lab', u'Optimer Inc', u'RFSU', u'Paladin Labs Inc', u'Prasco Laboratories', u'China Medical System Holdings Ltd', u'SK Chemicals Life Science', u'Depomed Inc', u'Washington University in St Louis', u'Cubist Pharmaceuticals Inc', u'Osel Inc', u'Biocon Ltd', u'Lupin Ltd', u'Ilsung Pharmaceutical Co Ltd', u'Hennepin Life Sciences', u'PharmaSwiss SA', u'Roche Palo Alto', u'Swedish Orphan Biovitrum AB', u'Casper Pharma LLC', u'Innovus Pharmaceuticals Inc']), u'Vaccination': set([u'Biovest International Inc', u'US Government', u'Karolinska Institutet', u'Henderson Morley plc', u'Advaxis Inc', u'Dynavax Technologies Corp', u'Vaxcel Inc', u'Sanofi Pasteur', u'European Commission', u'Oncovir Inc', u'Onxeo SA', u'Department of Health', u'GlaxoSmithKline plc', u'BTG plc', u'Inovio Pharmaceuticals Inc', u'FIT Biotech Oyj Plc', u'Vical Inc', u'DMX Inc', u'University of Colorado at Denver and Health Sciences Center', u'Bio Farma', u'Cytheris SA', u'Arizona State University', u'Centro Nacional de Biotechnologia', u'Ribi ImmunoChem Research Inc', u'University of Pennsylvania', u'Fred Hutchinson Cancer Research Center', u'University of Texas Health Science Center Houston', u'University of Rochester', u'Roche Holding AG', u'Cold Spring Harbor Laboratory', u'Stellar Biotechnologies Inc', u'Aviragen Therapeutics Inc', u'Aquila Biopharmaceuticals Inc', u'ANI Pharmaceuticals Inc', u'Allergy Therapeutics plc', u'US Department of the Treasury', u'Orexo AB', u'National Center for Research Resources', u'Pfizer Inc', u'ID Biomedical Corp', u'diaDexus Inc', u'Profectus BioSciences Inc', u'New York University', u'Swedish Institute for Infectious Disease Control', u'Antex Biologics Inc', u'Pfenex Inc', u'Pasteur Merieux', u'Abbott Laboratories', u'Eisai Co Ltd', u'Tulane University', u'US Health and Human Services Department', u'National Cancer Institute', u'Novartis AG', u'Neurolab', u'Acuvax Ltd', u'University of Alabama at Birmingham', u'Medical Research Council', u'SIGA Technologies Inc', u'Pevion Biotech Ltd', u'Wellcome Trust', u'Trudeau Institute', u'Genius Biotherapeutics', u'ImmuRx Inc', u'CytRx Corp', u'Johns Hopkins University', u'Swiss Tropical & Public Health Institute', u'University of California San Diego', u'University of Melbourne', u'University of Oxford', u'Green Cross Corp', u'Tuberculosis Vaccine Initiative', u'Fraunhofer USA Inc', u'SynthRx Inc', u'Eurocine Vaccines AB', u'Cangene Corp', u'Undisclosed', u'Telormedix SA', u'Active Biotech AB', u'ImmuneRegen BioSciences Inc', u'Merck & Co Inc', u'Spring Bank Pharmaceuticals Inc', u'University of Southern California', u'Centers for Disease Control and Prevention', u'GlaxoSmithKline Biologicals', u'Radboud University', u'Agenus Inc', u'CSL Ltd', u'JSC Binnopharm', u'VaxInnate Corp', u'Alligator Bioscience AB', u'Esteve', u'National Institute on Aging', u'National Center for Immunization and Respiratory Diseases', u'Caladrius Biosciences Inc', u'Corixa Corp', u'Progenics Pharmaceuticals Inc', u'AFFiRiS AG', u'Acambis plc', u'Memorial Sloan-Kettering Cancer Center', u'Scancell Ltd', u'IRX Therapeutics Inc', u'Adjuvantys Inc', u'Coley Pharmaceutical Group Inc', u'Sigma-Aldrich Corp', u'OM Pharma', u'Cancer Vaccine Acceleration Fund', u'Cambridge Biotechnology Ltd', u'University of Washington', u'Dalton Pharma Services', u'National Institute of Allergy and Infectious Diseases', u'Sanofi Pasteur MSD', u'SmithKline Beecham plc', u'UCB Celltech', u'Agency for Healthcare Research and Quality', u'MPI Research', u'Guangdong Medicine Group Corp', u\"St Jude Children's Research Hospital\", u'National Institutes of Health', u'Bill & Melinda Gates Foundation', u'OptiNose AS', u'Medicago Inc', u'Canadian Government', u'Global Vaccines Inc', u'Ascend Biopharmaceuticals Ltd', u'Saiba GmbH', u'Apovia AG', u'3M Drug Delivery Systems', u'Therapix Biosciences Ltd', u'Whitehead Institute for Biomedical Research', u'US Naval Medical Research Center', u'University of Georgia', u'Netherlands Vaccine Institute', u'Endocyte Inc', u'CEVEC Pharmaceuticals GmbH', u'Protherics plc', u'ProBioGen AG', u'Idera Pharmaceuticals Inc', u'Hawaii Biotech Inc', u'Hemispherx Biopharma Inc', u'Cantab Pharmaceuticals Research Ltd', u'US Department of Defense', u'Connaught Laboratories Inc', u'Pfizer Vaccines']), u'Spinalcorddisease': set([u'GE Healthcare', u'NU Trust', u'Osteomed LP', u'Neuralstem Inc', u'Bayer AG', u'Advanced Neuroscience Allies Pvt Ltd', u'Nuvectra Corp', u'Cleveland Clinic Foundation', u'Urosurge inc', u'Wenzel Spine Inc', u'Minnetronix Inc', u'Daiichi Sankyo Co Ltd', u'University of California San Francisco']), u'Metastaticbraincancer': set([u'United Therapeutics Corp', u'Leiden University Medical Center', u'Northwestern University', u'Lin Bioscience Inc', u'University of Southern California', u'Pfizer Inc', u'IntelliSyn Pharma', u'VU University Medical Center', u'University of Wisconsin-Madison', u'Undisclosed', u'Cellectar Biosciences Inc', u'Merrimack Pharmaceuticals Inc', u'Memorial Sloan-Kettering Cancer Center', u'University of Sydney', u'BBB Therapeutics BV', u'Biocept Inc', u'Massachusetts General Hospital', u'University of California San Francisco', u'American Brain Tumor Association', u'University of Miami']), u'Cytomegalovirusinfection': set([u'US Government', u'Novo Nordisk A/S', u'Henderson Morley plc', u'Cerus Corp', u'Astellas Pharma Global Development Inc', u'Therapeutic Systems Research Laboratories', u'Sanofi Pasteur', u'Biotest AG', u'GlaxoSmithKline plc', u'Inovio Pharmaceuticals Inc', u'ViroPharma Inc', u'Vical Inc', u'Chiron Corp', u'VGX Pharmaceuticals LLC', u'Ionis Pharmaceuticals Inc', u'Welsh School of Pharmacy', u'US Department of Veterans Affairs', u'MedImmune LLC', u'University of Michigan', u'University of Pennsylvania', u'Clinigen Group plc', u'Milstein Medical Asian American Partnership Foundation', u'Hospira Inc', u'Roche Holding AG', u'Pharmacia & Upjohn Co', u'Biovector Therapeutics SA', u'Aviragen Therapeutics Inc', u'Peregrine Pharmaceuticals Inc', u'Astellas Pharma Europe BV', u'Virginia Commonwealth University', u'Sandoz Ltd', u'InGen Biosciences', u'Genesis Bio-Pharmaceuticals', u'Tanabe Seiyaku Co Ltd', u'CTS Chemical Industries', u'University of Massachusetts Medical School', u'Pharmatek Laboratories Inc', u'Shire BioChem Inc', u'Blue Blood Biotech Corp', u'PDL BioPharma Inc', u'Biota Holdings Ltd', u'University of California San Francisco', u'Rega Institute for Medical Research', u'Mast Therapeutics Inc', u'Abbott Laboratories', u'Eisai Co Ltd', u'Boehringer Mannheim GmbH', u'The University of Birmingham', u'FermaVir Pharmaceuticals Inc', u'Novartis AG', u'Wayne State University', u'Mount Sinai Hospital', u'University of Alabama at Birmingham', u'University of Alabama', u'Chimerix Inc', u'Cell Medica Ltd', u'Sandoz Inc', u'Quintiles Transnational Corp', u'Pennsylvania State University', u'Juno Therapeutics GmbH', u'Viracyte', u'Australian Centre for Vaccine Development', u'Wellcome Trust', u'AnGes MG Inc', u'CytRx Corp', u'Czech Academy of Sciences', u'University of California San Diego', u'ProMetic BioTherapeutics Inc', u'Roche Palo Alto', u'Recordati SpA', u'Wistar Institute of Anatomy & Biology', u'Inagen Aps', u'Quidel Corp', u'Genentech Inc', u'Advanced Life Sciences Holdings Inc', u'Harvard Medical School', u'Guangzhou Chest Hospital', u'AlphaVax Inc', u'Axxima Pharmaceuticals AG', u'Medivir AB', u'Oregon Health Sciences University', u'Microbiotix Inc', u'University of California', u'Merck & Co Inc', u'Cell and Gene Therapy Catapult', u'Atara Biotherapeutics Inc', u'Sanofi', u'Duke University School of Medicine', u'University of Texas Southwestern Medical Center', u'University of Wisconsin-Madison', u'AiCuris Anti-infective Cures GmbH', u'Humabs BioMed SA', u'Chiron Vaccines Co', u'Leukaemia and Lymphoma Research', u'AstraZeneca plc', u'University of Southern California', u'Fournier Pharma', u'Gilead Sciences Inc', u'Medicines Patent Pool', u'Inhibitex Inc', u'4SC AG', u'Memorial Sloan-Kettering Cancer Center', u'Presidio Pharmaceuticals Inc', u'Helocyte Inc', u'NHS Blood & Transplant', u'4-Antibody AG', u'Sarawak MediChem Pharmaceuticals Inc', u'Nippon Kayaku Co Ltd', u'Universitatsklinikum Erlangen', u'National Institute of Allergy and Infectious Diseases', u'BL&H Co Ltd', u'Vakzine Projekt Management GmbH', u'Cancer Prevention and Research Institute of Texas', u'National Institutes of Health', u'Bristol-Myers Squibb Co', u'The First Affiliated Hospital of Dalian Medical University', u'City of Hope', u'INSERM', u'Trellis Bioscience Inc', u'NPS Allelix Corp', u'Redbiotec AG', u'Astellas Pharma Inc', u'Ciba-Geigy AG', u'Avanir Pharmaceuticals Inc', u'Undisclosed', u'Queensland Institute of Medical Research', u'GE Healthcare', u'CEVEC Pharmaceuticals GmbH', u'National Cancer Institute', u'Boryung Pharm Co Ltd']), u'Sicklecellanemia': set([u'Clinical Data Inc', u'US Government', u'BioMarin Pharmaceutical Inc', u'University of Zurich', u'Aevi Genomic Medicine Inc', u'Clayton Biotechnologies Inc', u'Biogen Inc', u\"Cincinnati Children's Hospital Medical Center\", u'Regenacy Pharmaceuticals LLC', u'McNeil Pharmaceuticals Inc', u'Oklahoma Center for the Advancement of Science and Technology', u'MaxCyte Inc', u'Sangamo Therapeutics Inc', u'OSI Pharmaceuticals Inc', u'Virginia Commonwealth University', u'Alpha-Therapeutics Inc', u'apceth GmbH & Co KG', u'Orphagen Pharmaceuticals Inc', u'University of Turin', u'Genethon', u'Imara Inc', u'Ergomed PLC', u'Boston University', u'Catalent Inc', u'National Heart Lung and Blood Institute', u'Rapidscan Pharma Solutions Inc', u'Xechem International Inc', u'National Center For Advancing Translational Sciences', u'SynthRx Inc', u'Israeli Government', u'Childrens Hospital Oakland Research Institute', u'RespireRx Pharmaceuticals Inc', u'Mast Therapeutics Inc', u'Cengent Therapeutics Inc', u'EpimedX LLC', u'Wuxi AppTec Inc', u'Acetylon Pharmaceuticals Inc', u'A1M Pharma AB', u'Morphogenesis Inc', u'Sirna Therapeutics Inc', u'Irix Pharmaceuticals Inc', u'Vanderbilt University', u'University of Alabama at Birmingham', u'University of Minnesota', u'FibroGen Inc', u'Errant Gene Therapeutics LLC', u'Cytovance Biologics LLC', u'SUNY Downstate Medical Center', u'CytRx Corp', u'AesRx LLC', u'Johns Hopkins University', u'Tapestry Pharmaceuticals Inc', u'Vanguard Therapeutics Inc', u'H Lundbeck A/S', u'Durbin PLC', u'Stanford University', u'French Muscular Dystrophy Association', u'National Institute of Diabetes, Digestive and Kidney Diseases', u'Thios Pharmaceuticals Inc', u'SunPharm Corp', u'Boston De Novo', u'Childrens Hospital of Philadelphia', u'Modus Therapeutics', u'University of California', u'Exemplar Genetics Llc', u'Jefferson Medical College', u'Massachusetts Life Sciences Center', u'Vertex Pharmaceuticals Inc', u'Addex Therapeutics Ltd', u'Bayer AG', u'CSL Ltd', u'bluebird bio Inc', u'Pierre Fabre SA', u'University of Virginia', u'Alembic Ltd', u'AstraZeneca plc', u'Schein Pharmaceutical Inc', u'Asubio Pharma Co Ltd', u'Gilead Sciences Inc', u'Strakan Europe', u'Synthetic Biologics Inc', u'Wyeth', u'Childrens Hospital and Medical Center', u'Memorial Sloan-Kettering Cancer Center', u'Calimmune Inc', u'Invenux Inc', u'Reprixys Pharmaceuticals Corp', u'Massachusetts Institute of Technology', u'ValiGen Inc', u'CSL Behring LLC', u'Phoenicia Biosciences Inc', u'Uniformed Services University of the Health Sciences', u'CRISPR Therapeutics', u'Hillhurst Biopharmaceuticals Inc', u'Albert Einstein College of Medicine', u'New York Blood Center', u'National Institutes of Health', u'Food and Drug Administration', u'Swiss Government', u'Bristol-Myers Squibb Co', u'Elan Corp plc', u'NKT Therapeutics Inc', u'INSERM', u'Accentia BioPharmaceuticals Inc', u'New England Research Institutes', u'Thomas Jefferson University', u'Kalypsys Inc', u'Ravizza Farmaceutici SpA', u'Research Development Foundation', u'Arabian Gulf University', u'Emmaus Medical Inc', u'Duke University', u'Global Blood Therapeutics Inc', u'Institut Pasteur', u'Alpha Therapeutic Corp', u'GE Healthcare', u'Icagen Inc (pre-merger)', u'National Cancer Institute', u'Biovail Laboratories International Srl', u'Addmedica', u'Nordic Group', u'Gamida Cell Ltd', u'Viva Biotech', u'National Institute for Pharmaceutical Research and Developments, Federal Republic of Nigeria', u'Doris Duke Charitable Foundation']), u'Adrenalglandtumor': set([u'LifeArc', u'AstraZeneca plc', u'Translational Genomics Research Institute', u'Merck & Co Inc', u'DRI Capital', u'Cedars-Sinai Medical Center']), u'Neisseriameningitidisinfection': set([u'Immunobiology Ltd', u'Health Protection Agency', u'New York University', u'Baxter International Inc', u'Ministry of Health, Brazil', u'Bio-Manguinhos/Fiocruz', u'Finlay Institute', u'Sanofi Pasteur', u'National Institute of Allergy and Infectious Diseases', u'SmithKline Beecham plc', u'Serum Institute of India Ltd', u'GlaxoSmithKline plc', u'Glaxo Norway AS', u'Chiron Corp', u'University of Bristol', u'Bill & Melinda Gates Foundation', u'Sanofi', u'Medical Research Council', u'Eli Lilly & Co', u'Funda\\xe7\\xe3o Ezequiel Dias - Funed', u'Imclone LLC', u'Global Alliance for Vaccines and Immunization', u'Virion Systems Inc', u'Norwegian Institute of Public Health', u'Janssen Biotech Inc', u'Pfizer Inc', u'National Center for Research Resources', u'Meningitis Vaccine Project', u'Technology Strategy Board', u'Center for Biomolecular Chemistry']), u'Nervoussystemtumor': set([u'University of Kentucky', u'Cell Genesys Inc', u'Navidea Biopharmaceuticals Inc', u'The University of Birmingham', u'Cancer Research UK', u'Chiron Corp', u\"Children's Cancer Group\", u'Nottingham Trent University', u'Mayo Clinic Foundation', u'Cantab Biopharmaceuticals Ltd', u'Dana-Farber Cancer Institute Inc', u'Pharmalucence Inc', u'ImmunoGen Inc', u'Trilex Pharmaceuticals Inc']), u'HepatitisBvirusinfection': set([u'The Chinese Centre for Disease Control and Prevention', u'US Health and Human Services Department', u'Technical University of Munich', u'Serum Institute of India Ltd', u'Life Technologies Corp', u'Mylan Laboratories Ltd', u'Inovio Pharmaceuticals Inc', u'Suzhou Ribo Life Science Co Ltd', u'Nippon Kotan KK', u'VGX Pharmaceuticals LLC', u'Bio Farma', u'Ionis Pharmaceuticals Inc', u'Biological E Ltd', u'Metabasis Therapeutics Inc', u'Colthurst Ltd', u'Amoytop Biotech Co Ltd', u'Sumitomo Pharmaceuticals Co Ltd', u'Anhui Medical University', u'Yuhan Corp', u'Galapagos NV', u'Kaketsuken', u'Aviragen Therapeutics Inc', u'Kuhnil Pharmaceutical Co Ltd', u'Handok Inc', u'BDI Pharma Inc', u'Zhejiang Huahai Pharmaceutical Group Co Ltd', u'National Research Council of Canada', u'BioAdvance', u'Green Cross Cell Corp', u'Julphar Gulf Pharmaceutical Industries', u'PDL BioPharma Inc', u'Romark Laboratories LC', u'BioKorea Co Ltd', u'Rega Institute for Medical Research', u'Nippon Kayaku Co Ltd', u'Mochida Pharmaceutical Co Ltd', u'Drogsan Ilaclari San. ve Tic. A.S.', u'Wayne State University', u'Beijing Kawin Technology Share-Holding Co Ltd', u'Triangle Pharmaceuticals Inc', u'Valneva SE', u'Bosch Pharmaceuticals Pvt Ltd', u'Micrologix International Ltd', u'Juvaris BioTherapeutics Inc', u'YM BioSciences Inc', u'Protein Sciences Corp', u'Synergy Pharmaceuticals Inc', u'Wellcome Trust', u'Starpharma Holdings Ltd', u'Genius Biotherapeutics', u'CSPC Zhongqi Pharmaceutical Technology (Shijiazhuang) Co Ltd', u'Grelan Pharmaceutical Co Ltd', u'Janssen Pharmaceutica NV', u'Institut Pasteur Korea', u'Biomolecular Research Institute Ltd', u'Biomics Biotechnologies (Nantong) Co Ltd', u'Kamada Ltd', u'ContraVir Pharmaceuticals Inc', u'Bio-Technology General Ltd', u'Monsanto Co', u'The 458th Hospital of PLA', u'Undisclosed', u'Sakai Chemical Industry Co Ltd', u'Daewoong Pharmaceutical Co Ltd', u'Dragon Pharmaceutical Inc', u'Laboratorios Columbia SA de CV', u'Vion Pharmaceuticals Inc', u'Eli Lilly & Co', u'GlaxoSmithKline Biologicals', u'University of Wisconsin-Madison', u'CSL Ltd', u'LG Life Sciences India Pvt Ltd', u'Fudan Haitai Biotech', u'Soligenix Inc', u'National Institute for the Control of Pharmaceutical and Biological Products', u'FDS Pharma', u'University of Cincinnati', u'Corixa Corp', u'Novartis Vaccines & Diagnostics', u'Genexine Co Ltd', u'Sanwa Kagaku Kenkyusho Co Ltd', u'Avid Corp', u'Harbor Therapeutics Inc', u'Johnson & Johnson', u'Coley Pharmaceutical Group Inc', u'National Taiwan University Hospital', u'Changchun Huapu Biotechnology Co Ltd', u'GeoVax Labs Inc', u'ViroMed Co Ltd', u'Poxel SA', u'SmithKline Beecham plc', u'Bavarian Nordic A/S', u'Beijing Zhifei Luzhu Biopharmaceutical Co Ltd', u'UCB Celltech', u'Sigma-Aldrich Corp', u'Edelris SAS', u'Walter Reed Army Institute of Research', u'Vitapharm Technology Development Co Ltd', u'Bristol-Myers Squibb Co', u'Newsummit Biopharma Co Ltd', u'Catholic University of Korea', u'Seoul National University', u'CCP Technologies Ltd', u'Arriani Pharmaceuticals SA', u'ChronTech Pharma AB', u'University of Oxford', u'US Army Medical Research Acquisition Activity', u'Benitec Biopharma Ltd', u'The Institute of Radiation Medicine Academy of Military Medical Sciences PLA', u'Hollister-Stier Laboratories LLC', u'Mellow Hope Inc', u'Altimmune Inc (pre-merger)', u'Panacea Biotec Ltd', u'University of Cambridge', u'Ministry of Health, Malaysia', u'Karolinska Institutet', u'Yamanouchi Pharmaceutical Co Ltd', u'Dynavax Technologies Corp', u'Institute of Pharmacology and Toxicology Academy of Military Medical Sciences PLA', u'CytoGenix Inc', u'BTG plc', u'HealthCare Asia Pharmaceuticals Inc', u'Chiron Corp', u'Genesis Technology Group Inc', u'Savient Pharmaceuticals Inc', u'Visible Genetics Inc', u'ArQule Inc', u'Onyvax Ltd', u'Lorantis Ltd', u'University of Pennsylvania', u'Roche Holding AG', u'Second Military Medical University PLA', u'Medeva plc', u'Sandoz Ltd', u'China National Biotec Group', u'Genecor International Inc', u'Temple University', u'Intercell AG', u'Cytopharm Inc', u'AltraVax Inc', u'Dongsheng Pharmaceutical International Co Ltd', u'CJ Corp', u'Arrowhead Pharmaceuticals Inc', u'Shanghai Wanxing Bio-Pharmaceutical Co Ltd', u'Johnson & Johnson Innovation Llc', u'Eunice Kennedy Shriver National Institute of Child Health & Human Development', u'Cambridge Biostability Ltd', u'Georgetown University', u'MabVax Therapeutics Holdings Inc', u'BioGeneric Pharma', u'University of Alabama at Birmingham', u'Massachusetts General Hospital', u'Therapix Biosciences Ltd', u'Transgene SA', u'Rhein Biotech GmbH', u'Immune Targeting Systems Ltd', u'Trimeris Inc', u'Cypralis Ltd', u'Janssen Pharmaceutical KK', u'Medmira Inc', u'Georgia State University', u'Center for Genetic Engineering and Biotechnology', u'TetraLogic Pharmaceuticals Corp', u'OnCore Biopharma Inc', u'DuPont Pharmaceuticals Ltd', u'AVAC Ltd', u'Duke University', u'F Hoffmann-La Roche AG', u'Novosom AG', u'Cankat Ilac Sanayi ve Ticaret Ltd', u'University of Witwatersrand', u'Stanford University', u'National Natural Science Foundation of China', u'Mitsubishi Pharma Corp', u'Paladin Labs Inc', u'National Health and Medical Research Council', u'GeneNews Ltd', u'Nanjing Science and Technology Bureau', u'Actavis Inc', u'Eden Biodesign Ltd', u'Xenetic Biosciences Inc', u'Institute of Biotechnology the Academy of Military Medical Sciences PLA', u'Sumitomo Dainippon Pharma Co Ltd', u'ViRexx Medical Corp', u'Scripps Research Institute', u'Spring Bank Pharmaceuticals Inc', u'Cocrystal Pharma Inc', u'Deutsches Rote Kreuze', u'AktiVax Inc', u'Deutsches Krebsforschungszentrum', u'Yeda Research and Development Co Ltd', u'iQur Ltd', u'AiCuris Anti-infective Cures GmbH', u'United Therapeutics Corp', u'Kedrion SpA', u'Cubist Pharmaceuticals Inc', u'Aktiv-Dry LLC', u'Technology Strategy Board', u'Guizhou Bailing Enterprise Group Pharmaceutical Co Ltd', u'Genencor International Inc', u'North China Pharmaceutical Group Corp (NCPC)', u'The Key Lab Of Chemistry For Natural Products Of Guizhou Province & Chinese Academy Of Sciences', u'CN Bio Innovations Ltd', u'UK Department of Trade & Industry', u'Hayashibara Co Ltd', u'Metdem Healthcare Ltd', u'Beijing Pason Pharmaceuticals Inc', u'Severance Hospital', u'Hemispherx Biopharma Inc', u'Alphatech Bioengineering Ltd', u'Cambridge Biotechnology Ltd', u'Ligand Pharmaceuticals Inc', u'Hepatera LLC', u'Haikou VTI Biological Institute', u'Guangdong Medicine Group Corp', u'Oncolys BioPharma Inc', u'ProMetic Life Sciences Inc', u'Tzamal Bio-Pharma Ltd', u'Maastricht University Medical Center', u'Funda\\xe7\\xe3o Ezequiel Dias - Funed', u'Valeant Pharmaceuticals International Inc', u'Medical University of South Carolina', u'National Vaccine and Serum Institute', u'Qilu Pharmaceutical Co Ltd', u'Objectif Recherche VACcin Sida', u'BioDiem Ltd', u'Mologic Ltd', u'Crucell Switzerland AG', u'CCL Pharmaceuticals', u'Walter and Eliza Hall Institute of Medical Research', u'PiSA Farmaceutica', u'SciVac Ltd', u'Nucorion Pharmaceuticals Inc', u'German Federal Ministry of Education and Research', u'Aldevron', u'Symphony Capital LLC', u'C&O Pharmaceutical Technology (Holdings) Ltd', u'Silence Therapeutics plc', u'Koken Co Ltd', u'Mologen Ag', u'Sanofi Pasteur', u'Hetero Drugs Ltd', u'Maxygen Inc', u'Vical Inc', u'Samaritan Pharmaceuticals Inc', u'OSI Pharmaceuticals Inc', u'Tianjin Institute of Pharmaceutical Research', u'Apotex Inc', u'Shanghai Desano Pharmaceuticals Co Ltd', u'Adjuvaris', u'Emcure Pharmaceuticals Ltd', u'NanoBio Corp', u'Novira Therapeutics Inc', u'Enzo Biochem Inc', u'Axis Genetics plc', u'Konkuk University', u'Apovia Inc', u'Inex Pharmaceuticals Corp', u'GenPhar Inc', u'Walvax Biotechnology Co Ltd', u'SCYNEXIS Inc', u'Nucleonics Inc', u'Harvard University', u'SciGen Ltd', u'Solexa Inc', u'VLP Biotech Inc', u'Boehringer Mannheim GmbH', u'Amarillo Biosciences Inc', u'MNLpharma Ltd', u'University of Heidelberg', u'Teva Pharmaceutical Industries Ltd', u'Chimerix Inc', u'GlobeImmune Inc', u'WuXi PharmaTech (Cayman) Inc', u'Beijing Four Rings Bio-Pharmaceutical Co Ltd', u'Association AZT', u'Achillion Pharmaceuticals Inc', u'Carrus Capital Corp', u'Glaxo Group Ltd', u'Fujirebio Europe NV', u'Boehringer Ingelheim Corp', u'Hoffmann-La Roche Inc', u'University of Melbourne', u'302 Military Hospital of China', u'Institute For Hepatitis & Virus Research', u'Enantigen Therapeutics Inc', u'Compass Biotechnologies Inc', u'IDIS Ltd', u'Biogen Inc (FL)', u'National Institute of Diabetes, Digestive and Kidney Diseases', u'Cipla Ltd', u'Cangene Corp', u'Schering-Plough Corp', u'Gilead Pharmasset LLC', u'Cellectar Biosciences Inc', u'XOMA Corp', u'University of California', u'Merck & Co Inc', u'Abivax', u'University Hospital Heidelberg', u'BioChem Pharma (International ) Inc', u'Hualida Biotech', u'Sanofi', u'Okamoto Industries', u'US Army Medical Research Institute of Infectious Diseases', u'Bio-Manguinhos/Fiocruz', u'African Health Solutions LLC', u'Nektar Therapeutics', u'Roivant Sciences Ltd', u'Viriom Inc', u'Anhui Anke Biotechnology (Group) Co Ltd', u'Gilead Sciences Inc', u'Medicines Patent Pool', u'Intarcia Therapeutics Inc', u'Ministry Of Industry & Trade Of The Russian Federation', u'University of Canberra', u'Institute for the Promotion of Innovation by Science and Technology in Flanders', u'Ichor Medical Systems Inc', u'Hoffmann-La Roche AG', u'OriGenix Technologies Inc', u'Fujian Cosunter Pharmaceutical Co Ltd', u'NeuroVive Pharmaceutical AB', u'Virology Networks', u'Akshaya Bio Inc', u'PowderJect Pharmaceuticals plc', u'MYR GmbH', u'Chinese Government', u'Xiamen Chengkun Biotech Co Ltd', u'Kuros Biosciences Ltd', u'Sanofi Genzyme', u'Stendhal International', u'Bukwang Pharmaceutical Co Ltd', u'EntoPharm Co Ltd', u'Staidson (Beijing) Biopharmaceutical Co Ltd', u'bioCSL PTY Ltd', u'Baruch S Blumberg Institute', u'Arecor Ltd', u'Ranbaxy Laboratories Ltd', u'Pharmabridge Inc', u'Shire plc', u'University of Georgia', u'Janssen Pharmaceuticals Inc', u'ProBiond Co Ltd', u'Crucell NV', u'MedinCell SA', u'CyTuVax RP', u'XTL Biopharmaceuticals Ltd', u'Pacific Pharmaceuticals Co Ltd', u'Hainan Noken Pharmaceutical Industry Ltd', u'US Government', u'University of Cologne', u'Nabi Biologics', u'China State Institute of Pharmaceutical Industry', u'Hebei Medical University', u'Fudan University', u'Biogen Inc', u'GlaxoSmithKline plc', u'Celltrion Inc', u'Sahar International Trading Inc', u'Interferon Sciences Inc', u'Cytheris SA', u'Fundacao Oswaldo Cruz (Fiocruz)', u'University of Michigan', u'Immunotope Inc', u'Aduro BioTech Inc', u'RxKinetix Inc', u'Aurobindo Pharma Ltd', u'Asahi Kasei Pharma Corp', u'University of Madras', u'Stanford Rook Ltd', u'Emory University', u'Alnylam Pharmaceuticals Inc', u'St Louis University', u'Reyon Pharmaceuticals Co Ltd', u'Shire BioChem Inc', u'Profectus BioSciences Inc', u'Indian Immunologicals Ltd', u'Zhengzhou University', u'Pharmasset Inc', u'Daiichi Sankyo Co Ltd', u'Abbott Laboratories', u'Eisai Co Ltd', u\"United Nations International Children's Fund\", u'Drexel University', u'National Cancer Institute', u'Novartis AG', u'Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd', u'Vacsyn SA', u'University of Maryland', u'Fresenius Medical Care AG', u'SciClone Pharmaceuticals Inc', u'GeneOne Life Science Inc', u'Arbutus Biopharma Corp', u'HEC Pharm Co Ltd', u'ALZA Corp', u'Immune Response BioPharma Inc', u'University of Colorado System', u'IXICO Plc', u'Czech Academy of Sciences', u'uniQure BV', u'Royalty Pharma', u'Orphan Australia', u'LIDQO Sl', u'GCA Therapeutics Ltd', u'Rhein Biotech NV', u'Ampac Fine Chemicals Llc', u'University of Montpellier', u'ImuThes Ltd', u'Otsuka Pharmaceutical Co Ltd', u'Chia Tai Tianqing Pharmaceutical Group Co Ltd', u'Medivir AB', u'Prescient Therapeutics Ltd', u'National Zhejiang Center for Safety Evaluation of New Drugs', u'Arcturus Therapeutics Inc', u'University College London', u'Galderma SA', u'Shanxi Kangbao Biological Products Co Ltd', u'Epimmune Inc', u'RegeneRx Biopharmaceuticals Inc', u'Valentis Inc', u'NCPC GeneTech Biotechnology Development Co Ltd', u'rEVO Biologics Inc', u'Nobex Corp', u'Sunovion Pharmaceuticals Inc', u'Esteve', u'Novation Science Llc', u'Strides Shasun Ltd', u'Yale University', u'ENYO Pharma SAS', u'Dr Reddy\\u2019s Research and Development BV', u'AusIndustry', u'Maxim Pharmaceuticals Inc', u'LG Life Sciences Ltd', u'Shanghai Biochemistry Pharmaceutical Co Ltd', u'Janssen R&D (Ireland)', u\"Lee's Pharmaceutical Holdings Limited\", u'PowderMed Ltd', u'National Institute of Allergy and Infectious Diseases', u'Viragen Inc', u'Russian AIDS Federal Centre', u'Albert Einstein College of Medicine', u'Vaxine Pty Ltd', u'New York Blood Center', u'National Institutes of Health', u'Bill & Melinda Gates Foundation', u'Sarepta Therapeutics Inc', u'GlobalAcorn', u'Grand Challenges in Global Health', u'Avac Pharma Ltd', u'Synvolux IP BV', u'Thomas Jefferson University', u'Roswell Park Cancer Institute', u'Anadys Pharmaceuticals Inc', u'Shantha Biotechnics PVT Ltd', u'Eiger BioPharmaceuticals Inc', u'Kagoshima University', u'Nuron Biotech Inc', u'Idera Pharmaceuticals Inc', u'Idenix Pharmaceuticals Inc']), u'Myxoma': set([u'Dutch Cancer Society', u'Netherlands Cancer Institute']), u'Non-sm': set([u'Eli Lilly & Co', u'ASTA Medica AG', u'Rhone-Poulenc Rorer Inc', u'AstraZeneca plc']), u'Headandnecktumor': set([u'Daiichi Seiyaku Co Ltd', u'Innogene Kalbiotech Pte Ltd', u'Etubics Corp', u'Chengdu Enduoshi Biotech Co Ltd', u'AmpliPhi Biosciences Corp', u'Shanghai Jing Ze Biotech Co Ltd', u'RedHill Biopharma Ltd', u'Advanced BioScience Laboratories Inc', u'Advaxis Inc', u'Vion Pharmaceuticals Inc', u'GenVec Inc', u'Incyte Corp', u'OncoTherapy Science Inc', u'Centre for Probe Development and Commercialization', u'Oncolys BioPharma Inc', u'Yakult Honsha Co Ltd', u'GlaxoSmithKline plc', u'NantKwest Inc', u'NeoPharm Inc', u'Inovio Pharmaceuticals Inc', u'Centelion SAS', u'Intensity Therapeutics Inc', u'Aura Biosciences Inc', u'PharmaCell', u'Australian Nuclear Science & Technology Organization', u'Ohio Third Frontier', u'University of Zurich', u'Cascadian Therapeutics Inc', u'Sanofi Winthrop France SA', u'Ipsen', u'Immunex Corp', u'Cleveland BioLabs Inc', u'Erimos Pharmaceutical LLC', u'Transcept Pharmaceuticals Inc', u'Elan Corp plc', u'Vernalis plc', u'MedImmune LLC', u'Intracel Corp', u'University of Pittsburgh', u'VentiRx Pharmaceuticals Inc', u'VIRTTU Biologics', u'OSI Pharmaceuticals Inc', u'Industrial Research Ltd', u'Fred Hutchinson Cancer Research Center', u'Swiss Group for Clinical Cancer Research', u'Shionogi & Co Ltd', u'Mateon Therapeutics Inc', u'Singapore Technologies Pte Ltd', u'Five Prime Therapeutics Inc', u'Roche Holding AG', u'Formation Biologics', u'PlantForm Corp', u'Mie University School of Medicine', u'Biocompatibles International plc', u'TOLMAR Therapeutics Inc', u'Kite Pharma Inc', u'Ludwig Institute for Cancer Research', u'Kuhnil Pharmaceutical Co Ltd', u'Netherlands Cancer Institute', u'US Department of the Treasury', u'Ergomed PLC', u'Biocon Ltd', u'Memorial Sloan-Kettering Cancer Center', u'BioVectra DCL', u'Epigenomics AG', u'National Center for Research Resources', u'National Heart Lung and Blood Institute', u'NantCell Inc', u'Light Sciences Corp', u'Immune Cell Therapy Inc', u'Dana-Farber Cancer Institute Inc', u'Microbial Chemistry Research Foundation', u'Orient Europharma', u'Hikma Pharmaceuticals plc', u'Transgene SA', u'Henry Ford Health System', u'Fournier Pharma', u'Exelixis Inc', u'Diomed Ltd', u'Iovance Biotherapeutics Inc', u'Diaxonhit', u'Selecta Biosciences Inc', u'XOMA Corp', u'Amgen Inc', u'Medarex Inc', u'CEL-SCI Corp', u'Cancer Genetics Inc', u'The European Union', u'Abbott Laboratories', u'Eisai Co Ltd', u'Marsala Biotech Inc', u'JCR Pharmaceuticals Co Ltd', u'Boehringer Mannheim GmbH', u'Ganymed Pharmaceuticals AG', u'Zeneus Pharma Ltd', u'InteRNA Technologies BV', u'i3 research', u'National Cancer Institute', u'Augusta University Research Institute Inc', u'Merck KGaA', u'Ferrer Internacional SA', u'Barrier Therapeutics Inc', u'Shenzhen SiBiono Gene Technologies Co Ltd', u'Aminex Therapeutics Inc', u'Fujisawa Pharmaceutical Co Ltd', u'Novelion Therapeutics Inc', u'Teva Pharmaceutical Industries Ltd', u'Dutch Cancer Society', u'Diatos SA', u'Hanmi Pharmaceutical Co Ltd', u'LAVI CARDIATEC LTD', u'Shanghai Henlius Biotech Co Ltd', u'CytomX Therapeutics Inc', u'Abgenix Inc', u'SuviCa Inc', u'YM BioSciences Inc', u'WuXi PharmaTech (Cayman) Inc', u'Enzon Pharmaceuticals Inc', u'RecipharmCobra Biologics', u'Oncolytics Biotech Inc', u'Sandoz Inc', u'Biotech Pharmaceutical Co Ltd', u'Quintiles Transnational Corp', u\"M's Science Corp\", u'Tessa Therapeutics Pte Ltd', u'Titan Pharmaceuticals Inc', u'Pharma Patch plc', u'Piramal Enterprises Ltd', u'ImmunoGen Inc', u'Luye Pharma Group Ltd', u'Viventia Bio Inc', u'Otsuka Pharmaceutical Co Ltd', u'Skolkovo', u'Carnegie-Mellon University', u'OncoVista Innovative Therapies Inc', u'Allergan Inc', u'Altor BioScience Corp', u'Byron Biopharma', u'University of Cincinnati', u'National Research Council of Canada', u'Boehringer Ingelheim Corp', u'The Center of Molecular Immunology', u'Tapestry Pharmaceuticals Inc', u'Kyowa Hakko Kogyo Co Ltd', u'Merck Serono SA', u'US Health and Human Services Department', u'Infinity Pharmaceuticals Inc', u'NantWorks LLC', u'Aventis Pharmaceuticals Inc', u'Oncobiologics Inc', u'Swedish Orphan Biovitrum AB', u'Windtree Therapeutics Inc', u'Oncormed Inc', u'Scotia Holdings plc', u'Benitec Biopharma Ltd', u'ILEX Oncology Inc', u'Onyx Pharmaceuticals Inc', u'Chugai Pharmaceutical Co Ltd', u'University of Maryland Baltimore County', u'Cancer Research UK', u'MethylGene Inc', u'Genentech Inc', u'Andrus Reo Ltd', u'FusionVax', u'Harvard Medical School', u'Biothera Pharmaceuticals Inc', u'North Central Cancer Treatment Group', u'SynCo BioPartners', u'WellSpring Pharmaceutical Corp', u'Laserscope', u'Protherics Salt Lake City Inc', u'Schering-Plough Corp', u'Farrah Fawcett Foundation', u'PharmaVigilant', u'Bioproperties Pty Ltd', u'Global BioPharma Inc', u'Undisclosed', u'Reliable Biopharmaceutical Corp', u'US Government', u'Cellectar Biosciences Inc', u'ImmunID', u'Daewoong Pharmaceutical Co Ltd', u'biolitec AG', u'Redx Pharma Plc', u'MD Anderson Cancer Center', u'Efamol', u'Merck & Co Inc', u'Immunovaccine Inc', u'Sanofi', u'Vertex Pharmaceuticals Inc', u'Consiglio Nazionale delle Ricerche', u'Eli Lilly & Co', u'Prasco Laboratories', u'MaxiVAX SA', u'Immune Pharmaceuticals Inc', u'Novogen Ltd', u'Phyton Biotech Inc', u'ScinoPharm Taiwan Ltd', u'Pharmacia Corp', u'Organon Teknika BV', u'Pierre Fabre SA', u'UC San Diego Moores Cancer Center', u'Selective Genetics Inc', u'Weizmann Institute of Science', u'Ewopharma AG', u'University of Maryland', u'Haemologic Ltd', u'Janssen Biotech Inc', u'SRI International', u'Almirall Prodesfarma SA', u'Therapure Biopharma Inc', u'AstraZeneca plc', u'Pfizer Inc', u'University of Southern California', u'AsclepiX Therapeutics LLC', u'Boehringer Ingelheim Pharmaceuticals Inc', u'Guizhou Bailing Enterprise Group Pharmaceutical Co Ltd', u'Vyriad', u'Synthetic Biologics Inc', u'European Organization for Research and Treatment of Cancer', u'Cancer Research Technology Ltd', u'PiSA Farmaceutica', u'Cadila Pharmaceuticals Ltd', u'Stanford University School of Medicine', u'CTI BioPharma Corp', u'Biologics Inc', u'Beijing Pason Pharmaceuticals Inc', u'Lonza Biologics plc', u'Baylor Scott & White Research Institute', u'Therion Biologics Corp', u'IRX Therapeutics Inc', u'Johns Hopkins University', u'LG Life Sciences Ltd', u'Tularik Inc', u'Introgen Therapeutics Inc', u'Baylor College of Medicine', u'Australian Government', u'Quay Pharmaceuticals Ltd', u'Imclone LLC', u'In Ovations Holdings Inc', u'Genmab A/S', u'Japanese National Cancer Center', u'ASTA Medica AG', u'University of Pennsylvania', u'MEI Pharma Inc', u'Nisco International Inc', u'Navidea Biopharmaceuticals Inc', u'BioNTech RNA Pharmaceuticals GmbH', u'SensoPath Technologies Inc', u'National Comprehensive Cancer Network', u'Ligand Pharmaceuticals Inc', u'Abzena plc', u'Shandong Luoxin Pharmaceutical Group Stock Co Ltd', u'Critical Outcome Technologies Inc', u'Takeda Pharmaceutical Co Ltd', u'Albert Einstein College of Medicine', u'Ethicon Inc', u'National Institutes of Health', u'TopoTarget A/S', u'Food and Drug Administration', u'Axxiom Inc', u'Bristol-Myers Squibb Co', u'Chinese Government', u'Vaccinogen Inc', u'Sphaera Pharma', u'Oncology Venture ApS', u'Presage Biosciences', u'American Cyanamid Co', u'Azanta A/S', u'Okayama University Hospital', u'Guangzhou Doublle Bioproducts Co Ltd', u'Roswell Park Cancer Institute', u'Rhone-Poulenc Rorer Inc', u'University of Chicago', u'GeneMedicine Inc', u'Sidney Kimmel Comprehensive Cancer Center', u'YM BioSciences USA', u'KS Biomedix Holdings plc', u'Columbia University', u'Regulon Inc', u'Wistar Institute of Anatomy & Biology', u'Ferozsons Laboratories Ltd', u'University of Guelph', u'Adaptimmune Therapeutics plc', u'Agouron Pharmaceuticals Inc', u'Takara Bio Inc', u'University of Toronto', u'Teikoku Pharma USA Inc', u'Hasumi International Research Foundation', u'Bar-Ilan Research & Development Co Ltd', u'Cyanamid Benelux NV', u'Novartis AG', u'Bayer HealthCare Pharmaceuticals Inc', u'European Organisation for Research and Treatment of Cancer (EORTC)', u'Abraxis BioScience Inc', u'Stand Up To Cancer', u'Radiation Control Technologies', u'Princeton University', u'Quiet Therapeutics', u'Mayne Pharma Pty Ltd', u'Aarhus University', u'VU University Medical Center', u'Danish Head and Neck Cancer Group']), u'Presbyopia': set([u'Univ Massachusetts', u'University of Nottingham', u'Encore Vision Inc', u'Presbia plc', u'NovaMedica', u'Neoptics Ag', u'National Eye Institute', u'Disease Interception Accelerator', u'S. Fyodorov Eye Microsurgery Complex']), u'Paroxysmalnocturnalhemoglobinuria': set([u'University of Pennsylvania', u'Apellis Pharmaceuticals Inc', u'NovelMed Therapeutics Inc', u'National Heart Lung and Blood Institute', u'INSERM U976', u'MABLife', u'Alnylam Pharmaceuticals Inc', u'Sanofi Genzyme']), u'Bacillusinfection': set([u'Aparna Biosciences Corp', u'National Institutes of Health']), u'Opticneuritis': set([u'University of Pennsylvania', u'Fast Forward LLC', u'Artielle ImmunoTherapeutics Inc', u'Teijin Ltd', u'Oregon Health Sciences University', u'Noveome Biotherapeutics Inc', u'Oklahoma Medical Research Foundation', u'Kaketsuken', u'National Eye Institute', u'Bionure Inc']), u'Topicalanesthesia': set([u'Johnson & Johnson', u'Medline Industries Inc', u'Taro Pharmaceuticals Inc (Canada)', u'Sato Pharmaceutical Co Ltd', u'Marathon Pharmaceuticals LLC', u'Galen Ltd', u'Powder Pharmaceuticals Inc', u'Nitto Denko Corp', u'Abbott Laboratories', u'US Government', u'Astra AB', u'Pacira Pharmaceuticals Inc', u'PowderJect Pharmaceuticals plc', u'Aspen Global Incorporated', u'ZARS Pharma Inc', u'Anesiva Inc', u'Scotia LipidTeknik AB', u\"Lee's Pharmaceutical Holdings Limited\", u'AlgoRx Pharmaceuticals Inc', u'St Renatus LLC', u'Mundipharma EDO GmbH', u'Chiroscience Group plc', u'Nuvo Pharmaceuticals Inc', u'Maruishi Pharmaceutical Co Ltd', u'Recipharm AB', u\"Connecticut Children's Medical Center\", u'AstraZeneca plc', u'Pfizer Inc', u'Sagent Pharmaceuticals Inc', u'Crescita Therapeutics Inc', u'DePuy Synthes Companies', u'UCB SA', u'Nippon Lederle KK']), u'Steatohepatitis': set([u'Jenken Bioscience Inc', u'North Carolina Biotechnology Center']), u'Menieredisease': set([u'Otifex Therapeutics Pty Ltd', u'Auris Medical Holding AG', u'Undisclosed']), u'Milkhypersensitivity': set([u'Nestle Health Science', u'DBV Technologies SA']), u'Alcoholichepatitis': set([u'Conatus Pharmaceuticals Inc', u'National Institute on Alcohol Abuse and Alcoholism']), u'Lungembolism': set([u'University of Michigan', u'DRAXIMAGE', u'Pulmo BioTech Inc', u'Daiichi Sankyo Co Ltd', u'Abbott Laboratories', u'Eisai Co Ltd', u'BioTechnology Consulting Poland Sp. z.o.o.', u'TeaRx LLC', u'Mitsui Pharmaceuticals Inc', u'Dendreon San Diego LLC', u'Zydus-Cadila Group', u'Savient Pharmaceuticals Inc', u'PAION AG', u'Merck & Co Inc', u'GlycoMimetics Inc', u'Jubilant Draximage Inc', u'Sanofi-Synthelabo', u'ImaRx Therapeutics Inc', u'GlaxoSmithKline plc', u'Sanofi', u'Tanabe Seiyaku Co Ltd', u'Thomas Jefferson University', u'Roche Holding AG', u'Bristol-Myers Squibb Co', u'Cyclopharm Ltd', u'Palatin Technologies Inc', u'Meridian Bioscience Inc', u'ProBioGen AG', u'Medicure Inc', u'Targeted Therapeutic Solutions LLC', u'National Heart Lung and Blood Institute', u'Pfizer Inc', u'Microbix Biosystems Inc', u'Loyola University Stritch School of Medicine']), u'Morquiosyndrome': set([u'St Louis University', u'Vivendy Therapeutics Ltd']), u'Thyroidassociatedophthalmopathy': set([u'Peregrine Pharmaceuticals Inc', u'Dios Therapeutics', u'CMC Biologics Inc', u'River Vision Development Corp', u'Food and Drug Administration']), u'Vacci': set([u'Coley Pharmaceutical Group Inc', u'Ludwig Institute for Cancer Research', u'University of Iowa']), u'Diarrheapredominantirritablebowelsyndrome': set([u'Alfa Wassermann SpA', u'Allergan plc', u'Ironwood Pharmaceuticals Inc', u'LTL Pharma Co Ltd', u'Third Military Medical University of the Chinese PLA', u'Johns Hopkins University School of Medicine', u'Astellas Pharma Inc', u'RedHill Biopharma Ltd', u'SonarMD', u'Orphomed LLC', u'Merckle GmbH', u'Aland (Jiangsu) Nutraceutical Co Ltd', u'Dong-A ST Co Ltd', u'Assembly Biosciences Inc', u'Patheon Pharmaceuticals Inc', u'Entera Health']), u'Autoimmunemyocarditis': set([u'University of Texas Health Science Center San Antonio', u'VG Life Sciences Inc']), u'Inbornerrorofmetabolism': set([u'Rare Disease Therapeutics Inc', u'Assistance Publique Hopitaux de Paris', u'Han Heng Industrial Co Ltd', u'Orphan Australia', u'Orphan Europe SARL', u'Swedish Orphan AB', u'Syngenta AG', u'INSERM', u'Orphan Medical Inc', u'Institut Pasteur', u'Sigma-Tau Ind Farm Riunite SpA']), u'Nasalcongestion': set([u'Johnson & Johnson', u'China Pharmaceutical University', u'Moberg Pharma AB', u'The Procter & Gamble Co', u'Prestige Brands Holdings Inc', u'University of Nebraska Medical Center']), u'Cerebralhemorrhage': set([u'RNL Bio Co Ltd', u'North Carolina Biotechnology Center', u'Niigata University', u'Medipost Co Ltd', u'St Michaels Hospital', u'Russian Academy of Sciences', u'Mayo Clinic Foundation', u'Duke University', u'MRI Interventions Inc', u'Edge Therapeutics Inc', u'Shimojani LLC', u'Dong-A ST Co Ltd']), u'Metabolicdisorder': set([u'Solvay SA', u'NEOMED Institute', u'InhibeX LLC', u'DayTwo Ltd', u'Envoy Therapeutics Inc', u'US Health and Human Services Department', u'Emerge Health Pty Ltd', u'The Leona M. and Harry B. Helmsley Charitable Trust', u'Maryland Technology Development Corp', u'Betagenon AB', u'Ionis Pharmaceuticals Inc', u'Novartis Pharma AG', u'Rani Therapeutics LLC', u'University of Prince Edward Island', u'TMS Co Ltd', u'DNX Biopharmaceuticals Inc', u'CymaBay Therapeutics Inc', u'Ambrx Inc', u'Orphagen Pharmaceuticals Inc', u'Polyphor Ltd', u'Handok Inc', u'Genethon', u'Humanetics Corp', u'23andMe Inc', u'Universit\\xe9 du Qu\\xe9bec \\xe0 Montr\\xe9al', u'Advanced Mr Analytics AB', u'Entelos Inc', u'Israeli Government', u'CareX SA', u'KeyBioScience AG', u'Tulane University', u'ASINEX Ltd', u'Egret Pharma (Shanghai) Ltd', u'Reset Therapeutics Inc', u'Hanmi Pharmaceutical Co Ltd', u'Agennix AG', u'Cortendo AB', u'Solvay Pharmaceuticals Inc', u'Verily Life Sciences LLC', u'Shifa Biomedical Corp', u'Pharmacopeia Inc', u'Les Laboratoires Servier', u'Kyorin Pharmaceutical Co Ltd', u'FASgen Inc', u'Nano Terra Inc', u'Celera Group', u'Second Genome Inc', u'National Health Research Institutes', u'Genfit SA', u'Infinity Pharmaceuticals Inc', u'Suzhou Ribo Life Science Co Ltd', u'Swedish Orphan Biovitrum AB', u'Institut de Recherches Cliniques de Montreal', u'Selventa', u'PeptiDream Inc', u'Flamel Technologies SA', u'TES Pharma Srl', u'Nimbus Therapeutics', u'Undisclosed', u'JW CreaGene Inc', u'7TM Pharma A/S', u'Pfizer Inc', u'Translational Research Ltd', u'Tokyo University of Agriculture & Technology Co Ltd', u'Eli Lilly & Co', u'Tikvah Therapeutics Inc', u'Gubra Aps', u'Weizmann Institute of Science', u'Palatin Technologies Inc', u'Metabasis Therapeutics Inc', u'ViroMed Co Ltd', u'Sunesis Pharmaceuticals Inc', u'University of Cincinnati', u'Thia Medica AS', u'Abide Therapeutics Inc', u'Sanwa Kagaku Kenkyusho Co Ltd', u'Harbor Therapeutics Inc', u'University of Tromso', u'Magenta Therapeutics Inc', u'Silence Therapeutics AG', u'BELLUS Health Inc', u'Taisho Pharmaceutical Co Ltd', u'Galmed Pharmaceuticals Ltd', u'Actelion Ltd', u'Servier', u'iPS Academia Japan Inc', u'Bristol-Myers Squibb Co', u'Bayer Pharmaceuticals Corp', u'Galapagos NV', u'Cambridge Drug Discovery Ltd', u'Astellas Pharma Inc', u'Daiichi Fine Chemicals Co Ltt', u'Insmed Inc', u'VIA Pharmaceuticals Inc', u'Sareum Holdings plc', u'Weill Medical College of Cornell University', u'Novo Nordisk A/S', u'CiToxLAB Group', u'Caisse de d\\xe9p\\xf4t et placement du Qu\\xe9bec', u'Translate Bio', u'iPierian Inc', u'Howard Hughes Medical Institute', u'Celladon Corp', u'Cyntellect Inc', u'Marcadia Biotech Inc', u'ArQule Inc', u'Genentech Inc', u'Zambon Co SpA', u'University of Pennsylvania', u'Lead Discovery Center GmbH', u'Imaxio', u'Roche Holding AG', u'Merck Sante SA', u'Alchemia Ltd', u'Procter & Gamble Pharmaceuticals Inc', u'Temple University', u'Duke Clinical Research Institute', u'Novus Therapeutics Inc', u'Beryllium Discovery Corp', u'ChemRar High Tech Center', u'Evotec AG', u'Exelixis Inc', u'Charles River Laboratories International Inc', u'Anchor Therapeutics Inc', u'Amgen Inc', u'Karo Pharma AB', u'EuroTransBio', u'Hospital Clinicas de Caracas', u'Ardana Bioscience Ltd', u'Gemini Genomics plc', u'LMC Diabetes & Endocrinology Ltd', u'University of Alabama at Birmingham', u'Massachusetts General Hospital', u'Convivia', u'Mercury Therapeutics Inc', u'Atlantic Canada Opportunities Agency', u'ENTEROME Bioscience SA', u'Echo Therapeutics Inc', u'Astex Therapeutics Ltd', u'Allergan Inc', u'Daegu Hanny University', u'University of California San Diego', u'Nivarta Inc', u'Joslin Diabetes Center Inc', u'Axcella Health Inc', u'University of Oxford', u'Stanford University', u'Mitsubishi Pharma Corp', u'Paladin Labs Inc', u'Mayo Clinic Foundation', u'National Health and Medical Research Council', u'Ore Pharmaceuticals Inc', u'LifeArc', u'Actavis Inc', u'Glenn Foundation for Medical Research', u'Sumitomo Dainippon Pharma Co Ltd', u'PDL BioPharma Inc', u'Theratechnologies Inc', u'University of Texas Southwestern Medical Center', u'Validus Pharmaceuticals', u'Japan Tobacco Inc', u'SEBIA', u'Pierre Fabre SA', u'MolMed SpA', u'Kadmon Pharmaceuticals LLC', u'Seres Therapeutics Inc', u'Arix Bioscience plc', u'AstraZeneca plc', u'University of Utah', u'Regione Lombardia', u'Aegerion Pharmaceuticals Inc', u'Sirtris Pharmaceuticals Inc', u'Santhera Pharmaceuticals AG', u'Amylin Pharmaceuticals Inc', u'University of Adelaide', u'H Lee Moffitt Cancer Center and Research Institute', u'Ligand Pharmaceuticals Inc', u'Dr Falk Pharma GmbH', u'Sihuan Pharmaceutical Holdings Group Ltd', u'Michigan Economic Development Corp', u'Discovery BioMed Inc', u'Theracos Inc', u'Massachusetts Eye & Ear Infirmary', u'Systems Integration Drug Discovery Co Inc', u'Zealand Pharma A/S', u'Esperion Therapeutics Inc', u'Kyoto University', u'Trans Genic Inc', u'Valeant Pharmaceuticals International Inc', u'ProSciento Inc', u'Covis Pharma Sarl', u'GVK Biosciences Pvt Ltd', u'Spencer Pharmaceutical Inc', u'Selecta Biosciences Inc', u'GE Healthcare', u'Indiana University', u'Anna University', u'Takeda Pharmaceutical Co Ltd', u'Xenome Ltd', u'Zen-Bio Inc', u'CuraGen Corp', u'Sanofi-Aventis US LLC', u'Royal DSM NV', u'Intercept Pharmaceuticals Inc', u'Orphan Europe SARL', u'Abdi Ibrahim Ilac Sanayi Ve Ticaret Anonim Sirketi', u'Caprion Pharmaceuticals Inc', u'Forest Laboratories Inc', u'Ventac Partners CH', u'Baltic Bio AB', u'Aventis Pharma AG', u'MedImmune LLC', u'OSI Pharmaceuticals Inc', u'University of Washington', u'GW Pharmaceuticals plc', u'Neuren Pharmaceuticals Ltd', u'MSD OSS BV', u'Gamida Cell Ltd', u'Biokier Inc', u\"Queen's University\", u'Novartis Pharmaceuticals Corp', u'WaVe Life Sciences Ltd', u'Navinta LLC', u'ModeRNA Therapeutics', u'Bioactis Ltd', u'Keio University', u'Knoll Farmaceutici SpA', u'Bioresearch SpA', u'4D Molecular Therapeutics LLC', u\"Children's National Medical Center\", u'SCYNEXIS Inc', u'Harvard University', u'D&A Pharma', u'Korea University', u'Leadiant Biosciences Inc', u'ZymoGenetics Inc', u'ActoGeniX NV', u'Medicure Inc', u'Yale University', u'Teva Pharmaceutical Industries Ltd', u'Perlecan Pharma Pvt Ltd', u'KineMed Inc', u'Florida Hospital', u'WuXi PharmaTech (Cayman) Inc', u'BTG plc', u'Ferring Pharmaceuticals SA', u'Prognomix', u'Millennium Pharmaceuticals Ltd', u'Boehringer Ingelheim Corp', u'Lipomics Technologies Inc', u'Carmot Therapeutics Inc', u'KaLy-Cell', u'Guangzhou Institutes of Biomedicine and Health', u'Wyeth Pharmaceuticals', u'Renova Therapeutics Inc', u'Harvard Medical School', u'National Institute of Diabetes, Digestive and Kidney Diseases', u'Takeda San Francisco Inc', u'Roche Innovation Center Copenhagen A/S', u'XOMA Corp', u'University of California', u'Erasmus University Rotterdam', u'Perlegen Sciences Inc', u'Sanofi', u'Daewon Pharm Co Ltd', u'Vertex Pharmaceuticals Inc', u'Columbia University', u'Bayer AG', u'Pharmacia Corp', u'Be The Match BioTherapies', u'Biosortia Pharmaceuticals', u'Bennu Pharmaceuticals Inc', u'Eternygen GmbH', u'Intarcia Therapeutics Inc', u'Janssen Human Microbiome Institute', u'Kineta Inc', u'Multiplicom N.V.', u'Institute for the Promotion of Innovation by Science and Technology in Flanders', u'FGH BIOTECH INC', u'4SC AG', u'Tularik Inc', u'Ubiquigent Limited', u'The University Of Buckingham', u'Essentialis Inc', u'Valens Pharma Ltd', u'Peptimmune Inc', u'Calporta Therapeutics Inc', u'Aurigene Discovery Technologies Ltd', u'Mitsubishi Chemical Corp', u'Ablynx NV', u'University of Oregon', u'Arena Pharmaceuticals Inc', u'Enteris BioPharma Inc', u'Sanofi Genzyme', u'Regulus Therapeutics Inc', u'Stendhal International', u'HemoShear Therapeutics LLC', u'Stealth BioTherapeutics Inc', u'CJ Corp', u'Takeda Cambridge Ltd', u'Research Development Foundation', u'Array BioPharma Inc', u'TWi Pharmaceuticals Inc', u'AstraZeneca AB', u'Ranbaxy Laboratories Ltd', u'Genovate Biotechnology Co Ltd', u'Wellcome Trust Sanger Institute', u'University of Leeds', u'Debiopharm SA', u'Janssen Pharmaceuticals Inc', u'Napo Pharmaceuticals Inc', u'XL-Protein GmbH', u'University of Alberta', u'UCL Business PLC', u'NGM Biopharmaceuticals Inc', u\"Dr Reddy's Laboratories Ltd\", u'US Government', u'Ecole Polytechnique Federale de Lausanne', u'Rosa & Co LLC', u'Catabasis Pharmaceuticals Inc', u'Shire Human Genetic Therapies Inc', u'California Institute of Regenerative Medicine', u'UMN Pharma Inc', u'GlaxoSmithKline plc', u'Covance Inc', u'vTv Therapeutics LLC', u'SK Group', u'Ipsen', u'European Eurostars Programme', u'ANI Pharmaceuticals Inc', u'ActivX Biosciences Inc', u'University of Michigan', u'NRC Research Institute', u'Abbott Healthcare Products BV', u'Vitae Pharmaceuticals Inc', u'Innovative Genomics Initiative', u'Xcellsyz Ltd', u'TransgenRx Inc', u'Sankyo Co Ltd', u'ERYtech Pharma', u'Fox Chase Cancer Center', u'Boston University', u'Zenyth Therapeutics Ltd', u'Emory University', u'BioMotiv LLC', u'Alnylam Pharmaceuticals Inc', u'UCB SA', u'NovaTarg Therapeutics Inc', u'Johnson & Johnson Pharmaceutical Research & Development LLC', u'Advinus Therapeutics Ltd', u'Regience KK', u'DiObex Inc', u'Reata Pharmaceuticals Inc', u'Daiichi Sankyo Co Ltd', u'Abbott Laboratories', u'UniQuest Pty Ltd', u'BioRestorative Therapies Inc', u'Merck KGaA', u'Ex scientia Ltd', u'The Ellison Medical Foundation', u'Bicycle Therapeutics Ltd', u'University of Maryland', u'University of Dundee', u'Simcere Pharmaceutical Group', u'Krish Biotech Research Pvt Ltd', u'Metabolic Solutions Development Co', u'Chung-Ang University', u'Cadus Corp', u'ALZA Corp', u'Bicoll GmbH', u'Piramal Enterprises Ltd', u'Xenon Pharmaceuticals Inc', u'HitGen Ltd', u'Midatech Pharma US Inc', u'Lupin Ltd', u'uniQure BV', u'Bird Rock Bio Inc', u'Growblox Sciences Inc', u'Lexicon Pharmaceuticals Inc', u'Aileron Therapeutics Inc', u'National Institute of Neurological Disorders and Stroke', u'ImuThes Ltd', u'Otsuka Pharmaceutical Co Ltd', u'BioTrove Inc', u'Southern Research Institute', u'Molecular Stethoscope Inc', u'Latitude Pharmaceuticals', u'Merck & Co Inc', u'Novo A/S', u'National Center for Complementary and Alternative Medicine', u'ChemGenex Pharmaceuticals Ltd', u'NicOx SA', u'Korean Ministry of Knowledge Economy', u'Janssen Biotech Inc', u'Teijin Ltd', u'Sanford-Burnham Medical Research Institute', u'The Salk Institute for Biological Studies', u'Human Genome Sciences Inc', u'deCODE genetics ehf', u'Hopital Universitaire de la Pitie Salpetriere', u'High Point Pharmaceuticals Llc', u'BioSeek LLC', u'Ipsen Bioscience Inc', u'Praecis Pharmaceuticals Inc', u'University of Liege', u'California Institute for Biomedical Research', u'Heptares Therapeutics Ltd', u'ObeTherapy Biotechnology', u'National Institutes of Health', u'Food and Drug Administration', u'Curis Inc', u'Chronogen Inc', u'Petra Pharma Corp', u'ChemDiv Inc', u'4Cyte Therapeutics Inc', u'Axxam SpA', u'Verva Pharmaceuticals Ltd', u'Jubilant Life Sciences Ltd', u'University of California Irvine', u'biOasis Technologies Inc', u'CISI Scrl Consorzio Interdisciplinare Di Studi Biomolecolari E Applicazioni Industriali', u'Biologics Inc', u'Sequana Therapeutics', u'Tripos Inc', u'Helsinn Group']), u'Pouchitis': set([u'Eli Lilly & Co', u'NITTO DENKO Avecia', u'Ionis Pharmaceuticals Inc', u'Mitsubishi Pharma Corp', u'Atlantic Healthcare plc', u'Mitsubishi Tanabe Pharma Corp', u'Kureha Corp', u'Daiichi Sankyo Co Ltd', u'Orphan Australia']), u'Rheumatoidarth': set([u'Weizmann Institute of Science', u'Merck Serono SA']), u'Pompesdisease': set([u'Valerion Therapeutics LLC', u'REGENXBIO Inc', u'Sanofi Genzyme', u'Genethon', u'National Institute of Arthritis and Musculoskeletal and Skin Diseases', u'Amicus Therapeutics Inc', u'Duke University Medical Center', u'University of Florida', u'Synpac Pharmaceuticals Ltd', u'National Institutes of Health', u'Neose Technologies Inc', u'EpiVax Inc', u'Audentes Therapeutics Inc', u'Duke University', u'Genzyme General', u'Health Resources and Services Administration', u'The Association of Public Health Laboratories', u'Food and Drug Administration', u'Pharming Group NV', u'Selecta Biosciences Inc', u'Muscular Dystrophy Association']), u'HIVinfection': set([u'Massachusetts Institute of Technology', u'Rostec State Corporation', u'Advanced BioScience Laboratories Inc', u'Celldex Therapeutics Inc (pre-merger)', u'Osel Inc', u'The Chinese Centre for Disease Control and Prevention', u'European Commission', u'Ceragenix Pharmaceuticals Inc', u'Tokai University', u'Mylan Laboratories Ltd', u'Paligent Inc', u'Inovio Pharmaceuticals Inc', u'Yamasa Shoyu Co Ltd', u'Stiefel Laboratories (UK) Ltd', u'Cure Medical Manufacturing', u'Questcor Pharmaceuticals Inc', u'bioLytical Laboratories Inc', u'EpiVax Inc', u'Ionis Pharmaceuticals Inc', u'Immuron Ltd', u'Inner Mongolia Lantai Industrial Co Ltd', u'European Community', u'Pharmaceutical Product Development LLC', u'Drexel University College of Medicine', u'University of Pittsburgh', u'Ribi ImmunoChem Research Inc', u'Celldex Therapeutics Inc', u'Colthurst Ltd', u'United States Agency for International Development', u'Hannover Medical School', u'University of Rochester', u'Transdermal Sciences PLC', u'Chinese Academy of Medical Sciences & Peking Union Medical College', u'Sirenas Marine Discovery LLC', u'OSE Immunotherapeutics', u'Mycosearch Inc', u'Galapagos NV', u'DSM Pharmaceuticals Inc', u'Cellectis SA', u'Aviragen Therapeutics Inc', u'Silence Therapeutics plc', u'Visible Genetics Inc', u'Population Council', u'Ergomed PLC', u'Atomo Diagnostics Pty Ltd', u'Formatech Inc', u'Cengent Therapeutics Inc', u'NeuroSearch A/S', u'Agence nationale de la recherche (ANR)', u'Replikun Biotech Pty Ltd', u'Zhejiang Huahai Pharmaceutical Group Co Ltd', u'National Research Council of Canada', u'Hollister-Stier Laboratories LLC', u'Omnia Biologics Inc', u'Academic Medical Center, University of Amsterdam', u'The Collaboration for AIDS Vaccine Discovery', u'National Health and Medical Research Council', u'New York University', u'PDL BioPharma Inc', u'Centre National de la Recherche Scientifique (CNRS)', u'ChemRar Pharma', u'CEL-SCI Corp', u'University of California San Francisco', u'Monash University', u'Beximco Pharmaceuticals Ltd', u'Cambridge Antibody Technology Group plc', u'Rega Institute for Medical Research', u'TaiMed Biologics Inc', u'Mochida Pharmaceutical Co Ltd', u'Drogsan Ilaclari San. ve Tic. A.S.', u'ToolGen Inc', u'Tulane University', u'Reef Pharmaceuticals Pty Ltd', u'Immune Disease Institute Inc', u'Teva Pharmaceutical Industries Ltd', u'Calimmune Inc', u'Japan Energy Corp', u'Geneart AG', u'Wayne State University', u'Cochin Institute', u'Genetic Therapy Inc', u'Center for Infectious Disease Research', u'Shanghai Target Drug Co Ltd', u'EPIcyte Pharmaceutical Inc', u'KRS Global Biotechnology Inc', u'Korea Research Institute of Chemical Technology', u'Boston University School of Medicine', u'Trimeris Inc', u'Asembia', u'University of Alabama', u'Ajinomoto Althea Inc', u'Brigham Young University', u'Beijing Cuzkon Co Ltd', u'Juvaris BioTherapeutics Inc', u\"Ministry of Health of the People's Republic of China\", u'Pharmacopeia Inc', u'Progenics Pharmaceuticals Inc', u'Creative Antibiotics Sweden AB', u'Cypralis Ltd', u'Wellcome Trust', u'Cytokine PharmaSciences Inc', u'Starpharma Holdings Ltd', u'Tri-Institutional Therapeutics Discovery Institute Inc', u'Genius Biotherapeutics', u'MegaPharm Ltd', u'Amplyx Pharmaceuticals Inc', u'Takeda Oncology', u'Biofrontera Discovery GmbH', u'Botswana-Harvard Partnership', u'Altor BioScience Corp', u'Consensus Pharmaceuticals Inc', u'University of Lausanne', u'Specialty Laboratories Inc', u'Arisyn Therapeutics Inc', u'The Vaccine and Gene Therapy Institute of Florida', u'Biomolecular Research Institute Ltd', u'Oslo University Hospital', u'Aventis Pharmaceuticals Inc', u'Rutgers University', u'Roche Diagnostics', u'Just Biotherapeutics', u'ContraVir Pharmaceuticals Inc', u'Pressure BioSciences Inc', u'ThyoGen Pharmaceuticals Inc', u'American Gene Technologies International Inc', u'Rheonix Inc', u'Immugen Pharmaceuticals Inc', u'Genomic Vision', u'Trana Discovery Inc', u'Thyovir Pharmaceuticals Inc', u'Medicines Development Ltd', u'Dutch Technology Foundation', u'Picower Institute for Medical Research', u'Myrexis Inc', u'irsiCaixa Foundation', u'pSivida Corp', u'Cannabis Science Inc', u'Omniviral Therapeutics LLC', u'Pregenen', u'Bioproperties Pty Ltd', u'Onconova Therapeutics Inc', u'Finnish Funding Agency for Technology and Innovation', u'National Institute of Infectious Diseases Japan', u'Advanced Viral Research Corp', u'Oregon Health Sciences University', u'Avid Bioservices', u'Pfizer Inc', u'Nanotherapeutics Inc', u'University of Iowa', u'Vion Pharmaceuticals Inc', u'Therion Biologics Corp', u'Centers for Disease Control and Prevention', u'GlaxoSmithKline Biologicals', u'Supratek Pharma Inc', u'ID Pharma Co Ltd', u'Sarawak State Government', u'University of Wisconsin-Madison', u'OriGenix Technologies Inc', u'Waisman Clinical Biomanufacturing Facility', u'Weizmann Institute of Science', u'OyaGen Inc', u'Istituto Superiore di Sanita', u'George Washington University', u'Shanghai Institute of Organic Chemistry', u'TheraGuide Inc', u'Uniroyal Chemical Co Inc', u'University of California Los Angeles', u'MedImmune LLC', u'Nissin Foods Holdings Co Ltd', u'Aspen South Africa', u'Fournier Pharma', u'NeED Pharmaceuticals Srl', u'Daktari Diagnostics Inc', u'Aarhus University Hospital', u'CytRx Corp', u'Kinesis Pharma', u'Novartis Vaccines & Diagnostics', u'Anza Therapeutics Inc', u'Advanced Plant Pharmaceuticals Inc', u'Genexine Co Ltd', u'ValiGen Inc', u'Hopital Saint-Louis', u'Presidio Pharmaceuticals Inc', u'Harbor Therapeutics Inc', u'Johnson & Johnson', u'Sigma-Aldrich Corp', u'Stehlin Foundation For Cancer Research', u'AbbVie Inc', u'Janssen Vaccines & Prevention BV', u'GeoVax Labs Inc', u'University of Washington', u'Immtech Pharmaceuticals Inc', u'Center For Special Immunology', u'SmithKline Beecham plc', u'Bavarian Nordic A/S', u'Institut Gustave Roussy', u'Program for Appropriate Technology in Health', u'Pharmaplaz Ltd', u'US Army Medical Research Acquisition Activity', u'Mercian Corp', u'Fresenius SE & Co KGaA', u'US Army Office of the Surgeon General', u'Deutsches Rote Kreuze', u'Bristol-Myers Squibb Co', u'National Institute of Cholera and Enteric Diseases', u'OSEO', u'Opus Bio Inc', u'NeXstar Pharmaceuticals Inc', u'St Vincents Hospital (Melbourne) Ltd', u'Evotec (UK) Ltd', u'THERAVECTYS', u'Rush University Medical Center', u'Newsummit Biopharma Co Ltd', u'Chinese Academy of Sciences', u'Peptimmune Inc', u'Seoul National University', u'Sumagen Co Ltd', u'Isconova AB', u'VINNOVA', u'Astellas Pharma Inc', u'BioDelivery Sciences International Inc', u'Vaxxit SRL', u'Mitsubishi Chemical Holdings Corp', u'Rougier Pharma Afrique SA', u'Institute of Cancer Research UK', u'Trinity Medical Group Co Ltd', u'V.I. PHARMA INTERNATIONAL SA', u'ViiV Healthcare Ltd', u'Elan Drug Technologies', u'The Macfarlane Burnet Institute For Medical Research & Public Health Ltd', u'Metaphore Pharmaceuticals Inc', u'VIA Pharmaceuticals Inc', u'Agouron Pharmaceuticals Inc', u'ChronTech Pharma AB', u'Virion Systems Inc', u'Immuno-Designed Molecules SA', u'SS Pharmaceutical Co Ltd', u'National Disease Research Interchange', u'Benitec Biopharma Ltd', u'Hoechst Marion Roussel Inc', u'Blood Systems Research Institute (BSRI)', u'Genoa Biotecnologia SA', u'NanoPass Technologies Ltd', u'Scotgen Biopharmaceuticals Inc', u'Sareum Holdings plc', u'University of Michigan', u'PPD Discovery Inc', u'Immunology Clinic of New York', u'Crimson Pharmaceutical (Hong Kong) Ltd', u'J David Gladstone Institutes', u'Biomira USA Inc', u\"PX'Therapeutics SA\", u\"King's College London\", u'Grupo International Inc', u'Karolinska Institutet', u'St Stephens Aids Trust', u\"St Jude Children's Research Hospital\", u'XL-Protein GmbH', u'Yunnan Institute of Materia Medica', u'Northstar Pharmaceuticals Inc', u'Peptisyntha Inc', u'Dynavax Technologies Corp', u'VIRxSYS Corp', u'Ardea Biosciences Inc', u'Virionics Corp', u'Gryphon Therapeutics Inc', u'Pharmacyclics Inc', u'University of North Carolina', u'Howard Hughes Medical Institute', u'BTG plc', u'Population Genetics Technologies Ltd', u'Ambrilia Biopharma Inc', u'NanoBio Corp', u'Chiron Corp', u'Umea University', u'Texas A&M University System', u'Institute of Human Virology', u'University Of Southampton', u'Virco BVBA', u'Ascletis Inc', u'Selexis SA', u'US Department of Veterans Affairs', u'Global Vaccines Inc', u'Novira Therapeutics Inc', u'Astex Pharmaceuticals Inc', u'Ampac Fine Chemicals Llc', u'Sangamo Therapeutics Inc', u'University of Montpellier', u'Amira Inc', u'Bioption AB', u'Shionogi & Co Ltd', u'Ono Pharmaceutical Co Ltd', u'PJSC Pharmsynthez', u'Triangle Pharmaceuticals Inc', u'Contraceptive Research and Development Organization', u'Beijing Mefuvir Medicinal Technology Co Ltd', u'Immunocore Ltd', u'Genzyme Molecular Oncology', u'University of British Columbia', u'South China Center for Innovative Pharmaceuticals', u'Mitsubishi Pharma Corp', u'The National Institute of Mental Health', u'Jinan University (Guangdong)', u'Temple University', u'Trianni Inc', u'Atreca Inc', u'Innovata plc', u'Nerium Biotechnology Inc', u'Statens Serum Institut', u'Dana-Farber Cancer Institute Inc', u'AltraVax Inc', u'University of Massachusetts Medical School', u'National Institute of General Medical Sciences', u'Yeshiva University', u'Evotec AG', u'The European Union', u'Charles River Laboratories International Inc', u'Impel NeuroPharma', u'Wellcome Trust - Burroughs Wellcome Fund', u'Cell Pharm GmbH', u'Amgen Inc', u'Behringwerke AG', u'Chinese Academy of Medical Sciences', u'Queens University of Belfast', u'Pasteur Merieux', u'Endo Pharmaceuticals Solutions Inc', u'Numerate Inc', u'Geron Corp', u'Laboratoire Laphal', u'Weill Medical College of Cornell University', u'Chemical Diversity Research Institute Ltd', u'National Institute for Medical Research, Tanzania', u'The University of Birmingham', u'Takeda Cambridge Ltd', u'Assistance Publique Hopitaux de Paris', u'Johns Hopkins University School of Medicine', u'Eunice Kennedy Shriver National Institute of Child Health & Human Development', u'Ciba US', u'Oklahoma Medical Research Foundation', u'Georgetown University', u'AlgoNomics NV', u'Georgia Research Alliance', u'Siemens Healthcare Diagnostics GmbH', u'University of Alabama at Birmingham', u'Interdisciplinary Center of Biomolecular Studies and Industrial Applications', u'Sanofi-Synthelabo', u'Dartmouth Medical School', u'Massachusetts General Hospital', u'Abgenix Inc', u'Transgene SA', u'Pevion Biotech Ltd', u'NanoViricides Inc', u'Peregrine Pharmaceuticals Inc', u'Mymetics Corp', u'Immunomedics Inc', u'Gene Shears Pty Ltd', u'General Medical Industries', u'Medmira Inc', u'Loyola University of Chicago', u'International Partnership for Microbicides', u'Dong-A ST Co Ltd', u'Echo Therapeutics Inc', u'InnaVirVax', u'Whitehead Institute for Biomedical Research', u'Actinobac Biomed Inc', u'The Research Council of Norway', u'Osaka University', u'Yuhan Corp', u'Xencor Inc', u'University of California San Diego', u'DuPont Pharmaceuticals Ltd', u'Medivir AB', u'Ranbaxy Laboratories Ltd', u'F Hoffmann-La Roche AG', u'University of Oxford', u'Prescient Therapeutics Ltd', u'Glaxo Wellcome (formerly The Wellcome Foundation)', u'Rockefeller University', u'ChemBridge Research Laboratories LLC', u'Strides Shasun Ltd', u'Tularik Inc', u'Genentech Inc', u'MaxCyte Inc', u'National Natural Science Foundation of China', u'BioAdvance', u'Biosearch Italia SpA', u'Aaron Diamond AIDS Research Center', u'Mayo Clinic Foundation', u'DelSite Biotechnologies Inc', u'Eurocine Vaccines AB', u'Baylor Research Institute', u'Dainabot KK', u'Yisheng Biopharma Co Ltd', u'Laureate Biopharmaceutical Services Inc', u'Axxima Pharmaceuticals AG', u'NascaCell GmbH', u'RFS Pharma LLC', u'Xenetic Biosciences Inc', u'Sunesis Pharmaceuticals Inc', u'Vivalis', u'Sumitomo Dainippon Pharma Co Ltd', u'Scripps Research Institute', u'Australian Research Council', u'Spring Bank Pharmaceuticals Inc', u'Juniper Pharmaceuticals Inc', u'Theratechnologies Inc', u'Bioclonetics Inc', u'University of Southern California', u'HIV Resistance Response Database Initiative', u'Monogram Biosciences Inc', u'Tranzyme Pharma Inc', u'Japan Tobacco Inc', u'CoNCERT Pharmaceuticals Inc', u'Vichem Chemie Ltd', u'Fuzians Biomedicals Inc', u'LION bioscience Inc', u'United Therapeutics Corp', u'Florida International University', u'IGXBio Inc', u'R-Pharm', u'AccuGenomics Inc', u'Genecure LLC', u'IVAX Corp', u'Fenway Community Health', u'INCELL Corp', u'Microbicide Trials Network', u'Pharmatek Laboratories Inc', u'Frontier Biotechnologies Co Ltd', u'Zydus Cadila Healthcare Ltd', u'Cook County Health & Hospitals System (CCHHS)', u'Janssen Diagnostics BVBA', u'ViroStatics', u'Hayashibara Co Ltd', u'Mutabilis SA', u'Genta Inc', u'Beijing Pason Pharmaceuticals Inc', u'Invenux Inc', u'Carrington Laboratories Inc', u'Sandoz AG', u'The Institute of Radiation Medicine Academy of Military Medical Sciences PLA', u'Shelys Pharmaceuticals Ltd', u'Introgen Therapeutics Inc', u'Fujimoto Diagnostics Inc', u'Australian Government', u'Hemispherx Biopharma Inc', u'Samjin Pharmaceutical Co Ltd', u'Covalent Immunology Products Inc', u'Genmab A/S', u'Profectus BioSciences Inc', u'Bioject Medical Technologies Inc', u'Hubei Qianjiang Pharmaceutical Co Ltd', u'NYU Langone Medical Center', u'Marc Pharmaceuticals Inc', u'Dainippon Pharmaceutical Co Ltd', u'Ligand Pharmaceuticals Inc', u'BioVex Inc', u'Haikou VTI Biological Institute', u'Critical Outcome Technologies Inc', u'Guangdong Medicine Group Corp', u'Allegro Biologics Inc', u'Epitogenesis Inc', u'SKAU Vaccines ApS', u'Janssen Sciences Ireland Uc', u'Novavax Inc', u'National Institute of Dental and Craniofacial Research', u'deCODE chemistry', u'Opal Therapeutics Inc', u'Roemmers Laboratory', u'Kirin Pharma Co Ltd', u'ICOS Corp', u'Novartis Diagnostics', u'Immunovaccine Inc', u'Florida Atlantic University', u'Howard University', u'Incyte Corp', u'Bristol-Myers Squibb Pharma Co', u'Valeant Pharmaceuticals International Inc', u'Virginia Polytechnic Institute and State University', u'Amerimmune Pharmaceuticals Inc', u'National Vaccine and Serum Institute', u'Preventis Inc', u'Objectif Recherche VACcin Sida', u'St James Associates Llc/Faber Research Series', u'Pfizer Vaccines', u'George Mason University', u'Cue Inc', u'University of Western Ontario', u'diaDexus Inc', u'Walter and Eliza Hall Institute of Medical Research', u'Avigen Inc', u'Timeway International Ltd', u'Dyax Corp', u'Biotechnology Research Corp Ltd', u'Locus Pharmaceuticals Inc', u'Dartmouth College', u'University of Cambridge', u'Georgia Institute of Technology', u'ID Vaccine Corp', u'Etubics Corp', u'Medical University of South Carolina', u'MolMed SpA', u'University of Florida', u'Apollon Inc', u'Cerus Corp', u'Vaccibody AS', u'Ogeda SA', u'SRD Pharmaceuticals Inc', u'Cardinal Health Inc', u'Koken Co Ltd', u'Mologen Ag', u'Sanofi Pasteur', u'Schering-Plough Research Institute', u'Hetero Drugs Ltd', u'US Government', u'Onxeo SA', u'Maxygen Inc', u'Global Clean Energy Holdings Inc', u'Indian Council of Medical Research', u'ImmuCell Corp', u'World Health Organization', u'FIT Biotech Oyj Plc', u'Vical Inc', u'CombiMatrix Corp', u'The Ragon Institute', u'MV Lomonosov Moscow State University', u'Immusoft Corp', u'Uppsala University', u'RW Johnson Pharmaceutical Research Institute', u'Welsh School of Pharmacy', u'Universite Pierre et Marie Curie', u'Kyoto Pharmaceutical University', u'Ark Diagnostics', u'Shaanxi Dacheng International Trade Co Ltd', u'Isla Lab Products LLC', u'Samaritan Pharmaceuticals Inc', u'OSI Pharmaceuticals Inc', u'Tianjin Institute of Pharmaceutical Research', u'Fred Hutchinson Cancer Research Center', u'Hughes Institute', u'CureVac GmbH', u'Shanghai Desano Pharmaceuticals Co Ltd', u'Kunming Institute of Zoology The Chinese Academy of Sciences', u'Hybrigenics SA', u'Hospital Clinic of Barcelona', u'Alfred Health', u'PlantForm Corp', u'ARIAD Pharmaceuticals Inc', u'University of Kansas Medical Center', u'PCAS Group', u'Emcure Pharmaceuticals Ltd', u'Auritec Pharmaceuticals Inc', u'Biovector Therapeutics SA', u'Covalent Bioscience Inc', u'Immune Network Ltd', u'HealthCare Asia Pharmaceuticals Inc', u'Aquila Biopharmaceuticals Inc', u'Astellas Pharma Europe BV', u'Enzo Biochem Inc', u'Navigen Inc', u'Creighton University', u'ModeRNA Therapeutics', u'ReiThera Srl', u'National Center for Research Resources', u'Chimerix Inc', u'CTS Chemical Industries', u'ImQuest Life Sciences Inc', u'Harvard TH Chan School of Public Health', u'Signal Research Division', u'Gen-Probe Inc', u'Discovery Genomics Inc', u'University of Nebraska Medical Center', u'Complete Pharmacy and Medical Solutions', u'Phoenix Biosciences Inc', u'University of Otago', u'Network Immunology Inc', u'Swedish Institute for Infectious Disease Control', u'GenPhar Inc', u'Adaptive Biotechnologies Corp', u'SCYNEXIS Inc', u'National AIDS Control Organization', u'Global Solutions for Infectious Diseases', u'Affitech A/S', u'International AIDS Vaccine Initiative', u'Harvard University', u'Mast Therapeutics Inc', u'Solexa Inc', u'Bio Jinopia', u'Boehringer Mannheim GmbH', u'CytoDyn Inc', u'GTx Inc', u'Repligen Corp', u'Polydex Pharmaceuticals Ltd', u'Sirna Therapeutics Inc', u'Aphios Corp', u'Amarillo Biosciences Inc', u'MNLpharma Ltd', u'UNC Center for AIDS Research Clinical Pharmacology and Analytical Chemistry Core', u'RNL Bio Co Ltd', u'Janssen Therapeutics', u'CytoCore Inc', u'Catholic University of Leuven', u'Kwang Dong Pharmaceutical Co Ltd', u'Diosynth BV', u'GlobeImmune Inc', u'VIRO Pharmaceuticals GmbH & Co KG', u'Universite Libre de Bruxelles', u'Affymetrix Inc', u'WuXi PharmaTech (Cayman) Inc', u'Novartis Vaccines and Diagnostics Ltd', u'Dendreon Corp', u'The Foundation for AIDS Research', u'Association AZT', u'Achillion Pharmaceuticals Inc', u'Carrus Capital Corp', u'Case Western Reserve University', u'bioMONTR Labs', u'Skolkovo', u'Glaxo Group Ltd', u'Immpheron Inc', u'Fujirebio Europe NV', u'Opiant Pharmaceuticals Inc', u'University of Cincinnati', u'Laboratorios Ramos', u'Boehringer Ingelheim Corp', u'Tobira Therapeutics Inc', u'Taiga Biotechnologies Inc', u'BioInvent International AB', u'TNI Pharmaceuticals Inc', u'University of Ghent', u'University of Sydney', u'Debiopharm SA', u'Virogenics Inc', u'Roche Holding AG', u'Medicines Patent Pool', u'Duke University Medical Center', u'Oncovir Inc', u'Wyeth Pharmaceuticals', u'Immunotech Laboratories Inc', u'Aspen PharmaCare Holdings Ltd', u'Omaera Pharmaceuticals', u'Advanced Life Sciences Holdings Inc', u'Harvard Medical School', u'Sunovion Pharmaceuticals Inc', u'Biogen Inc (FL)', u'National Institute of Diabetes, Digestive and Kidney Diseases', u'Cipla Ltd', u'US Department of Defense', u'University of Texas at El Paso', u'Schering-Plough Corp', u'Gilead Pharmasset LLC', u'Texas Biomedical Research Institute', u'Guangdong Lantai Viewland Pharmaceutical', u'Case Western Reserve University School of Medicine', u'Panacos Pharmaceuticals Inc', u'Zeon Corp', u'CMC Biologics Inc', u'Pharmix Corp', u'Zynaxis Inc', u'Argos Therapeutics Inc', u'University of California', u'Merck & Co Inc', u'Abivax', u'ResApp Health Ltd', u'Sanofi', u'The Salk Institute for Biological Studies', u'Vertex Pharmaceuticals Inc', u'Okamoto Industries', u'Erimos Pharmaceutical LLC', u'University of Oslo', u'Bayer AG', u'Bio-Bridge Science Inc', u'UK Government', u'University of York', u'Norbrook Laboratories Ltd', u'Pharmacia & Upjohn AB', u'AriaVax Inc', u'The Catholic University of America', u'Thymon LLC', u'University of Geneva', u'InNexus Biotechnology Inc', u'BBB Therapeutics BV', u'Merck Research Laboratories', u'Virology Networks', u'Biological Mimetics Inc', u'National Centre in HIV Epidemiology and Clinical Research', u'Canadian Department of National Defence', u'AIDS Research Alliance', u'SRI International', u'Universite Denis Diderot', u'Viriom Inc', u'Tamir Biotechnology Inc', u'ArQule Inc', u'Gilead Sciences Inc', u'Fox Chase Chemical Diversity Center Inc', u'The Microbicides Development Programme', u'Australian government Department of Innovation, Industry, Science and Research', u'Ministry Of Industry & Trade Of The Russian Federation', u'Kineta Inc', u'Novita Healthcare Ltd', u'University of Georgia', u'Aix-Marseille Universit\\xe9', u'Acambis plc', u'Orizon International Inc', u'Pecan Biotherapeutics Inc', u'Bachem Holding AG', u'Ichor Medical Systems Inc', u'AnorMED Inc', u'Antigen Express Inc', u'Solon Eiendom ASA', u'Cancer Vaccine Acceleration Fund', u'University of Cape Town', u'University of Missouri', u'University of Pennsylvania', u'Kureha Corp', u'Functional Genetics Inc', u'University of Utah', u\"President's Emergency Plan for AIDS Relief (PEPFAR)\", u'Neovacs SA', u'Welfide Corp', u'HIV Vaccine Trials Network', u'UK HIV Vaccine Consortium', u'The Australian National University', u'Acromax Dominicana', u'Lupin Inc', u'Bioagency AG', u'Virogen Ltd', u'Theraclone Sciences Inc', u'Chinese Government', u'City of Hope', u'Qura Therapeutics', u'INSERM', u'Biosyn Inc', u'Paragon Bioservices Inc', u'CJ Corp', u'NPS Allelix Corp', u'Celgene Corp', u'Staidson (Beijing) Biopharmaceutical Co Ltd', u'Array BioPharma Inc', u'Baruch S Blumberg Institute', u'IDT Australia Ltd', u'Ciba-Geigy AG', u'T.J. Martell Foundation', u'KS Biomedix Holdings plc', u'Swedish International Development Agency', u'Genelabs Technologies Inc', u'University of New South Wales', u'Duke University', u'Avanir Pharmaceuticals Inc', u'University Hospitals Case Medical Center', u'Chembio Diagnostic Systems Inc', u'Adaptimmune Therapeutics plc', u'ProLynx LLC', u'Istituto Scientifico H San Raffaele', u'Janssen Pharmaceuticals Inc', u'Cyto Pulse Sciences Inc', u'MacroGenics Inc', u'Crucell NV', u'University of Regensburg', u'Regal Pharmaceuticals', u'University of Zurich Institute of Medical Virology Unit', u'Leidos Biomedical Research Inc', u'Symbion Discovery Inc', u'American Red Cross', u'Beth Israel Deaconess Medical Center', u'Rhone-Poulenc Rorer Inc', u'Mintaka Medical Research Foundation', u\"Children's Hospital Inc\", u'St Georges University of London', u\"Dr Reddy's Laboratories Ltd\", u'University of Medicine and Dentistry of New Jersey', u'University of Nebraska', u'iCo Therapeutics Inc', u'University of Zurich', u'InvivoGen Therapeutics', u'China State Institute of Pharmaceutical Industry', u'GenVec Inc', u'European HIV Vaccine Alliance', u'California Institute of Regenerative Medicine', u'Biogen Inc', u'Oncolys BioPharma Inc', u'Breckenridge Pharmaceutical Inc', u'GlaxoSmithKline plc', u'Cell Genesys Inc', u'Bayer Schering Pharma AG', u'Abzyme Research Foundation', u'Interferon Sciences Inc', u'Cytheris SA', u'Immunex Corp', u'Laurus Labs Pvt Ltd', u'Shenzhen SiBiono Gene Technologies Co Ltd', u'BIOQUAL Inc', u'URRMA Biopharma Inc', u'Medical Research Council', u'Immunotope Inc', u'VGX Pharmaceuticals LLC', u'University of Texas Health Science Center Houston', u'Ministry of Economic Affairs, ROC', u'Aduro BioTech Inc', u'AbNovo Inc', u'Kendle International Inc', u'Cold Spring Harbor Laboratory', u'Protein Sciences Corp', u'Synthetic Biologics Inc', u'CCS Healthcare AB', u'Aurobindo Pharma Ltd', u'United Biomedical Inc', u'Suven Life Sciences Ltd', u'American Cyanamid Co', u'Emory University', u'National Heart Lung and Blood Institute', u'GlaxoSmithKline Inc', u'Aeras Global TB Vaccine Foundation', u'Boehringer Ingelheim (Canada) Ltd', u\"Boston Children's Hospital\", u'Alnylam Pharmaceuticals Inc', u'Lyndra Inc', u'RecipharmCobra Biologics', u'Rosetta Genomics Ltd', u'Salus Therapeutics Inc', u'Johnson & Johnson Pharmaceutical Research & Development LLC', u'Institute of Bioorganic Chemistry Polish Academy of Sciences', u'MD Anderson Cancer Center', u'Nexigen GmbH', u'Zhengzhou University', u'Medarex Inc', u'Pharmasset Inc', u'ConjuChem LLC', u'The CBR Institute For Biomedical Research Inc', u'Abbott Laboratories', u'European and Developing Countries Clinical Trials Partnership', u'Eisai Co Ltd', u'Commonwealth Scientific and Industrial Research Organization', u'Drexel University', u'Greffex Inc', u'Tanox Inc', u'VG Life Sciences Inc', u'National Cancer Institute', u'Biomas Inc', u'RetroVirox Inc', u\"Xi'an-Hex Life Sciences Co Ltd\", u'Texas Tech University', u'University of Maryland', u'Changchun High and New Technology Industries (Group) Inc', u'University of Puerto Rico', u'Scripps Florida', u'SciClone Pharmaceuticals Inc', u'Ministry of Health, Thailand', u'GeneOne Life Science Inc', u'University of Minnesota', u'Oxford BioMedica plc', u'Kainos Medicine Inc', u'Cornell University', u'AlphaVax Inc', u'HEC Pharm Co Ltd', u'Universite Paris Sud XI', u'Vaccine Solutions Pty Ltd', u'Infectious Disease Research Institute', u'Aplicare Inc', u'Ohr Pharmaceutical Inc', u'Wyeth', u'Complix NV', u'Immunomic Therapeutics Inc', u'Immune Response BioPharma Inc', u'University of Texas System', u'IPPOX Foundation', u'University of Colorado System', u'La Jolla Institute of Allergy & Immunology', u'McGill University', u'University of Barcelona', u'Intracell Vaccines Ltd', u'DFH Pharma Inc', u'CAPS Holdings Ltd', u'Ocean University of China', u'Johns Hopkins University', u'Czech Academy of Sciences', u'Kumamoto University', u'Royalty Pharma', u'AmpliPhi Biosciences Corp', u'Prosetta Biosciences Inc', u'Walter Reed Army Institute of Research', u'Omega Avtopostavka', u'GCA Therapeutics Ltd', u'University of Maryland Baltimore County', u'Shire BioChem Inc', u'Undisclosed', u'GENESIS Pharma SA', u'Universite Jean Monnet', u'Otsuka Pharmaceutical Co Ltd', u'ZymeTx Inc', u'Primus Pharmaceuticals Inc', u'International Therapeutics Inc', u'Rodos BioTarget GmbH', u'Drugs for Neglected Diseases Initiative', u'Lionex Diagnostics & Therapeutics GmbH', u'Cellectar Biosciences Inc', u'Southern Research Institute', u'Oak Crest Institute of Science', u'Boots Hoechst Celanese', u'French National Agency for Research on AIDS and Viral Hepatitis', u'iTherX Pharmaceuticals Inc', u'Kymab Ltd', u'Queen Mary University of London', u'VANC Pharmaceuticals Inc', u'Institut Pasteur', u'Heidelberg Pharma Holding Ltd', u'National Institute on Drug Abuse', u'ImmuneRegen BioSciences Inc', u'Yunnan University', u'University of Pittsburgh Medical Center', u'Antioxidant Pharmaceuticals Corp', u'University College London', u'The Francis Crick Institute', u'University of Miami', u'National Center for Complementary and Alternative Medicine', u'PharmaMar SA', u'Department for International Development', u'Epimmune Inc', u'Commissariat a l`Energie Atomique', u'Bionor AS', u\"Children's Hospital of Los Angeles\", u'University of Virginia', u'Immune Therapeutics Inc', u'RegeneRx Biopharmaceuticals Inc', u'Kissei Pharmaceutical Co Ltd', u'Cyclacel Pharmaceuticals Inc', u'Korean Ministry of Knowledge Economy', u'Genetics Institute LLC', u'Genaera Corp', u'PaxVax Inc', u'The University of Liverpool', u'Pashua Partners LP', u'Esteve', u'Peregrine Renovations LLC', u'Clinton HIV/AIDS Initiative', u'Human Genome Sciences Inc', u'Kleo Pharmaceuticals Inc', u'Wyeth-Ayerst Pharmaceuticals Inc', u'deCODE genetics ehf', u'Inhibitex Inc', u'Sankyo Co Ltd', u'SEPPIC SA', u'C4X Discovery Holdings plc', u'Wyeth BioPharma', u'BIOO Therapeutics', u'IRX Therapeutics Inc', u'NeoGenesis Pharmaceuticals Inc', u'Valentis Inc', u'Janssen R&D (Ireland)', u'The Green Cross Corp', u'Hetero Group', u'Antitope Ltd', u'PowderMed Ltd', u'Genexel-Sein Inc', u'National Institute of Allergy and Infectious Diseases', u'Quantum Pharmaceuticals LLC', u'Takeda Pharmaceutical Co Ltd', u'Yamanouchi Pharmaceutical Co Ltd', u'National Institute on Minority Health and Health Disparities', u'Viragen Inc', u'Octamer Inc', u'Russian AIDS Federal Centre', u'University of Melbourne', u'Albert Einstein College of Medicine', u'Shionogi-GlaxoSmithKline Pharmaceuticals LLC', u'National Institutes of Health', u'Bill & Melinda Gates Foundation', u'Food and Drug Administration', u'Swiss Government', u'Sarepta Therapeutics Inc', u'Jilin University', u'Wistar Institute of Anatomy & Biology', u'Cardiff University', u'FirstPoint Biotech Inc', u'US Army Medical Research Institute of Infectious Diseases', u'University of Athens', u'Thomas Jefferson University', u'Buckman Laboratories International, Inc', u'Chiron Viagene Inc', u'Kunming Institute of Botany The Chinese Academy of Sciences', u'Stanford University', u'Polymun Scientific Immunobiologische Forschung GmbH', u\"Institut d'Investigacions Biomediques August Pi I Sunyer\", u'Yale University', u'Childrens Hospital of Philadelphia', u'Takara Bio Inc', u'University of California Irvine', u'ProBioGen AG', u'Idera Pharmaceuticals Inc', u'Novartis AG', u'Medical College of Pennsylvania', u'Zenyth Therapeutics Ltd', u'PlantVax Inc', u'Idenix Pharmaceuticals Inc', u'Boryung Pharm Co Ltd', u'Tripos Inc', u'Connaught Laboratories Inc', u'AusAm Biotechnologies Inc']), u'Retinalvenousocclusion': set([u'Fujifilm Diosynth Biotechnologies', u'Regeneron Pharmaceuticals Inc', u'Bayer AG', u'Pfizer Inc', u'Genentech Inc', u'Grifols Inc', u'XOMA Corp', u'Bausch & Lomb Inc', u'Johns Hopkins University']), u'Endotoxicshock': set([u'Atox Bio Inc', u'Hebrew University of Jerusalem', u'Leiden University Medical Center', u'Binational Industrial Research and Development Foundation', u'OncoImmune Inc', u'Baxter International Inc', u'National Institute of Allergy and Infectious Diseases', u'XOMA Corp', u'Fast-Track Drugs and Biologics LLC', u'OMRIX Biopharmaceuticals SA', u'Integrated BioTherapeutics Inc', u'Peptor Ltd']), u'Glomerulardisease': set([u'Sanofi Genzyme', u'Kissei Pharmaceutical Co Ltd', u'Vifor Pharma', u'Cambridge Antibody Technology Group plc']), u'Mycobacteriumaviuminfection': set([u'Oregon Health Sciences University', u'Food and Drug Administration']), u'Vaginitis': set([u'Pear Tree Pharmaceuticals', u'Toltec Pharmaceuticals Llc', u'Kunming Institute of Zoology The Chinese Academy of Sciences', u'PEPTONIC medical AB', u'Yale University', u'Chinese Government', u'Formulation Technologies LLC', u'National Institute of Allergy and Infectious Diseases', u'Pharmarama International Ltd', u'Hygeia Therapeutics Inc']), u'Stomatitis': set([u'Ministry of Science, Education, and Sports', u'University of Zagreb']), u'Hemorrhagicenteritis': set([u'PDL BioPharma Inc', u'Teijin Ltd']), u'Noonansyndrome': set([u'Indiana University', u'University of Wisconsin-Madison']), u'Brutonsdisease': set([u'National Institute of Allergy and Infectious Diseases', u\"Seattle Children's Hospital\"]), u'Toxoplasmainfection': set([u'University of Chicago', u'Jacobus Pharmaceutical Co Inc', u'Bioproperties Pty Ltd', u'IMPAX Laboratories Inc', u'VitamFero SAS', u'Turing Pharmaceuticals LLC', u'Catalytica Inc', u'National Institutes of Health', u'National Institute of Allergy and Infectious Diseases', u'Walter and Eliza Hall Institute of Medical Research', u'Washington University in St Louis', u'Army Malaria Institute', u'OSEO', u'Cellectis SA', u'Snowdon Inc', u'Sanofi', u'Southern Research Institute', u'New Jersey Commission on Science and Technology', u'Australian Research Council']), u'Metastaticstomachcancer': set([u'Celltrion Healthcare Co Ltd', u'CMC Biologics Inc', u'MacroGenics Inc', u'AstraZeneca plc', u'Aduro BioTech Inc', u'Green Cross Corp', u'Samsung Medical Center (SMC)', u'Shandong Chengchuang Pharmaceutical R&D Co Ltd', u'Mylan Inc', u'3SBio Inc', u'Taiho Pharmaceutical Co Ltd', u'Teva Pharmaceutical Industries Ltd', u'Merck & Co Inc', u'Genentech Inc']), u'Onychomycosis': set([u'HairXpertise Ltd', u'Undisclosed', u'Sato Pharmaceutical Co Ltd', u'UK Government', u'Maruho Co Ltd', u'DUSA Pharmaceuticals Inc', u'POLA Pharma Inc', u'Kaken Pharmaceutical Co Ltd', u'Hexima Ltd', u'Michigan Economic Development Corp', u'University of Aberdeen', u'OzHealth Pharma', u'Transport Pharmaceuticals Inc', u'Bayer Schering Pharma AG', u'Elis Pharmaceuticals Ltd', u'National Institutes of Health', u'Moberg Pharma AB', u'Merck & Co Inc', u'MedPharm Ltd', u'Laboratorio EDOL Produtos Farmaceuticos S.A', u'Gebro Pharma GmbH', u'Galderma SA', u'Alterna LLC', u'Colep', u'Dong Wha Pharmaceutical Co Ltd', u'Taro Pharmaceuticals USA Inc', u'Kyorin Pharmaceutical Co Ltd', u'Merz Inc', u'NovaBiotics Ltd', u'Shiseido Co Ltd', u'Dong-A ST Co Ltd', u'Anacor Pharmaceuticals Inc', u'NovaBay Pharmaceuticals Inc', u'NanoBio Corp', u'NB Therapeutics Inc', u'Janssen Pharmaceutica NV', u'Stiefel', u'Novartis AG', u'Kyowa Hakko Kogyo Co Ltd', u'Kyowa Kirin', u'Sandoz Inc', u'PharmaSynth Pty Ltd', u'Apricus Biosciences Inc', u'Biotechnology and Biological Sciences Research Council (BBSRC)', u'AG Farma S.A']), u'Hepatorenalsyndrome': set([u'IS Pharma plc', u'ESP Pharma Inc', u'Orphan Therapeutics LLC', u'Cumberland Pharmaceuticals Inc', u'Vanderbilt University', u'Ikaria Inc']), u'Heartdisease': set([u'Daiichi Seiyaku Co Ltd', u\"Dr Reddy's Laboratories Ltd\", u'US Government', u'StrideBio LLC', u'Karolinska Institutet', u'Venus MedTech (HangZhou) Inc', u'CellCyte Genetics Corp', u'miRagen Therapeutics Inc', u'Wyeth AG', u'Digital Gene Technologies Inc', u'California Institute of Regenerative Medicine', u'Capricor Therapeutics Inc', u'Mount Sinai School of Medicine', u'Lantheus Medical Imaging Inc', u'GlaxoSmithKline plc', u'KineMed Inc', u'Berg Pharma LLC', u'Bayer Schering Pharma AG', u'Mera Pharmaceuticals Inc', u'PPD-SNBL', u'Novartis Pharma AG', u'McNeil Pharmaceuticals Inc', u'Queensland Government', u'MJM Productos Farmaceuticos e de Radioprotecao Ltda', u'PharmaDesign Inc', u'Hmicro Inc', u'MedImmune LLC', u'AliveCor Inc', u'University of Pittsburgh', u'Sangamo Therapeutics Inc', u'Celldex Therapeutics Inc', u'Pharmathen SA', u'Fibrocell Science Inc', u'Akers Biosciences Inc', u'Panasonic Corp', u'Takeda Oncology', u'Hafslund Nycomed Innovation AB', u'Roche Holding AG', u'HYUN IMC', u'Echelon Biosciences Inc', u'NewSouth Innovations', u'University of Wisconsin-Madison', u'Ancile Pharmaceuticals Inc', u'St Petersburg Institute of Experimental Medicine', u'Tensive Controls Inc', u'Tsinghua University', u'Molecular Biosystems Inc', u'AFA Insurance', u'LifeWatch AG', u'Shionogi & Co Ltd', u'Life Line Screening', u'Diacardio Ltd', u'Emory University', u'National Heart Lung and Blood Institute', u'Dalton Cardiovascular Research Center', u'Sanford-Burnham Medical Research Institute', u'Fate Therapeutics Inc', u'Henry Schein Medical', u'Dana-Farber Cancer Institute Inc', u'National Institute on Aging', u'Syncardia Systems Inc', u'ARCA Biopharma Inc', u'Victor Chang Cardiac Research Institute', u'National Research Council of Canada', u'Cell>Point LLC', u'National Center For Advancing Translational Sciences', u'Rosetta Genomics Ltd', u'Warren Pharmaceuticals Inc', u'Philip Morris Products Inc', u'SynthRx Inc', u'National Heart Centre of Singapore', u'4D Molecular Therapeutics LLC', u'MD Anderson Cancer Center', u'Innovation and Technology Commission', u'The Procter & Gamble Co', u'Harvard University', u'Human Longevity Inc', u'Abbott Laboratories', u'Texas Heart Institute', u'Galena Biopharma Inc', u'Geron Corp', u'WuXi NextCODE', u'Wellcome Trust', u'Opus Pharmaceuticals Inc', u'OPKO Health Inc', u'Silvergate Pharmaceuticals Inc', u'Tsumura & Co', u'University of Alabama at Birmingham', u'Hanmi Pharmaceutical Co Ltd', u'University of California San Francisco', u'RIKEN', u'University of Minnesota', u'Rijuven Corp', u'Inflazyme Pharmaceuticals', u'Affymetrix Inc', u'Empire Pharmaceuticals Inc', u'Mallinckrodt Inc', u'Immunomedics Inc', u'Theratechnologies Inc', u'Cleveland Clinic Foundation', u'Samsung Electronics Co Ltd', u'Rotta Research Lab SpA', u'Biotricity Inc', u'Biotoxtech Co Ltd', u'Scripps Research Institute', u'Galenica SA (Greece)', u'Imperial Cancer Research Technology Ltd', u'Novoheart Holdings Ltd', u'Armgo Pharma Inc', u'Hospital for Sick Children', u'Thermo Fisher Scientific Inc', u'Torrent Pharmaceuticals Ltd', u'CytRx Corp', u'Myriad Genetics Inc', u'University of California San Diego', u'National Cheng Kung University', u'National Institute of General Medical Sciences', u'Recordati SpA', u'Cordis Corp', u'Beijing Northland Biotech Co Ltd', u'Growblox Sciences Inc', u'H Lundbeck A/S', u'University of Queensland', u'Chugai Pharmaceutical Co Ltd', u'Armaghan Salamat Kish Group', u'Dreamtech Co Ltd', u'MRC Biotech Pty Ltd', u'Insmed Inc', u'The University of Notre Dame du Lac', u'AnaBios Corp', u'Oxford BioMedica plc', u'Biosig Technologies Inc', u'Rijksuniversiteit te Groningen', u'KUTLO-NITT', u'Avesthagen Ltd', u'MaRS Innovation', u'Neopharma', u'Undisclosed', u'National Institute on Drug Abuse', u'San Diego State University', u'Provid Pharmaceuticals Inc', u'CytoSorbents Corp', u'Minnetronix Inc', u'Edwards Lifesciences Corp', u'Merck & Co Inc', u'rEVO Biologics Inc', u'Mayo Clinic Arizona', u'Central Data Networks Pty Ltd', u'Columbia University', u'Eli Lilly & Co', u'First Check Diagnostics, LLC', u'Bayer AG', u'University of California Davis', u'bluebird bio Inc', u'Robarts Research Institute', u'ComGenex Inc', u'MRI Interventions Inc', u'NSW Government', u'Biovail Corp', u'RegeneRx Biopharmaceuticals Inc', u'Singulex Inc', u'Washington University in St Louis', u'National Institute Of Environmental Health Sciences', u'University of California Los Angeles', u'Centre for Applied Microbiology & Research', u'SRI International', u'Nuvelo Inc', u'Imanova Ltd', u'Pfizer Inc', u'Capricor Inc', u'Fournier Pharma', u'Gene Smart Health', u'Medtronic plc', u'Alberta Health Services', u'Makai Biotechnology LLC', u'University of Texas Southwestern Medical Center', u'ChemRegen Inc', u'Ottawa Health Research Institute', u'Tri-Institutional Therapeutics Discovery Institute Inc', u'Cardurion Pharmaceuticals', u'Biovec LLC', u'Broad Institute Inc', u'Mount Sinai Medical Center', u'PTS Diagnostics', u'Johnson & Johnson', u'LG Life Sciences Ltd', u'University of Michigan', u'Duke University School of Medicine', u'The European Union', u'Stem Cell Theranostics Inc', u'Rubicon Biotechnology Inc', u'University of Washington', u'North Shore Long Island Jewish Health System', u'Zambon Co SpA', u'US Stem Cell Inc', u'NYU Langone Medical Center', u'CRISPR Therapeutics', u'Boston Scientific Corp', u'Knoll Pharmaceuticals Ltd', u'Dainippon Pharmaceutical Co Ltd', u'University of Miami', u'IDT Australia Ltd', u'VistaGen Therapeutics Inc', u'Servier', u'National Institutes of Health', u'Clifton Africa Ltd', u'Endovasc Inc', u'Mallinckrodt Medical Inc', u'Bristol-Myers Squibb Co', u'Napp Pharmaceutical Group Ltd', u'Keystone Heart Ltd', u'CQDM', u'Kyoto University', u'WellSpring Pharma Services', u'University of Calgary', u'Perlegen Sciences Inc', u'Imperial College London', u'iCardiac Technologies Inc', u'CyDex Pharmaceuticals Inc', u'LoneStar Heart Inc', u'Adria Laboratories Inc', u'Medichem SA', u'University of Auckland', u'BlueRock Therapeutics', u'Duke University', u'Hospital de Sant Pau', u'Jubilant Life Sciences Ltd', u'ineedmd.com Inc', u'BioDiem Ltd', u'Centenary Institute Cancer Medicine & Cell Biology', u'Childrens Hospital of Philadelphia', u'Meda AB', u'GE Healthcare', u'Stanford University Medical Center', u'Napo Pharmaceuticals Inc', u'China Resources Double-Crane Pharmaceutical Co Ltd', u'NB Health Laboratory Co Ltd', u'Laboratory Corporation of America Holdings', u'Takeda Pharmaceutical Co Ltd', u'Molecular Targeting Technologies Inc', u'Pluriomics Bv']), u'Gastrointestinalfunctiondisorder': set([u'Takeda Pharmaceuticals International Inc', u'Solvay SA', u'Protein Therapeutics Inc', u'IDIS Ltd', u'Prana Biotechnology Ltd', u'California Institute of Regenerative Medicine', u'Motus Therapeutics Inc', u'Shanghai Pharmaceutical Group Corp', u'CLL Pharma', u'SangStat Medical Corp', u'National Institutes of Health', u'Ipsen', u'Latona Life Sciences Inc', u'Solvay Pharmaceuticals Inc', u'Sanofi Genzyme', u'Research Corporation Technologies', u'Synt:em', u'Shire-Movetis NV', u\"Children's Hospital of Los Angeles\", u'Thornton & Ross Ltd', u'Dong-A ST Co Ltd', u'Procter & Gamble Pharmaceuticals Inc', u'TG Therapeutics Inc', u'Mayo Clinic Foundation', u'Novozymes A/S']), u'Parvovirusinfection': set([u'Meridian Bioscience Inc', u'Meridian Life Science Inc', u'Chiron Corp', u'National Institutes of Health', u'National Heart Lung and Blood Institute', u'Boehringer Ingelheim Vetmedica GmbH', u'Rijksuniversiteit te Leiden', u'Elanco Animal Health', u'MedImmune LLC']), u'Peripheralarterialocclusivedisease': set([u'D Western Therapeutics Institute', u'Daiichi Seiyaku Co Ltd', u'CPC Clinical Research', u'S I Therapies Ltd', u'BioMarin Pharmaceutical Inc', u'Sanofi-Aventis US LLC', u'Kos Pharmaceuticals Inc', u'The New Energy and Industrial Technology Development Organization', u'Amgen Inc', u'Mitsubishi Pharma Corp', u'ViroMed Co Ltd', u'Otsuka Pharmaceutical Co Ltd', u'US Government', u'Boston Scientific Corp', u'Taisho Pharmaceutical Co Ltd', u'Oxford BioMedica plc', u'Ministry of Health, Welfare and Family Affairs', u'Yuhan Corp', u'Merck KGaA', u'Seikagaku Corp', u'National Institutes of Health', u'Asahi Glass Co Ltd', u'Endovasc Inc', u'Proteon Therapeutics Inc', u'Takeda Pharmaceuticals North America Inc', u'Sanofi', u'Fujifilm Diosynth Biotechnologies', u'LTT Bio-Pharma Co Ltd', u'Seoul National University', u'ERCell LLC', u'Par Pharmaceutical Co Inc', u'Roche Holding AG', u'Takeda Pharmaceuticals International GmbH', u'Sunovion Pharmaceuticals Canada Inc', u'Barr Pharmaceuticals Inc', u'PYRAMID Laboratories, Inc', u'QSV Biologics', u'Dong-A ST Co Ltd', u'Nuvelo Inc', u'Vericel Corp', u'ActivBiotics Inc', u'AnGes MG Inc', u'Diffusion Pharmaceuticals LLC', u'Chiron PathoGenesis', u'Bayer HealthCare AG', u'Asubio Pharma Co Ltd', u'Medistem Inc', u'Medicure Inc', u'Validus Pharmaceuticals', u'Aventis Pharmaceuticals Inc', u'deCODE genetics ehf', u'Loyola University Stritch School of Medicine', u'Kaneka Corp']), u'Cardiovascularinjury': set([u'Aziyo Biologics Inc', u'CorMatrix Cardiovascular Inc', u'Ligand Pharmaceuticals Inc']), u'Burkholderiainfection': set([u'diaDexus Inc', u'Oscient Pharmaceuticals Corp', u'Defence Science and Technology Laboratory', u'DxDiscovery Inc', u'Los Alamos National Laboratory (LANL)', u'University of South Alabama', u'Basilea Pharmaceutica International Ltd', u'Microbiotix Inc', u'US Department of Defense', u'ImmuneRegen BioSciences Inc', u'Arizona State University', u'University of Rochester', u'National Institute of Allergy and Infectious Diseases', u'Cangene Corp', u'US Army Medical Research Institute of Infectious Diseases', u'Bavarian Nordic A/S', u'Defense Threat Reduction Agency']), u'Breasttumor': set([u'RESprotect GmbH', u'Innogene Kalbiotech Pte Ltd', u'Quest Diagnostics Inc', u\"Hospital Vall D'Hebron\", u'TMRC Co Ltd', u'Solvay SA', u'Transcept Pharmaceuticals Inc', u'Formation Biologics', u'Center for Translational Molecular Medicine', u'Celldex Therapeutics Inc (pre-merger)', u'Koebenhavns Universitet', u'Hong Kong Polytechnic University', u'European Commission', u'Susan G. Komen Breast Cancer Foundation', u'Advanced Immune Therapeutics Inc', u'PathAI Inc', u'US Health and Human Services Department', u'Champions Oncology Inc', u'Lantheus Medical Imaging Inc', u'Buck Institute', u'BioBlocks Inc', u'Inovio Pharmaceuticals Inc', u'Eddingpharm Inc', u'Texas Emerging Technology Fund', u'Pulsalys Inc', u'Rexahn Pharmaceuticals Inc', u'Tube Pharmaceuticals GmbH', u'MethylGene Inc', u'Ionis Pharmaceuticals Inc', u'Oncomatryx SL', u'Georgetown University Medical Center', u'Choice Pharmaceuticals', u'Health Beacons Inc', u'Global Medical Solutions Taiwan Ltd', u'Snow Brand Milk Products Co Ltd', u'Octamer Inc', u'Hong Kong University of Science & Technology', u'Celldex Therapeutics Inc', u'Ontario Cancer Institute', u'Carna Biosciences Inc', u'Unigen Pharmaceuticals Inc', u'University of California Los Angeles', u'NantHealth Inc', u'Mithra Pharmaceuticals', u'Ambrx Inc', u'DormaTarg Inc', u'Stellar Biotechnologies Inc', u'Analytical Biochemistry Laboratories Inc', u'SG Austria', u'Shire Pharmaceutical Development Ltd', u'Zhejiang Xianju Pharmaceutical Corp Ltd', u'Almirall Prodesfarma SA', u'Chemopreventia LLC', u'Daiichi Sankyo Europe GmbH', u'Handok Inc', u'GP Pharm SA', u'Sarah Cannon Research Institute', u'ONCO Life Sciences', u'TTY Biopharm Co Ltd', u'Sorrento Therapeutics Inc', u'Fluxion Biosciences Inc', u'Tamir Biotechnology Inc', u'American BriVision Corporation', u'The UK Imperial Cancer Research Fund', u'Immune Cell Therapy Inc', u'Anhui Anke Biotechnology (Group) Co Ltd', u'Zhejiang Huahai Pharmaceutical Group Co Ltd', u'National Research Council of Canada', u'NovoLipid Inc', u'Sigma-Tau Ind Farm Riunite SpA', u'CrystalGenomics Inc', u'The Vaccine and Gene Therapy Institute of Florida', u'National Health and Medical Research Council', u'CadheRx Therapeutics Inc', u'Northeast Pharmaceutical Group Co Ltd', u'PDL BioPharma Inc', u'Chem-Master International Inc', u'Deutsche Forschungsgemeinschaft (DFG)', u'The Center of Molecular Immunology', u'CEL-SCI Corp', u'University of California San Francisco', u'Eli Lilly Japan KK', u'California Breast Cancer Research Program', u'Gunma University', u'Cambridge Antibody Technology Group plc', u'The European Union', u'Nippon Kayaku Co Ltd', u'US Army Research Office', u'University Of North Dakota', u'Tulane University', u'Mount Sinai School of Medicine', u'Presage Biosciences', u'University of Pittsburgh', u'Geisel School of Medicine', u'Weill Cornell Medical College, USA', u'IntelliGene Ltd', u'MediGene AG', u'Wayne State University', u'Theragence Inc', u'Jiangsu Hansoh Pharmaceutical Group Co Ltd', u'STC Biologics Inc', u'Sunshine Biopharma Inc', u'Uteron Pharma S.A.', u'Poniard Pharmaceuticals Inc', u'Immutep SA', u'Dutch Cancer Society', u'Life Technologies Corp', u'Stand Up To Cancer', u'Hanmi Pharmaceutical Co Ltd', u'Abcodia Ltd', u'Recombio', u'CytomX Therapeutics Inc', u'Centre For Imaging Technology Commercialization', u'Personalized Cancer Therapy Inc', u'National Jewish Health', u'Indivumed GmbH', u'Mallinckrodt Inc', u'Indian Institute Of Technology Madras', u'Regulon Inc', u'Centro Nacional de Investigaciones Oncologicas', u'ImmunoGen Inc', u'Donesta Bioscience Bv', u'MegaPharm Ltd', u'Genomic Health Inc', u'Novacell Technology Inc', u'Indian Institute of Integrative Medicine, Jammu', u'Janssen Pharmaceutica NV', u'Taiho Pharmaceutical Co Ltd', u'University of Lausanne', u'Inverness Medical Switzerland GmbH', u'Generex Biotechnology Corp', u'MedVax Technologies Inc', u'Theraclion', u'Infinity Pharmaceuticals Inc', u'Matrix-Bio Inc', u'Australian Nuclear Science & Technology Organization', u'Swedish Orphan Biovitrum AB', u'Helix Twelve Pharmaceuticals Inc', u'RPI Finance Trust', u'Acceptys Inc', u'Pharmexa A/S', u'Cancer Council New South Wales', u'Atani KK', u'OncoCyte Corp', u'Almac Group', u'Triton Biosystems Inc', u'Genomic Vision', u'CytImmune Sciences Inc', u'Medimmune Oncology Inc', u'Protherics Salt Lake City Inc', u'Quest PharmaTech Inc', u'Lamnotherapeutics Inc', u'Sichuang University', u'SAFC Pharma', u'Bioproperties Pty Ltd', u'NanoAxis', u'Sentinel Oncology Ltd', u'KunWha Pharmaceutical Co Ltd', u'Oregon Health Sciences University', u'Reliable Biopharmaceutical Corp', u'US Government', u'VaxOnco Inc', u'Avid Bioservices', u'Sakai Chemical Industry Co Ltd', u'Novartis Pharma AG', u'4P Pharma', u'Ewha Womans University', u'LEO Pharma A/S', u'Domainex Ltd', u'Shenogen Pharma Group Ltd', u\"Universita' Degli Studi Di Parma\", u'CTI BioPharma Corp', u'Eli Lilly & Co', u'Celsion Corp', u'GlaxoSmithKline Biologicals', u'Immune Pharmaceuticals Inc', u'US Surgical Corp', u'Agenus Inc', u'Phyton Biotech Inc', u'Louisiana State University', u'University of Ulster', u'AbbVie Inc', u'Weizmann Institute of Science', u'Naprogenix Inc', u'UNC Lineberger Comprehensive Cancer Center', u'Guangdong Jiaying Pharmaceutical Co Ltd', u'Astellas Pharma GmbH', u'Madrigal Pharmaceuticals Inc', u'PDS Biotechnology Corp', u'IBM Watson Health Life Sciences', u'Repros Therapeutics Inc', u'Washington University in St Louis', u'Busto Arsizio Hospital', u'Bracco SpA', u'SynCore Biotechnology Co Ltd', u'OSI Pharmaceuticals Inc', u'NanoString Technologies Inc', u'Synthon BV', u'Algae Dynamics Corp', u'Fournier Pharma', u'State University of New York', u'Therawis Diagnostics GmbH', u'GENova Biotherapeutics Inc', u'Corixa Corp', u'Apthera Inc', u'Cancer Research Technology Ltd', u'FCB-Pharmicell Co Ltd', u'Patrys Ltd', u'Akorn Inc', u'SpePharm AG', u'Caligor Opco Llc', u'Harbor Therapeutics Inc', u'Johnson & Johnson', u'Coley Pharmaceutical Group Inc', u'China Pharmaceutical University', u'Quay Pharmaceuticals Ltd', u'Eleison Pharmaceuticals Inc', u'ASCEND Therapeutics Inc', u'Milenia Labs', u'SEVA Therapeutics', u'Whitehead Institute for Biomedical Research', u'Dalton Pharma Services', u'Peter MacCallum Cancer Centre', u'East of England Development Agency', u'Ontario Cancer Biomarker Network', u'Tiziana Life Sciences PLC', u'Bavarian Nordic A/S', u'SIGA Technologies Inc', u'Institut Gustave Roussy', u'Northeast Ohio Medical University', u'Northwestern University', u'Duke Cancer Institute', u'Cancer Prevention and Research Institute of Texas', u'Actium Research Inc', u'Dr Susan Love Research Foundation', u'Epic Sciences Inc', u'Ajou University Hospital', u'A&G Pharmaceutical Inc', u'EpiThany Inc', u'Bristol-Myers Squibb Co', u'Lynntech Inc', u'Rush University Medical Center', u'US Oncology Inc', u'Paganini Biopharma Inc', u'University of Central Florida', u'Victorian Cancer Agency', u'MDxHealth SA', u'Astellas Pharma Inc', u'Medical Prognosis Institute ApS', u'Chromacon Ag', u'Invivis Pharmaceuticals', u'Vanderbilt-Ingram Cancer Center', u'Institute of Cancer Research UK', u'Antisoma plc', u'Florida Cancer Institute-New Hope', u'United Biotech Corp', u'DepYmed Inc', u'Lonza Group AG', u'The Methodist Hospital Research Institute', u'Hebrew University of Jerusalem', u'University of Oxford', u'Confirma Inc', u'YM BioSciences Inc', u'Benitec Biopharma Ltd', u'European Institute of Oncology', u'Hemispherx Biopharma Inc', u'Oncodesign Biotechnology SA', u'Shandong Luoxin Pharmaceutical Group Stock Co Ltd', u'MabVax Therapeutics Inc', u'Chronix Biomedical', u'Sareum Holdings plc', u'PPD Discovery Inc', u'DRI Capital', u'INRS - Institut Armand-Frappier', u'Crimson Pharmaceutical (Hong Kong) Ltd', u'Munich Biotech AG', u'Locus Pharmaceuticals Inc', u'Singapore Immunology Network', u'Pharmacia & Upjohn Co', u'Karolinska Institutet', u'Weill Medical College of Cornell University', u'Servier', u'TapImmune Inc', u'Cynvenio Biosystems LLC', u'Hospital Universitario Central de Asturias', u'Van Andel Institute', u'Barbara Ann Karmanos Cancer Institute', u'Biocartis', u'Salmedix Inc', u'Fitbit Inc', u'Northwestern University Feinberg School of Medicine', u'Accord Healthcare Inc', u'IDM Pharma Inc', u'The Cancer Council Victoria', u'Orion Corporation', u'PROLOR Biotech Inc', u'Sermonix Pharmaceuticals LLC', u'Pharmacyclics Inc', u'Louisiana State University Medical Center Foundation', u'University of North Carolina', u'Howard Hughes Medical Institute', u'BTG plc', u'Centelion SAS', u'Ambrilia Biopharma Inc', u'Ohio State University Comprehensive Cancer Center', u'Auckland UniServices Ltd', u'Chiron Corp', u'Green Cross Corp', u'Texas A&M University System', u'AlphaMed Inc', u'Reproductive Biotechnologies of India', u'Zhejiang Hisun Pharmaceutical Co Ltd', u'Arizona State University', u'Morphotek Inc', u'Selexis SA', u'MaxCyte Inc', u'QIMR Berghofer Medical Research Institute', u'ArQule Inc', u'IsoTis SA', u'Onyvax Ltd', u'Allysta Pharmaceuticals Inc', u'Gwangju Institute of Science & Technology', u'University of Pennsylvania', u'Navidea Biopharmaceuticals Inc', u'Aventis SA', u'Garvan Institute of Medical Research', u'Biotech Synergy', u'Zenyaku Kogyo Co Ltd', u'Roche Holding AG', u'Immunocore Ltd', u'Genzyme Molecular Oncology', u'University of Texas Health Science Center San Antonio', u'MorphoSys AG', u'Epigen Biosciences Inc', u'Biocompatibles International plc', u'TOLMAR Therapeutics Inc', u'Vaccinex Inc', u'Gradalis Inc', u'Jinan University (Guangdong)', u'Kaplan Medical Center', u'ANI Pharmaceuticals Inc', u'Stony Brook University Hospital', u'Virginia Commonwealth University', u'TESARO Inc', u'Laboratoires Besins International', u'Wilex Inc', u'Biocon Ltd', u'Integrated DNA Technologies Inc', u'Eukarion Inc', u'Agios Pharmaceuticals Inc', u'Mayo Clinic Foundation', u'Statens Serum Institut', u'Dana-Farber Cancer Institute Inc', u'Diplomat Pharmacy Inc', u'University of Pisa', u'Terry Fox Foundation', u'National Institute of General Medical Sciences', u'Amerinet Inc', u'Exelixis Inc', u'Atossa Genetics Inc', u'Fundaci\\xf3n Instituto Valenciano de Oncolog\\xeda', u'Diaxonhit', u'Rubicon Biotechnology Inc', u'University of Florida College of Medicine', u'Amgen Inc', u'Ozgene Pty Ltd', u'Institut Armand-Frappier', u'State University of New York at Stony Brook', u'Affibody AB', u'Geron Corp', u'Baxter Oncology GmbH', u'ImmuneXcite Inc', u'Zentaris GmbH', u'Seyer Pharmatec Inc', u'Galena Biopharma Inc', u'Besins Healthcare SA', u'AbClon Inc', u'MI Bioresearch', u'Arno Therapeutics Inc', u'MGI Pharma Biologics', u'i3 research', u'FUJIFILM RI Pharma Co', u'Ardana Bioscience Ltd', u'ZIOPHARM Oncology Inc', u'RedHill Biopharma Ltd', u'Arog Pharmaceuticals Inc', u'SRI International', u'Georgetown University', u'Robert H. Lurie Comprehensive Cancer Center', u'Evgen Pharma plc', u'Jiangsu Hengrui Medicine Co Ltd', u'DSM Pharmaceutical Products', u'Italfarmaco SpA', u'Imperial College London', u'Zymeworks Inc', u'Massachusetts General Hospital', u'Abgenix Inc', u'Samyang Corp', u'Transgene SA', u'Perceptive Imagineering LLC', u'Pevion Biotech Ltd', u'Enzon Pharmaceuticals Inc', u'Biovation Ltd', u'Boots Hoechst Celanese', u'Accelerate Long Island', u'Immunomedics Inc', u'Janssen Pharmaceutical KK', u'Syapse Inc', u'Pharma Patch plc', u'Robert H Lurie Cancer Center', u'Copharos Inc', u'Dong-A ST Co Ltd', u'University of Tokyo', u'Upstate Medical University', u'Imperial Cancer Research Technology Ltd', u'Allergan Inc', u'Cota Healthcare', u'Pangaea Biotech SA', u'TNK Therapeutics Inc', u'University of Waterloo', u'Chemokine Therapeutics Corp', u'Stegram Pharmaceuticals Ltd', u'University of California San Diego', u'Med Abome Inc', u'Columbia University Health Sciences', u'Radius Health Inc', u'TTFactor srl', u'Fuji Pharma Co Ltd', u'TopoTarget A/S', u'Varian Inc', u'Ohio State University', u'SICOR Inc', u'Cancer Research UK', u'Tartis Inc', u'Genentech Inc', u'Paladin Labs Inc', u'Silence Therapeutics plc', u'Korea Drug Development Fund', u'Natural Sciences and Engineering Research Council of Canada', u'Aegis Therapeutics LLC', u'For-Robin Inc', u'Oxford GlycoSciences plc', u'PDX Pharmaceuticals', u'Baylor Research Institute', u'Vivalis', u'The National Centre for Research and Development', u'Wilex AG', u'Laureate Biopharmaceutical Services Inc', u'LifeArc', u'Actavis Inc', u'Merck KGaA', u'HLL Lifecare Ltd', u'Oncormed Inc', u'Sumitomo Dainippon Pharma Co Ltd', u'Immunophotonics Inc', u'Henry M Jackson Foundation for the Advancement of Military Medicine', u'Redx Pharma Plc', u'Veristat, Inc.', u'Scripps Research Institute', u'Iterative Therapeutics Inc', u'Meda AB', u'University of Southern California', u'University of Texas Southwestern Medical Center', u'Bionovo Inc', u'CASI Pharmaceuticals Inc', u'DiaCarta LLC', u'ScinoPharm Taiwan Ltd', u'Oncobiologics Inc', u'Altiora d.o.o.', u'AdnaGen AG', u'TerSera Therapeutics', u'University of Pretoria', u'Applied Immune Sciences Inc', u'AEterna Zentaris Inc', u'West Virginia University', u'University of Iowa', u'Mologen Ag', u'University of Wisconsin-Madison', u'IVAX Corp', u'Proteome Sciences plc', u'Sydys Corp', u'Zhejiang Medicine Co Ltd', u'AstraZeneca plc', u'Technology Strategy Board', u'Boehringer Ingelheim Pharmaceuticals Inc', u'Danmarks Farmaceutiske Universitet', u'PharmaSwiss SA', u'University of Utah', u'UK Department of Trade & Industry', u'Undisclosed', u'diaDexus LLC', u'Beijing Pason Pharmaceuticals Inc', u'Lonza Biologics plc', u'Celltrion Healthcare Co Ltd', u'Oncotide Pharmaceuticals Inc', u'Harvard University', u'Introgen Therapeutics Inc', u'Australian Government', u'Hollister-Stier Laboratories LLC', u'Therex Technologies Inc', u'bioMerieux SA', u'Carrick Therapeutics UK Ltd', u'Translational Genomics Research Institute', u'Genmab A/S', u'Receptor Logic Inc', u'ASTA Medica AG', u'Yale School of Medicine', u'Shuwen Biotech', u'H Lee Moffitt Cancer Center and Research Institute', u'BioChem Therapeutic Inc', u'Kyowa Kirin', u'Nerviano Medical Sciences Srl', u'Ligand Pharmaceuticals Inc', u'Altea Therapeutics', u'National Cancer Centre of Singapore', u'Avera Medical Group', u'MacroGenics Inc', u'Power3 Medical Products Inc', u'Universitaet Stuttgart', u'Oncolys BioPharma Inc', u'Inner Mongolia Furui Medical Science Co Ltd', u'The Breast Cancer Research Foundation', u'The University Health Network', u'Bioenvision Inc', u'Cedars-Sinai Medical Center', u'Aronex Pharmaceuticals Inc', u'MicroVAX LLC', u'Immunovaccine Inc', u'Henkel KGaA', u'VectorLogics Inc', u'Bristol-Myers Squibb Pharma Co', u'Dong Wha Pharmaceutical Co Ltd', u'Adria Laboratories Inc', u'Medical University of South Carolina', u'Temple University', u'Hospira Adelaide Pty Ltd', u'GVK Biosciences Pvt Ltd', u'Fundacion Marques de Valdecilla', u'Invitae', u'GTx Inc', u'NanoCarrier Co Ltd', u'George Mason University', u'Selecta Biosciences Inc', u'GE Healthcare', u'Jules Bordet Institute', u'Mersana Therapeutics Inc', u'Amaran Biotechnology Inc', u'Walter and Eliza Hall Institute of Medical Research', u'University Hospital Halle', u'Maryland Innovation Initiative', u'PiSA Farmaceutica', u'Dyax Corp', u'3M Co', u'University of Toronto', u'Dartmouth College', u'University of Cambridge', u'Kadmon Pharmaceuticals LLC', u'German Federal Ministry of Education and Research', u'Etubics Corp', u'National Comprehensive Cancer Network', u'C&O Pharmaceutical Technology (Holdings) Ltd', u'Pink Ribbon Foundation', u'Specialised Therapeutics Australia Pty Ltd', u'Tempus Inc', u'Sectra Imtec Ab', u'Cerus Corp', u'MandalMed Inc', u'Advaxis Inc', u'University of Pennsylvania Health System', u'Cardinal Health Inc', u'Binex Co Ltd', u'Cellcor Inc', u'EMD Serono Inc', u'Breakthrough Breast Cancer', u'OncoTherapy Science Inc', u'Lynx Therapeutics GmbH', u'Global Clean Energy Holdings Inc', u'Kowa Co Ltd', u'NeoPharm Inc', u'Quintiles Transnational Corp', u'University of Maryland', u'Intensity Therapeutics Inc', u'Ministry of Health, Welfare and Family Affairs', u'Shenzhen BGI Genomics Techonology Co Ltd', u'Cytogen Corp', u'University of Colorado at Denver and Health Sciences Center', u'NovoMedix Inc', u'Asahi Kasei Pharma Corp', u'MGI Pharma Inc', u'ICON Clinical plc', u'Royal Melbourne Hospital', u'PHD Biosciences', u'MedImmune LLC', u'Exiqon A/S', u'Samaritan Pharmaceuticals Inc', u'AntiCancer Inc', u'University of Washington', u'Fred Hutchinson Cancer Research Center', u'Janssen Biotech Inc', u'Olon SpA', u'PlantForm Corp', u'ARIAD Pharmaceuticals Inc', u'Alvogen Korea', u'LIDDS AB', u\"Queen's University\", u'ARIUS Research Inc', u'Bavarian Research Foundation', u'Kite Pharma Inc', u'Aravive Biologics Inc', u'Ludwig Institute for Cancer Research', u'Aquila Biopharmaceuticals Inc', u'KuDOS Pharmaceuticals Ltd', u'Xenova Group plc', u'Agency For Science Technology & Research', u'Sopherion Therapeutics LLC', u'Sandoz Ltd', u'Optimer Pharmaceuticals Inc', u'National Center for Research Resources', u'Defense Advanced Research Projects Agency', u'Devicor Medical Products Inc', u'Siamab Therapeutics', u'Nuvera Biosciences Inc', u'Microbial Chemistry Research Foundation', u'Kalahari Greentech Inc', u'Klinge Pharma GmbH', u'PTC Therapeutics Inc', u'International Biotechnology Center Generium LLC', u'Xenova Ltd', u'Inex Pharmaceuticals Corp', u'Mundipharma International Corp Ltd', u'Intas Pharmaceuticals Ltd', u'Mylan Inc', u'Senior Scientific LLC', u'Dilon Technologies Inc', u'Affitech A/S', u'Cancer Genetics Inc', u'Eos Biotechnology Inc', u'Mast Therapeutics Inc', u'Mayo Clinic FLORIDA', u'Helix Polska', u'JCR Pharmaceuticals Co Ltd', u'Boehringer Mannheim GmbH', u'The Dow Chemical Co', u'Athenex Inc', u'Clovis Oncology Inc', u'Sirna Therapeutics Inc', u'Sanghyon Chemical Corp', u'University of Heidelberg', u'Acuvax Ltd', u'OPKO Health Inc', u'Teva Pharmaceutical Industries Ltd', u'Diatos SA', u'CytoCore Inc', u'Cougar Biotechnology Inc', u'Bionomics Ltd', u'Kwang Dong Pharmaceutical Co Ltd', u'Purdue Pharma LP', u'BerGenBio AS', u'Lumicell Inc', u'Medexus Inc', u'MultiCell ImmunoTherapeutics Inc', u'WuXi PharmaTech (Cayman) Inc', u'Oxford BioTherapeutics', u'MediBIC', u'University of Louisville', u'Symphony Evolution Inc', u'Evestra Inc', u'Dendreon Corp', u'Threshold Pharmaceuticals Inc', u'Senhwa Biosciences Inc', u'Ferring Pharmaceuticals SA', u'Astrazeneca Korea', u'Indiana University Melvin and Bren Simon Cancer Center', u'Zeneus Pharma Ltd', u'Sayre Therapeutics Private Ltd', u'Genta Inc', u'Millennium Pharmaceuticals Ltd', u'Corcept Therapeutics Inc', u'Xavier University of Louisiana', u'Regen BioPharma Inc', u'Micromet Inc', u'University of Illinois', u'Boehringer Ingelheim Corp', u'Hoffmann-La Roche Inc', u'Asan Medical Center', u'Janssen Korea Ltd', u'Memorial Sloan-Kettering Cancer Center', u'Albany Medical College', u'OncoTab Inc', u'Debiopharm SA', u'Vancouver Coastal Health Research Institute', u'21st Century Therapeutics Inc', u'Fujirebio Diagnostics Inc', u'Stanford Cancer Institute', u'Terpenoid Therapeutics Inc', u'Michigan Translational Research and Commercialization', u'University of Houston', u'Trovis Pharmaceuticals LLC', u'Duke University Medical Center', u'Medivation Inc', u'Virobay Inc', u'Endoceutics Inc', u'Race Oncology Ltd', u'Harvard Medical School', u'University of South Alabama', u'IDIS Ltd', u'bioTheranostics Inc', u'Onco360', u'Universita di Bologna', u'University of Texas at El Paso', u'Schering-Plough Corp', u'Insight Genetics Inc', u'AlphaVax Inc', u'ViaCell Inc', u'Color Genomics', u'CMC Biologics Inc', u'Boehringer Mannheim Corp', u'Baxter Healthcare Corp', u'OncoTartis Inc', u'Skolkovo', u'Alteogen Inc', u'BHR Pharma LLC', u'Cellectar Biosciences Inc', u'Medical College of Wisconsin', u'Cancer Research Campaign (UK)', u'XOMA Corp', u'University of California', u'Merck & Co Inc', u'Gemin X Pharmaceuticals Inc', u'Perlegen Sciences Inc', u'Vancouver General Hospital', u'CFD Therapeutics Inc', u'The Netherlands Organisation for Health Research and Development', u'BioChem Pharma (International ) Inc', u'rEVO Biologics Inc', u'Applied Biosystems Group', u'Vertex Pharmaceuticals Inc', u'Columbia University', u'Quantum Immunologics Inc', u'Tauriga Sciences Inc', u'NewBridge Pharmaceuticals Ltd', u'Ensemble Therapeutics Corp', u'Bayer AG', u'Calibrant Biosystems Inc', u'University of London School of Pharmacy', u'Pharmacia Corp', u'Parkside Scientific Inc', u'BD Diagnostics', u'FUJIFILM Holdings Corp', u'ImmunoBiochem Corporation', u'InNexus Biotechnology Inc', u'BBB Therapeutics BV', u'Cancerfonden', u'AAIPharma Services Corp', u'Kalgene Pharma Inc', u'Case Western Reserve University', u'Princeton University', u'Merus BV', u'Nektar Therapeutics', u'Savetherapeutics AG', u'Canadian Cancer Trials Group', u'Therapure Biopharma Inc', u'University of Oklahoma', u'G1 Therapeutics Inc', u'Astex Pharmaceuticals Inc', u'Oxon Life Science', u'Gilead Sciences Inc', u'GPC Biotech AG', u'Intarcia Therapeutics Inc', u'Saint Savas Cancer Hospital', u'Caladrius Biosciences Inc', u'Merrimack Pharmaceuticals Inc', u'Progenics Pharmaceuticals Inc', u'Biolife Science Qld Ltd', u'Vernalis plc', u'Advanomics Corp', u'Macrogen Inc', u'Genisphere LLC', u'Excel Life Sciences Pvt. Ltd', u'North Central Cancer Treatment Group', u'Pierre Fabre SA', u'Tularik Inc', u'University of Manitoba', u'Syndax Pharmaceuticals Inc', u'Janssen Diagnostics LLC', u'Antigen Express Inc', u'Pangene Corp', u'Imclone LLC', u'US Department of Defense', u'University of Missouri', u'National Institute of Allergy and Infectious Diseases', u'Oncolix Inc', u'Hainan Tianwang International Pharmaceutical', u'myTomorrows', u'University of Kansas', u\"Duksung Women's University\", u'American Brain Tumor Association', u'Novartis Pharma KK', u'Aurigene Discovery Technologies Ltd', u'AviPep Pty Ltd', u'Sophiris Bio Inc', u'CQDM', u'Endomagnetics Ltd', u'AVEO Oncology', u'Oxis Biotech Inc', u'Elan Corp plc', u'City of Hope', u'INSERM', u'Sanofi Genzyme', u'Mitsui Pharmaceuticals Inc', u'MSD Japan', u'Parke-Davis & Co', u'Berkshire Health Systems', u'CJ Corp', u'Cephalon Inc', u'Celgene Corp', u'Array BioPharma Inc', u'Max Delbruck Centrum Fur Molekulare Medizin', u'Sosei Group Corp', u'T.J. Martell Foundation', u'BC Cancer Agency', u'SixOne Solutions LLC', u'University of New South Wales', u'Duke University', u'Saudi Pharmaceutical Industries & Medical Appliances Corp', u'Adaptimmune Therapeutics plc', u'Thomas Jefferson University', u'Alethia Biotherapeutics Inc', u'Sophia Genetics Sa', u'Dako AG', u'Med Discovery SA', u'Adjuvantys Inc', u'Bayer HealthCare Pharmaceuticals Inc', u'OncoGenex Technologies Inc', u'European Organisation for Research and Treatment of Cancer (EORTC)', u'Abraxis BioScience Inc', u'Provectus Biopharmaceuticals Inc', u'Epeius Biotechnologies Corp', u'Rhone-Poulenc Rorer Inc', u'GD Searle & Co', u'OncoGenex Pharmaceuticals Inc', u'University of Western Ontario', u'Louisiana University', u\"Dr Reddy's Laboratories Ltd\", u'University of Medicine and Dentistry of New Jersey', u'University of Nebraska', u'BioMarin Pharmaceutical Inc', u'The Leukemia & Lymphoma Society', u'QUATRx Pharmaceuticals Co', u'Baxter International Inc', u'Humanwell Healthcare (Group) Co Ltd', u'Reveris Therapeutics Llc', u'Cancer Research Campaign Technology Ltd', u'SibTech Inc', u'Esperance Pharmaceuticals Inc', u'Allos Therapeutics Inc', u'China State Institute of Pharmaceutical Industry', u'Pharsight Corp', u'BioNTech AG', u'HTG Molecular Diagnostics Inc', u'Xcell Biosciences Inc', u'TargImmune Therapeutics AG', u'YIACO Medical Co', u'GlaxoSmithKline plc', u'Celltrion Inc', u'Cell Genesys Inc', u'Bayer Schering Pharma AG', u'BayPoint Biosystems', u'Biotoscana International', u'Cascadian Therapeutics Inc', u'Cytheris SA', u'Ipsen', u'Cleveland BioLabs Inc', u'European Eurostars Programme', u'Xynomic Pharmaceuticals', u'Targeted Medical Education', u'Institut Curie', u'Inspyr Therapeutics Inc', u'Keystone Nano Inc', u'University of Michigan', u'Vanderbilt University', u'University of Texas Health Science Center Houston', u'Takeda Oncology', u'Aduro BioTech Inc', u'Almac Diagnostics', u'Halozyme Therapeutics Inc', u'Abbott Healthcare Products BV', u'Leica Biosystems Newcastle', u'Coral Therapeutics, Inc', u'Selvita SA', u'Peregrine Pharmaceuticals Inc', u'Nascent Biotech Inc', u'Netherlands Cancer Institute', u'Adecto Pharmaceuticals Inc', u'Norwell Inc', u'Canadian Institutes of Health Research', u'Woomera Therapeutics Inc', u'Fox Chase Cancer Center', u'3M Pharmaceuticals', u'Shionogi & Co Ltd', u'Stanford Rook Ltd', u'iTherX Pharmaceuticals Inc', u'Emory University', u'National Heart Lung and Blood Institute', u'Boston University', u'Taiwan Liposome Co', u'ChemWerth USA', u'University of Florida', u'Belina Pharma AB', u'iCAD Inc', u'Biogen Inc (FL)', u'Alpha Imaging LLC', u'Sequenom Inc', u'Cell Pathways Inc', u'Select Therapeutics Inc', u'Heracles Pharmaceuticals LLC', u'New Alliance Pharmaceuticals Inc', u'Iovance Biotherapeutics Inc', u'Fujifilm Diosynth Biotechnologies', u'MD Anderson Cancer Center', u'The University of Hong Kong', u'Medarex Inc', u'Wyeth Pharmaceuticals', u'Gamma Medica Inc', u'Clearbridge BioMedics Pte Ltd', u'College Of Nanoscale Science & Engineering', u'Evestra GmbH', u'Daiichi Sankyo Co Ltd', u'Abbott Laboratories', u'HALO Healthcare, Inc', u'Affinity Pharmaceuticals', u'ClearLight Diagnostics', u'3SBio Inc', u'Ganymed Pharmaceuticals AG', u'Sygnature Discovery Ltd', u'Cloud Pharmaceuticals Inc', u'University of Chicago', u'National Cancer Institute', u'Novartis AG', u'Jiangsu Kanion Pharmaceutical Co Ltd', u'Almac Discovery Ltd', u'Marillion Pharmaceuticals Inc', u'Northwestern Memorial Hospital', u'Syngene International Ltd', u'Korea Research Institute of Bioscience and Biotechnology', u'Fujisawa Pharmaceutical Co Ltd', u'Novelion Therapeutics Inc', u'Nova Satra Dx Pte Ltd', u'Ewopharma AG', u'The Inflammatory Breast Cancer Research Foundation', u'Scripps Florida', u'Panorama Research Inc', u'SciClone Pharmaceuticals Inc', u'University of Minnesota', u'Oxford BioMedica plc', u'Institut National Des Sciences Appliquees de Rouen (INSA)', u'ChromaDex Corp', u'Oncoceutics Inc', u'Visionary Pharmaceuticals Inc', u'Galectin Therapeutics Inc', u'University of Manchester', u'Aptose Biosciences Inc', u'University Hospitals Seidman Cancer Center', u'SymBio Pharmaceuticals Ltd', u'Piramal Enterprises Ltd', u'Luye Pharma Group Ltd', u'Radient Pharmaceuticals Corp', u'University of Texas System', u'Kosan Biosciences Inc', u'Imaging Diagnostic Systems Inc', u'Pharmacia & Upjohn Inc', u'University of Colorado System', u'Sunnybrook Health Sciences Centre', u'Midatech Pharma US Inc', u'The Knut and Alice Wallenberg Foundation', u'EnzymeBioSystems', u'Health Care Logistics Inc', u'Johns Hopkins University', u'Onconova Therapeutics Inc', u'Tapestry Pharmaceuticals Inc', u'Myriad Genetics Inc', u'Kyowa Hakko Kogyo Co Ltd', u'LXR Biotechnology Inc', u'JADO Technologies GmbH', u'Breast International Group', u'Shanghai Henlius Biotech Co Ltd', u'Biocept Inc', u'Immunity Royalty Holdings LP', u'AmpliPhi Biosciences Corp', u'OncoMed Pharmaceuticals Inc', u'Chugai Pharmaceutical Co Ltd', u'University of Maryland Baltimore County', u'Ortho Biotech Products LP', u'GENESIS Pharma SA', u'Georgia Regents University Cancer Center', u'Shanghai ChemPartner Co Ltd', u'Torrey Pines Institute for Molecular Studies', u'Amarantus BioScience Holdings Inc', u'Hospital Services Limited', u'National Cancer Center Hospital, Tokyo, Japan', u'US Army Medical Research and Materiel Command', u'Southern Research Institute', u'Amgen Research (Munich) GmbH', u'Johnson & Johnson Pharmaceutical Research & Development LLC', u'Callisto Pharmaceuticals Inc', u'Centre Leon Berard', u'Dako Corp', u'Nuclea Biotechnologies LLC', u'Republic of Korea Government', u'Institut Pasteur', u'University of Alabama at Birmingham', u'ImmunID', u'Royal Philips Electronics', u'McMaster University', u'University College London', u'Ingenex Inc', u'Oxford BioDynamics Ltd', u'Biolite Inc', u'BiPar Sciences Inc', u'University of Miami', u'Eisai Inc', u'PharmaMar SA', u'Epimmune Inc', u'UC San Diego Moores Cancer Center', u'Chugai Biopharmaceuticals Inc', u'New York University School of Medicine, US', u'University of California Irvine', u'Kyowa Hakko Kirin Co Ltd', u'The University of Newcastle Upon Tyne', u'Pharmasyntez', u'Nankai University', u'Puma Biotechnology Inc', u'University of Bradford', u'Arriva Pharmaceuticals Inc', u'BioVectra DCL', u'Pfizer Inc', u'Sanofi', u'Faxitron Bioptics Llc', u'Norwegian Research Council', u'OntoChem GmbH', u'Immundiagnostik AG', u'Yale University', u'Central Drug Research Institute', u'Vion Pharmaceuticals Inc', u'deCODE genetics ehf', u'Sandoz Inc', u'Cadila Pharmaceuticals Ltd', u'GenQuest Inc', u'EPIX Pharmaceuticals Inc', u'Mount Sinai Medical Center', u'Therion Biologics Corp', u'Stason Pharmaceuticals Inc', u'OncoPep Inc', u'Baylor College of Medicine', u'Biocad Ltd', u'Mabion SA', u'University of Kashmir', u'In Ovations Holdings Inc', u'3-D Matrix Ltd', u'Novartis Pharmaceuticals Corp', u'Supratek Pharma Inc', u'MEI Pharma Inc', u'Prima BioMed Ltd', u'Canadian Breast Cancer Research Alliance', u'Miltenyi Biotec GmbH', u'Magnetic Insight Inc', u'Takeda Pharmaceutical Co Ltd', u'Novation', u'Novogen Ltd', u'Viragen Inc', u'Oasmia Pharmaceutical AB', u'Eisai Co Ltd', u'NuView Life Sciences', u'Aarhus University', u'Invivo Corp', u'Latona Therapeutics', u'National Institutes of Health', u'Serono Inc', u'Natco Pharma Ltd', u'Food and Drug Administration', u'Axxiom Inc', u'Sanford-Burnham Medical Research Institute', u'Menarini Asia-Pacific', u'Lightpoint Medical', u'Oncology Venture ApS', u'Cardiff University', u'Quark Pharmaceuticals Inc', u'GNI Group Ltd', u'National Institutes of Standards and Technology', u'Uppsala University', u'Roswell Park Cancer Institute', u'Ortho-Clinical Diagnostics Inc', u'JYANT Technologies Inc', u'Lytix Biopharma AS', u'Endorecherche Inc', u'Stanford University', u'Transgenomic Inc', u'Sidney Kimmel Comprehensive Cancer Center', u'OncoVista Innovative Therapies Inc', u'Taxolog Inc', u'Qiagen NV', u'Quantum Materials Corp', u'Ferozsons Laboratories Ltd', u'University of Guelph', u'OncoMab GmbH', u'Merck Serono SA', u'Torrent Pharmaceuticals Ltd', u'University Of Science & Technology Of China', u'The Menarini Group', u'H2Biologics, Inc', u'Teikoku Pharma USA Inc', u'AVAX Technologies Inc', u'Huntsman Cancer Institute', u'Cancer Therapeutics CRC Pty Ltd', u'Biologics Inc', u'Royalty Pharma', u'HybriGene Inc', u'Cypress Bioscience Inc', u'University of New Mexico', u'Gedeon Richter Ltd', u'Synteract Inc', u'Johns Hopkins University School of Medicine', u'University of Southern Denmark', u'Mayne Pharma Pty Ltd', u'Immunovative Therapies Ltd', u'University of Michigan Comprehensive Cancer Center', u'The Mary Kay Foundation']), u'Edema': set([u'Alcon Inc', u'Sanofi-Aventis US LLC', u'Celtic Pharmaceutical Holdings LP', u'Regeneron Pharmaceuticals Inc', u'Validus Pharmaceuticals', u'Mediolanum Farmaceutici SpA', u'Mitsubishi Pharma Corp', u'Neurological Technologies Inc', u'Jouveinal Laboratories Inc', u'Boehringer Mannheim GmbH', u'Augusta University Research Institute Inc', u'Kos Pharmaceuticals Inc', u'Pharmalink AB', u'Medical College of Wisconsin', u'Theratase plc', u'Advanced Ocular Systems Ltd', u'LEO Pharma A/S', u'Sanofi', u'Mirrx Therapeutics', u'bioCSL PTY Ltd', u'Shire-Movetis NV', u'BioPhyZica Inc', u'Duke University', u'Centenary Institute Cancer Medicine & Cell Biology', u'The Green Cross Corp', u'Apeptico Forschung und Entwicklung GmbH', u'Nycomed Christiaens BV', u'Shire Orphan Therapies GmbH', u'National Heart Lung and Blood Institute', u'Pfizer Inc', u'University of Adelaide', u'Toyama Chemical Co Ltd', u'Institute for the Promotion of Innovation by Science and Technology in Flanders', u'CHEPLAPHARM Arzneimittel GmbH', u'University of Arizona']), u'Bonetumor': set([u'Gen9 Inc', u'US Government', u'Prostate Cancer Foundation', u'Cancer Research UK', u'DRAXIMAGE', u'Genentech Inc', u'Harvard Medical School', u'Abbott Laboratories', u'H Lee Moffitt Cancer Center and Research Institute', u'NeoPharm Inc', u'H:S Rigshospitalet', u'National Cancer Institute', u'Novartis AG', u'Intezyne Technologies Inc', u'IsoTherapeutics Group Llc', u'Georgetown University', u'XOMA Corp', u'Asahi Kasei Pharma Corp', u'Astex Pharmaceuticals Inc', u'Stehlin Foundation For Cancer Research', u'Auburn University', u'University of Michigan', u'Onyx Pharmaceuticals Inc', u'Bone Support AB', u'Multiple Myeloma Research Foundation', u'Celgene Corp', u'Henkel KGaA', u'Pharmacia & Upjohn Co', u'Novartis Institutes for BioMedical Research Inc', u'Pfizer Inc', u'Sanofi', u'Cancer Research Technology Ltd', u'Modulation Therapeutics Inc', u'Guerbet']), u'Cardiachypertrophy': set([u'Novartis AG', u'Cytopia Inc', u'State University of New York', u'National Institutes of Health', u'Myogen GmbH', u'Makai Biotechnology LLC', u'Growblox Sciences Inc', u'Speedel Pharma AG']), u'Angioedema': set([u'Fujifilm Diosynth Biotechnologies', u'Shire Orphan Therapies GmbH', u'CMIC Holdings Co Ltd', u'Dyax Corp', u'Kos Pharmaceuticals Inc', u'Novellus Biopharma AG', u'Neopharm Ltd', u'Sanofi', u'Ryogen LLC', u'Life Technologies Corp']), u'Pulmonary': set([u'Synthetic Biologics Inc', u'National Institutes of Health']), u'Hypoparathyroidism': set([u'DRI Capital', u'NPS Pharmaceuticals Inc']), u'Xlinkedhypohidroticectodermaldysplasia': set([u'InformedDNA', u'Edimer Pharmaceuticals Inc', u'Food and Drug Administration']), u'Lipidmetabolismdisorder': set([u\"Dr Reddy's Laboratories Ltd\", u'Oscient Pharmaceuticals Corp', u'US Government', u'Novo Nordisk A/S', u'Solvay SA', u'Scil Technology GmbH', u'MDS Pharma Services', u'AOP Orphan Pharmaceuticals AG', u'Burgundy', u'Montreal Heart Institute', u'Cetero Research', u'Tribute Pharmaceuticals Inc', u'Healthcare Royalty Partners', u'Green Cross Corp', u'The Dow Chemical Co', u'Cerenis Therapeutics SA', u'Spherix Inc', u'Washington Hospital Center', u'University of Michigan', u'OSEO', u'Apotex Inc', u'Atherotech Inc', u'Resverlogix Corp', u'Roche Holding AG', u'CymaBay Therapeutics Inc', u'Mitsubishi Tanabe Pharma Corp', u'TOLMAR Therapeutics Inc', u'Farmaceutici Formenti SpA', u'Sun Pharmaceutical Industries Ltd', u'Veloxis Pharmaceuticals A/S', u'University of Kentucky', u'Temple University', u'Medpace Inc', u'Shionogi & Co Ltd', u'National Heart Lung and Blood Institute', u'Sonogene LLC', u'Casper Pharma LLC', u'Omthera Pharmaceuticals Inc', u'Amgen Inc', u'Karo Pharma AB', u'Oxford GlycoSciences plc', u'Affibody AB', u'Daiichi Sankyo Co Ltd', u'Anagen Therapeutics Inc', u'Medstar Research Institute', u'Tulane University', u'Kotobuki Pharmaceutical Co Ltd', u'Merck KGaA', u'Teva Pharmaceutical Industries Ltd', u'BG Medicine Inc', u'Pharmena Sp zoo', u'Scarista Ltd', u'Guangdong Zhongsheng Pharmaceutical Co Ltd', u'Obecure Ltd', u'Sichuan University', u'WuXi PharmaTech (Cayman) Inc', u'Metabolic Solutions Development Co', u'Abbott Laboratories', u'Lipid Sciences Inc', u'Nano Terra Inc', u'Dong-A ST Co Ltd', u'Midatech Pharma US Inc', u'Allergan Inc', u'CytRx Corp', u'Lupin Ltd', u'Connexios Life Sciences Pvt Ltd', u'Genfit SA', u'Scotia Holdings plc', u'Lexicon Pharmaceuticals Inc', u'Arisaph Pharmaceuticals Inc', u'National Institute of Neurological Disorders and Stroke', u'Undisclosed', u'Genentech Inc', u'Korea Drug Development Fund', u\"Dr Reddy's Research Foundation\", u'arGEN-X NV', u'Dishman Pharmaceuticals & Chemicals Ltd', u'Allergan plc', u'Shionogi Pharma Inc', u'Shionogi USA Inc', u'Staten Biotechnology B.V.', u'AAIPharma Inc', u'Nippon Chemiphar Co Ltd', u'Daewoong Pharmaceutical Co Ltd', u'Global Atherothrombotic Investigative Network', u'Redx Pharma Plc', u'Merck & Co Inc', u'Sanofi', u'Chong Kun Dang Pharmaceutical Corp', u'Eli Lilly & Co', u'Japan Tobacco Inc', u'Orient Pharma Co Ltd', u'Zhejiang University', u'Novasep', u'Theratechnologies Inc', u'Kadmon Pharmaceuticals LLC', u'Roivant Sciences Ltd', u'Dezima Pharma BV', u'AstraZeneca plc', u'Pfizer Inc', u'Fournier Pharma', u'VLP Biotech Inc', u'Central Drug Research Institute', u'Lipigon Pharmaceuticals', u'Sandoz Inc', u'Cadila Pharmaceuticals Ltd', u'Cortria Corp', u'Sanwa Kagaku Kenkyusho Co Ltd', u'Mount Sinai Medical Center', u'Nippon Shinyaku Co Ltd', u'Johnson & Johnson', u'Tularik Inc', u'Vaccine Research Institute of San Diego', u'Viking Therapeutics Inc', u'Essentialis Inc', u'Bioject Medical Technologies Inc', u'Technical University of Lodz', u'Amylin Pharmaceuticals Inc', u'Arena Pharmaceuticals Inc', u'Ligand Pharmaceuticals Inc', u'Galephar PR Inc', u'Servier', u'NAEJA Pharmaceuticals Inc', u'Plexcera Therapeutics LLC', u'Bristol-Myers Squibb Co', u'Laxdale Ltd', u'Amarin Corp plc', u'Aventis SA', u'Bayer Pharmaceuticals Corp', u'West Pharmaceutical Services Inc', u'Esperion Therapeutics Inc', u'Sanofi Genzyme', u'Quark Pharmaceuticals Inc', u'Cedars-Sinai Medical Center', u'Pronova BioPharma ASA', u'University of Chicago', u'Seoul National University', u'Imperial College London', u'Astellas Pharma Inc', u'Ranbaxy Laboratories Ltd', u'Ortho-McNeil Inc', u'Merck Serono SA', u'Tripos Inc', u'PPD Discovery Inc', u'GD Searle & Co', u'Slanmhor Pharmaceutical Inc']), u'Multipleorganfailure': set([u'TMS Co Ltd', u'InflammaGen Therapeutics Inc', u'University of California San Diego', u'Tokyo University of Agriculture & Technology Co Ltd']), u'Hyperammonemia': set([u'University of Pennsylvania', u'Clinigen Group plc', u'Orphan Europe SARL', u'Hyperion Therapeutics Inc', u'Valeant Pharmaceuticals International Inc', u'Shire plc', u'Medunik Canada', u'Accredo Health Group Inc', u'Swedish Orphan Biovitrum AB', u'Translate Bio', u'Seres Therapeutics Inc', u'Horizon Pharma plc']), u'Hemochromatosis': set([u'Genome Canada', u'Universite de Sherbrooke', u'Protagonist Therapeutics Inc', u'National Heart Lung and Blood Institute', u'Xenon Pharmaceuticals Inc', u'GlaxoSmithKline plc']), u'Prematurelabor': set([u'Biopasgroup', u'NX Prenatal Inc', u'National Health and Medical Research Council', u'Lumara Health Inc', u'Sera Prognostics Inc', u'Lipocine Inc', u'Harvard Medical School', u'University of Rhode Island', u'Hologic Inc', u'Mochida Pharmaceutical Co Ltd', u'Teikoku Hormone Manufacturing Co Ltd', u'Hokuriku Seiyaku KK', u'Case Western Reserve University School of Medicine', u'Actavis Inc', u'Eunice Kennedy Shriver National Institute of Child Health & Human Development', u'Massachusetts Institute of Technology', u'National Institutes of Health', u'Baxter Pharmaceutical Solutions LLC', u'US Government', u'ObsEva SA', u'Juniper Pharmaceuticals Inc', u'Theratechnologies Inc', u'Therapeutic Solutions International Inc', u'Massachusetts General Hospital', u'Medical Research Council', u'TriHealth', u'PDC Biotech GmbH', u'JCR Pharmaceuticals Co Ltd', u'Mitsubishi-Tokyo Pharmaceuticals Inc', u'St Johns University', u'Hospira Inc', u'NantHealth Inc', u'Vanderbilt University School of Medicine', u'Ferring Pharmaceuticals SA', u'Ferring Research Ltd', u'Kissei Pharmaceutical Co Ltd', u'Merck Serono SA', u'MediciNova Inc', u'University of Edinburgh', u'Washington University in St Louis', u'Laboratory Corporation of America Holdings', u'OmniBiome Therapeutics Inc', u'University of Utah', u'University of Adelaide', u'Wayne State University', u'AMAG Pharmaceuticals Inc', u'NxGEN MDx LLC', u'Antares Pharma Inc']), u'Neurotoxicitydrug-induced': set([u'Bolder BioTechnology Inc', u'US Government', u'Vitro Diagnostics Inc', u'Syntrix Biosystems Inc', u'National Institute on Aging', u'Genentech Inc', u'National Institutes of Health', u'DynPort Vaccine Company LLC', u'Atuka Ltd', u'TorreyPines Therapeutics Inc', u'Adolor Corp', u'US Department of Defense', u'Cenomed BioSciences LLC', u'University of Medicine and Dentistry of New Jersey', u'QR Pharma Inc', u'AI BioTech LLC', u'HemoGenix Inc', u'US Army Medical Research Institute of Infectious Diseases', u'Axonyx Inc', u'University of Colorado System', u'Rinat-Pfizer Inc']), u'Brucellainfection': set([u'US Department of Defense', u'Biothera Pharmaceuticals Inc', u'Takeda Vaccines Inc', u'Biophage Pharma Inc']), u'Metastaticesophagealcancer': set([u'Eli Lilly & Co', u'Shandong Chengchuang Pharmaceutical R&D Co Ltd', u'Athenex Inc', u'Hallym University Medical Center', u'National Cancer Center Hospital East', u'Japan Agency for Medical Research and Development', u'Taiho Pharmaceutical Co Ltd', u'Medinet Co Ltd', u'Jeil Pharmaceutical Co Ltd', u'3SBio Inc']), u'Kaposissarcoma': set([u'University of California', u'US Government', u'NantCell Inc', u'Hemispherx Biopharma Inc', u'Genentech Inc', u'Cell Pharm GmbH', u'Galen Ltd', u'Wyeth BioPharma', u'Cytran Inc', u'Innovata plc', u'Abbott Laboratories', u'Navidea Biopharmaceuticals Inc', u'Yamanouchi Pharmaceutical Co Ltd', u'JCR Pharmaceuticals Co Ltd', u'Cytran Ltd', u'Tapestry Pharmaceuticals Inc', u'National Cancer Institute', u'American Red Cross', u'Guangdong Medicine Group Corp', u'rEVO Biologics Inc', u'Merck KGaA', u'Interferon Sciences Inc', u'Novelion Therapeutics Inc', u'Sanofi Winthrop France SA', u'Ipsen', u'Bristol-Myers Squibb Co', u'Scripps Research Institute', u'Asembia', u'Astellas Pharma Europe BV', u'ArQule Inc', u'University of California San Francisco', u'Wyeth-Ayerst Pharmaceuticals Inc', u'Universite De Montreal', u'Eli Lilly & Co', u'CASI Pharmaceuticals Inc', u'Ligand Pharmaceuticals Inc', u'Clinigen Group plc', u'Phyton Biotech Inc', u'Melmotte Inc', u'Roche Holding AG', u'ALZA Corp', u'Hualida Biotech', u'Aptose Biosciences Inc', u'Avanir Pharmaceuticals Inc', u'Implicit Bioscience Ltd', u'Eyetech Inc', u'General Medical Industries', u'Canadian Department of National Defence', u'Allergan Inc', u'CCL Pharmaceuticals', u'CytRx Corp', u'American Cyanamid Co', u'Cyanamid Benelux NV', u'Gilead Sciences Inc', u'SUGEN Inc', u'CTS Chemical Industries', u'Boryung Pharm Co Ltd', u'Merrimack Pharmaceuticals Inc', u'Mayne Pharma Pty Ltd', u'US Department of Defense', u'Defense Threat Reduction Agency', u'Quest PharmaTech Inc', u'PTC Therapeutics Inc', u'Dalton Pharma Services']), u'Morningsickness': set([u'Aequus Pharmaceuticals Inc', u'Camargo Pharmaceutical Services', u'Duchesnay Inc', u'Alliance Pharma plc']), u'Prostatetumor': set([u'Quest Diagnostics Inc', u'Antev Ltd', u'Transcept Pharmaceuticals Inc', u'Johns Hopkins University School of Medicine', u'Sidney Kimmel Comprehensive Cancer Center', u'Koebenhavns Universitet', u'AxCell Biosciences Corp', u'Attenuon LLC', u'Madrigal Pharmaceuticals Inc', u'Advanced Immune Therapeutics Inc', u'US Health and Human Services Department', u'Champions Oncology Inc', u'National Comprehensive Cancer Network', u'Key Oncologics (Pty) Ltd', u'Inovio Pharmaceuticals Inc', u'University of Maryland', u'Royal DSM NV', u'Koch Institute for Integrative Cancer Research', u'Lab21 Group', u'C&C Research Laboratories', u'The Dow Chemical Co', u'NueHealth', u'University Medical Center Groningen', u'Ventana Medical Systems Inc', u'Tecnofarma', u'European Community', u'Pharmaceutical Product Development LLC', u'Intracel Corp', u'David Geffen School of Medicine at UCLA', u'Stanford Rook Ltd', u'University of Alabama at Birmingham', u'T.J. Martell Foundation', u'Unigen Pharmaceuticals Inc', u'Kobold Medical', u'University of California Los Angeles', u'Inventiv Health Clinical Inc', u'NantHealth Inc', u'Recipharm AB', u'Sanofi-Synthelabo', u'Orphagen Pharmaceuticals Inc', u'Vancouver Coastal Health Research Institute', u'Silence Therapeutics plc', u'Minomic International Ltd', u'Handok Inc', u'Catalent Inc', u'HanAll Biopharma Co Ltd', u'Abgenix Inc', u'Tamir Biotechnology Inc', u'Evgen Pharma plc', u'Mixture Sciences Inc', u'Sanofi Pasteur', u'National Research Council of Canada', u'Mepha Pharma AG', u'European Commission', u'University of Arizona', u'State University of New York', u'MGI GP Inc', u'New York University', u'PDL BioPharma Inc', u'Northwest Biotherapeutics Inc', u'ValiPharma', u'Ranbaxy Laboratories Ltd', u'CEL-SCI Corp', u'ADC Therapeutics Sarl', u'Prostate Cancer UK', u'Cambridge Antibody Technology Group plc', u'Essa Pharma Inc', u'Nitto Denko Corp', u'Tulane University', u'Fund for Assistance to Small Enterprises in Science and Technology', u'The New Energy and Industrial Technology Development Organization', u'Weill Cornell Medical College, USA', u'IntelliGene Ltd', u'Antisense Therapeutics Ltd', u'Oryzon Genomics SA', u'Ministry of Health & Welfare, Korea', u'Barrier Therapeutics Inc', u'OncoFusion Therapeutics', u'Sunshine Biopharma Inc', u'Nymox Pharmaceutical Corp', u'Mount Sinai School of Medicine', u'KRS Global Biotechnology Inc', u'Dutch Cancer Society', u'National Centre For Scientific Research \"Demokritos\"', u'Agennix AG', u'Georgia Institute of Technology', u'CytomX Therapeutics Inc', u'Gen-Probe Inc', u'Telesta Therapeutics Inc', u'Gardant Pharmaceuticals Inc', u'YM BioSciences Inc', u'Shifa Biomedical Corp', u'Regulon Inc', u'ALZA Corp', u'EpiCept Corp', u'IPS Genomix', u'Centro Nacional de Investigaciones Oncologicas', u'ImmunoGen Inc', u'Qiagen NV', u'Colby Pharmaceutical Co', u'BalOnco GmbH', u'White Rose Technology Seedcorn Fund', u'Altor BioScience Corp', u'The Jenner Institute', u'Cortice Biosciences Inc', u'PhotoBiotics Ltd', u'Prescient Therapeutics Ltd', u'Generex Biotechnology Corp', u'Infinity Pharmaceuticals Inc', u'Oslo University Hospital', u'Bexion Pharmaceuticals LLC', u'Rutgers University', u'Healthcare Royalty Partners', u'Swedish Orphan Biovitrum AB', u'F H Faulding & Co Ltd', u'D Western Therapeutics Institute', u'Vifor Pharma', u'ClinTrials BioResearch Ltd', u'Shanghai Institutes for Biological Sciences CAS', u'Triton Biosystems Inc', u'The University of Hong Kong', u'UroCor Inc', u'Hitachi Chemical Co Ltd', u'b3 bio Inc', u'University of Texas System', u'Teikoku Hormone Manufacturing Co Ltd', u'California Institute of Technology', u'Vancouver Prostate Centre', u'Seattle Genetics Inc', u'Bioproperties Pty Ltd', u'Ionis Pharmaceuticals Inc', u'Biomedica Life Sciences SA', u'Massachusetts Institute of Technology', u'Sinopharm', u'JW CreaGene Inc', u'VaxOnco Inc', u'Encore Pharmaceuticals Inc', u'Daewoong Pharmaceutical Co Ltd', u'biolitec AG', u'LEO Pharma A/S', u'Prostate Cancer Canada', u'Vion Pharmaceuticals Inc', u'CTI BioPharma Corp', u'Eli Lilly & Co', u'Celsion Corp', u'GlaxoSmithKline Biologicals', u'Berlex Biosciences', u'University of Wisconsin-Madison', u'Rubicon Biotechnology Inc', u'University of Victoria', u'Weizmann Institute of Science', u'Nippon Organon KK', u'AstraZeneca Canada Inc', u'Bracco SpA', u'MedImmune LLC', u'Japanese National Cancer Center', u'Algae Dynamics Corp', u'Scienion AG', u'Hyaluron Inc', u'GENova Biotherapeutics Inc', u'Corixa Corp', u'Apthera Inc', u'Cancer Research Technology Ltd', u'Pharmion Corp', u'FCB-Pharmicell Co Ltd', u'OneInSix Foundation', u'University of Pittsburgh', u'Johns Hopkins University', u'The Center of Molecular Immunology', u'Bostwick Laboratories', u'Immatics Biotechnologies GmbH', u'Johnson & Johnson', u'Merrion Pharmaceuticals Inc', u'MetCure Therapeutics LLC', u'AbbVie Inc', u'PDS Biotechnology Corp', u'Hologic Inc', u'Uniformed Services University of the Health Sciences', u'Dalton Pharma Services', u'SmithKline Beecham plc', u'Bavarian Nordic A/S', u'UroGene SA', u'BL&H Co Ltd', u'Northwestern University', u'Cancer Prevention and Research Institute of Texas', u'Mercian Corp', u'Speciality European Pharma Ltd', u'Epic Sciences Inc', u'Society of Nuclear Medicine', u'Fresenius SE & Co KGaA', u'Pro-Cure Therapeutics Ltd', u'Orca Therapeutics BV', u'Bristol-Myers Squibb Co', u'Institute For Systems Biology', u'OSEO', u'CEAMED SA', u'Janssen Research & Development LLC', u'MDxHealth SA', u'Silicon Biosystems SRL', u'Astellas Pharma Inc', u'Hitachi Ltd', u'Vanderbilt-Ingram Cancer Center', u'Institute of Cancer Research UK', u'Antisoma plc', u'Insmed Inc', u'Tianjin Medical University', u'Oncormed Inc', u'GenomIdea Inc', u'Lonza Group AG', u'Agouron Pharmaceuticals Inc', u'Depomed Inc', u'Immuno-Designed Molecules SA', u'Eigen', u'Chiltern International Ltd', u'Norwegian Medical Cyclotron Centre', u'Biotech Equity Partners Pty Ltd', u'Cerba HealthCare', u'Shandong Luoxin Pharmaceutical Group Stock Co Ltd', u'Chronix Biomedical', u'Canadian Government', u'University of Michigan', u'Biocare Medical', u'ImaginAb Inc', u'Pharmacia & Upjohn Co', u'Karolinska Institutet', u'Weill Medical College of Cornell University', u'University of Strathclyde', u'Alberta Cancer Board', u'Sangretech Biomedical', u'Barbara Ann Karmanos Cancer Institute', u'Myovant Sciences Ltd', u'Salmedix Inc', u'Jenner Biotherapies Inc', u'Bavarian Research Foundation', u'Incuron LLC', u'IDM Pharma Inc', u'IDEC Pharmaceuticals Corp', u'Oncovir Inc', u'Orion Corporation', u'SICOR Inc', u'BTG plc', u'Centelion SAS', u'Ambrilia Biopharma Inc', u'Invivo', u'Chiron Corp', u'DiagnoCure Inc', u'Zhejiang Xianju Pharmaceutical Corp Ltd', u'University Of Southampton', u'Morphotek Inc', u'Selexis SA', u'US Department of Veterans Affairs', u'Chinese Government', u'ArQule Inc', u'Stanford University', u'Onyvax Ltd', u'Syndax Pharmaceuticals Inc', u'Veristat, Inc.', u'Steba Beheer BV', u'Aventis SA', u'Mateon Therapeutics Inc', u'Garvan Institute of Medical Research', u'Roche Holding AG', u'AsymmetRx Medical Inc', u'Shire plc', u'University of British Columbia', u'University of Surrey', u'Biocompatibles International plc', u'Battelle', u'The National Institute of Mental Health', u'Paladin Labs Inc', u'Vituro Health', u'ANI Pharmaceuticals Inc', u'Virginia Commonwealth University', u'TESARO Inc', u'Sanofi Genzyme', u'Sonacare Medical LLC', u'Genyous Biomed International Inc', u'Biocon Ltd', u\"Xi'an Jiaotong University\", u'Prostate Cancer Foundation', u'Technology Partnerships Canada', u'Statens Serum Institut', u'Dana-Farber Cancer Institute Inc', u'Novus Therapeutics Inc', u'Terry Fox Foundation', u'National Institute of General Medical Sciences', u'Evotec AG', u'Diomed Ltd', u'Diaxonhit', u'University of London School of Pharmacy', u'Amgen Inc', u'Geron Corp', u'Baxter Oncology GmbH', u'Five Eleven Pharma, Inc.', u'Endo Health Solutions Inc', u'Endo Pharmaceuticals Solutions Inc', u'Elekta AB', u'Armune BioScience Inc', u'MGI Pharma Biologics', u'Biosintetica Farmaceutica Ltda', u'Ardana Bioscience Ltd', u'RedHill Biopharma Ltd', u'Center for Translational Molecular Medicine', u'German Consortium for Translational Cancer Research', u'Georgetown University', u'Robert H. Lurie Comprehensive Cancer Center', u'SkyePharma plc', u'Georgetown University Medical Center', u'Stason Pharmaceuticals Inc', u'Fondation Synergie Lyon Cancer', u'Immunovo BV', u'MoreinX AB', u'Massachusetts General Hospital', u'Fluxion Biosciences Inc', u'Transgene SA', u'Pevion Biotech Ltd', u'Enzon Pharmaceuticals Inc', u'Prostagenics LLC', u'Uteron Pharma S.A.', u'TBG Diagnostics Ltd', u'The Princess Margaret Hospital Foundation', u'Immunomedics Inc', u'Blue Earth Diagnostics Ltd', u'Janssen Pharmaceutical KK', u'Advantagene Inc', u'Elliott-Elliott-Head Breast Cancer Research And Treatment Center', u'Southern Adelaide Health Service-Flinders Medical Centre', u'Fougera Pharmaceuticals Inc', u'M2i limited', u'Imperial Cancer Research Technology Ltd', u'HealthLinx Ltd', u'Meditrina Pharmaceuticals Inc', u'Oncodrone BV', u'Osaka University', u'Biscayne Pharmaceuticals Inc', u'University of California San Diego', u'DuPont Pharmaceuticals Ltd', u'Phi Life Sciences LLC', u'Lynx Therapeutics GmbH', u'Oakwood Laboratories LLC', u'Sigma-Tau Ind Farm Riunite SpA', u'University of Bern', u'Fuji Pharma Co Ltd', u'Sanofi-Aventis US LLC', u'Dyna Therapeutics Co Ltd', u'Cancer Research UK', u'Shasun-NBI', u'Tartis Inc', u'Genentech Inc', u'Mustang Bio Inc', u'Instituto Diagnostico Varelli', u'DCPrime BV', u'Mayo Clinic Foundation', u'Medistem Inc', u'Rigel Pharmaceuticals Inc', u'National Health and Medical Research Council', u'GeneNews Ltd', u'Ore Pharmaceuticals Inc', u'Bavarian government', u'Laureate Biopharmaceutical Services Inc', u'Actavis Inc', u'Ark Therapeutics Group plc', u'JFE Group', u'Norris Comprehensive Cancer Center', u'Nippon Chemiphar Co Ltd', u'Henry M Jackson Foundation for the Advancement of Military Medicine', u'Australian Research Council', u'Organon Teknika BV', u'Efamol', u'Molecular Insight Pharmaceuticals Inc', u'Meda AB', u'University of Southern California', u'Pacific Coast Urology', u'University of Texas Southwestern Medical Center', u'Consiglio Nazionale delle Ricerche', u'Acaduceus Pharmaceutics Inc', u'CASI Pharmaceuticals Inc', u'Japan Tobacco Inc', u'ScinoPharm Taiwan Ltd', u'Deutsches Krebsforschungszentrum', u'Pierre Fabre SA', u'AdnaGen AG', u'Kotinos Pharmaceuticals', u'Crown Bioscience Inc', u'Ministry of Education, Culture, Sports, Science and Technology of Japan', u'SpePharm Holding BV', u'Caprion Pharmaceuticals Inc', u'ExonHit Therapeutics Inc', u'AEterna Zentaris Inc', u'Glide Pharmaceutical Technologies Ltd', u'Janssen Biotech Inc', u'Columbia-Presbyterian Medical Center', u'IVAX Corp', u'AstraZeneca plc', u'Technology Strategy Board', u'San Diego State University', u'C4 Imaging LLC', u'Nometics Inc', u'SUGEN Inc', u'Danmarks Farmaceutiske Universitet', u'Agensys Inc', u'UK Department of Trade & Industry', u'Kent State University', u'Undisclosed', u'Implicit Bioscience Ltd', u'Genta Inc', u'Do-Coop Technologies Ltd', u'Estero-Anstalt', u'Beijing Pason Pharmaceuticals Inc', u'Lonza Biologics plc', u'Nippon Shinyaku Co Ltd', u'Adjuvantys Inc', u'Sirnaomics Inc', u'Introgen Therapeutics Inc', u'Australian Government', u'Arvinas Inc', u'bioMerieux SA', u'Aureon Laboratories', u'Translational Genomics Research Institute', u'Physiomics plc', u'ASTA Medica AG', u'US Naval Medical Research Center', u'University of Manitoba', u'BioChem Therapeutic Inc', u'BioPro Pharmaceutical Inc', u'Nerviano Medical Sciences Srl', u'Medexis Biotech SA', u'Principio Inc', u'Medipharm Biotech Co Ltd', u'Propep Surgical Llc', u'Advanced Accelerator Applications SA', u'ZERO - The End of Prostate Cancer', u'Abeona Therapeutics Inc', u'Protagen AG', u'Novavax Inc', u'Pooyesh Darou Pharmaceuticals', u'University of Wurzburg', u'Three Rivers Provider Network', u'National Science Foundation', u'Beth Israel Deaconess Medical Center', u'Spectrum Pharmaceuticals Inc', u'Cedars-Sinai Medical Center', u'Fujifilm Diosynth Biotechnologies', u'IC-MedTech Inc', u'Cornell University', u'Valeant Pharmaceuticals International Inc', u'National Institute of Biomedical Imaging and Bioengineering', u'Covis Pharma Sarl', u'Karyopharm Therapeutics Inc', u'Mithra Pharmaceuticals', u'Crucell Switzerland AG', u'GE Healthcare', u'Aphton Corp', u\"Brigham & Women's Hospital\", u'PiSA Farmaceutica', u'Dyax Corp', u'Accelis Pharma', u'Quest PharmaTech Inc', u'Valera Pharmaceuticals Inc', u'University of Toronto', u'GPC Biotech AG', u'University of Cambridge', u'Wayne State University', u'Kadmon Pharmaceuticals LLC', u'Defense Threat Reduction Agency', u'German Federal Ministry of Education and Research', u\"Dr Reddy's Laboratories Ltd\", u'TSD Japan', u'MolMed SpA', u'C&O Pharmaceutical Technology (Holdings) Ltd', u'Hinova Pharmaceuticals Inc', u'University of Florida', u'TOLMAR Holding Inc', u'Cerus Corp', u'Kirin Brewery Co Ltd', u'Vaccibody AS', u'Advaxis Inc', u'University of Pennsylvania Health System', u'EMD Serono Inc', u'University of Heidelberg', u'Cosmo Bioscience Inc', u'US Government', u'Centre for Probe Development and Commercialization', u'Xbrane Biopharma AB', u'Adjuvantix Ltd', u'Yakult Honsha Co Ltd', u'BioStar Inc', u'NeoPharm Inc', u'VolitionRX Ltd', u'Kissei Pharmaceutical Co Ltd', u'Sotio AS', u'AndroBioSys Inc', u'Cytogen Corp', u'IASON GmbH', u'Poniard Pharmaceuticals Inc', u'University of Crete', u'Loma Linda University Medical Center', u'InteRNA Technologies BV', u'Long Island Pathology Inc', u'Sandhill Scientific Inc', u'C R Bard Inc', u'OSI Pharmaceuticals Inc', u'Fred Hutchinson Cancer Research Center', u'CureVac GmbH', u'Hybrigenics SA', u'Vital Living Inc', u'ARIAD Pharmaceuticals Inc', u'Trendlines Group Ltd', u'LIDDS AB', u\"Queen's University\", u'ARIUS Research Inc', u'Egenix Inc', u'Debiovision Inc', u'Kite Pharma Inc', u'Ludwig Institute for Cancer Research', u'Astellas Pharma Europe BV', u'Lankenau Institute for Medical Research', u'Axis Genetics plc', u'Royal Marsden Hospital', u'Optimer Pharmaceuticals Inc', u'National Center for Research Resources', u'Keio University', u'Lipomed AG', u'Kalahari Greentech Inc', u'Rubicon Genomics Inc', u'Helmholtz Zentrum M\\xfcnchen', u'OncoTherics', u'International Biotechnology Center Generium LLC', u'Oncology Sciences Corp', u'Iwate Medical University', u'University of Waterloo', u'Bayer Corp', u'OncoResponse Inc', u'Mylan Inc', u'Biota Holdings Ltd', u'KS Biomedix Holdings plc', u'Harvard University', u'OncBioMune Pharmaceuticals Inc', u'Boehringer Mannheim GmbH', u'GTx Inc', u'Eberhard-Karls-Universitaet Tuebingen', u'Scott And White Memorial Hospital', u'Aphios Corp', u'Yale University', u'Proscan Rx Pharma', u'Acuvax Ltd', u'The European Union', u'Teva Pharmaceutical Industries Ltd', u'Diatos SA', u'Cougar Biotechnology Inc', u'Arquer Diagnostics', u'Catholic University of Leuven', u'Kwang Dong Pharmaceutical Co Ltd', u'Siemens Medical Solutions Molecular Imaging', u'University of California San Francisco', u'UCB Pharma GmbH', u'Aytu BioScience Inc', u'Oncolytics Biotech Inc', u'OPKO Health Inc', u'Dendreon Corp', u'Biomedical Translational Imaging Centre', u'Ferring Pharmaceuticals SA', u'Jazz Pharmaceuticals plc', u'European Health Centre Otwock', u'Skolkovo', u'diaDexus LLC', u'Targepeutics Inc', u'Wellcome Trust', u'Prostate Cancer Clinical Trials Consortium', u'Micromet Inc', u'University of Cincinnati', u'Boehringer Ingelheim Corp', u'Asan Medical Center', u'Takeda Development Centre Europe Ltd', u'Janssen Korea Ltd', u'Beatson Institute for Cancer Research', u'Okayama University', u'University of Ghent', u'Debiopharm SA', u'Scotia Holdings plc', u'21st Century Therapeutics Inc', u'ILEX Oncology Inc', u'Arctic Diagnostics Oy', u'Medivation Inc', u'Hirosaki University', u'Harvard Medical School', u'IDIS Ltd', u'MegaPharm Ltd', u'Theramex', u'PLUS Diagnostics', u'Mitomics Inc', u'Oxford BioMedica plc', u'AlphaVax Inc', u'Institute of Molecular Genetics (Czech Republic)', u'PCT, a Caladrius company', u'Color Genomics', u'Boehringer Mannheim Corp', u'OncoTartis Inc', u'PharmAgra Labs Inc', u'Cancer Research Campaign (UK)', u'XOMA Corp', u'University of California', u'Erasmus University Rotterdam', u'Gemin X Pharmaceuticals Inc', u'Sienna Cancer Diagnostics Ltd', u'CFD Therapeutics Inc', u'The Netherlands Organisation for Health Research and Development', u'Cephalon Inc', u'Madison Vaccines Inc', u'Sanofi', u'Daewon Pharm Co Ltd', u'Vertex Pharmaceuticals Inc', u'Sanpower Group Co Ltd', u'Novogen Ltd', u'HedgePath Pharmaceuticals Inc', u'University of York', u'HemaCare Corp', u'Curadel LLC', u'International Health Technology Ltd', u'FUJIFILM Holdings Corp', u'Case Western Reserve University', u'BioSeek Plc', u'Nektar Therapeutics', u'Therapure Biopharma Inc', u'Akzo Nobel NV', u'Sellas Life Sciences Group', u'International Business Machines Corp', u'Saint Savas Cancer Hospital', u'Summa Health System', u'CIS Bio International SAS', u'University of Adelaide', u'Progenics Pharmaceuticals Inc', u'Wyeth', u'Mojave Therapeutics Inc', u'Vernalis plc', u'Charles University', u'Genisphere LLC', u'University of Iowa', u'Georgia Research Alliance', u'Tularik Inc', u'Purdue University', u'AnorMED Inc', u'Janssen Diagnostics LLC', u'Antigen Express Inc', u'Hoffmann-La Roche AG', u'Cancer Vaccine Acceleration Fund', u'Imclone LLC', u'University of Missouri', u'Avantogen Oncology Inc', u'University of Pennsylvania', u'Pasteur Merieux Connaught Canada', u'Cytran Inc', u'Knight Cancer Institute', u'Griffith University', u'Walter Reed Army Institute of Research', u'University of Utah', u'Knight Therapeutics Inc', u'BZL Biologics Inc', u'Abzena plc', u'PowderJect Pharmaceuticals plc', u'Aurigene Discovery Technologies Ltd', u'AviPep Pty Ltd', u'The Australian National University', u'Sophiris Bio Inc', u'Zbx Corp', u'AltheaDx Inc', u'University of Tokyo', u'Advagen Inc', u'Elan Corp plc', u'TAP Pharmaceuticals Inc', u'City of Hope', u'MorphoSys AG', u'PNP Therapeutics Inc', u'MSD Japan', u'Oita University', u'Berkshire Health Systems', u'Georgia Urology Pc', u'Celgene Corp', u'Telix Pharmaceuticals Ltd', u'Crescendo Pharmaceuticals Corp', u'Imperial College London', u'Astellas Pharma US Inc', u'Raven Biotechnologies Inc', u'Sosei Group Corp', u'BC Cancer Agency', u'Stegram Pharmaceuticals Ltd', u'Duke University', u'Sophia Bioscience Inc', u'HIFU Prostate Services', u'Salix Pharmaceuticals Ltd', u'The Insitute of Cancer Research', u'Cyto Pulse Sciences Inc', u'Endocyte Inc', u'Alethia Biotherapeutics Inc', u'Crucell NV', u'Adamis Pharmaceuticals Corp', u'Cancer Targeted Technology Llc', u'Bayer HealthCare Pharmaceuticals Inc', u'Leidos Biomedical Research Inc', u'OncoGenex Technologies Inc', u'Abraxis BioScience Inc', u'Provectus Biopharmaceuticals Inc', u'Parabon NanoLabs Inc', u'Bioenvision Inc', u'ValiRx plc', u'LI-COR Biosciences', u'OncoGenex Pharmaceuticals Inc', u'Foresee Pharmaceuticals LLC', u'Daiichi Seiyaku Co Ltd', u'TRACON Pharmaceuticals Inc', u'Singapore Technologies Pte Ltd', u'University of Sunderland', u'Rice University', u'Ultimovacs AS', u'Cancer Research Campaign Technology Ltd', u'W C Heraeus GmbH & Co KG', u'Netherlands Government', u'Recepta biopharma', u'Xcell Biosciences Inc', u'Peregrine Pharmaceuticals Inc', u'GlaxoSmithKline plc', u'NantKwest Inc', u'Cytran Ltd', u'Cell Genesys Inc', u'Vaccitech Ltd', u'Johnson Matthey plc', u'Bayer Schering Pharma AG', u'Riverside Research Institute', u'Cascadian Therapeutics Inc', u'OncBioMune Mexico SA de CV', u'Ipsen', u'Immunex Corp', u'Janssen Pharmaceutica NV', u'Cleveland BioLabs Inc', u'European Eurostars Programme', u'Variagenics Inc', u'Cavion LLC', u'Institut Curie', u'Inspyr Therapeutics Inc', u'Medical Research Council', u'Vanderbilt University', u'Genelux Corp', u'University of Texas Health Science Center Houston', u'Takeda Oncology', u'Aduro BioTech Inc', u'Almac Diagnostics', u'Abbott Healthcare Products BV', u'NCIC Clinical Trials Group', u'Siamab Therapeutics', u'Consejeria de Industria', u'Davos Life Science Pte Ltd', u'CompanDX', u'United Biomedical Inc', u'Canadian Institutes of Health Research', u'Netherlands Cancer Institute', u'Thrasos Therapeutics', u'Boston University', u'Endo International plc', u'Emory University', u'US Department of Defense', u'iCAD Inc', u'Henry Ford Health System', u'Rosetta Genomics Ltd', u'Cell Pathways Inc', u'AV Therapeutics Inc', u'GenomeDx Biosciences Inc', u'Pepscan Systems BV', u'Lalilab Inc', u'Aronex Pharmaceuticals Inc', u'Genset', u'MD Anderson Cancer Center', u'Medarex Inc', u'GenoSplice Technology', u'Immunovaccine Inc', u'College Of Nanoscale Science & Engineering', u'Daiichi Sankyo Co Ltd', u'Abbott Laboratories', u'SouthGenetics Inc', u\"Andros Men's Health Clinic\", u'Commonwealth Scientific and Industrial Research Organization', u'Empire Genomics Llc', u'Macquarie University', u'MediGene AG', u'MultiPlan Inc', u'Merck KGaA', u'Almac Discovery Ltd', u'Marillion Pharmaceuticals Inc', u'ChemDiv Inc', u'Syngene International Ltd', u'Schering-Plough Corp', u'NuvoBio Corp', u'PharmaCell', u'PJSC Pharmsynthez', u'Exact Imaging', u'General Research Laboratory Inc', u'BN ImmunoTherapeutics Inc', u'UCSF Helen Diller Family Comprehensive Cancer Center', u'Melmotte Inc', u'Haisco Pharmaceutical Group Co Ltd', u'Trillium Therapeutics Inc', u'Aptose Biosciences Inc', u'MBC Pharma Inc', u'ProteoNic', u'Solural Pharma Aps', u'Scripps Research Institute', u'Immune Response BioPharma Inc', u'Designed Biologics Inc', u'Kosan Biosciences Inc', u'BASF Pharma', u'Oxford Gene Technology (Operations) Ltd', u'Peking Union Medical College Hospital', u'CytRx Corp', u'Health Care Logistics Inc', u'Ferrer Internacional SA', u'Onconova Therapeutics Inc', u'Tapestry Pharmaceuticals Inc', u'Myriad Genetics Inc', u'Kyowa Hakko Kogyo Co Ltd', u'LXR Biotechnology Inc', u'Afandin Pty Ltd', u'Recordati SpA', u'Laboratorio TUTEUR', u'Sequenom Inc', u'University of Oxford', u'ARTA Bioscience Inc', u'OncoMed Pharmaceuticals Inc', u'Chugai Pharmaceutical Co Ltd', u'University of North Carolina', u'National Institute of Neurological Disorders and Stroke', u'Ortho Biotech Products LP', u'GENESIS Pharma SA', u'Industrial Research Ltd', u'Yorkshire Cancer Research', u'St Vincents Hospital Sydney Ltd', u'Herrick Foundation', u'Symphony Evolution Inc', u'Southern Research Institute', u'Amgen Research (Munich) GmbH', u'Bradley Pharmaceuticals Inc', u'ATLAB Pharma SAS', u'Nuclea Biotechnologies LLC', u'Heidelberg Pharma Holding Ltd', u'CureMeta LLC', u'ImmunoCellular Therapeutics Ltd', u'Merck & Co Inc', u'Hybridyne Imaging Technologies, Inc', u'Steba Biotech NV', u'Munich Biotech AG', u'Zentaris GmbH', u'Radboud University', u'University of Miami', u'PharmaMar SA', u'Vancouver General Hospital', u'Epimmune Inc', u'Arcis Biotechnology Ltd', u'University of Virginia', u'Kyowa Hakko Kirin Co Ltd', u'Immune Therapeutics Inc', u'Tecnofarma International Ltd', u'Allied-Bristol Life Sciences LLC', u'University of Tennessee', u'Arriva Pharmaceuticals Inc', u'BioVectra DCL', u'Pfizer Inc', u'Senior Scientific LLC', u'Queensland University of Technology', u'The Salk Institute for Biological Studies', u'Trim-edicine Inc', u'Elk OrthoBiologics Ltd', u'Gerald P Murphy Cancer Foundation', u'NeoOncoRx Inc', u'deCODE genetics ehf', u'Sandoz Inc', u'Cadila Pharmaceuticals Ltd', u'Context Therapeutics LLC', u'GenQuest Inc', u'Guerbet', u'Memorial Sloan-Kettering Cancer Center', u'Mount Sinai Medical Center', u'AusIndustry', u'Therion Biologics Corp', u'IRX Therapeutics Inc', u'Maxim Pharmaceuticals Inc', u'LG Life Sciences Ltd', u'Baylor College of Medicine', u'Avionco Ltd', u'Norsk Hydro AS', u'Mirna Therapeutics Inc', u'Paul Scherrer Institut', u'MEI Pharma Inc', u'Metamark Genetics Inc', u'Zevacor Molecular', u'National Institute of Allergy and Infectious Diseases', u'Spectros Corp', u'Takeda Pharmaceutical Co Ltd', u'Yamanouchi Pharmaceutical Co Ltd', u'Praecis Pharmaceuticals Inc', u'NuView Life Sciences', u'Albert Einstein College of Medicine', u'Invivo Corp', u'National Institutes of Health', u'Serono Inc', u'Food and Drug Administration', u'TOLMAR Therapeutics Inc', u'Sarepta Therapeutics Inc', u'Vaccinogen Inc', u'Japan Agency for Medical Research and Development', u'Oncology Venture ApS', u'RadioMedix Inc', u'US Army Medical Research Institute of Infectious Diseases', u'Xuzhou Rike Pharmaceutical Development Co Ltd', u'Thomas Jefferson University', u'Roswell Park Cancer Institute', u'University of Chicago', u'Colorado State University', u'University of Durham', u'MDNA Life Sciences Inc', u'YM BioSciences USA', u'Osta Biotechnologies Inc', u'Educational and Scientific LLC', u'Velindre NHS Trust', u'Medigen Inc', u'Ferozsons Laboratories Ltd', u'ProTrials Research, Inc', u'Merck Serono SA', u'Takara Bio Inc', u'Teikoku Pharma USA Inc', u'National Cancer Institute', u'Ezose Sciences Inc', u'Vitala Therapeutics', u'Novartis AG', u'University of Maryland Greenebaum Cancer Center', u'ViaCell Inc', u'Baltimore VA Medical Center', u'Prospect Therapeutics Inc', u'Mayne Pharma Pty Ltd', u'BlinkBio Inc', u'PSMA Development Co LLC', u'BioAvenir']), u'Prostatedisease': set([u'Daiichi Seiyaku Co Ltd', u'GE Healthcare', u'Cephalon Inc', u'Ono Pharmaceutical Co Ltd', u'Sophiris Bio Inc', u'TAP Pharmaceutical Products Inc', u'Pfizer Inc', u'Recordati SpA', u'Teikoku Hormone Manufacturing Co Ltd', u'Kissei Pharmaceutical Co Ltd', u'SmithKline Beecham plc', u'GlaxoSmithKline plc']), u'Mycobacteriumlepraeinfection': set([u'Massachusetts Institute of Technology', u'Mylan Inc', u'Abbott Laboratories', u'Dainippon Pharmaceutical Co Ltd', u'GlaxoSmithKline plc', u'National Institute of Immunology', u'National Institutes of Health', u'M.J. Murdock Charitable Trust', u'Lipomed AG', u'Research Corporation Technologies', u'CASI Pharmaceuticals Inc', u'Celgene Corp', u'Infectious Disease Research Institute', u'BIO Ventures for Global Health', u'Cadila Pharmaceuticals Ltd', u'Rhone-Poulenc SA', u'Renaissance Dental', u'Medicines for Malaria Venture', u'University of California Los Angeles', u'Stanford Rook Ltd', u'NanoPass Technologies Ltd', u'Alnylam Pharmaceuticals Inc', u'Bentley Pharmaceuticals Inc', u'Royalty Pharma', u'Genesis Research and Development Corp Ltd']), u'Chronicfatiguesyndrome': set([u'Johnson & Johnson', u'Edward P. Evans Foundation', u'International Association for Chronic Fatigue Syndrome', u'Avrio Biopharmaceuticals LLC', u'The European Union', u'Griffith University', u'myTomorrows', u'Laboratorios Dr Esteve SA', u'Emerge Health Pty Ltd', u'Quintiles Transnational Corp', u'Guangdong Medicine Group Corp', u'Undisclosed', u'Fujisawa Pharmaceutical Co Ltd', u'Eli Lilly & Co', u'Sigma-Aldrich Corp', u'Sanochemia Pharmazeutika AG', u'Biovail Corp', u'Shire plc', u'Immune Therapeutics Inc', u'Jazz Pharmaceuticals plc', u'Genius Biotherapeutics', u'Janssen Pharmaceutica NV', u'US Department of the Treasury', u'GP Pharm SA', u'Neuro-Immune Disease Alliance', u'Esteve', u'Hemispherx Biopharma Inc', u'JPT Peptide Technologies GmbH', u'Stafford Fox Medical Research Foundation', u'Hikma Pharmaceuticals plc', u'Charite Universitaetsmedizin Berlin', u'Hollister-Stier Laboratories LLC', u'Open Medicine Institute', u'Whittemore Peterson Institute For Neuro-Immune Disease']), u'Candidaglabratainfection': set([u'Promiliad Biopharma Inc', u'University of Connecticut']), u'Sebaceousglanddisease': set([u'Pfizer Inc', u'Graceway Pharmaceuticals Inc']), u'Prophylaxis': set([u'Merus Labs International Inc', u'Roche Holding AG', u'Immtech Pharmaceuticals Inc', u'Emergent BioSolutions Inc', u'Laboratorio EDOL Produtos Farmaceuticos S.A', u'Iroko Pharmaceuticals LLC', u'US Health and Human Services Department', u'Tulane University']), u'Lymphocytopenia': set([u'Centre Leon Berard', u'University of Southern California', u'Cytheris SA', u'ImmunID', u'Objectif Recherche VACcin Sida', u'National Institute of Allergy and Infectious Diseases', u'Genexine Co Ltd', u'NeoImmuneTech Inc', u'Tarix Pharmaceuticals LLC']), u'Prematureovarianfailure': set([u'Ardana Bioscience Ltd', u'Orion Corporation', u'Zentaris GmbH', u'Takeda Pharmaceutical Co Ltd']), u'Cataract': set([u'Alcon Inc', u'University of Nottingham', u'Baylor College of Medicine', u'Australian Government', u'Scil Technology GmbH', u'Cataract & Laser Institute', u'Dutch Ophthalmic Research Center BV', u'Aqumen Biopharmaceuticals KK', u'Anika Therapeutics Inc', u'Univ Massachusetts', u'Disease Interception Accelerator', u'Novartis AG', u'Evolutec Group plc', u'National Institutes of Health', u'Cirle', u'Senju Pharmaceutical Co Ltd', u'Merck & Co Inc', u'National Eye Institute', u'Santen Pharmaceutical Co Ltd', u'University of California San Francisco', u'ViewPoint Therapeutics', u'University of Michigan', u'InSite Vision Inc', u'VSY Biotechnology', u'Visco Technologies Inc', u'YouHealth Eyetech Inc', u'Douglas Pharmaceuticals', u'University of Canterbury', u'Hokkaido University', u'Plex Pharmaceuticals', u'Cambrex Corp', u'Acucela Inc', u'Washington University in St Louis', u'Imprimis Pharmaceuticals Inc', u'SS Pharmaceutical Co Ltd', u'Esteve', u'Lincoln University', u'Takeda Pharmaceutical Co Ltd', u'Parke-Davis & Co', u'Orient Europharma', u'R-Tech Ueno Ltd', u'Bausch & Lomb Inc', u'Medarex Inc', u'Calpain Therapeutics Pty Ltd']), u'Dyspareunia': set([u'Shionogi Inc', u'Shionogi & Co Ltd', u'Endoceutics Inc', u'IDIS Ltd', u'Duchesnay Inc', u'AMAG Pharmaceuticals Inc']), u'Boneandjointi': set([u'Chong Kun Dang Pharmaceutical Corp', u'Bayer AG']), u'Acutestressdisorder': set([u'BioSenex', u'University of Cincinnati', u'ROHA Arzneimittel GmbH', u'Lipogen Ltd', u'National Institutes of Health', u'OncBioMune Mexico SA de CV', u'Oneday - Biotech & Pharma Ltd', u'Ichor Therapeutics', u'XENESTA INTERNATIONAL INC', u'National Institute of Diabetes, Digestive and Kidney Diseases', u'Celdara Medical LLC', u'Scripps Research Institute', u'Yissum Research Development Co', u'Corcept Therapeutics Inc', u'Astex Pharmaceuticals Inc', u'GlaxoSmithKline plc']), u'Nipahvirusinfection': set([u'University of Texas Medical Branch at Galveston', u'Profectus BioSciences Inc', u'University of Queensland', u'Uniformed Services University of the Health Sciences', u'National Institute of Allergy and Infectious Diseases', u'Kineta Inc', u'Commonwealth Scientific and Industrial Research Organization']), u'Basalcellnevussyndrome': set([u'Cypress Pharmaceutical Inc', u'Burke Pharmaceuticals LLC']), u'Urinaryretention': set([u'University of Chicago', u'Leiras Oy', u'Astellas Pharma Inc', u'UR Labs Inc', u'Synthelabo', u'Progenics Pharmaceuticals Inc', u'Sanofi-Synthelabo', u'Schering SpA']), u'Trypanosomiasis': set([u'The Consortium for Parasitic Drug Development', u'Koninklijk Instituut voor de Tropen', u'iCo Therapeutics Inc', u'Fraunhofer USA Inc', u'Mercachem Holding BV', u'SCYNEXIS Inc', u'Takeda Pharmaceuticals International GmbH', u'Ministry of Health of Uganda', u'Upstream Biosciences Inc', u'Makerere University', u'Medecins Sans Frontieres', u'Drugs for Neglected Diseases Initiative', u'iBio Inc', u'Onxeo SA', u'University of North Carolina', u'World Health Organization', u'Top Institute Pharma', u'Pace University', u'Bayer Schering Pharma AG', u'University of Bristol', u'National Institutes of Health', u'Bill & Melinda Gates Foundation', u'MV Lomonosov Moscow State University', u'French Government', u'Aventis SA', u'Glaxo Group Ltd', u'Sanofi', u'Auburn University', u'Columbia University', u'La Agencia Espa\\xf1ola de Cooperaci\\xf3n Internacional para el Desarrollo', u'Department for International Development', u'German Government', u'Georgia State University', u'RTI International', u'Anacor Pharmaceuticals Inc', u'Vrije Universiteit van Amsterdam', u'IOTA Pharmaceuticals Ltd', u'McGill University', u'Pfizer Inc', u'Johns Hopkins University', u'Swiss Tropical & Public Health Institute', u'aRigen Pharmaceuticals Inc', u'Immtech Pharmaceuticals Inc', u'Dutch Ministry of Foreign Affairs', u'University of Bern', u'Zalicus Inc', u'Guo Kang Pharmaceutical & Medical Supplies Ltd']), u'Hematologicalneoplasm': set([u'University of Strathclyde', u'US Government', u'MolMed SpA', u'Regeneron Pharmaceuticals Inc', u'Apeiron Biologics GmbH', u'GT Biopharma Inc', u'Baxter International Inc', u'BioAtla Llc', u'Dynavax Technologies Corp', u'Hercules Capital Inc', u'ADC Therapeutics Sarl', u'Health Protection Agency', u'Biogen Inc', u'Eutropics Pharmaceuticals Inc', u'Oryzon Genomics SA', u'Il Dong Pharmaceutical Co Ltd', u'Life Technologies Corp', u'GlaxoSmithKline plc', u'NantKwest Inc', u'BioLife Solutions Inc', u'TTY Biopharm Co Ltd', u'Ministerio de Economia y Competitividad', u'Idun Pharmaceuticals Inc', u'Royal DSM NV', u'Takeda Pharmaceutical Co Ltd', u'Cytheris SA', u'Erimos Pharmaceutical LLC', u'Helix BioPharma Corp', u'NuCana', u'MedImmune LLC', u'Astex Pharmaceuticals Inc', u'Dragonfly Therapeutics Inc', u'HemoGenyx', u'Amphivena Therapeutics Inc', u'Dutch-Belgian Cooperative Trial Group for Hematology Oncology', u'Ono Pharmaceutical Co Ltd', u'Takeda Oncology', u'Ontario Institute for Cancer Research', u'Five Prime Therapeutics Inc', u'Roche Holding AG', u'apceth GmbH & Co KG', u'University of North Carolina', u'ARIUS Research Inc', u'Cellectis SA', u'Selvita SA', u'Proteolix Inc', u'Felicitex Therapeutics Inc', u'Rare Disease Therapeutics Inc', u'ZIOPHARM Oncology Inc', u'3M Pharmaceuticals', u'Memorial Sloan-Kettering Cancer Center', u'Sorrento Therapeutics Inc', u'NCI Division of Cancer Treatment & Diagnosis', u'TG Therapeutics Inc', u'LipoCure', u'Constellation Pharmaceuticals Inc', u'Heinrich Heine Universitat Dusseldorf', u'Fate Therapeutics Inc', u'Dana-Farber Cancer Institute Inc', u'St Louis University', u'Trellis Bioscience Inc', u'Biokine Therapeutics Ltd', u'ChemRar High Tech Center', u'Evotec AG', u'National Health and Medical Research Council', u'Lin Bioscience Inc', u'Israeli Government', u'MD Anderson Cancer Center', u'Nekonal SARL', u'Amgen Inc', u'Mylan Inc', u'The University Health Network', u'Pfenex Inc', u'Cancer Genetics Inc', u'Abbott Laboratories', u'Janssen Pharmaceutica Ltd', u'SalvaRx Group Plc', u'Geron Corp', u'LFB SA', u'US Health and Human Services Department', u'National Cancer Institute', u'Janssen Pharmaceutica NV', u'Johns Hopkins University School of Medicine', u'Pharmacyclics Inc', u\"Y's Therapeutics Co Ltd\", u'Gencia Corp', u'S*BIO Pte Ltd', u'Robert H. Lurie Comprehensive Cancer Center', u'Mount Sinai School of Medicine', u'Northlake Biosciences LLC', u'Istituto Scientifico H San Raffaele', u'Agennix AG', u'Osiris Therapeutics Inc', u'I N C Research LLC', u'Novera Therapeutics Inc', u'Massachusetts General Hospital', u'Lipomed AG', u'Universite De Montreal', u'University of Minnesota', u'UCSF Helen Diller Family Comprehensive Cancer Center', u'JCR Pharmaceuticals Co Ltd', u'BTG plc', u'Wuxi AppTec (Tianjin) Co Ltd', u'Mundipharma EDO GmbH', u'University of Cologne', u'Aptose Biosciences Inc', u'Cleveland Clinic Foundation', u'TRACON Pharmaceuticals Inc', u'EpiCept Corp', u'Checkpoint Therapeutics Inc', u'ImmunoGen Inc', u'Oxford BioTherapeutics', u'Jazz Pharmaceuticals plc', u'Navigate BioPharma Services Inc', u'Astex Therapeutics Ltd', u'Actinium Pharmaceuticals Inc', u'Altor BioScience Corp', u'Regen BioPharma Inc', u'Micromet Inc', u'Pharmion Corp', u'Boehringer Ingelheim Corp', u'Adicet Bio Inc', u'CerRx Inc', u'Yale University', u'Genfit SA', u'Infinity Pharmaceuticals Inc', u'Juno Therapeutics Inc', u'BioTheryX Inc', u'MilleGen SA', u'Innovent Biologics Inc', u'Wacker Biotech GmbH', u'Roche GlycArt Ag', u'Roswell Park Cancer Institute', u'Solasia Pharma KK', u'Denovo Biopharma LLC', u'Chugai Pharmaceutical Co Ltd', u'BioNano Genomics Inc', u'Cancer Research UK', u'Genentech Inc', u'MannKind Corp', u'Nippon Shinyaku Co Ltd', u'Progenra Inc', u'Mesoblast Ltd', u'Otsuka Pharmaceutical Co Ltd', u'Johnson & Johnson', u'Miltenyi Biotec GmbH', u'Stemline Therapeutics Inc', u'OncBioMune Pharmaceuticals Inc', u'Coley Pharmaceutical Group Inc', u'Institut Paoli-Calmettes IPC', u'Massachusetts General Hospital Cancer Center', u'TRION Pharma GmbH', u'University Of Southampton', u'Epizyme Inc', u'CMC Biologics Inc', u'Yuhan Corp', u'Verastem Inc', u'Undisclosed', u'Pathway Therapeutics Ltd', u'Cellectar Biosciences Inc', u'ImmunoCellular Therapeutics Ltd', u'Merck & Co Inc', u'AmorChem LP', u'Nanotherapeutics Inc', u'Sanofi', u'Vertex Pharmaceuticals Inc', u'CTI BioPharma Corp', u'Eli Lilly & Co', u'Strategia Therapeutics Inc', u'Immune Pharmaceuticals Inc', u'FORMA Therapeutics Inc', u'Cascade Lifesciences Inc', u'PharmaMar SA', u'CSL Ltd', u'bluebird bio Inc', u'Bio Analytical Research Corp', u'ChemGenex Pharmaceuticals Ltd', u\"Children's Hospital of Los Angeles\", u'Weizmann Institute of Science', u'Be The Match BioTherapies', u'Ascalon International Inc', u'Kissei Pharmaceutical Co Ltd', u'Case Western Reserve University', u'Octagon Research Solutions', u'University of Bradford', u'Janssen Biotech Inc', u'Mirna Therapeutics Inc', u'AstraZeneca plc', u'Trethera Corp', u'Rhizen Pharmaceuticals SA', u'The Leukemia & Lymphoma Society', u'Gilead Sciences Inc', u'Genencor International Inc', u'Caladrius Biosciences Inc', u'Vion Pharmaceuticals Inc', u'Pieris Pharmaceuticals Inc', u'Pluristem Therapeutics Inc', u'Yissum Research Development Co', u'Columbia University', u'Johns Hopkins University', u'Humboldt University of Berlin', u'Xynomic Pharmaceuticals', u'TopoTarget A/S', u'Immatics Biotechnologies GmbH', u'BioLineRx Ltd', u'Celyad', u'Tolero Pharmaceuticals Inc', u'NCIC Clinical Trials Group', u'Innate Pharma SA', u'Mabion SA', u'AbbVie Inc', u'Apogenix GmbH', u'Genmab A/S', u'Magenta Therapeutics Inc', u'Rockefeller University', u'University of Pennsylvania', u'MEI Pharma Inc', u'HemaQuest Pharmaceuticals Inc', u'H Lee Moffitt Cancer Center and Research Institute', u'Fred Hutchinson Cancer Research Center', u'NYU Langone Medical Center', u'CRISPR Therapeutics', u'OncoPep Inc', u'National Comprehensive Cancer Network', u'Ligand Pharmaceuticals Inc', u'Mundipharma International Corp Ltd', u'MacroGenics Inc', u'Phylogica Ltd', u'Albert Einstein College of Medicine', u'Servier', u'Perseus Proteomics Inc', u'Abeona Therapeutics Inc', u'Molecular Templates Inc', u'Hopital Maisonneuve-Rosemont', u'Bristol-Myers Squibb Co', u'MaxCyte Inc', u'Aqualis ASA', u'MorphoSys AG', u'CELLforCURE', u'Sanofi Genzyme', u'Kiadis Pharma Netherlands BV', u'BioInvent International AB', u'Jasco Pharmaceuticals LLC', u'The Menarini Group', u'Onyx Pharmaceuticals Inc', u'Hospira Inc', u'Intellia Therapeutics Inc', u'Celgene Corp', u'University of Chicago', u'Memgen LLC', u'Cornell University', u'University of Miyazaki', u'Objectif Recherche VACcin Sida', u'Exact Sciences Corp', u'Humanigen Inc', u'Adaptimmune Therapeutics plc', u'Meda AB', u'Hebrew University of Jerusalem', u'University of Oxford', u'Walter and Eliza Hall Institute of Medical Research', u'Neovii Biotech GmbH', u\"Brigham & Women's Hospital\", u'BeiGene Co Ltd', u'MultiPlan Inc', u'Gamida Cell Ltd', u'3M Co', u'Cancer Prevention and Research Institute of Texas', u'ProMIS Neurosciences Inc', u'ProMab Biotechnologies Inc', u'Morvus Technology Ltd', u'CuraGen Corp', u'Intellikine Inc']), u'Dermatitis': set([u'Perrigo Co Ltd', u'Apeiron Biologics GmbH', u'Galenica AG', u'Silence Therapeutics plc', u'Ceragenix Pharmaceuticals Inc', u'Signum Biosciences Inc', u'4SC Discovery GmbH', u'Commonwealth Government', u'GlaxoSmithKline plc', u'Quintiles Transnational Corp', u'Bayer Schering Pharma AG', u'Torii Pharmaceutical Co Ltd', u'Pantec Biosolutions AG', u'Onyvax Ltd', u'FAES Farma SA', u'Molnlycke Health Care AB', u'Takeda Oncology', u'Roche Holding AG', u'Cipher Pharmaceuticals Inc', u'SBI Biotech Co Ltd', u'TOLMAR Therapeutics Inc', u'Avidas Pharmaceuticals LLC', u'ANI Pharmaceuticals Inc', u'Orexo AB', u'Stanford Rook Ltd', u'Foamix Pharmaceuticals Ltd', u'UCB SA', u'R-Tech Ueno Ltd', u'Maruho Co Ltd', u'YM BioSciences Inc', u'Northern Sydney Area Health Service', u'Abbott Laboratories', u'Eisai Co Ltd', u'Therapeutics Inc', u'Biosintetica Farmaceutica Ltda', u'Ewopharma AG', u'Renaissance Acquisition Holdings LLC', u'Imaginative Research Associates Inc', u'Promics Pty Ltd', u'Massachusetts General Hospital', u'Inflazyme Pharmaceuticals', u'Heron Therapeutics Inc', u'Sothys USA', u'Concordia Pharmaceuticals Inc', u'Welichem Biotech Inc', u'Grelan Pharmaceutical Co Ltd', u'Allergan Inc', u'Ferrer Internacional SA', u'Lupin Ltd', u'Recordati SpA', u'ProtoKinetix Inc', u'Royalty Pharma', u'Rockefeller University', u'American Skin Association', u'ITR Laboratories Canada Inc', u'Ziarco Pharma Ltd', u'Journey Medical Corp', u'arGEN-X NV', u'Institut Biochimique SA', u'Undisclosed', u'Sakai Chemical Industry Co Ltd', u'Daewoong Pharmaceutical Co Ltd', u'LEO Pharma A/S', u'Rochal Industries Llp', u'Astion Pharma A/S', u'Eli Lilly & Co', u'Immune Pharmaceuticals Inc', u'The University of Manchester Intellectual Property Ltd', u'Warner Chilcott plc', u'NicOx SA', u'Stiefel Research Australia Pty Ltd', u'Stiefel', u'Pfizer Inc', u'LaRon Pharma Inc', u'Novozymes GroPep Ltd', u'Corixa Corp', u'Yissum Research Development Co', u'Estero-Anstalt', u'Block Drug Co Inc', u'Maxim Pharmaceuticals Inc', u'Shionogi Inc', u'Australian Government', u'BioPro Pharmaceutical Inc', u'Ligand Pharmaceuticals Inc', u'Helixir Co Ltd', u'Discovery BioMed Inc', u'National Institutes of Health', u'Grupo Uriach', u'Afecta Pharmaceuticals', u'PreCision Dermatology Inc', u'AmbioPharm Inc', u'The Menarini Group', u'Astellas Pharma Inc', u'Polymun Scientific Immunobiologische Forschung GmbH', u'Brickell Biotech Inc', u'IDOKI SCF Technologies SL', u'Tabuk Pharmaceutical Manufacturing Co', u'Aqua Pharmaceuticals LLC', u'National Kyushu Medical Center', u'Innovir Laboratories Inc', u'Takeda Pharmaceutical Co Ltd', u'Bri Biopharmaceuticals Research Inc', u'BIAL Group', u'Chemex Pharmaceuticals Inc', u'BioCryst Pharmaceuticals Inc', u'Beijing Wenfeng Tianji Pharmaceuticals Co Ltd']), u'Anaplasticastrocytoma': set([u'Orbus Therapeutics', u'DSG Inc', u'Sanofi', u'The University of Aston In Birmingham']), u'Rhabdomyosarcoma': set([u'Apricity Therapeutics Inc', u'Exelixis Inc', u'Ignyta Inc', u'National Cancer Institute', u'Cancer Research UK', u'Genentech Inc']), u'Bullouspemphigoid': set([u'TxCell SA', u'University of Lubeck']), u'Pancreastransplantrejection': set([u'National Institute of Allergy and Infectious Diseases', u'Nordic Network for Clinical Islet Transplantation', u'TikoMed AB']), u'Bonedevelopmentdisorder': set([u'University of California', u'Fate Therapeutics Inc']), u'Radiationsickness': set([u'Sanofi-Aventis US LLC', u'University of Texas Medical Branch at Galveston', u'Medisyn Technologies Inc', u'Humanetics Corp', u'United States Army Medical Research Institute of Chemical Defense', u'Aeolus Pharmaceuticals Inc', u'Maxygen Inc', u'GlaxoSmithKline plc', u'Bolder BioTechnology Inc', u'Ceramide Therapeutics LLC', u'Immuron Ltd', u'Heyltex Corp', u'Cleveland BioLabs Inc', u'IsoTis SA', u'University of Pittsburgh', u'Leiden University Medical Center', u'Fred Hutchinson Cancer Research Center', u'Apotex Inc', u'University of Rochester', u'Biotempt BV', u'Pinnacle Biologics Inc', u'St Petersburg Institute of Experimental Medicine', u'RxBio Inc', u'HealthCare Asia Pharmaceuticals Inc', u'Virginia Commonwealth University', u'Sanofi Genzyme', u'Purdue Pharma LP', u'Eukarion Inc', u'Defense Advanced Research Projects Agency', u'US Department of Defense', u'Zhejiang Hisun Pharmaceutical Co Ltd', u'Georgetown University', u'National Institute of General Medical Sciences', u'Neumedicines Inc', u'Thomas Jefferson University', u'Amgen Inc', u'Biomimetix Jv Llc', u'Peptor Ltd', u'US Health and Human Services Department', u'Leadiant Biosciences Inc', u'National Cancer Institute', u'Hadassah Medical Organization', u'University of Maryland', u'Mount Sinai Hospital', u'Osiris Therapeutics Inc', u'Massachusetts General Hospital', u'University of Rochester Medical Center', u'Fukushima Medical University', u'ALZA Corp', u'Cleveland Clinic Foundation', u'Qrono Inc', u'Symbion Research International', u'Innovative Medical Management', u'MegaPharm Ltd', u'Shriners Hospitals for Children', u'Numoda Corp', u'Exponential Biotherapies Inc', u'Chrysalis BioTechnology Inc', u'Pluristem Therapeutics Inc', u'Johnson Matthey Pharma Services', u'Steward Cross Pte Ltd', u'Orphan Medical Inc', u'Terapio Corp', u'Ore Pharmaceutical Holdings Inc', u'GENESIS Pharma SA', u'Armed Forces Radiobiology Research Institute', u'Medimmune Oncology Inc', u'Harvard Medical School', u'Biothera Pharmaceuticals Inc', u'IDIS Ltd', u'SynCo BioPartners', u'National Aeronautics & Space Administration', u'Cangene Corp', u'SRI International', u'Onconova Therapeutics Inc', u'XOMA Corp', u'US Government', u'Cellectar Biosciences Inc', u'ImmuneRegen BioSciences Inc', u'Henry M Jackson Foundation for the Advancement of Military Medicine', u'Cantex Pharmaceuticals Inc', u'MRIGlobal', u'Nanotherapeutics Inc', u'Candian Chemical, Biological, Radiological or Nuclear (CBRN) Research and Technology Initiative', u'BCN Biosciences LLC', u'Arizona State University', u'DiaCarta LLC', u'Bioincept LLC', u'Albany Molecular Research Inc', u'Long Island University', u'Soligenix Inc', u'Valentis Inc', u'Cellerant Therapeutics Inc', u'University of California Los Angeles', u'Dxterity Diagnostics', u'Tamir Biotechnology Inc', u'Tego BioSciences Corp', u'Caladrius Biosciences Inc', u'Canopus BioPharma Inc', u'Akorn Inc', u'Capture Pharmaceuticals Inc', u'University of Arkansas for Medical Sciences', u'Harbor Therapeutics Inc', u'Baylor College of Medicine', u'EpiStem Ltd', u'Uniformed Services University of the Health Sciences', u'National Institute of Allergy and Infectious Diseases', u'Walter Reed Army Institute of Research', u'Mundipharma International Corp Ltd', u'BL&H Co Ltd', u'Albert Einstein College of Medicine', u'University of Wisconsin-Madison', u'National Institutes of Health', u'Food and Drug Administration', u'Pacific Healthcare Thailand Co Ltd', u'Proteome Systems Inc', u'Inflammatory Response Research Inc', u'CJ Corp', u'Roswell Park Cancer Institute', u'Genedrive plc', u'University of Chicago', u'Medical University of South Carolina', u'Duke University', u'BioDiem Ltd', u'Institut Pasteur', u'TheraSource LLC', u'diaDexus Inc', u'Hameln Pharmaceuticals GmbH', u'Indiana University', u'Radiation Control Technologies', u'Thallia Pharmaceuticals SA', u'Defense Threat Reduction Agency']), u'Bacterialrespiratorytractinfection': set([u'Alaxia Biotechnologies', u'Oscient Pharmaceuticals Corp', u'Ciba-Geigy (Japan) Ltd', u'Meiji Seika Pharma Co Ltd', u'Chugai Pharmaceutical Co Ltd', u'JW Pharmaceutical Corp', u'Nektar Therapeutics', u'Grupo Praxis', u'Advanced Life Sciences Holdings Inc', u'Grunenthal GmbH', u'National Institute of Allergy and Infectious Diseases', u'Cystic Fibrosis Foundation Therapeutics Inc', u'European Commission', u'Abbott Laboratories', u'LG Life Sciences Ltd', u'Trine Pharmaceuticals Inc', u'Polydex Pharmaceuticals Ltd', u'Cempra Inc', u'Bayer Korea Ltd', u'US Health and Human Services Department', u'Eddingpharm Inc', u'Novartis AG', u'Aradigm Corp', u'Undisclosed', u'US Government', u'Novexel SA', u'Aventis Pharma AG', u'Lepetit International Inc', u'Zeneca Group plc', u'Arch Biopartners Inc', u'INSERM', u'Biovista Inc', u'Purdue Pharma LP', u'Melinta Therapeutics Inc', u'Chong Kun Dang Pharmaceutical Corp', u'Profile Therapeutics Inc', u'Eli Lilly & Co', u'The Menarini Group', u'University of Pennsylvania', u'TAP Pharmaceuticals Inc', u'Bayer AG', u'Sumitomo Pharmaceuticals Co Ltd', u'Sungjee IBPharm', u'SmithKline Beecham Corp', u'Toyama Chemical Co Ltd', u'ALZA Corp', u'Biovail Corp', u'Dong Wha Pharmaceutical Co Ltd', u'NovaBiotics Ltd', u'Axentis Pharma AG', u'Nanotherapeutics Inc', u'Forest Laboratories UK Ltd', u'Only For Children Pharmaceuticals', u'Enanta Pharmaceuticals Inc', u'Canadian Department of National Defence', u'Genaera Corp', u'Cook Pharmaceutical Solutions', u'Genesoft Inc', u'LG Chem Ltd', u'Cubist Pharmaceuticals Inc', u'AstraZeneca plc', u'Pfizer Inc', u'BCY LifeSciences Inc', u'Catalent Inc', u'Yuhan Corp', u'Mpex Pharmaceuticals Inc', u'Novosci', u'Lilly China Research & Development Co Ltd', u'Shionogi & Co Ltd', u'Vernalis plc', u'Dura Pharmaceuticals Inc', u'Dr Reddy\\u2019s Research and Development BV', u'Teva Pharma BV (Netherlands)', u'Defense Threat Reduction Agency']), u'Lipoproteinlipasedeficiency': set([u'Academic Medical Center, University of Amsterdam', u'Synageva BioPharma Corp', u'Universita degli Studi di Roma La Sapienza', u'US Department of the Treasury', u'Chiesi Farmaceutici SpA', u'AmpliPhi Biosciences Corp', u'Protein Sciences Corp', u'uniQure BV', u'University of British Columbia', u'Xenon Pharmaceuticals Inc', u'Netherlands Government', u'Aventis Pharmaceuticals Inc', u'Amsterdam Molecular Therapeutics BV', u'Medison Pharma Ltd', u'Asklepios Biopharmaceutical Inc']), u'Breastdisease': set([u'Daiichi Seiyaku Co Ltd', u'GE Healthcare', u'Atossa Genetics Inc', u'Bayer Schering Pharma AG', u'Sectra Imtec Ab', u'BHR Pharma LLC', u'University of California San Diego', u'ASCEND Therapeutics Inc', u'Laboratoires Besins International', u'Imaging Diagnostic Systems Inc', u'Massachusetts General Hospital', u'Besins Healthcare SA', u'EPIX Pharmaceuticals Inc']), u'Chlamydiapneumoniaeinfection': set([u'Ganymed Pharmaceuticals AG', u'ActivBiotics Inc', u'Concord Biosciences LLC', u'Kyowa Hakko Bio Co Ltd', u'Chiron PathoGenesis', u'Genset SA', u'Argonex Pharmaceuticals Inc', u'Corixa Corp', u'Kantonsspital St Gallen', u'Daiichi Sankyo Co Ltd', u'Pfizer Vaccines', u'Kaneka Corp', u'GlaxoSmithKline plc']), u'Neurobehavioraldisorder': set([u'Mindstrong Health Inc', u'Cannabis Science Inc', u'Endocan Corp', u'BlackThorn Therapeutics Inc', u'Intra-Cellular Therapies Inc', u'Siegfried Holding Ltd', u'University of California San Francisco']), u'Erythema': set([u'BioAdvance', u'Helsinn Group', u'SansRosa Pharmaceutical Development Inc', u'Advancell']), u'Alphamannosidosis': set([u'Zymenex A/S', u'The European Union', u'European Commission', u'H:S Rigshospitalet']), u'Bacterialendocarditis': set([u'Emisphere Technologies Inc', u'Cubist Pharmaceuticals Inc', u'Chiron Corp', u'Undisclosed', u'Sunovion Pharmaceuticals Canada Inc', u'Royalty Pharma', u'TTY Biopharm Co Ltd', u'Medison Pharma Ltd']), u'Gastricmotilitydisorder': set([u'Nippon Shinyaku Co Ltd', u'Novo Nordisk A/S', u'Paladin Labs Inc', u'Abbott Laboratories', u'Zeria Pharmaceutical Co Ltd', u'Eisai Co Ltd', u'Astra AB', u'Dainippon Pharmaceutical Co Ltd', u'Hokuriku Seiyaku KK', u'Ben Venue Laboratories Inc', u'Novartis AG', u'ARYx Therapeutics Inc', u'Sumitomo Dainippon Pharma Co Ltd', u'Daewoong Pharmaceutical Co Ltd', u'Elan Corp plc', u'Merck & Co Inc', u'Procter & Gamble Pharmaceuticals Inc', u'ZymoGenetics Inc', u'National Institutes of Standards and Technology', u'Mitsubishi-Tokyo Pharmaceuticals Inc', u'Astellas Pharma Inc', u'Bristol-Myers Squibb Co', u'Valeant Pharmaceuticals International Inc', u'Dynogen Pharmaceuticals Inc', u'Depomed Inc', u'Kosan Biosciences Inc', u'Fujisawa Synthelabo Co Ltd', u'Glaxo Group Ltd', u'Allergan Inc', u'Janssen Pharmaceutica NV', u'Aptalis Pharma Inc', u'Pfizer Inc', u'Boehringer Ingelheim Corp', u'Lupin Ltd', u'Seattle Life Sciences', u'Takeda Pharmaceutical Co Ltd', u'Edusa Pharmaceuticals Inc', u'Panos Therapeutics Ltd']), u'Angina': set([u'Daiichi Seiyaku Co Ltd', u\"Dr Reddy's Laboratories Ltd\", u'Speedel Holding AG', u'US Government', u'Telios Pharmaceuticals Inc', u'Asahi Kasei Corp', u'Baxter International Inc', u'University of Kuopio', u'Kirin Brewery Co Ltd', u'Inyx Inc', u'SamChunDang Pharm Co Ltd', u'Allos Therapeutics Inc', u'Digital Gene Technologies Inc', u'Mist Acquisition LLC', u'Iroko Pharmaceuticals LLC', u'Breckenridge Pharmaceutical Inc', u'GlaxoSmithKline plc', u'Quintiles Transnational Corp', u'Ministry of Health, Welfare and Family Affairs', u'Bayer Schering Pharma AG', u'AstraZeneca Pharmaceuticals LP', u'Aspen PharmaCare Australia Pty Ltd', u'SICOR Inc', u'Taxus Cardium Pharmaceuticals Group', u'Immunex Corp', u'Cranford Pharmaceuticals LLC', u'University of South Florida', u'Par Pharmaceutical Co Inc', u'Jilin Huakang Pharmaceutical Co Ltd', u'Academy of Traditional Chinese Medical Science & Medicine of Jilin Province', u'Hovione SA', u'Ono Pharmaceutical Co Ltd', u'Takeda Oncology', u'Chiesi USA Inc', u'Mitsubishi Tanabe Pharma Corp', u'Peptisyntha Inc', u'Shandong Disha Pharmaceutical Co Ltd', u'ANI Pharmaceuticals Inc', u'Sankyo Co Ltd', u'Handok Inc', u'Medicure Inc', u'AstraZeneca plc', u'Pfizer Inc', u'G Pohl-Boskamp GmbH & Co KG', u'Reliant Pharmaceuticals Inc', u'Universidade Federal de Sao Paulo - UNIFESP', u'Akrimax Pharmaceuticals LLC', u'Aralez Pharmaceuticals Inc', u'Amgen Inc', u'The Procter & Gamble Co', u'Schering AG', u'Daiichi Sankyo Co Ltd', u'Abbott Laboratories', u'Mochida Pharmaceutical Co Ltd', u'NovaDel Pharma Inc', u'Eisai Co Ltd', u'NitrOSystems Inc', u'Schwarz Pharma Inc', u'Zeneus Pharma Ltd', u'Novartis AG', u'Merck KGaA', u'Teva Pharmaceutical Industries Ltd', u'Sanofi-Synthelabo', u'Zeria Pharmaceutical Co Ltd', u'Samyang Corp', u'Prism Pharmaceuticals Inc', u'UCB Pharma GmbH', u'Bristol-Myers Squibb Pharma Co', u'Enzon Pharmaceuticals Inc', u'Imperial Chemical Industries Plc', u'Dendreon Corp', u'Insys Therapeutics Inc', u'Les Laboratoires Servier', u'Rotta Research Lab SpA', u'UCB SA', u'Lavipharm SA', u'Knoll GmbH', u'Galenica SA (Greece)', u'Glaxo Group Ltd', u'Encysive Pharmaceuticals Inc', u'Synthelabo-Lavipharm AE', u'Laboratoires Delagrange', u'Ark Therapeutics Group plc', u'Lusochimica SpA', u'Navamedic ASA', u'Roche Palo Alto', u'Recordati SpA', u'Pfizer Hellas AE', u'Selectus Pharmaceuticals Inc', u'Catalytica Inc', u'Roche Holding AG', u'CellPraxis Bioengenharia', u'Chugai Pharmaceutical Co Ltd', u'bioRASI LLC', u'Genentech Inc', u'Espero Pharmaceuticals Inc', u'Mitsubishi Pharma Corp', u'NOF Corp', u'Alexion Pharmaceuticals Inc', u'LTL Pharma Co Ltd', u'Baxter Healthcare Corp', u'Synthelabo SA', u'St Elizabeths Medical Center of Boston Inc', u'Undisclosed', u'Merck & Co Inc', u'COR Therapeutics Inc', u'Sanofi', u'Blue Note Pharmaceuticals BV', u'Eli Lilly & Co', u'FSC Laboratories Inc', u'Japan Tobacco Inc', u'Bayer AG', u'Nissan Chemical Industries Ltd', u'Kyowa Hakko Kirin Co Ltd', u'Penwest Pharmaceuticals Co', u'Hyundai Pharmaceutical', u'China Medical System Holdings Ltd', u'Janssen Biotech Inc', u'Actient Pharmaceuticals LLC', u'Almirall Prodesfarma SA', u'Aptalis Pharma Inc', u'CoTherix Inc', u'Fournier Pharma', u'Shanghai No 1 Biochemical & Pharmaceutical Co Ltd', u'Tsumura & Co', u'Sanwa Kagaku Kenkyusho Co Ltd', u'Nippon Shinyaku Co Ltd', u'Hoffmann-La Roche Inc', u'LG Life Sciences Ltd', u'Laboratorios Farmaceuticos Rovi SA', u'Gilead Palo Alto Inc', u'Yamanouchi Pharmaceutical Co Ltd', u'Tribute Pharmaceuticals Canada Inc', u'ViroMed Co Ltd', u'Euthymics Bioscience Inc', u'Berlex Biosciences', u'Merck SA', u'Valens Pharma Ltd', u'Molecumetics Ltd', u'SmithKline Beecham plc', u'Taisho Pharmaceutical Co Ltd', u'Dainippon Pharmaceutical Co Ltd', u'Sanofi KK', u'UCB Celltech', u'Dendreon San Diego LLC', u'Mitsubishi-Tokyo Pharmaceuticals Inc', u'TopRidge Pharma Ltd', u'Servier', u'Molecular Medicine BioServices Inc', u'Endovasc Inc', u'Sun Pharmaceutical Industries Ltd', u'Sumitomo Pharmaceuticals Co Ltd', u'Bristol-Myers Squibb Co', u'Elan Corp plc', u'Napp Pharmaceutical Group Ltd', u'The Medicines Company', u'Jilin University', u'Watson Laboratories Inc', u'Asahi Kasei Pharma Corp', u'MSD Japan', u'Cedars-Sinai Medical Center', u'ICOS Corp', u'The Menarini Group', u'MGI Pharma Inc', u'ESP Pharma Inc', u'Astellas Pharma Inc', u'Canyon Pharmaceuticals Inc', u'Zambon Co SpA', u'Biovail Corp', u'Teijin Ltd', u'Ranbaxy Laboratories Ltd', u'Meda AB', u'Aetas Pharma Co Ltd', u'Teva Canada Ltd', u'Instituto Invest y Desarrollo Quimico-Biologico SA', u'Jiangsu Kefeiping Medicine Co Ltd', u'MannKind Corp', u'Angiogenix Ltd', u'University of Alberta', u'Tripos Inc', u'Nuvelo Inc', u'GD Searle & Co', u'Ercopharm A/S']), u'Osteitis': set([u'MD Biosciences GmbH', u'Medisyn Technologies Inc']), u'Osteomyelitis': set([u'Merus Labs International Inc', u'BTG plc', u'Mallinckrodt Inc', u'Biomet Merck GmbH', u'Codevax Inc', u'National Institutes of Health', u'Resolution Pharmaceuticals Inc', u'MBC Pharma Inc', u'CIS Bio International SAS', u'AM-Pharma Holding BV', u'Undisclosed', u'DRAXIMAGE', u'National Institute of Allergy and Infectious Diseases', u'Royalty Pharma', u'Iroko Pharmaceuticals LLC', u'Palatin Technologies Inc']), u'Systemicinflammatoryresponsesyndrome': set([u'Curetis AG', u'Thermo Fisher Scientific Inc', u'Exponential Biotherapies Inc', u'Novartis AG', u'Albert Einstein College of Medicine', u'Armaghan Salamat Kish Group', u'Biotempt BV', u'EpiStem Ltd', u'CytoSorbents Corp', u'National Institute of Allergy and Infectious Diseases', u'Cardinal Therapeutics Inc', u'Cyon Therapeutics', u'Acumen Research Laboratories Pte Ltd', u'Singulex Inc']), u'Juninvirusinfection': set([u'National Institute of Allergy and Infectious Diseases', u'Mapp Biopharmaceutical Inc']), u'Trichophytoninfection': set([u'Kyorin Pharmaceutical Co Ltd', u'SpectraCure AB', u'PhotoBioChem NV', u'Maruho Co Ltd', u'Shiseido Co Ltd']), u'Asthmaattack': set([u'McGill University', u'VINNOVA', u'AmorChem LP', u'DuoCort Pharma AB']), u'Sarcopenia': set([u'Kansas State University', u\"Centre de Recherche en Nutrition Humaine d'Auvergne\", u'Human Longevity Inc', u'GlaxoSmithKline plc', u'GTx Inc', u'Betagenon AB', u'Baltic Bio AB', u'Merck & Co Inc', u'Emmyon Inc', u'Neurotune AG', u'University of Applied Sciences of Eastern Switzerland', u'Five Prime Therapeutics Inc', u'Anagenesis Biotechnologies', u'3i nature', u'Cloud Pharmaceuticals Inc', u'Applications Sante des Lipides', u'National Institute on Aging', u'Friedrich-Alexander-Universitaet Erlangen-Nuernberg', u'BIOPHYTIS', u'Sanofi', u'European Eurostars Programme', u'Boehringer Ingelheim Corp', u'Patheon Inc', u'Microcoat Biotechnologie Gmbh', u'Metabrain Research', u'Institut National de la Recherche Agronomique', u'Celgene Cellular Therapeutics', u'MYOS RENS Technology Inc']), u'Glioblastoma': set([u'Bradmer Pharmaceuticals Inc', u'Karolinska Institutet', u'Weill Medical College of Cornell University', u'Brown University', u'National Comprehensive Cancer Network', u'Regeneron Pharmaceuticals Inc', u'Aurora Biopharma Inc', u'Cancer Research Society', u'Rutgers Cancer Institute of New Jersey', u'R-Biopharm Ag', u'EMD Serono Inc', u'Cell and Gene Therapy Catapult', u'Ben and Catherine Ivy Foundation', u'California Institute of Regenerative Medicine', u'Swiss Federal Office of the Commission for Technology and Innovation', u'Lustgarten Foundation', u'Pharmacyclics Inc', u'GlaxoSmithKline plc', u'QIMR Berghofer Medical Research Institute', u'Inovio Pharmaceuticals Inc', u'Intensity Therapeutics Inc', u'Ohio State University Comprehensive Cancer Center', u'Kalgene Pharma Inc', u'Duke University Medical Center', u'Oryx GmbH & Co KG', u'Hackensack University Medical Center', u'University of Auckland', u'University of Florida', u'University of Chicago', u'Stanford University', u'MedImmune LLC', u'Curtana Pharmaceuticals Inc', u'Inspyr Therapeutics Inc', u'Sangamo Therapeutics Inc', u'Veristat, Inc.', u'University of Pennsylvania', u'Fred Hutchinson Cancer Research Center', u'Annias Immunotherapeutics Inc', u'Samsung Medical Center (SMC)', u'Hy BioPharma Inc', u'EGEN Inc', u'Aduro BioTech Inc', u'Roche Holding AG', u'Threshold Pharmaceuticals Inc', u'Bexion Pharmaceuticals LLC', u'Argon Pharma SL', u'Healthquest Pharma Ltd', u'Neon Therapeutics', u'Omniox Inc', u'Peregrine Pharmaceuticals Inc', u'Kite Pharma Inc', u'Sun Pharmaceutical Industries Ltd', u'Netherlands Cancer Institute', u'Terry Fox Foundation', u'TESARO Inc', u'Diffusion Pharmaceuticals LLC', u'Accurexa Inc', u'California Pacific Medical Center', u'Massachusetts General Hospital', u'Providence Health & Services - Oregon', u'AstraZeneca plc', u'WuXi Biologics', u'Emory University', u'University of California San Francisco', u'Medicell Co', u'Memorial Sloan-Kettering Cancer Center', u'Dana-Farber Cancer Institute Inc', u'Scripps Research Institute', u'Discovery Genomics Inc', u'University of Pisa', u'Karyopharm Therapeutics Inc', u'Ecole Nationale Superieure De Chimie De Montpellier', u'PTC Therapeutics Inc', u'Evotec AG', u'Wistar Institute of Anatomy & Biology', u'Green Cross Cell Corp', u'Iovance Biotherapeutics Inc', u'McMaster University', u'The University of Aston In Birmingham', u'Medarex Inc', u'National Institute of Neurological Disorders and Stroke', u'Alliance for Clinical Trials in Oncology', u'Infuseon Therapeutics, Inc', u'Accelerate Brain Cancer Cure', u'SIRO Clinpharm Private Limited', u'Sirnaomics Inc', u'Novella Clinical', u'Nippon Kayaku Co Ltd', u'Universita degli Studi di Roma La Sapienza', u'Ohio State University', u'University of Virginia', u'Nankai University', u'TransCure bioServices', u'National Cancer Institute', u'Center for Innovative Tech', u'Medicenna Therapeutics Pte Ltd', u'Tempus Inc', u'Panacea Pharmaceuticals Inc', u'N.N. Alexandrov National Cancer Centre of Belarus for Oncology and Medical Radiology', u'NeoPharm Inc', u'PharmaCell', u'Triphase Accelerator Corp', u'Teva Pharmaceutical Industries Ltd', u'Barrow Neurological Insitute', u'Hanmi Pharmaceutical Co Ltd', u'University of Texas Health Science Center San Antonio', u'National Brain Tumor Society', u'CytomX Therapeutics Inc', u'CANbridge Life Sciences Ltd', u'University of Minnesota', u'The Canadian Brain Tumour Consortium (CBTC)', u'CryoPort Inc', u'Itt Corp', u'Oklahoma Medical Research Foundation', u'Institut du Cerveau et de la Moelle epiniere', u'Oncoceutics Inc', u'Amoy Diagnostics Co Ltd', u'Yeda Research and Development Co Ltd', u'Sun Yat-Sen University', u'US Government', u'Insys Therapeutics Inc', u'Cleveland Clinic Foundation', u'Israel Innovation Authority', u'Wellcome Trust', u'Nottingham Trent University', u'German Government', u'Qiagen NV', u'Immunomic Therapeutics Inc', u'Live Like Bella Childhood Cancer Foundation', u'Millennium Pharmaceuticals Ltd', u'Augusta Pharmaceuticals Inc', u'MabPrex Inc', u'WuXi PharmaTech (Cayman) Inc', u'The Knut and Alice Wallenberg Foundation', u'University of Portsmouth', u'University of Southern California', u'CytRx Corp', u'National Research Council of Canada', u'Johns Hopkins University', u'Asan Medical Center', u'Hospira Adelaide Pty Ltd', u'University of California San Diego', u'Massachusetts General Hospital Cancer Center', u'Accium Biosciences Inc', u'Columbia University Health Sciences', u'BioInvent International AB', u'Lixte Biotechnology Holdings Inc', u'Cytopia Ltd', u'Heroes of Hope', u'Debiopharm SA', u'Regulus Therapeutics Inc', u'Orphan Australia', u'Tocagen Inc', u'G-treeBNT Co Ltd', u'Celltex Therapeutics Corp', u'SOM Biotech SL', u'Terpenoid Therapeutics Inc', u'Nativis Inc', u'University of North Carolina', u'Cancer Research UK', u'Genentech Inc', u'University of Milan', u'Mustang Bio Inc', u'ThromboGenics NV', u'Harvard Medical School', u'Mayo Clinic Foundation', u'Natural Sciences and Engineering Research Council of Canada', u'NantCell Inc', u'MGI GP Inc', u'Symphony Evolution Inc', u'Deciphera Pharmaceuticals LLC', u'Stason Pharmaceuticals Inc', u'Alcyone Lifesciences Inc', u'Boots Hoechst Celanese', u'Wuhan Yuanzheng Century Pharmaceutical Co Ltd', u'Sentinel Oncology Ltd', u'Weizmann Institute of Science', u'Republic of Korea Government', u'Eden Biodesign Ltd', u'Merck KGaA', u'Undisclosed', u'Nemucore Medical Innovations Inc', u'JW CreaGene Inc', u'University of Alabama at Birmingham', u'Polybiocept Ab', u'ImmunoCellular Therapeutics Ltd', u'Provid Pharmaceuticals Inc', u'University of California', u'Diosynth Biotechnology', u'Cantex Pharmaceuticals Inc', u'Atara Biotherapeutics Inc', u'Merck & Co Inc', u'Celonic AG', u'Sanofi', u'Medison Pharma Ltd', u'Columbia University', u'Ajou University', u'Celsion Corp', u'CASI Pharmaceuticals Inc', u'BiPar Sciences Inc', u'Novogen Ltd', u'Agenus Inc', u'Calibrant Biosystems Inc', u'IntelliSyn Pharma', u'Deutsches Krebsforschungszentrum', u'University Hospital Heidelberg', u'Cellmid Ltd', u'Helen F Graham Cancer Center at Christiana Care', u'MRI Interventions Inc', u'Mayo Clinic, Minnesota', u'Kadmon Pharmaceuticals LLC', u'Paradigm', u'Jonsson Comprehensive Cancer Center', u'Case Western Reserve University', u'University of Bradford', u'Universidad Complutense de Madrid', u'MDS Nordion', u'OncoSynergy Inc', u'NanoString Technologies Inc', u'Biomimetix Jv Llc', u'Pfizer Inc', u'University of Rochester', u'Midatech Pharma PLC', u'DelMar Pharmaceuticals Inc', u'Northwest Biotherapeutics Inc', u'Advanced Cancer Therapeutics', u'Cavion LLC', u'biOasis Technologies Inc', u'Yale University', u'University of Utah', u'Virginia Commonwealth University', u'FCB-Pharmicell Co Ltd', u'Onyvax Ltd', u'Health Research Institute of Santiago de Compostela', u'Broad Institute Inc', u'Eli Lilly & Co', u'Immatics Biotechnologies GmbH', u'Washington University in St Louis', u'Momenta Pharmaceuticals Inc', u'Translational Genomics Research Institute', u'Massachusetts Institute of Technology', u'New York University School of Medicine, US', u'Duke University School of Medicine', u'The European Union', u'VINNOVA', u'Apogenix GmbH', u'Genmab A/S', u'CHA General Hospital', u'PureMHC LLC', u'Guangxi Wuzhou Pharmaceutical Group Co Ltd', u'Averion International Corp', u'East of England Development Agency', u'European Organisation for Research and Treatment of Cancer (EORTC)', u'Alberta Glycomics Centre', u'American Brain Tumor Association', u'Ligand Pharmaceuticals Inc', u'University of Miami', u'Octamer Inc', u'Double Bond Pharmaceutical AB', u'Avrygen Corp', u'University of Alberta', u'Cancer Prevention and Research Institute of Texas', u'University of Pittsburgh', u'Discovery BioMed Inc', u'National Institutes of Health', u'ZGene A/S', u'Food and Drug Administration', u'Amal Therapeutics SA', u'Sanford-Burnham Medical Research Institute', u'Bristol-Myers Squibb Co', u'Chinese Government', u'City of Hope', u'Opus Bio Inc', u'INSERM', u'Moleculin Biotech Inc', u'Heptares Therapeutics Ltd', u'Internal Revenue Services', u'Laureate Biopharmaceutical Services Inc', u'Cedars-Sinai Medical Center', u'Viralytics Ltd', u'Immunovaccine Inc', u'Celgene Corp', u'The Musella Foundation For Brain Tumor Research & Information, Inc', u'VAXIMM AG', u'MD Anderson Cancer Center', u'MDxHealth SA', u'Memgen LLC', u'Cornell University', u'Karolinska University Hospital', u'National Institute of Biomedical Imaging and Bioengineering', u'Technology Strategy Board', u'EnduRx Pharmaceuticals Inc', u'Teijin Ltd', u'Duke University', u'ReNeuron Group plc', u'Tufts University', u'Royalty Pharma', u'Northwestern University', u'Stella Therapeutics LLC', u'NewGen Therapeutics Inc', u'F Hoffmann-La Roche AG', u'Novocure Inc', u'FDA Office of Orphan Products Development', u'DNAtrix Inc', u'Proximagen Group plc', u'University of Toronto', u'Rhode Island Hospital', u'Life Sciences Discovery Fund', u'PRA Health Sciences', u\"Brigham & Women's Hospital\", u'MediGene AG', u'Oncorus Inc', u'VBL Therapeutics', u'Cancer Therapy & Research Center', u'American Red Cross', u'Parabon NanoLabs Inc', u'PAREXEL International', u'BeneVir Biopharm Inc', u'Research Institute of Physical and Chemical Problems', u'Glionova Therapeutics', u'German Federal Ministry of Education and Research', u'Beta Innov SAS', u'University of Arizona', u\"King's College London\"]), u'Neuromusculardisease': set([u'Cytokinetics Inc', u'BioMarin Nederland BV', u'miRagen Therapeutics Inc', u'European Commission', u'Harvard University', u'Amarantus BioScience Holdings Inc', u'Biogen Inc', u'Galena Biopharma Inc', u'Amarin Corp plc', u'Pharnext SAS', u'National Institutes of Health', u'EpiVax Inc', u'Ionis Pharmaceuticals Inc', u'Ipsen', u'Marina Biotech Inc', u'Flex Pharma Inc', u'Massachusetts General Hospital', u'RRD International', u'Galderma SA', u'Leiden University Medical Center', u'US Army Medical Research Institute of Infectious Diseases', u'Astellas Pharma Inc', u'Neostem Oncology', u'Pennsylvania State University', u'The University of Newcastle Upon Tyne', u'Muscular Dystrophy Association', u'Power3 Medical Products Inc', u'Families of Spinal Muscular Atrophy', u'BioTherapeutics Inc', u'Yissum Research Development Co', u'ALS Therapy Development Institute', u'Rosetta Genomics Ltd']), u'Proteinosis': set([u'Virginia Commonwealth University', u\"Cincinnati Children's Hospital Medical Center\", u'Savara Inc', u'Nobelpharma Co Ltd', u'Serendex Pharmaceuticals A/S', u'PARI Pharma GmbH', u'Sanofi Genzyme']), u'Chondrosarcoma': set([u'Scottsdale Healthcare', u'Infinity Pharmaceuticals Inc', u'Arizona Oncology Associates', u'Translational Genomics Research Institute']), u'Lowerlimbfracture': set([u'ReWalk Robotics Ltd', u'Wyss Institute for Biologically Inspired Engineering']), u'Colorvisiondefect': set([u'University of Washington', u'Adverum Biotechnologies Inc']), u'Urticaria': set([u'Alcon Inc', u'Sanofi-Aventis US LLC', u'The Menarini Group', u'Galenica AG', u'Genentech Inc', u'Hyphens Pharma Pte Ltd', u'Pediapharm Inc', u'Andrx Corp', u'Mayo Clinic Foundation', u'Kaken Pharmaceutical Co Ltd', u'Daiichi Sankyo Co Ltd', u'Abbott Laboratories', u'GlaxoSmithKline plc', u'Shionogi Pharma Inc', u'Biosintetica Farmaceutica Ltda', u'Clinuvel Pharmaceuticals Ltd', u'SurModics Pharmaceuticals', u'Undisclosed', u'Grupo Uriach', u'GlaxoSmithKline KK', u'Nippon Boehringer Ingelheim Co Ltd', u'Merck & Co Inc', u'Italfarmaco SpA', u'Kanebo KK', u'Sanofi-Synthelabo', u'Ahn-Gook Pharmaceuticals Co Ltd', u'Sanofi', u'Sato Pharmaceutical Co Ltd', u'Mycenax Biotech Inc', u'UCB Japan Co Ltd', u'Sankyo Co Ltd', u'Gideon Pharmaceuticals Inc', u'Recordati SpA', u'FAES Farma SA', u'UCB SA', u'Pierre Fabre SA', u'Synthelabo', u'Biovail Technologies Ltd', u'Kyorin Pharmaceutical Co Ltd', u'Tabuk Pharmaceutical Manufacturing Co', u'AEterna Zentaris Inc', u'Merck Serono SA', u'Prasco Laboratories', u'Vianex SA', u'Sunovion Pharmaceuticals Inc', u'Pfizer Inc', u'Shionogi & Co Ltd', u'Tribute Pharmaceuticals Canada Inc', u'Farmalab Ltda', u'Tanabe Seiyaku Co Ltd', u'JADO Technologies GmbH', u'BIAL Group', u'UBE Industries Ltd', u'Elorac Inc', u'Takeda Pharmaceuticals International GmbH', u'J Uriach & Cia SA']), u'Fallopiantubecancer': set([u'National Comprehensive Cancer Network', u'Cancer Immunotherapy Trials Network', u'Genentech Inc', u'Amgen Inc', u'Gynecologic Oncology Group', u'University of Pennsylvania', u'US Health and Human Services Department', u'University of Cologne', u'National Cancer Institute', u'Medivir AB', u'Merck & Co Inc', u'City of Hope', u'IDT Biologika GmbH', u'Veristat, Inc.', u'Janssen Research & Development LLC', u'WuXi PharmaTech (Cayman) Inc', u'Juno Therapeutics Inc', u'Oncolytics Biotech Inc', u'Aduro BioTech Inc', u'Roche Holding AG', u'Madrigal Pharmaceuticals Inc', u'Millennium Pharmaceuticals Ltd', u'TESARO Inc', u'Walter and Eliza Hall Institute of Medical Research', u'NanoString Technologies Inc', u\"Brigham & Women's Hospital\", u'TetraLogic Pharmaceuticals Corp', u'Hemispherx Biopharma Inc', u'Myriad Genetics Inc', u'TopoTarget A/S', u'Merrimack Pharmaceuticals Inc', u'Memorial Sloan-Kettering Cancer Center']), u'Inflammatoryboweldisease': set([u'Akebia Therapeutics Inc', u'ViThera Pharmaceuticals Inc', u'Signum Biosciences Inc', u'Therapeutic Systems Research Laboratories', u'European Commission', u'Oxagen Ltd', u'US Health and Human Services Department', u'Amsterdam Molecular Therapeutics BV', u'Cellerix SA', u'Synergy Pharmaceuticals Inc', u'Vidasym LLC', u'AstraZeneca Pharmaceuticals LP', u'Sevion Therapeutics Inc', u'Ionis Pharmaceuticals Inc', u'Hawker Resources Inc', u'University of Pittsburgh', u'Creabilis Therapeutics Srl', u'Tel Aviv Sourasky Medical Center', u'Galapagos NV', u'Phenex Pharmaceuticals AG', u'Celera South San Francisco', u'Rimonyx Pharmaceuticals Ltd', u'Toray Industries Inc', u'US Department of the Treasury', u'AutoImmune Inc', u'Theralogics Inc', u'23andMe Inc', u'Polpharma Biologics', u'National Health and Medical Research Council', u'New York University', u'PDL BioPharma Inc', u'The European Union', u'Immune Disease Institute Inc', u'Znomics Inc', u'Rottapharm Madaus', u'IRICoR', u'Mallinckrodt Inc', u'Kyung Hee University', u'Kyorin Pharmaceutical Co Ltd', u'MegaPharm Ltd', u'Avexegen Therapeutics Inc', u'Entera Health', u'Janssen Pharmaceutica NV', u'Torrent Pharmaceuticals Ltd', u'LDN Research LLC', u'Swedish Orphan Biovitrum AB', u'Henry Ford Health Science Center', u'Ministry of Economy, Trade and Industry', u'Prometheus Laboratories Inc', u'Ajinomoto Co Inc', u'Biothera Pharmaceuticals Inc', u'Johnson & Johnson', u'Dong-A ST Co Ltd', u'CLL Pharma', u'Undisclosed', u'Emergent BioSolutions Inc', u'Lille Catholic University', u'Eli Lilly & Co', u'Immune Pharmaceuticals Inc', u'Synt:em', u'Weizmann Institute of Science', u'Soligenix Inc', u'Conaris Research Institute AG', u'Palatin Technologies Inc', u'XBiotech Inc', u'University of California Los Angeles', u'Aichi Gakuin University', u'Zalicus Inc', u'Picower Institute for Medical Research', u'AbbVie Inc', u'University of Washington', u'Kenneth Rainin Foundation', u'Morishita Jintan Co Ltd', u'Nestle Health Science', u'Pacific Healthcare Thailand Co Ltd', u'Evotec (UK) Ltd', u'DanioLabs Ltd', u'Janssen Research & Development LLC', u'Universidad Andres Bello', u'Seoul National University', u'Tianjin Jingsheng Biological Technology Development', u'Astellas Pharma Inc', u'Rougier Pharma Afrique SA', u'V.I. PHARMA INTERNATIONAL SA', u'James Cook University of North Queensland', u'Athersys Inc', u'Pharming Group NV', u\"King's College London\", u'GenPat77 Pharmacogenetics AG', u'Qu Biologics Inc', u'Medical University of Graz', u'Angiotech Pharmaceuticals Inc', u'Aevi Genomic Medicine Inc', u'Diosynth Ltd', u'Opocrin SpA', u'BTG plc', u'Edward Via Virginia College Of Osteopathic Medicine', u'Selexis SA', u'Genentech Inc', u'Vernalis plc', u'Opsona Therapeutics Ltd', u'University of Pennsylvania', u'Mateon Therapeutics Inc', u'Roche Holding AG', u'Shire plc', u'University of British Columbia', u'Mitsubishi Tanabe Pharma Corp', u'Applied Molecular Transport LLC', u'Procter & Gamble Pharmaceuticals Inc', u'Direct Relief International', u'Sanofi Genzyme', u'Temple University', u'Curant Health', u'J Uriach & Cia SA', u'Malin Corp plc', u'Phytochemindo', u'Meiji Seika Pharma Co Ltd', u'Sigmoid Pharma Ltd', u'Amgen Inc', u'Endo Pharmaceuticals Solutions Inc', u'Hubrecht Organoid Technology', u'Nordsjaellands Hospital', u'RedHill Biopharma Ltd', u'Massachusetts General Hospital', u'Inflazyme Pharmaceuticals', u'Yeda Research and Development Co Ltd', u'Pennsylvania State University', u'ENTEROME Bioscience SA', u'Albany Molecular Research Inc', u'St Josephs Healthcare Hamilton', u'Osaka University', u'F Hoffmann-La Roche AG', u'Symbiotix Biotherapies Inc', u'Viron Therapeutics Inc', u'Synovo GmbH', u'Stanford University', u'Mitsubishi Pharma Corp', u'Mayo Clinic Foundation', u'Rigel Pharmaceuticals Inc', u'Weill Medical College of Cornell University', u'Ore Pharmaceuticals Inc', u'Ferring International Center SA', u'Redx Pharma Plc', u'Genzyme General', u'Celonic AG', u'Numab AG', u'Synlogic Inc', u'Seres Therapeutics Inc', u'enGene Inc', u'China Medical System Holdings Ltd', u'Lycera Corp', u'Emulate Inc', u'AstraZeneca plc', u'Antibe Therapeutics Inc', u'Adenosine Therapeutics LLC', u'Edusa Pharmaceuticals Inc', u'EpiStem Ltd', u'Dr August Wolff GmbH & Co Arzneimittel', u'Cequent Pharmaceuticals Inc', u'Reliance Life Sciences Group', u'Axogen Ltd', u'ProMetic Life Sciences Inc', u'Maryland Innovation Initiative', u'deCODE chemistry', u'Zealand Pharma A/S', u'Cedars-Sinai Medical Center', u'Humboldt University of Berlin', u'Dong Wha Pharmaceutical Co Ltd', u'Virginia Polytechnic Institute and State University', u'IXICO Plc', u'Pepscan Systems BV', u'Altheus Therapeutics', u'NephRx Corp', u'Quotient Clinical Ltd', u'Takeda Pharmaceutical Co Ltd', u'Atlantic Healthcare plc', u'German Federal Ministry of Education and Research', u'University of Medicine and Dentistry of New Jersey', u'Digital Gene Technologies Inc', u'Mount Sinai School of Medicine', u'Aeolus Pharmaceuticals Inc', u'Tonghua Dongbao Pharmaceutical Co Ltd', u'Vernalis Group plc', u'Meyer Pharmaceuticals LLC', u'University of Queensland', u'University of Southern Denmark', u'Welsh School of Pharmacy', u'MedImmune LLC', u'Protagonist Therapeutics Inc', u'Biomodels LLC', u'Arriva Pharmaceuticals Inc', u'Hy BioPharma Inc', u'Gamida Cell Ltd', u'OnSite Diagnostic Labs India Pvt Ltd', u'ARIUS Research Inc', u'ReveraGen BioPharma Inc', u'American Osteopathic Association', u'Lankenau Institute for Medical Research', u'EPIRUS Biopharmaceuticals Inc', u'Fundacion Para La Investigacion Biomedica Del Hospital Universitario La Paz', u'Sanford-Burnham Medical Research Institute', u'NovaMedica', u'Norgine BV', u'University of Tsukuba', u'Hikma Pharmaceuticals plc', u'Complete Pharmacy and Medical Solutions', u'TxCell SA', u\"Tianjin Municipal People's Government\", u'Active Biotech AB', u'Delphi Genetics', u'Solexa Inc', u'Michigan Economic Development Corp', u'ZymoGenetics Inc', u'Pendopharm', u'Catholic University of Leuven', u'Applied Protein Sciences LLC', u'Affymetrix Inc', u'ubichem Ltd', u'Gelesis Inc', u'Ferring Pharmaceuticals SA', u'Affilogic Laboratories', u'Northwestern University Feinberg School of Medicine', u'AnGes MG Inc', u'Lead Pharma Holding BV', u'Cytokine PharmaSciences Inc', u'Boehringer Ingelheim Corp', u'Artizan Biosciences Inc', u'Ironshore Pharmaceuticals & Development Inc', u'Yeungnam University', u'Steward Cross Pte Ltd', u'Connetics Corp', u'Intralytix Inc', u'Iluten', u'National Institute of Diabetes, Digestive and Kidney Diseases', u'Salix Pharmaceuticals Inc', u'Case Western Reserve University School of Medicine', u'XOMA Corp', u'Merck & Co Inc', u'Second Genome Inc', u'ChemoCentryx Inc', u'rEVO Biologics Inc', u'IMAB China', u'Chong Kun Dang Pharmaceutical Corp', u'Novogen Ltd', u'Bayer AG', u'Ovamed GmbH', u'University of Zagreb', u'Case Western Reserve University', u'Pharmatel Pty Ltd', u'Therapure Biopharma Inc', u'Neurocrine Biosciences Inc', u'Cerimon Pharmaceuticals Inc', u'ImmuNext Inc', u'Pharmaceutics International Inc', u'Synthetic Biologics Inc', u'Institut National de la Recherche Agronomique', u'Copernicus Therapeutics Inc', u'Institute for the Promotion of Innovation by Science and Technology in Flanders', u'Broad Institute Inc', u'Genisphere LLC', u'Genisphere Inc', u'Intrexon Corp', u'Alma Biotherapeutics', u'Dendreon San Diego LLC', u'Acromax Dominicana', u'University of Tokyo', u'University of Oregon', u'Food & Nutrition Delta', u'Elan Corp plc', u'INSERM', u'Praeventix, LLC,', u'Regulus Therapeutics Inc', u'Centaur Pharmaceuticals Inc', u'Proteostasis Therapeutics Inc', u'Hosokawa Micron Corp', u'Imperial College London', u'CMP Therapeutics Ltd', u'Sosei Group Corp', u'KS Biomedix Holdings plc', u'University of Ghent', u'Ferring Research Ltd', u'Salix Pharmaceuticals Ltd', u'Napo Pharmaceuticals Inc', u'Amakem Therapeutics', u'Alberta Heritage Foundation For Medical Research', u'University of Lille Nord de France', u'Tiziana Life Sciences PLC', u'LeukoSite Inc', u'Anabolic Inc', u'US Government', u'iCo Therapeutics Inc', u'GT Biopharma Inc', u'BioAtla Llc', u'IMTM GmbH', u'Bill & Melinda Gates Foundation', u'Nodality Inc', u'Catabasis Pharmaceuticals Inc', u'Biogen Inc', u'GlaxoSmithKline plc', u'Interferon Sciences Inc', u'Immunex Corp', u'Massachusetts Life Sciences Center', u'Radikal Therapeutics Inc', u'Marina Biotech Inc', u'Renovis Inc', u'Instituto de Ci\\xeancias Farmac\\xeauticas', u'Tillotts Pharma AG', u'Novimmune SA', u'University of Michigan', u'ITH Immune Therapy Holdings AB', u'MabTrix', u'Virginia Commonwealth University', u'Takeda Oncology', u'The Collaborative Group', u'Huons Co Ltd', u'Anergen Inc', u'BioMotiv LLC', u'Amalyte Pharmaceuticals LLC', u'Orexo AB', u'BioTherapeutics Inc', u'Cell Pathways Inc', u'Biohit OYJ', u'Eisai Co Ltd', u'Commonwealth Scientific and Industrial Research Organization', u'Novartis AG', u'Almac Discovery Ltd', u'University College Dublin', u'REGiMMUNE Corp', u'Ewopharma AG', u'Tianjin Hemay Bio-Tech Co Ltd', u'Universite De Montreal', u\"Crohn's & Colitis Foundation of America\", u'Visionary Pharmaceuticals Inc', u'Adolor Corp', u'Immune Response BioPharma Inc', u'University of Texas System', u'Friedrich-Alexander-Universitaet Erlangen-Nuernberg', u'Washington University in St Louis', u'Johns Hopkins University', u'Avaxia Biologics Inc', u'Pluristem Therapeutics Inc', u'Bird Rock Bio Inc', u'Orphan Australia', u'NITTO DENKO Avecia', u'Oregon Health Sciences University', u'Cambrex Corp', u'Allergan plc', u'Giuliani SpA', u'Institut Pasteur', u'Rimaco Inc', u'Hanyang University', u'Galderma SA', u'US Naval Medical Research Center', u'Dr Falk Pharma GmbH', u'PLIVA dd', u'Maruho Co Ltd', u'University of Virginia School of Medicine', u'Kyowa Hakko Kirin Co Ltd', u'Immune Therapeutics Inc', u'BioRap Technologies Ltd', u'Janssen Biotech Inc', u'Pfizer Inc', u'Sanofi', u'Vertex Pharmaceuticals Inc', u'Northeastern University', u'Yissum Research Development Co', u'Mount Sinai Medical Center', u'BioLineRx Ltd', u'Alimentary Pharmabiotic Centre', u'University of Oklahoma', u'Pharmascience Inc', u'National Institute of Allergy and Infectious Diseases', u'Vedanta Biosciences Inc', u'TherapyX Inc', u'Avidin Biotechnology', u'Heptares Therapeutics Ltd', u'National Institutes of Health', u'Alizyme plc', u'Aspreva International Ltd', u'Synvista Therapeutics Inc', u'The Menarini Group', u'Encycle Therapeutics Inc', u'University of Chicago', u'Trinity College Dublin', u'Jubilant Life Sciences Ltd', u'Italian Ministry of Economic Development', u'Finch Therapeutics', u'ETX Pharma Inc', u'Torcan Chemicals Ltd', u'Cardion AG']), u'Maculardegeneration': set([u'US Government', u'Harvard Medical School', u'Dalton Pharma Services', u'The European Union', u'California Institute of Regenerative Medicine', u'University of California San Diego', u'S. Fyodorov Eye Microsurgery Complex', u'University of Mississippi', u'GlycoMira Therapeutics Inc', u'Merck KGaA', u'Crinetics Pharmaceuticals Inc', u'National Institutes of Health', u'Scripps Research Institute', u'National Eye Institute', u'Regulus Therapeutics Inc', u'KalVista Pharmaceuticals Inc (Pre-merger)', u'RIKEN', u'Nemus Bioscience Inc', u'AiVita Biomedical', u'Medical University of South Carolina', u'Targesome Inc', u'University of Colorado System', u'University of California Irvine', u'BioMotiv LLC', u'Johns Hopkins University', u'BIKAM Pharmaceuticals Inc', u'Caladrius Biosciences Inc', u'Taligen Therapeutics Inc', u'Stemedica Cell Technologies Inc', u'Shin Nippon Biomedical Laboratories Ltd']), u'Calcinosis': set([u'Stanford University', u'United Therapeutics Corp']), u'Acuteleukemia': set([u'Zhongyuan Union Cell & Gene Engineering Corp Ltd', u'Nankai University', u'Epizyme Inc', u'Kwang Dong Pharmaceutical Co Ltd', u'Cephalon Inc', u'Celgene Corp', u'The Leukemia & Lymphoma Society', u'Accenda Tech Co Ltd', u'Roche Holding AG', u'Uppsala University', u'Constellation Pharmaceuticals Inc', u'DiNonA Inc', u'Swedish Orphan Biovitrum AB', u\"Hospital Vall D'Hebron\", u'Cancer Research UK Manchester Institute', u'Oryzon Genomics SA', u'3SBio Inc', u'Akinion Pharmaceuticals AB', u'Institute of Hematology & Blood Diseases Hospital']), u'Clostridiumtetaniinfection': set([u\"Tianjin Municipal People's Government\", u'LG Life Sciences Ltd', u'Philogen SpA', u'Chiron Behring GmbH & Co', u'Rhein Biotech NV', u'Walvax Biotechnology Co Ltd', u'Nordic Vaccine A/S', u'Bio-Manguinhos/Fiocruz', u'Massachusetts Biologic Laboratories', u'National Institute of Allergy and Infectious Diseases', u'Sanofi Pasteur', u'Daiichi Sankyo Co Ltd', u'Abbott Laboratories', u'Sanofi Pasteur KK', u'Takeda Pharmaceutical Co Ltd', u'Serum Institute of India Ltd', u'GlaxoSmithKline plc', u'Sanofi KK', u'Abiogen Pharma SpA', u'Chiron Corp', u'Cambridge Biostability Ltd', u'Undisclosed', u'MNLpharma Ltd', u'Bio Farma', u\"United Nations International Children's Fund\", u'Biological E Ltd', u'Chinese Government', u'West Pharmaceutical Services Inc', u'Merck & Co Inc', u'Panacea Biotec Ltd', u'Fundacao Oswaldo Cruz (Fiocruz)', u'Centers for Disease Control and Prevention', u'Funda\\xe7\\xe3o Ezequiel Dias - Funed', u'UK Department of Trade & Industry', u'Shandong University', u'bioCSL PTY Ltd', u'SmithKline Beecham Corp', u'Astellas Pharma Inc', u'Shantha Biotechnics PVT Ltd', u'Mitsubishi Tanabe Pharma Corp', u'Kaketsuken', u'LG Life Sciences India Pvt Ltd', u'North American Vaccine Inc', u'Chiron Vaccines Co', u'BIKEN Foundation', u'New Zealand government', u'CanSino Biologics Inc', u'Xenetic Biosciences Inc', u'Crucell NV', u'Japan Poliomyelitis Research Institute', u'Quadrant Technologies Ltd', u'Mingxin Hi-Tech Development Co Ltd', u'Statens Serum Institut', u'University of Melbourne', u'UCB SA', u'Coloplast AS', u'Akorn Inc', u'Altimmune Inc (pre-merger)', u'Acambis plc', u'Kitasato Institute', u'University of Cambridge']), u'Insulinresistance': set([u'University of California Davis', u'Itamar Medical (Cm) 1997 Ltd', u'Allergan Inc', u'University of Washington', u'Insmed Inc', u'Ipsen Biopharmaceuticals Inc', u'Evotec International GmbH', u'Pfizer Inc', u'Boehringer Ingelheim Corp', u'Shanghai Institute of Materia Medica of the Chinese Academy of Sciences', u'Medros Inc', u'Synlab Services Gmbh', u'National Institute Of Environmental Health Sciences', u'Fujisawa Pharmaceutical Co Ltd', u'Baker IDI Heart & Diabetes Institute Holdings Ltd', u'Metabolon Inc', u'Fudan University', u'National Health and Medical Research Council', u'Galmed Pharmaceuticals Ltd']), u'Pituitaryadenoma': set([u'Ipsen', u'The Salk Institute for Biological Studies']), u'HyperlipoproteinemiatypeIIb': set([u'Karolinska Institutet', u'The Knut and Alice Wallenberg Foundation']), u'Urinarytracttumor': set([u'GenomeDx Biosciences Inc', u'Ezose Sciences Inc', u'MDxHealth SA', u'Hirosaki University', u'University of Ghent', u'Exact Sciences Corp', u'Cedars-Sinai Medical Center']), u'Alphavirusinfection': set([u'US Government', u'US Army Medical Research Institute of Infectious Diseases', u'Paradigm Biopharmaceuticals Ltd', u'Griffith University', u'US Health and Human Services Department', u'Akshaya Bio Inc', u'Zalicus Inc', u'University of Pittsburgh']), u'Lowerbackpain': set([u'Eli Lilly & Co', u'CVS Caremark', u'Depomed Inc', u'AnGes MG Inc', u'Pfizer Inc', u'BioDelivery Sciences International Inc', u'Grunenthal GmbH', u'Nippon Zoki Pharmaceutical Co Ltd']), u'Hepatobiliarysystemtumor': set([u'Eli Lilly & Co', u'OSI Pharmaceuticals Inc', u'AstraZeneca plc', u'ScinoPharm Taiwan Ltd', u'Genentech Inc', u'Roche Holding AG']), u'Bacterialskininfection': set([u'Daiichi Seiyaku Co Ltd', u\"Dr Reddy's Laboratories Ltd\", u'Johnson & Johnson', u'Medivir AB', u'The Menarini Group', u'Undisclosed', u'Daiichi Sankyo Co Ltd', u'Durata Therapeutics Inc', u'Unimedic AB', u'Nutrition 21 Inc', u'Meiji Seika Pharma Co Ltd', u'European Commission', u'Ceragenix Pharmaceuticals Inc', u'Abbott Laboratories', u'Trius Therapeutics Inc', u'Takeda Pharmaceutical Co Ltd', u'Forest Laboratories Inc', u'TAP Pharmaceuticals Inc', u'Foundation for the National Institutes of Health', u'Bayer Korea Ltd', u'Allergan plc', u'UCB Celltech', u'Medison Pharma Ltd', u'Eddingpharm Inc', u'Cardiome Pharma Corp', u'Covance Inc', u'AntibioTx ApS', u'Chiron Corp', u'Tzamal Medical Group Ltd', u'ZAI Laboratory Inc', u'US Government', u'Food and Drug Administration', u'Sumitomo Dainippon Pharma Co Ltd', u'Sanofi', u'Aventis Pharma AG', u'PolyMedix Inc', u'Furiex Pharmaceuticals Inc', u'GlaxoSmithKline plc', u'Purdue Pharma LP', u'Melinta Therapeutics Inc', u'Chong Kun Dang Pharmaceutical Corp', u'Emisphere Technologies Inc', u'Biosynexus Inc', u'Astellas Pharma Inc', u'Ligand Pharmaceuticals Inc', u'Kyowa Hakko Bio Co Ltd', u'Peninsula Pharmaceuticals Inc', u'Bayer AG', u'US Army Medical Research Institute of Infectious Diseases', u'Catalytica Inc', u'ALZA Corp', u'Basilea Pharmaceutica International Ltd', u'Sunovion Pharmaceuticals Canada Inc', u'Ranbaxy Laboratories Ltd', u'Paratek Pharmaceuticals Inc', u'Bioglan AB', u'NovaBay Pharmaceuticals Inc', u'Motif Bio plc', u'Innoviva Inc', u'LTL Pharma Co Ltd', u'Novexel SA', u'Janssen Pharmaceutica NV', u'ICON plc', u'Almirall Prodesfarma SA', u'Cubist Pharmaceuticals Inc', u'AstraZeneca plc', u'Pfizer Inc', u'Bayer HealthCare AG', u'Stiefel', u'Lilly China Research & Development Co Ltd', u'TTY Biopharm Co Ltd', u'Brigham Young University', u'Biota Europe Ltd', u'UCB SA', u'Royalty Pharma', u'Eurofarma', u'Jubilant Chemsys Ltd']), u'Gastrointestinalinfection': set([u'Eli Lilly & Co', u'ActivBiotics Inc', u'Depomed Inc', u'Ophidian Pharmaceuticals Inc', u'ActoGeniX NV', u'Isogen Life Science BV', u'Mobidiag Oy', u'Defense Advanced Research Projects Agency', u'Unilabs SA', u'University of Nebraska Medical Center', u'Bioportugal Qu\\xedmica Farmac\\xeautica Lda', u'Biomedica Medizinprodukte GmbH & Co KG', u'PerkinElmer Inc', u'YouMed Ltd', u'Institute for the Promotion of Innovation by Science and Technology in Flanders', u'Catholic University of Leuven', u'AB ANALITICA', u'Wyss Institute for Biologically Inspired Engineering', u'TriMed Research Inc']), u'Openangleglaucoma': set([u'High Point Pharmaceuticals Llc', u'US Government', u'SamChunDang Pharm Co Ltd', u'University of Mississippi', u'Merck & Co Inc', u'Radikal Therapeutics Inc', u'Hanmi Pharmaceutical Co Ltd', u'National Eye Institute', u'Asahi Kasei Pharma Corp', u'Santen Pharmaceutical Co Ltd', u'Quark Pharmaceuticals Inc', u'Clermont Pharmaceuticals Inc', u'Laboratoires Thea', u'Nanomerics Ltd', u'Sinphar Pharmaceutical Co Ltd', u'Zuellig Pharma Ltd', u'Albany Molecular Research Inc', u'Mundipharma Pte Ltd', u'Altheos Inc', u'Atheln Inc', u'Pfizer Inc', u'MSD Japan', u'R-Tech Ueno Ltd', u'Sucampo Pharmaceuticals Inc', u'Nemus Bioscience Inc']), u'Hypoglycemia': set([u'Novo Nordisk A/S', u'Baylor College of Medicine', u'Stanford University', u'Zucara Therapeutics Inc', u'Paladin Labs Inc', u'DiObex Inc', u'Aegis Therapeutics LLC', u'National Institute of Diabetes, Digestive and Kidney Diseases', u'Albireo Pharma Inc', u'The Leona M. and Harry B. Helmsley Charitable Trust', u'Juvenile Diabetes Research Foundation', u'Ben Venue Laboratories Inc', u'University of Toronto', u'Heptares Therapeutics Ltd', u'Oregon Health Sciences University', u'Zealand Pharma A/S', u'Marcadia Biotech Inc', u'Locemia Solutions ULC', u'Eli Lilly & Co', u'JDRF Canada', u'Camurus AB', u'Eiger BioPharmaceuticals Inc', u'BD Technologies', u'Beta Bionics Org', u'ViaCyte Inc', u'University of Colorado System', u'University of Texas Health Science Center San Antonio', u'Texas Diabetes Institute', u'Indiana University', u'Technology Strategy Board', u'XERIS Pharmaceuticals Inc', u'Centre for Drug Research and Development']), u'Betathalassemia': set([u'Fondazione Telethon', u'US Government', u'Acceleron Pharma Inc', u'Massachusetts Institute of Technology', u'Israeli Government', u'Childrens Hospital Oakland Research Institute', u'Stanford University', u'Protagonist Therapeutics Inc', u'French Muscular Dystrophy Association', u'New York Blood Center', u'Aevi Genomic Medicine Inc', u'Clayton Biotechnologies Inc', u'Phoenicia Biosciences Inc', u'National Institute of Diabetes, Digestive and Kidney Diseases', u'California Institute of Regenerative Medicine', u'Weill Medical College of Cornell University', u'Biogen Inc', u'GlaxoSmithKline plc', u\"Cincinnati Children's Hospital Medical Center\", u'Acetylon Pharmaceuticals Inc', u'Calimmune Inc', u'Universite de Sherbrooke', u'Merganser Biotech Inc', u'National Institutes of Health', u'Universita degli Studi di Ferrara', u'Istituto Scientifico H San Raffaele', u'Regenacy Pharmaceuticals LLC', u'INSERM', u'Vertex Pharmaceuticals Inc', u'Sangamo Therapeutics Inc', u'OSI Pharmaceuticals Inc', u'Celgene Corp', u'Ravizza Farmaceutici SpA', u'Research Development Foundation', u'bluebird bio Inc', u'Wellcome Trust', u'Errant Gene Therapeutics LLC', u'Gamida Cell Ltd', u'MolMed SpA', u'National Center For Advancing Translational Sciences', u'Institut Pasteur', u'Alpha Therapeutic Corp', u'Rare Partners Srl', u'University of California Los Angeles', u'Genethon', u'apceth GmbH & Co KG', u'National Heart Lung and Blood Institute', u'IRCCS San Raffaele', u'Associazione Veneta per la Lotta alla Talassemia', u\"Children's Hospital & Research Center Oakland\", u'Memorial Sloan-Kettering Cancer Center']), u'Diabeticfootulcer': set([u\"Dr Reddy's Laboratories Ltd\", u'Tasly Pharmaceutical Group Co Ltd', u'National Institute of Arthritis and Musculoskeletal and Skin Diseases', u'SkyePharma plc', u'Medefficiency Inc', u'National Institutes of Health', u'Baxter International Inc', u'Virchow Biotech Pvt Ltd', u'US Department of Veterans Affairs', u'AVACEN Medical', u'Essex Chemie AG', u'Smith & Nephew plc', u'ViroMed Co Ltd', u'Janssen Pharmaceuticals Inc', u'Taxus Cardium Pharmaceuticals Group', u'National Institute of Diabetes, Digestive and Kidney Diseases', u'Sandoz Inc', u'US Government', u'Derma Sciences Inc', u'Eisai Co Ltd', u'JSC Vertex', u'Louisiana State University Medical Center Foundation', u'King Pharmaceuticals R&D Inc', u'Microbion Corp', u'EUSA Pharma USA', u'US Department of Defense', u'LBT Innovations Ltd', u'Chiron Corp', u'Seoul National University', u'Capstone Therapeutics Corp', u'Innocoll AG', u'Devro plc', u'Smith & Nephew Biotherapeutics', u'RNL Bio Co Ltd', u'BioPharmaceuticals Australia', u'Daewoong Pharmaceutical Co Ltd', u'Derma Life Clinical Partners LP', u'Quark Venture Inc', u'Organogenesis Inc', u'Agennix AG', u'Nanotherapeutics Inc', u'Zhuhai Essex Bio-Pharmaceutical Co Ltd', u'Sanofi', u'Pioneer Surgical Orthobiologics', u'ZZ Biotech LLC', u'Advanced Tissue Sciences Inc', u'Undisclosed', u'Haisco Pharmaceutical Group Co Ltd', u'Glycotex Inc', u'FirstString Research Inc', u'Quintiles Transnational Corp', u'Basilea Pharmaceutica International Ltd', u'Virginia Polytechnic Institute and State University', u'Morulaa HealthTech', u'Russian Academy of Sciences', u'Cardio Derma Clinical Partners', u'Bioglan Pharmaceuticals Co', u'Kuros Biosurgery AG', u'Gemstone Biotherapeutics', u'Dong-A ST Co Ltd', u'Dermatools Biotech GmbH', u'Hikma Pharmaceuticals plc', u'TheraVasc Inc', u'Sunnybrook Health Sciences Centre', u'Genaera Corp', u'Aderis Pharmaceuticals Inc', u'Inotek Pharmaceuticals Corp', u'Kissei Pharmaceutical Co Ltd', u'Pfizer Inc', u'Johns Hopkins University', u'Intercytex Ltd', u'ProCyte Corp', u'University of Virginia', u'NYU Langone Medical Center', u'North Florida/South Georgia Veterans Health System', u'MacroChem Corp', u'Pluristem Therapeutics Inc', u'Ambalal Sarabhai Enterprises', u'Walter Reed Army Medical Center', u'Central Adelaide Local Health Network Inc', u'CardioVascular BioTherapeutics Inc', u'ProDerm Limited Partnership', u'Unimedic AB']), u'Toxicityandintoxication': set([u'National Institutes of Health', u'AurimMed Pharma Inc']), u'Hurler-Scheiesyndrome': set([u'OPKO Health Inc', u'University of Pennsylvania']), u'Vascularfistula': set([u'Eiger BioPharmaceuticals Inc', u'Theragene Pharmaceuticals', u'Cellerix SA', u'Aptalis Pharma Inc']), u'Entamoebahistolyticainfection': set([u'AB ANALITICA', u'Mobidiag Oy', u'Romark Laboratories LC', u'University of California San Diego', u'Wake Forest University', u'Techlab Inc', u'National Institute of Allergy and Infectious Diseases', u'Laboratorios Columbia SA de CV', u'University of California San Francisco']), u'Urogenitaltractinfection': set([u'Department for International Development', u'Endo Pharmaceuticals Solutions Inc', u'Pharmacia Corp', u'Recordati SpA']), u'Muscleinjury': set([u'Novalar Pharmaceuticals Inc', u'University of Pennsylvania', u'National Institute of Arthritis and Musculoskeletal and Skin Diseases', u'Emmyon Inc', u'University of Virginia', u'Septodont', u'Organovo Holdings', u'Pluristem Therapeutics Inc', u'National Institute on Aging', u'United States Army Institute of Surgical Research', u'Biogen Inc', u'Charite Universitaetsmedizin Berlin', u'Sanofi', u'Compass Biomedical', u'H.A. Systems Dental Imports Ltd']), u'Pityriasis': set([u'Janssen Pharmaceutica NV', u'Kyowa Hakko Kogyo Co Ltd']), u'Gastroparesis': set([u'University of Michigan', u'Stanford University', u'Mayo Clinic Foundation', u'National Institute of Diabetes, Digestive and Kidney Diseases', u'Abbott Laboratories', u'Alfa Wassermann SpA', u'Undisclosed', u'University of Louisville', u'Hokuriku Seiyaku KK', u'Tranzyme Pharma Inc', u'Virginia Commonwealth University', u'Shire-Movetis NV', u'Innoviva Inc', u'RaQualia Pharma Inc', u'Dynogen Pharmaceuticals Inc', u'University of Texas System', u'Fujisawa Synthelabo Co Ltd', u'The Michael J. Fox Foundation', u'ETX Pharma Inc', u'Temple University', u'Aptalis Pharma Inc', u'California Pacific Medical Center', u'Johns Hopkins University', u'Texas Tech University', u'Norgine BV', u'Edusa Pharmaceuticals Inc', u'Institute for the Promotion of Innovation by Science and Technology in Flanders']), u'Musculoskeletaldisease': set([u'Medtronic Sofamor Danek', u'Regenerative Sciences Inc', u'Yamanouchi Pharmaceutical Co Ltd', u'Stryker Corp', u'Bioventus LLC', u'Collagenesis Inc', u'Mitobridge Inc', u'National Institutes of Health', u'Amylin Pharmaceuticals Inc', u'Harvard University', u'Lockheed Martin Corp', u'CRISPR Therapeutics', u'University of Dundee', u'Geron Corp', u'GlaxoSmithKline plc', u'Novartis AG', u'Hospital for Special Surgery NY', u'Ubiquigent Limited', u'Meditronic Inc', u'Ablynx NV', u'MabVax Therapeutics Holdings Inc', u'Indicus Pharma LLC', u'MorphoSys AG', u'Osiris Therapeutics Inc', u'Procter & Gamble Pharmaceuticals Inc', u'Medical Research Council', u'Five Prime Therapeutics Inc', u'Anagenesis Biotechnologies', u'Hurley Consulting Associates Ltd', u'Galapagos NV', u'Rottapharm Biotech Srl', u'Wilshire Pharmaceuticals Inc', u'Savient Pharmaceuticals Inc', u'Noven Pharmaceuticals Inc', u'Genetics Institute LLC', u'B-Temia Inc', u'Ossacur', u'University of Edinburgh', u'Laboratoire Chauvin SA', u'Velcura Therapeutics Inc', u'Pfizer Inc', u'Merckle GmbH', u'Antitope Ltd', u'The Salk Institute for Biological Studies', u'Xenome Ltd', u'Caladrius Biosciences Inc', u'Rohto Pharmaceutical Co Ltd', u'Curis Inc', u'Rhone-Poulenc Rorer Inc', u'Wyeth BioPharma']), u'Laronsyndrome': set([u'Pharmacia & Upjohn AB', u'Biogen Inc (FL)']), u'Urgeurinaryincontinence': set([u'Sankyo Co Ltd', u'Urigen Pharmaceuticals Inc', u'Kalium Inc', u'Boehringer Ingelheim Corp', u'Novotech (Australia) Pty Ltd', u'Meiji Co Ltd', u'TheraVida Inc', u'Kissei Pharmaceutical Co Ltd', u'SK Chemicals Co Ltd']), u'Diuresis': set([u'Swedish Orphan Biovitrum AB', u'The European Union', u'University of Adelaide', u'University of Arizona', u'Only For Children Pharmaceuticals']), u'Respiratorytractbleeding': set([u'Serendex Pharmaceuticals A/S', u'Nobelpharma Co Ltd']), u'Pancreasisletdisease': set([u'TBG Diagnostics Ltd', u'The Australian National University']), u'Monkeypoxvirusinfection': set([u'PharmaJet Inc', u'US Army Medical Research Institute of Infectious Diseases', u'University of California', u'Chimerix Inc']), u'Cranialnervedisorder': set([u'Matador Medical', u'OssDsign AB']), u'Livertransplantation': set([u'Karolinska Institutet', u'European Research Council (ERC)', u'Regience KK', u'Keio University', u'Transplant Genomics', u'Mayo Clinic Foundation']), u'Retinopathyofprematurity': set([u'Monash University', u'Premacure AB', u'Phyton Biotech Inc', u'RxGen Inc', u'University of New Mexico', u'IDIS Ltd', u'Beth Israel Deaconess Medical Center', u'Radikal Therapeutics Inc', u'Recordati SpA', u'Insmed Inc', u'Azienda Ospedaliero Universitaria Meyer', u'National Eye Institute', u'BioDiem Ltd', u'University of Melbourne']), u'Hurlersyndrome': set([u'National Institute of Neurological Disorders and Stroke', u'Eunice Kennedy Shriver National Institute of Child Health & Human Development', u'ArmaGen Technologies Inc', u'University of Alabama at Birmingham', u'PTC Therapeutics Inc', u'University of Alabama']), u'Vasculardisease': set([u'Vascular Genetics Inc', u'Karolinska Institutet', u'BioMarin Pharmaceutical Inc', u'ICON Medical Corp', u'Angiotech Pharmaceuticals Inc', u'BioAtla Llc', u'The Charles Stark Draper Laboratory Inc', u'Mount Sinai School of Medicine', u'GlaxoSmithKline plc', u'Vical Inc', u'National Pharmaceuticals Corp', u'Sarepta Therapeutics Inc', u'Morphotek Inc', u'Hydra Biosciences Inc', u'Sangamo Therapeutics Inc', u'Lemaitre Vascular Inc', u'ARIAD Pharmaceuticals Inc', u'Theragen ETEX', u'CryoLife Inc', u'Ludwig Institute for Cancer Research', u'Faron Pharmaceuticals Ltd', u'VasGene Therapeutics Inc', u'Toray Industries Inc', u'St Elizabeths Medical Center of Boston Inc', u'Sujana Biotech LLC', u'National Center for Research Resources', u'National Heart Lung and Blood Institute', u'National Research Council of Canada', u'VIVUS Inc', u'Exelixis Inc', u'Innovation and Technology Commission', u'China Nuokang Bio-Pharmaceutical Inc', u'The European Union', u'Abbott Laboratories', u'Repligen Corp', u'Selten Pharma Inc', u'Jilin Yuhua', u'Korea Research Institute of Bioscience and Biotechnology', u'Poniard Pharmaceuticals Inc', u'Boston Therapeutics Inc', u'GeneOne Life Science Inc', u'Meito Sangyo KK', u'Plexxikon Inc', u'Pharmacopeia Inc', u'Asahikawa Medical College', u'Medinol Ltd', u'Hooke Laboratories Inc', u'Encysive Pharmaceuticals Inc', u'Genfit SA', u'Medtronic Inc', u'Hancock Jaffe Laboratories Inc', u'Stanford University', u'URIST Regenerative Med Inc', u'National Institute of Diabetes, Digestive and Kidney Diseases', u'Republic of Korea Government', u'Baxter Healthcare Corp', u'Cook Group Inc', u'Edwards Lifesciences Corp', u'Vascular Pharmaceuticals Inc', u'Mirrx Therapeutics', u'Eli Lilly & Co', u'Bayer AG', u'Strathmann Biotec AG', u'OiDE CapiSEA Inc', u'Ewha Womans University', u'Boehringer Ingelheim Austria GmbH', u'United Therapeutics Corp', u'Priaxon AG', u'Valentis Inc', u'University of California Irvine', u'IVAX Corp', u'Pfizer Inc', u'Asubio Pharma Co Ltd', u'Antibe Therapeutics Inc', u'Cancer Research Technology Ltd', u'InVasc Therapeutics Inc', u'Hoechst Marion Roussel Inc', u'Daiichi Sankyo Co Ltd', u'Globe Laboratories Inc', u'Magnetic Insight Inc', u'VIA Pharmaceuticals Inc', u'The Medipattern Corp', u'Servier', u'National Institutes of Health', u'Bristol-Myers Squibb Co', u'Cornell University', u'Aptahem AB', u'IXICO Plc', u'Qiagen NV', u'Insmed Inc', u'ReCyte Therapeutics Inc', u'Centenary Institute Cancer Medicine & Cell Biology', u'GE Healthcare', u'Supernus Pharmaceuticals Inc', u'Napo Pharmaceuticals Inc', u'The Institute of Radiation Medicine Academy of Military Medical Sciences PLA', u'Antitope Ltd', u'PPD Discovery Inc']), u'Pseudomonasinfection': set([u'Daiichi Seiyaku Co Ltd', u'Transave Inc', u'Grunenthal GmbH', u'InterMune Inc', u'Cystic Fibrosis Foundation Therapeutics Inc', u'Sanofi Pasteur', u'US Health and Human Services Department', u'Forest Laboratories Inc', u'Polyphor Ltd', u'GEOM Therapeutics Inc', u'Wellcome Trust', u'Medical College of Wisconsin', u'LegoChem Bioscience Inc', u'Sanofi Genzyme', u'University of California San Francisco', u'Bayer AG', u'Universite Catholique de Louvain', u'Roche Holding AG', u'ANTABIO', u'Creative Antibiotics Sweden AB', u'Pelias Biomedical Development AG', u'Microcide Pharmaceuticals Inc', u'Combating Antibiotic-Resistant Bacteria Biopharmaceutical Accelerator', u'Aviragen Therapeutics Inc', u'Humanigen Inc', u'Ancora Pharmaceuticals Inc', u'Nektar Therapeutics', u'National Heart Lung and Blood Institute', u'Novartis Vaccines & Diagnostics', u'Chiron Corp']), u'Cognitivedisorder': set([u'Servier', u'Symphony Capital LLC', u\"Alzheimer's Drug Discovery Foundation\", u'Opthea Ltd', u'DarPharma Inc', u'ProNeurogen Inc', u'AC Immune SA', u'Orion Corporation', u'US Government', u'Forest Laboratories Inc', u'GlaxoSmithKline plc', u'Clinical Investigations Group', u'University of Basel', u'Bristol-Myers Squibb Co', u'Perelman School of Medicine', u'Arizona State University', u'Scil Technology GmbH', u'Anvyl LLC', u'University of South Florida', u'OSI Pharmaceuticals Inc', u'Virogenomics Inc', u'The University Health Network', u'SeneXta Therapeutics SA', u'Ramot at Tel Aviv University Ltd', u'UCB SA', u'Roche Holding AG', u'Cold Spring Harbor Laboratory', u'The National Institute of Mental Health', u'Neurogen Corp', u'Sankyo Co Ltd', u'UCB Pharma SA', u'Selvita SA', u'Osprey Pharmaceutical Co', u'CogState Ltd', u'Emory University', u'Defense Advanced Research Projects Agency', u'Knoll Farmaceutici SpA', u'Bioresearch SpA', u'Iproteos', u'Sention Inc', u'International Consolidated Companies Inc', u'Russian Academy Medical Science', u'National Center For Advancing Translational Sciences', u'Sigma-Tau Ind Farm Riunite SpA', u'Cognition Pharmaceuticals LLC', u'Evotec AG', u'National Health and Medical Research Council', u'Biotie Therapies AG', u'Ophidion Inc', u'RespireRx Pharmaceuticals Inc', u'Eli Lilly Japan KK', u'Memory Pharmaceuticals Corp', u'Prana Biotechnology Ltd', u'Abbott Laboratories', u'NPS Allelix Corp', u'Eisai Co Ltd', u'University of Texas at El Paso', u'FUJIFILM RI Pharma Co', u'PsychoGenics Inc', u'OPKO Health Inc', u'AfaSci Inc', u'Belvit', u'Panorama Research Inc', u'Santen Pharmaceutical Co Ltd', u'University of California San Francisco', u'Neurotrope Inc', u'Inflazyme Pharmaceuticals', u'WuXi PharmaTech (Cayman) Inc', u'Hager Biosciences LLC', u'Newron Pharmaceuticals SpA', u'Scarista Ltd', u'Avera Pharmaceuticals Inc', u'Gliatech Inc', u'Wellcome Trust', u'NeurOp Inc', u'QR Pharma Inc', u\"M's Science Corp\", u'EndoLogic LLC', u'University of Edinburgh', u'Cortice Biosciences Inc', u'Theranexus SAS', u'Taiho Pharmaceutical Co Ltd', u'Boehringer Ingelheim Corp', u'DrugAbuse Sciences Inc', u'University of California San Diego', u'University of Florida', u'University of Arizona', u'Rutgers University', u'University of Sydney', u'F Hoffmann-La Roche AG', u'H Lundbeck A/S', u'Lexicon Pharmaceuticals Inc', u'Saegis Pharmaceuticals Inc', u'GCA Therapeutics Ltd', u'Tufts University', u'Galenea Corp', u'Stanford University', u'United BioSource Corp', u'Seoul University', u'Cambridge Cognition Ltd', u'Intra-Cellular Therapies Inc', u'Reino de Espana', u'Ctrl Group', u'Calico Life Sciences LLC', u'Ramaciotti Foundation', u'The Lieber Institute For Brain Development', u'AgeneBio Inc', u'Jeil Pharmaceutical Co Ltd', u'Aptinyx Inc', u'National Institute on Drug Abuse', u'Expression Drug Designs LLC', u'University of California', u'Merck & Co Inc', u'French Government', u'Sanofi', u'TorreyPines Therapeutics Inc', u'Eli Lilly & Co', u'Bayer AG', u'Laboratoire L Lafon SA', u'The Jerome Lejeune Foundation', u'Institute for the Study of Aging (ISOA), Ltd', u'University of Maryland Baltimore County', u'George Washington University', u'Pivot-IndUS', u'FORUM Pharmaceuticals Inc', u\"Alzheimer's Association\", u'AstraZeneca plc', u'Pfizer Inc', u'National Institute on Aging', u'International Business Machines Corp', u'Sanofi (pre-1999)', u'Yale University', u'Harrington Discovery Institute', u'Undisclosed', u'Yissum Research Development Co', u'Johns Hopkins University', u'EPIX Pharmaceuticals Inc', u'Scotia Holdings plc', u'Helicon Therapeutics Inc', u'Purdue University', u'NeuroSearch A/S', u'Australian Government', u'Xytis Inc', u'Cenomed BioSciences LLC', u'Pharmos Corp', u'Takeda Pharmaceutical Co Ltd', u'Spherium Biomed', u'Taisho Pharmaceutical Co Ltd', u'Cerecor Inc', u'University of New South Wales', u'Targacept Inc', u'Rensselaer Polytechnic Institute', u'National Institutes of Health', u'Alizyme plc', u'Agilis Biotherapeutics LLC', u'Laxdale Ltd', u'Dainippon Pharmaceutical Co Ltd', u'Aventis SA', u'Neurotez Inc', u'American Cyanamid Co', u'The Arthritis Society, Canada', u'Medical College of Georgia', u'MGI Pharma Inc', u'Cephalon Inc', u'Therapix Biosciences Ltd', u'Catalytica Inc', u'Daiichi Fine Chemicals Co Ltt', u'CBD Medicinals LLC', u'Innovative NeuroTechnologies Inc', u'Amylon LLC', u'Merck Serono SA', u'Coronis NeuroSciences', u'Hebrew University of Jerusalem', u'University of California Irvine', u'Neuralstem Inc', u'German Federal Ministry of Education and Research', u'Orexo AB', u'Gedeon Richter Ltd', u'University Of Western Sydney', u'Jagiellonian University', u'Pharmacia & Upjohn Co']), u'Cryptococcusinfection': set([u'Sankyo Co Ltd', u'Zeneus Pharma Ltd', u'Johnson & Johnson', u'US Government', u'Enzon Pharmaceuticals Inc', u'Sumitomo Pharmaceuticals Co Ltd', u'Gilead Sciences Inc', u'Astellas Pharma Inc', u'Barrier Therapeutics Inc', u'Romark Laboratories LC', u'Fujisawa Pharmaceutical Co Ltd', u'Elan Corp plc', u'NeXstar Pharmaceuticals Inc', u'Laboratorios Columbia SA de CV', u'Amplyx Pharmaceuticals Inc']), u'Legionellainfection': set([u'Bayer Korea Ltd', u'ID Vaccine Corp', u'University of California Los Angeles', u'Bayer AG', u'ALZA Corp', u'Novexel SA', u'Aventis Pharma AG', u'Chong Kun Dang Pharmaceutical Corp']), u'Unstableangina': set([u'Dendreon San Diego LLC', u'Immunex Corp', u'Dendreon Corp', u'Nuvelo Inc']), u'Metastaticnonsmallcelllungcancer': set([u'Cota Inc', u'Apexigen Inc', u'ValiSeek', u'NCIC Clinical Trials Group', u'MD Anderson Cancer Center', u'Genentech Inc', u'Incyte Corp', u'Amgen Inc', u'Genocea Biosciences Inc', u'University of Washington', u'Horizon Healthcare Services Inc', u'Daiichi Sankyo Co Ltd', u'Siteman Cancer Center', u'Symphony Evolution Inc', u'Lonza Walkersville Inc', u'National Comprehensive Cancer Network', u'Epizyme Inc', u'Innovive Pharmaceuticals Inc', u'National Cancer Institute', u'Novartis AG', u'Corvus Pharmaceuticals Inc', u'Biotoscana International', u'ZAI Laboratory Inc', u'SFJ Pharmaceuticals Inc', u'Food and Drug Administration', u'AVEO Oncology', u'University of Maryland', u'Poplar Healthcare', u'Bristol-Myers Squibb Co', u'Merck & Co Inc', u'Advanced Cell Diagnostics Inc', u'PAREXEL International', u'Cancer Research Institute (CRI)', u'Addario Lung Cancer Medical Institute', u'Foundation Medicine Inc', u'Flatiron Health', u'Biodesix Inc', u'Oncolytics Biotech Inc', u'Sichuan University', u'Memorial Sloan-Kettering Cancer Center', u'CureVac GmbH', u'Ono Pharmaceutical Co Ltd', u'Heat Biologics Inc', u'Roche Holding AG', u'Pierre Fabre SA', u'ARIAD Pharmaceuticals Inc', u'MedGenCell, Co Ltd', u'Neon Therapeutics', u'Kadmon Pharmaceuticals LLC', u'Biomarker Strategies Llc', u'Parker Institute for Cancer Immunotherapy', u'AstraZeneca plc', u'Pfizer Inc', u'Sanofi', u'Boehringer Ingelheim Corp', u'Ergomed PLC', u'Ariana Pharmaceuticals', u'Lung Cancer Research Foundation', u'Merrimack Pharmaceuticals Inc', u'Komipharm International Co Ltd', u'Dana-Farber Cancer Institute Inc', u'Diplomat Pharmacy Inc', u'Biocept Inc', u'Biologics Inc', u'Madrigal Pharmaceuticals Inc']), u'Seborrheickeratosis': set([u'Burke Inc', u'Aclaris Therapeutics Inc', u'Peroxychem Llc']), u'Hyperthyroidism': set([u'Merck Frosst Canada & Co', u'Theramex', u'AstraZeneca plc', u'Sumitomo Pharmaceuticals Co Ltd', u'DRAXIMAGE', u'Aralez Pharmaceuticals Inc', u'Aspen PharmaCare Holdings Ltd', u'Paladin Labs Inc', u'Windtree Therapeutics Inc', u'Recordati SpA', u'AstraZeneca Pharmaceuticals LP', u'Yuyu Inc', u'US Government', u'Catholic University of Leuven', u'Kissei Pharmaceutical Co Ltd', u'Guerbet', u'GlaxoSmithKline plc']), u'Traumaticbraininjury': set([u'US Government', u'Rice University', u'Mount Sinai School of Medicine', u'Medisan Pharmaceutical Co Ltd Harbin', u'Rainbow BioScience LLC', u'Mc10 Inc', u'ERA-NET NEURON', u'Fannin Innovation', u'US Department of Veterans Affairs', u'Pharmaceutical Product Development LLC', u'University of Bonn', u'University of Pennsylvania', u'Boston University School of Medicine', u'NuvOx Pharma LLC', u'Walter Reed Army Institute of Research', u'University of Texas Health Science Center Houston', u'Runar Backstrom Foundation', u'Cellvation Inc', u'ProMedica Health System', u'St Michaels Hospital', u'SynZyme Technologies LLC', u'IntelliCell BioSciences Inc', u'Boston University', u'University of Colorado, Boulder', u'Catalent Inc', u'Tenax Therapeutics Inc', u'Soroka University Medical Center', u'US Department of Defense', u'Omeros Corp', u'Banyan Biomarkers Inc', u'Oxeia Biopharmaceuticals Inc', u'KannaLife Sciences Inc', u'Shirley Ryan AbilityLab', u'Edge Therapeutics Inc', u'Abbott Laboratories', u'US Army Research Office', u'Besins Healthcare SA', u'Drexel University', u'Cohen Veterans Bioscience', u'Eunice Kennedy Shriver National Institute of Child Health & Human Development', u'ImmunArray Ltd', u'Loma Linda University', u'Neuren Pharmaceuticals Ltd', u'Massachusetts General Hospital', u'Neurotrope Inc', u'Acelerox LLC', u'QR Pharma Inc', u'San Francisco Veterans Administration Medical Center', u'York Instruments', u'McGill University', u'Ferrer Internacional SA', u'University of California San Diego', u'Particle Sciences Inc', u'University of Melbourne', u'Stemedica Cell Technologies Inc', u'National Institute of Neurological Disorders and Stroke', u'The Global Alliance for Innovation in Neuroscience Inc', u'Stanford University', u'Isomerase Therapeutics Ltd', u'Tetra Discovery Partners LLC', u'SAGE Therapeutics Inc', u'The University of Notre Dame du Lac', u'Amarantus BioScience Holdings Inc', u'H:S Rigshospitalet', u'Helocyte Inc', u'Undisclosed', u'BHR Pharma LLC', u'Rosalind Franklin University of Medicine & Science', u'University of California', u'Royal Philips Electronics', u'Neural Analytics Inc', u'US Naval Medical Research Center', u'University of Miami', u'Constance Therapeutics', u'Medicortex Finland Oy', u'University of California Los Angeles', u'Sanford-Burnham Medical Research Institute', u'The Center for Clinical and Translational Sciences (CCTS) Clinical Research Unit at The University of Texas Health Science Center at Houston', u'Hennepin Life Sciences', u'Broad Institute Inc', u'Baylor College of Medicine', u'bioMerieux SA', u'Translational Genomics Research Institute', u'University of Missouri', u'NeuroVive Pharmaceutical AB', u'Magnetic Insight Inc', u'Ben-Gurion University Of The Negev', u'Hillhurst Biopharmaceuticals Inc', u'Sihuan Pharmaceutical Holdings Group Ltd', u'National Institutes of Health', u'Aethlon Medical Inc', u'Jilin University', u'Hemarina', u'CyDex Pharmaceuticals Inc', u'Gridiron Cannabis Coalition', u'Apollo Endosurgery Inc', u'George Mason University', u'MediciNova Inc', u'University of Western Ontario', u'Athersys Inc', u'Indiana University', u'Medistem Inc', u'Quanterix Corp', u'Shin Nippon Biomedical Laboratories Ltd']), u'Ataxia': set([u'BioMarin Pharmaceutical Inc', u'American Cyanamid Co', u'Asubio Pharma Co Ltd', u'Saniona ApS', u'Takeda Pharmaceutical Co Ltd', u'Santhera Pharmaceuticals AG', u'Ataxion Inc', u'Applied Biosystems Group', u'Quark Pharmaceuticals Inc', u'Sigma-Tau Ind Farm Riunite SpA']), u'Narcoticdependence': set([u'Aoxing Pharmaceutical Co Inc', u'Johnson Matthey plc']), u'Hearingdisorder': set([u'US Government', u'Baylor College of Medicine', u'Australian Government', u'Genentech Inc', u'GenVec Inc', u'Roswell Park Cancer Institute', u'Oklahoma Medical Research Foundation', u'Sound Pharmaceuticals Inc', u'CepTor Corp', u'Athenex Inc', u'Novartis AG', u'Sirna Therapeutics Inc', u'National Institutes of Health', u'MuriGen Pty Ltd', u'Massachusetts General Hospital', u'Quark Pharmaceuticals Inc', u'Microbot Medical Inc', u'University of Michigan', u'Auris Medical Holding AG', u'Hough Ear Institute', u'Otologic Pharmaceutics Inc', u'Xigen SA', u'Zenyth Therapeutics Ltd', u'State University of New York', u'US Department of Defense', u'Fate Therapeutics Inc']), u'Borreliaburgdorferiinfection': set([u'University of Jyvaskyla', u'Lakewood-Amedex Inc']), u'B-celllymphoma': set([u'US Government', u'National Comprehensive Cancer Network', u'The Leukemia & Lymphoma Society', u'University of Zurich', u'Vaccibody AS', u'Advaxis Inc', u'IDEC Pharmaceuticals Corp', u'HTG Molecular Diagnostics Inc', u'GlaxoSmithKline plc', u'Tianjin Chase Sun Jinboda Biotechnology Co Ltd', u'Celltrion Inc', u'Caris Life Sciences', u'Bayer Schering Pharma AG', u'MethylGene Inc', u'Hackensack University Medical Center', u'Uppsala University', u'MedImmune LLC', u'Pharmaceutical Product Development LLC', u'Intracel Corp', u'Sigma-Aldrich Corp', u'University of Bonn', u'University of Washington', u'Fred Hutchinson Cancer Research Center', u'Aventis SA', u'Aegera Therapeutics Inc', u'Ono Pharmaceutical Co Ltd', u'Stanford University', u'Opus Bio Inc', u'Roche Holding AG', u'University of California Los Angeles', u'Alpha-Therapeutics Inc', u'Peregrine Pharmaceuticals Inc', u'Kite Pharma Inc', u'Oxis Biotech Inc', u'University Of Southampton', u'Nanjing Yoko Pharmaceutical Co Ltd', u'Trubion Pharmaceuticals Inc', u'EMD Lexigen Research Center Corp', u'The Menarini Group', u'MD Anderson Cancer Center', u'Cell Design Labs Inc', u'Medarex Inc', u'Cancer Genetics Inc', u'Daiichi Sankyo Co Ltd', u'Abbott Laboratories', u'National Cancer Institute', u'Novartis AG', u'Merck KGaA', u'Poniard Pharmaceuticals Inc', u'University of Minnesota', u'CryoPort Inc', u'Enzon Pharmaceuticals Inc', u'Biovation Ltd', u'Oxford BioTherapeutics', u'Immunomedics Inc', u'ImmunoGen Inc', u'Altor BioScience Corp', u'Micromet Inc', u'Leidos Biomedical Research Inc', u'SHAL Technologies Inc', u'Juno Therapeutics Inc', u'TRION Pharma GmbH', u'Debiopharm SA', u'Lymphoma Research Foundation', u'ILEX Oncology Inc', u'Chugai Pharmaceutical Co Ltd', u'Genentech Inc', u'Unum Therapeutics Inc', u'Quimatryx', u'IDIS Ltd', u'Rigel Pharmaceuticals Inc', u'Wyeth Pharmaceuticals', u'Oxford BioMedica plc', u'Seattle Genetics Inc', u'Epizyme Inc', u'LifeArc', u'Yale Cancer Center', u'Undisclosed', u'XOMA Corp', u'Emergent BioSolutions Inc', u'Centro para el Desarrollo Tecnologico Industrial', u'Merck & Co Inc', u'Zenyaku Kogyo Co Ltd', u'Scripps Research Institute', u'Sanofi', u'University of Texas Southwestern Medical Center', u'Columbia University', u'University of Oslo', u'T23 Biopharmaceutical', u'Karolinska University Hospital', u'Neovii Biotech GmbH', u'MDS Nordion', u'Actinobac Biomed Inc', u'AstraZeneca plc', u'Gilead Sciences Inc', u'University of Lausanne', u'Daysai Biopharmaceuticals Inc', u'Biotechnology Development Corp', u'Genta Inc', u'Genor Biopharma Co Ltd', u'Memorial Sloan-Kettering Cancer Center', u'GPC Biotech AG', u'Veristat, Inc.', u'Genmab A/S', u'Mirna Therapeutics Inc', u'Paul Scherrer Institut', u'Cancer Research Ventures Ltd', u'Pfanstiehl Laboratories Inc', u'Abiogen Pharma SpA', u'Lonza Group AG', u'National Institutes of Health', u'Food and Drug Administration', u'MMRGlobal', u'Bristol-Myers Squibb Co', u'Chinese Government', u'City of Hope', u'Curis Inc', u'MorphoSys AG', u'Ascend Biopharmaceuticals Ltd', u'ICOS Corp', u'Fujifilm Diosynth Biotechnologies', u'Celgene Corp', u'IATROS Bio/Pharma Inc', u'Takara Bio Inc', u'Xencor Inc', u'Idera Pharmaceuticals Inc', u'BeiGene Co Ltd', u'TopoTarget A/S', u'Bioenvision Inc', u'Molecular Templates Inc', u'CuraGen Corp']), u'Bonemarrowfailure': set([u'Advanced Tissue Sciences Inc', u'ViaCell Inc', u'National Cancer Institute', u'University of Florida', u'Genentech Inc', u'Amgen Inc', u'University of Maryland', u'ImmunoGen Inc', u'Dana-Farber Cancer Institute Inc', u'Kyowa Hakko Kirin Co Ltd', u'GD Searle & Co']), u'Shortbowelsyndrome': set([u'BioRx', u'NPS Allelix Corp', u'Naia Limited', u'NPS Pharmaceuticals Inc', u'Cato BioVentures', u'Undisclosed', u'Takeda Pharmaceuticals International GmbH', u'Amunix Inc', u'Bioject Medical Technologies Inc', u'Canadian Government', u'EMD Serono Inc', u'Merck Serono SA', u'Emmaus Medical Inc']), u'Alcoholicfattyliverdisease': set([u'Indiana University', u'Virginia Commonwealth University', u'Immuron Ltd', u'Mayo Clinic Foundation', u'National Institutes of Health']), u'Hepaticporphyria': set([u'Medunik Canada', u'CMIC Holdings Co Ltd', u'Excelsior Biopharma Inc', u'Orphan Europe SARL']), u'Dermatomycosis': set([u'Galderma SA', u'Stiefel', u'University of Arizona', u'Bayer Schering Pharma AG', u'Enamine Ltd', u'Bayer AG', u'National Institutes of Health', u'Novartis AG', u'DUSA Pharmaceuticals Inc', u'Pcovery ApS', u'Shaman Pharmaceuticals Inc', u'Berlex Laboratories Inc']), u'Seborrheicdermatitis': set([u'Summit Therapeutics plc', u'Orient Pharma Co Ltd', u'Laboratoires Biocodex', u'Sinclair Pharma plc', u'Bayer HealthCare Pharmaceuticals Inc', u'Alvogen Inc']), u'Ependymoma': set([u'National Cancer Institute', u'University of Pittsburgh']), u'Mouthinflammation': set([u'Celtrix Pharmaceuticals Inc', u'National Cancer Institute']), u'Melanoma': set([u'Fondazione IRCCS Istituto Nazionale Tumori', u'Quest Diagnostics Inc', u'VIRTTU Biologics', u'Immunicum AB', u'Phoenix Pharmacologics Inc', u'Jennerex Inc', u'European Commission', u'Inovio Pharmaceuticals Inc', u'Biotecnol SA', u'University of Maryland', u'Shanghai Institutes for Biological Sciences CAS', u'VGX Pharmaceuticals LLC', u'ViroTarg Pty Ltd', u'Seattle Genetics Inc', u'Reliable Biopharmaceutical Corp', u'University of Florida', u'Global Medical Solutions Taiwan Ltd', u'Intracel Corp', u'University of Pittsburgh', u'Ribi ImmunoChem Research Inc', u'BPH Energy Ltd', u'University of Alabama at Birmingham', u'Bellicum Pharmaceuticals Inc', u'Neon Therapeutics', u'Kuhnil Pharmaceutical Co Ltd', u'Sandoz Ltd', u'PowderJect Vaccines Inc', u'Abgenix Inc', u'Agence nationale de la recherche (ANR)', u'Theralase Technologies Inc', u'Sigma-Tau Ind Farm Riunite SpA', u'Polaris Pharmaceuticals Inc', u'New York University', u'Israeli Government', u'Laboratoires Cyclopharma', u'The Royal Swedish Academy of Sciences', u'Life Therapeutics Ltd', u'Protagen AG', u'John P. Hussman Foundation', u'Acetylon Pharmaceuticals Inc', u'MediGene AG', u'Plexxikon Inc', u'Beijing Kawin Technology Share-Holding Co Ltd', u'InteRNA Technologies BV', u'Rgenix Inc', u'Galectin Therapeutics Inc', u'Medac GmbH', u'Lipomed AG', u'YM BioSciences Inc', u'National Jewish Health', u'Providence Cancer Center, Earle A. Chiles Research Institute', u'Aptose Biosciences Inc', u'EpiCept Corp', u'Nottingham Trent University', u'Centro Nacional de Investigaciones Oncologicas', u'Nagoya University', u'Genius Biotherapeutics', u'MegaPharm Ltd', u'Altor BioScience Corp', u'Kura Oncology Inc', u'Generex Biotechnology Corp', u'Infinity Pharmaceuticals Inc', u'Piramal Enterprises Ltd', u'Rutgers University', u'F H Faulding & Co Ltd', u'Talon Therapeutics Inc', u'Ludwig-Maximilians University of Munich', u'Prometheus Laboratories Inc', u'Merck & Cie Schaffhausen', u'Myrexis Inc', u'Trilex Pharmaceuticals Inc', u'Tularik Inc', u'New Jersey Medical School', u'Finnish Funding Agency for Technology and Innovation', u'Oregon Health Sciences University', u'Emergent BioSolutions Inc', u'Sakai Chemical Industry Co Ltd', u'4P Pharma', u'LEO Pharma A/S', u'Eli Lilly & Co', u'Centers for Disease Control and Prevention', u'GlaxoSmithKline Biologicals', u'Agenus Inc', u'CSL Ltd', u'Helen F Graham Cancer Center at Christiana Care', u'Novopharm Biotech (USA)', u'Madrigal Pharmaceuticals Inc', u'CDP SWISS AG', u'BioHaven Pharmaceutical Holding Co Ltd', u'University of California Los Angeles', u'NanoString Technologies Inc', u'University of Cincinnati', u'Corixa Corp', u'Patrys Ltd', u'SpePharm AG', u'EU Horizon 2020', u'Coley Pharmaceutical Group Inc', u'Sigma-Aldrich Corp', u'Innate Pharma SA', u'Rubicon Biotechnology Inc', u'PDS Biotechnology Corp', u'University of Washington', u'Dalton Pharma Services', u'Stanford Cancer Institute', u'Elios Therapeutics LLC', u'Peter MacCallum Cancer Centre', u'Horizon Discovery Group plc', u'BioMed Valley Discoveries', u'Vrije University of Brussels', u'Stand Up To Cancer', u'Yamanouchi Pharmaceutical Co Ltd', u'Bristol-Myers Squibb Co', u'Opus Bio Inc', u'TRION Pharma GmbH', u'AltaRex Medical Corp', u'IMCOR Pharmaceutical Co', u'Institute of Cancer Research UK', u'Antisoma plc', u'Arriani Pharmaceuticals SA', u'Metaphore Pharmaceuticals Inc', u'Immuno-Designed Molecules SA', u'Nationales Centrum fur Tumorerkrankungen', u'Hayashibara Co Ltd', u'Hollister-Stier Laboratories LLC', u'University of Chile', u'Karolinska Institutet', u'Qu Biologics Inc', u'Barbara Ann Karmanos Cancer Institute', u'Oncnosis Pharma AIE', u'Genocea Biosciences Inc', u'IDM Pharma Inc', u'Adaptive Biotechnologies Corp', u'Enumeral Biomedical Holdings Inc', u'CytoGenix Inc', u'Pharmacyclics Inc', u'University of Maryland Baltimore County', u'Leo Pharmaceuticals', u'MabVax Therapeutics Inc', u'Auckland UniServices Ltd', u'Chiron Corp', u'Genesis Technology Group Inc', u'AlphaMed Inc', u'University Of Southampton', u'Morphotek Inc', u'US Department of Veterans Affairs', u'Wellcome Trust', u'ArQule Inc', u'TBG Diagnostics Ltd', u'Onyvax Ltd', u'Syndax Pharmaceuticals Inc', u'Navidea Biopharmaceuticals Inc', u'Imaxio', u'Ono Pharmaceutical Co Ltd', u'Roche Holding AG', u'Immunocore Ltd', u'Genzyme Molecular Oncology', u'University of British Columbia', u'Biocompatibles International plc', u'Eurogentec SA', u'Morphogenesis Inc', u'Sayre Therapeutics Private Ltd', u'ANI Pharmaceuticals Inc', u'Sanofi Genzyme', u'Melanovus Oncology Inc', u'Atreca Inc', u'Dana-Farber Cancer Institute Inc', u'Beike Biotechnology Co Ltd', u'Charite Universitaetsmedizin Berlin', u'University of Massachusetts Medical School', u'Ramaciotti Foundation', u'Alexis Biotech Ltd', u'Exelixis Inc', u'Orphan Australia', u'Regenacy Pharmaceuticals LLC', u'Amgen Inc', u'Lindis Biotech', u'University of Queensland Diamantina Institute', u'Cancer Research Institute Inc', u'Victorian Cancer Agency', u'MI Bioresearch', u'i3 research', u'Affichem', u'Johns Hopkins University School of Medicine', u'Italfarmaco SpA', u'Sanofi-Synthelabo', u'Massachusetts General Hospital', u'Medical Research Council', u'Transgene SA', u'Vericel Corp', u'Inflazyme Pharmaceuticals', u'Oncobiomed', u'Callisto Pharmaceuticals Inc', u'Mercury Therapeutics Inc', u'Immunomedics Inc', u'BioVex Inc', u'Pennsylvania State University', u'Pangaea Biotech SA', u'Curacel International Pty Ltd', u'University of California San Diego', u'Biostatin Gyogyszerkutato-Fejleszto Kft', u'F Hoffmann-La Roche AG', u'Bar-Ilan Research & Development Co Ltd', u'Varian Inc', u'CureTech Ltd', u'Health Research Council of New Zealand', u'Cancer Research UK', u'VGXI Inc', u'Genentech Inc', u'National Natural Science Foundation of China', u'Mitsubishi Pharma Corp', u'Mayo Clinic Foundation', u'Laureate Biopharmaceutical Services Inc', u'Eastern Virginia Medical School', u'PDL BioPharma Inc', u'iOx Therapeutics Ltd', u'Scripps Research Institute', u'Molecular Insight Pharmaceuticals Inc', u'University of Southern California', u'University of Texas Southwestern Medical Center', u'CASI Pharmaceuticals Inc', u'DiaCarta LLC', u'Pierre Fabre SA', u'The University of Aston In Birmingham', u'Jules Bordet Institute', u'Kadmon Pharmaceuticals LLC', u'AEterna Zentaris Inc', u'University of Debrecen', u'University of Wisconsin-Madison', u'AstraZeneca plc', u'Boehringer Ingelheim Pharmaceuticals Inc', u'Genencor International Inc', u'John Wayne Cancer Institute', u'Metdem Healthcare Ltd', u'Genta Inc', u'Estero-Anstalt', u'Introgen Therapeutics Inc', u'Australian Government', u'Hemispherx Biopharma Inc', u'bioMerieux SA', u'Molecular Discovery Systems', u'Translational Genomics Research Institute', u'Genmab A/S', u'Universidad Complutense de Madrid', u'ASTA Medica AG', u'H Lee Moffitt Cancer Center and Research Institute', u'Altea Therapeutics', u'Innovation Pharmaceuticals Inc', u'IDT Australia Ltd', u'SciBase AB', u'Viventia Bio Inc', u'University of Alberta', u'Guangdong Medicine Group Corp', u'Tulane University', u'New Jersey Health Foundation Inc', u'Axlr Satt Du Languedoc Roussillon', u'Novavax Inc', u'Massachusetts Eye & Ear Infirmary', u'Eczacibasi Ilac Pazarlama AS', u'University of Wurzburg', u'Aqualis ASA', u'Presage Biosciences', u'ICOS Corp', u'Fujifilm Diosynth Biotechnologies', u'Rex Medical LP', u'Institute for Drug Development', u'Melmotte Inc', u'Takis Biotech', u'Medical University of South Carolina', u'Hospira Adelaide Pty Ltd', u'Central Adelaide Local Health Network Inc', u'Wistar Institute of Anatomy & Biology', u'Undisclosed', u'George Mason University', u'CCL Pharmaceuticals', u'Inotek Pharmaceuticals Corp', u\"Brigham & Women's Hospital\", u'PiSA Farmaceutica', u'Dyax Corp', u'3M Co', u'GeneMedicine Inc', u'Pro Concepta Zug Ag', u'National Comprehensive Cancer Network', u'Cancer Immunotherapy Trials Network', u'Tempus Inc', u'Cerus Corp', u'Vaccibody AS', u'Silence Therapeutics plc', u'Cardinal Health Inc', u'Mologen Ag', u'Sanofi Pasteur', u'Cosmo Bioscience Inc', u'Oryzon Genomics SA', u'Intensity Therapeutics Inc', u'Vical Inc', u'Peptide Immune Ligands', u'Aventis Pharma AG', u'Cantab Biopharmaceuticals Ltd', u'SS Pharmaceutical - ethical drug division', u'MedImmune LLC', u'Leiden University Medical Center', u'Fred Hutchinson Cancer Research Center', u'Olon SpA', u'Five Prime Therapeutics Inc', u'Cipher Pharmaceuticals Inc', u'Primevax Immuno-Oncology Inc', u'Biovector Therapeutics SA', u'Implicit Bioscience Ltd', u'Kite Pharma Inc', u'Ludwig Institute for Cancer Research', u'KuDOS Pharmaceuticals Ltd', u'Cytavis Biopharma GmbH', u'Old Dominion University', u'National Center for Research Resources', u'Defense Advanced Research Projects Agency', u'Pfizer Inc', u'Melanoma Research Alliance', u'Xenova Ltd', u'Oncology Sciences Corp', u'Inex Pharmaceuticals Corp', u'EMD Lexigen Research Center Corp', u'Incyte Corp', u'Vaxeal Holding SA', u'Dermpath Diagnostics', u'OncBioMune Pharmaceuticals Inc', u'Boehringer Mannheim GmbH', u'Teva Pharmaceutical Industries Ltd', u'University of California San Francisco', u'Universite Libre de Bruxelles', u'Oncolytics Biotech Inc', u'Beijing Four Rings Bio-Pharmaceutical Co Ltd', u'Carrus Capital Corp', u'Virginia Biosciences Health Research Corp', u'Skolkovo', u'Hualida Biotech', u'GammaCan International Inc', u'Innogene Kalbiotech Pte Ltd', u'Micromet Inc', u'Titan Pharmaceuticals Inc', u'University of Illinois', u'Boehringer Ingelheim Corp', u'Hoffmann-La Roche Inc', u'University of Melbourne', u'Windtree Therapeutics Inc', u'Wyeth BioPharma', u'ILEX Oncology Inc', u'Arisaph Pharmaceuticals Inc', u'Guangzhou Institutes of Biomedicine and Health', u'American Skin Association', u'Freedom Eye Ltd', u'Oncovir Inc', u'Abramson Cancer Center of the University of Pennsylvania', u'Texas A&M University System', u'Advanced Life Sciences Holdings Inc', u'Harvard Medical School', u'IDIS Ltd', u'Schering-Plough Corp', u'AlphaVax Inc', u'PCT, a Caladrius company', u'CMC Biologics Inc', u'The Knut and Alice Wallenberg Foundation', u'Baxter Healthcare Corp', u'OncoTartis Inc', u'Cellectar Biosciences Inc', u'Cancer InSight, LLC', u'Merck & Co Inc', u'Queensland Genomics Health Alliance', u'BioChem Pharma (International ) Inc', u'rEVO Biologics Inc', u'Sanofi', u'Vertex Pharmaceuticals Inc', u'Columbia University', u'Novogen Ltd', u'Janssen Pharmaceutica NV', u'AnGes MG Inc', u'Case Western Reserve University', u'Nektar Therapeutics', u'Biomarker Strategies Llc', u'Lipotek Pty Ltd', u'OncoSec Medical Inc', u'Fox Chase Chemical Diversity Center Inc', u'Recombio', u'Progenics Pharmaceuticals Inc', u'Wyeth', u'MEI Pharma Inc', u'Vernalis plc', u'Broad Institute Inc', u'University of Iowa', u'Ichor Medical Systems Inc', u'Antigen Express Inc', u'Hoffmann-La Roche AG', u'Imclone LLC', u'Oncolix Inc', u'PharmaGap Inc', u'Cytran Inc', u'Pierre Fabre Laboratories', u'University of Kansas', u'The University Health Network', u'Wyss Institute for Biologically Inspired Engineering', u'University of North Carolina', u'The Australian National University', u'Sophiris Bio Inc', u'Batu Biologics', u'Elan Corp plc', u'Aventis SA', u'INSERM', u'Ascend Biopharmaceuticals Ltd', u'Ontario Institute for Cancer Research', u'CJ Corp', u'Celgene Corp', u'GigaGen Inc', u'Array BioPharma Inc', u'Memgen LLC', u'Max Delbruck Centrum Fur Molekulare Medizin', u'Avanir Pharmaceuticals Inc', u'University of Leeds', u'Adaptimmune Therapeutics plc', u'Queensland Institute of Medical Research', u'Viralytics Ltd', u'Viscum AG', u'Thomas Jefferson University', u'SIGA Technologies Inc', u'Bayer HealthCare Pharmaceuticals Inc', u'Abraxis BioScience Inc', u'Provectus Biopharmaceuticals Inc', u'Beth Israel Deaconess Medical Center', u'Rhone-Poulenc Rorer Inc', u'Metacine Inc', u'Defense Threat Reduction Agency', u'University of Medicine and Dentistry of New Jersey', u'University of Newcastle', u'Targovax AS', u'US Government', u'Cancer Research Campaign Technology Ltd', u'Netherlands Government', u'GenVec Inc', u'Biogen Inc', u'Oncolys BioPharma Inc', u'GlaxoSmithKline plc', u'Cytran Ltd', u'Cell Genesys Inc', u'Sahar International Trading Inc', u'Bayer Schering Pharma AG', u'Interferon Sciences Inc', u'Cytheris SA', u'Immunex Corp', u'Queensland Government', u'University of Michigan', u'Aduro BioTech Inc', u'Peregrine Pharmaceuticals Inc', u'RMR Technologies LLC', u'ERYtech Pharma', u'3M Pharmaceuticals', u'BioSignal Inc', u'Reata Pharmaceuticals Inc', u'Boston University', u'ChemWerth USA', u\"Boston Children's Hospital\", u'Alnylam Pharmaceuticals Inc', u'RecipharmCobra Biologics', u'Cell Pathways Inc', u'Stanford Rook Ltd', u'Johnson & Johnson Pharmaceutical Research & Development LLC', u'Oslo Cancer Cluster', u'Aronex Pharmaceuticals Inc', u'MD Anderson Cancer Center', u'Medarex Inc', u'Immunovaccine Inc', u'Greenville Health System', u'Daiichi Sankyo Co Ltd', u'Abbott Laboratories', u'NuView Life Sciences', u'Cancer Vaccine Institute', u'Ganymed Pharmaceuticals AG', u'Pediatric Oncology Experimental Therapeutics Investigation Consortium', u'Immune Design Corp', u'Accelovance Inc', u'National Cancer Institute', u'Novartis AG', u'Merck KGaA', u'InCytu Inc', u'Colorado State University', u'Fujisawa Pharmaceutical Co Ltd', u'ScanoMed Ltd', u'Life Science Pharmaceuticals Inc', u'Fresenius Medical Care AG', u'SciClone Pharmaceuticals Inc', u'University of Minnesota', u'Oncoceutics Inc', u'Western Australian Institute for Medical Research', u'CHU De Nantes', u'ALZA Corp', u'Applied Immune Technologies Ltd', u'Rockefeller University', u'Immunomic Therapeutics Inc', u'Lytix Biopharma AS', u'Kosan Biosciences Inc', u'SAFC Pharma', u'BASF Pharma', u'University of Colorado System', u'Midatech Pharma US Inc', u'Johns Hopkins University', u'RegeneRx Biopharmaceuticals Inc', u'TC BioPharm Ltd', u'Objectif Recherche VACcin Sida', u'US Public Health Service', u'AmpliPhi Biosciences Corp', u'NeoGenomics Inc', u'Chugai Pharmaceutical Co Ltd', u'Malaghan Institute of Medical Research', u'Protea Biosciences Inc', u'Andrus Reo Ltd', u'New York Genome Center', u'SRI International', u'Iovance Biotherapeutics Inc', u'TenX Biopharma Inc', u'Boots Hoechst Celanese', u'SunPharm Corp', u'Prescient Therapeutics Ltd', u'Tufts University School of Medicine', u'ImmunoCellular Therapeutics Ltd', u'ImmuneRegen BioSciences Inc', u'Syntrix Biosystems Inc', u'French Government', u'Arcturus Therapeutics Inc', u'Cellular Therapeutics Ltd', u'University of Pittsburgh Medical Center', u'Cancer Research Institute (CRI)', u'DermTech International', u'PharmaMar SA', u'Epimmune Inc', u'Commissariat a l`Energie Atomique', u'UC San Diego Moores Cancer Center', u'University of Virginia', u'Kyowa Hakko Kirin Co Ltd', u'DCI Biologicals Inc', u'Valentis Inc', u'University of Tennessee', u'Foundation for Applied Medical Research', u'Genaera Corp', u'Esteve', u'Yale University', u'Wyeth-Ayerst Pharmaceuticals Inc', u'University of Kentucky', u'GenQuest Inc', u'SEPPIC SA', u'Memorial Sloan-Kettering Cancer Center', u'Mount Sinai Medical Center', u'Therion Biologics Corp', u'Maxim Pharmaceuticals Inc', u'University of Western Australia', u'Viragen Inc', u'Mojave Therapeutics Inc', u'Takeda Pharmaceutical Co Ltd', u'Innovation Norway', u'Praecis Pharmaceuticals Inc', u'Vigene Biosciences', u'Vanderbilt University', u'Albert Einstein College of Medicine', u'Sia Latima', u'National Institutes of Health', u'Valo Therapeutics Ltd', u'Food and Drug Administration', u'Sanford-Burnham Medical Research Institute', u'South Texas Accelerated Research Therapeutics', u'Vaccinogen Inc', u'GNI Group Ltd', u'The Menarini Group', u'University of Chicago', u'Biotech Australia', u'Sidney Kimmel Comprehensive Cancer Center', u'Araxes Pharma LLC', u'The University of Birmingham', u'Merck Serono SA', u'University of California Irvine', u'AVAX Technologies Inc', u'The Royal Marsden NHS Trust', u'BeiGene Co Ltd', u'Royalty Pharma', u'Weizmann Institute of Science', u'University of New Mexico', u'Cancer Therapy & Research Center', u'Baltimore VA Medical Center', u'Scancell Ltd', u'Mayne Pharma Pty Ltd', u'Technion - Israel Institute of Technology']), u'Precociouspuberty': set([u'Ardana Bioscience Ltd', u'Paladin Labs Inc', u'Valera Pharmaceuticals Inc', u'Orion Corporation', u'Ipsen', u'Ferring Pharmaceuticals SA', u'Abbott Laboratories', u'Arbor Pharmaceuticals Inc', u'Debiopharm SA', u'Takeda Pharmaceutical Co Ltd', u'Endo Pharmaceuticals Solutions Inc', u'Zentaris GmbH']), u'Chronicinflammatorydemyelinatingpolyneuropathy': set([u'National Institutes of Health', u'GBS-CIDP Foundation International', u'Kaketsuken', u'Teijin Ltd', u'EpiVax Inc']), u'Chorea': set([u'Lundbeck Inc', u'Biovail Corp']), u'Acutelunginjury': set([u'Johnson & Johnson', u'US Government', u'National Institute of Neurological Disorders and Stroke', u'GT Biopharma Inc', u'Genentech Inc', u'Ony Inc', u'Mediolanum Farmaceutici SpA', u'University of South Alabama', u'University of Pennsylvania', u'National Institute of Allergy and Infectious Diseases', u'Forest Laboratories Inc', u'PlaSalus LLC', u\"Cincinnati Children's Hospital Medical Center\", u'geneRx+ Inc', u'CMC Biologics Inc', u'Finnish Funding Agency for Technology and Innovation', u'BioMarck Pharmaceuticals Ltd', u'Michigan Translational Research and Commercialization', u'National Institutes of Health', u'North Carolina State University', u'Georgetown University', u'Radikal Therapeutics Inc', u'Exscien Corp', u'Eli Lilly & Co', u'University of Michigan', u'Relief Therapeutics Holding AG', u'University of Chicago', u'InSymbiosis Discovery Inc', u'Navigen Inc', u'Maruishi Pharmaceutical Co Ltd', u'University of Virginia', u'Handok Inc', u'Windtree Therapeutics Inc', u'Implicit Bioscience Ltd', u'P2D Biosciences', u'University of Colorado System', u'Faron Pharmaceuticals Ltd', u'Altor BioScience Corp', u'Temple University', u'Apeptico Forschung und Entwicklung GmbH', u'Fibrex Medical R&D GmbH', u'INO Therapeutics Inc', u'National Heart Lung and Blood Institute', u'US Department of Defense', u'Ikaria Inc', u'HealthLinx Ltd', u'Pneuma Partners LLC', u'Charite Universitaetsmedizin Berlin']), u'Eosinophilicesophagitis': set([u'UCB Celltech', u'University of North Carolina', u'Receptos Inc', u'AbbVie Inc', u'Ception Therapeutics Inc', u'Merck & Co Inc', u'National Institute of Diabetes, Digestive and Kidney Diseases', u'Schering-Plough Corp']), u'Epidermolysisbullosadystrophica': set([u'Thomas Jefferson University', u'PCT, a Caladrius company', u'National Institute of Arthritis and Musculoskeletal and Skin Diseases', u'Tarix Orphan LLC', u'Stanford University', u'Intrexon Corp', u'Abeona Therapeutics Inc', u'Epidermolysis Bullosa Research Partnership', u'DEBRA Austria']), u'Generalizedanxietydisorder': set([u'Euthymics Bioscience Inc', u'Mochida Pharmaceutical Co Ltd', u'Onxeo SA', u'Quintiles Transnational Corp', u'Eisai Co Ltd', u'Actavis Inc', u'KYOWA Pharmaceutical Industry Co Ltd', u'Elan Corp plc', u'Sanofi', u'Eli Lilly & Co', u'Cephalon Inc', u'IMPAX Laboratories Inc', u'Astellas Pharma Inc', u'Shire plc', u'Mitsubishi Tanabe Pharma Corp', u'Eurand America Inc', u'Handok Inc', u'AstraZeneca plc', u'Pfizer Inc', u'Shionogi & Co Ltd', u'Boehringer Ingelheim Corp', u'Wyeth', u'H Lundbeck A/S']), u'HippelLindausyndrome': set([u'Agilent Technologies Inc', u'Consejo Superior De Investigaciones Cientificas', u'VHL Alliance', u'Ajinomoto Althea Inc', u'Ophthotech Corp']), u'Hotflashes': set([u'US Government', u'Scil Technology GmbH', u'Paladin Labs Inc', u'Eisai Co Ltd', u'PharmaNova Inc', u'Millendo Therapeutics Inc', u'Laxdale Ltd', u'University of Rochester', u'Medical Research Council', u'IMPAX Laboratories Inc', u'Uteron Pharma S.A.', u'Imperial College London', u'Scarista Ltd', u'Bristol-Myers Squibb Pharma Co', u'Azur Pharma Ltd', u'Barr Pharmaceuticals Inc', u'Donesta Bioscience Bv', u'Mithra Pharmaceuticals', u'Zhejiang Xianju Pharmaceutical Corp Ltd', u'ANI Pharmaceuticals Inc', u'GE Healthcare', u'Depomed Inc', u'AstraZeneca plc', u'Pfizer Inc', u'PharmaSwiss SA', u'Radius Health Inc', u'Depomed Development Ltd', u'Fuji Pharma Co Ltd', u'Scotia Holdings plc']), u'Hormonedeficiency': set([u'Roussel Uclaf Corp', u'Shire Pharmaceutical Development Ltd', u'Novo Nordisk A/S', u'University of Florida', u'Baxter International Inc', u'Karo Pharma AB', u'Bioject Medical Technologies Inc', u'IDIS Ltd', u'EMD Serono Inc', u'Nitto Denko Corp', u'Orion Corporation', u'SRI International', u'Amarin Corp plc', u'Sekisui Chemical Co Ltd', u'Welfide Corp', u'GTx Inc', u'Novartis AG', u'Jeil Pharmaceutical Co Ltd', u'Yakult Honsha Co Ltd', u'Teikoku Hormone Manufacturing Co Ltd', u'Ipsen', u'Aventis Pharma AG', u'Hanmi Pharmaceutical Co Ltd', u'Merck & Co Inc', u'Noven Pharmaceuticals Inc', u'Sanofi', u'Fujifilm Diosynth Biotechnologies', u'Pharmacia & Upjohn Inc', u'Cygnus Inc', u'Bridge Laboratories Inc', u'Phyton Biotech Inc', u'Ciba-Geigy AG', u'Shire plc', u'Emmaus Medical Inc', u'Donesta Bioscience Bv', u'Insmed Inc', u'Mithra Pharmaceuticals', u'Teysan Pharmaceutical Co Ltd', u'Osteometer BioTech AS', u'Merck Serono SA', u'Alvogen Inc', u'Janssen Pharmaceuticals Inc', u'Teijin Ltd', u'Pfizer Inc', u'Bayer HealthCare AG', u'Fournier Pharma', u'Pharmos Corp', u'Rhone-Poulenc Rorer Inc', u'Provalis plc', u'GD Searle & Co']), u'Moraxellacatarrhalisinfection': set([u'Alcon Inc', u'Bayer AG', u'Concordia Pharmaceuticals Inc', u'Novartis Vaccines & Diagnostics', u'Ancora Pharmaceuticals Inc', u'Teligent Inc']), u'Rosacea': set([u'CollaGenex Pharmaceuticals Inc', u'BioAdvance', u'Signum Biosciences Inc', u'National Institute of Arthritis and Musculoskeletal and Skin Diseases', u'Malvern Cosmeceutics Ltd', u'Undisclosed', u'Maruho Co Ltd', u'Quintiles Transnational Corp', u'GlycoMira Therapeutics Inc', u'MediGene AG', u'National Institutes of Health', u'Dermata Therapeutics LLC', u'Galderma SA', u'CSL Ltd', u'Brickell Biotech Inc', u'Warner Chilcott plc', u'Signum Dermalogix Inc', u'NovaBiotics Ltd', u'Valeant Pharmaceuticals International Inc', u'Paratek Pharmaceuticals Inc', u'Alvogen Inc', u'Allergan Inc', u'Intendis GmbH', u'Bayer HealthCare Pharmaceuticals Inc', u'Alliance Pharma plc', u'Accolade Pharmaceuticals Pte Ltd', u'SansRosa Pharmaceutical Development Inc']), u'Measlesvirusinfection': set([u'US Government', u'Australian Government', u'Walvax Biotechnology Co Ltd', u'Bio-Manguinhos/Fiocruz', u'Sanofi Pasteur', u'National Institute of Allergy and Infectious Diseases', u'Serum Institute of India Ltd', u'GlaxoSmithKline plc', u'Fiotec- Fundacao para o Desenvolvimento Cientifico e Tecnologico em Saude', u'Vical Inc', u'National Institutes of Health', u'Bill & Melinda Gates Foundation', u'The American Lung Association Asthma Clinical Research Centers', u'Univec Corp', u'Biological E Ltd', u'Merck & Co Inc', u'VBI Vaccines', u'Fundacao Oswaldo Cruz (Fiocruz)', u'Chongqing Zhifei Biological Products Co Ltd', u'bioCSL PTY Ltd', u'AktiVax Inc', u'Kaketsuken', u'University of Colorado System', u'Aktiv-Dry LLC', u'Johns Hopkins University', u'Emory University', u'Takeda Pharmaceutical Co Ltd']), u'Metastaticrectalcancer': set([u'Sanofi', u'Roche Holding AG']), u'Kneeinjury': set([u'Depuy', u'Two Cells Co Ltd', u'Chugai Pharmaceutical Co Ltd', u'St Michaels Hospital', u'Maxx Orthopedics Inc', u'Cornell University', u'Medipost Co Ltd', u'Invibio Ltd', u'Ryerson University', u'Materialise Dental NV', u'University of Calgary', u'Aspect Biosystems Ltd', u'Omni Life Science Inc', u'Global Orthopaedic Technology Pty Ltd', u'Histogenics Corp', u'Cell Therapies Pty Ltd', u'The Arthritis Society, Canada']), u'Metabolicbonedisease': set([u'Emisphere Technologies Inc', u'UAB Research Foundation', u'Lonza Group AG', u'National Institute of Arthritis and Musculoskeletal and Skin Diseases', u'Discovery BioMed Inc', u'Servier', u'Osteologix Holdings PLC', u'Genta Inc', u'Enobia Pharma Inc']), u'Celltransplantation': set([u'Healios KK', u'Cerus Corp', u'Kirin Brewery Co Ltd', u'Shin Nippon Biomedical Laboratories Ltd', u'University of California', u'The Salk Institute for Biological Studies', u'Life Technologies Corp']), u'Esophagealfunctiondisorder': set([u'Allergan Inc', u'Valeant Pharmaceuticals International Inc']), u'Hyperinsulinemia': set([u'XERIS Pharmaceuticals Inc', u'Food and Drug Administration', u'Aegis Therapeutics LLC', u'National Institute of Diabetes, Digestive and Kidney Diseases', u'Cook Childrens Medical Center', u'Childrens Hospital of Philadelphia', u'Albireo Pharma Inc']), u'Venousinsufficiency': set([u'EU Horizon 2020', u'NovaHep AB', u'Rex Medical LP', u'Argon Medical Devices Inc']), u'HepatitisCvi': set([u'Laboratorios Columbia SA de CV', u'Romark Laboratories LC']), u'SA': set([u'American Red Cross', u'Interferon Sciences Inc']), u'Intermittentclaudication': set([u'D Western Therapeutics Institute', u'CPC Clinical Research', u'Kos Pharmaceuticals Inc', u'Beijing Tide Pharmaceutical Co Ltd', u'Mitsubishi Pharma Corp', u'Otsuka Pharmaceutical Co Ltd', u'Taisho Pharmaceutical Co Ltd', u'Centelion SAS', u'CHA Bio & Diostech Co Ltd', u'Yuhan Corp', u'Merck KGaA', u'National Institutes of Health', u'Endovasc Inc', u'Biokey Inc', u'Cato Holding Ltd', u'Edwards Lifesciences Corp', u'Takeda Pharmaceuticals North America Inc', u'Sanofi', u'Sangamo Therapeutics Inc', u'LTT Bio-Pharma Co Ltd', u'Genovate Biotechnology Co Ltd', u'Sunovion Pharmaceuticals Canada Inc', u'Barr Pharmaceuticals Inc', u'Mitsubishi Tanabe Pharma Corp', u'PYRAMID Laboratories, Inc', u'Analytical Biochemistry Laboratories Inc', u'University of Virginia', u'Benxi Leilong Pharmaceutical Co Ltd', u'Sihuan Pharmaceutical Holdings Group Ltd', u'Pluristem Therapeutics Inc']), u'Enterovirus71infection': set([u'Chinese Academy of Sciences', u'Beijing Zhifei Luzhu Biopharmaceutical Co Ltd', u'Institut Pasteur Of Shanghai Chinese Academy Of Sciences', u'Hainan Honz Pharmaceutical Co Ltd', u'Jiangsu Province Centers for Disease Control and Prevention', u'Chinese Government', u'Institute of Medical Biology Chinese Academy of Medical Sciences', u'Beijing Vigoo Biological Co Ltd', u'Beijing Luzhu Biotechnology Co Ltd', u'LifeArc']), u'Bonemarrowtransplantation': set([u'Karolinska Institutet', u'Yamanouchi Pharmaceutical Co Ltd', u'US Government', u'The Leukemia & Lymphoma Society', u'Unigene Laboratories Inc', u'BTG plc', u\"Cincinnati Children's Hospital Medical Center\", u'Bayer Schering Pharma AG', u'Interferon Sciences Inc', u'Cytheris SA', u'Immunex Corp', u'Astex Pharmaceuticals Inc', u'Stanford University', u'TotipotentRX Corp', u'University of Washington', u'GDI Integrated Facility Services Inc', u'City of Hope', u'Apotex Inc', u'Takeda Oncology', u'InPEC BV', u'ARIAD Pharmaceuticals Inc', u'HealthCare Asia Pharmaceuticals Inc', u'Sandoz Ltd', u'Dana-Farber Cancer Institute Inc', u'Novus Therapeutics Inc', u'Targazyme Inc', u'PDL BioPharma Inc', u'MD Anderson Cancer Center', u'Amgen Inc', u'Medarex Inc', u'Compass Biomedical', u'Boehringer Mannheim GmbH', u'National Cancer Institute', u'Novartis AG', u'ZIOPHARM Oncology Inc', u'Hadassah Medical Organization', u'University of Maryland', u'SkyePharma plc', u'Genestack', u'Istituto Scientifico H San Raffaele', u'University of Wurzburg', u'Goodwin Biotechnology Inc', u'ImmunoGen Inc', u'Hikma Pharmaceuticals plc', u'Millennium Pharmaceuticals Ltd', u'Midatech Pharma US Inc', u'Actinium Pharmaceuticals Inc', u'Washington University in St Louis', u'MedStar Georgetown University Hospital', u'Roche Palo Alto', u'Pluristem Therapeutics Inc', u'Orphan Medical Inc', u'AmpliPhi Biosciences Corp', u'Kamada Ltd', u'ILEX Oncology Inc', u'Angioblast Systems Inc', u'Orcrist Bio Inc', u'Mesoblast Ltd', u'Cangene Corp', u'Southern Research Institute', u'Laureate Biopharmaceutical Services Inc', u'PCT, a Caladrius company', u'Burroughs Wellcome International Ltd', u'Scripps Research Institute', u'Sanofi', u'Bayer AG', u'Pierre Fabre SA', u'Case Western Reserve University', u'Genovo Inc', u'NeuroNova AB', u'University of Southern California', u'University of Utah', u'International Stem Cell Corp', u'Wyeth', u'Wyeth BioPharma', u'BioLineRx Ltd', u'AnorMED Inc', u'Imclone LLC', u'myTomorrows', u'Miltenyi Biotec GmbH', u\"St Jude Children's Research Hospital\", u'National Institutes of Health', u'Pharmalink AB', u'Food and Drug Administration', u'OSEO', u'Evotec (UK) Ltd', u'Cancer Molecular Diagnostic Laboratory', u'CJ Corp', u'Cephalon Inc', u'ESP Pharma Inc', u'Astellas Pharma Inc', u'Objectif Recherche VACcin Sida', u'Tarix Pharmaceuticals LLC', u'Albert-Ludwigs-Universit\\xe4t Freiburg', u'Gamida Cell Ltd', u'Cesca Therapeutics Inc', u'University of Alberta', u'GD Searle & Co', u'University of Cambridge']), u'Anorectaldisease': set([u'Adamis Pharmaceuticals Corp', u'National Institutes of Health', u'Cipher Pharmaceuticals Inc', u'Edesa Biotech']), u'Mastitis': set([u'Universite de Sherbrooke', u'Bayer AG']), u'Cholesterylesterstoragedisease': set([u'Synex Consulting Korea Limited', u'Alexion Pharmaceuticals Inc']), u'Hemolyticstreptococcusinfection': set([u'Active Biotech AB', u'Intellivax International Inc']), u'Injury': set([u'Picower Institute for Medical Research', u'US Government', u'Bioventus LLC', u'Massachusetts Institute of Technology', u'PDL BioPharma Inc', u'Scil Technology GmbH', u'Olympus Corp', u'Galen Ltd', u'Medical Developments International Ltd', u'National Institute of Allergy and Infectious Diseases', u'US Naval Medical Research Center', u'Clinquest Group', u'Abazali Bio Ventures', u'University of Cincinnati', u'Derma Sciences Inc', u'GlaxoSmithKline plc', u'Boehringer Mannheim GmbH', u'Neuro-Genesis Inc', u'US Health and Human Services Department', u'DuoCort Pharma AB', u'University of California', u'DURECT Corp', u'National Institutes of Health', u'Oklahoma Medical Research Foundation', u'CFM Pharma BV', u'Plethora Solutions Holdings plc', u'Smith & Nephew plc', u'Osiris Therapeutics Inc', u'NuVasive Inc', u'Biopure Corp', u'HCB Happy Child Birth Holding AG', u'AlloSource', u'University of Washington', u'Collplant Ltd', u'SCYNEXIS Inc', u'VINNOVA', u'Dendreon Corp', u'US Army Medical Research and Materiel Command', u'Medical University of South Carolina', u'Cytokine PharmaSciences Inc', u'Erasmus University Medical Center Rotterdam', u'Leaf Healthcare, Inc', u'TNO', u'State University of New York', u'University of Colorado System', u'Cytori Therapeutics Inc', u'Virginia Commonwealth University', u'Crosslink Genetics Corp', u'Imprimis Pharmaceuticals Inc', u'OPK Biotech', u'Tenax Therapeutics Inc', u'Merckle GmbH', u'Chrysalis BioTechnology Inc', u'PacificGMP', u'Humanzyme Ltd', u'Taligen Therapeutics Inc', u'Novuson Inc', u'Ossacur', u'Seredigm Corp', u'OncoGenex Pharmaceuticals Inc', u'National Institute of General Medical Sciences']), u'Consciousnessdisorder': set([u'Grunenthal GmbH', u'Nippon Shinyaku Co Ltd']), u'Drowsiness': set([u'BTG plc', u'Institut Curie', u'Victory Pharma Inc']), u'Dumpingsyndrome': set([u'Sumitomo Dainippon Pharma Co Ltd', u'Daewoong Pharmaceutical Co Ltd', u'Eisai Co Ltd', u'Dainippon Pharmaceutical Co Ltd']), u'Infectiousdisease': set([u'RESprotect GmbH', u'Syracuse University', u'Takeda Vaccines Inc', u\"Hospital Vall D'Hebron\", u'Lumara Health Inc', u'Phoenix Pharmacologics Inc', u'NOWDiagnostics Inc', u'KRS Global Biotechnology Inc', u'Advanced BioScience Laboratories Inc', u'Nutrition 21 Inc', u'Antigen Discovery Inc', u'The Chinese Centre for Disease Control and Prevention', u'Ceragenix Pharmaceuticals Inc', u'Novartis Institutes for BioMedical Research Inc', u'US Health and Human Services Department', u'Alpharma Inc', u'Serum Institute of India Ltd', u'Life Technologies Corp', u'Cadence Pharmaceuticals Inc', u\"Cincinnati Children's Hospital Medical Center\", u'University of Maryland', u'University of Pennsylvania Medical Center', u'MethylGene Inc', u'VGX Pharmaceuticals LLC', u'Bio Farma', u'Ionis Pharmaceuticals Inc', u'Biological E Ltd', u'PolyMedix Inc', u'PMV Pharmaceuticals Inc', u'Priaxon AG', u'Drexel University College of Medicine', u'Marinomed Biotechnologie GmbH', u'University of Pittsburgh', u'Ribi ImmunoChem Research Inc', u'Creabilis Therapeutics Srl', u'Select Exploration Ltd', u'IMPAX Laboratories Inc', u'Walter Reed Army Institute of Research', u'Sumitomo Pharmaceuticals Co Ltd', u'Renishaw Diagnostics Ltd', u'Hospira Inc', u'Chiesi USA Inc', u'SBI Biotech Co Ltd', u'PsiOxus Therapeutics Ltd', u'Galapagos NV', u'ImmGenics Pharmaceuticals Inc', u'Korean Research Institute of Bioscience and Biotechnology', u'Virion Systems Inc', u'Shanghai Fosun Pharmaceutical (Group) Co Ltd', u'Population Council', u'Audax Medical Inc', u'Procognia (Israel) Ltd', u'Catalent Inc', u'HanAll Biopharma Co Ltd', u'Biophage Pharma Inc', u'Graffinity Pharmaceuticals AG', u'Gravity Bio Inc', u'REGENXBIO Inc', u'Emery Pharma', u'Aquapharm Biodiscovery Ltd', u'Sanofi Pasteur', u'Transgene SA', u'National Research Council of Canada', u'Immunome Inc', u'National Health and Medical Research Council', u'New York University', u'Unimark Remedies Ltd', u'Israeli Government', u'Centre National de la Recherche Scientifique (CNRS)', u'CEL-SCI Corp', u'Medimmune Vaccines Inc', u'Monash University', u'Mutabilis SA', u'The European Union', u'Caerus Discovery LLC', u'Trine Pharmaceuticals Inc', u'Tulane University', u'Innoviva Inc', u'More Pharma Corp', u'Amplimmune Inc', u'Royal Gist-Brocades NV', u'moksha8 Pharmaceuticals Inc', u'Duke-NUS Graduate Medical School', u'Wayne State University', u'Hypha Discovery Ltd', u'Ministry Of Industry & Trade Of The Russian Federation', u'Nymox Pharmaceutical Corp', u'MerLion Pharmaceuticals Pte Ltd', u'Institut National de la Recherche Agronomique', u'Vanderbilt University', u'MeMed Diagnostics Ltd', u'New bioMerieux Alliance', u'Agennix AG', u'Micrologix International Ltd', u'Ajinomoto Althea Inc', u'Brigham Young University', u'Juvaris BioTherapeutics Inc', u'Thermo Fisher Scientific Inc', u'National Jewish Health', u'J Craig Venter Institute', u'Mallinckrodt Inc', u'University of Adelaide', u'Pharmacopeia Inc', u'Avista Pharma Solutions', u'Creative Antibiotics Sweden AB', u'BioVex Inc', u'EpiCept Corp', u'Cytokine PharmaSciences Inc', u'Paragon Bioservices Inc', u'Colby Pharmaceutical Co', u'Shire plc', u'Integrated BioTherapeutics Inc', u'Amplyx Pharmaceuticals Inc', u'Second Genome Inc', u'ImmuRx Inc', u'Altor BioScience Corp', u'Institut Pasteur Korea', u'CSPC Pharmaceuticals Group Limited', u'Therimunex', u'Arisyn Therapeutics Inc', u'20/20 HealthCare Partners LLC', u'NatImmune A/S', u'Victory Pharma Inc', u'Recalcine Pharmaceutical Corp', u'Swedish Orphan Biovitrum AB', u'Luna Quest', u'Presidio Pharmaceuticals Inc', u'Patheon Pharmaceuticals Inc', u'Acceptys Inc', u'ContraVir Pharmaceuticals Inc', u'Inovio Pharmaceuticals Inc', u'AMP-Therapeutics GmbH & Co KG', u'Mitsui & Co Ltd', u'Florida Department of Health', u'Questcor Pharmaceuticals Inc', u'Selventa', u'Medimmune Oncology Inc', u'Science Applications International Corp', u'Sinochem Corp', u'CRELUX GmbH', u'PeptiDream Inc', u'CorMedix Inc', u'Baillet Latour Fund', u'Nuevolution A/S', u'Flamel Technologies SA', u'Cerylid Biosciences Ltd', u'InViragen LLC', u'Oregon Health Sciences University', u'Immuron Ltd', u'Emergent BioSolutions Inc', u'Universita Degli Studi di Pavia', u'Frost & Sullivan', u'Nanotherapeutics Inc', u'UAB Bioseka', u'CTI BioPharma Corp', u'Eli Lilly & Co', u'Centers for Disease Control and Prevention', u'GlaxoSmithKline Biologicals', u'Therapeutic Systems Research Laboratories', u'University of Wisconsin-Madison', u'CSL Ltd', u'BIO Ventures for Global Health', u'BD Technologies', u'Janssen Vaccines & Prevention BV', u'Matinas BioPharma Inc', u'Soligenix Inc', u'Humabs BioMed SA', u'BioHaven Pharmaceutical Holding Co Ltd', u'Palatin Technologies Inc', u'alphaGEN Co Ltd', u'Biomet Orthopedics, LLC', u'Ubiquigent Limited', u'University of South Florida', u'Scienion AG', u'Universitat Autonoma de Barcelona', u'Tanox Inc', u'Cumberland Pharmaceuticals Inc', u'Corixa Corp', u'Novartis Vaccines & Diagnostics', u'Daan Gene Co Ltd of Sun Yat-Sen University', u'Patrys Ltd', u'Akorn Inc', u'Immunovaccine Inc', u'International Vaccine Institute', u'Atox Bio Inc', u'Harbor Therapeutics Inc', u'TetraLogic Pharmaceuticals Corp', u'Coley Pharmaceutical Group Inc', u'Sigma-Aldrich Corp', u'Innate Pharma SA', u'Blueberry Therapeutics Ltd', u'Changchun Huapu Biotechnology Co Ltd', u'University of Kansas', u'Dalton Pharma Services', u'Harbor-UCLA Research and Education Institute', u'Poxel SA', u'Centauri Therapeutics Ltd', u'Elanco Animal Health', u'Snowdon Inc', u'EntoMed SA', u'Northeast Ohio Medical University', u'Altermune Technologies Llc', u'Actelion Ltd', u'Bavarian Nordic A/S', u'Bristol-Myers Squibb Co', u'National Institute of Cholera and Enteric Diseases', u'OSEO', u'INRIA Institut National de Recherche en Informatique et en Automatique', u'Evotec (UK) Ltd', u'The PATH Malaria Vaccine Initiative', u'Panacela Labs Inc', u'Pontificia Universidad Catolica De Chile', u'Evocutis plc', u'Antibiotic Research UK', u'UK Ministry of Defence', u'Cambridge Drug Discovery Ltd', u'Astellas Pharma Inc', u'Synthetic Genomics Inc', u'Archimedes Pharma Ltd', u'Program for Appropriate Technology in Health', u'Zoetis Inc', u'Tabuk Pharmaceutical Manufacturing Co', u'Wistar Institute of Anatomy & Biology', u'Oscient Pharmaceuticals Corp', u'ElSohly Laboratories Inc', u'ActivBiotics Inc', u'Enamine Ltd', u'Microbiology Research Associates', u'Discuva Ltd', u'Azopharma Inc', u'Shanghai BravoBio Co Ltd', u'Xspray Microparticles Ab', u'University of Michigan', u'Biomira USA Inc', u'SK Chemicals Co Ltd', u'Novo Nordisk A/S', u'Medsintez', u'SmithKline Beecham Corp', u'Diatherix Laboratories Inc', u'Dynavax Technologies Corp', u'Oncovir Inc', u'Enumeral Biomedical Holdings Inc', u'Health Protection Agency', u'Trek Therapeutics PBC', u'GalPharma Co Ltd', u'Ningbo Health Gene Technologies Co Ltd', u'Cardiome Pharma Corp', u'The Medicines Company', u'International Medica Foundation', u'Chiron Corp', u'Texas A&M University System', u'MNLpharma Ltd', u'Oak Therapeutics Inc', u'Morphotek Inc', u'Selexis SA', u'Array BioPharma Inc', u'ArQule Inc', u'Stanford University', u'The Austrian Research Promotion Agency FFG', u'Vernalis plc', u'Opsona Therapeutics Ltd', u'University of Pennsylvania', u'Dynamic Microbials Ltd', u'Lead Discovery Center GmbH', u'University of Texas Austin', u'The Macfarlane Burnet Institute For Medical Research & Public Health Ltd', u'Stabilitech Ltd', u'Contraceptive Research and Development Organization', u'University of Iowa', u'Alchemia Ltd', u'Chaperone Technologies Inc', u'Reckitt Benckiser plc', u'MorphoSys AG', u'Microcide Pharmaceuticals Inc', u'Battelle', u'GSK Consumer Healthcare Schweiz AG', u'Medidata Ft Inc', u'China National Biotec Group', u'Thorne Research Inc', u'Jinan University (Guangdong)', u'ANI Pharmaceuticals Inc', u'Intercell AG', u'Biocon Ltd', u'Atreca Inc', u'Biotica Technology Ltd', u'Emergent Europe Ltd', u'AltraVax Inc', u'Inflabloc Pharmaceuticals Inc', u'ChemRar High Tech Center', u'National Institute of General Medical Sciences', u'PSI CRO AG', u'Akonni Biosystems', u'Meiji Seika Pharma Co Ltd', u'SynCo BioPartners', u'McMaster University', u'University of London School of Pharmacy', u'Amarantus BioScience Holdings Inc', u'Karo Pharma AB', u'Axela Inc', u'CytoMed Inc', u'Acella Pharmaceuticals LLC', u'Coelacanth Corp', u'Artes Biotechnology', u'ULURU Inc', u'Consejo Superior De Investigaciones Cientificas', u'University of Bristol', u'RedHill Biopharma Ltd', u'A*STAR Institute of Molecular and Cell Biology', u'SRI International', u'Georgetown University', u'Bruker Corporation', u'MabVax Therapeutics Holdings Inc', u'University of Alabama at Birmingham', u'Cropsolution Inc', u'New Life Scientific Inc', u'Massachusetts General Hospital', u'Abgenix Inc', u'RIKEN', u'Eagle Pharmaceuticals Inc', u'Symphogen A/S', u'Pevion Biotech Ltd', u'Libragen SA', u'Biovation Ltd', u'Humboldt State University', u'Perrigo Co plc', u'Immunomedics Inc', u'Basilea Pharmaceutica International Ltd', u'Atlantic Canada Opportunities Agency', u'Merck Millipore', u'Medizinische Universit\\xe4t Innsbruck', u'Albany Molecular Research Inc', u'PENCE Inc', u'Genetics Laboratory Inc', u'B Braun Melsungen AG', u'TeneoBio Inc', u'Genesto A/S', u'Nanosphere Inc', u'Liveleaf Inc', u'AriBio', u'DuPont Pharmaceuticals Ltd', u'Vybion Inc', u'AVAC Ltd', u'Medivir AB', u'Ranbaxy Laboratories Ltd', u'Fabentech', u'Swiss Federal Office of Public Health', u'Medline Industries Inc', u'ChemBridge Research Laboratories LLC', u'Genentech Inc', u'Agilvax Inc', u'DynPort Vaccine Company LLC', u'Mitsubishi Pharma Corp', u'Paladin Labs Inc', u'IATRICa Inc', u'University of Leeds', u'Weill Medical College of Cornell University', u'Baylor Research Institute', u'Vivalis', u'Riboxx Pharmaceuticals GmbH', u'Axxima Pharmaceuticals AG', u'LifeArc', u'Hi-Tech Pharmacal Co Inc', u'Eden Biodesign Ltd', u'Bioalvo SA', u'Nautilus Biotech SA', u'Venus Remedies Ltd', u'Sinclair Pharma plc', u'Scripps Research Institute', u'Australian Research Council', u'Spring Bank Pharmaceuticals Inc', u'Molecular Insight Pharmaceuticals Inc', u'Ahn-Gook Pharmaceuticals Co Ltd', u'CPX Corp', u'Knome Inc', u'Alkermes plc', u'Research Corporation Technologies', u'Validus Pharmaceuticals', u'ChronTech Pharma AB', u'Sequoia Sciences Inc', u'Proteo Biotech AG', u'Department of Science & Technology', u'Evolva SA', u'AiCuris Anti-infective Cures GmbH', u'INHIBRx LLC', u'Seres Therapeutics Inc', u'AEterna Zentaris Inc', u'Adimab LLC', u'Institut de Recherche pour le Developpement (IRD)', u'Janssen Biotech Inc', u'Emulate Inc', u'Cubist Pharmaceuticals Inc', u'AstraZeneca plc', u'INCELL Corp', u'Frontier Biotechnologies Co Ltd', u'Sonoma Pharmaceuticals Inc', u'Emergex Vaccines Limited', u'PharmaSwiss SA', u'CN Bio Innovations Ltd', u'Boehringer Ingelheim Vetmedica GmbH', u'Kent State University', u'Genta Inc', u'Terumo Corp', u'H&P Labs Inc', u'ProMetic Life Sciences Inc', u'Nobel Biocare Ab (Publ)', u'SutroVax Inc', u'bioMerieux SA', u'Translational Genomics Research Institute', u'Genmab A/S', u'Bioject Medical Technologies Inc', u'Evonik Industries AG', u'Emory University Technology Transfer Office', u'Institute of Materia Medica Chinese Academy of Medical Sciences & Peking Union Medical College', u'Ligand Pharmaceuticals Inc', u'Innovation Pharmaceuticals Inc', u'IDT Australia Ltd', u'MacroGenics Inc', u'University of Alberta', u'Sihuan Pharmaceutical Holdings Group Ltd', u'University of Dundee', u'Novavax Inc', u'Sinovac Biotech Ltd', u'Ministry of Health Saudi Arabia', u'Heat Biologics Inc', u'National Science Foundation', u'Zydus Healthcare USA LLC', u'BioPontis Alliance LLC', u'ICOS Corp', u'Fujifilm Diosynth Biotechnologies', u'ACE BioSciences A/S', u'IC-MedTech Inc', u'Florida State University', u'Applied Biocode Inc', u'3M Drug Delivery Systems', u'Intercell USA', u'Bristol-Myers Squibb Pharma Co', u'Summit Therapeutics plc', u'Chemizon Inc', u'Adria Laboratories Inc', u'University of Puerto Rico', u'Pepscan Systems BV', u'Elusys Therapeutics Inc', u'Cyclenium Pharma Inc', u'Innocoll Technologies Ltd', u'BioDiem Ltd', u'George Mason University', u'Ocean Pharmaceuticals Inc', u'CEVEC Pharmaceuticals GmbH', u'Cepheid', u'Beijing Public Health Bureau', u'Quadrant Technologies Ltd', u'Takeda Pharmaceutical Co Ltd', u'KBP Biosciences Co Ltd', u'GENERIUM Pharmaceuticals', u'VibioSphen LLC', u'ICU Medical Inc', u'University of British Columbia', u'MSD Wellcome Trust Hilleman Laboratories', u'German Federal Ministry of Education and Research', u'Clinical Data Inc', u\"Dr Reddy's Laboratories Ltd\", u'Texas Emerging Technology Fund', u'Royal DSM NV', u'Novartis Ophthalmics Inc', u'CPBS', u'Kirin Brewery Co Ltd', u'Advaxis Inc', u'GLYCODesign Inc', u'Humanetics Corp', u'Mologen Ag', u'Oragenics Inc', u'UAF Technologies and Research', u'Schering-Plough Research Institute', u'InterLink Biotechnologies LLC', u'Dorizoe Lifesciences Ltd', u'AzurRx BioPharma Inc', u'Aeolus Pharmaceuticals Inc', u'Maxygen Inc', u'Forest Laboratories Inc', u'Korea Research Institute of Chemical Technology', u'Schering Overseas Ltd', u'Pacgen Life Science Corp', u'Microbion Corp', u'NovaBay Pharmaceuticals Inc', u'CHA Bio & Diostech Co Ltd', u'Vical Inc', u'CombiMatrix Corp', u'Tris Pharma Inc', u'Hawker Resources Inc', u'Royal Melbourne Intitute of Technology', u'Uppsala University', u'Mount Sinai Hospital', u'Aventis Pharma AG', u'VenatoRx Pharmaceuticals Inc', u'MedImmune LLC', u'Mercachem Holding BV', u'Exiqon A/S', u'Samaritan Pharmaceuticals Inc', u'OSI Pharmaceuticals Inc', u'University of Washington', u'Fred Hutchinson Cancer Research Center', u'CureVac GmbH', u'Enigma Diagnostics Ltd', u'Hybrigenics SA', u'Biocartis', u'ARIAD Pharmaceuticals Inc', u'Dalian Jin Gang Group', u'Thomas Jefferson University', u'SARomics AB', u'Meridian Bioscience Inc', u'NanoBio Corp', u'Ludwig Institute for Cancer Research', u'Inhalation Sciences Sweden', u'RiboTargets Ltd', u'Agency For Science Technology & Research', u'Global Health Innovative Technology Fund', u'InGen Biosciences', u'SerImmune Inc', u'Optimer Pharmaceuticals Inc', u'National Center for Research Resources', u'Defense Advanced Research Projects Agency', u'Novogene Corp', u'ImQuest Life Sciences Inc', u'Helperby Therapeutics Ltd', u'Sorrento Therapeutics Inc', u'Pragma Pharmaceuticals LLC', u'Chiromics LLC', u'Hikma Pharmaceuticals plc', u'University of Nebraska Medical Center', u'TrovaGene Inc', u'Wyeth', u'HSRx LLC', u'Shogoo Pharmaceuticals KK', u'SciGenics Inc', u'SCYNEXIS Inc', u'Avidea Technologies', u'Pfenex Inc', u'Somagen Diagnostics', u'Harvard University', u'Samjin Pharmaceutical Co Ltd', u'Solexa Inc', u'Integral Molecular Inc', u'BIOCND', u'The Dow Chemical Co', u'UM Ventures', u'Affinium Pharmaceuticals Inc', u'Cellex Inc', u'University of Utah', u'UK Department of Trade & Industry', u'University of Colorado, Boulder', u'University of California San Francisco', u'Cetek Corp', u'Merus Labs International Inc', u'X-Gen Pharmaceuticals Inc', u'Angstrom Biotechnologies Inc', u'German Government', u'Pieris Pharmaceuticals Inc', u'Carrus Capital Corp', u'Avatar BioSci Inc', u'Apta Biosciences Ltd', u'Receptor Logic Inc', u'Wellcome Trust', u'SK Chemicals Life Science', u'AnGes MG Inc', u'Kyorin Pharmaceutical Co Ltd', u'Hygie Canada Inc', u'Boehringer Ingelheim Corp', u'Asan Medical Center', u'Visterra Inc', u'Phthisis Diagnostics LLC', u'University of Melbourne', u'University of Ghent', u'NovaMed Pharmaceuticals Inc', u'Debiopharm SA', u'Lophius Biosciences Gmbh', u'TransChem Inc', u'Consejo Nacional de Ciencia y Tecnolog\\xeda', u'Roche Holding AG', u'Themis Bioscience GmbH', u'University of Lund', u'Institute For Hepatitis & Virus Research', u'University of Sheffield', u'Quidel Corp', u'Wyeth Pharmaceuticals', u'Aspen PharmaCare Holdings Ltd', u'InSite Vision Inc', u'TerraGen Discovery Inc', u'Defyrus Inc', u'National Institute of Diabetes, Digestive and Kidney Diseases', u'Actavis Group HF', u'Shionogi Inc', u'Schering-Plough Corp', u'Roche Innovation Center Copenhagen A/S', u'Oxford BioMedica plc', u'Steris Inc', u'Aequus BioPharma Inc', u'KYOWA Pharmaceutical Industry Co Ltd', u'Argos Therapeutics Inc', u'The Korea National Institute of Health', u'XOMA Corp', u'Merck & Co Inc', u'Queensland Genomics Health Alliance', u'Covalon Technologies Ltd', u'Sanofi', u'Vertex Pharmaceuticals Inc', u'Xenova Group plc', u'Vivione Biosciences Llc', u'Quark Venture Inc', u'Japan Agency for Medical Research and Development', u'US Army Medical Research Institute of Infectious Diseases', u'Novel Anti-Infective Technologies', u'Pulmatrix Inc', u'Crosslink Genetics Corp', u'The University of the Incarnate Word', u'Turing Pharmaceuticals LLC', u'Pain Therapeutics Inc', u'Biosortia Pharmaceuticals', u'Concord Biosciences LLC', u'Luna Innovations Inc', u'Synthetic Biologics Inc', u'Caladrius Biosciences Inc', u'HUYA Bioscience International LLC', u'Kineta Inc', u'Adcock Ingram Ltd', u'Oxford Immunotec Ltd', u'Makefield Therapeutics Inc', u'Aptuit Inc', u'4SC AG', u'Alcon Inc', u'Bachem Holding AG', u'Evolva Holding SA', u'Massachusetts Institute of Technology', u'Crocus Nano Electronics LLC', u'Cancer Vaccine Acceleration Fund', u'Center for Discovery and Innovation in Parasitic Diseases', u'In-Cell-Art', u'Pierre Fabre Laboratories', u'Hologic Inc', u'Functional Genetics Inc', u'Knight Therapeutics Inc', u'Cempra Inc', u'University of Mississippi', u'Lonza Group AG', u'The Australian National University', u'EnBiotix Inc', u'University of Tokyo', u'University of Oregon', u'Zavante Therapeutics Inc', u'ARUP Laboratories', u'Aventis SA', u'Takeda Oncology', u'INSERM', u'Kuros Biosciences Ltd', u'Beryllium Discovery Corp', u'Goffin Molecular Technologies BV', u'The National Chemical Laboratories', u'Agence Nationale de Valorisation de la Recherche', u'Athelas SA', u'N8 Medical Inc', u'AstraZeneca AB', u'Technology Strategy Board', u'Genelabs Technologies Inc', u'Lumavita AG', u'Chembio Diagnostic Systems Inc', u'R-Pharm', u'Destiny Pharma Ltd', u'Pataigin LLC', u'Union Life Sciences Limited', u'Janssen Pharmaceuticals Inc', u'Nirvana Pharmaceuticals Inc', u'Atterx Biotherapeutics', u'Crucell NV', u'Vifor Consumer Health Ltd', u'NB Health Laboratory Co Ltd', u'Phylogica Ltd', u'Bayer HealthCare Pharmaceuticals Inc', u'Mitsubishi Tanabe Pharma Corp', u'Virogenics Inc', u'Isogenica Ltd', u'Pernix Therapeutics Holdings Inc', u'Beth Israel Deaconess Medical Center', u'ModeRNA Therapeutics', u'Pfizer Vaccines', u'Berlex Laboratories Inc', u'Defense Threat Reduction Agency', u'Daiichi Seiyaku Co Ltd', u'University of Medicine and Dentistry of New Jersey', u'DKSH Holding Ltd', u'US Government', u'University of Cologne', u'Spotlight Innovation Inc', u'National Institutes of Health', u'Baxter International Inc', u'Vaccinex Inc', u'Vilnius University', u'China State Institute of Pharmaceutical Industry', u'GenVec Inc', u'4SC Discovery GmbH', u'Breckenridge Pharmaceutical Inc', u'GlaxoSmithKline plc', u'AureoGen Biosciences Inc', u'Covance Inc', u'Bayer Schering Pharma AG', u'Henry Schein Inc', u'Ipsen', u'Immunex Corp', u'Queensland Government', u'Helix BioPharma Corp', u'SeD Biomedical Inc', u'Medical Research Council', u'Verenium Corp', u'University of Texas Health Science Center Houston', u'BioRelix Inc', u'Aduro BioTech Inc', u'Anatara Lifesciences', u'IDbyDNA Inc', u'University of Miami Miller School of Medicine', u'Intrexon Corp', u'Aurobindo Pharma Ltd', u'Tsinghua University', u'Avacta Ltd', u'Kirin Pharma Co Ltd', u'3M Pharmaceuticals', u'Shionogi & Co Ltd', u'Endo International plc', u'Ilsung Pharmaceutical Co Ltd', u'Emory University', u'Roche Diagnostics GmbH', u'Zirus Inc', u'US Department of Defense', u'Morphochem AG', u'Arsanis Biosciences GmbH', u'Mast Biosurgery Ag', u'Sequenom Inc', u'Neumedicines Inc', u'Profectus BioSciences Inc', u'Quratis Co Ltd', u'Ruthigen Inc', u'Medarex Inc', u'Pharmasset Inc', u'Cystic Fibrosis Foundation Therapeutics Inc', u'Daiichi Sankyo Co Ltd', u'Abbott Laboratories', u'DermaMed Pharmaceutical Inc', u'Goldfarb Corporation', u'Greffex Inc', u'Lytix Biopharma AS', u'Immune Design Corp', u'Grifols SA', u'GlaxoSmithKline Consumer Healthcare Ltd', u'National Cancer Institute', u'Novartis AG', u'Texas Tech University', u'Fujisawa Pharmaceutical Co Ltd', u'International Consortium on Anti-Virals', u'BG Medicine Inc', u'Oxford-Emergent Tuberculosis Consortium Ltd', u'Biovista Inc', u'Synageva BioPharma Corp', u'S C Johnson & Son Inc', u'Nemus Bioscience Inc', u'Arbutus Biopharma Corp', u'TechnoVax Inc', u'Concordia Pharmaceuticals Inc', u'Infectious Disease Research Institute', u'Aptose Biosciences Inc', u'NeuClone Pty Ltd', u'Sutro Biopharma Inc', u'Exciton Technologies Inc', u'OstriGen Inc', u'Xisle Pharma Ventures Trust', u'Pharmacia & Upjohn Inc', u'3-Dimensional Pharmaceuticals Inc', u'University of Barcelona', u'Montana State University', u'CytRx Corp', u'TCG Lifesciences Ltd', u'Ferrer Internacional SA', u'Immtech Pharmaceuticals Inc', u'Nosopharm SAS', u'Memcine Pharmaceuticals Inc', u'NovaNet Inc', u'SpeeDx Pty Ltd', u'Lexicon Pharmaceuticals Inc', u'goBalto Inc', u'Beiersdorf AG', u'ImageIQ Inc', u'Evotec AG', u'Undisclosed', u'Amicrobe Inc', u'GeneData AG', u'Drugs for Neglected Diseases Initiative', u'BioTrove Inc', u'GeneArrest Ltd', u'US Army Medical Research and Materiel Command', u'Southern Research Institute', u'University of Maryland School of Medicine', u'Aragen Bioscience Inc', u'Kymab Ltd', u'Celestar Lexico-Sciences Inc', u'Ben Franklin Technology Partners of Southeastern Pennsylvania', u'Institut Pasteur', u'Promore Pharma', u'Seegene Inc', u'ImmuneRegen BioSciences Inc', u'French Government', u'Royal Philips Electronics', u'University College London', u'US Naval Medical Research Center', u'University of Miami', u'Dr Falk Pharma GmbH', u'Mucosis BV', u'Hampton University', u'Bloom Burton & Co', u'Epimmune Inc', u'Commissariat a l`Energie Atomique', u\"Children's Hospital of Los Angeles\", u'University of Virginia', u'University of California Irvine', u'NovaBiotics Ltd', u'Immune Therapeutics Inc', u'BD Biosciences', u'Quintiles Transnational Corp', u'Walter and Eliza Hall Institute of Medical Research', u'Inhibikase Therapeutics Inc', u'Sunovion Pharmaceuticals Inc', u'Pfizer Inc', u'Midatech Pharma PLC', u'CureLab Inc', u'Norwegian Research Council', u'ZyGEM Corp Ltd', u'Human Genome Sciences Inc', u'Kleo Pharmaceuticals Inc', u'Northeastern University', u'Inhibitex Inc', u'Cadila Pharmaceuticals Ltd', u'Sankyo Co Ltd', u'Edico Genome Corp', u'ENYO Pharma SAS', u'Kitasato Institute', u'Teva Pharma BV (Netherlands)', u'Wyeth BioPharma', u'RGene Therapeutics Inc', u'Zalgen Labs LLC', u'NeoGenesis Pharmaceuticals Inc', u'Baylor College of Medicine', u'ProQuest Pharmaceuticals Inc', u'University of Western Australia', u'Oxxon Therapeutics Ltd', u'Tzamal Medical Group Ltd', u'AlgiPharma AS', u'University of California at Berkeley', u'Sichuan University', u'UniQuest Pty Ltd', u'National Institute of Allergy and Infectious Diseases', u'Omnio Healer AB', u'Claris Lifesciences Ltd', u'SEEK', u'Praecis Pharmaceuticals Inc', u'Cosmo Pharmaceuticals SpA', u'Eisai Co Ltd', u'Forest Laboratories UK Ltd', u'MPI Research', u'Albert Einstein College of Medicine', u'NAEJA Pharmaceuticals Inc', u'Bill & Melinda Gates Foundation', u'Calmune Corp', u'M.J. Murdock Charitable Trust', u'Rx for Africa', u'Menarini Asia-Pacific', u'Sarepta Therapeutics Inc', u'ImmunoVentis Inc', u'Takeda San Diego Inc', u'Business victoria', u'Mississippi State University', u'GNI Group Ltd', u'National Institutes of Standards and Technology', u'Sirona Biochem Corp', u'Nippon Shoji Co Ltd', u'Anadys Pharmaceuticals Inc', u'ChemDiv Inc', u'Aridis Pharmaceuticals Inc', u'Exakta-OPKO', u'Trinity College Dublin', u'Axxam SpA', u'Sanofi-Aventis US LLC', u'Qiagen NV', u'Jubilant Life Sciences Ltd', u'Sanford-Burnham Medical Research Institute', u'Merck Serono SA', u'Leonard Meron Biosciences Inc', u'MSN Laboratories Ltd', u'Nuron Biotech Inc', u'ProBioGen AG', u'Idera Pharmaceuticals Inc', u'Deinove', u'University of New Mexico', u'KVK-Tech Inc', u'Vedanta Biosciences Inc', u'Teligent Inc', u'Boryung Pharm Co Ltd', u'Global Alliance for Vaccines and Immunization', u'Iterum Therapeutics Ltd', u'Evec Inc', u'DiaSorin Inc', u'ContraFect Corp', u'University of Arkansas']), u'StreptococcusgroupBinfection': set([u'Takeda Vaccines Inc', u'Rockefeller University', u'Pfizer Inc', u'Eunice Kennedy Shriver National Institute of Child Health & Human Development', u'National Institutes of Health', u'Bill & Melinda Gates Foundation', u'National Research Council of Canada', u'North American Vaccine Inc', u'National Institute of Allergy and Infectious Diseases', u'Provalis plc', u'Chiron Vaccines Co', u'ContraFect Corp', u'University of Iowa']), u'Bordetellainfection': set([u'Elanco Animal Health', u'Boehringer Ingelheim Vetmedica GmbH']), u'Tineapedis': set([u'DreamPharma Corp', u'Undisclosed', u'Sinclair Pharma plc', u'Summit Pharmaceuticals International Corp', u'Topica Pharmaceuticals', u'Ranbaxy Laboratories Ltd', u'MedPharm Ltd', u'Nihon Nohyaku Co Ltd', u'Bayer Yakuhin Ltd']), u'Mineralmetabolismdisorder': set([u'Evotec AG', u'Vifor Pharma']), u'Transplantation': set([u'Allele Biotechnology & Pharmaceuticals Inc', u'SangStat Medical Corp', u'TxCell SA', u'Astellas Institute for Regenerative Medicine', u'American Society of Transplant Surgeons', u'Amgen Inc', u'Seragen Inc', u'Nextran Inc', u'INOXIA Lifesciences GmbH', u'National Institute of Diabetes, Digestive and Kidney Diseases', u'North Shore Long Island Jewish Health System', u'University of Virginia', u'Geron Corp', u'3d Systems Inc', u'Lux Biosciences Inc', u'Northwestern University', u'Weizmann Institute of Science', u'Novartis AG', u'Vical Inc', u'National Institutes of Health', u'Ionis Pharmaceuticals Inc', u'Kyocera Corp', u'GenoDive Pharma Inc', u'Transcriptome Sciences Inc', u'Cedars-Sinai Medical Center', u'One Lambda', u'University of Minnesota', u'INSERM Transfert', u'Celldex Therapeutics Inc', u'Thermo Fisher Scientific Inc', u'Astellas Pharma Inc', u'Epimmune Inc', u'Mitsubishi Tanabe Pharma Corp', u'United Therapeutics Corp', u'Hansa Medical AB', u'Organ Technologies Inc', u'Case Western Reserve University', u'RIKEN', u'Janssen Biotech Inc', u'Effimune SA', u'Procognia (Israel) Ltd', u'Novogene Corp', u'University of Bern', u'Fibrex Medical R&D GmbH', u'Dyax Corp', u'Fundacao para o Remedio Popular', u'National Center for Research Resources', u'University of California San Francisco', u'Sandoz Pharma Ltd', u'Ikaria Inc', u'Pluristem Therapeutics Inc', u'TikoMed AB', u'Novosom AG', u'TrovaGene Inc', u'Johns Hopkins University']), u'Tumorlysissyndrome': set([u'Selecta Biosciences Inc', u'3SBio Inc', u'EnzymeRx LLC']), u'Gastrointestinalinflammation': set([u'US Government', u'Digital Gene Technologies Inc', u'MD Anderson Cancer Center', u'Daewoong Pharmaceutical Co Ltd', u'Jenner Biotherapies Inc', u'National Institute of Diabetes, Digestive and Kidney Diseases', u'Allegiance Equity Corp', u'Leadiant Biosciences Inc', u'Verus Pharmaceuticals Inc', u'Synedgen Inc', u'XOMA Corp', u'Immunex Corp', u'Merck & Co Inc', u'Monash University', u'Panaxia Pharmaceutical Industries Ltd', u'Acambis Inc', u'Ferring Research Ltd', u'Soligenix Inc', u'Trillium Therapeutics', u'Emulate Inc', u'Meritage Pharma Inc', u'Avaxia Biologics Inc', u'Alfama Inc']), u'Hearttransplantation': set([u'Transplant Genomics', u'Mayo Clinic Foundation', u'MBA Medical', u'Paragonix Technologies Inc', u'Essential Pharmaceuticals, LLC']), u'Nasalpolyps': set([u'University of Ghent', u'Cilag AG', u'Regeneron Pharmaceuticals Inc', u'AstraZeneca plc']), u'Vesicularstomatitisvirusinfection': set([u'Pfizer Inc', u'National Institutes of Health']), u'Vibriocholeraeinfection': set([u'Incepta Pharmaceuticals Co Ltd', u'Active Biotech AB', u'Undisclosed', u'Chinese Academy of Medical Military Sciences', u'Harvard Medical School', u'SynCo BioPartners', u'National Institute of Allergy and Infectious Diseases', u'SmithKline Beecham plc', u'Valneva SE', u'GlaxoSmithKline plc', u'World Health Organization', u'Republic of Korea Government', u'VABIOTECH', u'Walter Reed Army Institute of Research', u'National Institutes of Health', u'Bill & Melinda Gates Foundation', u'University of Tokyo', u'University of Maryland', u'Biological E Ltd', u'Crucell Sweden AB', u'Celldex Therapeutics Inc', u'Shantha Biotechnics PVT Ltd', u'bioCSL PTY Ltd', u'CSL Ltd', u'Astellas Pharma Inc', u'BIO Ventures for Global Health', u'Swedish International Development Agency', u'LG Electronics Inc', u'International Centre For Diarrhoeal Disease Research, Bangladesh', u'Crucell Switzerland AG', u'PaxVax Inc', u'Shanghai United Cell Biotechnology Co Ltd', u'Biosidus SA', u'Crucell NV', u'Vaccine Technologies Inc', u'Sanofi', u'Swiss Tropical & Public Health Institute', u'University of California San Diego', u'Dartmouth College', u'Alnylam Pharmaceuticals Inc', u'Acambis plc', u'International Vaccine Institute']), u'Bunyavirusinfection': set([u'Juvaris BioTherapeutics Inc', u'National Institute of Allergy and Infectious Diseases', u'SIGA Technologies Inc']), u'Nervoussystemdevelopmentdisorder': set([u'US Government', u'Neurocrine Biosciences Inc', u'US Department of Defense', u'Pain Therapeutics Inc', u'SIBIA Neurosciences Inc', u'Snowdon Inc']), u'Pneumocystiscariniiinfection': set([u'University of North Carolina', u'Medimmune Oncology Inc', u'National Institute of Allergy and Infectious Diseases', u'Onxeo SA', u'Southern Research Institute', u'GlaxoSmithKline plc', u'World Health Organization', u'National Institutes of Health', u'Bill & Melinda Gates Foundation', u'Aventis SA', u'Schering Overseas Ltd', u'Auburn University', u'Eli Lilly & Co', u'Walter Reed Army Institute of Research', u'University of Rochester', u'ALZA Corp', u'MiniVax Inc', u'Piramal Enterprises Ltd', u'Duke University', u'Georgia State University', u'Par Pharmaceutical Inc', u'Pfizer Inc', u'University of Cincinnati', u'Immtech Pharmaceuticals Inc', u'Central Drug Research Institute', u'Zalicus Inc', u'Guo Kang Pharmaceutical & Medical Supplies Ltd']), u'Retinopathy': set([u'Celtrix Pharmaceuticals Inc', u'Aerie Pharmaceuticals Inc', u'Agence Nationale de Recherches sur le Sida et les hepatites virales (ANRS)', u'Regeneron Pharmaceuticals Inc', u'Karolinska Institutet', u'University of Florida', u'AGTC', u'Cellular Dynamics International Inc', u'European Commission', u'GenVec Inc', u'US Government', u'Centre de Physiopathologie de Toulouse Purpan', u'Royal DSM NV', u'Schepens Eye Research Institute', u'Advanced Ocular Systems Ltd', u'Astex Pharmaceuticals Inc', u'Genentech Inc', u'Microbot Medical Inc', u'INSERM Transfert', u'OSI Pharmaceuticals Inc', u'University of Pennsylvania', u'InFlectis BioScience SAS', u'Mateon Therapeutics Inc', u'Optovue Inc', u'MINU LLC', u'Santen Pharmaceutical Co Ltd', u'Wayne State University', u'Peregrine Pharmaceuticals Inc', u'ROCOL SA', u'Neurotech Pharmaceuticals Inc', u'NeuroSpheres Ltd', u'Tanabe Seiyaku Co Ltd', u'ElsaLys Biotech', u'NovaMedica', u'Universite de Nantes', u'Clearside Biomedical Inc', u'International Biotechnology Center Generium LLC', u'Apexian Pharmaceuticals Inc', u'New York University', u'MABLife', u'The European Union', u'University of New South Wales', u'Allegro Ophthalmics LLC', u'Clayton Foundation For Research', u'Ohio Development Services Agency', u'University of Heidelberg', u'Novelion Therapeutics Inc', u'Hanmi Pharmaceutical Co Ltd', u'Massachusetts General Hospital', u'Ajinomoto Althea Inc', u'RIKEN', u'Nemus Bioscience Inc', u'National Neurovision Research Institute', u'University of Manchester', u'Institute of Ophthalmology', u'pSivida Inc', u'Johns Hopkins University', u'Compugen Ltd', u'Parke-Davis & Co', u'Recordati SpA', u'Bausch & Lomb Inc', u'Healios KK', u'Undisclosed', u'Astellas Institute for Regenerative Medicine', u'University of Mississippi', u'Agilent Technologies Inc', u'Amarantus BioScience Holdings Inc', u'Apogee Biotechnology Corp', u'Oxford BioMedica plc', u'Ophthotech Corp', u'NuCoria', u'XOMA Corp', u'Scripps Research Institute', u'National Eye Institute', u'Sanofi', u'CASI Pharmaceuticals Inc', u'Bayer AG', u'Eye Co Pty Ltd', u'University of Virginia', u'BBB Therapeutics BV', u'Case Western Reserve University', u'Foundation Fighting Blindness', u'ReNeuron Group plc', u'Pfizer Inc', u'Neurocrine Biosciences Inc', u'Michigan State University', u'Universit\\xe9 De Strasbourg', u'Ministry Of Industry & Trade Of The Russian Federation', u'Harrington Discovery Institute', u'Adenosine Therapeutics LLC', u'International Stem Cell Corp', u'Retinagenix LLC', u'Hopital Saint-Louis', u'Alcon Inc', u'BioLineRx Ltd', u'Australian Government', u'UK Government', u'Preceyes BV', u'University of Oklahoma', u'Toyama University', u'Bascom Palmer Eye Institute', u'NightstaRx Ltd', u'S. Fyodorov Eye Microsurgery Complex', u'BioTime Inc', u'Editas Medicine Inc', u'University of Wisconsin-Madison', u'National Institutes of Health', u'RetroSense Therapeutics', u'Senju Pharmaceutical Co Ltd', u'Bristol-Myers Squibb Co', u'INSERM', u'Sanofi Genzyme', u'KalVista Pharmaceuticals Inc (Pre-merger)', u'BioInvent International AB', u'Proteostasis Therapeutics Inc', u'ThromboGenics NV', u'University of Pittsburgh Medical Center', u'Ciba-Geigy AG', u'Fovea Pharmaceuticals SA', u'Sanofi GmbH', u'Apollo Endosurgery Inc', u'Acucela Inc', u'University of Oxford', u'Dyax Corp', u'Japan Innovative Therapeutics Inc', u'ONL Therapeutics LLC', u'Adverum Biotechnologies Inc', u'Shin Nippon Biomedical Laboratories Ltd']), u'Raynaudsdisease': set([u'University of Mississippi', u'US Government', u'Seoul National University Hospital', u'Bayer Schering Pharma AG', u'Elis Pharmaceuticals Ltd', u'AstraZeneca plc', u'Covis Pharma Sarl', u'Roche Palo Alto', u'Tripos Inc', u'Nano Terra Inc', u'Kadmon Pharmaceuticals LLC', u'MediQuest Therapeutics Inc', u'Dong-A ST Co Ltd', u'Apricus Biosciences Inc', u'University of Tennessee', u'GlaxoSmithKline plc']), u'Ornithinetranscarbamylasedeficiency': set([u'Lucane Pharma SA', u'Isogenis Inc', u'Orpharma Pty Ltd', u'Dimension Therapeutics Inc', u'REGENXBIO Inc', u'National Institute of Allergy and Infectious Diseases']), u'Toxoplasmagondiiinfection': set([u'Whitehead Institute for Biomedical Research', u'US Government']), u'Carcinoidsyndrome': set([u'Symphony Capital LLC', u'Mateon Therapeutics Inc', u'Catalent Inc', u'Angiogene Pharmaceuticals Ltd', u'Ipsen', u'EMD Serono Inc', u'Diplomat Pharmacy Inc', u'Lexicon Pharmaceuticals Inc']), u'Panniculitis': set([u'NorthShore University HealthSystem (NorthShore)', u'Food and Drug Administration']), u'Nosedisease': set([u'Entellus Medical Inc', u'Fiagon Gmbh']), u'Psoriasis': set([u'Quest Diagnostics Inc', u'Scil Technology GmbH', u'BioXpress Therapeutics SA', u'European Commission', u'Cure Medical Manufacturing', u'VGX Pharmaceuticals LLC', u'Ionis Pharmaceuticals Inc', u'Coherus BioSciences Inc', u'NB Therapeutics Inc', u'Zhaoke Pharmaceutical (Hefei) Co Ltd', u'MedPharm Ltd', u'Creabilis Therapeutics Srl', u'Fluence Therapeutics Inc', u'Astralis Ltd', u'Sumitomo Pharmaceuticals Co Ltd', u'Galapagos NV', u'R&R Inc', u'Phenex Pharmaceuticals AG', u'Phosphagenics Ltd', u'mAbxience SA', u'Toray Industries Inc', u'Ennar Pharma AG', u'Catalent Inc', u'Foamix Pharmaceuticals Ltd', u'One World Cannabis Ltd', u'Baxalta Inc', u'Polpharma Biologics', u'Valocor Therapeutics Ltd', u'National Health and Medical Research Council', u'PDL BioPharma Inc', u'Eli Lilly Japan KK', u'The European Union', u'Harvard Scientific Corp', u'Antisense Therapeutics Ltd', u'Barrier Therapeutics Inc', u'Avillion LLP', u'Tonghua Dongbao Pharmaceutical Co Ltd', u'Hanmi Pharmaceutical Co Ltd', u'Imaginative Research Associates Inc', u'Gebro Pharma GmbH', u'ISDIN SA', u'Gardant Pharmaceuticals Inc', u'University of Manchester', u'Pharmacopeia Inc', u'Cytokine PharmaSciences Inc', u'Windtree Therapeutics Inc', u'Celera Group', u'MegaPharm Ltd', u'Grelan Pharmaceutical Co Ltd', u'Martek Biosciences Corp', u'Strathclyde Institute for Drug Research', u'Ministry of Science and Technology of the People\\xb4s Republic of China', u'Swedish Orphan Biovitrum AB', u'Biochemie GmbH', u'Bio-Technology General Ltd', u'Medimmune Oncology Inc', u'Cytodesign Inc', u'Oregon Health Sciences University', u'Emergent BioSolutions Inc', u'Telormedix SA', u'Schering Overseas Ltd', u'LEO Pharma A/S', u'Eli Lilly & Co', u'Isotechnika Pharma Inc', u'University of Wisconsin-Madison', u'CSL Ltd', u'Cook Pharmica', u'AbbVie Inc', u'GroupMed (Holding)', u'Biogen Idec International GmbH', u'PharmaEssentia Corp', u'Stiefel', u'Boston VA Research Institute, Inc.', u'Cumberland Pharmaceuticals Inc', u'Corixa Corp', u'Ferrer Internacional SA', u'The Center of Molecular Immunology', u'Picower Institute for Medical Research', u'Oxford University Innovation', u'Blueberry Therapeutics Ltd', u'OWC Pharmaceutical Research Corp', u'Pfanstiehl Laboratories Inc', u'Huapont Life Sciences Co Ltd', u'SmithKline Beecham plc', u'XERIS Pharmaceuticals Inc', u'Carna Biosciences Inc', u'Bristol-Myers Squibb Co', u'OSEO', u'Evotec (UK) Ltd', u'OptiMed Specialty Pharmacy', u'Dr Rentschler Biotechnologie GmbH', u'Astellas Pharma Inc', u'Advanced Biotherapy Inc', u'UCB Celltech', u'Knoll GmbH', u'University of Auckland', u'CS Portugal-Productos Farmaceuticos Lda', u'Hokkaido University', u'Coulter Pharmaceutical Inc', u'AET BioTechnology Ltd', u'Nordic Group', u'Universidad Polit\\xe9cnica De Catalu\\xf1a', u'Sareum Holdings plc', u'Advancell', u'Promius Pharma LLC', u'Merz North America', u'Genesis Research and Development Corp Ltd', u'Angiotech Pharmaceuticals Inc', u'University of Tokyo', u'IDEC Pharmaceuticals Corp', u'Yes Biotech Labs Ltd', u'Orion Corporation', u'Chugai Pharmaceutical Co Ltd', u'BTG plc', u'Medeva Ltd', u'Lead Pharma Holding BV', u'DRAXIS Health Inc', u'Erimos Pharmaceutical LLC', u'Selexis SA', u'Celera South San Francisco', u'Taizhou MTYB Biotech Co Ltd', u'Onyvax Ltd', u'Murdoch Childrens Research Institute', u'Roche Holding AG', u'Merck Sante SA', u'DMI BioSciences Inc', u'Second Military Medical University PLA', u'Mitsubishi Tanabe Pharma Corp', u'Panaxia Pharmaceutical Industries Ltd', u'Spherium Biomed', u'Vasogen Inc', u'VIB', u'Chemiderm Inc', u'Teikoku Seiyaku KK', u'KAHR Medical Ltd', u'Biocon Ltd', u'Inventiva', u'Diplomat Pharmacy Inc', u'R-Tech Ueno Ltd', u'University of Massachusetts Medical School', u'Maruho Co Ltd', u'Alberta Research Council', u'Northern Sydney Area Health Service', u'Galena Biopharma Inc', u'Airmid Inc', u'Stiefel Laboratories (UK) Ltd', u'SkyePharma plc', u'Acretia Inc', u'Synphora AB', u'Abgenix Inc', u'Polichem SA', u'NuMedii Inc', u'Yeda Research and Development Co Ltd', u'Orca Pharmaceuticals', u'Basilea Pharmaceutica International Ltd', u'Avexxin AS', u'OXO', u'Can-Fite BioPharma Ltd', u'Welichem Biotech Inc', u'Prasco Laboratories', u'Allergan Inc', u'LG Chem Ltd', u'Actinobac Biomed Inc', u'The Research Council of Norway', u'Curacel International Pty Ltd', u'ProtoKinetix Inc', u'University of Oxford', u'Rockefeller University', u'Domantis Ltd', u'Genentech Inc', u'Antisoma plc', u'Paladin Labs Inc', u'MRC Biotech Pty Ltd', u'ARC Ventures', u'Hyal Pharmaceutical Corp', u'Transport Pharmaceuticals Inc', u'Hi-Tech Pharmacal Co Inc', u'SFJ Pharmaceuticals Inc', u'Celonic AG', u'Stada Arzneimittel AG', u'Japan Tobacco Inc', u'Warner Chilcott plc', u'Bioglan Pharmaceuticals Co', u'Lycera Corp', u'AstraZeneca plc', u'Novozymes GroPep Ltd', u'Glasgow Caledonian University', u'Novel Therapeutic Technologies Inc', u'Juniper Pharma Services', u'Janssen-Cilag Ltd', u'Zynaxis Inc', u'Australian Government', u'Academia Sinica', u'Genmab A/S', u'Reliance Life Sciences Group', u'Immunotech Developments Inc', u'Ben-Gurion University Of The Negev', u'Mundipharma International Corp Ltd', u'Innovation Pharmaceuticals Inc', u'IDT Australia Ltd', u'ALTANA AG', u'Abeona Therapeutics Inc', u'ProMetic Life Sciences Inc', u'ICOS Corp', u'Velius', u'Valeant Pharmaceuticals International Inc', u'Medical University of South Carolina', u'Hospira Adelaide Pty Ltd', u'GVK Biosciences Pvt Ltd', u'Virobay Inc', u'Walter and Eliza Hall Institute of Medical Research', u'Pierre Fabre Dermatologie', u'Tiziana Life Sciences PLC', u'TopoTarget A/S', u'Medimetriks Pharmaceuticals Inc', u'Zhangjiang Biotechnology Co Ltd', u'Exicure', u'German Federal Ministry of Education and Research', u'Beijing Wenfeng Tianji Pharmaceuticals Co Ltd', u'Peptech (UK) Ltd', u'Phytomedics Inc', u'Sociedade Beneficente Israelita Brasileira Hospital Albert Einsten', u'Silence Therapeutics plc', u'Arana Therapeutics Ltd', u'Neovacs SA', u'Encore Dermatology Inc', u'Axim Biotechnologies Inc', u'Biotest AG', u'Commonwealth Government', u'Vernalis Group plc', u'Oncobiologics Inc', u'Meyer Pharmaceuticals LLC', u'University of Queensland', u'Torii Pharmaceutical Co Ltd', u'QUATRx Pharmaceuticals Co', u'Moberg Pharma AB', u'Aventis Pharma AG', u'Johannes Gutenberg Universitat Mainz', u'Janssen Biotech Inc', u'Hy BioPharma Inc', u'Hybrigenics SA', u'Cipher Pharmaceuticals Inc', u'NewSouth Innovations', u'Atrium Medical Corp', u'Sun Pharmaceutical Industries Ltd', u'University of Kentucky', u'EPIRUS Biopharmaceuticals Inc', u'Syntrix Biosystems Inc', u'Signal Research Division', u'Rogne Bioscience Inc', u'YM BioSciences Inc', u'Harvard University', u'IGI Inc', u'Therapeutics Inc', u'Boehringer Mannheim GmbH', u'Athenex Inc', u'ZymoGenetics Inc', u'Clinuvel Pharmaceuticals Ltd', u'IMIDomics SL', u'Teva Pharmaceutical Industries Ltd', u'Catholic University of Leuven', u'Amira Pharmaceuticals Inc', u'Purdue Pharma LP', u'Tolerx Inc', u'Affilogic Laboratories', u'Genta Inc', u'UC Davis InnovationAccess', u'AnGes MG Inc', u'Fujirebio Europe NV', u'Encysive Pharmaceuticals Inc', u'Boehringer Ingelheim Corp', u'Shandong Institute of Dermatology and Prevention', u'Neopharm Ltd', u'University of Sydney', u'Biotechnology and Biological Sciences Research Council (BBSRC)', u'ILEX Oncology Inc', u'American Skin Association', u'Freedom Eye Ltd', u'Wyeth Pharmaceuticals', u'Connetics Corp', u'Miravant Medical Technologies', u'Revotar Biopharmaceuticals AG', u'Biogen Inc (FL)', u'Theramex', u'Dermadis SAS', u'Schering-Plough Corp', u'Samsung BioLogics Co Ltd', u'Cellectar Biosciences Inc', u'XOMA Corp', u'University of California', u'British Heart Foundation', u'Zenyaku Kogyo Co Ltd', u'ChemoCentryx Inc', u'rEVO Biologics Inc', u'Sanofi', u'Vertex Pharmaceuticals Inc', u'Bayer AG', u'The University of Manchester Intellectual Property Ltd', u'InNexus Biotechnology Inc', u'CBio Ltd', u'Case Western Reserve University', u'Takeda Vaccines Inc', u'Almirall Prodesfarma SA', u'Torrent Pharmaceuticals Ltd', u'Synthetic Biologics Inc', u'Merrimack Pharmaceuticals Inc', u'Arrien Pharmaceuticals LLC', u'Institute for the Promotion of Innovation by Science and Technology in Flanders', u'Vernalis plc', u'4SC AG', u'Antares Pharma Inc', u'CollaGenex Pharmaceuticals Inc', u'Tularik Inc', u'Intrexon Corp', u'DUSA Pharmaceuticals Inc', u'Lonza Group AG', u'PharmaIN Ltd', u'Mateon Therapeutics Inc', u'Elan Corp plc', u'IBEX Technologies Inc', u'MorphoSys AG', u'Ligand Pharmaceuticals Inc', u'Cephalon Inc', u'Celgene Corp', u'bioCSL PTY Ltd', u'Wyeth', u'Ciba-Geigy AG', u'University of Ghent', u'BioTie Therapies Corp', u'Kuecept Limited', u'Pharma Pacific Pty Ltd', u'Queensland Institute of Medical Research', u'Yoshindo Inc', u'DermiPsor Ltd', u'Lipidor AB', u'Bioenvision Inc', u'Quest PharmaTech Inc', u'Berlex Laboratories Inc', u\"Dr Reddy's Laboratories Ltd\", u'University of Medicine and Dentistry of New Jersey', u'Council of Scientific and Industrial Research (India)', u'US Government', u'BioMarin Pharmaceutical Inc', u'Ganial Immunotherapeutics', u'GT Biopharma Inc', u'University of Zurich', u'Baxter International Inc', u'IMTM GmbH', u'Biogen Inc', u'4SC Discovery GmbH', u'Renaissance Acquisition Holdings LLC', u'GlaxoSmithKline plc', u'Celltrion Inc', u'Bayer Schering Pharma AG', u'Immunex Corp', u'European Eurostars Programme', u'Circassia Pharmaceuticals plc', u'Novimmune SA', u'Bio3 Research Srl', u'University of Michigan', u'Fibrocell Science Inc', u'Takeda Oncology', u'Sheba Medical Center', u'Cytochroma Inc', u'Alfacyte Ltd', u'Boston University', u'Shionogi & Co Ltd', u'Bionanoplus SL', u'Biomas Inc', u'Theradiag', u'Biomedical Primate Research Centre', u'UCB SA', u'RecipharmCobra Biologics', u'Stanford Rook Ltd', u'Nexell Therapeutics Inc', u'Medarex Inc', u'Daiichi Sankyo Co Ltd', u'Abbott Laboratories', u'Kurume University', u'Eisai Co Ltd', u'OzHealth Pharma', u'Novartis AG', u'Merck KGaA', u'Fujisawa Pharmaceutical Co Ltd', u'Novelion Therapeutics Inc', u'Ewopharma AG', u'Promics Pty Ltd', u'Monash University', u'Maurtisklinieken Den Haag', u'Penederm Inc', u'CHU De Nantes', u'Emilia Cosmetics', u'Immune Response BioPharma Inc', u'Trilex Pharmaceuticals Inc', u'Dermira Inc', u'McGill University', u'Effimune SA', u'Johns Hopkins University', u'Lupin Ltd', u'Bioskin GmbH', u'Bird Rock Bio Inc', u'SWITCH Biotech AG', u'Mayne Pharma Group Ltd', u'Undisclosed', u'Sphinx Pharmaceuticals Corp', u'Acyte Biotec Pty Ltd', u'Medicis Pharmaceutical Corp', u'Michepro Holding Ltd', u'SRI International', u'TenX Biopharma Inc', u'Allergan plc', u'Diabetogen BioSciences Inc', u'Seikagaku Corp', u'SurModics Pharmaceuticals', u'Merck & Co Inc', u'Galderma SA', u'PharmaMar SA', u'Amgen Inc', u'Kyowa Hakko Kirin Co Ltd', u'Enhance Biotech Inc', u'NicOx SA', u'Kissei Pharmaceutical Co Ltd', u'Arriva Pharmaceuticals Inc', u'Teijin Ltd', u'Pfizer Inc', u'Midatech Pharma PLC', u\"Brigham & Women's Hospital\", u'Sosei R&D Ltd', u'Avontec GmbH', u'deCODE genetics ehf', u'Cadila Pharmaceuticals Ltd', u'Ziarco Pharma Ltd', u'LG Life Sciences Ltd', u'University of Gothenburg', u'Laboratorios Farmaceuticos Rovi SA', u'Canadian Medical Discoveries Fund Inc', u'Allegiance Equity Corp', u'National Institutes of Health', u'Axxiom Inc', u'Pharma MAEHLE GmbH', u'Synvista Therapeutics Inc', u'Yuyu Inc', u'University of Athens', u'SonoLight Pharmaceuticals Corp', u'Brickell Biotech Inc', u'Cambrex Corp', u'Merck Serono SA', u'University Of Science & Technology Of China', u'XenoPort Inc', u'National Kyushu Medical Center', u'Cardion AG', u'Akaal Pharma Pty Ltd', u'Genoma Espa\\xf1a']), u'Cerebellarataxia': set([u'Cardiff University', u'Zedira GmbH']), u'Crohnsdisease': set([u'Biopasgroup', u'LeukoSite Inc', u'Nestle Health Science', u'US Government', u'Novo Nordisk A/S', u'Hunter-Fleming Ltd', u'Scil Technology GmbH', u'JSS University', u'MaSTherCell', u'Dynavax Technologies Corp', u'Transcription Factor Therapeutics', u'BioXpress Therapeutics SA', u'Boehringer Ingelheim GmbH', u'Orion Corporation', u'Swiss Federal Office of the Commission for Technology and Innovation', u'Biogen Inc', u'Amsterdam Molecular Therapeutics BV', u'Forest Laboratories Inc', u'GlaxoSmithKline plc', u'Selvita SA', u'Celltrion Inc', u'Synergy Pharmaceuticals Inc', u'Seres Therapeutics Inc', u'NITTO DENKO Avecia', u'Chiesi Farmaceutici SpA', u'Johns Hopkins University', u'University of Queensland', u'Pendopharm', u'Ionis Pharmaceuticals Inc', u'Immunex Corp', u'Anesiva Inc', u'Prague Clinical Services', u'Zeria Pharmaceutical Co Ltd', u'deCODE chemistry', u'Procter & Gamble Pharmaceuticals Inc', u'Assembly Biosciences Inc', u'Tillotts Pharma AG', u'Italchimici SpA', u'Novimmune SA', u'Synvista Therapeutics Inc', u'TMRC Co Ltd', u'Leiden University Medical Center', u'FAES Farma SA', u'UCB SA', u'Shire plc', u'University of British Columbia', u'CleveXel Pharma', u'Gamida Cell Ltd', u'Galapagos NV', u'Mitsubishi Pharma Corp', u'R-Pharm', u'R&R Inc', u'Debiovision Inc', u'Mesoblast Ltd', u'Sun Pharmaceutical Industries Ltd', u'Nippon Shinyaku Co Ltd', u'Nodthera Ltd', u'Lankenau Institute for Medical Research', u'mAbxience SA', u'PanGenetics BV', u'Verigen Inc', u'Protagonist Therapeutics Inc', u'Merckle GmbH', u'Rougier Pharma Afrique SA', u'Keio University', u'Theradiag', u'Neovacs SA', u'Curant Health', u'Perrigo Co plc', u'Fortress Biotech Inc', u'Hikma Pharmaceuticals plc', u'Inflabloc Pharmaceuticals Inc', u'University of Massachusetts Medical School', u'Complete Pharmacy and Medical Solutions', u'Omthera Pharmaceuticals Inc', u'Cell Pathways Inc', u'TxCell SA', u'Phytochemindo', u'National Health and Medical Research Council', u'Tramedico International', u'PDL BioPharma Inc', u'McMaster University', u'Amgen Inc', u'Romark Laboratories LC', u'Medarex Inc', u'Daiichi Sankyo Co Ltd', u'Peptor Ltd', u'Glenmark Pharmaceuticals Ltd', u'Eisai Co Ltd', u'Tulane University', u'Aspreva International Ltd', u'Boehringer Mannheim GmbH', u'Cloud Pharmaceuticals Inc', u'Leadiant Biosciences Inc', u'Novartis AG', u'rEVO Biologics Inc', u'University of Bristol', u'RedHill Biopharma Ltd', u'Stada Arzneimittel AG', u'IMIDomics SL', u'Mount Sinai School of Medicine', u'NovaMedica', u'Calypso Biotech', u'Osiris Therapeutics Inc', u'Universite de Sherbrooke', u'Tanabe Seiyaku Co Ltd', u'Lipomed AG', u\"Crohn's & Colitis Foundation of America\", u'Affymetrix Inc', u'Callisto Pharmaceuticals Inc', u'TiGenix NV', u'Janssen Pharmaceutical KK', u'Nektar Therapeutics', u'Wellcome Trust', u'Cytokine PharmaSciences Inc', u'Ferring Pharmaceuticals SA', u'Can-Fite BioPharma Ltd', u'Immune Response BioPharma Inc', u'Avexegen Therapeutics Inc', u'Northwestern University Feinberg School of Medicine', u'Prasco Laboratories', u'Numoda Corp', u'RecipharmCobra Biologics', u'Medeva Pharmaceuticals Inc', u'Synt:em', u'ENTEROME Bioscience SA', u'CytRx Corp', u'Caisson Biotech LLC', u'Qu Biologics Inc', u'EA Pharma Co Ltd', u'23andMe Inc', u'University of Florida', u'OXO', u'Oncobiologics Inc', u'Inception Sciences Inc', u'Biochemie GmbH', u'Debiopharm SA', u'Novosom AG', u'Orphan Australia', u'Pharmexa A/S', u'Prometheus Laboratories Inc', u'Centre for Digestive Diseases', u'NPS Pharmaceuticals Inc', u'Giaconda Ltd', u'Genentech Inc', u'Saniona ApS', u'Janssen-Cilag Ltd', u'Ajinomoto Co Inc', u'Acyte Biotec Pty Ltd', u'Xian-Janssen Pharmaceutical Ltd', u'Otsuka Pharmaceutical Co Ltd', u'IDIS Ltd', u'National Institute of Diabetes, Digestive and Kidney Diseases', u'Rijksuniversiteit te Leiden', u'Stiefel Laboratories (UK) Ltd', u'Wyeth Pharmaceuticals', u'Schering-Plough Corp', u'CLL Pharma', u'Allergan plc', u'Ferring International Center SA', u'Quest Diagnostics Inc', u'Oregon Health Sciences University', u'Merck Serono SA', u'Netherlands Government', u'Synedgen Inc', u'XOMA Corp', u'Daewoong Pharmaceutical Co Ltd', u'Merck & Co Inc', u'Australian Research Council', u'Perlegen Sciences Inc', u'ChemoCentryx Inc', u'Laboratorios Columbia SA de CV', u'Ind-Swift Ltd', u'Vertex Pharmaceuticals Inc', u'Eli Lilly & Co', u'CASI Pharmaceuticals Inc', u'NewBridge Pharmaceuticals Ltd', u'Dr Falk Pharma GmbH', u'Bayer AG', u'Synlogic Inc', u'Japan Agency for Medical Research and Development', u'Pharmacia Corp', u'Epimmune Inc', u'Kolon Pharmaceuticals Inc', u'Provention Bio Inc', u'Mipharm SpA', u\"Children's Hospital of Los Angeles\", u'Weizmann Institute of Science', u'Alder Biopharmaceuticals Inc', u'Immune Therapeutics Inc', u'Soligenix Inc', u'CBio Ltd', u'enGene Inc', u'GroupMed (Holding)', u'University of Iowa', u'China Medical System Holdings Ltd', u'Janssen Biotech Inc', u'University of California Los Angeles', u'MedImmune LLC', u'Sanofi', u'AstraZeneca plc', u'Pfizer Inc', u'Neurocrine Biosciences Inc', u'Boehringer Ingelheim Pharmaceuticals Inc', u'Gilead Sciences Inc', u'The Research Council of Norway', u'Human Genome Sciences Inc', u'Edusa Pharmaceuticals Inc', u'Wyeth', u'Kang Stem Holdings Co Ltd', u'Undisclosed', u'Boehringer Ingelheim Corp', u'Mount Sinai Medical Center', u'Genisphere LLC', u'BioSeek LLC', u'Picower Institute for Medical Research', u'Genisphere Inc', u'AnorMED Inc', u'Australian Government', u'Laboratorios Farmaceuticos Rovi SA', u'Delphi Genetics', u'University of London School of Pharmacy', u'AbbVie Inc', u'Genmab A/S', u'Kureha Corp', u'Axogen Ltd', u'Asphelia Pharmaceuticals Inc', u'Radiant Research Inc', u'Takeda Pharmaceutical Co Ltd', u'Zhejiang Huahai Pharmaceutical Group Co Ltd', u'Ben-Gurion University Of The Negev', u'Alfa Wassermann SpA', u'BL&H Co Ltd', u'AdAlta Pty Ltd', u'Galena Biopharma Inc', u'Lonza Group AG', u'University of Toronto', u'Acromax Dominicana', u'HAV Vaccines Ltd', u'Nogra Pharma Ltd', u'National Institutes of Health', u'University of Tokyo', u'University Hospitals Of Cleveland', u'Axxiom Inc', u'GenQual Corp', u'Bristol-Myers Squibb Co', u'Elan Corp plc', u'Pacific Healthcare Thailand Co Ltd', u'OSEO', u'INSERM', u'Accentia BioPharmaceuticals Inc', u'Cedars-Sinai Medical Center', u'Alma Biotherapeutics', u'Janssen Research & Development LLC', u'NPS Allelix Corp', u'Celgene Corp', u'JYANT Technologies Inc', u'Critical Therapeutics Inc', u'DBV Technologies SA', u'Advanced Biotherapy Inc', u'UCB Celltech', u'Knoll GmbH', u\"Institut d'Investigacions Biomediques August Pi I Sunyer\", u'IXICO Plc', u'Steward Cross Pte Ltd', u'Hospira Adelaide Pty Ltd', u'AlfaGene Biosciences Inc', u'Tufts University', u'Royalty Pharma', u'V.I. PHARMA INTERNATIONAL SA', u'Immune Disease Institute Inc', u'Ovamed GmbH', u'Salix Pharmaceuticals Ltd', u'F Hoffmann-La Roche AG', u'Queensland Institute of Medical Research', u'AET BioTechnology Ltd', u\"Crohn's and Colitis Foundation of Canada\", u'ETX Pharma Inc', u'University of Oxford', u'Walter and Eliza Hall Institute of Medical Research', u'Maryland Innovation Initiative', u'Mitsubishi Tanabe Pharma Corp', u'Nextera AS', u'Atlantic Healthcare plc', u'Canadian Government', u'SkyePharma plc', u'Kyowa Hakko Kirin Co Ltd', u'Australian Medical Therapy Investments Pty Ltd', u'Tiziana Life Sciences PLC', u'Femta Pharmaceuticals Inc']), u'Hypohidrosis': set([u'Edimer Pharmaceuticals Inc', u'CMC Biologics Inc']), u'Polymyalgiarheumatica': set([u'SkyePharma plc', u'Jagotec AG', u'Horizon Pharma GmbH']), u'Menkessyndrome': set([u'Cyprium Therapeutics Inc', u'Eunice Kennedy Shriver National Institute of Child Health & Human Development', u'Procypra Therapeutics LLC', u'Howard Florey Institute of Experimental Physiology and Medicine']), u'Mult': set([u'CytRx Corp', u'US Government']), u'Kapos': set([u'Zeneus Pharma Ltd', u'Elan Corp plc']), u'Hypozincemia': set([u'Nobelpharma Co Ltd', u'ASKA Pharmaceutical Co Ltd', u'MEDIPAL HOLDINGS Corp']), u'Bac': set([u'Pfizer Inc', u'AstraZeneca plc']), u'Persistentvegetativestate': set([u'US Government', u'NeuroHealing Pharmaceuticals Inc']), u'Neuroendocrinetumor': set([u'Immunicum AB', u'Mallinckrodt plc', u'VIRTTU Biologics', u'National Comprehensive Cancer Network', u'AnorMED Inc', u'Aspireo Pharmaceuticals Ltd', u'University of Zurich', u'bioMerieux SA', u'Triad Isotopes Inc', u'Translational Genomics Research Institute', u'UK Markey Cancer Center', u'Biomedica Life Sciences SA', u'Covidien plc', u'Cellcor Inc', u'EMD Serono Inc', u'Harvard University', u'Zevacor Molecular', u'Ohio State University', u'Tulane University', u'Empire Genomics Llc', u'Uppsala University', u'BioSynthema Inc', u'Callisto Pharmaceuticals Inc', u'Synergy Pharmaceuticals Inc', u'Chiasma Inc', u'Areva Med LLC', u'Centre Hospitalier Universitaire Vaudois', u'FUJIFILM RI Pharma Co', u'Advanced Accelerator Applications SA', u'Chiron Corp', u'National Institutes of Health', u'Menarini Asia-Pacific', u'Food and Drug Administration', u'Sompharmaceuticals SA', u'Ipsen', u'Swiss Government', u'Molecular Insight Pharmaceuticals Inc', u'University of Iowa', u'RadioMedix Inc', u'Cedars-Sinai Medical Center', u'CASI Pharmaceuticals Inc', u'Cornell University', u'Navidea Biopharmaceuticals Inc', u'US Surgical Corp', u'University of Wisconsin-Madison', u'Mateon Therapeutics Inc', u'Roche Holding AG', u'Camurus AB', u'Angiogene Pharmaceuticals Ltd', u\"Nationwide Children's Hospital\", u'Eckert & Ziegler Eurotope Gmbh', u'Torii Pharmaceutical Co Ltd', u'Debiovision Inc', u'Salix Pharmaceuticals Ltd', u'Sun Pharmaceutical Advanced Research Co Ltd', u'Sin Phyu Kyun Co Ltd', u'Erasmus University Medical Center Rotterdam', u'National Cancer Institute', u'Pfizer Inc', u'Health Care Logistics Inc', u'Novartis AG', u'Pierrel Research Italy', u'Cortendo AB', u'Debiopharm SA', u'IASON GmbH', u'Nuclear Diagnostic Products Inc']), u'Obesity': set([u'FIT-BioCeuticals Pty Ltd', u'Chelatexx LLC', u'Solvay SA', u'Envoy Therapeutics Inc', u'US Health and Human Services Department', u'Amsterdam Molecular Therapeutics BV', u'Il Dong Pharmaceutical Co Ltd', u'The Leona M. and Harry B. Helmsley Charitable Trust', u'Plasticell Ltd', u'Inven2', u'Maryland Technology Development Corp', u'Case Western Reserve University', u'Betagenon AB', u'Ionis Pharmaceuticals Inc', u'Novartis Pharma AG', u'Versartis Inc', u'Spherix Inc', u'University of South Florida', u'University of Pittsburgh', u'Bridge BioResearch International Ltd', u'Northwest Neurologic Inc', u'Alla Chem LLC', u'CymaBay Therapeutics Inc', u'Ambrx Inc', u'Critical Pharmaceuticals Ltd', u'Phosphagenics Ltd', u'Catalent Inc', u'Cengent Therapeutics Inc', u'Cascade Therapeutics Inc', u'Wake Forest University', u'National Research Council of Canada', u'BioAdvance', u'Advanced Mr Analytics AB', u'Entelos Inc', u'Bioobesity Co Ltd', u'Ergo Science Corp', u'Melior Pharmaceuticals Inc', u'Cambridge Antibody Technology Group plc', u'KeyBioScience AG', u'Amarna Therapeutics BV', u'Znomics Inc', u'Halsa Pharmaceuticals Inc', u'Egret Pharma (Shanghai) Ltd', u'Oleoyl-Estrone Developments', u'iNovacia AB', u'Hanmi Pharmaceutical Co Ltd', u'Siegfried Holding Ltd', u'S2 Therapeutics', u'Thermo Fisher Scientific Inc', u'VeroScience LLC', u'Wellcome Trust', u'Kyorin Pharmaceutical Co Ltd', u'FASgen Inc', u'Tri-Institutional Therapeutics Discovery Institute Inc', u'Probiodrug AG', u'CeNeRx BioPharma Inc', u'Second Genome Inc', u'Biofrontera Discovery GmbH', u'Proven Process Medical Devices Inc', u'Strathclyde Institute for Drug Research', u'Kinexis Inc', u'PreveCeutical Medical Inc', u'PolyNovo Ltd', u'Novasite Pharmaceuticals Inc', u'Genfit SA', u'Swedish Orphan Biovitrum AB', u'CHEPLAPHARM Arzneimittel GmbH', u'NPS Pharmaceuticals Inc', u'Galenea Corp', u'Progenra Inc', u'Fundacion Publica Andaluza para la Investigacion de Malaga en Biomedicina y Salud', u'Oregon Health Sciences University', u'Hillcrest Therapeutics Inc', u'Ewha Womans University', u'Eli Lilly & Co', u'Zafgen Inc', u'Palatin Technologies Inc', u'Argenta Discovery Ltd', u'Metabasis Therapeutics Inc', u'University of California Los Angeles', u'Mixture Sciences Inc', u'University of Cincinnati', u'GENova Biotherapeutics Inc', u'RenaSci Consultancy Ltd', u'Zentaris GmbH', u'Zalicus Inc', u'Consilient Health Limited', u'Johnson & Johnson', u'Saniona ApS', u'ETH Zurich', u'Productos Medix, S.A. de C.V.', u'Nordic Bioscience A/S', u'SmithKline Beecham plc', u'Taisho Pharmaceutical Co Ltd', u'Galmed Pharmaceuticals Ltd', u'Morishita Jintan Co Ltd', u'Servier', u'Bristol-Myers Squibb Co', u'OSEO', u'Evotec (UK) Ltd', u'Peptimmune Inc', u'Catholic University of Korea', u'Seoul National University', u'Astellas Pharma Inc', u'Knoll GmbH', u'Lundbeck Research USA Inc', u'Gyeonggi Institute Of Science & Technology Promotion', u'Ortho-McNeil Inc', u'PharmaNess Neuroscience', u'Glucox Biotech AB', u'Global Health Ventures Inc', u'Athersys Inc', u'Jeju Technopark', u'Rheoscience A/S', u'Galapagos NV', u'South African San Council', u'University of Cambridge', u'Theragen ETEX', u'Karolinska Institutet', u'Yamanouchi Pharmaceutical Co Ltd', u'Novo Nordisk A/S', u'Regeneron Pharmaceuticals Inc', u'Knoll Pharmaceuticals Co', u'Bioagency AG', u'Phase 2 Discovery Inc', u'Gyeongsang National University', u'AdipoGenix Inc', u'iPierian Inc', u'Howard Hughes Medical Institute', u'BTG plc', u'iNova Pharmaceuticals (Australia) Pty Ltd', u'Chiron Corp', u'DRAXIS Health Inc', u'Marcadia Biotech Inc', u'ArQule Inc', u'YD Life Science Inc', u'University of Montpellier', u'Mikah Pharma', u'TG Biotech Inc', u'Garvan Institute of Medical Research', u'Roche Holding AG', u'University of British Columbia', u'Nodthera Ltd', u'Ember Therapeutics', u'Sanofi Genzyme', u'Jenrin Discovery Inc', u'TG Therapeutics Inc', u'Charite Universitaetsmedizin Berlin', u'University of Massachusetts Medical School', u'WhanIn Pharmaceutical Co Ltd', u'Vivia Biotech SL', u'Amgen Inc', u'Karo Pharma AB', u'Arrowhead Pharmaceuticals Inc', u'Galena Biopharma Inc', u'Geron Corp', u'University of Minneapolis', u'Eunice Kennedy Shriver National Institute of Child Health & Human Development', u'ACADIA Pharmaceuticals Inc', u'Gemini Genomics plc', u'iNtRON Biotechnology Inc', u'CohBar Inc', u'Scigenic & Scigen Harvest Co Ltd', u'Massachusetts General Hospital', u'Medical Research Council', u'Thiakis Ltd', u'Solvay Pharmaceuticals GmbH', u'Yeda Research and Development Co Ltd', u'Merck Millipore', u'Dong-A ST Co Ltd', u'Braasch Biotech LLC', u'Celliance Bioservices Inc', u'LG Chem Ltd', u'Daegu Hanny University', u'Osaka University', u'Caisson Biotech LLC', u'Curl Bio LLC', u'Joslin Diabetes Center Inc', u'F Hoffmann-La Roche AG', u'NOXXON Pharma AG', u'Rockefeller University', u'CY Biotech Co Ltd', u'Emmyon Inc', u'Genentech Inc', u'University of Milan', u'PJSC Pharmsynthez', u'Alizyme Therapeutics Ltd', u'Aegis Therapeutics LLC', u'Savant HWP Inc', u\"Dr Reddy's Research Foundation\", u'National Health and Medical Research Council', u'Astex Pharmaceuticals Inc', u'Ramaciotti Foundation', u'Nara Biosciences Inc', u'Glenn Foundation for Medical Research', u'Xenetic Biosciences Inc', u'Nexus BioPharma Inc', u'Codon Pharmaceuticals Inc', u'Scripps Research Institute', u'University of Southern California', u'University of Texas Southwestern Medical Center', u'BioFocus DPI', u'Japan Tobacco Inc', u'Rhythm Metabolic Inc', u'Numab AG', u'Nisshin Flour Milling Co Ltd', u'Medinox Inc', u'Pierre Fabre SA', u'LION bioscience Inc', u'CEPTYR Inc', u'Kadmon Pharmaceuticals LLC', u'Seres Therapeutics Inc', u'enGene Inc', u'Hyundai Pharmaceutical', u'Mungyeong City', u'AstraZeneca plc', u'Eli Lilly Japan KK', u'University of Utah', u'Sirtris Pharmaceuticals Inc', u'American Diabetes Association', u'Genmab A/S', u'Pherin Pharmaceuticals Inc', u'Natural Partners Inc', u'Birkeland Innovasjon As', u'Organix Inc', u'CSIR (South Africa)', u'Abeome Corp', u'Evotec International GmbH', u'Discovery BioMed Inc', u'Zealand Pharma A/S', u'Kyoto University', u'Cedars-Sinai Medical Center', u'AGY Therapeutics Inc', u'Cornell University', u'Valeant Pharmaceuticals International Inc', u'IXICO Plc', u'Hospira Adelaide Pty Ltd', u'P2D Biosciences', u'Zhejiang University', u'Institut Pasteur', u'Indiana University', u'Biologix FZ Co', u'Xenome Ltd', u'CuraGen Corp', u'PhytoMedical Technologies Inc', u'Texas Emerging Technology Fund', u'Elixir Pharmaceuticals Inc', u'Lynx Therapeutics GmbH', u'Forest Laboratories Inc', u'Korea Research Institute of Chemical Technology', u'M Pharmaceutical Inc', u'SCOHIA PHARMA Inc', u'Baltic Bio AB', u'Bionas GmbH', u'Accelrys Inc', u'Vanderbilt University', u'Kyoto Pharmaceutical University', u'MedImmune LLC', u'Johannes Gutenberg Universitat Mainz', u'University of Washington', u'Hybrigenics SA', u'Yonsei University', u'Scotia Pharmaceuticals', u'Farmaceutici Formenti SpA', u'Orexigen Therapeutics Inc', u'Esteve', u'Norgine BV', u'Avineuro Pharmaceuticals Inc', u'VIVUS Inc', u'ABIC', u'TFChem SAS', u'Affymetrix Inc', u'Harvard University', u'University of Dundee', u'Santarus Inc', u'Meldex International plc', u'Teva Pharmaceutical Industries Ltd', u'Kwang Dong Pharmaceutical Co Ltd', u'University of California San Francisco', u'Emisphere Technologies Inc', u'Florida Hospital', u'Sun Yat-Sen University', u'Ferring Pharmaceuticals SA', u'Yakurigaku Chuo Kenkyusho', u'AEterna Zentaris Inc', u'Boehringer Ingelheim Corp', u'Connexios Life Sciences Pvt Ltd', u'Genset SA', u'Lipomics Technologies Inc', u'Navamedic ASA', u'Albany Medical College', u'Carmot Therapeutics Inc', u'Dura Pharmaceuticals Inc', u'Sirona Biochem Corp', u'Icure Pharmaceutical Corp', u'Duke University Medical Center', u'Universidade de Santiago de Compostela', u'National Institute of Diabetes, Digestive and Kidney Diseases', u'LG Life Sciences Ltd', u'Universita di Bologna', u'Sapphire Therapeutics Inc', u'Shanghai Institute of Materia Medica of the Chinese Academy of Sciences', u'Academy Medical LLC', u'University of California', u'Merck & Co Inc', u'Perlegen Sciences Inc', u'Qiqihar University', u'Sanofi', u'Daewon Pharm Co Ltd', u'Chong Kun Dang Pharmaceutical Corp', u'National Institute on Minority Health and Health Disparities', u'Bayer AG', u'University of California Davis', u'Camurus AB', u'Ember Therapeutics Inc (pre-merger)', u'Florida International University', u'Nektar Therapeutics', u'Concord Biosciences LLC', u'Neurocrine Biosciences Inc', u'Intarcia Therapeutics Inc', u'Synthetic Biologics Inc', u'Itamar Medical (Cm) 1997 Ltd', u'Amylin Pharmaceuticals Inc', u'FGH BIOTECH INC', u'Acambis plc', u'CamBP Ltd', u'Anthill Technologies', u'University of Iowa', u'Tularik Inc', u'Massachusetts Institute of Technology', u'University of Pennsylvania', u'AngioLab Inc', u'H Lee Moffitt Cancer Center and Research Institute', u'Motus Therapeutics Inc', u'Antaros Medical AB', u'Hokuriku Seiyaku KK', u'Aurigene Discovery Technologies Ltd', u'Bruno Farmaceutici', u'BioQuest Innovations Inc', u'Elan Corp plc', u'Enteris BioPharma Inc', u'INSERM', u'Ligand Pharmaceuticals Inc', u'Regulus Therapeutics Inc', u'Diartis Pharmaceuticals Inc', u'Rinat-Pfizer Inc', u'NPS Allelix Corp', u'Celgene Corp', u'Energesis Pharmaceuticals Inc', u'Imperial College London', u'Biovail Corp', u'Whitehead Institute for Biomedical Research', u'Duke University', u'Tufts University', u'HMGene Inc', u'EndoChem Inc', u'Union Life Sciences Limited', u'Janssen Pharmaceuticals Inc', u'Jin Yang Pharm Co Ltd', u'California Institute for Biomedical Research', u'Xcellsyz Ltd', u'Beth Israel Deaconess Medical Center', u'NGM Biopharmaceuticals Inc', u\"Dr Reddy's Laboratories Ltd\", u'US Government', u'QUATRx Pharmaceuticals Co', u'University of Zurich', u'MDS Pharma Services', u'MSD OSS BV', u'California Institute of Regenerative Medicine', u'Neurogen Corp', u'GlaxoSmithKline plc', u'Obecure Ltd', u'Ipsen', u'Massachusetts Life Sciences Center', u'Institute of Food Research', u'Marina Biotech Inc', u'Virtici LLC', u'Elite Pharmaceuticals Inc', u'Center for Biomarker Research in Medicine', u'Takeda Oncology', u'Institute for Research in Immunology and Cancer', u'Cold Spring Harbor Laboratory', u'Gleneagles Hospital', u'Selvita SA', u'Korea Institute of Oriental Medicine', u'Netherlands Cancer Institute', u'Boston University', u'National Heart Lung and Blood Institute', u'GlaxoSmithKline Inc', u'Compellis Pharmaceuticals Inc', u'Alnylam Pharmaceuticals Inc', u'Poetic Genetics LLC', u'Wellstat Therapeutics Corp', u'Vasade Biosciences Inc', u'Stryker Corp', u'Johnson & Johnson Pharmaceutical Research & Development LLC', u'Knoll AG', u'MD Anderson Cancer Center', u'Abbott Laboratories', u'UniQuest Pty Ltd', u'Eisai Co Ltd', u'BioRestorative Therapies Inc', u'National Cancer Institute', u'Novartis AG', u'Merck KGaA', u'DreamPharma Corp', u'The Ellison Medical Foundation', u'EstechPharma Co Ltd', u'Korea Research Institute of Bioscience and Biotechnology', u'Scripps Florida', u'Universite De Montreal', u'Kainos Medicine Inc', u'The Procter & Gamble Co', u'Metabolic Pharmaceuticals Pty Ltd', u'ALZA Corp', u'Ohr Pharmaceutical Inc', u'Xenon Pharmaceuticals Inc', u'ProSciento Inc', u'University of Barcelona', u'Washington University in St Louis', u'Leiden University (NL)', u'CytRx Corp', u'Johns Hopkins University', u'Myriad Genetics Inc', u'Avaxia Biologics Inc', u'Santhera Pharmaceuticals AG', u'Watson Laboratories Inc', u'Benitec Biopharma Ltd', u'GI Dynamics Inc', u'PROLOR Biotech Inc', u'University of North Carolina', u'Undisclosed', u'University of California San Diego School of Medicine', u'RMIT University', u'Corium International Inc', u'Circuit Therapeutics Inc', u'Republic of Korea Government', u'Medivir AB', u'Tufts University School of Medicine', u'National Institute on Drug Abuse', u'University of Florence', u'National Center for Complementary and Alternative Medicine', u'Inalco SpA', u'Cropsolution Inc', u'PLIVA dd', u'ChemGenex Pharmaceuticals Ltd', u'Kissei Pharmaceutical Co Ltd', u'Korean Ministry of Knowledge Economy', u'Genaera Corp', u'Nobex Corp', u'Pennington Biomedical Research Institute', u'Pfizer Inc', u'Satiogen Pharmaceuticals Inc', u'The Salk Institute for Biological Studies', u'Suntory Pharmaceutical Research Laboratories LLC', u'Wyeth-Ayerst Pharmaceuticals Inc', u'deCODE genetics ehf', u'Yissum Research Development Co', u'High Point Pharmaceuticals Llc', u'BioLineRx Ltd', u'NeoGenesis Pharmaceuticals Inc', u'Ipsen Bioscience Inc', u'Baylor College of Medicine', u'Laboratorios Farmaceuticos Rovi SA', u'Takeda Pharmaceutical Co Ltd', u'Arena Pharmaceuticals Inc', u'VA Medical Center', u'Vernalis Research Ltd', u'Albert Einstein College of Medicine', u'National Institutes of Health', u'Alizyme plc', u'Sanford-Burnham Medical Research Institute', u'Scios Inc', u'Curis Inc', u'Asahi Kasei Pharma Corp', u'ObeSys', u'Institute Of Enzymology Biological Research Center Hungarian Academy Of Sciences', u'University of Chicago', u'ChemDiv Inc', u'4Cyte Therapeutics Inc', u'Axxam SpA', u'Verva Pharmaceuticals Ltd', u'Jubilant Life Sciences Ltd', u'University of California Irvine', u'Enteromedics Inc', u'Jiangsu Kanion Pharmaceutical Co Ltd', u'Sequana Therapeutics', u'Tripos Inc', u'University Of Western Sydney', u'Helsinn Group']), u'Bonemarrowdepression': set([u'G1 Therapeutics Inc', u'National Cancer Institute']), u'Softtissuesarcoma': set([u'Exelixis Inc', u'Ventana Medical Systems Inc', u'Genentech Inc', u'Nanobiotix', u'Harvard Medical School', u'PRA Health Sciences', u'Ohio State University', u'Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium', u'Boise State University', u'Immune Design Corp', u'National Cancer Institute', u'Cancer Prevention and Research Institute of Texas', u'Blaze Bioscience Inc', u'Merck KGaA', u'University of Tokyo', u'GlobalCures', u'Merck & Co Inc', u'PharmaMar Inc', u'MedImmune LLC', u'Cedars-Sinai Medical Center', u'Eli Lilly & Co', u'Predictive Therapeutics', u'Threshold Pharmaceuticals Inc', u'PharmaEngine Inc', u'NanoCarrier Co Ltd', u'Hercules Technology Management Co V Inc', u'Gem Pharmaceuticals LLC', u'ZIOPHARM Oncology Inc', u'AstraZeneca plc', u'CytRx Corp', u'Loxo Oncology Inc', u'NantCell Inc', u'University of Texas Southwestern Medical Center']), u'Pediatricpsychiatricdisorder': set([u'Sumitomo Pharmaceuticals Co Ltd', u'Genentech Inc']), u'Liposarcoma': set([u'Infinity Pharmaceuticals Inc', u'US Government']), u'Vibri': set([u'BIO Ventures for Global Health', u'Medicines for Malaria Venture', u'Massachusetts Institute of Technology']), u'Generalanesthesia': set([u'Maruishi Pharmaceutical Co Ltd', u'Thornhill Research Inc', u'US Department of Defense', u'Daiichi Sankyo Co Ltd']), u'Worminfection': set([u'Merus Labs International Inc', u'Medicines for Malaria Venture', u'Sanofi', u'Drugs for Neglected Diseases Initiative']), u'VRSAinfection': set([u'Ruskin Chemipharm', u'AntexPharma Inc', u'Technion Research & Development Foundation Ltd', u'Undisclosed', u'iNtRON Biotechnology Inc', u'Breathtec Biomedical Inc', u'Lyotropic Therapeutics LLC', u'Reyon Pharmaceuticals Co Ltd']), u'Mucositis': set([u'SciDose LLC', u'Wyeth', u'US Government', u'Duke University Medical Center', u'EpiStem Ltd', u'RedHill Biopharma Ltd', u'Amgen Inc', u'Medimmune Oncology Inc', u'Cystic Fibrosis Foundation Therapeutics Inc', u'Stanford University School of Medicine', u'Reata Pharmaceuticals Inc', u'Aeolus Pharmaceuticals Inc', u'Michigan Economic Development Corp', u'GlaxoSmithKline plc', u'Mucosal Therapeutics LLC', u'BL&H Co Ltd', u'Univ Massachusetts', u'National Cancer Institute', u'PPL Therapeutics plc', u'Hyseq Inc', u'National Institutes of Health', u'Alizyme plc', u'Abeona Therapeutics Inc', u'NPS Pharmaceuticals Inc', u'Moberg Pharma AB', u'Immunex Corp', u'Elan Corp plc', u'Cleveland BioLabs Inc', u'Catholic University of Leuven', u'Demegen Inc', u'Rottapharm Madaus', u'Applied Protein Sciences LLC', u'Thomas Jefferson University', u'Serenex Inc', u'NPS Allelix Corp', u'Biomodels LLC', u'PharmaVigilant', u'Rowett Institute of Nutrition and Health', u'Periodontix Inc', u'ALZA Corp', u'Mipharm SpA', u'RxKinetix Inc', u'Kyowa Hakko Kirin Co Ltd', u'MegaPharm Ltd', u'NephRx Corp', u'Swedish Orphan Biovitrum AB', u'Child Health Corporation of America (CHCA)', u'University of California Irvine', u'Tego BioSciences Corp', u'National Center for Research Resources', u'Human Genome Sciences Inc', u'Canadian Government', u'Undisclosed', u'Cadila Pharmaceuticals Ltd']), u'Jointinfection': set([u'Wired Holdings Investment Corp', u'Sonoran Biosciences Inc', u'National Institute of Arthritis and Musculoskeletal and Skin Diseases', u'Zimmer Inc', u'EnBiotix Inc', u'Cimphoni Life Sciences LLC', u'Medical College of Wisconsin', u'Mayo Clinic Foundation', u'CD Diagnostics Llc', u'Humabs BioMed SA', u'MedImmune LLC']), u'DiamondBlackfananemia': set([u'Recursion Pharmaceuticals LLC', u'National Heart Lung and Blood Institute']), u'TypeItyrosinemia': set([u'Diplomat Pharmacy Inc', u'BL&H Co Ltd', u'Rare Disease Therapeutics Inc', u'Cycle Pharmaceuticals Ltd', u'Swedish Orphan Biovitrum AB']), u'Diabetesinsipidus': set([u'Biopasgroup', u'Merus Labs International Inc', u'Ferring Canada', u'Kyowa Hakko Kirin Co Ltd', u'Ferring Pharmaceuticals SA']), u'Thromboangiitisobliterans': set([u'RNL Bio Co Ltd', u'Yuhan Corp']), u'BipolarIIdisorder': set([u'Intra-Cellular Therapies Inc', u'Siegfried Holding Ltd', u'Recordati SpA', u'Gedeon Richter Ltd']), u'Renalcellcarcin': set([u'CASI Pharmaceuticals Inc', u'Celgene Corp']), u'Cellulitis': set([u\"Dr Reddy's Laboratories Ltd\", u'Kyowa Hakko Bio Co Ltd', u'Auxilium Pharmaceuticals Inc', u'BioSpecifics Technologies Corp', u'Daiichi Sankyo Co Ltd', u'GlaxoSmithKline plc']), u'Haemophilusinfluenzaeinfection': set([u'Alcon Inc', u'Beijing Minhai Biotechnology Co Ltd', u\"Tianjin Municipal People's Government\", u'Netherlands Vaccine Institute', u'Biovac Institute', u'Rhein Biotech NV', u'Walvax Biotechnology Co Ltd', u'Bio-Manguinhos/Fiocruz', u'Sanofi Pasteur', u'Daiichi Sankyo Co Ltd', u'Abbott Laboratories', u'Takeda Pharmaceutical Co Ltd', u'SmithKline Beecham plc', u'Serum Institute of India Ltd', u'BioNet-Asia Co Ltd', u'GlaxoSmithKline plc', u'Beijing Zhifei Luzhu Biopharmaceutical Co Ltd', u'Chiron Corp', u'Bayer AG', u'Undisclosed', u'Bio Farma', u\"United Nations International Children's Fund\", u'Emergent BioSolutions Inc', u'Statens Serum Institut', u'Biological E Ltd', u'Chinese Government', u'Breathtec Biomedical Inc', u'Technion Research & Development Foundation Ltd', u'Merck & Co Inc', u'BioChem Pharma (International ) Inc', u'MedImmune LLC', u'Fundacao Oswaldo Cruz (Fiocruz)', u'Ribi ImmunoChem Research Inc', u\"St Jude Children's Research Hospital\", u'Funda\\xe7\\xe3o Ezequiel Dias - Funed', u'bioCSL PTY Ltd', u'Sun Yat-Sen University', u'Shantha Biotechnics PVT Ltd', u'Imclone LLC', u'LG Life Sciences India Pvt Ltd', u'North American Vaccine Inc', u'Provalis plc', u'CanSino Biologics Inc', u'Nuron Biotech Inc', u'Crucell NV', u'Panacea Biotec Ltd', u'Human Genome Sciences Inc', u'Canopus BioPharma Inc', u'Institute of Medical Biology Chinese Academy of Medical Sciences', u'University of Melbourne', u'Toyama Chemical Co Ltd', u'Wyeth', u'Pfizer Vaccines', u'National Research Council of Canada', u'Mellow Hope Inc', u'Sumitomo Dainippon Pharma Co Ltd']), u'Nematodeinfection': set([u'Thomas Jefferson University', u'Merck & Co Inc', u'Shandong Xinhua Pharmaceutical Group Co Ltd', u'National Institutes of Health', u'Maruho Co Ltd', u'National Science Foundation', u'US Department of Agriculture', u'Divergence Inc', u'Lindsley F Kimball Research Institute', u'National Institute of Allergy and Infectious Diseases', u'Chinese Government']), u'Footandmouthdiseasevirusinfection': set([u'Il-Yang Pharmaceutical Co', u'Inovio Pharmaceuticals Inc', u'The Korea National Institute of Health', u'US Government', u'Agency For Science Technology & Research', u'Duke-NUS Graduate Medical School', u'InViragen LLC', u'University of Pennsylvania', u'Medigen Biotechnology Corp', u'GenVec Inc', u'Kuros Biosciences Ltd', u'Harrisvaccines Inc', u'International Vaccine Institute']), u'Sunburn': set([u'CollaGenex Pharmaceuticals Inc', u'Novogen Ltd', u'Galderma Spirig', u'3M Drug Delivery Systems', u'SurModics Pharmaceuticals', u'Clinuvel Pharmaceuticals Ltd', u'Commonwealth Scientific and Industrial Research Organization']), u'Tonicclonicepilepsy': set([u'Esteve', u'Eisai Co Ltd', u'CURx Pharmaceuticals Inc', u'Ligand Pharmaceuticals Inc']), u'Adrenoleukodystrophy': set([u'Ashvattha Therapeutics LLC', u'Academic Medical Center, University of Amsterdam', u'Health Resources and Services Administration', u'Orpheris Inc', u'Forendo Pharma Oy', u'QUATRx Pharmaceuticals Co', u'Minoryx Therapeutics sl', u'Viking Therapeutics Inc', u'bluebird bio Inc', u'National Institutes of Health', u'Institut Investigaci\\xf3 Biom\\xe8dica Bellvitge', u'US Government', u'Clayton Biotechnologies Inc', u'apceth GmbH & Co KG', u'Research Development Foundation', u'INSERM', u'Kennedy Krieger Institute', u'The Association of Public Health Laboratories', u'Institut Pasteur', u'NeuroVia Inc', u'Ligand Pharmaceuticals Inc']), u'Endometriosis': set([u\"The General Hospital of the People's Liberation Army\", u'Antev Ltd', u'ICON Clinical plc', u'Myovant Sciences Ltd', u'Oxagen Ltd', u'Orion Corporation', u'Key Oncologics (Pty) Ltd', u'VolitionRX Ltd', u'Kissei Pharmaceutical Co Ltd', u'Bayer Schering Pharma AG', u'Solvay SA', u'QUATRx Pharmaceuticals Co', u'Ipsen', u'Tecnofarma', u'Zentaris GmbH', u'Innothera', u'Shire plc', u'Abbott Healthcare Products BV', u'Alvogen Korea', u'TOLMAR Therapeutics Inc', u'Panaxia Pharmaceutical Industries Ltd', u'Orphagen Pharmaceuticals Inc', u'Handok Inc', u'Bayer HealthCare AG', u'AstraZeneca plc', u'Emory University', u'EmerGen Inc', u'Shionogi & Co Ltd', u'Universiteit Maastricht', u'Evotec AG', u'Vifor Pharma', u'Amgen Inc', u'Baxter Oncology GmbH', u'Nippon Kayaku Co Ltd', u'Mochida Pharmaceutical Co Ltd', u'Protagen AG', u'Biosintetica Farmaceutica Ltda', u'MediGene AG', u'Ardana Bioscience Ltd', u'Eunice Kennedy Shriver National Institute of Child Health & Human Development', u'Xbrane Biopharma AB', u'TOLMAR Holding Inc', u'Stiefel Laboratories (UK) Ltd', u'Bridge Organics Co', u'Sanofi-Synthelabo', u'Enzon Pharmaceuticals Inc', u'Evestra Inc', u'Taiho Pharmaceutical Co Ltd', u'Ferring Pharmaceuticals SA', u'Astrazeneca Korea', u'Lumara Health Inc', u'BalOnco GmbH', u'Boehringer Ingelheim Corp', u'BMP Sunstone Corp', u'Plethora Solutions Holdings plc', u'Generex Biotechnology Corp', u'Johnson & Johnson Development Corp', u'Universite Laval', u'Debiopharm SA', u'University of Oxford', u'United Laboratories Inc.', u'Teikoku Hormone Manufacturing Co Ltd', u'SRI International', u'Cerylid Biosciences Ltd', u'Meditrina Pharmaceuticals Inc', u'Forendo Pharma Oy', u'Undisclosed', u'AmorChem LP', u'Juniper Pharmaceuticals Inc', u'Sanofi', u'The National Centre for Research and Development', u'TerSera Therapeutics', u'Nippon Organon KK', u'InNexus Biotechnology Inc', u'Pfizer CentreSource', u'AEterna Zentaris Inc', u'Repros Therapeutics Inc', u'Nektar Therapeutics', u\"Prince Henry's Institute of Medical Research\", u'Pfizer Inc', u'Neurocrine Biosciences Inc', u'FemmePharma Inc', u'Wyeth', u'University of Illinois', u'Radius Pharmaceuticals', u'Abbott Laboratories', u'ASTA Medica AG', u'PregLem Holding SA', u'Allegiance Equity Corp', u'Takeda Pharmaceutical Co Ltd', u'Praecis Pharmaceuticals Inc', u'Genizon BioSciences Inc', u'Metris Therapeutics Ltd', u'National Institutes of Health', u'ObsEva SA', u'Elan Corp plc', u\"St. Joseph's Hospital and Medical Center\", u'MDNA Life Sciences Inc', u'Sosei Group Corp', u'Nobelpharma Co Ltd', u'Jenapharm GmbH & Co KG', u'Ferring Research Ltd', u'Merck Serono SA', u'Gedeon Richter Ltd', u'University of Cambridge', u'Wayne State University', u'GD Searle & Co', u'BioAvenir']), u'Tineacruris': set([u'Dong Wha Pharmaceutical Co Ltd', u'Novartis AG']), u'Bleeding': set([u'Haemostatix Ltd', u'Novuson Inc', u'Baxter International Inc', u'Cerus Corp', u'3-D Matrix Inc', u'Thrombotargets Corp', u'Rexan Pharmaceutical Co Ltd', u'Maxygen Inc', u'GlaxoSmithKline plc', u'Healthcare Royalty Partners', u'University of Queensland', u'Centro Nacional de Biotechnologia', u'CMIC Holdings Co Ltd', u'ISTA Pharmaceuticals Inc', u'National Endowment for Science, Technology and the Arts', u'NuvOx Pharma LLC', u'Planet Wheeler Foundation', u'Kunming Institute of Zoology The Chinese Academy of Sciences', u'Roche Holding AG', u'University of British Columbia', u'Grifols Inc', u'South China Center for Innovative Pharmaceuticals', u'Serendex Pharmaceuticals A/S', u'Debiovision Inc', u'Arch Therapeutics', u'Xcede Technologies Inc', u'Catalyst Biosciences Inc', u'National Heart Lung and Blood Institute', u'RxMP Therapeutics LLC', u'BDI Pharma Inc', u'United Health Products Inc', u'Omeros Corp', u'Alnylam Pharmaceuticals Inc', u\"Fundacio Privada I Institut De Recerca De L'Hospital De La Santa Creu I Sant Pau\", u'Hikma Pharmaceuticals plc', u'National Institute of General Medical Sciences', u'Grand Challenges Canada', u'Cook Biotech', u'Universitat de Girona', u'China Nuokang Bio-Pharmaceutical Inc', u'Daiichi Sankyo Co Ltd', u'Abbott Laboratories', u'Tulane University', u'ProFibrix BV', u'ASINEX Ltd', u'ZymoGenetics Inc', u'University of California', u'McCall MacBain Foundation', u'Monash University', u'UCB SA', u'Ferring Pharmaceuticals SA', u'United States Air Force', u'CMC Biologics Inc', u'Jiangsu Nhwa Pharmaceutical Group Co Ltd', u'Gem Pharmaceuticals LLC', u'AcSentient Inc', u'Cordis Corp', u'Neopharm Ltd', u'Debiopharm SA', u'Pharming Group NV', u'Eumedica', u'Bio Products Laboratory Ltd', u'Mallinckrodt plc', u'Carney Export-Import', u'CJSC Generium', u'LifeArc', u'Baxter Healthcare Corp', u'Undisclosed', u'US Army Medical Research and Materiel Command', u'Daewoong Pharmaceutical Co Ltd', u'rEVO Biologics Inc', u'Columbia University', u'Eli Lilly & Co', u'Dompe Farmaceutici SpA', u'University of Miami', u'Bayer AG', u'US Army Medical Research Institute of Infectious Diseases', u'Cypress Bioscience Inc', u'Takeda Pharmaceuticals International GmbH', u'University of Barcelona', u'Tactical Medical Solutions Llc', u'Hyundai Pharmaceutical', u'Cubist Pharmaceuticals Inc', u'AstraZeneca plc', u'Pfizer Inc', u'Okklo Life Sciences BV', u'Symbiosis Corp', u'Antibe Therapeutics Inc', u'Total Resources International', u'Universidad De Alcala', u'XL-Protein GmbH', u'LG Life Sciences Ltd', u'Massachusetts Institute of Technology', u'QRxPharma Ltd', u'CSL Behring LLC', u'Savara Inc', u'CogENT Therapeutics LLC', u'Portola Pharmaceuticals Inc', u'Curacyte AG', u'Warwick University', u'Sun Pharmaceutical Advanced Research Co Ltd', u'Hemosonics Llc', u'Ethicon Inc', u'EMS SA', u'Sanquin Blood Supply Foundation', u'Bristol-Myers Squibb Co', u'Tzamal Bio-Pharma Ltd', u'The Medicines Company', u'Central California Blood Center', u'OMRIX Biopharmaceuticals SA', u'Sanofi Genzyme', u'Fujifilm Diosynth Biotechnologies', u'Dr Rentschler Biotechnologie GmbH', u'Wyeth', u'Max Delbruck Centrum Fur Molekulare Medizin', u'Guangdong Sincody Pharmaceutical Development Co Ltd', u'Ranbaxy Laboratories Ltd', u'Medical Futures Inc', u'Salix Pharmaceuticals Ltd', u'Sin Phyu Kyun Co Ltd', u'Avigen Inc', u'Dyax Corp', u'Bayer HealthCare Pharmaceuticals Inc', u'Entellus Medical Inc', u'Takeda Pharmaceutical Co Ltd', u'Biosensors International Group Ltd', u'American Red Cross', u'Nycomed Inc', u'Laboratories Acbel SA']), u'Multidrugresistantinfection': set([u'Oscient Pharmaceuticals Corp', u'Shanghai ChemPartner Co Ltd', u'Orchid Pharma Ltd', u'University of Medicine and Dentistry of New Jersey', u'PDL BioPharma Inc', u'Barcelona Biomedical Research Park', u'TaiMed Biologics Inc', u'Aptuit', u'Melinta Therapeutics Inc', u'Abera Bioscience AB', u'European Commission', u'Rempex Pharmaceuticals Inc', u'National Institute of Allergy and Infectious Diseases', u'Ohio State University', u'BioVersys AG', u'DnaAcos AS', u'New Anti Infectives Consortium', u'Takeda Pharmaceutical Co Ltd', u'Sumitomo Dainippon Pharma Co Ltd', u'Lawrence Livermore National Laboratory', u'The Research Council of Norway', u'Agile Sciences Inc', u'Xellia Pharmaceuticals AS', u'Omnia Molecular', u'National Institutes of Health', u'NexThera Biosciences', u'Food and Drug Administration', u'Sequella Inc', u'Ionis Pharmaceuticals Inc', u'Achaogen Inc', u'OSEO', u'Instituto de Quimica Medica-CSIC', u'Synthetic Genomics Vaccines Inc', u'Discuva Ltd', u'Forge Therapeutics Inc', u'Thermo Fisher Scientific Inc', u'Eli Lilly & Co', u'Regione Lombardia', u'Jacobus Pharmaceutical Co Inc', u'Trius Therapeutics Inc', u'Lucane Pharma SA', u'NeED Pharmaceuticals Srl', u'OPKO Health Inc', u'Roche Holding AG', u'US Army Medical Research Institute of Infectious Diseases', u'Phylogica Ltd', u'Allecra Therapeutics GmbH', u'Basilea Pharmaceutica International Ltd', u'ANTABIO', u'BC Cancer Agency', u'TAXIS Pharmaceuticals Inc', u'Carrus Capital Corp', u'University of California San Diego', u'NovoBiotic Pharmaceuticals LLC', u'Cyclenium Pharma Inc', u'Paratek Pharmaceuticals Inc', u'Intravacc Inc', u'Neurogen Corp', u'Oxford Drug Design', u'Spider Biotech Srl', u'Wellcome Trust', u'University of British Columbia', u'Monash University', u'Trianni Inc', u'Cubist Pharmaceuticals Inc', u'Da Volterra', u'Enamine Ltd', u'AstraZeneca plc', u'Cellworks Group Inc', u'Synedgen Inc', u'Defense Advanced Research Projects Agency', u'US Health and Human Services Department', u'Technology Strategy Board', u'Yale University', u'Statens Serum Institut', u'Rutgers University', u'Fundaci\\xf3n MEDINA', u'KtedoGen srl', u'SINTEF Group', u'Techulon Inc', u\"Universita' Degli Studi Di Parma\", u'BIOASTER']), u'Eczema': set([u'University of Cincinnati', u'Wockhardt Ltd', u'Undisclosed', u'IGE Therapeutics Inc', u'National Institute of Allergy and Infectious Diseases', u'Mount Sinai School of Medicine', u'Huapont Life Sciences Co Ltd', u'Bayer Schering Pharma AG', u'National Institutes of Health', u'Sinclair Pharma plc', u'Merck & Co Inc', u'Synvista Therapeutics Inc', u'Italfarmaco SpA', u'MedPharm Ltd', u'Imaginative Research Associates Inc', u'Sanofi', u'Ferndale Laboratories Inc', u'Anesiva Inc', u'Azitra Inc', u'CSL Ltd', u'Hoth Therapeutics Inc', u'Roche Holding AG', u'Basilea Pharmaceutica International Ltd', u'IXICO Plc', u'ProtoKinetix Inc', u'Gamida Cell Ltd', u'Bridge Pharmaceuticals Inc', u'Yes Biotech Labs Ltd', u'Immune Network Ltd', u'Second Genome Inc', u'Intendis GmbH', u'Almirall Prodesfarma SA', u'Pfizer Inc', u'Shionogi & Co Ltd', u'Actelion Ltd', u'Foamix Pharmaceuticals Ltd', u'UK Department of Trade & Industry', u'Accolade Pharmaceuticals Pte Ltd', u'Neopharm Ltd', u'Transcription Factor Therapeutics', u\"King's College London\"]), u'Myelodysplasticsyndrome': set([u'US Government', u'Acceleron Pharma Inc', u'The Leukemia & Lymphoma Society', u'University of Florida', u'Baxter International Inc', u'Netherlands Government', u'Unigene Laboratories Inc', u'National Comprehensive Cancer Network', u'Strategia Therapeutics Inc', u'Cosmo Pharmaceuticals SpA', u'Innovive Pharmaceuticals Inc', u'MethylGene Inc', u'MGI Pharma Inc', u'Novartis Pharma AG', u'MDS Clinical Research Consortium', u'Astex Pharmaceuticals Inc', u'Wuxi Shanhe Group No 1 Pharmaceutical Co Ltd', u'Vernalis plc', u'Opsona Therapeutics Ltd', u'TMRC Co Ltd', u'Leiden University Medical Center', u'Dutch-Belgian Cooperative Trial Group for Hematology Oncology', u'Bellicum Pharmaceuticals Inc', u'Mateon Therapeutics Inc', u'Roche Holding AG', u'Theradex Systems Inc', u'Biocompatibles International plc', u'ANI Pharmaceuticals Inc', u'PanGenetics BV', u'General Hospital of Lanzhou Military Region', u'Catalent Inc', u'Biomas Inc', u'Constellation Pharmaceuticals Inc', u'Dana-Farber Cancer Institute Inc', u'Aplastic Anemia & MDS International Foundation', u'Sigma-Tau Ind Farm Riunite SpA', u'CrystalGenomics Inc', u'Weill Medical College of Cornell University', u'PDL BioPharma Inc', u'Kanebo KK', u'Amgen Inc', u'Cancer Genetics Inc', u'Nippon Kayaku Co Ltd', u'Sparta Pharmaceuticals Inc', u'Wuxi AppTec Inc', u'Stragen Group', u'CMIC ASIA-PACIFIC, PTE. LTD.', u'National Cancer Institute', u'Novartis AG', u'Ministry of Health & Welfare, Korea', u'Irix Pharmaceuticals Inc', u'MabVax Therapeutics Holdings Inc', u'CleveXel Pharma', u'Medac GmbH', u'Lipomed AG', u'Therapeutic Human Polyclonals Inc', u'FibroGen Inc', u'University of Cologne', u'Aptose Biosciences Inc', u'SymBio Pharmaceuticals Ltd', u'Pharmion Corp', u'SangStat Medical Corp', u'BioTheryX Inc', u'Fujifilm\\xa0Corp', u'Cure Medical Manufacturing', u'ILEX Oncology Inc', u'Novellusdx Ltd', u'Chugai Pharmaceutical Co Ltd', u'Ortho Biotech Products LP', u'Genentech Inc', u'Stemline Therapeutics Inc', u'ViaCell Inc', u'Actavis Inc', u'Onconova Therapeutics Inc', u'Medivir AB', u'Sumitomo Dainippon Pharma Co Ltd', u'Pfizer Inc', u'Cell and Gene Therapy Catapult', u'MD Anderson Cancer Center', u'Cellular Therapeutics Ltd', u'LEO Pharma A/S', u'Vertex Pharmaceuticals Inc', u'CTI BioPharma Corp', u'CASI Pharmaceuticals Inc', u'SATT Paca Corse', u'ChemGenex Pharmaceuticals Ltd', u'University of Virginia', u'Aprea Therapeutics AB', u'Walter and Eliza Hall Institute of Medical Research', u'Merus BV', u'Cellerant Therapeutics Inc', u'TetraLogic Pharmaceuticals Corp', u'AstraZeneca plc', u'EIP Pharma LLC', u'Vion Pharmaceuticals Inc', u'Lanzhou Institute Of Chemical Physics Chinese Academy Of Sciences', u'Rich Pharmaceuticals Inc', u'Yissum Research Development Co', u'Memorial Sloan-Kettering Cancer Center', u'Nippon Shinyaku Co Ltd', u'BioLineRx Ltd', u'AnorMED Inc', u'ASTA Medica AG', u'MEI Pharma Inc', u'H Lee Moffitt Cancer Center and Research Institute', u'Pfanstiehl Laboratories Inc', u'BL&H Co Ltd', u'BioMed Valley Discoveries', u'National Institutes of Health', u'Natco Pharma Ltd', u'Bristol-Myers Squibb Co', u'Evotec (UK) Ltd', u'Columbia University Medical Center', u'Celgene Corp', u'Institut Gustave Roussy', u'AltaRex Medical Corp', u'Tarix Pharmaceuticals LLC', u'Beijing Pason Pharmaceuticals Inc', u'Biologics Inc', u'Bayer HealthCare Pharmaceuticals Inc', u'TopoTarget A/S', u'Bioenvision Inc', u'CuraGen Corp', u'BASF AG', u'Helsinn Group']), u'Viralhemorrhagicfever': set([u'The Chinese Centre for Disease Control and Prevention', u'Wellcome Trust', u'Jilin Yatai Bio-Pharmaceutical Co Ltd', u'US Government', u'Wuhan Institute of Biological Products Co Ltd', u'Fourth Military Medical University PLA', u'Navigen Inc', u'Canadian Government', u'Emergent BioSolutions Inc', u'US Department of Defense', u'Defyrus Inc', u'Kineta Inc', u'Sarepta Therapeutics Inc', u'National Institute of Allergy and Infectious Diseases', u'United States Army Medical Research Institute of Chemical Defense', u'Peregrine Pharmaceuticals Inc', u'GeoVax Labs Inc', u'Integrated BioTherapeutics Inc', u'BioCryst Pharmaceuticals Inc', u'National Center For Advancing Translational Sciences', u'SIGA Technologies Inc']), u'Angelmansyndrome': set([u'The Foundation for Angelman Syndrome Therapeutics', u'Ovid Therapeutics Inc', u'Agilis Biotherapeutics LLC', u'Marinus Pharmaceuticals Inc', u'Marnier-Lapostolle Foundation', u'NeuroPointDX', u'H Lundbeck A/S', u'University of South Florida', u'Ligand Pharmaceuticals Inc']), u'Hoarseness': set([u'Sonde Health', u'Lincoln Laboratory Massachusetts Institute of Technology']), u'Hepatocellularcarcinoma': set([u'Brown University', u'National Comprehensive Cancer Network', u'Phoenix Pharmacologics Inc', u'Yakult Honsha Co Ltd', u'OSE Immunotherapeutics', u'Silence Therapeutics plc', u'Jennerex Inc', u'Sanofi Pasteur', u'Pertinax Therapeutics Inc', u'Ardea Biosciences Inc', u'OncoTherapy Science Inc', u'Ehime University', u'Onxeo SA', u'Lantheus Medical Imaging Inc', u'Kowa Co Ltd', u'Takeda Pharmaceutical Co Ltd', u'AVEO Oncology', u'Quintiles Transnational Corp', u'Ministry of Health, Welfare and Family Affairs', u'Medivation Inc', u'ZAI Laboratory Inc', u'Ipsen', u'Ascletis Inc', u'European Eurostars Programme', u'MedImmune LLC', u'ArQule Inc', u'Stanford University', u'Institut Curie', u'TMRC Co Ltd', u'Mateon Therapeutics Inc', u'Ontario Institute for Cancer Research', u'Roche Holding AG', u'tella Inc', u'Biocompatibles International plc', u'Yamaguchi University', u'Kite Pharma Inc', u'Agency For Science Technology & Research', u'Ergomed PLC', u'Medicell Co', u'Bayer HealthCare AG', u'Medigen Biotechnology Corp', u'University of Florida', u'Alnylam Pharmaceuticals Inc', u'Charite Universitaetsmedizin Berlin', u'National Research Council of Canada', u'National Center For Advancing Translational Sciences', u'Innovus Pharmaceuticals Inc', u'NovaTarg Therapeutics Inc', u'Institut National du Cancer', u'Exelixis Inc', u'Green Cross Cell Corp', u'Polaris Pharmaceuticals Inc', u'Q BioMed Inc', u'MD Anderson Cancer Center', u'Incyte Corp', u'SillaJen Inc', u'Rex Medical LP', u'Nippon Petrochem Co Ltd', u'Sichuan University', u'US Government', u'Daiichi Sankyo Co Ltd', u'Nippon Kayaku Co Ltd', u'Zeria Pharmaceutical Co Ltd', u'Eisai Co Ltd', u'Mount Sinai School of Medicine', u'Ganymed Pharmaceuticals AG', u'Pediatric Oncology Experimental Therapeutics Investigation Consortium', u'National Cancer Institute', u'Novartis AG', u'Merck KGaA', u'ZIOPHARM Oncology Inc', u'Panacea Pharmaceuticals Inc', u'Johannes Gutenberg Universitat Mainz', u'Hadassah Medical Organization', u'Nymox Pharmaceutical Corp', u'Suzhou Zelgen Biopharmaceutical Co Ltd', u'SciClone Pharmaceuticals Inc', u'Lipomed AG', u'North Carolina Department of Commerce', u'Juvaris BioTherapeutics Inc', u'Arbutus Biopharma Corp', u'TBG Diagnostics Ltd', u'Immunomedics Inc', u'Titan Pharmaceuticals Inc', u'University of Navarra', u'Windtree Therapeutics Inc', u'YM BioSciences USA', u'Can-Fite BioPharma Ltd', u'H\\xf4pital de la Croix-Rousse', u'Baylor University', u'CytRx Corp', u'Tragara Pharmaceuticals Inc', u'Light Sciences Oncology Inc', u'University of California San Diego', u'University of Texas Southwestern Medical Center', u'Complete Genomics Inc', u'Memorial Sloan-Kettering Cancer Center', u'Lixte Biotechnology Holdings Inc', u'Royalty Pharma', u'Debiopharm SA', u'Global TransBiotech Inc', u'Chugai Pharmaceutical Co Ltd', u'Institute For Hepatitis & Virus Research', u'Green Cross Corp', u'Shanghai Institutes for Biological Sciences CAS', u'Genentech Inc', u'Dicerna Pharmaceuticals Inc', u'Neostem Oncology', u'Enantigen Therapeutics Inc', u'twoXar Inc', u'Hangzhou Tigermed Consulting', u'Mayo Clinic Foundation', u'Light Sciences Corp', u'Oklahoma Medical Research Foundation', u'Universidad del Pais Vasco', u'INSERM UMR 991', u'Republic of Korea Government', u'Yuhan Corp', u'Somantix BV', u'Undisclosed', u'Immuron Ltd', u'JW CreaGene Inc', u'ImmunoCellular Therapeutics Ltd', u'Merck & Co Inc', u'Sanofi', u'Genosco', u'Chong Kun Dang Pharmaceutical Corp', u'Eli Lilly & Co', u'Celsion Corp', u'CASI Pharmaceuticals Inc', u'Zhejiang Hisun Pharmaceutical Co Ltd', u'Marina Biotech Inc', u'Bayer AG', u\"Children's Hospital of Los Angeles\", u'Kyowa Hakko Kirin Co Ltd', u'MolMed SpA', u'RegeneRx Biopharmaceuticals Inc', u'Universit\\xe9 De Rennes 1', u'Fourth Military Medical University PLA', u'NanoString Technologies Inc', u'AstraZeneca plc', u'Pfizer Inc', u'IntegraGen', u'Yale University', u'Corixa Corp', u'Copernicus Therapeutics Inc', u'Medivate Partners', u'Merck Sharp & Dohme Ltd', u'Apricus Biosciences Inc', u'4SC AG', u'Kitasato Institute', u'Broad Institute Inc', u'TopoTarget A/S', u'LG Life Sciences Ltd', u'Baylor College of Medicine', u'Australian Government', u\"Lee's Pharmaceutical Holdings Limited\", u'Genmab A/S', u'Japanese National Cancer Center', u'Taipei Medical University', u'ASLAN Pharmaceuticals Pte Ltd', u'GE Global Research', u'Prima BioMed Ltd', u'H Lee Moffitt Cancer Center and Research Institute', u'NeuroVive Pharmaceutical AB', u'Cellular Biomedicine Group Inc', u'Nerviano Medical Sciences Srl', u'Ligand Pharmaceuticals Inc', u'University of North Carolina', u'National Cancer Centre of Singapore', u'Northwestern University', u'Therapure Biopharma Inc', u'Centre Hospitalier Universitaire Vaudois', u'Evotec International GmbH', u'Rhode Island Hospital', u'The Australian National University', u'National Institutes of Health', u'MicroConstants China', u'Food and Drug Administration', u'Fresenius SE & Co KGaA', u'Ono Pharmaceutical Co Ltd', u'Menarini Asia-Pacific', u'Bristol-Myers Squibb Co', u'Seoul National University Hospital', u'Leap Therapeutics Inc', u'Ohio State University', u'Fujifilm Diosynth Biotechnologies', u'CJ Corp', u'Roswell Park Cancer Institute', u'Celgene Corp', u'Memgen LLC', u'Astellas Pharma Inc', u'Adria Laboratories Inc', u'Medical University of South Carolina', u'Global Medical Solutions Ltd', u'SinoMab Bioscience Ltd', u'Agouron Pharmaceuticals Inc', u'Mogam Biotechnology Institute', u'Bar-Ilan Research & Development Co Ltd', u'Biologics Inc', u'Dyax Corp', u'Bayer HealthCare Pharmaceuticals Inc', u'Engitix Ltd', u'Provectus Biopharmaceuticals Inc', u'Biocure Inc', u'Hadassah University Hospital', u'CuraGen Corp', u'Society of Interventional Oncology (SIO)', u'Tiziana Life Sciences PLC', u'Nucorion Pharmaceuticals Inc']), u'Spondylarthritis': set([u'Celltrion Inc', u'Kern Pharma SL']), u'Analtumor': set([u'AstraZeneca plc', u'Global BioPharma Inc', u'Radiation Therapy Oncology Group', u'FusionVax', u'Varian Medical System Inc', u'Advaxis Inc', u'Merck & Co Inc', u'Bionix Radiation Therapy']), u'Intestinetransplantation': set([u'Fujisawa Pharmaceutical Co Ltd', u'Janssen-Cilag Ltd']), u'Fanconi-Bickeldisease': set([u'Baylor Research Institute', u'Ultragenyx Pharmaceutical Inc']), u'Viralinfect': set([u'National Institute of Allergy and Infectious Diseases', u'Tamir Biotechnology Inc']), u'Acutebronchitis': set([u'FDA Office of Orphan Products Development', u'University of Michigan', u'Eddingpharm Inc', u'Kyowa Hakko Bio Co Ltd', u'Bayer AG', u'Concordia Pharmaceuticals Inc', u'Lilly China Research & Development Co Ltd', u'Daiichi Sankyo Co Ltd', u'Teligent Inc', u'Chong Kun Dang Pharmaceutical Corp']), u'Vascularneoplasm': set([u'Boehringer Mannheim GmbH', u\"Cincinnati Children's Hospital Medical Center\", u'GeneMedicine Inc', u'Food and Drug Administration']), u'Blindness': set([u'4D Molecular Therapeutics LLC', u'Amarantus BioScience Holdings Inc', u'AGTC', u'Korea Drug Development Fund', u'Drugs for Neglected Diseases Initiative', u'TheraKine Ltd', u'CRISPR Therapeutics', u'GlaxoSmithKline plc', u'Juvenile Diabetes Research Foundation', u'Dynamis Therapeutics Inc', u'Wayne State University', u'Bayer AG', u'National Institutes of Health', u'RetroSense Therapeutics', u'Ionis Pharmaceuticals Inc', u'CellSeed Inc', u'National Eye Institute', u'Sanofi Genzyme', u'Cell Care Therapeutics Inc', u'University of London', u'Celgene Corp', u'Development Center for Biotechnology', u'Jack and J.T. Snow Scientific Research Foundation', u'Sankara Nethralaya', u'Emmaus Medical Inc', u'Auritec Pharmaceuticals Inc', u'Chungnam National University', u'Foundation Fighting Blindness', u'University of Iowa', u'Washington University in St Louis', u'Bionic Sight LLC', u'International Stem Cell Corp', u'AmpliPhi Biosciences Corp']), u'Mastalgia': set([u'Gardant Pharmaceuticals Inc', u'Symbollon Pharmaceuticals Inc', u'BHR Pharma LLC', u'ASCEND Therapeutics Inc']), u'Progressivesupranuclearpalsy': set([u'C2N Diagnostics', u'Weston Brain Institute', u'US Government', u'Undisclosed', u'AbbVie Inc', u'Biogen Inc', u'Eisai Co Ltd', u'Procypra Therapeutics LLC', u'Howard Florey Institute of Experimental Physiology and Medicine', u'Cloud Pharmaceuticals Inc', u'Molecular Neuroimaging LLC', u'National Institutes of Health', u'Teva Pharmaceutical Industries Ltd', u'Instituto de Quimica Medica-CSIC', u'Sellas Life Sciences Group', u'University College London', u'The University Health Network', u'Bristol-Myers Squibb Co', u'Allon Therapeutics Inc', u'IXICO Plc', u'Noscira SA', u'Relief Therapeutics Holding AG', u'Rare Diseases Clinical Research Network', u'Nordic Biotech Venture Fund II K/S', u'PAREXEL International', u'Avid Radiopharmaceuticals Inc', u'Catalent Inc']), u'Bladdertumor': set([u'National Comprehensive Cancer Network', u'Silence Therapeutics plc', u'Karl Storz GmbH & Co KG', u'Allos Therapeutics Inc', u'Quintiles Transnational Corp', u'Centelion SAS', u'Bayer Schering Pharma AG', u'Planta Naturstoffe GmbH', u'University Of Southampton', u'Sanofi Winthrop France SA', u'Ipsen', u'Choice Pharmaceuticals', u'MedPharm Ltd', u'BioSyent Inc', u'Intracel Corp', u'Onyvax Ltd', u'OSI Pharmaceuticals Inc', u'Mercian Corp', u'Sanochemia Pharmazeutika AG', u'Medeva plc', u'Neon Therapeutics', u'Ludwig Institute for Cancer Research', u'ANI Pharmaceuticals Inc', u'Sanofi Genzyme', u'Peplin Inc', u'Stanford Rook Ltd', u'Keio University', u'IDIS Ltd', u'Eleven Biotherapeutics Inc', u'Sanofi Pasteur', u'Cell Pathways Inc', u'BCG Oncology PC', u'Cold Genesys Inc', u'Medarex Inc', u'Nippon Kayaku Co Ltd', u'Endo Health Solutions Inc', u'Eisai Co Ltd', u'Valera Pharmaceuticals Inc', u'Boehringer Mannheim GmbH', u'National Cancer Institute', u'Merck KGaA', u'Sirna Therapeutics Inc', u'Intervet International BV', u'Fujisawa Pharmaceutical Co Ltd', u'Novelion Therapeutics Inc', u'Technology Partnerships Canada', u'Ewopharma AG', u'Biosyn Arzneimittel GmbH', u'Ajinomoto Althea Inc', u'YM BioSciences Inc', u'Galectin Therapeutics Inc', u'Aptose Biosciences Inc', u'Nycomed Pharma AS', u'Pharmacia & Upjohn Inc', u'Yissum Research Development Co', u'Pharmion Corp', u'Kyowa Hakko Kogyo Co Ltd', u'SICOR Inc', u'Anthra Pharmaceuticals Inc', u'Paladin Labs Inc', u'Cobra Biologics Holding AB', u'Mayo Clinic Foundation', u'Undisclosed', u'Sakai Chemical Industry Co Ltd', u'Eli Lilly & Co', u'ScinoPharm Taiwan Ltd', u'Spectrum Pharmaceuticals Inc', u'Pierre Fabre SA', u'Kalgene Pharma Inc', u'AstraZeneca plc', u'Pfizer Inc', u'Corixa Corp', u'NeoOncoRx Inc', u'Telesta Therapeutics Inc', u'Genta Inc', u'Memorial Sloan-Kettering Cancer Center', u'Scotia Holdings plc', u'Stiefel', u'Introgen Therapeutics Inc', u'Collgard Biopharmaceuticals Ltd', u'DUSA Pharmaceuticals Inc', u'Tikcro Technologies Ltd', u'BL&H Co Ltd', u'PhotoCure ASA', u'National Institutes of Health', u'Food and Drug Administration', u'BioCancell Therapeutics Ltd', u'Bristol-Myers Squibb Co', u'Bioenvision Inc', u'Cardiff University', u'American Cyanamid Co', u'Aronex Pharmaceuticals Inc', u'Celgene Corp', u'Velindre NHS Trust', u'Relgen LLC', u'Oncormed Inc', u'GE Healthcare', u'The NDDO Research Foundation', u'Cyanamid Benelux NV', u'TopoTarget A/S', u'Bacilligen Inc', u'Berlex Laboratories Inc', u'Morvus Technology Ltd', u'CuraGen Corp', u'OncoGenex Pharmaceuticals Inc', u'Mentor Corp']), u'Throatdisease': set([u'Entellus Medical Inc', u'Fiagon Gmbh']), u'Hyperplasia': set([u'Northwestern University', u'Atossa Genetics Inc', u'Besins Healthcare SA', u'National Heart Lung and Blood Institute']), u'Osteodystrophy': set([u'Acologix Inc', u'Ortho Biotech Products LP', u'University College London', u'Curis Inc']), u'Poisonintoxication': set([u'University of Medicine and Dentistry of New Jersey', u'US Government', u'University of Florida', u'Wright State University', u'State Of Israel The Ministry Of Industry & Trade The National Physical Laboratory', u'Sanofi Pasteur', u'United States Army Medical Research Institute of Chemical Defense', u'Technical University of Munich', u'Kamada Ltd', u'IDT Biologika GmbH', u'Arizona State University', u'University of Pittsburgh', u'Fred Hutchinson Cancer Research Center', u'Walter Reed Army Institute of Research', u'University of Rochester', u'Merck Sante SA', u'PlantForm Corp', u'Azopharma Inc', u'Osiris Therapeutics Inc', u'Rare Disease Therapeutics Inc', u'Tenax Therapeutics Inc', u'National Center for Research Resources', u'US Department of Defense', u'Impel NeuroPharma', u'Israeli Government', u'Swedish Orphan AB', u'Quick-Med Technologies Inc', u'Cambridge Antibody Technology Group plc', u'US Army Research Office', u'Tulane University', u'National Cancer Institute', u'SRI International', u'Georgetown University', u'University of Maryland', u'MicroPharm Ltd', u'Georgia Institute of Technology', u'Protalix BioTherapeutics Inc', u'Infectious Disease Research Institute', u'Fougera Pharmaceuticals Inc', u'University of Colorado System', u'Countervail Corp', u'Twinstrand Therapeutics Inc', u'University of California San Diego', u'Orphan Medical Inc', u'Universidad Nacional Autonoma De Mexico', u'F H Faulding & Co Ltd', u'Lexicon Pharmaceuticals Inc', u'US Army Space and Missile Defense Command', u'National Institute of Neurological Disorders and Stroke', u'Paladin Labs Inc', u'IDIS Ltd', u'Cangene Corp', u'MicroDose Therapeutx Inc', u'Instituto Bioclon Sa De CV', u'New York University', u'XOMA Corp', u'Emergent BioSolutions Inc', u'ImmuneRegen BioSciences Inc', u'Scripps Research Institute', u'Maas BiolAB LLC', u'University of Texas Southwestern Medical Center', u'US Naval Medical Research Center', u'diaDexus Inc', u'US Army Medical Research Institute of Infectious Diseases', u'Boyce Thompson Institute for Plant Research Inc', u'Beacon Pharmaceuticals', u'Soligenix Inc', u'Rexahn Pharmaceuticals Inc', u'Canadian Department of National Defence', u'Southwest Research Institute (SwRI)', u'Caladrius Biosciences Inc', u'Cenomed Research LLC', u'Pieris Pharmaceuticals Inc', u'University of Arizona', u'Cenomed BioSciences LLC', u'Mapp Biopharmaceutical Inc', u'National Institute of Allergy and Infectious Diseases', u'King Pharmaceuticals Inc', u'BL&H Co Ltd', u'Protherics plc', u'MPI Research', u'National Institutes of Health', u'Food and Drug Administration', u'Chinese Government', u'Wadsworth Centre', u'INSERM', u'Archimedes Pharma Ltd', u'Cambridge Laboratories Ltd', u'Cambrex Corp', u'Institut Pasteur', u'Wacker Biotech GmbH', u'FDA Office of Orphan Products Development', u'Sickness Prevention and Control Centre of Chengdu Military Command', u'Ministry of Health, Israel', u'ArmaGen Technologies Inc', u'PlantVax Inc', u'Parabon NanoLabs Inc']), u'Metabolicbraindisease': set([u'Karolinska Institutet', u'The Knut and Alice Wallenberg Foundation']), u'Non-Hodgkinlymphom': set([u'GlaxoSmithKline plc', u'Genmab A/S']), u'Microsporuminfection': set([u'Dong Wha Pharmaceutical Co Ltd', u'Novartis AG']), u'Boneinfection': set([u'MBC Pharma Inc', u'New Jersey Health Foundation Inc', u'National Institutes of Health', u'Rowan University']), u'Innereardisease': set([u'Sensorion Pharmaceuticals', u'Palau Pharma SA', u'French Government', u'National Institute on Deafness and Other Communication Disorders', u'Auritec Pharmaceuticals Inc', u'National Science Foundation', u'Spiral Therapeutics Inc', u'Bionure Inc', u'ProLynx LLC', u'O-Ray Pharma Inc']), u'Onchocerciasis': set([u'M\\xe9decins Sans Fronti\\xe8res', u'Massachusetts Institute of Technology', u'AbbVie Inc', u'Bill & Melinda Gates Foundation', u'Drugs for Neglected Diseases Initiative', u'National Institute of Allergy and Infectious Diseases', u'Eisai Co Ltd', u'GlaxoSmithKline plc', u'd3 Medicine LLC', u'World Health Organization', u'United States Agency for International Development', u'New York Blood Center', u'Medicines Development Ltd', u'Lindsley F Kimball Research Institute', u'Sanofi', u'University of California San Francisco', u'Swiss Agency for Development and Cooperation', u'La Agencia Espa\\xf1ola de Cooperaci\\xf3n Internacional para el Desarrollo', u'Bayer AG', u'Department for International Development', u'Astellas Pharma Inc', u'BIO Ventures for Global Health', u'ExCRX Singapore Pte Ltd', u'Anacor Pharmaceuticals Inc', u'Oak Therapeutics Inc', u'Medicines for Malaria Venture', u'Liverpool School of Tropical Medicine', u'University of Buea', u'Pfizer Inc', u'University of Southern California', u'Michigan State University', u'Alnylam Pharmaceuticals Inc', u'German Federal Ministry of Education and Research']), u'Esophag': set([u'DRI Capital', u'LifeArc']), u'Cancer': set([u'vTv Therapeutics LLC', u'Royal Melbourne Hospital', u'SpectraScience Inc', u'Furen Pharmaceutical Group Co Ltd', u'Phoenix Pharmacologics Inc', u'InNexus Biotechnology Inc', u'Vanquish Oncology Inc', u'A*STAR Institute of Molecular and Cell Biology', u'Ceres Nanosciences LLLP', u'Tianjin Derun Biotechnology Co Ltd', u'AxCell Biosciences Corp', u'Ecrins Therapeutics', u'NYU School of Medicine', u'ADC Therapeutics Sarl', u'TargeGen Inc', u'Fujitsu Ltd', u'Serum Institute of India Ltd', u'Life Technologies Corp', u'Mylan Laboratories Ltd', u'Inovio Pharmaceuticals Inc', u'Merck Research Laboratories', u'Alliance Medical Group', u'Protagen AG', u'Aparna Biosciences Corp', u'Oncologix Inc', u'MethylGene Inc', u'Medicines Development Ltd', u'Leadd BV', u'Cannabis Science Inc', u'Betagenon AB', u'Oncomatryx SL', u'FLX Bio Inc', u'Imaxio', u'GemVax AS', u'Nynex Therapeutics LLC', u'Gritstone Oncology', u'Japan Science and Technology Agency', u'Ribi ImmunoChem Research Inc', u'MaSTherCell', u'Glycotope Biotechnology GmbH', u'Shandong University', u'Carna Biosciences Inc', u'Unibioscreen SA', u'University of Bath', u'tella Inc', u'Echelon Biosciences Inc', u'Genetic Therapy Inc', u'Alpha Cancer Technologies Inc', u'DormaTarg Inc', u'ICX Technologies', u'Cellectis SA', u'Bioceltran Co Ltd', u'Lana Management & Business Research International', u'Celera South San Francisco', u'PIKAMAB Inc', u'Biovertis AG', u'Koebenhavns Universitet', u'Sorrento Therapeutics Inc', u'Epigenomics AG', u'Graffinity Pharmaceuticals AG', u'Abgenix Inc', u'Dalton Cardiovascular Research Center', u'Upjohn Pharmaceuticals Ltd', u'Keystone Nano Inc', u'Neurocrine Biosciences Inc', u'Aquapharm Biodiscovery Ltd', u'Transgene SA', u'National Research Council of Canada', u'Senex Biotechnology Inc', u'CanTx Inc', u'Shenyang Institute Of Applied Ecology Chinese Academy Of Sciences', u'Valocor Therapeutics Ltd', u'National Health and Medical Research Council', u'ExperGen Drug Development GmbH', u'Upstate Medical University', u'Israeli Government', u'Northwest Biotherapeutics Inc', u'Tarrex Biopharma', u'Chengdu Kanghong Pharmaceutical Group Co Ltd', u'CEL-SCI Corp', u'Novartis Institutes for BioMedical Research Inc', u'MecRx ltd', u'Crown Bioscience Inc(Taicang)', u'Kunming Pharmaceutical Corp', u'Caerus Discovery LLC', u'University of Cambridge', u'Drogsan Ilaclari San. ve Tic. A.S.', u'Oxiquant Inc', u'Tallikut Pharmaceuticals Inc', u'MediGene AG', u'Lipopharma Therapeutics SL', u'BlueLink Pharmaceuticals', u'Sarah Cannon Research Institute', u'Biovation Ltd', u'Avidia Inc', u'Itel Telecomunicazioni Srl', u'Nuevolution A/S', u'Hypha Discovery Ltd', u'Carigent Therapeutics Inc', u\"Children's Oncology Group\", u'Vycellix Inc', u'MerLion Pharmaceuticals Pte Ltd', u'Hadasit Bio-Holdings Ltd', u'Teikyo Heisei University', u'Neuren Pharmaceuticals Ltd', u'Zaiya Inc', u'Juvaris BioTherapeutics Inc', u'Thermo Fisher Scientific Inc', u'IRICoR', u'Sea Lane Biotechnologies LLC', u'Verta Ltd', u'University of Illinois', u'Pharmacopeia Inc', u'Synergy Pharmaceuticals Inc', u\"FUNDACI\\xd3 INSTITUT DE RECERCA DE L'HOSPITAL DE LA SANTA CREU I SANT PAU\", u'Qrono Inc', u'Nottingham Trent University', u'Janssen Korea Ltd', u'Institute Of Strength Physics & Materials Science Siberian Branch Of The Russian Academy Of Sciences', u'Shanghai Institute of Biological Products Co Ltd', u'Celera Group', u'Genius Biotherapeutics', u'Colby Pharmaceutical Co', u'Zhejiang Jianfeng Group Co Ltd', u'Janssen Research & Development', u'DelMar Pharmaceuticals Inc', u'Biogazelle NV', u'Tandem Labs', u'National Health Research Institutes', u'ChemBridge Corp', u'Tianjin International Joint Academy of Biotechnology and Medicine', u'The Cancer Council Victoria', u'Medifocus Inc', u'Chonbuk National University', u'Adichunchanagiri Biotechnology and Cancer Research Institute', u'NatImmune A/S', u'iviGene Corp', u'Maryland Technology Development Corp', u'Biochemie GmbH', u'Luna Quest', u'Patheon Pharmaceuticals Inc', u'Talon Therapeutics Inc', u'Yamanouchi Pharmaceutical Co Ltd', u'Acceptys Inc', u'NextCell Pharma AB', u'HQ Specialty Pharma', u'Cancer Council New South Wales', u'Tianjin University of Science and Technology', u'Vegenics Ltd', u'Renji Hospital', u'Vaxon Biotech SA', u'University of Saskatchewan', u'CytImmune Sciences Inc', u'Hitachi Chemical Co Ltd', u'Keele University', u'Myrexis Inc', u'Lyndor Biosciences LLC', u'The Procter & Gamble Co', u'Alexion Pharmaceuticals Inc', u'Photochemical Co Ltd', u'EpiVax Inc', u'Apogee Biotechnology Corp', u'NMT Pharmaceuticals Pte Ltd', u'Algeta ASA', u'Cerylid Biosciences Ltd', u'Sentinel Oncology Ltd', u'International Center for Genetic Engineering and Biotechnology (ICGEB)', u'Cardiff University School of Medicine', u'Kumamoto University', u'Advanced Medical Isotope Corp', u'Sinopharm', u'Reliable Biopharmaceutical Corp', u'Greenovation Biotech GmbH', u'Verastem Inc', u'Queen Mary University of London', u'StemPar Sciences Inc', u'Daewoong Pharmaceutical Co Ltd', u'AmorChem LP', u'Cato Holding Ltd', u'Trieza Therapeutics Inc', u'Ewha Womans University', u'Zateras Therapeutics Inc', u'Girindus AG', u'HedgePath Pharmaceuticals Inc', u'USCN Life Science Inc', u\"Lee's Pharmaceutical Holdings Limited\", u'ID Pharma Co Ltd', u'University of Wisconsin-Madison', u'Phyton Biotech Inc', u'Translational Therapeutics Inc', u'Universita Degli Studi di Genova', u'Weizmann Institute of Science', u'Eisai Research Institute', u'Dare Bioscience Inc', u'DarwinHealth', u'Madrigal Pharmaceuticals Inc', u'Houston Methodist Hospital Research Institute', u'BioHaven Pharmaceutical Holding Co Ltd', u'University of Missouri', u'Varian Medical System Inc', u'Ubiquigent Limited', u'Centrose LLC', u'Ferring Pharmaceuticals SA', u'Trophogen Inc', u'National Institute on Aging', u'Novelogics Biotechnology Inc', u'Universitat Autonoma de Barcelona', u'Fluidigm Corp', u'Xcovery Inc', u'Storm Therapeutics Ltd', u'GENova Biotherapeutics Inc', u'Corixa Corp', u'Cabaret Biotech Ltd', u'Osaka University', u'AMAG Pharmaceuticals Inc', u'United Eastern Pharmaceutica', u'Genexine Co Ltd', u'Proteomics Consortium', u'Peptomyc SL', u'Baylor Scott & White Research Institute', u'Immatics Biotechnologies GmbH', u'TetraLogic Pharmaceuticals Corp', u'Sigma-Aldrich Corp', u'Pierre Fabre Laboratories', u'Imanis Life Sciences', u'F-star Biotechnologische Forschungs-und Entwicklungs GmbH', u'Changchun Huapu Biotechnology Co Ltd', u'PDS Biotechnology Corp', u'Navidea Biopharmaceuticals Inc', u'Silence Therapeutics AG', u'GE Global Research', u'Peking University Health Science Center', u'East of England Development Agency', u'Samsung Bioepis', u'mAbRx Inc', u'StressMarq Biosciences Inc', u'Bavarian Nordic A/S', u'Rhode Island Hospital', u'BL&H Co Ltd', u'AltaRex Medical Corp', u'Glycores 2000 Srl', u'XERIS Pharmaceuticals Inc', u'Ramot at Tel Aviv University Ltd', u'Anavex Life Sciences Corp', u'iPS Academia Japan Inc', u'BioCancell Therapeutics Ltd', u'Vitapharm Technology Development Co Ltd', u'Pfizer Japan Inc', u'Shire Pharmaceuticals Ltd', u'Bayer Pharmaceuticals Corp', u'Zomedica Pharmaceuticals Corp', u'CEAMED SA', u'Biopure Corp', u'Jiangsu Aotaixin Biomedical Technology Co Ltd', u'Taerim International Corp', u'Cambridge Drug Discovery Ltd', u'Bioceuticals Arzneimittel AG', u'Longevica Pharmaceuticals', u'Silicon Biosystems SRL', u'Provid Pharmaceuticals Inc', u'Medical Prognosis Institute ApS', u'Knoll GmbH', u'Rational Therapeutics', u'Archimedes Pharma Ltd', u'The Lymphoma Foundation', u'Institute of Cancer Research UK', u'Fujirebio KK', u'Avella', u'Southern Cross University', u'Pharmaceutical Research Institute', u'Oncormed Inc', u'Universal Cells Inc', u'Mabworks Biotech Co Ltd', u'Agouron Pharmaceuticals Inc', u'ElSohly Laboratories Inc', u'ActivBiotics Inc', u'Nationales Centrum fur Tumorerkrankungen', u'Scripps Korea Antibody Institute', u'Hayashibara Co Ltd', u'European Institute of Oncology', u'Kiara Health', u'LifeTime Pharmaceuticals Inc', u'Canadian Government', u'Taivex Therapeutics Inc', u'Kanebo KK', u'Prostate Cancer Clinical Trials Consortium', u'SGM Biotech Inc', u'Biocare Medical', u'Biomira USA Inc', u'Genesis Research and Development Corp Ltd', u'Instituto Cientifico Y Tecnologico De Navarra SA', u'Pfizer Central Research', u'Brown University', u'Super Religare Laboratories Ltd', u'ICON Clinical plc', u\"Universita' Degli Studi Di Urbino\", u'Beijing Jingyitaixiang Technology Development Co Ltd', u'Biocartis', u'Splash Pharmaceuticals Inc', u'Ciblex Corp', u'Anjin Group Inc', u'RadTargX Therapeutics Inc', u'Endomagnetics Ltd', u'Ardea Biosciences Inc', u'Quanticel Pharmaceuticals Inc', u'PanAm Global Logistics Inc', u'Shanghai Genomics Inc', u'BTG plc', u'Ambrilia Biopharma Inc', u'Okinawa Institute Of Science & Technology Graduate University', u'Theraclone Sciences Inc', u\"UniCredit Banca d'Impresa SpA\", u'Green Cross Corp', u'Medrex Ltd', u'North Carolina State University', u'NovoTyr Therapeutics Lts', u'Texas Tech University', u'Selexis SA', u'ARUP Laboratories', u'Terpenoid Therapeutics Inc', u'ArQule Inc', u'Onyvax Ltd', u'Mount Allison University', u'Andarix Pharmaceuticals Inc', u'Hovione SA', u'Absorption Systems Group Llc', u'Contextual Genomics Inc', u'Biotech Synergy', u'NeoPharm Inc', u'Roche Holding AG', u'Alchemia Ltd', u'Genzyme Molecular Oncology', u'American Type Culture Collection', u'INSERM', u'Mitsubishi Tanabe Pharma Corp', u'Vital Pharmaceutical Development', u'Sanquin Blood Supply Foundation', u'Battelle', u'Candela', u'EiRx Therapeutics plc', u'Aptanomics SA', u'Spirogen Ltd', u'Selvita SA', u'US Department of the Treasury', u'Samsung BioLogics Co Ltd', u'Integrated DNA Technologies Inc', u'Shire Orphan Therapies GmbH', u'ProChon Biotech Ltd', u'MSD Japan', u'Tianjin Binjiang Pharma Inc', u'Zander Therapeutics Inc', u'UniVax LLC', u'OncoArendi Therapeutics Sp Z Oo', u'Botanic Oil Innovations Inc', u'European Molecular Biology Laboratory', u'Oregon Health Sciences University', u'Mesothelioma Applied Research Foundation', u'Tianjin HuaiRen Pharmacy Co Ltd', u'Nanotargeting SL', u'Thermosome Gmbh', u'Sysmex Corp', u'Helix', u'Centre for Human Drug Research', u'Evotec AG', u'Precision BioSciences Inc', u'James A. Haley Veterans Administration Hospital', u'Charles River Laboratories International Inc', u'Epigenetics Pharma LLC', u'Anchor Therapeutics Inc', u'Rademacher Group Ltd', u'Karo Pharma AB', u'Institut Armand-Frappier', u'Alberta Research Council', u'University of Queensland Diamantina Institute', u'Intrinsik Health Sciences Inc', u'iDD biotech', u'Galena Biopharma Inc', u'Mitsui Pharmaceuticals Inc', u'Consejo Superior De Investigaciones Cientificas', u'LFB SA', u'InteRNA Technologies BV', u'R-Pharm US LLC', u'Stemcentrx Inc', u'Research Development Foundation', u'CGI Pharmaceuticals Inc', u'Evgen Pharma plc', u'MabVax Therapeutics Holdings Inc', u'Immunovo BV', u'ISU Chemical Co Ltd', u'PHusis Therapeutics Inc', u'Joule', u'TTY Biopharm Co Ltd', u'Medical Research Council', u'RIKEN', u'Guangdong Zhongsheng Pharmaceutical Co Ltd', u'Shinshu University', u'Nanjing University of Science and Technology', u'Fukushima Medical University', u'Enzon Pharmaceuticals Inc', u'Synex Consulting Korea Limited', u'Sichuan BoXin LaiTe Biotechnology Inc', u'Shin Poong Pharmaceutical Co Ltd', u'Atlantic Canada Opportunities Agency', u'Syapse Inc', u'Qatar University', u'Pharma Patch plc', u'YuanSci Bio-Tech (Tianjin) Co Ltd', u'Repugen', u'Pancreatic Cancer Action Network', u'Bio-Link Australia Pty Ltd', u'KS Biomedix Holdings plc', u'Actinium Pharmaceuticals Inc', u'Zhejiang Huahai Pharmaceutical Group Co Ltd', u'Southern Research Institute', u'Epitomics Inc', u'Parker Institute for Cancer Immunotherapy', u'Gene Techno Science Co Ltd', u'Celltrion Chemical Research Institute', u'Xencor Inc', u'GNT Pharma Co Ltd', u'DuPont Pharmaceuticals Ltd', u'Oncology Venture ApS', u'University Hospital Frankfurt', u'BioTheryX Inc', u'Lixte Biotechnology Holdings Inc', u'Celgene Cellular Therapeutics', u'Innovent Biologics Inc', u'Ranbaxy Laboratories Ltd', u'F Hoffmann-La Roche AG', u'Fujifilm\\xa0Corp', u'APIT Laboratories GmbH', u'Universitair Ziekenhuis Brussel', u'DeoBioSciences Inc', u'SICOR Inc', u'Guangxi Hebabiz Pharmaceutical Co Ltd', u'Cancer Research UK', u'Qinglong Hi-tech Co Ltd', u'DualTPharma', u'Mustang Bio Inc', u'White Rose Technology Seedcorn Fund', u'Guangdong Province, Department of Science and Technology', u'DCPrime BV', u'Korea Drug Development Fund', u'Kemin Pharma Europe', u'Epitarget AS', u'Aurigen SA', u'Zenetech Llc', u'Garden State Cancer Center', u'Norris Comprehensive Cancer Center', u'Warner-Lambert Co AG', u'Changzhou Qianhong Biopharma Co Ltd', u'Surface Oncology', u'Medial Ltd', u'Nexus BioPharma Inc', u'Spago Nanomedical AB', u'Evolve Oncology Inc', u'Australian Research Council', u'Shenzhen Hepalink Pharmaceutical Group Co Ltd', u'ImaRx Therapeutics Inc', u'Genosco', u'inGenium Research Inc', u'National Cancer Center of Korea', u'CASI Pharmaceuticals Inc', u'PeptiDream Inc', u'Imugene Ltd', u'Oxxon Therapeutics Ltd', u'SATT Paca Corse', u'CARBOGEN AMCIS AG', u'GMP Companies Inc', u'Bio Analytical Research Corp', u'SunGen Pharma LLC', u'PhosImmune Inc', u'Jules Bordet Institute', u'LION bioscience Inc', u'Antitumor Research Products Inc', u'United Therapeutics Corp', u'Taxolog Inc', u'Molecular Insight Pharmaceuticals Inc', u'INHIBRx LLC', u'Alethia Biotherapeutics Inc', u'AEterna Zentaris Inc', u'China Medical System Holdings Ltd', u'Nuvelo Inc', u'Medimmune Vaccines Inc', u'Novogene Corp', u'GenKyoTex SA', u'L2 Diagnostics Llc', u'Aptevo Therapeutics Inc', u'Genencor International Inc', u'Japanese Ministry of Health, Labor and Welfare', u'Agensys Inc', u'Medison Pharma Ltd', u'Kent State University', u'Undisclosed', u'SynteractHCR Inc', u'Tel Aviv University', u'Monogram Biosciences Inc', u'Horizon Pharma plc', u'Maxia Pharmaceuticals Inc', u'University of Turku', u'Celltrion Healthcare Co Ltd', u'IS Pharma plc', u'Krishna University', u'Arvinas Inc', u'bioMerieux SA', u'Carrick Therapeutics UK Ltd', u'Bioject Medical Technologies Inc', u'ASTA Medica AG', u'Serenex Inc', u'OncoGenex Technologies Inc', u'EnGeneIC Ltd', u'Kyowa Kirin', u'Nerviano Medical Sciences Srl', u'Ligand Pharmaceuticals Inc', u'Sanofi KK', u'DiaCarta LLC', u'MirImmune LLC', u'Sydys Corp', u'Guangdong Medicine Group Corp', u'Tulane University', u'Circulogene Theranostics', u'Vichem Chemie Ltd', u'Kirax Corp', u'MMRGlobal', u'MABSPACE Biosciences', u'Provenance Biopharmaceuticals Corp', u'Eczacibasi Ilac Pazarlama AS', u'Seoul National University Hospital', u'National Medical Research Council (NMRC), Singapore', u'Beth Israel Deaconess Medical Center', u'Stealthyx Therapeutics Ltd', u'Advanced Medical Imaging and Genetics', u'Aronex Pharmaceuticals Inc', u'Rex Medical LP', u'AGY Therapeutics Inc', u'10X Technologies Inc', u'Universite de Nice Sophia Antipolis', u'Bristol-Myers Squibb Pharma Co', u'Adria Laboratories Inc', u'Takis Biotech', u'Asset Realisation Co plc', u'Formula Pharmaceuticals Inc', u'Jinghua Pharmaceutical Group Co Ltd', u'GVK Biosciences Pvt Ltd', u'Invitae', u'Admera Health', u\"Children's National Health System\", u'Semaia Pharmaceuticals', u'GE Healthcare', u'Walloon Region of Belgium Government', u'Mersana Therapeutics Inc', u'Duke-NUS Graduate Medical School', u'University Hospital Halle', u'BioResearch Ireland', u'Central South University', u'Berkeley Lights Inc', u'Antitope Ltd', u'OncoGenex Pharmaceuticals Inc', u'Weill Cornell Medical College, USA', u'Serono Inc', u'Curadev Pharma Pvt Ltd', u'OncoEthix', u'Joyant Pharmaceuticals Inc', u'PROLOR Biotech Inc', u'TAP Pharmaceuticals Inc', u'VU University Medical Center', u'Cortecs International Ltd', u'Deltagen Research Laboratories', u'Daiichi Seiyaku Co Ltd', u'Chengdu Enduoshi Biotech Co Ltd', u'National Comprehensive Cancer Network', u'Molecular Targeting Technologies Inc', u'Phytomedics Inc', u'Cerus Corp', u'Advaxis Inc', u'Arana Therapeutics Ltd', u'Mologen Ag', u'Centre for Drug Research and Development', u'Hercules Capital Inc', u'Dorizoe Lifesciences Ltd', u'Centre for Probe Development and Commercialization', u'Aeolus Pharmaceuticals Inc', u'Biotest AG', u'BioMarin Pharmaceutical Inc', u'Il-Yang Pharmaceutical Co', u'AXA Diagnostics', u'The Leukemia & Lymphoma Society', u'Xerion Pharmaceuticals AG', u'7 Hills Pharma Llc', u'Jonsson Comprehensive Cancer Center', u'Advanced Therapies Inc', u'Beckpharma Ltd', u'Algen Biopharmaceuticals Inc', u'Royal Melbourne Intitute of Technology', u'Nara Institute of Science and Technology', u'Kwizda Gruppe', u'RW Johnson Pharmaceutical Research Institute', u'Shanghai Pharmaceuticals Holding Co Ltd', u'Accelrys Inc', u'LegoChem Bioscience Inc', u'Jounce Therapeutics Inc', u'Dutch Cancer Society', u'CT Atlantic AG', u'Pintex Pharmaceuticals Inc', u'The Chinese Centre for Disease Control and Prevention', u'Samaritan Pharmaceuticals Inc', u'Amaran Biotechnology Inc', u'The Pennsylvania NanoMaterials Commercialization Center', u'Sri Venkateswara Institute of Medical Sciences', u'AZ Sint Lucas Hospital', u'GL Pharmaceutical Inc', u'University of Bergen', u'Virus Research Institute Inc', u'Tyrian Diagnostics Ltd', u'Nanobiotix', u'TargImmune Therapeutics AG', u'Gamida Cell Ltd', u'Generalitat de Cataluna', u'Pharmacia & Upjohn Co', u'MabCure Inc', u'Biovector Therapeutics SA', u'BIOO Scientific Corp', u'GammaDelta Therapeutics Ltd', u'Archerdx Inc', u'Vrije Universiteit van Amsterdam', u'Cytori Therapeutics Inc', u'Guangzhou BeBetter Medicine Technology Co Ltd', u'Felicitex Therapeutics Inc', u'Cellona Therapeutics Inc', u'ZIOPHARM Oncology Inc', u'Peplin Inc', u'Inventiva', u'Medical University of Bialystok', u'eTheRNA immunotherapies NV', u'Roche Molecular Systems Inc', u'Innate Immunotherapeutics Ltd', u'7 Oaks Pharmaceutical Corp', u'Constellation Pharmaceuticals Inc', u'Heinrich Heine Universitat Dusseldorf', u'Ariel-University Research & Development Co Ltd', u'Kalahari Greentech Inc', u'Recepta biopharma', u'APO-T', u'Calitor Sciences Llc', u'Novellusdx Ltd', u'Midas Pharma GmbH', u\"Tianjin Municipal People's Government\", u'Hebei Medical University', u'Leica Mikrosysteme GmbH', u'Active Biotech AB', u'AstraZeneca UK Ltd', u'Immunodex Inc', u'Toxikon Corp', u'Biota Holdings Ltd', u'GeneKor SA', u'YM BioSciences Inc', u'Eos Biotechnology Inc', u'Siteman Cancer Center', u'Solexa Inc', u'Hubei Qianjiang Pharmaceutical Co Ltd', u'SUGEN Inc', u'Selective Genetics Inc', u'VAXIMM AG', u'GTx Inc', u'Clovis Oncology Inc', u'BRIM Biotechnology Inc', u'Aphios Corp', u'University of Heidelberg', u'Hadassah Medical Organization', u'Best Med Opinion Ltd', u'Universite De Reims Champagne Ardenne', u'BerGenBio AS', u'Boehringer Ingelheim International GmbH', u'Istituto di Ricerche Farmacologiche Mario Negri', u'Breast Cancer Research Trust', u'Florida Hospital', u'Fraunhofer-Institute fur Zelltherapy und Immunologie', u'QIMR Berghofer Medical Research Institute', u'PCI Biotech Holding ASA', u'Mundipharma EDO GmbH', u'University Of Toronto Mississauga', u'Threshold Pharmaceuticals Inc', u'SQZ Biotech', u'Tobira Therapeutics Inc', u'AITBiotech', u'Sparta Pharmaceuticals Inc', u'Dovetail Technologies Inc', u'Scientific Protein Laboratories', u'Eiken Chemical Co Ltd', u'Northwestern University Feinberg School of Medicine', u'Glaxo Group Ltd', u'CFR Pharmaceuticals SA', u'Scientific Products Pharmaceutical Co LTD', u'Encysive Pharmaceuticals Inc', u'University of Sussex', u'Macrogen Inc', u'Oncoinvent', u'BioLeap LLC', u'CoStim Pharmaceuticals Inc', u'Planet Biotechnology Inc', u'Venn Therapeutics', u'Personalized Cancer Therapy Inc', u'Universite Laval', u'LAB Research Inc', u'Nagoya University', u'Debiopharm SA', u'Scotia Holdings plc', u'Abo Akademi University', u'Praxis Pharmaceutical SA', u'Arisaph Pharmaceuticals Inc', u'University of Houston', u'Starpharma Holdings Ltd', u'NuVax Therapeutics Inc', u'Makoto Life Sciences Inc', u'Polypeptide Laboratories AB (SWEDEN)', u'OmniSeq', u'HYUN IMC', u'MabCure NV', u'Resolution Pharmaceuticals Inc', u'Meridian Lab', u'Y-Biologics Inc', u'Shanghai Green Valley Pharmaceutical Co Ltd', u'Lyvgen Biopharmaceutical Technology (Shanghai) Co Ltd', u'Cipla Ltd', u'Taivex LLC', u'Schering-Plough Corp', u'Shandong BuChang Pharmaceuticals Co Ltd', u'Oxford BioMedica plc', u'Institute of Molecular Genetics (Czech Republic)', u'The Knut and Alice Wallenberg Foundation', u'Dalian Wanchun Biotech', u'Somantix BV', u'Zynaxis Inc', u'VTT Technical Research Centre Of Finland', u'Austin Health', u'Medical College of Wisconsin', u'Europroteome AG', u'Poplar Healthcare', u'Erasmus University Rotterdam', u'Quebec government', u'Shouguang Fukang Pharmaceutical Co Ltd', u'PharmaCyte Biotech Inc', u'Pusan National University', u'Ajou University', u'Indian Institute of Integrative Medicine, Jammu', u'Roche Vitamins Inc', u'Marina Biotech Inc', u'Beta Pharma Inc', u'Bayer AG', u'Proligo LLC', u'University of York', u'Camurus AB', u'MedPacto Inc', u'Maccine Pte Ltd', u'TRION Pharma GmbH', u'Janssen Pharmaceutica NV', u'ImmunoBiochem Corporation', u'Ascalon International Inc', u'Alligator Bioscience AB', u'Crescendo Biologics Ltd', u'Enzo Life Sciences Inc', u'Checkmate Pharmaceuticals', u'Concord Biosciences LLC', u'Jikei University', u'Vector Oncology', u'Artemisia BioMedical Inc', u'Tamir Biotechnology Inc', u'Genetracer Biotech Sl', u'ImmuNext Inc', u'Pharmaceutics International Inc', u'SeD Biomedical Inc', u'ProBioGen AG', u'CIS Bio International SAS', u'Mymetics Corp', u'Genitrix LLC', u'National OncoVenture', u'Ranbaxy Pharmaceuticals Inc', u'FGH BIOTECH INC', u'Ligue Nationale Contre le Cancer', u'ViRexx Medical Corp', u'Bexion Pharmaceuticals LLC', u'Panacela Labs Inc', u'Bachem Holding AG', u'Evolva Holding SA', u'H-Immune SAS', u'Genisphere Inc', u'Massachusetts Institute of Technology', u'Janssen Diagnostics LLC', u'Advanced Neuroscience Allies Pvt Ltd', u'Hoffmann-La Roche AG', u'Shanghai Medicilon Inc', u'Imclone LLC', u'4-Antibody AG', u'Oncoscience AG', u'Sarcoma Oncology Center', u'Taipei Medical University', u'Pasteur Merieux Connaught Canada', u'Cancer Research Ventures Ltd', u'Knight Cancer Institute', u'MJM Productos Farmaceuticos e de Radioprotecao Ltda', u'SensoPath Technologies Inc', u'Ignyta Inc', u'Ingham Institute', u'Novartis Pharma KK', u'University of Mississippi', u'Dendreon San Diego LLC', u'Aurigene Discovery Technologies Ltd', u'The Australian National University', u'Acromax Dominicana', u'Millennium Predictive Medicine Inc', u'affinity BIO Ltd', u'Batu Biologics', u'Picower Institute for Medical Research', u'Wellstat Therapeutics Corp', u'CEA-Leti', u'Ablynx NV', u'AVEO Oncology', u'Penn State Hershey Medical Center', u'Beijing Xiehejianhao Medical Technology Development Co Ltd', u'Aton Pharma Inc', u'City of Hope', u'Takeda Oncology', u'CellMax Life Inc', u'Sanofi Genzyme', u'Aduro BioTech Inc', u'Beryllium Discovery Corp', u'Daegu-Gyeongbuk Medical Innovation Foundation', u'Gland Pharma Ltd', u'Double Rider Medicine Co Ltd', u'EcoBiotics Ltd', u'University of Kentucky', u'National Cancer Center Hospital East', u'Helmholtz Institute for Pharmaceutical Research Saarland', u'Inis Biotech LLC', u'Biovail Corp', u'BC Cancer Agency', u'Ascenta Therapeutics Inc', u'Efficient Pharma Management Corp', u'Avanir Pharmaceuticals Inc', u'RTI International', u'Apollo Endosurgery Inc', u'Celleron Therapeutics Ltd', u'Sheba Medical Center', u'MISSION Therapeutics Ltd', u'ProLynx LLC', u'MediciNova Inc', u'Queens University of Belfast', u'Thomas Jefferson University', u'Boehringer Ingelheim Austria GmbH', u'Applied Immune Sciences Inc', u'Viventia Bio Inc', u'Dako AG', u'Lab21 Group', u'Sunshine Lake Pharma Co Ltd', u'Bayer HealthCare Pharmaceuticals Inc', u'Cleveland State University', u'North Shore Long Island Jewish Health System', u'Abzyme Therapeutics LLC', u'Abraxis BioScience Inc', u'Dako AS', u'Oneday - Biotech & Pharma Ltd', u'Bioenvision Inc', u'Beijing Foreland Biopharma Co Ltd', u'University of North Texas', u'USC Norris Comprehensive Cancer Center', u'ProTherapeutics Pte Ltd', u'XTL Biopharmaceuticals Ltd', u'New York Medical College', u\"Dr Reddy's Laboratories Ltd\", u'Dr. Meng Pharma GmbH', u'Counterpoint Biomedica Llc', u'Council of Scientific and Industrial Research (India)', u'CBS Therapeutics Inc', u'Sotio AS', u'Gray Cancer Institute', u'Ultimovacs AS', u'Kobe Pharmaceutical University', u'Humanwell Healthcare (Group) Co Ltd', u'MSD OSS BV', u'The Breast Cancer Research Foundation', u'Morphochem Inc', u'Key Capital Corp', u'Peloton Therapeutics Inc', u'University of Nebraska Medical Center', u'Cytovia Inc', u'California Institute of Regenerative Medicine', u'Biogen Inc', u'University Hospitals Of Cleveland', u'Centre de Physiopathologie de Toulouse Purpan', u'UMeWorld Ltd', u'Ambit Biosciences Corp', u'Cytran Ltd', u\"Ataxia Telangiectasia Children's Project Inc\", u'Covance Inc', u'Boston Oncology LLC', u'Innovive Pharmaceuticals Inc', u'ZAI Laboratory Inc', u'Synermore Biologics Co Ltd', u'Ipsen', u'Immunex Corp', u'Cylene Pharmaceuticals Inc', u'Tee up for Tots Inc', u\"Phoenix Children's Hospital\", u'Variagenics Inc', u'Dragonfly Therapeutics Inc', u'Forge Therapeutics Inc', u'Hefei University', u'International Bioimmune Systems Inc', u'TDA Research Inc', u'Fujian Longhua Pharmaceutical Co Ltd', u'Soricimed Biopharma Inc', u'University of Texas Health Science Center Houston', u'Admune Therapeutics LLC', u'Stanford University', u'Leonardo Biosystems Inc', u'Angiogene Pharmaceuticals Ltd', u'Biosceptre International Ltd', u'Adnexus Therapeutics Inc', u'Novelix Pharmaceuticals Inc', u'Source MDx', u'Ningbo Wenda Pharma Technoloy Ltd', u'Wellspring Biosciences LLC', u'Peregrine Pharmaceuticals Inc', u'AlumiFuel Power Corp', u'Nascent Biotech Inc', u'Cognosci Inc', u'Aurobindo Pharma Ltd', u'Universitat Innsbruck', u'Spectrum Pharmaceuticals Inc', u'Shanghai Pharmaceutical Group Corp', u'BioMotiv LLC', u'Cistron Biotechnology Inc', u'Emory University', u'Roche Diagnostics GmbH', u'Foundation for Biomedical Research and Innovation', u'Taiwan Liposome Co', u'ChemWerth USA', u'Beijing Evergene Biomedical Technology', u'BC Platforms', u\"Boston Children's Hospital\", u'Alnylam Pharmaceuticals Inc', u'Fortress Biotech Inc', u'Cristalia', u'Philogen SpA', u'Proacta Inc', u'Henry Ford Health System', u'Ontogen Corp', u'BioTherapeutics Inc', u'Cell Pathways Inc', u'Apexigen Inc', u'Cancer Therapy Evaluation Program', u'Alpine Immune Sciences Inc (pre-merger)', u'University of Connecticut Health Center', u'AryoGen Biopharma', u'CellNexus LLC', u'GenoSplice Technology', u'ConjuChem LLC', u'Unilife', u'Zenotech Laboratories Ltd', u'Reata Pharmaceuticals Inc', u'Daiichi Sankyo Co Ltd', u'Inflazyme Pharmaceuticals', u'Eisai Co Ltd', u'ViraTherapeutics GmbH', u'Biosergen AS', u'Mimetogen Pharmaceuticals Inc', u'PSI Pharma Support Intl', u'TOMA Biosciences Inc', u'Immune Design Corp', u'Cloud Pharmaceuticals Inc', u'Beckman Research Institute', u'National Cancer Institute', u'LipoCure', u'Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd', u'Almac Discovery Ltd', u'Marillion Pharmaceuticals Inc', u'Syngene International Ltd', u'Tallinn University Of Technology', u'Kyushu University', u'PharmaCell', u'Planta Naturstoffe GmbH', u'Oxis Biotech Inc', u'Ewopharma AG', u'Regis Technologies Inc', u'Fresenius Medical Care AG', u'Juvenescence Limited', u'BN ImmunoTherapeutics Inc', u'ThromboGenics NV', u'TyrNovo Ltd', u'Institut National Des Sciences Appliquees de Rouen (INSA)', u'Vibalogics', u'Aptose Biosciences Inc', u'Amunix Inc', u'Tessa Therapeutics Pte Ltd', u'Premier Research Group Ltd', u'Apoplogic Pharmaceuticals Inc', u'Complix NV', u'Minzu University of China', u'Immune Response BioPharma Inc', u'TissuPath', u'Guilin University Of Electronic Technology', u'Sunnybrook Health Sciences Centre', u'Baylor University', u'National Institute of Biomedical Imaging and Bioengineering', u'NascaCell GmbH', u'Guided Therapeutics Inc', u'PharmaEngine Inc', u'AngioGenetics AB', u'Ferrer Internacional SA', u'Lupin Ltd', u'CoBioRes NV', u'Czech Academy of Sciences', u'LXR Biotechnology Inc', u'China Academy of Chinese Medical Sciences', u'Rhode Island Commerce Corporation', u'Compugen Ltd', u'Helmholtz Zentrum fur Infektionsforschung GmbH', u'Celentyx Ltd', u'Biocept Inc', u'Immunity Royalty Holdings LP', u'H Lundbeck A/S', u'KunWha Pharmaceutical Co Ltd', u'D Western Therapeutics Institute', u'GENESIS Pharma SA', u'Bothell Research Center', u'Vaccinogen Inc', u'GeneCare Research Institute Co Ltd', u'BioPhausia AB', u'Medivation Inc', u'OncoMab GmbH', u'NT Pharma (Group) Co Ltd', u'Dalat Nuclear Research Institute of Vietnam', u'JW CreaGene Inc', u'CharlestonPharma LLC', u'ARMO BioSciences Inc', u'Amgen Research (Munich) GmbH', u'Callisto Pharmaceuticals Inc', u'iTherX Pharmaceuticals Inc', u'Republic of Korea Government', u'Celestar Lexico-Sciences Inc', u'Jeil Pharmaceutical Co Ltd', u'SurModics Pharmaceuticals', u'Nurix Inc', u'National Institute on Drug Abuse', u'Ability Pharmaceuticals SL', u'HansMeical Company Ltd', u'Diosynth Biotechnology', u'Royal Philips Electronics', u'Blackfield Ag', u'Genewiz Inc', u'Indian Institute of Chemical Technology', u'Synactix Pharmaceuticals Inc', u'The Francis Crick Institute', u'Radboud University', u'Cambridge Epigenetix Ltd', u'University of Miami', u'Theranyx', u'VectorLogics Inc', u'Korea Science and Engineering Foundation', u'PLIVA dd', u'ChemGenex Pharmaceuticals Ltd', u'SNU R & Db Foundation', u'FONDEF', u'Okayama Prefectural University', u'NexusPharma Inc', u'Zetiq Technologies Ltd', u'Epigenetix Inc', u'Theragenics Corp', u'OncoSynergy Inc', u'Omniox Inc', u'Eclipse Therapeutics', u'AngioGenex Inc', u'Esteve', u'Prostate Cancer Canada', u'Shenyang Pharmaceutical University', u'National Institute for Health Research (NIHR)', u'Singhealth Foundation', u'Enzon Labs Inc', u'Ludwig Institute for Cancer Research (Australia)', u'FTG BIO', u'deCODE genetics ehf', u'Vectorite Biomedica Inc', u'Cadila Pharmaceuticals Ltd', u'Edico Genome Corp', u'Biotechnology Cluster Rhine Neckar (BioRN)', u'GenQuest Inc', u'C4X Discovery Holdings plc', u'Bristol-Myers Squibb Pharmaceutical Research Institute', u'ACT Biotech Inc', u'RGene Therapeutics Inc', u'Cato Research Ltd', u'LG Life Sciences Ltd', u'Centers for Disease Control and Prevention', u'Genstruct Inc', u'Boehringer Ingelheim BioXcellence', u'Leeds Cancer Centre', u'University of Western Australia', u'Cofactor Genomics Inc', u'Rabin Medical Center', u'VentiRx Pharmaceuticals Inc', u'Grail Inc', u'Briana Bio-Tech Inc', u'Orizon International Inc', u'Hubei Bio-Pharmaceutical Industrial Technological Institute Inc', u'Prima BioMed Ltd', u'National Institute of Allergy and Infectious Diseases', u'Swift Biosciences Inc', u'Innovation Norway', u'Arena Pharmaceuticals Inc', u'Octamer Inc', u'Mundipharma International Corp Ltd', u'Lantern Pharma', u'GlycoGenesys Inc', u'Albumedix A/S', u'Regenacy Pharmaceuticals LLC', u'Aarhus University', u'Invivo Corp', u'Faustus Forschung Translational Drug Development AG', u'Osaka City University', u'Natco Pharma Ltd', u'Xiamen University', u'Axxiom Inc', u'Menarini Asia-Pacific', u'Sarepta Therapeutics Inc', u'Idera Pharmaceuticals Inc', u'GlycoMimetics Inc', u'Vitae Pharmaceuticals Inc', u'Interpace Diagnostics Group Inc', u'Vipragen Biosciences', u'American Cyanamid Co', u'Synvolux IP BV', u'Tel Aviv Sourasky Medical Center', u'National Institutes of Standards and Technology', u'Emvolio Inc', u'Anadys Pharmaceuticals Inc', u'Tanox Inc', u'Oncotest GmbH', u'BioMed X GmbH', u'Barros Research Institute', u'SciDose LLC', u'Educational and Scientific LLC', u'Qiagen NV', u'Titan Pharmaceuticals Inc', u'Industrial Technology Research Institute', u'K L University', u'Churchill Pharmaceuticals LLC', u'Cambrex Corp', u'NatureWise Biotech & Medicals Corp', u'GeneCentric Diagnostics', u'University Of Science & Technology Of China', u'H2Biologics, Inc', u'CBT Pharmaceuticals', u'WuXi NextCODE', u'Numab AG', u'Novartis AG', u'Senectus Therapeutics Ltd', u'MannKind Corp', u'EUFETS AG', u'Medicenna Therapeutics Pte Ltd', u'Boryung Pharm Co Ltd', u'BioNumerik Pharmaceuticals Inc', u'Independent Pharmaceutica AB', u'NBE-Therapeutics Ltd', u'Mayne Pharma Pty Ltd', u'Ipsogen SA', u'Technion - Israel Institute of Technology', u'Guangdong Jiaying Pharmaceutical Co Ltd', u'Zila Inc', u'PrimeraDx', u'VIRTTU Biologics', u'Panacea Pharmaceuticals Inc', u'University of Northern Colorado', u'Jiangzhong Pharmaceutical Co Ltd', u'NEOMED Institute', u'Pearl Pharmaceutical', u'Formation Biologics', u'Celldex Therapeutics Inc (pre-merger)', u'Bicycle Therapeutics Ltd', u'AC Immune SA', u'Ehime University', u'Shenzhen Chipscreen Biosciences Ltd', u'Alpharma Inc', u'Nederlands Kanker Instituut-Antoni van Leeuwenhoek Ziekenhuis', u'Buck Institute', u'Sign Path Pharma', u'Aptabio Therapeutics Inc', u'BioMedical Materials Program', u'Fujisawa Pharmaceutical Co Ltd', u'Soochow University', u'AstraZeneca Pharmaceuticals LP', u'Plexxikon Inc', u'Biotech Precision Berhad', u'New Jersey Health Foundation Inc', u'Prolexys Pharmaceuticals Inc', u'Medicenna Biopharma Inc', u'Exiqon Diagnostics', u'Choice Pharmaceuticals', u'DRAXIMAGE', u'PainCeptor Pharma Corp', u'PhiloGene Inc', u'European Community', u'MonoSol Rx Inc', u'Drexel University College of Medicine', u'University of Pittsburgh', u'TMS Co Ltd', u'Fidson Healthcare', u'Creabilis Therapeutics Srl', u'GDI Integrated Facility Services Inc', u'Fluence Therapeutics Inc', u'SIOGEN Biotech', u'Chongqing Fochon Pharmaceutical Co Ltd', u'Palobiofarma SL', u'Pivot Park Screening Centre', u'Genomeon LLC', u'F-star Alpha Ltd', u'Guangzhou Esa Biotech Co Ltd', u'Ambrx Inc', u'Zunyi Medical University', u'Cormorant Pharmaceuticals', u'Sentieon Inc', u'Jiangsu Kingsley Pharmaceutical Co Ltd', u'Analytical Biochemistry Laboratories Inc', u'Living Pharma Inc', u'Exovita Biosciences Inc', u'Kuhnil Pharmaceutical Co Ltd', u'Sandoz Ltd', u'Carsgen Therapeutics Ltd', u'PharmAkea Therapeutics LLC', u'4d pharma plc', u'Federal Economic Development Agency for Southern Ontario', u'University of Valencia', u'HanAll Biopharma Co Ltd', u'Cold Spring Harbor Laboratory', u'Cengent Therapeutics Inc', u'Biohit OYJ', u'Cambrex Bio Science Walkersville Inc', u'Agence nationale de la recherche (ANR)', u'NanoPass Technologies Ltd', u'Hainan Sinotau Pharmaceutical Co Ltd', u'Michigan State University', u'Sigma-Tau Ind Farm Riunite SpA', u'St Louis University', u'Academic Medical Center, University of Amsterdam', u'Universit\\xe9 De Strasbourg', u'Green Cross Cell Corp', u'CadheRx Therapeutics Inc', u'Universidad Autonoma de Madrid', u'Chem-Master International Inc', u'Cold Genesys Inc', u'Biomedica Life Sciences SA', u'MABLife', u'Sichuan University', u'SIRTeX Medical Ltd', u'CanBas Co Ltd', u'Ras Therapeutics Inc', u'Medstar Research Institute', u'Tokyo Medical and Dental University', u'University of Strathclyde', u'Symphony Capital LLC', u'Presage Biosciences', u'PIQUR Therapeutics Ltd', u'Hormos Medical Corp', u'LanZhou University', u'Acetylon Pharmaceuticals Inc', u'Japan Energy Corp', u'Theragence Inc', u'Wellcome Trust', u'PrimeCyte Inc', u'Crown Dental + Medical Limited', u'MV Lomonosov Moscow State University', u'Mount Sinai Hospital', u'Galderma Laboratories LP', u'Georgia Institute of Technology', u'The Danish National Advanced Technology Foundation', u'Ajinomoto Althea Inc', u'Triphase Accelerator Corp', u'University of Manchester', u'OncoQuest Inc', u'Indivumed GmbH', u'Kancera AB', u'RuiYi Inc', u'AurimMed Pharma Inc', u'Ministry Of Industry & Trade Of The Russian Federation', u'Providence Cancer Center, Earle A. Chiles Research Institute', u'ALZA Corp', u'EpiCept Corp', u'FASgen Inc', u'Centro Nacional de Investigaciones Oncologicas', u'Windtree Therapeutics Inc', u'Molecular Response', u'Nano Terra Inc', u'Matrix Pharmaceutical Inc', u'BalOnco GmbH', u'The Ruth and Bruce Rappaport Faculty of Medicine', u'Grelan Pharmaceutical Co Ltd', u'Biofrontera Discovery GmbH', u'Itm Isotopen Technologien M\\xfcnchen Ag', u'Prime Health Services', u'EvoGenix Pty Ltd', u'CSPC Pharmaceuticals Group Limited', u'PharmAbcine', u'Tragara Pharmaceuticals Inc', u'Australian Cancer Research Foundation', u'Applied Integrin Sciences Inc', u'Diamyd Medical AB', u'Sutro Biopharma Inc', u'Cytogen Corp', u'Betta Pharmaceuticals Co Ltd', u'University Hospitals Case Medical Center', u'Prous Institute For Biomedical Research Sa', u'Lymphoma Research Foundation', u'Pressure BioSciences Inc', u'Sidney Kimmel Cancer Center', u'Almac Group', u'Genomic Vision', u'Ajinomoto Co Inc', u'Unum Therapeutics Inc', u'EndogenX Inc', u'Taipei Veterans General Hospital', u'Teikoku Hormone Manufacturing Co Ltd', u'Somru BioScience Inc', u'Xenerex Biosciences', u'Roche GlycArt Ag', u'ViroLogik Gmbh', u'Immune System Therapeutics Ltd', u'Zenyth Therapeutics Ltd', u'SAFC Pharma', u'Shanghai Cancer Institute', u'Abpro Inc', u'Marine Biological Laboratory', u'Avid Bioservices', u'Chia Tai Tianqing Pharmaceutical Group Co Ltd', u'Affinita Biotech', u'Matrix Pharma (Canada) Inc', u'Frost & Sullivan', u'Canada-Israel Industrial Research and Development Fund', u'Domainex Ltd', u'Sphinx Scientific Lab', u'Therion Biologics Corp', u'Proteros Biostructures GmbH', u'Berlex Biosciences', u'Union Life Sciences Limited', u'McGill University', u'CSL Ltd', u'Biognostik GmbH', u'Sofie Biosciences', u'Incheon National University', u'ComGenex Inc', u'Cumberland Emerging Technologies Inc', u'Navigo Proteins GmbH', u'Indigene Pharmaceuticals Inc', u'PharmaDesign Inc', u'Universitat Ulm', u'Univalor', u'Pivotal BioSciences Inc', u'Trillium Therapeutics', u'Repros Therapeutics Inc', u'Austin Research Institute', u'Bracco SpA', u'SynCore Biotechnology Co Ltd', u'Nissin Foods Holdings Co Ltd', u'NanoString Technologies Inc', u'Japanese National Cancer Center', u'International Drug Licensing', u'Cell Signals Inc', u'Hyaluron Inc', u'Leidos Biomedical Research Inc', u'Innovative Targeting Solutions Inc', u'Cancer Research Technology Ltd', u'Nanjing Forestry University', u'Bayer Healthcare LLC', u'Synergene Therapeutics Inc', u'Immunovaccine Inc', u'Beactica AB', u'Boston Biomedical Inc', u'Coley Pharmaceutical Group Inc', u'Saniona ApS', u'TMRC Co Ltd', u'Innate Pharma SA', u'Boston Biomedical Research Inst', u'Rigel Pharmaceuticals Inc', u'GeoVax Labs Inc', u'ViroMed Co Ltd', u'Leiden University Medical Center', u'Stanford University School of Medicine', u'Dalton Pharma Services', u'Stanford Cancer Institute', u'Yissum Research Development Co', u'Shanxi Pude Pharmaceutical Co Ltd', u'Isoplexis Corp', u'Prefectural University Of Hiroshima', u'Taisho Pharmaceutical Co Ltd', u'Institut Gustave Roussy', u'UCB Celltech', u'Aptamera Inc', u'NuvOx Pharma LLC', u'SmithKline Beecham plc', u'Celltech Pharmaceuticals Ltd', u'Servier', u'Epic Sciences Inc', u'Blue Cross Blue Shield', u'A&G Pharmaceutical Inc', u'OSEO', u'U3 Pharma AG', u'Isofol Medical AB', u'Snowdon Inc', u'Active Motif LLC', u'Newsummit Biopharma Co Ltd', u'Raven Biotechnologies Inc', u'Chinese Academy of Sciences', u'Janssen Research & Development LLC', u'Victorian Cancer Agency', u'MDxHealth SA', u'VINNOVA', u'Astellas Pharma Inc', u'CyDex Pharmaceuticals Inc', u'BioMed Valley Discoveries', u'Invivis Pharmaceuticals', u'Karus Therapeutics Ltd', u'Vanderbilt-Ingram Cancer Center', u'Antisoma plc', u'Northwestern University', u'Momotaro-Gene Inc', u'Todai TLO Ltd', u'GenomIdea Inc', u'Toray Industries Inc', u'New Zealand government', u'Zenith Technology Corp Ltd', u'Immuno-Designed Molecules SA', u'Simon Fraser University', u'National Defense Medical College', u'John Wayne Cancer Institute', u'Nordic Group', u'Hemispherx Biopharma Inc', u'Faustus Forschungs Cie Translational Cancer Research GmbH', u'Apoptosis Technology Inc', u'Anaeropharma Science Inc', u'Angitia AB', u'RedoxTherapies Inc', u'Procaps SA', u'Telo Therapeutics Inc', u'S-TARget therapeutics', u'ImaginAb Inc', u'LIDDS AB', u'Johns Hopkins Singapore Pte Ltd', u'PLIVA Lachema AS', u'Qu Biologics Inc', u'TapImmune Inc', u'Cynvenio Biosystems LLC', u'X4 Pharmaceuticals Inc', u'George Clinical', u'Accelerated Pharma Inc', u'CiToxLAB Group', u'National Kaohsiung Marine University', u'Phase 2 Discovery Inc', u'Oncnosis Pharma AIE', u'Genocea Biosciences Inc', u'Nemucore Medical Innovations Inc', u'IDEC Pharmaceuticals Corp', u'Oncovir Inc', u'Translate Bio', u'Suzhou Neupharma Co Ltd', u'Angelica Therapeutics Inc', u'University of North Carolina', u'Igenerix Pharma Pvt Ltd', u'Molecular Templates Inc', u'RespiVert Ltd', u'Ministerio de Economia y Competitividad', u'Chiesi Farmaceutici SpA', u'Chandra Bhagat Pharma Pvt Ltd', u'Specialised Therapeutics Australia Pty Ltd', u'Biokinesis', u'NeoTX Therapeutics Ltd', u'Dharmacon Inc', u'Wayne State University School of Medicine', u'AlphaMed Inc', u'Ludwig Institute for Cancer Research', u'MLL Munich Leukemia Laboratory', u'University Of Macau', u'NewBridge Pharmaceuticals Ltd', u'Federation of America David and Lucile Packard Foundation', u'Sellas Life Sciences Group', u'Opsona Therapeutics Ltd', u'Allysta Pharmaceuticals Inc', u'Veristat, Inc.', u'Lead Discovery Center GmbH', u'Telix Pharmaceuticals Ltd', u'Eleos Inc', u'Bio-Thera Solutions Ltd', u'Scandidos Ab', u'Opus Bio Inc', u'Novopyxis Inc', u'Phylos Inc', u'University of Texas Health Science Center San Antonio', u'GeneSegues Therapeutics', u'Molecular Design International Inc', u'Mie University School of Medicine', u'Foresee Pharmaceuticals LLC', u'Panaxia Pharmaceutical Industries Ltd', u'Morphogenesis Inc', u'Ospedale Pediatrico Bambino Ges\\xf9 (IRCCS)', u'Gradalis Inc', u'Allergan plc', u'Oncalis AG', u'THERAVECTYS', u'Procognia (Israel) Ltd', u'Caliber Biotherapeutics', u'Quimatryx', u'Biocon Ltd', u'HUYA Bioscience International LLC', u'WuXi Biologics', u'Otsuka Pharmaceutical Co Ltd', u'Nalco Co', u'Biotica Technology Ltd', u'Emergent Europe Ltd', u'CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences', u'Dana-Farber Cancer Institute Inc', u'Neoseed Technology LLC', u'National Institute of General Medical Sciences', u'University of Arkansas for Medical Sciences', u'Akonni Biosystems', u'Luoyang Ruize Petrochemical Engineering Co Ltd', u'Tasly Pharmaceuticals', u'Wellcome Trust - Burroughs Wellcome Fund', u'University of Florida College of Medicine', u'Affibody AB', u'South Carolina Research Authority', u'Endo Health Solutions Inc', u'University of Aberdeen', u'Chemical Diversity Research Institute Ltd', u'Biotech Australia', u'MGI Pharma Biologics', u'i3 research', u'Wylde LLC', u'Augusta University Research Institute Inc', u'Johns Hopkins University School of Medicine', u'Strata Oncology', u'LSK Biopartners Inc', u'NewLink Genetics Corp', u'axios Pharma GMBH', u'Center for Translational Molecular Medicine', u'Gemini Genomics plc', u'Sanofi Inc', u'Centro de Investigaci\\xf3n M\\xe9dica Aplicada (CIMA)', u'Jiangsu Hengrui Medicine Co Ltd', u'Mirati Therapeutics Inc', u'University of Manchester (UK)', u'Zymeworks Inc', u'Aurum Ventures MKI', u'Samyang Corp', u'Future Systems Inc', u'NiKem Research Srl', u'Neoantigenics LLC', u'Warp Drive Bio', u'Libragen SA', u'Numerate Inc', u'Biora Ab', u'Amoy Diagnostics Co Ltd', u\"Universite d'Angers\", u'Goodwin Biotechnology Inc', u'Indian Institute Of Technology Madras', u'Korea Research Institute of Bioscience and Biotechnology', u'PepTx Inc', u'Immunitor Inc', u'Shanxi Zhendong Pharmaceutical Co Ltd', u'Can-Fite BioPharma Ltd', u'BioReference Laboratories', u'ProlX Pharmaceuticals LP', u'Banook Central Imaging', u'Oxford Drug Design', u'Cytovance Biologics LLC', u'Imperial Cancer Research Technology Ltd', u'Yunnan Nationalities University', u'TeneoBio Inc', u'Actinobac Biomed Inc', u'Hong Kong Baptist University', u'Nereus Pharmaceuticals Inc', u'Curacel International Pty Ltd', u'Medical Research Commercialization Fund', u'Particle Sciences Inc', u'Suzhou Alphamab Co Ltd', u'Medicenna Ventures Inc', u'Medivir AB', u'Biomoda Inc', u'Pulsalys Inc', u'Novosom AG', u'Bar-Ilan Research & Development Co Ltd', u'Kairos Therapeutics Inc', u'Korea United Pharm Inc', u'Hospital Universitario Madrid Sanchinarro', u'Warwick University', u'Rockefeller University', u'MEBO International Group', u'Domantis Ltd', u'Melanovus Oncology Inc', u'Genentech Inc', u'Dicerna Pharmaceuticals Inc', u'The Macfarlane Burnet Institute For Medical Research & Public Health Ltd', u'University of Tokushima', u'Eurogentec SA', u'NOF Corp', u'Ascepion Pharmaceuticals Inc', u'DelSite Biotechnologies Inc', u'IATRICa Inc', u'TetraGene LLC', u'Elekta AB', u'Novation Pharmaceuticals Inc', u'Yangtze River Pharmaceutical Group Sichuan Hairong Pharmaceutical Co Ltd', u'Rhone-Poulenc SA', u'LifeArc', u'Ark Therapeutics Group plc', u'Reig Jofre Group', u'Intervet International BV', u'Nautilus Biotech SA', u'Institute of Biotechnology the Academy of Military Medical Sciences PLA', u'NanoSmart Pharmaceuticals Inc', u'Altus Formulation', u'Taiwan Government', u'Northern Lipids Inc', u'Sierra Oncology Inc', u'Scripps Research Institute', u'Mabicine Technologies Ltd', u'Redx Pharma Plc', u'Atara Biotherapeutics Inc', u'PetLife Pharmaceuticals Inc', u'CytoSorbents Corp', u'Iterative Therapeutics Inc', u'Meda AB', u'Yunnan University', u'Walvax Biotechnology Co Ltd', u'Huaqiao University', u'Research Corporation Technologies', u'ProQinase GmbH', u'BioWin', u'Deutsches Rote Kreuze', u'Sequoia Sciences Inc', u'OncoResponse Inc', u'National Tsing Hua University', u'Hebrew University of Jerusalem', u'Pierre Fabre SA', u'PharmaMar Inc', u'Depomed Inc', u'Riboxx Pharmaceuticals GmbH', u'University of Salzburg', u'VLST Corp', u'Kadmon Pharmaceuticals LLC', u'C4 Therapeutics Inc', u'Generate BioMed Inc', u'Adimab LLC', u'University of Iowa', u'Satavahana University', u'Galapagos Genomics BV', u'Emulate Inc', u'Cubist Pharmaceuticals Inc', u'AstraZeneca plc', u'MSM Protein Technologies', u'Boehringer Ingelheim Pharmaceuticals Inc', u'Guizhou Bailing Enterprise Group Pharmaceutical Co Ltd', u'James Graham Brown Cancer Center', u'Maryland Industrial Partnerships', u'Fushimi Pharmaceutical Co Ltd', u'metaGen Pharmaceuticals GmbH', u'Gendux Molecular Ltd', u'Celdara Medical LLC', u'Metdem Healthcare Ltd', u'Genta Inc', u'Wisconsin Genetics Inc', u'Estero-Anstalt', u'Pharmstandard OJSC', u'Nuance Biotech Inc', u'Race Oncology Ltd', u'Oncotide Pharmaceuticals Inc', u'University of Colorado at Denver and Health Sciences Center', u'NCIC Clinical Trials Group', u'National Institute for Biological Standards and Control', u'OM Pharma', u'BIND Therapeutics Inc', u'Cancer Innovations Inc', u'vivoPharm Pty Ltd', u'Yale School of Medicine', u'MitoSciences Inc', u'NYU Langone Medical Center', u'US Army Medical Research Institute of Infectious Diseases', u'Auven Therapeutics', u'PharmaNova Inc', u'Principio Inc', u'Tomsk Polytechnic University', u'Applied BioMath LLC', u'Abiogen Pharma SpA', u'Propep Surgical Llc', u'Institute of Advanced Chemistry of Catalonia', u'University of Dundee', u'Discovery BioMed Inc', u'Abeona Therapeutics Inc', u'Axlr Satt Du Languedoc Roussillon', u'Rockland Immunochemicals Inc', u'Probactive Biotech Inc', u'Womens & Childrens Hospital', u'Albert Einstein Medical Center', u'ABL Bio Inc', u'Heat Biologics Inc', u'WntRx Pharmaceuticals Inc', u'Kirin Pharma Co Ltd', u'ICOS Corp', u'Fujifilm Diosynth Biotechnologies', u'Primevax Immuno-Oncology Inc', u'Arcus Biosciences Inc', u'Calando Pharmaceuticals Inc', u'ADT Pharmaceuticals', u'SonoLight Pharmaceuticals Corp', u'Cornell University', u'Supratech Micropath Laboratory and Research Institute Pvt. Ltd', u'Grenoble Institute of Neurosciences', u'MediGene Ltd', u'Mycosynthetix Inc', u'CELLIPSE', u'BioDiem Ltd', u'Inhibikase Therapeutics Inc', u'Bio-Matrix Scientific Group Inc', u'Reprogen Inc', u'CEVEC Pharmaceuticals GmbH', u'Walter and Eliza Hall Institute of Medical Research', u'Accuro Immunology AB', u\"Children's Hospital of Los Angeles\", u'Indiana University', u'SuviCa Inc', u'Quadrant Technologies Ltd', u'Vivo Biosciences', u'Locus Pharmaceuticals Inc', u'Tensha Therapeutics Inc', u'Jiangsu Qyun Bio-Pharmaceutical Co Ltd', u'Bio Research Corp of Yokohama', u'CiMaas BV', u'University of British Columbia', u'US Oncology Inc', u'Novozymes A/S', u'Society of Interventional Oncology (SIO)', u'German Federal Ministry of Education and Research', u'Enact Pharma plc', u'Walter Reed Army Institute of Research', u'Oscient Pharmaceuticals Corp', u'Umicore', u'Elixir Pharmaceuticals Inc', u'Beijing Sinotau Pharmaceuticals Co Ltd', u'Kirin Brewery Co Ltd', u'ImmuPharma plc', u'Cardinal Health Inc', u'Koken Co Ltd', u'Neovacs SA', u'EMD Serono Inc', u'TGen Drug Development', u'Christian Doppler Research Association', u'Globavir Biosciences Inc', u'Onxeo SA', u'Novo Nordisk A/S', u'Department of Science and Technology of Zhejiang Province', u'Paradigm', u'Vernalis Group plc', u'Australian Nuclear Science & Technology Organization', u'University of Queensland', u'Radiology Oncology Systems Inc', u'Cell Matrix Inc', u'University of Southern Denmark', u'Arch Biopartners Inc', u'Universite Pierre et Marie Curie', u'CIMYM BioSciences', u'Raylo Chemicals', u'Quirem Medical', u'TriAct Therapeutics', u'Simfo GmbH', u'Notable Labs', u'Konica Minolta Camera Inc', u'Delcath Systems Inc', u'Cortech Inc', u'Sagres Discovery', u'Aurora Biosciences Corp', u'Five Prime Therapeutics Inc', u'Cipher Pharmaceuticals Inc', u'Bio-Optronics Inc', u'Ciba-Geigy Pty Ltd', u'BioSavita Inc', u'Debiovision Inc', u'leon-nanodrugs GmbH', u'University of Maryland Biotechnology Institute', u'Catholic University of Leuven', u'Aquila Biopharmaceuticals Inc', u'Sage Bionetworks', u'Applied NeuroSolutions Inc', u'Dynavax Technologies Corp', u'Southern Methodist University', u'3D Signatures Inc', u'Epinomics Inc', u'Viewray Inc', u'Ground Fluor Pharmaceuticals Inc', u'Konruns Pharmaceutical Co Ltd', u'Devicor Medical Products Inc', u'Vertex Pharmaceuticals Inc', u'Cetek Corp', u'Tiziana Life Sciences PLC', u'Chiromics LLC', u'Business New Brunswick', u'IDM Pharma Inc', u'GenOdyssee SA', u'The Scottish government', u'RedHill Biopharma Ltd', u'Oncternal Therapeutics Inc', u'EMD Lexigen Research Center Corp', u'Thallion Pharmaceuticals Inc', u'Bayer Corp', u'Response Genetics Inc', u'Incyte Corp', u'Chinese Academy of Medical Military Sciences', u'Mylan Inc', u'OncoSurg Inc', u'Affitech A/S', u'Bundesministerium fur Bildung und Forschung', u'Affymetrix Inc', u'Newgex Inc', u'Semorex Inc', u'University of Michigan', u'Abcam plc', u'Sia Latima', u'Modern Biosciences plc', u'Reyon Pharmaceuticals Co Ltd', u'BIOCND', u'Korea University', u'Third Venture Biopharma', u'Ergon Pharmaceuticals LLC', u'Healthscope Pathology', u'Panther Biotechnology Inc', u'Kleo Pharmaceuticals Inc', u'Diatos SA', u'Morvus Technology Ltd', u'Cougar Biotechnology Inc', u'Jiangsu SMK pharmaceutical Co Ltd', u'Bionomics Ltd', u'University of Colorado, Boulder', u'University of California San Francisco', u'Canteck Pharma Inc', u'Technion Research & Development Foundation Ltd', u'Amersham Health', u'Oncolytics Biotech Inc', u'OPKO Health Inc', u'University of Louisville', u'Evestra Inc', u'Universite Catholique de Louvain', u'Carlsberg Foundation', u'Pieris Pharmaceuticals Inc', u'Stress/Genzyme LLC', u'EpiGenesis Pharmaceuticals Inc', u'Jazz Pharmaceuticals plc', u'Kyukyu Pharmaceutical Co Ltd', u'Xinjiang Institute of Materia Medica', u'Houston Pharmaceuticals', u'Skolkovo', u'Quorex Pharmaceuticals Inc', u'QED Bioscience Inc', u'UAB Research Foundation', u'Gem Pharmaceuticals LLC', u'Regen BioPharma Inc', u'Micromet Inc', u'Laboratorios Ramos', u'Boehringer Ingelheim Corp', u'Hoffmann-La Roche Inc', u'TaiGen Biotechnology Co Ltd', u'Kitasato Institute', u'GenoSyst', u'Avalon Pharmaceuticals Inc', u'Turku PET Centre', u'South China Center for Innovative Pharmaceuticals', u'SynDevRx Inc', u'Hyogo College of Medicine', u'NovaMed Pharmaceuticals Inc', u'Global TransBiotech Inc', u'Victoria University of Wellington', u'Sci-Engi-Medco Solutions Inc', u'KINAXO Biotechnologies GmbH', u'Human Monoclonals International', u'Entrinsic Health Solutions Llc', u'Smart Bioscience', u'Freedom Eye Ltd', u'High Point Pharmaceuticals Llc', u'Advenchen Laboratories LLC', u'MiNeueT Therapeutics Ltd', u'IRX Therapeutics Inc', u'Compass Biotechnologies Inc', u'Miravant Medical Technologies', u'Harvard Medical School', u'Raysearch Medical Ab', u'IDIS Ltd', u'Biogen Inc (FL)', u'Neose Technologies Inc', u'Histogen Inc', u'Acharaya Nagarjuna University', u'Theramex', u'University of Texas at El Paso', u'Ascenta Pharmaceuticals', u'University Hospitals Seidman Cancer Center', u'Theragnostics Limited', u'Hospital for Sick Children', u'Innova Biosciences Ltd', u'IDC-GP Pharm LLC', u'Argos Therapeutics Inc', u'University of Wales Swansea', u'SBI Pharmaceuticals', u'University of London School of Pharmacy', u'Merck & Co Inc', u'Wonik Cube Corp.', u'Perlegen Sciences Inc', u'Sienna Cancer Diagnostics Ltd', u'Chugai Biopharmaceuticals Inc', u'rEVO Biologics Inc', u'Chong Kun Dang Pharmaceutical Corp', u'Columbia University', u'Ascletis Inc', u'Development Center for Biotechnology', u'University of California Davis', u'St Johns University', u'Vyriad', u'Phistem S\\xe0rl', u'Avant Diagnostics Inc', u'Pulmatrix Inc', u'MacroChem Corp', u'Propanc Biopharma Inc', u'Oncoceutics Inc', u'SignaBlok Inc', u'SDP Technology Ltd', u'Scottish Enterprise', u'University of Geneva', u'The UK Imperial Cancer Research Fund', u'LEITAT Technological Center', u'Nektar Therapeutics', u'Centre for Applied Microbiology & Research', u'SystemsX', u'Virginia Polytechnic Institute and State University', u'Vaxeal Holding SA', u'Astex Pharmaceuticals Inc', u'International Business Machines Corp', u'National Center For Advancing Translational Sciences', u'University of Cologne', u'Intarcia Therapeutics Inc', u'Synthetic Biologics Inc', u'Caladrius Biosciences Inc', u'BioM Biotech Cluster Development GmbH', u'Merrimack Pharmaceuticals Inc', u'Copernicus Therapeutics Inc', u'Wyeth', u'Institute for the Promotion of Innovation by Science and Technology in Flanders', u'Panzhihua Central Hospital', u'Advanomics Corp', u'Broad Institute Inc', u'University of California at Berkeley', u'Fluxion Biosciences Inc', u'iCeutica Inc', u'DC Vaccine Consortium', u'Ichor Medical Systems Inc', u'Bioven Holdings Sdn Bhd', u'Antigen Express Inc', u'Marie Curie Cancer Care', u'Serina Therapeutics Inc', u'Lipocine Inc', u'Wellmarker Bio Co Ltd', u'Chongqing LUMMY Pharmaceutical Co Ltd', u'Zeneca Pharmaceuticals', u'LeadArtis SL', u'iBeCa Therapeutics', u'PharmaGap Inc', u'Cytran Inc', u'NantPharma LLC', u'Hope Biosciences Inc', u'University Medical Center Groningen', u'Genset SA', u'Azanta A/S', u'National Cheng Kung University', u'CoGenesys Inc', u'Protherics plc', u'Changzhou Pharmaceutical Co Ltd', u\"St Jude Children's Research Hospital\", u'CQDM', u'AnaptysBio Inc', u'Proteolix Inc', u'Advagen Inc', u'GlobalCures', u'Wuxi Biortus Biosciences Co Ltd', u'BMG Pharma LLC', u'Praecis Pharmaceuticals Inc', u'Aventis SA', u'Cura Pharmaceutical Inc', u'FedMed Inc', u'Stendhal International', u'Molplex Pharmaceuticals', u'Medical College of Georgia', u'SibTech Inc', u'MGI Pharma Inc', u'Beijing Cotimes Biotech Ltd', u'AbClon Inc', u'Semafore Pharmaceuticals Inc', u'Macrophage Therapeutics Inc', u'Mauna Kea Technologies', u'Agence Nationale de Valorisation de la Recherche', u'Eurofarma', u'Fabric Genomics', u'Robert H Lurie Cancer Center', u'Czech Ministry of Trade and Industry', u'Immunocore Ltd', u'Tufts University', u\"Nationwide Children's Hospital\", u'Shire plc', u'Adaptimmune Therapeutics plc', u'Queensland Institute of Medical Research', u'AERase Inc', u'Janssen Pharmaceuticals Inc', u'Endocyte Inc', u'Crucell NV', u'Oncochel Therapeutics LLC', u'Phylogica Ltd', u'MedinCell SA', u'MicroConstants China', u'Radboud University Medical Center Nijmegen', u'Asana BioSciences LLC', u'AiRNA Pharmaceuticals Inc', u'Compendia Bioscience', u'ILEX Oncology Inc', u'Zhaotai Invivo Biomedicine Ltd Co', u'Quest PharmaTech Inc', u'Dassault Syst\\xe8mes', u'National Dong-Hwa University', u'National Jewish Health', u'ClinTec International', u'Korea Institute of Science and Technology', u'Aratana Therapeutics Inc', u'Mercachem Holding BV', u'Kanisa Pharmaceuticals Inc', u'Yakult Honsha Co Ltd', u'AOP Orphan Pharmaceuticals AG', u'University of Surrey', u'Molecular Express Inc', u'China State Institute of Pharmaceutical Industry', u'GenVec Inc', u'BioNTech AG', u'Fudan University', u'Guangzhou Institutes of Biomedicine and Health', u'Ascenion GmbH', u'Clayton Foundation For Research', u'UMN Pharma Inc', u'GlaxoSmithKline plc', u'NantKwest Inc', u'Grannus BioSciences Ltd', u'Breitling Energy Corp', u'Radient Pharmaceuticals Corp', u'Johnson Matthey plc', u'QBiotics Ltd', u'HumOrigin Inc', u'Cascadian Therapeutics Inc', u'South Texas Accelerated Research Therapeutics', u'University of Basel', u'The Leukaemia Foundation', u'Cleveland BioLabs Inc', u'N-Gene Research Laboratories Inc', u'Renovis Inc', u'ZELOR S.A.P.I.', u'TaconicArtemis GmbH', u'Nodthera Ltd', u'Xynomic Pharmaceuticals', u'Institut Curie', u'Rappaport Family Institute for Research in the Medical Sciences', u'Schering-Plough Research Institute', u'Phynova Group Ltd', u'Vanderbilt University', u'Immunotope Inc', u'Cenix BioScience GmbH', u'Virginia Commonwealth University', u'Stemmed Ltd', u'FusionVax', u'Pono Pharma', u'Almac Diagnostics', u'Van Andel Institute', u'Christian de Duve Institute of Cellular Pathology', u'Jilin University', u'Coral Therapeutics, Inc', u'Cytochroma Inc', u'Invenra Inc', u'Temple University', u'Consejeria de Industria', u'CarboMed Inc', u'Intermedic Arfran Sa', u'CZ BioMed Corp', u'Kinki University', u'Exosome Diagnostics', u'Bioview Ltd', u'Fox Chase Cancer Center', u'Pohang University of Science & Technology', u'Miodx', u'Ohio University', u'Therasis Inc', u'Biomas Inc', u'Asterias Biotherapeutics Inc', u'Murdoch University', u'Matrix Therapeutics Ltd', u'Pharmaniaga Bhd', u'Universiteit Maastricht', u'Stemline Therapeutics Inc', u'NeoGenomics Inc', u'Jasco Pharmaceuticals LLC', u'Miikana Therapeutics Inc', u'Receptome', u'Lalilab Inc', u'The Menarini Group', u'Advinus Therapeutics Ltd', u'Nexigen GmbH', u'H3 Biomedicine Inc', u'Neumedicines Inc', u'Onyx Pharmaceuticals Inc', u'Nexell Therapeutics Inc', u'Priaxon AG', u'ZoBio BV', u'Agamyxis', u'Henan Topfond Pharmaceutical Co Ltd', u'Clearbridge BioMedics Pte Ltd', u'Catalyst Biosciences Inc', u'UniQuest Pty Ltd', u'Catena Pharmaceuticals Inc', u'Kansas Bioscience Authority', u'3SBio Inc', u'Nankai University', u'Edinburgh Molecular Imaging Ltd', u'ATIII LLC', u'Merck KGaA', u'DAE HWA Pharm Co Ltd', u'ReceptoPharm Inc', u'Revalesio Corp', u'Fennec Pharmaceuticals Inc', u'Symphogen A/S', u'Innovaro Inc', u'SciClone Pharmaceuticals Inc', u'Audeo Oncology Inc', u'Affimed NV', u'Laboratorios Bioprofarma', u'University of Minnesota', u'Tumor Biology Center, Freiburg', u'Alliance Oncology', u'Monash University', u'Multiple Myeloma Research Foundation', u'Medvill Co Ltd', u'Visionary Pharmaceuticals Inc', u'Oryzon Genomics SA', u'Tibet University', u'Beijing Science Sun Pharmaceutical Co Ltd', u'PCT, a Caladrius company', u'YM BioSciences USA', u'Syndivia SAS', u'Immunomic Therapeutics Inc', u'HitGen Ltd', u'Kosan Biosciences Inc', u'University of Pisa', u'Shantha West Inc', u'Midatech Pharma US Inc', u'Hamlet Pharma AB', u'MabPlex International Ltd', u'Chiba University', u'Washington University in St Louis', u'Poniard Pharmaceuticals Inc', u'R-Pharm', u'BioCanRx', u'The Center of Molecular Immunology', u'Tapestry Pharmaceuticals Inc', u'Myriad Genetics Inc', u'Kyowa Hakko Kogyo Co Ltd', u'ChemRar High Tech Center', u'Fuso Pharmaceutical Industries Ltd', u'Cellectar Biosciences Inc', u'Cyterix Pharmaceuticals Inc', u'Takara Shuzo Co Ltd', u'PharmAgra Labs Inc', u'Tocris Neuramin Ltd', u'Opal Oncology Ltd', u'Medicinal Bioconvergence Research Center', u'Benitec Biopharma Ltd', u'Labco', u'RNAture Inc', u'BioCurex Inc', u'Liquidia Technologies Inc', u'Wyeth-Ayerst International Inc', u'Shanghai Institute of Materia Medica of the Chinese Academy of Sciences', u'Chugai Pharmaceutical Co Ltd', u'Jubilant Life Sciences Ltd', u'Vanguard Technologies LLC', u'Ortho Biotech Products LP', u'Zymo Research Corp', u'Andrus Reo Ltd', u'University Of Eastern Finland', u'Station X Inc', u'Full Spectrum Genetics Inc', u'Ferozsons Laboratories Ltd', u'Centre for the Commercialization of Antibodies and Biologics', u'Meiji Seika Pharma Co Ltd', u'BioTrove Inc', u'Compliment Corp', u'Molecular Libraries Probe Centers Network', u'Montefiore Medical Center', u'Calico Life Sciences LLC', u'Boots Hoechst Celanese', u'Kymab Ltd', u'BMP Sunstone Corp', u'Anosys Inc', u'Heidelberg Pharma Holding Ltd', u'Dekk-Tec Inc', u'MiReven Pty Ltd', u'CureMeta LLC', u'AD Biotech Co Ltd', u'ImmuneRegen BioSciences Inc', u'Syntrix Biosystems Inc', u'Purdue Neuroscience Corp', u'Latitude Pharmaceuticals', u'Diaxonhit', u'Johann Wolfgang Goethe-Universitat Frankfurt am Main', u'Helomics Corp', u'Nanjing University', u'University College London', u'ManRos Therapeutics', u'3B Pharmaceuticals Gmbh', u'National Center for Complementary and Alternative Medicine', u'Tocagen Inc', u'Kobe University', u'Cellmid Ltd', u'Arcis Biotechnology Ltd', u'ImmuVen Inc', u'New York University School of Medicine, US', u'Calithera Biosciences', u'Kyowa Hakko Kirin Co Ltd', u'Immune Therapeutics Inc', u'The University of Newcastle Upon Tyne', u'Chicago Labs Inc', u'RegeneRx Biopharmaceuticals Inc', u'BD Biosciences', u'\\xd6stersj\\xf6stiftelsen', u'University of Tennessee', u'Mogam Biotechnology Institute', u'Genaera Corp', u'Mirna Therapeutics Inc', u'Nobex Corp', u'AHAR Pharma', u'BioVectra DCL', u'Martek Biosciences Corp', u'Sanofi', u'Midatech Pharma PLC', u'Peak Harvest Health', u'Bioplatin AG', u'All India Institute of Medical Sciences', u'Trim-edicine Inc', u'Strides Shasun Ltd', u'Human Genome Sciences Inc', u'Shandong Luoxin Pharmaceutical Group Stock Co Ltd', u'Sankyo Co Ltd', u'ENYO Pharma SAS', u'Biologics Inc', u'Mabtech Holdings Limited', u'Mount Sinai Medical Center', u'Biocheck Inc', u'Jiangsu Normal University', u'Nanoscale Combinatorial Synthesis Inc', u'UK Government', u'ApoGen Biotechnologies Inc', u'LeadInvent Technologies Pvt Ltd', u'University of Oklahoma', u'Viragen Inc', u'MEI Pharma Inc', u'PowderMed Ltd', u'Kanazawa University', u'Guangzhou University of Chinese Medicine', u'Quantum Pharmaceuticals LLC', u'Allegiance Equity Corp', u'Gedeon Richter Ltd', u'Endo Pharmaceuticals Solutions Inc', u'DNA Therapeutics SA', u'United BioPharma Inc', u'Checkpoint Immunology Inc', u'Avidin Biotechnology', u'Albert Einstein College of Medicine', u'MegaPharm Ltd', u'Crinetics Pharmaceuticals Inc', u'Oncoholdings Inc', u'Licentia Ltd', u'Medinet Co Ltd', u'Institut Universitari de Ciencia i Tecnologia (IUCT)', u'Danish Government', u'The National Centre for Research and Development', u'Foundation Medicine Inc', u'Tripos Inc', u'Intradigm Corp', u'University of Wisconsin-Milwaukee', u'Gaur Diagno Pvt Ltd', u'Pacific Northwest Research Institute', u'Plandai Biotechnology Inc', u'Dompe Group', u'Proteonomix Inc', u'Alion Pharmaceuticals Inc', u'GENOPOEITIC SAS', u'Araxes Pharma LLC', u'Oklahoma State University Center for Health Sciences', u'JW Pharmaceutical Corp', u'Exact Sciences Corp', u'HenKan Pharmaceutical Co Ltd', u'Cancer Research UK Manchester Institute', u'Childrens Hospital of Philadelphia', u'Tianjin University of Technology', u'Australasian Lung Cancer Trials Group', u'Celera Diagnostics', u'Molecular Discoveries LLC', u'Incozen Therapeutics Pvt Ltd', u'Hedral Therapeutics Inc', u'Seven Bridges Genomics Inc', u'biOasis Technologies Inc', u'Royalty Pharma', u'Kerun Biopharmaceutical R & D Co Ltd', u'Cypress Bioscience Inc', u'University of New Mexico', u'Cancer Therapy & Research Center', u'Epitome Pharmaceuticals Ltd', u'CellCentric Ltd', u'Nortis Inc', u'Manhattan Scientifics Inc', u'Medicon Pharmaceuticals Inc', u'BioCryst Pharmaceuticals Inc', u'Affymax Inc', u'Rondaxe Enterprises', u\"Hospital Vall D'Hebron\", u'Immunicum AB', u'Merck Sharp & Dohme (Australia) Pty Ltd', u'Altropus Gmbh', u'Universidad De Jaen', u'TranXenoGen Inc', u'Jennerex Inc', u'Archemix Corp', u'Hong Kong Polytechnic University', u'Attenuon LLC', u'Ceragenix Pharmaceuticals Inc', u'Advanced Immune Therapeutics Inc', u'CLB Research & Development', u'Champions Oncology Inc', u'Lantheus Medical Imaging Inc', u'Warner-Lambert Co', u'BioBlocks Inc', u\"Cincinnati Children's Hospital Medical Center\", u'Boreal Genomics Inc', u'Yuki Gosei Kogyo Co Ltd', u'Tube Pharmaceuticals GmbH', u'Shanghai Institutes for Biological Sciences CAS', u'Harvard Law School', u'Bio Farma', u'Case Western Reserve University', u'Sevion Therapeutics Inc', u'Virogenetics Corp', u'University of Kashmir', u'Transcept Pharmaceuticals Inc', u'PMV Pharmaceuticals Inc', u'Zydus-Cadila Group', u'Idac Theranostics Inc', u'Bridge BioResearch International Ltd', u'Tempus Inc', u'University of Arizona', u'Aegera Therapeutics Inc', u'OBI Pharma Inc', u'CohBar Inc', u'Fort Dodge Animal Health', u'SBI Biotech Co Ltd', u'Inventiv Health Clinical Inc', u'PsiOxus Therapeutics Ltd', u'LivTech Inc', u'Galapagos NV', u'ImmGenics Pharmaceuticals Inc', u'Proportional Technologies Inc', u'University of Turin', u'Handok Inc', u'PowderJect Vaccines Inc', u'AbMax Biotechnology Co. Ltd', u'OGD2 Pharma SAS', u'North Carolina Biotechnology Center', u'Inception Sciences Inc', u'Mount Sinai Services', u'TrovaGene Inc', u'American BriVision Corporation', u'Fate Therapeutics Inc', u'Peking University', u'Replikun Biotech Pty Ltd', u'Baxalta Inc', u'Emiliem Inc', u'Alkopharma', u'Shanghai Infectious Diseases Hospital', u'European Commission', u'CrystalGenomics Inc', u'LifePharms Inc', u'Weill Medical College of Cornell University', u'Polaris Pharmaceuticals Inc', u'NanoMed Pharmaceuticals Inc', u'PDL BioPharma Inc', u'Swiss Federal Office of the Commission for Technology and Innovation', u'Nventa Biopharmaceuticals Corp', u'University of Bonn', u'Sopo-Xingda Pharmaceutical Inc', u'Hormone Laboratory, Aker University Hospital, Oslo, Norway', u'Eli Lilly Japan KK', u'Tianjin Medical University', u'Rega Institute for Medical Research', u'The European Union', u'ProDa BioTech LLC', u'Scios Inc', u'South China Sea Institute of Oceanology Chinese Academy of Sciences', u'Pelican Therapeutics Inc', u'ASINEX Ltd', u'US Health and Human Services Department', u'ICON plc', u'Antisense Therapeutics Ltd', u'X-Rx Discovery Inc', u'Wayne State University', u'Cyprus University of Technology', u'Ministry of Health & Welfare, Korea', u'Burning Rock', u'Darui Biotechnology Co Ltd', u'OncoFusion Therapeutics', u'Center for Infectious Disease Research', u'Sanghyon Chemical Corp', u'Modern Healthcare Solutions Co Ltd', u'Harrington Discovery Institute', u'Cantab Biopharmaceuticals Ltd', u'Reset Therapeutics Inc', u'Hanmi Pharmaceutical Co Ltd', u'Agennix AG', u'Medac GmbH', u'University of Alabama', u'NeuClone Pty Ltd', u'UCB SA', u'Gardant Pharmaceuticals Inc', u'JCR Pharmaceuticals Co Ltd', u'University of Florence', u'Community of Madrid', u'BioVex Inc', u'Greenville Health System', u'Ottawa Health Research Institute', u'Biotecnol SA', u'The Moscow Institute of Physics and Technology', u'HeliTec', u'Probiodrug AG', u'Amplyx Pharmaceuticals Inc', u'ImmuRx Inc', u'Institut Pasteur Korea', u'Helsinn Healthcare SA', u'ESBATech AG', u'Meito Sangyo KK', u'Kura Oncology Inc', u'Vaccine Solutions Pty Ltd', u'Infinity Pharmaceuticals Inc', u'Tusk Therapeutics Ltd', u'Recalcine Pharmaceutical Corp', u'East Tennessee State University', u'Solasia Pharma KK', u'Omnis Pharma Inc', u'AmpliMed Corp', u'Pharmexa A/S', u'Hunan Fangsheng Pharmaceutical Co Ltd', u'PENCE Inc', u'Mitsui & Co Ltd', u'Atani KK', u'Clarient', u'Rift Biotherapeutics Inc', u'Piramed Pharma', u'Progenra Inc', u'Medimmune Oncology Inc', u'Merck & Cie Schaffhausen', u'Mediolanum Farmaceutici SpA', u'Biothera Pharmaceuticals Inc', u'Medigen Biotechnology Corp', u'Noviga Research AB', u'Sunesis Pharmaceuticals Inc', u'Celyad', u'ViroTarg Pty Ltd', u'arGEN-X NV', u'Deciphera Pharmaceuticals LLC', u'Pacira Pharmaceuticals Inc', u'Tularik Inc', u'Denmark Technical University', u'Advanced Proteome Therapeutics Inc', u'European Research Council (ERC)', u'OncoVista Innovative Therapies Inc', u'Onconova Therapeutics Inc', u'National Institute of Infectious Diseases Japan', u'Sun BioPharma Inc', u'Evelo Biosciences', u'Protea Biosciences Inc', u'St Vincents Hospital Sydney Ltd', u'Welzon Group', u'Cytavis Biopharma GmbH', u'Centro para el Desarrollo Tecnologico Industrial', u'Novartis Pharma AG', u'biolitec AG', u'Cisen Pharmaceutical Co Ltd', u'NewGenPharm Inc', u'SZYY Group Pharmaceutical Ltd', u'CTI BioPharma Corp', u'Eli Lilly & Co', u'Celsion Corp', u'NanOlogy LLC', u'Chiroscience R&D Ltd', u'US Surgical Corp', u'University of South Alabama', u'EyeGene Inc', u'Louisiana State University', u'Seikagaku Corp', u'eFFECTOR Therapeutics Inc', u'ProMab Biotechnologies Inc', u'Ophtimed Instrument', u'MedPharm Ltd', u'Helen F Graham Cancer Center at Christiana Care', u'UNC Lineberger Comprehensive Cancer Center', u'NSW Government', u'AstraZeneca Canada Inc', u'Horizon Orphan LLC', u'Telormedix SA', u'alphaGEN Co Ltd', u'Erasmus University Medical Center Rotterdam', u'CeNeS Pharmaceuticals Inc', u'Reliance GeneMedix plc', u'Trethera Corp', u'Algae Dynamics Corp', u'Fournier Pharma', u'GenWay Biotech Inc', u'University of Toulouse', u'Advanced Cancer Therapeutics', u'RareCyte Inc', u\"Institut De Cancerologie De L'Ouest\", u'KRS Global Biotechnology Inc', u'Telesta Therapeutics Inc', u'Pharmion Corp', u'Marshall University Research Corp', u'X-Chem Inc', u'Sanwa Kagaku Kenkyusho Co Ltd', u'Hainan Tianwang International Pharmaceutical', u'Inform Genomics Inc', u'University of Georgia', u'NeuroSearch A/S', u'The Liposome Company Inc', u'Helsinki University', u'Collgard Biopharmaceuticals Ltd', u'AbbVie Inc', u'Janssen Vaccines & Prevention BV', u'ADC Biotechnology Ltd', u'Griffith University', u'Nano3D Biosciences, Inc', u'Xcell Biosciences Inc', u'Akeso Biopharma Inc', u'Multiple Myeloma Research Consortium', u'Centauri Therapeutics Ltd', u'Garnett McKeen Laboratory Inc', u'Proteus Digital Health Inc', u'EntoMed SA', u'Belgian Volition Pte Ltd', u'Actelion Ltd', u'Affomix Corp', u'Eilaf Pharma S.A.E', u'East China University of Science & Technology', u'Shandong Target Drug Research Co Ltd', u'University of Pittsburgh Cancer Institute', u'Hope Heart Institute', u'Sumitomo Pharmaceuticals Co Ltd', u'Orca Therapeutics BV', u'Green Cross LabCell', u'Knome Inc', u'University of Rochester', u'Targent Inc', u'Proteome Systems Inc', u'Formosa Laboratories Inc', u'UbiVac', u'PPD Discovery Inc', u'Hospira Inc', u'NERx Biosciences Inc', u'University of Kansas', u'BioDelivery Sciences International Inc', u'Toagosei Co Ltd', u'Sinil Pharmaceutical', u'PhaseBio Pharmaceuticals Inc', u'Rougier Pharma Afrique SA', u'PureTech Health Plc', u'Vindico Pharmaceuticals Inc', u'United Biotech Corp', u'City University of New York Queens College', u'Arriani Pharmaceuticals SA', u'Universidad Nacional Autonoma De Mexico', u'Metaphore Pharmaceuticals Inc', u'Lonza Group AG', u'University of Bristol', u'Hanson Institute', u'Athersys Inc', u'NantHealth Inc', u'University of Bern', u'Hoechst Marion Roussel Inc', u'Cellular Biomedicine Group Inc', u'Chronix Biomedical', u'JHL Biotech', u'Mitsubishi Chemical Corp', u'DRI Capital', u'Rutgers University', u'Aphton Corp', u'Intellikine Inc', u'Singapore Immunology Network', u\"King's College London\", u'Karolinska Institutet', u'Vitruvian Networks Inc', u'Alberta Cancer Board', u'Regeneron Pharmaceuticals Inc', u'Barbara Ann Karmanos Cancer Institute', u'Angiotech Pharmaceuticals Inc', u'University of Colorado Cancer Center', u'Jenner Biotherapies Inc', u'Stellar Biotechnologies Inc', u'Welson Pharmaceuticals Inc', u'University of Medicine and Dentistry of New Jersey', u\"Sookmyung Women's University\", u'Liquid Biotech USA Inc', u'Enumeral Biomedical Holdings Inc', u'CytoGenix Inc', u'Eutropics Pharmaceuticals Inc', u'Celator Pharmaceuticals Inc', u'Potenza Therapeutics', u'Apeloa Pharmaceutical Co Ltd', u'NormOxys Inc', u'University of Oregon', u'EdgeLeap', u'Chiron Corp', u'University of Coimbra', u'Texas A&M University System', u'Indiana University School of Medicine', u'Synchem Research Inc', u'Zhejiang Hisun Pharmaceutical Co Ltd', u'Epimab Biotherapeutics Inc', u'Somatix Therapy Corp', u'Arizona State University', u'EctoPharma Ltd', u'US Department of Veterans Affairs', u'MaxCyte Inc', u'NuCana', u'Santen SAS', u'Domain Therapeutics SA', u'Fujian provincial government', u'HemoGenyx', u'Jiangxi Herbfine Hi-Tech Co Ltd', u'Waters Corp', u'Mateon Therapeutics Inc', u'National Natural Science Foundation of China', u'TherapySelect GmbH & Co', u'Stealth Biologics', u'Pinnacle Biologics Inc', u'Chiroscience Group plc', u'Owlstone Medical Ltd', u'apceth GmbH & Co KG', u'Biocompatibles International plc', u'University of Munster', u'The National Institute of Mental Health', u'Medidata Ft Inc', u'GLG Pharma LLC', u'Canada Pension Plan Investment Board', u'Herlev Hospital Region Hovedstaden', u'ANI Pharmaceuticals Inc', u'Stony Brook University Hospital', u'ValiRx plc', u'TESARO Inc', u'Yeungnam University', u'Cytolumina Technologies Corp', u'Trianni Inc', u'Impath Inc', u'Ergomed PLC', u'Interprotein Corp', u'Aelan Cell Technologies Inc', u'DAC Srl', u'Technology Partnerships Canada', u'Statens Serum Institut', u'Institute Of Life Sciences', u'Natural Sciences and Engineering Research Council of Canada', u'Cancer trials Australia', u'Charite Universitaetsmedizin Berlin', u'ImmunoFrontier Inc', u'Cell>Point LLC', u'Trubion Pharmaceuticals Inc', u'Onco-Pharmakon Inc', u'Immunicon Corp', u'Conatus Pharmaceuticals Inc', u'EPTTCO Ltd', u'Cureon A/S', u'Nippon Petrochem Co Ltd', u'BioMena SA', u'Inflection Biosciences Ltd', u'Univ Massachusetts', u'Formatech Inc', u'Baxter Oncology GmbH', u'EuroTransBio', u'Chinese PLA General Hospital', u'Cancer Research Institute Inc', u'Genmab Holding BV', u'Geron Corp', u'Cloaked Therapeutics', u'Unleash Immuno Oncolytics', u'Top Technology Cluster', u'NantCell Inc', u'Pi Therapeutics Ltd', u'GW Pharmaceuticals plc', u'GloboMax Holdings Llc', u'Ore Pharmaceuticals Inc', u'Alla Chem LLC', u'Sanofi-Synthelabo', u'Takeda Development Centre Europe Ltd', u'ACCESS Oncology Inc', u'Shattuck Labs Inc', u'Eagle Pharmaceuticals Inc', u'Biodesix Inc', u'Oncobiomed', u'Genomic Systems LLC', u'Predictive Therapeutics', u'Nanjing University of Chinese Medicine', u\"Queen's University at Kingston\", u'Mercury Therapeutics Inc', u'Borean Pharma A/S', u'Basilea Pharmaceutica International Ltd', u'Advantagene Inc', u'Uni Pharma Co Ltd', u'Reliant Pharmaceuticals Inc', u'Instituto Catalan de Oncologia', u'Chan-Zuckerberg Foundation', u'Momenta Pharmaceuticals Inc', u'Osaka Prefecture University', u'Dong-A ST Co Ltd', u'Numoda Corp', u'Radiant Pharma & Tech Co Ltd', u'SARomics AB', u'InnaVirVax', u'Ribapharm Inc', u'University of Edinburgh', u'Mabquest SA', u'HonorHealth Research Institute', u'University of Vermont', u'ImmunGene Inc', u'National Institute of Biomedical Innovation', u'Cancer Treatment Centers of America', u'Chemokine Therapeutics Corp', u'CerRx Inc', u'MolecuVax Inc', u'TopoTarget UK Ltd', u'Dignity Health', u'CompleGen Inc', u'Roche Palo Alto', u'BeyondSpring Pharmaceuticals Inc', u'Selected Value Therapeutics', u'Euclises Pharmaceuticals Inc', u'Labcyte Inc', u'Cyclofluidic Ltd', u'ChemBridge Research Laboratories LLC', u'Novogen Ltd', u'TBG Diagnostics Ltd', u'Weihe Pharmaceuticals Co Ltd', u'Chugai Lilly Clinical Research Co Ltd', u'Wellcome Trust Sanger Institute', u'The University of Notre Dame du Lac', u'Harbin Gloria Pharmaceuticals Co Ltd', u'MGI GP Inc', u'Baylor Research Institute', u'Novuspharma SpA', u'i2 Pharmaceuticals Inc', u'Vivex Biomedical Inc', u'Pharmaron Inc', u'Actavis Inc', u'Papivax LLC', u'Eden Biodesign Ltd', u'Quebec Clinical Research Organization in Cancer', u'Japanese Cancer Institute', u'Universitaet Stuttgart', u'Summa Health System', u'Immunophotonics Inc', u'Nippon Chemiphar Co Ltd', u'iOx Therapeutics Ltd', u'Henry M Jackson Foundation for the Advancement of Military Medicine', u'Samus Therapeutics Inc', u'Universidad De Salamanca', u'Virometix AG', u'Avila Therapeutics Inc', u'Paranta Biosciences Ltd', u'Celonic AG', u'Sovicell GmbH', u'Alkermes plc', u'La Jolla Pharmaceutical Co', u'CoNCERT Pharmaceuticals Inc', u'Valeant Pharmaceuticals International Inc', u'Deutsches Krebsforschungszentrum', u'XW Laboratories Inc', u'Albert Bonniot Institute', u'Barr Pharmaceuticals Inc', u'Kite Pharma Inc', u'Crown Bioscience Inc', u'Bioglan Pharmaceuticals Co', u'Theratechnologies Inc', u'SYGNIS AG', u'Caprion Pharmaceuticals Inc', u'Shanghai Hansheng Biotech Co Ltd', u'University of Jyvaskyla', u'Lycera Corp', u'MDS Nordion', u'Dune Medical Devices Ltd', u'Tianjin Medical University Cancer Institute and Hospital', u'Technology Strategy Board', u'X-BODY BioSciences', u'Pan-Provincial Vaccine Enterprise Inc', u'ILEX Oncology Research SA', u'Cellth Systems LLC', u'Bioprocess Capital Ventures', u'SEPPIC SA', u'Merck & Cie KG', u'Adamis Pharmaceuticals Corp', u'University of Illinois at Urbana-Champaign', u'PolyTherics Ltd', u'China Regenerative Medicine International Limited', u'Cancer Targeted Technology Llc', u'Tasly Pharmaceutical Group Co Ltd', u'Sirtris Pharmaceuticals Inc', u'Introgen Therapeutics Inc', u'Australian Government', u'Hortonworks', u'CSL Behring LLC', u'Kambridge Life Science Technology Co Ltd', u'Genmab A/S', u'Universidad Complutense de Madrid', u'Nippon Kayaku Co Ltd', u'OncoSec Medical Inc', u'Mochida Pharmaceutical Co Ltd', u'H Lee Moffitt Cancer Center and Research Institute', u'Silicon therapeutics', u'Green Cross HS Co Ltd', u'Jiangsu Sihuan Bioengineering Co Ltd', u'SalvaRx Group Plc', u'Innovation Pharmaceuticals Inc', u'Chemotherapeutisches Forschungsinstitut', u'Critical Outcome Technologies Inc', u'Advanced Accelerator Applications SA', u'Universita degli Studi di Napoli Federico II', u'Macau University of Science and Technology', u'PhenoMatriX', u'Progenetics LLC', u'Shandong Simcere Medgenn Bio-Pharmaceutical Co Ltd', u'Oncolys BioPharma Inc', u'F-star Beta Ltd', u'Hopital Maisonneuve-Rosemont', u'Niiki Pharma Inc', u'The University Health Network', u'Aqualis ASA', u'Quintiles IMS Holdings', u'Summit Pharmaceuticals International Corp', u'Pepgen Corp', u'BioPontis Alliance LLC', u'Kyoto University', u'Cedars-Sinai Medical Center', u'Tokyo University of Pharmacy & Life Sciences', u'Novascreen Biosciences Corp', u'The New Energy and Industrial Technology Development Organization', u'MicroVAX LLC', u'Guangzhou Doublle Bioproducts Co Ltd', u'Hamburgische Investitions- und Forderbank', u'American Heart Association', u'Enchira Biotechnology Corp', u'The Princess Margaret Cancer Centre', u'Sichuan Kelun Pharmaceutical Co Ltd', u'Washington State University', u'Fujikura Kasei Co Ltd', u'Karolinska University Hospital', u'Celularity Inc', u'PX Biosolutions Pty Ltd', u'Hospira Adelaide Pty Ltd', u'Karyopharm Therapeutics Inc', u'Cyclenium Pharma Inc', u'Rijksuniversiteit te Leiden', u'University Hospital Basel', u'George Mason University', u'Selecta Biosciences Inc', u'Accelera Srl', u'National Institutes of Health Clinical Center', u'PNO Resources Ltd', u'Vettore LLC', u'Inotek Pharmaceuticals Corp', u'Neovii Biotech GmbH', u'The NDDO Research Foundation', u'PiSA Farmaceutica', u'Dyax Corp', u'Ethical Oncology Science SpA', u'YOUAI', u'NuRx Pharmaceuticals Inc', u'Xenome Ltd', u'University of Toronto', u'GamaMabs Pharma', u'Berlex Laboratories Inc', u'GeneMedicine Inc', u'CuraGen Corp', u'Viteava Pharmaceuticals Inc', u'RXi Pharmaceuticals Corp', u'University of Ulsan', u'IPS Biopharma', u'Etubics Corp', u'Medical University of South Carolina', u'Hinova Pharmaceuticals Inc', u'Ventana Medical Systems Inc', u'Oak Ridge National Laboratory', u'Agennix USA Inc', u'GLYCODesign Inc', u'Binex Co Ltd', u'Cellular Dynamics International Inc', u'Oragenics Inc', u'UAF Technologies and Research', u'University of Barcelona', u'Lifespan Health System', u'VIB', u'Mount Sinai School of Medicine', u'Kechow Pharma Inc', u'ASKA Pharmaceutical Co Ltd', u'Cohen-McNiece Foundation', u'Sunshine Biopharma Inc', u'Quintiles Transnational Corp', u'University of Maryland', u'Intensity Therapeutics Inc', u'Universite de Caen Basse-Normandie', u'Nymox Pharmaceutical Corp', u'Idun Pharmaceuticals Inc', u'CombiMatrix Corp', u'Apeiron Biologics GmbH', u'Diatheva srl', u'Percipio Biosciences', u'Aventis Pharma AG', u'Rasna Therapeutics Inc', u'Johannes Gutenberg Universitat Mainz', u'Baxter International Inc', u'Exiqon A/S', u'OSI Pharmaceuticals Inc', u'University of Washington', u'ApoBiologix', u'Cannabics Pharmaceuticals Inc', u'Oncomab Ltd', u'Fondazione Matilde Tettamanti e Menotti de Marchi ONLUS', u'Intermed GmbH', u'Yonsei University', u'NewSouth Innovations', u'ARIAD Pharmaceuticals Inc', u'Sarissa Inc', u'Aptalis Pharma Srl', u'ARIUS Research Inc', u'CryoLife Inc', u'Kinetix Pharmaceuticals Inc', u'Torrey Pines Institute for Molecular Studies', u'New Zealand Foundation for Research, Science and Technology', u'Faron Pharmaceuticals Ltd', u'KuDOS Pharmaceuticals Ltd', u'Wake Forest University', u'Ontario Institute for Cancer Research', u'Agency For Science Technology & Research', u'General Hospital of Lanzhou Military Region', u'California Pacific Medical Center', u'Gloucester Pharmaceuticals Inc', u\"Prince Henry's Institute of Medical Research\", u'Biosite Inc', u'InterMune Inc', u'National Center for Research Resources', u'CURE Pharmaceutical Inc', u'University Medical Centre St Radboud', u'ImQuest Life Sciences Inc', u'Signal Research Division', u'Ogeda SA', u'Nuvera Biosciences Inc', u'KODE Biotech Ltd', u'Hikma Pharmaceuticals plc', u'Novimmune SA', u'Angion Biomedica Corp', u'IncellDx Inc', u'Ceretek', u'3D BioOptima', u'Xenova Ltd', u'Singapore Technologies Pte Ltd', u'Pentabase ApS', u'Apexian Pharmaceuticals Inc', u'Rafael Pharmaceuticals Inc', u'Intas Pharmaceuticals Ltd', u'Australian Genome Research Facility', u'SCYNEXIS Inc', u'OmniComm Systems', u'XL-Protein GmbH', u'HTG Molecular Diagnostics Inc', u'AnalytiCon Discovery GmbH', u'Royal College of Surgeons in Ireland', u'iCell Therapeutics', u'Novonco Therapeutics Inc', u'Hyundai Hope on Wheels Foundation', u'Boehringer Mannheim GmbH', u'Enlyton Ltd', u'Pharmatest', u'Biostream Technolgies', u'4SC Discovery GmbH', u'Sirna Therapeutics Inc', u'Cancer Research Initiatives Foundation', u'Roslin Institute', u'Nature Technology Corp', u'Optimata Ltd', u'Bolder BioTechnology Inc', u'Mallinckrodt Inc', u'Teva Pharmaceutical Industries Ltd', u'Zeneca Group plc', u'Kwang Dong Pharmaceutical Co Ltd', u'MRC Biotech Pty Ltd', u'Sonrgy Inc', u'Universite Libre de Bruxelles', u'Cell Medica Ltd', u'AvidBiotics Corp', u'Targon Corp', u'Oxford BioTherapeutics', u'FibroGen Inc', u'RaQualia Pharma Inc', u'Pionyr Immunotherapeutics Inc', u'Peakdale Molecular', u'CuriRx Inc', u'Trovis Pharmaceuticals LLC', u'Oncoral Pharma Aps', u'Shanghai Yingli Pharmaceutical Co Ltd', u'Fusion Antibodies Ltd', u'Millennium Pharmaceuticals Ltd', u'Honolulu Pharmacy', u'SK Chemicals Life Science', u'Innogene Kalbiotech Pte Ltd', u'Photolitec LLC', u'Errant Gene Therapeutics LLC', u'University of Cincinnati', u'Hookipa Biotech GmbH', u'Technology New Zealand', u'Complete Genomics Inc', u'Juno Therapeutics Inc', u'BioInvent International AB', u'KNC Laboratories Co., Ltd.', u'Carmot Therapeutics Inc', u'The Key Lab Of Chemistry For Natural Products Of Guizhou Province & Chinese Academy Of Sciences', u'21st Century Therapeutics Inc', u'Biotechnology and Biological Sciences Research Council (BBSRC)', u'Jiangxi Science & Technology Normal University', u'National Biomanufacturing Centre', u'Open Monoclonal Technologies Inc', u'Duke University Medical Center', u'University of Sheffield', u'Universidade de Santiago de Compostela', u'ImmunoClin Laboratories Ltd', u'Nippon Shinyaku Co Ltd', u'Oncology Research Information Exchange Network', u'Laboratorios Liomont Sa De Cv', u'National Institute of Diabetes, Digestive and Kidney Diseases', u'Healx Ltd', u'MediGene Inc', u'Perseus Proteomics Inc', u'Institut Paoli-Calmettes IPC', u'Genomic Health Inc', u'Roche Innovation Center Copenhagen A/S', u'HS Pharmaceuticals LLC', u'AlphaVax Inc', u'Epizyme Inc', u'CMC Biologics Inc', u'Baxter Healthcare Corp', u'OncoTartis Inc', u'TheraGlass Ltd', u'Competence Centre for Cancer Research', u'Academic Drug Discovery Consortium', u'Alteogen Inc', u'Melmotte Inc', u'Dublin City University', u'PureMHC LLC', u'XOMA Corp', u'Terumo Corp', u'Dalian Institute of Chemical Physics Chinese Academy of Sciences', u'Syndax Pharmaceuticals Inc', u'Morphisto GmbH', u'Ascentage Pharma Group Corporation Ltd', u'Celtic Biotech Ltd', u'The Salk Institute for Biological Studies', u'Alectos Therapeutics Inc', u'Feinstein Institute for Medical Research', u'State Science and Technology Commission', u'Quantum Immunologics Inc', u'Tauriga Sciences Inc', u'Insilico Medicine Inc', u'Oklahoma Center for the Advancement of Science and Technology', u'Ensemble Therapeutics Corp', u'VGX Pharmaceuticals LLC', u'Gilead Palo Alto Inc', u'TheraTarget Inc', u'Helix BioPharma Corp', u'Phytera Inc', u'Molecular Discovery Systems', u'TC BioPharm Ltd', u'Curadel LLC', u'FUJIFILM Holdings Corp', u'OntoChem GmbH', u'Tizona Therapeutics Inc', u'SphynKx Therapeutics LLC', u'Pain Therapeutics Inc', u'Biosortia Pharmaceuticals', u'Ensysce Biosciences Inc', u'BioSeek Plc', u'Norris Cotton Cancer Center', u'Link Health Group', u'Therapure Biopharma Inc', u'Northern Sydney Local Health District', u'LifeMap Sciences Inc', u'Cambridge University Technical Services Ltd', u'Torrent Pharmaceuticals Ltd', u'Gilead Sciences Inc', u'US Government', u'Canopus BioPharma Inc', u'Recombio', u'NEC Corp', u'PolaRx Biopharmaceuticals Inc', u'Merck Sharp & Dohme Ltd', u'Aix-Marseille Universit\\xe9', u'Swiss Group for Clinical Cancer Research', u'4SC AG', u'Baxter Healthcare Ltd', u'Reliance Life Sciences Group', u'CollaGenex Pharmaceuticals Inc', u'LinXis BV', u'Multimeric Biotherapeutics Inc', u'Dual Therapeutics LLC', u'Institute for Research in Biomedicine Barcelona', u'Cancer Vaccine Acceleration Fund', u'Cantargia AB', u'Apogenix GmbH', u'INSERM U976', u'Eberhard Karls Universit\\xe4t T\\xfcbingen', u'Phosplatin Therapeutics LLC', u'Shire BioChem Inc', u'Knight Therapeutics Inc', u'Amarin Corp plc', u'Protein Mechanics Inc', u'Naviscan Inc', u'Nuclisome AB', u'Sophiris Bio Inc', u'SymBio Pharmaceuticals Ltd', u'China Medical University (Taiwan)', u'Bioagency AG', u'Strategia Therapeutics Inc', u\"The Vannie E. Cook Jr. Children's Cancer and Hematology Clinic\", u'Oscotec Inc', u'Chinese Government', u'IBEX Technologies Inc', u'Rotop Pharmaka GmbH', u'MorphoSys AG', u'Hamamatsu Photonics', u'Kuros Biosciences Ltd', u'Ascend Biopharmaceuticals Ltd', u'UNIST (Ulsan National Institute Of Science & Technology)', u'TOLLYS SAS', u'Cephalon Inc', u'Binary Therapeutics Inc', u'Takeda Cambridge Ltd', u'Imperial College London', u'Esperas Pharma Inc', u'Genrix (Shanghai) Biopharmaceutical Co Ltd', u'BrightPath Biotherapeutics Co Ltd', u'AgonOx', u'University of Hawaii', u'Duke University', u'The University of Birmingham', u'University of Leeds', u'Pinteon Therapeutics', u'ModiQuest BV', u'Aetna Inc', u'YIACO Medical Co', u'Isu Abxis Inc', u'Viralytics Ltd', u'Inno Biologics Sdn Bhd', u'F H Faulding & Co Ltd', u'Flexion Therapeutics Inc', u'Sophia Genetics Sa', u'Camerino University', u'GlycoMantra Inc', u'Delta-Fly Pharma Inc', u'MedoLution Ltd', u'Instillo GmbH', u'Provectus Biopharmaceuticals Inc', u'ProMIS Neurosciences Inc', u'IGDRASOL', u'PAREXEL International', u'Rhone-Poulenc Rorer Inc', u'ModeRNA Therapeutics', u'Chemex Pharmaceuticals Inc', u'GD Searle & Co', u'VM Discovery Inc', u'Defense Threat Reduction Agency', u'ViRx Inc', u'HQL Pharmaceuticals', u'Hummingbird Bioscience Pte Ltd', u'Agence Nationale de Recherches sur le Sida et les hepatites virales (ANRS)', u'Diatide Inc', u'Rice University', u'Portage Biotech Inc', u'Sonic Healthcare Ltd', u'Viracta Therapeutics Inc', u'Pharmaco Kinesis Corp', u'Burgundy', u'Cancer Research Campaign Technology Ltd', u'Equicare Health Inc', u'Apollon Inc', u'University of Lyon', u'Allos Therapeutics Inc', u'Universidade Federal do Rio de Janeiro', u'Virtualscopics LLC', u'Prometheus Laboratories Inc', u'BioActa Ltd', u'Target Discovery Inc', u'bioRASI LLC', u'Novavax Inc', u'Good Cell Life Inc', u'Caris Life Sciences', u'Okan University Hospital', u'MultiCell Technologies Inc', u'Southwest University', u'Michigan Translational Research and Commercialization', u'BioStratum Inc', u'Trojantec Ltd', u'Novotech (Australia) Pty Ltd', u'Cytheris SA', u'Sunnylife Pharma Inc', u'LiPlasome Pharma AS', u'IntelligentNano Inc', u'Therinject LLC', u'Zeria Pharmaceutical Co Ltd', u'deCODE chemistry', u'PTC Therapeutics Inc', u'Inspyr Therapeutics Inc', u'Benxi Ruisheng Kang Pharmaceutical R & D Co Ltd', u'Virogenomics Inc', u'MIR Preclinical Services', u'Claremont Biosolutions Llc', u'Ministry of Economic Affairs, ROC', u'Bavarian Research Foundation', u'M2Gen', u'Orcrist Bio Inc', u'Institute for Research in Immunology and Cancer', u'NewBiotics Inc', u'Innovative Genomics Initiative', u'Eckert & Ziegler Eurotope Gmbh', u'Provecs Medical GmbH', u'Xcellsyz Ltd', u'Harle Group Inc', u'Moleculin Biotech Inc', u'Siamab Therapeutics', u'Colgate-Palmolive Co', u'AFP Sino Development Co LLC', u'Sunstone Biosciences Inc', u'Chiroscience R&D Inc', u'Avacta Ltd', u'ERYtech Pharma', u'Philipps-Universitat Marburg', u'Boston University', u'University of California Los Angeles', u'ECI Inc', u'Inpharmatica Ltd', u'PhoreMost Ltd', u'Ariana Pharmaceuticals', u'Nanyang Institute of Technology', u'Nanyang Technological University', u'Morphochem AG', u'Genticel', u'University of Tennessee Research Foundation Office of Technology Transfer', u'iCAD Inc', u'Purdue University', u'ElexoPharm GmbH', u'MEDIT SA', u'Meristem Therapeutics', u'Antyra Inc', u'National Institute of Technology, Srinagar', u'BioSignal Inc', u'Iovance Biotherapeutics Inc', u'Centella Therapeutics Inc', u'University of Oxford', u'Institute of Bioorganic Chemistry Polish Academy of Sciences', u'MD Anderson Cancer Center', u'Quintessence Biosciences Inc', u'Zhengzhou University', u'Shandong Chengchuang Pharmaceutical R&D Co Ltd', u'Medarex Inc', u'Humboldt University of Berlin', u'University of Tokyo', u'Florida Atlantic University', u'PharPoint Reasearch Inc', u'Jaiva Technologies', u'Sygnature Discovery Ltd', u'Solana Therapeutics Inc', u'Accelovance Inc', u'MultiPlan Inc', u'Ex scientia Ltd', u'Beijing Purunao Biotech Co Ltd', u'Hospital del Mar', u'Combinature Biopharm AG', u'EndGenitor Technologies Inc', u'3M Drug Delivery Systems', u'University of London', u'Qurient Therapeutics', u'Karolinska Development AB', u'Monopar Therapeutics LLC', u'Korean Research Institute of Bioscience and Biotechnology', u'Chaperone Therapeutics Inc', u'Eurofins Genomics', u'Tianjin Hemay Bio-Tech Co Ltd', u'Theragen ETEX', u'National Institute Of Radiological Sciences', u'Arbutus Biopharma Corp', u'National University Hospital (Singapore) Pte Ltd', u'Tianjin Institute of Medical and Pharmaceutical Science', u'Galectin Therapeutics Inc', u'Petra Pharma Corp', u'Agena Bioscience Inc', u'University of South Florida', u'Hawthorn Pharmaceuticals Inc', u'MetaSafe AB', u'Dako Diagnostics Ltd', u'Engineering and Physical Sciences Research Council', u'Tarveda Therapeutics Inc', u'Kuala Innovations Limited', u'University of Texas System', u'UBI Pharma Inc', u'BASF Pharma', u'Boehringer Mannheim Italia SpA', u'Sanochemia Pharmazeutika AG', u'Universitair Medisch Centrum Utrecht', u'WuXi PharmaTech (Cayman) Inc', u'CytRx Corp', u'GuiZhou YiBai Pharmaceutical Co Ltd', u'Johns Hopkins University', u'National Cancer Research Network', u'Funda\\xe7\\xe3o Universidade Federal De S\\xe3o Carlos', u'Immtech Pharmaceuticals Inc', u'Laxai Avanti Life Sciences', u'Molecular Partners AG', u'CytoSen Therapeutics Inc', u'National University of Singapore', u'Pepscan Systems BV', u'Saitama Medical University', u'OncoMed Pharmaceuticals Inc', u'York Pharma plc', u'Advanced Viral Research Corp', u'Health Protection Agency', u'University of Maryland Baltimore County', u'National Institute of Neurological Disorders and Stroke', u'Syngenta AG', u'Ministry of Research and Innovation', u'Sphinx Pharmaceuticals Corp', u'Samsung Medical Center (SMC)', u'Monvida Pharmaceuticals LLC', u'Medicis Pharmaceutical Corp', u'Covidien plc', u'McCasland Foundation', u'NantWorks LLC', u'Herrick Foundation', u'Symphony Evolution Inc', u'Phoenix Biotechnology Inc', u'Royalmount Pharma', u'Profectus BioSciences Inc', u'Encore Pharmaceuticals Inc', u'French National Agency for Research on AIDS and Viral Hepatitis', u'Cellzome', u'IOmet Pharma Ltd', u'Yuhan Corp', u'MedChemica Ltd', u'Institut Pasteur', u'North Carolina Central University', u'Genomics England Ltd', u'Yield10 Bioscience Inc', u'Nohla Therapeutics Inc', u'ImmunoCellular Therapeutics Ltd', u'ImmunID', u'Gene Network Sciences Inc', u'Cephalon Australia Pty Ltd', u'Munich Biotech AG', u'Zentaris GmbH', u'Galderma SA', u'BiPar Sciences Inc', u'FORMA Therapeutics Inc', u'University of Waterloo', u'Agalimmune Ltd', u'Pharminox Ltd', u'UbiQ Bio BV', u'UC San Diego Moores Cancer Center', u'EKR Therapeutics Inc', u'HealthLinx Ltd', u'SIRO ClinPharm USA LLC', u'Scholar Rock Inc', u'Allied-Bristol Life Sciences LLC', u'Valentis Inc', u'LEO Pharma A/S', u'University of Siena', u'NeoTropiX Inc', u'Genetics Institute LLC', u'Cellerant Therapeutics Inc', u'Shanghai Sine Pharmaceutical Co Ltd', u'Teijin Ltd', u'Japanese Foundation For Cancer Research', u'University of Porto', u'Canceropole Lyon Auvergne Rhone-Alpes', u'Challenge Meditech Company Co Ltd', u'Yale University', u'Bioyong Technologies Inc', u'GeneDx', u'SFFT Developing Co Ltd', u'Sandoz Inc', u'Zhejiang CONBA Pharmaceutical Co Ltd', u'Norgen Biotek Corp', u'Mie University Hospital', u'Netherlands Cancer Institute', u'Guerbet', u'College Of Nanoscale Science & Engineering', u'AusIndustry', u'BIOO Therapeutics', u'Block Drug Co Inc', u'Illumina Inc', u'NeoGenesis Pharmaceuticals Inc', u'Strida Pharma Inc', u'Proteome Sciences plc', u'Naroo Ditech', u'Abbott Laboratories', u'Paul Scherrer Institut', u'Supratek Pharma Inc', u'Luqa Pharmaceuticals', u'Pure Protein LLC', u'Spectros Corp', u'Takeda Pharmaceutical Co Ltd', u'Astron Clinica Ltd', u'Teneovita Medical', u'Nimura Genetic Solutions Co Ltd', u'SymbioTec GmbH', u'GeneGo Inc', u'JSK Therapeutics Inc', u'Waterstone Pharmaceuticals Inc', u'Gachon University', u'NAEJA Pharmaceuticals Inc', u'TopoTarget A/S', u'University of South Carolina', u'Amal Therapeutics SA', u'Lightpoint Medical', u'IntelliSyn Pharma', u'BioImagene Inc', u'InnoVision Therapeutics', u'University of Athens', u'GNI Group Ltd', u'EPO Experimentelle Pharmakologie & Onkologie Berlin-Buch Gmbh', u'University of Manitoba', u'ApoVax Inc', u'ChemDiv Inc', u'Medical Guidance Systems LLC', u'Polymun Scientific Immunobiologische Forschung GmbH', u'Pediatric Oncology Experimental Therapeutics Investigation Consortium', u'Syngen Inc', u'Osta Biotechnologies Inc', u'Axxam SpA', u'Maruishi Pharmaceutical Co Ltd', u'Montana State University', u'Covagen AG', u'Industry-Academy Cooperation Corps Of Sunchon National University', u'Artios Pharma Ltd', u'StingInn LLC', u'Origen Therapeutics', u'Humanigen Inc', u'Targesome Inc', u'Endece LLC', u'3DMed', u'AqVida GmbH', u'Biogem Scarl', u'University of California Irvine', u'National Yang Ming University', u'AVAX Technologies Inc', u'Huntsman Cancer Institute', u'Cytopia Ltd', u'Chengdu Institute Of Organic Chemistry Chinese Academy Of Sciences', u'Kodiak Sciences Inc', u'ReproCELL Inc', u'Paligent Inc', u'Progenitor Inc', u'PhytoMedical Technologies Inc', u'Coland Pharmaceutical Co Ltd', u'Beijing Dongfang Baitai Biotechnology Co Ltd', u'BlinkBio Inc', u'KT&G Life Sciences Corp', u'Corvus Pharmaceuticals Inc', u'Novopharm Biotech (USA)', u'RESprotect GmbH', u'Biovest International Inc', u'Quest Diagnostics Inc', u'US Civilian Research and Development Foundation', u'Top Institute Pharma', u'National Research Foundation of Korea', u'Osaka International Cancer Institute', u'OSE Immunotherapeutics', u'University of Newcastle', u'Sareum Holdings plc', u'GlycoNex Inc', u\"People's Government of Guangdong Province\", u'COARE Biotechnology Inc', u'ValiPharma', u'Essa Pharma Inc', u'Drais Pharmaceuticals Inc', u'Zacharon Pharmaceuticals Inc', u'Turgut \\u0130laclari As', u'Il Dong Pharmaceutical Co Ltd', u'Christie Hospital NHS Foundation Trust', u'Asuragen Inc', u'Eddingpharm Inc', u'Hudson Alpha Institute For Biotechnology', u'Aura Biosciences Inc', u'Plasticell Ltd', u'Natural Pharmacia International Inc', u'Cure Medical Manufacturing', u'Natera Inc', u'Questcor Pharmaceuticals Inc', u'Hauser Inc', u'NexImmune Inc', u'Seattle Genetics Inc', u'Ionis Pharmaceuticals Inc', u'The Dow Chemical Co', u'Keryx Biopharmaceuticals Inc', u'Igeneon GmbH', u'amp biosimilars AG', u'Vigilant Biosciences', u'Pharmaceutical Product Development LLC', u'Spanish National Research Council', u'Bioncotech Therapeutics SL', u'OPK Biotech', u'Sir Mortimer B Davis Jewish General Hospital', u'Eczacibasi Ozgun Kimyasal Urunler Sanayi ve Ticaret AS', u'BPH Energy Ltd', u'Ontario Cancer Institute', u'Bellicum Pharmaceuticals Inc', u'Cancer Institute New South Wales', u'ACT Genomics Co Ltd', u'Chinese Academy of Medical Sciences & Peking Union Medical College', u'ProTrials Research, Inc', u'AhR Pharmaceuticals Inc', u'R&D-Biopharmaceuticals GmbH', u'Simcere Pharmaceutical Group', u'State of Queensland', u'Merck Sharp & Dohme Corp', u'Neon Therapeutics', u'Beijing Chao-Yang Hospital', u'Microsoft Corp', u'MedGenome Labs Pvt Ltd', u'Taif University College Of Pharmacy Of Taif University', u'Shanghai Fosun Pharmaceutical (Group) Co Ltd', u'Lincoln Park Capital', u'mAbxience SA', u'PharmaEssentia Corp', u'Orion Corporation', u'Regeneus Pty Ltd', u'McGuff Pharmaceuticals, Inc', u'Catalent Inc', u'Loxo Oncology Inc', u'Italian Institute Of Technology (Iit)', u'Humanetics Corp', u'Association for International Cancer research', u'ElsaLys Biotech', u'Baker IDI Heart & Diabetes Institute Holdings Ltd', u'Glasgow University', u'Mycenax Biotech Inc', u'Aposense Ltd', u'Sanofi Pasteur', u'Sartorius Stedim Biotech Gmbh', u'TNK Therapeutics Inc', u'23andMe Inc', u'Pharmacare Ltd', u'State University of New York', u'Biotecnol Inc', u'New York University', u\"Children's Cancer Institute Australia for Medical Research\", u'Centre National de la Recherche Scientifique (CNRS)', u'Institut de Recherche en Cancerologie de Montpellier', u'Kakatiya University', u'ChemRar Pharma', u'The Royal Swedish Academy of Sciences', u'California Breast Cancer Research Program', u'Cambridge Antibody Technology Group plc', u'Human Longevity Inc', u'Milkhaus Laboratory Inc', u'Glenmark Pharmaceuticals Ltd', u'Ibex Biosciences LLC', u'Bioceros BV', u'Abmaxis Inc', u'Chodang Pharm Co Ltd', u'Geisel School of Medicine', u'Amplimmune Inc', u'Maxygen Inc', u'Brock University', u'Pioneer Valley Life Sciences Institute', u'Pangaea Biotech SA', u'Immutep SA', u'National Centre For Scientific Research \"Demokritos\"', u'Guangzhou Boji Medical & Biotechnological Co Ltd', u'National Taiwan University', u'University of Gottingen', u'CytomX Therapeutics Inc', u'Curza Global LLC', u'Brigham Young University', u'Institut Catala de Nanotecnologia', u'Poseida Therapeutics Inc', u'Seegene Inc', u'Institute of Bioinformatics (IOB)', u'Premier Biomedical Inc', u'SmithKline Beecham Corp', u'Accutest Research Laboratories (I) Pvt Ltd', u'Regulon Inc', u'Cytokine PharmaSciences Inc', u'Checkpoint Therapeutics Inc', u'ImmunoGen Inc', u'Kangwon University Pharmaceutical College', u'Patrys Ltd', u'Ganymed Pharmaceuticals AG', u'Novacell Technology Inc', u'Shandong Academy of Medical Sciences', u'The Gladstone Institute of Cardiovascular Disease', u'VasGene Therapeutics Inc', u'Altor BioScience Corp', u'Cortice Biosciences Inc', u'Enterprise Ireland', u'Shanghai Jiao Tong University', u'University of Lausanne', u'PhotoBiotics Ltd', u'Shenzhen BGI Genomics Techonology Co Ltd', u'Arisyn Therapeutics Inc', u'Ministry of Science and Technology of the People\\xb4s Republic of China', u'Saint Petersburg State University', u'Macrophage Pharma Limited', u'Chiron Technologies (US)', u'Monash Institute of Medical Research', u'Oncobiologics Inc', u'Swedish Orphan Biovitrum AB', u'Bausch & Lomb Inc', u'BriaCell Therapeutics Corp', u'Hartford Hospital', u'Ludwig-Maximilians University of Munich', u'Sistemic Scotland Limited', u'SGX Pharmaceuticals Inc', u'AmorePacific Corp', u'Axiom Biotechnologies Inc', u'Hoosier Cancer Research Network', u'LifeLabs Medical Laboratory Services', u'Harbor Therapeutics Inc', u'IBC Pharmaceuticals Inc', u'Johnson & Johnson', u'CRELUX GmbH', u'Guilin Normal College', u'Synthetic Genomics Inc', u'Burzynski Research Institute Inc', u'Portal del Estado Peruano', u'Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd', u'California Institute of Technology', u'Vancouver Prostate Centre', u'Sichuang University', u'Squibb Diagnostics', u'Areva Med LLC', u'Nimbus Therapeutics', u'Finnish Funding Agency for Technology and Innovation', u'National Taiwan University Hospital', u'China Three Gorges University', u'Vaxine Pty Ltd', u'Emergent BioSolutions Inc', u'Chroma Therapeutics Ltd', u'Modulate Therapeutics Inc', u'Bioxel Pharma Inc', u'4P Pharma', u'Vedanta Biosciences Inc', u'Sprint Bioscience', u'PamGene International BV', u'Vion Pharmaceuticals Inc', u'Tokyo University of Agriculture & Technology Co Ltd', u'GlaxoSmithKline Biologicals', u'Immune Pharmaceuticals Inc', u'TherapyX Inc', u'Agenus Inc', u'ETH Zurich', u'bluebird bio Inc', u'Peoples Friendship University of Russia (PFUR)', u'Changzhou Le Sun Pharmaceuticals Ltd', u'Brunel University', u'BD Technologies', u'Shanxi Medical University', u'Foundation for Children with Leukaemia', u'Rexahn Pharmaceuticals Inc', u'Argenta Discovery Ltd', u'VG Life Sciences Inc', u'Kylin Therapeutics Inc', u'Hunan University of Traditional Chinese Medicine', u'Bar-Ilan University', u'Hong Kong Jockey Club Institute of Chinese Medicine Ltd', u'Gerstner Family Foundation', u'AbbVie Biotherapeutics Inc', u'Rhizen Pharmaceuticals SA', u'SemaCo Inc', u'Therawis Diagnostics GmbH', u'Codon Devices', u'Fonds zur F\\xf6rderung der wissenschaftlichen Forschung', u'LAVI CARDIATEC LTD', u'Accuray Inc', u'Anza Therapeutics Inc', u'Akorn Inc', u'Lascco SA', u'Hopital Saint-Louis', u'EU Horizon 2020', u'Shanghai ChemPartner Co Ltd', u'Eortc New Drug Development Office', u'China Pharmaceutical University', u'Stehlin Foundation For Cancer Research', u'Chosun University', u'Hong Kong Life Sciences and Technologies Group Ltd', u'Amphora Discovery Corp', u'Smart Assays', u'Amrita Therapeutics Ltd', u'Hungarian Government', u'Peter MacCallum Cancer Centre', u'R-Action Distribution', u'Iconic Therapeutics Inc', u'Abazali Bio Ventures', u'Horizon Discovery Group plc', u'HERMES Biosciences', u'Ben Venue Laboratories Inc', u'King Hamad University Hospital', u'Pharnext SAS', u'Cynata Therapeutics Ltd', u'Harbor Branch Oceanographic Institute Inc', u'Cancer Prevention and Research Institute of Texas', u'Edelris SAS', u'SurgiMab', u'Western Maryland Health System (WMHS)', u'Fresenius SE & Co KGaA', u'Pro-Cure Therapeutics Ltd', u'Bristol-Myers Squibb Co', u'Pharmis Biofarmaceutica', u'Lumiphore', u'Addario Lung Cancer Medical Institute', u'Pontificia Universidad Catolica De Chile', u'Sapient Discovery LLC', u'ConverGene LLC', u'Weifang Bochuang International Academy Of Biotechnology & Medicine', u'CollabRx Inc', u'Seoul National University', u'PAI Life Sciences', u'Galera Therapeutics Inc', u'University of Auckland', u'Maine Medical Center Research Institute', u'Taiwan Major Chemical & Pharmaceutical Corp', u'Editas Medicine Inc', u'T.J. Martell Foundation', u'Insmed Inc', u'OcellO BV', u'BioMetrx', u'Medical Biology Institute', u'DNAtrix Inc', u'Proximagen Group plc', u'University of Pretoria', u'University of Hyderabad', u'Life Sciences Discovery Fund', u'Enamine Ltd', u'AmpliPhi Biosciences Corp', u'Rhone-Poulenc Rorer Ltd', u'Hollister-Stier Laboratories LLC', u'Oncodesign Biotechnology SA', u'Stand Up To Cancer', u'Nexgenix Pharmaceuticals Inc', u'Celecure AS', u'Q-Biologicals', u'Crimson Pharmaceutical (Hong Kong) Ltd', u'Albert-Ludwigs-Universit\\xe4t Freiburg', u'Systems Medicine Inc', u'American Association for Cancer Research', u'Mera Pharmaceuticals Inc', u'Vedantra Pharmaceuticals Inc', u'Phenomix Corp', u'Hybrid BioSystems Ltd', u'Salmedix Inc', u'Egenix Inc', u'Ben and Catherine Ivy Foundation', u'Adaptive Biotechnologies Corp', u'NauchTekhStroy Plus', u'Kereos Inc', u'Pharmacyclics Inc', u'Galaxy Biotech LLC', u'Howard Hughes Medical Institute', u'University of Wurzburg', u'PPI Pharmaceuticals LLC', u'Centelion SAS', u'Apocare Pharma GmbH', u'University of Vienna', u'Auckland UniServices Ltd', u'Sangamo Therapeutics Inc', u'DiagnoCure Inc', u'Savient Pharmaceuticals Inc', u'University Of Southampton', u'Schering AG', u'NHS Supply Chain', u'Erimos Pharmaceutical LLC', u'Advanced Cell Diagnostics Inc', u'Fuzhou University', u'Genetic Health Solution', u'The Austrian Research Promotion Agency FFG', u'Vernalis plc', u'aPODD Foundation', u'POLA Pharma Inc', u'BioPharmaWorks', u'Pharmacia Inc', u'Amira Inc', u'Curelab Oncology Inc', u'Rescue Therapeutics Inc', u'Aurelium BioPharma Inc', u'Meditrade Ltd', u'Second Military Medical University PLA', u'St Michaels Hospital', u'Cantech Holding Inc', u'Vaccinex Inc', u'Nihon Medi-Physics Co Ltd', u'Catherex Inc', u'Guangzhou Institute of Biomedicine and Health, Chinese Academy of Sciences', u'Sayre Therapeutics Private Ltd', u'Tensive Controls Inc', u'Arius Pharmaceuticals Inc', u'SignalRx Pharmaceuticals Inc', u'GalChimia', u'Bayer HealthCare AG', u'Stony Brook Medicine', u'Agios Pharmaceuticals Inc', u'Anchen Pharmaceuticals Inc', u'Alliance Pharma plc', u'University of Melbourne', u'Eyetech Inc', u'Innopharmax Inc', u'Y-mAbs Therapeutics Inc', u'IntraImmune Therapies Inc', u'Du Pont Radiopharmaceuticals Inc (US)', u'University of Massachusetts Medical School', u'Rosetta Genomics Ltd', u'OCTIMET Oncology NV', u'Duquesne University', u'Alexis Biotech Ltd', u'Exelixis Inc', u'Orphan Australia', u'Aspyrian Therapeutics Inc', u'Mission Biomedical Scientific Inc', u'Rubicon Biotechnology Inc', u'Xantos Biomedicine AG', u'Immune-Onc Therapeutics Inc', u'Amgen Inc', u'Seragen Inc', u'Denovo Sciences Inc', u'State University of New York at Stony Brook', u'Japan Pharmaceutical Development Co Ltd', u'Tikcro Technologies Ltd', u'Chemilia AB', u'Ohio State University', u'Boise State University', u'CircaGen Pharmaceutical', u'Shanghai Wanxing Bio-Pharmaceutical Co Ltd', u'Arno Therapeutics Inc', u'Genomics Medicine Ireland', u\"Seattle Children's Hospital\", u'Assistance Publique Hopitaux de Paris', u'Kotobuki Pharmaceutical Co Ltd', u'Ardana Bioscience Ltd', u'Harbin Pharmaceutical Group Co Ltd', u'Quark Venture Inc', u'Arog Pharmaceuticals Inc', u\"CureSearch for Children's Cancer\", u'Georgetown University', u'Bruker Corporation', u'Georgetown University Medical Center', u'iNtRON Biotechnology Inc', u'European Neuroblastoma Association', u'Sapience Therapeutics Inc', u'Biosyn Corp', u'Iconix Biosciences Inc', u'Massachusetts General Hospital', u'Confluence Life Sciences Inc', u'OncoQR OG', u'Perceptive Imagineering LLC', u'Bio-Path Holdings Inc', u'Nihon Pharmaceutical Co Ltd', u'Cryo-Cell International Inc', u'Immune Targeting Systems Ltd', u'Changsha Huozi Biotechnology Co Ltd', u'JAK3 Pharma Inc', u'Immunomedics Inc', u'Cleveland Clinic Foundation', u\"M's Science Corp\", u'Pennsylvania State University', u'ENTEROME Bioscience SA', u'Georgia State University', u'Welichem Biotech Inc', u'Albany Molecular Research Inc', u'VLP Therapeutics LLC', u'SunPharm Corp', u'Astex Therapeutics Ltd', u'Allergan Inc', u'Changzhou Runnor Biological Technology Co Ltd', u'PeptiMimesis', u'OctreoPharm Sciences GmbH', u'CellSight Technology, Inc.', u'BioZyme Inc', u'OncoTherics', u'Shaanxi University of Chinese Medicine', u'Scandion Oncology', u'Wyeth-Ayerst Pharmaceuticals Inc', u'Biostatin Gyogyszerkutato-Fejleszto Kft', u'Maxygen Holdings Ltd', u'Royal DSM NV', u'NOXXON Pharma AG', u'Saphetor', u'CureTech Ltd', u'Medidata Solutions Worldwide', u'TyrogeneX', u'Synovo GmbH', u'Mitsubishi Pharma Corp', u'Paladin Labs Inc', u'Agilent Technologies Inc', u'V.I. PHARMA INTERNATIONAL SA', u'Mayo Clinic Foundation', u'SynCo BioPartners', u'Oxford GlycoSciences plc', u'Reino de Espana', u'Wilex AG', u'Arriva Pharmaceuticals Inc', u'Laureate Biopharmaceutical Services Inc', u'Pennsylvania Department of Health', u'KUTLO-NITT', u'Avesthagen Ltd', u'Xstrahl Ltd', u'Alnis BioSciences Inc', u'Vivalis', u'Sumitomo Dainippon Pharma Co Ltd', u'OV-SPV2 Aps', u'ATGen Co Ltd', u'Cell and Gene Therapy Catapult', u'Transition Therapeutics Inc', u'Genzyme General', u'Akrivis Technologies LLC', u'CPX Corp', u'BioFocus DPI', u'Acaduceus Pharmaceutics Inc', u'Bionovo Inc', u'Hutchison Medipharma Enterprises Ltd', u'MRIGlobal', u'Universidad de Valladolid', u'ScinoPharm Taiwan Ltd', u'ViaMune', u'Pharmasol Corp', u'Yeda Research and Development Co Ltd', u'TOLMAR Therapeutics Inc', u'Celsee Diagnostics Inc', u'Tsukuba Research Institute', u'CEPTYR Inc', u'MolMed SpA', u'Orega Biotech', u'Yorkshire Cancer Research', u'Seres Therapeutics Inc', u'Hefei Everlife Pharmaceutical Co Ltd', u'IVAX Corp', u'ReNeuron Group plc', u'Yabao Pharmaceutical Group Co Ltd', u'National Cancer Center Research Institute', u'Schrodinger Inc', u'Immuno-Biological Laboratories Co Ltd', u'Perseis Therapeutics Ltd', u'UK Department of Trade & Industry', u'PerkinElmer Inc', u'Implicit Bioscience Ltd', u'diaDexus LLC', u'Beatson Institute for Cancer Research', u'Arbele Limited', u'Exact Corp', u'Danish Cancer Society', u'Beijing Institute of Technology (BIT)', u'Genomics Institute of the Novartis Research Foundation', u'Tolero Pharmaceuticals Inc', u'IGM Biosciences Ic', u'Samjin Pharmaceutical Co Ltd', u'Academia Sinica', u'Translational Genomics Research Institute', u'ASLAN Pharmaceuticals Pte Ltd', u'Inner Mongolia Qite Biological High-tech (Group) Co Ltd', u'Triumvira Immunologics Inc', u'OncBioMune Pharmaceuticals Inc', u'Shuwen Biotech', u'University of Utah', u'BioChem Therapeutic Inc', u'Institute of Materia Medica Chinese Academy of Medical Sciences & Peking Union Medical College', u'Marc Pharmaceuticals Inc', u'Ottawa Regional Cancer Foundation', u'Ben-Gurion University Of The Negev', u'Alfa Wassermann SpA', u'Ascentia Biomedical Corp', u'IDT Australia Ltd', u'National Cancer Centre of Singapore', u'Universita\\' Degli Studi \"Magna Graecia\" Di Catanzaro', u'MacroGenics Inc', u'Evotec International GmbH', u'East China Normal University', u'Blueprint Medicines Corp', u'BioNovis', u'Akriveia Therapeutics LLC', u'ProMetic Life Sciences Inc', u'TKsignal Ltd', u'Hadassah University Hospital', u'Activate Immunotherapy', u'Piramal Enterprises Ltd', u'National Science Foundation', u'Tella Pharma', u'Suzhou Industrial Park Biotech Development Co Ltd', u'Whitehead Institute for Biomedical Research', u'Stratose Inc', u'ApoCell Inc', u'IC-MedTech Inc', u'SBH Sciences', u'Systems Oncology LLC', u'Urology of Virginia', u'Invetech Pty Ltd', u'Zalicus Inc', u'Chemizon Inc', u'Funakoshi Corp', u'LifeNet Health', u'Shanxi Kangbao Biological Products Co Ltd', u'Harvard University', u'Objectif Recherche VACcin Sida', u'Wistar Institute of Anatomy & Biology', u'Medical Research Consulting Services', u'Athenex Inc', u'NanoCarrier Co Ltd', u'Zhejiang University', u'Ohio State University Comprehensive Cancer Center', u'Kaldi Pharma SAS', u\"Brigham & Women's Hospital\", u'PREDICT Consortium', u'ZymoGenetics Inc', u'Igenica Inc', u'Laboratory Corporation of America Holdings', u'3M Co', u'Scott And White Memorial Hospital', u'Dartmouth College', u'Proteologics Inc', u'SkyePharma plc', u'Xenova Group plc', u'Veeda Clinical Research', u'Sanofi-Aventis US LLC', u\"Y's Therapeutics Co Ltd\", u'Nascent Pharmaceuticals Inc', u'Texas Emerging Technology Fund', u'University of Connecticut', u'CellAct Pharma GmbH', u'University of Leipzig', u'Aventis Research & Technologies', u'VIB center for Cancer Biology', u'Silence Therapeutics plc', u'Pola Chemical Ind Inc', u'Starvax Inc', u'Cellcor Inc', u'Senetek plc', u'OncoTherapy Science Inc', u'Lynx Therapeutics GmbH', u'Forest Laboratories Inc', u'Korea Research Institute of Chemical Technology', u'Tanabe Research Labs USA Inc', u'University of Granada', u'Lin Bioscience Inc', u'VolitionRX Ltd', u'Delphian Pharmaceuticals', u'Vical Inc', u\"Oncology Children's Foundation\", u'IDB Resources', u'Medipost Co Ltd', u'Helmholtz Association', u'University of Tsukuba', u'Uppsala University', u'Frederick National Laboratory for Cancer Research', u'Zhejiang Starry Pharmaceutical Co Ltd', u'SD Pharmaceuticals Inc', u'MedImmune LLC', u'Xenogen Corp', u'Varian Inc', u'LGC Ltd', u'AntiCancer Inc', u'Fred Hutchinson Cancer Research Center', u'Hughes Institute', u'CureVac GmbH', u'Hy BioPharma Inc', u'Hybrigenics SA', u'Stelis Biopharma Pvt Ltd', u'Cell Signaling Technology Inc', u'Celestial Pharmaceuticals (Shenzhen) Ltd', u'Scotia Pharmaceuticals', u'Definiens AG', u'W C Heraeus GmbH & Co KG', u'Plex Pharmaceuticals', u'Novartis Pharmaceuticals Corp', u'Aravive Biologics Inc', u'Vigene Biosciences', u'Upstream Biosciences Inc', u'N-Of-One Therapeutics Inc', u'Chapman University', u'Axis Genetics plc', u'Medicell Co', u'Medical University of Vienna', u'Incuron LLC', u'Defense Advanced Research Projects Agency', u'Sanford-Burnham Medical Research Institute', u'Takeda GmbH', u'Meir Medical Center', u'BetaCat Pharmaceuticals Inc', u'Melanoma Research Alliance', u'Hyogo University of Health Sciences', u'Helmholtz Zentrum M\\xfcnchen', u'Chiome Bioscience Inc', u'Complete Pharmacy and Medical Solutions', u'University of Nottingham', u'International Biotechnology Center Generium LLC', u'Hanmi Holdings Co Ltd', u'Immunova Ltd', u'Transposagen Biopharmaceuticals Inc', u'Inex Pharmaceuticals Corp', u'Oslo University Hospital', u'Pan Am Cancer Treatment center', u'ExoTech Bio Solutions Ltd', u'Angel Biotechnology Holdings plc', u'SciGenics Inc', u'Nekonal SARL', u'Medexus Inc', u'Palacky University', u'Avidea Technologies', u'Pfenex Inc', u'Cancer Genetics Inc', u'Genome Institute Of Singapore National University', u'Vivamer Ltd', u'Mast Therapeutics Inc', u'CePep AB', u'TransGenex Nanobiotech Inc', u'Orum Therapeutics', u'Galexis', u'Repligen Corp', u'Amarillo Biosciences Inc', u'MNLpharma Ltd', u'S*BIO Pte Ltd', u'Acuvax Ltd', u'CytoCore Inc', u'Sun Yat-Sen University', u'Alvos Therapeutics Inc', u'Hopitaux Universitaires de Strasbourg', u'Purdue Pharma LP', u'Chimerix Inc', u'ProteomTech Inc', u'GlobeImmune Inc', u'Merus Labs International Inc', u'CryoPort Inc', u'Angelini Pharmaceuticals SpA', u'Clarity Pharmaceuticals Pty Ltd', u'Sumo Biosciences LLC', u'Dendreon Corp', u'CAO Pharmaceuticals Inc', u'Senhwa Biosciences Inc', u'Forty Seven Inc', u'Profound Medical Inc', u'MabVax Therapeutics Inc', u'Avatar BioSci Inc', u'Zeneus Pharma Ltd', u'Lonn Ryonn Pharma Ltd', u'Receptor Logic Inc', u'Azaya Therapeutics Inc', u'Hong Kong Government', u'Therapeutic Solutions International Inc', u'AnGes MG Inc', u'Synergys Biotherapeutics Inc', u'Northwest University', u'Genor Biopharma Co Ltd', u'Asan Medical Center', u'ScreenCell', u'Argenta Discovery Inc', u'Universidad De Le Republica - Uruguay', u'Carrus Capital Corp', u'Camargo Pharmaceutical Services', u'Olivia Newton-John Cancer Research Institute', u'Parilis Biopharmaceuticals', u'University of Ghent', u'InKine Pharmaceutical Co Inc', u'CTT Cancer Targeting Technologies Oy', u'Xavier University of Louisiana', u'Affilogic Laboratories', u'Celldex Therapeutics Inc', u'Universiteit Utrecht', u'Endocare Inc', u'Wyeth Pharmaceuticals', u'Aspen PharmaCare Holdings Ltd', u'Abramson Cancer Center of the University of Pennsylvania', u'Connetics Corp', u'Genesis Technology Group Inc', u'Shanghai Union Biopharm Co Ltd', u'Harmonic Pharma', u'bioTheranostics Inc', u'Onco360', u'Guardant Health Inc', u'Universita di Bologna', u'UCB Pharma GmbH', u'Case Western Reserve University School of Medicine', u'Northern Biologics Inc', u'Pharmix Corp', u'Norwegian Research Council', u'Kolltan Pharmaceuticals Inc', u'Indena SpA', u'US Army Medical Research and Materiel Command', u'Cancer Research Campaign (UK)', u'Bionovion Holding Bv', u'British Heart Foundation', u'TL Biopharmaceutical Ltd', u'De Novo Pharmaceuticals Ltd', u'University Hospital Heidelberg', u'National Eye Institute', u'Therabiologics Inc', u'Onkos Surgical', u'Sanpower Group Co Ltd', u'Flatiron Health', u'Tanabe Seiyaku Co Ltd', u'MEDIAN Technologies SA', u'Triangle Pharmaceuticals Inc', u'Morphotek Inc', u'University of Oslo', u'Anhui University', u'NuChem Pharmaceuticals Inc', u'Pharmacia Corp', u'Jilin Yatai Bio-Pharmaceutical Co Ltd', u'Chemo Group', u'BD Diagnostics', u'Cytlimic Inc', u'Pierrel Research Italy', u'In Ovations Holdings Inc', u'iTeos Therapeutics SA', u'Aprea Therapeutics AB', u'Invivoscribe Technologies Inc', u'Pitney Pharmaceuticals Pty Ltd', u'Kalgene Pharma Inc', u'Childrens Medical Research Institute', u'Princeton University', u'Merus BV', u'Bridge Laboratories Inc', u'Sphaera Pharma', u'Almirall Prodesfarma SA', u'Nvidia Corp', u'Anhui Anke Biotechnology (Group) Co Ltd', u'NeoGenix Oncology Inc', u'The Netherlands Organisation for Health Research and Development', u'Kyto Biopharma Inc', u'Phoenicia Biosciences Inc', u'Fox Chase Chemical Diversity Center Inc', u'NuOncology Labs Inc', u'STC Biologics Inc', u'Axelar AB', u'Progenics Pharmaceuticals Inc', u'Cyclotek', u'Tri-Institutional Therapeutics Discovery Institute Inc', u'Max Delbruck Centrum Fur Molekulare Medizin', u'Aptuit Inc', u'Genisphere LLC', u'North Central Cancer Treatment Group', u'LA Cell Inc', u'Keaise Medicine Corp', u'AnorMED Inc', u'Warnex Research Inc', u'Shenogen Pharma Group Ltd', u'Intrexon Corp', u'Takeda Pharmaceuticals International GmbH', u'US Department of Defense', u'Noble Life Sciences', u'Synthon BV', u'Maverick Therapeutics Inc', u'University of Pennsylvania', u'National University of Ireland Galway', u'Miltenyi Biotec GmbH', u'Chonbuk National University Hospital', u'CRISPR Therapeutics', u'Somanta Pharmaceuticals Inc', u'American Brain Tumor Association', u'PRISM Pharma Co Ltd', u'Abzena plc', u'Redbiotec AG', u'Merck Frosst Canada & Co', u'AviPep Pty Ltd', u'Max-Planck-Gesellschaft', u'Ethicon Inc', u'Fudan University Shanghai Cancer Center', u'SignalGene Inc', u'Protarga Inc', u'Ono Pharmaceutical Co Ltd', u'Vermillion Inc', u'Elan Corp plc', u'Biomar Microbial Technologies', u'5AM Solutions', u'Garvan Institute of Medical Research', u'Tolerx Inc', u'Airmed Biopharma Ltd', u'Regulus Therapeutics Inc', u'HemoShear Therapeutics LLC', u'Takara Bio Inc', u'NeOnc Technologies Inc', u'CJ Corp', u'Celgene Corp', u'Bioleaders Corp', u'Array BioPharma Inc', u'Memgen LLC', u'Sinopharma A-Think Pharmaceutical Co Ltd', u'State of Indiana', u'Ciba-Geigy AG', u'Staatsministerium fur Wissenschaft und Kunst', u'Molecular Technology Business Group', u'University of New South Wales', u'BioTie Therapies Corp', u'University of Sydney', u'Nidus Laboratories Inc', u'Wakayama Medical University', u'Leica Biosystems Inc', u'SinoMab Bioscience Ltd', u'IOTA Pharmaceuticals Ltd', u'Genovax Srl', u'MediaPharma Srl', u'BioImage A/S', u'VCN Biosciences SL', u'Receptor BioLogix Inc', u'Med Discovery SA', u'Digna Biotech SL', u'Adjuvantys Inc', u'Physiomics plc', u'Symbion Discovery Inc', u'European Organisation for Research and Treatment of Cancer (EORTC)', u'University of Alberta', u'Clinical Value Corp', u'Cytoclonal Pharmaceuticals Inc', u'Sinorda Biomedicine Ltd', u'DM Bio Ltd', u'NGM Biopharmaceuticals Inc', u'Clark University', u'Sugentech Inc', u'TargaGenix Inc', u'Kinetek Pharmaceuticals Inc', u'Cancer Research Technology Pioneer Fund', u'University of Zurich', u'Ecole Polytechnique Federale de Lausanne', u'BioAtla Llc', u'Zenobia Therapeutics Inc', u'Gynecologic Oncology Group', u'Netherlands Government', u'Rubicon Genomics Inc', u'Napier University of Edinburgh', u'Tottori University', u'Maxim Pharmaceuticals Inc', u'Breckenridge Pharmaceutical Inc', u'Celltrion Inc', u'Cell Genesys Inc', u'Bayer Schering Pharma AG', u'Nanjing Anji Biotechnology Co Ltd', u'Cyclis Pharmaceuticals Inc', u'Elara Pharmaceuticals GmbH', u'York University Ontario', u'Genalyte Inc', u'Clininvent Research Pvt Ltd', u'European Eurostars Programme', u'ImmunoVentis Inc', u'Shizuoka University', u'Curtana Pharmaceuticals Inc', u'INSERM Transfert', u'CeMines Inc', u'ITH Immune Therapy Holdings AB', u'Annias Immunotherapeutics Inc', u'OriGene Technologies Inc', u'Halozyme Therapeutics Inc', u'Abbott Healthcare Products BV', u'University of Texas Southwestern Medical Center', u'Bionaut Pharmaceuticals Inc', u'EDAP TMS', u'Kochi University', u'Tsinghua University', u'Oncaidia Ltd', u'Syros Pharmaceuticals', u'PanGenetics BV', u'Experimental Therapeutics Centre of Singapore', u'BioWa Inc', u'Orexo AB', u'Shionogi & Co Ltd', u'Alere Inc', u'Endo International plc', u'Celtic Biotech Iowa Inc', u'National Heart Lung and Blood Institute', u'Mars Symbioscience', u'Bioex Therapeutics Inc', u'University of Florida', u'TransMolecular Inc', u'Prana Therapeutics Inc', u'FLAG Therapeutics Inc', u'Xechem International Inc', u'Siena Biotech SpA', u'RecipharmCobra Biologics', u'Sequenom Inc', u'Viscum AG', u'Cytokinetics Inc', u'Light Sciences Corp', u'Johnson & Johnson Pharmaceutical Research & Development LLC', u'Beckman Coulter Inc', u'EMC Microcollections GmbH', u'Orphan Canada Inc', u'Xenetic Biosciences Inc', u'TG Therapeutics Inc', u'The Research Council of Norway', u'Accelerate Brain Cancer Cure', u'Atreca Inc', u'Academy of Scientific Innovation and Research', u'Personal Genome Diagnostics Inc', u'Commonwealth Scientific and Industrial Research Organization', u'Gerinda Therapeutics Inc', u'Bessor Pharma LLC', u'Suzhou Kintor Pharmaceuticals Inc', u'Fisons plc', u'IntelliHep', u'Chengdu University of Traditional Chinese Medicine', u'Sunol Molecular Corp', u'University of Chicago', u'Neomics Co Ltd', u'Innovata plc', u'La Trobe University', u'University of Chile', u'EpiTherapeutics ApS', u'Indian Government Department of Biotechnology', u'Novelion Therapeutics Inc', u'ipal GmbH', u'Institute of Medicinal Biotechnology Chinese Academy of Medical Sciences', u'VAR2 Pharmaceuticals ApS', u'Life Science Pharmaceuticals Inc', u'Trillium Therapeutics Inc', u'Scripps Florida', u'Panorama Research Inc', u'Synageva BioPharma Corp', u'ParAllele Bioscience Inc', u'Universite De Montreal', u'Royal Free and University College Medical School', u'Shantha Biotechnics PVT Ltd', u'Norsk Hydro AS', u'Concordia Pharmaceuticals Inc', u'Infectious Disease Research Institute', u'TRACON Pharmaceuticals Inc', u'Beech Tree Labs Inc', u'SYNthesis med chem', u'Glycyx PharmaVentures Ltd', u'Predictive Biomarker Sciences Inc', u'Gifu Pharmaceutical University', u'PharmaIN Ltd', u'Lytix Biopharma AS', u'Alfresa Pharma Corp', u'University of Kansas Medical Center', u'Pharmacia & Upjohn Inc', u'SeraCare Life Sciences Inc', u'University of Colorado System', u'Dermira Inc', u'Vericel Corp', u'Greiner Bio-One North America Inc', u'University of Southern California', u'Ocean University of China', u'American University of Beirut Medical Center', u'SignalChem Pharmaceuticals', u'Afraxis Inc', u'Afandin Pty Ltd', u'Suzhou Ribo Life Science Co Ltd', u'Vaxil BioTherapeutics Ltd', u'Xijing Hospital', u'Servier Canada Inc', u'NanoMaterials Technology Pte Ltd', u'Cerenis', u'Lexicon Pharmaceuticals Inc', u'Aileron Therapeutics Inc', u'Lipitek International Inc', u'Rhein Biotech NV', u'Medical University of Lodz', u'Personalis Inc', u'Guangdong Medical Laboratory Animal Center', u'GeneData AG', u'Mesoblast Ltd', u'Suzhou Tianma Pharma Group Tianji Bio-Pharmaceutical Co Ltd', u'Isarna Therapeutics GmbH', u'InSphero AG', u'Vakzine Projekt Management GmbH', u'Amarantus BioScience Holdings Inc', u'Sosei Group Corp', u'Theralase Technologies Inc', u'SRI International', u'DSM Pharmaceutical Products', u'University of California San Diego', u'Centre Leon Berard', u'Nuclea Biotechnologies LLC', u'Orygen Biotecnologia Ltda', u'Jinan University (Guangdong)', u'Prescient Therapeutics Ltd', u'Kalos Therapeutics Inc', u'Tufts University School of Medicine', u'Rush University Medical Center', u'Syncom BV', u'University of Alabama at Birmingham', u'Selventa', u'University of California', u'French Government', u'Arcturus Therapeutics Inc', u'Alliance for Cancer Gene Therapy', u'Shuttle Pharmaceuticals LLC', u'University of Pittsburgh Medical Center', u'Novo A/S', u'Cancer Research Institute (CRI)', u'Atrin Pharmaceuticals', u'Gemin X Pharmaceuticals Inc', u'Biolite Inc', u'US Naval Medical Research Center', u'Finance and Technology International SA', u'Eisai Inc', u'PharmaMar SA', u'OncoImmune Inc', u'Cristal Therapeutics', u'Vancouver General Hospital', u'Epimmune Inc', u'Commissariat a l`Energie Atomique', u'Adamed Group', u'University of Virginia', u'Sidney Kimmel Comprehensive Cancer Center', u'Sorgente', u'JW Life Science Corp', u'Evestra Onkologia Sp. z.o.o.', u'Cyclacel Pharmaceuticals Inc', u'Korean Ministry of Knowledge Economy', u'University of Bradford', u'Janssen Biotech Inc', u'Shaman Pharmaceuticals Inc', u'HD Biosciences', u'NanoVector Inc', u'Pfizer Inc', u'Saladax Biomedical Inc', u'Immunome Inc', u'Senior Scientific LLC', u'Seattle Life Sciences', u'Polybiocept Ab', u'JPT Peptide Technologies GmbH', u'Exsal Ltda', u'NeoOncoRx Inc', u'Tetragenex Pharmaceuticals Inc', u'Northeastern University', u\"The 180th Hospital of the People's Liberation Army\", u'Dr Reddy\\u2019s Research and Development BV', u'Memorial Sloan-Kettering Cancer Center', u'Wyeth BioPharma', u'Ohara Pharmaceutical Co Ltd', u'BioLineRx Ltd', u'Tohoku University', u'McMaster University', u'Enlibrium', u'Baylor College of Medicine', u'GPC Biotech AG', u'Core Diagnostics India', u'Taiho Pharmaceutical Co Ltd', u'Chengdu University', u'Synthelabo', u'CritiTech Inc', u'Angsana Molecular & Diagnostics Laboratory Pte Ltd', u'Pharmascience Inc', u'Kolling Institute of Medical Research', u'Canadian Medical Discoveries Fund Inc', u'iBio Inc', u'Magnetic Insight Inc', u'Eureka Therapeutics Inc', u'BioTime Inc', u'Oasmia Pharmaceutical AB', u'ARTMS Products Inc', u'Cure Forward Corp', u'Heptares Therapeutics Ltd', u'National Institutes of Health', u'Southern Home Medical Inc', u'Food and Drug Administration', u'University of South Australia', u'CTI Clinical Trial and Consulting Services', u'Biotrial SAS', u'Curis Inc', u'Tibet Cheezheng Tibetan Medicine Co Ltd', u'Trellis Bioscience Inc', u'Cardiff University', u'Applied Research using OMIC Sciences SL', u'Select Therapeutics Inc', u'Molecular Logix Inc', u'University of Wollongong', u'Roswell Park Cancer Institute', u'Chiron Viagene Inc', u'Hamamatsu University School of Medicine', u'Transgenomic Inc', u'ACEA Biosciences Inc', u'Trinity College Dublin', u'Mitsui Norin Co Ltd', u'FeRx Inc', u'Guangxi Normal University', u'IBM Watson Health Life Sciences', u'Omega Pharmaceutical Inc', u'Peking University Cancer Hospital', u'Opthea Ltd', u'Merck Serono SA', u'VBL Therapeutics', u'Teikoku Pharma USA Inc', u'Cancer Therapeutics CRC Pty Ltd', u'BeiGene Co Ltd', u'BeneVir Biopharm Inc', u'Institute of Botany Jiangsu Province and Chinese Academy of Sciences', u'NCI Alliance for Nanotechnology in Cancer', u'Immunovative Therapies Ltd', u'Cesca Therapeutics Inc', u'ViroStatics', u'Scancell Ltd', u'University at Buffalo', u'Super-T Cell Cancer Company', u'Technical University of Munich', u'Minerva Biotechnologies Corp', u'Prospect Therapeutics Inc']), u'Polycysticovarysyndrome': set([u'Teva Pharmaceutical Industries Ltd', u'EffRx Pharmaceuticals SA', u'Eunice Kennedy Shriver National Institute of Child Health & Human Development', u'Crinetics Pharmaceuticals Inc', u'National Institutes of Health', u'Millendo Therapeutics Inc', u'AstraZeneca plc', u'Amylin Pharmaceuticals Inc', u'European Commission']), u'Rheumatoidarthritis': set([u'Quest Diagnostics Inc', u'Gismo Therapeutics Inc', u'Augurex Life Sciences Corp', u'Scil Technology GmbH', u'WuXi PharmaTech (Cayman) Inc', u'BioXpress Therapeutics SA', u'Sandoz International GmbH', u'European Commission', u'MENTRIK Biotech LLC', u'Turgut \\u0130laclari As', u'Suntory Ltd', u'Warner-Lambert Co', u'Synergy Pharmaceuticals Inc', u'Innovimmune Biotherapeutics Inc', u'Eddingpharm Inc', u'National Institutes of Health', u'Questcor Pharmaceuticals Inc', u'SkyePharma plc', u'Ionis Pharmaceuticals Inc', u'Ribomic Inc', u'Coherus BioSciences Inc', u'Fannin Innovation', u'University of Florida', u'Italchimici SpA', u'ISTA Pharmaceuticals Inc', u'Celldex Therapeutics Inc', u'Carna Biosciences Inc', u'Hospira Inc', u'Shenzhen Main Luck Pharmaceuticals Inc', u'CeNeS Pharmaceuticals plc', u'Inventiv Health Clinical Inc', u'Yuhan Corp', u'Galapagos NV', u'Kaketsuken', u'Hansa Medical AB', u'Orphagen Pharmaceuticals Inc', u'Microbio Co Ltd', u'Vasogen Inc', u'Phenex Pharmaceuticals AG', u'Celera South San Francisco', u'Sandoz Ltd', u'mAbxience SA', u'Toray Industries Inc', u'Catalent Inc', u'Merckle GmbH', u'AutoImmune Inc', u'Medical Research Council', u'Sinocelltech Ltd', u'Alseres Pharmaceuticals Inc', u'Neurocrine Biosciences Inc', u'Baxalta Inc', u'Biomeks Ilac', u'Curative Health Services', u'CrystalGenomics Inc', u'Academic Medical Center, University of Amsterdam', u'Valocor Therapeutics Ltd', u'National Health and Medical Research Council', u'Entelos Inc', u'Israeli Government', u'Protalix BioTherapeutics Inc', u'CEL-SCI Corp', u'Cambridge Antibody Technology Group plc', u'The European Union', u'Nippon Kayaku Co Ltd', u'Glenmark Pharmaceuticals Ltd', u'Livzon MabPharm', u'Bioceros BV', u'Abmaxis Inc', u'US Health and Human Services Department', u'Znomics Inc', u'Maxygen Inc', u'Phytomedics Inc', u'Vanderbilt University', u'Hanmi Pharmaceutical Co Ltd', u'Merrimack Pharmaceuticals Inc', u'Santen Pharmaceutical Co Ltd', u'Mallinckrodt Inc', u'SuppreMol GmbH', u'Pharmacopeia Inc', u'Toyama Chemical Co Ltd', u'Univ Massachusetts', u'Wellcome Trust', u'Kyorin Pharmaceutical Co Ltd', u'Ohr Pharmaceutical Inc', u'MegaPharm Ltd', u'Taligen Therapeutics Inc', u'Janssen Pharmaceutica NV', u'Verigen Inc', u'CSPC Pharmaceuticals Group Limited', u'Torrent Pharmaceuticals Ltd', u'4SC AG', u'Diamyd Medical AB', u'Oncobiologics Inc', u'Swedish Orphan Biovitrum AB', u'Nichi-Iko Pharmaceutical Co Ltd', u'Pharmexa A/S', u'University of Queensland', u'AmorePacific Corp', u'Mitsui & Co Ltd', u'moksha8 Pharmaceuticals Inc', u'Shanghai Institutes for Biological Sciences CAS', u'Progenra Inc', u'VGX Pharmaceuticals LLC', u'Grunenthal GmbH', u'Dong-A ST Co Ltd', u'Apogee Biotechnology Corp', u'Velcura Therapeutics Inc', u'Arthrogen BV', u'Tularik Inc', u'Medical University of South Carolina', u'Advanced Proteome Therapeutics Inc', u'Advanced Viral Research Corp', u'Oregon Health Sciences University', u'The Dow Chemical Co', u'JW CreaGene Inc', u'Emergent BioSolutions Inc', u'Chia Tai Tianqing Pharmaceutical Group Co Ltd', u'Daewoong Pharmaceutical Co Ltd', u'TcLand SA', u'Meda AB', u'Eli Lilly & Co', u'Isotechnika Pharma Inc', u'CSL Ltd', u'Cook Pharmica', u'Humanigen Inc', u'Alder Biopharmaceuticals Inc', u'Penwest Pharmaceuticals Co', u'GroupMed (Holding)', u'Washington University in St Louis', u'University of California Los Angeles', u'MedImmune LLC', u'EIP Pharma LLC', u'Michigan State University', u'Cell Signals Inc', u'Cumberland Pharmaceuticals Inc', u'Corixa Corp', u'Denki Kagaku Kogyo Kabushiki Kaisha', u'Kern Pharma SL', u'RuiYi Inc', u'Kang Stem Holdings Co Ltd', u'Johns Hopkins University', u'Zalicus Inc', u'University of Regensburg', u'Johnson & Johnson', u'Artielle ImmunoTherapeutics Inc', u'AbbVie Inc', u'SomaLogic Inc', u'Protein Therapeutics Inc', u'Poseidon Pharmaceuticals A/S', u'Metabolon Inc', u'Samsung Bioepis', u'Tiziana Life Sciences PLC', u'SmithKline Beecham plc', u'Taisho Pharmaceutical Co Ltd', u'Victory Pharma Inc', u'UCB Celltech', u'Takeda Pharmaceutical Co Ltd', u'Servier', u'Kereos Inc', u'Fresenius SE & Co KGaA', u'GenQual Corp', u'Bristol-Myers Squibb Co', u'ChemOvation Ltd', u'OSEO', u'Evotec (UK) Ltd', u'Accentia BioPharmaceuticals Inc', u'Rush University Medical Center', u'Chinese Academy of Sciences', u'Dr Rentschler Biotechnologie GmbH', u'Galera Therapeutics Inc', u'Astellas Pharma Inc', u'Advanced Biotherapy Inc', u'Knoll GmbH', u'Beijing Collab Pharma Co Ltd', u'Antisoma plc', u'Coulter Pharmaceutical Inc', u'Metaphore Pharmaceuticals Inc', u'AET BioTechnology Ltd', u'Arthritis Foundation', u'Hebrew University of Jerusalem', u'University of Oxford', u'Immuno-Designed Molecules SA', u'Hayashibara Co Ltd', u'Nordic Group', u'Proter', u'Hadassah University Hospital', u'Theragen Inc', u'INOVA Diagnostics Inc', u'Enceladus Pharmaceuticals', u'Rheumco LLC', u'Cell Therapies Pty Ltd', u'University of Cambridge', u'DSM Pharmaceuticals Inc', u'MaimoniDex RA', u'GenPat77 Pharmacogenetics AG', u'Novo Nordisk A/S', u'Regeneron Pharmaceuticals Inc', u'NovelMed Therapeutics Inc', u'Angiotech Pharmaceuticals Inc', u'Universiteit Hasselt', u'Dynavax Technologies Corp', u'Stellar Biotechnologies Inc', u'IDEC Pharmaceuticals Corp', u'Incyte Corp', u'Orion Corporation', u'PROLOR Biotech Inc', u'Diurnal Ltd', u'BTG plc', u'Unitech Pharmaceuticals Inc', u'Torii Pharmaceutical Co Ltd', u'Medidata Solutions Worldwide', u'Lead Pharma Holding BV', u'A&G Pharmaceutical Inc', u'Chiron Corp', u'Savient Pharmaceuticals Inc', u'Latona Life Sciences Inc', u'DSM Chemie Linz GmbH', u'Xenova Group plc', u'Erimos Pharmaceutical LLC', u'Selexis SA', u'US Department of Veterans Affairs', u'Aton Pharma Inc', u'Astex Pharmaceuticals Inc', u'Stanford University', u'Valentis Inc', u'Vernalis plc', u'LTT Bio-Pharma Co Ltd', u'Navidea Biopharmaceuticals Inc', u'Aventis SA', u'Ono Pharmaceutical Co Ltd', u'Roche Holding AG', u'Shire plc', u'MorphoSys AG', u'Mitsubishi Tanabe Pharma Corp', u'Cellinbio Co Ltd', u'Sanomune Inc', u'Sayre Therapeutics Private Ltd', u'Nodthera Ltd', u'UCB Pharma SA', u'Selvita SA', u'ImmuLogic Pharmaceutical Corp', u'KAHR Medical Ltd', u'Biocon Ltd', u'Eukarion Inc', u'Interprotein Corp', u'Teijin Pharma Ltd', u'Biomedical Research Models Inc', u'Diplomat Pharmacy Inc', u'Charite Universitaetsmedizin Berlin', u'University of Massachusetts Medical School', u'AAA Canada', u'National Institute of General Medical Sciences', u'Evotec AG', u'Trubion Pharmaceuticals Inc', u'Polysan Scientific Technological Pharmaceutical Co', u'McMaster University', u'Amgen Inc', u'Opexa Therapeutics Inc', u'Saudi-Arabian Japanese Pharmaceutical Co', u'Fujifilm Kyowa Kirin Biologics Co Ltd', u'Catholic University of Korea', u'Galena Biopharma Inc', u'University of Aberdeen', u'Conpharm AB', u'AnaMar Medical AB', u\"Seattle Children's Hospital\", u'University of Bristol', u'Palau Pharma SA', u'Stiefel Laboratories (UK) Ltd', u'CGI Pharmaceuticals Inc', u'Jiangsu Hengrui Medicine Co Ltd', u'CleveXel Pharma', u'Sanofi-Synthelabo', u'Abgenix Inc', u'Inflazyme Pharmaceuticals', u'Commence Bio Inc', u'GenPharm International Inc', u'Allergan plc', u'Lonza Group AG', u'Immunomedics Inc', u'Navigen Inc', u'Janssen Pharmaceutical KK', u'Merck Millipore', u'OXO', u'Can-Fite BioPharma Ltd', u'Acelerox LLC', u'Albany Molecular Research Inc', u'Janssen-Cilag Ltd', u'Alvogen Inc', u'Zhejiang Huahai Pharmaceutical Group Co Ltd', u'GeneBlue Corp', u'Osaka University', u'Caisson Biotech LLC', u'International Medical University', u'Xencor Inc', u'Promosome LLC', u'DuPont Pharmaceuticals Ltd', u'Wyeth-Ayerst Pharmaceuticals Inc', u'Seikagaku Corp', u'Highnoon Laboratories Ltd', u'Ranbaxy Laboratories Ltd', u'F Hoffmann-La Roche AG', u'Novosom AG', u'Nuon Therapeutics Inc', u'Viron Therapeutics Inc', u'Argenes Inc', u'The Center of Molecular Immunology', u'Shanghai Genomics Inc', u'Genentech Inc', u'OJSC Farmak', u'OxyPharma AB', u'Xian-Janssen Pharmaceutical Ltd', u'Prismic Pharmaceuticals Inc', u'Korea Drug Development Fund', u'Rigel Pharmaceuticals Inc', u'ARC Ventures', u'Hi-Tech Pharmacal Co Inc', u'Uman Pharma', u'PAZ Arzneimittelentwicklungsgesellschaft GmbH', u'Phenicia Group', u'SFJ Pharmaceuticals Inc', u'Eastern Virginia Medical School', u'PDL BioPharma Inc', u'Scripps Research Institute', u'Celonic AG', u'Stada Arzneimittel AG', u'BioFocus DPI', u'Research Corporation Technologies', u'Monogram Biosciences Inc', u'CASI Pharmaceuticals Inc', u'Japan Tobacco Inc', u'Blansett Pharmacal Co Inc', u'GMP Companies Inc', u'ActivBiotics Inc', u'Vittal Mallya Scientific Research Foundation', u'Vitaeris Inc', u'Kangwon National University', u'R-Pharm', u'Hyundai Pharmaceutical', u'Lycera Corp', u'IVAX Corp', u'AstraZeneca plc', u'L2 Diagnostics Llc', u'Immuno-Biological Laboratories Co Ltd', u'Glasgow Caledonian University', u'Alkermes plc', u'Horizon Pharma plc', u'Lonza Biologics plc', u'Terumo Corp', u'Han Seo Pharm Co Ltd', u'Introgen Therapeutics Inc', u'Zynaxis Inc', u'Australian Government', u'CSL Behring LLC', u'Genmab A/S', u'Portola Pharmaceuticals Inc', u'Reliance Life Sciences Group', u'Axogen Ltd', u'Mochida Pharmaceutical Co Ltd', u'Institute of Materia Medica Chinese Academy of Medical Sciences & Peking Union Medical College', u'Knoll Pharmaceuticals Ltd', u'Ben-Gurion University Of The Negev', u'Alfa Wassermann SpA', u'Tokyo Medical and Dental University', u'Abiogen Pharma SpA', u'Laboratorio Medinfar - Productos Farmaceuticos Lda', u'BioNovis', u'Theracos Inc', u'MMRGlobal', u'Senju Pharmaceutical Co Ltd', u'Samil Pharmaceutical Co Ltd', u'Horizon Pharma GmbH', u'TechnoPhage SA', u'Fujifilm Diosynth Biotechnologies', u'Immunovaccine Inc', u'VG Life Sciences Inc', u'Critical Therapeutics Inc', u'Dong Wha Pharmaceutical Co Ltd', u'Valeant Pharmaceuticals International Inc', u'Hurley Consulting Associates Ltd', u'Hospira Adelaide Pty Ltd', u'Kennedy Institute of Rheumatology', u'Pepscan Systems BV', u'Undisclosed', u'Nexpep Pty Ltd', u'arGentis Pharmaceuticals LLC', u'GE Healthcare', u'CEVEC Pharmaceuticals GmbH', u'Walter and Eliza Hall Institute of Medical Research', u'Institute of Medicinal Molecular Design Inc', u'DGX Pharma', u'Antitope Ltd', u'Nextera AS', u'Zhangjiang Biotechnology Co Ltd', u'Berlex Laboratories Inc', u'German Federal Ministry of Education and Research', u'Biopasgroup', u'Sanofi-Aventis US LLC', u'Ignyta Inc', u'Acceleron Pharma Inc', u'Royal DSM NV', u'Takeda GmbH', u'Sociedade Beneficente Israelita Brasileira Hospital Albert Einsten', u'Arana Therapeutics Ltd', u'Neovacs SA', u'Anika Therapeutics Inc', u'Biotest AG', u'Forest Laboratories Inc', u'Tonghua Dongbao Pharmaceutical Co Ltd', u'University of Gottingen', u'ProtAb Ltd', u'Rice University', u'Vernalis Group plc', u'Cytogen Corp', u'Meyer Pharmaceuticals LLC', u'Hunter-Fleming Ltd', u'Inflammatics Inc', u'Medipost Co Ltd', u'TR-Pharm', u'Aventis Pharma AG', u'Hunan University of Traditional Chinese Medicine', u'Johannes Gutenberg Universitat Mainz', u'Leiden University Medical Center', u'Molecumetics Ltd', u'Zeneca Group plc', u'Mercian Corp', u'Five Prime Therapeutics Inc', u'Nissan Chemical Industries Ltd', u'Cipher Pharmaceuticals Inc', u'University of Manitoba', u'Instituto Vital Brazil', u'ARIUS Research Inc', u'Atrium Medical Corp', u'Fidia Group', u'LLD Nybohov Invest Ltd', u'University of Kentucky', u'EPIRUS Biopharmaceuticals Inc', u'Korean Ministry of Commerce, Industry & Energy', u'Keio University', u'Pfizer Inc', u'Vertex Pharmaceuticals Inc', u'Signal Research Division', u'Hikma Pharmaceuticals plc', u'Nereus Pharmaceuticals Inc', u'TxCell SA', u\"Tianjin Municipal People's Government\", u'Polpharma Biologics', u'Mylan Inc', u'Pediapharm Inc', u'Japan Science and Technology Agency', u'Angelini Pharmaceuticals SpA', u'LocomoGene Inc', u'Harvard University', u'Laboratorios Elmor SA', u'Therapeutic Human Polyclonals Inc', u'twoXar Inc', u'Santarus Inc', u'Vasix Corp', u'Repligen Corp', u'Amarillo Biosciences Inc', u'Isogenica Ltd', u'Bolder BioTechnology Inc', u'IMIDomics SL', u'Teva Pharmaceutical Industries Ltd', u'CytoCore Inc', u'Kwang Dong Pharmaceutical Co Ltd', u'Tolerx Inc', u'Boehringer Ingelheim International GmbH', u'Medexus Inc', u'Affymetrix Inc', u'MediGene Ltd', u'Lacer SA', u'Ferring Pharmaceuticals SA', u'Affilogic Laboratories', u'Millennium Pharmaceuticals Ltd', u'AnGes MG Inc', u'Fujirebio Europe NV', u'Encysive Pharmaceuticals Inc', u'Boehringer Ingelheim Corp', u'Hoffmann-La Roche Inc', u'TiGenix NV', u'Debiopharm SA', u'21st Century Therapeutics Inc', u'GNS Healthcare', u'ILEX Oncology Inc', u'Beijing Sciecure Pharmaceutical Co Ltd', u'Duke University Medical Center', u'Wyeth Pharmaceuticals', u'Idogen AB', u'Celltrion Healthcare Co Ltd', u'Connetics Corp', u'Modern Biosciences plc', u'Cipla Ltd', u'Dendright Pty Ltd', u'Schering-Plough Corp', u'Baxter Healthcare Corp', u'Shanghai Institute of Materia Medica of the Chinese Academy of Sciences', u'Elan Pharmaceutical Technologies', u'Orygen Biotecnologia Ltda', u'XOMA Corp', u'University of California', u'Merck & Co Inc', u'Perlegen Sciences Inc', u'ChemoCentryx Inc', u'rEVO Biologics Inc', u'Sanofi', u'ForHumanTech Co Ltd', u'DNA Pharmaceuticals Inc', u'Feinstein Institute for Medical Research', u'Tanabe Seiyaku Co Ltd', u'NewBridge Pharmaceuticals Ltd', u'Ensemble Therapeutics Corp', u'Bayer AG', u'Phytera Inc', u'InNexus Biotechnology Inc', u'CBio Ltd', u'Nektar Therapeutics', u'Jagotec AG', u'Jikei University', u'Almirall Prodesfarma SA', u'Therapure Biopharma Inc', u'ArQule Inc', u'Gilead Sciences Inc', u'Kaken Pharmaceutical Co Ltd', u'Taizhou MTYB Biotech Co Ltd', u'Synthetic Biologics Inc', u'CIS Bio International SAS', u'Kineta Inc', u'TSH Biopharm Corporation Limited', u'Wyeth', u'Aptuit Inc', u'Acambis plc', u'Antares Pharma Inc', u'Nuo Therapeutics Inc', u'AnorMED Inc', u'Advanced Neuroscience Allies Pvt Ltd', u'Takeda Pharmaceuticals International GmbH', u'InnVentis', u'University of Kansas', u'Walter Reed Army Institute of Research', u'Astra AB', u'Dojin Iyaku-Kako Co Ltd', u'Pfizer Japan Inc', u'Novartis Pharma KK', u'Juvenile Diabetes Research Foundation', u'Aurigene Discovery Technologies Ltd', u'University of Tokyo', u'Ablynx NV', u'Oscotec Inc', u'Elan Corp plc', u'City of Hope', u'INSERM', u'Kuros Biosciences Ltd', u'Ligand Pharmaceuticals Inc', u'Regulus Therapeutics Inc', u'Mundipharma International Corp Ltd', u'Celgene Corp', u'Par Pharmaceutical Co Inc', u'Eurofarma', u'SangStat Medical Corp', u'KS Biomedix Holdings plc', u'BioTie Therapies Corp', u'Tufts University', u'School of Medicine, Keio University', u'Sosei R&D Ltd', u'Queensland Institute of Medical Research', u'Endocyte Inc', u'GD Searle & Co', u'13Therapeutics Inc', u'BioSeek LLC', u'Novis Pharmaceuticals Llc', u'LeukoSite Inc', u'US Government', u'Cooper Maroc Pharmaceuticals', u'Ganial Immunotherapeutics', u'Galenica AG', u'Baxter International Inc', u'Humanwell Healthcare (Group) Co Ltd', u'MSD OSS BV', u'Nodality Inc', u'Melacure Therapeutics AB', u'HTG Molecular Diagnostics Inc', u'Biogen Inc', u'Unigene Laboratories Inc', u'GlaxoSmithKline plc', u'Celltrion Inc', u'Covance Inc', u'Bayer Schering Pharma AG', u'Meizler UCB Biopharma SA', u'NPS Pharmaceuticals Inc', u'Immunex Corp', u'I N C Research Ltd', u'Dynamix Pharmaceuticals Ltd', u'Circassia Pharmaceuticals plc', u'Novimmune SA', u'University of Michigan', u'Protein Mechanics Inc', u'FAES Farma SA', u'Takeda Oncology', u'Coral Therapeutics, Inc', u'CarboMed Inc', u'Davos Life Science Pte Ltd', u'Shanghai Pharmaceutical Group Corp', u'Shionogi & Co Ltd', u'Alere Inc', u'Reata Pharmaceuticals Inc', u'Institute of Bone and Joint Research', u'LipoCure', u'Theradiag', u'Murdoch University', u'Biomedical Primate Research Centre', u'UCB SA', u'ECI Inc', u'SS Pharmaceutical - ethical drug division', u'Apexigen Inc', u'National Institute of Arthritis and Musculoskeletal and Skin Diseases', u'Aronex Pharmaceuticals Inc', u'Lansen Pharmaceutical Holdings Limited', u'MD Anderson Cancer Center', u'Alexion Pharmaceuticals Inc', u'Mitsubishi Corp', u'Medarex Inc', u'Botanix Pharmaceuticals Ltd', u'MIKA Pharma GmbH', u'National Institute for Health Research (NIHR)', u'Daiichi Sankyo Co Ltd', u'Abbott Laboratories', u'Eisai Co Ltd', u'3SBio Inc', u'Warner Lambert Pty Ltd', u'Proteros Biostructures GmbH', u'National Cancer Institute', u'Novartis AG', u'Merck KGaA', u'arGEN-X NV', u'Korea Research Institute of Bioscience and Biotechnology', u'PharmaCell', u'Novelion Therapeutics Inc', u'Ewopharma AG', u'Pacira Pharmaceuticals Inc', u'Simcere Pharmaceutical Group', u'SIBIA Neurosciences Inc', u'Tianjin Hemay Bio-Tech Co Ltd', u'Mycenax Biotech Inc', u'Novartis Pharma AG', u'Monash University', u'Oryn Therapeutics', u'CHU De Nantes', u'Firalis SAS', u'National Institute Of Environmental Health Sciences', u'Sunovion Pharmaceuticals Canada Inc', u'Orient Europharma', u'Piramal Enterprises Ltd', u'Immune Response BioPharma Inc', u'University of Colorado System', u'McGill University', u'Ethypharm SA', u'Montana State University', u'Effimune SA', u'Ferrer Internacional SA', u'Lupin Ltd', u'AcSentient Inc', u'Covis Pharma Sarl', u'Kyowa Hakko Kogyo Co Ltd', u'RecipharmCobra Biologics', u'Compugen Ltd', u'Recordati SpA', u'Bird Rock Bio Inc', u'Royalty Pharma', u'Pharming Group NV', u'Epitech Group Srl', u'Chugai Pharmaceutical Co Ltd', u'Ortho Biotech Products LP', u'Acyte Biotec Pty Ltd', u'Hayashibara Biochemical Laboratories Inc', u'Otsuka Pharmaceutical Co Ltd', u'Morvus Technology Ltd', u'Hanwha Corp', u'Ultrafine Chemicals Ltd', u'University of California San Diego', u'TenX Biopharma Inc', u'Callisto Pharmaceuticals Inc', u'TCH Pharmaceuticals', u'Diabetogen BioSciences Inc', u'Republic of Korea Government', u'Queen Mary University of London', u'Jeil Pharmaceutical Co Ltd', u'National Institute on Drug Abuse', u'Syntrix Biosystems Inc', u'Merck Sharp & Dohme de Espana SA', u'Nanjing University', u'Oxford BioDynamics Ltd', u'Radboud University', u'Alloksys Life Sciences BV', u'OncoImmune Inc', u'Laboratoire L Lafon SA', u'Epimmune Inc', u'Cellmid Ltd', u'Maruho Co Ltd', u'Recoly NV', u'Crossject', u'Kyowa Hakko Kirin Co Ltd', u'The University of Newcastle Upon Tyne', u'NicOx SA', u'Merck Research Laboratories', u'Kissei Pharmaceutical Co Ltd', u'Cyclacel Pharmaceuticals Inc', u'University of Tennessee', u'Janssen Biotech Inc', u'Hebei Feinisi Biotechnology Co Ltd', u'Daewon Pharm Co Ltd', u'Human Genome Sciences Inc', u'Tsumura & Co', u'Chong Kun Dang Pharmaceutical Corp', u'deCODE genetics ehf', u'Zhejiang CONBA Pharmaceutical Co Ltd', u'Yissum Research Development Co', u'Tobira Therapeutics Inc', u'Block Drug Co Inc', u'BioLineRx Ltd', u'LG Life Sciences Ltd', u'Baylor College of Medicine', u'University of Gothenburg', u'Laboratorios Farmaceuticos Rovi SA', u'Mabion SA', u'UK Government', u'Yoshindo Inc', u'Hubei Bio-Pharmaceutical Industrial Technological Institute Inc', u'National Institute of Allergy and Infectious Diseases', u'Merck Frosst Canada & Co', u'Praecis Pharmaceuticals Inc', u'EUSA Pharma USA', u'Phylogica Ltd', u'Development Center for Biotechnology', u'NAEJA Pharmaceuticals Inc', u'Aspreva International Ltd', u'Axxiom Inc', u'Asahi Kasei Pharma Corp', u'AYUMI Pharmaceutical Corp', u'Sino Biological Inc', u'Thomas Jefferson University', u'Onyx Pharmaceuticals Inc', u'Shanghai Biomabs Pharmaceutical Co Ltd', u'SignaBlok Inc', u'The University of Birmingham', u'Cambrex Corp', u'Merck Serono SA', u'Idera Pharmaceuticals Inc', u'Cypress Bioscience Inc', u'Cardion AG', u'Gedeon Richter Ltd', u'Paligent Inc', u'AcurePharma AB', u'BioCryst Pharmaceuticals Inc', u'BASF AG']), u'Oculardisease': set([u'ForSight VISION4 Inc', u'Ocugen Inc', u'Archemix Corp', u'Neurobiological Technologies Inc', u'Univ Massachusetts', u'Royal DSM NV', u'MethylGene Inc', u'pSivida Corp', u'MacuSight Inc', u'Ionis Pharmaceuticals Inc', u'ViSci Ltd', u'Advanced Ocular Systems Ltd', u'MedPharm Ltd', u'ActiveSite Pharmaceuticals Inc', u'ISTA Pharmaceuticals Inc', u'Sigma-Aldrich Corp', u'RPS Diagnostics', u'Ramot at Tel Aviv University Ltd', u'University of Rochester', u'National Institute of Advanced Industrial Science and Technology', u'DNX Biopharmaceuticals Inc', u'Grifols Inc', u'Galapagos NV', u'Recipharm AB', u'Retina Vitreous Associates, P.C.', u'Polyphor Ltd', u'Shire Orphan Therapies GmbH', u'Abbott Medical Optics Inc', u'Catalent Inc', u'HanAll Biopharma Co Ltd', u'ElsaLys Biotech', u'Senju Pharmaceutical Co Ltd', u'REGENXBIO Inc', u'Alcon Research Ltd', u'National Health and Medical Research Council', u'PDL BioPharma Inc', u'McLean Hospital Corp', u'MABLife', u'Sirnaomics Inc', u'Jerini Ophthalmic Inc', u'Peptor Ltd', u'Croma Pharma GmbH', u'Nuvue Technologies Inc', u'The New Energy and Industrial Technology Development Organization', u'Essex Bio-Technology Ltd', u'SIFI Societa Industria Farmaceutica Italiana SpA', u'Hanmi Pharmaceutical Co Ltd', u'Agennix AG', u'Santen Pharmaceutical Co Ltd', u'TRACON Pharmaceuticals Inc', u'Ceregene Inc', u'Precision Lens', u'Shire plc', u'ESBATech AG', u'20/20 HealthCare Partners LLC', u'ImmersiveTouch', u'Infinity Pharmaceuticals Inc', u'Rutgers University', u'Bausch & Lomb Inc', u'RheoGene Inc', u'Innocore Technologies BV', u'NPS Pharmaceuticals Inc', u'Institut de Recherches Cliniques de Montreal', u'Mirati Therapeutics Inc', u'Kato Pharmaceuticals Inc', u'Ajinomoto Co Inc', u'Origenis GmbH', u'Ophthotech Corp', u'Juvantia Pharma Ltd', u'PR Pharmaceuticals Inc', u'Abpro Inc', u'Oregon Health Sciences University', u'US Government', u'Daewoong Pharmaceutical Co Ltd', u'AmorChem LP', u'LEO Pharma A/S', u'Isotechnika Pharma Inc', u\"Lee's Pharmaceutical Holdings Limited\", u'ID Pharma Co Ltd', u'Fight for Sight', u'CSL Ltd', u'Eyegate Pharmaceuticals Inc', u'Taejoon Pharm Co Ltd', u'University of Ulster', u'IBM Watson Health Life Sciences', u'CeNeS Pharmaceuticals Inc', u'pSivida Inc', u'Akorn Inc', u'Hopital Saint-Louis', u'Government of the Republic of Singapore', u'Harbor Therapeutics Inc', u'Johnson & Johnson', u'Dalton Pharma Services', u'Lux Biosciences Inc', u'Nanomerics Ltd', u'Medical Need Europe AB', u'Bristol-Myers Squibb Co', u'MacuCLEAR Inc', u'KalVista Pharmaceuticals Inc (Pre-merger)', u'Catholic University of Korea', u'Astellas Pharma Inc', u'Editas Medicine Inc', u'Eyenovia Inc', u'Avedro Inc', u'Fischer Pharmaceuticals Ltd', u'Oncodesign Biotechnology SA', u'Bridge Pharmaceuticals Inc', u'Amdipharm Mercury Company Ltd', u'Luitpold Pharmaceuticals Inc', u'Regeneron Pharmaceuticals Inc', u'Universitaire Ziekenhuizen Leuven', u'Angiotech Pharmaceuticals Inc', u'SurModics Inc', u'Gene Signal SAS', u'RetroSense Therapeutics', u'University of Waterloo', u'TheraKine Ltd', u'Pharmacyclics Inc', u'BTG plc', u'DURECT Corp', u'Dharmacon Inc', u'Texas A&M University System', u'Savient Pharmaceuticals Inc', u'The European Union', u'Genentech Inc', u'Vital Art & Science Inc', u'Vernalis plc', u'RFE Pharma Corp', u'Mateon Therapeutics Inc', u'Angioblast Systems Inc', u'Roche Holding AG', u'Chiroscience Group plc', u'University of British Columbia', u'INSERM', u'DelSiTech Ltd', u'The National Institute of Mental Health', u'ANI Pharmaceuticals Inc', u'Nicox Ophthalmics Inc', u'Biocon Ltd', u'Bayer HealthCare AG', u'Catalyst Biosciences Inc', u'Tangible Science LLC', u'Orient Europharma', u'R-Tech Ueno Ltd', u'Stealth BioTherapeutics Inc', u'University of Massachusetts Medical School', u'Sorrento Therapeutics Inc', u'Sysmex Corp', u'Beijing Beidestar Technology and Development Ltd', u'Diaxonhit', u'Amgen Inc', u'Easton Pharmaceuticals Inc', u'Affibody AB', u'Stelis Biopharma Pvt Ltd', u'Amring Pharmaceuticals Inc', u'ACADIA Pharmaceuticals Inc', u'BioPharmaceuticals Australia', u'Singapore Eye Research Institute', u'RIKEN', u'Guangdong Zhongsheng Pharmaceutical Co Ltd', u'Inflazyme Pharmaceuticals', u'Yeda Research and Development Co Ltd', u'Mati Therapeutics Inc', u'RxGen Inc', u\"M's Science Corp\", u'Lubris BioPharma', u'NVISION Eye Centers', u'MingSight Pharmaceuticals', u'MD Distributor Corp', u'Albany Molecular Research Inc', u'Prasco Laboratories', u'Allergan Inc', u'Actinobac Biomed Inc', u'Gene Techno Science Co Ltd', u'Ark Therapeutics Group plc', u'Oculex Pharmaceuticals Inc', u'University of California San Diego', u'GHO Capital Partners LLP', u'Inception Sciences Inc', u'University of Oxford', u'Xcovery Vision', u'Astellas Institute for Regenerative Medicine', u'Mayo Clinic Foundation', u'Laureate Biopharmaceutical Services Inc', u'Acucela Inc', u'Hi-Tech Pharmacal Co Inc', u'EyeCyte Inc', u'Sumitomo Dainippon Pharma Co Ltd', u'University of Florida', u'StrideBio LLC', u'Alkermes plc', u'Flinders Medical Centre', u'CASI Pharmaceuticals Inc', u'Zuellig Pharma Ltd', u'Novaliq GmbH', u'Disease Interception Accelerator', u'AEterna Zentaris Inc', u'University of Debrecen', u'University of Melbourne', u'AstraZeneca plc', u'SUGEN Inc', u'University of Utah', u'Adenosine Therapeutics LLC', u'Benitec Inc', u'Paragon BioTeck Inc', u'Portola Pharmaceuticals Inc', u'Eyecopharm AG', u'Pharmos Corp', u'University of Mississippi', u'Auven Therapeutics', u'PharmaNova Inc', u'Massachusetts Eye & Ear Infirmary', u'Samil Pharmaceutical Co Ltd', u'MeiraGTx', u'Spectrum Pharmaceuticals Inc', u'Kyoto University', u'Fujifilm Diosynth Biotechnologies', u'ThromboGenics NV', u'Valeant Pharmaceuticals International Inc', u'Jinan Bestcomm Pharmaceutical R&D Co Ltd', u'Alphagen Laboratories Inc', u'BioDiem Ltd', u'HOYA Vision Care', u'3M Co', u'Xenome Ltd', u'ONL Therapeutics LLC', u'Master Medical Technology Co.', u'Teligent Inc', u'RXi Pharmaceuticals Corp', u'Clinical Data Inc', u'Scope Ophthalmics', u'Symphony Capital LLC', u'Johnson & Johnson Vision Products Inc', u'Novartis Ophthalmics Inc', u'Henderson Morley plc', u'Inflamalps SA', u'Cytopathfinder Inc', u'Merck Sharp & Dohme BV', u'Ocular Therapeutix Inc', u'Axim Biotechnologies Inc', u'OncoTherapy Science Inc', u'Lynx Therapeutics GmbH', u'Forest Laboratories Inc', u'CHA Bio & Diostech Co Ltd', u'Parion Sciences Inc', u'LegoChem Bioscience Inc', u'Kala Pharmaceuticals Inc', u'Leiden University Medical Center', u'NuvOx Pharma LLC', u'Apotex Inc', u'Hy BioPharma Inc', u'Aurora Biosciences Corp', u'University of London', u'Sinphar Pharmaceutical Co Ltd', u'Opthea Ltd', u'ARIAD Pharmaceuticals Inc', u'SamChunDang Pharm Co Ltd', u'Sun Pharmaceutical Industries Ltd', u'Lankenau Institute for Medical Research', u'Peplin Inc', u'Eyetech Inc', u'Inspire Pharmaceuticals Inc', u'Allegro Ophthalmics LLC', u'NovaMedica', u'Eyecro Llc', u'Forsight Labs, LLC', u'Saphetor', u'ZaBeCor Pharmaceutical Co', u'4D Molecular Therapeutics LLC', u'Harvard University', u'Institut de la Vision', u'Leadiant Biosciences Inc', u'BRIM Biotechnology Inc', u'Alimera Sciences Inc', u'National Neurovision Research Institute', u'Teva Pharmaceutical Industries Ltd', u'Moorfields Eye Hospital', u'University of California San Francisco', u'Angelini Pharmaceuticals SpA', u'Novartis Ophthalmics AG', u'OPKO Health Inc', u'Incept LLC', u'Sirion Therapeutics Inc', u'Carrus Capital Corp', u'United States Air Force', u'RxElite', u'Biozone Laboratories Inc', u'Jade Therapeutics', u'BIKAM Pharmaceuticals Inc', u'BioInvent International AB', u'University of Sydney', u'CIBA Vision Corp', u'Consejo Nacional de Ciencia y Tecnolog\\xeda', u'Kinetek Pharmaceuticals Inc', u'Quidel Corp', u'Wyeth Pharmaceuticals', u'Miravant Medical Technologies', u'Harvard Medical School', u'Oxford BioMedica plc', u'TOT Biopharm Co Ltd', u'XOMA Corp', u'University of California', u'Merck & Co Inc', u'National Eye Institute', u'Sanofi', u'Chong Kun Dang Pharmaceutical Corp', u'Columbia University', u'Bayer AG', u'Pharmacia Corp', u'Case Western Reserve University', u'BioSeek Plc', u'SynergEyes Inc', u'Gilead Sciences Inc', u'Childrens Medical Center Corp', u'Synthetic Biologics Inc', u'Caladrius Biosciences Inc', u'Kineta Inc', u'US Department of Defense', u'Institute for the Promotion of Innovation by Science and Technology in Flanders', u'Sucampo Pharmaceuticals Inc', u'Alcon Inc', u'Genisphere LLC', u'Apellis Pharmaceuticals Inc', u'University of Michigan', u'Intrexon Corp', u'University of Pennsylvania', u'SBI Holdings Inc', u'CRISPR Therapeutics', u'Knight Therapeutics Inc', u'DanioLabs Ltd', u'PowderJect Pharmaceuticals plc', u'Idx Llc', u'Athena Vision Ltd', u'Cirle', u'Ablynx NV', u'Gifu Pharmaceutical University', u'GlaxoSmithKline KK', u'Iris Pharma', u'MorphoSys AG', u'Parke-Davis & Co', u'Kalypsys Inc', u'Cephalon Inc', u'Par Pharmaceutical Co Inc', u'Sosei Group Corp', u'Repugen', u'BC Cancer Agency', u'Apollo Endosurgery Inc', u'Destiny Pharma Ltd', u'ProLynx LLC', u'The Michael J. Fox Foundation', u'Laboratoire Chauvin SA', u'Amakem Therapeutics', u'XL-Protein GmbH', u'EP Global Communications Inc', u'Nexus Pharmaceuticals Inc', u'Eyeon Therapeutics Inc', u'Shin Nippon Biomedical Laboratories Ltd', u'Aerie Pharmaceuticals Inc', u'Gifu University', u'Agence Nationale de Recherches sur le Sida et les hepatites virales (ANRS)', u'University of Cologne', u'iCo Therapeutics Inc', u'AGTC', u'China State Institute of Pharmaceutical Industry', u'GenVec Inc', u'Capricor Therapeutics Inc', u'Biogen Inc', u'Centre de Physiopathologie de Toulouse Purpan', u'Breckenridge Pharmaceutical Inc', u'GlaxoSmithKline plc', u'InMed Pharmaceuticals Inc', u'Bayer Schering Pharma AG', u'MultiCell Technologies Inc', u'BioLight Life Sciences Investments Ltd', u'Cipla-Medpro (Pty) Ltd', u'FDC Ltd', u'MediVas LLC', u'INSERM Transfert', u'Acuity Pharmaceuticals', u'Laboratoires Thea', u'Avellino Lab Usa Inc', u'Zhuhai Essex Bio-Pharmaceutical Co Ltd', u'Peregrine Pharmaceuticals Inc', u'Neurotech Pharmaceuticals Inc', u'Sankyo Co Ltd', u'Toyobo Co Ltd', u'BioMotiv LLC', u'Clearside Biomedical Inc', u'Emory University', u'Orexo AB', u'NeuMedics Inc', u\"Boston Children's Hospital\", u'Shionogi & Co Ltd', u'UCB SA', u'Warren Pharmaceuticals Inc', u'Apexigen Inc', u'National Institutes of Standards and Technology', u'EyeMedics LLC', u'Daiichi Sankyo Co Ltd', u'Abbott Laboratories', u'Eisai Co Ltd', u'National Cancer Institute', u'Novartis AG', u'Prima Pharmaceutical Inc', u'Bicycle Therapeutics Ltd', u'University of Maryland', u'Novelion Therapeutics Inc', u'Scripps Florida', u'Odin Biotech Partners LLC', u'Nemus Bioscience Inc', u'Tumor Biology Center, Freiburg', u'Chongqing Cory Pharmaceutical (Group) Co Ltd', u'ALZA Corp', u'Synpromics Ltd', u'AVEO Oncology', u'University of Colorado System', u'Baylor University', u'Imprimis Pharmaceuticals Inc', u'AngioGenetics AB', u'RegeneRx Biopharmaceuticals Inc', u'Molecular Partners AG', u'Fovea Pharmaceuticals SA', u'H Lundbeck A/S', u'Activus Pharma Co Ltd', u'Healios KK', u'Undisclosed', u'Isarna Therapeutics GmbH', u'Otsuka Pharmaceutical Co Ltd', u'DSM Pharmaceutical Products', u'Allergan plc', u'IOMED Inc', u'Diosynth Biotechnology', u'University College London', u'Alcon Pharmaceuticals Ltd', u'InSite Vision Inc', u'University of Virginia', u'Contamac Limited', u'NicOx SA', u'Foundation Fighting Blindness', u'Medvet Science Pty Ltd', u'AngioGenex Inc', u'Pfizer Inc', u'Midatech Pharma PLC', u'Spark Therapeutics LLC', u'Pieris Pharmaceuticals Inc', u'University of Illinois', u'Dr Reddy\\u2019s Research and Development BV', u'Resolvyx Pharmaceuticals Inc', u'Baylor College of Medicine', u'Synthelabo', u'University of Oklahoma', u'BioTime Inc', u'AdAlta Pty Ltd', u'Crinetics Pharmaceuticals Inc', u'National Institutes of Health', u'Streetlab', u'OncoNOx ApS', u'IACTA Pharmaceuticals Inc', u'ORA Inc', u'Aequus Pharmaceuticals Inc', u'Rohto Pharmaceutical Co Ltd', u'Quark Pharmaceuticals Inc', u'UCB Japan Co Ltd', u'Intradigm Corp', u'Rising Pharmaceuticals Inc', u'Exakta-OPKO', u'Transgenomic Inc', u'Axxam SpA', u'Lederle Laboratories', u'Purdue Neuroscience Corp', u'Kubota Pharmaceutical Holdings Co Ltd', u'Johns Hopkins University School of Medicine', u'Opthea Pty Ltd', u'Adverum Biotechnologies Inc', u'Bio-Tissue Inc', u'Merz & Co GmbH']), u'Adenocarcinoma': set([u'Enlyton Ltd', u'University of Maryland Baltimore County', u'National Cancer Institute', u'AstraZeneca plc', u'ADT Pharmaceuticals', u'Apptec Inc', u'DeGregorio Family Foundation', u'Triton Biosystems Inc', u'Aspen PharmaCare Holdings Ltd', u'XOMA Corp', u'Lung Cancer Research Foundation', u'University of South Alabama', u'Price Family Foundation', u'Merck & Co Inc', u'Raven Biotechnologies Inc', u'Fred Hutchinson Cancer Research Center', u'Pancreatic Cancer Action Network', u'Memorial Sloan-Kettering Cancer Center', u'ANI Pharmaceuticals Inc']), u'Immediatetypehypersensitivity': set([u'Galenica AG', u'AlleCure Corp', u'Mylan Inc', u'Dynavax Technologies Corp', u'Meridian Medical Technologies Inc', u'BL&H Co Ltd', u'Shionogi Pharma Inc', u'DuoCort Pharma AB', u'Biosintetica Farmaceutica Ltda', u'Novartis AG', u'Verus Pharmaceuticals Inc', u'Grupo Uriach', u'Teva Pharmaceutical Industries Ltd', u'Kaleo Inc', u'Lincoln Medical Ltd', u'Sanofi', u'Tabuk Pharmaceutical Manufacturing Co', u'Tanox Inc', u'VINNOVA', u'Sosei Group Corp', u'The Peanut Foundation', u'Ranbaxy Laboratories Ltd', u'Mylan Seiyaku Ltd', u'Deerfield Management Company LP', u'Senetek plc', u'BD Biosciences', u'G2B Pharma Inc', u'Meda AB', u'Allergy Therapeutics plc', u'Pfizer Inc', u'Adamis Pharmaceuticals Corp', u'BIAL Group', u'Watson Laboratories Inc', u'Recordati SpA', u'Shin Nippon Biomedical Laboratories Ltd', u'Mount Sinai Medical Center']), u'Respiratorytractinfection': set([u'Akonni Biosystems', u'LG Life Sciences Ltd', u'Australian Government', u'Cytopathfinder Inc', u'SmithKline Beecham Corp', u'National Institute of Allergy and Infectious Diseases', u'US Government', u'Eisai Co Ltd', u'IASO Pharma Inc', u'Schering-Plough Corp', u'Cempra Inc', u'Apax Partners LLP', u'Bristol-Myers Squibb Co', u'Arch Biopartners Inc', u'Frost & Sullivan', u'MedImmune LLC', u'Sanofi', u'Protein Sciences Corp', u'Furiex Pharmaceuticals Inc', u'Dong Wha Pharmaceutical Co Ltd', u'Invent Farma ehf', u'Kyorin Pharmaceutical Co Ltd', u'Janssen Pharmaceutica NV', u'Qiagen NV', u'Celera Group', u'Roche Madison Inc', u'Genesoft Inc', u'LG Chem Ltd', u'Pulmatrix Inc', u'University of Cincinnati', u'Optimer Pharmaceuticals Inc', u'Defense Advanced Research Projects Agency', u'US Department of Defense', u'University of Melbourne', u'DHP Korea Co Ltd']), u'Ulcerativeproctitis': set([u'Allergan plc', u'Ironwood Pharmaceuticals Inc']), u'Ventriculartachycardia': set([u'Biosig Technologies Inc', u'Undisclosed', u'University of California Los Angeles', u'National Heart Lung and Blood Institute', u'Fondazione Salvatore Maugeri Clinica del Lavoro e della Riabilitazione IRCCS', u'Armetheon Inc', u'Case Western Reserve University', u'Cardiogen Sciences']), u'Confusion': set([u'CHEPLAPHARM Arzneimittel GmbH', u'AstraZeneca plc']), u'Tropicalspasticparaparesis': set([u'Bioniz Therapeutics Inc', u'National Institutes of Health']), u'Parainfluenzavirusinfection': set([u'Direct Relief International', u'St Andrews University', u'Napo Pharmaceuticals Inc', u'Pfizer Inc', u'University of Bath', u\"St Jude Children's Research Hospital\", u'National Institutes of Health', u'Bill & Melinda Gates Foundation', u'Ansun BioPharma Inc', u'National Institute of Allergy and Infectious Diseases', u'Weill Medical College of Cornell University', u'MedImmune LLC', u'BioCryst Pharmaceuticals Inc']), u'Sitosterolemia': set([u'Merck Sharp & Dohme Ltd', u'Laboratorios Farmaceuticos Rovi SA']), u'Interstitiallungdisease': set([u'LTT Bio-Pharma Co Ltd', u'Celgene Corp', u'Pharmacopeia Inc', u'Beijing Tide Pharmaceutical Co Ltd', u'University of Alberta', u'Pluristem Therapeutics Inc', u'Chong Kun Dang Pharmaceutical Corp']), u'Sleepapnea': set([u'VIVUS Inc', u'US Government', u'Undisclosed', u'MSD OSS BV', u'RespireRx Pharmaceuticals Inc', u'Pier Pharmaceuticals Inc', u'Armstrong Laboratories Inc', u'BTG plc', u'National Institutes of Health', u'University of California', u'Sanofi', u'University of Calgary', u'Cephalon Inc', u'Laboratoire L Lafon SA', u'Biotricity Inc', u'Jazz Pharmaceuticals plc', u'University of Sydney', u'Kadmon Pharmaceuticals LLC', u'Dompe SpA', u'Supernus Pharmaceuticals Inc', u'Biovail Laboratories International Srl', u'Collegium Pharmaceutical Inc', u'Merckle GmbH', u'Cypress Bioscience Inc', u'Resmed Ltd', u'Taiwan Biotech Co Ltd', u'Cepa Schwarz Pharma Sl', u'Hikma Pharmaceuticals plc', u'H Lundbeck A/S', u'University of Illinois']), u'Colondisease': set([u'Cell Pathways Inc', u'OSI Pharmaceuticals Inc', u'Nippon Shoji Co Ltd', u'National Cancer Institute', u'Pfizer Inc', u'PLIVA dd', u'Nutrition 21 Inc', u'Bioject Medical Technologies Inc', u'Paladin Labs Inc', u'University of Zagreb', u'Merck Serono SA']), u'Sturge-Webersyndrome': set([u'Sturge-Weber Foundation', u'ORIG3N Inc']), u'Glomerulonephritis': set([u'Sankyo Pharma Inc', u'Scottsdale Scientific DBA Allergy Research Group/Nutricology, INC.', u'National Institute of Diabetes, Digestive and Kidney Diseases', u'Daiichi Sankyo Co Ltd', u'Arrow International Ltd', u'Forest Laboratories Inc', u'King Pharmaceuticals Inc', u'Walter Reed Army Institute of Research', u'Pharmalink AB', u'Taisho Pharmaceutical Co Ltd', u'SkyePharma plc', u'West Pharmaceutical Services Inc', u'GlaxoSmithKline plc', u'Sanofi', u'Taligen Therapeutics Inc', u'The Menarini Group', u'Celldex Therapeutics Inc', u'Bayer AG', u'FibroGen Inc', u'Imperial College London', u'Dompe SpA', u'Avexxin AS', u'Medical University of South Carolina', u'Achillion Pharmaceuticals Inc', u'Ranbaxy Laboratories Ltd', u'University of Colorado System', u'Sankyo Co Ltd', u'IXICO Plc', u'Aderis Pharmaceuticals Inc', u'AstraZeneca plc', u'The Research Council of Norway', u'University of Bern', u'University of Virginia', u'Aventis Pharmaceuticals Inc', u'Recordati SpA', u'Wyeth', u'Bio-Quant Inc', u'Patheon Pharmaceuticals Inc']), u'Boneandjointinfection': set([u\"Dr Reddy's Laboratories Ltd\", u'Catalytica Inc', u'Sanofi', u'GlaxoSmithKline plc']), u'Spondylosyndesis': set([u'Depuy', u'Medvet Science Pty Ltd', u'Collplant Ltd', u'Bioventus LLC', u'National Institute of Arthritis and Musculoskeletal and Skin Diseases', u'National Institute on Aging', u'Mesoblast Ltd', u'Interventional Spine Inc', u'Theracell Inc', u'Yissum Research Development Co', u'Nanovis Inc']), u'PuntaTorovirusinfection': set([u'National Institute of Allergy and Infectious Diseases', u'Defyrus Inc']), u'Hemophagocyticlymphohistiocytosis': set([u\"Cincinnati Children's Hospital Medical Center\", u'European Commission', u'Novimmune SA', u'National Heart Lung and Blood Institute']), u'Hyperphosphatemia': set([u'Chugai Pharmaceutical Co Ltd', u'AnorMED Inc', u'Phosphate Therapeutics', u'Panion & BF Biotech Inc', u'Swedish Orphan AB', u'Panacor Bioscience Ltd', u'Patheon Inc', u'National Institute of Diabetes, Digestive and Kidney Diseases', u'Braintree Laboratories Inc', u'Abbott Laboratories', u'Japan Tobacco Inc', u'Vidasym LLC', u'3SBio Inc', u'Bayer Yakuhin Ltd', u'Shandong Weigao Pharmaceutical Co Ltd', u'BTG plc', u'GelTex Pharmaceuticals Inc', u'Mitsubishi-Tokyo Pharmaceuticals Inc', u'Novartis AG', u'Vernalis Group plc', u'KDL Co Ltd', u'Yamanouchi Pharmaceutical Co Ltd', u'Undisclosed', u'US Government', u'The Dow Chemical Co', u'Keryx Biopharmaceuticals Inc', u'Acologix Inc', u'INEOS Group', u'Sanofi Genzyme', u'Sanofi', u'Medical Research Council', u'University College London', u'Ardelyx Inc', u'Altair Nanotechnologies Inc', u'DuoPhos LLC', u'Astellas Pharma Inc', u'Eurofarma', u'Shire plc', u'Kyowa Hakko Kirin Co Ltd', u'JW Pharmaceutical Corp', u'Cytochroma Inc', u'Sebo GmbH', u'Aviragen Therapeutics Inc', u'Ilypsa', u'Sankyo Co Ltd', u'Spectrum Pharmaceuticals Inc', u'Toray Industries Inc', u'AstraZeneca plc', u'Vectura Group plc', u'CM&D Pharma Ltd', u'Aova Technologies Inc', u'University of Messina', u'Sanwa Kagaku Kenkyusho Co Ltd', u\"King's College London\"]), u'Thermalinjury': set([u'Cytokine PharmaSciences Inc', u'Picower Institute for Medical Research']), u'Transitionalcellcarcino': set([u'Biologics Inc', u'AstraZeneca plc']), u'Weightloss': set([u'KSF Acquisition UK Ltd', u'GenoVive Llc', u'Chelatexx LLC', u'AstraZeneca plc', u'M Pharmaceutical Inc', u'Par Pharmaceutical Co Inc', u'Undisclosed', u'United Laboratories Inc.', u'OptiBiotix Health plc', u'US Department of Veterans Affairs', u'Dana-Farber Cancer Institute Inc', u'Fitbit Inc', u'Axim Biotechnologies Inc', u'Elan Drug Technologies', u'Medtronic plc', u'C4X Discovery Holdings plc']), u'Portalhypertension': set([u'Galectin Therapeutics Inc', u'Pharmaceutical Product Development LLC', u'NicOx SA', u'Aptalis Pharma Inc']), u'Acinetobacterbaumaniiinfection': set([u'Southern Methodist University', u'CMC Biologics Inc', u'National Human Genome Research Institute', u'Fox Chase Chemical Diversity Center Inc', u'US Department of Defense', u'Biological Anti-infective Medicines LLC', u'National Institute of Allergy and Infectious Diseases', u'Universidade de Santiago de Compostela', u'Spero Therapeutics LLC', u'Pro Bono Bio', u'Trellis Bioscience Inc']), u'Influenzavirusinfection': set([u'Biovest International Inc', u'Solvay SA', u'NEOMED Institute', u'Korea Kolmar Holdings Co Ltd', u'Ansun BioPharma Inc', u'Vaccine Research Institute of San Diego', u'Therapeutic Systems Research Laboratories', u'Keystone Nano Inc', u'Global Kinetics, Inc', u'Ceragenix Pharmaceuticals Inc', u'US Health and Human Services Department', u'Il Dong Pharmaceutical Co Ltd', u'Life Technologies Corp', u'University of Alabama', u'Genome British Columbia', u'Inovio Pharmaceuticals Inc', u'VGX Pharmaceuticals LLC', u'Evry Genopole Biopark', u'EpiVax Inc', u'Biological E Ltd', u\"Japan's Council for Science & Technology\", u'University of Prince Edward Island', u'European Community', u'MonoSol Rx Inc', u'Pharmaceutical Product Development LLC', u'University of Pittsburgh', u'Ploughshare Innovations Ltd', u'Celldex Therapeutics Inc', u'Laboratorios Imperiales', u'Sanofi Pasteur MSD', u'Select Exploration Ltd', u'Lebanese-Canadian Hospital', u'University of Rochester', u'University of Bath', u'Ajanta Pharma Ltd', u'Kaketsuken', u'Aviragen Therapeutics Inc', u'Virion Systems Inc', u'Sobhan Recombinant Protein', u'Kuhnil Pharmaceutical Co Ltd', u'US Department of the Treasury', u'SciClone Pharmaceuticals Inc', u'PacificGMP', u'Agence nationale de la recherche (ANR)', u'Scripps Research Institute', u'National Research Council of Canada', u'European Commission', u'PharmaJet Inc', u'National Health and Medical Research Council', u'Julphar Gulf Pharmaceutical Industries', u'Israeli Government', u'Romark Laboratories LC', u'ChemRar Pharma', u'CEL-SCI Corp', u'Medimmune Vaccines Inc', u'Sirnaomics Inc', u'Nitto Denko Corp', u'University of Cambridge', u'Tulane University', u'Medigen Vaccine Biologics Co', u'Albemarle Corp', u'Virosome Biologicals BV', u'Serum Institute of India Ltd', u'Yisheng Biopharma Co Ltd', u'Mount Sinai Hospital', u'Vanderbilt University', u'Trimeris Inc', u'Asembia', u'Solvay Pharmaceuticals Inc', u'VBI Vaccines', u'Ajinomoto Althea Inc', u'Brigham Young University', u'UCB SA', u'Juvaris BioTherapeutics Inc', u'Verta Ltd', u'University of Adelaide', u'Protein Sciences Corp', u'SAB Biotherapeutics Inc', u'Icon Genetics AG', u'Genius Biotherapeutics', u'Institute of Biotechnology IBT', u'Exponential Biotherapies Inc', u'4SC AG', u'Generex Biotechnology Corp', u'Ministry of Science and Technology of the People\\xb4s Republic of China', u'Oslo University Hospital', u'Niigata TLO Corp', u'Healthcare Royalty Partners', u'Avatar Medical LLC', u'Pharmexa A/S', u'Ministry of Health of the Kyrgyz Republic', u'AnC Bio Group', u'moksha8 Pharmaceuticals Inc', u'Alexander BioDiscoveries LLC', u'University of Saskatchewan', u'Nobilon International BV', u'Johnson & Johnson', u'Bio Farma', u'Fraunhofer USA Inc', u'Beijing Centers for Disease Control and Prevention', u'La Jolla Institute of Allergy & Immunology', u'InViragen LLC', u'Finnish Funding Agency for Technology and Innovation', u'National Institute of Infectious Diseases Japan', u'Undisclosed', u'Immuron Ltd', u'Emergent BioSolutions Inc', u'Centro De Investigaci\\xf3n Y Asistencia En Tecnolog\\xeda Y Dise\\xf1o Del Estado De Jalisco Ac(Ciatej Ac)', u'Centers for Disease Control and Prevention', u'GlaxoSmithKline Biologicals', u'ID Pharma Co Ltd', u'Agenus Inc', u'CSL Ltd', u'Louisiana State University', u'Weizmann Institute of Science', u'BD Technologies', u'Government of Russia', u'Prosetta Biosciences Inc', u'Chiron Vaccines Co', u'Secretech Inc', u'University of California Los Angeles', u'Erasmus University Medical Center Rotterdam', u'Ihi Corp', u'National Institute on Aging', u'Novartis Vaccines & Diagnostics', u'Akorn Inc', u'International Vaccine Institute', u'Beactica AB', u'Immunobiology Ltd', u'Sigma-Aldrich Corp', u'Amyxa Therapeutics', u'InDevR LLC', u'Janssen Vaccines & Prevention BV', u'Hungarian Government', u'Fountain Medical', u'Mahidol University', u'Program for Appropriate Technology in Health', u'Walter Reed Army Institute of Research', u'Bristol-Myers Squibb Co', u'GenoMed Inc', u'Opus Bio Inc', u'Vaxart Inc', u'The Chinese Centre for Disease Control and Prevention', u'Autoimmune Technologies', u'Ventaleon GmbH', u'Astellas Pharma Inc', u'European Investment Bank', u'Archimedes Pharma Ltd', u'Respublikanskoe Unitarnoe Proizvodstvennoe Predprijatie \"Belmedpreparaty\"', u'Tabuk Pharmaceutical Manufacturing Co', u'Arriani Pharmaceuticals SA', u'GenomIdea Inc', u'Public Health Agency of Canada', u'Vectura Group plc', u'Hollister-Stier Laboratories LLC', u'Canadian Government', u'Bacilligen Inc', u'Albert-Ludwigs-Universit\\xe4t Freiburg', u'Panacea Biotec Ltd', u'SK Chemicals Co Ltd', u'Weill Medical College of Cornell University', u'University of Texas Medical Branch at Galveston', u'Center For Disease Control Department Of Health Taiwan Roc', u'Dynavax Technologies Corp', u'Oncovir Inc', u'CytoGenix Inc', u'Laboratorio Avimex', u'Viroblock SA', u'The Korea National Institute of Health', u'Bumimedic (Malaysia) Sdn. Bhd.', u'Chiron Corp', u'Green Cross Corp', u'Genesis Technology Group Inc', u'Zhejiang Hisun Pharmaceutical Co Ltd', u'The Government Pharmaceutical Organization', u'Arizona State University', u'Erimos Pharmaceutical LLC', u'DiaMedica Inc', u'Chinese Government', u'The European Union', u'AVIR Green Hills Biotechnology AG', u'University of Pennsylvania', u'Hovione SA', u'Imaxio', u'The Macfarlane Burnet Institute For Medical Research & Public Health Ltd', u'Biotempt BV', u'Roche Holding AG', u'Shire plc', u'Reckitt Benckiser plc', u'Mitsubishi Tanabe Pharma Corp', u'University of Munster', u'VIB', u'Direct Relief International', u'Ministry of Health, France', u'Vironova AB', u'Intercell AG', u\"Xi'an Jiaotong University\", u'Xcellerex LLC', u'Texas Tech University', u'Cytopharm Inc', u'AltraVax Inc', u'Myungmoon Pharm Co Ltd', u'The Jenner Institute', u'Charles River Laboratories International Inc', u'McMaster University', u'Cell Pharm GmbH', u'Pasteur Merieux', u'Epixis SA', u'Johns Hopkins University School of Medicine', u'Universite de Sherbrooke', u'Onepharm', u'Cambridge Biostability Ltd', u'UK Ministry of Defence', u'A*STAR Institute of Molecular and Cell Biology', u'SRI International', u'iNtRON Biotechnology Inc', u'University of Alabama at Birmingham', u'Alla Chem LLC', u'Medical Research Council', u'Transgene SA', u'Thai government', u'NanoViricides Inc', u'City University of Hong Kong', u'Mymetics Corp', u'Institute of Microbiology and Epidemiology Academy of Military Medical Sciences PLA', u'Albany Molecular Research Inc', u'FORGE Life Science LLC', u'Cytovance Biologics LLC', u'National Institute of Biomedical Innovation', u'Yuhan Corp', u'Zirus Inc', u'University of California San Diego', u'SCOLR Pharma Inc', u'Sclavo SpA', u'F Hoffmann-La Roche AG', u'Fujifilm\\xa0Corp', u'Borealis AG', u'Hard To Treat Diseases Inc', u'Bharat Biotech International Ltd', u'Fabentech', u'Swiss Federal Office of Public Health', u'ASD Healthcare', u'Sentry BioPharma Services', u'Stanford University', u'DynPort Vaccine Company LLC', u'University of British Columbia', u'Agilent Technologies Inc', u'NPO Petrovax Pharm LLC', u'DelSite Biotechnologies Inc', u'Eurocine Vaccines AB', u'Baylor Research Institute', u'Bavarian government', u'Shanghai government', u'Eden Biodesign Ltd', u'Xenetic Biosciences Inc', u'Max-Planck-Institute of Biochemistry', u'Nanolek LLC', u'Microbiotix Inc', u'Vivalis', u'Greenwith', u'Intas Pharmaceuticals Ltd', u'Henry M Jackson Foundation for the Advancement of Military Medicine', u'Aerogen Inc', u'Valneva SE', u'Avanzcare', u'DNA Electronics Ltd', u'Sinovac Biotech Ltd', u'Alentia Biotech', u'Fuzians Biomedicals Inc', u'iQur Ltd', u'Hunan University', u'Beijing Public Health Bureau', u'United Therapeutics Corp', u'Glide Pharmaceutical Technologies Ltd', u'Norwegian Institute of Public Health', u'Cocrystal Discovery Inc', u'Napo Pharmaceuticals Inc', u'InGen Biosciences', u'Parenteral Biotech Ltd', u'VLP Biotech Inc', u'Emergex Vaccines Limited', u'German Ministry of Health', u'Metdem Healthcare Ltd', u'Genta Inc', u'Terumo Corp', u'Severance Hospital', u'BiondVax Pharmaceuticals Ltd', u'EpiStem Ltd', u'CTC Bio Inc', u'TaiMed Biologics Inc', u'Ministry of Health, Brazil', u'CSL Behring LLC', u'Bioject Medical Technologies Inc', u'US Naval Medical Research Center', u'Temasek Life Sciences Laboratory', u'US Army Research Office', u'Emory University Technology Transfer Office', u'Immunome Inc', u'Organix Inc', u'Altea Therapeutics', u'Haikou VTI Biological Institute', u'MacroGenics Inc', u'Guangdong Medicine Group Corp', u'SKAU Vaccines ApS', u'Novavax Inc', u'Seoul National University Hospital', u'OMRIX Biopharmaceuticals SA', u'Trellis Bioscience Inc', u'Okinawa Industry Promotion Public Corp', u'Immunovaccine Inc', u'3M Drug Delivery Systems', u'Intercell USA', u'Melmotte Inc', u'Federal Department of Defence, Civil Protection and Sport', u'St James Associates Llc/Faber Research Series', u'BioDiem Ltd', u'Institut Pasteur', u'Adamas Pharmaceuticals Inc', u'Crucell Switzerland AG', u'GE Healthcare', u'diaDexus Inc', u'Altimmune Inc (pre-merger)', u'Alios BioPharma Inc', u'PiSA Farmaceutica', u'US Department of Agriculture', u'Isconova AB', u'Takeda Pharmaceutical Co Ltd', u'FluGen Inc', u'AmVac AG', u'Georgia Institute of Technology', u'Rx for Africa', u'Hemispherx Biopharma Inc', u'Rostec State Corporation', u'Etubics Corp', u'Henderson Morley plc', u'Vaccibody AS', u'Cardinal Health Inc', u'Sanofi Pasteur', u'Hetero Drugs Ltd', u'Mount Sinai School of Medicine', u'Onxeo SA', u'Maxygen Inc', u'China Food and Drug Administration', u'Indian Council of Medical Research', u'Il-Yang Pharmaceutical Co', u'World Health Organization', u'FIT Biotech Oyj Plc', u'Pasteur Institute in Ho Chi Minh City', u'Vical Inc', u'CombiMatrix Corp', u'University of Queensland', u'Vrije Universiteit van Amsterdam', u'Taipei Veterans General Hospital', u'NanoAxis', u'Kukje Pharmaceuticals', u'Denka Seiken Co Ltd', u'Universite Pierre et Marie Curie', u'MedImmune LLC', u'OSI Pharmaceuticals Inc', u'University of Washington', u'hVIVO plc', u'CureVac GmbH', u'Enigma Diagnostics Ltd', u'Tyrian Diagnostics Ltd', u'University Hospitals of Leicester - Leicester Royal Infirmary', u'University of Manitoba', u'Visionary Medical Products Corp', u'Biovector Therapeutics SA', u'Implicit Bioscience Ltd', u'Fondation M\\xe9rieux', u'NanoBio Corp', u'Unigen Inc.', u'Aquila Biopharmaceuticals Inc', u'MDM Group Inc', u'Yantai Rongchang Biotechnologies Co Ltd', u'Wave Biotech LLC', u'Medical University of Vienna', u'National Center for Research Resources', u'Defense Advanced Research Projects Agency', u'Pfizer Inc', u'Netherlands Government', u'Italian Ministry of Health', u'Omni Bio Pharmaceutical Inc', u'ID Biomedical Corp', u'Hikma Pharmaceuticals plc', u'AIMM Therapeutics BV', u'Pharmatek Laboratories Inc', u'I&L Biosystems GmbH', u'GenPhar Inc', u'Biota Holdings Ltd', u'Harvard University', u'Mast Therapeutics Inc', u'Pasteur Merieux Serums et Vaccins SA', u'The Dow Chemical Co', u'Hallym University', u'TRIA Bioscience Corp', u'Japanese Government', u'Zhejiang Tianyuan Bio-Pharmaceutical Co Ltd', u'Aphios Corp', u'Amarillo Biosciences Inc', u'Visterra Inc', u'Teva Pharmaceutical Industries Ltd', u'Shenzhen Neptunus Bioengineering Co Ltd', u'AbCellera Biologics Inc', u'VABIOTECH', u'National Institute of Biomedical Imaging and Bioengineering', u'Fraunhofer-Institute fur Zelltherapy und Immunologie', u'Celltrion Inc', u'OPKO Health Inc', u'Taiga Biotechnologies Inc', u'Trudeau Institute', u'Pharos Biologicals LLC', u'Chonnam National University Medical School', u'SK Chemicals Life Science', u'Scientific Products Pharmaceutical Co LTD', u'Seqirus', u'University of Melbourne', u'Neopharm Ltd', u'Harrisvaccines Inc', u'IIT Research Institute', u'Japan Government', u'Texas A&M University System', u'Laboratorios Liomont Sa De Cv', u'Harvard Medical School', u'Cipla Ltd', u'Codagenix Inc', u'Universita di Bologna', u'The Austrian Research Promotion Agency FFG', u'The Institute of Microbiology Chinese Academy of Sciences', u'AlphaVax Inc', u'MCP Hahnemann University', u'Zynaxis Inc', u'Australian Government', u'XOMA Corp', u'Merck & Co Inc', u'Zenyaku Kogyo Co Ltd', u'Mercia Pharma Inc', u'Instituto Butantan', u'Sanofi', u'Chong Kun Dang Pharmaceutical Corp', u'Friedrich Loeffler Institute', u'University of Oslo', u'Academia Sinica', u'Pulmatrix Inc', u'Cilian AG', u'Canadian Department of National Defence', u'Martek Biosciences Corp', u'Savira Pharmaceuticals', u'Gilead Sciences Inc', u'Fox Chase Chemical Diversity Center Inc', u'DreamCIS Inc', u'Caladrius Biosciences Inc', u'Kineta Inc', u'New Amsterdam Sciences', u'Sea Lane Biotechnologies LLC', u'Wyeth', u'Acambis plc', u'Evolva Holding SA', u'Arisan Therapeutics Inc', u'Ichor Medical Systems Inc', u'Purdue University', u'Massachusetts Institute of Technology', u'Antigen Express Inc', u'Cancer Vaccine Acceleration Fund', u'Takeda Pharmaceuticals International GmbH', u'Cytran Inc', u'Functional Genetics Inc', u'PowderJect Pharmaceuticals plc', u'Micron Biomedical Inc', u'Lonza Group AG', u'Protherics plc', u'The Australian National University', u'Sang-A Pharmaceutical Co Ltd', u\"St Jude Children's Research Hospital\", u'Sinergium Biotech', u'Theraclone Sciences Inc', u'Elan Corp plc', u'FFF Enterprises', u'Parkedale Pharmaceuticals Inc', u'Kuros Biosciences Ltd', u'MSD Japan', u'CJ Corp', u'Rutgers University', u'bioCSL PTY Ltd', u'Imperial College London', u'Therapix Biosciences Ltd', u'Philip Morris International', u'Medizinische Universit\\xe4t Innsbruck', u'SC World Inc', u'Duke University', u'Ceva Sante Animale', u'Chembio Diagnostic Systems Inc', u'University of Georgia', u'Janssen Pharmaceuticals Inc', u'Korea Center for Disease Control & Prevention', u'Crucell NV', u'Pan-Provincial Vaccine Enterprise Inc', u'Adamis Pharmaceuticals Corp', u'American Red Cross', u'Pfizer Vaccines', u'BIKEN Foundation', u'Defense Threat Reduction Agency', u'National Health Research Institutes', u'Aplicare Inc', u'US Government', u'Vichem Chemie Ltd', u'Baxter International Inc', u'Max Neeman International', u'Molecular Express Inc', u'GenVec Inc', u'UMN Pharma Inc', u'GlaxoSmithKline plc', u'Cytran Ltd', u'Vaccitech Ltd', u'Covance Inc', u'Institute of Vaccines and Medical Biologicals', u'Interferon Sciences Inc', u'Tetragenetics Inc', u'Immunex Corp', u'Marina Biotech Inc', u'Galenea Corp', u'Adimmune Corp', u'Sarepta Therapeutics Inc', u'University of Michigan', u'Immunotope Inc', u'Cold Spring Harbor Laboratory', u'St Petersburg Institute of Experimental Medicine', u'Netherlands Cancer Institute', u'Sankyo Co Ltd', u'Laboratorio de Biologicos y Reactivos de Mexico', u'Canadian Institutes of Health Research', u'Caliber Biotherapeutics', u'Orexo AB', u'Shionogi & Co Ltd', u'Cistron Biotechnology Inc', u'Emory University', u'US Department of Defense', u'Shaanxi Maike Aote Technology Co Ltd', u'Medigen Biotechnology Corp', u'Alnylam Pharmaceuticals Inc', u'Omninvest', u'Folia Biotech Inc', u'Helmholtz Zentrum fur Infektionsforschung GmbH', u'Shire BioChem Inc', u'Philip Morris Products Inc', u'NT Pharma (Group) Co Ltd', u'Sanquin Blood Supply Foundation', u'Thomas Jefferson University', u'ASAVI LLC', u'Changchun BCHT Biotechnology Co', u'Abera Bioscience AB', u'Daiichi Sankyo Co Ltd', u'Commonwealth Scientific and Industrial Research Organization', u'Greffex Inc', u'Immune Design Corp', u'Accelovance Inc', u'Novartis AG', u'Synthetic Genomics Vaccines Inc', u'pSivida Corp', u'Fresenius Medical Care AG', u'Simcere Pharmaceutical Group', u'Lovelace Respiratory Research Institute', u'Quidel Corp', u'GeneOne Life Science Inc', u'Monash University', u'Dana-Farber Cancer Institute Inc', u'TechnoVax Inc', u'Vivaldi Biosciences Inc', u'Hualan Biological Engineering Inc', u'Infectious Disease Research Institute', u'ALZA Corp', u'Protheon Inc', u'University of Texas System', u'PiKe Pharma GmbH', u'Klinikum der Albert-Ludwigs Universitaet Freiburg', u'Biomedical Research Institute', u'Leidos Biomedical Research Inc', u'Johns Hopkins University', u'European Molecular Biology Laboratory', u'Duke Human Vaccine Institute', u'Jamieson Laboratories', u'Beijing Jindike Biotechnology Co ltd', u'Orphan Australia', u'Gamma Vaccines Pty Ltd', u'Rhein Biotech NV', u'Ampac Fine Chemicals Llc', u'The Institute of Virology and Immunoprophylaxis', u'Hanwha Corp', u'Southern Research Institute', u'Aragen Bioscience Inc', u'Immunitor Inc', u'Orygen Biotecnologia Ltda', u'Medivir AB', u'Novacta Biosystems Ltd', u'Neugenesis Corp', u'Australian Government Department of Health and Ageing', u'ImmuneRegen BioSciences Inc', u'French Government', u'PharmswellBio Co Ltd', u'Johann Wolfgang Goethe-Universitat Frankfurt am Main', u'Bulgarian Academy of Science', u'Transgovernment Enterprise for Pandemic Influenza of Korea', u'Mucosis BV', u'Microgen State Scientific Industrial Company', u'Gemmus Pharma Inc', u'Zhejiang University', u'TNO', u'University of Virginia', u'VaxInnate Corp', u'G-Con LLC', u'Nanotherapeutics Inc', u'RegeneRx Biopharmaceuticals Inc', u'NovaBay Pharmaceuticals Inc', u'University of Siena', u'Inhibikase Therapeutics Inc', u'PaxVax Inc', u'Austrian Ministry of Health', u'Esteve', u'Midatech Pharma PLC', u'CureLab Inc', u'Northeastern University', u'Cadila Pharmaceuticals Ltd', u'Baxter Healthcare SA', u'Utah State University', u'University of Arizona', u'Ratio Inc', u'IRX Therapeutics Inc', u'BioChem Vaccines Inc', u'LG Life Sciences Ltd', u'VersiTech Ltd', u'Indena SpA', u'Laboratorios Farmaceuticos Rovi SA', u'Proinnovera', u'Nordic Vaccine A/S', u'UK Government', u'Antitope Ltd', u'PowderMed Ltd', u'National Institute of Allergy and Infectious Diseases', u'iBio Inc', u'SEEK', u'Viragen Inc', u'MPI Research', u'Albert Einstein College of Medicine', u'Vaxine Pty Ltd', u'University of Wisconsin-Madison', u'National Institutes of Health', u'Bill & Melinda Gates Foundation', u'Food and Drug Administration', u'OptiNose AS', u'Medicago Inc', u'MediVas LLC', u'West Pharmaceutical Services Inc', u'Avidity Biosciences LLC', u'Quratis Co Ltd', u'Apovia AG', u'Sanofi Pasteur Inc', u'University of Chicago', u'Colorado State University', u'Aridis Pharmaceuticals Inc', u'Cantacuzino Institute', u'Ministry of Health and Welfare,Taiwan', u'Medigen Inc', u'Chilean government', u'JW Pharmaceutical Corp', u'Sanford-Burnham Medical Research Institute', u'Biocore Co Ltd', u'Mogam Biotechnology Institute', u'ProBioGen AG', u'Merck Serono SA', u'MannKind Corp', u'Boryung Pharm Co Ltd', u'ALERT B&C Corp', u'Coloplast AS', u'ContraFect Corp', u'BioCryst Pharmaceuticals Inc', u'University of Reading']), u'Tickborneencephalitisvirusinfecti': set([u'National Institute of Allergy and Infectious Diseases', u'Defyrus Inc']), u'Benigntumor': set([u'Roche Holding AG', u'Oryzon Genomics SA']), u'Graftversushostdisease': set([u'Quest Diagnostics Inc', u'US Government', u'Ocugen Inc', u'Pharmagenesis Inc', u'Baxter International Inc', u\"Boston Children's Hospital\", u'Tanner Pharma Group Plc', u'Netherlands Government', u'IDEC Pharmaceuticals Corp', u'Incyte Corp', u'Capricor Therapeutics Inc', u'Unigene Laboratories Inc', u'Celltrion Inc', u'Univ Massachusetts', u'The Leukemia & Lymphoma Society', u'Bayer Schering Pharma AG', u'University of Wurzburg', u'Oncobiologics Inc', u'Chiron Corp', u'Celmed BioSciences Inc', u'Medipost Co Ltd', u'Seattle Genetics Inc', u'Vium Inc', u'Anesiva Inc', u'Astex Pharmaceuticals Inc', u'Novimmune SA', u'University of Michigan', u'Leiden University Medical Center', u'Bellicum Pharmaceuticals Inc', u'Takeda Oncology', u'Hospira Inc', u'Roche Holding AG', u'ARIAD Pharmaceuticals Inc', u'Vasogen Inc', u'Universita Degli Studi Di Perugia', u'Sanofi Genzyme', u'ZIOPHARM Oncology Inc', u'Emory University', u'Keio University', u'Theralogics Inc', u'University of Queensland', u'Heinrich Heine Universitat Dusseldorf', u'Dana-Farber Cancer Institute Inc', u'The Clinical Trial Company', u'Talent Biotechs Ltd', u'R-Tech Ueno Ltd', u'Hikma Pharmaceuticals plc', u'Targazyme Inc', u'Diaclone SA', u'Sigmoid Pharma Ltd', u'Israeli Government', u'Amgen Inc', u'Medarex Inc', u'Vedanta Biosciences Inc', u'University of California San Francisco', u'BioTransplant Inc', u'Mochida Pharmaceutical Co Ltd', u'Eisai Co Ltd', u\"Seattle Children's Hospital\", u'Leadiant Biosciences Inc', u'National Cancer Institute', u'Novartis AG', u'Ministry of Health & Welfare, Korea', u'REGiMMUNE Corp', u\"Children's Oncology Group\", u'Hadassah Medical Organization', u'Fujisawa Pharmaceutical Co Ltd', u'MerLion Pharmaceuticals Pte Ltd', u'Istituto Scientifico H San Raffaele', u'Osiris Therapeutics Inc', u'Massachusetts General Hospital', u'Abgenix Inc', u'MEDIPAL HOLDINGS Corp', u'University of Minnesota', u'Oxford BioMedica plc', u'JCR Pharmaceuticals Co Ltd', u'BTG plc', u'Universite Catholique de Louvain', u'myTomorrows', u'Kyorin Pharmaceutical Co Ltd', u'Dong-A ST Co Ltd', u'Cellect Biotechnology Ltd', u'Millennium Pharmaceuticals Ltd', u'Numoda Corp', u'Univalor', u'Fujirebio Europe NV', u'National Institute of Biomedical Innovation', u'Boehringer Ingelheim Corp', u'Tobira Therapeutics Inc', u'TransBio Ltd', u'Steward Cross Pte Ltd', u'DendroCyte Biotech Pty Ltd', u'Orphan Australia', u'Kamada Ltd', u'ILEX Oncology Inc', u'University of Oregon', u'Genentech Inc', u'Mesoblast Ltd', u'IDIS Ltd', u'MegaPharm Ltd', u'Stiefel Laboratories (UK) Ltd', u'Baylor Research Institute', u'Lumen Therapeutics LLC', u'CLL Pharma', u'Clalit Health Services', u'Synt:em', u'SangStat Medical Corp', u'PDL BioPharma Inc', u'XOMA Corp', u'AmorChem LP', u'Zenyaku Kogyo Co Ltd', u'National Eye Institute', u'Celonic AG', u'Eli Lilly & Co', u'Central Institute For Experimental Animals', u'Dr Falk Pharma GmbH', u'Bayer AG', u'Waisman Clinical Biomanufacturing Facility', u'Enlivex Therapeutics Ltd', u'Pierre Fabre SA', u'FUJIFILM Holdings Corp', u'MolMed SpA', u'Soligenix Inc', u'Case Western Reserve University', u'Genovo Inc', u'Pfizer Inc', u'Hadasit Bio-Holdings Ltd', u'US Department of Defense', u'Wyeth', u'University of Illinois', u'Johns Hopkins University', u'Janssen-Cilag Ltd', u'Johnson & Johnson', u'Baylor College of Medicine', u'New York University School of Medicine, US', u'Intrexon Corp', u'Apogenix GmbH', u'University of Washington', u'Miltenyi Biotec GmbH', u'National Institute of Allergy and Infectious Diseases', u'H Lee Moffitt Cancer Center and Research Institute', u'Ligand Pharmaceuticals Inc', u'BL&H Co Ltd', u'Lonza Group AG', u'Cynata Therapeutics Ltd', u'Cancer Prevention and Research Institute of Texas', u'ANZAC Research Institute', u'National Institutes of Health', u'University of Tokyo', u'Food and Drug Administration', u'Axxiom Inc', u'Hopital Maisonneuve-Rosemont', u'Bristol-Myers Squibb Co', u'Pacific Healthcare Thailand Co Ltd', u'City of Hope', u'Accentia BioPharmaceuticals Inc', u'Kiadis Pharma Netherlands BV', u'Astellas Pharma Inc', u'Swedish Orphan Biovitrum AB', u'Tarix Pharmaceuticals LLC', u'FDA Office of Orphan Products Development', u'Takara Bio Inc', u'Athersys Inc', u'AVAX Technologies Inc', u'Repligen Corp', u'IMED AB', u'Xenikos BV', u'OPi SA', u'Kyowa Hakko Kirin Co Ltd', u'National Heart Lung and Blood Institute', u'University of Cambridge']), u'Femalegenitaltracttumor': set([u'Quintiles Transnational Corp', u'Eisai Co Ltd', u'Ewopharma AG', u'Almirall Prodesfarma SA', u'Microbial Chemistry Research Foundation']), u'Seizuredisorder': set([u'University of Minnesota', u'1st Order Pharmaceuticals', u'US Government', u'National Institute of Neurological Disorders and Stroke', u'Wyeth Pharmaceuticals', u'Pairnomix LLC', u'Neurelis Inc', u'Koebenhavns Universitet', u'Blackfynn', u'Aegis Therapeutics LLC', u'Meridian Medical Technologies Inc', u'UniQuest Pty Ltd', u'Eisai Co Ltd', u'Amarin Corp plc', u'GlaxoSmithKline plc', u'US Health and Human Services Department', u'Jeil Pharmaceutical Co Ltd', u'Servier', u'National Institutes of Health', u'University of Utah', u'Elan Corp plc', u'East Gate Pharmaceuticals', u'Q-State Biosciences Inc', u'StemoniX Inc', u'The European Union', u'University of California San Francisco', u'Chong Kun Dang Pharmaceutical Corp', u'UCB SA', u'Eli Lilly & Co', u'University of Kentucky', u'Roche Holding AG', u'AurimMed Pharma Inc', u'Toronto Western Hospital', u'Valeant Pharmaceuticals International Inc', u'Only For Children Pharmaceuticals', u'Taiho Pharmaceutical Co Ltd', u'Xenon Pharmaceuticals Inc', u'Jazz Pharmaceuticals plc', u'Neurogen Corp', u'Metabasis Therapeutics Inc', u'Ikano Therapeutics Inc', u'UCB Pharma SA', u'IVAX Corp', u'Sunovion Pharmaceuticals Inc', u'Pfizer Inc', u'PreveCeutical Medical Inc', u'BIAL Group', u'Swedish Orphan Biovitrum AB', u'Ultragenyx Pharmaceutical Inc', u'Cita NeuroPharmaceuticals Inc']), u'Atopicdermatitis': set([u\"Dr Reddy's Laboratories Ltd\", u'Signum Biosciences Inc', u'Regeneron Pharmaceuticals Inc', u'University of Florida', u'Silence Therapeutics plc', u'InterMune Inc', u'Ceragenix Pharmaceuticals Inc', u'Mayne Pharma Group Ltd', u'MEDRx Co Ltd', u'EXAM Co., Ltd.', u'Korea Research Institute of Chemical Technology', u'GlaxoSmithKline plc', u'Sekisui Chemical Co Ltd', u'Quintiles Transnational Corp', u'GalPharma Co Ltd', u'Covance Inc', u'Bayer Schering Pharma AG', u'Inter Cyto Nano Science Co Ltd', u'Meyer Pharmaceuticals LLC', u'Circassia Pharmaceuticals plc', u'Astex Pharmaceuticals Inc', u'Gideon Pharmaceuticals Inc', u'Ono Pharmaceutical Co Ltd', u'BIOCND', u'Hoth Therapeutics Inc', u'Roche Holding AG', u'DMI BioSciences Inc', u'Bridge Pharmaceuticals Inc', u'TOLMAR Therapeutics Inc', u'Immune Network Ltd', u'Laboratoires Biocodex', u'Toray Industries Inc', u'Chemiderm Inc', u'Intendis GmbH', u'elbion AG', u'Shionogi & Co Ltd', u'Ontogen Corp', u'Bionanoplus SL', u'HanAll Biopharma Co Ltd', u'Revotar Biopharmaceuticals AG', u'Tecrea Ltd', u'RIKEN', u'Diplomat Pharmacy Inc', u'R-Tech Ueno Ltd', u'Fountain BioPharma Inc', u'Burke Pharmaceuticals LLC', u'York Pharma plc', u'Wockhardt Ltd', u'Kanebo KK', u'Maruho Co Ltd', u'Pediapharm Inc', u'Cambridge Antibody Technology Group plc', u'Harvard University', u'The European Union', u'Abbott Laboratories', u'Eisai Co Ltd', u'AnaMar Medical AB', u'Airmid Inc', u'Novartis AG', u'Stiefel', u'Ferndale Laboratories Inc', u'Madam Therapeutics BV', u'Tanabe Seiyaku Co Ltd', u'Boehringer Ingelheim International GmbH', u'ISDIN SA', u'Maurtisklinieken Den Haag', u'University of Manchester', u'Arexis AB', u'Kyorin Pharmaceutical Co Ltd', u'Exeltis USA Dermatology Llc', u'Welichem Biotech Inc', u'MegaPharm Ltd', u'Alfresa Pharma Corp', u'Dermira Inc', u'Prasco Laboratories', u'Allergan Inc', u'AnGes MG Inc', u'LG Chem Ltd', u'Encysive Pharmaceuticals Inc', u'Osaka University', u'Boehringer Ingelheim Corp', u'University of California San Diego', u'Foamix Pharmaceuticals Ltd', u'Kao Corp', u'Synairgen plc', u'Biotechnology and Biological Sciences Research Council (BBSRC)', u'SWITCH Biotech AG', u'Chugai Pharmaceutical Co Ltd', u'Genentech Inc', u'Hyphens Pharma Pte Ltd', u'Connetics Corp', u'Biofrontera AG', u'Otsuka Pharmaceutical Co Ltd', u'Korea Drug Development Fund', u'Atopix Pharmaceuticals Corp', u'Suzhou Connect Biopharmaceuticals Ltd', u'TG Therapeutics Inc', u'PPL Therapeutics plc', u'Maxygen Holdings Ltd', u'Undisclosed', u'US Government', u'Sinclair Pharma plc', u'Sakai Chemical Industry Co Ltd', u'Cypress Pharmaceutical Inc', u'Daewoong Pharmaceutical Co Ltd', u'Oneness Biotech Co Ltd', u'LEO Pharma A/S', u'Hanyang University', u'Sonoma Pharmaceuticals Inc', u'UBE Industries Ltd', u'BioFocus DPI', u'Galderma SA', u'Bayer AG', u'Syntrix Biosystems Inc', u'Mipharm SpA', u'University of California Irvine', u'Enhance Biotech Inc', u'Axim Biotechnologies Inc', u'Kissei Pharmaceutical Co Ltd', u'AEterna Zentaris Inc', u'Arriva Pharmaceuticals Inc', u'IVAX Corp', u'Roivant Sciences Ltd', u'AstraZeneca plc', u'Technology Strategy Board', u'University of Cincinnati', u'Kaken Pharmaceutical Co Ltd', u'Japan Energy Corp', u'Elorac Inc', u'Kang Stem Holdings Co Ltd', u'Horizon Pharma plc', u'Ziarco Pharma Ltd', u'Blueberry Therapeutics Ltd', u'National Institute of Allergy and Infectious Diseases', u'BioPro Pharmaceutical Inc', u'SmithKline Beecham plc', u'Arena Pharmaceuticals Inc', u'Ligand Pharmaceuticals Inc', u'Top Institute Pharma', u'Abiogen Pharma SpA', u'MatriSys Bioscience', u'Spherium Biomed', u'Development Center for Biotechnology', u'National Institutes of Health', u'Abeona Therapeutics Inc', u'ProMetic Life Sciences Inc', u'Sumitomo Pharmaceuticals Co Ltd', u'Menarini Asia-Pacific', u'Dainippon Pharmaceutical Co Ltd', u'Thesan Pharmaceuticals Inc', u'AmDerma Pharmaceuticals', u'PreCision Dermatology Inc', u'Zengen Inc', u'JADO Technologies GmbH', u'Azitra Inc', u'VINNOVA', u'Astellas Pharma Inc', u'SkinMedica Inc', u'D\\xe1vi II - Farmac\\xeautica SA', u'Hokkaido University', u'Thornton & Ross Ltd', u'Advancell', u'Boehringer Ingelheim Austria GmbH', u\"Brigham & Women's Hospital\", u'Creabilis Therapeutics Srl', u'Medimetriks Pharmaceuticals Inc', u'SK Chemicals Co Ltd', u'Genesis Research and Development Corp Ltd']), u'Hyperlipoproteinemia': set([u'West Pharmaceutical Services Inc', u'Ionis Pharmaceuticals Inc', u'Interleukin Genetics Inc', u'Amgen Inc']), u'StageIVmelanoma': set([u'Karolinska Institutet', u'Dynavax Technologies Corp', u'Genocea Biosciences Inc', u'Incyte Corp', u'California Institute of Regenerative Medicine', u'Human Longevity Inc', u'Onxeo SA', u'GlaxoSmithKline plc', u'Inovio Pharmaceuticals Inc', u'HumOrigin Inc', u'MedImmune LLC', u'University of South Florida', u'Institut Curie', u'Sangamo Therapeutics Inc', u'Celldex Therapeutics Inc', u'University of Pennsylvania', u'Fred Hutchinson Cancer Research Center', u'Ono Pharmaceutical Co Ltd', u'Roche Holding AG', u'Immunocore Ltd', u'JHL Biotech', u'Merck Sharp & Dohme Corp', u'Neon Therapeutics', u'Analytical Biochemistry Laboratories Inc', u'Gradalis Inc', u'Melanovus Oncology Inc', u'Otsuka Pharmaceutical Co Ltd', u'National Center for Research Resources', u'Technology Strategy Board', u'ChemWerth USA', u'IO Biotech ApS', u'Melanoma Research Alliance', u'TrovaGene Inc', u'Novellusdx Ltd', u'Apexigen Inc', u'MD Anderson Cancer Center', u'Amgen Inc', u'Daiichi Sankyo Co Ltd', u'Eisai Co Ltd', u'Pediatric Oncology Experimental Therapeutics Investigation Consortium', u'National Cancer Institute', u'Novartis AG', u'Merck KGaA', u'Viewpoint Molecular Targeting LLC', u'PharmaCell', u'CHU De Nantes', u'Massachusetts General Hospital', u'University of California San Francisco', u'WuXi PharmaTech (Cayman) Inc', u'Dana-Farber Cancer Institute Inc', u'Plexxikon Inc', u'Galectin Therapeutics Inc', u'Pennsylvania State University', u'Cadila Pharmaceuticals Ltd', u'Altor BioScience Corp', u'Parker Institute for Cancer Immunotherapy', u'Taiho Pharmaceutical Co Ltd', u'Osaka University', u'SolaranRx Inc', u'Genentech Inc', u'Neostem Oncology', u'Biothera Pharmaceuticals Inc', u'Iovance Biotherapeutics Inc', u'Ramaciotti Foundation', u'The Knut and Alice Wallenberg Foundation', u'Prescient Therapeutics Ltd', u'Immunophotonics Inc', u'ImmunID', u'Merck & Co Inc', u'Cancer Research Institute (CRI)', u'Eli Lilly & Co', u'University of Wisconsin-Madison', u'Agalimmune Ltd', u'University of Virginia', u'Madrigal Pharmaceuticals Inc', u'University of Tennessee', u'University of Iowa', u'Checkmate Pharmaceuticals', u'Pfizer Inc', u'Norwegian Research Council', u'Caladrius Biosciences Inc', u'Region Hovedstaden V/Herlev Hospital', u'Memorial Sloan-Kettering Cancer Center', u'Mount Sinai Medical Center', u'OncoSec Medical Inc', u'University of Washington', u'H Lee Moffitt Cancer Center and Research Institute', u'NYU Langone Medical Center', u'Ligand Pharmaceuticals Inc', u'BioMed Valley Discoveries', u'National Institutes of Health', u'Novavax Inc', u'siRNAsense AS', u'Bristol-Myers Squibb Co', u'RadioMedix Inc', u'MSD Japan', u'Edith Cowan University', u'University of Chicago', u'Hoag Memorial Hospital Presbyterian', u'Adaptimmune Therapeutics plc', u'GenomIdea Inc', u'Takara Bio Inc', u'Walter and Eliza Hall Institute of Medical Research', u'Idera Pharmaceuticals Inc', u'Technion - Israel Institute of Technology', u'Provectus Biopharmaceuticals Inc', u'Scancell Ltd', u'Science & Technology Corporation @ UNM', u'Society of Interventional Oncology (SIO)']), u'Familialmediterraneanfever': set([u'Novartis Pharma AG', u'Medarex Inc']), u'Conjunctivitis': set([u'Alcon Inc', u'Nippon Shinyaku Co Ltd', u'Johnson & Johnson', u'Evolutec Group plc', u'Quidel Corp', u'Acuity Pharmaceuticals', u'Cardinal Health Inc', u'Atlantic Technology Ventures Inc', u'Maxim Pharmaceuticals Inc', u'Daiichi Sankyo Co Ltd', u'DevCo Pharmaceuticals Ltd', u'Pathogenics Inc', u'Sucampo Pharmaceuticals Inc', u'4SC Discovery GmbH', u'The New Energy and Industrial Technology Development Organization', u'Fujisawa Pharmaceutical Co Ltd', u'Redox Pharmaceutical Corp', u'CLS Pharmaceuticals Inc', u'Johnson & Johnson Vision Products Inc', u'Undisclosed', u'NicOx SA', u'Bioceutica SA', u'Sun Pharmaceutical Industries Ltd', u'Clinipace', u'Nidek Co Ltd', u'ORA Inc', u'Sanofi-Synthelabo', u'MegaPharm Ltd', u'ANI Pharmaceuticals Inc', u'Santen Pharmaceutical Co Ltd', u'Marinomed Biotechnologie GmbH', u'Vernalis plc', u'MGI Pharma Inc', u'Biem Pharmaceuticals', u'Laboratoires Thea', u'RPS Diagnostics', u'Bayer AG', u'Ono Pharmaceutical Co Ltd', u'InSite Vision Inc', u'Laboratorios Leti SL', u'Novartis AG', u'Janssen Pharmaceutical KK', u'Kyorin Pharmaceutical Co Ltd', u'Harrison Clinical Research', u'Universitat Innsbruck', u'Kyowa Hakko Kirin Co Ltd', u'Dong-A ST Co Ltd', u'Cambrex Corp', u'Kissei Pharmaceutical Co Ltd', u'OPKO Health Inc', u'Kuhnil Pharmaceutical Co Ltd', u'Celera South San Francisco', u'Sankyo Co Ltd', u'Senju Pharmaceutical Co Ltd', u'Allergan Inc', u'CIBA Vision Corp', u'SS Pharmaceutical Co Ltd', u'Inspire Pharmaceuticals Inc', u'Boehringer Ingelheim Corp', u'Lupin Ltd', u'Otsuka Pharmaceutical Co Ltd', u'Foresight Biotherapeutics Inc', u'Pharmos Corp', u'Okogen Inc', u'Toyama Chemical Co Ltd', u'UCB SA', u'Panoptes Pharma Ges.m.b.H', u'Bausch & Lomb Inc', u'Estero-Anstalt', u'Catalent Inc', u'Activus Pharma Co Ltd']), u'Genitourinarydisease': set([u'Biopasgroup', u'Daiichi Seiyaku Co Ltd', u'Novo Nordisk A/S', u'Lumara Health Inc', u'Mount Cook BioSciences', u'Life-Tech. Inc.', u'Quintiles Transnational Corp', u'PEPTONIC medical AB', u'Makoto Life Sciences Inc', u'moksha8 Pharmaceuticals Inc', u'Altus Pharmaceuticals Inc', u'Formulation Technologies LLC', u'Pharmaceutical Product Development LLC', u'POLA Pharma Inc', u'Swetox', u'Novartis Pharmaceuticals Corp', u'ANI Pharmaceuticals Inc', u'Selvita SA', u'3M Pharmaceuticals', u'Shionogi & Co Ltd', u'Auxilium Pharmaceuticals Inc', u'Alliance Pharma plc', u'Roche Diagnostics GmbH', u\"Boston Children's Hospital\", u'Perrigo Co plc', u'TrovaGene Inc', u'Sequenom Inc', u'Urigen Pharmaceuticals Inc', u'Validus Pharmaceuticals', u'Evestra GmbH', u'Abbott Laboratories', u'Mochida Pharmaceutical Co Ltd', u'Eisai Co Ltd', u'Serenity Pharmaceuticals', u'Vantia Therapeutics', u'Ajinomoto Althea Inc', u'Merus Labs International Inc', u'UCB Pharma GmbH', u'Newron Pharmaceuticals SpA', u'Taiho Pharmaceutical Co Ltd', u'Ferring Pharmaceuticals SA', u'Starpharma Holdings Ltd', u'Prasco Laboratories', u'Biomolecular Research Institute Ltd', u'Graceway Pharmaceuticals Inc', u'Recordati SpA', u'Debiopharm SA', u'Gynelogix Inc', u'Endeavor Pharmaceuticals', u'Upsher-Smith Laboratories Inc', u'Paladin Labs Inc', u'Miravant Medical Technologies', u'IDIS Ltd', u'Actavis Inc', u'Laborie Medical Technologies Inc', u'Azure Biotech Inc', u'Daewoong Pharmaceutical Co Ltd', u'Merck & Co Inc', u\"Dr Reddy's Laboratories Ltd\", u'Xanodyne Pharmaceuticals Inc', u'Eli Lilly & Co', u'Sofgen Pharmaceuticals', u'Pharmacia Corp', u'F Lima SA', u'Dynogen Pharmaceuticals Inc', u'Barr Pharmaceuticals Inc', u'Enhance Biotech Inc', u'Kissei Pharmaceutical Co Ltd', u'Novogene Corp', u'Neurocrine Biosciences Inc', u'Hyaluron Inc', u'Urosurge inc', u'CPEX Pharmaceuticals Inc', u'Akorn Inc', u'4SC AG', u'Shionogi Inc', u'CTC Bio Inc', u'Phebra Pty Ltd', u'Solvay SA', u'Ligand Pharmaceuticals Inc', u'Millar Instruments Inc', u'The Medicines Company', u'Asahi Kasei Pharma Corp', u'Futura Medical plc', u'Astellas Pharma Inc', u'Ranbaxy Laboratories Ltd', u'Noven Pharmaceuticals Inc', u'XenoPort Inc', u'Crucell NV', u'Strides Shasun Ltd', u'Kalium Inc', u'Novartis AG', u'Gedeon Richter Ltd', u'Chinese University of Hong Kong', u'Rhone-Poulenc Rorer Inc', u'GenuPro Inc']), u'Retrovirusinfection': set([u'University of Colorado at Denver and Health Sciences Center', u'National Center for Research Resources']), u'Stutter': set([u'Pfizer Inc', u'Endo Pharmaceuticals Solutions Inc', u'Teva Pharmaceutical Industries Ltd']), u'Glycogenstoragedisease': set([u'Universite Pierre et Marie Curie', u'Genethon']), u'Stressurinaryincontinence': set([u'Cytori Therapeutics Inc', u'Japanese Ministry of Health, Labor and Welfare', u'Nagoya University']), u'Diverticulitis': set([u'TAP Pharmaceutical Products Inc', u'Allergan plc', u'Ironwood Pharmaceuticals Inc', u'Pacific Pharmaceuticals Co Ltd', u'Shire plc']), u'Multiplesystematrophy': set([u'FDA Office of Orphan Products Development', u'Rex Griswold Foundation', u'PsychoGenics Inc', u'University of California San Diego School of Medicine', u'Translational Genomics Research Institute', u'Food and Drug Administration', u'Mayo Clinic Foundation', u'Vanderbilt University', u'uniQure BV', u'University of Cambridge', u'University of Toulouse']), u'Choroiddisease': set([u'Optovue Inc', u'ROCOL SA']), u'Intervertebraldiscdisease': set([u'Liaoning Weibang Biopharmaceutical Co Ltd', u'China State Institute of Pharmaceutical Industry']), u'Malesexualdysfunction': set([u'VIVUS Inc', u'Johnson & Johnson', u'Chugai Pharmaceutical Co Ltd', u'Paladin Labs Inc', u'RespireRx Pharmaceuticals Inc', u'Abbott Laboratories', u'US Government', u'Harvard Scientific Corp', u'Astra AB', u'Forest Laboratories Inc', u'Vernalis Research Ltd', u'XION Corp', u'Bayer AG', u'Undisclosed', u'Novartis Pharma AG', u'Marina Biotech Inc', u'Watson Laboratories Inc', u'Meda AB', u'Servier', u'ICOS Corp', u'Eli Lilly & Co', u'Janssen Pharmaceutica Ltd', u'Khandelwal Laboratories Ltd', u'Bio-Sphere Technology Inc', u'Northwest Neurologic Inc', u'PN Gerolymatos SA', u'PT Kalbe Farma Tbk', u'Biovail Corp', u'LION bioscience Inc', u'Senetek plc', u'Ramot at Tel Aviv University Ltd', u'Rexahn Pharmaceuticals Inc', u'Palatin Technologies Inc', u'Glaxo Group Ltd', u'Handok Inc', u'Xian-Janssen Pharmaceutical Ltd', u'Orexo AB', u'Neurocrine Biosciences Inc', u'Adamis Pharmaceuticals Corp', u'biotask', u'Kyowa Kirin', u'DuPont Pharmaceuticals Ltd', u'Pfizer Inc', u'Calmare Therapeutics Inc', u'Recordati SpA', u'GenuPro Inc', u'H Lundbeck A/S', u'University of Arizona', u'Innovus Pharmaceuticals Inc']), u'Lowerrespiratorytractinfection': set([u'Akonni Biosystems', u'Mylan Inc', u'National Institute of Allergy and Infectious Diseases', u'Abbott Laboratories', u'Rhone-Poulenc SA', u'Dainippon Pharmaceutical Co Ltd']), u'Cerebralamyloidangiopathy': set([u'National Institute on Aging', u'University of Houston', u'Brain Canada', u'University of Calgary']), u'Neurologicalsymptom': set([u'University of Rochester Medical Center', u'Synapse Biomedical Inc', u'Usci Japan Ltd', u'Ohio Third Frontier', u'National Institutes of Health', u'University of Tokyo', u'Case Western Reserve University', u'BioFocus DPI']), u'Sleeparousaldisorder': set([u'Elis Pharmaceuticals Ltd', u'Innovus Pharmaceuticals Inc']), u'Marburgvirusinfection': set([u'University of Washington', u'University of Texas Medical Branch at Galveston', u'BioProtection Systems Corp', u'GenPhar Inc', u'UK Government', u'GeoVax Labs Inc', u'Profectus BioSciences Inc', u'Defyrus Inc', u'Mapp Biopharmaceutical Inc', u'National Institute of Allergy and Infectious Diseases', u'United States Army Medical Research Institute of Chemical Defense', u'Bavarian Nordic A/S', u'Charles River Laboratories International Inc', u'AlphaVax Inc', u'Vanderbilt University', u'University of Toronto', u'The Paul G. Allen Family Foundation', u'NewLink Genetics Corp', u'National Institutes of Health', u'Kyushu University', u'Joint Project Manager Transformational Medical Technologies', u'Omm Scientific Inc', u'Sarepta Therapeutics Inc', u'Merck & Co Inc', u'Genzyme General', u'Scripps Research Institute', u'rEVO Biologics Inc', u'Paragon Bioservices Inc', u'Protiva Biotherapeutics Inc', u'Arbutus Biopharma Corp', u'Agenus Inc', u'US Army Medical Research Institute of Infectious Diseases', u'NanoViricides Inc', u'US Government', u'Navigen Inc', u'Battelle', u'Chembio Diagnostic Systems Inc', u'University of Texas System', u'Integrated BioTherapeutics Inc', u'Public Health Agency of Canada', u'The Vaccine and Gene Therapy Institute of Florida', u'Biosidus SA', u'Crucell NV', u'Boston University', u'Midatech Pharma PLC', u'Sumitomo Metal Industries Ltd', u'Emergex Vaccines Limited', u'University of Utah', u'Kineta Inc', u'US Department of Defense', u'Alnylam Pharmaceuticals Inc', u'Biologics Consulting Group Inc', u'University of Illinois', u'BioCryst Pharmaceuticals Inc', u'Immunovaccine Inc', u'Defense Threat Reduction Agency']), u'Enuresis': set([u'Undisclosed', u'Ferring Pharmaceuticals SA', u'Kyowa Hakko Kirin Co Ltd', u'Plethora Solutions Holdings plc']), u'Hyperkalemia': set([u'Relypsa Inc', u'Vifor-Fresenius Medical Care Renal Pharma Ltd', u'CytoSorbents Corp', u'US Government', u'Sanofi']), u'Toothdisease': set([u'Akervall Technologies Inc', u'Servier', u'Radiation Monitoring Devices Inc', u'Purdue University', u'Henry Schein Inc', u'Riemser Pharma GmbH', u'Evonik Industries AG', u'J. M. Huber Corp', u'Stryker Corp', u'OraPharma Inc', u'Straumann Holding AG', u'Align Technology Inc', u'Germiphene Corp', u\"Guy's & St Thomas' Hospital NHS Trust\", u'National Institutes of Health', u'Sinclair Pharma plc', u'Curis Inc', u'National Science Foundation', u'Osteologix Holdings PLC', u'Johnson & Johnson Consumer Products Inc', u'3shape ApS', u'University of Miami', u'Oral Antibacterials Inc', u'Therapix Biosciences Ltd', u'BioMed X GmbH', u'Dentsply Sirona Inc', u'Actinova Ltd', u'Biolase Technology Inc', u'The McGuire Institute', u'Rodo Medical', u'Rafa Laboratories Ltd', u'Salvin Dental Specialties Inc', u'Patterson Companies', u'Curasan AG', u\"Boston Children's Hospital\", u'Exactech Inc', u'Wyeth BioPharma', u\"King's College London\"]), u'Cardiovascularsurgicalprocedure': set([u'National Institutes of Health', u'Alexion Pharmaceuticals Inc']), u'Hearttransplantrejection': set([u'Janssen-Cilag Ltd', u'Astellas Pharma Inc', u'Fujisawa Pharmaceutical Co Ltd', u'Hikma Pharmaceuticals plc', u'Ryogen LLC', u'Life Technologies Corp']), u'Bacterialvaginosis': set([u'Laccure Ab', u'Lumara Health Inc', u'Easton Pharmaceuticals Inc', u'UAB Profarma', u'National Institute of Allergy and Infectious Diseases', u'Alfa Wassermann SpA', u'Actavis Inc', u'Aspen PharmaCare Australia Pty Ltd', u'Undisclosed', u'Scientelle LLC', u'BMV Medica', u'Juniper Pharmaceuticals Inc', u'RIMSA Laboratorios', u'Okamoto Industries', u'MilanaPharm', u'Valeant Pharmaceuticals International Inc', u'Recipharm AB', u'Starpharma Holdings Ltd', u'Windsor Pharmaceuticals SA', u'Lithuanian State Science and Studies Foundation', u'Merckle GmbH', u'Hammock Pharmaceuticals Inc', u'Gedeon Richter Ltd']), u'Elephantiasis': set([u'Liverpool School of Tropical Medicine', u'University of Buea', u'Swiss Agency for Development and Cooperation', u'Celgene Corp', u'La Agencia Espa\\xf1ola de Cooperaci\\xf3n Internacional para el Desarrollo', u'United States Agency for International Development', u'Department for International Development', u'University of Illinois', u'Michigan State University', u'AbbVie Inc', u'Bill & Melinda Gates Foundation', u'Drugs for Neglected Diseases Initiative', u'National Institute of Allergy and Infectious Diseases', u'Anacor Pharmaceuticals Inc', u'Eisai Co Ltd', u'German Federal Ministry of Education and Research', u'M\\xe9decins Sans Fronti\\xe8res']), u'Arterydisease': set([u'Akebia Therapeutics Inc', u\"Lee's Pharmaceutical Holdings Limited\", u'Kanebo KK', u'Interferon Sciences Inc', u'Pierre Fabre SA', u'Pluristem Therapeutics Inc', u'Torii Pharmaceutical Co Ltd', u'Sigma-Tau Ind Farm Riunite SpA', u'Massachusetts General Hospital', u'EPIX Pharmaceuticals Inc', u'Procter & Gamble Pharmaceuticals Inc']), u'Malecontraception': set([u'Evotec AG', u'Eppin Pharma', u'University of Massachusetts Medical School', u'Merrion Pharmaceuticals Inc', u'Baylor College of Medicine', u'Ardana Bioscience Ltd', u'Bayer Schering Pharma AG', u'ChemDiv Inc', u'Spermatech AS', u'F Lima SA', u'The Salk Institute for Biological Studies', u'ASTA Medica AG', u'Siwa Biotech Corp', u'Population Council', u'Church & Dwight Co Inc', u'Eunice Kennedy Shriver National Institute of Child Health & Human Development', u'Teikoku Hormone Manufacturing Co Ltd', u'Zentaris GmbH', u'Focused Scientific Inc', u'Futura Medical plc', u'Milsing d.o.o.']), u'Acromegaly': set([u'Evotec AG', u'SynCo BioPartners', u'Ascent Pharmaceuticals Ltd', u'Aspireo Pharmaceuticals Ltd', u'Centurion Pharma', u'Paladin Labs Inc', u'Cobra Biologics Holding AB', u'Covidien plc', u'Omega Pharmaceutical Inc', u'EMD Serono Inc', u'National Institute of Diabetes, Digestive and Kidney Diseases', u'Torii Pharmaceutical Co Ltd', u'Tulane University', u'University of Sheffield', u'Menarini Asia-Pacific', u'Chiasma Inc', u'Ambrilia Biopharma Inc', u'Sun Pharmaceutical Advanced Research Co Ltd', u'Centre Hospitalier Universitaire Vaudois', u'Antisense Therapeutics Ltd', u'University of Texas Health Science Center Houston', u'SurModics Pharmaceuticals', u'Crinetics Pharmaceuticals Inc', u'University of Zurich', u'Kwizda Gruppe', u'Sompharmaceuticals SA', u'Ionis Pharmaceuticals Inc', u'Ipsen', u'Teva Pharmaceutical Industries Ltd', u'Erasmus University Rotterdam', u'Medical Research Council', u'Pharmis Biofarmaceutica', u'DiAthegen LLC', u'Phyton Biotech Inc', u'Shin Poong Pharmaceutical Co Ltd', u'Camurus AB', u'Roche Holding AG', u'Ipsen Bioinnovation', u'Albany Molecular Research Inc', u'Debiovision Inc', u'Salix Pharmaceuticals Ltd', u'Glide Pharmaceutical Technologies Ltd', u'Swiss Government', u'Sin Phyu Kyun Co Ltd', u'Teijin Ltd', u'Health Care Logistics Inc', u'Midatech Pharma PLC', u'Novartis AG', u'Ohio University', u'Cortendo AB', u'Debiopharm SA']), u'Blepharoconjunctivitis': set([u'InSite Vision Inc', u'US Government']), u'Emesis': set([u\"Dr Reddy's Laboratories Ltd\", u'Afferon Corp', u'Pharmacare Ltd', u'SciClone Pharmaceuticals Inc', u'Chugai Pharmaceutical Co Ltd', u'Novo Nordisk A/S', u'Sanofi-Aventis US LLC', u'Unimed Pharmaceuticals Inc', u'Questcor Pharmaceuticals Inc', u'Stanford University', u'Validus Pharmaceuticals', u'Helsinn Healthcare SA', u'CSC Pharmaceuticals Handels GmbH', u'University of Tokyo', u'Daiichi Sankyo Inc', u'Abbott Laboratories', u'US Government', u'Allegiance Equity Corp', u'Galena Biopharma Inc', u'ULURU Inc', u'GlaxoSmithKline plc', u'Mundipharma International Corp Ltd', u'Vernalis Research Ltd', u'Onxeo SA', u'R-Pharm US LLC', u'LTL Pharma Co Ltd', u'Bayer Schering Pharma AG', u'Galenica SA (Greece)', u'Braeburn Pharmaceuticals Inc', u'National Institutes of Health', u'Normaco Inc', u'Specialised Therapeutics Australia Pty Ltd', u'MonoSol Rx Inc', u'Meldex International plc', u'Kukje Pharmaceuticals', u'Crinos SpA', u'Merck & Co Inc', u'Mitsubishi Tanabe Pharma Factory Ltd', u'Ahn-Gook Pharmaceuticals Co Ltd', u'APR Applied Pharma Research SA', u'Reckitt Benckiser Healthcare (UK) Ltd', u'ICOS Corp', u'Eli Lilly & Co', u'Camurus AB', u'Ligand Pharmaceuticals Inc', u'Ono Pharmaceutical Co Ltd', u'Mundipharma EDO GmbH', u'Astellas Pharma Inc', u'Teewinot Life Sciences Corp', u'Melmed Holding AG', u'Dynogen Pharmaceuticals Inc', u'Charleston Laboratories Inc', u'Ranbaxy Laboratories Ltd', u'Panaxia Pharmaceutical Industries Ltd', u'R&R Inc', u'Arachnova Ltd', u'SCOLR Pharma Inc', u'tesa Labtec GmbH', u'Glaxo Group Ltd', u'Sankyo Co Ltd', u'Par Specialty Pharmaceuticals', u'Accentia BioPharmaceuticals Inc', u'Arius Pharmaceuticals Inc', u'Orexo AB', u'Sanofi', u'Midatech Pharma PLC', u'Laboratorios Silesia SA', u'Kyowa Kirin', u'Lacer SA', u'Locl Pharma Inc', u'Helsinn Group', u'Purdue Pharma Canada', u'Athena Drug Delivery Solutions Pvt Ltd']), u'Fecalincontinence': set([u'Innovacell Biotechnologie AG', u'Rochester Medical Corp', u'Solvay SA', u'SLA Pharma UK Ltd', u'Mayo Clinic Foundation', u'Norgine BV']), u'HepatitisAvirusinfection': set([u'LG Life Sciences Ltd', u'Walvax Biotechnology Co Ltd', u'Cambridge Biotechnology Ltd', u'Finlay Institute', u'The Chinese Centre for Disease Control and Prevention', u'Pharmstandard-Biolek', u'SmithKline Beecham plc', u'Shanghai government', u'Eden Biodesign Ltd', u'National Institute of Infectious Diseases Japan', u\"Ministry of Health of the People's Republic of China\", u'Undisclosed', u'Merck & Co Inc', u'Chinese Government', u'University of California San Francisco', u'University College London', u'bioCSL PTY Ltd', u'Sinovac Biotech Ltd', u'CSL Ltd', u'iQur Ltd', u'Beijing Public Health Bureau', u'Kaketsuken', u'Mologic Ltd', u'Crucell Switzerland AG', u'Glasgow University', u'PaxVax Inc', u'Technology Strategy Board', u'National Center for Research Resources', u'Institute of Medical Biology Chinese Academy of Medical Sciences', u'Shanghai Municipal Center for Disease Control and Prevention']), u'Adenoidtumor': set([u'NantKwest Inc', u'University of Pennsylvania', u'Sidney Kimmel Cancer Center', u'AstraZeneca plc', u'Oncolys BioPharma Inc', u'Adenoid Cystic Carcinoma Research Foundation', u'Merck & Co Inc', u'Peter MacCallum Cancer Centre', u'Tocagen Inc', u'Victorian Cancer Agency']), u'Hypertriglyceridemia': set([u'US Government', u'Solvay SA', u'Scil Technology GmbH', u'GlaxoSmithKline plc', u'Amarin Corp plc', u'Nisshin Pharma Inc', u'Amarin Pharmaceuticals Inc', u'Eddingpharm Inc', u'Jeil Pharmaceutical Co Ltd', u'Undisclosed', u'Laxdale Ltd', u'Spherix Inc', u'Ligand Pharmaceuticals Inc', u'Tillotts Pharma AG', u'Pronova BioPharma ASA', u'Defiante Farmaceutica Lda', u'Scarista Ltd', u'Gyeonggi Institute Of Science & Technology Promotion', u'Shionogi Pharma Inc', u'Radiant Research Inc', u'Veloxis Pharmaceuticals A/S', u'University of Kentucky', u'Medpace Inc', u'Catalent Inc', u'Healthcare Royalty Partners', u'Reliant Pharmaceuticals Inc', u'Omthera Pharmaceuticals Inc']), u'Barrettsesophagus': set([u\"Cincinnati Children's Hospital Medical Center\", u'Light Sciences Corp', u'Oncoscope Inc', u'National Cancer Institute', u'Ohio Development Services Agency', u'National Institutes of Health', u'National Heart Lung and Blood Institute', u'DUSA Pharmaceuticals Inc', u'Roswell Park Cancer Institute', u'Case Western Reserve University', u'SpectraScience Inc']), u'Colorectaltumor': set([u'ARUP Laboratories', u'Quest Diagnostics Inc', u\"Hospital Vall D'Hebron\", u'Altropus Gmbh', u'Koebenhavns Universitet', u'COARE Biotechnology Inc', u'European Commission', u'NYU School of Medicine', u'SpectraScience Inc', u'US Health and Human Services Department', u'Lantheus Medical Imaging Inc', u'Asuragen Inc', u'Biotecnol SA', u'PLx Pharma Inc (pre-merger)', u'Inven2', u'Lab21 Group', u'The Dow Chemical Co', u'NueHealth', u'MedPrimex', u'Igeneon GmbH', u'VU University Medical Center', u'POZEN Inc', u'Pharmaceutical Product Development LLC', u'Intracel Corp', u'University of Pittsburgh', u'Sigma-Aldrich Corp', u'Cancer Council New South Wales', u'Walter Reed Army Institute of Research', u'Guangzhou Esa Biotech Co Ltd', u'Merck Sharp & Dohme Corp', u'Handok Inc', u'Ergomed PLC', u'Binex Co Ltd', u'Abgenix Inc', u'Mologen Ag', u'The UK Imperial Cancer Research Fund', u'Sanofi Pasteur', u'Zhejiang Huahai Pharmaceutical Group Co Ltd', u'National Research Council of Canada', u'Sigma-Tau Ind Farm Riunite SpA', u'CrystalGenomics Inc', u'CadheRx Therapeutics Inc', u'Israeli Government', u'Centre National de la Recherche Scientifique (CNRS)', u'Ranbaxy Laboratories Ltd', u'Cambridge Antibody Technology Group plc', u'Tallikut Pharmaceuticals Inc', u'Symphony Capital LLC', u'SBI Pharmaceuticals', u'Millenia Hope Inc', u'MediGene AG', u'Wayne State University', u'Theragence Inc', u'Poniard Pharmaceuticals Inc', u'Cantab Biopharmaceuticals Ltd', u'Concordia Pharmaceuticals Inc', u'ArcticDx Inc', u'The Danish National Advanced Technology Foundation', u'Lipomed AG', u'Warner-Lambert Co', u'YM BioSciences Inc', u'Indivumed GmbH', u'Mallinckrodt Inc', u'Indian Institute Of Technology Madras', u'Regulon Inc', u'Nottingham Trent University', u'ImmunoGen Inc', u'Oxford BioTherapeutics', u'Second Genome Inc', u'National Health Research Institutes', u'Tragara Pharmaceuticals Inc', u'Kura Oncology Inc', u'Shenzhen BGI Genomics Techonology Co Ltd', u'Oncobiologics Inc', u'Betta Pharmaceuticals Co Ltd', u'Biochemie GmbH', u'Talon Therapeutics Inc', u'Medial EarlySign', u'Targeted Diagnostics and Therapeutics Inc', u'Triton Biosystems Inc', u'Genomic Vision', u'Medimmune Oncology Inc', u'ElexoPharm GmbH', u'Genetic Technologies Ltd', u'Onconova Therapeutics Inc', u'KunWha Pharmaceutical Co Ltd', u'Undisclosed', u'Novartis Pharma AG', u'Taiho Oncology Inc', u'Schering Overseas Ltd', u'CTI BioPharma Corp', u'Eli Lilly & Co', u'US Surgical Corp', u'Agenus Inc', u'eFFECTOR Therapeutics Inc', u'Weizmann Institute of Science', u'XBiotech Inc', u'University of Pittsburgh Cancer Institute', u'Algae Dynamics Corp', u'Hyaluron Inc', u'SIRTeX Medical Ltd', u'Corixa Corp', u'Cancer Research Technology Ltd', u'UPMC Cancer Centers', u'Nuance Biotech Inc', u'Syncor International Corp', u'Immatics Biotechnologies GmbH', u'The Center of Molecular Immunology', u'Jennerex Inc', u'Stehlin Foundation For Cancer Research', u'AbbVie Inc', u'Japanese National Cancer Center', u'Peter MacCallum Cancer Centre', u'Horizon Discovery Group plc', u'SmithKline Beecham plc', u'UCB Celltech', u'Belgian Volition Pte Ltd', u'King Hamad University Hospital', u'Cancer Prevention and Research Institute of Texas', u'Unisensor SA', u'Servier', u'Fresenius SE & Co KGaA', u'Bristol-Myers Squibb Co', u'US Oncology Inc', u'Five Prime Therapeutics Inc', u'Victorian Cancer Agency', u'MDxHealth SA', u'Silicon Biosystems SRL', u'PerImmune Inc', u'Institute of Cancer Research UK', u'Antisoma plc', u'PureTech Health Plc', u'Oncormed Inc', u'Immuno-Designed Molecules SA', u'PlantForm Corp', u'Hollister-Stier Laboratories LLC', u'Incanthera Ltd', u'DRI Capital', u'Munich Biotech AG', u'Karolinska Institutet', u'The Genetics Co Inc', u'Cynvenio Biosystems LLC', u'Barbara Ann Karmanos Cancer Institute', u'Biocartis', u'Dynavax Technologies Corp', u'Bavarian Research Foundation', u'Accord Healthcare Inc', u'IDM Pharma Inc', u'University of Waterloo', u'Incyte Corp', u'Enumeral Biomedical Holdings Inc', u'BTG plc', u'Centelion SAS', u'University of Bonn', u'Chiron Corp', u'DiagnoCure Inc', u'Arizona State University', u'Selexis SA', u'MaxCyte Inc', u'Astex Pharmaceuticals Inc', u'Stanford University', u'Onyvax Ltd', u'Syndax Pharmaceuticals Inc', u'University of Montpellier', u'Navidea Biopharmaceuticals Inc', u'University of Kentucky', u'Mateon Therapeutics Inc', u'Garvan Institute of Medical Research', u'Biotech Synergy', u'Roche Holding AG', u'University of British Columbia', u'Sandoz Ltd', u'Biocompatibles International plc', u'Bispebjerg Hospital', u'Sellas Life Sciences Group', u'Stony Brook University Hospital', u'VIB', u'Novigenix', u'Biocon Ltd', u'Korea Drug Development Fund', u'Jenner Biotherapies Inc', u'WarraPharm Pty Ltd', u'Terry Fox Foundation', u'Exelixis Inc', u'Immunicon Corp', u'Amgen Inc', u'Nippon Petrochem Co Ltd', u'Epigenomics AG', u'State University of New York at Stony Brook', u'EuroTransBio', u'iDD biotech', u'Hubrecht Organoid Technology', u'Baylor Research Institute', u'Wyeth KK', u'MGI Pharma Biologics', u'The University of Birmingham', u'Johns Hopkins University School of Medicine', u'Robert H. Lurie Comprehensive Cancer Center', u'Georgetown University Medical Center', u'Royalmount Pharma', u'University of Alabama at Birmingham', u'PsiOxus Therapeutics Ltd', u'Sanofi-Synthelabo', u'Confluence Life Sciences Inc', u'Perceptive Imagineering LLC', u'Enzon Pharmaceuticals Inc', u'Immunomedics Inc', u'Janssen Pharmaceutical KK', u'Pennsylvania State University', u'Alberta government', u'Cytovance Biologics LLC', u'Imperial Cancer Research Technology Ltd', u'Parker Institute for Cancer Immunotherapy', u'TNK Therapeutics Inc', u'Advanced Medical German Company', u'Pulsalys Inc', u'F Hoffmann-La Roche AG', u'NOXXON Pharma AG', u'CureTech Ltd', u'SICOR Inc', u'Cancer Research UK', u'Genentech Inc', u'National Natural Science Foundation of China', u'StemSynergy Therapeutics Inc', u'Mayo Clinic Foundation', u'Rigel Pharmaceuticals Inc', u'GeneNews Ltd', u'Yale University', u'Laureate Biopharmaceutical Services Inc', u'LifeArc', u'Ark Therapeutics Group plc', u'Celprogen Inc', u'BioRealites SAS', u'PDL BioPharma Inc', u'Scripps Research Institute', u'National Cancer Center of Korea', u'Redx Pharma Plc', u'Organon Teknika BV', u'University of Southern California', u'University of Texas Southwestern Medical Center', u'Eureka Genomics Corp', u'AIT Austrian Institute Of Technology Gmbh', u'Cyto Pulse Sciences Inc', u'MolMed SpA', u'West Virginia University', u'University of Melbourne', u'AstraZeneca plc', u'Technology Strategy Board', u'Caprion Proteomics Inc', u'Agensys Inc', u'Genta Inc', u'Arbele Limited', u'China Regenerative Medicine International Limited', u'Introgen Therapeutics Inc', u'Hemispherx Biopharma Inc', u'Lab21 Inc', u'CASI Pharmaceuticals Inc', u'Translational Genomics Research Institute', u'ASTA Medica AG', u'ASLAN Pharmaceuticals Pte Ltd', u'Reliance Life Sciences Group', u'Medipharm Biotech Co Ltd', u'IDT Australia Ltd', u'Celleron Therapeutics Ltd', u'MacroGenics Inc', u'Aqualis ASA', u'Early Diagnosis Consortium', u'Cedars-Sinai Medical Center', u'Fujifilm Diosynth Biotechnologies', u'Shandong Chengchuang Pharmaceutical R&D Co Ltd', u'ADT Pharmaceuticals', u'ThromboGenics NV', u'Melmotte Inc', u'Adria Laboratories Inc', u'ST Pharm Co Ltd', u'GE Healthcare', u'Polymedco Inc', u'PiSA Farmaceutica', u'Dyax Corp', u'Ethical Oncology Science SpA', u'Takeda Pharmaceutical Co Ltd', u'University of Toronto', u'TopoTarget A/S', u'CuraGen Corp', u'German Federal Ministry of Education and Research', u'Ignyta Inc', u'National Comprehensive Cancer Network', u'University of Florida', u'Arana Therapeutics Ltd', u'Cellcor Inc', u'EMD Serono Inc', u'OncoTherapy Science Inc', u'Yakult Honsha Co Ltd', u'CBS Therapeutics Inc', u'VolitionRX Ltd', u'ChemImage Inc', u'Cytogen Corp', u'Mera Pharmaceuticals Inc', u'University of Southern Denmark', u'Teva Pharmaceutical Industries Ltd', u'Vanderbilt University', u'MedImmune LLC', u'OSI Pharmaceuticals Inc', u'Fred Hutchinson Cancer Research Center', u'Hybrigenics SA', u'Taxolog Inc', u'Abcodia Ltd', u'ARIUS Research Inc', u'Implicit Bioscience Ltd', u'Kite Pharma Inc', u'Ludwig Institute for Cancer Research', u'KuDOS Pharmaceuticals Ltd', u'Biosite Inc', u'Keio University', u'Konruns Pharmaceutical Co Ltd', u'Kiadis Pharma Netherlands BV', u'TrovaGene Inc', u'International Biotechnology Center Generium LLC', u'Inex Pharmaceuticals Corp', u'Intas Pharmaceuticals Ltd', u'Mylan Inc', u'OncoSurg Inc', u'Medicover', u'Mast Therapeutics Inc', u'Sanghyon Chemical Corp', u'Gendux Molecular Ltd', u'Zeneca Group plc', u'BARD1AG SA', u'Cancer Advances Inc', u'GlobeImmune Inc', u'Warnex Laboratories', u'Oncolytics Biotech Inc', u'Sun Yat-Sen University', u'University of Texas Medical Branch at Galveston', u'Precision Biologics Inc', u'diaDexus LLC', u'Titan Pharmaceuticals Inc', u'Boehringer Ingelheim Corp', u'Hoffmann-La Roche Inc', u'Universit\\xe4tsklinikum Hamburg-Eppendorf', u'BioInvent International AB', u'Debiopharm SA', u'Lonza Biologics plc', u'ILEX Oncology Inc', u'Guangzhou Institutes of Biomedicine and Health', u'Duke University Medical Center', u'Xenova Group plc', u'University of South Alabama', u'IDIS Ltd', u'Onco360', u'Schering-Plough Corp', u'Oxford BioMedica plc', u'Somantix BV', u'Cancer Research Campaign (UK)', u'XOMA Corp', u'Merck & Co Inc', u'Sienna Cancer Diagnostics Ltd', u'CFD Therapeutics Inc', u'Rigshospitalet, Denmark', u'Sanofi', u'Vertex Pharmaceuticals Inc', u'Columbia University', u'Pharmacia Corp', u'Academia Sinica', u'Cambridge Biomedical Inc', u'InNexus Biotechnology Inc', u'University of Geneva', u'Princeton University', u'Merus BV', u'Nektar Therapeutics', u'Centre for Applied Microbiology & Research', u'Almirall Prodesfarma SA', u'Therapure Biopharma Inc', u'ArQule Inc', u'NeoGenix Oncology Inc', u'Samuel Lunenfeld Research Institute', u'Synthetic Biologics Inc', u'Ministry Of Industry & Trade Of The Russian Federation', u'Institut National de la Recherche Agronomique', u'Merrimack Pharmaceuticals Inc', u'Institute for the Promotion of Innovation by Science and Technology in Flanders', u'Vernalis plc', u'Light Sciences Oncology Inc', u'AnorMED Inc', u'Janssen Diagnostics LLC', u'Imclone LLC', u'Pasteur Merieux Connaught Canada', u'Cytran Inc', u'Braintree Laboratories Inc', u'Western University Of Health Sciences', u'Neovacs SA', u'Lonza Group AG', u'Taivex Therapeutics Inc', u'SillaJen Inc', u'AltheaDx Inc', u'AVEO Oncology', u'Aushon BioSystems', u'Elan Corp plc', u'Aventis SA', u'INSERM', u'Sanofi Genzyme', u'MSD Japan', u'Olivia Newton-John Cancer Research Institute', u'Celgene Corp', u'Array BioPharma Inc', u'Par Pharmaceutical Co Inc', u'KS Biomedix Holdings plc', u'University of Hawaii', u'Oakwood Laboratories LLC', u'Salix Pharmaceuticals Ltd', u'YIACO Medical Co', u'Inno Biologics Sdn Bhd', u'Alethia Biotherapeutics Inc', u'Massachusetts Institute of Technology', u'Bayer HealthCare Pharmaceuticals Inc', u'North Shore Long Island Jewish Health System', u'European Organisation for Research and Treatment of Cancer (EORTC)', u'Abraxis BioScience Inc', u'University of Alberta', u'Epeius Biotechnologies Corp', u'Rhone-Poulenc Rorer Inc', u'Synteract Inc', u'OncoGenex Pharmaceuticals Inc', u'Defense Threat Reduction Agency', u'Daiichi Seiyaku Co Ltd', u'US Government', u'BioMarin Pharmaceutical Inc', u'BioChain (Beijing) Science and Technology', u'Ecole Polytechnique Federale de Lausanne', u'BioAtla Llc', u'OnSite Diagnostic Labs India Pvt Ltd', u'Cancer Research Campaign Technology Ltd', u'W C Heraeus GmbH & Co KG', u'Pharsight Corp', u'Yamaguchi University', u'GlaxoSmithKline plc', u'Cytran Ltd', u'Bayer Schering Pharma AG', u'Cascadian Therapeutics Inc', u'ZAI Laboratory Inc', u'Novotech (Australia) Pty Ltd', u'Ipsen', u'Immunex Corp', u'Cleveland BioLabs Inc', u'Marina Biotech Inc', u'University of Michigan', u'Takeda Oncology', u'Ontario Institute for Cancer Research', u'Almac Diagnostics', u'NewBiotics Inc', u'Check-Cap Llc', u'Peregrine Pharmaceuticals Inc', u'Netherlands Cancer Institute', u'BioMotiv LLC', u'Emory University', u'ChemWerth USA', u'Radient Pharmaceuticals Corp', u'Philogen SpA', u'Sequenom Inc', u'DanDrit Biotech USA Inc', u'Light Sciences Corp', u'Windlas Healthcare Private Limited', u'MD Anderson Cancer Center', u'Medarex Inc', u'Biohit OYJ', u'Daiichi Sankyo Co Ltd', u'Abbott Laboratories', u'UniQuest Pty Ltd', u'3SBio Inc', u'Edinburgh Molecular Imaging Ltd', u'National Cancer Institute', u'Novartis AG', u'Merck KGaA', u'Fujisawa Pharmaceutical Co Ltd', u'Affimed NV', u'Monash University', u'Oncoceutics Inc', u'Galectin Therapeutics Inc', u'ALZA Corp', u'Taiho Pharmaceutical Co Ltd', u'University of Navarra', u'University of Texas System', u'Kosan Biosciences Inc', u'SAFC Pharma', u'Sunnybrook Health Sciences Centre', u'Vericel Corp', u'Numoda Corp', u'Oxford Gene Technology (Operations) Ltd', u'Johns Hopkins University', u'Lupin Ltd', u'Royalty Pharma', u'OncoMed Pharmaceuticals Inc', u'Starvax Inc', u'Chugai Pharmaceutical Co Ltd', u'Andrus Reo Ltd', u'Southern Research Institute', u'Amgen Research (Munich) GmbH', u'Maimonides Medical Center', u'Agendia BV', u'Jeil Pharmaceutical Co Ltd', u'HS Hvidovre Hospital', u'Genomac International Ltd', u'National Institute on Drug Abuse', u'DNAlytics', u'Cancer Research Institute (CRI)', u'University College London', u'Mekanistic Therapeutics LLC', u'Epimmune Inc', u'Cellmid Ltd', u'University of Virginia', u'Kyowa Hakko Kirin Co Ltd', u'Immune Therapeutics Inc', u'The Netherlands Organisation for Health Research and Development', u'University of Bradford', u'Janssen Biotech Inc', u'Lab Medical Center Dr. Risch AG', u'Pfizer Inc', u'Veterans Administration', u'Human Genome Sciences Inc', u'Memorial Sloan-Kettering Cancer Center', u'Riyadh Pharma', u'AusIndustry', u'Therion Biologics Corp', u'Stason Pharmaceuticals Inc', u'Norsk Hydro AS', u'In Ovations Holdings Inc', u'Paul Scherrer Institut', u'National Institute of Allergy and Infectious Diseases', u'2cureX', u'VA Medical Center', u'Centre Hospitalier Universitaire UCL Mont-Godinne-Dinant', u'PhotoCure ASA', u'National Institutes of Health', u'Geron Corp', u'Axxiom Inc', u'South Texas Accelerated Research Therapeutics', u'Vaccinogen Inc', u'Curis Inc', u'American Cyanamid Co', u'Thomas Jefferson University', u'Onyx Pharmaceuticals Inc', u'Roswell Park Cancer Institute', u'University of Chicago', u'Ono Pharmaceutical Co Ltd', u'Araxes Pharma LLC', u'Qiagen NV', u'Ferozsons Laboratories Ltd', u'Exact Sciences Corp', u'University of Guelph', u'Peking University Cancer Hospital', u'Childrens Hospital of Philadelphia', u'Merck Serono SA', u'Clinical Genomics Pty Ltd', u'ProBioGen AG', u'Idera Pharmaceuticals Inc', u'Biologics Inc', u'Cancer Therapy & Research Center', u'Scancell Ltd', u'University at Buffalo', u'Prospect Therapeutics Inc']), u'Hypogonadism': set([u'Urigen Pharmaceuticals Inc', u'Oscient Pharmaceuticals Corp', u'University of Washington', u'US Government', u'Solvay SA', u'Unimed Pharmaceuticals Inc', u'Genentech Inc', u'Validus Pharmaceuticals', u'Aspen PharmaCare Holdings Ltd', u'Lipocine Inc', u'ASCEND Therapeutics Inc', u'Paladin Labs Inc', u'Mereo BioPharma Group Ltd', u'Monash University', u'TesoRx Pharma', u'Orion Corporation', u'Endo Health Solutions Inc', u'Endo Pharmaceuticals Solutions Inc', u'Astra AB', u'GlaxoSmithKline plc', u'Therapeutic Discovery Corp', u'Quintiles Transnational Corp', u'Novartis Pharmaceuticals Corp', u'ICON plc', u'Teva Pharmaceutical Industries Ltd', u'Actavis Inc', u'Bayer Schering Pharma AG', u'Ardana Bioscience Ltd', u'Jeil Pharmaceutical Co Ltd', u'PT Kalbe Farma Tbk', u'Cytochemia Corp', u'Bayer Inc', u'Ipsen', u'IASO Biomed Inc', u'Merck & Co Inc', u'Auxilium Pharmaceuticals Inc', u'Hanmi Pharmaceutical Co Ltd', u'Juniper Pharmaceuticals Inc', u'M et P Pharma AG', u'Samyang Corp', u'ICOS Corp', u'Produtos Farmaceuticos Bioty LDA', u'UCB Pharma GmbH', u'Lohmann Therapie-Systeme GmbH & Co KG', u'Acrux Ltd', u'Novartis AG', u'Mipharm SpA', u'Jangobio Llc', u'Ferring Pharmaceuticals SA', u'Invaron Pharmaceuticals Inc', u'MW Encap Ltd', u'Grelan Pharmaceutical Co Ltd', u'ANI Pharmaceuticals Inc', u'Prasco Laboratories', u'McGill University', u'Laboratoires Besins International', u'PDI Research Laboratories Inc', u'Orexo AB', u'National Institute on Aging', u'Fournier Pharma', u'DPT Laboratories', u'Plethora Solutions Holdings plc', u'Population Council', u'Kyowa Kirin', u'Watson Laboratories Inc', u'Bentley Pharmaceuticals Inc', u'Adamis Pharmaceuticals Corp', u'Antares Pharma Inc']), u'Impulsecontroldisorder': set([u'Janssen Pharmaceuticals Inc', u'IVAX Corp', u'University of Cincinnati', u'Britannia Pharmaceuticals Ltd', u'Takeda Pharmaceuticals International GmbH', u'Eczacibasi Ilac Pazarlama AS', u'WhanIn Pharmaceutical Co Ltd', u'BioTie Therapies Corp', u'Somaxon Pharmaceuticals Inc']), u'Non-small-celllungcance': set([u'Takeda Oncology', u'Pharsight Corp']), u'Paralysis': set([u'Allergan Inc', u'Taro Pharmaceutical Industries Ltd', u'University of Rochester', u'National Institutes of Health', u'Valeant Pharmaceuticals International Inc', u'Strongbridge Biopharma plc', u'Ranbaxy Laboratories Ltd', u'Diplomat Pharmacy Inc', u'Merck & Co Inc', u'Muscular Dystrophy Association']), u'Periarthritis': set([u'Tokuhon Co Ltd', u'Mitsubishi Pharma Corp']), u'Vasculardementia': set([u'Pfizer Inc', u'Catalytica Inc', u'Undisclosed', u'Emory University', u'ProNeurogen Inc', u'Stemedica Cell Technologies Inc', u'Eisai Co Ltd', u'University of Arizona']), u'Streptococcuspneumoniaeinfe': set([u'Cardiome Pharma Corp', u'Tzamal Medical Group Ltd']), u'Neoplasmbysite': set([u'Pfizer Inc', u'Sandoz AG', u'Immunomedics Inc', u'Mallinckrodt Medical', u'Adria Laboratories Inc']), u'Westernequineencephalitisvirusinf': set([u'Ichor Medical Systems Inc', u'Profectus BioSciences Inc']), u'Bacterialmeningitis': set([u'Childrens Hospital Oakland Research Institute', u'Baxter International Inc', u'Paladin Labs Inc', u'Immunovaccine Inc', u'Sanofi Pasteur', u'Peptor Ltd', u'Mochida Pharmaceutical Co Ltd', u\"United Nations International Children's Fund\", u'Lepetit International Inc', u'Emerge Health Pty Ltd', u'Beijing Zhifei Luzhu Biopharmaceutical Co Ltd', u'Yuhan Corp', u'Epitogenesis Inc', u'Undisclosed', u'Emergent BioSolutions Inc', u'XOMA Corp', u'Chinese Government', u'Action Medical Research', u'Zeneca Group plc', u'Sanofi', u'Leiden University Medical Center', u'Bayer AG', u'Sumitomo Pharmaceuticals Co Ltd', u'Concordia Pharmaceuticals Inc', u'Mitsubishi Tanabe Pharma Corp', u'LG Life Sciences India Pvt Ltd', u'Nuron Biotech Inc', u'Cubist Pharmaceuticals Inc', u'AstraZeneca plc', u'Pfizer Inc', u'Acambis plc', u'Takeda Pharmaceutical Co Ltd', u'Novartis Vaccines & Diagnostics', u'Wyeth', u'Teligent Inc', u'University of Oxford', u'National Research Council of Canada', u'Mellow Hope Inc']), u'Colic': set([u'Noventure', u'Pierre Fabre Pharma GmbHWebsiteDirections']), u'Bacillusanthracisinfection': set([u'Takeda Vaccines Inc', u'US Government', u'Center for Commercialization of Advanced Technology', u'University of Florida', u'Cerus Corp', u'Celldex Therapeutics Inc (pre-merger)', u'Netherlands Government', u'UK Department of Trade & Industry', u'Rockefeller University', u'US Health and Human Services Department', u'Department of Health', u'Life Technologies Corp', u'GlaxoSmithKline plc', u'The Korea National Institute of Health', u'Biologics Resources LLC', u'Vical Inc', u'Achaogen Inc', u'Syntiron LLC', u'Arizona State University', u'PolyMedix Inc', u'Protein Potential LLC', u'Fraunhofer Institut Molekularbiologie Und Angewandte Oekologie', u'University of Michigan', u'Celldex Therapeutics Inc', u'Trius Therapeutics Inc', u'SomaGenics Inc', u'University of Rochester', u'Aduro BioTech Inc', u'Biotempt BV', u'University of British Columbia', u'Grifols Inc', u'Battelle', u'Paratek Pharmaceuticals Inc', u'NanoBio Corp', u'New Zealand Foundation for Research, Science and Technology', u'ANI Pharmaceuticals Inc', u'Dynavax Technologies Corp', u'Innovative Biologics Inc', u'Biophage Pharma Inc', u'Innate Immunotherapeutics Ltd', u'Defense Advanced Research Projects Agency', u'US Department of Defense', u'Emergent Europe Ltd', u'Fujifilm Finechemicals Co Ltd', u'Loyola University of Chicago', u'Paragon Bioservices Inc', u'Oregon State University', u'Juvaris BioTherapeutics Inc', u'Profectus BioSciences Inc', u'AFG Biosolutions Inc', u'Medarex Inc', u'Pfenex Inc', u'Cambridge Antibody Technology Group plc', u'Harvard University', u'Daiichi Sankyo Co Ltd', u'Cengent Therapeutics Inc', u'Greffex Inc', u'National Cancer Institute', u'Aradigm Corp', u'Cambridge Biostability Ltd', u'UK Ministry of Defence', u'MNLpharma Ltd', u'Xenerex Biosciences', u'University of Alabama at Birmingham', u'PsiOxus Therapeutics Ltd', u'Galveston National Laboratory', u'Lovelace Respiratory Research Institute', u'North Atlantic Treaty Organization', u'Intercell USA', u'Emisphere Technologies Inc', u'Science Applications International Corp', u'Infectious Disease Research Institute', u'Basilea Pharmaceutica International Ltd', u'Navigen Inc', u'University of Colorado System', u'Montana State University', u'Exponential Biotherapies Inc', u'Planet Biotechnology Inc', u'University of Minnesota', u'Avanir Pharmaceuticals Inc', u'Health Protection Agency', u'AnC Bio Group', u'National Institute of Neurological Disorders and Stroke', u'Fraunhofer USA Inc', u'DynPort Vaccine Company LLC', u'IQ Corp', u'Texas A&M University System', u'Advanced Life Sciences Holdings Inc', u'Biothera Pharmaceuticals Inc', u'National Institute of Diabetes, Digestive and Kidney Diseases', u'Cangene Corp', u'Yale University', u'Baxter Healthcare Corp', u'Institute of Biotechnology the Academy of Military Medical Sciences PLA', u'US Army Medical Research and Materiel Command', u'Emergent BioSolutions Inc', u'ImmuneRegen BioSciences Inc', u'Diosynth Biotechnology', u'CUBRC', u'Merck & Co Inc', u'Chong Kun Dang Pharmaceutical Corp', u'Centers for Disease Control and Prevention', u'Altimmune Inc', u'Bayer AG', u'US Army Medical Research Institute of Infectious Diseases', u'VectorLogics Inc', u'Texas Tech University', u'Pulmatrix Inc', u'BD Technologies', u'Soligenix Inc', u'University of Nevada', u'Glide Pharmaceutical Technologies Ltd', u'Canadian Department of National Defence', u'PaxVax Inc', u'Virtual Drug Development Inc', u'VLP Biotech Inc', u'Human Genome Sciences Inc', u'University of Utah', u'Adenosine Therapeutics LLC', u'Medison Pharma Ltd', u'Anza Therapeutics Inc', u'University of Illinois', u'International Vaccine Institute', u'Evolva Holding SA', u'Coley Pharmaceutical Group Inc', u'Ichor Medical Systems Inc', u'EpiStem Ltd', u'PanThera Biopharma LLC', u'US Naval Medical Research Center', u'Tetraphase Pharmaceuticals Inc', u'National Institute of Allergy and Infectious Diseases', u'iBio Inc', u'Cempra Inc', u'Ohio State University', u'Lonza Group AG', u'Albert Einstein College of Medicine', u'Walter Reed Army Institute of Research', u'National Institutes of Health', u'Novavax Inc', u'Guizhou Taibang Biological Products Co Ltd', u'Sarepta Therapeutics Inc', u'Wadsworth Centre', u'Stabilitech Ltd', u'Cardiff University', u'Tulane National Primate Research Center', u'Icoria Inc', u'Fujifilm Diosynth Biotechnologies', u'Immunovaccine Inc', u'Kyowa Hakko Bio Co Ltd', u'Aridis Pharmaceuticals Inc', u'Advanced Biotherapy Inc', u'Archimedes Pharma Ltd', u'Elusys Therapeutics Inc', u'BioDiem Ltd', u'diaDexus Inc', u'Crucell NV', u'nanoMR Inc', u'AntexPharma Inc', u'Hawaii Biotech Inc', u'University of New Mexico', u'Encorium Group Inc', u'Altimmune Inc (pre-merger)', u'ContraFect Corp', u'University of Cambridge', u'Defense Threat Reduction Agency']), u'Giardialambliainfection': set([u'AB ANALITICA', u'University of North Carolina', u'Mobidiag Oy', u'Immtech Pharmaceuticals Inc', u'University of California San Diego', u'Romark Laboratories LC', u'National Institute of Allergy and Infectious Diseases', u'Laboratorios Columbia SA de CV']), u'Diarrhea': set([u\"Dr Reddy's Laboratories Ltd\", u'Texas Emerging Technology Fund', u'Syngene International Ltd', u'Alizyme plc', u'EMD Serono Inc', u'R&R Inc', u'Novartis Institutes for BioMedical Research Inc', u'Scandinavian Biopharma', u'Serum Institute of India Ltd', u'GlaxoSmithKline plc', u'BTG plc', u'Univ Massachusetts', u'Cosmo Pharmaceuticals SpA', u'Texas A&M University System', u'Henry Schein Inc', u'Immuron Ltd', u'University of Florida', u'National Institute of Cholera and Enteric Diseases', u'Celldex Therapeutics Inc', u'Walter Reed Army Institute of Research', u'OBI Pharma Inc', u'ISM Therapeutics', u'Medique Products', u'MSD Wellcome Trust Hilleman Laboratories', u'Quality Brands International Direct', u'Debiovision Inc', u'Laboratoires Biocodex', u'Procter & Gamble Pharmaceuticals Inc', u'Direct Relief International', u'Etvax AB', u'Intercell AG', u'Merckle GmbH', u'Optimer Pharmaceuticals Inc', u'US Department of Defense', u'Norgine BV', u'University of Nebraska Medical Center', u'Meristem Therapeutics', u'Meiji Seika Pharma Co Ltd', u'RxBio Inc', u'MD Anderson Cancer Center', u'Chinese Academy of Medical Military Sciences', u'Apimeds Inc', u'Medarex Inc', u'Zyma SA', u'Cystic Fibrosis Foundation Therapeutics Inc', u'Glenmark Pharmaceuticals Ltd', u'Trine Pharmaceuticals Inc', u'Tulane University', u'McKesson Corp', u'National Cancer Institute', u'Merck KGaA', u'RedHill Biopharma Ltd', u'Integrated Animal Nutrition and Health Inc', u'TriMed Research Inc', u'University of California San Francisco', u'Rottapharm Madaus', u'Monash University', u'Creative Antibiotics Sweden AB', u'Laboratoires Mayoly Spindler', u'Taiho Pharmaceutical Co Ltd', u'Luye Pharma Group Ltd', u'Fougera Pharmaceuticals Inc', u'Entera Health', u'Shanxi Kangbao Biological Products Co Ltd', u'Helsinn Healthcare SA', u'Health Care Logistics Inc', u'Johns Hopkins University', u'Lupin Ltd', u'Kyowa Hakko Kogyo Co Ltd', u'Debiopharm SA', u'Patheon Pharmaceuticals Inc', u'Bharat Biotech International Ltd', u'VINNOVA', u'Ventria Bioscience', u'Active Pass Pharmaceuticals Inc', u'Glycosyn LLC', u'IDIS Ltd', u'National Institute of Diabetes, Digestive and Kidney Diseases', u'Codagenix Inc', u'SRI International', u'CLL Pharma', u'Roussel Uclaf SA', u'SunPharm Corp', u'SangStat Medical Corp', u'Ipsen', u'University of Gothenburg', u'Merck & Co Inc', u'BioFocus DPI', u'GlaxoSmithKline Biologicals', u'US Naval Medical Research Center', u'Prokarium', u'Dr Falk Pharma GmbH', u'Mucosis BV', u'J.P. Equine Services Corp', u'Romark Laboratories LC', u'University of Iowa', u'China Medical System Holdings Ltd', u'Cubist Pharmaceuticals Inc', u'BioProjet, Societe Civile de Recherche', u'National Institute of Biomedical Innovation', u'Acambis plc', u'Zhiyi Pharmaceuticals Inc', u'Inclinix Inc', u'EpiStem Ltd', u'UK Government', u'Probiomed S.A. de C.V', u'The Institute for OneWorld Health', u'National Institute of Allergy and Infectious Diseases', u'Alberta Glycomics Centre', u'Salient Pharmaceuticals Inc', u'Synt:em', u'Alfa Wassermann SpA', u'Program for Appropriate Technology in Health', u'Sun Pharmaceutical Advanced Research Co Ltd', u'California Institute for Biomedical Research', u'Southern Medical University Nanfang Hospital', u'National Institutes of Health', u'Bill & Melinda Gates Foundation', u'University of Tokyo', u'Taisho Pharmaceutical Co Ltd', u'Maryland Innovation Initiative', u'Menarini Asia-Pacific', u'Chinese Government', u'PanTheryx Inc', u'Sanofi Genzyme', u'University of Calgary', u'Janssen Research & Development LLC', u'Roche Holding AG', u'Intercell USA', u'Astellas Pharma Inc', u'Federal government of Mexico', u'University of Hawaii', u'Salix Pharmaceuticals Ltd', u'Sin Phyu Kyun Co Ltd', u'Shanghai United Cell Biotechnology Co Ltd', u'Jaguar Health Inc', u'Napo Pharmaceuticals Inc', u'Takeda Pharmaceutical Co Ltd', u'EpiBiome Inc', u'Kaneka Corp']), u'Gastrointestinaldiseasebyprocess': set([u'FDA Office of Orphan Products Development', u'National Institutes of Health', u'Fred Hutchinson Cancer Research Center', u'Soligenix Inc']), u'Polymyositis': set([u'Zenyaku Kogyo Co Ltd', u'Genentech Inc', u'Roche Holding AG', u'Medarex Inc', u'XOMA Corp', u'Corixa Corp', u'IDEC Pharmaceuticals Corp', u'Coulter Pharmaceutical Inc', u'Pharma Pacific Pty Ltd', u'RecipharmCobra Biologics']), u'Seasonalaffectivedisorder': set([u'Sanofi', u'Photoswitch Biosciences Inc', u'Biovail Corp', u'The National Institute of Mental Health']), u'Musclehypertonia': set([u'Neurana Pharmaceuticals Inc', u'Mallinckrodt plc', u'US Government', u'National Institute of Neurological Disorders and Stroke', u'Quay Pharmaceuticals Ltd', u'Acorda Therapeutics Inc', u'Hebrew University of Jerusalem', u'Piramal Critical Care Inc', u'Cipla Ltd', u'MEDRx Co Ltd', u'University of Mississippi', u'XenoPort Inc', u'Oxford Natural Products', u'Neurorecovery Inc', u'Novartis AG', u'Eunice Kennedy Shriver National Institute of Child Health & Human Development', u'PathMaker Neurosystems Inc', u'CoNCERT Pharmaceuticals Inc', u'DRAXIS Health Inc', u'Ionis Pharmaceuticals Inc', u'Ipsen', u'Novartis Pharma AG', u'Elan Corp plc', u'University of Tokushima', u'OSEO', u'Cephalon Inc', u'Bayer AG', u'Mallinckrodt Inc', u'Sanochemia Pharmazeutika AG', u'CytoDel LLC', u'Valeant Pharmaceuticals International Inc', u'MMJ PhytoTech Ltd', u'Farmak AS', u'Axim Biotechnologies Inc', u'Cognitive Research Corp', u'Yissum Research Development Co', u'GW Pharmaceuticals plc', u'Allergan Inc', u'Almirall Prodesfarma SA', u'Fast Forward LLC', u'Elan Pharmaceuticals Inc', u'Saol Therapeutics Inc', u'Technology Strategy Board', u'Canbex Therapeutics Ltd', u'Institut du Cerveau et de la Moelle epiniere', u'Shionogi & Co Ltd', u'Neopharm Ltd', u'Medtronic Inc', u'University of California', u'Osmotica Pharmaceutical Corp']), u'Muscledisease': set([u'Beactica AB', u'Regeneron Pharmaceuticals Inc', u'Amgen Inc', u'TLH Research Inc', u'University of Nevada', u'Solid Biosciences LLC', u'GlaxoSmithKline plc', u'Ark Therapeutics Group plc', u'Massachusetts Eye & Ear Infirmary', u'European Community', u'SiteOne Therapeutics Inc', u'Columbia University', u'The Procter & Gamble Co', u'Five Prime Therapeutics Inc', u'Anagenesis Biotechnologies', u'University of Miami Miller School of Medicine', u'Scholar Rock Inc', u'Institut Pasteur', u'Selecta Biosciences Inc', u'Vrije Universiteit van Amsterdam', u'University of Iowa', u'Armgo Pharma Inc', u'Boehringer Ingelheim Corp', u'StrykaGen', u'European Molecular Biology Laboratory', u'Institute for the Promotion of Innovation by Science and Technology in Flanders', u'Pharming Group NV', u'University of Cambridge', u'Innovus Pharmaceuticals Inc']), u'Leishmaniamexicanainfection': set([u'Georgia State University', u'Immtech Pharmaceuticals Inc']), u'Infantilespasms': set([u'University of Rochester Medical Center', u'Mallinckrodt plc', u'Questcor Pharmaceuticals Inc', u'West Therapeutic Development LLC', u'Child Neurology Foundation', u'Massachusetts General Hospital']), u'Myeloproliferativedisorder': set([u'US Government', u'Inex Pharmaceuticals Corp', u'Baxter International Inc', u'Swedish Orphan AB', u'Mayo Clinic Foundation', u'Incyte Corp', u'Novartis Institutes for BioMedical Research Inc', u'H Lee Moffitt Cancer Center and Research Institute', u'GlaxoSmithKline plc', u'ViaCell Inc', u'National Institutes of Health', u'S*BIO Pte Ltd', u'University of California San Francisco', u'Vion Pharmaceuticals Inc', u'CTI BioPharma Corp', u'Onyx Pharmaceuticals Inc', u'WuXi PharmaTech (Cayman) Inc', u'Dendreon Corp', u'Genentech Inc', u'Amgen Inc', u'Immune Response BioPharma Inc', u'Shire plc', u'Tan Tock Seng Hospital', u'Beijing Pason Pharmaceuticals Inc']), u'Centralnervoussystemdisease': set([u'Lumara Health Inc', u'Sareum Holdings plc', u'Neurobiological Technologies Inc', u'Lantheus Medical Imaging Inc', u'GW Pharmaceuticals plc', u'University of Maryland', u'Kadmus Pharmaceuticals Inc', u'Questcor Pharmaceuticals Inc', u'Novartis Pharma AG', u'GeneProt Inc', u'University of Prince Edward Island', u'European Community', u'Pharmaceutical Product Development LLC', u'Zydus-Cadila Group', u'Hydra Biosciences Inc', u'University of Pittsburgh', u\"The Parkinson's Institute and Clinical Center\", u'Celldex Therapeutics Inc', u'IMPAX Laboratories Inc', u'University of California Los Angeles', u'Ambrx Inc', u'Merck Sharp & Dohme Corp', u'Intec Pharma Ltd', u'CeNeS Pharmaceuticals Inc', u'PharmaSeed Ltd', u'Cardinal Health Inc', u'NeuroSpheres Ltd', u'Catalent Inc', u'NeuCyte Inc', u'Cengent Therapeutics Inc', u'NeuroSearch A/S', u'Peking University', u'Alseres Pharmaceuticals Inc', u'TransForm Pharmaceuticals Inc', u'National Research Council of Canada', u'Asubio Pharma Co Ltd', u'Sigma-Tau Ind Farm Riunite SpA', u'CrystalGenomics Inc', u'MGI GP Inc', u'NewNeural LLC', u'Biotie Therapies AG', u'BioProjet, Societe Civile de Recherche', u'Evolus Inc', u'Ranbaxy Laboratories Ltd', u'ChemRar Pharma', u'Medimmune Vaccines Inc', u'Melior Pharmaceuticals Inc', u'Milkhaus Laboratory Inc', u'Censo Biotechnologies Ltd', u'Castle Creek Pharmaceuticals LLC', u'MedDay Pharmaceuticals', u'Rhenovia Pharma SAS', u'National Multiple Sclerosis Society', u'Leiras Oy', u'Myelin Repair Foundation Inc', u'MerLion Pharmaceuticals Pte Ltd', u'PAION AG', u'Instituto de Quimica Medica-CSIC', u'Agennix AG', u'Solvay Pharmaceuticals Inc', u'University of Alabama', u'Ogeda SA', u'JCR Pharmaceuticals Co Ltd', u'Newron Pharmaceuticals SpA', u'Pharmacopeia Inc', u'Karuna Pharmaceuticals', u'EpiCept Corp', u'CalciMedica Inc', u'CeNeRx BioPharma Inc', u'Janssen Pharmaceutica NV', u'Kinexis Inc', u'PreveCeutical Medical Inc', u'Genfit SA', u'Vyrex Corp', u'Neuro Assessment Systems Inc', u'Medtronic Inc', u'NeuroCog Trials', u'AmorePacific Corp', u'RheoGene Inc', u'moksha8 Pharmaceuticals Inc', u'Galenea Corp', u'Telethon Institute of Genetics and Medicine', u'CRELUX GmbH', u'NeuroMetrix Inc', u'California Institute of Technology', u'Alcyone Lifesciences Inc', u'Denmark Technical University', u'Sentinel Oncology Ltd', u'Undisclosed', u'Daewoong Pharmaceutical Co Ltd', u'Roche Palo Alto', u'Spherics Inc', u'Southwest Research Institute (SwRI)', u'Eli Lilly & Co', u'Proteros Biostructures GmbH', u'Solstice Neurosciences Inc', u'Ossianix Inc', u'Naprogenix Inc', u'Alder Biopharmaceuticals Inc', u'Amphora Discovery Corp', u'AstraZeneca Canada Inc', u'NsGene A/S', u'Horizon Orphan LLC', u'Argenta Discovery Ltd', u'Bracco SpA', u'Elan International Services Ltd', u'NeuroNova AB', u'National Institute on Aging', u'Fournier Pharma', u'State University of New York', u'Promentis Pharmaceuticals Inc', u'The Ruth and Bruce Rappaport Faculty of Medicine', u'SIBIA Neurosciences Inc', u'Johns Hopkins University', u'Beactica AB', u'Harbor Therapeutics Inc', u'Johnson & Johnson', u'Marathon Pharmaceuticals LLC', u'Rubicon Biotechnology Inc', u'Ministero per l Universita e la Ricerca Scientifica e Tecnologica', u'Serenics Inc', u'Silence Therapeutics AG', u'Valeant Pharmaceuticals North America LLC', u'Rodin Therapeutics Inc', u'University of California San Diego', u'Taisho Pharmaceutical Co Ltd', u'Northwestern University', u'Actelion Ltd', u'Servier', u'iPS Academia Japan Inc', u'Shire Richwood', u'Bristol-Myers Squibb Co', u'Portuguese Government', u'Evotec (UK) Ltd', u'Orasi Medical Inc', u'University of London', u'Astellas Pharma Inc', u'CyDex Pharmaceuticals Inc', u'Facio Therapies BV', u'Lundbeck Research USA Inc', u'Amylon LLC', u'PharmaNess Neuroscience', u'Tabuk Pharmaceutical Manufacturing Co', u'VigiCell', u'Hebrew University of Jerusalem', u'Athersys Inc', u'Life Sciences Discovery Fund', u'Enamine Ltd', u'PerkinElmer Inc', u'National Institute for Biological Standards and Control', u'MediSynergics LLC', u'Canadian Government', u'PPD Discovery Inc', u'University of Cambridge', u'Sumitomo Dainippon Pharma Co Ltd', u'Novo Nordisk A/S', u'Regeneron Pharmaceuticals Inc', u\"Alzheimer's Drug Discovery Foundation\", u'Mallinckrodt plc', u'Dalhousie University', u'Translate Bio', u'DRAXIS Health Inc', u'Instytut Psychiatrii i Neurologii', u'Psyadon Pharmaceuticals Inc', u'Congenica Ltd', u'Shanghai Fosun Pharmaceutical (Group) Co Ltd', u'Sellas Life Sciences Group', u'Stanford University', u'Microbot Medical Inc', u'Vernalis plc', u'University of Pennsylvania', u'The University Health Network', u'University of Kentucky', u'Ono Pharmaceutical Co Ltd', u'Sanochemia Pharmazeutika AG', u'Roche Holding AG', u'Genzyme Molecular Oncology', u'Biosearch Italia SpA', u'The National Institute of Mental Health', u'Medidata Ft Inc', u'VIB', u'Sanofi Genzyme', u'Temple University', u'Tenax Therapeutics Inc', u'Eukarion Inc', u'Catalyst Biosciences Inc', u'Wisconsin Department of Commerce', u'Neurologix Inc', u'European Molecular Biology Laboratory', u'Evotec AG', u'Meiji Seika Pharma Co Ltd', u'Impel NeuroPharma', u'Diaxonhit', u'Wyeth Research', u'Amgen Inc', u'CuroNZ Ltd', u'Axela Inc', u'Montana University', u'e-Therapeutics Plc', u'Endo Health Solutions Inc', u'Numerate Inc', u'University of Aberdeen', u'Takeda Cambridge Ltd', u'Assistance Publique Hopitaux de Paris', u'FUJIFILM RI Pharma Co', u'Eunice Kennedy Shriver National Institute of Child Health & Human Development', u'University of Bristol', u'ACADIA Pharmaceuticals Inc', u'Gemini Genomics plc', u'CGI Pharmaceuticals Inc', u'MabVax Therapeutics Holdings Inc', u'Sanofi-Synthelabo', u'Massachusetts General Hospital', u'Medical Research Council', u'NiKem Research Srl', u'PharmaVigilant', u'Yeda Research and Development Co Ltd', u'Berlin Free University', u'Scarista Ltd', u'Cypralis Ltd', u'Atlantic Canada Opportunities Agency', u\"M's Science Corp\", u'United States Army Institute of Surgical Research', u'Biovail Corp', u'Albany Molecular Research Inc', u'Bio-Link Australia Pty Ltd', u'Allergan Inc', u'University of Edinburgh', u'Niigata University', u'GNT Pharma Co Ltd', u'Protana Inc', u'Seelos Therapeutics Inc', u'BioTie Therapies Corp', u'F Hoffmann-La Roche AG', u'University of Oxford', u'Temmler GmbH', u'Rockefeller University', u'Bioprojet Pharma', u'Active Pass Pharmaceuticals Inc', u'Emmyon Inc', u'Genentech Inc', u'Upsher-Smith Laboratories Inc', u'Mitsubishi Pharma Corp', u'Mayo Clinic Foundation', u'Rigel Pharmaceuticals Inc', u'Intra-Cellular Therapies Inc', u'Ore Pharmaceuticals Inc', u'Laureate Biopharmaceutical Services Inc', u'LifeArc', u'Novia Pharmaceuticals Ltd', u'EmulTech bv', u'Molecular Insight Pharmaceuticals Inc', u'Thuris Corp', u\"French Army's Biomedical Research Institute\", u'Alkermes plc', u'La Jolla Pharmaceutical Co', u'Altimmune Inc', u'The Michael J. Fox Foundation', u'Pharmasol Corp', u'Proximagen Group plc', u'Pierre Fabre SA', u'LION bioscience Inc', u'VivaCell Biotechnology Espana SL', u'SYGNIS AG', u'Cellectricon Ab', u'Adimab LLC', u'University of Iowa', u'Proteome Sciences plc', u'ReNeuron Group plc', u'AstraZeneca plc', u'Technology Strategy Board', u'Bioelectron Technology Corp', u'University of Utah', u'BioFocus DPI', u'Scotia Holdings plc', u'Memory Pharmaceuticals Corp', u'Australian Government', u'QRxPharma Ltd', u'Tranzyme Pharma Inc', u'Genmab A/S', u'Milo Biotechnology', u'Pherin Pharmaceuticals Inc', u'ArmaGen Technologies Inc', u'Ligand Pharmaceuticals Inc', u'Critical Outcome Technologies Inc', u'Rensselaer Polytechnic Institute', u'Abeona Therapeutics Inc', u'University of Wisconsin-Milwaukee', u'Noscira SA', u'deCODE chemistry', u'SeneXta Therapeutics SA', u'Spectrum Pharmaceuticals Inc', u'Kyoto University', u'AGY Therapeutics Inc', u'3M Drug Delivery Systems', u'Bristol-Myers Squibb Pharma Co', u'Dong Wha Pharmaceutical Co Ltd', u'Valeant Pharmaceuticals International Inc', u'XW Laboratories Inc', u'Asset Realisation Co plc', u'GVK Biosciences Pvt Ltd', u'Institut Pasteur', u'GE Healthcare', u'Eucalyptus Ltd', u'Molecular Simulations Inc', u'Neuralstem Inc', u'Walter and Eliza Hall Institute of Medical Research', u'Avigen Inc', u'Ono Pharma UK Ltd', u'Takeda Pharmaceutical Co Ltd', u'Xenome Ltd', u'University of Toronto', u'KBP Biosciences Co Ltd', u'CuraGen Corp', u'Hennig Arzneimittel GmbH', u'Orphan Europe SARL', u'Transparency Life Sciences LLC', u'Silence Therapeutics plc', u'4d pharma plc', u'Humanetics Corp', u'Harvard NeuroDiscovery Center', u'OncoTherapy Science Inc', u'Lynx Therapeutics GmbH', u'Maxygen Inc', u'Forest Laboratories Inc', u'Korea Research Institute of Chemical Technology', u'Quintiles Transnational Corp', u'Idun Pharmaceuticals Inc', u'Tris Pharma Inc', u'LTS Lohmann Therapie-Systeme', u'NanoAxis', u'Uppsala University', u'RW Johnson Pharmaceutical Research Institute', u'Aventis Pharma AG', u'MedImmune LLC', u'Biocortech', u'Revaax Pharmaceuticals LLC', u'Galapagos NV', u'Cortech Inc', u'UCB SA', u'Aurora Biosciences Corp', u'Five Prime Therapeutics Inc', u'Zenobia Therapeutics Inc', u'D-Pharm Ltd', u'IMTM GmbH', u'Ciba-Geigy Pty Ltd', u'Novartis Pharmaceuticals Corp', u'Sun Pharmaceutical Industries Ltd', u'Vrije Universiteit van Amsterdam', u'Sage Bionetworks', u'Applied NeuroSolutions Inc', u'Optivia Biotechnology', u'IntelliPharmaCeutics International Inc', u'Relief Therapeutics Holding AG', u'Keio University', u'Pfizer Inc', u'Future Systems Inc', u'Omeros Corp', u'University of Nebraska Medical Center', u'PTC Therapeutics Inc', u'4D Molecular Therapeutics LLC', u'SCYNEXIS Inc', u'SunGen Pharma LLC', u'Mylan Inc', u'Pediapharm Inc', u'Chelsea Therapeutics International Ltd', u'Marinus Pharmaceuticals Inc', u'Harvard University', u'InterMed Discovery GmbH', u'Marquette University', u'PsychoGenics Inc', u'Sirna Therapeutics Inc', u'Aphios Corp', u'Yale University', u'Teva Pharmaceutical Industries Ltd', u'Bionomics Ltd', u'Purdue Pharma LP', u'Affymetrix Inc', u'Senhwa Biosciences Inc', u'Affilogic Laboratories', u'DIREVO Industrial Biotechnology GmbH', u'NPS Allelix Corp', u'Glaxo Group Ltd', u'Fujirebio Europe NV', u'Boehringer Ingelheim Corp', u'Genset SA', u'EPIX Pharmaceuticals Inc', u'BioAxone Therapeutic Inc', u'NovaMed Pharmaceuticals Inc', u'Saegis Pharmaceuticals Inc', u'Jazz Pharmaceuticals plc', u'Wilmington Pharmaceuticals Inc', u'Tsinghua University', u'Harvard Medical School', u'SAGE Therapeutics Inc', u'MediGene Inc', u'Roche Innovation Center Copenhagen A/S', u'Nisshin Pharma Inc', u'Health Policy and Research Foundation', u'KYOWA Pharmaceutical Industry Co Ltd', u'University of California', u'Merck & Co Inc', u'NextWave Pharmaceuticals Inc', u'Chugai Biopharmaceuticals Inc', u'National Eye Institute', u'rEVO Biologics Inc', u'Sanofi', u'Columbia University', u'Bayer AG', u'University of California Davis', u'Chemo Group', u'US Department of Veterans Affairs', u'University College Cork', u'BBB Therapeutics BV', u'Neurocrine Biosciences Inc', u'International Business Machines Corp', u'Progenics Pharmaceuticals Inc', u'4SC AG', u'Antares Pharma Inc', u'NeuroNascent Inc', u'RaNeDis Pharmaceuticals', u'Xytis Inc', u'Vect-Horus', u'BrainCells Inc', u'Rexahn Pharmaceuticals Inc', u'Amarin Corp plc', u'Max-Planck-Gesellschaft', u'Ablynx NV', u'Elan Corp plc', u'Aventis SA', u'INSERM', u'A2M Pharma GmbH', u'Organix Inc', u'Beryllium Discovery Corp', u'MGI Pharma Inc', u'Cephalon Inc', u'Celgene Corp', u'Pharma Pass LLC', u'National Institute on Alcohol Abuse and Alcoholism', u'SK Biopharmaceuticals', u'Ciba-Geigy AG', u'Takeda Singapore Pte Ltd', u'BC Cancer Agency', u'KeyNeurotek Pharmaceuticals AG', u'Duke University', u'Warren Pharmaceuticals Inc', u'Sun Moral International Limited', u'Shire plc', u'Janssen Pharmaceuticals Inc', u'RNL Bio Co Ltd', u'Supernus Pharmaceuticals Inc', u'Flexion Therapeutics Inc', u'Cracow University of Technology', u'PAREXEL International', u'VM Discovery Inc', u'Sugentech Inc', u'US Government', u'Hunter-Fleming Ltd', u'GT Biopharma Inc', u'MSD OSS BV', u'Acorda Therapeutics Inc', u'Psychiatric Genomics Inc', u'Tocris Neuramin Ltd', u'Biogen Inc', u'4SC Discovery GmbH', u'UMeWorld Ltd', u'Ambit Biosciences Corp', u'GlaxoSmithKline plc', u'Amarin Pharmaceuticals Inc', u'Bayer Schering Pharma AG', u'BioHaven Pharmaceutical Holding Co Ltd', u'Cipla-Medpro (Pty) Ltd', u'Toyota Tsusho Corp', u'Elite Pharmaceuticals Inc', u'Axon Biochemicals BV', u'MakScientific LLC', u'Cenix BioScience GmbH', u'Takeda Oncology', u'Voyager Therapeutics', u'Cerca Insights Sdn Bhd', u'Abbott Healthcare Products BV', u'Edunn Biotechnology Inc', u'Layton Bioscience Inc', u'St Marianna University School of Medicine', u'Encefa', u'Emory University', u'Nanyang Technological University', u'Institut du Cerveau et de la Moelle epiniere', u'Shionogi & Co Ltd', u'St Louis University', u'Siena Biotech SpA', u'MedGenesis Therapeutix Inc', u'Shire BioChem Inc', u'Johnson & Johnson Pharmaceutical Research & Development LLC', u'National Institute of Arthritis and Musculoskeletal and Skin Diseases', u'Cyberkinetics Neurotechnology Systems Inc', u'Advinus Therapeutics Ltd', u'Medarex Inc', u'RespireRx Pharmaceuticals Inc', u'Reata Pharmaceuticals Inc', u'Abbott Laboratories', u'UniQuest Pty Ltd', u'Eisai Co Ltd', u'Caden Biosciences Inc', u'Cloud Pharmaceuticals Inc', u'Novartis AG', u'Trillium Therapeutics Inc', u'RST Biomedikal Sanayi AS', u'Fujisawa Pharmaceutical Co Ltd', u'Scripps Florida', u'Chaperone Therapeutics Inc', u'Avanti Therapeutics', u'Synageva BioPharma Corp', u'NoAb BioDiscoveries Inc', u'Neurotrope Inc', u'McLean Hospital Corp', u'Monash University', u'Cadus Corp', u'ALZA Corp', u'Invent Farma ehf', u'University of South Florida', u'NeurOp Inc', u'ZGene A/S', u'Immune Response BioPharma Inc', u'Kosan Biosciences Inc', u'McGill University', u'Lay Line Genomics SpA', u'Ethypharm SA', u'AMO Pharma Ltd', u'Ferrer Internacional SA', u'Lupin Ltd', u'uniQure BV', u'Afraxis Inc', u'Recordati SpA', u'H Lundbeck A/S', u'Lexicon Pharmaceuticals Inc', u'Aileron Therapeutics Inc', u'University of North Carolina', u'National Institute of Neurological Disorders and Stroke', u'Ampac Fine Chemicals Llc', u'GeneData AG', u'Mesoblast Ltd', u'Otsuka Pharmaceutical Co Ltd', u'Sosei Group Corp', u'Asklepios Biopharmaceutical Inc', u'Howard Florey Institute of Experimental Physiology and Medicine', u'IOmet Pharma Ltd', u'Lifespan Biosciences Inc', u'SurModics Pharmaceuticals', u'TheraSci Ltd', u'National Institute on Drug Abuse', u'Efarmes SA', u'French Government', u'MD Anderson Cancer Center', u'TorreyPines Therapeutics Inc', u'University College London', u'University of Western Ontario', u'Neuro Therapeutics Inc', u'Addex Therapeutics Ltd', u'Adamed Group', u'PNO Resources Ltd', u'ZZ Biotech LLC', u'Janssen Biotech Inc', u'Sunovion Pharmaceuticals Inc', u'Esteve', u'Axon Medical Inc', u'Strides Shasun Ltd', u'Human Genome Sciences Inc', u'Neurome Inc', u'University of Illinois', u'Memorial Sloan-Kettering Cancer Center', u'Desitin Arzneimittel GmbH', u'NeoGenesis Pharmaceuticals Inc', u'Baylor College of Medicine', u'Pharmascience Inc', u'Childrens Hospital of Orange County', u'Arena Pharmaceuticals Inc', u'Apax Partners LLP', u'Vernalis Research Ltd', u'VistaGen Therapeutics Inc', u'Targacept Inc', u'Heptares Therapeutics Ltd', u'IntelGenx Technologies Corp', u'National Institutes of Health', u'Serono Inc', u'Afecta Pharmaceuticals', u'Scios Inc', u'Synvista Therapeutics Inc', u'Curis Inc', u'Suven Life Sciences Ltd', u'Institute Of Enzymology Biological Research Center Hungarian Academy Of Sciences', u'National Institutes of Standards and Technology', u'Homology Medicines Inc', u'University of Chicago', u'ChemDiv Inc', u'Neurion Pharmaceuticals Inc', u'Axxam SpA', u'Merck Serono SA', u'Purdue Neuroscience Corp', u'The Menarini Group', u'Icagen Inc (pre-merger)', u'Attenua Inc', u'Biovail Laboratories International Srl', u'biOasis Technologies Inc', u'Cypress Bioscience Inc', u'Gedeon Richter Ltd', u'BioNumerik Pharmaceuticals Inc', u'Merz & Co GmbH', u'BASF AG']), u'Musculoskeletalsysteminflammation': set([u'PharmaNet Group Ltd', u'Molecular Pharmacology (USA) Ltd']), u'Bacterialeyeinfection': set([u'Allergan Inc', u'Shenzhen Relin Medicine', u'InSite Vision Inc', u'Shin Poong Pharmaceutical Co Ltd', u'Shenyang Pharmtech Pharmaceutical R & D Ltd', u'Kyorin Pharmaceutical Co Ltd']), u'Hyperparathyroidism': set([u'Ranbaxy Pharmaceuticals Inc', u'Chugai Pharmaceutical Co Ltd', u'University of Wisconsin-Madison', u'NPS Pharmaceuticals Inc', u'ARAM Medical', u'Validus Pharmaceuticals', u'Roche Holding AG', u'Kirin Brewery Co Ltd', u'Amgen Inc', u'Sumitomo Pharmaceuticals Co Ltd', u'Rockwell Medical Inc', u'Yuyu Inc', u'Windtree Therapeutics Inc', u'Fontus Pharmaceuticals Inc', u'Abbott Laboratories', u'Kissei Pharmaceutical Co Ltd', u'Swedish Orphan Biovitrum AB', u'Mitsubishi Tanabe Pharma Factory Ltd']), u'Colonoscopy': set([u'Owlstone Medical Ltd', u'Mayo Clinic Foundation', u'CeNeS Pharmaceuticals plc', u'GlaxoSmithKline plc']), u'Upperrespiratorytractinfection': set([u'National Institute for the Control of Pharmaceutical and Biological Products', u'Genentech Inc', u'Undisclosed', u'Newsummit Biopharma Co Ltd', u'Inspire Pharmaceuticals Inc']), u'VitaminEdeficiency': set([u'Medunik Canada', u'Orphan Europe SARL']), u'Hypovolemia': set([u'Fujifilm Diosynth Biotechnologies', u'Inflazyme Pharmaceuticals']), u'Glaucoma': set([u'Aerie Pharmaceuticals Inc', u'Agence Nationale de Recherches sur le Sida et les hepatites virales (ANRS)', u'Universitaire Ziekenhuizen Leuven', u'Novartis Ophthalmics Inc', u'National Institutes of Health', u'Angiotech Pharmaceuticals Inc', u'Knoll Pharmaceuticals Co', u'SamChunDang Pharm Co Ltd', u'Ocular Therapeutix Inc', u'Advanced Refractive Technologies', u'US Government', u'Califia Bio Inc', u'Centre de Physiopathologie de Toulouse Purpan', u'AZAD Pharmaceutical Ingredients AG', u'Korea Research Institute of Chemical Technology', u'GlaxoSmithKline plc', u'Sensimed Ag', u'InMed Pharmaceuticals Inc', u'University of Connecticut', u'pSivida Corp', u'Uppsala University', u'ViSci Ltd', u'University of Florida', u'Microbot Medical Inc', u'ISTA Pharmaceuticals Inc', u'INSERM Transfert', u'Ramot at Tel Aviv University Ltd', u'Ono Pharmaceutical Co Ltd', u'The Helmholtz Moscow Research Institute of Eye Diseases', u'MitoKor', u'Mitacs Inc', u'University of British Columbia', u'Wakamoto Pharmaceutical Co Ltd', u'Sandoz Ltd', u'Sun Pharmaceutical Industries Ltd', u'Mundipharma Pte Ltd', u'Handok Inc', u'Belupo', u'Catalent Inc', u'Glaukos Corp', u'MSD Japan', u'ElsaLys Biotech', u'Technology Strategy Board', u'Nanyang Technological University', u'Mayo Clinic Foundation', u\"Boston Children's Hospital\", u'Clearside Biomedical Inc', u'R-Tech Ueno Ltd', u'Weill Medical College of Cornell University', u'Q BioMed Inc', u'Neurobiological Technologies Inc', u'MABLife', u'Sichuan University', u'SKS Ocular LLC', u'Daiichi Sankyo Co Ltd', u'Abbott Laboratories', u'Eisai Co Ltd', u'twoXar Inc', u'Boehringer Mannheim GmbH', u'Essex Bio-Technology Ltd', u'Novartis AG', u'DFB Pharmaceuticals Inc', u'DreamPharma Corp', u'ACADIA Pharmaceuticals Inc', u'Forest Laboratories Inc', u'Fujisawa Pharmaceutical Co Ltd', u'Novelion Therapeutics Inc', u'NovaMedica', u'Singapore Eye Research Institute', u'Jenivision Inc', u'Mannin Research Inc', u'Kowa Co Ltd', u'Santen Pharmaceutical Co Ltd', u'Angelini Pharmaceuticals SpA', u'Italian Ministry of Health', u'FibroGen Inc', u'Summit Therapeutics plc', u'Mati Therapeutics Inc', u'Incept LLC', u'Cleveland Clinic Foundation', u'Ceregene Inc', u'BioSpecifics Technologies Corp', u'BioSpring Gesellschaft Fur Biotechnologie mbH', u'Ohr Pharmaceutical Inc', u'Dong-A ST Co Ltd', u'Peregrine Ophthalmic', u'CeNeRx BioPharma Inc', u'Prasco Laboratories', u'McGill University', u'Allergan Inc', u'Kyorin Pharmaceutical Co Ltd', u'Boehringer Ingelheim Corp', u'AcSentient Inc', u'AriBio', u'Fondazione Rome', u'University of Arizona', u'Universite Laval', u'SK Biopharmaceuticals', u'Stemedica Cell Technologies Inc', u'Santen Inc', u'H Lundbeck A/S', u'D Western Therapeutics Institute', u'Genentech Inc', u'Mitsubishi Pharma Corp', u'Harvard Medical School', u'Otsuka Pharmaceutical Co Ltd', u'Korea Drug Development Fund', u'Amarantus BioScience Holdings Inc', u'Center for Drug Chemistry', u'Integral BioSystems LLC', u'University of California San Diego', u'Oxford BioMedica plc', u'Pharmacia & Upjohn Inc', u'Undisclosed', u'NicOx SA', u'Daewoong Pharmaceutical Co Ltd', u'Anabasis Pharma', u'Smith & Nephew plc', u'Mimetogen Pharmaceuticals Inc', u'Merck & Co Inc', u'National Eye Institute', u'Union Life Sciences Limited', u'Chong Kun Dang Pharmaceutical Corp', u'ID Pharma Co Ltd', u'University of Miami', u'University of Wisconsin-Madison', u'InSite Vision Inc', u'Orient Pharma Co Ltd', u'Proximagen Group plc', u'FKD Therapies OY', u'Barr Pharmaceuticals Inc', u'Nippon Organon KK', u'Navigo Proteins GmbH', u'Acorn Biomedical Inc', u'Quark Pharmaceuticals Inc', u'Axim Biotechnologies Inc', u'IBM Watson Health Life Sciences', u'BioSeek Plc', u'CeNeS Pharmaceuticals Inc', u'Inspire Pharmaceuticals Inc', u'Pfizer Inc', u'Neurocrine Biosciences Inc', u'Ocular Therapeutics Inc', u'Childrens Medical Center Corp', u'Moscow Endocrine Plant', u'Caladrius Biosciences Inc', u'UBE Industries Ltd', u'Wyeth', u'Akorn Inc', u'Sucampo Pharmaceuticals Inc', u'Johns Hopkins University', u'Hopital Saint-Louis', u'Canadian Bio Med Systems Inc', u'Alcon Inc', u'Danube Pharmaceuticals Inc', u'Allysta Pharmaceuticals Inc', u'Dose Medical Corp', u'Intrexon Corp', u'Ministero per l Universita e la Ricerca Scientifica e Tecnologica', u'Biocydex', u'Pharmos Corp', u'Kennedy Krieger Institute', u'Bascom Palmer Eye Institute', u'S. Fyodorov Eye Microsurgery Complex', u'PharmaNova Inc', u'Octamer Inc', u'PharmaNess Neuroscience', u'Idx Llc', u'Asahi Glass Co Ltd', u'Senju Pharmaceutical Co Ltd', u'Samil Pharmaceutical Co Ltd', u'ORA Inc', u'Ueno Fine Chemicals Industry Ltd', u'Altacor Ltd', u'Othera Pharmaceuticals Inc', u'Imperial College London', u'BioAxone Biosciences Inc', u'IXICO Plc', u'University of Florence', u'Apollo Endosurgery Inc', u'Avedro Inc', u'Lederle Laboratories', u'Acucela Inc', u'Graybug Vision Inc', u'OphthalmoPharma Ltd', u'Hebrew University of Jerusalem', u'Bausch & Lomb Inc', u'Amakem Therapeutics', u'Adverum Biotechnologies Inc', u'Devgen NV', u'Merz & Co GmbH']), u'Purpura': set([u'Biogen Inc', u'Dartmouth Medical School', u'Eisai Co Ltd']), u'Bonesurgery': set([u'Medical Center Arlington', u'Amend Surgical Inc', u'University of Florida Research Foundation', u'VOX Telehealth', u'Shandong Weigao Orthopedic Device Co Ltd', u'Misonix Inc']), u'CarbamoylphosphatesynthaseIdeficiency': set([u'Lucane Pharma SA', u'Orpharma Pty Ltd']), u'Salmonellatyphiinfection': set([u'Megan Health Inc', u'Baylor College of Medicine', u'Protein Potential LLC', u'Walvax Biotechnology Co Ltd', u'Finlay Institute', u'Sanofi Pasteur', u'DelSite Biotechnologies Inc', u'Severance Hospital', u'National Institute of Allergy and Infectious Diseases', u'SK Group', u'Valneva SE', u'University of Maryland School of Medicine', u'Korea Advanced Institute of Science and Technology', u'Novartis AG', u'TerahVax', u'National Institutes of Health', u'Bill & Melinda Gates Foundation', u'Bio Farma', u'Regione Toscana', u'Emergent BioSolutions Inc', u'Biological E Ltd', u'Affinivax Inc', u'Chinese Government', u'Abivax', u'Nanotherapeutics Inc', u'Massachusetts General Hospital', u'University of Minnesota', u'Celldex Therapeutics Inc', u'Prokarium', u'bioCSL PTY Ltd', u'CSL Ltd', u'SK Chemicals Life Science', u'Wellcome Trust', u'Huons Co Ltd', u'Alfresa Pharma Corp', u'Crucell Switzerland AG', u'Fondazione Monte dei Paschi di Siena', u'PaxVax Inc', u'Yuxi Walvax Biotech Co Ltd', u'Pfizer Inc', u'Novartis Vaccines Institute for Global Health', u\"Boston Children's Hospital\", u'Toyama Chemical Co Ltd', u'UCB SA', u'Acambis plc', u'SK Chemicals Co Ltd', u'International Vaccine Institute']), u'Maleinfertility': set([u'Trivector Biomed LLC', u'GryNumber Health', u'Tani Medikal Ltd', u'MSD OSS BV', u'Parque Technologico de Valencia', u'Cordex Pharma Inc', u'Ligand Pharmaceuticals Inc', u'Cell Genesys Inc', u'Tecomedical Ag', u'THP Medical Products', u'Jeil Pharmaceutical Co Ltd', u'Parallabs', u'Clinical Trials International LLC', u'Los Angeles Biomedical Research Institute', u'Merck & Co Inc', u'Chun Fo Pharmaceutical', u'Eli Lilly & Co', u'University of Pennsylvania', u'Aytu BioScience Inc', u'Roche Holding AG', u'Alvogen Korea', u'Astrazeneca Korea', u'Naka International Corporation', u'Beijing SL Pharmaceutical Co Ltd', u'Queensland Institute of Medical Research', u'Creative Medical Health Inc', u'University of Padua', u'CNC Biotech Inc', u'Akzo Nobel NV', u'Beijing Ruikang Medical Technology', u'BioXell SpA', u'Neoteric Medical Systems (NMS)', u'diaDexus LLC', u'University of Minnesota']), u'Prioninfection': set([u'ProMetic Life Sciences Inc', u'Centre for Applied Microbiology & Research', u'Maco Pharma', u'New York University', u'Phylogica Ltd', u'National Institute on Aging', u'Genencor International Inc', u'Abraxis BioScience Inc', u'Dynamic Microbials Ltd', u'Medical Research Council', u'University of Cambridge']), u'Gastrointestinaltumor': set([u'US Government', u'National Comprehensive Cancer Network', u'Ascent Pharmaceuticals Ltd', u'JSS University', u'Binex Co Ltd', u'Sanofi Pasteur', u'Kowa Co Ltd', u'Synergy Pharmaceuticals Inc', u'Ambrilia Biopharma Inc', u'Rice University', u'Fujirebio Diagnostics Inc', u'Cascadian Therapeutics Inc', u'Rafarma Pharmaceuticals Inc', u'Selexis SA', u'Elan Corp plc', u'MedImmune LLC', u'OSI Pharmaceuticals Inc', u'Newsummit Biopharma Co Ltd', u'Pinnacle Biologics Inc', u'Second Military Medical University PLA', u'Bavarian Research Foundation', u'Alkopharma', u'Exelixis Inc', u'Orphan Canada Inc', u'Amgen Inc', u'Nippon Kayaku Co Ltd', u'Eisai Co Ltd', u'MediGene AG', u'Ganymed Pharmaceuticals AG', u'Zeneus Pharma Ltd', u'Athenex Inc', u'National Cancer Institute', u'Clovis Oncology Inc', u'Ewopharma AG', u'Hanmi Pharmaceutical Co Ltd', u'Bionix Radiation Therapy', u'Cancer Advances Inc', u'Pennsylvania State University', u'Shanghai Jiao Tong University', u'Luye Pharma Group Ltd', u'ProlX Pharmaceuticals LP', u'Vericel Corp', u'Helsinn Healthcare SA', u'Infinity Pharmaceuticals Inc', u'Aphton Corp', u'Duke University Medical Center', u'Stanford University', u'Mayo Clinic Foundation', u'Actavis Inc', u'Undisclosed', u'XOMA Corp', u'JSC F-Synthesis', u'Gemin X Pharmaceuticals Inc', u'MD Anderson Cancer Center', u'Shuttle Pharmaceuticals LLC', u'LEO Pharma A/S', u'Eli Lilly & Co', u'Midatech Pharma US Inc', u'Immune Pharmaceuticals Inc', u'Weizmann Institute of Science', u'Kyowa Hakko Kirin Co Ltd', u'Immune Therapeutics Inc', u'PharmaEssentia Corp', u'BioVectra DCL', u'Pfizer Inc', u'Sandoz Inc', u'Exact Corp', u'BIND Therapeutics Inc', u'Japanese National Cancer Center', u'Pfizer Japan Inc', u'Ligand Pharmaceuticals Inc', u'National Institutes of Health', u'AVEO Oncology', u'Bristol-Myers Squibb Co', u'MaxCyte Inc', u'Aduro BioTech Inc', u'Onyx Pharmaceuticals Inc', u'Shanghai Wanxing Bio-Pharmaceutical Co Ltd', u'Array BioPharma Inc', u'Astellas Pharma Inc', u'Varian Medical System Inc', u'OncoVista Innovative Therapies Inc', u'AlfaGene Biosciences Inc', u'NanoCarrier Co Ltd', u'Crown Bioscience Inc', u'Novartis AG', u'Synthon BV', u'Munich Biotech AG', u'German Federal Ministry of Education and Research']), u'Metastaticovarycancer': set([u'University of Pennsylvania', u'Agence Nationale de Recherches sur le Sida et les hepatites virales (ANRS)', u'Clovis Oncology Inc', u'Genentech Inc', u'Inventiva', u'Northwest Biotherapeutics Inc', u'Yale University', u'Bristol-Myers Squibb Co', u'The Mary Kay Foundation', u'European Eurostars Programme', u'Gradalis Inc']), u'Rubinstein-Taybisyndrome': set([u'Pfizer Inc', u'University of Oxford']), u'Seasonalallergicrhinitis': set([u'Dr Beckmann Pharma GmbH', u'Sunovion Pharmaceuticals Inc', u'Sedor Pharmaceuticals LLC', u'Kaken Pharmaceutical Co Ltd', u'Grupo Uriach', u'Kyorin Pharmaceutical Co Ltd', u'Farmalab Ltda', u'Recordati SpA', u'Roxall Medizin GmbH', u'Collegium Pharmaceutical Inc', u'Teamm Pharmaceuticals', u'Ligand Pharmaceuticals Inc']), u'Neurofibromatosis': set([u'Exelixis Inc', u'Bayer Schering Pharma AG', u'Centre National de la Recherche Scientifique (CNRS)', u'Genentech Inc', u'National Institute of Neurological Disorders and Stroke', u'Food and Drug Administration', u'US Department of Defense', u'Marnac Inc', u'Indiana University Purdue University Indianapolis', u'Scripps Research Institute', u'Nexgenix Pharmaceuticals Inc']), u'Abscess': set([u'Concordia Pharmaceuticals Inc', u'Teligent Inc', u'Kyowa Hakko Bio Co Ltd', u'Daiichi Sankyo Co Ltd']), u'Pancreaticductaladenocarcinoma': set([u'McGill University', u'Roswell Park Cancer Institute', u'Victorian Cancer Agency', u'CytRx Corp', u'MD Anderson Cancer Center', u'Boehringer Ingelheim Corp', u'Diazon Pharmaceuticals Inc', u'NantCell Inc', u'University of California', u'Cleveland BioLabs Inc', u'Peter MacCallum Cancer Centre', u'University of Texas Southwestern Medical Center']), u'Braininjury': set([u'University of Texas Medical Branch at Galveston', u'Cato BioVentures', u'Remedy Pharmaceuticals Inc', u'Acorda Therapeutics Inc', u'Boehringer Ingelheim GmbH', u'Oncovir Inc', u'United States Army Medical Research Institute of Chemical Defense', u'Biogen Inc', u'Heriot-Watt University', u'GlaxoSmithKline plc', u'SpringTree Global Investors', u'National Institute of Neurological Disorders and Stroke', u'Oklahoma Center for the Advancement of Science and Technology', u'University of Florida', u\"Phoenix Children's Hospital\", u'Virogenomics Inc', u'Cortech Inc', u'SurModics Inc', u'Hospira Inc', u'Hough Ear Institute', u'St Michaels Hospital', u'Venus MedTech (HangZhou) Inc', u'Relevare Pharmaceuticals Ltd', u'Fresenius Kabi AG', u'Tenax Therapeutics Inc', u'Bayer HealthCare AG', u'North Carolina Biotechnology Center', u'Emory University', u'NeuroSearch A/S', u'Morphochem AG', u'Federal Economic Development Agency for Southern Ontario', u'Russian Academy Medical Science', u'Banyan Biomarkers Inc', u'Stryker Corp', u'NewNeural LLC', u'New York University', u'Israeli Government', u'Amgen Inc', u'Tego BioSciences Corp', u'US Government', u'Edge Therapeutics Inc', u'US Army Research Office', u'Proneuron Biotechnologies Inc', u'European Brain Injury Consortium', u'Migragen AG', u'Trillium Therapeutics Inc', u'PsychoGenics Inc', u'Georgetown University', u'PresSura Neuro Ltd', u'Barrow Neurological Insitute', u'Neuren Pharmaceuticals Ltd', u'Santen Pharmaceutical Co Ltd', u'STATegics Inc', u'AurimMed Pharma Inc', u'Neurosciences Victoria Ltd', u\"M's Science Corp\", u'NeurOp Inc', u'RemeGenix Inc', u'Chrysalis BioTechnology Inc', u'PolyNovo Ltd', u'Lixte Biotechnology Holdings Inc', u'Medtronic Inc', u'H Lundbeck A/S', u'The Bronx Project Inc', u'Saegis Pharmaceuticals Inc', u'Duke University Medical Center', u'Ortho Biotech Products LP', u'Stanford University', u'EndogenX Inc', u'Chi Sheng Chemical Corp', u'St Andrews University', u'Undisclosed', u'BHR Pharma LLC', u'Universidad De Le Republica - Uruguay', u'M et P Pharma AG', u'US Naval Medical Research Center', u'University of Miami', u'CoNCERT Pharmaceuticals Inc', u'US Army Medical Research Institute of Infectious Diseases', u'University of California Irvine', u'BBB Therapeutics BV', u'RegeneRx Biopharmaceuticals Inc', u'Maroon Biotech Corp', u'Stallion Therapeutics Inc', u'CeNeS Pharmaceuticals Inc', u'NeuroNova AB', u'National Institute on Aging', u'State University of New York', u'Maas BiolAB LLC', u'Intrust, Post-traumatic Stress Disorder and Traumatic Brain Injury Clinical Consortium', u'US Department of Defense', u'Medicon A/S', u'University of Wyoming', u'Wyeth BioPharma', u'Vatea Fund', u'Cato Research Ltd', u'Purdue University', u'Baylor College of Medicine', u'Translational Genomics Research Institute', u'University of Tasmania', u'Pharmos Corp', u'NeuroVive Pharmaceutical AB', u'New Jersey Commission on Science and Technology', u'National Institute on Drug Abuse', u'NeuroHealing Pharmaceuticals Inc', u'National Institutes of Health', u'Walter Reed Army Institute of Research', u'Food and Drug Administration', u'University of Oregon', u'Keystone Heart Ltd', u'Curis Inc', u'Blanchette Rockefeller Neurosciences Institute (BRNI)', u'Spectrum Pharmaceuticals Inc', u'Zenyth Therapeutics Ltd', u'Exscien Corp', u'Medical College of Georgia', u'AGY Therapeutics Inc', u'University of Chicago', u'Plandai Biotechnology Inc', u'VINNOVA', u'Sangart Inc', u'KeyNeurotek Pharmaceuticals AG', u'Duke University', u'The Salk Institute for Biological Studies', u'Warren Pharmaceuticals Inc', u'Shire plc', u'F Hoffmann-La Roche AG', u'James Cook University of North Queensland', u'Hebrew University of Jerusalem', u'Athersys Inc', u'Jan Medical Inc', u'Fidia-Georgetown Institute for the Neurosciences', u'13Therapeutics Inc']), u'Persistentpulmonaryhypertensionofthenewborn': set([u'US Government', u'Radikal Therapeutics Inc']), u'Poliovirusinfection': set([u'Evotec AG', u\"Tianjin Municipal People's Government\", u'Netherlands Vaccine Institute', u'US Government', u'Vaxess Technologies Inc', u'Massachusetts Institute of Technology', u'Stanford University', u'Corium International Inc', u'Bio-Manguinhos/Fiocruz', u'University of Washington', u'Bioject Medical Technologies Inc', u'National Institute of Allergy and Infectious Diseases', u'State University of New York at Stony Brook', u'Sanofi Pasteur', u'Schering-Plough Research Institute', u'Daiichi Sankyo Co Ltd', u'Abbott Laboratories', u'Sanofi Pasteur KK', u'Horizon Genomics GmbH', u'GlaxoSmithKline plc', u'Aragen Bioscience Inc', u'World Health Organization', u'Program for Appropriate Technology in Health', u'Beijing Tiantan Biological Products Corporation Limited', u'PharmaJet Inc', u'Xenetic Biosciences Inc', u'Rotary International', u'Bill & Melinda Gates Foundation', u'SRI International', u'Statens Serum Institut', u'Biological E Ltd', u'Chinese Government', u'Global Vaccines Inc', u'University of California San Francisco', u'Centers for Disease Control and Prevention', u'Funda\\xe7\\xe3o Ezequiel Dias - Funed', u'Janssen Pharmaceuticals Inc', u'Sinovac Biotech Ltd', u'Astellas Pharma Inc', u'ViroDefense Inc', u'Mitsubishi Tanabe Pharma Corp', u'Kaketsuken', u'North American Vaccine Inc', u'University of Maryland College Park', u'University of Leeds', u'Biological Mimetics Inc', u'Sanofi KK', u'CanSino Biologics Inc', u'Thomas Jefferson University', u'Merck & Co Inc', u'University of Vermont', u'Japan Poliomyelitis Research Institute', u'M P Chumakov Institute of Poliomyelitis and Virus Encephalitides', u'University of Virginia', u'Takeda Pharmaceutical Co Ltd', u'NanoPass Technologies Ltd', u'Institute of Medical Biology Chinese Academy of Medical Sciences', u'Vaxxas Pty Ltd', u'BIKEN Foundation', u'Kitasato Institute', u'Immunome Inc']), u'Actinickeratosis': set([u'Biofrontera Bioscience GmbH', u'BioLineRx Ltd', u'Athenex Inc', u'PharmaEssentia Corp', u'Graceway Pharmaceuticals Inc', u'Pierre Fabre Dermo-Cosmetique', u'3M Pharmaceuticals', u'DUSA Pharmaceuticals Inc', u'Mylan Inc', u'Biofrontera AG', u'Valeant Pharmaceuticals International Inc', u'Daewoong Pharmaceutical Co Ltd', u'Pharmacenter Holding Ltd', u'Innovative Pharmaceutical Concepts (IPC) Inc', u'Perrigo Co Ltd', u'Hill Dermaceuticals Inc', u'Meda AB', u'Spirit Healthcare Ltd', u'Perrigo Israel Agencies Ltd', u'Louis Widmer SA']), u'Ocularmelanoma': set([u'H Lee Moffitt Cancer Center and Research Institute', u'Exelixis Inc', u'National Cancer Institute', u'Delcath Systems Inc']), u'Hypoactivesexualdesiredisorder': set([u'S1 Biopharma Inc', u'UPM Pharmaceuticals Inc', u'Novavax Inc', u'Sprout Pharmaceuticals', u'AMAG Pharmaceuticals Inc', u'Esprit Pharma Inc', u'Procter & Gamble Pharmaceuticals Inc', u'Palatin Technologies Inc', u'Chong Kun Dang Pharmaceutical Corp', u'Noven Pharmaceuticals Inc']), u'Overactivebladder': set([u'Lipella Pharmaceuticals Inc', u'Afferent Pharmaceuticals', u'Nippon Shinyaku Co Ltd', u'US Government', u'Massachusetts Institute of Technology', u'The Danish National Advanced Technology Foundation', u'Undisclosed', u'Saniona ApS', u'AltheRx Pharmaceuticals Inc', u'Seipel Group Pty Ltd', u'Harvard Medical School', u'Ferring Canada', u'UroGen Pharma Ltd', u'National Institute of Diabetes, Digestive and Kidney Diseases', u'Daiichi Sankyo Co Ltd', u'Endo Pharmaceuticals Solutions Inc', u'Eisai Co Ltd', u'GlaxoSmithKline plc', u'ASINEX Ltd', u'Allergan plc', u'Quintiles Transnational Corp', u'Actavis Inc', u'Novartis AG', u'Ardana Bioscience Ltd', u'National Institutes of Health', u'Yale University', u'Novotech (Australia) Pty Ltd', u'Tzu Chi University', u'Bristol-Myers Squibb Co', u'Merck & Co Inc', u'Juniper Pharmaceuticals Inc', u'Esprit Pharma Inc', u'Kwang Dong Pharmaceutical Co Ltd', u'Massachusetts General Hospital', u'Pharmacia Corp', u'BioXell SpA', u'University of Pittsburgh', u'Merus Labs International Inc', u'Novartis Pharma AG', u'UCB Pharma GmbH', u'Apogepha Arzneimittel GmbH', u'Ion Channel Innovations LLC', u'Xention Ltd', u'UCB SA', u'Nisshin Flour Milling Co Ltd', u'Astellas Pharma Inc', u'Roche Holding AG', u'ALZA Corp', u'Ipsen Bioinnovation', u'Kyorin Pharmaceutical Co Ltd', u'Meiji Co Ltd', u'Speciality European Pharma Ltd', u'Madaus AG', u'Duchesnay Inc', u'PLIVA Inc', u'Kyorin Holdings Inc', u'Urovant Sciences', u'Kissei Pharmaceutical Co Ltd', u'Merck Sharp & Dohme Corp', u'Meda AB', u'Sankyo Co Ltd', u'GW Pharmaceuticals plc', u'Allergan Inc', u'Toray Industries Inc', u'Taiho Pharmaceutical Co Ltd', u'Pfizer Inc', u'Sanofi', u'Plethora Solutions Holdings plc', u'Takeda Pharmaceutical Co Ltd', u'Laboratorios SALVAT SA', u'Boryung Pharm Co Ltd', u'Synmosa Biopharma Corp', u'UroGene SA', u'TheraVida Inc', u'Recordati SpA', u'Warner Chilcott plc', u'Neopharm Ltd', u'Saudi Pharmaceutical Industries & Medical Appliances Corp', u'Innovus Pharmaceuticals Inc', u'SK Chemicals Co Ltd', u'Antares Pharma Inc']), u'Vulvadisease': set([u'Uteron Pharma S.A.', u'Genentech Inc', u'Endoceutics Inc', u'Mylan Inc', u'AMAG Pharmaceuticals Inc', u'Mithra Pharmaceuticals', u'Zhejiang Xianju Pharmaceutical Corp Ltd']), u'Cartilagedisease': set([u'GliaMed Inc', u'National Health and Medical Research Council', u'University of Connecticut', u'Scil Technology GmbH', u'Angioblast Systems Inc', u'Intrexon Corp', u'Alkem Laboratories Ltd', u'Mesoblast Ltd', u'Johnson & Johnson Professional Inc', u'Roche Diagnostics GmbH', u'Histogenics Corp', u'Fidia Advanced Biopolymers SrL', u'Quintiles Transnational Corp', u'Max-Planck-Gesellschaft', u'University of Queensland', u'Capstone Therapeutics Corp', u'Medipost Co Ltd', u'Geron Corp', u'MGI Pharma Inc', u'Smith & Nephew plc', u'Chondrogenics Inc', u'TissueGene Inc', u'Bio3 Research Srl', u'University Campus Suffolk', u'La Jolla Pharmaceutical Co', u'Smith & Nephew Inc', u'Integra LifeSciences Holdings Corp', u'Matricel Gmbh', u'Cornell University', u'TiGenix NV', u'TaconicArtemis GmbH', u'Piramal Enterprises Ltd', u'Kolon Life Science Inc', u'Protelica Inc', u'Dong-A ST Co Ltd', u'Innova Onlus', u'University of Iowa', u'Vericel Corp', u'Arthritis Foundation', u'Medvet Science Pty Ltd', u'Nanotope Inc', u'Queensland University of Technology', u'Therapure Biopharma Inc', u'Korean Ministry of Commerce, Industry & Energy', u'Chrysalis BioTechnology Inc', u'ProChon Biotech Ltd', u'Kyowa Kirin', u'Innovative Cellular Therapeutics Co Ltd', u'Purpose Co Ltd']), u'Atrialflutter': set([u'Sunovion Pharmaceuticals Canada Inc', u'Pharmacia Canada Inc']), u'Helicobacterinfection': set([u'Eli Lilly & Co', u'Pfizer Inc', u'Takeda GmbH', u'Boehringer Ingelheim Corp', u'Takeda Pharmaceutical Co Ltd', u'Agennix AG', u'Eisai Co Ltd', u'Sanofi', u'Sigma-Tau Ind Farm Riunite SpA']), u'Chemotherapy-inducedemesis': set([u\"Dr Reddy's Laboratories Ltd\", u'LG Life Sciences Ltd', u'Specialised Therapeutics Australia Pty Ltd', u'Undisclosed', u'Nippon Organon KK', u\"Lee's Pharmaceutical Holdings Limited\", u'Onxeo SA', u'CSC Pharmaceuticals Handels GmbH', u'Baxter Oncology GmbH', u'Nitto Denko Corp', u'NovaDel Pharma Inc', u'Eisai Co Ltd', u'Mundipharma International Corp Ltd', u'Sinclair Pharma plc', u'Galena Biopharma Inc', u'R-Pharm US LLC', u'Takeda Pharmaceutical Co Ltd', u'Almac Discovery Ltd', u'Therabel Pharma NV', u'Questcor Pharmaceuticals Inc', u'MGI Pharma Inc', u'MonoSol Rx Inc', u'Menarini Asia-Pacific', u'Talon Therapeutics Inc', u'Crinos SpA', u'NewBridge Pharmaceuticals Ltd', u'Merck & Co Inc', u'Kwang Dong Pharmaceutical Co Ltd', u'APR Applied Pharma Research SA', u'Eli Lilly & Co', u'IS Pharma plc', u'CJ Corp', u'Angelini Pharmaceuticals SpA', u'Ono Pharmaceutical Co Ltd', u'Par Pharmaceutical Co Inc', u'PT Kalbe Farma Tbk', u'Ribosepharm GmbH', u'Shire plc', u'Archimedes Pharma Ltd', u'Cambridge Laboratories Ltd', u'Kyowa Hakko Kirin Co Ltd', u'Valeant Pharmaceuticals International Inc', u'Axim Biotechnologies Inc', u'Galenica SA (Greece)', u'Nektar Therapeutics', u'Par Pharmaceutical Inc', u'Ahn-Gook Pharmaceuticals Co Ltd', u'Helsinn Healthcare SA', u'LION bioscience Inc', u'Orexo AB', u'SciClone Pharmaceuticals Inc', u'Midatech Pharma PLC', u'Laboratorios Silesia SA', u'Rafa Laboratories Ltd', u'Kyowa Kirin', u'Pfizer Inc', u'PharmaSwiss SA', u'BioNumerik Pharmaceuticals Inc', u'Unimed Pharmaceuticals Inc', u'Lacer SA', u'Dura Pharmaceuticals Inc', u'Purdue Pharma Canada', u'Solasia Pharma KK', u'Helsinn Group']), u'PeripheralT-celllymphoma': set([u\"Dr Reddy's Laboratories Ltd\", u'Meiji Seika Pharma Co Ltd', u'Inex Pharmaceuticals Corp', u'The Leukemia & Lymphoma Society', u'IDIS Ltd', u'Allos Therapeutics Inc', u'Rigel Pharmaceuticals Inc', u'Hercules Capital Inc', u'Onxeo SA', u'Southern Research Institute', u'National Comprehensive Cancer Network', u'Quintiles Transnational Corp', u'Eisai Co Ltd', u'Duke Cancer Institute', u'Verastem Inc', u'SRI International', u'Elan Corp plc', u'Choice Pharmaceuticals', u'Spectrum Pharmaceuticals Inc', u'Columbia University', u'Mundipharma EDO GmbH', u'University of British Columbia', u'Gold Nanotech Inc', u'AstraZeneca plc', u'Talon Therapeutics Inc', u'Shenzhen Chipscreen Biosciences Ltd', u'TopoTarget A/S', u'HUYA Bioscience International LLC', u'Solasia Pharma KK', u'Pint Pharma', u'BioCryst Pharmaceuticals Inc', u'Memorial Sloan-Kettering Cancer Center']), u'FactorVIIIdeficiency': set([u'Karolinska Institutet', u'US Government', u'BioMarin Pharmaceutical Inc', u'Baxter International Inc', u'Cardinal Health Inc', u'Archemix Corp', u'Shire Human Genetic Therapies Inc', u'IDEC Pharmaceuticals Corp', u'Biogen Inc', u'Biotest AG', u'Novo Nordisk A/S', u'Chiron Corp', u'Green Cross Corp', u'Hemobras', u'Neose Technologies Inc', u'EpiVax Inc', u'Ipsen', u'Paul Capital Healthcare', u'Novimmune SA', u'Sangamo Therapeutics Inc', u'Kedrion SpA', u'Bioverativ Inc', u'Roche Holding AG', u'Shire plc', u'Grifols Inc', u\"Fondazione IRCCS Ca' Granda-Ospedale Maggiore Policlinico\", u'Bayer Australia Ltd', u'Nara Medical University', u'Bayer HealthCare AG', u'Catalyst Biosciences Inc', u'National Heart Lung and Blood Institute', u'Genavia Therapeutics', u'REGENXBIO Inc', u'Syncona Ltd', u'Discovery Genomics Inc', u'Pro Bono Bio', u'European Commission', u'4D Molecular Therapeutics LLC', u'Bayer Corp', u'Symbiosis Corp', u'Emory University', u'Inspiration Biopharmaceuticals Inc', u'San Raffaele Telethon Institute for Gene Therapy', u'Grifols SA', u'Sernova Corp', u'Medical Research Council', u'University of Minnesota', u'Tolerx Inc', u'UCB SA', u'Ferring Pharmaceuticals SA', u'Immune Response BioPharma Inc', u'National Cancer Coalition', u'uniQure BV', u'Swedish Orphan Biovitrum AB', u'Octapharma AG', u'Wyeth BioPharma', u'Virogenics Inc', u'Chugai Pharmaceutical Co Ltd', u'ASD Healthcare', u'Genentech Inc', u'Idogen AB', u'Biogen Inc (FL)', u'Cangene Corp', u'Oxford BioMedica plc', u'Zilip-Pharma BV', u'CMC Biologics Inc', u'Baxter Healthcare Corp', u'HemaSure Denmark A/S', u'Medical College of Wisconsin', u'XOMA Corp', u'Zenyaku Kogyo Co Ltd', u'University College London', u'Zoetic Pharmaceuticals', u'Bayer AG', u'CSL Ltd', u'Isogenis Inc', u'Dimension Therapeutics Inc', u'Kyowa Hakko Kirin Co Ltd', u'Nektar Therapeutics', u'Pfizer Inc', u'Expression Therapeutics LLC', u'ToolGen Inc', u'Spark Therapeutics LLC', u'Wyeth', u'PolyTherics Ltd', u'Vectura Group plc', u'CSL Behring GmbH', u'UK Government', u'Magenta Therapeutics Inc', u'Uniformed Services University of the Health Sciences', u'National Institute of Allergy and Infectious Diseases', u\"St Jude Children's Research Hospital\", u'National Institutes of Health', u'Opus Bio Inc', u'INSERM', u'Apitope Technology (Bristol) Ltd', u'Seoul National University', u'Chatham Therapeutics LLC', u'DBV Technologies SA', u'JW Pharmaceutical Corp', u'Medicyte Gmbh', u'Origen Therapeutics', u'Selecta Biosciences Inc', u'Alpha Therapeutic Corp', u'RNL Bio Co Ltd', u'GeneSegues Therapeutics', u'Dyax Corp', u'Antitope Ltd', u'Octagen Corp', u'University at Buffalo', u'UCL Business PLC']), u'Posttransplantlymphoproliferativedisease': set([u'Stanford University', u'Federation of America David and Lucile Packard Foundation', u'National Institutes of Health']), u'Medulloblastoma': set([u'aPODD Foundation', u'Chugai Pharmaceutical Co Ltd', u'Hospital for Sick Children', u'Cancer Research UK', u'Advanced Accelerator Applications SA', u'Spectrum Health Hospitals', u'ThromboGenics NV', u'National Institute of Neurological Disorders and Stroke', u'Emory University', u'Vyriad', u\"Nationwide Children's Hospital\", u'The Northwestern Mutual Life Insurance Company', u'Mayo Clinic Foundation', u'Healx Ltd', u'Ignyta Inc', u'F Hoffmann-La Roche AG', u'University of California San Francisco', u'American Brain Tumor Association', u'University of Iowa']), u'Nephropathiccystinosis': set([u\"Seattle Children's Hospital\", u'Cystinosis Research Foundation', u'Chiesi Farmaceutici SpA', u'University of California San Diego', u'Horizon Orphan LLC', u'Horizon Pharma plc']), u'Neuroma': set([u'Massachusetts General Hospital', u'Abeona Therapeutics Inc', u'National Institute of Neurological Disorders and Stroke']), u'Maculardisease': set([u'Alcon Inc', u'The Leona M. and Harry B. Helmsley Charitable Trust', u'ThromboGenics NV', u'Allegro Ophthalmics LLC', u'Auritec Pharmaceuticals Inc', u'Hanmi Pharmaceutical Co Ltd', u'Institute for the Promotion of Innovation by Science and Technology in Flanders', u'National Eye Institute']), u'Familialhypercholesterolemia': set([u'Laboratorios Farmaceuticos Rovi SA', u'Advanced BioScience Laboratories Inc', u'Helix', u'Novartis AG', u'Amryt Pharmaceuticals DAC', u'Ionis Pharmaceuticals Inc', u'University of California', u'Merck & Co Inc', u'West Pharmaceutical Services Inc', u'Zydus-Cadila Group', u'Chong Kun Dang Pharmaceutical Corp', u'University of Pennsylvania', u'Synex Consulting Korea Limited', u'Nissan Chemical Industries Ltd', u'Amgen Inc', u'Merck Sharp & Dohme Ltd', u'Admera Health', u'Sun Pharmaceutical Industries Ltd', u'Kastle Therapeutics', u'Pfizer Inc', u'Catalent Inc', u'REGENXBIO Inc', u'Reliant Pharmaceuticals Inc', u'Aegerion Pharmaceuticals Inc']), u'Fanconianemia': set([u'University of Minnesota', u'EuroFancolen', u\"Cincinnati Children's Hospital Medical Center\", u'Centre for Biomedical Network Research on Rare Diseases (CIBERER)', u'Oregon Health Sciences University', u'Stanford University', u'National Institutes of Health', u'Abeona Therapeutics Inc', u'Food and Drug Administration', u'Genethon', u'MaxCyte Inc', u'Discovery Genomics Inc', u'National Heart Lung and Blood Institute', u'Centro De Investigaciones Energeticas Medioambientales Y Tecnologicas (CIEMAT)']), u'Cardiovascularinfection': set([u'Endo International plc', u'Aspen PharmaCare Holdings Ltd']), u'Enterococcusinfection': set([u'Eli Lilly & Co', u'Biosynexus Inc', u'Technion Research & Development Foundation Ltd', u'Rockefeller University', u'Cubist Pharmaceuticals Inc', u'OBI Pharma Inc', u'US Army Medical Research Institute of Infectious Diseases', u'Sunol Molecular Corp', u'Optimer Pharmaceuticals Inc', u'National Institute of Allergy and Infectious Diseases', u'Breathtec Biomedical Inc', u'CytoCore Inc', u'Paratek Pharmaceuticals Inc', u'Ancora Pharmaceuticals Inc', u'ContraFect Corp', u'Novartis Vaccines & Diagnostics']), u'Stroke': set([u'European Commission', u'Neurobiological Technologies Inc', u'Il Dong Pharmaceutical Co Ltd', u'University of Maryland', u'BioHaven Pharmaceutical Holding Co Ltd', u'Questcor Pharmaceuticals Inc', u'McNeil Pharmaceuticals Inc', u'Fannin Innovation', u'University of Pittsburgh', u'Walter Reed Army Institute of Research', u'Resverlogix Corp', u'Hospira Inc', u'CeNeS Pharmaceuticals plc', u'Thrombolytic Science International LLC', u'Neuralexo LLC', u'Relevare Pharmaceuticals Ltd', u'PharmaSeed Ltd', u'Toray Industries Inc', u'Catalent Inc', u'Formatech Inc', u'NeuroSearch A/S', u'Baker IDI Heart & Diabetes Institute Holdings Ltd', u'Glasgow University', u'Alseres Pharmaceuticals Inc', u'Life Sciences Research Partners VZW', u'Aposense Ltd', u'ZZ Biotech LLC', u'Innovus Pharmaceuticals Inc', u'MGI GP Inc', u'Israeli Government', u'Centre National de la Recherche Scientifique (CNRS)', u'Nventa Biopharmaceuticals Corp', u'Science Council of British Columbia', u'Kunming Pharmaceutical Corp', u'Mochida Pharmaceutical Co Ltd', u'Tulane University', u'Lipopharma Therapeutics SL', u'Oriens Life Sciences Ltd', u'Weizmann Institute of Science', u'Lantheus Medical Imaging Inc', u'PAION AG', u'Santen Pharmaceutical Co Ltd', u'Boston Therapeutics Inc', u'JCR Pharmaceuticals Co Ltd', u'Institute of Bioinformatics (IOB)', u'Progenics Pharmaceuticals Inc', u'AurimMed Pharma Inc', u'Kyung Hee University', u'Nordmark Arzneimittel GmbH & Co KG', u'Cytokine PharmaSciences Inc', u'Harrison Clinical Research', u'Celera Group', u'NeuMed Inc', u'Janssen Pharmaceutica NV', u'Arete Therapeutics Inc', u'Jiangsu Wanbang Biochemical Pharmaceutical Co Ltd', u'University of Nebraska Omaha', u'Medicon A/S', u'Halimed Pharmaceuticals Inc', u'Aventis Pharmaceuticals Inc', u'Duramed Pharmaceuticals Inc', u'Medtronic Inc', u'SanBio Co Ltd', u'Henry Ford Health Science Center', u'GliaMed Inc', u'Ludwig-Maximilians University of Munich', u'Pressure BioSciences Inc', u'AnC Bio Group', u'NPS Pharmaceuticals Inc', u'Cadence Biomedical', u'Dutch Technology Foundation', u'EndogenX Inc', u'Alexion Pharmaceuticals Inc', u'Oregon Health Sciences University', u'Chi Sheng Chemical Corp', u'Toronto Hospital', u'Pfizer Inc', u'University of Florence', u'Ewha Womans University', u'COR Therapeutics Inc', u'Eli Lilly & Co', u'Neural Analytics Inc', u\"Lee's Pharmaceutical Holdings Limited\", u'Rubicon Biotechnology Inc', u'University of Santo Tomas Hospital', u'Horizon Orphan LLC', u'University of California Los Angeles', u'Erasmus University Medical Center Rotterdam', u'CeNeS Pharmaceuticals Inc', u'EIP Pharma LLC', u'Universitat Autonoma de Barcelona', u'SIBIA Neurosciences Inc', u'InVasc Therapeutics Inc', u'Johns Hopkins University', u'Zalicus Inc', u'Vatea Fund', u'Picower Institute for Medical Research', u'Artielle ImmunoTherapeutics Inc', u'Mipharm SpA', u'BELLUS Health Inc', u'GNT Pharma Co Ltd', u'Geymonat SpA', u'Taisho Pharmaceutical Co Ltd', u'Vascular Laboratory Inc', u'Hyland Immuno', u'Actelion Ltd', u'SmithKline Beecham plc', u'China Medical University Hospital', u'Stryker Corp', u'Bristol-Myers Squibb Co', u'Seoul National University', u'Astellas Pharma Inc', u'CyDex Pharmaceuticals Inc', u'Daiichi Fine Chemicals Co Ltt', u'Fujirebio KK', u'Chungnam National University', u'Wacker Biotech GmbH', u'Metaphore Pharmaceuticals Inc', u'Lonza Group AG', u'Hebrew University of Jerusalem', u'National Center for Complementary and Integrative Health', u'The Institute of Radiation Medicine Academy of Military Medical Sciences PLA', u'Crimson Pharmaceutical (Hong Kong) Ltd', u'University of Cambridge', u'Karolinska Institutet', u'Servier', u'Hospices Civils De Lyon', u'Novo Nordisk A/S', u'Regeneron Pharmaceuticals Inc', u'Ion Beam Applications SA', u'Peptisyntha Inc', u'Armetheon Inc', u'Boehringer Ingelheim GmbH', u'National Heart Foundation of Australia', u'BTG plc', u'Chiesi Farmaceutici SpA', u'DRAXIS Health Inc', u'Texas A&M University System', u'LeukoSite Inc', u'US Department of Veterans Affairs', u'Chinese Government', u'Stanford University', u'Vernalis plc', u'University of Pennsylvania', u'Hovione SA', u'Ono Pharmaceutical Co Ltd', u'Roche Holding AG', u'Shire plc', u'Mitsubishi Tanabe Pharma Corp', u'Paladin Labs Inc', u'Population Health Research Institute', u'UCB Pharma SA', u'Sanofi Genzyme', u'Tenax Therapeutics Inc', u'Bayer HealthCare AG', u'Duke Clinical Research Institute', u'Korea Drug Development Fund', u'Charite Universitaetsmedizin Berlin', u'Cell>Point LLC', u'Brain Canada', u'Evotec AG', u'Exelixis Inc', u'The Wolfson Institute for Biomedical Research', u'Amgen Inc', u'Innovation and Technology Commission', u'Sanofi (pre-1999)', u'Edge Therapeutics Inc', u'Trigen GmbH', u'NPS Allelix Corp', u'Endo Pharmaceuticals Solutions Inc', u'Geron Corp', u'Theraptosis', u'Hamamatsu University School of Medicine', u'FUJIFILM RI Pharma Co', u'CSPC NBP Pharmaceutical Co Ltd', u'Universite de Sherbrooke', u'SkyePharma plc', u'Italfarmaco SpA', u'Physiotherapy Foundation of Canada', u'Massachusetts General Hospital', u'Enzon Pharmaceuticals Inc', u'Cholestech Corp', u'Cleveland Clinic Foundation', u\"M's Science Corp\", u'Fundacion Para La Investigacion Hospital La Fe', u'Acelerox LLC', u'Cytovance Biologics LLC', u'Daegu Hanny University', u'Mimotopes Pty Ltd', u'Roche Palo Alto', u'Stemedica Cell Technologies Inc', u'F Hoffmann-La Roche AG', u'China Pharma Holdings Inc', u'Rockefeller University', u'Green Cross Corp', u'NoNO Inc', u'Genentech Inc', u'Cognetix Inc', u'Mitsubishi Pharma Corp', u'Corimmun GmbH', u'Mayo Clinic Foundation', u'Laureate Biopharmaceutical Services Inc', u'Synthelabo SA', u'Rosalind Franklin University of Medicine & Science', u'Sumitomo Dainippon Pharma Co Ltd', u'Nencki Institute of Experimental Biology', u'Nippon Chemiphar Co Ltd', u'ImaRx Therapeutics Inc', u'Celonic AG', u'University of Texas Southwestern Medical Center', u'Institut Germans Trias I Pujol (Igtp)', u'La Jolla Pharmaceutical Co', u'Japan Tobacco Inc', u'Royal Philips Electronics', u'Promenade Software Inc', u'CoNCERT Pharmaceuticals Inc', u'Athersys Inc', u'MRI Interventions Inc', u'SYGNIS AG', u'Galileo Pharmaceuticals Inc', u'Matrix Pharmaceuticals Ltd', u'Hyundai Pharmaceutical', u'IVAX Corp', u'Proteome Sciences plc', u'Nuvelo Inc', u'ReNeuron Group plc', u'AstraZeneca plc', u'Undisclosed', u'Socratech LLC', u'Russian Academy Medical Science', u'University of Arkansas for Medical Sciences', u'Nattermann & Cie GmbH', u'Quantum Genomics Corp', u'The European Union', u'Academia Sinica', u'Neuron Therapeutics Inc', u'Glenmark Pharmaceuticals Ltd', u'Pharmos Corp', u'Institute of Materia Medica Chinese Academy of Medical Sciences & Peking Union Medical College', u'Ben-Gurion University Of The Negev', u'Top Institute Pharma', u'Astra Merck Inc', u'Novavax Inc', u'Senju Pharmaceutical Co Ltd', u'Seoul National University Hospital', u'National Medical Research Council (NMRC), Singapore', u'Spectrum Pharmaceuticals Inc', u'Cedars-Sinai Medical Center', u'Michigan Translational Research and Commercialization', u'AGY Therapeutics Inc', u'Aronora Inc', u'ThromboGenics NV', u'Dong Wha Pharmaceutical Co Ltd', u'Aptahem AB', u'IXICO Plc', u'Medical College of Georgia', u'Neuralstem Inc', u\"Brigham & Women's Hospital\", u'Takeda Pharmaceutical Co Ltd', u'Zhongzhu Healthcare Holding Co Ltd', u'Anhui Healstar Pharmaceutical Co Ltd', u'Institut Henri Beaufour', u\"Dr Reddy's Laboratories Ltd\", u'Max Planck Institut fur Experimentelle Medizin', u'Telios Pharmaceuticals Inc', u'Cardinal Health Inc', u'Abdi Ibrahim Ilac Sanayi Ve Ticaret Anonim Sirketi', u'Aeolus Pharmaceuticals Inc', u'Forest Laboratories Inc', u'Korea Research Institute of Chemical Technology', u'Legacy Health System', u'Quintiles Transnational Corp', u'Ministry of Health, Welfare and Family Affairs', u'Idun Pharmaceuticals Inc', u'Cerevast Therapeutics Inc', u'Tes Holdings Co Ltd', u'TheraSource LLC', u'AvantGen Inc', u'PharmaDesign Inc', u'University of Bonn', u'University of Washington', u'Molecumetics Ltd', u'NuvOx Pharma LLC', u'Cortech Inc', u'Atherotech Inc', u'Gamida Cell Ltd', u'Ancile Pharmaceuticals Inc', u'Sun Pharmaceutical Industries Ltd', u'Cytori Therapeutics Inc', u'University of Kentucky', u'Soroka University Medical Center', u'Knoll Farmaceutici SpA', u'Bioresearch SpA', u'Hikma Pharmaceuticals plc', u'Randox Laboratories Ltd', u'University of Le\\xf3n', u'Annovis Inc', u'Hengdian Group Ltd', u'Kanebo KK', u'Angel Biotechnology Holdings plc', u'Shirley Ryan AbilityLab', u'Fudan University', u'Arrow International Ltd', u'NeuroRepair Inc', u'Korea University', u'Arbor Vita Corp', u'Repligen Corp', u'Unigene Laboratories Inc', u'Pronota NV', u'Irix Pharmaceuticals Inc', u'Amira Pharmaceuticals Inc', u'Purdue Pharma LP', u'Diosynth BV', u'Empire Pharmaceuticals Inc', u'Fraunhofer-Institute fur Zelltherapy und Immunologie', u'FibroGen Inc', u'BioPhyZica Inc', u'Glaxo Group Ltd', u'Encysive Pharmaceuticals Inc', u'Boehringer Ingelheim Corp', u'Tomen Corp', u'Parke-Davis & Co', u'Wyeth BioPharma', u'Saegis Pharmaceuticals Inc', u'Fujifilm Diosynth Biotechnologies', u'Inha University', u'AMRAD Pharmaceuticals Pty Ltd', u'Integrative Research Laboratories Sweden AB', u'Duke University Medical Center', u'Wyeth Pharmaceuticals', u'APT Therapeutics Inc', u'Nippon Shinyaku Co Ltd', u'Biofrontera AG', u'Advanced Life Sciences Holdings Inc', u'Faraday Pharmaceuticals Inc', u'CMC Biologics Inc', u'Medical College of Wisconsin', u'XOMA Corp', u'University of California', u'Merck & Co Inc', u'Sanofi', u'The Salk Institute for Biological Studies', u'Vertex Pharmaceuticals Inc', u'Ajou University', u'Bayer AG', u'University of California Davis', u'Renovis Inc', u'Phytera Inc', u'BBB Therapeutics BV', u'University of Geneva', u'Nektar Therapeutics', u'Almirall Prodesfarma SA', u'West-Ward Columbus', u'Neurocrine Biosciences Inc', u'Gene Smart Health', u'Gilead Sciences Inc', u'Moleac Pte Ltd', u'International Stem Cell Corp', u'Wyeth', u'AxoTect Inc', u'Health Research Institute of Santiago de Compostela', u'Global Biotech Inc', u'University of Wyoming', u'Cecoura Therapeutics Inc', u'Purdue University', u'Primary Peptides', u'Takeda Pharmaceuticals International GmbH', u'Apogenix GmbH', u'Yabao Pharmaceutical Group Co Ltd', u'NeuroVive Pharmaceutical AB', u'University of Mississippi', u'Dendreon San Diego LLC', u'Mitsubishi-Tokyo Pharmaceuticals Inc', u'Max-Planck-Gesellschaft', u'University of Tokyo', u'University of Oregon', u'Elan Corp plc', u'BioTime Inc', u'INSERM', u'Hamamatsu Photonics', u'King Pharmaceuticals Inc', u'KAI Pharmaceuticals Inc', u'Centaur Pharmaceuticals Inc', u'MGI Pharma Inc', u'Cephalon Inc', u'Vernalis Research Ltd', u'KeyNeurotek Pharmaceuticals AG', u'Duke University', u'Government of Ontario', u'Molecuence', u'FDA Office of Orphan Products Development', u'Azur Pharma Ltd', u'Kaleida Health', u'NB Health Laboratory Co Ltd', u'Jan Medical Inc', u'Brainomix', u'ArmaGen Technologies Inc', u'Translational Sciences Inc', u'nEUROinflammation consortium', u'Daiichi Seiyaku Co Ltd', u'US Government', u'Rice University', u'Asahi Kasei Corp', u'GT Biopharma Inc', u'NAEJA Pharmaceuticals Inc', u'Baxter International Inc', u'Remedy Pharmaceuticals Inc', u'MSD OSS BV', u'Acorda Therapeutics Inc', u'Allos Therapeutics Inc', u'deCODE genetics ehf', u'California Institute of Regenerative Medicine', u'Biogen Inc', u'4SC Discovery GmbH', u'UMeWorld Ltd', u'GlaxoSmithKline plc', u'ProMetic Life Sciences Inc', u\"Ataxia Telangiectasia Children's Project Inc\", u'Bayer Schering Pharma AG', u'Bristol Heart Institute', u'Taxus Cardium Pharmaceuticals Group', u'Mc10 Inc', u'European Eurostars Programme', u'Zeria Pharmaceutical Co Ltd', u'Agahan Ayandeye Pars Inc', u'Osaka National Hospital', u'University of Michigan', u'Virogenomics Inc', u'University of Texas Health Science Center Houston', u'Takeda Oncology', u'Halozyme Therapeutics Inc', u'Abbott Healthcare Products BV', u'Huons Co Ltd', u'Neurogen Corp', u'StemCyte Inc', u'Sankyo Co Ltd', u'Xigen SA', u'Medicure Inc', u'Shionogi & Co Ltd', u'Emory University', u'National Heart Lung and Blood Institute', u'US Department of Defense', u'Juno Biomedical Inc', u\"Boston Children's Hospital\", u'Universiteit Maastricht', u'Suntory Ltd', u'Warren Pharmaceuticals Inc', u'Asset Realisation Co plc', u'Johnson & Johnson Pharmaceutical Research & Development LLC', u'Evolutec Group plc', u'MD Anderson Cancer Center', u'Canadian Stroke Prevention Intervention Network', u'RespireRx Pharmaceuticals Inc', u'Daiichi Sankyo Co Ltd', u'Abbott Laboratories', u'Sparta Pharmaceuticals Inc', u'Eisai Co Ltd', u'Janssen Biologics BV', u'Wuxi AppTec Inc', u'National Cancer Institute', u'Novartis AG', u'Merck KGaA', u'Korea Research Institute of Bioscience and Biotechnology', u'Fujisawa Pharmaceutical Co Ltd', u'Simcere Pharmaceutical Group', u'Gaia BioPharma Ltd', u'SurModics Inc', u'Universite De Montreal', u'Neurotrope Inc', u'The Procter & Gamble Co', u'Yungjin Pharmaceutical Co Ltd', u'NeurOp Inc', u'3-Dimensional Pharmaceuticals Inc', u'Inflabloc Pharmaceuticals Inc', u'CytRx Corp', u'Ferrer Internacional SA', u'LXR Biotechnology Inc', u'Pluristem Therapeutics Inc', u'Loyola University Stritch School of Medicine', u'H Lundbeck A/S', u'Pharming Group NV', u'National Institute of Neurological Disorders and Stroke', u'Ortho Biotech Products LP', u'Samsung Medical Center (SMC)', u'Otsuka Pharmaceutical Co Ltd', u'SynthRx Inc', u'AmKor Pharma Inc', u'TeaRx LLC', u'Sanofi Chimie SA', u'Republic of Korea Government', u'Queen Mary University of London', u'Jeil Pharmaceutical Co Ltd', u'Dongguk University', u'ENKAM Pharmaceuticals A/S', u'Diosynth Biotechnology', u'MRIGlobal', u'Hanyang University', u'US Naval Medical Research Center', u'Aurum Biosciences Ltd', u'University of Miami', u'RegeneRx Biopharmaceuticals Inc', u'Kissei Pharmaceutical Co Ltd', u'Janssen Biotech Inc', u'Australian Neuromuscular Research Institute', u'Teijin Ltd', u'Esteve', u'Yale University', u'Ministry of Education Science and Technology, Korea', u'D-Pharm Ltd', u'Mount Sinai Medical Center', u'Wyss Institute for Biologically Inspired Engineering', u'Baylor College of Medicine', u'UK Government', u'Synthelabo', u'Synaptive Medical (Barbados) Inc', u'DevCo Pharmaceuticals Ltd', u'Magnetic Insight Inc', u'Galecto Biotech AB', u'Arena Pharmaceuticals Inc', u'Octamer Inc', u'University of Melbourne', u'Phylogica Ltd', u'ReWalk Robotics Ltd', u'Shionogi-GlaxoSmithKline Pharmaceuticals LLC', u'XO1 Ltd', u'National Institutes of Health', u'Chromos Molecular Systems Inc', u'Sanford-Burnham Medical Research Institute', u'Synvista Therapeutics Inc', u'Curis Inc', u'Zenyth Therapeutics Ltd', u'Quark Pharmaceuticals Inc', u'Thomas Jefferson University', u'TNO Pharma', u'FB Health', u'ALS Association', u'Mitsui Norin Co Ltd', u'JW Pharmaceutical Corp', u'Merck Serono SA', u'Purdue Neuroscience Corp', u'University of California Irvine', u'Saneron CCEL Therapeutics Inc', u'ProBioGen AG', u'MannKind Corp', u'Gedeon Richter Ltd', u'Epitome Pharmaceuticals Ltd', u'Trillium Therapeutics Inc', u'University at Buffalo', u'BaYi Brain Hospital', u'BioCryst Pharmaceuticals Inc', u'Merz & Co GmbH']), u'Plasmodiumfalciparuminfection': set([u'Synstar Japan Co Ltd', u'US Government', u'Liquidia Technologies Inc', u'National Institutes of Health', u'United States Army Medical Material Development Activity', u'Bill & Melinda Gates Foundation', u'Koebenhavns Universitet', u'Genocea Biosciences Inc', u'Netherlands Government', u'Sanofi Pasteur', u'European Commission', u'GenVec Inc', u'Technical University of Munich', u'Indian Council of Medical Research', u'Center for Infectious Disease Research', u'Inovio Pharmaceuticals Inc', u'Pasteur Institute in Ho Chi Minh City', u'Vical Inc', u'National Institute of Allergy and Infectious Diseases', u'VGX Pharmaceuticals LLC', u'University of Geneva', u'University of Basel', u'PolyMedix Inc', u'Fraunhofer USA Inc', u'Universite Pierre et Marie Curie', u'Cilian AG', u'University of South Florida', u'Drexel University College of Medicine', u'Swiss Agency for Development and Cooperation', u'University of Pennsylvania', u'Imaxio', u'The Macfarlane Burnet Institute For Medical Research & Public Health Ltd', u'Aduro BioTech Inc', u'Paratek Pharmaceuticals Inc', u'Radix Pharmaceuticals Inc', u'Paladin Labs Inc', u'Medicines for Malaria Venture', u'Tongji University', u'Antigen Discovery Inc', u'Global Health Innovative Technology Fund', u'Catalent Inc', u'Medical Research Council', u'Ifakara Health Institute', u'US Department of Defense', u'Agence nationale de la recherche (ANR)', u'Biomedical Primate Research Centre', u'Universiti Sains Malaysia', u'National Institute of General Medical Sciences', u'Sigma-Tau Ind Farm Riunite SpA', u'Evotec AG', u'National Health and Medical Research Council', u'Tokyo Institute of Technology', u'Regenacy Pharmaceuticals LLC', u'University of California San Francisco', u'Jomaa Pharma GmbH', u'Monash University', u'Gunma University', u'Medecins Sans Frontieres', u'The European Union', u'Eisai Co Ltd', u'Tulane University', u'Drexel University', u'World Health Organization', u'Accelovance Inc', u'Novartis AG', u'Sanaria Inc', u'La Trobe University', u'Protein Potential LLC', u'Indian Government Department of Biotechnology', u'Georgetown University', u'Celtaxsys Inc', u'London School of Hygiene and Tropical Medicine', u'Loma Linda University', u'Gennova Biopharmaceuticals', u'GlaxoSmithKline plc', u'Ajinomoto Althea Inc', u'Guilin Pharmaceutical Co Ltd', u'CryoPort Inc', u'Jacobus Pharmaceutical Co Inc', u'SBI Pharmaceuticals', u'La Agencia Espa\\xf1ola de Cooperaci\\xf3n Internacional para el Desarrollo', u'Schrodinger Inc', u'Mutual Pharmaceutical Co Inc', u'Shin Poong Pharmaceutical Co Ltd', u'French Development Agency', u'Wellcome Trust', u'Shanghai Jiao Tong University', u'Komfo Anokye Teaching Hospital', u'University of Edinburgh', u'University of Lausanne', u'Johns Hopkins University', u'Swiss Tropical & Public Health Institute', u'Immtech Pharmaceuticals Inc', u'National Center For Global Health & Medicine', u'Rutgers University', u'University of Oxford', u'Walter Reed Army Institute of Research', u'Gold Coast Hospital', u'AR Scientific Inc', u'Novartis Research Foundation', u'National Natural Science Foundation of China', u'Ellipse Pharmaceuticals', u'Science Applications International Corp', u'Drugs for Neglected Diseases Initiative', u'The Jenner Institute', u'Cellfree Sciences Co Ltd', u'Ramaciotti Foundation', u'International Center for Genetic Engineering and Biotechnology (ICGEB)', u'LifeArc', u'Oregon Health Sciences University', u'Modus Therapeutics', u'US Army Medical Research and Materiel Command', u'University of California', u'Merck & Co Inc', u'Australian Research Council', u'Scripps Research Institute', u'rEVO Biologics Inc', u'Sanofi', u'University of Texas Southwestern Medical Center', u'Columbia University', u'GlaxoSmithKline Biologicals', u'Radboud University', u'Department for International Development', u'US Army Medical Research Institute of Infectious Diseases', u'University of Wollongong', u'Pierre Fabre SA', u'VaxInnate Corp', u'Anacor Pharmaceuticals Inc', u'Biological Mimetics Inc', u'Institut de Recherche pour le Developpement (IRD)', u'University of Iowa', u'Universidade Estadual de Campinas', u'Vaxeal Holding SA', u'Pfizer Inc', u'Pfenex Inc', u'Human Frontier Science Program', u'Zydus-Cadila Group', u'Central Drug Research Institute', u'Centre for Drug Candidate Optimisation', u'University of Rhode Island', u'Amyris Inc', u'SIO2 Medical Products Inc', u'Ferrer Internacional SA', u'Broad Institute Inc', u'University of California at Berkeley', u'University of Washington', u'University of Mississippi', u'Instituto de Tecnologia em Farmacos (Brazil)', u'Institute For Medical Research (Inc In Malaysia)', u'Kenya Medical Research Institute', u'Cambridge Biotechnology Ltd', u'University of Cape Town', u'Bioject Medical Technologies Inc', u'Eberhard Karls Universit\\xe4t T\\xfcbingen', u'Dalton Pharma Services', u'The Institute for OneWorld Health', u'Griffith University', u'Mahidol University', u'University of California San Diego', u'SmithKline Beecham plc', u'NYU Langone Medical Center', u'Rhode Island Hospital', u'Quintiles Transnational Corp', u'University of Dundee', u\"St Jude Children's Research Hospital\", u'East China University of Science & Technology', u'Bioagency AG', u'University of Tokyo', u'Novavax Inc', u'Cardinal systems', u'Medicine in Need', u'INSERM', u'Grand Challenges in Global Health', u'Kuros Biosciences Ltd', u'Sanofi Genzyme', u'Molplex Pharmaceuticals', u'Johns Hopkins Bloomberg School of Public Health', u'European Vaccine Initiative', u'European and Developing Countries Clinical Trials Partnership', u'VINNOVA', u'Stanford University', u'National Science & Technology Development Agency (NSTDA)', u'US Naval Medical Research Center', u'Institut Pasteur', u'Queensland Institute of Medical Research', u'Acetylon Pharmaceuticals Inc', u'IPCA Laboratories Ltd', u'Walter and Eliza Hall Institute of Medical Research', u'Crucell NV', u'Isconova AB', u'Universite de Bordeaux', u'The PATH Malaria Vaccine Initiative', u'BIKEN Foundation', u'BASF AG']), u'Chagascardiomyopathy': set([u'Lafepe', u'Drugs for Neglected Diseases Initiative']), u'Varic': set([u'PDL BioPharma Inc', u'Sandoz Ltd']), u'Staphylococceaeinfection': set([u'National Institute of Allergy and Infectious Diseases', u'Callisto Pharmaceuticals Inc', u'Institute For Hepatitis & Virus Research', u'US Army Research Office']), u'Apnea': set([u'Nippon Boehringer Ingelheim Co Ltd', u'Nobelpharma Co Ltd']), u'Fibrodysplasiaossificansprogressiva': set([u'La Jolla Pharmaceutical Co', u'Blueprint Medicines Corp', u'National Institutes of Health', u'Vanderbilt University', u'Alexion Pharmaceuticals Inc', u'Massachusetts General Hospital']), u'SyndromeX': set([u'BioLineRx Ltd', u'US Government', u'Orphagen Pharmaceuticals Inc', u'University of California at Berkeley', u'National Institute of Diabetes, Digestive and Kidney Diseases', u'Abbott Laboratories', u'Motus Therapeutics Inc', u'Evotec International GmbH', u'Ipsen', u'Novartis Pharma AG', u'Perlegen Sciences Inc', u'Sanofi', u'Bionovo Inc', u'National Center for Complementary and Alternative Medicine', u'Yeda Research and Development Co Ltd', u'Astellas Pharma Inc', u'LION bioscience Inc', u'Fujirebio KK', u'Insmed Inc', u'Kissei Pharmaceutical Co Ltd', u'Palatin Technologies Inc', u'UCB Pharma SA', u'Napo Pharmaceuticals Inc', u'Pfizer Inc', u'Boehringer Ingelheim Corp', u'Novartis AG']), u'Agerelatedmaculardegeneration': set([u'Daiichi Seiyaku Co Ltd', u'Aerie Pharmaceuticals Inc', u'TRACON Pharmaceuticals Inc', u'Agence Nationale de Recherches sur le Sida et les hepatites virales (ANRS)', u'Charlesson LLC', u'iCo Therapeutics Inc', u'University of Medicine and Dentistry of New Jersey', u'NovelMed Therapeutics Inc', u'AGTC', u'PanOptica Inc', u'Archemix Corp', u'Neovacs SA', u'European Commission', u'GenVec Inc', u'California Institute of Regenerative Medicine', u'Jerini Ophthalmic Inc', u'Biogen Inc', u'Centre de Physiopathologie de Toulouse Purpan', u'Korea Research Institute of Chemical Technology', u'Cosmo Pharmaceuticals SpA', u'Regeneron Pharmaceuticals Inc', u'Tufts University School of Medicine', u'IBM Watson Health Life Sciences', u'Regenerative Patch Technologies, LLC', u'National Institute of Neurological Disorders and Stroke', u'MacuSight Inc', u'Ionis Pharmaceuticals Inc', u'The Dow Chemical Co', u'Novartis Pharma AG', u'Cosmix Therapeutics Llc', u'Oklahoma Center for the Advancement of Science and Technology', u'Advanced Ocular Systems Ltd', u'Universite Pierre et Marie Curie', u'Moorfields Eye Hospital', u'European Community', u'Science Center', u'Astex Pharmaceuticals Inc', u'Genentech Inc', u'Microbot Medical Inc', u'ISTA Pharmaceuticals Inc', u'INSERM Transfert', u'Celldex Therapeutics Inc', u'University of Pennsylvania', u'University of Arizona', u'University of Kentucky', u'Mateon Therapeutics Inc', u'MINU LLC', u'Hospira Inc', u'Sinphar Pharmaceutical Co Ltd', u'DNX Biopharmaceuticals Inc', u'Motility Inc', u'PhiloGene Inc', u'Sanwa Kagaku Kenkyusho Co Ltd', u'A H Robins Co Ltd', u'Peregrine Pharmaceuticals Inc', u'Sun Pharmaceutical Industries Ltd', u'Ludwig Institute for Cancer Research', u'Kuhnil Pharmaceutical Co Ltd', u'Intellect Neurosciences Inc', u'Weill Medical College of Cornell University', u'Miravant Medical Technologies', u'Cell Cure Neurosciences Ltd', u'Toray Industries Inc', u'Eyetech Inc', u'Shionogi & Co Ltd', u'Emory University', u'Medical Research Council', u'ElsaLys Biotech', u'Biomas Inc', u'RIKEN', u'Alcon Research Ltd', u'Alnylam Pharmaceuticals Inc', u'Ribomic Inc', u'R-Tech Ueno Ltd', u'University of Massachusetts Medical School', u'PTC Therapeutics Inc', u'Sequenom Inc', u'Maryland Department of Business and Economic Development', u'Light Sciences Corp', u'Ascendis Pharma A/S', u'Hemera Biosciences Inc', u'PDL BioPharma Inc', u'Ocular Therapeutics Inc', u'Nippon Petrochem Co Ltd', u'Aqumen Biopharmaceuticals KK', u'MABLife', u'Pfenex Inc', u'Sirnaomics Inc', u'OncoTherapy Science Inc', u'Eyemedix Inc', u'Roswell Park Cancer Institute', u'Galena Biopharma Inc', u'Croma Pharma GmbH', u'Samyang Corp', u'University of Pittsburgh', u'Graybug Vision Inc', u'National Cancer Institute', u'Antisense Therapeutics Ltd', u'Johns Hopkins University School of Medicine', u'Clayton Foundation For Research', u'Alimera Sciences Inc', u'University of Bristol', u'OcuCure Therapeutics Inc', u'The European Union', u'Novelion Therapeutics Inc', u'Teva Pharmaceutical Industries Ltd', u'Jiangsu Hengrui Medicine Co Ltd', u'Singapore Eye Research Institute', u'iNovacia AB', u'ArcticDx Inc', u'Santen Pharmaceutical Co Ltd', u'Ajinomoto Althea Inc', u'MRC Biotech Pty Ltd', u'Guangdong Zhongsheng Pharmaceutical Co Ltd', u'Midwestern University', u'Monash University', u'Laureate Biopharmaceutical Services Inc', u'National Neurovision Research Institute', u'Pharmacopeia Inc', u'US Government', u'Navigen Inc', u'Ohr Pharmaceutical Inc', u'RxGen Inc', u'Ceregene Inc', u'X-BODY BioSciences', u'Nuraging Biotech Srl', u'Carilion Biomedical Institute', u'Georgia State University', u'Dong-A ST Co Ltd', u'Potentia Pharmaceuticals Inc', u'Allergan Inc', u'Sucampo Pharmaceuticals Inc', u'Osaka University', u'Johns Hopkins University', u'SynCore Biotechnology Co Ltd', u'AcSentient Inc', u'Molecular Partners AG', u'Israel Science Foundation', u'BioInvent International AB', u'Maryland Technology Development Corp', u'Stemedica Cell Technologies Inc', u'Wacker Biotech GmbH', u'Bausch & Lomb Inc', u'SurModics Pharmaceuticals', u'Alkeus Pharmaceuticals Inc', u'Optherion Inc', u'iVeena LLC', u'Healios KK', u'Active Pass Pharmaceuticals Inc', u'Nanoscope Technologies LLC', u'Astellas Institute for Regenerative Medicine', u'University of Melbourne', u'Agilent Technologies Inc', u'Harvard Medical School', u'Otsuka Pharmaceutical Co Ltd', u'Korea Drug Development Fund', u'Aciont Inc', u'Yuyu Inc', u'Amarantus BioScience Holdings Inc', u'National Health and Medical Research Council', u'Photochemical Co Ltd', u'Reino de Espana', u'Pharmacyclics Inc', u'Charles River Laboratories International Inc', u'Oxford BioMedica plc', u'Boots Hoechst Celanese', u'Intradigm Corp', u'London Project to Cure Blindness', u'iTherX Pharmaceuticals Inc', u'Ophthotech Corp', u'Genzyme Pharmaceuticals', u'Ark Therapeutics Group plc', u'PR Pharmaceuticals Inc', u'Kalos Therapeutics Inc', u'Oregon Health Sciences University', u'University of California San Francisco', u'Sumitomo Dainippon Pharma Co Ltd', u'XOMA Corp', u'IOMED Inc', u'Merck & Co Inc', u'Scripps Research Institute', u'National Eye Institute', u'Sanofi', u'Steba Biotech NV', u'University College London', u'Cambridge Enterprise Ltd', u'CASI Pharmaceuticals Inc', u'Alcon Pharmaceuticals Ltd', u'Bayer AG', u'Santen SAS', u'Selexis SA', u'Orient Pharma Co Ltd', u'UCL Institute of Ophthalmology', u'Weizmann Institute of Science', u'Zuellig Pharma Ltd', u'InNexus Biotechnology Inc', u'OliX Pharmaceuticals Inc', u'NicOx SA', u'Institute of Ophthalmology', u'Medarex Inc', u'AEterna Zentaris Inc', u'Tri-Inov', u'Foundation Fighting Blindness', u'Genaera Corp', u'Parke-Davis & Co', u'OSI Pharmaceuticals Inc', u'Pfizer Inc', u'University of New Mexico', u'AsclepiX Therapeutics LLC', u'Intercytex Ltd', u'Gilead Sciences Inc', u'SUGEN Inc', u'Indiana University', u'Caladrius Biosciences Inc', u'University of Utah', u'International Stem Cell Corp', u'Pieris Pharmaceuticals Inc', u'Hanlim Pharmaceutical Co Ltd', u'Columbia University', u'National Human Genome Research Institute', u'Hopital Saint-Louis', u'Alcon Inc', u'XL-Protein GmbH', u'NeoGenesis Pharmaceuticals Inc', u'Ichor Medical Systems Inc', u'Baylor College of Medicine', u'Advanced Vision Technology (Avt) Ltd', u'Prana Biotechnology Ltd', u'Intrexon Corp', u'Durlach Pharma', u'pSivida Inc', u'ProDa BioTech LLC', u'LeadArtis SL', u'Silence Therapeutics AG', u'Canadian Bio Med Systems Inc', u'CenterState CEO', u'Sirna Therapeutics Inc', u'Iconic Therapeutics Inc', u'Texas Emerging Technology Fund', u'Bascom Palmer Eye Institute', u'Wellstat Ophthalmics Corp', u'AdAlta Pty Ltd', u'Northwestern University', u'Lonza Group AG', u'University of London', u'Idx Llc', u'XERIS Pharmaceuticals Inc', u'Walter Reed Army Institute of Research', u'National Institutes of Health', u'Synthetic Biologics Inc', u'Senju Pharmaceutical Co Ltd', u'Bristol-Myers Squibb Co', u'TG United', u'INSERM', u'Opthea Pty Ltd', u'Sanofi Genzyme', u'MacuCLEAR Inc', u'Quark Pharmaceuticals Inc', u'ICOS Corp', u'Chinese Academy of Sciences', u'Fujifilm Diosynth Biotechnologies', u'Mystic Pharmaceuticals Inc', u'Cephalon Inc', u'Resolvyx Pharmaceuticals Inc', u'Taejoon Pharm Co Ltd', u'ThromboGenics NV', u'Astellas Pharma Inc', u'Summit Therapeutics plc', u'Valeant Pharmaceuticals International Inc', u'National University of Singapore', u'Undisclosed', u'Apollo Endosurgery Inc', u'BioDiem Ltd', u'Acucela Inc', u'Lumenis Ltd', u'Sysmex Corp', u'AyoxxA Biosystems GmbH', u'Maryland Biotechnology Center', u'Hebrew University of Jerusalem', u'NewSouth Innovations', u'Idera Pharmaceuticals Inc', u'Wallace H Coulter Foundation', u'Novartis AG', u'Antitope Ltd', u'Axordia Ltd', u'MicroConstants China', u'Hadassah University Hospital', u'Beth Israel Deaconess Medical Center', u'ProTherapeutics Pte Ltd', u'NOXXON Pharma AG', u'German Federal Ministry of Education and Research', u'Shin Nippon Biomedical Laboratories Ltd', u'RXi Pharmaceuticals Corp']), u'Arenavirusinfection': set([u'Inovio Pharmaceuticals Inc', u'Immunovaccine Inc', u'US Government', u'La Jolla Institute of Allergy & Immunology', u'Crucell NV', u'Verta Ltd', u'US Army Medical Research Institute of Infectious Diseases', u'SIGA Technologies Inc', u'Microbiotix Inc', u'Zalgen Labs LLC', u'US Department of Defense', u'Medigen Inc', u'National Institute of Allergy and Infectious Diseases', u'Kineta Inc', u'US Civilian Research and Development Foundation', u'SciClone Pharmaceuticals Inc']), u'Calciummetabolismdisorder': set([u'University of Manchester', u'Immunodiagnostic Systems Ltd']), u'Beckermusculardystrophy': set([u'Parent Project Muscular Dystrophy', u\"Nationwide Children's Hospital\", u'Marina Biotech Inc', u'Rosetta Genomics Ltd']), u'Acutesinusitis': set([u'Genesoft Inc', u'LG Life Sciences Ltd', u'Kyowa Hakko Bio Co Ltd', u'LTL Pharma Co Ltd', u'Bayer AG', u'Paratek Pharmaceuticals Inc', u'Astellas Pharma Inc', u'Daiichi Sankyo Co Ltd', u'US Army Medical Research Institute of Infectious Diseases', u'Chong Kun Dang Pharmaceutical Corp']), u'Ankylosingspondylitis': set([u'SS Pharmaceutical - ethical drug division', u'Janssen-Cilag Ltd', u'Polpharma Biologics', u'Baxter International Inc', u'Amgen Inc', u'Pediapharm Inc', u'Novartis Pharma KK', u'BioXpress Therapeutics SA', u'Daiichi Sankyo Co Ltd', u'Abbott Laboratories', u'UniQuest Pty Ltd', u'Biogen Inc', u'Eisai Co Ltd', u'Dojin Iyaku-Kako Co Ltd', u'Victory Pharma Inc', u'Allergan plc', u'UCB Celltech', u'Santarus Inc', u'Laboratorio Medinfar - Productos Farmaceuticos Lda', u'Hi-Tech Pharmacal Co Inc', u'Oncobiologics Inc', u'FAES Farma SA', u'Axxiom Inc', u'Stiefel Laboratories (UK) Ltd', u'Samil Pharmaceutical Co Ltd', u'Coherus BioSciences Inc', u'Ewopharma AG', u'Elan Corp plc', u'Merck Sharp & Dohme de Espana SA', u'Alvogen Inc', u'Taizhou MTYB Biotech Co Ltd', u'Celltrion Inc', u'OptiMed Specialty Pharmacy', u'Roche Holding AG', u'Dong Wha Pharmaceutical Co Ltd', u'Knoll GmbH', u'Sunovion Pharmaceuticals Canada Inc', u'Mitsubishi Tanabe Pharma Corp', u'St Vincents Hospital (Melbourne) Ltd', u'Novartis AG', u'Xian-Janssen Pharmaceutical Ltd', u'AET BioTechnology Ltd', u'Janssen Biotech Inc', u'Yoshindo Inc', u'Orion Corporation', u'EPIRUS Biopharmaceuticals Inc', u'Pfizer Inc', u'Shionogi & Co Ltd', u'Boehringer Ingelheim Corp', u'Lupin Ltd', u'Tanabe Seiyaku Co Ltd', u'Zhejiang Huahai Pharmaceutical Group Co Ltd', u'Zhangjiang Biotechnology Co Ltd', u'Recordati SpA', u'Wyeth', u'Biochemie GmbH', u'F Hoffmann-La Roche AG', u'GD Searle & Co']), u'Gastrointestinalbleeding': set([u'Santarus Inc', u'Ministry of Science and Technology of the People\\xb4s Republic of China', u'Sihuan Pharmaceutical Holdings Group Ltd', u'Beijing Yipuan Bio-Medical Technology Co. Ltd', u'Beijing Liang Fang Pharmaceutical Co. Ltd', u'Norgine BV', u'Otsuka America Pharmaceutical Inc']), u'Stargardtdisease': set([u'Oxford BioMedica plc', u'University of California Los Angeles', u'US Government', u'Bayer AG', u'National Neurovision Research Institute', u'Johns Hopkins University', u'Astellas Institute for Regenerative Medicine', u'Vision Medicines', u'Oregon Health Sciences University', u'Alkeus Pharmaceuticals Inc', u'CRISPR Therapeutics', u'Case Western Reserve University', u'Foundation Fighting Blindness', u'Columbia University']), u'Spinal': set([u'US Government', u'Microbot Medical Inc']), u'Renaltumor': set([u'Daiichi Seiyaku Co Ltd', u'Immunicum AB', u'RuiYi Inc', u'Regeneron Pharmaceuticals Inc', u'DRAXIMAGE', u'Cancer Research Campaign Technology Ltd', u'Koken Co Ltd', u'Mologen Ag', u'EMD Serono Inc', u'OncoMax LLC', u'Lynx Therapeutics GmbH', u'GlaxoSmithKline plc', u'Cytran Ltd', u'Berg Pharma LLC', u'Tufts University School of Medicine', u'MethylGene Inc', u'Genesis Technology Group Inc', u'Ipsen', u'Stanford University', u'Vernalis plc', u'Sigma-Aldrich Corp', u'University of Washington', u'University of Texas Health Science Center Houston', u'Roche Holding AG', u'Shire plc', u'PlantForm Corp', u'Implicit Bioscience Ltd', u'Kuhnil Pharmaceutical Co Ltd', u'Biosceptre International Ltd', u'ONCO Life Sciences', u'Shionogi & Co Ltd', u'Epigenomics AG', u'University of California San Francisco', u'Tamir Biotechnology Inc', u'Cell Pathways Inc', u'EMD Lexigen Research Center Corp', u'Amgen Inc', u'Medarex Inc', u'Boehringer Mannheim GmbH', u'Accelovance Inc', u'National Cancer Institute', u'Novartis AG', u'Merck KGaA', u'Wilex AG', u'Fujisawa Pharmaceutical Co Ltd', u'Georgetown University Medical Center', u'Xcell Biosciences Inc', u'Fresenius Medical Care AG', u'SciClone Pharmaceuticals Inc', u'Fluxion Biosciences Inc', u'Mallinckrodt Inc', u'Beijing Four Rings Bio-Pharmaceutical Co Ltd', u'Protein Sciences Corp', u'ALZA Corp', u'Genius Biotherapeutics', u'MegaPharm Ltd', u'Midatech Pharma US Inc', u'Health Care Logistics Inc', u'Johns Hopkins University', u'Hoffmann-La Roche Inc', u'Radius Health Inc', u'TC BioPharm Ltd', u'Cognate BioServices Inc', u'Orphan Australia', u'Asieris Pharmaceuticals Co Ltd', u'Cancer Research UK', u'Shanghai Institutes for Biological Sciences CAS', u'GENESIS Pharma SA', u'Biogen Inc (FL)', u'Deciphera Pharmaceuticals LLC', u'CMC Biologics Inc', u'Sinopharm', u'Argos Therapeutics Inc', u'Sumitomo Dainippon Pharma Co Ltd', u'Merck & Co Inc', u'University of Southern California', u'University of Texas Southwestern Medical Center', u'CTI BioPharma Corp', u'Eli Lilly & Co', u'ScinoPharm Taiwan Ltd', u'Kyowa Hakko Kirin Co Ltd', u'RegeneRx Biopharmaceuticals Inc', u'Paradigm', u'University of Bradford', u'University of California Los Angeles', u'Centrose LLC', u'AstraZeneca plc', u'Esteve', u'Northwest Biotherapeutics Inc', u'Cancer Research Technology Ltd', u'PiSA Farmaceutica', u'Metdem Healthcare Ltd', u'Genor Biopharma Co Ltd', u'Guerbet', u'Lonza Biologics plc', u'Pharmstandard OJSC', u'EU Horizon 2020', u'Maxim Pharmaceuticals Inc', u'Syndax Pharmaceuticals Inc', u'Hemispherx Biopharma Inc', u'Hoffmann-La Roche AG', u'Imclone LLC', u'Translational Genomics Research Institute', u'Chongqing LUMMY Pharmaceutical Co Ltd', u'Cytran Inc', u'National Institute of Allergy and Infectious Diseases', u'Laboratorios Dr Esteve SA', u'SillaJen Inc', u'Somanta Pharmaceuticals Inc', u'UroGene SA', u'Innovation Pharmaceuticals Inc', u'Guangdong Medicine Group Corp', u'Sophiris Bio Inc', u'National Institutes of Health', u'Food and Drug Administration', u'Bristol-Myers Squibb Co', u'Cedars-Sinai Medical Center', u'Thomas Jefferson University', u'CJ Corp', u'Roswell Park Cancer Institute', u'Viragen Inc', u'VINNOVA', u'Melmotte Inc', u'Technology Strategy Board', u'Undisclosed', u'Antisoma plc', u'University of Guelph', u'Arriani Pharmaceuticals SA', u'Metaphore Pharmaceuticals Inc', u'GE Healthcare', u'AVAX Technologies Inc', u'Hayashibara Co Ltd', u'Hollister-Stier Laboratories LLC', u'Takeda Pharmaceutical Co Ltd', u'Provectus Biopharmaceuticals Inc', u'GeneMedicine Inc', u'Biomira USA Inc', u\"PX'Therapeutics SA\", u'Defense Threat Reduction Agency']), u'Diabeticgastroparesis': set([u'Salix Pharmaceuticals Inc', u'ETX Pharma Inc', u'Cosma SpA', u'Shire-Movetis NV', u'Amulet Pharmaceuticals Inc', u'Evoke Pharma Inc', u'Undisclosed', u'Spaulding Clinical', u'Catalyst Biosciences Inc', u'National Institute of Diabetes, Digestive and Kidney Diseases', u'University of Texas System', u'SynteractHCR Inc', u'Institute for the Promotion of Innovation by Science and Technology in Flanders', u'Wilmington Pharmaceuticals Inc', u'inVentiv Clinical Solutions']), u'Bodyweightchange': set([u'Medical Research Council', u'University of Aberdeen']), u'Uterinecervixtumor': set([u'Daiichi Seiyaku Co Ltd', u'US Government', u'Intronn Inc', u'Vaccibody AS', u'Advaxis Inc', u'Cancer Research Campaign Technology Ltd', u'Gynecologic Oncology Group', u'Netherlands Government', u'Allos Therapeutics Inc', u'Incyte Corp', u'US Health and Human Services Department', u'Yakult Honsha Co Ltd', u'GlaxoSmithKline plc', u'Zhejiang Academy Of Medical Sciences', u'Inovio Pharmaceuticals Inc', u'Ministry of Health, Welfare and Family Affairs', u'Bayer Schering Pharma AG', u'University of Queensland', u'Novelion Therapeutics Inc', u'Sanofi Winthrop France SA', u'Ipsen', u'Xenova Group plc', u'European Eurostars Programme', u'Sagentia Ltd', u'Kobold Medical', u'MedImmune LLC', u'oncgnostics GmbH', u'Hong Kong University of Science & Technology', u'OSI Pharmaceuticals Inc', u'Konica Minolta Camera Inc', u'Fred Hutchinson Cancer Research Center', u'Hovione SA', u'KuDOS Pharmaceuticals Ltd', u'ShigaMediX', u'Xiamen Innovax Biotech Co Ltd', u'Roche Holding AG', u'MDL Asia', u'Inventiv Health Clinical Inc', u'Gradalis Inc', u'Bionaturis', u'Ludwig Institute for Cancer Research', u'ImuThes Ltd', u'Lankenau Institute for Medical Research', u'Netherlands Cancer Institute', u'US Department of the Treasury', u'3M Pharmaceuticals', u'Roche Molecular Systems Inc', u'Biocon Ltd', u'The Chinese Centre for Disease Control and Prevention', u'The Althea Foundation', u'Dana-Farber Cancer Institute Inc', u'Orient Europharma', u'Loyola University of Chicago', u'RecipharmCobra Biologics', u'Cell Pathways Inc', u'Inex Pharmaceuticals Corp', u'MD Anderson Cancer Center', u'Nventa Biopharmaceuticals Corp', u'CEL-SCI Corp', u'Medicines Patent Pool', u'Abbott Laboratories', u'Shin Nippon Biomedical Laboratories Ltd', u'Pharmacia Corp', u'ApoVax Inc', u'National Cancer Institute', u'MediGene AG', u'University of Bristol', u'PharmaCell', u'MerLion Pharmaceuticals Pte Ltd', u'Cantab Biopharmaceuticals Ltd', u'Italfarmaco SpA', u'Merrimack Pharmaceuticals Inc', u'Kwang Dong Pharmaceutical Co Ltd', u'Transgene SA', u'University of Minnesota', u'YM BioSciences Inc', u'WuXi PharmaTech (Cayman) Inc', u'Biovation Ltd', u'Tessa Therapeutics Pte Ltd', u'Novacell Technology Inc', u'Pharmacia & Upjohn Inc', u'University of Colorado System', u'Guided Therapeutics Inc', u'The Research Council of Norway', u'Johns Hopkins University', u'The Center of Molecular Immunology', u'Kyowa Hakko Kogyo Co Ltd', u'Shandong Yaohua Medical Instrument Corporation', u'Shenghuo Medical LLC', u'ILEX Oncology Inc', u'Sinopharm', u'Genentech Inc', u'Georgia Regents University Cancer Center', u'FusionVax', u'IRX Therapeutics Inc', u'Paladin Labs Inc', u'Cobra Biologics Holding AB', u'Unilabs-IHS', u'DelSite Biotechnologies Inc', u'Rigel Pharmaceuticals Inc', u'Elekta AB', u'SRI International', u'Iovance Biotherapeutics Inc', u'Farrah Fawcett Foundation', u'Bioproperties Pty Ltd', u'Avesthagen Ltd', u'Global BioPharma Inc', u'Skolkovo', u'Zhejiang Pukang Biotechnology Co Ltd', u'Dekk-Tec Inc', u'Andes Biotechnologies', u'Selecta Biosciences Inc', u'IncellDx Inc', u'Poplar Healthcare', u'Chimera Pharma', u'Virometix AG', u'Ewha Womans University', u'Merck & Co Inc', u'Sanofi', u'Vion Pharmaceuticals Inc', u'Consiglio Nazionale delle Ricerche', u'Novogen Ltd', u'Bio-Bridge Science Inc', u'JSC Binnopharm', u'Helix BioPharma Corp', u'Global Alliance for Vaccines and Immunization', u'The Mary Kay Foundation', u'The Netherlands Organisation for Health Research and Development', u'AnGes MG Inc', u'Disease Interception Accelerator', u'Vyriad', u'Almirall Prodesfarma SA', u'Therapure Biopharma Inc', u'Kaken Pharmaceutical Co Ltd', u'SynCo BioPartners', u'European Organization for Research and Treatment of Cancer', u'Undisclosed', u'Boehringer Ingelheim Corp', u'Genisphere LLC', u'Bachem Holding AG', u'Coley Pharmaceutical Group Inc', u'Baylor College of Medicine', u'Australian Government', u'Prima BioMed Ltd', u'AbbVie Inc', u'Japanese National Cancer Center', u'MEI Pharma Inc', u'Novacyt', u'National Institute of Allergy and Infectious Diseases', u'Navidea Biopharmaceuticals Inc', u'BioChem Therapeutic Inc', u'Abzymo Biosciences Co Ltd', u'Beijing Zhifei Luzhu Biopharmaceutical Co Ltd', u'Morishita Jintan Co Ltd', u'Critical Outcome Technologies Inc', u'University of Toronto', u'Cancer Prevention and Research Institute of Texas', u'PhotoCure ASA', u'National Institutes of Health', u'Kirax Corp', u'Xiamen University', u'ProMetic Life Sciences Inc', u'Bristol-Myers Squibb Co', u'Chinese Government', u'ISA Pharmaceuticals BV', u'American Cyanamid Co', u'Deutsches Krebsforschungszentrum', u'Immunovaccine Inc', u'Kentucky Science and Technology Corp', u'Viragen Inc', u'MDxHealth SA', u'University of New South Wales', u'Qiagen NV', u'Chilean government', u'Ferozsons Laboratories Ltd', u'Cancer Research UK Manchester Institute', u'Merck Serono SA', u'University of Oxford', u'Propep Surgical Llc', u'PiSA Farmaceutica', u'Cyanamid Benelux NV', u'Novartis AG', u'3M Co', u'Stand Up To Cancer', u'University of Cambridge', u'Enact Pharma plc', u'Tokyo Medical and Dental University', u'University of Arkansas']), u'Gynecomastia': set([u'Laboratoires Besins International', u'BHR Pharma LLC', u'ASCEND Therapeutics Inc']), u'MRSAinfection': set([u'Serenta Biotechnology LLC', u'Korea Institute of Science and Technology', u'University of Connecticut', u'Serendex Pharmaceuticals A/S', u'Sanofi Pasteur', u'Ceragenix Pharmaceuticals Inc', u'CytoGenix Inc', u'Iroko Pharmaceuticals LLC', u'US Health and Human Services Department', u'Forest Laboratories Inc', u'Korea Research Institute of Chemical Technology', u'The Danish National Advanced Technology Foundation', u'Valevia UK', u'Cardiome Pharma Corp', u'QSV Biologics', u'National Institute of Neurological Disorders and Stroke', u'VGX Pharmaceuticals LLC', u'Novacta Biosystems Ltd', u'Kukje Pharmaceuticals', u'Breathtec Biomedical Inc', u'European Eurostars Programme', u'University of Bonn', u'Leiden University Medical Center', u'Lead Discovery Center GmbH', u'Peninsula Pharmaceuticals Inc', u'XBiotech Inc', u'Wakamoto Pharmaceutical Co Ltd', u'Galapagos NV', u'Aeon Medix Inc', u'Paratek Pharmaceuticals Inc', u'Relief Therapeutics Holding AG', u'Newton Fund', u'AuricX Pharmaceuticals Inc', u'Shionogi & Co Ltd', u'Sorrento Therapeutics Inc', u'National Heart Lung and Blood Institute', u'SinoFresh Healthcare Inc', u'Heinrich Heine Universitat Dusseldorf', u'Aquapharm Biodiscovery Ltd', u'Trellis Bioscience Inc', u'Techulon Inc', u'Reyon Pharmaceuticals Co Ltd', u'Helmholtz Zentrum fur Infektionsforschung GmbH', u'Squarix GmbH', u'CrystalGenomics Inc', u'Nemus Bioscience Inc', u'Meiji Seika Pharma Co Ltd', u'Ruhr Universitat Bochum', u'McMaster University', u'University of Antwerp', u'Cystic Fibrosis Foundation Therapeutics Inc', u'Catalyst Pharmaceutical Partners Inc', u'Haptogen Ltd', u'Innoviva Inc', u'Promiliad Biopharma Inc', u'Agile Sciences Inc', u'Evaxion Biotech ApS', u'Calvert T1 LLC', u'University of Maryland', u'Pendopharm', u'Absynth Biologics Ltd', u'iNtRON Biotechnology Inc', u'Madam Therapeutics BV', u'Brigham Young University', u'Merus Labs International Inc', u'Astellas Pharma Inc', u'Denmark Technical University', u'Yungjin Pharmaceutical Co Ltd', u'Technion Research & Development Foundation Ltd', u'RaQualia Pharma Inc', u'Basilea Pharmaceutica International Ltd', u'Lakewood-Amedex Inc', u'Wellcome Trust', u'German Government', u'Codevax Inc', u'University of Colorado System', u'Janssen Pharmaceutica NV', u'Montana State University', u'Novita Healthcare Ltd', u'University of California San Diego', u'IQ Therapeutics BV', u'Kitasato University', u'21st Century Therapeutics Inc', u'Georgia State University', u'National Biomanufacturing Centre', u'Rockefeller University', u'Green Cross Corp', u'Royal Liverpool and Broadgreen University Hospitals NHS Trust', u'National Natural Science Foundation of China', u'Alkem Laboratories Ltd', u'Lung Biotechnology Inc', u'Harvard Medical School', u'Korea Drug Development Fund', u'Universiteit Utrecht', u'National Yang Ming University', u'Allergan plc', u'Unimedic AB', u'CMC Biologics Inc', u'Republic of Korea Government', u'Eden Biodesign Ltd', u'NovaDigm Therapeutics Inc', u'Undisclosed', u'US Government', u'Sumitomo Dainippon Pharma Co Ltd', u'NovoBiotic Pharmaceuticals LLC', u'Daewoong Pharmaceutical Co Ltd', u'Scripps Research Institute', u'Redx Pharma Plc', u'Lyotropic Therapeutics LLC', u'Eli Lilly & Co', u'Galderma SA', u'US Army Medical Research Institute of Infectious Diseases', u'ImmuVen Inc', u'AiCuris Anti-infective Cures GmbH', u'Kyowa Hakko Kirin Co Ltd', u'NovaBay Pharmaceuticals Inc', u'University Medical Center Groningen', u'Medgel Corp', u'University of California Los Angeles', u'Erasmus University Medical Center Rotterdam', u'SRI International', u'AstraZeneca plc', u'aRigen Pharmaceuticals Inc', u'National Taiwan University', u'US Department of Defense', u'Institute for the Promotion of Innovation by Science and Technology in Flanders', u'University of Illinois', u'Theravance Biopharma Inc', u'Baylor College of Medicine', u'Phico Therapeutics Ltd', u'Savara Inc', u'Tzamal Medical Group Ltd', u'University of Oklahoma', u'University of Pennsylvania', u'Avir Pharma Inc', u'National Institute of Allergy and Infectious Diseases', u'East of England Development Agency', u'University of Mississippi', u'Bavarian Nordic A/S', u'Clinigen Group plc', u'Top Institute Pharma', u'National Institutes of Health', u'Strox Biopharmaceuticals LLC', u'Furiex Pharmaceuticals Inc', u'MorphoSys AG', u'Shanghai Institute of Pharmaceutical Industry', u'Kyoto University', u'Cedars-Sinai Medical Center', u'Ondine Biomedical Inc', u'The New Energy and Industrial Technology Development Organization', u'Ethicor Pharma Ltd', u'University of Rochester Medical Center', u'Virginia Polytechnic Institute and State University', u'Pepscan Systems BV', u'JW Pharmaceutical Corp', u'Royalty Pharma', u'BioDiem Ltd', u'Oxford Pharmascience Group Plc', u'AntexPharma Inc', u'CAM-Global, LLC', u'Takeda Pharmaceutical Co Ltd', u'Syntiron LLC', u'University Of Western Sydney', u'ContraFect Corp', u'University of Cambridge']), u'Temporalarteritis': set([u'Celltrion Inc', u'Bristol-Myers Squibb Co']), u'Appendicitis': set([u'Mallinckrodt Inc', u'Pfizer Inc', u'Palatin Technologies Inc', u'AstraZeneca plc']), u'Skinphotosensitivitydisorder': set([u'Spear Pharmaceuticals Inc', u'Valeant Pharmaceuticals International Inc']), u'Fibromyalgia': set([u'EpicGenetics Llc', u'TONIX Pharmaceuticals Inc', u'Inmedix LLC', u'AXIS Inc', u'UCB Pharma GmbH', u'AVACEN Medical', u'ASTA Medica AG', u'One World Cannabis Ltd', u'University of California Los Angeles', u'Eisai Co Ltd', u'Forest Laboratories Inc', u'GlaxoSmithKline plc', u'Quintiles Transnational Corp', u'Harris FRC Corp', u'Undisclosed', u'Nihon Schering KK', u'Georgetown University Medical Center', u'Elan Corp plc', u'Sanofi-Synthelabo', u'Asahi Kasei Pharma Corp', u'Eli Lilly & Co', u'McLean Hospital Corp', u'Lohmann Therapie-Systeme GmbH & Co KG', u'IMPAX Laboratories Inc', u'Valeant Pharmaceuticals International Inc', u'UCB Celltech', u'Janssen Pharmaceutical KK', u'Sheba Medical Center', u'Morulaa HealthTech', u'White Mountain Pharma Inc', u'Pierre Fabre SA', u'Jazz Pharmaceuticals plc', u'Kissei Pharmaceutical Co Ltd', u'Meda AB', u'Aderis Pharmaceuticals Inc', u'Handok Inc', u'ErgoNex Pharma GmbH', u'Pfizer Inc', u'Shionogi & Co Ltd', u'Boehringer Ingelheim Corp', u'Cypress Bioscience Inc', u'Synthetic Biologics Inc', u'Dartmouth College', u'UCB SA', u'Orphan Medical Inc', u'Hikma Pharmaceuticals plc']), u'Nervetumor': set([u'Stanford University', u'Nexgenix Pharmaceuticals Inc', u'National Cancer Institute', u'AstraZeneca plc']), u'Estrogendeficiency': set([u'Daiichi Seiyaku Co Ltd', u'Roussel Uclaf Corp', u'VIVUS Inc', u'Shire Pharmaceutical Development Ltd', u'Vifor Pharma', u'Novo Nordisk A/S', u'Lumara Health Inc', u'Undisclosed', u'Adcock Ingram Pharmaceuticals Ltd', u'Aspen PharmaCare Holdings Ltd', u'Esprit Pharma Inc', u'The Procter & Gamble Co', u'Schering Health Care Ltd', u'Torii Pharmaceutical Co Ltd', u'Abbott Laboratories', u'Yakult Honsha Co Ltd', u'Amarin Corp plc', u'Ligand Pharmaceuticals Inc', u'Sekisui Chemical Co Ltd', u'Actavis Inc', u'Bayer Schering Pharma AG', u'Merck KGaA', u'Pharmacia & Upjohn Inc', u'DreamPharma Corp', u'Solvay SA', u'Oregon Health Sciences University', u'Novavax Inc', u'Aventis Pharma AG', u'Juniper Pharmaceuticals Inc', u'Elan Corp plc', u'Noven Pharmaceuticals Inc', u'HRA Pharma', u'University of California San Francisco', u'Fidia Farmaceutici SpA', u'Lohmann Therapie-Systeme GmbH & Co KG', u'Cygnus Inc', u'Crescendo Pharmaceuticals Corp', u'Acrux Ltd', u'ALZA Corp', u'Amarin Technologies SA', u'Shire plc', u'Rotta Research Lab SpA', u'Wyeth', u'Graceway Pharmaceuticals Inc', u'Ciba-Geigy AG', u'Donesta Bioscience Bv', u'Mithra Pharmaceuticals', u'Amdipharm', u'Warner Chilcott plc', u'Osteometer BioTech AS', u'ANI Pharmaceuticals Inc', u'Janssen Pharmaceuticals Inc', u'Orion Corporation', u'3M Pharmaceuticals', u'Sanofi', u'Novartis AG', u'Plethora Solutions Holdings plc', u'Population Council', u'Pfizer Inc', u'Watson Laboratories Inc', u'Rhone-Poulenc Rorer Inc', u'University of Ghent', u'Provalis plc', u'Nichi-Iko Pharmaceutical Co Ltd', u'Ciba-Geigy Plc', u'Antares Pharma Inc']), u'Neoplasticmeningitis': set([u'Nippon Shinyaku Co Ltd', u'Pharmis Biofarmaceutica', u'Enzon Pharmaceuticals Inc', u'Baylor College of Medicine', u'Mundipharma EDO GmbH', u'Undisclosed', u'SkyePharma plc', u'Paladin Labs Inc', u'ASTA Medica AG', u'Pharmacia & Upjohn Co', u'Biocept Inc', u'Elan Pharma International Ltd', u'Pacira Pharmaceuticals Inc']), u'WestNilevirusinfection': set([u\"St Jude Children's Research Hospital\", u'US Government', u'Arbovax Inc', u'Isotechnika Pharma Inc', u'National Institutes of Health', u'Baxter International Inc', u'Cell Pharm GmbH', u'CEL-SCI Corp', u'University of Oklahoma', u'Virogenomics Inc', u'Sanofi Pasteur', u'Vical Inc', u'National Institute of Allergy and Infectious Diseases', u'UniQuest Pty Ltd', u'Cangene Corp', u'Nanotherapeutics Inc', u'SRI International', u'Apath LLC', u'Organix Inc', u'Duke-NUS Graduate Medical School', u'InViragen LLC', u'Guangdong Medicine Group Corp', u'SEEK', u'National Institute of Neurological Disorders and Stroke', u'Interferon Sciences Inc', u'Johns Hopkins Bloomberg School of Public Health', u'Acuvax Ltd', u'Georgetown University Medical Center', u'Merck & Co Inc', u'GenoMed Inc', u'Centro De Investigaci\\xf3n Y Asistencia En Tecnolog\\xeda Y Dise\\xf1o Del Estado De Jalisco Ac(Ciatej Ac)', u'OMRIX Biopharmaceuticals SA', u'Gen-Probe Inc', u'Novartis Diagnostics', u'Centers for Disease Control and Prevention', u'University of Washington', u'Mount Sinai Hospital', u'Science Applications International Corp', u'The Vaccine and Gene Therapy Institute of Florida', u'OPKO Health Inc', u'US Army Medical Research Institute of Infectious Diseases', u'Evolva SA', u'MacroGenics Inc', u'National University of Singapore', u'Duke University', u'Scripps Research Institute', u'Asembia', u'Plex Pharmaceuticals', u'Washington University in St Louis', u'Canadian Department of National Defence', u'Netherlands Vaccine Institute', u'Agency For Science Technology & Research', u'Crucell NV', u'Scientific Products Pharmaceutical Co LTD', u'Replikun Biotech Pty Ltd', u'Hawaii Biotech Inc', u'Hemispherx Biopharma Inc', u'RecipharmCobra Biologics', u'SG Austria', u'Vybion Inc', u'Kineta Inc', u'Northeastern University', u'Oregon Health Sciences University', u'St Louis University', u'Acambis plc', u'BioCryst Pharmaceuticals Inc']), u'Tourettesyndrome': set([u'Hannover Medical School', u'Layton Bioscience Inc', u'Lundbeck Inc', u'Therapix Biosciences Ltd', u'Saniona ApS', u'Bristol-Myers Squibb Co', u'Biovail Corp', u'NeuroSearch A/S', u'Yale University', u'Cambridge Laboratories Ltd', u'Rafa Laboratories Ltd', u'Tourette Syndrome Association Inc', u'Intra-Cellular Therapies Inc', u'Psyadon Pharmaceuticals Inc', u'University of South Florida']), u'Trisomy': set([u'LifeCodexx AG', u'Sequenom Inc']), u'LongQTsyndrome': set([u'Transgenomic Inc', u'National Heart Lung and Blood Institute', u'Mayo Clinic Foundation', u'Laboratory Corp Of America Holdings Inc', u'Massachusetts General Hospital', u'AliveCor Inc']), u'Respiratorydistresssyndrome': set([u'US Government', u'Baxter International Inc', u'DarPharma Inc', u'IL Therapeutics Inc', u'European Commission', u'Aeolus Pharmaceuticals Inc', u'Forest Laboratories Inc', u\"Cincinnati Children's Hospital Medical Center\", u'Chiesi Farmaceutici SpA', u'North Carolina State University', u'Savient Pharmaceuticals Inc', u'Arizona State University', u'University of Saskatchewan', u'University of Pittsburgh', u'Cell Biologics Inc', u'Celldex Therapeutics Inc', u'Cortech Inc', u'InSymbiosis Discovery Inc', u'Defiante Farmaceutica Lda', u'Lombard Life Sciences', u'Chiesi USA Inc', u'Relief Therapeutics Holding AG', u'Battelle', u'Serendex Pharmaceuticals A/S', u'Faron Pharmaceuticals Ltd', u'Sankyo Co Ltd', u'Handok Inc', u'Temple University', u'Hisamitsu Pharmaceutical Co Inc', u'Eukarion Inc', u'INO Therapeutics Inc', u'National Heart Lung and Blood Institute', u'Technology Strategy Board', u'Orient Europharma', u'Suntory Ltd', u'SS Pharmaceutical - ethical drug division', u'New Alliance Pharmaceuticals Inc', u'Zeria Pharmaceutical Co Ltd', u'National Cancer Institute', u'Repligen Corp', u'Wayne State University', u'BioMarck Pharmaceuticals Ltd', u'UK Ministry of Defence', u'Quintiles Transnational Corp', u'Navigen Inc', u'Windtree Therapeutics Inc', u'University of Colorado System', u'Glaxo Group Ltd', u'Altor BioScience Corp', u'LG Chem Ltd', u'Encysive Pharmaceuticals Inc', u'Recordati SpA', u'Ortho Pharmaceutical Corp', u'Healios KK', u'Genentech Inc', u'Ony Inc', u'Lung Biotechnology Inc', u'Advanced Life Sciences Holdings Inc', u'Revotar Biopharmaceuticals AG', u'Johnson & Johnson', u'Undisclosed', u'ImmuneRegen BioSciences Inc', u'Scripps Research Institute', u'Cell and Gene Therapy Catapult', u'Eli Lilly & Co', u'Dompe Farmaceutici SpA', u'Medinox Inc', u'HealthLinx Ltd', u'United Therapeutics Corp', u'RegeneRx Biopharmaceuticals Inc', u'Kissei Pharmaceutical Co Ltd', u'China Medical System Holdings Ltd', u'PaxVax Inc', u'Pfizer Inc', u'Asubio Pharma Co Ltd', u'Ares-Serono Inc', u'US Department of Defense', u'Pneuma Partners LLC', u'Bachem Holding AG', u'BioLineRx Ltd', u'Purdue University', u'Samaritan Pharmaceuticals Inc', u'Savara Inc', u'Universities of Giessen and Marburg Lung Center', u'Laboratorios Dr Esteve SA', u'Ben-Gurion University Of The Negev', u'Glycomed Inc', u'Dendreon San Diego LLC', u'Walter Reed Army Institute of Research', u'National Institutes of Health', u'Food and Drug Administration', u'University of Rochester', u'National Institute on Alcohol Abuse and Alcoholism', u'Astellas Pharma Inc', u'Nobelpharma Co Ltd', u'3-Dimensional Pharmaceuticals Inc', u'P2D Biosciences', u'diaDexus Inc', u'Athersys Inc', u'Hoechst Marion Roussel Inc', u'Pacgen Life Science Corp', u'Henry Ford Health Science Center', u'BioCryst Pharmaceuticals Inc']), u'Peritonitis': set([u'Curetis AG', u'Roche Holding AG', u'Ambiotis SAS', u'Human Genome Sciences Inc', u'Probiodrug AG', u'Biotest AG']), u'Testosteronedeficiency': set([u'Solvay SA', u'Paladin Labs Inc', u'Acerus Pharmaceuticals Corp', u'GTx Inc', u'Actavis Inc', u'Bayer Schering Pharma AG', u'Viramal Limited', u'Bayer Inc', u'Ipsen', u'IASO Biomed Inc', u'Merck & Co Inc', u'Solvay Pharmaceuticals Inc', u'ICOS Corp', u'The Procter & Gamble Co', u'McGill University', u'Par Pharmaceutical Co Inc', u'PT Kalbe Farma Tbk', u'ANI Pharmaceuticals Inc', u'Aptys Pharmaceuticals SAS', u'Laboratoires Besins International', u'Orexo AB', u'Adamis Pharmaceuticals Corp', u'Endo International plc', u'Population Council', u'Kyowa Kirin', u'Custopharm Inc', u'Watson Laboratories Inc', u'Perrigo Co plc', u'Zydus Cadila Healthcare Ltd', u'Auxilium Pharmaceuticals Inc', u'Antares Pharma Inc']), u'Hypertrophiccardiomyopathy': set([u'Stem Cell Theranostics Inc', u'MyoKardia Inc', u'Beth Israel Deaconess Medical Center', u'National Science Foundation', u'Sanofi', u'Therapeutics for Rare and Neglected Diseases']), u'Livercirrhosis': set([u'Daiichi Seiyaku Co Ltd', u'Bachem Holding AG', u'University of North Carolina', u'Fundaci\\xf3n Cient\\xedfica De La Asociaci\\xf3n Espa\\xf1ola Contra El C\\xe1ncer', u'National Institutes of Health', u'Conatus Pharmaceuticals Inc', u'Regience KK', u'University of Newcastle', u'Mitsubishi Pharma Corp', u'Koken Co Ltd', u'Korea Drug Development Fund', u'Kureha Corp', u'Nitto Denko Corp', u'Aeolus Pharmaceuticals Inc', u'Amsterdam Molecular Therapeutics BV', u'Allergan plc', u'Novartis AG', u'Kos Pharmaceuticals Inc', u'PharmaIN Ltd', u'Sumitomo Dainippon Pharma Co Ltd', u'Bristol-Myers Squibb Co', u'Massachusetts General Hospital', u'Institute for Research in Biomedicine Barcelona', u'Universita degli Studi di Roma La Sapienza', u'IMPAX Laboratories Inc', u'BIOCND', u'Galectin Therapeutics Inc', u'ALZA Corp', u'Sosei Group Corp', u'Exalenz Bioscience Ltd', u'Undisclosed', u'University of Georgia', u'Toray Industries Inc', u'Sanofi', u'Shire Orphan Therapies GmbH', u'BioVie Inc', u'National Institute of Biomedical Innovation', u'Digna Biotech SL', u'Asan Medical Center', u'Intarcia Therapeutics Inc', u'Takara Shuzo Co Ltd', u'Osaka University']), u'Oculartumor': set([u'VIB', u\"St Jude Children's Research Hospital\", u'University of North Carolina', u'InSite Vision Inc', u'National Human Genome Research Institute', u'Oraya Therapeutics Inc', u'National Institutes of Health', u'Massachusetts Eye & Ear Infirmary', u'IMCOR Pharmaceutical Co', u'Dana-Farber Cancer Institute Inc', u'Rijksuniversiteit te Leiden', u'Vernalis plc']), u'Mantlecelllymphoma': set([u'MENTRIK Biotech LLC', u'National Comprehensive Cancer Network', u'Tensha Therapeutics Inc', u'Genentech Inc', u'Incyte Corp', u'CryoPort Inc', u'Genmab A/S', u'Clayton Biotechnologies Inc', u'Cancer Genetics Inc', u'Veristat, Inc.', u'Pharsight Corp', u'Daiichi Sankyo Co Ltd', u'H Lee Moffitt Cancer Center and Research Institute', u'Biogen Inc', u'Pharmacyclics Inc', u'Southern Research Institute', u'Angelica Therapeutics Inc', u'GlaxoSmithKline plc', u'Oxford BioMedica plc', u'Onconova Therapeutics Inc', u'National Cancer Institute', u'Bayer Schering Pharma AG', u'Undisclosed', u'US Government', u'Cellectar Biosciences Inc', u'Hackensack University Medical Center', u'ImmunoCellular Therapeutics Ltd', u'Merck & Co Inc', u'Beth Israel Medical Center', u'Lypro Biosciences Inc', u'Scripps Research Institute', u'I N C Research LLC', u'Presage Biosciences', u'Avicin Therapeutics Ltd', u'US Oncology Inc', u'Eli Lilly & Co', u'Columbia University Medical Center', u'Fred Hutchinson Cancer Research Center', u'Takeda Oncology', u'Memgen LLC', u'Immunomedics Inc', u'Janssen Pharmaceutical KK', u'Sevion Therapeutics Inc', u'Seattle Cancer Care Alliance', u'Piramal Enterprises Ltd', u'Pretoria East Hospital', u'Antisoma plc', u'Kite Pharma Inc', u'Millennium Pharmaceuticals Ltd', u'TESARO Inc', u'WuXi PharmaTech (Cayman) Inc', u'BeiGene Co Ltd', u'Novartis AG', u'TG Therapeutics Inc', u'Groote Schuur Hospital', u'Dana-Farber Cancer Institute Inc', u'Sanofi', u'The Gladstone Institute of Cardiovascular Disease', u'Medarex Inc', u'Lymphoma Research Foundation', u'Xynomic Pharmaceuticals']), u'Cushingsdisease': set([u'ChemDiv Inc', u'Aspireo Pharmaceuticals Ltd', u'National Institutes of Health', u'AstraZeneca plc', u'Interprotein Corp', u'Yale University', u'Food and Drug Administration', u'University of Sheffield', u'Ipsen', u'Bristol-Myers Squibb Co', u'Cortendo AB', u'University of Oxford', u'HRA Pharma', u'Diurnal Ltd']), u'Restlesslegssyndrome': set([u'Axxonis Pharma AG', u'Orion Corporation', u'Eisai Co Ltd', u'SmithKline Beecham plc', u'Ligand Pharmaceuticals Inc', u'BL&H Co Ltd', u'Bayer Schering Pharma AG', u'Undisclosed', u'Samil Pharmaceutical Co Ltd', u'Teva Pharmaceutical Industries Ltd', u'InterLab Pharmaceutica', u'RIMSA Laboratorios', u'GlaxoSmithKline plc', u'UCB Pharma GmbH', u'Lohmann Therapie-Systeme GmbH & Co KG', u'Recordati SpA', u'IMPAX Laboratories Inc', u'Pharmacia Corp', u'Astellas Pharma Inc', u'Roche Holding AG', u'UCB SA', u'Jazz Pharmaceuticals plc', u'Axim Biotechnologies Inc', u'Neurogen Corp', u'XenoPort Inc', u'Aderis Pharmaceuticals Inc', u'Prestwick Pharmaceuticals Inc', u'Pfizer Inc', u'Asubio Pharma Co Ltd', u'Novartis AG', u'Kyowa Hakko Kogyo Co Ltd', u'Omeros Corp', u'Seelos Therapeutics Inc', u'Swedish Orphan Biovitrum AB', u'Boehringer Ingelheim Corp', u'Antares Pharma Inc']), u'Neuritis': set([u'Rijksuniversiteit te Groningen', u'Netherlands Cancer Institute', u'Leiden University (NL)', u'Washington University in St Louis', u'Vanderbilt University', u'AC Immune SA', u'Consiglio Nazionale delle Ricerche', u'University of Dundee', u'University Medical Center Groningen', u'Essex Bio-Technology Ltd']), u'Stomachdisease': set([u'Third Military Medical University of the Chinese PLA', u'Takeda Pharmaceutical Co Ltd', u'Biohit OYJ', u'Taisho Pharmaceutical Co Ltd', u'Biohit Healthcare Ltd', u'Wuhu Kang Wei Biotechnology Co Ltd']), u'Microsporidialinfection': set([u'Tulane University', u'National Center for Research Resources']), u'Mucorinfection': set([u'Unimedic AB', u'Pfizer Inc', u'Biotoscana International', u'Basilea Pharmaceutica International Ltd', u'Sumitomo Pharmaceuticals Co Ltd', u'NeXstar Pharmaceuticals Inc', u'Hikma Pharmaceuticals plc', u'Asahi Kasei Pharma Corp']), u'Anesthesia': set([u'Roche Holding AG', u'Terumo Corp', u'Pierrel SpA', u'Hana Pharm Co Ltd', u'MGI GP Inc', u'Retina Vitreous Associates, P.C.', u'Piramal Enterprises Ltd', u'Instituto Invest y Desarrollo Quimico-Biologico SA', u'Aspen PharmaCare Holdings Ltd', u'Centre Hospitalier Universitaire D Amiens', u'Orion Corporation', u'SkyePharma Canada', u'Life-Tech. Inc.', u'ProQuest Pharmaceuticals Inc', u'Abbott Laboratories', u'Endo Health Solutions Inc', u'NovaDel Pharma Inc', u'Rivanna Medical Llc', u'Dainabot KK', u'GlaxoSmithKline plc', u'CRH Medical Corp', u'Sumitomo Dainippon Pharma Co Ltd', u'UCB Celltech', u'Faraday Pharmaceuticals Inc', u'Cosmo Pharmaceuticals SpA', u'Cardiome Pharma Corp', u'Vance Thompson Vision', u'Baxter Healthcare Corp', u'Wyeth', u'Aspen Global Incorporated', u'US Government', u'Puget Sound Gastroenterology', u'Central Admixture Pharmacy Services', u'SkyePharma plc', u'PAION AG', u'Merck & Co Inc', u'OAO \"Akrikhin\"', u'BioSyent Inc', u'Hana Biologics Inc', u'Massachusetts General Hospital', u'Zenyth Therapeutics Ltd', u'Innoviva Inc', u'Hospira Inc', u'Zeneca Group plc', u'Ono Pharmaceutical Co Ltd', u'Annovation Biopharma Inc', u'Astellas Pharma Inc', u'Codonics Inc', u'CeNeS Pharmaceuticals plc', u'Maruishi Pharmaceutical Co Ltd', u'Bridge Pharmaceuticals Inc', u'Primex Pharmaceuticals AG', u'Purdue Pharma LP', u'Immune Response BioPharma Inc', u'Imprimis Pharmaceuticals Inc', u'Plexus Technology Group LLC', u'R-Pharm', u'Glaxo Group Ltd', u'Janssen Pharmaceutica NV', u'Anaquest Inc', u'CeNeS Pharmaceuticals Inc', u'AstraZeneca plc', u'Kimberly-Clark Worldwide Inc', u'Nanomedex LLC', u'Phosphagenics Ltd', u'Laboratories UPSA', u'TG Therapeutics Inc', u'Montavit', u'Abraxis BioScience Inc', u'Pfizer Inc', u'BD Technologies', u'Vertec Scientific Ltd', u'Vyrex Corp', u'UCB SA', u'Akorn Inc', u'Advicenne Pharma', u'National Institute of General Medical Sciences']), u'Androgendeficiency': set([u\"Brigham & Women's Hospital\", u'Eli Lilly & Co', u'Transition Therapeutics Ireland Ltd']), u'Clostridiumdifficileinfection': set([u'Oscient Pharmaceuticals Corp', u'US Government', u'Royal DSM NV', u'Mediphos', u'Ceragenix Pharmaceuticals Inc', u'Massachusetts Biologic Laboratories', u'Matrivax Research & Development Corp', u'Iroko Pharmaceuticals LLC', u'ImmuCell Corp', u'Univ Massachusetts', u'ViroPharma Inc', u'Eddingpharm Inc', u'Novacta Biosystems Ltd', u'Immuron Ltd', u'EMM Life Science AB', u'MedImmune LLC', u'Hawker Resources Inc', u'Par Pharmaceutical Co Inc', u'Welsh Assembly Government', u'Leiden University Medical Center', u'University of Texas Health Science Center Houston', u'OBI Pharma Inc', u'Stellar Biotechnologies Inc', u'BioSavita Inc', u'AB ANALITICA', u'Specialised Therapeutics Australia Pty Ltd', u'University of Leicester', u'Intercell AG', u'Sorrento Therapeutics Inc', u'Merckle GmbH', u'Optimer Pharmaceuticals Inc', u'Emory University', u'Glasgow University', u'Scripps Research Institute', u'Immunome Inc', u'Da Volterra', u'Tramedico International', u'University of Nottingham', u'McMaster University', u'Amgen Inc', u'Romark Laboratories LC', u'Medarex Inc', u'Novartis AG', u'ActoGeniX NV', u'MicroPharm Ltd', u'Catholic University of Leuven', u'Medical Research Council', u'Lilly China Research & Development Co Ltd', u'Merus Labs International Inc', u'Monash University', u'AvidBiotics Corp', u\"Queen's University at Kingston\", u'Summit Therapeutics plc', u'TechLab Therapeutics LLC', u'Atlantic Canada Opportunities Agency', u'University of Guelph', u'ENTEROME Bioscience SA', u'NovoBiotic Pharmaceuticals LLC', u'OstriGen Inc', u'Wellcome Trust', u'Universite Denis Diderot', u'KamTek Inc', u'AmpliPhi Biosciences Corp', u'Bestbion dx', u'Biosynex', u'Health Protection Agency', u'University of Maryland Baltimore County', u'Genepoc Inc', u'University of North Texas', u'Biosearch Italia SpA', u'SRI International', u'Massachusetts Institute of Technology', u'Sequella Inc', u'Merck & Co Inc', u'Near Patient Diagnostics Ltd', u'Hospital Bichat Claude Bernard', u'Nanotherapeutics Inc', u'Ilypsa', u'Laboratorios Columbia SA de CV', u'Southwest Research Institute (SwRI)', u'Australian Research Council', u'Eli Lilly & Co', u'Centers for Disease Control and Prevention', u'Prokarium', u'University of Wisconsin-Madison', u'University of Western Australia', u'Welsh Government', u'Fannin Ltd', u'University of Virginia', u'Seres Therapeutics Inc', u'Meridian Bioscience Inc', u'Cubist Pharmaceuticals Inc', u'AstraZeneca plc', u'Technology Strategy Board', u'Astra Formedic s.r.l.', u'Mobidiag Oy', u'Synthetic Biologics Inc', u'Progenics Pharmaceuticals Inc', u'Institute for the Promotion of Innovation by Science and Technology in Flanders', u'Acambis plc', u'University of Arizona', u'Immunobiology Ltd', u'Baylor College of Medicine', u'Australian Government', u'Intrexon Corp', u'Arietis Corp', u'Pharmascience Inc', u'Mapp Biopharmaceutical Inc', u'Vedanta Biosciences Inc', u'National Institute of Allergy and Infectious Diseases', u'East of England Development Agency', u'Alfa Wassermann SpA', u'Institut Gustave Roussy', u'Appili Therapeutics Inc', u'Max-Planck-Gesellschaft', u'Nestle Health Science', u'University of Strathclyde', u'National Institutes of Health', u'Vitro S.A.B. de C.V', u'Sanofi Genzyme', u'Boulos & Cooper Pharmaceuticals Pty Ltd', u'Thomas Jefferson University', u'Astellas Pharma Inc', u'Berlin Free University', u'Virginia Polytechnic Institute and State University', u'OpenBiome', u'MGB Biopharma Ltd', u'Finch Therapeutics', u'GLSynthesis Inc', u'Hines VA Hospital', u'Excelimmune Inc', u'Beth Israel Deaconess Medical Center', u'DiaSorin Inc', u'Prev AbR LLC']), u'Musculoskeletalinjury': set([u'Ceremed Inc', u'CTC Bio Inc', u'Maxx Orthopedics Inc', u'Takeda Pharmaceuticals International GmbH', u'US Department of Defense', u'Endevr Llc', u'The European Union', u'Unigene Laboratories Inc', u'Compass Healthcare Advisers', u'Antibe Therapeutics Inc', u'Medipost Co Ltd', u'RTI Surgical Inc', u'Smith & Nephew plc', u'Xtant Medical Holdings Inc', u'Bone Therapeutics SA', u'St Michaels Hospital', u'Musculoskeletal Transplant Foundation', u'TiGenix NV', u'Genpharm Services', u'Ferring Pharmaceuticals SA', u'TOLMAR Therapeutics Inc', u'Kuros Biosurgery AG', u'MIV Therapeutics Inc', u'NovaThera Ltd', u'Athersys Inc', u'Mor Research Applications Ltd', u'Pfizer Inc', u'Sites Medical', u'Induce Biologics Inc', u'ProChon Biotech Ltd', u'Invibio Ltd', u'Ryerson University', u'Jingyuan Bio-Tech Ltd', u'Yale University', u'DePuy Synthes Companies', u'Synthes (USA)', u'Swedish Orphan Biovitrum AB', u'XTL Biopharmaceuticals Ltd', u'Pharming Group NV']), u'Molluscumcontagiosuminfection': set([u'National Institute of Allergy and Infectious Diseases', u'University of Pennsylvania', u'University of Aberdeen', u'Fox Chase Chemical Diversity Center Inc', u'Kyowa Kirin']), u'Fibrocysticbreastdisease': set([u'Symbollon Pharmaceuticals Inc', u'Laboratoires Besins International', u'BHR Pharma LLC', u'Integra Labs Inc', u'ASCEND Therapeutics Inc', u'Mimetix Inc']), u'Mildcognitiveimpairment': set([u'C2N Diagnostics', u'US Government', u'Solvay SA', u'Tetra Discovery Partners LLC', u'CereSpir Inc', u'Centre for Drug Research and Development', u'Djavad Mowafaghian Centre for Brain Health', u'NYU Langone Medical Center', u'Molecular Neuroimaging LLC', u'Chiesi Farmaceutici SpA', u'TG United', u'Ramot at Tel Aviv University Ltd', u'DiaGenic ASA', u'DiamiR LLC', u'Theratechnologies Inc', u'Foundation for the National Institutes of Health', u'Beryllium Discovery Corp', u'Affymetrix Inc', u'Navidea Biopharmaceuticals Inc', u'Bayer AG', u'Therapix Biosciences Ltd', u'Cytox Ltd', u'Caprion Biosciences Inc', u'Yissum Research Development Co', u'West Virginia University', u'Cerveau Technologies Inc', u'GE Healthcare', u'Laboratoires Besins International', u'Washington University in St Louis', u'Imanova Ltd', u'Technology Strategy Board', u'National Institute on Aging', u'Ferrer Internacional SA', u'Emory University', u'Synthetic Biologics Inc', u'Cognition Therapeutics Inc', u'Orient Europharma', u'Avid Radiopharmaceuticals Inc', u'GenOmind LLC']), u'Retinoblastoma': set([u'Icon Bioscience Inc', u'National Cancer Institute', u'National Human Genome Research Institute', u'Astellas Pharma Inc', u'VCN Biosciences SL', u\"Children's Hospital of Los Angeles\", u'University of North Carolina', u'RXi Pharmaceuticals Corp', u'Memorial Sloan-Kettering Cancer Center', u'Ministerio de Economia y Competitividad']), u'Respiratorydisorder': set([u'CollaGenex Pharmaceuticals Inc', u'Evotec AG', u'University of California', u'US Government', u'PharmaPatents Global Ltd', u'Elan Corp plc', u'Dreamtech Co Ltd', u'GeneData AG', u'BRK Inc', u'RespireRx Pharmaceuticals Inc', u'Acerus Pharmaceuticals Corp', u'Numedicus Ltd', u'Innovata plc', u'Laboratorios Dr Esteve SA', u'NovaMed Pharmaceuticals Inc', u'GlaxoSmithKline plc', u'MacroGenics Inc', u'Chiesi Farmaceutici SpA', u'X-Chem Inc', u'IR Pharma Ltd', u'Undisclosed', u'Synthetic Biologics Inc', u'University of Maryland', u'University of Alberta', u'Aerogen Inc', u'GeNO LLC', u'Biovail Laboratories International Srl', u'Hmicro Inc', u'Ligand Pharmaceuticals Inc', u'Ogeda SA', u'BioFocus DPI', u'NanoSystems LLC', u'INSERM Transfert', u\"Lee's Pharmaceutical Holdings Limited\", u'Monash University', u'Mitovie Pharma Ltd', u'Genaera Corp', u'UCB SA', u'Seelos Therapeutics Inc', u'Alchemia Ltd', u'Symbollon Pharmaceuticals Inc', u'Medeva plc', u'Windtree Therapeutics Inc', u'Battelle', u'Meda AB', u'NiKem Research Srl', u'Ludwig Institute for Cancer Research', u'Activaero GmbH', u'Eurodrug Laboratories', u'GE Healthcare', u'Bas Rutten LLC', u'BioCide Pharma Inc', u'MedImmune LLC', u'Almirall Prodesfarma SA', u'AMO Pharma Ltd', u'AstraZeneca plc', u'Pfizer Inc', u'Bayer HealthCare AG', u'Boehringer Ingelheim Corp', u'Dyax Corp', u'BCY LifeSciences Inc', u'Beijing CoSci Med-Tech Co Ltd', u'St Elizabeths Medical Center of Boston Inc', u'Canadian Microbiology Consortium Inc (CMCI)', u'Pieris Pharmaceuticals Inc', u'Hybio Pharmaceutical Co Ltd', u'Debiopharm SA', u'Dr Lo Zambeletti SpA', u'TSI Inc']), u'Resistanthypertension': set([u'Sanford-Burnham Medical Research Institute', u'Recor Medical Inc', u'Otsuka Holdings Co Ltd', u'GlaxoSmithKline plc']), u'Amyloidosis': set([u'US Government', u'National Institute of Arthritis and Musculoskeletal and Skin Diseases', u'Advanced Life Sciences Holdings Inc', u'Mayo Clinic Foundation', u'Pharsight Corp', u'BELLUS Health Inc', u'GlaxoSmithKline plc', u'Argonne National Laboratory', u'National Institutes of Health', u'Food and Drug Administration', u'Ionis Pharmaceuticals Inc', u'University of California', u'Sanofi Genzyme', u'University of California San Francisco', u'Lipomed AG', u'Prothena Corp plc', u'Malin Corp plc', u'CASI Pharmaceuticals Inc', u'Arbutus Biopharma Corp', u'Dr Rentschler Biotechnologie GmbH', u'Celgene Corp', u'Pentraxin Therapeutics Ltd', u'Takeda Oncology', u'Dendreon Corp', u'Janssen Pharmaceutical KK', u'Immune Response BioPharma Inc', u'ProteoTech Inc', u'Kinexis Inc', u'Kiacta S\\xe0rl', u'Parke-Davis & Co', u'Wren Therapeutics Limited', u'Alnylam Pharmaceuticals Inc', u'Royalty Pharma', u'F Hoffmann-La Roche AG']), u'Uterinehemorrhage': set([u'Biopasgroup', u'World Health Organization', u'Meditrina Pharmaceuticals Inc', u'Novartis AG', u'Wayne State University', u'Torrent Pharmaceuticals Ltd', u'Aspen PharmaCare Holdings Ltd', u'Ferring Pharmaceuticals SA', u'Merck & Co Inc', u'ANI Pharmaceuticals Inc']), u'Sporadicinclusionbodymyositis': set([u'Parent Project Muscular Dystrophy', u\"Nationwide Children's Hospital\", u'University of Kansas Medical Center', u'Food and Drug Administration']), u'Leishmaniadonovaniinfection': set([u'Council of Scientific and Industrial Research (India)', u'Advinus Therapeutics Ltd', u'University of Antwerp', u'SCYNEXIS Inc', u'Drugs for Neglected Diseases Initiative', u'Knight Therapeutics Inc', u'GlaxoSmithKline plc', u'Bill & Melinda Gates Foundation', u'SVKMs NMIMS', u'London School of Hygiene and Tropical Medicine', u'NeXstar Pharmaceuticals Inc', u'Zydus-Cadila Group', u'WuXi PharmaTech (Cayman) Inc', u'Celgene Corp', u'Walter Reed Army Institute of Research', u'Sumitomo Pharmaceuticals Co Ltd', u'Astellas Pharma Inc', u'Infectious Disease Research Institute', u'French Development Agency', u'University of Auckland', u'Chembio Diagnostic Systems Inc', u'Anacor Pharmaceuticals Inc', u'Institut Pasteur', u'Sandexis LLP', u'Institut de Recherche pour le Developpement (IRD)', u'Pfizer Inc', u'Osaka University', u'Gilead Sciences Inc', u'The Global Alliance for TB Drug Development']), u'Ichthyosis': set([u'Patagonia Pharmaceuticals LLC', u'Monash University', u'Almirall Prodesfarma SA', u'Ferrer Internacional SA', u'Barrier Therapeutics Inc', u'Arexis AB', u'Dermadis SAS', u'Factor Therapeutics Ltd', u'Med Discovery SA', u'VINNOVA']), u'Acutemyelogenousleukemia': set([u'Quest Diagnostics Inc', u'CarthaGenetics', u'Archemix Corp', u'European Commission', u'US Health and Human Services Department', u'Champions Oncology Inc', u'Asuragen Inc', u'Inovio Pharmaceuticals Inc', u'Pulsalys Inc', u'Cure Medical Manufacturing', u'MethylGene Inc', u'Bellicum Pharmaceuticals Inc', u'Orphan Europe SARL', u'Guangzhou Esa Biotech Co Ltd', u'Allyence Research Inc', u'Cellectis SA', u'Universita Degli Studi Di Perugia', u'PacificGMP', u'National Research Council of Canada', u'Sigma-Tau Ind Farm Riunite SpA', u'Weill Medical College of Cornell University', u'Tensha Therapeutics Inc', u'Israeli Government', u'The University of Aston In Birmingham', u'MABLife', u'Weill Cornell Medical College, USA', u'Acetylon Pharmaceuticals Inc', u'Medac GmbH', u'Juvaris BioTherapeutics Inc', u'Chinese Government', u'EpiCept Corp', u'Errant Gene Therapeutics LLC', u'Hefei Co-Source Pharmaceuticals Co Ltd', u'ImmunoGen Inc', u'Cleveland Clinic Foundation', u'Navigate BioPharma Services Inc', u'MegaPharm Ltd', u'Crystal Pharmatech Co Ltd', u'Altor BioScience Corp', u'National Health Research Institutes', u'CHEPLAPHARM Arzneimittel GmbH', u'F H Faulding & Co Ltd', u'The American Society of Hematology', u'Sentinel Oncology Ltd', u'Areva Med LLC', u'Onconova Therapeutics Inc', u'Undisclosed', u'4P Pharma', u'Sprint Bioscience', u'LEO Pharma A/S', u'Vion Pharmaceuticals Inc', u'CTI BioPharma Corp', u'Eli Lilly & Co', u'Proteros Biostructures GmbH', u'Immune Pharmaceuticals Inc', u'CSL Ltd', u'Actinium Pharmaceuticals Inc', u'Madrigal Pharmaceuticals Inc', u'Sunesis Pharmaceuticals Inc', u'University of Cincinnati', u'The Gladstone Institute of Cardiovascular Disease', u'Johnson & Johnson', u'Innate Pharma SA', u'AbbVie Inc', u'Peter MacCallum Cancer Centre', u'Pfanstiehl Laboratories Inc', u'BL&H Co Ltd', u'BioMed Valley Discoveries', u'Aptamera Inc', u'Stand Up To Cancer', u'Bristol-Myers Squibb Co', u'Evotec (UK) Ltd', u'Chinese Academy of Sciences', u'ConverGene LLC', u'Janssen Research & Development LLC', u'Victorian Cancer Agency', u'Institut Gustave Roussy', u'Astellas Pharma Inc', u'AltaRex Medical Corp', u'Antisoma plc', u'Meda AB', u'Hebrew University of Jerusalem', u'Gamida Cell Ltd', u'Cancer Prevention and Research Institute of Texas', u'DRI Capital', u'Pint Pharma', u'Karolinska Institutet', u'University of South Australia', u'Southeast TechInventures Inc', u'Anjin Group Inc', u'Pertinax Therapeutics Inc', u'Incyte Corp', u'Eutropics Pharmaceuticals Inc', u'Celator Pharmaceuticals Inc', u'Ministerio de Economia y Competitividad', u'Chiron Corp', u'University Of Southampton', u'US Department of Veterans Affairs', u'MaxCyte Inc', u'Astex Pharmaceuticals Inc', u'Senz Oncology Pty Ltd', u'Vernalis plc', u'Veristat, Inc.', u'University of Pennsylvania', u'The University Health Network', u'Dutch-Belgian Cooperative Trial Group for Hematology Oncology', u'Mateon Therapeutics Inc', u'Touchstone Innovations Plc', u'Shire plc', u'Biocompatibles International plc', u'ANI Pharmaceuticals Inc', u'VIB', u'Selvita SA', u'Invenio Therapeutics Inc', u'Agios Pharmaceuticals Inc', u'CellProtect Nordic Pharmaceuticals AB', u'Dana-Farber Cancer Institute Inc', u'Biokine Therapeutics Ltd', u'National Institute of General Medical Sciences', u'Evotec AG', u'Exelixis Inc', u'Lin Bioscience Inc', u'Regenacy Pharmaceuticals LLC', u'Wyeth Research', u'Amgen Inc', u'Berlin-Chemie AG', u'Ohio State University', u'Dermin Spzoo', u'CircaGen Pharmaceutical', u'Zeneus Pharma Ltd', u'Johns Hopkins University School of Medicine', u'ZIOPHARM Oncology Inc', u'Prometrika LLC', u'British Canadian Biosciences Corp', u'Janssen Pharmaceutical KK', u'Pennsylvania State University', u'Allergan Inc', u'Biosuccess Biotech Co', u'The Research Council of Norway', u'Pharmion Corp', u'TetraLogic Pharmaceuticals Corp', u'Xencor Inc', u'Ichor Therapeutics', u'BioTheryX Inc', u'Salzburg Therapeutics Inc', u'F Hoffmann-La Roche AG', u'University of Oxford', u'Cancer Research UK', u'Stanford University', u'PJSC Pharmsynthez', u'DCPrime BV', u'Rigel Pharmaceuticals Inc', u'LifeArc', u'william lawrence and blanche hughes foundation', u'Xenetic Biosciences Inc', u'NerPharMa Srl', u'PDL BioPharma Inc', u'Scripps Research Institute', u'Cell and Gene Therapy Catapult', u'University of Southern California', u'CASI Pharmaceuticals Inc', u'ProQinase GmbH', u'Genus Oncology LLC', u'MolMed SpA', u'BioLineRx Ltd', u'AstraZeneca plc', u'Methuselah Foundation', u'Agensys Inc', u'Estero-Anstalt', u'Race Oncology Ltd', u'Skyline Diagnostics', u'Tolero Pharmaceuticals Inc', u'Albany College Of Pharmacy', u'University of Halle', u'Genmab A/S', u'Nerviano Medical Sciences Srl', u'Ligand Pharmaceuticals Inc', u'Critical Outcome Technologies Inc', u'Aqualis ASA', u'Moleculin Biotech Inc', u'Aronex Pharmaceuticals Inc', u'Medical University of South Carolina', u'Karyopharm Therapeutics Inc', u'P2D Biosciences', u'Ohio State University Comprehensive Cancer Center', u'Walter and Eliza Hall Institute of Medical Research', u'Laboratory Corporation of America Holdings', u'Takeda Pharmaceutical Co Ltd', u'TopoTarget A/S', u'CuraGen Corp', u'National Comprehensive Cancer Network', u'University of Florida', u'Deltagen Inc', u'Industrial Technology Research Institute', u'Oryzon Genomics SA', u'SGX Pharmaceuticals Inc', u'Rasna Therapeutics Inc', u\"Alex's Lemonade Stand Foundation\", u'OSI Pharmaceuticals Inc', u'Leiden University Medical Center', u'Fred Hutchinson Cancer Research Center', u'Cellerant Therapeutics Inc', u'Olon SpA', u'ARIAD Pharmaceuticals Inc', u'Kite Pharma Inc', u'Aravive Biologics Inc', u'University of Kentucky', u'Diffregen LLC', u'Konruns Pharmaceutical Co Ltd', u'Signal Research Division', u'AnnaMed Inc', u'TrovaGene Inc', u'National Center For Advancing Translational Sciences', u'Novellusdx Ltd', u'Kanebo KK', u'Cancer Genetics Inc', u'Harvard University', u'Hyundai Hope on Wheels Foundation', u'Stragen Group', u'CMIC ASIA-PACIFIC, PTE. LTD.', u'Teva Pharmaceutical Industries Ltd', u'Warnex Laboratories', u'Oxford BioTherapeutics', u'EpiGenesis Pharmaceuticals Inc', u'Forty Seven Inc', u'Invivoscribe Technologies Inc', u'Boehringer Ingelheim Corp', u'National Cheng Kung University', u'University of Arizona', u'Fairview Health Services', u'Debiopharm SA', u'Novartis Molecular Diagnostics (MDx)', u'ILEX Oncology Inc', u'Nippon Shinyaku Co Ltd', u'IDIS Ltd', u'Stemline Therapeutics Inc', u'Institut Paoli-Calmettes IPC', u'Oxford BioMedica plc', u'Epizyme Inc', u'Zhongyuan Union Cell & Gene Engineering Corp Ltd', u'CMC Biologics Inc', u'Provid Pharmaceuticals Inc', u'Merck & Co Inc', u'The Netherlands Organisation for Health Research and Development', u'rEVO Biologics Inc', u'Sanofi', u'Columbia University', u'University of California Davis', u'Janssen Pharmaceutica NV', u'University of Geneva', u'Princeton University', u'Merus BV', u'Vector Oncology', u'Sellas Life Sciences Group', u'University of Adelaide', u'Wyeth', u'MEI Pharma Inc', u'Aptuit Inc', u'4SC AG', u'Broad Institute Inc', u'AnorMED Inc', u'Hoffmann-La Roche AG', u'Apogenix GmbH', u'Precision Oncology', u'Clinigen Group plc', u\"St Jude Children's Research Hospital\", u'Strategia Therapeutics Inc', u'Elan Corp plc', u'City of Hope', u'INSERM', u'Sanofi Genzyme', u'Columbia University Medical Center', u'Munchner Leukamie Labor GmbH', u'Cephalon Inc', u'Celgene Corp', u'TWi Pharmaceuticals Inc', u'Ascenta Therapeutics Inc', u'Duke University', u'Theradex Systems Inc', u'Crown Bioscience Inc', u'Delta-Fly Pharma Inc', u'Bayer HealthCare Pharmaceuticals Inc', u'University of Alberta', u'Bioenvision Inc', u'UCL Business PLC', u'US Government', u'University of Cologne', u'The Leukemia & Lymphoma Society', u'Baxter International Inc', u'Netherlands Government', u'Pharsight Corp', u'California Institute of Regenerative Medicine', u'GlaxoSmithKline plc', u'NantKwest Inc', u'Celltrion Inc', u'Cell Genesys Inc', u'Innovive Pharmaceuticals Inc', u'Immunex Corp', u'European Eurostars Programme', u'Dragonfly Therapeutics Inc', u'University of Michigan', u'Formula Pharmaceuticals Inc', u'Amphivena Therapeutics Inc', u'Institute of Hematology & Blood Diseases Hospital', u'Takeda Oncology', u'IriSys LLC', u'ERYtech Pharma', u'Nordic Nanovector ASA', u'National Heart Lung and Blood Institute', u'Biomas Inc', u'St Louis University', u'Philogen SpA', u'MD Anderson Cancer Center', u'Genentech Inc', u'Cell Design Labs Inc', u'Medarex Inc', u'Abbott Laboratories', u'Eisai Co Ltd', u'Nankai University', u'National Cancer Institute', u'Novartis AG', u'Khon Kaen University', u'Kyushu University', u'University of Maryland', u'Ewopharma AG', u'Protocol First', u'Kainos Medicine Inc', u'Sichuan University', u'Oncoceutics Inc', u'Aptose Biosciences Inc', u'UCB SA', u'Universitair Medisch Centrum Utrecht', u'Johns Hopkins University', u'Royalty Pharma', u'Wyeth-Ayerst International Inc', u'University of North Carolina', u'Ortho Biotech Products LP', u'Update Pharma Inc', u'Callisto Pharmaceuticals Inc', u'Medivir AB', u'Nohla Therapeutics Inc', u'Cellular Therapeutics Ltd', u'University College London', u'Biovica AB', u'ChemGenex Pharmaceuticals Ltd', u'Institute of Hematology Chinese Academy of Medical Sciences', u'University of Virginia', u'Kyowa Hakko Kirin Co Ltd', u'The Northwestern Mutual Life Insurance Company', u'Janssen Biotech Inc', u'Leukaemia and Lymphoma Research', u'Pfizer Inc', u'Cancer Therapeutics CRC Pty Ltd', u'Yissum Research Development Co', u'Memorial Sloan-Kettering Cancer Center', u'Mount Sinai Medical Center', u'Maxim Pharmaceuticals Inc', u'Paul Scherrer Institut', u'Rich Pharmaceuticals Inc', u'Zevacor Molecular', u'Selected Value Therapeutics', u'Tongji Medical College', u'MyeloRx LLC', u'University of New South Wales', u'National Institutes of Health', u'Serono Inc', u'The Menarini Group', u'Childrens Hospital of Philadelphia', u'Merck Serono SA', u'PRA Health Sciences', u'Biologics Inc', u'Baltimore VA Medical Center', u'Ipsogen SA', u'Helsinn Group']), u'Choroidalneovascularization': set([u'Leiden University Medical Center', u'Idera Pharmaceuticals Inc', u'L2 Diagnostics Llc', u'Abzyme Therapeutics LLC', u'The European Union', u'National Eye Institute', u'KalVista Pharmaceuticals Inc (Pre-merger)']), u'Coma': set([u'US Government', u'NeuroHealing Pharmaceuticals Inc']), u'Colitis': set([u'BioLineRx Ltd', u'US Government', u'Takeda Pharmaceuticals International Inc', u'CellAct Pharma GmbH', u'Zcube SRL', u'Wyeth Pharmaceuticals', u'Protagonist Therapeutics Inc', u'AbbVie Inc', u'National Institute of Diabetes, Digestive and Kidney Diseases', u'Prana Biotechnology Ltd', u'Alberta Glycomics Centre', u'Schering-Plough Corp', u'Universita degli Studi di Napoli Federico II', u'Allergan plc', u'University of Zurich', u'Elan Corp plc', u'University Hospital Tubingen', u'Scripps Research Institute', u'Ironwood Pharmaceuticals Inc', u'Massachusetts General Hospital', u'University of California San Francisco', u'University of Calgary', u'Universita Degli Studi Di Perugia', u'University of British Columbia', u'Galapagos NV', u'Yissum Research Development Co', u'Cognosci Inc', u'Janssen Biotech Inc', u'Inotek Pharmaceuticals Corp', u'Gilead Sciences Inc', u'Defensin Therapeutics ApS', u'Sichuan BoXin LaiTe Biotechnology Inc', u'Wyeth', u'Novozymes A/S', u'National Institute of General Medical Sciences']), u'Acne': set([u'Council of Scientific and Industrial Research (India)', u'Perrigo Co Ltd', u'Paratek Pharmaceuticals Inc', u'IMTM GmbH', u'Incyte Corp', u'Renaissance Acquisition Holdings LLC', u'GlaxoSmithKline plc', u'NovaBay Pharmaceuticals Inc', u'Cosmo Pharmaceuticals SpA', u'Bayer Schering Pharma AG', u'Shasun Pharmaceuticals Ltd', u'Michigan Translational Research and Commercialization', u'DRAXIS Health Inc', u'SkyePharma plc', u'Hain Diagnostika GmbH', u'NB Therapeutics Inc', u'Phosphagenics Ltd', u'University of Michigan', u'New Anti Infectives Consortium', u'IMPAX Laboratories Inc', u'FAES Farma SA', u'Ono Pharmaceutical Co Ltd', u'Acrux Ltd', u'Cipher Pharmaceuticals Inc', u'Wakamoto Pharmaceutical Co Ltd', u'TOLMAR Therapeutics Inc', u'Cytochroma Inc', u'Avidas Pharmaceuticals LLC', u'Immune Network Ltd', u'Laboratoires Biocodex', u'Astellas Pharma Europe BV', u'Ranbaxy Pharmaceuticals Inc', u'Intendis GmbH', u'Taro International Ltd', u'CollaGenex International Ltd', u'Stiefel', u'Foamix Pharmaceuticals Ltd', u'Alliance Pharma plc', u'Orient Europharma', u'Spear Pharmaceuticals Inc', u'Galderma KK', u'Valocor Therapeutics Ltd', u'Cobrek Pharmaceuticals Inc', u'Genset', u'Pierrel SpA', u'Maruho Co Ltd', u'Mylan Inc', u'Alberta Research Council', u'Dow Pharmaceutical Sciences', u'Abbott Laboratories', u'Vyome Biosciences', u'Skinvisible Inc', u'University of California', u'Novelion Therapeutics Inc', u'Teva Pharmaceutical Industries Ltd', u'Galderma Laboratories LP', u'ISDIN SA', u'Heron Therapeutics Inc', u'Humboldt State University', u'Penederm Inc', u'PhotoMedex Inc', u'Pan-Malayan Pharmaceuticals', u'Graceway Pharmaceuticals Inc', u'Windtree Therapeutics Inc', u'Valeant Pharmaceuticals International Inc', u'Alfresa Pharma Corp', u'Laboratorios Andromaco SA (Spain)', u'Alvogen Inc', u'Allergan Inc', u'Fujirebio Europe NV', u'DS Biopharma', u'Genset SA', u'Recordati SpA', u'H Lundbeck A/S', u'BASF Pharma (Callanish) Ltd', u'Biotechnology and Biological Sciences Research Council (BBSRC)', u'Janus Pharmaceuticals Inc', u'York Pharma plc', u'Mayne Pharma Group Ltd', u'Otsuka Holdings Co Ltd', u'Connetics Corp', u'Medicis Pharmaceutical Corp', u'Grunenthal GmbH', u'Journey Medical Corp', u'Jago Pharma AG', u'Hyal Pharmaceutical Corp', u'Transport Pharmaceuticals Inc', u'National Institute of Arthritis and Musculoskeletal and Skin Diseases', u'Actavis Inc', u'Karr Dental AG', u'Undisclosed', u'XOMA Corp', u'Sinclair Pharma plc', u'Napa Biosciences Inc', u'NexThera Biosciences', u'Niadyne Pharma Inc', u'Montana Department of Commerce', u'Sonoma Pharmaceuticals Inc', u'Eli Lilly & Co', u'Galderma SA', u'DermTech International', u'University of Wisconsin-Madison', u'CSL Ltd', u'Beacon Pharmaceuticals', u'Blueberry Therapeutics Ltd', u'Dermaxon', u'GeNOsys Inc', u'NovaBiotics Ltd', u'Kissei Pharmaceutical Co Ltd', u'Willvonseder & Marchesani GmbH & Co KG', u'AstraZeneca plc', u'Pfizer Inc', u'LaRon Pharma Inc', u'aRigen Pharmaceuticals Inc', u'Teikoku Seiyaku KK', u'Quadro de Refer\\xeancia Estrat\\xe9gica Nacional', u'Corixa Corp', u'Deltanoid Pharmaceuticals', u'Genta Inc', u'CollaGenex Pharmaceuticals Inc', u'Research Corporation Technologies', u'University of Manchester', u'Malvern Cosmeceutics Ltd', u'Equity Labs Inc', u'Academia Sinica', u'DUSA Pharmaceuticals Inc', u'SmithKline Beecham plc', u'Ligand Pharmaceuticals Inc', u'AndroScience Corp', u'PhotoCure ASA', u'National Institutes of Health', u'Sumitomo Pharmaceuticals Co Ltd', u'Menarini Asia-Pacific', u'Shire Pharmaceuticals Ltd', u'Yuyu Inc', u'Evotec (UK) Ltd', u'AmDerma Pharmaceuticals', u'PreCision Dermatology Inc', u'Evocutis plc', u'Critical Therapeutics Inc', u'Orient Pharma Co Ltd', u'SonoLight Pharmaceuticals Corp', u'Summit Therapeutics plc', u'Brickell Biotech Inc', u'Cambrex Corp', u'Warner Chilcott plc', u'Meda AB', u'Janssen Pharmaceuticals Inc', u\"Brigham & Women's Hospital\", u'Patheon Pharmaceuticals Inc', u'Bayer HealthCare Pharmaceuticals Inc', u'Quest PharmaTech Inc', u'Luzitin SA', u'Zen-Bio Inc', u'Pharma Med Inc', u'Pfizer Vaccines', u'Merz North America', u'Berlex Laboratories Inc']), u'Hemolyticanemia': set([u'Symphogen A/S', u'Kedrion SpA', u'Zenyaku Kogyo Co Ltd', u'Ortho-Clinical Diagnostics Inc', u'Genentech Inc', u'Roche Holding AG', u'OncBioMune Mexico SA de CV', u'XOMA Corp', u'Cambridge Antibody Technology Group plc', u'IDEC Pharmaceuticals Corp', u'Octapharma AG', u'Cangene Corp', u'Kamada Ltd']), u'Vaginalinfection': set([u'General Biologicals Corp', u'Sinclair Pharma plc', u'Pacgen Life Science Corp', u'BMG Pharma LLC', u'Duchesnay Inc', u'Demegen Inc', u'MediNova Ltd']), u'Suicidalideation': set([u'WuXi PharmaTech (Cayman) Inc', u'Premier Biomedical Inc', u'MVK Therapeutics', u'Turing Pharmaceuticals LLC', u'AstraZeneca plc', u'Undisclosed', u'William Beaumont Army Medical Center', u'US Department of Defense', u'Marina Biotech Inc', u'NeuroRx Inc']), u'Pneumonia': set([u'Oscient Pharmaceuticals Corp', u'US Government', u'National Comprehensive Cancer Network', u'BioVeris Corp', u'Biovector Therapeutics SA', u'Lanzhou Institute of Biological Products', u'Humanetics Corp', u'European Commission', u'US Health and Human Services Department', u'Polydex Pharmaceuticals Ltd', u'Forest Laboratories Inc', u'Emerge Health Pty Ltd', u'Quintiles Transnational Corp', u'The Korea National Institute of Health', u'Sabin Vaccine Institute', u'Biotoscana International', u'TaiGen Biotechnology Co Ltd', u'MedImmune LLC', u'University of Michigan', u'LTT Bio-Pharma Co Ltd', u'Trius Therapeutics Inc', u'Inhibikase Therapeutics Inc', u'Ono Pharmaceutical Co Ltd', u'Sungjee IBPharm', u'Hospira Inc', u'Roche Holding AG', u'Serendex Pharmaceuticals A/S', u'Genesoft Inc', u'Zhejiang Medicine Co Ltd', u'Bayer HealthCare AG', u'BCY LifeSciences Inc', u'Novosci', u'Cardiovascular Systems Inc', u'Hikma Pharmaceuticals plc', u'National Research Council of Canada', u'Shire BioChem Inc', u'Meiji Seika Pharma Co Ltd', u'Amgen Inc', u'Medarex Inc', u'Harvard University', u'SmithKline Beecham Corp', u'Roswell Park Cancer Institute', u'Innoviva Inc', u'Novartis AG', u'Austell Laboratories', u'Merus Labs International Inc', u'TiGenix NV', u'Basilea Pharmaceutica International Ltd', u'Dong-A ST Co Ltd', u'LG Chem Ltd', u'University of Southern California', u'Xavier University of Louisiana', u'Liquidia Technologies Inc', u'Gamma Vaccines Pty Ltd', u'Mercer University', u'Pulmotect Inc', u'Unimedic AB', u'Venus Remedies Ltd', u'Synedgen Inc', u'Covalon Technologies Ltd', u'Sanofi', u'Chong Kun Dang Pharmaceutical Corp', u'Eli Lilly & Co', u'GlaxoSmithKline Biologicals', u'Masimo Corp', u'Global Alliance for Vaccines and Immunization', u'Nektar Therapeutics', u'Cubist Pharmaceuticals Inc', u'Pfizer Inc', u'Nabriva Therapeutics AG', u'University of Cincinnati', u'Human Genome Sciences Inc', u'University of Adelaide', u'Novartis Vaccines & Diagnostics', u'Toyama Chemical Co Ltd', u'Adcock Ingram Ltd', u'International Vaccine Institute', u'BioChem Vaccines Inc', u'LG Life Sciences Ltd', u'Australian Government', u'Savara Inc', u'Avir Pharma Inc', u'National Institute of Allergy and Infectious Diseases', u'Cempra Inc', u'Haikou VTI Biological Institute', u'Bill & Melinda Gates Foundation', u'Achaogen Inc', u'BiosYnth srl', u'The Menarini Group', u'Sanofi Pasteur Inc', u'Chiesi USA Inc', u'Astellas Pharma Inc', u'Dong Wha Pharmaceutical Co Ltd', u'Biovail Corp', u'National Institute of Biomedical Imaging and Bioengineering', u'Program for Appropriate Technology in Health', u'Cook Pharmaceutical Solutions', u'Nuron Biotech Inc', u'Cepheid', u'Synspira', u'Takeda Pharmaceutical Co Ltd', u'PARI Pharma GmbH', u'Novozymes A/S', u'BioAegis Therapeutics Inc']), u'Lysosomalacidlipasedeficiency': set([u'Synex Consulting Korea Limited', u\"Cincinnati Children's Hospital Medical Center\", u'Synageva BioPharma Corp', u'Shire Human Genetic Therapies Inc', u'Alexion Pharmaceuticals Inc']), u'Endocrinedisease': set([u'BioMarin Pharmaceutical Inc', u'Baxter International Inc', u'Bioactis Ltd', u'Novo Nordisk A/S', u'Verily Life Sciences LLC', u'Questcor Pharmaceuticals Inc', u'Glide Pharmaceutical Technologies Ltd', u'NPS Pharmaceuticals Inc', u'Ipsen', u'Formulation Technologies LLC', u'Cardiokine Inc', u'Bennu Pharmaceuticals Inc', u'Zentaris GmbH', u'Endoceutics Inc', u'Takeda Oncology', u'Halozyme Therapeutics Inc', u'Abbott Healthcare Products BV', u'ARIAD Pharmaceuticals Inc', u'Galapagos NV', u'Xcellsyz Ltd', u'Procter & Gamble Pharmaceuticals Inc', u'HanAll Biopharma Co Ltd', u'Optimer Pharmaceuticals Inc', u'Cambrex Bio Science Walkersville Inc', u'REGENXBIO Inc', u'Novus Therapeutics Inc', u'Repligen Corp', u'Karo Pharma AB', u'Abbott Laboratories', u'Geron Corp', u'GTx Inc', u'Novartis AG', u'Anthera Pharmaceuticals Inc', u'MerLion Pharmaceuticals Pte Ltd', u'Scitech Medical Products Pte', u'Valeo Pharma Inc', u'GlaxoSmithKline plc', u'Cadus Corp', u'Boehringer Ingelheim International GmbH', u'OPKO Health Inc', u'Pharmacopeia Inc', u'ALZA Corp', u'Solural Pharma Aps', u'Tocris Neuramin Ltd', u'Corcept Therapeutics Inc', u'Prasco Laboratories', u'Generex Biotechnology Corp', u'Antares Pharma Inc', u'Patheon Pharmaceuticals Inc', u'Chugai Pharmaceutical Co Ltd', u'Active Pass Pharmaceuticals Inc', u'Ortho Biotech Products LP', u'Dicerna Pharmaceuticals Inc', u'PJSC Pharmsynthez', u'Mitsubishi Pharma Corp', u'Paladin Labs Inc', u'PeptiDream Inc', u'Ark Therapeutics Group plc', u'Undisclosed', u'Merck Serono SA', u'Translational Research Ltd', u'Erasmus University Rotterdam', u'Theratechnologies Inc', u'Eli Lilly & Co', u'Ardelyx Inc', u'Kyowa Hakko Kirin Co Ltd', u'Medarex Inc', u'AEterna Zentaris Inc', u'Repros Therapeutics Inc', u'Argenta Discovery Ltd', u'MedImmune LLC', u'AstraZeneca plc', u'Pfizer Inc', u'Neurocrine Biosciences Inc', u'Human Genome Sciences Inc', u'HUYA Bioscience International LLC', u'Cortendo AB', u'NHTherapeutics Inc', u'NeoGenesis Pharmaceuticals Inc', u'Tularik Inc', u'ASCEND Therapeutics Inc', u'Institute of Materia Medica Chinese Academy of Medical Sciences & Peking Union Medical College', u'Arena Pharmaceuticals Inc', u'Ligand Pharmaceuticals Inc', u'PPC', u'CoGenesys Inc', u'National Institutes of Health', u'Cempra Inc', u'Syndexa Pharmaceuticals Corp', u'Sanofi Genzyme', u'ChemDiv Inc', u'Endorecherche Inc', u'Knoll GmbH', u'Medical University of South Carolina', u'Lundbeck Research USA Inc', u'University of Milan', u'Innovate Biopharmaceuticals Inc', u'Antisense Therapeutics Ltd', u'Takeda Pharmaceutical Co Ltd', u'DRI Capital', u'NGM Biopharmaceuticals Inc']), u'Non-Hodgkinlympho': set([u'Boots Hoechst Celanese', u'Pharmacyclics Inc']), u'Cerebralpalsy': set([u'Ashvattha Therapeutics LLC', u'Athersys Inc', u'US Government', u'Lonza Group AG', u'Orpheris Inc', u'National Institutes of Health', u'Acorda Therapeutics Inc', u'University of Oregon', u'Elan Corp plc', u'ReNeuron Group plc', u'Microbot Medical Inc', u'Medical College of Georgia']), u'Metastaticnonsmallcelllun': set([u'Eli Lilly & Co', u'Princeton University', u'Takeda Pharmaceutical Co Ltd']), u'Hearingloss': set([u'Maryland Department of Business and Economic Development', u'BioAdvance', u'US Government', u'Sensorion Pharmaceuticals', u'The European Union', u'GN Resound A/S', u'Otsuka Pharmaceutical Co Ltd', u'Cystic Fibrosis Foundation Therapeutics Inc', u'Oricula Therapeutics LLC', u'Olive Devices LLC', u'University of Toulouse', u'Loop Therapeutics Inc', u'Sound Pharmaceuticals Inc', u'Essetifin SpA', u'Otomagnetics LLC', u'Fennec Pharmaceuticals Inc', u'Audion Therapeutics', u'French Government', u'Beltone A/S', u'Flextronics International USA Inc', u'Sanofi', u'Cochlear Acoustics Ltd', u'Eli Lilly & Co', u'University of Washington', u'Hough Ear Institute', u'KAM Hearing Health', u'Spiral Therapeutics Inc', u'Natus Medical Inc', u'Netherlands Cancer Institute', u'Life Sciences Discovery Fund', u'Boehringer Ingelheim Corp', u'uniQure BV', u'Living Cell Technologies Ltd', u'Otologic Pharmaceutics Inc', u'Ihear Medical Inc', u'Southeast University', u'University of Cambridge']), u'Deafness': set([u'Fred Hutchinson Cancer Research Center', u'Australian Government', u'National Institutes of Health', u'Ipsen', u'MuriGen Pty Ltd', u'INSERM', u'US Government', u'Ohio State University', u'University of California San Francisco', u'Sound Pharmaceuticals Inc', u'University of Pittsburgh']), u'Ebolavirusinfection': set([u'University of Texas Medical Branch at Galveston', u'Regeneron Pharmaceuticals Inc', u'RedHill Biopharma Ltd', u'NOWDiagnostics Inc', u'Oncovir Inc', u'CytoGenix Inc', u'US Health and Human Services Department', u'Apath LLC', u'GlaxoSmithKline plc', u'Inovio Pharmaceuticals Inc', u'Clinical Research Management Inc', u'Vical Inc', u'Maryland Technology Development Corp', u'Interferon Sciences Inc', u'Texas A&M University System', u'NanoAxis', u'Zhejiang Hisun Pharmaceutical Co Ltd', u'Immunex Corp', u'Medical Research Council', u'University of Pennsylvania', u'The University Health Network', u'Public Health England', u'Beijing Wellso Pharmaceutical Co Ltd', u'PlantForm Corp', u'Battelle', u'Theraclone Sciences Inc', u'rEVO Biologics Inc', u'Nuvelo Inc', u'Canadian Institutes of Health Research', u'Caliber Biotherapeutics', u'ReiThera Srl', u'Emory University', u'Defense Advanced Research Projects Agency', u'US Department of Defense', u'Alnylam Pharmaceuticals Inc', u'National Research Council of Canada', u'The Jenner Institute', u'Charles River Laboratories International Inc', u'GenPhar Inc', u'US Government', u'Atreca Inc', u'Harvard University', u'United States Army Medical Research Institute of Chemical Defense', u'Numerate Inc', u'Integral Molecular Inc', u'Greffex Inc', u'Arno Therapeutics Inc', u'ExpreS2ion Biotechnologies', u'OraSure Technologies Inc', u'Johnson & Johnson', u'Kyushu University', u'Southern Research Institute', u'Yisheng Biopharma Co Ltd', u'The Geneva Foundation', u'Vanderbilt University', u'MicroPharm Ltd', u'Texas Biomedical Research Institute', u'Institute of Basic Medical Sciences Academy of Military Medical Sciences of PLA', u'GeneOne Life Science Inc', u'VIDO-InterVac', u'Protiva Biotherapeutics Inc', u'Arbutus Biopharma Corp', u'University of California at Berkeley', u'Dendreon Corp', u'Navigen Inc', u'Wellcome Trust', u'Starpharma Holdings Ltd', u'Institute of Microbiology and Epidemiology Academy of Military Medical Sciences PLA', u'University of Texas System', u'Integrated BioTherapeutics Inc', u'Kymab Ltd', u'CanSino Biologics Inc', u'AnGes MG Inc', u'Washington University in St Louis', u'Omm Scientific Inc', u'University of Massachusetts Medical School', u'Emory University Hospital', u'Sumitomo Metal Industries Ltd', u'Biomolecular Research Institute Ltd', u'ANP Technologies Inc', u'University of Oxford', u'BioProtection Systems Corp', u'Undisclosed', u'Agilvax Inc', u'Innovative Medicines Initiative', u'Academy of Military Medical Sciences', u'Harvard Medical School', u'Defyrus Inc', u'Chimerix Inc', u'Profectus BioSciences Inc', u'CMC Biologics Inc', u'University of Washington', u'Oregon Health Sciences University', u'Institute of Biotechnology the Academy of Military Medical Sciences PLA', u'Microbiotix Inc', u'Zalgen Labs LLC', u'Emergent BioSolutions Inc', u'University of California', u'Merck & Co Inc', u'Abivax', u'Genzyme General', u'Scripps Research Institute', u'Candian Chemical, Biological, Radiological or Nuclear (CBRN) Research and Technology Initiative', u'Sanofi', u'Southwest Research Institute (SwRI)', u'Centers for Disease Control and Prevention', u'Agenus Inc', u'Department for International Development', u'Dale and Betty Bumpers Vaccine Research Center', u'AbCellera Biologics Inc', u'Global Alliance for Vaccines and Immunization', u'BioFactura Inc', u'Soligenix Inc', u'Adimab LLC', u'University of Iowa', u'Corgenix Medical Corp', u'OncoSynergy Inc', u'Biosidus SA', u'Midatech Pharma PLC', u'Gilead Sciences Inc', u'Emergex Vaccines Limited', u'Canopus BioPharma Inc', u'Kineta Inc', u'Toyama Chemical Co Ltd', u'Biologics Consulting Group Inc', u'University of Illinois', u'Mapp Biopharmaceutical Inc', u'H&P Labs Inc', u'Evolva Holding SA', u'Arisan Therapeutics Inc', u'UK Government', u'Janssen Vaccines & Prevention BV', u'GeoVax Labs Inc', u'Phelix Therapeutics Llc', u'Uniformed Services University of the Health Sciences', u'Makerere University', u'Multimeric Biotherapeutics Inc', u'National Institute of Allergy and Infectious Diseases', u'iBio Inc', u'University of Utah', u'Bavarian Nordic A/S', u'Ben-Gurion University Of The Negev', u'Dendreon San Diego LLC', u'Mabworks Biotech Co Ltd', u'Ministry of Science and Technology of the People\\xb4s Republic of China', u'Albert Einstein College of Medicine', u'Walter Reed Army Institute of Research', u'National Institutes of Health', u'Bill & Melinda Gates Foundation', u'Medicago Inc', u'Sarepta Therapeutics Inc', u'OSEO', u'INSERM', u'Biosyn Inc', u'US Army Medical Research Institute of Infectious Diseases', u'Auburn University', u'Paragon Bioservices Inc', u'Thomas Jefferson University', u'TheraCour Pharma Inc', u'Howard University', u'NewLink Genetics Corp', u'NanoViricides Inc', u'Federal Department of Defence, Civil Protection and Sport', u'University of Hawaii', u'Duke University', u'Wistar Institute of Anatomy & Biology', u'Chembio Diagnostic Systems Inc', u'The Paul G. Allen Family Foundation', u'The Vaccine and Gene Therapy Institute of Florida', u'University of Toronto', u'Public Health Agency of Canada', u'Crucell NV', u'Hawaii Biotech Inc', u'Hemispherx Biopharma Inc', u'University of New Mexico', u'American Red Cross', u\"King's College London\", u'BioCryst Pharmaceuticals Inc', u'St Georges University of London', u'Defense Threat Reduction Agency']), u'Hepaticencephalopathy': set([u'Bama-Geve SL', u'Pennsylvania Biotechnology Center', u'Mitsubishi Pharma Corp', u'Umecrine AB', u'Kureha Corp', u'Daiichi Sankyo Co Ltd', u'Alfa Wassermann SpA', u'National Institutes of Health', u'Ocera Therapeutics Inc', u'KannaLife Sciences Inc', u'CleveXel Pharma', u'Medical Research Council', u'University College London', u'Salix Pharmaceuticals Inc', u'Clinigen Group plc', u'Valeant Pharmaceuticals International Inc', u'Mitsubishi Tanabe Pharma Corp', u'Salix Pharmaceuticals Ltd', u'AMI Pharm Co Ltd', u'Aptalis Pharma Inc', u'Catalent Inc', u'Lupin Ltd', u'Hyperion Therapeutics Inc', u'Pacific Pharmaceuticals Co Ltd', u'Swedish Orphan Biovitrum AB', u'Horizon Pharma plc', u'Merz & Co GmbH']), u'Pseudomonasaeruginosainfection': set([u'Daiichi Seiyaku Co Ltd', u'US Government', u'Solvay SA', u'EnBiotix Inc', u'Orphan Europe SARL', u'Immunotech SA (Argentina)', u'US Health and Human Services Department', u'Inovio Pharmaceuticals Inc', u'Immunsystem IMS AB', u'Chiron Corp', u'University of Zurich', u'MedImmune LLC', u'CURx Pharmaceuticals Inc', u'University of Pittsburgh', u'University of Pennsylvania', u'Wired Holdings Investment Corp', u'University of London', u'Shire plc', u'Microcide Pharmaceuticals Inc', u'Fresenius Kabi AG', u'Sorrento Therapeutics Inc', u'InterMune Inc', u'National Heart Lung and Blood Institute', u'Visterra Inc', u'Pherecydes Pharma', u'Pro Bono Bio', u'Juvaris BioTherapeutics Inc', u'Meiji Seika Pharma Co Ltd', u'PDL BioPharma Inc', u'University of California San Francisco', u'Cystic Fibrosis Foundation Therapeutics Inc', u'Affibody AB', u'The European Union', u'Ohio State University', u'Kenta Biotech Ltd', u'Agile Sciences Inc', u'Teva Pharmaceutical Industries Ltd', u'Massachusetts General Hospital', u'Ajinomoto Althea Inc', u'Symphogen A/S', u'Ethicor Pharma Ltd', u'Creative Antibiotics Sweden AB', u'Lakewood-Amedex Inc', u'MegaPharm Ltd', u'Chiron PathoGenesis', u'University of Sydney', u'Yokohama City University', u'AmpliPhi Biosciences Corp', u'Transave Inc', u'Medimmune Oncology Inc', u'Harvard Medical School', u'Albany Molecular Research Inc', u'Hospital for Sick Children', u'PPL Therapeutics plc', u'Medivir AB', u'Westmead Millennium Institute for Medical Research', u'Microbiotix Inc', u'Special Phage Holdings Pty Ltd', u'Medical College of Wisconsin', u'Crucell Switzerland AG', u'Demegen Inc', u'Bayer AG', u'Phico Therapeutics Ltd', u'INHIBRx LLC', u'Nektar Therapeutics', u'Technology Strategy Board', u'Mid-Atlantic Biotherapeutics', u'Gilead Sciences Inc', u'Quorex Pharmaceuticals Inc', u'Spero Therapeutics LLC', u'Dr Reddy\\u2019s Research and Development BV', u'Teva Pharma BV (Netherlands)', u'Alcon Inc', u'Baylor College of Medicine', u'Australian Government', u'Cytovax Biotechnologies Inc', u'Intrexon Corp', u'Eberhard Karls Universit\\xe4t T\\xfcbingen', u'Mapp Biopharmaceutical Inc', u'National Institute of Allergy and Infectious Diseases', u'Forest Laboratories UK Ltd', u'Phylogica Ltd', u'National Institutes of Health', u'University of Wisconsin-Milwaukee', u'Bristol-Myers Squibb Co', u'Aires Pharmaceuticals Inc', u'Biocontrol Ltd', u'Immuno International AG', u'Aridis Pharmaceuticals Inc', u'Dompe Group', u'Periodontix Inc', u'Duke University', u'Axentis Pharma AG', u'Insmed Inc', u'Institut Pasteur', u'Child Health Corporation of America (CHCA)', u'Cepheid', u\"Brigham & Women's Hospital\", u'Novartis AG', u'Immunovaccine Inc', u'PARI Pharma GmbH', u'Defense Advanced Research Projects Agency']), u'Arteriosclerosis': set([u'D Western Therapeutics Institute', u'Solvay SA', u'Beijing Tide Pharmaceutical Co Ltd', u'Japan Science and Technology Agency', u'Otsuka Pharmaceutical Co Ltd', u'European Commission', u'National Institute of Diabetes, Digestive and Kidney Diseases', u'National Heart Lung and Blood Institute', u'GlaxoSmithKline plc', u'SUNY Downstate Medical Center', u'Sociedade Beneficente Israelita Brasileira Hospital Albert Einsten', u'Aventis Pharma AG', u'Sanofi', u'Pronova BioPharma ASA', u'LTT Bio-Pharma Co Ltd', u'Mitsubishi-Tokyo Pharmaceuticals Inc', u'Sumitomo Pharmaceuticals Co Ltd', u'CHU De Nantes', u'Sosei Group Corp', u'United Therapeutics Corp', u'Toray Industries Inc', u'Effimune SA', u'Catalent Inc', u'Kaken Pharmaceutical Co Ltd', u'Endogenous Stem Cells Activators Inc', u'Biomedical Primate Research Centre', u'Glasgow Caledonian University', u'Reliant Pharmaceuticals Inc', u'University of Oxford', u'ECI Inc']), u'Spinocerebellarataxia': set([u'University of Texas Medical Branch at Galveston', u'National Institute of Neurological Disorders and Stroke', u'Fox Chase Chemical Diversity Center Inc', u'Ionis Pharmaceuticals Inc', u'University of Utah', u'Elan Corp plc', u'Acorda Therapeutics Inc', u'Scripps Florida', u'University of Mississippi', u'BioHaven Pharmaceutical Holding Co Ltd', u'National Institute of General Medical Sciences']), u'Spinalstenosis': set([u'The New Energy and Industrial Technology Development Organization', u'LTT Bio-Pharma Co Ltd', u'China Chemical & Pharmaceutical Co Ltd', u'Ono Pharmaceutical Co Ltd', u'Beijing Tide Pharmaceutical Co Ltd', u'Sumitomo Dainippon Pharma Co Ltd', u'Meiji Seika Pharma Co Ltd']), u'Scartissue': set([u'Sanford-Burnham Medical Research Institute', u'Sientra Inc', u'NovoTek Pharmaceuticals Ltd', u'National Institute of Arthritis and Musculoskeletal and Skin Diseases', u'Royal DSM NV', u'National Institutes of Health', u'Glytrix Inc', u'Stratpharma AG', u'ASCEND Therapeutics Inc', u'Korea Drug Development Fund', u'Cambridge Antibody Technology Group plc', u'Glenmark Pharmaceuticals Ltd', u'Scarless Laboratories Inc', u'BTG plc', u'Pallane Medical Ltd', u'Ambrilia Biopharma Inc', u'Hospital for Sick Children', u'MaRS Innovation', u'Baker Medical Research Institute', u'Capstone Therapeutics Corp', u'Renovo Group plc', u'BHR Pharma LLC', u'Irix Pharmaceuticals Inc', u'Ionis Pharmaceuticals Inc', u'Sanofi Genzyme', u'ArQule Inc', u'BioVascular Inc', u'AzERx Inc', u'Hugel Pharma', u'Milstein Medical Asian American Partnership Foundation', u'FibroGen Inc', u'AdeTherapeutics Inc', u'University of Manchester', u'Biovail Corp', u'Shire plc', u'BioSpecifics Technologies Corp', u'Technology Strategy Board', u'Graceway Pharmaceuticals Inc', u'Wuxi AppTec Inc', u'Advanced Bio-Technologies Inc', u'OliX Pharmaceuticals Inc', u'Enaltus LLC', u'Laboratoires Biocodex', u'Ember Therapeutics', u'Laboratoires Besins International', u'VBS Pharmaceuticals', u'AstraZeneca plc', u'Pfizer Inc', u'Catalent Inc', u'Intercytex Ltd', u'RecipharmCobra Biologics', u'Merck KGaA', u'US Department of Defense', u'Xijing Hospital', u'Excaliard Pharmaceuticals Inc', u'National Institute of General Medical Sciences', u'Sinclair Pharma plc']), u'Coxiellainfection': set([u'CSL Ltd', u'DynPort Vaccine Company LLC']), u'Neuromuscularblockade': set([u'Cornell University', u'Recro Pharma Inc']), u'Borreliainfection': set([u'Zovec AB', u'Intercell AG']), u'Rheumatoidar': set([u'Genentech Inc', u'Zenyaku Kogyo Co Ltd', u'Roche Holding AG', u'XOMA Corp', u'IDEC Pharmaceuticals Corp']), u'HepatitisCvirusinfection': set([u'US Civilian Research and Development Foundation', u'Baltic Technology Development Ltd', u'Koebenhavns Universitet', u'B&C Biopharm', u'US Health and Human Services Department', u'Apath LLC', u'University of Alabama', u'Mylan Laboratories Ltd', u'Key Oncologics (Pty) Ltd', u'Inovio Pharmaceuticals Inc', u'Biotecnol SA', u'Nippon Kotan KK', u'Medicines Development Ltd', u'Bio Farma', u'EpiVax Inc', u'Ionis Pharmaceuticals Inc', u'Immuron Ltd', u'Biota Scientific Management', u'Rostec State Corporation', u'Zydus-Cadila Group', u'Sigma-Aldrich Corp', u'Colthurst Ltd', u'Amoytop Biotech Co Ltd', u'Galapagos NV', u'Kaketsuken', u'Merck Sharp & Dohme Corp', u'Siemens AG', u'Aviragen Therapeutics Inc', u'Microbio Co Ltd', u'Prasco Laboratories', u'Kuhnil Pharmaceutical Co Ltd', u'Celera South San Francisco', u'Toray Industries Inc', u'Sorrento Therapeutics Inc', u'HanAll Biopharma Co Ltd', u'1608557 Ontario Inc', u'Cengent Therapeutics Inc', u'Genoscience', u'National Research Council of Canada', u'BGN Technologies', u'European Commission', u'National Health and Medical Research Council', u'New York University', u'Chongqing Fagen Biopharmaceutical Co Ltd', u'Romark Laboratories LC', u'ChemRar Pharma', u'Shanghai Sundise Traditional Chinese Medicine Co Ltd', u'Sichuan University', u'BioKorea Co Ltd', u'Rega Institute for Medical Research', u'Mochida Pharmaceutical Co Ltd', u'Drogsan Ilaclari San. ve Tic. A.S.', u'Viriom Inc', u'Beijing Kawin Technology Share-Holding Co Ltd', u'Shanghai Target Drug Co Ltd', u'Vanderbilt University', u'Asembia', u'Gen-Probe Inc', u'DEM Pharmaceuticals Ltd', u'Korean Drug Co Ltd', u'Verta Ltd', u'Synergy Pharmaceuticals Inc', u'Kyung Hee University', u'EpiCept Corp', u\"People's Government of Jiangsu Province\", u'ViroPharma Inc', u'Celera Group', u'Genius Biotherapeutics', u'MegaPharm Ltd', u'Integrated BioTherapeutics Inc', u'Janssen Pharmaceutica NV', u'Institut Pasteur Korea', u'CSPC Pharmaceuticals Group Limited', u'4SC AG', u'Arisyn Therapeutics Inc', u'Botanic Century (Beijing) Co Ltd', u'Laboratory Corp Of America Holdings Inc', u'Roche Diagnostics', u'F H Faulding & Co Ltd', u'American Gene Technologies International Inc', u'Novalex Therapeutics', u'VGX Pharmaceuticals LLC', u'Monsanto Co', u'irsiCaixa Foundation', u'California Institute of Technology', u'Flamel Technologies SA', u'Suzhou Nanomicro Technology Company Limited', u'National Institute of Infectious Diseases Japan', u'Sinopharm', u'Ibis Therapeutics', u'Chia Tai Tianqing Pharmaceutical Group Co Ltd', u'Eli Lilly & Co', u'Centers for Disease Control and Prevention', u'Chiroscience R&D Ltd', u'University of Wisconsin-Madison', u'OriGenix Technologies Inc', u'Cook Pharmica', u'Weizmann Institute of Science', u'Prosetta Biosciences Inc', u'Horizon Orphan LLC', u'Metabasis Therapeutics Inc', u'Chonnam National University', u'Reliance GeneMedix plc', u'University of Cincinnati', u'Daktari Diagnostics Inc', u'Japan Energy Corp', u'Sungkyunkwan University', u'YiChang HEC ChangJiang Pharmaceutical Co Ltd', u'Novartis Vaccines & Diagnostics', u'Anza Therapeutics Inc', u'Sanwa Kagaku Kenkyusho Co Ltd', u'Presidio Pharmaceuticals Inc', u'Harbor Therapeutics Inc', u'Immunobiology Ltd', u'Coley Pharmaceutical Group Inc', u'Innate Pharma SA', u'AbbVie Inc', u'Population Council', u'University of California San Diego', u'SmithKline Beecham plc', u'University of Rhode Island', u'US Army Medical Research Acquisition Activity', u'SomaGenics Inc', u'Arrow Therapeutics Ltd', u'Vitapharm Technology Development Co Ltd', u'Bristol-Myers Squibb Co', u'Foundation for Assistance to Small Innovative Enterprises', u'OSEO', u'Opus Bio Inc', u'Pharming Group NV', u'Sumagen Co Ltd', u'VINNOVA', u'Arriani Pharmaceuticals SA', u'Three Rivers Pharmaceuticals LLC', u'Agouron Pharmaceuticals Inc', u'ChronTech Pharma AB', u'University of Oxford', u'Benitec Biopharma Ltd', u'Hoechst Marion Roussel Inc', u'Hollister-Stier Laboratories LLC', u'Sareum Holdings plc', u'Nucorion Pharmaceuticals Inc', u'Karolinska Institutet', u'Anadys Pharmaceuticals Europe GmbH', u'Yamanouchi Pharmaceutical Co Ltd', u'Dynavax Technologies Corp', u'Boehringer Ingelheim GmbH', u'Virionics Corp', u'Howard Hughes Medical Institute', u'Trek Therapeutics PBC', u'Chiron Corp', u'Genesis Technology Group Inc', u'TaiGen Biotechnology Co Ltd', u'Ascletis Inc', u'Chinese Government', u'iDialog', u'Genentech Inc', u'MIP-11', u'LTT Bio-Pharma Co Ltd', u'Shire Pharmaceuticals Ltd', u'Omnia Biologics Inc', u'Genovate Biotechnology Co Ltd', u'NanoZyme Inc', u'University of British Columbia', u'Mitsubishi Tanabe Pharma Corp', u'The National Institute of Mental Health', u'Genecor International Inc', u'Temple University', u'Intercell AG', u'Biocon Ltd', u'Mayo Clinic Foundation', u'Diplomat Pharmacy Inc', u'Georgetown University', u'Evotec AG', u'Orphan Australia', u'Cell Pharm GmbH', u'Molcode Ltd', u'Amgen Inc', u'Health Science Council', u'Artes Biotechnology', u'Numerate Inc', u'Shanghai Wanxing Bio-Pharmaceutical Co Ltd', u'Epixis SA', u'Eunice Kennedy Shriver National Institute of Child Health & Human Development', u'CJ Corp', u'Stiefel Laboratories (UK) Ltd', u'SkyePharma plc', u'BioPartners GmbH', u'BioGeneric Pharma', u'Massachusetts General Hospital', u'Transgene SA', u'Enzon Pharmaceuticals Inc', u'Bosch Pharmaceuticals Pvt Ltd', u'Trimeris Inc', u'Cypralis Ltd', u'Axcan Pharma Inc', u'Medmira Inc', u'Georgia State University', u'Can-Fite BioPharma Ltd', u'Venturepharm Laboratories Ltd', u'Albany Molecular Research Inc', u'Astex Therapeutics Ltd', u'First Hospital of Jilin University', u'Osaka University', u'OnCore Biopharma Inc', u'Pharco Pharmaceuticals Inc', u'Roche Palo Alto', u'AVAC Ltd', u'Sclavo SpA', u'Maxygen Holdings Ltd', u'F Hoffmann-La Roche AG', u'Novosom AG', u'Rockefeller University', u'Biotron Ltd', u'IsoTis SA', u'The Macfarlane Burnet Institute For Medical Research & Public Health Ltd', u'Mitsubishi Pharma Corp', u'Paladin Labs Inc', u'Korea Drug Development Fund', u'Kemin Pharma Europe', u'Rigel Pharmaceuticals Inc', u'Oxford GlycoSciences plc', u'Weill Medical College of Cornell University', u'Baylor Research Institute', u'Oklahoma Medical Research Foundation', u'Laureate Biopharmaceutical Services Inc', u'Arkray Inc', u'Pennsylvania Department of Health', u'LifeArc', u'Actavis Inc', u'RFS Pharma LLC', u'Nautilus Biotech SA', u'Institute of Biotechnology the Academy of Military Medical Sciences PLA', u'Microbiotix Inc', u'Vivalis', u'Sumitomo Dainippon Pharma Co Ltd', u'GenPhar Inc', u'Scripps Research Institute', u'Shanghai University of Traditional Chinese Medicine', u'Spring Bank Pharmaceuticals Inc', u'Avila Therapeutics Inc', u'Japan Tobacco Inc', u'GinkgoPharma Co Ltd', u'Deutsches Rote Kreuze', u'Fuzians Biomedicals Inc', u'United Therapeutics Corp', u'Kadmon Pharmaceuticals LLC', u'BioLineRx Ltd', u'Kedrion SpA', u'Affitech A/S', u'Oxeltis', u'Genencor International Inc', u'Hayashibara Co Ltd', u'Metdem Healthcare Ltd', u'Estero-Anstalt', u'Horizon Pharma plc', u'ProMetic Life Sciences Inc', u'ViroChem Pharma Inc', u'Australian Government', u'Hemispherx Biopharma Inc', u'Cambridge Biotechnology Ltd', u'Genmab A/S', u'Profectus BioSciences Inc', u'Bioject Medical Technologies Inc', u'AM-Pharma Holding BV', u'Biolex Therapeutics Inc', u'Ligand Pharmaceuticals Inc', u'Alfa Wassermann SpA', u'Abiogen Pharma SpA', u'AB Pharma Ltd', u'Guangdong Medicine Group Corp', u'VivoQuest Inc', u'Oncolys BioPharma Inc', u'Pomona Ricerca Srl', u'Sogang University', u'Opal Therapeutics Inc', u'Bioenvision Inc', u'Nanogen Inc', u'VG Life Sciences Inc', u'Calando Pharmaceuticals Inc', u'VectorLogics Inc', u'Melmotte Inc', u'Dong Wha Pharmaceutical Co Ltd', u'Valeant Pharmaceuticals International Inc', u'Medical University of South Carolina', u'Objectif Recherche VACcin Sida', u'Institut Pasteur', u'University of Western Ontario', u'CCL Pharmaceuticals', u'Alios BioPharma Inc', u\"Brigham & Women's Hospital\", u'PiSA Farmaceutica', u'Antitope Ltd', u'Pacific Pharmaceuticals Co Ltd', u'US Department of Defense', u'German Federal Ministry of Education and Research', u'Aldevron', u'Symphony Capital LLC', u'University of Florida', u'Cerus Corp', u'Koken Co Ltd', u'Sanofi Pasteur', u'Maxygen Inc', u'Commonwealth Government', u'Vernalis Group plc', u'CombiMatrix Corp', u'The Ragon Institute', u'Exiqon A/S', u'Samaritan Pharmaceuticals Inc', u'OSI Pharmaceuticals Inc', u'American Red Cross', u'Cocrystal Discovery Inc', u'Newsummit Biopharma Co Ltd', u'Hybrigenics SA', u'Emcure Pharmaceuticals Ltd', u'Implicit Bioscience Ltd', u'Immune Network Ltd', u'HealthCare Asia Pharmaceuticals Inc', u'Enanta Pharmaceuticals Inc', u'Novadex Pharmaceuticals AB', u'ReiThera Srl', u'Roche Molecular Systems Inc', u'National Center for Research Resources', u'Defense Advanced Research Projects Agency', u'ViroLogik Gmbh', u'Pfizer Inc', u'ImQuest Life Sciences Inc', u'University of Cheyney', u'Loyola University of Chicago', u'University of Nebraska Medical Center', u'PTC Therapeutics Inc', u'Institute of Cell & Molecular Science', u'Wyeth', u'Tianjin Chase Sun Pharmaceutical Co Ltd', u'Biopharm (UK) Ltd', u'Angel Biotechnology Holdings plc', u'SCYNEXIS Inc', u'Nucleonics Inc', u'Biota Holdings Ltd', u'Japan Science and Technology Agency', u'Janssen Diagnostics BVBA', u'Solexa Inc', u'VLP Biotech Inc', u'Integral Molecular Inc', u'ZymoGenetics Inc', u'Sirna Therapeutics Inc', u'Amarillo Biosciences Inc', u'Hadassah Medical Organization', u'Teva Pharmaceutical Industries Ltd', u'Catholic University of Leuven', u'Boehringer Ingelheim International GmbH', u'GlobeImmune Inc', u'UCB Pharma GmbH', u'WuXi PharmaTech (Cayman) Inc', u'Cytran Ltd', u'Beijing Four Rings Bio-Pharmaceutical Co Ltd', u'Achillion Pharmaceuticals Inc', u'Carrus Capital Corp', u'Glaxo Group Ltd', u'Wellcome Trust', u'Fujirebio Europe NV', u'Novita Healthcare Ltd', u'Boehringer Ingelheim Corp', u'Hoffmann-La Roche Inc', u'Virogen Ltd', u'University of Melbourne', u'Debiopharm SA', u'Changzhou Yinsheng Pharmaceutical Co Ltd', u'DURECT Corp', u'Roche Holding AG', u'SC Liver Research Consortium', u'Wyeth Pharmaceuticals', u'Immunotech Laboratories Inc', u'Connetics Corp', u'Compass Biotechnologies Inc', u'IDIS Ltd', u'Cipla Ltd', u'Schering-Plough Corp', u'Roche Innovation Center Copenhagen A/S', u'Shanghai Institute of Materia Medica of the Chinese Academy of Sciences', u'Cellectar Biosciences Inc', u'Merck & Co Inc', u'Perlegen Sciences Inc', u'Hualida Biotech', u'Sanofi', u'Vertex Pharmaceuticals Inc', u'The Royal London Hospital', u'Bayer AG', u'US Army Medical Research Institute of Infectious Diseases', u'Altor BioScience Corp', u'Bionika Pharmaceuticals', u'InNexus Biotechnology Inc', u'Merck Research Laboratories', u'Canadian Department of National Defence', u'Nektar Therapeutics', u'Questcor Pharmaceuticals Inc', u'National Health Research Institutes', u'Therapure Biopharma Inc', u'Prime Therapeutics LLC', u'Vaxeal Holding SA', u'Gilead Sciences Inc', u'Medicines Patent Pool', u'Intarcia Therapeutics Inc', u'Australian government Department of Innovation, Industry, Science and Research', u'Triangle Pharmaceuticals Inc', u'Kineta Inc', u'Progenics Pharmaceuticals Inc', u'Merck Sharp & Dohme Ltd', u'Institute for the Promotion of Innovation by Science and Technology in Flanders', u'Vernalis plc', u'Acambis plc', u'Ichor Medical Systems Inc', u'Hoffmann-La Roche AG', u'Zydus Cadila Healthcare Ltd', u'Montclair State University', u'University of Pennsylvania', u'Cytran Inc', u'NeuroVive Pharmaceutical AB', u'Virology Networks', u'Akshaya Bio Inc', u'Dendreon San Diego LLC', u'Lonza Group AG', u'Zannan Scitech Co Ltd', u'Gifu Pharmaceutical University', u'Elan Corp plc', u'INSERM', u'Organix Inc', u'Regulus Therapeutics Inc', u'Stendhal International', u'EntoPharm Co Ltd', u'California Institute of Molecular Medicine Inc', u'Array BioPharma Inc', u'Baruch S Blumberg Institute', u'Transition Therapeutics Inc', u'Genelabs Technologies Inc', u'Ranbaxy Laboratories Ltd', u'Oxford Natural Products', u'Shire plc', u'University of Georgia', u'Janssen Pharmaceuticals Inc', u'Boehringer Ingelheim Austria GmbH', u'Crucell NV', u'Digna Biotech SL', u'Hetero Group', u'Beth Israel Deaconess Medical Center', u'University of Lille Nord de France', u'XTL Biopharmaceuticals Ltd', u'New York Medical College', u'Defense Threat Reduction Agency', u'Daiichi Seiyaku Co Ltd', u'US Government', u'Korea Institute of Science and Technology', u'InterMune Inc', u'China State Institute of Pharmaceutical Industry', u'Biogen Inc', u'UMeWorld Ltd', u'GlaxoSmithKline plc', u'AureoGen Biosciences Inc', u'Sahar International Trading Inc', u'Interferon Sciences Inc', u'BioSyntech Inc', u'Cytheris SA', u'Bio-Rad Laboratories Inc', u'Laurus Labs Pvt Ltd', u'Oklahoma Center for the Advancement of Science and Technology', u'ACLIRES', u'Sarepta Therapeutics Inc', u'Acceleration Biopharmaceuticals', u'Vaccine Research Institute of San Diego', u'Phynova Group Ltd', u'Immunotope Inc', u'Aduro BioTech Inc', u'Cold Spring Harbor Laboratory', u'Weston Medical Ltd', u'Peregrine Pharmaceuticals Inc', u'Aurobindo Pharma Ltd', u'Avac Pharma Ltd', u'Aviron Pharma LLC', u'Fides Pharma Spa', u'3M Pharmaceuticals', u'Boehringer Ingelheim (Canada) Ltd', u'Jichi Medical School', u'Alnylam Pharmaceuticals Inc', u'St Louis University', u'Philogen SpA', u'Institute for Bioscience and Biotechnology Research', u'Shire BioChem Inc', u'Minapharm Pharmaceuticals', u'Thomas Jefferson University', u'MD Anderson Cancer Center', u'Sigma-Tau Ind Farm Riunite SpA', u'Visible Genetics Inc', u'Pharmasset Inc', u'Tularik Inc', u'Emory University', u'Vical Inc', u'Abbott Laboratories', u'Commonwealth Scientific and Industrial Research Organization', u'Drexel University', u'Tacere Therapeutics Inc', u'Grifols SA', u'National Cancer Institute', u'Novartis AG', u'RetroVirox Inc', u'OraSure Technologies Inc', u'Syngene International Ltd', u'Rhode Island Hospital', u'University of Maryland', u'Fresenius Medical Care AG', u'Atea Pharmaceuticals Inc', u'SciClone Pharmaceuticals Inc', u'GeneOne Life Science Inc', u'Arbutus Biopharma Corp', u'HEC Pharm Co Ltd', u'Galectin Therapeutics Inc', u'ALZA Corp', u'Immune Response BioPharma Inc', u'Pharmacia & Upjohn Inc', u'University of Colorado System', u'3-Dimensional Pharmaceuticals Inc', u'Washington University in St Louis', u'R-Pharm', u'Johns Hopkins University', u'Immtech Pharmaceuticals Inc', u'Galenisearch Laboratories', u'Idealp-Pharma', u'Chugai Pharmaceutical Co Ltd', u'University of North Carolina', u'Ciclofilin Pharmaceuticals Inc', u'Undisclosed', u'China Medical City', u'Otsuka Pharmaceutical Co Ltd', u'ZymeTx Inc', u'Rodos BioTarget GmbH', u'Drugs for Neglected Diseases Initiative', u'Connex GmbH', u'Asklepios Biopharmaceutical Inc', u'French National Agency for Research on AIDS and Viral Hepatitis', u'iTherX Pharmaceuticals Inc', u'Yuhan Corp', u'Medivir AB', u'Dekk-Tec Inc', u'National Institute on Drug Abuse', u\"Dr Reddy's Laboratories Ltd\", u'Biota Inc', u'Theravance Biopharma Inc', u'Shanxi Kangbao Biological Products Co Ltd', u'ResApp Health Ltd', u'Lyon Biopole', u'Epimmune Inc', u'Commissariat a l`Energie Atomique', u'Barts & The London School of Medicine & Dentistry', u'C-Pharma', u'elbion NV', u'RegeneRx Biopharmaceuticals Inc', u'Valentis Inc', u'Adaltis Bio Med Company', u'rEVO Biologics Inc', u'Nobex Corp', u'Aptalis Pharma Inc', u'Esteve', u'Strides Shasun Ltd', u'Human Genome Sciences Inc', u'Wyeth-Ayerst Pharmaceuticals Inc', u'Northeastern University', u'Inhibitex Inc', u'University of Illinois', u'Dr Reddy\\u2019s Research and Development BV', u'Wyeth BioPharma', u'IRX Therapeutics Inc', u'Maxim Pharmaceuticals Inc', u'Isotechnika Pharma Inc', u'University of Gothenburg', u'Janssen R&D (Ireland)', u'Rabin Medical Center', u'National Institute of Allergy and Infectious Diseases', u'Institut Pasteur de Lille', u'TWINCORE', u'Viragen Inc', u'National Institutes of Health', u'Walter Reed Army Institute of Research', u'Natco Pharma Ltd', u'Genedrive plc', u'GenScript Corp', u'Cardiff University', u'Applied Research using OMIC Sciences SL', u'National Institutes of Standards and Technology', u'Anadys Pharmaceuticals Inc', u'ChemDiv Inc', u'Imperial College School of Medicine', u'Stanford University', u'Eiger BioPharmaceuticals Inc', u'Southeast University', u'PolyMASC Pharmaceuticals plc', u'Merck Serono SA', u'Takara Bio Inc', u'Nuron Biotech Inc', u'Idera Pharmaceuticals Inc', u'Idenix Pharmaceuticals Inc', u'Independent Pharmaceutica AB', u'Ortho-Clinical Diagnostics Inc', u'BioCryst Pharmaceuticals Inc']), u'Adrenalglandhypofunction': set([u'Phoqus Pharmaceuticals Ltd', u'Clinigen Group plc', u'VINNOVA', u'National Institutes of Health', u'IDIS Ltd', u'Recipharm AB', u'European Commission', u'Diurnal Ltd', u'Patheon Pharmaceuticals Inc', u'Medison Pharma Ltd', u'DuoCort Pharma AB']), u'Dwarfism': set([u'Pfizer Inc', u'Kaken Pharmaceutical Co Ltd', u'Korea Drug Development Fund', u'Genexine Co Ltd', u'Kwang Dong Pharmaceutical Co Ltd', u'Tulane University']), u'Salmonellainfection': set([u'US Government', u'University of Maryland School of Medicine', u'Progenra Inc', u'Wellcome Trust', u'University of Maryland', u'Syntiron LLC', u'University of Texas Southwestern Medical Center', u'National Institute of Allergy and Infectious Diseases', u'Novartis Vaccines Institute for Global Health', u'Bharat Biotech International Ltd']), u'Myelitis': set([u'Maryland Stem Cell Research Fund', u'Elan Corp plc', u'Q Therapeutics Inc', u'Acorda Therapeutics Inc']), u'Biliarytractdisease': set([u'Medipharm Biotech Co Ltd', u'Asklepion Pharmaceuticals LLC', u'Merck KGaA', u'National Institutes of Health', u'Orpharma Pty Ltd', u'Retrophin Inc', u'Synthetic Biologics Inc', u'Paul Scherrer Institut', u'Oakwood Laboratories LLC', u'Peregrine Pharmaceuticals Inc']), u'Sepsi': set([u'Royalty Pharma', u'Undisclosed']), u'InappropriateADHsyndrome': set([u'Pfizer Inc', u'Cardiokine Inc']), u'Deepveinthrombosis': set([u'Daiichi Seiyaku Co Ltd', u'BioLineRx Ltd', u'Momenta Pharmaceuticals Inc', u'Thomas Jefferson University', u'DRAXIMAGE', u'Genentech Inc', u'MSD OSS BV', u'Mitsubishi Pharma Corp', u'Epimmune Inc', u'Cardinal Health Inc', u'Armetheon Inc', u'Leiden University Medical Center', u'University of Michigan', u'Daiichi Sankyo Co Ltd', u'Abbott Laboratories', u'Regado Biosciences Inc', u'Eisai Co Ltd', u'SmithKline Beecham plc', u'Tanabe Seiyaku Co Ltd', u'GlaxoSmithKline plc', u'UCB Pharma GmbH', u'Dendreon San Diego LLC', u'Bayer Schering Pharma AG', u'Synthelabo SA', u'Teijin Ltd', u'US Government', u'Diakron Pharmaceuticals Inc', u'Immunex Corp', u'University of Pennsylvania', u'Bristol-Myers Squibb Co', u'Merck & Co Inc', u'Schwarz Pharma SpA', u'GlycoMimetics Inc', u'Kanebo KK', u'Sanofi-Synthelabo', u'LEO Pharma A/S', u'Mitsui Pharmaceuticals Inc', u'Sanofi', u'Medtronic plc', u'Emisphere Technologies Inc', u'Fujifilm Diosynth Biotechnologies', u\"Lee's Pharmaceutical Holdings Limited\", u'Berlex Biosciences', u'Molecumetics Ltd', u'Mitsubishi-Tokyo Pharmaceuticals Inc', u'Sumitomo Pharmaceuticals Co Ltd', u'Dendreon Corp', u'Sandoz Inc', u'Canyon Pharmaceuticals Inc', u'Knoll GmbH', u'Targeted Therapeutic Solutions LLC', u'Elusys Therapeutics Inc', u'Celera Group', u'Savient Pharmaceuticals Inc', u'Palatin Technologies Inc', u'Hyundai Pharmaceutical', u'Janssen Biotech Inc', u'Almirall Prodesfarma SA', u'AstraZeneca plc', u'Encysive Pharmaceuticals Inc', u'Bayer HealthCare AG', u'Fournier Pharma', u'Novartis AG', u'MannKind Corp', u'National Heart Lung and Blood Institute', u'Pfizer Inc', u'American Venous Forum', u'Matrix Pharma (Canada) Inc', u'Nuvelo Inc']), u'Weightgain': set([u'Eli Lilly & Co', u'Bionovo Inc', u'US Department of the Treasury', u'National Center for Complementary and Alternative Medicine', u'Xceleron Ltd', u'University of California at Berkeley', u'Obecure Ltd', u'Farmaceutici Formenti SpA', u'Corcept Therapeutics Inc']), u'Progressivemultifocalleukoencephalopathy': set([u'Neuway Pharma GmbH', u'Inhibikase Therapeutics Inc', u'Brown University', u'National Institute of Neurological Disorders and Stroke', u'Cobra Biologics Holding AB', u'National Institute of Allergy and Infectious Diseases', u'IXICO Plc', u'Alnylam Pharmaceuticals Inc', u'Emory University Technology Transfer Office', u'Biogen Inc', u'FORGE Life Science LLC']), u'Anemia': set([u'Akebia Therapeutics Inc', u'US Government', u'Acceleron Pharma Inc', u'Lumara Health Inc', u'BioLink Life Sciences Inc', u'Galenica AG', u'Baxter International Inc', u'Kirin Brewery Co Ltd', u'Aevi Genomic Medicine Inc', u'Shire Human Genetic Therapies Inc', u'ASKA Pharmaceutical Co Ltd', u'GlaxoSmithKline plc', u'Irix Pharmaceuticals Inc', u'Kissei Pharmaceutical Co Ltd', u'Chiesi Farmaceutici SpA', u'Cyntellect Inc', u'Rhone-Poulenc Rorer GmbH', u'ICON Clinical plc', u'Blau Pharmaceuticals', u'RW Johnson Pharmaceutical Research Institute', u'Aventis Pharma AG', u'Astex Pharmaceuticals Inc', u'Zydus-Cadila Group', u'Bio3 Research Srl', u'OSI Pharmaceuticals Inc', u'University of Pennsylvania', u'American Peptide Co', u'Amoytop Biotech Co Ltd', u'Hospira Inc', u'Roche Holding AG', u'Scotia Pharmaceuticals', u'Mitsubishi Tanabe Pharma Corp', u'Hindustan Bio Sciences', u'Standard Chemical & Pharmaceutical Co Ltd', u'Sankyo Co Ltd', u'Tenax Therapeutics Inc', u'Boston University', u'Catalent Inc', u'AstraZeneca plc', u'HanAll Biopharma Co Ltd', u'1608557 Ontario Inc', u'National Heart Lung and Blood Institute', u'Technology Strategy Board', u'GlycoForm Ltd', u'Shanghai Qiangbang Biotech Co Ltd', u'Inflabloc Pharmaceuticals Inc', u'Eukarion Inc', u'CrystalGenomics Inc', u'Evotec AG', u'Merckle GmbH', u'Wockhardt Ltd', u'Charles River Laboratories International Inc', u'Israeli Government', u'Amgen Inc', u'The Center of Molecular Immunology', u'Allist Pharmaceuticals Inc', u'PolyTherics Ltd', u'The European Union', u'SmithKline Beecham Corp', u'Eisai Co Ltd', u'3SBio Inc', u'Boryung Biopharma Co Ltd', u'Boehringer Mannheim GmbH', u'Wuxi AppTec Inc', u'GeneraMedix Inc', u'US Department of Defense', u'Serum Institute of India Ltd', u'Bolder BioTechnology Inc', u'Palkion Inc', u'BioGeneric Pharma', u'Italfarmaco SpA', u'Fresenius Medical Care AG', u'Royal Free and University College Medical School', u'JCR Pharmaceuticals Co Ltd', u'Shanghai Chemo Wanbang Biopharma Co Ltd', u'FibroGen Inc', u'Pieris Pharmaceuticals Inc', u'Xenon Pharmaceuticals Inc', u'KBI Biopharma Inc', u'Dong-A ST Co Ltd', u'NOBEL ILAC Sanayii ve Ticaret AS', u'Center for Genetic Engineering and Biotechnology', u'Boston De Novo', u'Fresenius Medical Care North America (FMCNA)', u'Gene Techno Science Co Ltd', u'Plasticell Ltd', u'Wyeth BioPharma', u'Qu\\xedmica Ariston Ecuador LLC', u'Fuji Pharma Co Ltd', u'Biotechnology and Biological Sciences Research Council (BBSRC)', u'Rockefeller University', u'Green Cross Corp', u'Ortho Biotech Products LP', u'GENESIS Pharma SA', u'Otsuka Holdings Co Ltd', u'VGX Pharmaceuticals LLC', u'TPG Biotech', u'Vifor Pharma', u'National Institute of Diabetes, Digestive and Kidney Diseases', u'Alexion Pharmaceuticals Inc', u'Cipla Ltd', u'Cangene Corp', u'Oklahoma Medical Research Foundation', u'Proteos SRL', u'ViaCell Inc', u'Actavis Inc', u'Ionis Pharmaceuticals Inc', u'Xenetic Biosciences Inc', u'Nautilus Biotech SA', u'Rockwell Medical Inc', u'Chi Sheng Chemical Corp', u'Daewoong Pharmaceutical Co Ltd', u'Dragon Pharmaceutical Inc', u'Perelman School of Medicine', u'Shandong Kexing Bioproducts Co Ltd', u'Chong Kun Dang Pharmaceutical Corp', u'Alkermes plc', u'Eli Lilly & Co', u\"Lee's Pharmaceutical Holdings Limited\", u'Regen BioPharma Inc', u'Japan Tobacco Inc', u'DaVita Inc', u'The University of Aston In Birmingham', u'Ancora Pharmaceuticals Inc', u'BioMena SA', u'DNAPrint genomics Inc', u'Repros Therapeutics Inc', u'DSI Renal', u'China Medical System Holdings Ltd', u'Nektar Therapeutics', u'Almirall Prodesfarma SA', u'Therapure Biopharma Inc', u'Fuji Seiyaku Kogyo KK', u'Pfizer Inc', u'National Institute on Aging', u'Suzhou Kangju Biological Technology Co Ltd', u'Fox Chase Chemical Diversity Center Inc', u'Makoff R&D Laboratories Inc', u'Human Genome Sciences Inc', u'Undisclosed', u'AMAG Pharmaceuticals Inc', u'Genexine Co Ltd', u'Sanwa Kagaku Kenkyusho Co Ltd', u'Lonza Biologics plc', u'Vatea Fund', u'ProMetic Life Sciences Inc', u'Baylor College of Medicine', u'Biocad Ltd', u'Viking Therapeutics Inc', u'Mipharm SpA', u'Bioject Medical Technologies Inc', u'US Naval Medical Research Center', u'Quintiles IMS Holdings', u'SmithKline Beecham plc', u'Ligand Pharmaceuticals Inc', u'Suzhou Shengji Pharmaceutical Co Ltd', u'ALTANA AG', u'Takeda Pharmaceutical Co Ltd', u'Hetero Group', u'Walter Reed Army Institute of Research', u'National Institutes of Health', u'Fresenius SE & Co KGaA', u'Republic of Korea Government', u'Chinese Government', u'Elanex Pharmaceuticals Inc', u'US Renal Care Inc', u'CJ Corp', u'Celgene Corp', u'Bioceuticals Arzneimittel AG', u'Astellas Pharma Inc', u'Valeant Pharmaceuticals International Inc', u'JW Pharmaceutical Corp', u'V.I. PHARMA INTERNATIONAL SA', u'Prolong Pharmaceuticals Inc', u'Concordia International Corp', u'National Cancer Institute', u'RG Pharmaceutica Pvt Ltd', u'Gedeon Richter Ltd', u'Boryung Pharm Co Ltd', u'Beth Israel Deaconess Medical Center', u'Affymax Inc', u'Emcure Pharmaceuticals Ltd']), u'Wolmandisease': set([u'Synex Consulting Korea Limited', u'Alexion Pharmaceuticals Inc']), u'Ulcer': set([u'Celtrix Pharmaceuticals Inc', u'Ipsen Biopharmaceuticals Inc', u'Massachusetts Institute of Technology', u'Genentech Inc', u'Maruho Co Ltd', u'Cangene Corp', u'Japan Upjohn Ltd', u'Taisho Pharmaceutical Co Ltd', u'GlaxoSmithKline plc', u'M.J. Murdock Charitable Trust', u'World Health Organization', u'National Cancer Institute', u'Takeda Pharmaceutical Co Ltd', u'Chiron Corp', u'Ikeda Mohando Co Ltd', u'Telormedix SA', u'Bristol-Myers Squibb Co', u'Vanderbilt University', u'Aventis SA', u'Sanofi', u'Giddi Pharma Co Ltd', u'Galderma SA', u'Ono Pharmaceutical Co Ltd', u'Infectious Disease Research Institute', u'Transition Therapeutics Inc', u'BIO Ventures for Global Health', u'Grelan Pharmaceutical Co Ltd', u'Medicines for Malaria Venture', u'Janssen Pharmaceuticals Inc', u'Pfizer Inc', u'Boehringer Ingelheim Corp', u'Swiss Tropical & Public Health Institute', u'Biologix FZ Co', u'Alnylam Pharmaceuticals Inc', u'Sigma-Tau Ind Farm Riunite SpA']), u'Macularedema': set([u'Eyegate Pharmaceuticals Inc', u'Regeneron Pharmaceuticals Inc', u'Bayer AG', u'Clearside Biomedical Inc', u'AsclepiX Therapeutics LLC', u'Dyax Corp', u'Ministry of Economic Affairs, ROC', u'Valeant Pharmaceuticals International Inc', u'Taiwan Liposome Co', u'Novellus Biopharma AG', u'The European Union', u'National Eye Institute', u'Eyekor LLC', u'KalVista Pharmaceuticals Inc (Pre-merger)']), u'Neuraltubedefect': set([u'National Institute Of Environmental Health Sciences', u\"Boston Children's Hospital\"]), u'Hemoglobinopathy': set([u'SEBIA', u'Ravizza Farmaceutici SpA', u'Bayer AG', u'Childrens Hospital Oakland Research Institute', u'Phoenicia Biosciences Inc', u'National Heart Lung and Blood Institute', u'Caisse de d\\xe9p\\xf4t et placement du Qu\\xe9bec', u'Vertex Pharmaceuticals Inc', u'MaxCyte Inc', u'Provepharm SAS', u'Daiichi Sankyo Co Ltd', u'CRISPR Therapeutics', u'Alpha Therapeutic Corp']), u'Infectiousendocarditis': set([u'National Institutes of Health', u'University of California Los Angeles', u'ContraFect Corp', u'US Department of Defense', u'Agile Sciences Inc']), u'Inclusionbodymyositis': set([u'MorphoSys AG', u'Novartis AG']), u'Abdominalcavityinflammation': set([u'Merck Serono SA', u'PregLem Holding SA']), u'Gallbladdertumor': set([u'Eli Lilly & Co', u'National Comprehensive Cancer Network', u'Bayer AG', u'Pfizer Inc', u'Genentech Inc', u'Halozyme Therapeutics Inc', u'Princeton University', u'Takeda Pharmaceutical Co Ltd', u'Memorial Sloan-Kettering Cancer Center']), u'Enterococcusfaeciuminfection': set([u'Oscient Pharmaceuticals Corp', u'Johnson & Johnson', u'Catalytica Inc', u'Biosearch Italia SpA', u'Microcide Pharmaceuticals Inc', u'Ardea Biosciences Inc', u'Sanofi']), u'Gout': set([u'Tianjin Linda Biotechnology Ltd', u\"Tianjin Municipal People's Government\", u'Polaris Pharmaceuticals Inc', u'CymaBay Therapeutics Inc', u'Mountain View Pharmaceuticals Inc', u'Jiangsu University', u'Selecta Biosciences Inc', u'Kunming Pharmaceutical Corp', u'Aspen PharmaCare Holdings Ltd', u'Medarex Inc', u'Grunenthal GmbH', u'Kowa Pharmaceuticals America Inc', u'Algorithm SAL', u'Ardea Biosciences Inc', u'Savient Pharmaceuticals Inc', u'3SBio Inc', u'GlaxoSmithKline plc', u'XOMA Corp', u'Juvenile Diabetes Research Foundation', u'Santarus Inc', u'Cardiome Pharma Corp', u'Sigma-Tau PharmaSource Inc', u'Hi-Tech Pharmacal Co Inc', u'Servier', u'Undisclosed', u'Ipsen', u'Knight Therapeutics Inc', u'Altus Pharmaceuticals Inc', u'Novartis Pharma AG', u'Elan Corp plc', u'Myungin Pharm Co Ltd', u'Phoenix Pharmacologics Inc', u'US Department of Veterans Affairs', u'SK Group', u'Nodthera Ltd', u'Ironwood Pharmaceuticals Inc', u'Ajinomoto Althea Inc', u'Prasco Laboratories', u'Revive Therapeutics Ltd', u'Heumann Pharma GmbH & Co KG', u'Astellas Pharma Inc', u'Roche Holding AG', u'Sunovion Pharmaceuticals Canada Inc', u'Cellix Bio Pvt Ltd', u'Duke University', u'Kunming Medical University', u'Kissei Pharmaceutical Co Ltd', u'Atom Bioscience and Pharmaceutical Co Ltd', u'EnzymeRx LLC', u'Alvogen Inc', u'Fuji Yakuhin Co Ltd', u'The Menarini Group', u'Takeda Pharmaceuticals North America Inc', u'Selvita SA', u'AstraZeneca plc', u'Pfizer Inc', u'Shionogi & Co Ltd', u'Johns Hopkins University', u'Teijin Ltd', u'Takeda Pharmaceutical Co Ltd', u'Antibe Therapeutics Inc', u'Victory Pharma Inc', u'Teijin Pharma Ltd', u'Recordati SpA', u'Sanwa Kagaku Kenkyusho Co Ltd', u'ILEX Oncology Inc']), u'Cerebrovasculartrauma': set([u'Boehringer Ingelheim Corp', u'NPO Petrovax Pharm LLC']), u'Cornealinjury': set([u'Allergan Inc', u'Jade Therapeutics', u'University of North Carolina', u'China Resources Zizhu Pharmaceutical Co Limited', u'Inspire Pharmaceuticals Inc', u'FirstString Research Inc', u'Biotoxtech Co Ltd', u'Wenzhou Medical College', u'Beijing Northland Biotech Co Ltd', u'Teika Seiyaku KK', u'The University of Newcastle Upon Tyne', u'Guangdong Jida Genetic Medicine Engineering Research Center Co Ltd', u'National Eye Institute', u'Kissei Pharmaceutical Co Ltd', u'Santen Pharmaceutical Co Ltd', u'Medical Research Council', u'BioTime Inc', u'Uni-Bio Science Group Ltd']), u'Obstructivesleepapnea': set([u'Weston Brain Institute', u'McGill University', u'SleepMed Inc', u'RespireRx Pharmaceuticals Inc', u'Earlysense Ltd', u'University of Illinois']), u'Allergy': set([u'Solvay SA', u'Eddingpharm Inc', u'Verus Pharmaceuticals Inc', u'EpiVax Inc', u'Novartis Pharma AG', u'MonoSol Rx Inc', u'University of Lyon', u'IMPAX Laboratories Inc', u'Sumitomo Pharmaceuticals Co Ltd', u'Allergopharma GmbH & Co KG', u'Hospira Inc', u'SBI Biotech Co Ltd', u'Galapagos NV', u'St Georges University of London', u'Orphagen Pharmaceuticals Inc', u'Silence Therapeutics plc', u'Dompe SpA', u'Toray Industries Inc', u'Catalent Inc', u'HanAll Biopharma Co Ltd', u'Abgenix Inc', u'Alseres Pharmaceuticals Inc', u'National Institute on Aging', u'Michigan State University', u'Pharmacare Ltd', u'Weill Medical College of Cornell University', u'University of Nottingham', u'Julphar Gulf Pharmaceutical Industries', u'Centre National de la Recherche Scientifique (CNRS)', u'Nventa Biopharmaceuticals Corp', u'Beximco Pharmaceuticals Ltd', u'Cambridge Antibody Technology Group plc', u'The European Union', u'Mount Sinai School of Medicine', u'Maxygen Inc', u'Cobalis Corp', u'Sam-Oh Pharm Co Ltd', u'Sixal Corp', u'Santen Pharmaceutical Co Ltd', u'Thermo Fisher Scientific Inc', u'National Jewish Health', u'Pharmacopeia Inc', u'Kyorin Pharmaceutical Co Ltd', u'Nycomed Canada Inc', u'Janssen Pharmaceutica NV', u'Taiho Pharmaceutical Co Ltd', u'Genfit SA', u'Nippon Boehringer Ingelheim Co Ltd', u'Laboratorios Servimedic', u'Swedish Orphan Biovitrum AB', u'Bausch & Lomb Inc', u'YSP South Asia Holding Bhd', u'Hartford Hospital', u'Ministry of Economy, Trade and Industry', u'Axiom Biotechnologies Inc', u'Ajinomoto Co Inc', u'IGE Therapeutics Inc', u'Grunenthal GmbH', u'Universita degli Studi di Napoli Federico II', u'Undisclosed', u'Biomay AG', u'7TM Pharma A/S', u'Sakai Chemical Industry Co Ltd', u'Bernofarm Pharmaceutical Co', u'Domainex Ltd', u'Agenus Inc', u'CSL Ltd', u'Mimetrix', u'Fournier Pharma', u'Scienion AG', u'Nanotechnology Victoria Pty Ltd', u'Corixa Corp', u'Zalicus Inc', u'Taisho Pharmaceutical Co Ltd', u'Heska Corp', u'Northwestern University', u'Danish National University Hospital', u'Servier', u'Bristol-Myers Squibb Co', u'VaxLogic LLC', u'VINNOVA', u'Astellas Pharma Inc', u'Mitsubishi Chemical Holdings Corp', u'ImVisioN Therapeutics Inc', u'Fujirebio KK', u'AllerQuest', u'Discovery Partners LLC', u'Hebrew University of Jerusalem', u'Hayashibara Co Ltd', u'NanoPass Technologies Ltd', u'Hadassah University Hospital', u'Bio-Quant Inc', u'S-TARget therapeutics', u'Singapore Immunology Network', u'DSM Pharmaceuticals Inc', u'Karolinska Institutet', u'Merck Sharp & Dohme BV', u'Dynavax Technologies Corp', u'Indiso Ltd', u'BTG plc', u'Chiesi Farmaceutici SpA', u'Inter Cyto Nano Science Co Ltd', u'Selexis SA', u'Genentech Inc', u'Onyvax Ltd', u'Lorantis Ltd', u'Ono Pharmaceutical Co Ltd', u'Roche Holding AG', u'Shire plc', u'University of British Columbia', u'Kaken Pharmaceutical Co Ltd', u'ANI Pharmaceuticals Inc', u'Virginia Commonwealth University', u'UCB Pharma SA', u'Teikoku Seiyaku KK', u'ImmuLogic Pharmaceutical Corp', u'Interprotein Corp', u'TG Therapeutics Inc', u'Eleven Biotherapeutics Inc', u'J Uriach & Cia SA', u'International Shipping and Marketing LLC', u'Meiji Seika Pharma Co Ltd', u'Charles River Laboratories International Inc', u'Cureon A/S', u'Axela Inc', u'CytoMed Inc', u'The University of Birmingham', u'University of Bristol', u'MabVax Therapeutics Holdings Inc', u'Italfarmaco SpA', u'Imperial College London', u'Tanabe Seiyaku Co Ltd', u'RIKEN', u'University of Szeged', u'Albany Molecular Research Inc', u'Prasco Laboratories', u'Allergan Inc', u'Ribapharm Inc', u'AllerPharma Inc', u'Xencor Inc', u'Roche Palo Alto', u'Highnoon Laboratories Ltd', u'Gyeonggi Institute Of Science & Technology Promotion', u'Health Research Council of New Zealand', u'Stanford University', u'Paladin Labs Inc', u'Andrx Corp', u'Mayo Clinic Foundation', u'Rigel Pharmaceuticals Inc', u'Ore Pharmaceuticals Inc', u'Xerion Pharmaceuticals AG', u\"Centre d'Immunologie de Marseille-Luminy\", u'Sumitomo Dainippon Pharma Co Ltd', u'Nippon Chemiphar Co Ltd', u'Australian Research Council', u'BioFocus DPI', u'Japan Tobacco Inc', u'Janssen Pharmaceuticals Inc', u'Commense Inc', u'National Tsing Hua University', u'Tunitas Therapeutics Inc', u'University of Debrecen', u'AstraZeneca plc', u'Boehringer Ingelheim Pharmaceuticals Inc', u'VLP Biotech Inc', u'Consortium of Food Allergy Research', u'University College London', u'Array BioPharma Inc', u'Academia Sinica', u'ASLAN Pharmaceuticals Pte Ltd', u'Pharmos Corp', u'Dainippon Pharmaceutical Co Ltd', u'Ligand Pharmaceuticals Inc', u'DuoCort Pharma AB', u'MacroGenics Inc', u'Senju Pharmaceutical Co Ltd', u'BIAL Group', u'Eczacibasi Ilac Pazarlama AS', u'ICOS Corp', u'Anergis SA', u'Fovea Pharmaceuticals SA', u'Thornton & Ross Ltd', u'Institut Pasteur', u'Selecta Biosciences Inc', u'Par Pharmaceutical Inc', u'Walter and Eliza Hall Institute of Medical Research', u'Ono Pharma UK Ltd', u'Dyax Corp', u'Takeda Pharmaceutical Co Ltd', u'Genesis Research and Development Corp Ltd', u'Novozymes A/S', u'Prestige Brands Holdings Inc', u'Sanofi-Aventis US LLC', u'University of Connecticut', u'Aero Pharmaceuticals Inc', u'Rhone-Poulenc Rorer Pharm Inc', u'Advaxis Inc', u'US Government', u'Lynx Therapeutics GmbH', u'Biotest AG', u'Quintiles Transnational Corp', u'Vical Inc', u'Swiss Innovation Fund', u'Schepens Eye Research Institute', u'Moberg Pharma AB', u'MedImmune LLC', u'Johannes Gutenberg Universitat Mainz', u'Exiqon A/S', u'Cortech Inc', u'Newsummit Biopharma Co Ltd', u'Senetek plc', u'Genetic Immunity LLC', u'Allergy Therapeutics plc', u'Fountain BioPharma Inc', u'Kanebo KK', u'Japan Science and Technology Agency', u'YM BioSciences Inc', u'Laboratorios Elmor SA', u'TransGenex Nanobiotech Inc', u'Universite de Rouen', u'ActoGeniX NV', u'Alimera Sciences Inc', u'Zeneca Group plc', u'Allakos Inc', u'University of Colorado, Boulder', u'VTU Technology', u'Lonn Ryonn Pharma Ltd', u'Wolwo Biotech Co Ltd', u'Technology New Zealand', u'Makoto Life Sciences Inc', u'Schering-Plough Corp', u'Minophagen Pharm Co', u'Sumitomo Chemical Co Ltd', u'Merck & Co Inc', u'OAO \"Akrikhin\"', u'Sanofi', u'Interstitial NanoSystems Pty Ltd', u'Bayer AG', u'Phytera Inc', u'Almirall Prodesfarma SA', u'VentiRx Pharmaceuticals Inc', u'Gilead Sciences Inc', u'Luna Innovations Inc', u'Allergy Laboratories Inc', u'Wyeth', u'Institute for the Promotion of Innovation by Science and Technology in Flanders', u'Acambis plc', u'Alcon Inc', u'University of Iowa', u'Antigen Express Inc', u'AlleCure Corp', u'PowderJect Pharmaceuticals plc', u'Helixir Co Ltd', u'Lonza Group AG', u'Scottish Biomedical Ltd', u'GlaxoSmithKline KK', u'Chinese Government', u'Annapurna Therapeutics SAS', u'INSERM', u'Kuros Biosciences Ltd', u'MSD Japan', u'CJ Corp', u'bioCSL PTY Ltd', u'Agence Nationale de Valorisation de la Recherche', u'Eurofarma', u'Sosei Group Corp', u'Ranbaxy Laboratories Ltd', u'SenzaGen AB', u'Adamis Pharmaceuticals Corp', u'Meda Pharmaceuticals Inc', u'Milex Biotech', u'Pernix Therapeutics Holdings Inc', u'Perrigo Co Ltd', u'iCo Therapeutics Inc', u'Hunter-Fleming Ltd', u'Fujian Institute of Microbiology', u'Biogen Inc', u'GlaxoSmithKline plc', u'InMed Pharmaceuticals Inc', u'Cascadian Therapeutics Inc', u'Circassia Pharmaceuticals plc', u'Procter & Gamble Pharmaceuticals Inc', u'Roxall Medizin GmbH', u'Vaccine Research Institute of San Diego', u'Elite Pharmaceuticals Inc', u'Laboratoires Thea', u'FAES Farma SA', u'Takeda Oncology', u'Oneday - Biotech & Pharma Ltd', u'Novis Pharmaceuticals Llc', u'Sankyo Co Ltd', u'United Biomedical Inc', u'Universitat Innsbruck', u'Boston University', u'Amalyte Pharmaceuticals LLC', u'ECI Inc', u'Stanford Rook Ltd', u'Ariana Pharmaceuticals', u'Resistentia Pharmaceuticals AB', u'Shionogi & Co Ltd', u'UCB SA', u'Meristem Therapeutics', u'Medarex Inc', u'Daiichi Sankyo Co Ltd', u'Abbott Laboratories', u'SARM Srl', u'Eisai Co Ltd', u'AlerGenetica SL', u'Tanox Inc', u'Immune Design Corp', u'Novartis AG', u'Merck KGaA', u'REGiMMUNE Corp', u'Keryx Biopharmaceuticals Inc', u'Theragen ETEX', u'Cornell University', u'Concordia Pharmaceuticals Inc', u'Cadus Corp', u'University of Manchester', u'National Institute Of Environmental Health Sciences', u'Biovail Technologies Ltd', u'Orient Europharma', u'Immunomic Therapeutics Inc', u'University of Barcelona', u'Johns Hopkins University', u'Recordati SpA', u'Centre National de Genotypage (CNG)', u'Malaghan Institute of Medical Research', u'Rodos BioTarget GmbH', u'Shionogi Pharma Inc', u'Yuhan Corp', u'Seikagaku Corp', u'American Cancer Society', u'University of California', u'UBE Industries Ltd', u'Novartis International Pharmaceutical Ltd', u'Epimmune Inc', u'Strathmann Biotec AG', u'Rademacher Group Ltd', u'Meiji Co Ltd', u'Kyowa Hakko Kirin Co Ltd', u'Fujian Mindong Rejuvenation Pharmaceutical Co Ltd', u'Torii Pharmaceutical Co Ltd', u'BD Biosciences', u'Protectimmun GmbH', u'Janssen Biotech Inc', u'Sunovion Pharmaceuticals Inc', u'Pfizer Inc', u'Midatech Pharma PLC', u'Idera Pharmaceuticals Inc', u'Tsumura & Co', u'Yissum Research Development Co', u'Mount Sinai Medical Center', u'Shionogi Inc', u'Synthelabo', u'Angsana Molecular & Diagnostics Laboratory Pte Ltd', u'National Institute of Allergy and Infectious Diseases', u'SEEK', u'United BioPharma Inc', u'Epsilon Therapeutics', u'Zambon Co SpA', u'Shanghai Pharmaceutical Group Corp', u'Stallergenes SA', u'Albumedix A/S', u'National Institutes of Health', u'ALK-Abello', u'Zenyth Therapeutics Ltd', u'UCB Japan Co Ltd', u'DBV Technologies SA', u'3-Dimensional Pharmaceuticals Inc', u'JDP Therapeutics Inc', u'Deerfield Management Company LP', u'ProBioGen AG', u'Strides Shasun Ltd', u'ECR Pharmaceuticals', u'EUROIMMUN GmbH', u'Boryung Pharm Co Ltd']), u'Musculoskeletalpain': set([u'Eli Lilly & Co', u'Kalvista Pharmaceuticals Inc', u'Quintiles Transnational Corp', u'Shanghai Jingfeng Pharmaceutical Co Ltd']), u'Stomachulcer': set([u'Nippon Shinyaku Co Ltd', u'Exomed Australia Pty Ltd', u'US Government', u'CTC Bio Inc', u'Acambis Inc', u'Ajinomoto Co Inc', u'Yuhan Corp', u'The Procter & Gamble Co', u'Melior Pharmaceuticals Inc', u'Zeria Pharmaceutical Co Ltd', u'Abbott Laboratories', u'Eurocine Vaccines AB', u'Eisai Co Ltd', u'Michigan Economic Development Corp', u'Taisho Pharmaceutical Co Ltd', u'GlaxoSmithKline plc', u'Salix Pharmaceuticals Inc', u'Hamamatsu University School of Medicine', u'Santarus Inc', u'Astra Merck Inc', u'Beijing Yipuan Bio-Medical Technology Co. Ltd', u'Sihuan Pharmaceutical Holdings Group Ltd', u'R-Pharm', u'Laboratorios Andromaco SA (Chile)', u'Ikeda Mohando Co Ltd', u'Daewoong Pharmaceutical Co Ltd', u'Otsuka America Pharmaceutical Inc', u'Hanmi Pharmaceutical Co Ltd', u'R2 Pharma LLC', u'Sanofi', u'Zydus-Cadila Group', u'UBE Industries Ltd', u'ParaPRO LLC', u'Sankyo Co Ltd', u\"Lee's Pharmaceutical Holdings Limited\", u'Marathon Pharmaceuticals LLC', u'Ministry of Science and Technology of the People\\xb4s Republic of China', u'Il-Yang Pharmaceutical Co', u'Astellas Pharma Inc', u'Taejoon Pharm Co Ltd', u'Novartis AG', u'Shenzhen Zhijun Pharmaceutical Co Ltd', u'Taiho Pharmaceutical Co Ltd', u'Mitsubishi Pharma Corp', u'Fujirebio KK', u'Dong-A ST Co Ltd', u'NephRx Corp', u'Grelan Pharmaceutical Co Ltd', u'GE Healthcare', u'Amneal Pharmaceutical LLC', u'Shanghai Pharmaceutical Group Corp', u'Takeda GmbH', u'Aptalis Pharma Inc', u'Pfizer Inc', u'Boehringer Ingelheim Corp', u'AstraZeneca plc', u'Kotobuki Pharmaceutical Co Ltd', u'Takeda Pharmaceutical Co Ltd', u'Beijing Liang Fang Pharmaceutical Co. Ltd', u'RedHill Biopharma Ltd', u'Norgine BV', u'Valeant Pharmaceuticals North America LLC', u'Helicure AB', u'Horizon Pharma plc', u'SK Chemicals Co Ltd', u'Sigma-Tau Ind Farm Riunite SpA']), u'Isletcelltransplantrejection': set([u'AmbioPharm Inc', u'Karolinska Institutet', u'ITR Laboratories Canada Inc', u'University of Miami', u'University of Oslo', u'University of Alberta', u'Biscayne Pharmaceuticals Inc', u'Isogenis Inc', u'Undisclosed', u'ProtoKinetix Inc', u'Dresden University of Technology', u'Bri Biopharmaceuticals Research Inc', u'Uppsala University', u'Korea Drug Development Fund', u'DiNonA Inc', u'National Institute of Diabetes, Digestive and Kidney Diseases', u'Melanoma Research Alliance', u'TikoMed AB', u'Wistar Institute of Anatomy & Biology']), u'Gingivitis': set([u'National Institute of Dental and Craniofacial Research', u'Four Tigers LLC', u'Inotek Pharmaceuticals Corp', u'Wockhardt Ltd', u'Massachusetts Institute of Technology', u'PPL Therapeutics plc', u'Periodontix Inc', u'Newsummit Biopharma Co Ltd', u'Aphios Corp', u'National Institutes of Health', u'Sinclair Pharma plc', u'Pacgen Life Science Corp', u'Scripps Research Institute', u'Laboratoires Expanscience', u'DermaMed Pharmaceutical Inc', u'Child Health Corporation of America (CHCA)', u'Evocutis plc']), u'Keratoconus': set([u'Barraquer', u'The Ocular Microsurgery Institute', u'Universidade de Santiago de Compostela', u'Bioftalmik SL', u'Centro de Ojos Quilmes', u'IROS RC Srl', u'S. Fyodorov Eye Microsurgery Complex', u'Hospital Angeles Pedregal', u'VISSUM Corporaci\\xf3n Oftalmol\\xf3gica', u'Hospital La Arruzafa', u'Spectrum Thea Pharmaceuticals Limited', u'Centro Oftalmologico Virgilio Galvis', u'Cartuja Vision', u'National Eye Institute', u'Jimenez Diaz Foundation', u'Columbia University', u'Centre for Sight', u'Servimed SA', u'Organes Tissus Regeneration Reparation Replacement (OTR3)', u'Instituto Oftalmosalud SRL', u'Instituto Tecnologico y de Estudios Superiores de Monterrey', u'Ferrara Ophthalmics', u'The Basque Foundation for Health Innovation and Research', u'Universitatsklinikum Erlangen', u'The Instituto Cl\\xednico Quir\\xfargico de Oftalmologia', u'Fernandez-Vega Ophthalmological Institute', u'NovaMedica']), u'Necrotizingenterocolitis': set([u'Avexegen Therapeutics Inc', u'Takeda Pharmaceutical Co Ltd']), u'Acidosis': set([u'Ipsen Biopharmaceuticals Inc', u'Genentech Inc', u'Ipsen', u'Biologix FZ Co', u'Menarini Asia-Pacific', u'Giddi Pharma Co Ltd']), u'N-acetylglutamatesynthasedeficiency': set([u'Accredo Health Group Inc', u'Orphan Europe SARL']), u'Facioscapulohumeralmusculardystrophy': set([u'Evotec AG', u'Leiden University Medical Center', u'FSHD Stichting', u'Novogen Ltd', u'University of Rochester', u'Stanford University', u'US Government', u'Facio Therapies BV', u'Ultragenyx Pharmaceutical Inc', u'St Louis University', u'University of Washington', u'The Center for World Health & Medicine at Saint Louis University', u'GlaxoSmithKline plc', u'Fred Hutchinson Cancer Research Center', u'Muscular Dystrophy Association', u'FSHD Global Research Foundation', u'Genea Biocells']), u'Papovavir': set([u'University of California', u'Chimerix Inc']), u'Pancreastu': set([u'US Government', u'Immunomedics Inc']), u'Xerophthalmia': set([u'Scope Ophthalmics', u'US Government', u'Ocugen Inc', u'Ocular Therapeutix Inc', u'RegeneRx Biopharmaceuticals Inc', u'Provence Technologies Group', u'BioLight Life Sciences Investments Ltd', u'MacuSight Inc', u'Schepens Eye Research Institute', u'Novartis Pharma AG', u'Cambium Medical Technologies LLC', u'Allysta Pharmaceuticals Inc', u'Laboratoires Thea', u'Ramot at Tel Aviv University Ltd', u'Aurinia Pharmaceuticals Inc', u'Fischer Pharmaceuticals Ltd', u'Yonsei University', u'Mitsubishi Tanabe Pharma Corp', u'Southern College of Optometry', u'Huons Co Ltd', u'Sankyo Co Ltd', u'Temple University', u'Nicox Ophthalmics Inc', u'DiagnosTear Ltd', u'HanAll Biopharma Co Ltd', u'Emory University', u'Eleven Biotherapeutics Inc', u'R-Tech Ueno Ltd', u'Apexigen Inc', u'TearLab Corp', u'Topivert Pharma Ltd', u'Portola Pharmaceuticals Inc', u'Redwood Pharma AB', u'Neuroptis Biotech', u'Novartis AG', u'BRIM Biotechnology Inc', u'Parion Sciences Inc', u'Lantibio Inc', u'Hanmi Pharmaceutical Co Ltd', u'EyeRx Research Inc', u'Santen Pharmaceutical Co Ltd', u'Tanabe Seiyaku Co Ltd', u'Incept LLC', u'Lubris BioPharma', u'Dong-A ST Co Ltd', u'Shire plc', u'Imprimis Pharmaceuticals Inc', u'Chonbuk National University', u'Teika Seiyaku KK', u'Bausch & Lomb Inc', u'G-treeBNT Co Ltd', u'Vegenics Ltd', u'Green Cross Corp', u'Merck Animal Health', u'Otsuka Pharmaceutical Co Ltd', u'AFT Pharmaceuticals Ltd', u'Allergan plc', u'Undisclosed', u'Eastern Virginia Medical School', u'Daewoong Pharmaceutical Co Ltd', u'Anabasis Pharma', u'Mimetogen Pharmaceuticals Inc', u'Merck & Co Inc', u'National Eye Institute', u'Chong Kun Dang Pharmaceutical Corp', u'Biem Pharmaceuticals', u'InSite Vision Inc', u'Eyegate Pharmaceuticals Inc', u'OphthalmoPharma Ltd', u'University of Virginia', u'Navigo Proteins GmbH', u'Novaliq GmbH', u'Axim Biotechnologies Inc', u'Kissei Pharmaceutical Co Ltd', u'James Madison University', u'Chonnam National University', u'Inspire Pharmaceuticals Inc', u'Pfizer Inc', u'Ursapharm Arzneimittel GmbH & Co KG', u'Yissum Research Development Co', u'University of Illinois', u'Resolvyx Pharmaceuticals Inc', u'Alcon Inc', u'BioLineRx Ltd', u'University of Missouri', u'Augusta State University', u'Auven Therapeutics', u'PharmaNova Inc', u'Allosterix Pharmaceuticals LLC', u'Lux Biosciences Inc', u'Albumedix A/S', u'Senju Pharmaceutical Co Ltd', u'Samil Pharmaceutical Co Ltd', u'ORA Inc', u'Physician Recommended Nutriceuticals', u'University of Aberdeen', u'Altacor Ltd', u'SightLife', u'MGI Pharma Inc', u'Seoul National University', u'Dompe Group', u'arGentis Pharmaceuticals LLC', u'Acucela Inc', u'Broda Technologies Co Ltd', u'Bio-Tissue Inc']), u'Cysticfibrosis': set([u'UK Cystic Fibrosis Gene Therapy Consortium', u'Pharmaxis Ltd', u'BioMarin Pharmaceutical Inc', u'Ludwig-Maximilians University of Munich', u'OrPro Therapeutics Inc', u'FAES Farma SA', u'AOP Orphan Pharmaceuticals AG', u'InterMune Inc', u'Sanofi Pasteur', u'China State Institute of Pharmaceutical Industry', u'GenVec Inc', u'Cystic Fibrosis Foundation', u'Synteract Inc', u'Aeolus Pharmaceuticals Inc', u'Polydex Pharmaceuticals Ltd', u'UMeWorld Ltd', u'Global Clean Energy Holdings Inc', u'GlaxoSmithKline plc', u'Quintiles Transnational Corp', u'Chiesi Farmaceutici SpA', u'Vical Inc', u'Calista Therapeutics Inc', u'ALIGN Pharmaceuticals LLC', u'Pulmagen Therapeutics', u'North Carolina State University', u'Ionis Pharmaceuticals Inc', u'Teva Pharmaceutical Industries Ltd', u'Arch Biopartners Inc', u'Vanderbilt University', u'Congenica Ltd', u'Argenta Discovery Ltd', u'Hawker Resources Inc', u'Kala Pharmaceuticals Inc', u'Sangamo Therapeutics Inc', u'Colthurst Ltd', u'Fondazione per la ricerca sulla Fibrosi Cistica', u'Cortech Inc', u'Defiante Farmaceutica Lda', u'Aurora Biosciences Corp', u'ISM Therapeutics', u'Universita Degli Studi Di Perugia', u'Shire plc', u'University of British Columbia', u'Grifols Inc', u'Laurent Pharmaceuticals', u'Galapagos NV', u'Progenra Inc', u'Serendex Pharmaceuticals A/S', u'Combating Antibiotic-Resistant Bacteria Biopharmaceutical Accelerator', u'Aviragen Therapeutics Inc', u'La Jolla Pharmaceutical Co', u'Tensive Controls Inc', u'Polyphor Ltd', u'Canadian Institutes of Health Research', u'ModeRNA Therapeutics', u'Catalent Inc', u'Inspire Pharmaceuticals Inc', u'National Center for Research Resources', u'Medical Research Council', u'Dalton Cardiovascular Research Center', u'MSBi Valorisation', u'Constellation Pharmaceuticals Inc', u'Fujifilm Finechemicals Co Ltd', u'Alnylam Pharmaceuticals Inc', u'Transgene SA', u'Meristem Therapeutics', u'PharmaSwiss SA', u'PTC Therapeutics Inc', u'Sequenom Inc', u'Aravo Healthcare', u'Salus Therapeutics Inc', u'University of Cincinnati', u'National Health and Medical Research Council', u'Corbus Pharmaceuticals Holdings Inc', u'Norwegian Research Council', u'Good Start Genetics Inc', u'The University Health Network', u'SEER Pharmaceuticals LLC', u'National Institute for Health Research (NIHR)', u'Cystic Fibrosis Foundation Therapeutics Inc', u'Harvard University', u'Mast Therapeutics Inc', u'National Heart Lung and Blood Institute', u'Eisai Co Ltd', u'Hubrecht Organoid Technology', u'Laboratorios Bago SA', u'ANUTECH Pty Ltd', u'geneRx+ Inc', u'University of Washington', u'Agile Sciences Inc', u'Akari Therapeutics Plc', u'Aradigm Corp', u'Mucokinetica', u'Ohio Development Services Agency', u'Johnson & Johnson', u'Affinium Pharmaceuticals Inc', u'Silurian Pharmaceuticals Inc', u'Southern Research Institute', u'Parion Sciences Inc', u'Celtaxsys Inc', u'Canadian Bacterial Diseases Network', u'Vanda Pharmaceuticals Inc', u'University of Alabama at Birmingham', u'Lattice Biotech LLC', u'Murdoch University', u'SciClone Pharmaceuticals Inc', u'Cystic Fibrosis Trust', u'Boehringer Ingelheim International GmbH', u'RespirTech', u'NuMedii Inc', u'Relief Therapeutics Holding AG', u'National Jewish Health', u'Enzon Pharmaceuticals Inc', u'University of Pittsburgh School of Medicine', u'Schneider Childrens Medical Center of Israel', u'ANTABIO', u'Windtree Therapeutics Inc', u'GenMark Diagnostics Inc', u'Novoteris LLC', u'Albany Molecular Research Inc', u'Nobelpharma Co Ltd', u'Activaero GmbH', u'Genaera Corp', u'McGill University', u'University of Edinburgh', u'University of California San Francisco', u'Ferrer Internacional SA', u'Horizon Pharma plc', u'Ministry of Economic Development, Innovation and Export Trade', u'Solvay Seiyaku KK', u'Woolcock Institute of Medical Research', u'Sanofi', u'United Therapeutics Corp', u'Royalty Pharma', u'AmpliPhi Biosciences Corp', u'Kamada Ltd', u'Ortho Pharmaceutical Corp', u'Walter Reed Army Institute of Research', u'Flatley Discovery Lab LLC', u'SGX Pharmaceuticals Inc', u'University of North Carolina', u'Wuhan University of Science and Technology', u'Genentech Inc', u'PJSC Pharmsynthez', u'Connetics Corp', u'VGX Pharmaceuticals LLC', u'Spyryx Biosciences Inc', u'IDIS Ltd', u'Verona Pharma plc', u'Universita San Raffaele', u'Oxford GlycoSciences plc', u'Oriel Therapeutics Inc', u'Sanofi Genzyme', u'Lantibio Inc', u'Hospital for Sick Children', u'NuChem Therapeutics Inc', u'PPL Therapeutics plc', u'Maxygen Holdings Ltd', u'Xenetic Biosciences Inc', u'Soroka University Medical Center', u'Undisclosed', u'Solvay SA', u'US Government', u'Synedgen Inc', u'Rosalind Franklin University of Medicine & Science', u'Merck & Co Inc', u'Arcturus Therapeutics Inc', u'Royal Philips Electronics', u'Genzyme General', u'Scripps Research Institute', u'Glaxo Group Ltd', u'Novadex Pharmaceuticals Ltd', u'Vertex Pharmaceuticals Inc', u'Columbia University', u'Vectura Group plc', u'ManRos Therapeutics', u'Cystic Fibrosis Canada', u'Dompe Farmaceutici SpA', u'National Institute on Minority Health and Health Disparities', u'Bayer AG', u'Traffick Therapeutics Inc', u'US Army Medical Research Institute of Infectious Diseases', u'AbbVie Inc', u'Pulmatrix Inc', u'United Medical', u'NovaBiotics Ltd', u'Woods Hole Oceanographic Institution', u'Predix Pharmaceuticals Inc', u'Theratechnologies Inc', u'RegeneRx Biopharmaceuticals Inc', u'Kissei Pharmaceutical Co Ltd', u'Cyclacel Pharmaceuticals Inc', u'BioSeek Plc', u'Canadian Department of National Defence', u'Arriva Pharmaceuticals Inc', u'Genovo Inc', u'Galapagos Genomics BV', u'Center for Blood Research Inc', u'Aptalis Pharma Inc', u'Pfizer Inc', u'BCY LifeSciences Inc', u'Enterprise Therapeutics Ltd', u'Gilead Sciences Inc', u'Fluidigm Corp', u'HSC R&D Ltd Partnership', u'Mpex Pharmaceuticals Inc', u'Copernicus Therapeutics Inc', u'Koronis Biomedical Technologies', u'Institute for the Promotion of Innovation by Science and Technology in Flanders', u'Quorex Pharmaceuticals Inc', u'University of Pittsburgh', u'Boehringer Ingelheim Corp', u'EPIX Pharmaceuticals Inc', u'Mount Sinai Medical Center', u'ProQR Therapeutics BV', u'Translate Bio', u'Harbor Therapeutics Inc', u'Johns Hopkins University', u'VistaGen Therapeutics Inc', u'Baylor College of Medicine', u'Valentis Inc', u'Centurion Pharma', u'The European Union', u'AIT Therapeutics Inc', u'Savara Inc', u'Peregrine Renovations LLC', u'AlgiPharma AS', u'University of Pennsylvania', u'National Institute of Allergy and Infectious Diseases', u'ID Pharma Co Ltd', u'Horizon Discovery Group plc', u'CRISPR Therapeutics', u'Aberdeen Royal Hospitals NHS Trust', u'Cempra Inc', u'Institut Gustave Roussy', u'Editas Medicine Inc', u'Hyland Immuno', u'Discovery BioMed Inc', u'CoNCERT Pharmaceuticals Inc', u'National Institutes of Health', u'Plexcera Therapeutics LLC', u'Food and Drug Administration', u'Sarepta Therapeutics Inc', u'Elucigene Diagnostics', u'Synspira', u'University of Iowa', u'Aires Pharmaceuticals Inc', u'Proteostasis Therapeutics Inc', u'UNC School of Medicine', u'ChemDiv Inc', u'Imperial College London', u'Zalicus Inc', u'Biovail Corp', u'Corus Pharma Inc', u'Baylor Genetics', u'GeneGo Inc', u'Duke University', u'Salus Pharma Inc', u'University of Sydney', u'Indiana University Research and Technology Corp Inc', u'FDA Office of Orphan Products Development', u'Rare Partners Srl', u'Cook Pharmaceutical Solutions', u'Boehringer Ingelheim Austria GmbH', u'Medeva plc', u'Patheon Pharmaceuticals Inc', u'Rhone-Poulenc Rorer Ltd', u'University of Wisconsin-Madison', u'Genome Medical Inc', u'Anthera Pharmaceuticals Inc', u'Dartmouth College', u'Beth Israel Deaconess Medical Center', u'University of Michigan', u'PARI Pharma GmbH', u'GD Searle & Co', u'Laboratorios Dr Esteve SA']), u'Candidainfection': set([u'Sosei Group Corp', u'University of Medicine and Dentistry of New Jersey', u'Johnson & Johnson', u'US Government', u'Lumara Health Inc', u'MD Anderson Cancer Center', u'The European Union', u'Shafayab Gostar', u'Novartis Institutes for BioMedical Research Inc', u'Janssen Diagnostics BVBA', u'Kyowa Hakko Kogyo Co Ltd', u'Takis Biotech', u'National Institute of Allergy and Infectious Diseases', u'Harbor-UCLA Research and Education Institute', u'Onxeo SA', u'University of Strathclyde', u'Bayer Yakuhin Ltd', u'Innovation Pharmaceuticals Inc', u'Unimedic AB', u'NovaDigm Therapeutics Inc', u'Abiogen Pharma SpA', u'Hi-Tech Pharmacal Co Inc', u'QSV Biologics', u'National Institutes of Health', u'Barrier Therapeutics Inc', u'Pacgen Life Science Corp', u'Novartis Consumer Health Inc', u'SpePharm Holding BV', u'Los Angeles Biomedical Research Institute', u'PolyMedix Inc', u'RIMSA Laboratorios', u'Demegen Inc', u'University of Toronto', u'Pevion Biotech Ltd', u'Veristat, Inc.', u'Universita Degli Studi Di Roma \"Tor Vergata\"', u'CSL Ltd', u'Louisiana State University', u'Basilea Pharmaceutica International Ltd', u'PLIVA dd', u'Mission Pharmacal Co Inc', u'Orient Europharma', u'Janssen Pharmaceutica NV', u'NovaBiotics Ltd', u'RHEI Pharmaceuticals Inc', u'Vectans Pharma', u'Istituto Superiore di Sanita', u'Aviragen Therapeutics Inc', u'Novartis AG', u'Sun Pharmaceutical Industries Ltd', u'Amplyx Pharmaceuticals Inc', u'UK Government', u'Midatech Pharma US Inc', u'Par Pharmaceutical Inc', u'Handok Inc', u'Intercell AG', u'Vestiq Pharmaceuticals Inc', u'Ferrer Internacional SA', u'BioResearch Ireland', u'Fox Chase Chemical Diversity Center Inc', u'US Health and Human Services Department', u'University of Alberta', u'Cidara Therapeutics Inc', u'R-Pharm US LLC', u'Zengen Inc', u'Inhibitex Inc', u'Neopharm Ltd', u'NovaMed Pharmaceuticals Inc', u'F Hoffmann-La Roche AG', u'Bausch & Lomb Inc', u'Midatech Pharma PLC', u'Tetraphase Pharmaceuticals Inc']), u'Heartarrhythmia': set([u'Daiichi Seiyaku Co Ltd', u'AOP Orphan Pharmaceuticals AG', u'Armetheon Inc', u'Boehringer Ingelheim GmbH', u'Tamro AB', u'Forest Laboratories Inc', u'GlaxoSmithKline plc', u'Eddingpharm Inc', u'Cardiome Pharma Corp', u'Bayer Schering Pharma AG', u'ARYx Therapeutics Inc', u'Michigan Translational Research and Commercialization', u'Biospifar SA', u'Philips Medical Systems Technologies Ltd', u'Biotectix Llc', u'University of Michigan', u'Metrion Biosciences', u'Hospira Inc', u'Vianex SA', u'Toyobo Co Ltd', u'F Hoffmann-La Roche AG', u'Siemens Healthineers Inc', u'National Heart Lung and Blood Institute', u'Reliant Pharmaceuticals Inc', u'Acutus Medical Inc', u'Abbott Laboratories', u'Axiogenesis AG', u'Biogal Gyogyszergyar RT', u'Health Research International', u'Univar Usa Inc', u'Sanofi-Synthelabo', u'Santen Pharmaceutical Co Ltd', u'Tanabe Seiyaku Co Ltd', u'Prism Pharmaceuticals Inc', u'UCB Pharma GmbH', u'The Procter & Gamble Co', u'Galectin Therapeutics Inc', u'Taiho Pharmaceutical Co Ltd', u'St Jude Medical Inc', u'Armgo Pharma Inc', u'Hansen Medical Inc', u'Swati Spentose Pvt Ltd', u'Selectus Pharmaceuticals Inc', u'Chugai Pharmaceutical Co Ltd', u'Aspen PharmaCare Holdings Ltd', u'Axol Bioscience Ltd', u'Helopharm', u'Toa Eiyo KK', u'Astellas Pharma Inc', u'Life-Assist Inc', u'Biosig Technologies Inc', u'Faraday Pharmaceuticals Inc', u'Blue Ash Therapeutics LLC', u'Shanghai Institute of Materia Medica of the Chinese Academy of Sciences', u'Undisclosed', u'Merck & Co Inc', u'Sanofi', u'Lotus Pharmaceutical Co Ltd', u'Columbia University', u'Japan Tobacco Inc', u'UDG Healthcare plc', u'Warner Chilcott plc', u'Greenstone LLC', u'Mayo Clinic, Minnesota', u'Cardiogen Sciences', u'CeNeS Pharmaceuticals Inc', u'Pfizer Inc', u'Logista Pharma', u'HUYA Bioscience International LLC', u'National Taiwan University', u'Wyeth', u'Tzamal Medical Group Ltd', u'LifePharma (ZAM) Ltd', u'Astra AB', u'Taisho Pharmaceutical Co Ltd', u'UCB Celltech', u'Dendreon San Diego LLC', u'Fondazione Salvatore Maugeri Clinica del Lavoro e della Riabilitazione IRCCS', u'Zealand Pharma A/S', u'Cedars-Sinai Medical Center', u'Par Pharmaceutical Co Inc', u'CyDex Pharmaceuticals Inc', u'Knoll GmbH', u'Lundbeck Research USA Inc', u'JW Pharmaceutical Corp', u'ELEX Biotech LLC', u'HenKan Pharmaceutical Co Ltd', u'National Defense Medical Center', u'Imricor Medical Systems Inc', u'Aetas Pharma Co Ltd', u'Bristol-Myers Squibb Pharma Co', u'Gedeon Richter Ltd']), u'Chlamydiatrachomatisinfection': set([u'Antex Biologics Inc', u'Childrens Hospital Oakland Research Institute', u'British Columbia Centre for Disease Control', u'Harvard Medical School', u'Genocea Biosciences Inc', u'Harvard University', u'Abbott Laboratories', u'GlaxoSmithKline plc', u'Genome British Columbia', u'Epitogenesis Inc', u'National Institutes of Health', u'XOMA Corp', u'Merck & Co Inc', u'University of Pittsburgh Medical Center', u'BioPort Corp', u'Leiden University Medical Center', u'Walter Reed Army Institute of Research', u'University of Texas Health Science Center San Antonio', u'Peptor Ltd', u'National Institute of Allergy and Infectious Diseases', u'ActivBiotics Inc', u'Concord Biosciences LLC', u'Chiron PathoGenesis', u'Isconova AB', u'Genset SA', u'Pan-Provincial Vaccine Enterprise Inc', u'Corixa Corp', u'Toyama Chemical Co Ltd', u'Pfizer Vaccines', u'Kaneka Corp']), u'Melioidosis': set([u'Oscient Pharmaceuticals Corp', u'Evolva Holding SA', u'US Government', u'Defence Science and Technology Laboratory', u'Syntiron LLC', u'US Army Medical Research Institute of Infectious Diseases', u'Intrexon Corp', u'Basilea Pharmaceutica International Ltd', u'Microbiotix Inc', u'Advanced Life Sciences Holdings Inc', u'National Institute of Allergy and Infectious Diseases', u'Immunovaccine Inc', u'Novartis Vaccines & Diagnostics', u'US Army Research Office', u'Ancora Pharmaceuticals Inc', u'Soligenix Inc', u'Defense Threat Reduction Agency', u'Tulane University', u'Bavarian Nordic A/S', u'Canadian Department of National Defence']), u'Intestinetumor': set([u'Undisclosed', u'Tianjin Hemay Bio-Tech Co Ltd']), u'P': set([u'Alvogen Korea', u'Astrazeneca Korea', u'Bristol-Myers Squibb Co', u'Novartis AG']), u'Bladderdisease': set([u'Laboratorios Inibsa SA', u'US Government', u'Eunice Kennedy Shriver National Institute of Child Health & Human Development', u'Dignify Therapeutics Inc', u'North Carolina Biotechnology Center', u'Tribute Pharmaceuticals Canada Inc', u'Scottish Biomedical Ltd', u'Jeilmedix Pharmaceutical Co', u'Procter & Gamble Pharmaceuticals Inc']), u'Xerostomia': set([u'US Government', u'Thomas Jefferson University', u'MGI Pharma Inc', u'Medimmune Oncology Inc', u'Luqa Pharmaceuticals', u'Daiichi Sankyo Inc', u'MegaPharm Ltd', u'Nippon Kayaku Co Ltd', u'Marillion Pharmaceuticals Inc', u'Cumberland Pharmaceuticals Inc', u'GlaxoSmithKline plc', u'Medpharma plc', u'National Cancer Institute', u'Senju Pharmaceutical Co Ltd', u'EUSA Pharma', u'National Institutes of Health', u'Parion Sciences Inc', u'BMG Pharma LLC', u'Selexis SA', u'Snow Brand Milk Products Co Ltd', u'Ferring Controlled Therapeutics Ltd', u'IS Pharma plc', u'Kainos Medicine Inc', u'Clinigen Group plc', u'Biora Ab', u'Astellas Pharma Inc', u'ALZA Corp', u'Lubris BioPharma', u'Daiichi Pharmaceutical Corp', u'Kadmon Pharmaceuticals LLC', u'Kissei Pharmaceutical Co Ltd', u'Ranbaxy Pharmaceuticals Inc', u'National Institute of Dental and Craniofacial Research', u'CIBA Vision Corp', u'Republic of Korea Government', u'Pfizer Inc', u'Tego BioSciences Corp', u'Keio University', u'Arcoral Pharma As', u'Laboratoires Carilene', u'Allegheny General Hospital', u'Laclede Inc']), u'Naildisease': set([u'OzHealth Pharma', u'HairXpertise Ltd', u'Moberg Pharma AB', u'AG Farma S.A', u'MedPharm Ltd', u'Biotechnology and Biological Sciences Research Council (BBSRC)']), u'Embolism': set([u'InspireMD Inc', u'Boehringer Ingelheim Korea Ltd', u'1A Medical AG', u'Yuhan SP Corp']), u'Stemcelltransplantation': set([u'US Biotest Inc', u'Academia Sinica', u'CellCyte Genetics Corp', u'Magenta Therapeutics Inc', u'US Government', u'National Heart Lung and Blood Institute', u'Schering-Plough Corp', u'Breath Therapeutics Holding BV', u'Leo Pharmaceuticals', u'Astellas Pharma Canada Inc', u'Teva Pharmaceutical Industries Ltd', u'Hospital for Sick Children', u'Antisense Therapeutics Ltd', u'Northwestern Memorial Hospital', u'Zydus-Cadila Group', u'Immunex Corp', u'University of Southern California', u'Medical Research Council', u'Universite De Montreal', u'The University Health Network', u'Cleveland Clinic Foundation', u'Imclone LLC', u'BC Cancer Agency', u'Neovii Biotech GmbH', u'Gamida Cell Ltd', u'Be The Match BioTherapies', u'The University of Newcastle Upon Tyne', u'Tarix Pharmaceuticals LLC', u'Trillium Therapeutics', u'StemCyte Inc', u'Tianjin International Joint Academy of Biotechnology and Medicine', u'Hs Diagnomics Gmbh', u'Taiga Biotechnologies Inc', u'Zymeworks Inc', u'Wyeth', u'PARI Pharma GmbH', u'Helmholtz Zentrum M\\xfcnchen', u'Charite Universitaetsmedizin Berlin', u'German Federal Ministry of Education and Research', u'Targazyme Inc', u'NOXXON Pharma AG']), u'Ascites': set([u'Neovii Biotech GmbH', u'BioVie Inc', u'Shire-Movetis NV', u'Undisclosed', u'MRC Biotech Pty Ltd', u'NewSouth Innovations', u'TRION Pharma GmbH', u'Swedish Orphan Biovitrum AB', u'Institute for the Promotion of Innovation by Science and Technology in Flanders']), u'Renovascularhypertension': set([u'Daiichi Seiyaku Co Ltd', u'BTG plc', u'UCB Pharma SA', u'GE Healthcare', u'Novartis AG', u'Mallinckrodt Inc', u'Genentech Inc', u'BioProjet, Societe Civile de Recherche', u'Mitsubishi Tanabe Pharma Corp', u'Eli Lilly & Co', u'Ipsen', u'Kyowa Hakko Kirin Co Ltd', u'Fujirebio KK', u'UCB SA', u'Merck & Co Inc', u'Kissei Pharmaceutical Co Ltd', u'Sanofi', u'Sanofi KK']), u'Breasttum': set([u'Merck & Co Inc', u'AstraZeneca plc']), u'Statusepilepticus': set([u'National Institute of Neurological Disorders and Stroke', u'University of California', u'CyDex Pharmaceuticals Inc', u'Bio-Pharm Solutions Co Ltd', u'Texas A&M University System', u'SAGE Therapeutics Inc', u'Korea Drug Development Fund', u'Marinus Pharmaceuticals Inc', u'Ligand Pharmaceuticals Inc']), u'Mouthdisease': set([u'Pan Pacific Pet', u'Corium International Inc', u'OSI Pharmaceuticals Inc', u'Paladin Labs Inc', u'Hayashibara Biochemical Laboratories Inc', u'Sylphar NV', u'Oraceuticals Inc', u'KLOX Technologies Inc', u'Novartis AG', u'General Biologicals Corp', u'Amarillo Biosciences Inc', u'VGX Pharmaceuticals LLC', u'Abeona Therapeutics Inc', u'GlaxoSmithKline plc', u'MGI Pharma Inc', u'University of Pennsylvania', u'Apotex Inc', u'Procter & Gamble Manufacturing company', u'Colgate-Palmolive Co', u'Kissei Pharmaceutical Co Ltd', u'National Institute of Dental and Craniofacial Research', u'Pfizer Inc', u'Induce Biologics Inc', u'Daiichi Sankyo Co Ltd', u'Kane Biotech Inc', u'Antibe Therapeutics Inc', u'Pacgen Life Science Corp', u'Undisclosed']), u'Galactorrhea': set([u'Sun Pharmaceutical Industries Ltd', u'Novartis AG']), u'Sweatglanddisease': set([u'Allergan Inc', u'Valeant Pharmaceuticals International Inc']), u'Nonalcoholicfattyliverdisease': set([u'Karolinska Institutet', u'Sanyal Biotechnology', u'NuSirt Sciences Inc', u'Viking Therapeutics Inc', u'University of California San Diego School of Medicine', u'Zhejiang Chinese Medical University', u'Shenzhen Municipal Government', u'National Institute of Diabetes, Digestive and Kidney Diseases', u'Antaros Medical AB', u'Galmed Pharmaceuticals Ltd', u'Ligand Pharmaceuticals Inc', u'European Research Council (ERC)', u'Albert Einstein College of Medicine', u'DURECT Corp', u'Shenzhen HighTide Biopharmaceutical Ltd', u'National Institutes of Health', u'Immuron Ltd', u'Merck & Co Inc', u'Organovo Holdings', u'Chong Kun Dang Pharmaceutical Corp', u'Gelesis Inc', u'ProSciento Inc', u'Weizmann Institute of Science', u'Dong-A ST Co Ltd', u'Italian Ministry of Economic Development', u'Virginia Commonwealth University', u'OWL Metabolomics', u'Fox Chase Chemical Diversity Center Inc', u'Shenzhen Hepalink Pharmaceutical Group Co Ltd', u'Tobira Therapeutics Inc']), u'Febrileneutropenia': set([u'Tianjin Institute of Pharmaceutical Research', u'Dalian Wanchun Biotech', u'Tianjin Pegylatt Biotechnology Co Ltd', u'Coherus BioSciences Inc', u'Institute of Process Engineering Chinese Academy of Sciences', u'Nereus Pharmaceuticals Inc', u'Cytovance Biologics LLC']), u'Nerveinjury': set([u'Onconova Therapeutics Inc', u'Sinobioway Bio-medicine Co Ltd', u\"Children's Hospital of Los Angeles\", u'National Institute of Neurological Disorders and Stroke', u'Polyganics BV', u'Institute of Biotechnology the Academy of Military Medical Sciences PLA', u'Lanzhou Institute of Biological Products', u'Axol Bioscience Ltd', u'California Institute of Regenerative Medicine', u'Microaire Surgical Instruments Inc', u'Horizon Discovery Group plc', u'Sichuan ZehaTimes Pharmaceutical Co Ltd']), u'Sicklecellcrisis': set([u'Pfizer Inc', u'National Heart Lung and Blood Institute', u'University of Basel', u'PHD Biosciences', u'GlycoMimetics Inc', u'Mast Therapeutics Inc', u'Theradex Systems Inc', u'Halozyme Therapeutics Inc', u'Patheon Pharmaceuticals Inc', u'National Center For Advancing Translational Sciences']), u'Myocardialinfarction': set([u'Clinical Data Inc', u'Daiichi Seiyaku Co Ltd', u'Servier', u'Inotek Pharmaceuticals Corp', u'Molecular Targeting Technologies Inc', u'Top Institute Pharma', u'DRAXIMAGE', u'Schwarz Pharma Ltd', u'Shanghai Tasly Pharmaceutical Co Ltd', u'MandalMed Inc', u'CellCyte Genetics Corp', u'Agennix USA Inc', u'Proteo Biotech AG', u'Allos Therapeutics Inc', u'European Commission', u'Roseman University of Health Sciences', u'California Institute of Regenerative Medicine', u'Rockefeller University', u'Biogen Inc', u'iPS Academia Japan Inc', u'National Heart Foundation of Australia', u'Il Dong Pharmaceutical Co Ltd', u'Cohen-McNiece Foundation', u\"Ataxia Telangiectasia Children's Project Inc\", u'Handok Inc', u'Cardiome Pharma Corp', u'Bayer Schering Pharma AG', u'AstraZeneca Pharmaceuticals LP', u'Aspen PharmaCare Australia Pty Ltd', u'Solvay SA', u'Questcor Pharmaceuticals Inc', u'SkyePharma plc', u'TargeGen Inc', u'MGI Pharma Inc', u'Tonghua Yujin Pharmaceutical Co Ltd', u'Ipsen', u'ABX GmbH', u'Versant Ventures', u'Domainex Ltd', u'Henry Ford Hospital', u'ActiveSite Pharmaceuticals Inc', u'CellProthera', u'NeoBiocon', u'OPK Biotech', u'Celldex Therapeutics Inc', u'University of Montpellier', u'Molecumetics Ltd', u'PAION AG', u'Akers Biosciences Inc', u'Janssen Biotech Inc', u'Sumitomo Pharmaceuticals Co Ltd', u'Takeda Oncology', u'Newsummit Biopharma Co Ltd', u'Roche Holding AG', u'Fujisawa USA Inc', u'Erasmus University Medical Center Rotterdam', u'Peptisyntha Inc', u'Sanofi-Synthelabo', u'Paladin Labs Inc', u'Sankyo Co Ltd', u'Daiichi Sankyo Europe GmbH', u'AFA Insurance', u'Temple University', u'Medicure Inc', u'National Center for Complementary and Integrative Health', u'Catalent Inc', u'Medical University of Vienna', u'Formatech Inc', u'MSD Japan', u'Baker IDI Heart & Diabetes Institute Holdings Ltd', u'Korea Drug Development Fund', u'Soroka University Medical Center', u'VistaGen Therapeutics Inc', u'Sangamo Therapeutics Inc', u'National Institute on Aging', u'Reliant Pharmaceuticals Inc', u'Universiteit Maastricht', u'Curative Health Services', u'Henry Ford Health System', u'IDM Pharma Inc', u'Evotec AG', u'National Health and Medical Research Council', u'Meiji Seika Pharma Co Ltd', u'MGI GP Inc', u'Aralez Pharmaceuticals Inc', u'Centre National de la Recherche Scientifique (CNRS)', u'Genentech Inc', u'Amarantus BioScience Holdings Inc', u'Columbia University Medical Center', u'Wyeth BioPharma', u'Axela Inc', u'Eli Lilly Japan KK', u'US Naval Medical Research Center', u'Collateral Therapeutics Inc', u'Severance Hospital', u'The European Union', u'Arrow International Ltd', u'Mochida Pharmaceutical Co Ltd', u'Kansas Bioscience Authority', u'NuvOx Pharma LLC', u'Iroko Pharmaceuticals LLC', u'Boehringer Mannheim GmbH', u'Microheart Inc', u'King Pharmaceuticals R&D Inc', u'QualiMed Innovative Medizinprodukte GmbH', u'Phytera Inc', u'Novartis AG', u'Johns Hopkins University School of Medicine', u'Unigene Laboratories Inc', u'Tissue Genesis Inc', u'Konica Minolta Holdings Inc', u'Duke Clinical Research Institute', u'HuBit Genomix Inc', u'TSH Biopharm Corporation Limited', u'Mount Sinai School of Medicine', u'Keryx Biopharmaceuticals Inc', u'Imperial College London', u'Shanghai Kehua Bio-engineering Co Ltd (KHB)', u'Osiris Therapeutics Inc', u'LG Life Sciences Ltd', u'GlaxoSmithKline plc', u'Massachusetts General Hospital', u'UCB SA', u'Lev Pharmaceuticals Inc', u'UCB Pharma GmbH', u'The Procter & Gamble Co', u'Universita degli Studi di Roma La Sapienza', u'Enzon Pharmaceuticals Inc', u'Mallinckrodt Inc', u'TiGenix NV', u'Scripps Translational Science Institute', u'Biomedical Research and Commercialization Program (BRCP)', u'Dendreon Corp', u'Cell Genesys Inc', u'Cleveland Clinic Foundation', u'Wellcome Trust', u'Merck Sharp & Dohme Ltd', u'Harrison Clinical Research', u'Wyeth', u'Celera Group', u'University of Texas System', u'SciClone Pharmaceuticals Inc', u'Alvogen Inc', u'Mitsubishi-Tokyo Pharmaceuticals Inc', u'Undisclosed', u'Inha University', u'University of Edinburgh', u'Washington University in St Louis', u'Encysive Pharmaceuticals Inc', u'Osaka University', u'Express Scripts Inc', u'Schering AG', u'Global Biotech Inc', u'DuPont Pharmaceuticals Ltd', u'BlueRock Therapeutics', u'Aventis Pharmaceuticals Inc', u'Recordati SpA', u'California Initiative to Advance Precision Medicine', u'University of Sydney', u'F Hoffmann-La Roche AG', u'Magnus Invention Management Ltd', u'Universitaire Ziekenhuizen Leuven', u'Bharat Biotech International Ltd', u'Walter Reed Army Institute of Research', u'GliaMed Inc', u'CVS Caremark', u'Chugai Pharmaceutical Co Ltd', u'Integrative Research Laboratories Sweden AB', u'Shanghai Institutes for Biological Sciences CAS', u'Angioblast Systems Inc', u'Isomerase Therapeutics Ltd', u'APT Therapeutics Inc', u'University of Melbourne', u'Mitsubishi Pharma Corp', u'Mesoblast Ltd', u'Research Council of the South East Sweden (FORSS)', u'University of South Alabama', u'Johnson & Johnson', u'Taxus Cardium Pharmaceuticals Group', u'Minapharm Pharmaceuticals', u'Alexion Pharmaceuticals Inc', u'Mayo Clinic Foundation', u'AmKor Pharma Inc', u'Thios Pharmaceuticals Inc', u'DSM Pharmaceutical Products', u'Flamel Technologies SA', u'PledPharma AB', u'Walloon Region of Belgium Government', u'ViaCell Inc', u'Republic of Korea Government', u'Ark Therapeutics Group plc', u'Synthelabo SA', u'Richter-Helm BioTec GmbH & Co KG', u'Baylor College of Medicine', u'Capstone Therapeutics Corp', u'Institute of Biotechnology the Academy of Military Medical Sciences PLA', u'US Government', u'Queen Mary University of London', u'Serodus ASA', u'Immunex Corp', u'Diosynth Biotechnology', u'Innopharmax Inc', u'Perlegen Sciences Inc', u'Laboratorios Farmaceuticos Rovi SA', u'Merck & Co Inc', u'COR Therapeutics Inc', u'Sanofi', u'Lotus Pharmaceutical Co Ltd', u'LXR Biotechnology Inc', u'Eli Lilly & Co', u'La Jolla Pharmaceutical Co', u'PhRMA Foundation', u'Japan Tobacco Inc', u'University of Miami', u'Bayer AG', u'Vasogenix Pharmaceuticals Inc', u'Epimmune Inc', u'Cellmid Ltd', u'University of Wisconsin-Madison', u'Pronova BioPharma ASA', u'University of Pennsylvania', u'University of Virginia', u'Navigo Proteins GmbH', u'MediciNova Inc', u'Teva Pharmaceutical Industries Ltd', u'Ageless Regenerative Institute', u'RegeneRx Biopharmaceuticals Inc', u'Galileo Pharmaceuticals Inc', u'VM Discovery Inc', u'Maroon Biotech Corp', u'XBiotech Inc', u'Hyundai Pharmaceutical', u'Inje University Ilsan Paik Hospital', u'Medvet Science Pty Ltd', u'Celonic AG', u'Nuvelo Inc', u'AstraZeneca plc', u'Pfizer Inc', u'Capricor Inc', u'Shanghai No 1 Biochemical & Pharmaceutical Co Ltd', u'Shionogi & Co Ltd', u'The Research Council of Norway', u'Caladrius Biosciences Inc', u'National Taiwan University', u'deCODE genetics ehf', u'Celdara Medical LLC', u'FCB-Pharmicell Co Ltd', u'Vernalis plc', u'Mitsui Chemicals Inc', u'Dr Reddy\\u2019s Research and Development BV', u'Mount Sinai Medical Center', u'The Medicines Company', u'BioLineRx Ltd', u'Celyad', u'Nuo Therapeutics Inc', u'Wonju Christian Hospital', u'AnorMED Inc', u'Kansas State University', u'Gilead Palo Alto Inc', u'Rubicon Biotechnology Inc', u'Apogenix GmbH', u'US Stem Cell Inc', u'Abbott Laboratories', u'Sihuan Pharmaceutical Holdings Group Ltd', u'Sparta Pharmaceuticals Inc', u'National Cardiovascular Center Research Institute', u'Abazali Bio Ventures', u'GNT Pharma Co Ltd', u'Galecto Biotech AB', u'NeuroVive Pharmaceutical AB', u'Arena Pharmaceuticals Inc', u'Ben-Gurion University Of The Negev', u'Glycomed Inc', u'Quintiles Transnational Corp', u'Dendreon San Diego LLC', u'Hovione SA', u'Astra Merck Inc', u'Actelion Ltd', u'Albert Einstein College of Medicine', u'SmithKline Beecham plc', u'PharmaHungary Group', u'National Institutes of Health', u'Teijin Ltd', u'University of Tokyo', u'BioCardia Inc (pre-merger)', u'ProMetic Life Sciences Inc', u'University of Oregon', u'Bristol-Myers Squibb Co', u'Scios Inc', u'FFF Enterprises', u'Seoul National University Hospital', u'Xymogen', u'Evotec (UK) Ltd', u'King Pharmaceuticals Inc', u'Biopure Corp', u'Exscien Corp', u'Cedars-Sinai Medical Center', u'Stealth BioTherapeutics Inc', u'The Menarini Group', u'CJ Corp', u'Uppsala University', u'Cephalon Inc', u'University of Chicago', u'VentriNova Inc', u'ESP Pharma Inc', u'ThromboGenics NV', u'Astellas Pharma Inc', u'CyDex Pharmaceuticals Inc', u'PT Kalbe Farma Tbk', u'Biovail Corp', u'Proteonomix Inc', u'3-Dimensional Pharmaceuticals Inc', u'Stemedica Cell Technologies Inc', u'Athera Biotechnologies AB', u'ITEM Development AB', u'Clinical Pharmacology of Miami Inc', u'JW Pharmaceutical Corp', u'HenKan Pharmaceutical Co Ltd', u'Loyola University Stritch School of Medicine', u'Lonza Group AG', u'DecImmune Therapeutics', u'The Michael J. Fox Foundation', u'Aetas Pharma Co Ltd', u'Athersys Inc', u'Cynata Therapeutics Ltd', u'Institute of Medicinal Molecular Design Inc', u\"Brigham & Women's Hospital\", u'Jiangsu Kefeiping Medicine Co Ltd', u'Ryhov County Hospital', u'MannKind Corp', u'Takeda Pharmaceutical Co Ltd', u'Linkoping University', u'Actavis Group HF', u'Chengdu Jinpeng Bio-technology Co Ltd', u'University of Michigan', u'Hoffmann-La Roche Inc', u'National Heart Lung and Blood Institute', u'Hengdian Group Ltd', u'BioCryst Pharmaceuticals Inc', u'SPS Cardio LLC']), u'Headache': set([u'Afferon Corp', u'Allergan Inc', u'LG Life Sciences Ltd', u'Senju Pharmaceutical Co Ltd', u'ISTA Pharmaceuticals Inc', u'Mundipharma EDO GmbH', u'National Institutes of Health', u'AcSentient Inc', u'Block Drug Co Inc', u'Valeant Pharmaceuticals International Inc', u'Eastern Virginia Medical School', u'National Institute of Dental and Craniofacial Research', u'MedVadis Research Corp', u'Zambon Italia Srl', u'MediciNova Inc', u'University of Adelaide', u'Bracco Eisai', u'Trigemina Inc', u'Eisai Co Ltd', u'Wyeth Pharmaceuticals', u'ICOS Corp']), u'Phenylketonuria': set([u'BL&H Co Ltd', u'Synthetic Biologics Inc', u'Centre for Applied Microbiology & Research', u'BioMarin Pharmaceutical Inc', u'McGill University', u'Merck KGaA', u'Aarhus University', u'Asubio Pharma Co Ltd', u'Par Pharmaceutical Co Inc', u'Intrexon Corp', u'Innopharmax Inc', u'Merck Serono SA', u'Dimension Therapeutics Inc', u'Altus Pharmaceuticals Inc', u'Perelman School of Medicine', u'IBEX Technologies Inc', u'MipSalus ApS', u'University of Pittsburgh Medical Center', u'The Danish National Advanced Technology Foundation', u'Ajinomoto Althea Inc', u'American Gene Technologies International Inc']), u'Infectiousmeningitis': set([u'Shire BioChem Inc', u'GlaxoSmithKline Biologicals', u'BioChem Vaccines Inc', u'Biovector Therapeutics SA']), u'Endstagerenaldisease': set([u'Evotec AG', u'Vifor Pharma', u'Stryker Corp', u'Acceleron Pharma Inc', u'European Foundation for the Study of Diabetes', u'Ludwig-Maximilians University of Munich', u'Interface Biologics Inc', u'University of California San Diego School of Medicine', u'National Center for Research Resources', u'Mitsubishi Pharma Corp', u'Harvard Medical School', u'ElexoPharm GmbH', u'Kureha Corp', u'National Institute of Diabetes, Digestive and Kidney Diseases', u'Metabolon Inc', u'US Government', u'Humacyte', u'Shenzhen University', u\"Seattle Children's Hospital\", u'Assistance Publique Hopitaux de Paris', u'Novartis AG', u'Johns Hopkins University', u'Undisclosed', u'Ablynx NV', u'Bolder BioTechnology Inc', u'Stemmed Ltd', u'Keryx Biopharmaceuticals Inc', u'DaVita Clinical Research', u'Spring Bank Pharmaceuticals Inc', u'Atara Biotherapeutics Inc', u'INSERM', u'ChemoCentryx Inc', u'Sanofi Genzyme', u'Kyoto University', u'University of Sao Paulo', u'Algomedix Inc', u'Eli Lilly & Co', u'AlloSource', u'Celgene Corp', u'Bayer AG', u'OPKO Health Inc', u'Shanghai Desano Pharmaceuticals Co Ltd', u'Fresenius Medical Care AG', u'Roche Holding AG', u'MorphoSys AG', u'Mitsubishi Tanabe Pharma Corp', u'Emcure Pharmaceuticals Ltd', u'Panorama Research Inc', u'SphynKx Therapeutics LLC', u'University of Sydney', u'Horizon Orphan LLC', u'Harvard Stem Cell Institute', u'Aurobindo Pharma Ltd', u'Janssen Pharmaceuticals Inc', u'Ember Therapeutics', u'University of California Irvine', u'AstraZeneca plc', u'Boehringer Ingelheim Corp', u'Gilead Sciences Inc', u'Celtic Biotech Iowa Inc', u'Medicines Patent Pool', u'Sun Pharmaceutical Industries Ltd', u'University of Utah', u'University of Michigan', u'Patheon Inc', u'Charite Universitaetsmedizin Berlin', u'Angion Biomedica Corp', u'Catalent Inc', u'National Institute of General Medical Sciences']), u'Intellectualimpairment': set([u'Scripps Research Institute', u'The National Institute of Mental Health']), u'Ischemicheartdisease': set([u'Daiichi Seiyaku Co Ltd', u\"Dr Reddy's Laboratories Ltd\", u'US Government', u'Schwarz Pharma Ltd', u'Pola Chemical Ind Inc', u'IDM Pharma Inc', u'Korea Research Institute of Chemical Technology', u'Guangdong Zhongke Drug Research & Development Co Ltd', u'Quintiles Transnational Corp', u'Collagen Medical LLC', u'Questcor Pharmaceuticals Inc', u'Taxus Cardium Pharmaceuticals Group', u'Advanced Medical Imaging LLC', u'Shijiazhuang Yiling Pharmaceutical Co Ltd', u'Jilin Huakang Pharmaceutical Co Ltd', u'OPK Biotech', u'Grindeks, Publiska Akciju Sabiedriba', u'Ono Pharmaceutical Co Ltd', u'Takeda Oncology', u'Hainan Sihuan Cardio-cerebral Vascular Drugs Research Institute Co Ltd', u'Bracco SpA', u'Jilin University', u'Yuyu Inc', u'Osaka University Hospital', u'Chengdu Diao Group', u'Cytori Therapeutics Inc', u'Boston University', u'National Heart Lung and Blood Institute', u'Theregen Inc', u'InfiMed Therapeutics Inc', u'Tohoku University', u'Sanofi (pre-1999)', u'Compass Biomedical', u'Johns Hopkins University School of Medicine', u'Guidant Corp', u'Tumor Biology Center, Freiburg', u'Mallinckrodt Inc', u'Angionetics Inc', u'Cleveland Clinic Foundation', u'Sunovion Pharmaceuticals Canada Inc', u'Hefei Qixing Pharmaceutical Sci & Tech Co Ltd', u'SK Pharmaceutical Co Ltd', u'AnGes MG Inc', u'AngioGenetics AB', u'Ferrer Internacional SA', u'Pluristem Therapeutics Inc', u'Vasade Biosciences Inc', u'Henry Ford Health Science Center', u'D Western Therapeutics Institute', u'Tes Holdings Co Ltd', u'Otsuka Pharmaceutical Co Ltd', u'Nara Biosciences Inc', u'Seikagaku Corp', u'Capstone Therapeutics Corp', u'XOMA Corp', u'University of California', u'Quantum Genomics Corp', u'Johann Wolfgang Goethe-Universitat Frankfurt am Main', u'Molecular Insight Pharmaceuticals Inc', u'UBE Industries Ltd', u'US Naval Medical Research Center', u'Japan Agency for Medical Research and Development', u'Epimmune Inc', u'Anhui Jiufang Pharmaceutical Co Ltd', u'MDS Nordion', u'Pfizer Inc', u'State University of New York', u'Guangzhou Municipal Zhongwei Biotechnology Co Ltd', u'Yissum Research Development Co', u'University of Pittsburgh', u'Pharmstandard OJSC', u'Laboratorios Farmaceuticos Rovi SA', u'Grandis Biotech GmbH', u'Gilead Palo Alto Inc', u'Abazali Bio Ventures', u'Huapont Life Sciences Co Ltd', u'Dendreon San Diego LLC', u'Baker Heart Research Institute', u'Phylogica Ltd', u'Servier', u'National Institutes of Health', u'Sumitomo Pharmaceuticals Co Ltd', u'Chinese Government', u'The Medicines Company', u'CSL Ltd', u'INSERM', u'Sanofi Genzyme', u'Biopure Corp', u'Roche Holding AG', u'Catalytica Inc', u'Cytopia Inc', u'GE Healthcare', u't2cure GmbH', u'Chengdu Institute of Biology Chinese Academy of Sciences']), u'Intoxication': set([u'US Government', u'EMD Pharmaceuticals Inc', u'California Institute of Technology', u'Protherics plc', u'MedImmune LLC', u'Sanofi', u'University of California San Francisco', u'Columbia University', u'Convivia', u'Novalar Pharmaceuticals Inc', u'US Army Medical Research Institute of Infectious Diseases', u'Merck Sante SA', u'Uni Pharma Co Ltd', u'Bennu Pharmaceuticals Inc', u'Septodont', u'Horizon Orphan LLC', u'Merck Serono SA', u'ANI Pharmaceuticals Inc', u'Centre for Applied Microbiology & Research', u'Inotek Pharmaceuticals Corp', u'Planet Biotechnology Inc', u'Indi Molecular Inc', u'H.A. Systems Dental Imports Ltd', u'Swedish Orphan Biovitrum AB', u'National Institute of General Medical Sciences']), u'Zikavirusinfection': set([u'University of Texas Medical Branch at Galveston', u'Chiba Prefectural Government', u'Cerus Corp', u'Advanced BioScience Laboratories Inc', u'Sanofi Pasteur', u'US Government', u'US Health and Human Services Department', u'UMN Pharma Inc', u'Inovio Pharmaceuticals Inc', u'Clinical Research Management Inc', u'University of Queensland', u'Texas A&M University System', u'Rheonix Inc', u'Isla Lab Products LLC', u'SystemOne', u'University of Pennsylvania', u'hVIVO plc', u'Shizuoka University', u'Houston Methodist Hospital', u'City University of New York', u'University of Miami Miller School of Medicine', u'Sun Pharmaceutical Industries Ltd', u'ModeRNA Therapeutics', u'Siemens Healthineers Inc', u'Visterra Inc', u'National Center For Advancing Translational Sciences', u'PharmaJet Inc', u'HSRx LLC', u'Rega Institute for Medical Research', u'The European Union', u'Integral Molecular Inc', u'Greffex Inc', u'Leidos Inc', u'Acuitas Therapeutics Inc', u'Johns Hopkins University School of Medicine', u'Eunice Kennedy Shriver National Institute of Child Health & Human Development', u'NewLink Genetics Corp', u'Valneva SE', u\"Texas Children's Hospital\", u'Vanderbilt University', u'TechnoVax Inc', u'Protein Sciences Corp', u'Infectious Disease Research Institute', u'Pharos Biologicals LLC', u'Integrated BioTherapeutics Inc', u'Banco de Sangre de Servicios Mutuos Inc', u'U.S. Department of Health and Human Services', u'Johns Hopkins University', u'BluSense', u'Florida Gulf Coast University', u'Queensland Health', u'Florida Department of Health', u'Spotlight Innovation Inc', u'Themis Bioscience GmbH', u'University of North Carolina', u'Excivion Ltd', u'Biotron Ltd', u'Ennaid Therapeutics', u'SRI International', u'Institut Pasteur', u'Xenetic Biosciences Inc', u'Emergent BioSolutions Inc', u'Inbios International Inc', u'Centers for Disease Control and Prevention', u'Prokarium', u'UK Government', u'Dale and Betty Bumpers Vaccine Research Center', u'Evolva SA', u'Washington University in St Louis', u'Luminex Corp', u'Viriom Inc', u'Technology Strategy Board', u'Midatech Pharma PLC', u'Emergex Vaccines Limited', u'Kineta Inc', u'University of Sao Paulo', u'Purdue University', u'KU Leuven R&D', u'Bio-Manguinhos/Fiocruz', u'GeoVax Labs Inc', u'Hologic Inc', u'National Institute of Allergy and Infectious Diseases', u'SEEK', u'University of Miami', u'Abeome Corp', u'Walter Reed Army Institute of Research', u'National Institutes of Health', u'Bill & Melinda Gates Foundation', u'Sinergium Biotech', u'Heat Biologics Inc', u'Quratis Co Ltd', u'Immunovaccine Inc', u'Florida State University', u'OraSure Technologies Inc', u'Federal government of Mexico', u'Wistar Institute of Anatomy & Biology', u'Chembio Diagnostic Systems Inc', u'The Paul G. Allen Family Foundation', u'National Institute of Dental and Craniofacial Research', u'CEVEC Pharmaceuticals GmbH', u'Duke-NUS Graduate Medical School', u'Takeda Pharmaceutical Co Ltd', u'NanoPass Technologies Ltd', u'Beth Israel Deaconess Medical Center', u'National Institute of Virology', u'BIKEN Foundation', u'DiaSorin Inc']), u'Hernia': set([u'LifeCell Corp', u'Via Surgical Ltd', u'TELA Bio Inc', u'Progressive Medical Inc']), u'Non-insulindepen': set([u'Ipsen', u'Menarini Asia-Pacific']), u'Analfistula': set([u'Cellerix SA', u'Origenis GmbH']), u'Calcification': set([u'Calgenex', u'Stryker Corp', u'Ortho Biotech Products LP', u'Nanobac Pharmaceuticals Inc', u'Curis Inc']), u'Movementdisorder': set([u'Weston Brain Institute', u'New Jersey Health Foundation Inc', u'Pierre Fabre SA', u'Integrative Research Laboratories Sweden AB', u'National Institute of Neurological Disorders and Stroke', u'Junaxo Inc', u'Saniona ApS', u'Atuka Ltd', u'Neurolixis Inc', u'Neuraltus Pharmaceuticals Inc', u'Centre for Drug Research and Development', u'National Institute of Diabetes, Digestive and Kidney Diseases', u'Amarantus BioScience Holdings Inc', u'Intra-Cellular Therapies Inc', u'US Government', u'The Danish National Advanced Technology Foundation', u'Synchroneuron LLC', u'XenoPort Inc', u'Targacept Inc', u'H:S Rigshospitalet', u'Johns Hopkins University', u'Metabolic Solutions Development Co', u'National Institutes of Health', u'Ipsen', u'Merck & Co Inc', u'Valeant Pharmaceuticals International Inc', u'Santhera Pharmaceuticals AG', u'CleveXel Pharma', u'Medtronic plc', u'Universite De Montreal', u\"The Parkinson's Institute and Clinical Center\", u'Addex Therapeutics Ltd', u'IRICoR', u'Ariston Pharmaceuticals Inc', u'bioCSL PTY Ltd', u'MediBIC', u'Imperial College London', u'VINNOVA', u'Genegrafts Ltd', u'Biovail Corp', u'Samsung Electronics Co Ltd', u'Adolor Corp', u'Mitsubishi Tanabe Pharma Corp', u'Motac Neuroscience Ltd', u'Thomas Jefferson University', u'Avanir Pharmaceuticals Inc', u'Somaxon Pharmaceuticals Inc', u'Adamas Pharmaceuticals Inc', u'The Michael J. Fox Foundation', u'Allergan Inc', u'AstraZeneca plc', u'Neurocrine Biosciences Inc', u'Catalent Inc', u'Skybridge Pharmaceuticals Inc', u'Emory University', u'Contera Pharma', u'NeuroSearch A/S', u'MentiNova Inc', u'Solural Pharma Aps', u'Van Andel Institute', u'Omeros Corp', u'Institut du Cerveau et de la Moelle epiniere', u'PsychoGenics Inc', u'Asubio Pharma Co Ltd', u\"King's College London\"]), u'Hydronephrosis': set([u'Synthelabo', u'Leiras Oy', u'Astellas Pharma Inc', u'Schering SpA', u'Sanofi-Synthelabo']), u'Ocularneoplasm': set([u'Genentech Inc', u'XOMA Corp']), u'Gastrointestinalinjury': set([u'University of Arkansas for Medical Sciences', u'US Government', u'Anteana Therapeutics Inc', u'Avaxia Biologics Inc', u'National Institute of Allergy and Infectious Diseases', u'Novartis Pharma AG', u'Cleveland BioLabs Inc', u'National Institute of Diabetes, Digestive and Kidney Diseases', u'Courtagen Life Sciences Inc', u'US Health and Human Services Department', u'Apogee Biotechnology Corp']), u'Limbgirdlemusculardystrophy': set([u'Evotec AG', u'PROOF Centre of Excellence', u'Genethon', u'University of Chicago', u'National Institute of Arthritis and Musculoskeletal and Skin Diseases', u'Jain Foundation', u'National Institutes of Health', u'Emory University', u\"Nationwide Children's Hospital\", u'Scripps Research Institute', u'MRM Proteomics Inc', u'Kurt+Peter Foundation', u'Massachusetts General Hospital', u'University of Georgia', u'Muscular Dystrophy Association']), u'Acinetobacterinfection': set([u'Kenta Biotech Ltd', u'US Government', u'AvidBiotics Corp', u'Aridis Pharmaceuticals Inc', u'PolyMedix Inc', u'LegoChem Bioscience Inc', u'Office of Naval Research (ONR)', u'GEOM Therapeutics Inc']), u'Urolithiasis': set([u'Pharmaplan GmbH', u'Hi-Tech Pharmacal Co Inc', u'Synthelabo', u'Filament BioSolutions Inc', u'Astellas Pharma Inc', u'Schering SpA', u'Mission Pharmacal Co Inc', u'Retrophin Inc', u'Altus Pharmaceuticals Inc', u'Recordati SpA', u'Leiras Oy', u'Sanofi-Synthelabo', u'Paladin Labs Inc', u'Massachusetts General Hospital', u'Ajinomoto Althea Inc', u'Yamanouchi Pharmaceutical Co Ltd', u'GlaxoSmithKline plc']), u'Bradycardia': set([u'Cato BioVentures', u'DSM Pharmaceuticals Inc', u'Cordex Pharma Inc']), u'Metastaticlungcancer': set([u'NT Pharma (Group) Co Ltd', u'National Comprehensive Cancer Network', u'Massachusetts Institute of Technology', u'H Lee Moffitt Cancer Center and Research Institute', u'Weill Cornell Medical College, USA', u'University of Maryland Baltimore County', u'Lytix Biopharma AS', u'National Cancer Institute', u'University of Tokyo', u'Chinese Government', u'Australian Research Council', u'Helix BioPharma Corp', u'Huaqiao University', u'Idac Theranostics Inc', u'Monash University', u'NewLink Genetics Corp', u'National Institute Of Environmental Health Sciences', u'Starpharma Holdings Ltd', u'Hefei Everlife Pharmaceutical Co Ltd', u'Cumberland Pharmaceuticals Inc', u'Lung Cancer Research Foundation', u'BCN Biosciences LLC', u\"Dana-Farber/Brigham and Women's Cancer Center\"]), u'Keratosis': set([u'SS Pharmaceutical - ethical drug division', u'Australian Government', u'National Institutes of Health', u'NuChem Pharmaceuticals Inc', u'Academia Sinica', u'Biofrontera AG', u'Alberta Research Council', u'University of Nebraska Medical Center', u'photonamic GmbH & Co KG', u'Dojin Iyaku-Kako Co Ltd', u'Novartis Pharma KK', u'Bradley Pharmaceuticals Inc', u'Hyal Pharmaceutical Corp', u'Transport Pharmaceuticals Inc', u'Meditrina Pharmaceuticals Inc', u'Bayer Schering Pharma AG', u'Clinuvel Pharmaceuticals Ltd', u'Heidelberg Pharma Holding Ltd', u'PhotoCure ASA', u'DRAXIS Health Inc', u'Telormedix SA', u'National Cancer Institute', u'Kythera Biopharmaceuticals Inc', u'SkyePharma plc', u'Niadyne Pharma Inc', u'NB Therapeutics Inc', u'Galderma Laboratories LP', u'European Eurostars Programme', u'Acretia Inc', u'Meda AB', u'Parabolic Drugs Ltd', u'Novartis Pharma AG', u'Galderma SA', u'Heron Therapeutics Inc', u'Laboratoires Thea', u'Galderma Spirig', u'bioCSL PTY Ltd', u'Deutsches Krebsforschungszentrum', u'PhotoMedex Inc', u'Dong Wha Pharmaceutical Co Ltd', u'SonoLight Pharmaceuticals Corp', u'Cipher Pharmaceuticals Inc', u'MedPharm Ltd', u'Graceway Pharmaceuticals Inc', u'Bioglan Pharmaceuticals Co', u'Valeant Pharmaceuticals International Inc', u'Fougera Pharmaceuticals Inc', u'Novartis AG', u'Intendis GmbH', u'Allergan Inc', u'F H Faulding & Co Ltd', u'Almirall Prodesfarma SA', u'Peplin Inc', u'Stiefel', u'Boston University', u'Dermik Laboratories Inc', u'MediGene AG', u'Foamix Pharmaceuticals Ltd', u'Accelis Pharma', u'NDDO Oncology BV', u'SurModics Pharmaceuticals', u'DUSA Pharmaceuticals Inc', u'Takeda Pharmaceuticals International GmbH', u'Charite Universitaetsmedizin Berlin', u'Spear Pharmaceuticals Inc', u'Quest PharmaTech Inc', u'Berlex Laboratories Inc', u'Meditech Research Ltd']), u'Ostealgia': set([u'Grunenthal GmbH', u'Abiogen Pharma SpA', u'Virobay Inc', u'National Cancer Institute', u'NovaPharm Therapeutics']), u'Variolavirusinfection': set([u'LifePharms Inc', u'AvaxisBio Corp', u'Brown University', u'PharmaJet Inc', u'Antigen Express Inc', u'Baxter International Inc', u'Vaccinex Inc', u'National Center for Research Resources', u'AFG Biosolutions Inc', u'CEL-SCI Corp', u'Therapeutic Systems Research Laboratories', u'Biothera Pharmaceuticals Inc', u'Mayo Clinic Foundation', u'Kemin Pharma Europe', u'Fox Chase Chemical Diversity Center Inc', u'National Institute of Allergy and Infectious Diseases', u'University of Texas Medical Branch at Galveston', u'US Health and Human Services Department', u'Bavarian Nordic A/S', u'Immuno Resources Inc', u'GlaxoSmithKline plc', u'AlphaVax Inc', u'Inovio Pharmaceuticals Inc', u'The Korea National Institute of Health', u'Albemarle Corp', u'MacroGenics Inc', u'InViragen LLC', u'Aphios Corp', u'National Institutes of Health', u'VGX Pharmaceuticals LLC', u'US Government', u'EpiVax Inc', u'Emergent BioSolutions Inc', u'University of Maryland', u'Vanderbilt University', u'MDM Group Inc', u'Danish Government', u'Organix Inc', u'Sanofi', u'Therion Biologics Corp', u'Centers for Disease Control and Prevention', u'University of Pennsylvania', u'TapImmune Inc', u'National Center for Complementary and Alternative Medicine', u'Viragen Inc', u'Imperial College London', u'US Army Medical Research Institute of Infectious Diseases', u'Epimmune Inc', u'PowderJect Pharmaceuticals plc', u'German Government', u'USAF', u'University of Texas Health Science Center San Antonio', u'ViroPharma Inc', u'Kaketsuken', u'RTI International', u'Acambis Inc', u'BioFactura Inc', u'vTv Therapeutics LLC', u'diaDexus Inc', u'BioReliance Corp', u'INCELL Corp', u'Probetex Inc', u'SIGA Technologies Inc', u'Biophage Pharma Inc', u'Emory University', u'University of California San Diego', u'US Department of Defense', u'Canadian Government', u'Undisclosed', u'International Vaccine Institute', u'Acambis plc', u'Nanotherapeutics Inc', u'Memorial Sloan-Kettering Cancer Center', u'Defense Threat Reduction Agency']), u'Hyperoxia': set([u'University of Pennsylvania', u'National Heart Lung and Blood Institute']), u'Pituitarytumor': set([u'US Government', u'Ipsen', u'Crinetics Pharmaceuticals Inc', u'bioMerieux SA']), u'Disseminatedintravascularcoagulation': set([u'Armour Pharmaceuticals Co Ltd', u'Behringwerke AG', u'Mochida Pharmaceutical Co Ltd', u'Asahi Kasei Pharma Corp', u'Pfizer Japan Inc', u'JCR Pharmaceuticals Co Ltd']), u'Cardiacreperfusioninjury': set([u'Universite de Sherbrooke', u'Isotechnika Pharma Inc', u'Proteo Biotech AG', u'ICM Pharma Pte Ltd', u'Hospices Civils De Lyon', u'Alloksys Life Sciences BV', u'NeuroVive Pharmaceutical Asia Inc', u'Louisiana State University Health Sciences Center New Orleans', u'Ocean University of China', u'German Government', u'University of Tokyo', u'University of South Alabama', u'Sanofi', u'Georgia State University', u'NEOMED Institute', u'Inner Mongolia Lantai Industrial Co Ltd', u'NeuroVive Pharmaceutical AB', u'Universite De Montreal', u'National Research Council of Canada', u'Exscien Corp', u'Univalor']), u'Nutritionaldisorder': set([u'Ipsen Biopharmaceuticals Inc', u'Mitsubishi-Tokyo Pharmaceuticals Inc', u'Genentech Inc', u'Biologix FZ Co', u'Kowa Pharmaceutical Co Ltd', u'Giddi Pharma Co Ltd']), u'Gliosarcoma': set([u'Northwest Biotherapeutics Inc', u'Jonsson Comprehensive Cancer Center']), u'Pediatricvaricellazostervirusinfection': set([u'bioCSL PTY Ltd', u'Australian Government', u'CSL Ltd', u'Technion Research & Development Foundation Ltd', u'Merck & Co Inc', u'Breathtec Biomedical Inc', u'SK Chemicals Co Ltd']), u'Amphetaminedependence': set([u'New York State Psychiatric Institute', u'University of California Los Angeles', u'Virogenomics Inc', u'US Government', u'Avigen Inc', u'Medicago Inc', u'National Institute on Alcohol Abuse and Alcoholism', u'National Institute of Neurological Disorders and Stroke', u'National Institutes of Health', u'National Institute on Drug Abuse', u'Kyorin Pharmaceutical Co Ltd', u'Scripps Research Institute', u'Brookhaven National Laboratory', u'Catalyst Pharmaceutical Partners Inc', u'MediciNova Inc', u'InterveXion Therapeutics LLC', u'Alkermes plc']), u'BipolarIdisorder': set([u'Brown University', u'Recordati SpA', u'The National Institute of Mental Health', u'Childrens Medical Center Corp', u'Gedeon Richter Ltd', u'Aptalis Pharma Srl', u'Perrigo Co plc', u'Transition Therapeutics Inc', u'Merz & Co GmbH', u'GlaxoSmithKline plc']), u'Circadianrhythmsleepdisorder': set([u'US Government', u'National Institute of Neurological Disorders and Stroke', u'Tikvah Therapeutics Inc', u'National Institutes of Health', u'Phase 2 Discovery Inc', u'Scripps Florida', u'Circadian Therapeutics Ltd', u'Scripps Research Institute', u'The National Institute of Mental Health', u'Orphagen Pharmaceuticals Inc', u'University of Oxford']), u'Tuberoussclerosis': set([u'Osaka University', u'Transgenomic Inc', u'Tuberous Sclerosis Alliance', u'Nobelpharma Co Ltd']), u'Folliclecenterlymphoma': set([u'Biovest International Inc', u'Coley Pharmaceutical Group Inc', u'Cancer Research UK', u'Daiichi Sankyo Co Ltd', u'Genmab A/S', u'Biothera Pharmaceuticals Inc', u'Hercules Capital Inc', u'Pharmacyclics Inc', u'Oxford BioMedica plc', u'Epizyme Inc', u'Sahar International Trading Inc', u'Novartis AG', u'Verastem Inc', u'Beijing Kawin Technology Share-Holding Co Ltd', u'ImmunoCellular Therapeutics Ltd', u'Bristol-Myers Squibb Co', u'Xynomic Pharmaceuticals', u'US Oncology Inc', u'Columbia University', u'CryoPort Inc', u'Takeda Oncology', u'Memgen LLC', u'University of Manchester', u'Janssen Pharmaceutical KK', u'Kyowa Hakko Kirin Co Ltd', u'Stellar Biotechnologies Inc', u'Kite Pharma Inc', u'Ludwig Institute for Cancer Research', u'University of Iowa', u'Janssen Biotech Inc', u'Sandoz Ltd', u'Pharm-Olam International', u'Defense Advanced Research Projects Agency', u'Infinity Pharmaceuticals Inc', u'Medarex Inc', u'Rosetta Genomics Ltd']), u'Genitourinarytracttumor': set([u'Cancer Genetics Inc', u'National Comprehensive Cancer Network', u'MultiPlan Inc', u'Pfizer Inc', u'SGX Pharmaceuticals Inc', u'Peakdale Molecular', u'National Institute for Health Research (NIHR)', u'Morvus Technology Ltd', u'UroGene SA', u'Vancouver General Hospital', u'AstraZeneca Canada Inc', u'Cardiff University', u'GlaxoSmithKline plc']), u'Adrenaldisease': set([u'ChemDiv Inc', u'National Institutes of Health', u'Stegram Pharmaceuticals Ltd', u'IDIS Ltd', u'Bioenvision Inc', u'Medison Pharma Ltd', u'Dana-Farber Cancer Institute Inc', u'Massachusetts General Hospital', u'Diurnal Ltd']), u'Familialadenomatouspolyposis': set([u'Sucampo Pharmaceuticals Inc', u'Windlas Healthcare Private Limited', u'US Department of the Treasury', u'Metabolomic Technologies Inc', u'Lab Express LLC', u'Cancer Prevention Pharmaceuticals Inc', u'Marina Biotech Inc', u'Microlin Bio Inc', u'Tillotts Pharma AG', u'Atlantic Diagnostic Laboratories LLC']), u'Neuropathy': set([u'SciDose LLC', u'Afferon Corp', u'MGI GP Inc', u'Merrion Pharmaceuticals Inc', u'Hunter-Fleming Ltd', u'Genentech Inc', u'Prismic Pharmaceuticals Inc', u'Rinat-Pfizer Inc', u'Nippon Kayaku Co Ltd', u'US Government', u'Biogen Inc', u'Eisai Co Ltd', u'University of North Carolina', u'Oxford BioMedica plc', u'Univ Massachusetts', u'US Health and Human Services Department', u'Takeda Pharmaceutical Co Ltd', u'MultiCell Technologies Inc', u'Sigma-Tau Ind Farm Riunite SpA', u'National Institutes of Health', u'Abeona Therapeutics Inc', u'American Cyanamid Co', u'Mundipharma EDO GmbH', u'ICOS Corp', u'Tanabe Seiyaku Co Ltd', u'OSI Pharmaceuticals Inc', u'Newron Pharmaceuticals SpA', u'Capha Pharmaceuticals Inc', u'Columbia University', u'ARIAD Pharmaceuticals Inc', u\"Hannah's Hope Fund\", u'NsGene A/S', u'Pfizer Inc', u'Neurocrine Biosciences Inc', u'Afgin Pharma Llc', u'Signal Research Division', u'PNA Center for Neurological Research', u'Loyola University of Chicago', u'FoldRx Pharmaceuticals Inc', u'Epitech Group Srl', u\"King's College London\"]), u'Osteolysis': set([u'LifeArc', u'New York University']), u'Francisellatularensisinfection': set([u'US Government', u'University of Maryland Baltimore County', u'DynPort Vaccine Company LLC', u'Diatherix Laboratories Inc', u'Advanced Life Sciences Holdings Inc', u'Tetraphase Pharmaceuticals Inc', u'National Institute of Allergy and Infectious Diseases', u'US Health and Human Services Department', u'US Army Medical Research Institute of Infectious Diseases', u'UMeWorld Ltd', u'Cempra Inc', u'GlaxoSmithKline plc', u'Affinium Pharmaceuticals Inc', u'EpiVax Inc', u'Achaogen Inc', u'MRIGlobal', u'DiaMedica Inc', u'Nanotherapeutics Inc', u'Lovelace Respiratory Research Institute', u'Aridis Pharmaceuticals Inc', u'University of Texas Southwestern Medical Center', u'Juvaris BioTherapeutics Inc', u'Virogenomics Inc', u'Defence Science and Technology Laboratory', u'Colorado State University', u'Cerus Corp', u'Aduro BioTech Inc', u'Basilea Pharmaceutica International Ltd', u'Pulmatrix Inc', u'University of Texas System', u'University of New Mexico', u'Defense Advanced Research Projects Agency', u'CUBRC', u'Anza Therapeutics Inc', u'University of Illinois', u'Defense Threat Reduction Agency']), u'Myalgia': set([u'Imprimis Pharmaceuticals Inc', u'IMPAX Laboratories Inc', u'Pierre Fabre SA', u'Pfizer Inc', u'Boehringer Ingelheim Corp', u'Cypress Bioscience Inc', u'Mitsubishi Pharma Corp', u'Professional Compounding Centers Of America Ltd', u'Tokuhon Co Ltd', u'Dartmouth College', u'Piramal Enterprises Ltd', u'Myungin Pharm Co Ltd', u'Recordati SpA', u'Bentley Pharmaceuticals Inc', u'Amdipharm', u'Eisai Co Ltd', u'Pharmacia Corp', u'GlaxoSmithKline plc']), u'Varicosisulcer': set([u'ChronTech Pharma AB', u'Derma Life Clinical Partners LP', u'Novogen Ltd', u'Glycotex Inc', u'Defiante Farmaceutica Lda', u'ProDerm Limited Partnership', u'National Institutes of Health', u'Linkoping University', u'Cardio Derma Clinical Partners', u'Pontificia Universidad Catolica De Chile', u'Recalcine Pharmaceutical Corp', u'Undisclosed', u'RegeneRx Biopharmaceuticals Inc', u'CardioVascular BioTherapeutics Inc', u'G-treeBNT Co Ltd']), u'Lipidmetabolism': set([u'Eli Lilly & Co', u'Ligand Pharmaceuticals Inc']), u'Respiratorydepression': set([u'Canadian Institutes of Health Research', u'University of Alberta', u'University of Florida', u'National Institute on Drug Abuse', u'RespireRx Pharmaceuticals Inc', u'Duke University']), u'Metastaticcolorectalcancer': set([u'Shanghai Jing Ze Biotech Co Ltd', u'Merck Sharp & Dohme BV', u\"Hospital Vall D'Hebron\", u'National Comprehensive Cancer Network', u'Biocartis', u'OncoTherapy Science Inc', u'Mount Sinai School of Medicine', u'NantKwest Inc', u'Cancer Research UK', u'University Of Southampton', u'IntegraGen', u'Navidea Biopharmaceuticals Inc', u'Roche Holding AG', u'Alchemia Ltd', u'Second Military Medical University PLA', u'Yamaguchi University', u'Gradalis Inc', u'mAbxience SA', u'National Center for Research Resources', u'NantCell Inc', u'Saladax Biomedical Inc', u'Sysmex Corp', u'DanDrit Biotech USA Inc', u'Exelixis Inc', u'National Health and Medical Research Council', u'Centre National de la Recherche Scientifique (CNRS)', u'Amgen Inc', u'Alliance for Clinical Trials in Oncology', u'Liverpool Hospital', u'l\\u2019Universite Paris Descartes', u'The European Union', u'3SBio Inc', u'VAXIMM AG', u'Assistance Publique Hopitaux de Paris', u'Novartis AG', u'Merck KGaA', u'Amoy Diagnostics Co Ltd', u'National Cancer Institute', u'Shanghai Henlius Biotech Co Ltd', u'Symphogen A/S', u'Oncolytics Biotech Inc', u'Taiho Pharmaceutical Co Ltd', u'FivePhusion Pty Ltd', u'MegaPharm Ltd', u'Altor BioScience Corp', u'Libbs Farmaceutica Ltda', u'Precision Biologics Inc', u'Johns Hopkins Hospital', u'Mount Sinai Medical Center', u'GNS Healthcare', u'NOXXON Pharma AG', u'OncoMed Pharmaceuticals Inc', u'Arisaph Pharmaceuticals Inc', u'Duke University Medical Center', u'Undisclosed', u'Genentech Inc', u'Guardant Health Inc', u'Haixin Biotechnology Co Ltd', u'Merck & Co Inc', u'Sanofi', u'University of Texas Southwestern Medical Center', u'Eli Lilly & Co', u'Hutchison Medipharma Enterprises Ltd', u'Bayer AG', u'Japan Agency for Medical Research and Development', u'University of Wollongong', u'XBiotech Inc', u'Merus BV', u'University of Southern California', u'Southern Medical Day Care Centre', u'AusIndustry', u'NCIC Clinical Trials Group', u'IRCCS AOU San Martino \\u2013 IST', u'Servier', u'Bristol-Myers Squibb Co', u'Medinet Co Ltd', u'INSERM', u'Shandong Chengchuang Pharmaceutical R&D Co Ltd', u'Roswell Park Cancer Institute', u'Central European Society for Anticancer Drug Research', u'National Cancer Center Hospital East', u'Array BioPharma Inc', u\"Gruppo Italiano per lo studio dei Carcinomi dell'Apparato Digerente\", u'Merck Serono SA', u'Nationales Centrum fur Tumorerkrankungen', u'Biologics Inc', u'Laboratorio Elea']), u'Mycobacteriumtuberculosisinfection': set([u'US Civilian Research and Development Foundation', u'iThemba Pharmaceuticals Pty Ltd', u'Advanced BioScience Laboratories Inc', u'University of Lille', u'The Chinese Centre for Disease Control and Prevention', u'B&C Biopharm', u'Serum Institute of India Ltd', u'RMX Pharmaceutical Technology Co Ltd', u'Bio Farma', u'EpiVax Inc', u'EyeGene Inc', u'European Community', u'University of Pittsburgh', u'AnHui Longcom Biologic Pharmacy Co Ltd', u'Colthurst Ltd', u'Walter Reed Army Institute of Research', u'Tulane National Primate Research Center', u'Farmabrasilis', u'Birla Institute of Technology', u'Shanghai Fosun Pharmaceutical (Group) Co Ltd', u'Shire Orphan Therapies GmbH', u'Ifakara Health Institute', u'AstraZeneca plc', u'Sichuan BoXin LaiTe Biotechnology Inc', u'Sanofi Pasteur', u'Hans Knoell Institute of Natural Products Research', u'Universiti Sains Malaysia', u'European Commission', u'LifePharms Inc', u'Weill Medical College of Cornell University', u'Infectex', u'Australian Agency for International Development', u'Sichuan University', u'Upstream Biosciences Inc', u'The European Union', u'Tokyo Medical and Dental University', u'Tulane University', u'GlaxoSmithkline Pharmaceuticals (India) Ltd', u'The Chao Center for Industrial Pharmacy & Contract Manufacturing', u'Wayne State University', u'National Institutes of Biomedical Imaging and Bioengineering', u'Max Planck Institute for Infection Biology', u'YM BioSciences Inc', u'National Jewish Health', u'Verta Ltd', u'Wellcome Trust', u'FASgen Inc', u'MegaPharm Ltd', u'Maxwell Biotech Group', u'Genexine Co Ltd', u'Indian Institute of Integrative Medicine, Jammu', u'Cumbre Pharmaceuticals Inc', u'Janssen Pharmaceutica NV', u'SIOGEN Biotech', u'Rutgers University', u'Saurashtra University', u'Ludwig-Maximilians University of Munich', u'Fraunhofer USA Inc', u'Pan African Consortium for Evaluation of Antituberculosis Antibiotics', u'Immunobiology Ltd', u'Nanologica Ab', u'BioVersys AG', u'International Center for Genetic Engineering and Biotechnology (ICGEB)', u'Oregon Health Sciences University', u'TB-VAC', u'Emergent BioSolutions Inc', u'Sakai Chemical Industry Co Ltd', u'Frost & Sullivan', u'Immuno-Mycologics Inc', u'Eli Lilly & Co', u'Centers for Disease Control and Prevention', u'GlaxoSmithKline Biologicals', u'Sarawak State Government', u'Agenus Inc', u'BIO Ventures for Global Health', u'Istituto Superiore di Sanita', u'University of California Los Angeles', u'Universidade Estadual de Campinas', u'State University of New York', u'Corixa Corp', u'Akorn Inc', u'Johns Hopkins University', u'Zalicus Inc', u'Harbor Therapeutics Inc', u'Johnson & Johnson', u'SomaLogic Inc', u'Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - CNPq', u'John Radcliffe Hospital', u'Stirling Products Ltd', u'Indiana Economic Development Corp', u'Snowdon Inc', u'Yamanouchi Pharmaceutical Co Ltd', u'Collaborative Drug Discovery Inc', u'Sphaera Pharma', u'ISA Pharmaceuticals BV', u'Auburn University', u'Maharaja Krishnakumarsinhji Bhavnagar University', u'PAI Life Sciences', u'University of Auckland', u'Rhone-Poulenc SA', u'ActivBiotics Inc', u'University of Oxford', u'Cyprotex Plc', u'National Institute for Biological Standards and Control', u'NanoPass Technologies Ltd', u'The John Curtin School of Medical Research', u'Genesis Research and Development Corp Ltd', u'Karolinska Institutet', u'Cumencor Pharmaceuticals', u'Procrysta Biologix Inc', u'Novartis Institute for Tropical Diseases Pvt Ltd', u'Howard Hughes Medical Institute', u'Xcelris Lab Ltd', u'Texas A&M University System', u'Indiana University School of Medicine', u'Zhejiang Hisun Pharmaceutical Co Ltd', u'Arizona State University', u'Medicines for Malaria Venture', u'Lipotek Pty Ltd', u'Onyvax Ltd', u'University of Pennsylvania', u'Imaxio', u'Indiana University Medical Group Foundation', u'Otsuka Novel Products GmbH', u'Roche Holding AG', u'University of British Columbia', u'Universita degli Studi di Sassari', u'China National Biotec Group', u'VIB', u'Intercell AG', u'Immune Solutions Ltd', u'Atreca Inc', u'Aarden Pharmaceuticals Inc', u'Statens Serum Institut', u'ChemRar High Tech Center', u'Akonni Biosystems', u'The Jenner Institute', u'Shreya Life Sciences Pvt Ltd', u'McMaster University', u'Vakzine Projekt Management GmbH', u'Chemical Diversity Research Institute Ltd', u'The University of Birmingham', u'Southern Research Institute', u'Dartmouth Medical School', u'Transgene SA', u'University of Havana', u'Inflazyme Pharmaceuticals', u'National Institute of Oceanography', u'Vanderbilt University School of Medicine', u'Chinese Academy of Sciences', u'Georgia State University', u'National Institute of Biomedical Innovation', u'Swiss Tropical & Public Health Institute', u'The Global Health Institute', u'UNITAID', u'Fujifilm\\xa0Corp', u'Tuberculosis Vaccine Initiative', u'The Macfarlane Burnet Institute For Medical Research & Public Health Ltd', u'Finlay Institute', u'Korea Drug Development Fund', u'The University of Notre Dame du Lac', u'Eurocine Vaccines AB', u'Baylor Research Institute', u'Reino de Espana', u'Dishman Pharmaceuticals & Chemicals Ltd', u'Arkray Inc', u'Avesthagen Ltd', u'Microbiotix Inc', u'Sequella Inc', u'Scripps Research Institute', u'Dartmouth-Hitchcock Medical Center', u'R-Pharm', u'University of Wisconsin-Madison', u'Syntrix Biosystems Inc', u'Biofabri SL', u'VacTex Corp', u'Janssen Therapeutics', u'UK Department of Trade & Industry', u'Savine Therapeutics Pty Ltd', u'Pharmstandard OJSC', u'UK National Institute of Medical Research', u'Sirenas Marine Discovery LLC', u'EpiStem Ltd', u'Academia Sinica', u'Mylan Pharmaceuticals Inc', u'Small and Medium Business Administration (SMBA)', u'Institute of Materia Medica Chinese Academy of Medical Sciences & Peking Union Medical College', u'Alberta Glycomics Centre', u'Dainippon Pharmaceutical Co Ltd', u'Haikou VTI Biological Institute', u'Fundacao de Amparo a Pesquisa do Estado Sao Paulo', u'Novavax Inc', u'deCODE chemistry', u'National Center for Biotechnology of the Republic of Kazakhstan', u'ACE BioSciences A/S', u'European and Developing Countries Clinical Trials Partnership', u'Cornell University', u'Summit Therapeutics plc', u'Mycosynthetix Inc', u'St James Associates Llc/Faber Research Series', u'US Department of Energy', u'BioDiem Ltd', u'Institut Pasteur', u'Janssen Diagnostics BVBA', u\"Brigham & Women's Hospital\", u'Antitope Ltd', u'Takeda Pharmaceutical Co Ltd', u'Dartmouth College', u'Beijing Union Pharmaceutical Factory', u'SPA Societa Prodotti Antibiotici SpA', u'Veeda Clinical Research', u'ID Vaccine Corp', u'Aurum Institute', u'Vaccibody AS', u'Silence Therapeutics plc', u'Lanzhou Institute of Biological Products', u'Mologen Ag', u'Oragenics Inc', u'The Technology Innovation Agency', u'Oxford-Emergent Tuberculosis Consortium Ltd', u'Onxeo SA', u'Korea Research Institute of Chemical Technology', u'Center for Infectious Disease Research', u'World Health Organization', u'FIT Biotech Oyj Plc', u'Vical Inc', u'University of Queensland', u'LegoChem Bioscience Inc', u'London School of Hygiene and Tropical Medicine', u'University of London', u'Yonsei University', u'Immune Network Ltd', u'Foundation for Innovative New Diagnostics', u'Oak Therapeutics Inc', u'Relief Therapeutics Holding AG', u'Global Health Innovative Technology Fund', u'ReiThera Srl', u'National Center for Research Resources', u'Microbial Chemistry Research Foundation', u'TB Drug Accelerator', u'SCYNEXIS Inc', u'Mylan Inc', u'International AIDS Vaccine Initiative', u'Harvard University', u'Lucane Pharma SA', u'Acuvax Ltd', u'Teva Pharmaceutical Industries Ltd', u'AbCellera Biologics Inc', u'GlobeImmune Inc', u'Affymetrix Inc', u'WuXi PharmaTech (Cayman) Inc', u'OPKO Health Inc', u'German Government', u'Achillion Pharmaceuticals Inc', u'Amneal Pharmaceutical LLC', u'Cellworks Group Inc', u'Muhimbili University College of Health Sciences', u'University of Melbourne', u'Albany Medical College', u'University of Ghent', u'University of Sydney', u'Changzhou Yinsheng Pharmaceutical Co Ltd', u'Liaoning Hongwuxing Pharmaceutical Co Ltd', u'Aspen PharmaCare Holdings Ltd', u'National Institute for Food and Drug Control', u'Advanced Life Sciences Holdings Inc', u'Harvard Medical School', u'The Institute of Microbiology Chinese Academy of Sciences', u'Oxford BioMedica plc', u'Rafarma Pharmaceuticals Inc', u'Australian Government', u'University of California', u'Merck & Co Inc', u'Kemwell Biopharma Pvt Ltd', u'Sanofi', u'Chong Kun Dang Pharmaceutical Corp', u'Columbia University', u'TapImmune Inc', u'University of Oslo', u'Bayer AG', u'Only For Children Pharmaceuticals', u'FUJIFILM Holdings Corp', u'Anacor Pharmaceuticals Inc', u'Case Western Reserve University', u'Medicines Patent Pool', u'Critical Path Institute', u'Spero Therapeutics LLC', u'Broad Institute Inc', u'Massachusetts Institute of Technology', u'University of Cape Town', u'University of Utah', u'Max-Planck-Gesellschaft', u\"St Jude Children's Research Hospital\", u'Danish International Development Agency (DANIDA)', u'iviGene Corp', u'Medicine in Need', u'INSERM', u'Whitehead Institute for Biomedical Research', u'Ranbaxy Laboratories Ltd', u'University of Georgia', u'Crucell NV', u'Research Institute of Influenza', u'California Institute for Biomedical Research', u'MicuRx Pharmaceuticals Inc', u'New York Medical College', u'University of Medicine and Dentistry of New Jersey', u'US Government', u'UMeWorld Ltd', u'GlaxoSmithKline plc', u'Global BioDiagnostics Corp', u'Chulalongkorn University', u'Oklahoma Center for the Advancement of Science and Technology', u'Myongji University (MJU)', u'GlobalAcorn', u'Menzies School of Health Research', u'Paratek Pharmaceuticals Inc', u'Intravacc Inc', u'Create Vaccine Co', u'Sankyo Co Ltd', u'Pohang University of Science & Technology', u'Orexo AB', u'Shionogi & Co Ltd', u'Alere Inc', u'Stanford Rook Ltd', u'Emory University', u'Aeras Global TB Vaccine Foundation', u'Institute for Tuberculosis Research', u'Reyon Pharmaceuticals Co Ltd', u'MD Anderson Cancer Center', u'Abera Bioscience AB', u'Daiichi Sankyo Co Ltd', u'Abbott Laboratories', u'Eisai Co Ltd', u'Novartis AG', u'Indian Government Department of Biotechnology', u'pSivida Corp', u'Qurient Therapeutics', u'BG Medicine Inc', u'SciClone Pharmaceuticals Inc', u'Jacobus Pharmaceutical Co Inc', u'Infectious Disease Research Institute', u'ALZA Corp', u'NovoBiotic Pharmaceuticals LLC', u'CanSino Biologics Inc', u'Montana State University', u'NeED Pharmaceuticals Srl', u'Chiron PathoGenesis', u'Biochem Pharma', u'Immtech Pharmaceuticals Inc', u'South African Tuberculosis Vaccine Initiative', u\"South Africa's Innovation Fund\", u'University of North Carolina', u'Undisclosed', u'Rodos BioTarget GmbH', u'Cosmosid Inc', u'Biopreparaty/Russian Research Center for Molecular Diagnostics & Therapy', u'SRI International', u'Bayer Korea Ltd', u'French National Agency for Research on AIDS and Viral Hepatitis', u'Cellzome', u'Medivir AB', u'MRIGlobal', u'Indian Institute of Chemical Technology', u'Pharmarare SA', u'Pfizer Inc', u'Cystic Fibrosis Foundation Therapeutics Inc', u'Wyeth-Ayerst Pharmaceuticals Inc', u'Cadila Pharmaceuticals Ltd', u'University of Illinois', u'Memorial Sloan-Kettering Cancer Center', u'Wyeth BioPharma', u'National Institute of Allergy and Infectious Diseases', u'iBio Inc', u'TWINCORE', u'Albert Einstein College of Medicine', u'Universidad de Zaragoza', u'Christian-Albrechts-University Kiel', u'National Institutes of Health', u'Bill & Melinda Gates Foundation', u'Food and Drug Administration', u'M.J. Murdock Charitable Trust', u'Sarepta Therapeutics Inc', u'Shenyang Hongqi Pharmaceutical Co Ltd', u'Grand Challenges in Global Health', u'Quratis Co Ltd', u'Janssen Pharmaceutica Ltd', u'ApoVax Inc', u'Colorado State University', u'Dompe Group', u'Sichuan Long March Pharmaceutical Co Ltd', u'Qiagen NV', u'Jubilant Life Sciences Ltd', u'Centenary Institute Cancer Medicine & Cell Biology', u'Takara Bio Inc', u'Incozen Therapeutics Pvt Ltd', u'ProBioGen AG', u'Paligent Inc', u'The Global Alliance for TB Drug Development', u'The Lilly TB Drug Discovery Initiative', u'Kaneka Corp', u'Guo Kang Pharmaceutical & Medical Supplies Ltd']), u'Bloodtransfusion': set([u'Haemonetics Corp', u'New Alliance Pharmaceuticals Inc', u'US Government', u'Sanquin Blood Supply Foundation', u'National Institutes of Health', u'Cerus Corp', u'Takeda Pharmaceuticals International GmbH', u'Vatea Fund', u'Mesoblast Ltd', u'Japanese Ministry of Health, Labor and Welfare', u'US Naval Medical Research Center', u'US Army Research Office', u'Abazali Bio Ventures', u'China PharmaHub Corp', u'Office of Naval Research (ONR)', u'BioTime Inc', u'Texas Stem Cell', u'Boehringer Mannheim GmbH', u'National Cancer Institute', u'Plasticell Ltd', u'Organon Teknika Corp', u'Gambro AB', u'Chi Sheng Chemical Corp', u'CytoSorbents Corp', u'Summit Pharmaceuticals International Corp', u'Walter Reed National Military Medical Center', u'Biopure Corp', u'OPK Biotech', u'CJ Corp', u'Sangart Inc', u'Fred Hutchinson Cancer Research Center', u'Northfield Laboratories Inc', u'Walter Reed Army Institute of Research', u'Hospira Inc', u'Oxygenix Co Ltd', u'Taiga Biotechnologies Inc', u'University of California San Diego', u'Wyeth BioPharma', u'Tenax Therapeutics Inc', u'Technology Strategy Board', u'Waseda University', u'State University of New York', u'Cypress Bioscience Inc', u'Keio University', u'Cesca Therapeutics Inc', u'American Red Cross', u'US Department of Defense', u'National Heart Lung and Blood Institute', u'OncoGenex Pharmaceuticals Inc', u'Entegrion Inc']), u'Vulvarintraepithelialneoplasia': set([u'Netherlands Government', u'Bachem Holding AG', u'ISA Pharmaceuticals BV', u'Cancer Research Technology Ltd', u'Xenova Group plc']), u'Ventriculararrhythmia': set([u'Blue Ash Therapeutics LLC', u'Forest Laboratories Inc', u'Warner Chilcott plc']), u'Cholangiocarcinoma': set([u'National Comprehensive Cancer Network', u'Thomas Jefferson University', u'Translational Genomics Research Institute', u'Mayo Clinic Foundation', u'MEI Pharma Inc', u'H Lee Moffitt Cancer Center and Research Institute', u'ASLAN Pharmaceuticals Pte Ltd', u'National Cancer Centre of Singapore', u'Sanghyon Chemical Corp', u'ARUP Laboratories', u'ArQule Inc', u'Perceptive Imagineering LLC', u'Sigma-Aldrich Corp', u'Thermo Fisher Scientific Inc', u'Novogen Ltd', u'Bayer AG', u'Galectin Therapeutics Inc', u'Kangwon National University', u'Korea Drug Development Fund', u'YIACO Medical Co', u'SAFC Pharma', u'Ludwig Institute for Cancer Research', u'Concordia International Corp', u'Hyundai Pharmaceutical', u'Pfizer Inc', u'Agios Pharmaceuticals Inc', u'ChemWerth USA']), u'Menstruationdisorder': set([u'Pfizer Inc', u'FAES Farma SA', u'Elan Pharmaceutical Technologies', u'Bayer Schering Pharma AG']), u'Non-small-cell': set([u'Takeda Oncology', u'Janssen Pharmaceutical KK']), u'LeschNyhansyndrome': set([u'Par Pharmaceutical Co Inc', u'BioMarin Pharmaceutical Inc']), u'Periodontitis': set([u'University of Michigan', u'National Institute of Dental and Craniofacial Research', u'US Government', u'GlycoMira Therapeutics Inc', u'Uppsala Clinical Research Center', u'Onepharm', u'Caladrius Biosciences Inc', u'Innoventus Project AB', u'Bionetworks GmbH', u'Millennium Dental Technologies Inc', u'TOLMAR Therapeutics Inc', u'Theratechnologies Inc']), u'Acidemia': set([u'Accredo Health Group Inc', u'Orphan Europe SARL']), u'Staphylococcusinfection': set([u'CrystalGenomics Inc', u'Merus Labs International Inc', u'Rockefeller University', u'New York University', u'Biota Holdings Ltd', u'Sanofi Pasteur', u'Mapp Biopharmaceutical Inc', u'Phage Consultants', u'Sunol Molecular Corp', u'National Institute of Allergy and Infectious Diseases', u'US Government', u'Iroko Pharmaceuticals LLC', u'PolyMedix Inc', u'Tulane University', u'Forest Laboratories Inc', u'GlaxoSmithKline plc', u'Innoviva Inc', u'Quintiles Transnational Corp', u'ViroPharma Inc', u'Teva Pharmaceutical Industries Ltd', u'Technion Research & Development Foundation Ltd', u'National Institutes of Health', u'Affinium Pharmaceuticals Inc', u'Korea Research Institute of Bioscience and Biotechnology', u'ProMetic Life Sciences Inc', u'Novozymes A/S', u'Syntiron LLC', u'Merck & Co Inc', u'Breathtec Biomedical Inc', u'CytoCore Inc', u'NanoSave Technologies Inc', u'Vanderbilt University', u'Avanti Therapeutics', u'Sanofi', u'Eli Lilly & Co', u'Biosynexus Inc', u'GlaxoSmithKline Biologicals', u'Hospira Inc', u'Morphotek Inc', u'Bayer AG', u'Tulane National Primate Research Center', u'Catalytica Inc', u'BPI Technologies Corp', u'Basilea Pharmaceutica International Ltd', u'Trinity College Dublin', u'Shire plc', u'ImmuVen Inc', u'Microcide Pharmaceuticals Inc', u'FUJIFILM Holdings Corp', u'Elusys Therapeutics Inc', u'Ortho-McNeil Inc', u'Ancora Pharmaceuticals Inc', u'Aviragen Therapeutics Inc', u'Nutrition 21 Inc', u'Integrated BioTherapeutics Inc', u'Hikma Pharmaceuticals plc', u'ANI Pharmaceuticals Inc', u'FDA Office of Orphan Products Development', u'Wellcome Trust', u'MedImmune LLC', u'Zyngenia Inc', u'Cubist Pharmaceuticals Inc', u'Paladin Labs Inc', u'Nabriva Therapeutics AG', u'BioResearch Ireland', u'National Center for Research Resources', u'US Department of Defense', u'Novartis Vaccines & Diagnostics', u'Inhibitex Inc', u'Pfizer Vaccines', u'Debiopharm SA', u'ContraFect Corp']), u'Enterobacteriaceaeinfection': set([u'National Institute of Allergy and Infectious Diseases', u'Achaogen Inc', u'Thermo Fisher Scientific Inc', u'US Health and Human Services Department', u'Massachusetts Institute of Technology']), u'FamilialLCATdeficiency': set([u'Nissui Pharmaceutical Co Ltd', u'CellGenTech Inc']), u'Asphyxia': set([u'Universiteit Utrecht', u'University College London', u'Neurophyxia BV', u'Chiesi Farmaceutici SpA']), u'Fungalrespiratorytracti': set([u'Johnson & Johnson', u'Barrier Therapeutics Inc']), u'Viralinfection': set([u'Biovest International Inc', u'Therapeutic Systems Research Laboratories', u'Soligenix Inc', u'Marine Biotechnology Australia Pty Ltd', u'Serum Institute of India Ltd', u'Apath LLC', u'Mylan Laboratories Ltd', u'Synergy Pharmaceuticals Inc', u'ViroPharma Inc', u'Nippon Kotan KK', u'Evry Genopole Biopark', u'Ionis Pharmaceuticals Inc', u'Bioanalytical Systems Inc', u'Ploughshare Innovations Ltd', u'Celldex Therapeutics Inc', u'Walter Reed Army Institute of Research', u'Galapagos NV', u'Korea Drug Development Fund', u'Virion Systems Inc', u'Kuhnil Pharmaceutical Co Ltd', u'Viriom Inc', u'US Department of the Treasury', u'1608557 Ontario Inc', u'Cengent Therapeutics Inc', u'Genoscience', u'National Research Council of Canada', u'Shanghai Infectious Diseases Hospital', u'Weill Medical College of Cornell University', u'Centre National de la Recherche Scientifique (CNRS)', u'Nventa Biopharmaceuticals Corp', u'Sichuan University', u'Rega Institute for Medical Research', u'The European Union', u'Mochida Pharmaceutical Co Ltd', u'Merial Llc', u'Avipero Ltd', u'Medtronic Diabetes', u'Center for Infectious Disease Research', u'MerLion Pharmaceuticals Pte Ltd', u'Vanderbilt University', u'MeMed Diagnostics Ltd', u'Virus Research Institute Inc', u'Kineta Inc', u'State Research Center of Virology and Biotechnology VECTOR', u'Gen-Probe Inc', u'Undisclosed', u'Tolerx Inc', u'Albany Molecular Research Inc Singapore Research Centre', u'Cytokine PharmaSciences Inc', u'Starpharma Holdings Ltd', u'MegaPharm Ltd', u'Altor BioScience Corp', u'EvoGenix Pty Ltd', u'CSPC Pharmaceuticals Group Limited', u'4SC AG', u'Biomolecular Research Institute Ltd', u'Rutgers University', u'International Vaccine Institute', u'AmpliMed Corp', u'ContraVir Pharmaceuticals Inc', u'Galenea Corp', u'Monsanto Co', u'Novacta Biosystems Ltd', u'Viracyte', u'Flamel Technologies SA', u'La Jolla Institute of Allergy & Immunology', u'Oregon Health Sciences University', u'Ewha Womans University', u'Eli Lilly & Co', u'Centers for Disease Control and Prevention', u'University of Wisconsin-Madison', u'Universita Degli Studi di Genova', u'Drug Innovation Ventures', u'Progenitor Inc', u'Prosetta Biosciences Inc', u'Sunesis Pharmaceuticals Inc', u'Nissin Foods Holdings Co Ltd', u'Novartis Vaccines & Diagnostics', u'Abide Therapeutics Inc', u'Akorn Inc', u'AMAG Pharmaceuticals Inc', u'Sanwa Kagaku Kenkyusho Co Ltd', u'Presidio Pharmaceuticals Inc', u'Beactica AB', u'TetraLogic Pharmaceuticals Corp', u'Coley Pharmaceutical Group Inc', u'Kansas State University', u'University of Bonn', u'Dalton Pharma Services', u'Horizon Discovery Group plc', u'SmithKline Beecham plc', u'Horizon Genomics GmbH', u'EntoMed SA', u'Yamanouchi Pharmaceutical Co Ltd', u'Bavarian Nordic A/S', u'Arrow Therapeutics Ltd', u'Bristol-Myers Squibb Co', u'Shire Pharmaceuticals Ltd', u'Janssen Research & Development LLC', u'Seoul National University', u'NanoViricides Inc', u'Full Spectrum Genetics Inc', u'Archimedes Pharma Ltd', u'Arriani Pharmaceuticals SA', u'Agouron Pharmaceuticals Inc', u'Orphan Australia', u'Rhone-Poulenc Rorer Ltd', u'Hoechst Marion Roussel Inc', u'Hemispherx Biopharma Inc', u'Microbix Biosystems Inc', u'Locus Pharmaceuticals Inc', u'NeuroVive Pharmaceutical AB', u'University of Texas Medical Branch at Galveston', u'Barbara Ann Karmanos Cancer Institute', u'Ardea Biosciences Inc', u'BTG plc', u'Chiron Corp', u'OOO VagaPharm', u'Genesis Technology Group Inc', u'iDialog', u'ArQule Inc', u'Fidia Farmaceutici SpA', u'University of Pennsylvania', u'Lead Discovery Center GmbH', u'Eleos Inc', u'Roche Holding AG', u'Shire plc', u'Microcide Pharmaceuticals Inc', u'The National Institute of Mental Health', u'Genecor International Inc', u'NAUKA', u'Temple University', u'Biotica Technology Ltd', u'Emergent Europe Ltd', u'NPO Petrovax Pharm LLC', u'Dana-Farber Cancer Institute Inc', u'Beike Biotechnology Co Ltd', u'National Institute of General Medical Sciences', u'Alexis Biotech Ltd', u'Evotec AG', u'McMaster University', u'CJ Corp', u'Chinese Academy of Medical Sciences', u'Alberta Research Council', u'Coelacanth Corp', u'Artes Biotechnology', u'Gravity Bio Inc', u'Viragen Inc', u'Arno Therapeutics Inc', u'ViroStatics', u'Eunice Kennedy Shriver National Institute of Child Health & Human Development', u'Ciba US', u'UK Ministry of Defence', u'SRI International', u'Bruker Corporation', u'University of Alabama at Birmingham', u'Novirio Pharmaceuticals Inc', u'Massachusetts General Hospital', u'Medical Research Council', u'Trimeris Inc', u'Immunomedics Inc', u'Cleveland Clinic Foundation', u'FORGE Life Science LLC', u'Three Rivers Pharmaceuticals LLC', u'LG Chem Ltd', u'The Research Council of Norway', u'Nanosphere Inc', u'University of California San Diego', u'Roche Palo Alto', u'University of Oxford', u'Medidata Solutions Worldwide', u'TBG Diagnostics Ltd', u'The Macfarlane Burnet Institute For Medical Research & Public Health Ltd', u'Mayo Clinic Foundation', u'DelSite Biotechnologies Inc', u'Oxford GlycoSciences plc', u'Yale University', u'Laureate Biopharmaceutical Services Inc', u'Actavis Inc', u'RFS Pharma LLC', u'Microbiotix Inc', u'Vivalis', u'Scripps Research Institute', u'Australian Research Council', u'Spring Bank Pharmaceuticals Inc', u'Atara Biotherapeutics Inc', u'Ahn-Gook Pharmaceuticals Co Ltd', u'Evolva SA', u'LION bioscience Inc', u'United Therapeutics Corp', u'Kadmon Pharmaceuticals LLC', u'Norwegian Institute of Public Health', u'Cocrystal Discovery Inc', u'Primagen Holding BV', u'InGen Biosciences', u'Genencor International Inc', u'SmithKline Beecham Seiyaku KK', u'Metdem Healthcare Ltd', u'Genta Inc', u'Life Technologies Corp', u'bioMerieux SA', u'CSL Behring LLC', u'Bioject Medical Technologies Inc', u'BioChem Therapeutic Inc', u'PharmaNova Inc', u'ProMetic Life Sciences Inc', u'Pepgen Corp', u'Immunovaccine Inc', u\"Xi'an-Hex Life Sciences Co Ltd\", u'Cornell University', u'Valeant Pharmaceuticals International Inc', u'National Institute of Biomedical Imaging and Bioengineering', u'Hospira Adelaide Pty Ltd', u'Karyopharm Therapeutics Inc', u'Cyclenium Pharma Inc', u'Institut Pasteur', u'Adamas Pharmaceuticals Inc', u'The Vaccine and Gene Therapy Institute of Florida', u'Alios BioPharma Inc', u'Walter and Eliza Hall Institute of Medical Research', u'AiCuris Anti-infective Cures GmbH', u'PiSA Farmaceutica', u'Dyax Corp', u'Questcor Pharmaceuticals Inc', u'Wayne State University', u'Rx for Africa', u\"Dr Reddy's Laboratories Ltd\", u'Sanofi Pasteur', u'Hetero Drugs Ltd', u'Yakult Honsha Co Ltd', u'Quintiles Transnational Corp', u'CombiMatrix Corp', u'SGX Pharmaceuticals Inc', u'Shaanxi Dacheng International Trade Co Ltd', u'OSI Pharmaceuticals Inc', u'University of Washington', u'Hughes Institute', u'Newsummit Biopharma Co Ltd', u'ImmuneMed Inc', u'BIOO Scientific Corp', u'University of Maryland Biotechnology Institute', u'Waterstone Pharmaceuticals Inc', u'Academia Sinica', u'ModeRNA Therapeutics', u'AstraZeneca plc', u'National Center for Research Resources', u'Defense Advanced Research Projects Agency', u'ViroLogik Gmbh', u'University of Nebraska Medical Center', u'PTC Therapeutics Inc', u'GenOdyssee SA', u'Oncovir Inc', u'SCYNEXIS Inc', u'National AIDS Control Organization', u'Affitech A/S', u'Harvard University', u'Mast Therapeutics Inc', u'Aphios Corp', u'MNLpharma Ltd', u'Chimerix Inc', u'Cetek Corp', u'Wichita State University', u'AvidBiotics Corp', u'OPKO Health Inc', u'PCI Biotech Holding ASA', u'Achillion Pharmaceuticals Inc', u'Carrus Capital Corp', u'Biologics Consulting Group Inc', u'Fusion Antibodies Ltd', u'Glaxo Group Ltd', u'Novita Healthcare Ltd', u'Hoffmann-La Roche Inc', u'Virogen Ltd', u'University of Arizona', u'InKine Pharmaceutical Co Inc', u'Debiopharm SA', u'AMRAD Pharmaceuticals Pty Ltd', u'Quidel Corp', u'Isomerase Therapeutics Ltd', u'University of South Alabama', u'Defyrus Inc', u'Schering-Plough Corp', u'Roche Innovation Center Copenhagen A/S', u'Oxford BioMedica plc', u'University of California', u'Merck & Co Inc', u'Gemin X Pharmaceuticals Inc', u'ResApp Health Ltd', u'Sanofi', u'Kyoto Biken Laboratories Inc', u'Beijing Bio-Fortune Ltd', u'US Army Medical Research Institute of Infectious Diseases', u'Provention Bio Inc', u'Cambridge Biotechnology Ltd', u'Protech Ltd', u'InNexus Biotechnology Inc', u'Anacor Pharmaceuticals Inc', u'Merck Research Laboratories', u'Nektar Therapeutics', u'Therapure Biopharma Inc', u'Tamir Biotechnology Inc', u'Gilead Sciences Inc', u'Triangle Pharmaceuticals Inc', u'Mymetics Corp', u'Theragenex LLC', u'Adcock Ingram Ltd', u'Institute for the Promotion of Innovation by Science and Technology in Flanders', u'Acambis plc', u'JB Chemicals & Pharmaceuticals Ltd', u'Broad Institute Inc', u'Evolva Holding SA', u'Arisan Therapeutics Inc', u'Tularik Inc', u'Massachusetts Institute of Technology', u'Cancer Vaccine Acceleration Fund', u'Functional Genetics Inc', u'Small and Medium Business Administration (SMBA)', u'Immunotope Inc', u'Peptimmune Inc', u'PowderJect Pharmaceuticals plc', u'Lonza Group AG', u'Pfizer Central Research', u'Ablynx NV', u'Elan Corp plc', u'MorphoSys AG', u'Kuros Biosciences Ltd', u'University of Melbourne', u'Bukwang Pharmaceutical Co Ltd', u'MGI Pharma Inc', u'TheraCour Pharma Inc', u'Vyrex Corp', u'Bioleaders Corp', u'Baruch S Blumberg Institute', u'Biovail Corp', u'Whitehead Institute for Biomedical Research', u'Zirus Inc', u'Ranbaxy Laboratories Ltd', u'vTv Therapeutics LLC', u'Crucell NV', u'Adamis Pharmaceuticals Corp', u'SIGA Technologies Inc', u'Universita degli Studi di Sassari', u'Kim & Friends Inc', u'GD Searle & Co', u'Defense Threat Reduction Agency', u'Daiichi Seiyaku Co Ltd', u'US Government', u'University of Cologne', u'InterMune Inc', u'GlaxoSmithKline plc', u'Novavax Inc', u'Interferon Sciences Inc', u'Marina Biotech Inc', u'University of Michigan', u'Clinigen Group plc', u'Takeda Oncology', u'Universitat Innsbruck', u'Kendle International Inc', u'Epiphany Biosciences Inc', u'Peregrine Pharmaceuticals Inc', u'Tianjin Linda Biotechnology Ltd', u'Avacta Ltd', u'Inpharmatica Ltd', u'Emory University', u'US Department of Defense', u'Beijing Evergene Biomedical Technology', u'Boehringer Ingelheim (Canada) Ltd', u'Alnylam Pharmaceuticals Inc', u'St Louis University', u'Foresight Biotherapeutics Inc', u'BioTherapeutics Inc', u'Shire BioChem Inc', u'Institute of Bioorganic Chemistry Polish Academy of Sciences', u'MD Anderson Cancer Center', u'Abbott Laboratories', u'Commonwealth Scientific and Industrial Research Organization', u'Drexel University', u'Tanox Inc', u'Advanced Biological Laboratories Sa', u'National Cancer Institute', u'Novartis AG', u'CLS Pharmaceuticals Inc', u'Korea Research Institute of Bioscience and Biotechnology', u'University of Maryland', u'Qurient Therapeutics', u'Fresenius Medical Care AG', u'Scripps Florida', u'University of Minnesota', u'Monash University', u'Aplicare Inc', u'Acambis Inc', u'HitGen Ltd', u'Pharmacia & Upjohn Inc', u'NeED Pharmaceuticals Srl', u'Duke Human Vaccine Institute', u'Oregon State University', u'Recordati SpA', u'Benitec Biopharma Ltd', u'Leukocare AG', u'Aileron Therapeutics Inc', u'Chugai Pharmaceutical Co Ltd', u'University of North Carolina', u'National Institute of Neurological Disorders and Stroke', u'Marine Biological Laboratory', u'GENESIS Pharma SA', u'Atlantic Technology Ventures Inc', u'Morvus Technology Ltd', u'Southern Research Institute', u'Medivir AB', u'VaxyGen Vaccines Ltd', u'Radboud University', u'Epimmune Inc', u'ImmuVen Inc', u'University of Siena', u'PaxVax Inc', u'Pfizer Inc', u'Midatech Pharma PLC', u'New bioMerieux Alliance', u'Hitachi High-Technologies Corp', u'Longevity Biotech Inc', u'Human Genome Sciences Inc', u'Inhibitex Inc', u'Utah State University', u'Memorial Sloan-Kettering Cancer Center', u'Wyeth BioPharma', u'NeoGenesis Pharmaceuticals Inc', u'Baylor College of Medicine', u'University of Gothenburg', u'Janssen R&D (Ireland)', u'University of California at Berkeley', u'National Institute of Allergy and Infectious Diseases', u'Quantum Pharmaceuticals LLC', u'Praecis Pharmaceuticals Inc', u'Immtech Pharmaceuticals Inc', u'Ohio State University', u'Bayer AG', u'National Institutes of Health', u'Bill & Melinda Gates Foundation', u'Medicago Inc', u'Sarepta Therapeutics Inc', u'ZymeTx Inc', u'Solon Eiendom ASA', u'Anadys Pharmaceuticals Inc', u'Colorado State University', u'Barros Research Institute', u'3-Dimensional Pharmaceuticals Inc', u'Merck Serono SA', u'Kolon Pharmaceuticals Inc', u'Hawaii Biotech Inc', u'Lung Cancer Research Foundation', u'Phogen Ltd']), u'Lunginflammation': set([u'Harbor Therapeutics Inc', u'Takeda Vaccines Inc', u'NovelMed Therapeutics Inc', u'Angiotech Pharmaceuticals Inc', u'Pulmo BioTech Inc', u'Harvard Medical School', u'China State Institute of Pharmaceutical Industry', u'National Institute of Allergy and Infectious Diseases', u'Sparta Pharmaceuticals Inc', u'BioTechnology Consulting Poland Sp. z.o.o.', u'Astra Merck Inc', u'Chiesi Farmaceutici SpA', u'Discovery BioMed Inc', u'National Institutes of Health', u'Pulmagen Therapeutics', u'ProtAffin Biotechnologie AG', u'Immuron Ltd', u'Merck & Co Inc', u'MedImmune LLC', u'University of California San Francisco', u'The Austrian Research Promotion Agency FFG', u'Eli Lilly & Co', u'University of Pennsylvania', u'Sanofi Pasteur Inc', u'Ono Pharmaceutical Co Ltd', u'VINNOVA', u'InDex Pharmaceuticals AB', u'Dong-A ST Co Ltd', u'GW Pharmaceuticals plc', u'Emulate Inc', u'Repligen Corp', u'National Heart Lung and Blood Institute', u\"King's College London\"]), u'Socialphobia': set([u'H Lundbeck A/S', u'Actavis Inc', u'Tikvah Therapeutics Inc', u'Shire plc', u'Mitsubishi Tanabe Pharma Corp', u'Therapade Technologies LLC', u'Mochida Pharmaceutical Co Ltd', u'Onxeo SA']), u'Obsessivecompulsivedisord': set([u'Eli Lilly & Co', u'Chugai Pharmaceutical Co Ltd']), u'Irondeficiencyanemia': set([u'Nippon Shinyaku Co Ltd', u'Luitpold Pharmaceuticals Inc', u'US Government', u'Galenica AG', u'Panion & BF Biotech Inc', u'AOP Orphan Pharmaceuticals AG', u'Vifor Pharma', u'National Institute of Diabetes, Digestive and Kidney Diseases', u'Zeria Pharmaceutical Co Ltd', u'Sanova Pharma GesmbH', u'GlaxoSmithKline plc', u'Shandong Weigao Pharmaceutical Co Ltd', u'Vitra Pharmaceuticals Ltd', u'Shield Therapeutics', u'ARAM Medical', u'Rockwell Medical Inc', u'Moberg Pharma AB', u'Keryx Biopharmaceuticals Inc', u'Ewopharma AG', u'Fresenius Medical Care AG', u'EURO-PHARM International Canada Inc', u'Medical Research Council', u'Pharmacosmos A/S', u'Phosphate Therapeutics', u'Sandoz AG', u'Vifor (International) SA', u'University of California Los Angeles', u'American Regent Inc', u'Jiangsu Wanbang Biochemical Pharmaceutical Co Ltd', u'AstraZeneca plc', u'Pfizer Inc', u'Lupin Ltd', u'Patheon Inc', u'Takeda Pharmaceutical Co Ltd', u'Sidero Bioscience', u'Probi AB', u'Strides Shasun Ltd', u'AMAG Pharmaceuticals Inc', u'Hikma Pharmaceuticals plc', u'Helsinn Group']), u'Oligodendroglioma': set([u'National Brain Tumor Society', u'Stanford University', u'Northwest Biotherapeutics Inc', u'Jonsson Comprehensive Cancer Center', u'University of California San Francisco']), u'Insulindependentdiabetes': set([u'MaSTherCell', u'Nutrition 21 Inc', u'Clayton Biotechnologies Inc', u'European Commission', u'The Leona M. and Harry B. Helmsley Charitable Trust', u'Hadasit Medical Research Services and Development Ltd', u'OnQ Consulting', u'EpiVax Inc', u'University of Pittsburgh', u'University of California Los Angeles', u'CymaBay Therapeutics Inc', u'Kinexum Metabolics Inc', u'JHL Biotech', u'AutoImmune Inc', u'Insulet Corp', u'Fate Therapeutics Inc', u'National Research Council of Canada', u'Orgenesis Inc', u'National Health and Medical Research Council', u'Entelos Inc', u'Israeli Government', u'Centre National de la Recherche Scientifique (CNRS)', u'The European Union', u'Peptor Ltd', u'Caladrius Biosciences Inc', u'University of Nebraska', u'ImmunoMolecular Therapeutics', u'Sernova Corp', u'Asembia', u'Institute for Biological Research', u'Tolerx Inc', u'Protein Sciences Corp', u'Wellcome Trust', u'Adcock Ingram Ltd', u'ViaCyte Inc', u'Dance Biopharm Inc', u'Proven Process Medical Devices Inc', u'Strathclyde Institute for Drug Research', u'Generex Biotechnology Corp', u'Diamyd Medical AB', u'Aventis Pharmaceuticals Inc', u'Swedish Orphan Biovitrum AB', u'Medical University of South Carolina', u'AIM Therapeutics Inc', u'Benaroya Research Center at Virginia Mason', u'Flamel Technologies SA', u'HealthPartners Institute US', u'DPT Laboratories', u'Undisclosed', u'Google Inc', u'CTI BioPharma Corp', u'Eli Lilly & Co', u'Isotechnika Pharma Inc', u'JDRF Canada', u'Phyton Biotech Inc', u'Ibatech Sp. zo.o', u'reMYND NV', u'Weizmann Institute of Science', u'BD Technologies', u'Canadian Diabetes Association', u'GroupMed (Holding)', u'FDS Pharma', u'Dreamed-Diabetes Ltd', u'Johnson & Johnson', u'Merrion Pharmaceuticals Inc', u'Samsung Bioepis', u'Taisho Pharmaceutical Co Ltd', u'UCB Celltech', u'Northwestern University', u'Servier', u'Bristol-Myers Squibb Co', u'OSEO', u'Semma Therapeutics', u'Accentia BioPharmaceuticals Inc', u'Janssen Research & Development LLC', u'Kanyos Bio Inc', u'Astellas Pharma Inc', u'DiaVacs Inc', u'Oramed Pharmaceuticals Inc', u'Insmed Inc', u'New Zealand government', u'Hebrew University of Jerusalem', u'Thermalin Diabetes LLC', u'Canadian Government', u'University of Cambridge', u\"King's College London\", u'Karolinska Institutet', u'Yamanouchi Pharmaceutical Co Ltd', u'Ipsen Biopharmaceuticals Inc', u'Pacific Diabetes Technologies Inc', u'Carolinas Medical Center', u'BTG plc', u'Iacocca Family Foundation', u'DiaKine Therapeutics Inc', u'Sirona Biochem Corp', u'Dharmacon Inc', u'North Carolina State University', u'Savient Pharmaceuticals Inc', u'Giner Inc', u'Lilly Industries Ltd', u'TBG Diagnostics Ltd', u'University of Pennsylvania', u'The University Health Network', u'AnTolRx Inc', u'Garvan Institute of Medical Research', u'Roche Holding AG', u'Immunocore Ltd', u'University of British Columbia', u'Mitsubishi Tanabe Pharma Corp', u'Tandem Diabetes Care Inc', u'Andromeda Biotech Ltd', u'Cour Pharmaceutical Development Co Inc', u'Tenax Therapeutics Inc', u'Biocon Ltd', u'University of Massachusetts Medical School', u'Amgen Inc', u'Oxford GlycoSciences plc', u'Geron Corp', u'Airmid Inc', u'Onevax LLC', u'SkyePharma plc', u'University of Alabama at Birmingham', u'Massachusetts General Hospital', u'Abgenix Inc', u'BioXell SpA', u'Advanced Biotherapy Inc', u'Type 1 Diabetes Clinical Research Network', u'Defymed', u'Dong-A ST Co Ltd', u'BioPancreate Inc', u'Fondazione Umberto Di Mario Onlus', u'Lyfebulb', u'Joslin Diabetes Center Inc', u'ProtoKinetix Inc', u'University of Oxford', u'Rockefeller University', u'Tolera Therapeutics Inc', u'Stanford University', u'Korea Drug Development Fund', u'Harbin Gloria Pharmaceuticals Co Ltd', u'Xenetic Biosciences Inc', u'Amphastar Pharmaceuticals Inc', u'Parvus Therapeutics Inc', u'PDL BioPharma Inc', u'Aerogen Inc', u'Australian Research Council', u'Scripps Research Institute', u'Giddi Pharma Co Ltd', u'University of Texas Southwestern Medical Center', u'Research Corporation Technologies', u'CEPTYR Inc', u'Disease Interception Accelerator', u'R-Pharm', u'Biomedical Frontiers Inc', u'Fast Forward LLC', u'AstraZeneca plc', u'L2 Diagnostics Llc', u'SUGEN Inc', u'University of Utah', u'Tolerion Inc', u'Glasgow Caledonian University', u'Immune Tolerance Network', u'Inclinix Inc', u'Takara Bio Europe Ab', u'American Diabetes Association', u'PharmaCyte Biotech Inc', u'Amylin Pharmaceuticals Inc', u'Medy-Tox Inc', u'Veterin\\xe4rmedizinische Universit\\xe4t Wien', u'King Pharmaceuticals Inc', u'Altea Therapeutics', u'Alberta Heritage Foundation For Medical Research', u'MacroGenics Inc', u'Evotec International GmbH', u'Hadassah University Hospital', u'Sanford Research', u'Fujifilm Diosynth Biotechnologies', u'VG Life Sciences Inc', u'Automated Glucose Control LLC', u'ProSciento Inc', u'Nexpep Pty Ltd', u'Selecta Biosciences Inc', u'University of Western Ontario', u'Rare Partners Srl', u'Inotek Pharmaceuticals Corp', u\"Brigham & Women's Hospital\", u'Biologix FZ Co', u'Schneider Childrens Medical Center of Israel', u'University of Toronto', u'Zen-Bio Inc', u'Quantum Materials Corp', u'Akston Biosciences Corp', u'University of Florida', u'Sociedade Beneficente Israelita Brasileira Hospital Albert Einsten', u'TypeZero Technologies LLC', u'Neovacs SA', u'Sanofi Pasteur', u'Aeolus Pharmaceuticals Inc', u'Meso Scale Technologies', u'Kadimastem Ltd', u'NovoMedix Inc', u'Ureka Sarl', u'Glide Pharmaceutical Technologies Ltd', u'NanoAxis', u'Aventis Pharma AG', u'University of Washington', u'ARIAD Pharmaceuticals Inc', u'Pharmacia & Upjohn Co', u'Atrium Medical Corp', u'Protomer Technologies Inc', u'TFS Trial Form Support', u'Omni Bio Pharmaceutical Inc', u'Hikma Pharmaceuticals plc', u'Wyeth', u'Mylan Inc', u'TFChem SAS', u'Genomics Institute of the Novartis Research Foundation', u'Arrow International Ltd', u'Dong Sung Pharmaceuticals Co Ltd', u'ActoGeniX NV', u'Hadassah Medical Organization', u'Teva Pharmaceutical Industries Ltd', u'CytoCore Inc', u'Catholic University of Leuven', u'University of California San Francisco', u'Lilly China Research & Development Co Ltd', u'Emisphere Technologies Inc', u'Affymetrix Inc', u'Affilogic Laboratories', u'Virginia Biosciences Health Research Corp', u'SystemsX', u'Bioholdings Co Ltd', u'Hospital Cochin', u'Beta Therapeutics Pty Ltd', u'University of Lund', u'Novo Nordisk A/S', u'Medros Inc', u'Harvard Medical School', u'IDIS Ltd', u'National Institute of Diabetes, Digestive and Kidney Diseases', u'PCT, a Caladrius company', u'Westmead Millennium Institute for Medical Research', u'XOMA Corp', u'Merck & Co Inc', u'Perlegen Sciences Inc', u'rEVO Biologics Inc', u'Sanofi', u'The Salk Institute for Biological Studies', u'Bayer AG', u'CPEX Pharmaceuticals Inc', u'Camurus AB', u'Provention Bio Inc', u'American BioScience Inc', u'University of Geneva', u'Neurocrine Biosciences Inc', u'Bioton SA', u'Kineta Inc', u'Ottawa Health Research Institute', u'Institute for the Promotion of Innovation by Science and Technology in Flanders', u'Ypsomed Holding AG', u'White Rock Capital Partners LP', u'Antigen Express Inc', u'Yale School of Medicine', u'Intrexon Corp', u'Wyss Institute for Biologically Inspired Engineering', u'Juvenile Diabetes Research Foundation', u'Lonza Group AG', u'The Australian National University', u'Adocia SAS', u'PharmaIN Ltd', u'Elan Corp plc', u'City of Hope', u'TheraCyte, Inc', u'INSERM', u'Ben-Gurion University Of The Negev', u'University of Calgary', u'Imperial College London', u'Therapix Biosciences Ltd', u'Transition Therapeutics Inc', u'Arecor Ltd', u'Duke University', u'SemBioSys Genetics Inc', u'Janssen Pharmaceuticals Inc', u'Propagenix Inc', u'Medistem Inc', u'University of Alberta', u'Beyond Type 1', u'NGM Biopharmaceuticals Inc', u'MiNA Therapeutics Ltd', u'US Government', u'Ganial Immunotherapeutics', u'Baxter International Inc', u'MDS Pharma Services', u'PanCel Corp', u'Islet Technology Inc', u'California Institute of Regenerative Medicine', u'GlaxoSmithKline plc', u'MultiCell Technologies Inc', u'Tetragenetics Inc', u'Ipsen', u'Genalyte Inc', u'Novimmune SA', u'Synvista Therapeutics Inc', u'Centre for Commercialization of Regenerative Medicine', u'Takeda Oncology', u'Halozyme Therapeutics Inc', u'Orban Biotech LLC', u'Anergen Inc', u'MicroIslet Inc', u'Waratah Pharmaceuticals Inc', u'Boston University', u'Shionogi & Co Ltd', u'Ontogen Corp', u'Biomedical Primate Research Centre', u\"Boston Children's Hospital\", u'UCB SA', u'Genentech Inc', u'Medarex Inc', u'DiObex Inc', u'Abbott Laboratories', u'3SBio Inc', u'National Cancer Institute', u'Novartis AG', u'Aradigm Corp', u'REGiMMUNE Corp', u'Rhode Island Hospital', u'University of Maryland', u'Osiris Therapeutics Inc', u'Monash University', u'CHU De Nantes', u'ViaCell Inc', u'Immune Response BioPharma Inc', u'University of Colorado System', u'McGill University', u'Effimune SA', u'Johns Hopkins University', u'Glucometrics Inc', u'Benitec Biopharma Ltd', u'Lexicon Pharmaceuticals Inc', u'University of North Carolina', u'The Diabetes Australia Research Trust', u'ITR Laboratories Canada Inc', u'Islet Sciences Inc', u'Hayashibara Biochemical Laboratories Inc', u'Amarantus BioScience Holdings Inc', u'Alba Therapeutics Corp', u'Desmos Inc', u'Diabetogen BioSciences Inc', u'Yuhan Corp', u'Regenetech Inc', u'University of Technology Sydney', u'Walloon Region of Belgium Government', u'Combs Lab Inc', u'Housey Pharmaceutical Research Laboratories', u'University of Virginia', u'Walter and Eliza Hall Institute of Medical Research', u'Janssen Biotech Inc', u'Anokion SA', u'Nobex Corp', u'Pfizer Inc', u'Unitio', u'Midatech Pharma PLC', u'Living Cell Technologies Ltd', u'Yale University', u'Mertiva AB', u'Yissum Research Development Co', u'BioLineRx Ltd', u'Theramex', u'Algiax Pharmaceuticals GmbH', u'CureDM Inc', u'Mercia Pharma Inc', u'National Institute of Allergy and Infectious Diseases', u'ILTOO Pharma', u'Albumedix A/S', u'California Institute for Biomedical Research', u'National Institutes of Health', u'Alizyme plc', u'Menarini Asia-Pacific', u'CTI Clinical Trial and Consulting Services', u'NeoBiocon', u'Cardiff University', u'AmbioPharm Inc', u'ApoVax Inc', u'Colorado State University', u'Axxam SpA', u'ReNeuron Group plc', u'Jubilant Life Sciences Ltd', u\"Seattle Children's Hospital\", u'Sertoli Technologies Inc', u'MannKind Corp', u'Vactech Oy', u'Bri Biopharmaceuticals Research Inc', u'Tripos Inc', u'Bentley Pharmaceuticals Inc']), u'Antiphospholipidsyndrome': set([u'University of Texas Southwestern Medical Center', u'National Heart Lung and Blood Institute', u'OncoNOx ApS', u'PolyTherics Ltd', u'AURA Biopharm AS', u'Medical Research Council', u'University College London']), u'Systemiclupuserythematosus': set([u'Invion Ltd', u'Medical University of South Carolina', u'Novo Nordisk A/S', u'University of Florida', u'CareDx Inc', u'Dynavax Technologies Corp', u'Neovacs SA', u'EMD Serono Inc', u'Alliance for Lupus Research', u'University of Lund', u'Biogen Inc', u'Buck Institute', u'Celltrion Inc', u'Berg Pharma LLC', u'Edward Via Virginia College Of Osteopathic Medicine', u'Massachusetts Life Sciences Center', u'Pharma Pacific Pty Ltd', u'Excell Therapeutics LLC', u'MedImmune LLC', u'Genentech Inc', u'Amega Biotech', u'University of Michigan', u'Celldex Therapeutics Inc', u'University of Pennsylvania', u'Fred Hutchinson Cancer Research Center', u'Nektar Therapeutics', u'Immunovia AB', u'Stanford University', u'Roche Holding AG', u'Genovate Biotechnology Co Ltd', u'Wyeth Pharmaceuticals', u'Bio-Path Holdings Inc', u'Stellar Biotechnologies Inc', u\"People's Hospital Peking University\", u'Nodality Inc', u'Ember Therapeutics', u'Temple University', u'BioSense Global LLC', u'Eukarion Inc', u'Emory University', u'Biotica Technology Ltd', u'Agence nationale de la recherche (ANR)', u'Pontificia Universidad Catolica De Chile', u'Biomedical Research Models Inc', u'UCB SA', u'University of Massachusetts Medical School', u'Catalent Inc', u'New York University', u'Trubion Pharmaceuticals Inc', u'Stryker Corp', u'Rigel Pharmaceuticals Inc', u'National Institute of Arthritis and Musculoskeletal and Skin Diseases', u'PDL BioPharma Inc', u'MD Anderson Cancer Center', u'Amgen Inc', u'Medarex Inc', u'Cambridge Antibody Technology Group plc', u'Abbott Laboratories', u'Eisai Co Ltd', u'Aspreva International Ltd', u'The Methodist Hospital Research Institute', u\"Seattle Children's Hospital\", u'US Department of Defense', u'Anthera Pharmaceuticals Inc', u'Kindstar Diagnostics Co. Ltd', u'ImmunArray Ltd', u'Caladrius Biosciences Inc', u'IMIDomics SL', u'Teva Pharmaceutical Industries Ltd', u'University of Alabama at Birmingham', u'Hanmi Pharmaceutical Co Ltd', u'Dartmouth Medical School', u'Massachusetts General Hospital', u'University of California San Francisco', u'National Jewish Health', u'Yeda Research and Development Co Ltd', u'Advanced Biotherapy Inc', u'Tolerx Inc', u'Immunomedics Inc', u'Cleveland Clinic Foundation', u'Pennsylvania State University', u'SymBio Pharmaceuticals Ltd', u'National Institute Of Environmental Health Sciences', u'Glaxo Group Ltd', u'CFR Pharmaceuticals SA', u'Neurome Inc', u'Washington University in St Louis', u'ImmuNext Inc', u'Caisson Biotech LLC', u'Xencor Inc', u'23andMe Inc', u'Karyopharm Therapeutics Inc', u'F Hoffmann-La Roche AG', u'Ludwig-Maximilians University of Munich', u'Rockefeller University', u'Astellas Institute for Regenerative Medicine', u'Lupus Research Institute', u'Resolve Therapeutics LLC', u'Shanghai Union Biopharm Co Ltd', u'Benaroya Research Center at Virginia Mason', u'Delos Pharmaceuticals Inc', u'Baylor Research Institute', u'Oklahoma Medical Research Foundation', u'University of California San Diego', u'LifeArc', u'Actavis Inc', u'Hospital for Special Surgery NY', u'Undisclosed', u'US Government', u'Argos Therapeutics Inc', u'Protagen AG', u'Scripps Research Institute', u'Cephalon Australia Pty Ltd', u'Zenyaku Kogyo Co Ltd', u'LEO Pharma A/S', u'SuppreMol GmbH', u'Sanofi', u'Centurion Pharma', u'Chong Kun Dang Pharmaceutical Corp', u'Feinstein Institute for Medical Research', u'Eli Lilly & Co', u'La Jolla Pharmaceutical Co', u'Simbec-Orion Group Ltd', u'Numoda Corp', u'GMP Companies Inc', u'Weizmann Institute of Science', u'Beijing SL Pharmaceutical Co Ltd', u'GroupMed (Holding)', u'Mount Tam Biotechnologies', u'Janssen Biotech Inc', u'University of California Los Angeles', u'AstraZeneca plc', u'Pfizer Inc', u'Innate Immune Inc', u\"Brigham & Women's Hospital\", u'Human Genome Sciences Inc', u'Corixa Corp', u'University of Texas Southwestern Medical Center', u'deCODE genetics ehf', u'Horizon Pharma plc', u'Broad Institute Inc', u'Cellatope', u'AbbVie Inc', u'Progentec Diagnostics Inc', u'Portola Pharmaceuticals Inc', u'University of Washington', u'University of California at Berkeley', u'National Institute of Allergy and Infectious Diseases', u'Molecumetics Ltd', u'Walter Reed Army Institute of Research', u'Takeda Pharmaceutical Co Ltd', u'Thunderbolt Pharma Inc', u'ILTOO Pharma', u'RecipharmCobra Biologics', u'Neovacs Inc', u'ImmuPharma plc', u'Lonza Group AG', u'Servier', u'National Institutes of Health', u'University of Tokyo', u'Ablynx NV', u'Sanford-Burnham Medical Research Institute', u'Bristol-Myers Squibb Co', u'INSERM', u'Cedars-Sinai Medical Center', u'Shanghai Science and Technique Committee', u'Cephalon Inc', u'Celgene Corp', u'University of Chicago', u'Agence Nationale de Valorisation de la Recherche', u'VINNOVA', u'Astellas Pharma Inc', u'CyDex Pharmaceuticals Inc', u'3-Dimensional Pharmaceuticals Inc', u'Genelabs Technologies Inc', u'Duke University', u'SBI Biotech Co Ltd', u'Yale University', u'PharmedArtis GmbH', u'Coulter Pharmaceutical Inc', u'Merck Serono SA', u'Arthritis Foundation', u'Idera Pharmaceuticals Inc', u'Cypress Bioscience Inc', u'Laboratory Corporation of America Holdings', u'13Therapeutics Inc', u'Oneday - Biotech & Pharma Ltd', u'Beth Israel Deaconess Medical Center', u'DRI Capital', u'XTL Biopharmaceuticals Ltd', u'German Federal Ministry of Education and Research', u'BioCryst Pharmaceuticals Inc']), u'Myopia': set([u'University of California Los Angeles', u'Novartis Ophthalmics Inc', u'Astellas Institute for Regenerative Medicine', u'Valley Forge Pharmaceuticals Inc', u'NovaMedica', u'University of California at Berkeley', u'National Eye Institute', u'S. Fyodorov Eye Microsurgery Complex']), u'Fattyacidoxidationdisorder': set([u'Swedish Orphan Biovitrum AB', u'Baylor Research Institute', u'Ultragenyx Pharmaceutical Inc', u'Clinigen Group plc', u'Horizon Pharma plc']), u'Non-small-celllungcan': set([u'Genta Inc', u'IDIS Ltd']), u'Plasmodiummalariaeinfection': set([u'Profectus BioSciences Inc', u'Henogen SA', u'The Macfarlane Burnet Institute For Medical Research & Public Health Ltd', u'GeoVax Labs Inc', u'Antigen Discovery Inc', u'Jomaa Pharma GmbH', u'Eberhard Karls Universit\\xe4t T\\xfcbingen', u'European Commission', u'GenVec Inc', u'National Institute of Allergy and Infectious Diseases', u'The PATH Malaria Vaccine Initiative', u'Millenia Hope Inc', u'Chongqing Holley Holding', u'National Institutes of Health', u'University of Heidelberg', u'Center for Infectious Disease Research', u'Merck & Co Inc', u'London School of Hygiene and Tropical Medicine', u'Sage Bionetworks', u'Medical Research Council', u'European Vaccine Initiative', u'Centre National de Recherche et de Formation sur le Paludisme', u'University of Chicago', u'African Malaria Network Trust', u'University of Hawaii', u'US Naval Medical Research Center', u'West Virginia University', u'Medicines for Malaria Venture', u'Albert Schweitzer Hospital', u'Walter and Eliza Hall Institute of Medical Research', u'Pfizer Inc', u'Hawaii Biotech Inc', u'University of California San Francisco', u'Statens Serum Institut', u'Sigma-Tau Ind Farm Riunite SpA']), u'Immunedisorder': set([u'FIT-BioCeuticals Pty Ltd', u'Henogen SA', u'CLB Research & Development', u'VGX Pharmaceuticals LLC', u'Jeffrey Modell Foundation', u'Immuron Ltd', u'amp biosimilars AG', u'University of South Florida', u'Drexel University College of Medicine', u'Marinomed Biotechnologie GmbH', u'University of Pittsburgh', u'Fidson Healthcare', u'Celldex Therapeutics Inc', u'Carna Biosciences Inc', u'Sumitomo Pharmaceuticals Co Ltd', u'Northwest Neurologic Inc', u'UCB Celltech', u'DNX Biopharmaceuticals Inc', u'Galapagos NV', u'Orphagen Pharmaceuticals Inc', u'Dompe SpA', u'Genethon', u'HanAll Biopharma Co Ltd', u'Shanghai Infectious Diseases Hospital', u'Lev Pharmaceuticals Inc', u'Valocor Therapeutics Ltd', u'Green Cross Cell Corp', u'New York University', u'PDL BioPharma Inc', u'Centre National de la Recherche Scientifique (CNRS)', u'Ability Biomedical Corp', u'Bioceros BV', u'Somatix Therapy Corp', u'Immune Disease Institute Inc', u'MediGene AG', u'Cerep SA', u'Galderma Laboratories LP', u'Ogeda SA', u'IRICoR', u'Pharmacopeia Inc', u'Community of Madrid', u'Wellcome Trust', u'Kyorin Pharmaceutical Co Ltd', u'KBI Biopharma Inc', u'Colby Pharmaceutical Co', u'Rappaport Family Institute for Research in the Medical Sciences', u'Therimunex', u'Generex Biotechnology Corp', u'Roche Products Ltd', u'Swedish Orphan Biovitrum AB', u'Biochemie GmbH', u'Nurix Inc', u'Otsuka Holdings Co Ltd', u'Immune Control Inc', u'California Institute of Technology', u'Proteos SRL', u'Seattle Genetics Inc', u'Nimbus Therapeutics', u'Undisclosed', u'Melacure Therapeutics AB', u'Institute of Organic Chemistry And Biochemistry of The Academy of Sciences of The Czech Republic', u'Eli Lilly & Co', u'Proteros Biostructures GmbH', u\"Lee's Pharmaceutical Holdings Limited\", u'Agenus Inc', u'AbbVie Inc', u'Sunesis Pharmaceuticals Inc', u'Immunic AG', u'Japan Energy Corp', u'Imclone LLC', u'Cancer Research Technology Ltd', u'Genexine Co Ltd', u'Kang Stem Holdings Co Ltd', u'Zalicus Inc', u'Harbor Therapeutics Inc', u'Coley Pharmaceutical Group Inc', u'Innate Pharma SA', u'F-star Biotechnologische Forschungs-und Entwicklungs GmbH', u'GeoVax Labs Inc', u'ViroMed Co Ltd', u'Peter MacCallum Cancer Centre', u'Galmed Pharmaceuticals Ltd', u'Shenzhen University', u'Pharnext SAS', u'Actelion Ltd', u'Cancer Prevention and Research Institute of Texas', u'Yamanouchi Pharmaceutical Co Ltd', u'Bristol-Myers Squibb Co', u'OSEO', u'NeXstar Pharmaceuticals Inc', u'Janssen Research & Development LLC', u'Seoul National University', u'MDxHealth SA', u'Astellas Pharma Inc', u'Advanced Biotherapy Inc', u'Juvenile Diabetes Research Foundation', u'University of Auckland', u'Rougier Pharma Afrique SA', u'Institute of Cancer Research UK', u'V.I. PHARMA INTERNATIONAL SA', u'Oncormed Inc', u'Nidus Laboratories Inc', u'Enamine Ltd', u'Rhone-Poulenc Rorer Ltd', u'Hemispherx Biopharma Inc', u'Sareum Holdings plc', u'Bio-Quant Inc', u'Albert-Ludwigs-Universit\\xe4t Freiburg', u'ImaginAb Inc', u\"King's College London\", u'Novo Nordisk A/S', u'Regeneron Pharmaceuticals Inc', u'Phenomix Corp', u'Dynavax Technologies Corp', u'IDM Pharma Inc', u'Adaptive Biotechnologies Corp', u'Potenza Therapeutics', u'Centelion SAS', u'Chiesi Farmaceutici SpA', u'TaiGen Biotechnology Co Ltd', u'Morphotek Inc', u'Fraunhofer Institut Molekularbiologie Und Angewandte Oekologie', u'ArQule Inc', u'Opsona Therapeutics Ltd', u'Lorantis Ltd', u'University of Pennsylvania', u'Lead Discovery Center GmbH', u'Garvan Institute of Medical Research', u'University of British Columbia', u'TESARO Inc', u'HUYA Bioscience International LLC', u'Alliance Pharma plc', u'Ribomic Inc', u'Charite Universitaetsmedizin Berlin', u'National Institute of General Medical Sciences', u'Evotec AG', u'XOMA Corp', u'Amgen Inc', u'Clinquest Group', u'Affibody AB', u'Galena Biopharma Inc', u'Geron Corp', u'University of Aberdeen', u'Genomics Medicine Ireland', u'Johns Hopkins University School of Medicine', u'Medical Research Council', u'RIKEN', u'Novotectid GmbH', u'Schrodinger Inc', u'JAK3 Pharma Inc', u'ENTEROME Bioscience SA', u'University of Edinburgh', u'National Human Genome Research Institute', u'BioTheryX Inc', u'Denali Therapeutics Inc', u'University of Oxford', u'Rockefeller University', u'Viron Therapeutics Inc', u'Medidata Solutions Worldwide', u'Domantis Ltd', u'Genentech Inc', u'Dicerna Pharmaceuticals Inc', u'Rigel Pharmaceuticals Inc', u'National Health and Medical Research Council', u'Osaka University Immunology Frontier Research Center', u'Bioalvo SA', u'Sumitomo Dainippon Pharma Co Ltd', u'Scripps Research Institute', u'Australian Research Council', u'University of Texas Southwestern Medical Center', u'BioFocus DPI', u'Hutchison Medipharma Enterprises Ltd', u'Japan Tobacco Inc', u'Janssen Pharmaceuticals Inc', u'ViaMune', u'LION bioscience Inc', u'Kangwon National University', u'Seres Therapeutics Inc', u'Institut de Recherche pour le Developpement (IRD)', u'Great Ormond Street Hospital for Children NHS Foundation Trust', u'Lycera Corp', u'University of Wisconsin-Madison', u'Pharma Bio', u'Emulate Inc', u'AstraZeneca plc', u'University of Utah', u'Berlin-Brandenburg Center for Regenerative Therapies', u'iTeos Therapeutics SA', u'Santhera Pharmaceuticals AG', u'CSL Behring LLC', u'Genmab A/S', u'ASTA Medica AG', u'Natural Partners Inc', u'Immunotech Developments Inc', u'Institute of Materia Medica Chinese Academy of Medical Sciences & Peking Union Medical College', u'Ligand Pharmaceuticals Inc', u'MacroGenics Inc', u'ProMetic Life Sciences Inc', u'VG Life Sciences Inc', u'Dong Wha Pharmaceutical Co Ltd', u'Hospira Adelaide Pty Ltd', u'Wistar Institute of Anatomy & Biology', u'Cyclenium Pharma Inc', u'US Department of Energy', u'Institut Pasteur', u'SQI Diagnostics Systems Inc', u'Walter and Eliza Hall Institute of Medical Research', u'Takeda Pharmaceutical Co Ltd', u'KBP Biosciences Co Ltd', u'GENERIUM Pharmaceuticals', u'Norwood Immunology Ltd', u'AMRAD Pharmaceuticals Pty Ltd', u'Kirin Brewery Co Ltd', u'F-star Alpha Ltd', u'Piramed Pharma', u'University of Gottingen', u'Oncobiologics Inc', u'MedImmune LLC', u'OSI Pharmaceuticals Inc', u'University of Washington', u'Molecumetics Ltd', u'INRIA Institut National de Recherche en Informatique et en Automatique', u'Newsummit Biopharma Co Ltd', u'Five Prime Therapeutics Inc', u'Rosa & Co LLC', u'Introgen Therapeutics Inc', u'Ludwig Institute for Cancer Research', u'Pfizer Inc', u'Signal Research Division', u'Complete Pharmacy and Medical Solutions', u'Active Biotech AB', u'Prothix Bv', u'Harvard University', u'University of Dundee', u'TransGenex Nanobiotech Inc', u'Repligen Corp', u\"Y's Therapeutics Co Ltd\", u'Yale University', u'Hadassah Medical Organization', u'Catholic University of Leuven', u'GlobeImmune Inc', u'WuXi PharmaTech (Cayman) Inc', u'Sun Yat-Sen University', u'German Government', u'Kyung Hee University', u'Fujirebio Europe NV', u'Boehringer Ingelheim Corp', u'Scottish Biomedical Ltd', u'InKine Pharmaceutical Co Inc', u'Lophius Biosciences Gmbh', u'21st Century Therapeutics Inc', u'Kinetek Pharmaceuticals Inc', u'Institute For Hepatitis & Virus Research', u'Open Monoclonal Technologies Inc', u'Wyeth Pharmaceuticals', u'Tsinghua University', u'PCT, a Caladrius company', u'CMC Biologics Inc', u'Hospital for Sick Children', u'Argos Therapeutics Inc', u'Provid Pharmaceuticals Inc', u'Merck & Co Inc', u'ChemoCentryx Inc', u'Sanofi', u'The Salk Institute for Biological Studies', u'Xenova Group plc', u'US Army Medical Research Institute of Infectious Diseases', u'Robarts Research Institute', u'Biosortia Pharmaceuticals', u'Therapure Biopharma Inc', u'Human Frontier Science Program', u'Institut National de la Recherche Agronomique', u'Wyeth', u'Oxford Immunotec Ltd', u'4SC AG', u'Broad Institute Inc', u'CollaGenex Pharmaceuticals Inc', u'Tularik Inc', u'Miikana Therapeutics Inc', u'TAP Pharmaceutical Products Inc', u'4-Antibody AG', u'LeadArtis SL', u'University of Regensburg', u'University of Kansas', u'PowderJect Pharmaceuticals plc', u'Lonza Group AG', u'Acromax Dominicana', u'Ablynx NV', u'Gifu Pharmaceutical University', u'National University Of Ireland Maynooth', u'INSERM', u'Kuros Biosciences Ltd', u'Regulus Therapeutics Inc', u'Celgene Corp', u'Imperial College London', u'Ligon Discovery Inc', u'Biovail Corp', u'Whitehead Institute for Biomedical Research', u'Abbott Healthcare Products BV', u'IPCA Laboratories Ltd', u'XL-Protein GmbH', u'Rhone-Poulenc Rorer Inc', u'US Government', u'Baxter International Inc', u'MSD OSS BV', u'Nodality Inc', u'Biogen Inc', u'GlaxoSmithKline plc', u'University of Wisconsin-Milwaukee', u'Boston Oncology LLC', u'Immunex Corp', u'Glycobia Inc', u'Novimmune SA', u'Cenix BioScience GmbH', u'UCB Pharma SA', u'Institute for Research in Immunology and Cancer', u'Selventa', u'Sankyo Co Ltd', u'Netherlands Cancer Institute', u'BioMotiv LLC', u'PhoreMost Ltd', u'Emory University', u'Beijing Evergene Biomedical Technology', u'Genticel', u'UCB SA', u'Suntory Ltd', u'MD Anderson Cancer Center', u'Medarex Inc', u'Accelerate Brain Cancer Cure', u'Abbott Laboratories', u'Eisai Co Ltd', u'National Cancer Institute', u'Novartis AG', u'Merck KGaA', u'Fujisawa Pharmaceutical Co Ltd', u'Novelion Therapeutics Inc', u'Monash University', u'Cadus Corp', u'ViaCell Inc', u'University of Texas System', u'Kosan Biosciences Inc', u'University of Colorado System', u'Inflabloc Pharmaceuticals Inc', u'Effimune SA', u'Leidos Biomedical Research Inc', u'Immunosyn Corp', u'Molecular Partners AG', u'Compugen Ltd', u'Pluristem Therapeutics Inc', u'Chugai Pharmaceutical Co Ltd', u'GeneData AG', u'ImuThes Ltd', u'Otsuka Pharmaceutical Co Ltd', u'BioTrove Inc', u'Universiteit Utrecht', u'Cellzome', u'IOmet Pharma Ltd', u'Ben Franklin Technology Partners of Southeastern Pennsylvania', u'Bionovion Holding Bv', u'Daewoong Pharmaceutical Co Ltd', u'University College London', u'Epimmune Inc', u'Commissariat a l`Energie Atomique', u'Kyowa Hakko Kirin Co Ltd', u'Immune Therapeutics Inc', u'Argyll Biotechnologies LLC', u'Immune-Onc Therapeutics Inc', u'DNAPrint genomics Inc', u'Janssen Biotech Inc', u'Sanford-Burnham Medical Research Institute', u'Human Genome Sciences Inc', u'Institute of Advanced Chemistry of Catalonia', u'Memorial Sloan-Kettering Cancer Center', u'IRX Therapeutics Inc', u'Baylor College of Medicine', u'GlaxoSmithKline Biologicals', u'Prima BioMed Ltd', u'National Institute of Allergy and Infectious Diseases', u'3M Co', u'Albert Einstein College of Medicine', u'Heptares Therapeutics Ltd', u'Ubiquigent Limited', u'National Institutes of Health', u'Veterinary Research Institute Brno', u'National Institutes of Standards and Technology', u'Merck Serono SA', u'Icagen Inc (pre-merger)', u'Peptos Pharma Llc', u'Mogam Biotechnology Institute', u'University Medical Centre St Radboud', u'MannKind Corp', u'Cesca Therapeutics Inc', u'X-Chem Inc', u'Scancell Ltd', u'AcurePharma AB', u'Synthego', u'MetaMorphix Inc']), u'Homocystinuria': set([u'ERYtech Pharma', u'Fox Chase Cancer Center', u'Orphan Technologies Ltd', u'University of Colorado at Denver and Health Sciences Center', u'Food and Drug Administration', u'University of Colorado System']), u'Constipation': set([u'Organix Inc', u'Takeda Pharmaceuticals International Inc', u'Progenics Pharmaceuticals Inc', u'Sucampo AG', u'Wyeth Pharmaceuticals', u'Prana Biotechnology Ltd', u'Ajinomoto Co Inc', u'Acino Holding AG', u'Abbott Laboratories', u'IDIS Ltd', u'US Government', u'ROHA Arzneimittel GmbH', u'Daiichi Sankyo Co Ltd', u'Harbin Gloria Pharmaceuticals Co Ltd', u'Mochida Pharmaceutical Co Ltd', u'Takeda Pharmaceutical Co Ltd', u'Knight Therapeutics Inc', u'GlaxoSmithKline plc', u'Motus Therapeutics Inc', u'Allergan plc', u'Synergy Pharmaceuticals Inc', u'Prostrakan Pharmaceuticals', u'Novartis AG', u'Universitat des Saarlandes', u'National Institute on Drug Abuse', u'MicroDose Therapeutx Inc', u'OncBioMune Mexico SA de CV', u'Ipsen', u'Bristol-Myers Squibb Co', u'Virginia Commonwealth University', u'Albireo Ltd', u'The Michael J. Fox Foundation', u'The Parkinson Study Group', u'University of Chicago', u'PAREXEL International', u'Ironwood Pharmaceuticals Inc', u'Purdue Pharma LP', u'Mayo Clinic Foundation', u'Eli Lilly & Co', u'Salix Pharmaceuticals Inc', u'Mitsubishi-Tokyo Pharmaceuticals Inc', u'Nektar Therapeutics', u'Ono Pharmaceutical Co Ltd', u'Shire-Movetis NV', u'Astellas Pharma Inc', u'RaQualia Pharma Inc', u'Laboratoires Mayoly Spindler', u'Dynogen Pharmaceuticals Inc', u'Adolor Corp', u'Ferring Pharmaceuticals SA', u'Sanofi GmbH', u'Shire plc', u'Pediapharm Inc', u'Salix Pharmaceuticals Ltd', u'University of Tennessee', u'Modi Mundipharma Pvt Ltd', u'Janssen Pharmaceutica NV', u'Ethypharm SA', u'Almirall Prodesfarma SA', u'AstraZeneca plc', u'Shionogi & Co Ltd', u'Lupin Ltd', u'UR Labs Inc', u'EA Pharma Co Ltd', u'Cumberland Pharmaceuticals Inc', u'Korea Drug Development Fund', u'Norgine BV', u'Edusa Pharmaceuticals Inc', u'Sucampo Pharmaceuticals Inc', u'Poly Pharmaceuticals Inc', u'Klinge Pharma GmbH', u'EPIX Pharmaceuticals Inc', u'SK Biopharmaceuticals']), u'FactorIXdeficiency': set([u'Wyeth', u'Celtic Pharmaceutical Holdings LP', u\"St Jude Children's Research Hospital\", u'US Government', u'Novo Nordisk A/S', u'4D Molecular Therapeutics LLC', u'Undisclosed', u'Baxter International Inc', u'CSL Behring LLC', u'Archemix Corp', u'Biogen Inc (FL)', u'Neose Technologies Inc', u'Inspiration Biopharmaceuticals Inc', u'San Raffaele Telethon Institute for Gene Therapy', u'CJSC Generium', u'Universita degli Studi di Roma La Sapienza', u'Biogen Inc', u'Cangene Corp', u'Amsterdam Molecular Therapeutics BV', u'Asklepios Biopharmaceutical Inc', u'Cell Genesys Inc', u'UCL Business PLC', u'Stragen Group', u'CMC Biologics Inc', u'Baxter Healthcare Corp', u'Green Cross Corp', u'Nautilus Biotech SA', u'Freeline Therapeutics', u'Ipsen', u'Marina Biotech Inc', u'rEVO Biologics Inc', u'Stanford University', u'University College London', u'UCB SA', u'Sangamo Therapeutics Inc', u'University of Washington', u'Dr Rentschler Biotechnologie GmbH', u'Bayer AG', u'Chatham Therapeutics LLC', u'Bioverativ Inc', u'Protein Sciences Corp', u'LFB SA', u'Cook Pharmica', u'Shire plc', u'Swedish Orphan Biovitrum AB', u'Albumedix A/S', u'Discovery Genomics Inc', u'uniQure BV', u'Childrens Hospital of Philadelphia', u'Nektar Therapeutics', u'Syncona Ltd', u'Avigen Inc', u'Pfizer Inc', u'Chiesi Farmaceutici SpA', u'Symbiosis Corp', u'Catalyst Biosciences Inc', u'National Heart Lung and Blood Institute', u'Spark Therapeutics LLC', u'REGENXBIO Inc', u'Copernicus Therapeutics Inc', u'Baxalta Inc', u'Bayer Healthcare LLC', u'Isu Abxis Inc']), u'Diabeticnephropathy': set([u'Clinical Data Inc', u'US Government', u'BioMarin Pharmaceutical Inc', u'European Foundation for the Study of Diabetes', u'Novartis Institutes for BioMedical Research Inc', u'Mount Sinai School of Medicine', u'Forest Laboratories Inc', u'GlaxoSmithKline plc', u'Warner-Lambert Co', u'University of Ottawa', u'BioStratum Inc', u'Sankyo Pharma Inc', u'Ionis Pharmaceuticals Inc', u'Leiden University Medical Center', u'Newsummit Biopharma Co Ltd', u'University of Texas Health Science Center San Antonio', u'Mitsubishi Tanabe Pharma Corp', u'Aptalis Pharma Srl', u'Sankyo Co Ltd', u'Medpace Inc', u'Reata Pharmaceuticals Inc', u'CisThera Inc', u'Collaborative Study Group of nephrologists', u'Vifor Pharma', u'The Menarini Group', u'MD Anderson Cancer Center', u'Medarex Inc', u'Daiichi Sankyo Co Ltd', u'Abbott Laboratories', u'Vidasym LLC', u'twoXar Inc', u'Antisense Therapeutics Ltd', u'Fujisawa Pharmaceutical Co Ltd', u'Keryx Biopharmaceuticals Inc', u'Shanghai Yizhong Biotechnology Co Ltd', u'Kowa Co Ltd', u'Istituto di Ricerche Farmacologiche Mario Negri', u'FibroGen Inc', u'Pharmacopeia Inc', u'Shenzhen Royal Asset Management Co Ltd', u'Boehringer Ingelheim Corp', u'University of California San Diego', u'Joslin Diabetes Center Inc', u'Recordati SpA', u'Bird Rock Bio Inc', u'China Pharma Holdings Inc', u'NOXXON Pharma AG', u'Biorex Research and Development Co', u'Zedira GmbH', u'Green Cross Corp', u'vTv Therapeutics LLC', u'Genentech Inc', u'SCOHIA PHARMA Inc', u'National Institute of Diabetes, Digestive and Kidney Diseases', u'New Jersey Medical School', u'Belupo', u'Merck & Co Inc', u'Medikine Inc', u'ChemoCentryx Inc', u'GenKyoTex SA', u'Vascular Pharmaceuticals Inc', u'University of Miami', u'University of Virginia', u'Kyowa Hakko Kirin Co Ltd', u'NephroGenex Inc', u'University Medical Center Groningen', u'Gilead Colorado Inc', u'Janssen Biotech Inc', u'AstraZeneca plc', u'Pfizer Inc', u'Sanofi', u'Asubio Pharma Co Ltd', u'Dimerix Bioscience Pty Ltd', u'Australian Government', u'American Diabetes Association', u'National Institute of Allergy and Infectious Diseases', u'Glycadia Inc', u'Taisho Pharmaceutical Co Ltd', u'Alfa Wassermann SpA', u'Shenzhen University', u'National Institutes of Health', u'ProMetic Life Sciences Inc', u'Bristol-Myers Squibb Co', u'Synvista Therapeutics Inc', u'Yuyu Inc', u'Thomas Jefferson University', u'Juvenile Diabetes Research Foundation', u'Ranbaxy Laboratories Ltd', u'Janssen Pharmaceuticals Inc', u'Supernus Pharmaceuticals Inc', u'Neuralstem Inc', u'Hoechst Marion Roussel Inc', u'Gamida Cell Ltd', u'Takeda Pharmaceutical Co Ltd', u'German Federal Ministry of Education and Research']), u'Postmenopausalosteoporosis': set([u'Orion Corporation Fermion', u'Novo Nordisk A/S', u'EffRx Pharmaceuticals SA', u'QUATRx Pharmaceuticals Co', u'Amgen Inc', u'IDIS Ltd', u'Daiichi Sankyo Co Ltd', u'GlaxoSmithKline plc', u'Faran Laboratories SA', u'Unigene Laboratories Inc', u'Ligand Pharmaceuticals Inc', u'Lonza Group AG', u'Bayer Schering Pharma AG', u'A-Strong Co Ltd', u'Servier', u'Undisclosed', u'Aventis Pharma AG', u'Enteris BioPharma Inc', u'Merck & Co Inc', u'Asahi Kasei Pharma Corp', u'Nanomedic Inc', u'University of Wisconsin-Madison', u'Vetter Pharma International', u'Roche Holding AG', u'Upsher-Smith Laboratories Inc', u'Osteologix Holdings PLC', u'Mithra Pharmaceuticals', u'Hyundai Pharmaceutical', u'Amneal Pharmaceutical LLC', u'Almirall Prodesfarma SA', u'CSPC Pharmaceuticals Group Limited', u'Teijin Ltd', u'3M Pharmaceuticals', u'Shionogi & Co Ltd', u'Novartis AG', u'Pfizer Inc', u'Radius Health Inc', u'Deltanoid Pharmaceuticals', u'Royalty Pharma', u'Tzamal Bio-Pharma Ltd', u'National Center For Advancing Translational Sciences']), u'Noiseinducedhearingloss': set([u'University of Washington', u'Massachusetts Institute of Technology', u'University of Florida', u'Pragma Therapeutics', u'Hough Ear Institute', u'Royal National Institute for Deaf People', u'US Department of Defense', u'Otologic Pharmaceutics Inc', u'National Institute on Deafness and Other Communication Disorders', u'Frequency Therapeutics', u'University of South Florida', u'Oklahoma Medical Research Foundation', u'Sound Pharmaceuticals Inc', u'Partners Healthcare']), u'Mooddisorder': set([u'Mitsubishi Pharma Corp', u'Amylin Pharmaceuticals Inc', u'BrainCells Inc', u'Ligand Pharmaceuticals Inc', u'Targacept Inc', u'PsychoGenics Inc', u'National Institutes of Health', u'National Institute on Drug Abuse', u'Vanderbilt University', u'Molecular Insight Pharmaceuticals Inc', u'GlaxoSmithKline plc', u'Medison Pharma Ltd', u'Alkermes plc', u'McLean Hospital Corp', u'IntelGenx Technologies Corp', u'Affectis Pharmaceuticals AG', u'IriSys LLC', u'Avanir Pharmaceuticals Inc', u'The National Institute of Mental Health', u'West Virginia University', u'Wellcome Trust', u'Yale University', u'Parke-Davis & Co', u'Cynapsus Therapeutics Inc', u'University of Cambridge']), u'Skininjury': set([u'SANUWAVE Health Inc', u'Avita Medical Ltd', u'Medline Industries Inc', u'Oxford MEStar', u'TEC-PHARMA SA', u'Derma Sciences Inc', u'Ekare Inc', u'ATG Allied Technologies', u'Aghraas-Cigalah', u'Elanix Biotechnologies SA', u'Ministry of Health Saudi Arabia', u'Covalon Technologies Ltd', u'Smith & Nephew plc', u'Vomaris Wound Care Inc', u'MolecuLight Inc', u'Integra LifeSciences Holdings Corp', u'Zuellig Pharma Holdings Pte Ltd', u'University Of Huddersfield', u'Sincopharm SA', u'Comvita New Zealand Ltd', u'APR Applied Pharma Research SA', u'Alat Medika Indonesia', u'SastoMed Gmbh']), u'Erythropoieticprotoporphyria': set([u'Clinuvel Pharmaceuticals Ltd', u'Biotech Lab Singapore Pte Ltd']), u'NeurofibromatosistypeII': set([u'Recombinetics', u'National Institute of Neurological Disorders and Stroke']), u'Rubellavirusinfection': set([u'Fiotec- Fundacao para o Desenvolvimento Cientifico e Tecnologico em Saude', u'ID Vaccine Corp', u'Tianjin Genstar Vaccine LLC', u'Takeda Pharmaceutical Co Ltd', u'bioCSL PTY Ltd', u'Australian Government', u'Walvax Biotechnology Co Ltd', u'Univec Corp', u'Bio-Manguinhos/Fiocruz', u'Bill & Melinda Gates Foundation', u'University of British Columbia', u'University of Lausanne', u'Biological E Ltd', u'RMF Dictagene SA', u'Kaketsuken', u'Wistar Institute of Anatomy & Biology', u'Merck & Co Inc', u'GlaxoSmithKline plc', u'Sanofi Pasteur', u'Chongqing Zhifei Biological Products Co Ltd']), u'Basalcellcarcinoma': set([u'University of Iowa', u'Chugai Pharmaceutical Co Ltd', u'Cancer Research UK', u'Genentech Inc', u'CASI Pharmaceuticals Inc', u'Biofrontera AG', u'Coley Pharmaceutical Group Inc', u'Sun Pharmaceuticals', u'Ignyta Inc', u'GlaxoSmithKline plc', u'Bradley Pharmaceuticals Inc', u'Hyal Pharmaceutical Corp', u'LifeArc', u'Meditrina Pharmaceuticals Inc', u'MediGene AG', u'Johns Hopkins University School of Medicine', u'Prescient Therapeutics Ltd', u'PhotoCure ASA', u'Telormedix SA', u'Merck & Co Inc', u'Galderma Laboratories LP', u'Curis Inc', u'MedPharm Ltd', u'Ascend Biopharmaceuticals Ltd', u'University of California San Francisco', u'Transgene SA', u'Eli Lilly & Co', u'Sigma-Aldrich Corp', u'Galderma SA', u'Ligand Pharmaceuticals Inc', u'Celgene Corp', u'PhotoMedex Inc', u'University of California San Diego', u'Fougera Pharmaceuticals Inc', u'Ludwig Institute for Cancer Research', u'Parabolic Drugs Ltd', u'Allergan Inc', u'Peplin Inc', u'AstraZeneca plc', u\"Brigham & Women's Hospital\", u'PellePharm Inc', u'Novartis AG', u'Accelis Pharma', u'Defense Advanced Research Projects Agency', u'Infinity Pharmaceuticals Inc', u'DRI Capital', u'F Hoffmann-La Roche AG']), u'No': set([u'US Government', u'SciClone Pharmaceuticals Inc']), u'Orthostatichypotension': set([u'Chelsea Therapeutics International Ltd', u'Synergia Pharma Inc', u'Takeda Pharmaceuticals International GmbH', u'Shire plc']), u'Wetagerelatedmaculardegeneration': set([u'Aerie Pharmaceuticals Inc', u'Oraya Therapeutics Inc', u'US Government', u'Apexigen Inc', u'Regeneron Pharmaceuticals Inc', u'Royal DSM NV', u'Genentech Inc', u'Agilent Technologies Inc', u'The Leona M. and Harry B. Helmsley Charitable Trust', u'LeadArtis SL', u'Korea Drug Development Fund', u'Ocular Therapeutix Inc', u'Exonate', u'Reino de Espana', u'Tulane University', u'Ocugen Inc', u'Xbrane Biopharma AB', u'Allergan plc', u'University of New South Wales', u'Lonza Group AG', u'Novartis AG', u'Johns Hopkins University School of Medicine', u'Kodiak Sciences Inc', u'National Institutes of Health', u'Alteogen Inc', u'Calvert T1 LLC', u'Senju Pharmaceutical Co Ltd', u'Hanmi Pharmaceutical Co Ltd', u'National Eye Institute', u'Santen Pharmaceutical Co Ltd', u'Ajinomoto Althea Inc', u\"Lee's Pharmaceutical Holdings Limited\", u'Lions Eye Institute of Western Australia Inc', u'Bayer AG', u'University of Nottingham', u'Taejoon Pharm Co Ltd', u'TRACON Pharmaceuticals Inc', u'Helvetic BioPharma', u'Qrono Inc', u'Jiangsu T-mab BioPharma', u'Apollo Endosurgery Inc', u'Retina Pharma Inc', u'Kissei Pharmaceutical Co Ltd', u'Molecular Partners AG', u'University of Colorado System', u'Ophthotech Corp', u'Wellcome Trust', u'Pfizer Inc', u'Midatech Pharma PLC', u'NovelMed Therapeutics Inc', u'Allegro Ophthalmics LLC', u'TOT Biopharm Co Ltd', u'REGENXBIO Inc', u'Dana-Farber Cancer Institute Inc', u'Adverum Biotechnologies Inc', u'National Institute of General Medical Sciences']), u'Viralinfe': set([u'Oxford GlycoSciences plc', u'Teva Pharmaceutical Industries Ltd']), u'Solid': set([u'Celgene Corp', u'National Cancer Institute', u'MethylGene Inc', u'TopoTarget A/S', u'US Health and Human Services Department', u'CTI BioPharma Corp']), u'Discoidlupuserythematosus': set([u'viDA Therapeutics Inc', u'Pharmacopeia Inc', u'Celgene Corp', u'Centre for Drug Research and Development']), u'Zollinger-Ellisonsyndrome': set([u'Takeda GmbH', u'Marathon Pharmaceuticals LLC', u'Mitsubishi Pharma Corp', u'Valeant Pharmaceuticals North America LLC', u'Daiichi Sankyo Co Ltd', u'Eisai Co Ltd', u'Salix Pharmaceuticals Inc', u'RedHill Biopharma Ltd', u'Daewoong Pharmaceutical Co Ltd', u'Merck & Co Inc', u'Immunovo BV', u'Sanofi', u'ParaPRO LLC', u'Eli Lilly & Co', u'Astellas Pharma Inc', u'Pepscan Systems BV', u'GE Healthcare', u'Amneal Pharmaceutical LLC', u'AstraZeneca plc', u'Pfizer Inc', u'Boehringer Ingelheim Corp', u'Takeda Pharmaceutical Co Ltd', u'R2 Pharma LLC', u'Hanmi Pharmaceutical Co Ltd', u'Sigma-Tau Ind Farm Riunite SpA']), u'Perniciousanemia': set([u'Swedish Orphan Biovitrum AB', u'Questcor Pharmaceuticals Inc', u'QOL Medical', u'Par Specialty Pharmaceuticals', u'Marina Biotech Inc']), u'Allergicconjunctivitis': set([u'Alcon Inc', u'Meiji Seika Pharma Co Ltd', u'iCo Therapeutics Inc', u'Santen SAS', u'Takeda Pharmaceuticals International GmbH', u'Hitachi Chemical Co Ltd', u'ASTA Medica AG', u'Cambridge Antibody Technology Group plc', u'NicOx SA', u'Pharmos Corp', u'Croma Pharma GmbH', u'GlaxoSmithKline plc', u'Allergan plc', u'Quintiles Transnational Corp', u'Lonza Group AG', u'Stallergenes SA', u'Bluejay Diagnostics Inc', u'Schepens Eye Research Institute', u'Griffin Discoveries BV', u'ORA Inc', u'Santen Pharmaceutical Co Ltd', u'MSD Japan', u'Chong Kun Dang Pharmaceutical Corp', u'ISTA Pharmaceuticals Inc', u'The Menarini Group', u'RPS Diagnostics', u'FAES Farma SA', u'Taejoon Pharm Co Ltd', u'Incept LLC', u'Vianex SA', u'Pierre Fabre SA', u'Taiho Pharmaceutical Co Ltd', u'Fovea Pharmaceuticals SA', u'Kyowa Hakko Kirin Co Ltd', u'A H Robins Co Ltd', u'Fisons plc', u'Merck Serono SA', u'Kuhnil Pharmaceutical Co Ltd', u'Senju Pharmaceutical Co Ltd', u'Allergan Inc', u'TOPIGEN Pharmaceuticals Inc', u'Boehringer Ingelheim Corp', u'AcSentient Inc', u'Tanabe Seiyaku Co Ltd', u'Ariana Pharmaceuticals', u'BIAL Group', u'Eleven Biotherapeutics Inc', u'Roxall Medizin GmbH', u'Bausch & Lomb Inc', u'Zalicus Inc', u'Ocular Therapeutix Inc']), u'Retinitis': set([u'Gilead Sciences Inc', u'Pharmacia & Upjohn Co']), u'Lungmalformation': set([u'FDA Office of Orphan Products Development', u\"Cincinnati Children's Hospital Medical Center\", u'Johnson & Johnson', u'Dompe Farmaceutici SpA', u'JCR Pharmaceuticals Co Ltd', u'National Cancer Institute', u'Syntrix Biosystems Inc', u'Ares-Serono Inc', u'Tufts Medical Center', u'Food and Drug Administration', u'Airway Therapeutics LLC', u'University of North Carolina', u'Windtree Therapeutics Inc', u'Scripps Research Institute', u'Savient Pharmaceuticals Inc', u'Laboratorios Dr Esteve SA', u'Aeolus Pharmaceuticals Inc', u'Quintiles Transnational Corp', u'Ortho Pharmaceutical Corp', u'National Heart Lung and Blood Institute']), u'Dystonia': set([u'Taiwan Specialty Pharma Corp', u'National Institute of Neurological Disorders and Stroke', u'University of Rome Tor Vergata', u'Lifehealth Ltd', u'EUSA Pharma USA', u'AFT Pharmaceuticals Ltd', u'Lundbeck Inc', u'EpiVax Inc', u'Ipsen', u'Daewoong Pharmaceutical Co Ltd', u'Massachusetts General Hospital', u'Giddi Pharma Co Ltd', u'Addex Therapeutics Ltd', u'Biovail Corp', u'Cambridge Laboratories Ltd', u'Valeant Pharmaceuticals International Inc', u'Alfresa Pharma Corp', u'Allergan Inc', u'MediFront Ltd', u'Japanese Ministry of Health, Labor and Welfare', u'Alnylam Pharmaceuticals Inc', u'UCB SA', u'Orphan Australia']), u'AngioimmunoblasticT-celllymphoma': set([u'Boryung Pharm Co Ltd', u'Yale University', u'National Cancer Institute', u'PharmaMar SA']), u'Musclewastingdisease': set([u'Biopharma Forest Inc', u'National Institute of Arthritis and Musculoskeletal and Skin Diseases', u'Viking Therapeutics Inc', u'Endoceutics Inc', u'Karo Pharma AB', u'Virtualscopics LLC', u'Wyeth Pharmaceuticals', u'Tulane University', u'Ligand Pharmaceuticals Inc', u'KineMed Inc', u'Nara Biosciences Inc', u'GTx Inc', u'Bayer Schering Pharma AG', u'Ardana Bioscience Ltd', u'Pfizer Inc', u'Merck & Co Inc', u'Elan Corp plc', u'GlaxoSmithKline plc', u'Tanabe Seiyaku Co Ltd', u'University of Washington', u'Endorecherche Inc', u'Five Prime Therapeutics Inc', u'ALZA Corp', u'Theratechnologies Inc', u'Athersys Inc', u'Boston University', u'Ark Therapeutics Group plc', u'Population Council', u'Johns Hopkins University School of Medicine', u'Fate Therapeutics Inc', u'Radius Health Inc', u'Ottawa Health Research Institute', u'Zydus Cadila Healthcare Ltd', u'MetaMorphix Inc']), u'Choroideremia': set([u'University of Oxford', u'Oxford University Innovation', u'4D Molecular Therapeutics LLC', u'Choroideremia Research Foundation Canada', u'Wellcome Trust', u'University of Alberta', u'University of Pennsylvania', u'Spark Therapeutics LLC', u'Bascom Palmer Eye Institute', u'NightstaRx Ltd', u'Foundation Fighting Blindness']), u'Ulcerativecolitis': set([u'Biopasgroup', u'Anabolic Inc', u'Nestle Health Science', u'TSD Japan', u'Qu Biologics Inc', u'GT Biopharma Inc', u'National Institutes of Health', u'JSS University', u'ANANDA Scientific Inc', u'Diosynth Ltd', u'Zhiyi Pharmaceuticals Inc', u'Orion Corporation', u'US Government', u'Biogen Inc', u'Aeolus Pharmaceuticals Inc', u'Amsterdam Molecular Therapeutics BV', u'GlaxoSmithKline plc', u'Celltrion Inc', u'Seres Therapeutics Inc', u'Cosmo Pharmaceuticals SpA', u'Hadasit Medical Research Services and Development Ltd', u'Chiesi Farmaceutici SpA', u'Shasun Pharmaceuticals Ltd', u'Oncobiologics Inc', u'Advanced Therapeutic Products, Inc', u'SkyePharma plc', u'Ionis Pharmaceuticals Inc', u'Anesiva Inc', u'University of Florida', u'MedPharm Ltd', u'Elan Corp plc', u'Procter & Gamble Pharmaceuticals Inc', u'Assembly Biosciences Inc', u'Tillotts Pharma AG', u'Hawker Resources Inc', u'Novimmune SA', u'LeukoSite Inc', u'LTT Bio-Pharma Co Ltd', u'FAES Farma SA', u'Roche Holding AG', u'Shire plc', u'University of British Columbia', u'Gamida Cell Ltd', u'Mitsubishi Pharma Corp', u'Aptalis Pharma Srl', u'Panorama Research Inc', u'rEVO Biologics Inc', u'Celera South San Francisco', u'VIB', u'Lankenau Institute for Medical Research', u'Temple University', u'Amalyte Pharmaceuticals LLC', u'Zydus Pharmaceuticals Inc', u'AutoImmune Inc', u'NovaMedica', u'Curant Health', u'Synairgen plc', u'Fortress Biotech Inc', u'Primus Pharmaceuticals Inc', u'Hikma Pharmaceuticals plc', u'Zhejiang Huahai Pharmaceutical Group Co Ltd', u'Complete Pharmacy and Medical Solutions', u'TxCell SA', u'Meiji Seika Pharma Co Ltd', u'Sigmoid Pharma Ltd', u'PDL BioPharma Inc', u'McMaster University', u'Pierrel SpA', u'PPM Services S.A.', u'Cambridge Antibody Technology Group plc', u'Abbott Laboratories', u'Mochida Pharmaceutical Co Ltd', u'Eisai Co Ltd', u'Cloud Pharmaceuticals Inc', u'Leadiant Biosciences Inc', u'Novartis AG', u'Universite de Sherbrooke', u'IMIDomics SL', u'Pendopharm', u'CleveXel Pharma', u'Norgine BV', u'Zeria Pharmaceutical Co Ltd', u'Tanabe Seiyaku Co Ltd', u'Ogeda SA', u\"Crohn's & Colitis Foundation of America\", u'Salix Pharmaceuticals Inc', u'Medical University of Graz', u'Affymetrix Inc', u'Genome British Columbia', u'Chinese Government', u'Mathilda and Terrence Kennedy Institute of Rheumatology Trust', u'ENTEROME Bioscience SA', u'Ferring Pharmaceuticals SA', u'Georgia State University', u'Avexegen Therapeutics Inc', u'St Josephs Healthcare Hamilton', u'Northwestern University Feinberg School of Medicine', u'Second Genome Inc', u'Prasco Laboratories', u'Pennsylvania State University', u'Medeva Pharmaceuticals Inc', u'Washington University in St Louis', u'Kyorin Pharmaceutical Co Ltd', u'ProtoMed Inc', u'Boehringer Ingelheim Corp', u'EA Pharma Co Ltd', u'Genset SA', u'Vernalis Group plc', u'LDN Research LLC', u'Recordati SpA', u'Inception Sciences Inc', u'BioTie Therapies Corp', u'Mount Sinai Medical Center', u'Orphan Australia', u'NITTO DENKO Avecia', u'Genisphere LLC', u'Questcor Pharmaceuticals Inc', u'Genentech Inc', u'Beijing Tide Pharmaceutical Co Ltd', u'Saniona ApS', u'Ajinomoto Co Inc', u'Xian-Janssen Pharmaceutical Ltd', u'Alizyme Therapeutics Ltd', u'Origenis GmbH', u'National Institute of Diabetes, Digestive and Kidney Diseases', u'Apogee Biotechnology Corp', u'CLL Pharma', u'Allergan plc', u'Ferring International Center SA', u'Giuliani SpA', u'SunPharm Corp', u'Seikagaku Corp', u'Undisclosed', u'Aspen Global Incorporated', u'Transcription Factor Therapeutics', u'Merck & Co Inc', u'Rimaco Inc', u'TAP Pharmaceutical Products Inc', u'Scripps Research Institute', u'Ironwood Pharmaceuticals Inc', u'Chong Kun Dang Pharmaceutical Corp', u'Eli Lilly & Co', u'Synt:em', u'Dr Falk Pharma GmbH', u'Bayer AG', u'Synlogic Inc', u'Pharmacia Corp', u'PLIVA dd', u'Ovamed GmbH', u'Kyowa Hakko Kirin Co Ltd', u'Immune Therapeutics Inc', u'Soligenix Inc', u'Kissei Pharmaceutical Co Ltd', u'enGene Inc', u'University of Iowa', u'China Medical System Holdings Ltd', u'Janssen Biotech Inc', u'Pharmatel Pty Ltd', u'MedImmune LLC', u'AstraZeneca plc', u'Pfizer Inc', u'Neurocrine Biosciences Inc', u'Norgine Ltd', u'Kaken Pharmaceutical Co Ltd', u'23andMe Inc', u'Vertex Pharmaceuticals Inc', u'Edusa Pharmaceuticals Inc', u'University of Zagreb', u'Yissum Research Development Co', u'Johns Hopkins University', u'Athena Drug Delivery Solutions Pvt Ltd', u'Carrington Laboratories Inc', u'Janssen-Cilag Ltd', u'Kenneth Rainin Foundation', u'Genisphere Inc', u'Rougier Pharma Afrique SA', u'University of London School of Pharmacy', u'AbbVie Inc', u'Lipid Therapeutics GmbH', u'Pharmascience Inc', u'Axogen Ltd', u'Asphelia Pharmaceuticals Inc', u'National Institute of Allergy and Infectious Diseases', u'Tiziana Life Sciences PLC', u'Southern Medical University Nanfang Hospital', u'Ben-Gurion University Of The Negev', u'UCB Celltech', u'Targacept Inc', u'Lonza Group AG', u'University of Toronto', u'Acromax Dominicana', u'Asahi Glass Co Ltd', u'Axxiom Inc', u'Maryland Innovation Initiative', u'deCODE chemistry', u'Synvista Therapeutics Inc', u'PAREXEL International', u'Sanofi Genzyme', u'Stendhal International', u'The Menarini Group', u'Janssen Research & Development LLC', u'Celgene Corp', u'Critical Therapeutics Inc', u'VINNOVA', u'InDex Pharmaceuticals AB', u'Knoll GmbH', u'KS Biomedix Holdings plc', u'University of Ghent', u'AlfaGene Biosciences Inc', u'Provention Bio Inc', u'Cureveda LLC', u'V.I. PHARMA INTERNATIONAL SA', u'Immune Disease Institute Inc', u'Salix Pharmaceuticals Ltd', u'Merck Serono SA', u\"Crohn's and Colitis Foundation of Canada\", u'Kolon Pharmaceuticals Inc', u'Athersys Inc', u'Flexion Therapeutics Inc', u'Patheon Pharmaceuticals Inc', u'Mitsubishi Tanabe Pharma Corp', u'Takeda Pharmaceutical Co Ltd', u'Abraxis BioScience Inc', u'Atlantic Healthcare plc', u'Beth Israel Deaconess Medical Center', u'German Federal Ministry of Education and Research', u'Pacific Pharmaceuticals Co Ltd']), u'Rhinovirusinfection': set([u'Agouron Pharmaceuticals Inc', u'Cocrystal Discovery Inc', u'Wayne State University', u'Japan Tobacco Inc', u'Teva Pharmaceutical Industries Ltd', u'Undisclosed', u'National Institutes of Health', u'Meissa Vaccines Inc', u'Korea Research Institute of Bioscience and Biotechnology', u'Eli Lilly & Co', u'Maruishi Pharmaceutical Co Ltd', u'Planet Biotechnology Inc', u'Galapagos NV', u'Marina Biotech Inc', u'Kanazawa University', u'National Institute of Allergy and Infectious Diseases', u'Institute for the Promotion of Innovation by Science and Technology in Flanders', u'Bionaturis', u'Biological Mimetics Inc', u'GlaxoSmithKline plc']), u'Clostridiumperfringensinfection': set([u'National Institute of Allergy and Infectious Diseases', u'Innovative Biologics Inc', u'Mapp Biopharmaceutical Inc']), u'Neuronalceroidlipofuscinosis': set([u'Robert Wood Johnson Medical School', u'US Government', u'Sanofi Genzyme', u'Microbot Medical Inc']), u'Cerebraledema': set([u'Celtic Pharmaceutical Holdings LP', u'MGI GP Inc', u'Enterprise Ireland', u'National Institute of Neurological Disorders and Stroke', u'University of Florida', u'Avena Therapeutics Ltd', u'InDex Pharmaceuticals AB', u'Remedy Pharmaceuticals Inc', u'Neurological Technologies Inc', u'Scios Inc', u'US Department of Defense', u'Pharmos Corp', u'US Government', u'Aeromics LLC', u'Merck Serono SA']), u'Neutropenia': set([u'FortuneRock Biotech (China) Co Ltd', u'Harbor Therapeutics Inc', u'Chugai Pharmaceutical Co Ltd', u'AMRAD Pharmaceuticals Pty Ltd', u'Pharmagenesis Inc', u'University of Zurich', u'Ribotech (Pty) Ltd', u'Amgen Inc', u'Medarex Inc', u'Bioject Medical Technologies Inc', u'ASTA Medica AG', u'Korea Drug Development Fund', u'Phoenicia Biosciences Inc', u'UniQuest Pty Ltd', u'Xuhua (Shanghai) Biological Research and Development Center Co Ltd', u'PhytoHealth Corp', u'Amoytop Biotech Co Ltd', u'Gedeon Richter Ltd', u'Merck Bioventures', u'Serum Institute of India Ltd', u'Lepetit International Inc', u'Novartis AG', u'Tianjin Pegylatt Biotechnology Co Ltd', u'Xenetic Biosciences Inc', u'Centre for Commercialization of Regenerative Medicine', u'Tufts University School of Medicine', u'US Government', u'Yakult Honsha Co Ltd', u'Bolder BioTechnology Inc', u'Swiss Government', u'Teva Pharmaceutical Industries Ltd', u'MabVax Therapeutics Holdings Inc', u'BioGeneric Pharma', u'Zeneca Group plc', u'Hanmi Pharmaceutical Co Ltd', u'Spectrum Pharmaceuticals Inc', u'Enzychem Lifesciences Corp', u'TMRC Co Ltd', u'CJ Corp', u'Tianjin Institute of Pharmaceutical Research', u'Clinigen Group plc', u'Apotex Inc', u'Sumitomo Pharmaceuticals Co Ltd', u\"Children's Hospital of Los Angeles\", u'Handok Inc', u'Kyowa Hakko Kirin Co Ltd', u'Acorn Biomedical Inc', u'Insmed Inc', u'Institute of Process Engineering Chinese Academy of Sciences', u'University of Southern California', u'Generon (Shanghai) Corp Ltd', u'Midatech Pharma US Inc', u'Virginia Commonwealth University', u'Allergan Inc', u'Cancer Institute (Hospital) Chinese Academy of Medical Sciences', u'Reliance GeneMedix plc', u'Cubist Pharmaceuticals Inc', u'AstraZeneca plc', u'Stada Arzneimittel AG', u'Rhone-Poulenc Rorer Ltd', u'Yuhan Corp', u'Intas Biopharmaceuticals', u'Wyeth BioPharma', u'Cumberland Pharmaceuticals Inc', u'Boryung Pharm Co Ltd', u'Rhone-Poulenc Rorer Inc', u'Io Therapeutics Inc', u'Genexine Co Ltd', u'National Heart Lung and Blood Institute', u'Med Discovery SA', u'Solidago AG']), u'Cornealulcer': set([u'Sankyo Co Ltd', u'Wayne State University', u'Johnson & Johnson', u'Jade Therapeutics', u'Spectrum Thea Pharmaceuticals Limited', u'ORA Inc', u'National Institutes of Health', u'US Government', u'United States Army Medical Research Institute of Chemical Defense', u'Organes Tissus Regeneration Reparation Replacement (OTR3)', u'Daiichi Sankyo Co Ltd', u'National Science Foundation', u'RegeneRx Biopharmaceuticals Inc', u'Santen Pharmaceutical Co Ltd', u'G-treeBNT Co Ltd', u'Ligand Pharmaceuticals Inc']), u'Erectiledysfunction': set([u'Matrix Pharma (Pvt) Ltd', u'US Government', u'Humanetics Corp', u'Senetek plc', u'Topharman Shanghai Co Ltd', u'GlaxoSmithKline plc', u'Bayer Schering Pharma AG', u'Yangtze River Pharmaceutical Group', u'ASTA Medica Inc', u'Palatin Technologies Inc', u'Paul Capital Healthcare', u'Marina Biotech Inc', u'Pacific Therapeutics Ltd', u'Zydus-Cadila Group', u'Vernalis plc', u'Tianjin Institute of Pharmaceutical Research', u'University of Maryland School of Medicine', u'Ion Channel Innovations LLC', u'Ono Pharmaceutical Co Ltd', u'Ampio Pharmaceuticals Inc', u'Mitsubishi Tanabe Pharma Corp', u'Q Pharma SL Lab', u'Huons Co Ltd', u'Symphony Neuro Development Co', u'Handok Inc', u'Auxilium Pharmaceuticals Inc', u'Laboratoires Majorelle', u'Universidade Federal de Sao Paulo - UNIFESP', u'Innovus Pharmaceuticals Inc', u'VIVUS Inc', u'MGI GP Inc', u'Mylan Inc', u'Pilotage South Corp', u'Henan Topfond Pharmaceutical Co Ltd', u'Makefield Therapeutics Inc', u'Abbott Laboratories', u'NovaDel Pharma Inc', u'National Cancer Institute', u'Ardana Bioscience Ltd', u'Syngene International Ltd', u'Fujisawa Pharmaceutical Co Ltd', u'Hanmi Pharmaceutical Co Ltd', u'New Life Scientific Inc', u'Dong Kook Pharmaceutical Co Ltd', u'Tanabe Seiyaku Co Ltd', u'UCB Pharma GmbH', u'Lohmann Therapie-Systeme GmbH & Co KG', u'Milsing d.o.o.', u'Pentech Pharmaceuticals Inc', u'Ferring Pharmaceuticals SA', u'Nagoya University', u'Dong-A ST Co Ltd', u'Quantum Pharma Plc', u'AGI Dermatics Inc', u'Glaxo Group Ltd', u'Wake Forest University', u'Ethypharm SA', u'Beijing Wannianchun Biopharmaceutical High-tech Co Ltd', u'Lupin Ltd', u'Britannia Pharmaceuticals Ltd', u'Janssen Korea Ltd', u'Recordati SpA', u'Eli Lilly do Brasil Ltda', u'Neopharm Ltd', u'Shanghai Institute of Materia Medica of the Chinese Academy of Sciences', u'Chugai Pharmaceutical Co Ltd', u'Sandoz AG', u'Paladin Labs Inc', u'Pahang Pharmacy Sdn Bhd', u'Laborat\\xf3rio Qu\\xedmico Farmac\\xeautico Bergamo Ltda', u'Dainabot KK', u'Bayer Korea Ltd', u'Yung-Shin Pharmaceutical Industry Co Ltd', u'Jeil Pharmaceutical Co Ltd', u'KunWha Pharmaceutical Co Ltd', u'Undisclosed', u'Merck & Co Inc', u'Macropharma Corp', u'ETV Capital SA', u'Sanofi', u'Therapex', u'Chong Kun Dang Pharmaceutical Corp', u'Eli Lilly & Co', u'Vyrix Pharmaceuticals', u'IntelGenx Technologies Corp', u'F Lima SA', u'TAP Pharmaceutical Products Inc', u'Rexahn Pharmaceuticals Inc', u'Otechestvennie Lekarstva OJSC', u'Bracco SpA', u'Pfizer Inc', u'Neurocrine Biosciences Inc', u'Benxi Leilong Pharmaceutical Co Ltd', u'National Taiwan University', u'Mertiva AB', u'Akorn Inc', u'Apricus Biosciences Inc', u'Sanofi Chimie SA', u'Scotia Holdings plc', u'Nippon Shinyaku Co Ltd', u'CTC Bio Inc', u'Takeda Pharmaceuticals International GmbH', u'Plethora Solutions Holdings plc', u'Sihuan Pharmaceutical Holdings Group Ltd', u'Metuchen Pharmaceuticals LLC', u'Astra AB', u'Harvard Scientific Corp', u'King Pharmaceuticals Inc', u'Jin Yang Pharm Co Ltd', u'Hetero Group', u'Elis Pharmaceuticals Ltd', u'Universidade Federal de Minas Gerais', u'Bayer AG', u'Taisho Pharmaceutical Co Ltd', u'Menarini Asia-Pacific', u'Pharma MAEHLE GmbH', u'Synvista Therapeutics Inc', u'Jilin University', u'Futura Medical plc', u'ICOS Corp', u'The Menarini Group', u'CJ Corp', u'Pharmaserve', u'Janssen Pharmaceutica Ltd', u'Chevron Phillips Chemical Co Lp', u'Douglas Pharmaceuticals', u'JW Pharmaceutical Corp', u'Deerfield Management Company LP', u'Tabuk Pharmaceutical Manufacturing Co', u'Warner Chilcott plc', u'Meda AB', u'YooYoung Pharmaceuticals Co Ltd', u'Sandoz Pharmaceuticals Corp', u'Takeda Pharmaceutical Co Ltd', u'Albert Einstein College of Medicine', u'Calmare Therapeutics Inc', u'Procaps SA', u'SK Chemicals Co Ltd']), u'Citrullinuria': set([u'Dimension Therapeutics Inc', u'Lucane Pharma SA', u'Perelman School of Medicine', u'Orpharma Pty Ltd']), u'Systemiclup': set([u'PDL BioPharma Inc', u'Biogen Inc']), u'Degeneration': set([u'Genea Ltd', u'IsoTis SA', u'Intrexon Corp', u'Creative Medical Technology Holdings Inc', u'4SC Discovery GmbH', u'Novogen Ltd', u'Bavarian government', u'Seaspine Inc', u'Eunice Kennedy Shriver National Institute of Child Health & Human Development', u'Cyntellect Inc', u'University of California', u'Nlt-Spine Ltd', u'Thomas Jefferson University', u'Fred Hutchinson Cancer Research Center', u'Fibrocell Science Inc', u'National Neurovision Research Institute', u'Cypralis Ltd', u'Boston University', u'Eukarion Inc', u'Chemokine Therapeutics Corp', u'Technology Strategy Board', u'Pluristem Therapeutics Inc', u'CRELUX GmbH', u'Helmholtz Zentrum M\\xfcnchen', u'Charite Universitaetsmedizin Berlin', u'Resolvyx Pharmaceuticals Inc']), u'Gigantism': set([u'Pharmis Biofarmaceutica', u'Shin Poong Pharmaceutical Co Ltd', u'Kwizda Gruppe', u'Ambrilia Biopharma Inc', u'Covidien plc', u'Omega Pharmaceutical Inc']), u'Celiacdisease': set([u'ImmunogenX', u'Alvine Pharmaceuticals Inc', u'National Health and Medical Research Council', u'Zedira GmbH', u'Artielle ImmunoTherapeutics Inc', u'Selecta Biosciences Inc', u'Intrexon Corp', u'Amgen Inc', u'OnSite Diagnostic Labs India Pvt Ltd', u'BioLineRx Ltd', u'Biohit OYJ', u'National Institute of Diabetes, Digestive and Kidney Diseases', u'iDD biotech', u'Alba Therapeutics Corp', u'Alfa Wassermann SpA', u'BTG plc', u'Numerate Inc', u'University of Chicago', u'National Cancer Institute', u'Pharmix Corp', u'Oxford University Innovation', u'Oregon Health Sciences University', u'Innovate Biopharmaceuticals Inc', u'Royal Melbourne Hospital', u'Australian Research Council', u'Calypso Biotech', u'Sanofi', u'Stanford University', u'Genten Therapeutics Inc', u'Cephalon Inc', u'Dr Falk Pharma GmbH', u'Kanyos Bio Inc', u'Astellas Pharma Inc', u'Shire plc', u'Cour Pharmaceutical Development Co Inc', u'Nexpep Pty Ltd', u'Celimmune LLC', u'Fusion Antibodies Ltd', u'Anokion SA', u'Univalor', u'Walter and Eliza Hall Institute of Medical Research', u'Merckle GmbH', u'PvP Biologics', u'ImmusanT Inc', u'Takeda Pharmaceutical Co Ltd', u'Mayo Clinic Foundation', u'University of Oxford', u'German Federal Ministry of Education and Research']), u'Acuteenterocolitis': set([u'RedHill Biopharma Ltd', u'Concordia International Corp']), u'Mesothelioma': set([u'Agence Nationale de Recherches sur le Sida et les hepatites virales (ANRS)', u'National Comprehensive Cancer Network', u'Cancer Institute New South Wales', u'Advanced BioScience Laboratories Inc', u'Allos Therapeutics Inc', u'OncoTherapy Science Inc', u'BTG plc', u'Innovive Pharmaceuticals Inc', u'IDT Biologika GmbH', u'Choice Pharmaceuticals', u'European Eurostars Programme', u'Sellas Life Sciences Group', u'British Lung Foundation', u'Formula Pharmaceuticals Inc', u'Universite de Nantes', u'MorphoSys AG', u'Ludwig Institute for Cancer Research', u'Mesothelioma Applied Research Foundation', u'Netherlands Cancer Institute', u'Inventiva', u'Bayer HealthCare AG', u'Pfizer Inc', u'Shionogi & Co Ltd', u'Wake Forest University', u'Rosetta Genomics Ltd', u'Cambridge Antibody Technology Group plc', u'Nitto Denko Corp', u'Taxolog Inc', u'National Cancer Institute', u'Novartis AG', u\"Y's Therapeutics Co Ltd\", u'SRI International', u'NeoPharm Inc', u'Dutch Cancer Society', u'Massachusetts General Hospital', u'University of California San Francisco', u'Transgene SA', u'Enzon Pharmaceuticals Inc', u'Kyorin Pharmaceutical Co Ltd', u'ImmunoGen Inc', u'MegaPharm Ltd', u'University of California San Diego', u'Okayama University', u'June Hancock Mesothelioma Research Fund', u'ILEX Oncology Inc', u'GENESIS Pharma SA', u'Par Specialty Pharmaceuticals', u'Southern Research Institute', u'Oxford BioMedica plc', u'Verastem Inc', u'US Government', u'Merck & Co Inc', u'Cancer Research Institute (CRI)', u'Columbia University', u'Eli Lilly & Co', u'Bayer AG', u'MolMed SpA', u'Kissei Pharmaceutical Co Ltd', u'Princeton University', u'University of Bradford', u'AstraZeneca plc', u'Tamir Biotechnology Inc', u'US Pharmacia SP ZOO', u'Synthetic Biologics Inc', u'Triangle Pharmaceuticals Inc', u'Memorial Sloan-Kettering Cancer Center', u'GeneKor SA', u'University of Pennsylvania', u'EnGeneIC Ltd', u'National Institute of Allergy and Infectious Diseases', u'NYU Langone Medical Center', u'Targovax AS', u'National Institutes of Health', u'Salmedix Inc', u'University of Tokyo', u'Hopital Maisonneuve-Rosemont', u'INSERM', u'Cardiff University', u'Aduro BioTech Inc', u'Fujifilm Diosynth Biotechnologies', u'MGI Pharma Inc', u'Roswell Park Cancer Institute', u'Research Development Foundation', u'Wistar Institute of Anatomy & Biology', u'Institute of Cancer Research UK', u'NanoCarrier Co Ltd', u'Institut Pasteur', u'Selecta Biosciences Inc', u'Concordia International Corp', u'H2Biologics, Inc', u'Laboratory Corporation of America Holdings', u'Takeda Pharmaceutical Co Ltd', u'TopoTarget A/S', u'CuraGen Corp', u'Technion - Israel Institute of Technology']), u'Bloodclottingfactordeficiency': set([u'Swedish Orphan Biovitrum AB', u'LFB SA']), u'Bursitis': set([u'Santarus Inc', u'Hi-Tech Pharmacal Co Inc', u'Roche Holding AG', u'Sunovion Pharmaceuticals Canada Inc', u'Elan Corp plc', u'Recordati SpA', u'Victory Pharma Inc']), u'GM2gangliosidosis': set([u'Orphic Therapeutics Inc', u'Amicus Therapeutics Inc', u'National Institute of Neurological Disorders and Stroke']), u'Menopause': set([u'Orion Corporation Fermion', u'University of Chile', u'PharmaNova Inc', u'Novo Nordisk A/S', u'Lumara Health Inc', u'Endeavor Pharmaceuticals', u'Endoceutics Inc', u'Takeda Pharmaceuticals International GmbH', u'ASCEND Therapeutics Inc', u'Paladin Labs Inc', u'Pola Chemical Ind Inc', u'Harvard Medical School', u'Acerus Pharmaceuticals Corp', u'IDIS Ltd', u'US Government', u'University of California at Berkeley', u'Orion Corporation', u'Shionogi Inc', u'Ligand Pharmaceuticals Inc', u'Vertical Pharmaceuticals Inc', u'Actavis Inc', u'Novartis AG', u'Massachusetts Institute of Technology', u'Azure Biotech Inc', u'Eastern Virginia Medical School', u'Novavax Inc', u'QUATRx Pharmaceuticals Co', u'Elan Corp plc', u'Meda AB', u'Juniper Pharmaceuticals Inc', u'Merck & Co Inc', u'Solvay Pharmaceuticals Inc', u'ANI Pharmaceuticals Inc', u'Massachusetts General Hospital', u'Schering SpA', u'Bionovo Inc', u'Lohmann Therapie-Systeme GmbH & Co KG', u'National Center for Complementary and Alternative Medicine', u'Innothera', u'Endorecherche Inc', u'TherapeuticsMD Inc', u'Acrux Ltd', u'Mission Pharmacal Co Inc', u'Barr Pharmaceuticals Inc', u'Graceway Pharmaceuticals Inc', u'Duchesnay Inc', u'Royalty Pharma', u'United Biotech Corp', u'Shire plc', u'AEterna Zentaris Inc', u'Merck Serono SA', u'Hyundai Pharmaceutical', u'Amneal Pharmaceutical LLC', u'Upsher-Smith Laboratories Inc', u'Torrent Pharmaceuticals Ltd', u'Pfizer Inc', u'Shionogi & Co Ltd', u'Theramex', u'Population Council', u'Gedeon Richter Ltd', u'Recalcine Pharmaceutical Corp', u'Orient Europharma', u'Duramed Pharmaceuticals Inc', u'Antares Pharma Inc']), u'Idiopathicpulmonaryfibrosis': set([u'Genoa Pharmaceuticals Inc', u'Stony Brook University Hospital', u'Pharmaxis Ltd', u'InterMune Inc', u'US Government', u'Biogen Inc', u'UNC School of Medicine', u'Nostrum Pharmaceuticals Inc', u'GlaxoSmithKline plc', u'Chiesi Farmaceutici SpA', u'ZAI Laboratory Inc', u'North Carolina State University', u'Harvard Stem Cell Institute', u'Pacific Therapeutics Ltd', u'University of Pittsburgh', u'Stromedix Inc', u'Afimmune', u'Galapagos NV', u'SATT CONECTUS ALSACE', u'Relief Therapeutics Holding AG', u'Toray Industries Inc', u'Inventiva', u'Shionogi & Co Ltd', u'Sorrento Therapeutics Inc', u'National Heart Lung and Blood Institute', u'ElsaLys Biotech', u'Moerae Matrix Inc', u'Synairgen plc', u'Aptuit LLC', u'X-Rx Discovery Inc', u'University of Nottingham', u'McMaster University', u'NuMedii Inc', u'Antegrin Therapeutics LLC', u'Cambridge Antibody Technology Group plc', u'Novici Biotech LLC', u'Korea Health Industry Development Institute', u'Parion Sciences Inc', u'Panorama Research Inc', u'Massachusetts General Hospital', u'Alfred Hospital', u'Boehringer Ingelheim International GmbH', u'Guangdong Zhongsheng Pharmaceutical Co Ltd', u'Ethris GmbH', u'WuXi PharmaTech (Cayman) Inc', u'FibroGen Inc', u'University of Colorado System', u'Janssen Pharmaceutica NV', u'University of Vermont', u'Boehringer Ingelheim Corp', u'Compugen Ltd', u'DS Biopharma', u'Genentech Inc', u'Progenra Inc', u'Korea Drug Development Fund', u'MicroDose Therapeutx Inc', u'University of California', u'University of Pittsburgh Medical Center', u'Sanofi', u'Bonac Corp', u'Auspex Pharmaceuticals Inc', u'University of Miami', u'CoNCERT Pharmaceuticals Inc', u'Pulmatrix Inc', u'OliX Pharmaceuticals Inc', u'AstraZeneca plc', u'Gilead Sciences Inc', u'Celdara Medical LLC', u'Horizon Pharma plc', u'Australian Government', u'Centurion Pharma', u'iBio Inc', u'NYU Langone Medical Center', u'AdAlta Pty Ltd', u'Bioneer Corp', u'University of Tokyo', u'Bristol-Myers Squibb Co', u'Curis Inc', u'Cedars-Sinai Medical Center', u'Fujifilm Diosynth Biotechnologies', u'Columbia University Medical Center', u'Medical University of South Carolina', u'Duke University', u'Global Blood Therapeutics Inc', u'Three Lakes Partners LLC', u'Boehringer Ingelheim Austria GmbH', u'XL-Protein GmbH', u'BioGenerator']), u'Maleosteoporosis': set([u'Novartis AG', u'A-Strong Co Ltd', u'EffRx Pharmaceuticals SA', u'Asahi Kasei Pharma Corp', u'Sanofi', u'Procter & Gamble Pharmaceuticals Inc']), u'Stage': set([u'Genentech Inc', u'Exelixis Inc']), u'Hyperpigmentation': set([u'Galderma SA', u'Intendis GmbH', u'GP Pharm SA', u'Scientis Pharma', u'Bayer HealthCare Pharmaceuticals Inc', u'Valeant Pharmaceuticals International Inc', u'Sinclair Pharma plc', u'Bristol-Myers Squibb Co', u'Jahrom University of Medical', u'Alvogen Inc', u'Spear Pharmaceuticals Inc', u'Laboratoires Biocodex', u'Centre de Dermatologie Geneva']), u'Genitalsystemdisease': set([u'Allergan Inc', u'Ligand Pharmaceuticals Inc']), u'Eosinophilia': set([u'Intrexon Corp', u'Fibrocell Science Inc']), u'Headinjury': set([u'MGI GP Inc', u'GT Biopharma Inc', u'DRAXIS Health Inc', u'Synthelabo', u'RespireRx Pharmaceuticals Inc', u'GlaxoSmithKline plc', u'KineMed Inc', u'BTG plc', u\"Ataxia Telangiectasia Children's Project Inc\", u'Novartis AG', u'Shionogi-GlaxoSmithKline Pharmaceuticals LLC', u'National Institutes of Health', u'Oxeia Biopharmaceuticals Inc', u'Elan Corp plc', u'Sanofi', u'Enzon Pharmaceuticals Inc', u'Cortech Inc', u'Astellas Pharma Inc', u'Azur Pharma Ltd', u'Purdue Neuroscience Corp', u'Pfizer Inc', u'Purdue Pharma LP', u'Questcor Pharmaceuticals Inc', u'Shionogi & Co Ltd', u'AxoTect Inc', u'SIBIA Neurosciences Inc']), u'Diabeticperipheralneuropathy': set([u'Relief Therapeutics Holding AG', u'NeuroMetrix Inc', u\"PX'Therapeutics SA\", u'Fukuda Denshi Co Ltd']), u'Grampositivebacteriuminfection': set([u'BioSource Pharm Inc', u'Eli Lilly & Co', u'University of Sunderland', u'Korea Institute of Science and Technology', u'Baylor College of Medicine', u'Royal Liverpool and Broadgreen University Hospitals NHS Trust', u'National Institutes of Health', u'Almac Group', u'Mansoura University', u'University of Western Australia', u'Royalty Pharma', u'Virtual Drug Development Inc', u'Biota Holdings Ltd', u'National Institute of Allergy and Infectious Diseases', u'InterMune Inc', u'Novacta Biosystems Ltd', u'Ardea Biosciences Inc', u'Abbott Laboratories', u'Roussel Uclaf SA', u'MGB Biopharma Ltd', u'Bayer Korea Ltd', u'Allergan plc', u'Avance Pharma Inc', u'Promiliad Biopharma Inc', u'Cardiome Pharma Corp', u'Karo Bio', u'Merck KGaA', u'Undisclosed', u'University of Connecticut', u'King Saud University', u'Pendopharm', u'Microbiotix Inc', u'University of Alabama at Birmingham', u'Synedgen Inc', u'NexThera Biosciences', u'RW Johnson Pharmaceutical Research Institute', u'Aventis Pharma AG', u'Redx Pharma Plc', u'Synspira', u'Agennix AG', u'Cantab Biopharmaceuticals Ltd', u'Sanofi', u'Melinta Therapeutics Inc', u'Chong Kun Dang Pharmaceutical Corp', u'Icoria Inc', u'Boulos & Cooper Pharmaceuticals Pty Ltd', u'Innoviva Inc', u'Catalytica Inc', u'Trius Therapeutics Inc', u'New Anti Infectives Consortium', u'Theravance Biopharma Inc', u'Bayer AG', u'Imperial College London', u'Astellas Pharma Inc', u'Yungjin Pharmaceutical Co Ltd', u'ALZA Corp', u'Basilea Pharmaceutica International Ltd', u'AiCuris Anti-infective Cures GmbH', u'Microcide Pharmaceuticals Inc', u'Carrus Capital Corp', u'NovoBiotic Pharmaceuticals LLC', u'St Petersburg Institute of Experimental Medicine', u'Ortho-McNeil Inc', u'BioDiem Ltd', u'Tzamal Medical Group Ltd', u'Novexel SA', u'MaxThera Inc', u'Trine Pharmaceuticals Inc', u'Cubist Pharmaceuticals Inc', u'AstraZeneca plc', u'Bayer HealthCare AG', u'Crestone Inc', u'International Health Management Associates Inc', u'US Health and Human Services Department', u'US Department of Defense', u'Canadian Government', u'Molplex Pharmaceuticals', u'Toyama Chemical Co Ltd', u'Bayer Healthcare LLC', u'Spero Therapeutics LLC', u'ContraFect Corp']), u'Viralrespiratorytractinfection': set([u'Regeneron Pharmaceuticals Inc', u'The University of Hong Kong', u'Hong Kong Polytechnic University', u'Mapp Biopharmaceutical Inc', u'National Institute of Allergy and Infectious Diseases', u'hVIVO plc', u'Functional Genetics Inc', u'US Health and Human Services Department', u'Viroblock SA', u'Kenta Biotech Ltd', u'ViroNovative BV', u'ViroPharma Inc', u'National Institutes of Health', u'PrEP Biopharm Limited', u'MedImmune LLC', u'Sanofi', u'Janssen Research & Development LLC', u'Hangzhou Converd Co Ltd', u'Kineta Inc', u'Aridis Pharmaceuticals Inc', u'Guangzhou Xiangxue Pharmaceutical Co Ltd', u'Ansun BioPharma Inc', u'Sichuan Academy of Chinese Medicine Sciences', u'Sichuan Dikang Sci-Tech Pharmaceutical Industry Co Ltd']), u'Enzymedeficiency': set([u'Retrophin Inc', u'Grace Wilsey Foundation', u'Protea Biosciences Inc', u'Laboratoires Mayoly Spindler', u'University of Notre Dame Australia']), u'Atrialfibrillation': set([u'Fujisawa Healthcare Inc', u'Anthem Inc', u'Solvay SA', u'Biosense Webster', u'Angiotech Pharmaceuticals Inc', u'Symphony Medical Inc', u'Koebenhavns Universitet', u'Netherlands Government', u'Acutus Medical Inc', u'Daiichi Sankyo Co Ltd', u'Sanofi Biosurgery', u'Innovation Norway', u'GlaxoSmithKline plc', u'Northwestern University', u'Cardiome Pharma Corp', u'Servier', u'Wellcome Trust', u'Xention Ltd', u'Bristol-Myers Squibb Co', u'Merck & Co Inc', u'Danish Government', u'Biotectix Llc', u'Nyken Therapeutics', u'Chong Kun Dang Pharmaceutical Corp', u'BioFocus DPI', u'Pronova BioPharma ASA', u'Japan Tobacco Inc', u'USpharma Windlas LLC', u'Excigen Inc', u'Astellas Pharma Inc', u'Nissan Chemical Industries Ltd', u'Aetas Pharma Co Ltd', u'Sunovion Pharmaceuticals Canada Inc', u'OMEICOS Therapeutics GmbH', u'Granules India Ltd', u'Teijin Ltd', u'Roche Diagnostics', u'Celera Group', u'Medtronic Inc', u'Bio-Medisinsk Innovasjon AS', u'F Hoffmann-La Roche AG', u'Hannover Medical School', u'Aderis Pharmaceuticals Inc', u'Icagen Inc (pre-merger)', u'AstraZeneca plc', u'Acesion Pharma ApS', u'Catalent Inc', u'Boehringer Ingelheim Pharmaceuticals Inc', u'Duke Clinical Research Institute', u'deCODE genetics ehf', u'Servier Canada Inc', u'ARCA Biopharma Inc', u'German Federal Ministry of Education and Research', u'Pharmacia Canada Inc', u'PRA International']), u'Neurologicaldisease': set([u'NovAliX', u'Quest Diagnostics Inc', u'Signum Biosciences Inc', u'Phoenix Biotechnology Inc', u'A*STAR Institute of Molecular and Cell Biology', u'Koebenhavns Universitet', u'European Commission', u'US Health and Human Services Department', u'Neurobiological Technologies Inc', u\"Cincinnati Children's Hospital Medical Center\", u'Alliance Medical Group', u'BioHaven Pharmaceutical Holding Co Ltd', u'Questcor Pharmaceuticals Inc', u'Cannabis Science Inc', u'Ionis Pharmaceuticals Inc', u'The Dow Chemical Co', u'Princeton University', u'BioSyent Inc', u'Spanish National Research Council', u'Creabilis Therapeutics Srl', u'Aegera Therapeutics Inc', u'University of Bath', u'Botulinum Toxin Research Associates Inc', u'Nautilus Neurosciences Inc', u'NeuroSearch A/S', u'BioCrea GmbH', u'Peking University', u'National Institute on Aging', u'Aptuit LLC', u'Universite De Montreal', u'National Research Council of Canada', u'23andMe Inc', u'Immunome Inc', u'CrystalGenomics Inc', u'MGI GP Inc', u'Israeli Government', u'FTLD Consortium', u'Tel Aviv University', u'Cambridge Antibody Technology Group plc', u'Censo Biotechnologies Ltd', u'Stem Cell Medicine Ltd', u'General Atlantic LLC', u'Epiomed Therapeutics Inc', u'Yeda Research and Development Co Ltd', u'Modern Healthcare Solutions Co Ltd', u'HUYA Bioscience International LLC', u'Cantab Biopharmaceuticals Ltd', u'National Organization for Rare Disorders', u'Reset Therapeutics Inc', u'Neuren Pharmaceuticals Ltd', u'Kineta Inc', u'Siegfried Holding Ltd', u'Ajinomoto Althea Inc', u'Thermo Fisher Scientific Inc', u'JCR Pharmaceuticals Co Ltd', u'University of Adelaide', u'Neurosciences Victoria Ltd', u'Ceregene Inc', u'Titan Pharmaceuticals Inc', u'National Aeronautics & Space Administration', u'Biodesy Inc', u'NeuroNascent Inc', u'Janssen Pharmaceutica NV', u'Cortice Biosciences Inc', u'ImmunoClin Corp', u'Chinese Ministry of Science and Technology', u'20/20 HealthCare Partners LLC', u'ImmersiveTouch', u'Infinity Pharmaceuticals Inc', u'Vyrex Corp', u'ZZ Biotech LLC', u'SanBio Co Ltd', u'MD Biosciences GmbH', u'Lysosomal Therapeutics Inc', u'NPS Pharmaceuticals Inc', u'Shanghai Institutes for Biological Sciences CAS', u'Institut de Recherches Cliniques de Montreal', u'Genomic Vision', u'CRELUX GmbH', u'University of Modena and Reggio Emilia', u'California Institute of Technology', u'Mount Sinai School of Medicine', u'Revance Therapeutics Inc', u'Hadasit Bio-Holdings Ltd', u'Oregon Health Sciences University', u'Aoxing Pharmaceutical Co Inc', u'AmorChem LP', u'Worcester Polytechnic Institute', u'Eli Lilly & Co', u'Isotechnika Pharma Inc', u'ID Pharma Co Ltd', u'Rio Grande Neurosciences Inc', u'AbbVie Inc', u'Weizmann Institute of Science', u'NsGene A/S', u'Horizon Orphan LLC', u\"Alzheimer's Association\", u'Ubiquigent Limited', u'CeNeS Pharmaceuticals Inc', u'EIP Pharma LLC', u'Algae Dynamics Corp', u'Universit\\xe9 De Strasbourg', u'ORIG3N Inc', u'The Pharmaceutical Institute', u'Aarhus University Hospital', u'PCAS Finland OY', u'KRS Global Biotechnology Inc', u'PharmaGap Inc', u'Kang Stem Holdings Co Ltd', u'Ehave Inc', u'Helsinki University', u'Icagen Inc', u'Metrion Biosciences', u'BrainLAB Inc', u'Korea National Enterprise for Clinical Trials', u'University of California San Diego', u'Boston Scientific Corp', u'Cerecor Inc', u'Axerion Therapeutics Inc', u'Northwestern University', u'Chronos Therapeutics', u'Crossbeta Biosciences BV', u'Bristol-Myers Squibb Co', u'Curemark LLC', u'Evotec (UK) Ltd', u'ConverGene LLC', u'Janssen Research & Development LLC', u'Integra LifeSciences Holdings Corp', u'Astellas Pharma Inc', u'Rosetta Biosoftware', u'ChronTech Pharma AB', u'Proximagen Group plc', u'Canadian Government', u'StemCell Technologies', u'J David Gladstone Institutes', u'Science & Technology Corporation @ UNM', u'University of Cambridge', u\"King's College London\", u'Karolinska Institutet', u'1st Order Pharmaceuticals', u'Institute of Pharmacology and Toxicology Academy of Military Medical Sciences PLA', u'Mayne Pharma Group Ltd', u'Endovasc Inc', u'CRH Medical Corp', u'SYGNIS Bioscience GmbH & Co KG', u'Dharmacon Inc', u'Texas A&M University System', u'Indiana University School of Medicine', u'University Of Southampton', u'IMBA - Institute of Molecular Biotechnology GmbH', u'Arizona State University', u'Aspire Capital Fund LLC', u'Anvyl LLC', u'ArQule Inc', u'Stanford University', u'Microbot Medical Inc', u'Domain Therapeutics SA', u'University of Pennsylvania', u'The University Health Network', u'Lead Discovery Center GmbH', u'Roche Holding AG', u'Alchemia Ltd', u'University of British Columbia', u'St Michaels Hospital', u'The National Institute of Mental Health', u'Nihon Medi-Physics Co Ltd', u'Vasogen Inc', u'Elan Pharmaceuticals Inc', u'Eukarion Inc', u'Biotica Technology Ltd', u'Ultragenyx Pharmaceutical Inc', u'University of Massachusetts Medical School', u'Brain Canada', u'Evotec AG', u'Meiji Seika Pharma Co Ltd', u'Charles River Laboratories International Inc', u'Impel NeuroPharma', u'Beijing Beidestar Technology and Development Ltd', u'Corium International Inc', u'Amgen Inc', u'CytoMed Inc', u'Edge Therapeutics Inc', u'NPS Allelix Corp', u'Galena Biopharma Inc', u'Genomics Medicine Ireland', u'Eunice Kennedy Shriver National Institute of Child Health & Human Development', u'University of Bristol', u'RedHill Biopharma Ltd', u'ACADIA Pharmaceuticals Inc', u'SRI International', u'CJ Corp', u'BioPharmaceuticals Australia', u'Evgen Pharma plc', u'Array BioPharma Inc', u'Medical Research Council', u'Imago Pharmaceuticals Inc', u'Garnet BioTherapeutics Inc', u'Canabo Medical Corporation', u'Cryo-Cell International Inc', u'Bionik Laboratories Inc', u'Avraham Pharmaceuticals Ltd', u'Perrigo Co plc', u\"Nationwide Children's Hospital\", u'Sosei Group Corp', u'Albany Molecular Research Inc', u'Ottawa Hospital Research Institute', u'Allergan Inc', u'Zhejiang Huahai Pharmaceutical Group Co Ltd', u'Wistron Corp', u'Niigata University', u'GNT Pharma Co Ltd', u'Wyeth-Ayerst Pharmaceuticals Inc', u'Lixte Biotechnology Holdings Inc', u'Denali Therapeutics Inc', u'F Hoffmann-La Roche AG', u'University of Oxford', u'Medidata Solutions Worldwide', u'Genentech Inc', u'Saniona ApS', u'Cognetix Inc', u'IntelliCell BioSciences Inc', u'Djavad Mowafaghian Centre for Brain Health', u'Piramal Critical Care Inc', u'National Health and Medical Research Council', u'Eastern Chemicals (Mumbai) Pvt Ltd', u'Oklahoma Medical Research Foundation', u'CHU Sainte Justine', u'LifeArc', u'Actavis Inc', u'Celprogen Inc', u'Braeburn Pharmaceuticals Inc', u'Nautilus Biotech SA', u'DiamiR LLC', u'Sumitomo Dainippon Pharma Co Ltd', u'Metrion Biosciences Ltd', u'Scripps Research Institute', u'Tranzyme Pharma Inc', u'CoNCERT Pharmaceuticals Inc', u'MRI Interventions Inc', u'Cellectricon Ab', u'Emulate Inc', u'AstraZeneca plc', u'Sojitz Corp', u'SUGEN Inc', u'Janssen Therapeutics', u'Socratech LLC', u'University of Sussex', u'University of Turku', u'Memory Pharmaceuticals Corp', u'Sirenas Marine Discovery LLC', u'Australian Government', u'Euthymics Bioscience Inc', u'Cenomed BioSciences LLC', u'Medy-Tox Inc', u'Pharmos Corp', u'University of Utah', u'Institute of Materia Medica Chinese Academy of Medical Sciences & Peking Union Medical College', u'Ligand Pharmaceuticals Inc', u'TCA Cellular Therapy LLC', u'New Jersey Health Foundation Inc', u'Senju Pharmaceutical Co Ltd', u'Sareum Holdings plc', u'Proclara Biosciences', u'National Science Foundation', u'BioPontis Alliance LLC', u'Kyoto University', u'Synergetics Inc', u'Florida Atlantic University', u'BioAxone Biosciences Inc', u'Engineering and Physical Sciences Research Council', u'Teijin Ltd', u'Tianjin Pharmaceutical Holdings Ltd', u'Cyclenium Pharma Inc', u'University of Western Ontario', u'Par Pharmaceutical Inc', u'nEUROinflammation consortium', u'Neuralstem Inc', u'Repligen Corp', u'Emerald Logic', u'Cooper pharma', u'Master Medical Technology Co.', u'German Federal Ministry of Education and Research', u'Royal DSM NV', u'ConfometRx Inc', u'ASDERA LLC', u'Centre for Drug Research and Development', u'Q Therapeutics Inc', u'Industrial Technology Research Institute', u'Lynx Therapeutics GmbH', u'Forest Laboratories Inc', u'Quintiles Transnational Corp', u'Neurorecovery Inc', u'Puget Sound Gastroenterology', u'Mount Sinai Hospital', u'Cell Design, LLC', u'Vanderbilt University', u'Allergan Pharmaceuticals Ireland', u'OSI Pharmaceuticals Inc', u'University of Washington', u'PAION AG', u'Apotex Inc', u'UmanDiagnostics AB', u'PlantForm Corp', u'Alvogen Korea', u'Proteome Sciences plc', u'Sun Pharmaceutical Industries Ltd', u'Solvay Pharmaceuticals Inc', u'Neuromics Inc', u'Two Cells Co Ltd', u\"Children's Hospital of Pittsburgh\", u'Pharmatronic Co', u'Receptor Life Sciences', u'Keio University', u'Sanford-Burnham Medical Research Institute', u'Signal Research Division', u'Centre for Addiction and Mental Health', u'Institute for Molecular Medicine', u'Avineuro Pharmaceuticals Inc', u'National Center For Advancing Translational Sciences', u'4D Molecular Therapeutics LLC', u'Tohoku University', u'University of Ottawa', u'Affitech A/S', u'Blackfynn', u'Harvard University', u'Reckitt & Colman plc', u'University of Dundee', u'Samyang Corp', u'Boehringer Mannheim GmbH', u'iPierian Inc', u'MAC Clinical Research', u'Axiogenesis AG', u'Yale University', u'Palkion Inc', u'Vanda Pharmaceuticals Inc', u'Nanomerics Ltd', u'Purdue Pharma LP', u'KineMed Inc', u'Medexus Inc', u'NeuroRepair Inc', u'OPKO Health Inc', u'Asahikawa Medical College', u'Publicis Touchpoint Solutions', u'ALS Biopharma LLC', u'Astrazeneca Korea', u'Glaxo Group Ltd', u'Boehringer Ingelheim Corp', u'MentiNova Inc', u'Camargo Pharmaceutical Services', u'Parke-Davis & Co', u'Universite Laval', u'The Michael J. Fox Foundation', u'Weston Brain Institute', u'The Global Alliance for Innovation in Neuroscience Inc', u'Wyeth Pharmaceuticals', u'ImmunoClin Laboratories Ltd', u'Harvard Medical School', u'SAGE Therapeutics Inc', u'BioLineRx Ltd', u'Biogen Inc (FL)', u'National Institute on Deafness and Other Communication Disorders', u'Axon Neuroscience SE', u'Bloomage BioTechnology Corporation Limited', u'AnaBios Corp', u'Roche Innovation Center Copenhagen A/S', u'Sirtris Pharmaceuticals Inc', u'Montavit', u'Nansen Neuroscience Network', u'ViaCell Inc', u'Hospital for Sick Children', u'Baxter Healthcare Corp', u'Kaleidos Pharma Inc', u'NuCoria', u'Medicenna Ventures Inc', u'University of California', u'Merck & Co Inc', u'Gemin X Pharmaceuticals Inc', u'UCB Pharma Ltd', u'Sanofi', u'Daewon Pharm Co Ltd', u'Vertex Pharmaceuticals Inc', u'Feinstein Institute for Medical Research', u'US Army Medical Research Institute of Infectious Diseases', u'Camurus AB', u'Yichang Humanwell Pharmaceutical Co Ltd', u'ThioPharma Inc', u'BBB Therapeutics BV', u'BioSeek Plc', u'Canadian Department of National Defence', u'Hannover Medical School', u'Roivant Sciences Ltd', u'BioProjet, Societe Civile de Recherche', u'Applied StemCell Inc', u'Harrington Discovery Institute', u'Merrimack Pharmaceuticals Inc', u'Multiplicom N.V.', u'US Department of Defense', u'Wyeth', u'Aptuit Inc', u'Health Research Institute of Santiago de Compostela', u'University of Wyoming', u'Nichi-Iko Pharmaceutical Co Ltd', u'Massachusetts Institute of Technology', u'Axcella Health Inc', u'F-star Gamma Ltd', u'iPS Academia Japan Inc', u'University of Kansas', u'NeuroVive Pharmaceutical AB', u'CRISPR Therapeutics', u'BrainXell Inc', u'Amarin Corp plc', u'AGP Therapeutics LLC', u'CANTABio Pharmaceuticals Inc', u'Sophiris Bio Inc', u'Medsintez', u'Ablynx NV', u'University of Oregon', u'Elan Corp plc', u'Flowonix Medical', u'INSERM', u'Stealth BioTherapeutics Inc', u'University of Calgary', u'MGI Pharma Inc', u'Cephalon Inc', u'Celgene Corp', u'Terra Life Sciences Inc', u'Imperial College London', u'Therapix Biosciences Ltd', u'Vernalis Research Ltd', u'AstraZeneca AB', u'Whitehead Institute for Biomedical Research', u'ARTMS Products Inc', u'Duke University', u'Avanir Pharmaceuticals Inc', u'RTI International', u'Zocere Inc', u'Wellcome Trust Sanger Institute', u'MediciNova Inc', u'Janssen Pharmaceuticals Inc', u'Delivra Corp', u'Bayer HealthCare Pharmaceuticals Inc', u'Jan Medical Inc', u'North Shore Long Island Jewish Health System', u'ArmaGen Technologies Inc', u'Linkoping University', u'Neose Technologies Inc', u'Coral Therapeutics, Inc', u'DKSH Holding Ltd', u'US Government', u'BioMarin Pharmaceutical Inc', u'Korea Institute of Science and Technology', u'The Legacy of Angels Foundation', u'Luc Therapeutics Inc', u'MSD OSS BV', u'Acorda Therapeutics Inc', u'GenVec Inc', u'Biogen Inc', u'4SC Discovery GmbH', u'UMeWorld Ltd', u'GlaxoSmithKline plc', u'Johnson Matthey plc', u'Bayer Schering Pharma AG', u'Rainbow BioScience LLC', u'Unistraw Patent Holdings Ltd', u'Ipsen', u'Cerebral Therapeutics Inc', u'European Eurostars Programme', u'Hoechst-Roussel Pharmaceuticals Inc', u'Variagenics Inc', u'Kringle Pharma Inc', u'GlobalAcorn', u'BrainStorm Cell Therapeutics Inc', u'Cold Spring Harbor Laboratory', u'Neurotech Pharmaceuticals Inc', u'BioMotiv LLC', u'Ivivi Health Sciences Llc', u'Emory University', u'Orexo AB', u'CoMentis Inc', u'Quintiles Ltd', u'Akhu Therapeutics Inc', u\"Boston Children's Hospital\", u'Alnylam Pharmaceuticals Inc', u'Pharmaniaga Bhd', u'Stony Brook Medicine', u'BioTherapeutics Inc', u'Warren Pharmaceuticals Inc', u'Stryker Corp', u'Nova Molecular Technologies Inc', u'Q BioMed Inc', u'Cipla Ltd', u'Unilife', u'UniQuest Pty Ltd', u'Sunovion Pharmaceuticals Inc', u'Abbott Laboratories', u'Catalyst Pharmaceutical Partners Inc', u'Eisai Co Ltd', u'Proneuron Biotechnologies Inc', u'Neuroem Therapeutics Inc', u'National Cancer Institute', u'Novartis AG', u'Nanyang Technological University', u'Molecular Sciences Institute Inc', u'Nuevolution A/S', u'Q-State Biosciences Inc', u'SIBIA Neurosciences Inc', u'Gaia BioPharma Ltd', u'DePuy Synthes Companies', u'University of Minnesota', u'Oxford BioMedica plc', u'Monash University', u'Neuromed Pharmaceuticals Inc', u'UCB SA', u'Xenon Pharmaceuticals Inc', u'Prestwick Chemical Inc', u'Immune Response BioPharma Inc', u'University of Texas System', u'Ramot at Tel Aviv University Ltd', u'Sunnybrook Health Sciences Centre', u'McGill University', u'Washington University in St Louis', u'Johns Hopkins University', u'Kyowa Hakko Kogyo Co Ltd', u'uniQure BV', u'Afraxis Inc', u'Recordati SpA', u'H Lundbeck A/S', u'Lexicon Pharmaceuticals Inc', u'Helius Medical Technologies Inc', u'Mallinckrodt plc', u'Chugai Pharmaceutical Co Ltd', u'University of North Carolina', u'National Institute of Neurological Disorders and Stroke', u'Undisclosed', u'XoNovo Inc', u'Otsuka Pharmaceutical Co Ltd', u'Transdermal Research Pharm Laboratories LLC', u'Amarantus BioScience Holdings Inc', u'AmKor Pharma Inc', u'Circuit Therapeutics Inc', u'Southern Research Institute', u'Allergan plc', u'The Wolfson Institute for Biomedical Research', u'Republic of Korea Government', u'Alexza Pharmaceuticals Inc', u'Onyx Scientific Ltd', u'French Government', u'Novo A/S', u'Zydus-Cadila Group', u'Addex Therapeutics Ltd', u'FORMA Therapeutics Inc', u'University of Virginia', u'University of California Irvine', u'Immune Therapeutics Inc', u'Nexstim Oy', u'Scholar Rock Inc', u'Kissei Pharmaceutical Co Ltd', u'Servier', u'RespireRx Pharmaceuticals Inc', u'Pfizer Inc', u'International University Of Health & Welfare', u'The Salk Institute for Biological Studies', u'ArunA Biomedical Inc', u'Living Cell Technologies Ltd', u'Target ALS Foundation', u'Indi Molecular Inc', u'GeneDx', u'deCODE genetics ehf', u'Yissum Research Development Co', u'Columbia University', u'University of Arizona', u'Hopital Universitaire de la Pitie Salpetriere', u'Cato Research Ltd', u'VistaGen Therapeutics Inc', u'Avant Diagnostics Inc', u'Cypress Bioscience Inc', u'Synaptive Medical (Barbados) Inc', u'Takeda Pharmaceutical Co Ltd', u'BioTime Inc', u'A&B Company Limited', u'Scientus Pharma Inc', u'GeneGo Inc', u'MPI Research', u'California Institute for Biomedical Research', u'Heptares Therapeutics Ltd', u'National Institutes of Health', u'Teva Pharmaceuticals USA Inc', u'Parent Project Muscular Dystrophy', u'MediVas LLC', u'Scios Inc', u'Curis Inc', u'Aequus Pharmaceuticals Inc', u'Zhejiang Chiral Medicine Chemicals Co Ltd', u'Zenyth Therapeutics Ltd', u'Siena Biotech SpA', u'Thomas Jefferson University', u'ChemDiv Inc', u'Vertical Pharmaceuticals Inc', u'Dompe Group', u'Axxam SpA', u'Maruishi Pharmaceutical Co Ltd', u'Dosecann Inc', u'Jubilant Life Sciences Ltd', u'IBM Watson Health Life Sciences', u'Universita Degli Studi di Genova', u'Merck Serono SA', u'XenoPort Inc', u'Icagen Inc (pre-merger)', u'Saneron CCEL Therapeutics Inc', u'Biovail Laboratories International Srl', u'MannKind Corp', u'Quanterix Corp', u'BASF AG']), u'Pulmonaryhypertension': set([u'Symphony Capital LLC', u'BioMarin Pharmaceutical Inc', u'University of Florida', u'GeoPharma Inc', u'Pulmo BioTech Inc', u'US Government', u'Biogen Inc', u'Unigene Laboratories Inc', u'GlaxoSmithKline plc', u'New York State Psychiatric Institute', u'Quintiles Transnational Corp', u'Bayer Schering Pharma AG', u'Radikal Therapeutics Inc', u'GeNO LLC', u'University of Pittsburgh', u'Relief Therapeutics Holding AG', u'Handok Inc', u'Toray Industries Inc', u'Bayer HealthCare AG', u'Profile Therapeutics Inc', u'HanAll Biopharma Co Ltd', u'National Heart Lung and Blood Institute', u'Rapidscan Pharma Solutions Inc', u'23andMe Inc', u'Ludwig Boltzmann Institute', u'Interprotein Corp', u'Henan Topfond Pharmaceutical Co Ltd', u'YM BioSciences Inc', u'Artes Biotechnology', u'Mochida Pharmaceutical Co Ltd', u'BioTechnology Consulting Poland Sp. z.o.o.', u'geneRx+ Inc', u'Respira Therapeutics Inc', u'Aradigm Corp', u'Astellas Pharma Inc', u'Actelion Pharmaceuticals US Inc', u'BASF Pharma', u'Glaxo Group Ltd', u'Encysive Pharmaceuticals Inc', u'Johns Hopkins University', u'Mimotopes Pty Ltd', u'Pluristem Therapeutics Inc', u'Orphan Australia', u'Lexicon Pharmaceuticals Inc', u'Mallinckrodt plc', u'Topharman Shanghai Co Ltd', u'Respironics Inc', u'Stanford University', u'Nippon Shinyaku Co Ltd', u'Lung Biotechnology Inc', u'Paladin Labs Inc', u'Schering Health Care Ltd', u'Minapharm Pharmaceuticals', u'PR Pharmaceuticals Inc', u'Shanghai Institute of Materia Medica of the Chinese Academy of Sciences', u'Novartis International Pharmaceutical Ltd', u'Columbia University', u'Eli Lilly & Co', u'Bellerophon Therapeutics LLC', u'Northern Therapeutics Inc', u'United Therapeutics Corp', u'Korean Ministry of Knowledge Economy', u'Gilead Colorado Inc', u'ErgoNex Pharma GmbH', u'CoTherix Inc', u'Accredo Therapeutics Inc', u'Gilead Sciences Inc', u'Kaken Pharmaceutical Co Ltd', u'Nihon Schering KK', u'Bachem Holding AG', u'Accredo Health Group Inc', u'Icagen Inc', u'Navitas Pharma Inc', u'Baker Heart Research Institute', u'Actelion Ltd', u'National Institutes of Health', u'Food and Drug Administration', u'Menarini Asia-Pacific', u'NEBU-TEC', u'Asahi Kasei Pharma Corp', u'ICOS Corp', u'Imperial College London', u'Par Pharmaceutical Co Inc', u'Pulmokine Inc', u'Antigen Pharmaceuticals Inc', u'Austrian Academy of Sciences', u'Tarix Pharmaceuticals LLC', u'Aires Pharmaceuticals Inc', u'Proteo Biotech AG', u'University of Toronto', u'Quadrant Technologies Ltd', u'University of Alberta', u'Eunice Kennedy Shriver National Institute of Child Health & Human Development', u'New York Medical College', u'Omdana Therapeutics Inc']), u'Drugoverdose': set([u'US Department of Defense', u'Purdue Pharma Canada', u'Roche Holding AG', u'National Institute on Drug Abuse', u'Qrono Inc', u'Klaria Pharma Holding Ab', u'CHEPLAPHARM Arzneimittel GmbH', u'Eagle Pharmaceuticals Inc']), u'Coccidioidesinfection': set([u'FDA Office of Orphan Products Development', u'US Government', u'Bayer AG', u'Viamet Pharmaceuticals Holdings LLC', u'Valley Fever Solutions Inc', u'University of Arizona']), u'Leiomyosarcoma': set([u'Eli Lilly & Co', u'ScinoPharm Taiwan Ltd', u'AstraZeneca plc']), u'Skinburns': set([u'Avita Medical Ltd', u'US Government', u'BioMarin Pharmaceutical Inc', u'The Jordanian Stem Cell Company', u'Schwarz Pharma Ltd', u'Minerva Healthcare', u'Knoll Pharmaceuticals Co', u'Smith & Nephew plc', u'IDM Pharma Inc', u'Learning Organized LLC', u'US Health and Human Services Department', u'Ipsen Biopharmaceuticals Inc', u'Cell Genesys Inc', u'McComb Foundation Inc', u'Avalon Pharmaceutical S.A', u'Taxus Cardium Pharmaceuticals Group', u'Hackensack University Medical Center', u'Vomaris Wound Care Inc', u'Upside Biotechnologies Ltd', u'University of Michigan', u'Leiden University Medical Center', u'Sumitomo Pharmaceuticals Co Ltd', u'Newsummit Biopharma Co Ltd', u'Tyrian Diagnostics Ltd', u'National Science Foundation', u'NanoBio Corp', u'Astellas Pharma Europe BV', u'Cytori Therapeutics Inc', u'Meditrade Ltd', u'Biosidus SA', u'Eukarion Inc', u'Tenax Therapeutics Inc', u'RenovaCare Inc', u'CTS Chemical Industries', u'Genfa Medica SA', u'Hikma Pharmaceuticals plc', u'Inflabloc Pharmaceuticals Inc', u'National Institute of General Medical Sciences', u'Zhejiang Academy Of Medical Sciences', u'Hengdian Group Ltd', u'McMaster University', u'Stratatech Corp', u'Kaken Pharmaceutical Co Ltd', u'Abbott Laboratories', u'Derma Sciences Inc', u'National Cancer Institute', u'US Department of Defense', u'DFB Pharmaceuticals Inc', u'Obagi System', u'Teva Pharmaceutical Industries Ltd', u'Solvay Pharmaceuticals Inc', u'Mintcare', u'ISDIN SA', u'Creative Antibiotics Sweden AB', u'BioSpecifics Technologies Corp', u'United States Army Institute of Surgical Research', u'CorMedix Inc', u'Comvita New Zealand Ltd', u'Microbion Corp', u'Republic of Korea Government', u'Boehringer Ingelheim Corp', u'GNT Pharma Co Ltd', u'Stemedica Cell Technologies Inc', u'Laboratorio TUTEUR', u'CardioVascular BioTherapeutics Inc', u'W R Grace & Co', u'Undisclosed', u'Genentech Inc', u'Kerecis Ehf', u'IDIS Ltd', u'AmKor Pharma Inc', u'Almalco', u'Medial Ltd', u'Sinopharm', u'Devro plc', u'US Army Medical Research and Materiel Command', u'Sinclair Pharma plc', u'XOMA Corp', u'CytoSorbents Corp', u'Organogenesis Inc', u'Genzyme General', u'rEVO Biologics Inc', u'APR Applied Pharma Research SA', u'Giddi Pharma Co Ltd', u'University College London', u'Regenicin Inc', u'Sarasota Medical Products Inc', u'University of Wisconsin-Madison', u'Phyton Biotech Inc', u'Berlin-Brandenburg Center for Regenerative Therapies', u'Epimmune Inc', u'University Of Huddersfield', u'Maroon Biotech Corp', u'Wake Forest University', u'Biosolution Co Ltd', u'Sanford-Burnham Medical Research Institute', u'Intercytex Ltd', u'Ningbo Renjian Pharmaceutical Co Ltd', u'Luna Innovations Inc', u'BioInnovation SA', u'Sandoz Inc', u'MediWound Ltd', u'LifeCell Corp', u'Novan Inc', u'Massachusetts Institute of Technology', u'Mipharm SpA', u'Peptor Ltd', u'Sumitomo Metal Industries Ltd', u'ATG Allied Technologies', u'Quintiles Transnational Corp', u'Lonza Group AG', u'Phylogica Ltd', u'Lifecore Biomedical Inc', u'National Institutes of Health', u'PolyNovo Biomaterials Pty Ltd', u'MorphoSys AG', u'Advanced Tissue Sciences Inc', u'Mundipharma Korea Ltd', u'Integra LifeSciences Holdings Corp', u'University of Chicago', u'Glycotex Inc', u'COVALEO SA de CV', u'Avanir Pharmaceuticals Inc', u'Insmed Inc', u'DecImmune Therapeutics', u'Digna Biotech SL', u'National Institute for Biological Standards and Control', u'Biologix FZ Co', u'Arizona Burn Center', u'Boryung Pharm Co Ltd', u'BexPharm Co Ltd']), u'Migraine': set([u\"Dr Reddy's Laboratories Ltd\", u'DKSH Holding Ltd', u'Symphony Capital LLC', u'Solvay SA', u'BioLink Life Sciences Inc', u'Transcept Pharmaceuticals Inc', u'Nautilus Neurosciences Inc', u'Kowa Pharmaceuticals America Inc', u'Fudan University', u'US Government', u'NPS Allelix Corp', u'Forest Laboratories Inc', u'GlaxoSmithKline plc', u'BTG plc', u'Tribute Pharmaceuticals Inc', u'The Medicines Company', u'Soochow University', u'BioHaven Pharmaceutical Holding Co Ltd', u'DRAXIS Health Inc', u'DSM Chemie Linz GmbH', u'Marina Biotech Inc', u'Cranford Pharmaceuticals LLC', u'MonoSol Rx Inc', u'Par Pharmaceutical Co Inc', u'Vernalis plc', u'Nexeon MedSystems Inc', u'IMPAX Laboratories Inc', u'Nektar Therapeutics', u'Roche Holding AG', u'CeNeS Pharmaceuticals plc', u'Mission Pharmacal Co Inc', u'Reckitt Benckiser plc', u'Migco Pharmaceuticals Ltd', u'Antares Pharma Inc', u'Paladin Labs Inc', u'ANI Pharmaceuticals Inc', u'UCB Pharma SA', u'AstraZeneca plc', u'Alliance Pharma plc', u'CoLucid Pharmaceuticals Inc', u'Scripps Research Institute', u'UCB SA', u'University of Nebraska Medical Center', u'Endo International plc', u'Nelson Pharmaceuticals LLC', u'Impel NeuroPharma', u'Aspyrian Therapeutics Inc', u'University of Oxford', u'Amgen Inc', u'Mylan Inc', u'Lohmann Therapie-Systeme GmbH & Co KG', u'Abbott Laboratories', u'Endo Health Solutions Inc', u'Eisai Co Ltd', u'Teva Pharmaceuticals USA Inc', u'NeuroTek Medical Inc', u'Trigemina Inc', u'Harris FRC Corp', u'Novartis AG', u'Aradigm Corp', u'Xcel Pharmaceuticals', u'RedHill Biopharma Ltd', u'Il Dong Pharmaceutical Co Ltd', u'Teva Pharmaceutical Industries Ltd', u'MabVax Therapeutics Holdings Inc', u'Italfarmaco SpA', u'Massachusetts General Hospital', u'Polichem SA', u'UCB Pharma GmbH', u'Bristol-Myers Squibb Pharma Co', u'Melmed Holding AG', u'Valeant Pharmaceuticals International Inc', u'Janssen-Ortho Inc (Canada)', u'Pharmacia & Upjohn Inc', u'Weston Medical Group plc', u'Pharmachemie BV', u'Allergan Inc', u'Boehringer Ingelheim Corp', u'Lupin Ltd', u'Klaria Pharma Holding Ab', u'Pharmatronic Co', u'Camargo Pharmaceutical Services', u'Recordati SpA', u'AstraZeneca Pharmaceuticals LP', u'Selectus Pharmaceuticals Inc', u'CIMA Labs Inc', u'NOXXON Pharma AG', u'Shanghai Institute of Materia Medica of the Chinese Academy of Sciences', u'National Institute of Neurological Disorders and Stroke', u'Undisclosed', u'Migraine Research Foundation', u'SIRENADE Pharmaceuticals AG', u'Grupo JUSTE', u'Grunenthal GmbH', u'Otsuka Pharmaceutical Co Ltd', u'National Institute on Drug Abuse', u'The Procter & Gamble Co', u'Vernalis Group plc', u'SK Chemicals Co Ltd', u'American Biogenetic Sciences Inc', u'Allergan plc', u'Hartford Healthcare', u'Faraday Pharmaceuticals Inc', u'Shionogi Pharma Inc', u'LifeArc', u'Lundbeck Inc', u'Yuhan Corp', u'Alexza Pharmaceuticals Inc', u'Arteaus Therapeutics', u'Merckle GmbH', u'Sumitomo Dainippon Pharma Co Ltd', u'Daewoong Pharmaceutical Co Ltd', u'Merck & Co Inc', u'tesa Labtec GmbH', u'MRIGlobal', u'Lundbeck Canada Inc', u'Paul Capital Healthcare', u'APR Applied Pharma Research SA', u'Vertex Pharmaceuticals Inc', u'Eli Lilly & Co', u'Immune Pharmaceuticals Inc', u'IntelGenx Technologies Corp', u'Capha Pharmaceuticals Inc', u'Pharmacia & Upjohn AB', u'Department of Science & Technology', u'Penwest Pharmaceuticals Co', u'Renhe Group Development Co Ltd', u'Caelus Biosciences Inc', u'Horizon Orphan LLC', u'Glide Pharmaceutical Technologies Ltd', u'BioSeek Plc', u'GW Pharmaceuticals plc', u'Minster Pharmaceuticals plc', u'IVAX Corp', u'CeNeS Pharmaceuticals Inc', u'Farmitalia Carlo Erba Srl', u'Pfizer Inc', u'BioProjet, Societe Civile de Recherche', u'Afgin Pharma Llc', u'POZEN Inc', u'Wyeth-Ayerst Pharmaceuticals Inc', u'Wyeth', u'Satsuma Pharmaceuticals Inc', u'Ferrer Internacional SA', u'University of Arizona', u'Desitin Arzneimittel GmbH', u'Han Seo Pharm Co Ltd', u'MAP Pharmaceuticals Inc', u'Takeda Pharmaceuticals International GmbH', u'BlackThorn Therapeutics Inc', u'SmithKline Beecham plc', u'Yamanouchi Pharmaceutical Co Ltd', u'Galephar PR Inc', u'Heptares Therapeutics Ltd', u'Bayer AG', u'National Institutes of Health', u'Synthetic Biologics Inc', u'OptiNose AS', u'GlaxoSmithKline KK', u'Bristol-Myers Squibb Co', u'Elan Corp plc', u'ULURU Inc', u'Janssen LP', u'INSERM', u'Weston Medical Ltd', u'Inpharmakon Corp', u'Spectrum Pharmaceuticals Inc', u'Zogenix Inc', u'The Menarini Group', u'Cephalon Inc', u'Almirall Prodesfarma SA', u'Tecnifar-Ind\\xfastria T\\xe9cnica Farmac\\xeautica Sa', u'Array BioPharma Inc', u'Astellas Pharma US Inc', u'Catalytica Inc', u'Immunotech SA', u'Uppsalagruppen Medical Ab', u'Avanir Pharmaceuticals Inc', u'NuPathe Inc', u'Labrys Biologics Inc', u'Shire plc', u'Purdue Neuroscience Corp', u'Meda AB', u'XenoPort Inc', u'National Institute of Dental and Craniofacial Research', u'Depomed Inc', u'Pernix Therapeutics Holdings Inc', u'Merz & Co GmbH', u'GD Searle & Co', u'Aralez Pharmaceuticals Inc', u'Shin Nippon Biomedical Laboratories Ltd', u'Berlex Laboratories Inc', u'Zeneca Group plc']), u'Metastaticprostatecancer': set([u'US Government', u'National Comprehensive Cancer Network', u'Merck & Co Inc', u'MD Anderson Cancer Center', u'MetCure Therapeutics LLC', u'United Laboratories Inc.', u'University of Kansas', u'Prostate Cancer Foundation', u'NantKwest Inc', u'ATLAB Pharma SAS', u'Lantern Pharma', u'National Cancer Institute', u'Telix Pharmaceuticals Ltd', u'Ipsen', u'Massachusetts Life Sciences Center', u'University of Colorado System', u'Oncology Venture ApS', u'Madison Vaccines Inc', u'Massachusetts General Hospital', u'University of California San Francisco', u'University of Pittsburgh', u'Veristat, Inc.', u'WuXi PharmaTech (Cayman) Inc', u'Bayer AG', u'Orient Europharma', u'Foresee Pharmaceuticals LLC', u'Institute of Cancer Research UK', u'Millennium Pharmaceuticals Ltd', u'TESARO Inc', u'Life Sciences Discovery Fund', u'Cancer Targeted Technology Llc', u'Nang Kuang Pharmaceutical Co Ltd', u'Progenics Pharmaceuticals Inc', u'DRI Capital', u'Debiopharm SA']), u'Pulmonaryfibrosis': set([u'University of Medicine and Dentistry of New Jersey', u'Pharmaxis Ltd', u'Humanetics Corp', u'Netherlands Government', u'Dalhousie University', u'US Government', u'Biogen Inc', u'UNC School of Medicine', u'Il Dong Pharmaceutical Co Ltd', u'University of Alabama', u'University of Wurzburg', u'Bayer Schering Pharma AG', u'North Carolina State University', u'ImmuneWorks Inc', u'Shanghai Pharmaceuticals Holding Co Ltd', u'Pacific Therapeutics Ltd', u'University of Michigan', u'LTT Bio-Pharma Co Ltd', u'Fred Hutchinson Cancer Research Center', u'Biomodels LLC', u'Ono Pharmaceutical Co Ltd', u'University of Rochester', u'Five Prime Therapeutics Inc', u'University of British Columbia', u'Azopharma Inc', u'Handok Inc', u'Connetics Corp', u'Sankyo Co Ltd', u'Relief Therapeutics Holding AG', u'Shionogi & Co Ltd', u'InterMune Inc', u'National Heart Lung and Blood Institute', u'US Department of Defense', u\"People's Government of Guangdong Province\", u'National Research Council of Canada', u'23andMe Inc', u'Amgen Inc', u'Medarex Inc', u'Cambridge Antibody Technology Group plc', u'National Cancer Institute', u'Novici Biotech LLC', u'Pulmonary Fibrosis Foundation', u'NeoPharm Inc', u'Stiefel Laboratories (UK) Ltd', u'Keryx Biopharmaceuticals Inc', u'Marnac Inc', u'University of California San Francisco', u'Guangdong Zhongsheng Pharmaceutical Co Ltd', u'Sichuan University', u'National Jewish Health', u'FibroGen Inc', u'Galectin Therapeutics Inc', u'Pharmacopeia Inc', u'Shenzhen Royal Asset Management Co Ltd', u'Dong-A ST Co Ltd', u'Boehringer Ingelheim Corp', u'Compugen Ltd', u'Takara Shuzo Co Ltd', u'University of Sydney', u'F Hoffmann-La Roche AG', u'F H Faulding & Co Ltd', u'Lung Biotechnology Inc', u'Paladin Labs Inc', u'Lanthio Pharma', u'Fujian Medical University', u'AFT Pharmaceuticals Ltd', u'Flamel Technologies SA', u'CLL Pharma', u'ImmuneRegen BioSciences Inc', u'Auxagen Inc', u'Australian Research Council', u'GenKyoTex SA', u'Chong Kun Dang Pharmaceutical Corp', u'Eli Lilly & Co', u'Synt:em', u'Takeda Pharmaceuticals International GmbH', u'Fujian Mindong Rejuvenation Pharmaceutical Co Ltd', u'SIRO ClinPharm USA LLC', u'Janssen Biotech Inc', u'Caladrius Biosciences Inc', u'Wyeth', u'Context Therapeutics LLC', u'Bachem Holding AG', u'University of Western Australia', u'AbbVie Inc', u'Canadian Institutes of Health Research', u'National Institute of Allergy and Infectious Diseases', u'Taisho Pharmaceutical Co Ltd', u'UCB Celltech', u'Global Health Ventures Inc', u'Cynata Therapeutics Ltd', u'MPI Research', u'National Institutes of Health', u'Food and Drug Administration', u'ProMetic Life Sciences Inc', u'Chinese Government', u'Sanofi Genzyme', u'Regulus Therapeutics Inc', u'Stendhal International', u'Cedars-Sinai Medical Center', u'GNI Group Ltd', u'Celgene Corp', u'Sosei Group Corp', u'Archimedes Pharma Ltd', u'Duke University', u'Tufts University', u'Biotherapix SLU', u'Digna Biotech SL', u'South China Center for Innovative Pharmaceuticals']), u'Fibrosis': set([u'US Government', u'BioMarin Pharmaceutical Inc', u'Intercept Pharmaceuticals Inc', u'GLYCODesign Inc', u'InterMune Inc', u'Dalhousie University', u'Biogen Inc', u'Kiniksa Pharmaceuticals', u'GlaxoSmithKline plc', u'KineMed Inc', u'University of Wurzburg', u'Bayer Schering Pharma AG', u'Collagen Medical LLC', u'Pilotage South Corp', u'Ionis Pharmaceuticals Inc', u'Nodthera Ltd', u'ArQule Inc', u'The Center for World Health & Medicine at Saint Louis University', u'University of Michigan', u'University of Pennsylvania', u'UCB SA', u'Five Prime Therapeutics Inc', u'Afimmune', u'4D Science GmbH', u'Oncodesign Biotechnology SA', u'Galapagos NV', u'Nobex Corp', u'Harvard Stem Cell Institute', u'Sankyo Co Ltd', u'Ember Therapeutics', u'Selvita SA', u'Caliber Biotherapeutics', u'Grunenthal GmbH', u'Catalent Inc', u'Inventiva', u'Interprotein Corp', u'Medical Research Council', u'Ribomic Inc', u'Northern Biologics Inc', u'National Center For Advancing Translational Sciences', u'Evotec AG', u'Medarex Inc', u'Stryker Corp', u'Boehringer Ingelheim Corp', u'Antegrin Therapeutics LLC', u'Cambridge Antibody Technology Group plc', u'Harvard University', u'Nitto Denko Corp', u'In2Gen Co', u'Galena Biopharma Inc', u'Celgene Corp', u'Wuxi AppTec Inc', u\"Seattle Children's Hospital\", u'Novici Biotech LLC', u'La Trobe University', u'Covella Pharmaceuticals Inc', u'Irix Pharmaceuticals Inc', u'Mount Sinai Hospital', u'Marnac Inc', u'Catholic University of Leuven', u'University of Alabama', u'Massachusetts General Hospital', u'Alfred Hospital', u'Universite Libre de Bruxelles', u'FibroGen Inc', u'Galectin Therapeutics Inc', u'Pharmacopeia Inc', u'ALZA Corp', u'Tobira Therapeutics Inc', u'Dong-A ST Co Ltd', u'Karo Pharma AB', u'Imprimis Pharmaceuticals Inc', u'DS Biopharma', u'Nordic Bioscience A/S', u'National Institute of General Medical Sciences', u'Bird Rock Bio Inc', u'University of Ghent', u'Phrixus Pharmaceuticals Inc', u'University of Sheffield', u'Undisclosed', u'Stanford University', u'Otsuka Holdings Co Ltd', u'Connetics Corp', u'Isarna Therapeutics GmbH', u'National Institute of Diabetes, Digestive and Kidney Diseases', u'PDX Pharmaceuticals', u'Cangene Corp', u'LifeArc', u'MaRS Innovation', u'Abpro Inc', u'Oregon Health Sciences University', u'National Eye Institute', u'GenKyoTex SA', u'Eli Lilly & Co', u'University of Miami', u'ChronTech Pharma AB', u'SphynKx Therapeutics LLC', u'Allist Pharmaceuticals Inc', u'Horizon Orphan LLC', u'Florida International University', u'Argenta Discovery Ltd', u'ErgoNex Pharma GmbH', u'PharmAkea Therapeutics LLC', u'AstraZeneca plc', u'Pfizer Inc', u'Pacific Therapeutics Ltd', u'Corthera Inc', u'Haikou Pharmaceutical Factory', u'Gilead Sciences Inc', u'Intarcia Therapeutics Inc', u'Nihon Schering KK', u'Institute for the Promotion of Innovation by Science and Technology in Flanders', u'ABLS II LLC', u'Excaliard Pharmaceuticals Inc', u'EPIX Pharmaceuticals Inc', u'LG Life Sciences Ltd', u'Australian Government', u'AbbVie Inc', u'iBio Inc', u'Taisho Pharmaceutical Co Ltd', u'Allied Minds', u'AdAlta Pty Ltd', u'Global Health Ventures Inc', u'California Institute for Biomedical Research', u'Genedrive plc', u'ProMetic Life Sciences Inc', u'Bristol-Myers Squibb Co', u'IBEX Technologies Inc', u'National Science Foundation', u'Sanofi Genzyme', u'Regulus Therapeutics Inc', u'Quark Pharmaceuticals Inc', u'Fujifilm Diosynth Biotechnologies', u'Integra LifeSciences Holdings Corp', u'Array BioPharma Inc', u'Eton Pharmaceuticals Inc', u'Transition Therapeutics Inc', u'BioTie Therapies Corp', u'Apollo Endosurgery Inc', u'The University of Birmingham', u'University of Georgia', u'GE Healthcare', u'Janssen Pharmaceuticals Inc', u\"Brigham & Women's Hospital\", u'XL-Protein GmbH', u'Central South University', u'Arresto BioSciences', u'Linkoping University', u'BioGenerator', u'Technion - Israel Institute of Technology', u'New York Medical College', u'SK Chemicals Co Ltd']), u'Vestibulocochlearnervedisorder': set([u'Auris Medical Holding AG', u'Sensorion Pharmaceuticals', u'Undisclosed', u'Otifex Therapeutics Pty Ltd', u'Griffin Discoveries BV', u'European Eurostars Programme']), u'UshersyndromeI': set([u'University of Pennsylvania', u'National Institute on Deafness and Other Communication Disorders']), u'Arterialthrombosis': set([u'Oregon Health Sciences University', u'Chiesi USA Inc', u'The Medicines Company', u'Bayer AG']), u'Steatorrhea': set([u'Nordmark Arzneimittel GmbH & Co KG', u'Aptalis Pharma Inc']), u'Asepticmeningitis': set([u'National Institute of Allergy and Infectious Diseases', u'AvidBiotics Corp']), u'Neisseriameningitidismeningitis': set([u'Health Protection Agency', u'BioVeris Corp', u'Childrens Hospital Oakland Research Institute', u'Baxter International Inc', u'UK Government', u'Bio-Manguinhos/Fiocruz', u'Finlay Institute', u'Shire Biologics', u'Serum Institute of India Ltd', u'GlaxoSmithKline plc', u'Fiotec- Fundacao para o Desenvolvimento Cientifico e Tecnologico em Saude', u'Baxter Healthcare Corp', u'Chiron Corp', u'Abivax', u'CSL Ltd', u'VABIOTECH', u'bioCSL PTY Ltd', u'Imperial College London', u'Rijksinstituut voor Volksgezondheid en Milieu', u'Shire plc', u'Norwegian Institute of Public Health', u'Pfizer Inc', u'Novartis Vaccines & Diagnostics', u'ID Biomedical Corp', u'Pfizer Vaccines', u'University of Oxford']), u'Chronicgranulomatousdisease': set([u'Fondazione Telethon', u'Genethon', u'Istituto Scientifico H San Raffaele', u'Yuhan Corp', u'National Institutes of Health', u'ViroMed Co Ltd', u'MaxCyte Inc', u'MolMed SpA', u'National Institute of Allergy and Infectious Diseases', u'GlaxoSmithKline plc']), u'Tonsillitis': set([u'DoctorDirectory', u'Clonmel Healthcare', u'MiddleBrook Pharmaceuticals Inc', u'Victory Pharma Inc']), u'Histoplasmainfection': set([u'Janssen Pharmaceutica NV', u'Kyowa Hakko Kogyo Co Ltd']), u'Congenitaladrenalhyperplasia': set([u'Phoqus Pharmaceuticals Ltd', u'William Harvey Research Ltd', u'LifeArc', u'ChemDiv Inc', u'National Institutes of Health', u'Yale University', u'IDIS Ltd', u'Diurnal Ltd', u'Patheon Pharmaceuticals Inc', u'Medison Pharma Ltd']), u'Myastheniagravis': set([u'Cytokinetics Inc', u'Novo Nordisk A/S', u'Evolutec Group plc', u'New York University School of Medicine, US', u'National Institutes of Health', u'Yissum Research Development Co', u'Myasthenia Gravis Alliance', u'The Garden State Chapter of the Myasthenia Gravis Foundation, Inc', u'European Commission', u'The European Union', u'Aspreva International Ltd', u'Amarin Corp plc', u'Boehringer Mannheim GmbH', u'Sanofi Genzyme', u'Toleranzia AB', u'Evotec International GmbH', u'UAB Biotechnologines Farmacijos Centras \"Biotechpharma\"', u'National Institute of Neurological Disorders and Stroke', u'CuraVac Inc', u'Korea Research Institute of Bioscience and Biotechnology', u'University of Gothenburg', u'Ipsen', u'Teva Pharmaceutical Industries Ltd', u'Nerviano Medical Sciences Srl', u'Global Pharmaceuticals', u'Accentia BioPharmaceuticals Inc', u'CTI BioPharma Corp', u'Wacker Biotech GmbH', u'SoyMeds Inc', u'VINNOVA', u'Astellas Pharma Inc', u'Alpha Cancer Technologies Inc', u'Undisclosed', u'George Washington University', u'Cambrex Corp', u'F Hoffmann-La Roche AG', u'Muscular Dystrophy Association', u'McGill University', u'rEVO Biologics Inc', u'Johns Hopkins University', u'AutoImmune Inc', u'Tecrea Ltd', u'Corixa Corp', u'Merrimack Pharmaceuticals Inc', u'Alnylam Pharmaceuticals Inc', u'Debiopharm SA', u'Hikma Pharmaceuticals plc']), u'Eclampsia': set([u'Bioniche Teoranta', u'Barbeau Pharma Inc']), u'Legulcer': set([u'Organogenesis Inc', u'Intercytex Ltd', u'Smith & Nephew Biotherapeutics', u'PharmaResearch Products Co Ltd', u'Servier Canada Inc', u'US Department of Veterans Affairs', u'Lipopeptide AB', u'Fonds de solidarit\\xe9 FTQ']), u'R': set([u'Novartis Pharma AG', u'Medarex Inc']), u'Biliarycirrhosis': set([u'Asklepion Pharmaceuticals LLC', u'Dr Falk Pharma GmbH']), u'Diabetesmellitus': set([u'Dongeui University', u'Lumara Health Inc', u'ANANDA Scientific Inc', u'TranXenoGen Inc', u'European Commission', u'Envoy Therapeutics Inc', u'Il Dong Pharmaceutical Co Ltd', u'Life Technologies Corp', u'Montreal Heart Institute', u'Hadasit Medical Research Services and Development Ltd', u'Miraculins Inc', u'Maryland Technology Development Corp', u'Equis & Zaroo Co Ltd', u'Shanghai Institutes for Biological Sciences CAS', u'Invigorcell', u'OnQ Consulting', u'Ionis Pharmaceuticals Inc', u'The Dow Chemical Co', u'Metacrine', u'Anesiva Inc', u'Capsant Neurotechnologies Ltd', u'MonoSol Rx Inc', u'University of South Florida', u'University of Pittsburgh', u'Metabasis Therapeutics Inc', u'The Hartwell Foundation', u'Resverlogix Corp', u'DNX Biopharmaceuticals Inc', u'CymaBay Therapeutics Inc', u'Kinexum Metabolics Inc', u'Galapagos NV', u'Uni-Bio Science Group Ltd', u'Roche Diabetes Care Inc', u'Harvard Stem Cell Institute', u'University of Turin', u'Handok Inc', u'QDose Ltd', u'Encapsulation Systems Inc', u'Insulet Corp', u'NeuroSearch A/S', u'Baker IDI Heart & Diabetes Institute Holdings Ltd', u'Glasgow University', u'Perrigo Co plc', u'US Department of Agriculture', u'Orgenesis Inc', u'Medipolis', u'CrystalGenomics Inc', u'Universit\\xe9 du Qu\\xe9bec \\xe0 Montr\\xe9al', u'BioAdvance', u'Advanced Mr Analytics AB', u'Entelos Inc', u'New York University', u'Julphar Gulf Pharmaceutical Industries', u'Israeli Government', u'Centre National de la Recherche Scientifique (CNRS)', u'Chongqing Fagen Biopharmaceutical Co Ltd', u'Thiakis Ltd', u'Ergo Science Corp', u'Aegis Therapeutics LLC', u'KeyBioScience AG', u'NovaDel Pharma Inc', u'Fujian Haixi Pharmaceuticals Co Ltd', u'Devgen NV', u'Halsa Pharmaceuticals Inc', u'Xymogen', u'Modern Healthcare Solutions Co Ltd', u'Egret Pharma (Shanghai) Ltd', u'Tonghua Dongbao Pharmaceutical Co Ltd', u'Hanmi Pharmaceutical Co Ltd', u'Asembia', u'Kowa Co Ltd', u'Boston Therapeutics Inc', u'AdPharma Inc', u'Samsung Electronics Co Ltd', u'Kyorin Pharmaceutical Co Ltd', u'Diabetes UK', u'Nano Terra Inc', u'Bahrain Defense Force Royal Medical Service Hospital', u'Probiodrug AG', u'MegaPharm Ltd', u'ViaCyte Inc', u'Chungnam national University Hospital', u'Biofrontera Discovery GmbH', u'Dance Biopharm Inc', u'Jiangsu Wanbang Biochemical Pharmaceutical Co Ltd', u'National Health Research Institutes', u'Corestem Co Ltd', u'4SC AG', u'Plasticell Ltd', u'Ohio University', u'Generex Biotechnology Corp', u'Diamyd Medical AB', u'Oslo University Hospital', u'Betta Pharmaceuticals Co Ltd', u'Therakind Ltd', u'Medtronic Inc', u'Cigalah', u'FunPep Co Ltd', u'Ajinomoto Co Inc', u'Device Technologies', u'MicroDose Therapeutx Inc', u'Bayer Yakuhin Ltd', u'La Jolla Institute of Allergy & Immunology', u'Finnish Funding Agency for Technology and Innovation', u'PR Pharmaceuticals Inc', u'Beijing Sun Novo Pharmaceutical Research Co Ltd', u'Oregon Health Sciences University', u'Hillcrest Therapeutics Inc', u'Meda AB', u'Ewha Womans University', u'BioPancreate Inc', u'CTI BioPharma Corp', u'Eli Lilly & Co', u'DiAthegen LLC', u'Reverx Pty Ltd', u'Phyton Biotech Inc', u'University of Ulster', u'i360medical Ltd', u'Palatin Technologies Inc', u'Argenta Discovery Ltd', u'ETI Karle Clinical Pvt Ltd', u'University of California Los Angeles', u'Reliance GeneMedix plc', u'Livongo Health Inc', u'Fournier Pharma', u'YiChang HEC ChangJiang Pharmaceutical Co Ltd', u'Hybio Pharmaceutical Co Ltd', u'Genexine Co Ltd', u'DUKE MOLECULAR PHYSIOLOGY INSTITUTE', u'University of California Santa Cruz', u'Sanwa Kagaku Kenkyusho Co Ltd', u'Forbes Medi-Tech Inc', u'Harbor Therapeutics Inc', u'Johnson & Johnson', u'Merrion Pharmaceuticals Inc', u'ETH Zurich', u'Silence Therapeutics AG', u'Metabolon Inc', u'Macrogen Inc', u'BELLUS Health Inc', u'Mimotopes Pty Ltd', u'SmithKline Beecham plc', u'Taisho Pharmaceutical Co Ltd', u'Amersham Biosciences AB', u'BL&H Co Ltd', u'Baker Heart Research Institute', u'Takeda Pharmaceutical Co Ltd', u'StressMarq Biosciences Inc', u'Orphan Pacific, Inc', u'Servier', u'University Hospital Inselspital, Berne', u'Bristol-Myers Squibb Co', u'Semma Therapeutics', u'Evotec (UK) Ltd', u'Joslin Diabetes Center Inc', u'Rechon Life Science AB', u'Hybrigenics SA', u'SmartCells Inc', u'Astellas Pharma Inc', u'Knoll GmbH', u'Lundbeck Research USA Inc', u'Oramed Pharmaceuticals Inc', u'Ortho-McNeil Inc', u'Insmed Inc', u'Tabuk Pharmaceutical Manufacturing Co', u'Yabao Pharmaceutical Group Co Ltd', u'CoGenesys Inc', u'Depomed Inc', u'Thermalin Diabetes LLC', u'Assured Pharmacy', u'PerkinElmer Inc', u'Max-Planck-Gesellschaft', u'Rheoscience A/S', u'Curtin University', u'Locus Pharmaceuticals Inc', u\"King's College London\", u'Karolinska Institutet', u'University of Strathclyde', u'Ipsen Biopharmaceuticals Inc', u'Beijing Jingyitaixiang Technology Development Co Ltd', u'SurModics Inc', u'Kyungpook National University', u'Gyeongsang National University', u'SciGen Ltd', u'AdipoGenix Inc', u'The Institute for Diabetes Discovery LLC', u'Opocrin SpA', u'Howard Hughes Medical Institute', u'Ascensia Diabetes Care Holdings', u'Sirona Biochem Corp', u'Cyntellect Inc', u'Novo Nordisk A/S', u'Dermisonics Inc', u'NewBridge Pharmaceuticals Ltd', u'Marcadia Biotech Inc', u'Chinese Government', u'Marcas de Renombre SA de CV', u'The European Union', u'Genentech Inc', u'Microbot Medical Inc', u'Sangamo Therapeutics Inc', u'University of Pennsylvania', u'The University Health Network', u'Enteris BioPharma Inc', u'Mitsubishi-Tokyo Pharmaceuticals Inc', u'Mateon Therapeutics Inc', u'Garvan Institute of Medical Research', u'Continental Pharma Laboratories', u'Roche Holding AG', u'Merck Sante SA', u'Genovate Biotechnology Co Ltd', u'Shire plc', u'University of British Columbia', u'Mitsubishi Tanabe Pharma Corp', u'Tandem Diabetes Care Inc', u'University of North Carolina', u'Islet Sciences Inc', u'TS BioPharma', u'Capillary Biomedical Inc', u'ANI Pharmaceuticals Inc', u'Sanofi Genzyme', u'Jenrin Discovery Inc', u'Binational Industrial Research and Development Foundation', u'ImmuLogic Pharmaceutical Corp', u'Andrx Corp', u'Biocon Ltd', u'Bayer HealthCare AG', u'Shire Orphan Therapies GmbH', u'Proteostasis Therapeutics Inc', u'Dana-Farber Cancer Institute Inc', u'MedGen Corp', u'Avid Radiopharmaceuticals Inc', u'Charite Universitaetsmedizin Berlin', u'University of Massachusetts Medical School', u'ChemRar High Tech Center', u'Ascensia Diabetes Care US, Inc', u'Diabetica Ltd', u'Harmony Biopharm Ltd', u'Exelixis Inc', u'Charles River Laboratories International Inc', u'Amgen Inc', u'Qiqihar University', u'Vyteris Inc', u'Biomm SA', u'VistaGen Therapeutics Inc', u'Geron Corp', u'Gemini Genomics plc', u'CJ Corp', u'SkyePharma plc', u'MabVax Therapeutics Holdings Inc', u'LMC Diabetes & Endocrinology Ltd', u'Array BioPharma Inc', u'University of Texas Health Science Center San Antonio', u'Iconix Biosciences Inc', u'Medical Research Council', u'RIKEN', u'Inflazyme Pharmaceuticals', u'SBI Pharmaceuticals', u'PMG SA', u'Pennsylvania State University', u'Merck Millipore', u'Dong-A ST Co Ltd', u'Echo Therapeutics Inc', u'Radiant Pharma & Tech Co Ltd', u'Institute Of Chinese Materia Medica China Academy Of Chinese Medical Sciences', u'Alvogen Inc', u'Allergan Inc', u'Daegu Hanny University', u'Trividia Health Inc', u'Caisson Biotech LLC', u'Yuhan Corp', u'Curl Bio LLC', u'AVAC Ltd', u'Prosidion Ltd', u'Seikagaku Corp', u'China Pharma Holdings Inc', u'Humana Inc', u'ProSciento Inc', u'Tufts University', u'Active Pass Pharmaceuticals Inc', u'IsoTis SA', u'Paladin Labs Inc', u'Agilent Technologies Inc', u'IntelliCell BioSciences Inc', u'Korea Drug Development Fund', u'Helix', u\"Dr Reddy's Research Foundation\", u'National Health and Medical Research Council', u'Nexus BioPharma Inc', u'Ore Pharmaceuticals Inc', u'Nara Biosciences Inc', u'LifeArc', u'Merck KGaA', u'Amphastar Pharmaceuticals Inc', u'Eastern Virginia Medical School', u'Sumitomo Dainippon Pharma Co Ltd', u'Aerogen Inc', u'Australian Research Council', u'MAP Pharmaceuticals Inc', u'Scripps Research Institute', u'Ahn-Gook Pharmaceuticals Co Ltd', u'Giddi Pharma Co Ltd', u'University of Texas Southwestern Medical Center', u'Alkermes plc', u'LifeScan Inc', u'Numab AG', u'GMP Companies Inc', u'Pierre Fabre SA', u'Vittal Mallya Scientific Research Foundation', u'Biocision Inc', u'LION bioscience Inc', u'Senseonics Inc', u'Bioglan Pharmaceuticals Co', u'Theratechnologies Inc', u'Kadmon Pharmaceuticals LLC', u'enGene Inc', u'Serodus ASA', u'University of Wisconsin-Madison', u'Shanghai Institute of Pharmaceutical Industry', u'Napo Pharmaceuticals Inc', u'AstraZeneca plc', u'Guizhou Bailing Enterprise Group Pharmaceutical Co Ltd', u'Hongkong Invengen Pharmaceutical Technology Co Ltd', u'Vascular Pharmaceuticals Inc', u'Lorem Vascular Co Ltd', u'Adenosine Therapeutics LLC', u'Undisclosed', u'Melior Pharmaceuticals Inc', u'BioFocus DPI', u'Sirtris Pharmaceuticals Inc', u'American Diabetes Association', u'Insilico Medicine Inc', u'Genmab A/S', u'Swiss Caps AG', u'Amylin Pharmaceuticals Inc', u'Pukyong National University', u'H Lee Moffitt Cancer Center and Research Institute', u'Benta Group', u'Albireo Pharma Inc', u'Sanofi KK', u'LoneStar Heart Inc', u'The National Center For Drug Screening', u'Abiogen Pharma SpA', u'Abeome Corp', u'Evotec International GmbH', u'Discovery BioMed Inc', u'Shenzhen HighTide Biopharmaceutical Ltd', u'Abeona Therapeutics Inc', u'Theracos Inc', u'Beijing Dongfang Baitai Biotechnology Co Ltd', u'Zealand Pharma A/S', u'Summit Pharmaceuticals International Corp', u'Kyoto University', u'Cedars-Sinai Medical Center', u'Cense Biosciences Inc', u'BHV Pharma Inc', u'AGY Therapeutics Inc', u'American Heart Association', u'Vasade Biosciences Inc', u'Cornell University', u'Asset Realisation Co plc', u'USV Ltd', u'Admera Health', u'Spencer Pharmaceutical Inc', u'Institut Pasteur', u'OOO Geropharm', u'University of Western Ontario', u'Inotek Pharmaceuticals Corp', u'Patia Biopharma', u'Indiana University', u'PiSA Farmaceutica', u'Quadrant Technologies Ltd', u'ReceptorBio Inc', u'Antitope Ltd', u'Interthyr Corp', u'Chinese University of Hong Kong', u'University of Toronto', u'PharmaRoth Labs Inc', u'CuraGen Corp', u'ESI BIO', u'PhytoMedical Technologies Inc', u'Clinical Data Inc', u'Symphony Capital LLC', u'Texas Emerging Technology Fund', u'Elixir Pharmaceuticals Inc', u'Cardinal Health Inc', u'TypeZero Technologies LLC', u'US Government', u'Lynx Therapeutics GmbH', u'Forest Laboratories Inc', u'Korea Research Institute of Chemical Technology', u'Applied Biosystems', u'Kadimastem Ltd', u'FIT Biotech Oyj Plc', u'Vernalis Group plc', u'R-Pharm', u'jinan tianhe stem cell biotechnology ltd', u'University of Queensland', u'SCOHIA PHARMA Inc', u'Ureka Sarl', u'Precisense AS', u'CellMed AG', u'Aventis Pharma AG', u'MedImmune LLC', u'Biosequel LLC', u'OSI Pharmaceuticals Inc', u'University of Washington', u'Genaera Corp', u'UCB SA', u'Five Prime Therapeutics Inc', u'Tianjin Zhongxin Pharmaceutical Group Co Ltd', u'Biokier Inc', u'CannScience Innovations Inc', u'Cytori Therapeutics Inc', u'Dexcom, Inc', u'Agency For Science Technology & Research', u'Beijing CoSci Med-Tech Co Ltd', u'Vertex Pharmaceuticals Inc', u'Omni Bio Pharmaceutical Inc', u'Hikma Pharmaceuticals plc', u'National Center For Advancing Translational Sciences', u'Saphetor', u'MidaSol Therapeutics LP', u'Ascendis Pharma A/S', u'Biota Holdings Ltd', u'Shenzhen Municipal Government', u'Royal College of Surgeons in Ireland', u'Harvard University', u'ZymoGenetics Inc', u'Yale University', u'Teva Pharmaceutical Industries Ltd', u'PreveCeutical Medical Inc', u'Maryland Stem Cell Research Fund', u'Kunming Pharmaceutical Corp', u'University of California San Francisco', u'Lilly China Research & Development Co Ltd', u'Emisphere Technologies Inc', u'Zhejiang University', u'Florida Hospital', u'Therapeutic Human Polyclonals Inc', u'N-Gene Research Laboratories Inc', u'Mathilda and Terrence Kennedy Institute of Rheumatology Trust', u'Ferring Pharmaceuticals SA', u'University of California San Diego', u'Symphony GenIsis', u'Glaxo Group Ltd', u'Chengdu municipal government', u'Diabetology Ltd', u'Libbs Farmaceutica Ltda', u'Connexios Life Sciences Pvt Ltd', u'Genset SA', u'DiaKine Therapeutics Inc', u'NovaMed Pharmaceuticals Inc', u'Mount Sinai Medical Center', u'Dura Pharmaceuticals Inc', u'Health Management Resources', u'Arisaph Pharmaceuticals Inc', u'Somru BioScience Inc', u'Wyeth Pharmaceuticals', u'Diasend', u'Neocrin', u'National Institute of Diabetes, Digestive and Kidney Diseases', u'NeoGenesis Pharmaceuticals Inc', u'Cangene Corp', u'Takeda San Francisco Inc', u'Roche Innovation Center Copenhagen A/S', u'Oxford BioMedica plc', u'ViaCell Inc', u'Boehringer Mannheim Corp', u'Baxter Healthcare Corp', u'Innova Biosciences Ltd', u'Shanghai Institute of Materia Medica of the Chinese Academy of Sciences', u'Academic Drug Discovery Consortium', u'XOMA Corp', u'University of California', u'Erasmus University Rotterdam', u'Queensland Genomics Health Alliance', u'CTC Bio Inc', u'Chugai Biopharmaceuticals Inc', u'National Eye Institute', u'rEVO Biologics Inc', u'Sanofi', u'The Salk Institute for Biological Studies', u'Chong Kun Dang Pharmaceutical Corp', u'Feinstein Institute for Medical Research', u'CORD:USE Cord Blood Bank', u'Bayer AG', u'Dalian University', u'Camurus AB', u'Phytera Inc', u'PharmaBrand SA', u'US Department of Veterans Affairs', u'Andong National University', u'Florida International University', u'BioSeek Plc', u'Nektar Therapeutics', u'International Business Machines Corp', u'Kaken Pharmaceutical Co Ltd', u'Intarcia Therapeutics Inc', u'Synthetic Biologics Inc', u'Bioton SA', u'Multiplicom N.V.', u'Pherin Pharmaceuticals Inc', u'Acambis plc', u'Boehringer Ingelheim Corp', u'Ypsomed Holding AG', u'Evolva Holding SA', u'Tularik Inc', u'Massachusetts Institute of Technology', u'Advanced Neuroscience Allies Pvt Ltd', u'Takeda Pharmaceuticals International GmbH', u'AgaMatrix Inc', u'Valens Pharma Ltd', u'Glycadia Inc', u'Motus Therapeutics Inc', u'Antaros Medical AB', u'Institute For Systems Biology', u'Glytech Inc', u'Juvenile Diabetes Research Foundation', u'Tel Hashomer - Medical Research Infrastructure & Services Ltd', u'Aurigene Discovery Technologies Ltd', u'Lipomics Technologies Inc', u'Welch Foundation', u'Bioagency AG', u'Ono Pharmaceutical Co Ltd', u'Beijing Xiehejianhao Medical Technology Development Co Ltd', u'Elan Corp plc', u'City of Hope', u'Shenzhen Meheco and Hefei Life Sciences Technology', u'Ligand Pharmaceuticals Inc', u'Regulus Therapeutics Inc', u'Novartis Korea Ltd', u'Bukwang Pharmaceutical Co Ltd', u'Columbia University Medical Center', u'NPS Allelix Corp', u'Celgene Corp', u'Changchun Institute Of Applied Chemistry Chinese Academy Of Sciences', u'Crescendo Pharmaceuticals Corp', u'Imperial College London', u'Arabian Gulf University', u'Transition Therapeutics Inc', u'Swedish Orphan Biovitrum AB', u'BioTie Therapies Corp', u'SemBioSys Genetics Inc', u'Janssen Pharmaceuticals Inc', u'RNL Bio Co Ltd', u'Glusense Ltd', u'Patheon Pharmaceuticals Inc', u'XL-Protein GmbH', u'University of Alberta', u'Beth Israel Deaconess Medical Center', u'UCL Business PLC', u'GD Searle & Co', u'NGM Biopharmaceuticals Inc', u'Tiziana Life Sciences PLC', u'Sugentech Inc', u\"Dr Reddy's Laboratories Ltd\", u'Perrigo Co Ltd', u'BioMarin Pharmaceutical Inc', u'European Foundation for the Study of Diabetes', u'Armenian Development Agency', u'Burgundy', u'Alizyme plc', u'Allos Therapeutics Inc', u'China State Institute of Pharmaceutical Industry', u'California Institute of Regenerative Medicine', u'Unigene Laboratories Inc', u'GlaxoSmithKline plc', u'vTv Therapeutics LLC', u'Ipsen', u'Radikal Therapeutics Inc', u'Marina Biotech Inc', u'Procter & Gamble Pharmaceuticals Inc', u'YOUAI', u'Novimmune SA', u'Particle Therapeutics Ltd', u'University of Michigan', u'Fibrocell Science Inc', u'Metdia Biotech SL', u'Stanford University', u'Curis Inc', u'Halozyme Therapeutics Inc', u'Yuyu Inc', u'Xcellsyz Ltd', u'Indosys Ltd', u'Sankyo Co Ltd', u'Boston University', u'National Heart Lung and Blood Institute', u'PSI Pharma Support Intl', u'Medpace Inc', u'Alnylam Pharmaceuticals Inc', u'Pharmaniaga Bhd', u'Antyra Inc', u'BioTherapeutics Inc', u'Bayer Healthcare LLC', u'Telesso Technologies Ltd', u'Wockhardt Ltd', u'Daiichi Sankyo Co Ltd', u'Abbott Laboratories', u'Hefei\\xa0Tianhui Incubator of Technologies Co Ltd', u'Eisai Co Ltd', u'3SBio Inc', u'BioRestorative Therapies Inc', u'National Cancer Institute', u'Novartis AG', u'Jiangsu Kanion Pharmaceutical Co Ltd', u'Encorium Group Inc', u'Ex scientia Ltd', u'Scottish Biomedical Ltd', u'AntriaBio Inc', u'RST Biomedikal Sanayi AS', u'Fujisawa Pharmaceutical Co Ltd', u'Keryx Biopharmaceuticals Inc', u'Osiris Therapeutics Inc', u'Juvenescence Limited', u'Flextronics International USA Inc', u'MEDIPAL HOLDINGS Corp', u'University of Minnesota', u'Kainos Medicine Inc', u'The Procter & Gamble Co', u'ALZA Corp', u'Amunix Inc', u'Poetic Genetics LLC', u'Piramal Enterprises Ltd', u'Luye Pharma Group Ltd', u'Nemaura Medical Inc', u'Freedom Meditech', u'PamGene International BV', u'NOBEL ILAC Sanayii ve Ticaret AS', u'McGill University', u'Bigfoot Biomedical', u'Iowa State University', u'Washington University in St Louis', u'The Principals MENA DMCC', u'CytRx Corp', u'Ferrer Internacional SA', u'Lupin Ltd', u'Myriad Genetics Inc', u'Neopharma', u'Liberty Medical LLC', u'Royalty Pharma', u'Chongqing University of Technology', u'JW Pharmaceutical Corp', u'The Diabetes Australia Research Trust', u'Evotec AG', u'Southern Medical University', u'Leosons General Trading Company', u'Andromeda Biotech Ltd', u'Mesoblast Ltd', u'Kerecis Ehf', u'Morvus Technology Ltd', u'Amarantus BioScience Holdings Inc', u'Shreya Life Sciences Pvt Ltd', u'iTherX Pharmaceuticals Inc', u'Republic of Korea Government', u'SangStat Medical Corp', u'Jeil Pharmaceutical Co Ltd', u'Alexza Pharmaceuticals Inc', u'Baxter Pharmaceutical Solutions LLC', u'Daewoong Pharmaceutical Co Ltd', u'Merck & Co Inc', u'Medtronic plc', u'Harmony Asset Ltd', u'University of Miami', u'Pall Corp', u'Queensland Government', u'Tianjin Leading Biotechnology', u'Housey Pharmaceutical Research Laboratories', u'ChemGenex Pharmaceuticals Ltd', u'X-Chem Inc', u'University of Virginia', u'Kyowa Hakko Kirin Co Ltd', u'Nankai University', u'Kissei Pharmaceutical Co Ltd', u'Janssen Biotech Inc', u'Texas Diabetes Institute', u'Epichem Pty Ltd', u'Pfizer Inc', u'Midatech Pharma PLC', u'Shenyang Pharmaceutical University', u'Dong Sung Pharmaceuticals Co Ltd', u'Human Genome Sciences Inc', u'Central Drug Research Institute', u'Mertiva AB', u'Sandoz Inc', u'Yissum Research Development Co', u'Columbia University', u'Hopital Universitaire de la Pitie Salpetriere', u'AusIndustry', u'LG Life Sciences Ltd', u'JCOM Ltd', u'Kinexus Theranostics', u'UniQuest Pty Ltd', u'National Institute of Allergy and Infectious Diseases', u'Biologix FZ Co', u'W L Gore & Associates Inc', u'Yamanouchi Pharmaceutical Co Ltd', u'National Institute on Minority Health and Health Disparities', u'ARTORG Center for Biomedical Engineering Research of the University of Bern', u'Centre Hospitalier Universitaire Vaudois', u'Phylogica Ltd', u'Albert Einstein College of Medicine', u'Heptares Therapeutics Ltd', u'Gachon University', u'National Institutes of Health', u'Innodia Inc', u'Commonwealth Scientific and Industrial Research Organization', u'Sanford-Burnham Medical Research Institute', u'Menarini Asia-Pacific', u'Scios Inc', u'Furiex Pharmaceuticals Inc', u'Vitae Pharmaceuticals Inc', u'Shanghai Shyndec Pharmaceutical Co Ltd', u'Thomas Jefferson University', u'Vietnam Academy of Science and Technology', u'ChemDiv Inc', u'4Cyte Therapeutics Inc', u'Proteonomix Inc', u'Verva Pharmaceuticals Ltd', u'ABP-Comercio', u'Jubilant Life Sciences Ltd', u'University of Guelph', u'PolyMASC Pharmaceuticals plc', u'Merck Serono SA', u'Celera Diagnostics', u'Takara Bio Inc', u'West China Hospital', u'China Resources Double-Crane Pharmaceutical Co Ltd', u'Phosphagenics Ltd', u'MannKind Corp', u'Jamaica BLU Ltd', u'Gedeon Richter Ltd', u'Debiotech', u'Korea-Israel Industrial R&D Foundation', u'Eternity Healthcare Inc', u'Technische Universitat Dresden', u'Bentley Pharmaceuticals Inc']), u'Pancreatitis': set([u'Picower Institute for Medical Research', u'Sun BioPharma Inc', u'Beijing Tide Pharmaceutical Co Ltd', u'University of Pennsylvania', u'EMD Serono Inc', u'National Institute of Diabetes, Digestive and Kidney Diseases', u'Torii Pharmaceutical Co Ltd', u'DevCo Pharmaceuticals Ltd', u'Sparta Pharmaceuticals Inc', u'Samsung Bioepis', u'Eisai Co Ltd', u'Forest Laboratories Inc', u'GlaxoSmithKline plc', u'Shanghai Pharmaceutical Group Corp', u'CMC Biologics Inc', u'Astra Merck Inc', u'PPL Therapeutics plc', u'National Institutes of Health', u'Flinders University of South Australia', u'Ipsen', u'University of California', u'CytoSorbents Corp', u'Ishihara Sangyo Kaisha Ltd', u'Taiho Pharmaceutical Co Ltd', u'Zeria Pharmaceutical Co Ltd', u'Tanabe Seiyaku Co Ltd', u'Cedars-Sinai Medical Center', u'Vernalis plc', u'LTT Bio-Pharma Co Ltd', u'Oklahoma Medical Research Foundation', u'Sumitomo Pharmaceuticals Co Ltd', u'Cypralis Ltd', u'Medical University of South Carolina', u'Cytokine PharmaSciences Inc', u'Windtree Therapeutics Inc', u'CalciMedica Inc', u'Dong-A ST Co Ltd', u'Nordmark Arzneimittel GmbH & Co KG', u'Meditrade Ltd', u'The University of Liverpool', u'University of Edinburgh', u'Medial Ltd', u'AstraZeneca plc', u'Technology Strategy Board', u'Health Care Logistics Inc', u'Boehringer Ingelheim Corp', u'Aptalis Pharma Inc', u'Takeda Pharmaceutical Co Ltd', u'Xenome Ltd', u'Solvay Seiyaku KK', u'Rottapharm Madaus', u'Swedish Orphan Biovitrum AB']), u'Hypercholesterolemia': set([u'Clinical Data Inc', u\"Dr Reddy's Laboratories Ltd\", u'Yamanouchi Pharmaceutical Co Ltd', u'US Government', u'Regeneron Pharmaceuticals Inc', u'QUATRx Pharmaceuticals Co', u'Merck Sharp & Dohme (Australia) Pty Ltd', u'Wyeth AG', u'Kowa Pharmaceuticals America Inc', u'SciGenics Inc', u'Amsterdam Molecular Therapeutics BV', u'GlaxoSmithKline plc', u'BTG plc', u'Ionis Pharmaceuticals Inc', u'Aventis Pharma AG', u'Takeda Pharmaceuticals North America Inc', u'Zydus-Cadila Group', u'Par Pharmaceutical Co Inc', u'Samaritan Pharmaceuticals Inc', u'Celldex Therapeutics Inc', u'University of Pennsylvania', u'Mitsubishi-Tokyo Pharmaceuticals Inc', u'Ono Pharmaceutical Co Ltd', u'Phaedrus Pharmaceuticals Inc', u'Nissan Chemical Industries Ltd', u'Mitsubishi Tanabe Pharma Corp', u'University of Wisconsin-Madison', u'Orphagen Pharmaceuticals Inc', u'Kastle Therapeutics', u'Scigenic & Scigen Harvest Co Ltd', u'Medicure Inc', u'Shionogi & Co Ltd', u'AstraZeneca plc', u'National Heart Lung and Blood Institute', u'Duke Clinical Research Institute', u'Alnylam Pharmaceuticals Inc', u'Reliant Pharmaceuticals Inc', u'CiVi Biopharma Inc', u'Klinge Pharma GmbH', u'Inex Pharmaceuticals Corp', u'Nutrilinea Ltd', u'Amgen Inc', u'Mylan Inc', u'Karo Pharma AB', u'Cortria Corp', u'Daiichi Sankyo Co Ltd', u'Abbott Laboratories', u'Glenmark Pharmaceuticals Ltd', u'OptiBiotix Health plc', u'Novartis AG', u'Merck KGaA', u'Pharmabiota NZ Ltd', u'DAE HWA Pharm Co Ltd', u'Kos Pharmaceuticals Inc', u'Korea Research Institute of Bioscience and Biotechnology', u'Georgetown University', u'University of Alabama at Birmingham', u'Hanmi Pharmaceutical Co Ltd', u'Pharmena Sp zoo', u'Kowa Co Ltd', u'UCB Pharma GmbH', u'Arbutus Biopharma Corp', u'Cholestech Corp', u'Sunovion Pharmaceuticals Canada Inc', u'Symphony GenIsis', u'Ethypharm SA', u'American College of Cardiology', u'Lupin Ltd', u'Innovative Pharma Developments Ltd', u'Planet Biotechnology Inc', u'Long-E International', u'Recordati SpA', u'Ranbaxy Laboratories Ltd', u'F Hoffmann-La Roche AG', u'ILEX Oncology Inc', u'University of California', u'Progenra Inc', u'Andrx Corp', u'IDIS Ltd', u'National Institute of Diabetes, Digestive and Kidney Diseases', u'Circ Pharma Ltd', u'Schering-Plough Corp', u'Bayer Yakuhin Ltd', u'X-Ceptor Therapeutics Inc', u'Shionogi Pharma Inc', u'Neopharma', u'Capstone Therapeutics Corp', u'Daewoong Pharmaceutical Co Ltd', u'Merck & Co Inc', u'AmorChem LP', u'Sanofi', u'Chong Kun Dang Pharmaceutical Corp', u'HLH BioPharma Vertriebs GmbH', u'Eli Lilly & Co', u'IntelGenx Technologies Corp', u'Pierre Fabre SA', u'Barr Pharmaceuticals Inc', u'Univalor', u'Genovo Inc', u'Almirall Prodesfarma SA', u'Aptalis Pharma Inc', u'Pfizer Inc', u'Satiogen Pharmaceuticals Inc', u'Bioton SA', u'University of Texas Southwestern Medical Center', u'Sandoz Inc', u'Merck Sharp & Dohme Ltd', u'Sankyo Co Ltd', u'Wyeth BioPharma', u'Tularik Inc', u'Laboratorios Farmaceuticos Rovi SA', u'Viking Therapeutics Inc', u'OSI Pharmaceuticals Inc', u'Portola Pharmaceuticals Inc', u'Amylin Pharmaceuticals Inc', u'LipimetiX LLC', u'Ligand Pharmaceuticals Inc', u'Alfa Wassermann SpA', u'Abeome Corp', u'Athpharma Ltd', u'Bayer AG', u'National Institutes of Health', u'Sumitomo Pharmaceuticals Co Ltd', u'Bristol-Myers Squibb Co', u'The Medicines Company', u'West Pharmaceutical Services Inc', u'Sanofi Genzyme', u'MSD Japan', u'MGI Pharma Inc', u'Roche Holding AG', u'Bristol-Myers Squibb Pharma Co', u'Biovail Corp', u'Duke University', u'EndoChem Inc', u'Merck Serono SA', u'Par Pharmaceutical Inc', u'Srx Cardio Llc', u'Biovail Laboratories International Srl', u'BiOLAB Farmaceutica', u'Aegerion Pharmaceuticals Inc']), u'Latentautoimmuneadultdiabetes': set([u'Emergent BioSolutions Inc', u'Janssen Pharmaceuticals Inc', u'US Government', u'Mertiva AB', u'Swedish Orphan Biovitrum AB']), u'Aging': set([u'Phosphagenics Ltd', u'BioSenex', u'Sens Foundation Inc', u'US Government', u'Harvard University', u'New York University', u'Synteni Inc', u'Genstruct Inc', u'Tartis Inc', u'Ecole Polytechnique Federale de Lausanne', u'Insilico Medicine Inc', u'Yuyu Inc', u'Aelan Cell Technologies Inc', u'Delos Pharmaceuticals Inc', u'Roswell Park Cancer Institute', u'Eisai Co Ltd', u'Geron Corp', u'Buck Institute', u'Calico Life Sciences LLC', u'DanioLabs Ltd', u'Sirtris Pharmaceuticals Inc', u'ProGeLife', u'Kissei Pharmaceutical Co Ltd', u'TES Pharma Srl', u'Nuclea Biotechnologies LLC', u'National Cancer Institute', u'Novartis AG', u'Cyntellect Inc', u'National Institutes of Health', u'Intas Pharmaceuticals Ltd', u'University of California', u'Recursion Pharmaceuticals LLC', u'Curis Inc', u'INSERM', u'Jackson Laboratory', u'Juvenescence Limited', u'Chiroscience R&D Inc', u'ArQule Inc', u'Pharma Cosmetics Laboratories Ltd', u'Proteostasis Therapeutics Inc', u'Science to Consumers Inc', u'Ligand Pharmaceuticals Inc', u'Unity Biotechnology', u'Sumitomo Pharmaceuticals Co Ltd', u'PhotoMedex Inc', u'Valeant Pharmaceuticals International Inc', u'Universidad de Oviedo', u'University of Hawaii', u'QB3', u'Biomatrix Inc', u'Wistar Institute of Anatomy & Biology', u'Elysium Health Inc', u'Theratechnologies Inc', u'PureTech Health Plc', u'C4 Therapeutics Inc', u'AEterna Zentaris Inc', u'Brain Canada', u'Cardax Inc', u'Allergan Inc', u'Ascentage Pharma Group Corporation Ltd', u'Windtree Therapeutics Inc', u'Boston University', u'National Institute on Aging', u'Eukarion Inc', u'PhoreMost Ltd', u'Biotica Technology Ltd', u'Ichor Therapeutics', u'Dassault Syst\\xe8mes', u'Sanofi', u'Centre for Addiction and Mental Health', u'Senexis Ltd', u'Spear Pharmaceuticals Inc', u'Senex Biotechnology Inc', u'Broad Institute Inc']), u'Lunginjury': set([u'CollaGenex Pharmaceuticals Inc', u'Therabron Therapeutics Inc', u'King Pharmaceuticals Inc', u'Undisclosed', u'Baxter International Inc', u'EMD Pharmaceuticals Inc', u'Aerpio Therapeutics Inc', u'Savara Inc', u'Advanced Life Sciences Holdings Inc', u'InterMune Inc', u'Royal College of Surgeons in Ireland', u'Albany Molecular Research Inc', u'National Institute of Allergy and Infectious Diseases', u'National Jewish Health', u'Laboratorios Dr Esteve SA', u'Aeolus Pharmaceuticals Inc', u'Oklahoma Medical Research Foundation', u'GlaxoSmithKline plc', u'Windtree Therapeutics Inc', u'Medial Ltd', u'Parion Sciences Inc', u'National Institutes of Health', u'US Government', u'Cellectar Biosciences Inc', u'National Institute of Dental and Craniofacial Research', u'CytoSorbents Corp', u'Aerogen Inc', u'Alpha-1 Foundation', u'Massachusetts General Hospital', u'University of California San Francisco', u'BCN Biosciences LLC', u'Medical College of Georgia', u'Eli Lilly & Co', u'University of Pennsylvania', u'Dr Rentschler Biotechnologie GmbH', u'National Cancer Institute', u'US Army Medical Research Acquisition Activity', u'Ono Pharmaceutical Co Ltd', u'University of Rochester', u'Johnson Matthey Pharma Services', u'Merck Sante SA', u'Symbion Research International', u'Duke University', u'Scripps Research Institute', u'Serendex Pharmaceuticals A/S', u'Dong-A ST Co Ltd', u'Merck Serono SA', u'University of Colorado System', u'Faron Pharmaceuticals Ltd', u'Meditrade Ltd', u'Temple University', u'LG Chem Ltd', u'Apeptico Forschung und Entwicklung GmbH', u'Encysive Pharmaceuticals Inc', u'Revotar Biopharmaceuticals AG', u'National Heart Lung and Blood Institute', u'US Department of Defense', u'Yale University', u'CompleGen Inc', u'Alnylam Pharmaceuticals Inc', u'Swedish Orphan Biovitrum AB', u'University of Maryland', u'University of Pittsburgh', u'National Institute of General Medical Sciences']), u'Metastaticheadandneckcancer': set([u'The University of Birmingham', u'Silence Therapeutics plc', u'Merck & Co Inc', u'Amgen Inc', u'PDS Biotechnology Corp']), u'Spinabifida': set([u'Avion Pharmaceuticals LLC', u'Gnosis Srl']), u'Pancreaticcystadenocarcinoma': set([u'Bristol-Myers Squibb Co', u'Celgene Corp']), u'Sleepdisorder': set([u'Evotec AG', u'Merckle GmbH', u'Novo Nordisk A/S', u'Medidata Solutions Worldwide', u'Sakai Chemical Industry Co Ltd', u'Pharsight Corp', u'Daewoong Pharmaceutical Co Ltd', u'Neurim Pharmaceuticals', u'Mitsubishi Pharma Corp', u'Phase 2 Discovery Inc', u'RespireRx Pharmaceuticals Inc', u'iCAN:Israel-Cannabis', u'Armstrong Laboratories Inc', u'National Institute of Diabetes, Digestive and Kidney Diseases', u'Intra-Cellular Therapies Inc', u'Glenmark Pharmaceuticals Ltd', u'Eisai Co Ltd', u'SRI International', u'GlaxoSmithKline plc', u'Strong Dental', u'H Lundbeck A/S', u'Aspen PharmaCare Australia Pty Ltd', u'National Institutes of Health', u'TheraSci Ltd', u'Camino Products LLC', u'Exeltis USA Inc', u'AfaSci Inc', u'Merck & Co Inc', u'Myungin Pharm Co Ltd', u'Bristol-Myers Squibb Co', u'Scios Inc', u'Siegfried Holding Ltd', u'POZEN Inc', u'Tanabe Seiyaku Co Ltd', u'Vanda Pharmaceuticals Inc', u'Eli Lilly & Co', u'Addex Therapeutics Ltd', u'Cephalon Inc', u'Smart Science Laboratories Inc', u'University of Chicago', u'Tikvah Therapeutics Inc', u'CannRx Technology', u'Laboratoire L Lafon SA', u'Roche Holding AG', u'ALZA Corp', u'CeNeS Pharmaceuticals plc', u'Nobelpharma Co Ltd', u'Pennsylvania State University', u'INSERM', u'Cognition Life Science Inc', u'Earlysense Ltd', u'Jazz Pharmaceuticals plc', u'Theratechnologies Inc', u'Wake Forest University', u'Alfresa Pharma Corp', u'Novartis AG', u'Laboratoires Biocodex', u'Kuhnil Pharmaceutical Co Ltd', u'University of Kentucky', u'Dompe SpA', u'Delivra Corp', u'Neuralstem Inc', u'Sunovion Pharmaceuticals Inc', u'Patheon Pharmaceuticals Inc', u'Ferrer Internacional SA', u'Max-Planck-Gesellschaft', u'BioProjet, Societe Civile de Recherche', u'Defense Advanced Research Projects Agency', u'SomnoMed', u'University of California Los Angeles', u'SleepMed Inc', u'Dosecann Inc', u'Taiwan Biotech Co Ltd', u'Rhone-Poulenc Rorer Inc', u'Undisclosed', u'Somnology Inc', u'Cepa Schwarz Pharma Sl', u'Global Quest Ltd', u'German Federal Ministry of Education and Research', u'Lexicon Pharmaceuticals Inc', u'Broad Institute Inc', u'National Heart Lung and Blood Institute']), u'Angiosarcoma': set([u'National Comprehensive Cancer Network', u'Pfizer Inc', u'National Institutes of Health', u'Harvard Medical School', u'GlobalCures', u'University of North Carolina']), u'Henipavirusinfection': set([u'University of Washington', u'University of Texas Medical Branch at Galveston', u'National Cancer Institute', u'Kineta Inc', u'National Institute of Allergy and Infectious Diseases', u'Weill Medical College of Cornell University']), u'Coronaryatherosclerosis': set([u'US Government', u'Novartis AG', u'University of Texas Health Science Center Houston', u'National Heart Lung and Blood Institute', u'InNexus Biotechnology Inc', u'Reliant Pharmaceuticals Inc']), u'Plannedabortion': set([u'Exelgyn Laboratories', u'Northeast Pharmaceutical Group Co Ltd', u'Femagen', u'Population Council', u'Danco Laboratories LLC', u'Linepharma International Ltd', u'Contragest GmbH', u'Chinese Government', u'Celopharma Inc', u'Marie Stopes International', u'Aventis Pharma AG']), u'Parturition': set([u'Biopasgroup', u'BTG plc', u'Hyundai Pharmaceutical', u'University of Texas Medical Branch at Galveston', u'RW Johnson Pharmaceutical Research Institute', u'BMP Sunstone Corp', u'Hyphens Pharma Pte Ltd', u'Cytokine PharmaSciences Inc', u'Ferring Pharmaceuticals SA', u'AMAG Pharmaceuticals Inc', u'Roussel Laboratories Ltd', u'F H Faulding & Co Ltd', u'Xanodyne Pharmaceuticals Inc', u'Forest Laboratories Inc', u'Teikoku Hormone Manufacturing Co Ltd', u'Ferring Controlled Therapeutics Ltd']), u'Parkinsonsdis': set([u'Genentech Inc', u'Microbot Medical Inc']), u'Ocularsurgicalprocedure': set([u'Imprimis Pharmaceuticals Inc', u'Vance Thompson Vision', u'Esteve', u'Ferrer Internacional SA', u'VSY Biotechnology', u'Undisclosed']), u'Wolframsyndrome': set([u'Jack and J.T. Snow Scientific Research Foundation', u'University of Massachusetts Medical School', u'Washington University in St Louis', u'Amarantus BioScience Holdings Inc']), u'Astrovirusinfection': set([u'AB ANALITICA', u'Mobidiag Oy']), u'Healing': set([u'Delivra Corp', u'SMG Pharmaceuticals Inc', u'EPI Health LLC', u'National Institutes of Health', u'Cimphoni Life Sciences LLC', u'Spike Marks Inc', u'Kalytera Therapeutics Inc', u'Medical College of Wisconsin', u'University of Toronto', u'Evolva Holding SA', u'Agenta Biotechnologies Inc']), u'Takayasusarteritis': set([u'Celltrion Inc', u'Bristol-Myers Squibb Co']), u'Sexualdeviation': set([u'Pfizer Inc', u'Debiopharm SA', u'Ipsen', u'Green Cross Corp']), u'Parkinsonsdisease': set([u'Gismo Therapeutics Inc', u'Solvay SA', u'Scil Technology GmbH', u'DarPharma Inc', u'Foundation for Mitochondrial Medicine', u\"People's Government of Guangdong Province\", u\"Hospital Vall D'Hebron\", u'Envoy Therapeutics Inc', u'Amsterdam Molecular Therapeutics BV', u'Buck Institute', u'University of Alabama', u'Warner-Lambert Co', u'Centaur Pharmaceuticals Inc', u'IBM Watson Health Life Sciences', u'Cure Medical Manufacturing', u'MethylGene Inc', u'Case Western Reserve University', u'Ionis Pharmaceuticals Inc', u'Trophos SA', u'University of Florida', u'University of Prince Edward Island', u'European Community', u'MonoSol Rx Inc', u'Pharmaceutical Product Development LLC', u'Spanish National Research Council', u'University of Pittsburgh', u'Sigma-Aldrich Corp', u'IMPAX Laboratories Inc', u'ProNeura Inc', u'Parkinsons Disease Society', u'CeNeS Pharmaceuticals plc', u'Recipharm AB', u'Intec Pharma Ltd', u'Max Planck Institute for Molecular Biomedicine', u'Bar-Ilan University', u'Handok Inc', u'Koebenhavns Universitet', u'Banner Sun Health Research Institute', u'NeuroSpheres Ltd', u'Catalent Inc', u'North Carolina Biotechnology Center', u'R J Reynolds Tobacco Co', u'Tanabe Seiyaku Co Ltd', u'NeuroSearch A/S', u'Alseres Pharmaceuticals Inc', u'Capo Therapeutics Inc', u'Collaborative Medicinal Development Llc', u'23andMe Inc', u'Polichem SA', u'University of Cincinnati', u'MGI GP Inc', u'Q Therapeutics Inc', u'Biotie Therapies AG', u'Israeli Government', u'Centre National de la Recherche Scientifique (CNRS)', u'McLean Hospital Corp', u'Medimmune Vaccines Inc', u'Xtrexa Bio Inc', u'Melior Pharmaceuticals Inc', u'Prana Biotechnology Ltd', u'Deutsche Parkinson Vereinigung e.V', u'Devgen NV', u'Mount Sinai School of Medicine', u'Cantab Biopharmaceuticals Ltd', u'Siemens Medical Systems Inc', u'Istituto Scientifico H San Raffaele', u'Sernova Corp', u'Siegfried Holding Ltd', u'Ogeda SA', u'University of Windsor', u'Gladstone Institute of Neurological Disease', u'Newron Pharmaceuticals SpA', u'Pharmacopeia Inc', u'RaQualia Pharma Inc', u'Ceregene Inc', u'Titan Pharmaceuticals Inc', u'QR Pharma Inc', u'Biodesy Inc', u'RayBiotech Inc', u'Pharmacia & Upjohn AB', u'Cortice Biosciences Inc', u'Genfit SA', u'Rutgers University', u'Swedish Orphan Biovitrum AB', u'Medtronic Inc', u'Prous Institute For Biomedical Research Sa', u'Cigalah', u'The Bronx Project Inc', u'M3 Biotechnology Inc', u'MD Biosciences GmbH', u'Lysosomal Therapeutics Inc', u'RheoGene Inc', u'Harbor Therapeutics Inc', u'Progenra Inc', u'uMotif', u'Juvantia Pharma Ltd', u'NeuroNascent Inc', u'Undisclosed', u'University of Colorado System', u'Varinel Inc', u'LamdaGen Llc', u'DNage BV', u'University of Wisconsin-Madison', u'reMYND NV', u'University of Victoria', u'Weizmann Institute of Science', u'AC Immune SA', u'NsGene A/S', u'Horizon Orphan LLC', u'Argenta Discovery Ltd', u'University of California Los Angeles', u'CeNeS Pharmaceuticals Inc', u'NeuroNova AB', u'National Institute on Aging', u'Asubio Pharma Co Ltd', u'Universit\\xe9 De Strasbourg', u'Universitat Autonoma de Barcelona', u'KRS Global Biotechnology Inc', u'University of Maryland', u'SIBIA Neurosciences Inc', u'Center for Applied Medical Research', u'Eboo Pharmaceuticals Inc', u'Alkermes plc', u'Saniona ApS', u\"The Parkinson's Institute and Clinical Center\", u'Helsinki University', u'AbbVie Inc', u'Synaging', u'University of Washington', u'BrainLAB Inc', u'University of Toulouse', u'SmithKline Beecham plc', u'Snowdon Inc', u'NeuroGeneration Inc', u'BL&H Co Ltd', u'NeuroDerm Ltd', u'Northwestern University', u'Servier', u'Pfizer Inc (Philippines)', u'Anavex Life Sciences Corp', u'iPS Academia Japan Inc', u'Bristol-Myers Squibb Co', u'University of Rochester', u'NeuroTransit Inc', u'Recordati SpA', u'VINNOVA', u'University of Auckland', u'MAP Medical Technologies Oy', u'BlueRock Therapeutics', u'Tabuk Pharmaceutical Manufacturing Co', u'Chungnam National University', u'Growblox Sciences Inc', u'Metaphore Pharmaceuticals Inc', u'Pacific Northwest National Laboratory', u'Hebrew University of Jerusalem', u'Depomed Inc', u'The Australian National University', u'Power3 Medical Products Inc', u'BIAL Group', u'StemCell Technologies', u'Kaldi Pharma SAS', u'University of Cambridge', u\"King's College London\", u'Karolinska Institutet', u'Weill Medical College of Cornell University', u'Global Kinetics Corp Pty Ltd', u'Regeneron Pharmaceuticals Inc', u'Herantis Pharma Plc', u\"Alzheimer's Drug Discovery Foundation\", u'SurModics Inc', u'Knoll Pharmaceuticals Co', u'Hypgen Inc', u'Boehringer Ingelheim GmbH', u'Araclon Biotech Sl', u'Orion Corporation', u'Reckitt & Colman plc', u'NeurAxon Inc', u'KineMed Inc', u'BTG plc', u'Centelion SAS', u'University of Bonn', u'Edward Via Virginia College Of Osteopathic Medicine', u'Chiesi Farmaceutici SpA', u'DRAXIS Health Inc', u'Neose Technologies Inc', u'Giner Inc', u'University Of Macau', u'Arizona State University', u'NewBridge Pharmaceuticals Ltd', u'University of York', u'BioCrossroads', u'ArQule Inc', u'Genentech Inc', u'Microbot Medical Inc', u'Domain Therapeutics SA', u'Opsona Therapeutics Ltd', u'Sangamo Therapeutics Inc', u'University of California San Diego School of Medicine', u'Navidea Biopharmaceuticals Inc', u'Amicus Therapeutics Inc', u'Shionogi & Co Ltd', u'Ono Pharmaceutical Co Ltd', u'Garvan Institute of Medical Research', u'Sanochemia Pharmazeutika AG', u'Roche Holding AG', u'Procypra Therapeutics LLC', u'Shire plc', u'University of British Columbia', u'Panaxia Pharmaceutical Industries Ltd', u'The National Institute of Mental Health', u'Jinan University (Guangdong)', u'Sellas Life Sciences Group', u'Symphony Neuro Development Co', u'Virginia Commonwealth University', u'Asceneuron SA', u'Sanofi Genzyme', u'Dialean Ltd', u'Elan Pharmaceuticals Inc', u'Medivators Inc', u'Neurologix Inc', u'Accenture', u'Orient Europharma', u'Avid Radiopharmaceuticals Inc', u'Charite Universitaetsmedizin Berlin', u'University of Massachusetts Medical School', u'Brain Canada', u'Evotec AG', u'Universidad Complutense de Madrid', u'Meiji Seika Pharma Co Ltd', u'The Jenner Institute', u'Charles River Laboratories International Inc', u'Vivia Biotech SL', u'Diaxonhit', u'Amgen Inc', u'Endo Health Solutions Inc', u'Endo Pharmaceuticals Solutions Inc', u'Numerate Inc', u'Geron Corp', u'Takata Seiyaku', u'Institute for Neurodegenerative Disorders', u'Consejo Superior De Investigaciones Cientificas', u'Assistance Publique Hopitaux de Paris', u'FUJIFILM RI Pharma Co', u'ACADIA Pharmaceuticals Inc', u'Pfizer Global Research & Development', u'Georgetown University', u'SkyePharma plc', u'University of Alabama at Birmingham', u'CleveXel Pharma', u'Massachusetts General Hospital', u'Medical Research Council', u'Imago Pharmaceuticals Inc', u'Garnet BioTherapeutics Inc', u'GenPharm International Inc', u'Actelion Pharmaceuticals Ltd', u'Scarista Ltd', u'Perrigo Co plc', u'BioVex Inc', u'Cleveland Clinic Foundation', u'Allon Therapeutics Inc', u'Pennsylvania State University', u'XCell Science Inc', u'Allergan Inc', u'Southern Research Institute', u'Actavis Inc', u'Florida A & M University', u'National Research Council of Canada', u'National Human Genome Research Institute', u'University of California San Diego', u'Seelos Therapeutics Inc', u'Stemedica Cell Technologies Inc', u'Denali Therapeutics Inc', u'University of Oxford', u'Green Cross Corp', u'IsoTis SA', u'Mind-NRG', u'Cognetix Inc', u'Mitsubishi Pharma Corp', u'Mayo Clinic Foundation', u'Natural Sciences and Engineering Research Council of Canada', u'Intra-Cellular Therapies Inc', u'National Health and Medical Research Council', u'St Andrews University', u'LifeArc', u'Epitomics Inc', u'DiamiR LLC', u'Sumitomo Dainippon Pharma Co Ltd', u'Scripps Research Institute', u\"Parkinson's Disease Foundation\", u'Molecular Insight Pharmaceuticals Inc', u'Universidad Nacional De Tucum\\xe1n', u'University of Texas Southwestern Medical Center', u'BioFocus DPI', u'Teikoku Seiyaku KK', u'The Michael J. Fox Foundation', u'CARBOGEN AMCIS AG', u'Proximagen Group plc', u'Pierre Fabre SA', u\"The Cure Parkinson's Trust\", u'Dermaxon', u'Athersys Inc', u'Kangwon National University', u'Harvard NeuroDiscovery Center', u'FORUM Pharmaceuticals Inc', u'ProteoTech Inc', u'MDS Nordion', u'Emulate Inc', u'ReNeuron Group plc', u'AstraZeneca plc', u'Technology Strategy Board', u'University of Southern California', u'UK Department of Trade & Industry', u'Cognition Therapeutics Inc', u'Tel Aviv University', u'FoldRx Pharmaceuticals Inc', u'Scotia Holdings plc', u'Nattermann & Cie GmbH', u'Mitoconix Bio Ltd', u'Harvard University', u'Australian Government', u'QRxPharma Ltd', u'The European Union', u'Oasis Diagnostics Corp', u'Mylan Pharmaceuticals Inc', u'Yale School of Medicine', u'Pharmos Corp', u'Institute of Materia Medica Chinese Academy of Medical Sciences & Peking Union Medical College', u'Ligand Pharmaceuticals Inc', u'Altea Therapeutics', u'IDT Australia Ltd', u'Fundacao de Amparo a Pesquisa do Estado Sao Paulo', u'Molecular Neuroimaging LLC', u'Advanced Accelerator Applications SA', u'New Jersey Health Foundation Inc', u'STATegics Inc', u'Samil Pharmaceutical Co Ltd', u'Proclara Biosciences', u'PharmatrophiX', u'MeiraGTx', u'Kyoto University', u'Lawrence Berkeley Laboratory', u'ProterixBio', u'PacificGMP', u'Bristol-Myers Squibb Pharma Co', u'Valeant Pharmaceuticals International Inc', u'Toronto Western Hospital', u'IXICO Plc', u'Hospira Adelaide Pty Ltd', u'NuPathe Inc', u'Intel Corp', u'GE Healthcare', u'Walloon Region of Belgium Government', u'PNO Resources Ltd', u'Avigen Inc', u\"Brigham & Women's Hospital\", u'Takeda Pharmaceutical Co Ltd', u'ProteoSys AG', u'Aleva Neurotherapeutics Sa', u'PsychoGenics Inc', u'Aventis Pharma SA', u'Brain and Mind Research Institute', u'Takeda GmbH', u'Orphan Europe SARL', u'Mount Cook BioSciences', u'Cardinal Health Inc', u'Centre for Drug Research and Development', u'Digital Gene Technologies Inc', u'VIB', u'MISSION Therapeutics Ltd', u'Aeolus Pharmaceuticals Inc', u'Oryzon Genomics SA', u'Forest Laboratories Inc', u'Korea Research Institute of Chemical Technology', u'University of Ulsan', u'IASON GmbH', u'University of Queensland', u'Royal Melbourne Hospital', u'Hermo Pharma Oy Ltd', u'Aventis Pharma AG', u'Vanderbilt University', u'SynAgile Corp', u'Revaax Pharmaceuticals LLC', u'OSI Pharmaceuticals Inc', u'Medisyn Technologies Inc', u'nLife Therapeutics SL', u'Inhibikase Therapeutics Inc', u'Oncodesign Biotechnology SA', u'Auritec Pharmaceuticals Inc', u'University of Kentucky', u'Ralexar Therapeutics Inc', u'National Center for Research Resources', u'Keio University', u'Sanford-Burnham Medical Research Institute', u'Vertex Pharmaceuticals Inc', u'Prothena Corp plc', u'Omeros Corp', u'Ottawa Hospital Research Institute', u'University of Nebraska Medical Center', u'Annovis Inc', u'TFS AB', u'Neurodyn Inc', u'UCB Pharma GmbH', u'Mylan Inc', u'Adagio Pharmaceuticals Ltd', u'Yabao Pharmaceutical Group Co Ltd', u'Blackfynn', u'Genomics Institute of the Novartis Research Foundation', u'InterMed Discovery GmbH', u'Califia Bio Inc', u'Boehringer Mannheim GmbH', u'Prestwick Pharmaceuticals Inc', u'Center for Innovative Tech', u'CNS Therapeutics Inc', u'Hadassah Medical Organization', u'Ntz Lab Ltd', u'Teva Pharmaceutical Industries Ltd', u'Valeo Pharma Inc', u'Catholic University of Leuven', u'University of California San Francisco', u'Signum Biosciences Inc', u'CryoPort Inc', u'Lohmann Therapie-Systeme GmbH & Co KG', u'OPKO Health Inc', u'Cell Genesys Inc', u'Eisai China Inc', u'Plex Pharmaceuticals', u'University of Ottawa', u'Elegene AG', u'Boehringer Ingelheim Corp', u'Hoffmann-La Roche Inc', u'Britannia Pharmaceuticals Ltd', u'Seqirus', u'University of Melbourne', u'Universite Laval', u'Carmot Therapeutics Inc', u'Henri Mondor Hospital', u'Weston Brain Institute', u'University of Lund', u'Integrative Research Laboratories Sweden AB', u'Duke University Medical Center', u'University of Sheffield', u'Wyeth Pharmaceuticals', u'Neurolixis Inc', u'Harvard Medical School', u'Biogen Inc (FL)', u'National Institute on Deafness and Other Communication Disorders', u'National Institute of Diabetes, Digestive and Kidney Diseases', u'Zyentia Ltd', u'MediGene Inc', u'The Austrian Research Promotion Agency FFG', u'Sirtris Pharmaceuticals Inc', u'Oxford BioMedica plc', u'Mindset BioPharmaceuticals (USA) Inc', u'The Knut and Alice Wallenberg Foundation', u'Kaleidos Pharma Inc', u'NeoCytex Biopharma Inc', u'University of California', u'Merck & Co Inc', u'Santhera Pharmaceuticals AG', u'Sanofi', u'The Salk Institute for Biological Studies', u'Alectos Therapeutics Inc', u'Columbia University', u'Auspex Pharmaceuticals Inc', u'Bayer AG', u'Capha Pharmaceuticals Inc', u'BBB Therapeutics BV', u'GeneCode Ltd', u'LobSor Pharmaceuticals AB', u'Proven Process Medical Devices Inc', u'Mount Tam Biotechnologies', u'SpeechVive Inc', u'Almirall Prodesfarma SA', u'Imanova Ltd', u'Neurocrine Biosciences Inc', u'International Business Machines Corp', u'Shijiazhuang Yiling Pharmaceutical Co Ltd', u'Zymes Inc', u'Northwest A&F University', u'Copernicus Therapeutics Inc', u'International Stem Cell Corp', u'Vernalis plc', u'Purdue University', u'Massachusetts Institute of Technology', u'University of Texas Austin', u'Institute for Research in Biomedicine Barcelona', u'Serina Therapeutics Inc', u'Universidad de Antioquia', u'University of Pennsylvania', u'Rexahn Pharmaceuticals Inc', u'Amarin Corp plc', u'Loyola Medical School', u'CANTABio Pharmaceuticals Inc', u'Max-Planck-Gesellschaft', u'University of Oregon', u'Elan Corp plc', u'A2M Pharma GmbH', u'Organix Inc', u'Voyager Therapeutics', u'Medical College of Georgia', u'Malin Corp plc', u'MGI Pharma Inc', u'Cephalon Inc', u'Celgene Corp', u'National Authority for Technological Innovation', u'Imperial College London', u'Catalytica Inc', u'Biovail Corp', u'Whitehead Institute for Biomedical Research', u'KeyNeurotek Pharmaceuticals AG', u'Duke University', u'Avanir Pharmaceuticals Inc', u'US WorldMeds LLC', u'University of Leeds', u'BioSolveIT Gmbh', u'Azur Pharma Ltd', u'Ester Neurosciences Ltd', u'ArmaGen Technologies Inc', u'Rhone-Poulenc Rorer Inc', u'Io Therapeutics Inc', u'Shin Nippon Biomedical Laboratories Ltd', u'Daiichi Seiyaku Co Ltd', u'University of Medicine and Dentistry of New Jersey', u'US Government', u'Korea Institute of Science and Technology', u'Ludwig-Maximilians University of Munich', u'Ecole Polytechnique Federale de Lausanne', u'Entia Biosciences Inc', u'Zenobia Therapeutics Inc', u'Acorda Therapeutics Inc', u'GenVec Inc', u'California Institute of Regenerative Medicine', u'Biogen Inc', u'Heriot-Watt University', u'GlaxoSmithKline plc', u\"Ataxia Telangiectasia Children's Project Inc\", u'Berg Pharma LLC', u'Bayer Schering Pharma AG', u'Cyto Therapeutics Pty Ltd', u'Rainbow BioScience LLC', u'Neuroscience Research Australia', u'Ipsen', u'Queensland Government', u'Renovis Inc', u'Max-Planck-Institut f\\xfcr Biophysikalische Chemie', u'Protein Production Services Ltd', u'University of Michigan', u'Axon Biochemicals BV', u'Fibrocell Science Inc', u'University of Texas Health Science Center Houston', u'NRC Research Institute', u'Stanford University', u'Lawson Health Research Institute', u'Abbott Healthcare Products BV', u'Nortis Inc', u'BrainStorm Cell Therapeutics Inc', u'SIRENADE Pharmaceuticals AG', u'Neurogen Corp', u'Neurotech Pharmaceuticals Inc', u'Intellect Neurosciences Inc', u'Aderis Pharmaceuticals Inc', u'Philipps-Universitat Marburg', u'Encefa', u'PhoreMost Ltd', u'Emory University', u'Ariana Pharmaceuticals', u'Biomas Inc', u'Nanyang Technological University', u'Institut du Cerveau et de la Moelle epiniere', u'Alnylam Pharmaceuticals Inc', u'UCB SA', u'MedGenesis Therapeutix Inc', u'New York University', u'Sequenom Inc', u'Shire BioChem Inc', u'Link Medicine Corp', u'Stryker Corp', u'Axxonis Pharma AG', u'Proteostasis Therapeutics Inc', u'RespireRx Pharmaceuticals Inc', u'Daiichi Sankyo Co Ltd', u'Abbott Laboratories', u'Eisai Co Ltd', u'Proneuron Biotechnologies Inc', u'Neuroem Therapeutics Inc', u'National Cancer Institute', u'Novartis AG', u'University of Chile', u'Panacea Pharmaceuticals Inc', u'Celmed USA', u'Scripps Florida', u'Chaperone Therapeutics Inc', u'Aguettant SA', u'Universite De Montreal', u'Kainos Medicine Inc', u'Monash University', u'Jichi Medical School', u'Metabolic Solutions Development Co', u'TechnoPhage SA', u'National Institute Of Environmental Health Sciences', u'Adolor Corp', u'NeurOp Inc', u'Trevena Inc', u'OrbiMed Advisors LLC', u'McGill University', u'Lay Line Genomics SpA', u'Washington University in St Louis', u'Johns Hopkins University', u'DrugAbuse Sciences Inc', u'Russian Academy of Sciences', u'Kyowa Hakko Kogyo Co Ltd', u'uniQure BV', u'Finnish Funding Agency for Technology and Innovation', u'National Institute of General Medical Sciences', u'Pluristem Therapeutics Inc', u'Cynapsus Therapeutics Inc', u'H Lundbeck A/S', u'University of Maryland Baltimore County', u'Takeda Pharmaceuticals International Inc', u'National Institute of Neurological Disorders and Stroke', u'Syngenta AG', u'Industrial Research Ltd', u'Mesoblast Ltd', u'Neuropore Therapies Inc', u'Otsuka Pharmaceutical Co Ltd', u'Amarantus BioScience Holdings Inc', u'Wockhardt Ltd', u'Seneb BioSciences Inc', u'Howard Florey Institute of Experimental Physiology and Medicine', u'Rijksuniversiteit te Groningen', u'Ben Franklin Technology Partners of Southeastern Pennsylvania', u'Medivir AB', u'National Parkinson Foundation', u'Onyx Scientific Ltd', u'Worldwide Clinical Trials', u'French Government', u'MRIGlobal', u'Universidad De Le Republica - Uruguay', u'University College London', u'Vectura Group plc', u'University of Western Ontario', u'Addex Therapeutics Ltd', u'FORMA Therapeutics Inc', u'University of Miami', u'XenoPort Inc', u'University of Padova', u'Kyowa Hakko Kirin Co Ltd', u'Immune Therapeutics Inc', u'Neopharma AB', u'Enhance Biotech Inc', u'Kissei Pharmaceutical Co Ltd', u'Janssen Biotech Inc', u'Oxalys Pharmaceuticals Inc', u'Pfizer Inc', u'Tego BioSciences Corp', u'Longevity Biotech Inc', u'Afgin Pharma Llc', u'Living Cell Technologies Ltd', u'Mertiva AB', u'AFFiRiS AG', u'Memorial Sloan-Kettering Cancer Center', u'Wyeth BioPharma', u'Eli Lilly & Co', u'VistaGen Therapeutics Inc', u'Compass Research', u'Somerset Pharmaceuticals Inc', u'Neuraltus Pharmaceuticals Inc', u'Cita NeuroPharmaceuticals Inc', u'Rich Pharmaceuticals Inc', u'DevCo Pharmaceuticals Ltd', u'Allegiance Equity Corp', u'Renishaw plc', u'Imphar AG', u'Zambon Co SpA', u'Greatbatch Ltd', u'Targacept Inc', u'National Institutes of Health', u'Synthonics Inc', u'Laxdale Ltd', u'Curis Inc', u'Aequus Pharmaceuticals Inc', u'Pharmacia Corp', u'Technische Universit\\xe4t Darmstadt', u'Kentucky Science and Technology Corp', u'University of Chicago', u'Mitochon Pharmaceuticals', u'Plandai Biotechnology Inc', u'Anida Pharma Inc', u'Alion Pharmaceuticals Inc', u'Civitas Therapeutics Inc', u'Merck Serono SA', u'Purdue Neuroscience Corp', u'BioArctic Neuroscience AB', u'Icagen Inc (pre-merger)', u'Upsher-Smith Laboratories Inc', u'Biovail Laboratories International Srl', u'Ezose Sciences Inc', u'The Mental Health Research Institute of Victoria', u'Tripos Inc', u'Wren Therapeutics Limited', u'Mylan Specialty', u'Technion - Israel Institute of Technology', u'Merz & Co GmbH']), u'HutchinsonGilfordprogeriasyndrome': set([u'University of California Los Angeles', u'National Institutes of Health', u'National Heart Lung and Blood Institute', u'Merck & Co Inc', u'The Progeria Research Foundation Inc', u'Scripps Research Institute']), u'Sicklebeta0thalassemia': set([u'Emmaus Medical Inc', u'Durbin PLC']), u'Malignanthyperthermia': set([u'SpePharm Holding BV', u'AAIPharma Services Corp', u'JHP Pharmaceuticals LLC', u'The Procter & Gamble Co', u'Eagle Pharmaceuticals Inc']), u'Spontaneousabortion': set([u'Australian Government', u'CombiMatrix Corp', u'Universal Diagnostic Laboratories Inc', u'Novozymes GroPep Ltd', u'OmniBiome Therapeutics Inc', u'ProPath Laboratory, Inc', u'Therapeutic Solutions International Inc']), u'Adenosinedeaminasedeficiency': set([u'Sangamo Therapeutics Inc', u'University of California Los Angeles', u'Leadiant Biosciences Inc', u'Orphan Technologies Ltd', u'Orchard Therapeutics', u'Teijin Ltd', u'National Institutes of Health', u'Wellcome Trust', u'St Georges University of London', u'MolMed SpA', u'California Institute of Regenerative Medicine', u'GlaxoSmithKline plc', u'University College London', u'Great Ormond Street Hospital for Children NHS Foundation Trust']), u'Anaplasticlargecelllymphoma': set([u'Seattle Genetics Inc', u'Takeda Oncology']), u'Adultrespiratorydistresssyndrome': set([u'Pharmbio Korea Co., Ltd', u'Dr Rentschler Biotechnologie GmbH', u'Navigen Inc', u'Maruishi Pharmaceutical Co Ltd', u'National Institute of Allergy and Infectious Diseases', u'Faron Pharmaceuticals Ltd']), u'Chronicmyelocyticleukemia': set([u'US Government', u'University of Cologne', u'Incyte Corp', u'Inovio Pharmaceuticals Inc', u'Cancer Research UK', u'Georg-Speyer-Haus Chem Inst', u'University Of Southampton', u'University College Cork', u'Astex Pharmaceuticals Inc', u'Vernalis plc', u'Allysta Pharmaceuticals Inc', u'Olon SpA', u'Roche Holding AG', u'ARIAD Pharmaceuticals Inc', u'Specialised Therapeutics Australia Pty Ltd', u'Temple University', u'Heinrich Heine Universitat Dusseldorf', u'Dana-Farber Cancer Institute Inc', u'Lin Bioscience Inc', u'Thomas Jefferson University', u'PDL BioPharma Inc', u'MD Anderson Cancer Center', u'OncoResponse Inc', u'Chinese Academy of Medical Sciences', u'The Royal Swedish Academy of Sciences', u'ValiGen Inc', u'Abbott Laboratories', u'Mochida Pharmaceutical Co Ltd', u'Nankai University', u'Stragen Group', u'National Cancer Institute', u'Novartis AG', u'Jiangsu Hansoh Pharmaceutical Group Co Ltd', u'Avillion LLP', u'University of Maryland', u'Teva Pharmaceutical Industries Ltd', u'Jiangsu Hengrui Medicine Co Ltd', u'Angelini Pharmaceuticals SpA', u\"Boston Children's Hospital\", u'Cell Genesys Inc', u'SymBio Pharmaceuticals Ltd', u'Carrus Capital Corp', u'Kosan Biosciences Inc', u'DelMar Pharmaceuticals Inc', u'Tianjin International Joint Academy of Biotechnology and Medicine', u'Johns Hopkins University', u'TetraLogic Pharmaceuticals Corp', u'Sclavo SpA', u'University of Bern', u'SGX Pharmaceuticals Inc', u'Guangzhou Institutes of Biomedicine and Health', u'Atani KK', u'Ortho Biotech Products LP', u'Genentech Inc', u'Paladin Labs Inc', u'Otsuka Pharmaceutical Co Ltd', u'Amarantus BioScience Holdings Inc', u'Universita di Bologna', u'arGEN-X NV', u'Schering-Plough Corp', u'Callisto Pharmaceuticals Inc', u'La Jolla Institute of Allergy & Immunology', u'Medivir AB', u'Oregon Health Sciences University', u'Scripps Research Institute', u'Merck & Co Inc', u'The Salk Institute for Biological Studies', u'University College London', u'Columbia University', u'MolecularMD Corp', u'Housey Pharmaceutical Research Laboratories', u'ChemGenex Pharmaceuticals Ltd', u'AEterna Zentaris Inc', u'University of California Los Angeles', u'Leukaemia and Lymphoma Research', u'Pfizer Inc', u'CytRx Corp', u'Vertex Pharmaceuticals Inc', u'Memorial Sloan-Kettering Cancer Center', u'Nippon Shinyaku Co Ltd', u'Hoffmann-La Roche Inc', u'AnorMED Inc', u'Stehlin Foundation For Cancer Research', u'Guangxi Wuzhou Pharmaceutical Group Co Ltd', u'Hainan Tianwang International Pharmaceutical', u'Knight Cancer Institute', u'Sang-A Pharmaceutical Co Ltd', u'Bristol-Myers Squibb Co', u'Chinese Government', u'Evotec (UK) Ltd', u'Aronex Pharmaceuticals Inc', u'Hospira Adelaide Pty Ltd', u'Walter and Eliza Hall Institute of Medical Research', u'Hayashibara Co Ltd', u'Oncotide Pharmaceuticals Inc', u'Biologix FZ Co', u'Power3 Medical Products Inc', u'Pint Pharma', u'Sojo University']), u'Hidradenitissuppurativa': set([u'XBiotech Inc', u'American Skin Association', u'University of Athens', u'University of California San Francisco']), u'Solidtumor': set([u'RESprotect GmbH', u'Quest Diagnostics Inc', u'Shin Poong Pharmaceutical Co Ltd', u'Phoenix Pharmacologics Inc', u'Altropus Gmbh', u'Advanced BioScience Laboratories Inc', u'Celldex Therapeutics Inc (pre-merger)', u'Jennerex Inc', u'Archemix Corp', u'South Plains Oncology Consortium', u'Attenuon LLC', u'NYU School of Medicine', u'Wellstat Biologics Corp', u'Ignyta Inc', u'US Health and Human Services Department', u'Life Technologies Corp', u'BioLife Solutions Inc', u\"Cincinnati Children's Hospital Medical Center\", u'Biotecnol SA', u'Eddingpharm Inc', u'MethylGene Inc', u'Seattle Genetics Inc', u'Ionis Pharmaceuticals Inc', u'Novartis Pharma AG', u'Igeneon GmbH', u'Transcept Pharmaceuticals Inc', u'University of Pittsburgh', u'Japan Science and Technology Agency', u'Celldex Therapeutics Inc', u'University of Arizona', u'Bellicum Pharmaceuticals Inc', u'State of Queensland', u'AurKa Pharma Inc', u'SBI Biotech Co Ltd', u'LivTech Inc', u'Merck Sharp & Dohme Corp', u'Cormorant Pharmaceuticals', u'Cellectis SA', u'Aviragen Therapeutics Inc', u'Kuhnil Pharmaceutical Co Ltd', u'PharmaEssentia Corp', u'US Department of the Treasury', u'Sorrento Therapeutics Inc', u'OGD2 Pharma SAS', u'Beijing Jenkem Technology Co Ltd', u'Aurum Ventures MKI', u'ElsaLys Biotech', u'NantCell Inc', u'American BriVision Corporation', u'Alseres Pharmaceuticals Inc', u'National Research Council of Canada', u'European Commission', u'CrystalGenomics Inc', u'CadheRx Therapeutics Inc', u'PDL BioPharma Inc', u'Centre National de la Recherche Scientifique (CNRS)', u'The University of Aston In Birmingham', u'MABLife', u'Cambridge Antibody Technology Group plc', u'Nippon Kayaku Co Ltd', u'S*BIO Pte Ltd', u'SalvaRx Group Plc', u'Tallikut Pharmaceuticals Inc', u'Lynx Therapeutics GmbH', u'Lipopharma Therapeutics SL', u'The New Energy and Industrial Technology Development Organization', u'MediGene AG', u'Apptec Inc', u'Ministry of Health & Welfare, Korea', u'Poniard Pharmaceuticals Inc', u'Rgenix Inc', u'Istituto Scientifico H San Raffaele', u'Agennix AG', u'NewVac LLC', u'Oncolytics Biotech Inc', u'Thermo Fisher Scientific Inc', u'National Jewish Health', u'Indivumed GmbH', u'Kancera AB', u'Puma Biotechnology Inc', u'VU University Medical Center', u'Inovio Pharmaceuticals Inc', u'Galilaeus OY', u'EpiCept Corp', u'Errant Gene Therapeutics LLC', u'Checkpoint Therapeutics Inc', u'BioSpring Gesellschaft Fur Biotechnologie mbH', u'Strategia Therapeutics Inc', u'Celera Group', u'MegaPharm Ltd', u\"M's Science Corp\", u'Ryogen LLC', u'DelMar Pharmaceuticals Inc', u'Altor BioScience Corp', u'Cortice Biosciences Inc', u'Enterprise Ireland', u'Taiho Pharmaceutical Co Ltd', u'Kura Oncology Inc', u'MedVax Technologies Inc', u'Principia Biopharma Inc', u'Infinity Pharmaceuticals Inc', u'Oslo University Hospital', u'Oncobiologics Inc', u'Swedish Orphan Biovitrum AB', u'Talon Therapeutics Inc', u'Denovo Biopharma LLC', u'Pharmexa A/S', u'Syndivia SAS', u'Vegenics Ltd', u'Clarient', u'CytImmune Sciences Inc', u'Medigen Biotechnology Corp', u'Myrexis Inc', u'Danish Medicines Agency', u'Protherics Salt Lake City Inc', u'Xenerex Biosciences', u'Apogee Biotechnology Corp', u'Deciphera Pharmaceuticals LLC', u'Pacira Pharmaceuticals Inc', u'Universita degli Studi di Napoli Federico II', u'International Center for Genetic Engineering and Biotechnology (ICGEB)', u'Undisclosed', u'US Government', u'Kyorin University Hospital', u'SignalChem Life Sciences', u'LEO Pharma A/S', u'Stehlin Foundation For Cancer Research', u'Vion Pharmaceuticals Inc', u'CTI BioPharma Corp', u'Eli Lilly & Co', u'Celsion Corp', u'Immune Pharmaceuticals Inc', u'University of Wisconsin-Madison', u'bluebird bio Inc', u'eFFECTOR Therapeutics Inc', u'ProMab Biotechnologies Inc', u'Weizmann Institute of Science', u'Dare Bioscience Inc', u'Madrigal Pharmaceuticals Inc', u'Rexahn Pharmaceuticals Inc', u'Vyriad', u'OSI Pharmaceuticals Inc', u'NanoString Technologies Inc', u'Rhizen Pharmaceuticals SA', u'Fournier Pharma', u'University of Cincinnati', u'Hyaluron Inc', u'Corixa Corp', u'Cancer Research Technology Ltd', u'Anza Therapeutics Inc', u'Patrys Ltd', u'SpePharm AG', u'Synergene Therapeutics Inc', u'Hopital Saint-Louis', u'Avicenna Oncology GmbH', u'Immatics Biotechnologies GmbH', u'Johnson & Johnson', u'Coley Pharmaceutical Group Inc', u'China Pharmaceutical University', u'MosaMedix BV', u'Innate Pharma SA', u'Pierre Fabre Laboratories', u'AbbVie Inc', u'ViroMed Co Ltd', u'Silence Therapeutics AG', u'Akeso Biopharma Inc', u'Horizon Discovery Group plc', u'Centauri Therapeutics Ltd', u'Pfanstiehl Laboratories Inc', u'BL&H Co Ltd', u'BioMed Valley Discoveries', u'Aptamera Inc', u'Takeda Pharmaceutical Co Ltd', u'Stand Up To Cancer', u'Servier', u'Kereos Inc', u'Green Cross LabCell', u'Ventana Medical Systems Inc', u'Sphaera Pharma', u'Helmholtz Zentrum Dresden Rossendorf', u'ISA Pharmaceuticals BV', u'Biostatin Gyogyszerkutato-Fejleszto Kft', u'ConverGene LLC', u'Galera Therapeutics Inc', u'Astellas Pharma Inc', u'Regulon Inc', u'Institute of Cancer Research UK', u'Antisoma plc', u'PureTech Health Plc', u'Wacker Biotech GmbH', u'Lonza Group AG', u'Agouron Pharmaceuticals Inc', u'ActivBiotics Inc', u'Immuno-Designed Molecules SA', u'YM BioSciences Inc', u'John Wayne Cancer Institute', u'PTC Therapeutics Inc', u'Arresto BioSciences', u'NANTiBody LLC', u'Hadassah University Hospital', u'University of Michigan', u'Incanthera Ltd', u'Munich Biotech AG', u'Intellikine Inc', u'ImaginAb Inc', u'Karolinska Institutet', u'Synergy Pharmaceuticals Inc', u'Neon Therapeutics', u'Regeneron Pharmaceuticals Inc', u'Mera Pharmaceuticals Inc', u'Barbara Ann Karmanos Cancer Institute', u'Dynavax Technologies Corp', u'Adaptive Biotechnologies Corp', u'Rubicon Biotechnology Inc', u'Pharmacyclics Inc', u'Tapestry Pharmaceuticals Inc', u'BTG plc', u'MabVax Therapeutics Inc', u'University of Bonn', u'Auckland UniServices Ltd', u'Green Cross Corp', u'Texas A&M University System', u'Ludwig Institute for Cancer Research', u'Synchem Research Inc', u'Bristol-Myers Squibb Co', u'Xenova Group plc', u'Erimos Pharmaceutical LLC', u'Selexis SA', u'ARUP Laboratories', u'ArQule Inc', u'IsoTis SA', u'Vernalis plc', u'Syndax Pharmaceuticals Inc', u'Navidea Biopharmaceuticals Inc', u'City of Hope', u'Dutch-Belgian Cooperative Trial Group for Hematology Oncology', u'Mateon Therapeutics Inc', u'Roche Holding AG', u'Shire plc', u'University of British Columbia', u'MorphoSys AG', u'apceth GmbH & Co KG', u'MiNA Therapeutics Ltd', u'VasGene Therapeutics Inc', u'Sellas Life Sciences Group', u'Stony Brook University Hospital', u'Binational Industrial Research and Development Foundation', u'Biocon Ltd', u'Bayer HealthCare AG', u'Interprotein Corp', u'Otsuka Pharmaceutical Co Ltd', u'Mayo Clinic Foundation', u'Dana-Farber Cancer Institute Inc', u'Beike Biotechnology Co Ltd', u'Thermosome Gmbh', u'Evotec AG', u'Exelixis Inc', u'Lin Bioscience Inc', u'Bukwang Pharmaceutical Co Ltd', u'CK Life Sciences International Holdings Inc', u'Immunicon Corp', u'National University Hospital (Singapore) Pte Ltd', u'EPTTCO Ltd', u'Amgen Inc', u'TetraGene LLC', u'Genemen Biotech (Suzhou) Co Ltd', u'Baxter Oncology GmbH', u'e-Therapeutics Plc', u'Endo Health Solutions Inc', u'Ohio State University', u'University of Aberdeen', u'CircaGen Pharmaceutical', u'Biotech Australia', u\"Seattle Children's Hospital\", u'Ethicon Endo-Surgery Inc', u'ZIOPHARM Oncology Inc', u'RedHill Biopharma Ltd', u'Arog Pharmaceuticals Inc', u'Stemcentrx Inc', u'Georgetown University', u'CGI Pharmaceuticals Inc', u'MabVax Therapeutics Holdings Inc', u'Stason Pharmaceuticals Inc', u'University of Alabama at Birmingham', u'MoreinX AB', u'Massachusetts General Hospital', u'Abgenix Inc', u'Samyang Corp', u'Transgene SA', u'Symphogen A/S', u'Enzon Pharmaceuticals Inc', u'Plexxikon Inc', u'Immunomedics Inc', u'Advantagene Inc', u'PepTx Inc', u'Optimum Therapeutics LLC', u'Albany Molecular Research Inc', u'Astex Therapeutics Ltd', u'AgonOx', u'Nagoya University', u'Pangaea Biotech SA', u'Pharmion Corp', u'Chemokine Therapeutics Corp', u'CerRx Inc', u'Old Dominion University', u'BioTheryX Inc', u'Oakwood Laboratories LLC', u'F Hoffmann-La Roche AG', u'Fujifilm\\xa0Corp', u'CG Therapeutics Inc', u'Cancer Research UK', u'Louisiana State University Health Sciences Center New Orleans', u'Genentech Inc', u'MaxCyte Inc', u'Mitsubishi Pharma Corp', u'Paladin Labs Inc', u'Agilent Technologies Inc', u'Korea Drug Development Fund', u'Rigel Pharmaceuticals Inc', u'Harbin Gloria Pharmaceuticals Co Ltd', u'Baylor Research Institute', u'Reino de Espana', u'Wilex AG', u'Universitaet Stuttgart', u'NanoSmart Pharmaceuticals Inc', u'Novuspharma SpA', u'Sumitomo Dainippon Pharma Co Ltd', u'University Hospital of Navarra', u'iOx Therapeutics Ltd', u'Scripps Research Institute', u'Cell and Gene Therapy Catapult', u'TOMA Biosciences Inc', u'CancerCare Manitoba Foundation Inc.', u'University of Southern California', u'Monogram Biosciences Inc', u'CASI Pharmaceuticals Inc', u\"Children's National Medical Center\", u'ProQinase GmbH', u'Deutsches Krebsforschungszentrum', u'Pierre Fabre SA', u'Breitling Energy Corp', u'Inflection Biosciences Ltd', u'MolMed SpA', u'Kadmon Pharmaceuticals LLC', u'Glide Pharmaceutical Technologies Ltd', u'AstraZeneca plc', u'BioGaia Biologics AB', u'Boehringer Ingelheim Pharmaceuticals Inc', u'Aptevo Therapeutics Inc', u'SUGEN Inc', u'Agensys Inc', u'Kent State University', u'Beijing Pason Pharmaceuticals Inc', u'Praxis Pharmaceutical SA', u'University of Washington', u'Introgen Therapeutics Inc', u'Australian Government', u'BIND Therapeutics Inc', u'Genmab A/S', u'Remedyne Corp', u'ASTA Medica AG', u'Hutchison Medipharma Enterprises Ltd', u'H Lee Moffitt Cancer Center and Research Institute', u'Ligand Pharmaceuticals Inc', u'Medipharm Biotech Co Ltd', u'IDT Australia Ltd', u'National Cancer Centre of Singapore', u'MacroGenics Inc', u'University of Alberta', u'Tulane University', u'Molecular Therapeutics Inc', u'Oncolys BioPharma Inc', u'ProMetic Life Sciences Inc', u'University of Wurzburg', u'Aqualis ASA', u'Leap Therapeutics Inc', u'British Canadian Biosciences Corp', u'Presage Biosciences', u'Cedars-Sinai Medical Center', u'ICOS Corp', u'Fujifilm Diosynth Biotechnologies', u'Rex Medical LP', u'IC-MedTech Inc', u'Intellia Therapeutics Inc', u'Calando Pharmaceuticals Inc', u'Incyte Corp', u'Bristol-Myers Squibb Pharma Co', u'Adria Laboratories Inc', u'Hospira Adelaide Pty Ltd', u'National University of Singapore', u'Objectif Recherche VACcin Sida', u'Wistar Institute of Anatomy & Biology', u'Stragen Group', u'NanoCarrier Co Ltd', u'Novocure Inc', u'Walter and Eliza Hall Institute of Medical Research', u'Ottawa Regional Cancer Foundation', u'PiSA Farmaceutica', u'Dyax Corp', u'3M Co', u'University of Toronto', u'TopoTarget A/S', u'Wayne State University', u'CuraGen Corp', u'German Federal Ministry of Education and Research', u\"Y's Therapeutics Co Ltd\", u'Drais Pharmaceuticals Inc', u'National Comprehensive Cancer Network', u'Pharmagenesis Inc', u'Royal DSM NV', u'University of Florida', u'Unigen Pharmaceuticals Inc', u'University of Newcastle', u'Advaxis Inc', u'Sarah Cannon Research Institute', u'Globavir Biosciences Inc', u'Centre for Probe Development and Commercialization', u'Onxeo SA', u'Yakult Honsha Co Ltd', u'Kowa Co Ltd', u'NeoPharm Inc', u'Idun Pharmaceuticals Inc', u'CombiMatrix Corp', u'SGX Pharmaceuticals Inc', u'Kirin Holdings Co Ltd', u'Medipost Co Ltd', u'Cell Matrix Inc', u'Teva Pharmaceutical Industries Ltd', u'IDT Biologika GmbH', u'LegoChem Bioscience Inc', u'MedImmune LLC', u'Johannes Gutenberg Universitat Mainz', u'Ozmosis Research Inc.', u'Eleison Pharmaceuticals Inc', u'Leiden University Medical Center', u'Zeneca Group plc', u'Five Prime Therapeutics Inc', u'ARIAD Pharmaceuticals Inc', u'Pharmacia & Upjohn Co', u'National OncoVenture', u'GammaDelta Therapeutics Ltd', u'Kite Pharma Inc', u'Specialised Therapeutics Australia Pty Ltd', u'Archerdx Inc', u'KuDOS Pharmaceuticals Ltd', u'Ontario Institute for Cancer Research', u'Medical University of Vienna', u'Incysus Ltd', u'Sanford-Burnham Medical Research Institute', u'Constellation Pharmaceuticals Inc', u'Vertex Pharmaceuticals Inc', u'Zymeworks Inc', u'Future Systems Inc', u'Rexgene Biotech Co Ltd', u'KODE Biotech Ltd', u'Nereus Pharmaceuticals Inc', u'National Center For Advancing Translational Sciences', u'International Biotechnology Center Generium LLC', u'Xenova Ltd', u'L2 Diagnostics Llc', u'Inex Pharmaceuticals Corp', u'Leica Mikrosysteme GmbH', u'Intas Pharmaceuticals Ltd', u'Bayer Corp', u'Ardea Biosciences Inc', u'Nekonal SARL', u'Tactiva Therapeutics Inc', u'Affitech A/S', u'Cancer Genetics Inc', u'Harvard University', u'Solexa Inc', u'Poseida Therapeutics Inc', u'NCI Division of Cancer Treatment & Diagnosis', u'Athenex Inc', u'SEQUUS Pharmaceuticals Inc', u'Clovis Oncology Inc', u'Clayton Foundation For Research', u'Lunamed Operations AG', u'Optimata Ltd', u'Acuvax Ltd', u'IMBiotechnologies Ltd', u'Diatos SA', u'CytoCore Inc', u'Cougar Biotechnology Inc', u'Bionomics Ltd', u'RTP Pharma Corp', u'Istituto di Ricerche Farmacologiche Mario Negri', u'Cell Medica Ltd', u'Guangzhou LifeTech Pharmaceutical Co Ltd', u'MediBIC', u'Bioenvision Inc', u'Threshold Pharmaceuticals Inc', u'Les Laboratoires Servier', u'Carrus Capital Corp', u'ProlX Pharmaceuticals LP', u'Iontas Ltd', u'Azaya Therapeutics Inc', u'GammaCan International Inc', u'Micromet Inc', u'Polymed Therapeutics Inc', u'Boehringer Ingelheim Corp', u'Hoffmann-La Roche Inc', u'Juno Therapeutics Inc', u'BioInvent International AB', u'ImmunoGen Inc', u'Debiopharm SA', u'21st Century Therapeutics Inc', u'ILEX Oncology Inc', u'VINNOVA', u'Duke University Medical Center', u'Oncovir Inc', u'Medivation Inc', u'Wyeth Pharmaceuticals', u'OmniSeq', u'Advanced Life Sciences Holdings Inc', u'Harvard Medical School', u'Guardant Health Inc', u'Vical Inc', u'Universita di Bologna', u'Schering-Plough Corp', u'Oxford BioMedica plc', u'Epizyme Inc', u'CMC Biologics Inc', u'Dalian Wanchun Biotech', u'Pharmaceutical Research Institute', u'Indena SpA', u'Cellectar Biosciences Inc', u'NCIC Clinical Trials Group', u'Merck & Co Inc', u'Gemin X Pharmaceuticals Inc', u'Vancouver General Hospital', u'rEVO Biologics Inc', u'Sanofi', u'NN Petrov Research Institute of Oncology', u'Chong Kun Dang Pharmaceutical Corp', u'Columbia University', u'Marina Biotech Inc', u'Pharmacia Corp', u'Helix BioPharma Corp', u'Robarts Research Institute', u'Janssen Pharmaceutica NV', u'ImmunoBiochem Corporation', u'Ascalon International Inc', u'Alligator Bioscience AB', u'Merus BV', u'Nektar Therapeutics', u'Centre for Applied Microbiology & Research', u'Therapure Biopharma Inc', u'Thallion Pharmaceuticals Inc', u'Tamir Biotechnology Inc', u'Astex Pharmaceuticals Inc', u'Gilead Sciences Inc', u'OncoSec Medical Inc', u'University of Cologne', u'Ministry Of Industry & Trade Of The Russian Federation', u'HUYA Bioscience International LLC', u'Merrimack Pharmaceuticals Inc', u'Genitrix LLC', u'US Department of Defense', u'X-BODY BioSciences', u'4SC AG', u'North Central Cancer Treatment Group', u'Celyad', u'AnorMED Inc', u'Hoffmann-La Roche AG', u'Intrexon Corp', u'Imclone LLC', u'Apogenix GmbH', u'Phosplatin Therapeutics LLC', u'CRISPR Therapeutics', u'Knight Therapeutics Inc', u'BZL Biologics Inc', u'PRISM Pharma Co Ltd', u'Dendreon San Diego LLC', u'Aurigene Discovery Technologies Ltd', u'Bioneer Corp', u'Selected Value Therapeutics', u'Spectrum Pharmaceuticals Inc', u'AltheaDx Inc', u'University of Tokyo', u'BCN Peptides SA', u'Ono Pharmaceutical Co Ltd', u'Chinese Government', u'Semafore Pharmaceuticals Inc', u'Aventis SA', u'INSERM', u'Sanofi Genzyme', u'MSD Japan', u'Parke-Davis & Co', u'Grid Therapeutics LLC', u'CJ Corp', u'Cephalon Inc', u'Celgene Corp', u'Array BioPharma Inc', u'Raven Biotechnologies Inc', u'BC Cancer Agency', u'University of Hawaii', u'University of New South Wales', u'Duke University', u'Bioniche Teoranta', u'Adaptimmune Therapeutics plc', u'MediciNova Inc', u'Viralytics Ltd', u'Wuxi AppTec (Tianjin) Co Ltd', u'Endocyte Inc', u'Sophia Genetics Sa', u'Quadro de Refer\\xeancia Estrat\\xe9gica Nacional', u'Trillium Therapeutics Inc', u'PNP Therapeutics Inc', u'OncoGenex Technologies Inc', u'Abraxis BioScience Inc', u'Provectus Biopharmaceuticals Inc', u'Niiki Pharma Inc', u'Epeius Biotechnologies Corp', u'BeneVir Biopharm Inc', u'OncoGenex Pharmaceuticals Inc', u'Tara Immuno-Oncology LLC', u'TRACON Pharmaceuticals Inc', u'Targovax AS', u'Agence Nationale de Recherches sur le Sida et les hepatites virales (ANRS)', u'BioMarin Pharmaceutical Inc', u'Apeiron Biologics GmbH', u'National Institutes of Health', u'BioAtla Llc', u'Cancer Research Campaign Technology Ltd', u'W C Heraeus GmbH & Co KG', u'Recepta biopharma', u'GenVec Inc', u'Siamab Therapeutics', u'Virtualscopics LLC', u'Biogen Inc', u'Centre de Physiopathologie de Toulouse Purpan', u'Ambit Biosciences Corp', u'GlaxoSmithKline plc', u'NantKwest Inc', u'Oxford BioTherapeutics', u'QBiotics Ltd', u'Bayer Schering Pharma AG', u'Innovive Pharmaceuticals Inc', u'Biotoscana International', u'Cascadian Therapeutics Inc', u'Novotech (Australia) Pty Ltd', u'Cytheris SA', u'University of Sheffield', u'Ipsen', u'Immunex Corp', u'Cylene Pharmaceuticals Inc', u'European Eurostars Programme', u'Xynomic Pharmaceuticals', u'Massachusetts General Hospital Cancer Center', u'Inspyr Therapeutics Inc', u'Medical Research Council', u'Pharmis Biofarmaceutica', u'University of Texas Health Science Center Houston', u'Takeda Oncology', u'Aduro BioTech Inc', u'Angiogene Pharmaceuticals Ltd', u'Shanghai SunTerra Biotechnology Ltd', u'Halozyme Therapeutics Inc', u'Predictive Therapeutics', u'Northwest Biotherapeutics Inc', u'Peregrine Pharmaceuticals Inc', u'CarboMed Inc', u'Institut Quimic De Sarria CETS', u'Netherlands Cancer Institute', u'ERYtech Pharma', u'Fox Chase Cancer Center', u'BioWa Inc', u'3M Pharmaceuticals', u'F1 Oncology Inc', u'Emory University', u'Technische Universitat Dresden', u'Alnylam Pharmaceuticals Inc', u'Philogen SpA', u'RecipharmCobra Biologics', u'Nanovalent Pharmaceuticals Inc', u'Apexigen Inc', u'Centella Therapeutics Inc', u'The Menarini Group', u'MD Anderson Cancer Center', u'Sigma-Tau Ind Farm Riunite SpA', u'Medarex Inc', u'National Institute for Health Research (NIHR)', u'Immunovaccine Inc', u'Daiichi Sankyo Co Ltd', u'Abbott Laboratories', u'Sparta Pharmaceuticals Inc', u'Eisai Co Ltd', u'3SBio Inc', u'Ganymed Pharmaceuticals AG', u'Pediatric Oncology Experimental Therapeutics Investigation Consortium', u'University of Chicago', u'National Cancer Institute', u'Novartis AG', u'Medicenna Therapeutics Pte Ltd', u'Almac Discovery Ltd', u'Fujisawa Pharmaceutical Co Ltd', u'Novelion Therapeutics Inc', u'Simcere Pharmaceutical Group', u'SciClone Pharmaceuticals Inc', u'CANbridge Life Sciences Ltd', u'University of Minnesota', u'Tumor Biology Center, Freiburg', u'UCSF Helen Diller Family Comprehensive Cancer Center', u'Arbutus Biopharma Corp', u'Concordia Pharmaceuticals Inc', u'Aptose Biosciences Inc', u'Tessa Therapeutics Pte Ltd', u'SymBio Pharmaceuticals Ltd', u'AVEO Oncology', u'YM BioSciences USA', u'Luye Pharma Group Ltd', u'Auckland Division Cancer Society of New Zealand Inc', u'Kosan Biosciences Inc', u'Histosonics Inc', u'BASF Pharma', u'SeraCare Life Sciences Inc', u'Baylor University', u'WuXi PharmaTech (Cayman) Inc', u'Washington University in St Louis', u'CytRx Corp', u'Johns Hopkins University', u'Adicet Bio Inc', u'Myriad Genetics Inc', u'Kyowa Hakko Kogyo Co Ltd', u'Harbor Branch Oceanographic Institute Inc', u'Vaxil BioTherapeutics Ltd', u'Biotecnol Ltd', u'Cognate BioServices Inc', u'AmpliPhi Biosciences Corp', u'OncoMed Pharmaceuticals Inc', u'Chugai Pharmaceutical Co Ltd', u'Synthon Biopharmaceuticals', u'Medical University of Lodz', u'GENESIS Pharma SA', u'Steba Beheer BV', u'Samsung Medical Center (SMC)', u'Yorkshire Cancer Research', u'Centre for the Commercialization of Antibodies and Biologics', u'Symphony Evolution Inc', u'SRI International', u'Amgen Research (Munich) GmbH', u'Iovance Biotherapeutics Inc', u'Callisto Pharmaceuticals Inc', u'The Indiana 21st Century Research and Technology Fund', u'ChemConnection BV', u'Yuhan Corp', u'Heidelberg Pharma Holding Ltd', u'Morphotek Inc', u'Ability Pharmaceuticals SL', u'ImmunID', u'Johann Wolfgang Goethe-Universitat Frankfurt am Main', u'Australasian Lung Cancer Trials Group', u'Cancer Research Institute (CRI)', u'Steba Biotech NV', u'Ingenex Inc', u'Zentaris GmbH', u'Biolite Inc', u'BiPar Sciences Inc', u'PharmaMar SA', u'Cristal Therapeutics', u'J-Pharma Co Ltd', u'ChemGenex Pharmaceuticals Ltd', u'FKD Therapies OY', u\"Children's Hospital of Los Angeles\", u'Kyowa Hakko Kirin Co Ltd', u'Sprint Bioscience', u'R-Biopharm Ag', u'Evestra Onkologia Sp. z.o.o.', u'Kissei Pharmaceutical Co Ltd', u'Valentis Inc', u'University of Bradford', u'Janssen Biotech Inc', u'TetraLogic Pharmaceuticals Corp', u'Pfizer Inc', u'ProBioGen AG', u'The Royal Marsden NHS Trust', u'Universiteit Maastricht', u'Pieris Pharmaceuticals Inc', u'Yissum Research Development Co', u'Mirrx Therapeutics', u'GenQuest Inc', u'Dr Reddy\\u2019s Research and Development BV', u'Memorial Sloan-Kettering Cancer Center', u'Mount Sinai Medical Center', u'Maxim Pharmaceuticals Inc', u'LG Life Sciences Ltd', u'Baylor College of Medicine', u'GPC Biotech AG', u'Western Oncolytics Ltd', u'Norsk Hydro AS', u'In Ovations Holdings Inc', u'Fujifilm Kyowa Kirin Biologics Co Ltd', u'Paul Scherrer Institut', u'MEI Pharma Inc', u'Prima BioMed Ltd', u'National Institute of Allergy and Infectious Diseases', u'Miltenyi Biotec GmbH', u'AAVP Biosystems Inc', u'Innovation Norway', u'Praecis Pharmaceuticals Inc', u'Octamer Inc', u'Kansas Bioscience Authority', u'NuView Life Sciences', u'Lantern Pharma', u'Aarhus University', u'Crinetics Pharmaceuticals Inc', u'National Cancer Center of Korea', u'Food and Drug Administration', u'South Texas Accelerated Research Therapeutics', u'Scancell Ltd', u'Medinet Co Ltd', u'Curis Inc', u'Oncology Venture ApS', u'Serenex Inc', u'Jasco Pharmaceuticals LLC', u'Intradigm Corp', u'Onyx Pharmaceuticals Inc', u'Roswell Park Cancer Institute', u'Mebiopharm Co Ltd', u'Anadys Pharmaceuticals Inc', u'Lytix Biopharma AS', u'Stanford University', u'Transgenomic Inc', u'Krankenhaus Nordwest', u'Trinity College Dublin', u'Araxes Pharma LLC', u'Qiagen NV', u'Jubilant Life Sciences Ltd', u'Ferozsons Laboratories Ltd', u'The University of Birmingham', u'Centenary Institute Cancer Medicine & Cell Biology', u'Merck Serono SA', u'GemVax & Kael Co Ltd', u'Lawson Health Research Institute', u'Takara Bio Inc', u'Incozen Therapeutics Pvt Ltd', u'AVAX Technologies Inc', u'Cancer Therapeutics CRC Pty Ltd', u'Cytopia Ltd', u'BeiGene Co Ltd', u'Biologics Inc', u'LeadInvent Technologies Pvt Ltd', u'NDDO Oncology BV', u'Merck KGaA', u'Luzitin SA', u'Translational Therapeutics Inc', u'Technion - Israel Institute of Technology', u'Sojo University']), u'SARScoronavirusinfect': set([u'Hollister-Stier Laboratories LLC', u'Hemispherx Biopharma Inc']), u'Peripheralnervoussystemdisease': set([u'Optivia Biotechnology', u'French Muscular Dystrophy Association', u'Rhenovia Pharma SAS', u'Roche Palo Alto', u'Celera South San Francisco']), u'Premenstrualsyndrome': set([u'Eli Lilly & Co', u'Warner Chilcott plc', u'Onxeo SA', u'Intendis GmbH', u'Ergomed PLC', u'Bayer Schering Pharma AG', u'FAES Farma SA', u'Bayer HealthCare Pharmaceuticals Inc', u'MSD OSS BV', u'Mitsubishi Pharma Corp', u'Umecrine AB', u'Mitsubishi Tanabe Pharma Corp', u'Scios Inc', u'Pherin Pharmaceuticals Inc', u'Myungin Pharm Co Ltd', u'Panaxia Pharmaceutical Industries Ltd', u'Mochida Pharmaceutical Co Ltd', u'Allegiance Equity Corp', u'H Lundbeck A/S', u'GlaxoSmithKline plc']), u'Occlusivecoronaryarterydisease': set([u'Pennsylvania State University', u'Trovis Pharmaceuticals LLC']), u'Catatonia': set([u'The National Institute of Mental Health', u'University of North Carolina', u'Organix Inc']), u'Dysuria': set([u'Daiichi Seiyaku Co Ltd', u'Pharmaplan GmbH', u'Kissei Pharmaceutical Co Ltd', u'Almirall Prodesfarma SA', u'Astellas Pharma Inc', u'Takeda Pharmaceuticals International GmbH', u'Recordati SpA', u'JW Pharmaceutical Corp', u'Eisai Co Ltd', u'ASKA Pharmaceutical Co Ltd']), u'Dementia': set([u'Roussel Uclaf Corp', u'Karolinska Institutet', u'University of Newcastle', u'University of South Australia', u'Hunter-Fleming Ltd', u\"Alzheimer's Drug Discovery Foundation\", u'Weston Brain Institute', u'Prodotti Formenti Srl', u'Cardinal Health Inc', u'ProNeurogen Inc', u'University of Tokyo', u'MAMORIO Inc', u'Neurobiological Technologies Inc', u'Forest Laboratories Inc', u'Siemens Medical Systems Inc', u'GlaxoSmithKline plc', u'University of Queensland', u'Flinders University of South Australia', u'Ipsen', u'Aventis Pharma AG', u'University of Michigan', u'Chinese Academy of Medical Sciences & Peking Union Medical College', u'Stemedica International SA', u'Pharmacia & Upjohn Co', u'Shionogi & Co Ltd', u'Keio University', u'Teijin Pharma Ltd', u\"Boston Children's Hospital\", u'Loyola University of Chicago', u'Hikma Pharmaceuticals plc', u'Brain Canada', u'Sigma-Tau Ind Farm Riunite SpA', u'Exelixis Inc', u'National Health and Medical Research Council', u'University of Oxford', u'Neurodyn Inc', u'RespireRx Pharmaceuticals Inc', u'National Institute for Health Research (NIHR)', u'Memory Pharmaceuticals Corp', u'SmithKline Beecham Corp', u'University of Cambridge', u'Eisai Co Ltd', u'Novartis AG', u'DreamPharma Corp', u'Toyo Jozo Co Ltd', u'Alzeca Biosciences Inc', u'Meldex International plc', u'Teva Pharmaceutical Industries Ltd', u'Juvenescence Limited', u'Kwang Dong Pharmaceutical Co Ltd', u'Santen Pharmaceutical Co Ltd', u'Medical Research Council', u'Digital Biotech Co Ltd', u'Monash University', u'Newron Pharmaceuticals SpA', u'University of Manchester', u'Laboratoires Mayoly Spindler', u'Gliatech Inc', u\"M's Science Corp\", u'Avid Radiopharmaceuticals Inc', u'Glaxo Group Ltd', u'McGill University', u'Lay Line Genomics SpA', u'Janssen Pharmaceutica NV', u'Boehringer Ingelheim Corp', u'Myriad Genetics Inc', u'Yale University', u'Laboratoires Houde SA', u'Parke-Davis & Co', u'University of Sydney', u'H Lundbeck A/S', u'Saegis Pharmaceuticals Inc', u'Pharmexa A/S', u'Icure Pharmaceutical Corp', u'University of Houston', u'The Global Alliance for Innovation in Neuroscience Inc', u'IntelliCell BioSciences Inc', u'Bago', u'Astellas Pharma Inc', u'Howard Florey Institute of Experimental Physiology and Medicine', u'The Knut and Alice Wallenberg Foundation', u'Yuhan Corp', u'AgeneBio Inc', u'Undisclosed', u'Pharmasum Therapeutics', u'DiamiR LLC', u'Hamilton Pharmaceuticals Ltd', u'Merck & Co Inc', u'Hoffmann-La Roche AG', u'Columbia University', u'Eli Lilly & Co', u'Tanabe Seiyaku Co Ltd', u'Bayer AG', u'Japan Agency for Medical Research and Development', u'University of Wollongong', u'Allergan Inc', u'FUJIFILM Holdings Corp', u'Toronto Rehabilitation Institute', u'Alector LLC', u'Wellness Open Living Labs LLC', u'Adimab LLC', u'Eurand America Inc', u'Minster Pharmaceuticals plc', u'AstraZeneca plc', u'Pfizer Inc', u'National Institute on Aging', u'Norwegian Research Council', u'Childrens Medical Center Corp', u'Allelix Neuroscience Inc', u'University of Arizona', u'Merrion Pharmaceuticals Inc', u'Australian Government', u'Galantos Pharma GmbH', u'Insilico Medicine Inc', u'University of Western Australia', u'Endogenous Stem Cells Activators Inc', u'SmithKline Beecham plc', u'Dainippon Pharmaceutical Co Ltd', u'Vernalis Research Ltd', u'University of New South Wales', u'Northwestern University', u'CANTABio Pharmaceuticals Inc', u'Takeda Pharmaceutical Co Ltd', u'Shionogi-GlaxoSmithKline Pharmaceuticals LLC', u'Servier', u'National Institutes of Health', u'Osaka City University', u'Abeona Therapeutics Inc', u'Senju Pharmaceutical Co Ltd', u'Elan Corp plc', u'Aventis SA', u'Kyoto University', u'University of Melbourne', u'Proteostasis Therapeutics Inc', u'Sanochemia Pharmazeutika AG', u'Seoul National University', u'Catalytica Inc', u'Ciba-Geigy AG', u'IXICO Plc', u'Daiichi Pharmaceutical Corp', u'Russian Academy of Sciences', u'Adamas Pharmaceuticals Inc', u'The Michael J. Fox Foundation', u'RNL Bio Co Ltd', u'University of California Irvine', u'Sysmex Corp', u'The Australian National University', u'ElcomScience', u'University of Tasmania', u'Gedeon Richter Ltd', u'SK Chemicals Co Ltd', u'University Of Western Sydney', u'Curtin University', u'Merz & Co GmbH']), u'Solidtum': set([u'Fujifilm Diosynth Biotechnologies', u'US Government', u'Mateon Therapeutics Inc', u'Aventis SA', u'Chugai Pharmaceutical Co Ltd', u'Genta Inc']), u'X-linkedgeneticdisorder': set([u'National Neurovision Research Institute', u'Edimer Pharmaceuticals Inc', u'CMC Biologics Inc', u'AGTC']), u'Alportsyndrome': set([u'Stryker Corp', u'Ember Therapeutics', u'Sanofi Genzyme', u'BioStratum Inc']), u'Ovarycyst': set([u'Insmed Inc', u'Hospital Clinicas de Caracas', u'National Institutes of Health', u'Taisho Pharmaceutical Co Ltd']), u'Taeniainfection': set([u'Bill & Melinda Gates Foundation', u'University of Melbourne']), u'Myopathy': set([u'Gradalis Inc', u'US Government', u'CSL Behring LLC', u'Progenra Inc', u'miRagen Therapeutics Inc', u'Harvard Medical School', u'University of Washington', u'The New Energy and Industrial Technology Development Organization', u'Escala Therapeutics Inc', u'Myotubular Trust', u'National Institutes of Health', u'HIBM Research Group Inc', u'Mary Crowley Cancer Center', u'INSERM', u'University of Texas Southwestern Medical Center', u'University of Amsterdam', u'Monash University', u'Nobelpharma Co Ltd', u'Valerion Therapeutics LLC', u'AAIPharma Services Corp', u'Muscular Dystrophy Association', u'University of California Los Angeles', u'Wake Forest University', u'Genethon', u'Virginia Polytechnic Institute and State University', u'Audentes Therapeutics Inc', u'National Institute on Aging', u'National Human Genome Research Institute', u'New Zealand Pharmaceuticals Ltd', u'REGENXBIO Inc', u'Ultragenyx Pharmaceutical Inc', u'Johns Hopkins University']), u'Cystinuria': set([u'Revive Therapeutics Ltd', u'Massachusetts General Hospital', u'Undisclosed']), u'Barthsyndrome': set([u'Undisclosed', u'New York University']), u'HIV-associatedlipodystrophy': set([u'Phyton Biotech Inc', u'BL&H Co Ltd', u'Praxis Pharmaceutical SA', u'Sakai Chemical Industry Co Ltd', u'Ardana Bioscience Ltd', u'Sanofi', u'Ferrer Internacional SA', u'National Institute of Allergy and Infectious Diseases', u'IDIS Ltd', u'EMD Serono Inc', u'Insmed Inc', u'Theratechnologies Inc', u'Massachusetts General Hospital', u'Zentaris GmbH']), u'Clostridiumbotulinuminfection': set([u'Health Protection Agency', u'Massachusetts Institute of Technology', u'PanThera Biopharma LLC', u'DynPort Vaccine Company LLC', u'National Institute of Allergy and Infectious Diseases', u'United States Army Medical Research Institute of Chemical Defense', u'Cangene Corp', u'US Army Medical Research Institute of Infectious Diseases', u'California Institute of Technology', u'AlphaVax Inc', u'US Health and Human Services Department', u'Cambridge Biostability Ltd', u'National Institutes of Health', u'XOMA Corp', u'Microbiotix Inc', u'Emergent BioSolutions Inc', u'The Dow Chemical Co', u'Scripps Research Institute', u'Morphotek Inc', u'University of Florida', u'Nanotherapeutics Inc', u'Iterative Therapeutics Inc', u'University of California San Francisco', u'Centers for Disease Control and Prevention', u'Inventox LLC', u'US Government', u'Ossianix Inc', u'Battelle', u'Soligenix Inc', u'Thomas Jefferson University', u'Hawaii Biotech Inc', u'Fox Chase Chemical Diversity Center Inc', u'US Department of Defense', u'Planet Biotechnology Inc', u'Indi Molecular Inc', u'Undisclosed', u'Molecular Targeting Technologies Inc', u'Immunome Inc']), u'Hemorrhagicshock': set([u'University of Minnesota', u'Jiangsu Nhwa Pharmaceutical Group Co Ltd', u'Prolong Pharmaceuticals Inc', u'US Naval Medical Research Center', u'US Government', u'Diffusion Pharmaceuticals LLC', u'NuvOx Pharma LLC', u'Tenax Therapeutics Inc', u'Fibrex Medical R&D GmbH', u'Sangart Inc', u'Medinox Inc', u'National Heart Lung and Blood Institute', u'ORPHY', u'Ikaria Inc', u'US Department of Defense', u'Orient Europharma', u'Caelus Biosciences Inc', u'US Army Medical Research and Materiel Command', u'TheraSource LLC', u'Hemarina']), u'Pancytopenia': set([u'National Institute of Allergy and Infectious Diseases', u'Coherus BioSciences Inc', u'Cascade Lifesciences Inc', u'Cytovance Biologics LLC']), u'Mania': set([u'Otsuka Pharmaceutical Co Ltd', u'Memory Pharmaceuticals Corp', u'Eisai Co Ltd', u'DRAXIS Health Inc', u'KYOWA Pharmaceutical Industry Co Ltd', u'Bristol-Myers Squibb Co', u'Elan Corp plc', u'Merck & Co Inc', u'Eli Lilly & Co', u'University of Pennsylvania', u'Bayer AG', u'Astellas Pharma Inc', u'Pierre Fabre SA', u'The National Institute of Mental Health', u'SIBIA Neurosciences Inc', u'AstraZeneca plc', u'University of Cincinnati', u'Cypress Bioscience Inc', u'The Stanley Medical Research Institute', u'Gedeon Richter Ltd', u'Recordati SpA', u'H Lundbeck A/S']), u'EpsteinBarrvirusinfection': set([u'University of North Carolina', u'Cancer Research UK', u'Henderson Morley plc', u'The University of Hong Kong', u'University Grants Committee', u'Admedus Immunotherapies', u'National Institute of Allergy and Infectious Diseases', u'Ohio State University', u'GlaxoSmithKline plc', u'Northwestern University', u'MacroGenics Inc', u'Cancer Prevention and Research Institute of Texas', u'Undisclosed', u'National Cancer Institute', u'Chroma Therapeutics Ltd', u'University of California', u'Atara Biotherapeutics Inc', u'MedImmune LLC', u'Chimerix Inc', u'University of Wisconsin-Madison', u'Trimeris Inc', u'Immune Therapeutics Inc', u'Tufts University', u'Viracyte', u'Viracta Therapeutics Inc', u'Australian Centre for Vaccine Development', u'Vironika LLC', u'Hocuslocus Llc', u'Fox Chase Chemical Diversity Center Inc', u'Chinese University of Hong Kong', u'Memorial Sloan-Kettering Cancer Center', u'Wistar Institute of Anatomy & Biology']), u'Gaucherdisease': set([u'Lysosomal Therapeutics Inc', u'University of Lund', u'Green Cross Corp', u'Israeli Government', u'State Of Israel The Ministry Of Industry & Trade The National Physical Laboratory', u'Oxford GlycoSciences plc', u'Mayo Clinic Foundation', u'Zywie Bio LLC', u'Neuraltus Pharmaceuticals Inc', u'GlaxoSmithKline plc', u'Sekisui Chemical Co Ltd', u'Belrose Pharma Inc', u'Hospital for Sick Children', u'Undisclosed', u'Zacharon Pharmaceuticals Inc', u'Teva Pharmaceutical Industries Ltd', u'Genzyme General', u'Sanofi Genzyme', u'University of Pittsburgh', u'Warner-Lambert Co', u'Protalix BioTherapeutics Inc', u'Fred Hutchinson Cancer Research Center', u'JCR Pharmaceuticals Co Ltd', u'Hybrigenics SA', u'Shire plc', u'Weizmann Institute of Science', u'ExSAR Corp', u'AVROBIO Inc', u'GD Searle & Co', u'Pfizer Inc', u'Shaare Zedek Medical Center', u'National Human Genome Research Institute', u'EMS SA', u'National Center for Research Resources', u'University of California San Diego', u'Ministry Of Industry & Trade Of The Russian Federation', u'Theragen Inc', u'Isu Abxis Inc', u'AmpliPhi Biosciences Corp', u'Institute of Advanced Chemistry of Catalonia', u'SK Chemicals Co Ltd', u'International Biotechnology Center Generium LLC']), u'Hypereosinophilicsyndrome': set([u'McGill University', u'UCB Celltech', u'Ception Therapeutics Inc', u'Merck & Co Inc', u'AmorChem LP', u'National Institute of Allergy and Infectious Diseases', u'Knopp Biosciences LLC', u'Schering-Plough Corp']), u'Extrapyramidalsyndrome': set([u'Taiwan Specialty Pharma Corp', u'Layton Bioscience Inc', u'Targacept Inc', u'Lundbeck Inc', u'MediFront Ltd', u'Lifehealth Ltd', u'Biovail Corp', u'University of South Florida', u'Japanese Ministry of Health, Labor and Welfare', u'Cambridge Laboratories Ltd', u'UCB SA', u'Alfresa Pharma Corp', u'EUSA Pharma USA', u'Orphan Australia', u'Giddi Pharma Co Ltd', u'AFT Pharmaceuticals Ltd']), u'Prader-Willisyndrome': set([u'FDA Office of Orphan Products Development', u'University of California Irvine', u'Rhythm Metabolic Inc', u'University of California', u'Levo Therapeutics Inc', u'Kalytera Therapeutics Inc', u'NutriForward LLC', u'Ferring Pharmaceuticals SA', u'Essentialis Inc', u'Shaare Zedek Medical Center', u'Foundation for Prader-Willi Research']), u'Perianalfistula': set([u'TiGenix NV', u'Takeda Pharmaceutical Co Ltd', u'The Madrid Network', u'Cellerix SA', u'Lonza Group AG']), u'Enteritis': set([u'Leadiant Biosciences Inc', u'Kenneth Rainin Foundation', u'Stanford University', u'National Cancer Institute', u'National Institute of Diabetes, Digestive and Kidney Diseases', u'Symberix LLC', u'Soligenix Inc']), u'Prostatitis': set([u'Pharmaplan GmbH', u'Gold Coast Therapeutics', u'Calgenex', u'Astellas Pharma Inc', u'Roche Holding AG', u'Insys Therapeutics Inc', u'Beech Tree Labs Inc', u'Synthelabo', u'Recordati SpA', u'Leiras Oy', u'Milkhaus Laboratory Inc', u'Sanofi-Synthelabo', u'BioChemics Inc', u'Nanobac Pharmaceuticals Inc', u'BioXell SpA', u'Schering SpA']), u'Flavivirusinfection': set([u'PharmaJet Inc', u'SIGA Technologies Inc', u'US Government', u'GenPhar Inc', u'Ennaid Therapeutics', u'US Naval Medical Research Center', u'Sanofi Pasteur', u'The European Union', u'National Institute of Allergy and Infectious Diseases', u'Mahidol University', u'Maxygen Inc', u'GlaxoSmithKline plc', u'Inovio Pharmaceuticals Inc', u'InViragen LLC', u'Johns Hopkins University School of Medicine', u'National Institutes of Health', u'Biological E Ltd', u'Scripps Research Institute', u'Instituto Butantan', u'GeneOne Life Science Inc', u'Centers for Disease Control and Prevention', u'University of Washington', u'Walter Reed Army Institute of Research', u'Shantha Biotechnics PVT Ltd', u'Pharos Biologicals LLC', u'University of Texas System', u'GeoVax Labs Inc', u'Institut Pasteur', u'University of Georgia', u'Crucell NV', u'Tamir Biotechnology Inc', u'Hawaii Biotech Inc', u'Gilead Sciences Inc', u'Idenix Pharmaceuticals Inc', u'Florida Gulf Coast University', u'Kineta Inc', u'St Louis University', u'Acambis plc', u'Panacea Biotec Ltd']), u'Rettsyndrome': set([u'Recursion Pharmaceuticals LLC', u'IPT-Pharma AG', u'Baylor College of Medicine', u'Stanford University', u'Luc Therapeutics Inc', u'Neurolixis Inc', u'RespireRx Pharmaceuticals Inc', u'Melior Pharmaceuticals Inc', u'Numedicus Ltd', u'IDIBELL', u'University of Gottingen', u'Mitochon Pharmaceuticals', u'Novartis AG', u'Ben Franklin Technology Partners of Southeastern Pennsylvania', u'Eunice Kennedy Shriver National Institute of Child Health & Human Development', u'University of Bristol', u'Oregon Health Sciences University', u'Anavex Life Sciences Corp', u\"Texas Children's Hospital\", u'University of California', u'University of Alabama at Birmingham', u'Neuren Pharmaceuticals Ltd', u'INSERM', u'Ashvattha Therapeutics LLC', u'Neurotrope Inc', u'AveXis Inc', u'Orpheris Inc', u'University of Wisconsin-Madison', u'Revive Therapeutics Ltd', u'SATT Paca Corse', u'Pierre Fabre SA', u'PharmedArtis GmbH', u'BioHaven Pharmaceutical Holding Co Ltd', u'Horizon Orphan LLC', u'International Rett Syndrome Foundation', u'University of Barcelona', u'ORPHELIA Pharma SA', u'AMO Pharma Ltd', u'AstraZeneca plc', u'Emory University', u'ArmaGen Technologies Inc', u'Assistance Publique Hopitaux De Marseille', u'REGENXBIO Inc', u'Rett Syndrome Research Trust']), u'Denguevirusinfection': set([u'University of Texas Medical Branch at Galveston', u'Advanced BioScience Laboratories Inc', u'Clayton Biotechnologies Inc', u'Sanofi Pasteur', u'GenVec Inc', u'Novartis Institute for Tropical Diseases Pvt Ltd', u'Chugai Pharmaceutical Co Ltd', u'US Health and Human Services Department', u'Maxygen Inc', u'Serum Institute of India Ltd', u'GlaxoSmithKline plc', u'Il-Yang Pharmaceutical Co', u'Inovio Pharmaceuticals Inc', u'The Korea National Institute of Health', u'Mount Sinai Hospital', u'FIT Biotech Oyj Plc', u'Viroclinics BV', u'Vical Inc', u'Visterra Inc', u'Texas A&M University System', u'Biological E Ltd', u'Bio-Rad Laboratories Inc', u'Fundacao Oswaldo Cruz (Fiocruz)', u'Institut Curie', u'SystemOne', u'Phynova Group Ltd', u'Immunotope Inc', u'VGX Pharmaceuticals LLC', u'Walter Reed Army Institute of Research', u'GeneSegues Therapeutics', u'Kaketsuken', u'ImmunoBiosciences Inc', u'Sun Pharmaceutical Industries Ltd', u'Medicines for Malaria Venture', u'Agency For Science Technology & Research', u'Caliber Biotherapeutics', u'Global Health Innovative Technology Fund', u'Atomo Diagnostics Pty Ltd', u'National Center for Research Resources', u'Tamir Biotechnology Inc', u'Medigen Biotechnology Corp', u'Glasgow University', u'Alnylam Pharmaceuticals Inc', u'RecipharmCobra Biologics', u'PTC Therapeutics Inc', u'National Health and Medical Research Council', u'Nagasaki University', u'Oneness Biotech Co Ltd', u'Acuvax Ltd', u'Research Institute for Tropical Medicine', u'Globavir Biosciences Inc', u'Greffex Inc', u'Duke-NUS Graduate Medical School', u'BRIM Biotechnology Inc', u'Photochem Laboratories Pvt Ltd', u'Wellcome Trust', u'Indian Government Department of Biotechnology', u'Georgetown University', u'Heber Biotec SA', u'MerLion Pharmaceuticals Pte Ltd', u'Georgetown University Medical Center', u'Vanderbilt University', u'Catholic University of Leuven', u'Avanti Therapeutics', u'SIGA Technologies Inc', u'University of Rochester Medical Center', u'VABIOTECH', u'Monash University', u'OPKO Health Inc', u'ViveBio LLC', u'AltraVax Inc', u'US Government', u'World Health Organization', u'Qrono Inc', u'ViroPharma Inc', u'Scripps Research Institute', u'Codevax Inc', u'Plex Pharmaceuticals', u'Echo Therapeutics Inc', u'VLP Therapeutics LLC', u'Center for Genetic Engineering and Biotechnology', u'Janssen Pharmaceutica NV', u'Meridian Life Science Inc', u'Fibrex Medical R&D GmbH', u'Nanjing University of Technology', u'BluSense', u'Botanic Century (Beijing) Co Ltd', u'Florida Gulf Coast University', u'Singapore General Hospital Pte Ltd', u'University of Melbourne', u'The Binding Site Ltd', u'Merck & Co Inc', u'Themis Bioscience GmbH', u'Guangzhou Institutes of Biomedicine and Health', u'University of North Carolina', u'Excivion Ltd', u'Biotron Ltd', u'Undisclosed', u'Enantigen Therapeutics Inc', u'Ennaid Therapeutics', u'European Lead Factory', u'Harvard Medical School', u'Finlay Institute', u'Defyrus Inc', u'University of Texas System', u'Codagenix Inc', u'Malaysian Technology Development Corp', u'BioNet-Asia Co Ltd', u'International Center for Genetic Engineering and Biotechnology (ICGEB)', u'InViragen LLC', u'Medivir AB', u'Xenetic Biosciences Inc', u'Massachusetts Institute of Technology', u'Oregon Health Sciences University', u'Isotechnika Pharma Inc', u'US Army Medical Research and Materiel Command', u'Pediatric Dengue Vaccine Initiative', u'Henry M Jackson Foundation for the Advancement of Military Medicine', u'Abivax', u'Centro De Investigaci\\xf3n Y Asistencia En Tecnolog\\xeda Y Dise\\xf1o Del Estado De Jalisco Ac(Ciatej Ac)', u'Instituto Butantan', u'Sentinext Therapeutics Sdn Bhd', u'Centers for Disease Control and Prevention', u'US Naval Medical Research Center', u'The Vaccine and Gene Therapy Institute of Florida', u'US Army Medical Research Institute of Infectious Diseases', u'SKAU Vaccines ApS', u'Sabin Vaccine Institute', u'Evolva SA', u'University of Pennsylvania', u'United Therapeutics Corp', u'Biological Mimetics Inc', u'University of Wisconsin-Madison', u'Sanford-Burnham Medical Research Institute', u'Midatech Pharma PLC', u'Emergex Vaccines Limited', u'Kineta Inc', u'Isla Lab Products LLC', u'Aix-Marseille Universit\\xe9', u'The Paul G. Allen Family Foundation', u'Johns Hopkins University', u'International Vaccine Institute', u'University of Washington', u'Johnson & Johnson', u'Arisan Therapeutics Inc', u'Arbovax Inc', u'Institute For Medical Research (Inc In Malaysia)', u'Australian Government', u'Academia Sinica', u'CaPtivate Pharmaceuticals LLC', u'University of California at Berkeley', u'National Institute of Allergy and Infectious Diseases', u'Mahidol University', u'SEEK', u'Peptimmune Inc', u'MacroGenics Inc', u'The Australian National University', u\"St Jude Children's Research Hospital\", u'National Institutes of Health', u'Bill & Melinda Gates Foundation', u'Sarepta Therapeutics Inc', u'Global Vaccines Inc', u'Dengue Vaccine Initiative', u'National Medical Research Council (NMRC), Singapore', u'Molplex Pharmaceuticals', u'National Institute of Virology', u'European Vaccine Initiative', u'Imperial College London', u'Astellas Pharma Inc', u'Effecta Pharma', u'National Science & Technology Development Agency (NSTDA)', u'60\\xb0 Pharmaceuticals LLC', u'Ranbaxy Laboratories Ltd', u'Chembio Diagnostic Systems Inc', u'BioDiem Ltd', u'Institut Pasteur', u'NanoViricides Inc', u'BIO Ventures for Global Health', u'Cyto Pulse Sciences Inc', u'Crucell NV', u'Hawaii Biotech Inc', u'Chiang Mai University', u'Ikaria Inc', u'VaxInnate Corp', u'German Federal Ministry of Education and Research', u'Singapore Immunology Network']), u'Sepsis': set([u'Clinical Data Inc', u'Takeda Vaccines Inc', u'US Government', u'BioVeris Corp', u'Biocartis', u'BioCritica Inc', u'European Commission', u'Iroko Pharmaceuticals LLC', u'US Health and Human Services Department', u'Global Clean Energy Holdings Inc', u'Emerge Health Pty Ltd', u\"Cincinnati Children's Hospital Medical Center\", u'Ministry of Health, Welfare and Family Affairs', u'T2 Biosystems Inc', u'VGX Pharmaceuticals LLC', u'Cytheris SA', u'Spectral Medical Inc', u'Immunex Corp', u'Aventis Pharma AG', u'TheraSource LLC', u'SignaBlok Inc', u'MedImmune LLC', u'The Austrian Research Promotion Agency FFG', u'University of Pittsburgh', u'Cell Biologics Inc', u'Creabilis Therapeutics Srl', u'University of Pennsylvania', u'GDI Integrated Facility Services Inc', u'National Endowment for Science, Technology and the Arts', u'Sumitomo Pharmaceuticals Co Ltd', u'Biotempt BV', u'Lawson Health Research Institute', u'ImmunNovative Developments SL', u'Galapagos NV', u'Hansa Medical AB', u'Implicit Bioscience Ltd', u'Huons Co Ltd', u'Cyon Therapeutics', u'Cognosci Inc', u'Meditrade Ltd', u'Toray Industries Inc', u'Pohang University of Science & Technology', u'Teijin Ltd', u'Defense Advanced Research Projects Agency', u'US Department of Defense', u'Orient Europharma', u'National Research Council of Canada', u'National Institute of General Medical Sciences', u'Academic Medical Center, University of Amsterdam', u'Tianjin Chase Sun Pharmaceutical Co Ltd', u'TFS AB', u'Behringwerke AG', u'Yabao Pharmaceutical Group Co Ltd', u'National Institute for Health Research (NIHR)', u'US Army Research Office', u'Endacea Inc', u'National Heart Lung and Blood Institute', u'Hallym University', u'Novartis AG', u'Zephyr Sciences Inc', u'Genesis Biomedical Ltd', u'Vanderbilt University', u'Tonghua Dongbao Pharmaceutical Co Ltd', u'Agennix AG', u'National Taiwan University', u'GlaxoSmithKline plc', u'Medical Research Council', u'Merus Labs International Inc', u'Thermo Fisher Scientific Inc', u'Callisto Pharmaceuticals Inc', u'Friedrich Schiller University of Jena', u'TiGenix NV', u'Navigen Inc', u'Samsung Electronics Co Ltd', u'Seoul Pharma Co Ltd', u'Taiho Pharmaceutical Co Ltd', u'United States Army Institute of Surgical Research', u'ImmuneXpress', u'MegaPharm Ltd', u'Cardinal Therapeutics Inc', u'University of Barcelona', u'LG Chem Ltd', u'Exponential Biotherapies Inc', u'Encysive Pharmaceuticals Inc', u'Fibrex Medical R&D GmbH', u'Tenax Therapeutics Inc', u'Sumitomo Metal Industries Ltd', u'Fuso Pharmaceutical Industries Ltd', u'Swedish Orphan Biovitrum AB', u'Debiopharm SA', u'Curetis AG', u'Institute For Hepatitis & Virus Research', u'InflaRx GmbH', u'Armaghan Salamat Kish Group', u'The Macfarlane Burnet Institute For Medical Research & Public Health Ltd', u'Revotar Biopharmaceuticals AG', u'Allergan plc', u'Medial Ltd', u'Nautilus Biotech SA', u'AyuVis Research Ltd', u'Merck Serono SA', u'Sumitomo Dainippon Pharma Co Ltd', u'EpiStem Ltd', u'XOMA Corp', u'Bio-Rad Laboratories Inc', u'CytoSorbents Corp', u'Genzyme General', u'Celonic AG', u'Sanofi', u'University College London', u'Feinstein Institute for Medical Research', u'Eli Lilly & Co', u'OncoImmune Inc', u'Epimmune Inc', u'Medinox Inc', u'University of Virginia', u'Singulex Inc', u'BRAHMS AG', u'Janssen Biotech Inc', u'rEVO Biologics Inc', u'Biosidus SA', u'AstraZeneca plc', u'Pfizer Inc', u'Peregrine Renovations LLC', u'Sungkyunkwan University', u'Adenosine Therapeutics LLC', u'Vertex Pharmaceuticals Inc', u'Toyama Chemical Co Ltd', u'Wyeth', u'Vernalis plc', u'University of Illinois', u'Boehringer Ingelheim Corp', u'Atox Bio Inc', u'Johnson & Johnson', u'Axis-Shield Asa', u'Purdue University', u'University of Michigan', u'Australian Government', u'University of Western Australia', u'Apogenix GmbH', u'National Institute of Allergy and Infectious Diseases', u'AM-Pharma Holding BV', u'DevCo Pharmaceuticals Ltd', u'Curacyte AG', u'Takeda Pharmaceutical Co Ltd', u'Taisho Pharmaceutical Co Ltd', u'Pathogenex GmbH', u'Dong-A University', u'Ohio State University', u'Armour Pharmaceuticals Co Ltd', u'Protherics plc', u'Albert Einstein College of Medicine', u'National Institutes of Health', u'Bill & Melinda Gates Foundation', u'University of Tokyo', u'ProMetic Life Sciences Inc', u'University of California Davis', u'Achaogen Inc', u'Bristol-Myers Squibb Co', u'Chinese Government', u'Acumen Research Laboratories Pte Ltd', u'Axis-Shield plc', u'Lyntek Medical Technologies Inc', u'Aronora Inc', u'Southwest Hospital Chongqing', u'Critical Therapeutics Inc', u'Imperial College London', u'Dong Wha Pharmaceutical Co Ltd', u'Objectif Recherche VACcin Sida', u'Undisclosed', u'Yung-Shin Pharmaceutical Industry Co Ltd', u'Abionic SA', u'Mabworks Biotech Co Ltd', u'University of Western Ontario', u'Nuron Biotech Inc', u'Adrenomed AG', u'Lascco SA', u'Chungbuk National University', u'Sepsicure LLC', u'Oneday - Biotech & Pharma Ltd', u'Ikaria Inc', u'Ortho-Clinical Diagnostics Inc', u'German Federal Ministry of Education and Research', u'13Therapeutics Inc']), u'Partialseizure': set([u'UCB SA', u'Otsuka Pharmaceutical Co Ltd']), u'Parasiticinfection': set([u'LeukoSite Inc', u'Walter Reed Army Institute of Research', u'University of Queensland', u'Shionogi Inc', u'Novo Nordisk A/S', u'iCo Therapeutics Inc', u'Inagen Aps', u'Undisclosed', u'SCYNEXIS Inc', u'Center for Discovery and Innovation in Parasitic Diseases', u'Romark Laboratories LC', u'Morvus Technology Ltd', u'Upstream Biosciences Inc', u'Czech Academy of Sciences', u'Drugs for Neglected Diseases Initiative', u'BioChem Therapeutic Inc', u'Onxeo SA', u'GlaxoSmithKline plc', u'ProMetic Life Sciences Inc', u'University of Granada', u'New York University', u'Protherics plc', u'University of Bristol', u'National Institutes of Health', u'Bill & Melinda Gates Foundation', u'University of Tokyo', u'Center for Infectious Disease Research', u'MV Lomonosov Moscow State University', u'University of California', u'MabVax Therapeutics Holdings Inc', u'Merck & Co Inc', u'Medicines for Malaria Venture', u'University of South Florida', u'Auburn University', u'Imaxio', u'Concordia Pharmaceuticals Inc', u'University of British Columbia', u'Mycosynthetix Inc', u'University of North Carolina', u'Georgia State University', u'Cellectis SA', u'Horizon Orphan LLC', u'Glaxo Group Ltd', u'McGill University', u'The University of Liverpool', u'Epichem Pty Ltd', u'VitamFero SAS', u'Pfizer Inc', u'Global Health Innovative Technology Fund', u'University of Valencia', u'Lupin Ltd', u'Solubest Ltd', u'Immtech Pharmaceuticals Inc', u'Murdoch University', u'Zalicus Inc', u'Abide Therapeutics Inc', u'National Institute of General Medical Sciences', u'Guo Kang Pharmaceutical & Medical Supplies Ltd']), u'Adenovirusinfection': set([u'US Government', u'Oxford University Innovation', u'Henderson Morley plc', u'Oxxon Therapeutics Ltd', u'Therapeutic Systems Research Laboratories', u'Defyrus Inc', u'National Institute of Allergy and Infectious Diseases', u'TheraCour Pharma Inc', u'Croma Pharma GmbH', u'Cancer Prevention and Research Institute of Texas', u'Adenovir Pharma AB', u'Advanced Viral Research Corp', u'National Institutes of Health', u'Food and Drug Administration', u'University of California', u'Brookhaven National Laboratory', u'Lovelace Respiratory Research Institute', u'Chimerix Inc', u'University College London', u'Protein Sciences Corp', u'Cell Medica Ltd', u'Walter Reed Army Institute of Research', u'VINNOVA', u'NanoViricides Inc', u'Ohr Pharmaceutical Inc', u'Barr Pharmaceuticals Inc', u'Viracyte', u'AB ANALITICA', u'Wilson Wolf Manufacturing Corp', u'PaxVax Inc', u'BioReliance Corp', u'Technology Strategy Board', u'SIGA Technologies Inc', u'Mobidiag Oy', u'National Heart Lung and Blood Institute', u'Umea University', u'US Department of Defense', u'Undisclosed']), u'Hairycellleukemia': set([u'Roche Holding AG', u'Enzon Pharmaceuticals Inc', u'Pfizer Inc', u'National Institutes of Health', u'Genentech Inc', u'Hospira Inc', u'Beijing Kawin Technology Share-Holding Co Ltd', u'Wyeth', u'Weizmann Institute of Science', u'Teva Pharmaceutical Industries Ltd', u'Scripps Research Institute', u'Italfarmaco SpA', u'Ortho Biotech Products LP', u'Abbott Laboratories', u'Astex Pharmaceuticals Inc', u'Merck Serono SA', u'Sahar International Trading Inc']), u'Respiratoryfailure': set([u'German Government', u'Hemovent GmbH']), u'Proteinenergydeficiency': set([u'DaVita Clinical Research', u'Atara Biotherapeutics Inc']), u'Perennialallergicrhinitis': set([u'Dr Beckmann Pharma GmbH', u'Sunovion Pharmaceuticals Inc', u'Kaken Pharmaceutical Co Ltd', u'Teamm Pharmaceuticals', u'Kyorin Pharmaceutical Co Ltd', u'Farmalab Ltda', u'Collegium Pharmaceutical Inc', u'Roxall Medizin GmbH']), u'Demyelinatingdisease': set([u'Neuralstem Inc', u\"UCSF Benioff Children's Hospital\", u'NeuroSpheres Ltd', u'Johns Hopkins University', u'Dyax Corp', u'Ciba-Geigy AG', u'Sumitomo Dainippon Pharma Co Ltd', u'Koken Co Ltd', u'Myelin Repair Foundation Inc', u'US Government', u'Biogen Inc', u'Maryland Stem Cell Research Fund', u'Microbot Medical Inc']), u'Ironoverload': set([u'US Government', u'Merganser Biotech Inc', u'University of Florida', u'Protagonist Therapeutics Inc', u'Kang Ning Pharmaceutical Co Ltd', u'National Institute of Diabetes, Digestive and Kidney Diseases', u'Cipla Ltd', u'Weill Medical College of Cornell University', u'GlaxoSmithKline plc', u'BL&H Co Ltd', u'SunPharm Corp', u'Chiesi Farmaceutici SpA', u'Eunice Kennedy Shriver National Institute of Child Health & Human Development', u'Apotex Inc', u'National Institutes of Health', u'Teva Pharmaceutical Industries Ltd', u'Zealand Pharma A/S', u'INSERM', u'Panorama Research Inc', u'University of Michigan', u'La Jolla Pharmaceutical Co', u'BTG plc', u'ZoneOne Pharma Inc', u'Xenon Pharmaceuticals Inc', u'Heart Research Institute Ltd', u'Nanotherapeutics Inc', u'Biomedical Frontiers Inc', u'University of California Los Angeles', u'Genome Canada', u'Schein Pharmaceutical Inc', u'PolyNovo Ltd', u'National Heart Lung and Blood Institute', u'Hemosol Inc', u'Universite de Sherbrooke']), u'Neoplasm': set([u'Sanofi-Aventis US LLC', u'Scil Technology GmbH', u'ADC Therapeutics Sarl', u'Shenzhen Chipscreen Biosciences Ltd', u'Champions Oncology Inc', u'Life Technologies Corp', u'Seattle Genetics Inc', u'Intracel Corp', u'Celldex Therapeutics Inc', u'T.J. Martell Foundation', u'Inventiv Health Clinical Inc', u'Mycosearch Inc', u'Ambrx Inc', u'Cellectis SA', u'Aviragen Therapeutics Inc', u'Syren Pharmaceuticals Ltd', u'Shanghai Fosun Pharmaceutical (Group) Co Ltd', u'Sandoz Ltd', u'Sorrento Therapeutics Inc', u'Clinipace', u'Weill Medical College of Cornell University', u'PDL BioPharma Inc', u'Centre National de la Recherche Scientifique (CNRS)', u'AADi LLC', u'Acino Holding AG', u'Cambridge Antibody Technology Group plc', u'Rega Institute for Medical Research', u'Weill Cornell Medical College, USA', u'Hanmi Pharmaceutical Co Ltd', u'YM BioSciences Inc', u'JCR Pharmaceuticals Co Ltd', u'Les Laboratoires Servier', u'Molecular Response', u'Starpharma Holdings Ltd', u'CSPC Zhongqi Pharmaceutical Technology (Shijiazhuang) Co Ltd', u'Itm Isotopen Technologien M\\xfcnchen Ag', u'Link Health Group', u'20/20 HealthCare Partners LLC', u'Tusk Therapeutics Ltd', u'Ludwig-Maximilians University of Munich', u'Prometheus Laboratories Inc', u'Ajinomoto Co Inc', u'Medimmune Oncology Inc', u'Sentinel Oncology Ltd', u'Abpro Inc', u'Undisclosed', u'Sakai Chemical Industry Co Ltd', u'Schering Overseas Ltd', u'Sprint Bioscience', u'Domainex Ltd', u'Vion Pharmaceuticals Inc', u'Eli Lilly & Co', u\"Lee's Pharmaceutical Holdings Limited\", u'University of Wisconsin-Madison', u'Phyton Biotech Inc', u'Neogen NV', u'Government of Russia', u'NanoString Technologies Inc', u'Scienion AG', u'Corixa Corp', u'Cancer Research Technology Ltd', u'Daan Gene Co Ltd of Sun Yat-Sen University', u'HalioDx', u'Harbor Therapeutics Inc', u'Oxford University Innovation', u'Innate Pharma SA', u'ETH Zurich', u'F-star Biotechnologische Forschungs-und Entwicklungs GmbH', u'Xencor Inc', u'Horizon Discovery Group plc', u'Boston Scientific Corp', u'University of Amsterdam', u'Institut Gustave Roussy', u'Cancer Prevention and Research Institute of Texas', u'Asterand Bioscience Inc', u'Molecular Templates Inc', u'Bristol-Myers Squibb Co', u'Active Motif LLC', u'Integra LifeSciences Holdings Corp', u'MDxHealth SA', u'Astellas Pharma Inc', u'Oncormed Inc', u'Oncodesign Biotechnology SA', u'Power3 Medical Products Inc', u'ImaginAb Inc', u'Society of Interventional Oncology (SIO)', u'Ipsen Biopharmaceuticals Inc', u'Mera Pharmaceuticals Inc', u'Barbara Ann Karmanos Cancer Institute', u'Caisse de d\\xe9p\\xf4t et placement du Qu\\xe9bec', u'Adaptive Biotechnologies Corp', u'Orion Corporation', u'BTG plc', u'Centelion SAS', u'Astex Pharmaceuticals Inc', u'Genentech Inc', u'Onyvax Ltd', u'Lead Discovery Center GmbH', u'Mitsubishi-Tokyo Pharmaceuticals Inc', u'Angioblast Systems Inc', u'Roche Holding AG', u'Alchemia Ltd', u'Biocompatibles International plc', u'Medidata Ft Inc', u'TESARO Inc', u'Genyous Biomed International Inc', u'Bayer HealthCare AG', u'ChemRar High Tech Center', u'Evotec AG', u'SynthRx Inc', u'Amgen Inc', u'Axela Inc', u'EUSA Pharma USA', u'Geron Corp', u'CollabRx Inc', u'Arno Therapeutics Inc', u'Georgetown University Medical Center', u'CleveXel Pharma', u'Novotectid GmbH', u'Warp Drive Bio', u'Enzon Pharmaceuticals Inc', u'Plexxikon Inc', u'IOmet Pharma Ltd', u'University of Edinburgh', u'Inform Genomics Inc', u'Niigata University', u'San Raffaele Hospital', u'Medidata Solutions Worldwide', u'Stanford University', u'Ascepion Pharmaceuticals Inc', u'Aegis Therapeutics LLC', u'Wilex AG', u'LifeArc', u'Scripps Research Institute', u'Australian Research Council', u'Organon Teknika BV', u'University of Southern California', u'Giddi Pharma Co Ltd', u'Alkermes plc', u'CASI Pharmaceuticals Inc', u'Royal Philips Electronics', u'Crown Bioscience Inc', u'MolMed SpA', u'AEterna Zentaris Inc', u'University of Iowa', u'AstraZeneca plc', u'SUGEN Inc', u'Berlin-Brandenburg Center for Regenerative Therapies', u'Terumo Corp', u'Nippon Shinyaku Co Ltd', u'Sirenas Marine Discovery LLC', u'BIND Therapeutics Inc', u'OncoSec Medical Inc', u'ASLAN Pharmaceuticals Pte Ltd', u'INOXIA Lifesciences GmbH', u'SEBIA', u'Applied BioMath LLC', u'Sihuan Pharmaceutical Holdings Group Ltd', u'Spectrum Pharmaceuticals Inc', u'Kyoto University', u'Aronex Pharmaceuticals Inc', u'SBH Sciences', u'INyDIA Labs', u'Medical University of South Carolina', u'National University of Singapore', u'Karyopharm Therapeutics Inc', u'Cyclenium Pharma Inc', u'University of Western Ontario', u'Mersana Therapeutics Inc', u'Takeda Pharmaceutical Co Ltd', u'Innocutis Holdings LLC', u'TopoTarget A/S', u'AgResearch Ltd', u'Beijing Novogene Bioinformatics Technology Co Ltd', u'Ignyta Inc', u'Ventana Medical Systems Inc', u'Silence Therapeutics plc', u'EMD Serono Inc', u'TGen Drug Development', u'Oryzon Genomics SA', u'Yakult Honsha Co Ltd', u'CHA Bio & Diostech Co Ltd', u'Oncobiologics Inc', u'Pre-clinical Oncology Services', u'API Co Ltd', u'SignalChem Life Sciences', u'Pharmatech Inc', u'MedImmune LLC', u'Five Prime Therapeutics Inc', u'Bordeaux INP', u'ARIAD Pharmaceuticals Inc', u'Introgen Therapeutics Inc', u'Bavarian Research Foundation', u'Ludwig Institute for Cancer Research', u'Incuron LLC', u'Keio University', u'Pfizer Inc', u'Optimedx', u'Woodland Pharmaceuticals LLC', u'Leica Mikrosysteme GmbH', u'Harvard University', u'Boehringer Mannheim GmbH', u'Athenex Inc', u'Teva Pharmaceutical Industries Ltd', u'Diatos SA', u'Catholic University of Leuven', u'WuXi PharmaTech (Cayman) Inc', u'Oxford BioTherapeutics', u'Guangzhou Xiangxue Pharmaceutical Co Ltd', u'Ferring Pharmaceuticals SA', u'Imaging Endpoints', u'Jazz Pharmaceuticals plc', u'Boehringer Ingelheim Corp', u'Dauntless Pharmaceuticals Inc', u'Argenta Discovery Inc', u'BioInvent International AB', u'University of Ghent', u'NovaMed Pharmaceuticals Inc', u'Debiopharm SA', u'Consejo Nacional de Ciencia y Tecnolog\\xeda', u'Pantarhei Bioscience BV', u'Open Monoclonal Technologies Inc', u'Tsinghua University', u'Institut Paoli-Calmettes IPC', u'Cangene Corp', u'Schering-Plough Corp', u'CellNetix Pathology & Laboratories LLC', u'Oxford BioMedica plc', u'PCT, a Caladrius company', u'CMC Biologics Inc', u'Hospital for Sick Children', u'Dalian Wanchun Biotech', u'KYOWA Pharmaceutical Industry Co Ltd', u'Cancer Research Campaign (UK)', u'University of California', u'Upjohn Inc', u'rEVO Biologics Inc', u'Sanofi', u'MEDIAN Technologies SA', u'Bayer AG', u'Ascalon International Inc', u'Gilead Sciences Inc', u'AB SCIEX', u'Hannover Medical School', u'Swiss Federal Office of the Commission for Technology and Innovation', u'University of Adelaide', u'Progenics Pharmaceuticals Inc', u'Aptuit Inc', u'Massachusetts Institute of Technology', u'Lonza Group AG', u'Adocia SAS', u'AnaptysBio Inc', u'Ablynx NV', u'Cephalon Inc', u'Celgene Corp', u'Imperial College London', u'AstraZeneca AB', u'KS Biomedix Holdings plc', u'University of Hawaii', u'Mission Pharmacal Co Inc', u'IPCA Laboratories Ltd', u'Dako AG', u'Bayer HealthCare Pharmaceuticals Inc', u'Physiomics plc', u'ProMIS Neurosciences Inc', u'Universite de Bordeaux', u'ValiRx plc', u'ILEX Oncology Inc', u\"Dr Reddy's Laboratories Ltd\", u'US Government', u'Baxter International Inc', u'BioAtla Llc', u'Rosa & Co LLC', u'Structural Genomics Consortium', u'China State Institute of Pharmaceutical Industry', u'UMN Pharma Inc', u'GlaxoSmithKline plc', u'Strategia Therapeutics Inc', u'Covance Inc', u'ZAI Laboratory Inc', u'Cipla-Medpro (Pty) Ltd', u'Ipsen', u'Forge Therapeutics Inc', u'INSERM Transfert', u'Cenix BioScience GmbH', u'Takeda Oncology', u'Aduro BioTech Inc', u'Halozyme Therapeutics Inc', u'Selventa', u'Zhuhai Essex Bio-Pharmaceutical Co Ltd', u'ZoBio BV', u'Histogenex Nv', u'Shionogi & Co Ltd', u'Stanford Rook Ltd', u'Aquitaine Science Transfert', u'NeoGenomics Inc', u'Tangent Reprofiling', u'Advinus Therapeutics Ltd', u'Priaxon AG', u'Daiichi Sankyo Co Ltd', u'Abbott Laboratories', u'UniQuest Pty Ltd', u'Eisai Co Ltd', u'Ganymed Pharmaceuticals AG', u'National Cancer Institute', u'Novartis AG', u'Corvus Pharmaceuticals Inc', u'University of Maryland', u'CeloNova Biosciences Inc', u'Simcere Pharmaceutical Group', u'Corgenix Medical Corp', u'University of Minnesota', u'Monash University', u'University of Manchester', u'NeuClone Pty Ltd', u'Gold Nanotech Inc', u'Solural Pharma Aps', u'Tarveda Therapeutics Inc', u'HitGen Ltd', u'Midatech Pharma US Inc', u'CytRx Corp', u'Lupin Ltd', u'Tapestry Pharmaceuticals Inc', u'Myriad Genetics Inc', u'Czech Academy of Sciences', u'LXR Biotechnology Inc', u'Watson Laboratories Inc', u'Memcine Pharmaceuticals Inc', u'GeneData AG', u'Amarantus BioScience Holdings Inc', u'Ultrafine Chemicals Ltd', u'Actelion Pharmaceuticals Ltd', u'Agendia BV', u'Cellaria Biosciences', u'Mallinckrodt Medical', u'Infusaid LLC', u'MD Anderson Cancer Center', u'FORMA Therapeutics Inc', u'Kyowa Hakko Kirin Co Ltd', u'Medarex Inc', u'Janssen Biotech Inc', u'InfuSystem Holdings', u'Sanford-Burnham Medical Research Institute', u'Saladax Biomedical Inc', u'Vitala Therapeutics', u'Pieris Pharmaceuticals Inc', u'Constellation Diagnostics Inc', u'Memorial Sloan-Kettering Cancer Center', u'Illumina Inc', u'NeoGenesis Pharmaceuticals Inc', u'Tauriga Sciences Inc', u'Biologix FZ Co', u'PEP-Therapy SAS', u'California Institute for Biomedical Research', u'National Institutes of Health', u'Genedrive plc', u'Menarini Asia-Pacific', u'Vaccinogen Inc', u'Oncology Venture ApS', u'Foundation Medicine Inc', u'Siena Biotech SpA', u'Taconic Biosciences Inc', u'Exakta-OPKO', u'Merck Serono SA', u'BeiGene Co Ltd', u'Acusphere Inc', u'NBE-Therapeutics Ltd', u'Mayne Pharma Pty Ltd']), u'Pe': set([u'Medivir AB', u'TetraLogic Pharmaceuticals Corp']), u'Bacterialinfection': set([u'Wired Holdings Investment Corp', u'Roussel Uclaf Corp', u'Syracuse University', u'Takeda Vaccines Inc', u'Lumara Health Inc', u'Unimed Pharmaceuticals Inc', u'UK Ministry of Defence', u'Pharma Integra Ltd', u'University of Hull', u'Nutrition 21 Inc', u'Koebenhavns Universitet', u'Axxess Pharma Inc', u'European Commission', u'Ceragenix Pharmaceuticals Inc', u'PediaMed Pharmaceuticals Inc', u'Technical University of Munich', u'Life Technologies Corp', u'RMX Pharmaceutical Technology Co Ltd', u'Paligent Inc', u'Inovio Pharmaceuticals Inc', u'ViroPharma Inc', u'Eddingpharm Inc', u'Karo Bio', u'GEOM Therapeutics Inc', u'University of Connecticut', u'MethylGene Inc', u'Novacta Biosystems Ltd', u'Seattle Genetics Inc', u'Ionis Pharmaceuticals Inc', u'Novartis Pharma AG', u'Zhaoke Pharmaceutical (Hefei) Co Ltd', u'Health Protection Agency', u'University of Florida', u'Vernalis plc', u'Priaxon AG', u'Hawker Resources Inc', u'Celldex Therapeutics Inc', u'Ferric Technologies Inc', u'Ingenza Ltd', u'Oclassen Pharmaceuticals Inc', u'Walter Reed Army Institute of Research', u'Sumitomo Pharmaceuticals Co Ltd', u'Sungjee IBPharm', u'Chinese Academy of Medical Sciences & Peking Union Medical College', u'Incara Research Laboratories', u'University of California Los Angeles', u'PolyPid Ltd', u'Galapagos NV', u'Spero Therapeutics LLC', u'Beijing Chao-Yang Hospital', u'Polyphor Ltd', u'Handok Inc', u'GLYCODesign Inc', u'The Forsyth Institute', u'Sorrento Therapeutics Inc', u'Biophage Pharma Inc', u'Tanabe Seiyaku Co Ltd', u'Fujifilm Finechemicals Co Ltd', u'Perrigo Co plc', u'DHP Korea Co Ltd', u'Sanofi Pasteur', u'National Research Council of Canada', u'Sigma-Tau Ind Farm Riunite SpA', u'CrystalGenomics Inc', u'LifePharms Inc', u'Academic Medical Center, University of Amsterdam', u'Ercros SA', u'New York University', u'Israeli Government', u'Biomet Merck GmbH', u'Romark Laboratories LC', u'Ardigen SA', u'Sichuan University', u'The European Union', u'Peptor Ltd', u'US Army Research Office', u'Trine Pharmaceuticals Inc', u'LICA Pharmaceuticals A/S', u'Haptogen Ltd', u'GlaxoSmithkline Pharmaceuticals (India) Ltd', u'Promiliad Biopharma Inc', u'Essex Bio-Technology Ltd', u'Agile Sciences Inc', u'Universit\\xe9 De Lorraine', u'Adaptive Phage Therapeutics Inc', u'Forest Laboratories Inc', u'Center for Infectious Disease Research', u'DSM Fine Chemicals', u'Evolva Bio UK Ltd', u'RW Johnson Pharmaceutical Research Institute', u'Vanderbilt University', u'Korea Research Institute of Chemical Technology', u'Concordia Pharmaceuticals Inc', u'Agennix AG', u'Neuron Bio SA', u'Curza Global LLC', u'Brigham Young University', u'Warner-Lambert Co', u'Nosocomial Vaccine Corp', u'Toyama Chemical Co Ltd', u'ANTABIO', u'Aptose Biosciences Inc', u'Wellcome Trust', u'Kyorin Pharmaceutical Co Ltd', u'Starpharma Holdings Ltd', u'Provalis plc', u'MegaPharm Ltd', u'Amplyx Pharmaceuticals Inc', u'Biofrontera Discovery GmbH', u'Pharmacia & Upjohn AB', u'Janssen Pharmaceutica NV', u'Institut Pasteur Korea', u'Helsinn Healthcare SA', u'Exponential Biotherapies Inc', u'Tianjin International Joint Academy of Biotechnology and Medicine', u'Chrysalis BioTechnology Inc', u'Academisch Ziekenhuis Leiden', u'NatImmune A/S', u'Biomolecular Research Institute Ltd', u'Accium Biosciences Inc', u'Ondine Biomedical Inc', u'Rutgers University', u'Swedish Orphan Biovitrum AB', u'Biochemie GmbH', u'Bausch & Lomb Inc', u'AmpliMed Corp', u'Atox Bio Inc', u'Northern Antibiotics Ltd', u'Questcor Pharmaceuticals Inc', u'Otsuka Holdings Co Ltd', u'Palacky University', u'J2h Biotech', u'Biothera Pharmaceuticals Inc', u'Dong-A ST Co Ltd', u'Shandong New Time Pharmaceutical Co Ltd', u'BioVersys AG', u'Kosan Biosciences Inc', u'Flamel Technologies SA', u'Atriva Therapeutics GmbH', u'North Bristol NHS Trust', u'NovaDigm Therapeutics Inc', u'Undisclosed', u'Emergent BioSolutions Inc', u'Chia Tai Tianqing Pharmaceutical Group Co Ltd', u'NexThera Biosciences', u'Daewoong Pharmaceutical Co Ltd', u'Unilever', u'The Althexis Co Inc', u'LEO Pharma A/S', u'Domainex Ltd', u'Southwest Research Institute (SwRI)', u'Eli Lilly & Co', u'Centers for Disease Control and Prevention', u'GlaxoSmithKline Biologicals', u'PolyMedix Inc', u'CSL Ltd', u'MediLoc Laborsysteme GmbH', u'LegoChem Bioscience Inc', u'Essential Science Ltd', u'University of Maryland College Park', u'Argenta Discovery Ltd', u'Bracco SpA', u'Asubio Pharma Co Ltd', u'University of Cincinnati', u'Corixa Corp', u'Nanjing Forestry University', u'Quiescence Technologies LLC', u'University of Maryland', u'Johns Hopkins University', u'Cytran Inc', u'Beactica AB', u'Johnson & Johnson', u'Coley Pharmaceutical Group Inc', u'China Pharmaceutical University', u'Kansas State University', u'Blueberry Therapeutics Ltd', u'University of Washington', u'Singapore Health Services Pte Ltd', u'East of England Development Agency', u'SmithKline Beecham plc', u'Mpex Pharmaceuticals Inc', u'Korea Advanced Institute of Science and Technology', u'ImmuPharma plc', u'Program for Appropriate Technology in Health', u'Peninsula Pharmaceuticals Inc', u'Takeda Pharmaceutical Co Ltd', u'EpiBiome Inc', u'Innothera', u'Regione Toscana', u'Arrow Therapeutics Ltd', u'Achaogen Inc', u'Bristol-Myers Squibb Co', u'Bayer Pharmaceuticals Corp', u'NeXstar Pharmaceuticals Inc', u'PanTherix Ltd', u'Victory Pharma Inc', u'Rush University Medical Center', u'Auburn University', u'Protea Vaccine Technologies Ltd', u'Chinese Academy of Sciences', u'Qingdao University of Science and Technology', u'University of Bath', u'Astellas Pharma Inc', u'University of Constance', u'Cornerstone BioPharma Inc', u'Tanox Inc', u'Zoetis Inc', u'DoctorDirectory', u'Chungnam National University', u'Oscient Pharmaceuticals Corp', u'Novexel SA', u'Hebrew University of Jerusalem', u'MaxThera Inc', u'Enamine Ltd', u'Sandoz Pharmaceuticals Corp', u'Hoechst Marion Roussel Inc', u'Wakamoto Pharmaceutical Co Ltd', u'Alopexx Pharmaceuticals', u'Zannan Scitech Co Ltd', u'Sichuan BoXin LaiTe Biotechnology Inc', u'Targanta Therapeutics Inc', u'Vicuron Pharmaceuticals Inc', u'SK Chemicals Co Ltd', u'SARomics AB', u'University of Strathclyde', u'Ardea Biosciences Inc', u'CytoGenix Inc', u'Pharmacia & Upjohn SpA', u'Polydex Pharmaceuticals Ltd', u'Apeloa Pharmaceutical Co Ltd', u'Howard Hughes Medical Institute', u'BTG plc', u'TTY Biopharm Co Ltd', u'University of Bonn', u'Chiesi Farmaceutici SpA', u'Galleon Pharmaceuticals LLC', u'Chiron Corp', u'OOO VagaPharm', u'North Carolina State University', u'Phagelux Inc', u'TaiGen Biotechnology Co Ltd', u'Y B Chavan College of Pharmacy', u'US Department of Veterans Affairs', u'Chinese Government', u'Fuzhou University', u'ArQule Inc', u'Stanford University', u'Biomar Microbial Technologies', u'Clonmel Healthcare', u'Dynamic Microbials Ltd', u'New Anti Infectives Consortium', u'Stabilitech Ltd', u'Contraceptive Research and Development Organization', u'Alchemia Ltd', u'Chaperone Technologies Inc', u'University of British Columbia', u'Sumitomo Seika Chemicals Co Ltd', u'Microcide Pharmaceuticals Inc', u'Sandoz Ltd', u'Searchlight Minerals Corp', u'University of Munster', u'The National Institute of Mental Health', u'Check-Points BV', u'Hovione Inter Ltd', u'NAUKA', u'Entasis Therapeutics', u'Temple University', u'Binational Industrial Research and Development Foundation', u'Intercell AG', u'Xian-Janssen Pharmaceutical Ltd', u'Otsuka Pharmaceutical Co Ltd', u'Biotica Technology Ltd', u'Emergent Europe Ltd', u'Inspire Pharmaceuticals Inc', u'Pherecydes Pharma', u'Nosopharm SAS', u'Miyarisan Pharmaceutical Co Ltd', u'Evotec AG', u'Fujisawa Healthcare Inc', u'Meiji Seika Pharma Co Ltd', u'Institute of Organic Chemistry And Biochemistry of The Academy of Sciences of The Czech Republic', u'Maruho Co Ltd', u'Karo Pharma AB', u'University of Sheffield', u'State University of New York at Stony Brook', u'Coelacanth Corp', u'e-Therapeutics Plc', u'Endo Pharmaceuticals Solutions Inc', u'EUSA Pharma USA', u'Lonza Walkersville Inc', u'Hoechst Marion Roussel SA (France)', u'LFB SA', u'Molsoft LLC', u'University of Bristol', u'Trius Therapeutics Inc', u'Innocoll AG', u'SRI International', u'Bruker Corporation', u'Absynth Biologics Ltd', u'Array BioPharma Inc', u'Madam Therapeutics BV', u'Acura Pharmaceuticals Inc', u'Shaanxi Synthetic Pharmaceutical Co Ltd', u'Massachusetts General Hospital', u'Medical Research Council', u'Ethicor Pharma Ltd', u'Enzon Pharmaceuticals Inc', u'EndoBiologics Inc', u'ACS Dobfar SpA', u'Basilea Pharmaceutica International Ltd', u'Pennsylvania State University', u'Swedish University of Agricultural Science', u'PepTx Inc', u'YuanSci Bio-Tech (Tianjin) Co Ltd', u'Albany Molecular Research Inc', u'Oxford Drug Design', u'Astral Pharmaceutical Industries', u'Allergan Inc', u'LG Chem Ltd', u'The Research Council of Norway', u'University of California San Diego', u'Wyeth-Ayerst Pharmaceuticals Inc', u'Wakunaga Pharmaceutical Co Ltd', u'Medivir AB', u'F Hoffmann-La Roche AG', u'University of Oxford', u'Novolytics Ltd', u'Warwick University', u'Univ Massachusetts', u'Ohio State University', u'MiddleBrook Pharmaceuticals Inc', u'Green Cross Corp', u'Tularik Inc', u'Dr Babasaheb Ambedkar Marathwada University', u'Genentech Inc', u'Biosearch Italia SpA', u'Paladin Labs Inc', u'Newton Fund', u'Mayo Clinic Foundation', u'Natural Sciences and Engineering Research Council of Canada', u'DelSite Biotechnologies Inc', u'Tokyo Institute of Technology', u'Sumitomo Dainippon Pharma Co Ltd', u'Roussel Uclaf SA', u'Rhone-Poulenc SA', u'LifeArc', u'Actavis Inc', u'Nanosphere Inc', u'Microbiotix Inc', u'Venus Remedies Ltd', u'Sequella Inc', u'PDL BioPharma Inc', u'ID Genomics Inc', u'Scripps Research Institute', u'Australian Research Council', u'CUBRC', u'Centre National de la Recherche Scientifique (CNRS)', u'Genzyme General', u'French Government', u'Ironwood Pharmaceuticals Inc', u'Medison Pharma Ltd', u'BioFocus DPI', u'Verax Biomedical Inc', u'La Jolla Pharmaceutical Co', u'Altimmune Inc', u'Sequoia Sciences Inc', u'Commense Inc', u'ActivBiotics Inc', u'Pierre Fabre SA', u'AiCuris Anti-infective Cures GmbH', u'Universitat Innsbruck', u'Life Sciences Greenhouse of Central Pennsylvania', u'R-Pharm', u'Adimab LLC', u'China Medical System Holdings Ltd', u'Cubist Pharmaceuticals Inc', u'AstraZeneca plc', u'Technology Strategy Board', u'Cardiovascular Systems Inc', u'Mobidiag Oy', u'Suez Canal University', u'North China Pharmaceutical Group Corp (NCPC)', u'PharmaSwiss SA', u'University of Utah', u'University College London', u'Aviragen Therapeutics Inc', u'Dr Karl Thomae GmbH', u'Nippon Shinyaku Co Ltd', u'SIGA Technologies Inc', u'University of Plymouth', u'Australian Government', u'bioMerieux SA', u'Tranzyme Pharma Inc', u'US Naval Medical Research Center', u'Nippon Soda Co Ltd', u'AM-Pharma Holding BV', u'Pharmos Corp', u'Nitten Pharmaceutical Co. Ltd', u'Dainippon Pharmaceutical Co Ltd', u'Alfa Wassermann SpA', u'Top Institute Pharma', u'Inimex Pharmaceuticals Inc', u'BioResearch Ireland', u'Eskitis Institute for Cell and Molecular Therapies', u'deCODE chemistry', u'Lepetit International Inc', u'Zuellig Pharma Holdings Pte Ltd', u'British Biotech Inc', u'University of Technology Sydney', u'Trellis Bioscience Inc', u'Innoviva Inc', u'Novalar Pharmaceuticals Inc', u'Bristol-Myers Squibb Pharma Co', u'Allecra Therapeutics GmbH', u'Dong Wha Pharmaceutical Co Ltd', u'Engineering and Physical Sciences Research Council', u'Medical University of South Carolina', u'Alpha-Beta Technology Inc', u'PLIVA dd', u'Cyclenium Pharma Inc', u'BioDiem Ltd', u'Institut Pasteur', u'Ocean Pharmaceuticals Inc', u'GLSynthesis Inc', u'Walter and Eliza Hall Institute of Medical Research', u'Korea Pharma Co Ltd', u'Barr Pharmaceuticals Inc', u'Dyax Corp', u'Antitope Ltd', u'3M Co', u'University of Toronto', u'CHD Bioscience Inc', u'University of Cambridge', u'Novozymes A/S', u'SPA Societa Prodotti Antibiotici SpA', u'Amura Technologies Ltd', u\"Dr Reddy's Laboratories Ltd\", u'Molecular Targeting Technologies Inc', u'DRAXIMAGE', u'Nippon Wyeth KK', u'CPBS', u'Isogenica Ltd', u'Cardinal Health Inc', u'Tanner Pharma Group Plc', u'Oragenics Inc', u'Centre for Drug Research and Development', u'Maxygen Inc', u'ASKA Pharmaceutical Co Ltd', u'Global Clean Energy Holdings Inc', u'University of Cologne', u'Sichuan Saizhuo Pharmacy Co Ltd', u'RGM Media Ltd', u'Valevia UK', u'University of Wurzburg', u'SGX Pharmaceuticals Inc', u'MerLion Pharmaceuticals Pte Ltd', u'Kukje Pharmaceuticals', u'Aventis Pharma AG', u'University of Siena', u'Arch Biopartners Inc', u'SetLance srl', u'MedImmune LLC', u'Par Pharmaceutical Co Inc', u'MeMed Diagnostics Ltd', u'Roche Diagnostics GmbH', u'Imperial College London', u'Leiden University Medical Center', u'Apotex Inc', u'UCB SA', u'University of London', u'City University of New York', u'Nobelex Biotech Inc', u'University of Manitoba', u'Hyglos GmbH', u'Pharmacia & Upjohn Co', u'Implicit Bioscience Ltd', u'NanoBio Corp', u'RiboTargets Ltd', u'University of Kentucky', u'Southern Methodist University', u'Genesoft Inc', u'Agency For Science Technology & Research', u'ModeRNA Therapeutics', u'InGen Biosciences', u'Defense Advanced Research Projects Agency', u'Pfizer Inc', u'Vertex Pharmaceuticals Inc', u'Gen-Probe Inc', u'Pragma Pharmaceuticals LLC', u'TAXIS Pharmaceuticals Inc', u'Hikma Pharmaceuticals plc', u'PTC Therapeutics Inc', u'Merus Labs International Inc', u'Shenyang Pharmaceutical University', u'Angel Biotechnology Holdings plc', u'Incyte Corp', u'Mylan Inc', u'Biota Holdings Ltd', u'Dairy Australia', u'SymbioPharm GmbH', u'Harvard University', u'WuXi PharmaTech (Cayman) Inc', u'Alberta Peptide Institute', u'Microheart Inc', u'Lawrence Livermore National Laboratory', u'SEQUUS Pharmaceuticals Inc', u'Austell Laboratories', u'Affinium Pharmaceuticals Inc', u'UMeWorld Ltd', u'DSM Sinochem Pharmaceuticals Ltd', u'International Vaccine Institute', u'Zeneca Group plc', u'Helicon Group Ltd', u'Purdue Pharma LP', u'Cetek Corp', u'Emisphere Technologies Inc', u'Universite Libre de Bruxelles', u'Angelini Pharmaceuticals SpA', u'Osel Inc', u'AvidBiotics Corp', u'Cytran Ltd', u'OPKO Health Inc', u'PCI Biotech Holding ASA', u'Inhibitex Inc', u'Lakewood-Amedex Inc', u'Creative Antibiotics Sweden AB', u'VenatoRx Pharmaceuticals Inc', u'AO Foundation', u'Carrus Capital Corp', u'Resolution Pharmaceuticals Inc', u'Korea Institute Of Energy Research', u'Prolysis Ltd', u'Glaxo Group Ltd', u'Novosci', u'SK Chemicals Life Science', u'Guangzhou General Pharmaceutical Research Institute Co Ltd', u'Fujirebio Europe NV', u'GlycoVaxyn AG', u'Boehringer Ingelheim Corp', u'Achillion Pharmaceuticals Inc', u'BioLeap LLC', u'Ferring Pharmaceuticals SA', u'University of Melbourne', u'University of Ghent', u'Patheon Inc', u'Debiopharm SA', u'Roche Holding AG', u'Good Doctor Pharmaceutical Group Co Ltd', u'Changzhou Longthera Pharmaceuticals Inc', u'Quidel Corp', u'Universidade de Santiago de Compostela', u'BioRelix Inc', u'LLC \"NC-Bio\"', u'Innovative Medicines Initiative', u'Advanced Life Sciences Holdings Inc', u'Harvard Medical School', u'Intralytix Inc', u'Cipla Ltd', u'NeoGenesis Pharmaceuticals Inc', u'Cangene Corp', u'Unimedic AB', u'CMC Biologics Inc', u'LTL Pharma Co Ltd', u'Baxter Healthcare Corp', u'Shanghai Institute of Materia Medica of the Chinese Academy of Sciences', u'Shaanxi XinAn Medical Science and Technology Co Ltd', u'Medical College of Wisconsin', u'State Research Center of Virology and Biotechnology VECTOR', u'Provid Pharmaceuticals Inc', u'University of California', u'Merck & Co Inc', u'De Novo Pharmaceuticals Ltd', u'Chirologix Pharmaceuticals Inc', u'Sanofi', u'Melinta Therapeutics Inc', u'Chong Kun Dang Pharmaceutical Corp', u'Bayer AG', u'HedgePath Pharmaceuticals Inc', u'US Army Medical Research Institute of Infectious Diseases', u'Phytera Inc', u'IHM Labs', u'Anacor Pharmaceuticals Inc', u'Merck Research Laboratories', u'Princeton University', u'Nektar Therapeutics', u'Concord Biosciences LLC', u'Thallion Pharmaceuticals Inc', u'Gilead Sciences Inc', u'Novita Healthcare Ltd', u'Institute for the Promotion of Innovation by Science and Technology in Flanders', u'Guangzhou Baiyunshan Pharmaceutical Co Ltd', u'4SC AG', u'Broad Institute Inc', u'Tetraphase Pharmaceuticals Inc', u'Alcon Inc', u'Evolva Holding SA', u'PharmaLinks', u'Purdue University', u'University of Michigan', u'Intrexon Corp', u'US Department of Defense', u'Fujisawa Pharmaceutical Corp', u'Griffith University', u'Astra AB', u'Cempra Inc', u'RQx Pharmaceuticals Inc', u'Botanic Century (Beijing) Co Ltd', u'Syracuse Veterans Administration Medical Center', u\"St Jude Children's Research Hospital\", u'EnBiotix Inc', u'University of Tokyo', u'Elan Corp plc', u'Fulcrum Pharmaceuticals Inc', u'MorphoSys AG', u'VCA Inc', u'Kuros Biosciences Ltd', u'Sentinella Pharmaceuticals Inc', u'CJ Corp', u'Kyowa Hakko Bio Co Ltd', u'Khandelwal Laboratories Ltd', u'Agence Nationale de Valorisation de la Recherche', u'Catalytica Inc', u'Athelas SA', u'Eurofarma', u'BC Cancer Agency', u'Genelabs Technologies Inc', u'Ranbaxy Laboratories Ltd', u'Tufts University', u'Janssen Pharmaceuticals Inc', u'Crucell NV', u'AntexPharma Inc', u'Phylogica Ltd', u'Penederm Inc', u'Pernix Therapeutics Holdings Inc', u'Bioenvision Inc', u'GD Searle & Co', u'Oregon State University', u'Defense Threat Reduction Agency', u'Daiichi Seiyaku Co Ltd', u'University of Medicine and Dentistry of New Jersey', u'DKSH Holding Ltd', u'US Government', u'Orchid Pharma Ltd', u'Korea Institute of Science and Technology', u'National Institutes of Health', u'Baxter International Inc', u'The New Energy and Industrial Technology Development Organization', u'Essex Chemie AG', u'InterMune Inc', u'Netherlands Government', u'Vilnius University', u'Fudan University', u'Iroko Pharmaceuticals LLC', u'Ascenion GmbH', u'Breckenridge Pharmaceutical Inc', u'GlaxoSmithKline plc', u'AureoGen Biosciences Inc', u'AB ANALITICA', u'SinSa Labs', u'Biotoscana International', u'ZAI Laboratory Inc', u'Bioceutica SA', u'Clinipace', u'European Eurostars Programme', u'Forge Therapeutics Inc', u'Biosynexus Inc', u'Phynova Group Ltd', u'University of Leipzig', u'University of Texas Health Science Center Houston', u'UCB Pharma SA', u'National Science Foundation', u'Canadian Institutes of Health Research', u'The Collaborative Group', u'Paratek Pharmaceuticals Inc', u'Eli Lilly Canada Inc', u'Washington University in St Louis', u'Sankyo Co Ltd', u'RMR Technologies LLC', u'Avacta Ltd', u'FUJIFILM Pharma Co Ltd', u'Protez Pharmaceuticals Inc', u'Ecolab Inc', u'Mediolanum Farmaceutici SpA', u'Boston University', u'Key Organics Ltd', u'Inpharmatica Ltd', u'Ilsung Pharmaceutical Co Ltd', u'Lilly China Research & Development Co Ltd', u'Technische Universitat Dresden', u'Morphochem AG', u'Shionogi & Co Ltd', u'Arsanis Biosciences GmbH', u'Universiteit Maastricht', u'Suntory Ltd', u'Helmholtz Zentrum fur Infektionsforschung GmbH', u'York Pharma plc', u'Shire BioChem Inc', u'Johnson & Johnson Pharmaceutical Research & Development LLC', u'The Menarini Group', u'Industrial Research Ltd', u'Medarex Inc', u'Daiichi Sankyo Co Ltd', u'Abbott Laboratories', u'Catalyst Pharmaceutical Partners Inc', u'Eisai Co Ltd', u'Teva Pharmaceuticals USA Inc', u'Fisons plc', u'National Cancer Institute', u'Novartis AG', u'Merck KGaA', u'University of Pune', u'ChemDiv Inc', u'Synthetic Genomics Vaccines Inc', u'Korea Research Institute of Bioscience and Biotechnology', u'Calvert T1 LLC', u'Fujisawa Pharmaceutical Co Ltd', u'UAB Bioseka', u'Kalexsyn Inc', u'Biovista Inc', u'Fedora Pharmaceuticals Inc', u'SciClone Pharmaceuticals Inc', u'University of Minnesota', u'Melmotte Inc', u'Hawon Pharmaceutical Corp', u'Oryn Therapeutics', u'Guangzhou Boji Medical & Biotechnological Co Ltd', u'ALZA Corp', u'Sunovion Pharmaceuticals Canada Inc', u'Taiho Pharmaceutical Co Ltd', u'Rockefeller University', u'Alfresa Pharma Corp', u'University of Colorado System', u'Biolog Inc', u'Montana State University', u'Chiron PathoGenesis', u'TCG Lifesciences Ltd', u'Ferrer Internacional SA', u'Lupin Ltd', u'Immtech Pharmaceuticals Inc', u'US Health and Human Services Department', u'China Academy of Chinese Medical Sciences', u'National Institute of General Medical Sciences', u'Recordati SpA', u'Xijing Hospital', u'Royalty Pharma', u'AmpliPhi Biosciences Corp', u'Wistar Institute of Anatomy & Biology', u'Chugai Pharmaceutical Co Ltd', u'University of North Carolina', u'Armaghan Salamat Kish Group', u'Bayer Yakuhin Ltd', u'GeneData AG', u'Almac Sciences Ltd', u'Medicis Pharmaceutical Corp', u'Atlantic Technology Ventures Inc', u'Handong University', u'GeneArrest Ltd', u'Universiteit Utrecht', u'MGB Biopharma Ltd', u'University of Maryland School of Medicine', u'Bayer Korea Ltd', u'Callisto Pharmaceuticals Inc', u'Republic of Korea Government', u'Yuhan Corp', u'Jeil Pharmaceutical Co Ltd', u'XOMA Corp', u'Affinivax Inc', u'CytoSorbents Corp', u'Latitude Pharmaceuticals', u'McMaster University', u'PharmaMar Inc', u'Merck Sharp & Dohme de Espana SA', u'Nanjing University', u'UBE Industries Ltd', u'Theravance Biopharma Inc', u'Johnson & Johnson Consumer Cos Inc', u'Galderma SA', u'Biem Pharmaceuticals', u'FORMA Therapeutics Inc', u'InSite Vision Inc', u'Par Pharmaceutical Inc', u'Fresenius Kabi USA Inc', u'Indiana University Research and Technology Corp Inc', u'Kyowa Hakko Kirin Co Ltd', u'Woods Hole Oceanographic Institution', u'NPO Petrovax Pharm LLC', u'Nankai University', u'NovaBay Pharmaceuticals Inc', u'Korean Ministry of Knowledge Economy', u'Genaera Corp', u'Laboratorios Columbia SA de CV', u'Esteve', u'Peregrine Renovations LLC', u'aRigen Pharmaceuticals Inc', u'Hitachi High-Technologies Corp', u'Research Center for Medical Polymers and Biomaterials', u'Human Genome Sciences Inc', u'Central Drug Research Institute', u'Tetragenex Pharmaceuticals Inc', u'Fundaci\\xf3n MEDINA', u'University of Illinois', u'Memorial Sloan-Kettering Cancer Center', u'Wyeth BioPharma', u'Ciba-Geigy (Japan) Ltd', u'BioLineRx Ltd', u'LG Life Sciences Ltd', u'Baylor College of Medicine', u'Elitra Pharmaceuticals Inc', u\"Lee's Pharmaceutical Holdings Limited\", u'Arietis Corp', u'SmithKline Beecham Corp', u'Avir Pharma Inc', u'University of California at Berkeley', u'National Institute of Allergy and Infectious Diseases', u'Merck Frosst Canada & Co', u'Auspherix Limited', u'Yamanouchi Pharmaceutical Co Ltd', u'TAP Pharmaceuticals Inc', u'Oman Pharmaceutical Products Co', u'Zambon Co SpA', u'Numerate Inc', u'Karveel Pharmaceuticals', u'Albert Einstein College of Medicine', u'NAEJA Pharmaceuticals Inc', u'Bill & Melinda Gates Foundation', u'FOB Synthesis Inc', u'Xiamen University', u'Sarepta Therapeutics Inc', u'Verenium Corp', u'Furiex Pharmaceuticals Inc', u'Taisho Pharmaceutical Co Ltd', u'Foster Corp', u'National Institutes of Standards and Technology', u'Anadys Pharmaceuticals Inc', u'Colorado State University', u'Aridis Pharmaceuticals Inc', u'3-Dimensional Pharmaceuticals Inc', u'JW Pharmaceutical Corp', u'Austrian Academy of Sciences', u'Teligent Inc', u'Takara Bio Inc', u'Sagent Pharmaceuticals Inc', u'Deinove', u'Gedeon Richter Ltd', u'X-Chem Inc', u'Boryung Pharm Co Ltd', u'BD Technologies', u'Iterum Therapeutics Ltd', u'ContraFect Corp', u'Kaneka Corp']), u'Nutritionaldeficiency': set([u\"Dr Reddy's Laboratories Ltd\", u'Blaine Pharmaceuticals', u'US Government', u'Filament BioSolutions Inc', u'Astellas Institute for Regenerative Medicine', u'Aspen PharmaCare Holdings Ltd', u'Beyond Human LLC', u'Ajinomoto Co Inc', u'Cardinal Health Inc', u'DUSA Pharmaceuticals Inc', u'Vertical Pharmaceuticals Inc', u'NBTY Inc', u'By-Health Co Ltd', u'InterMed Discovery GmbH', u'Life Technologies Corp', u'Emerge Health Pty Ltd', u'Vitabiotics Ltd', u'Hi-Tech Pharmacal Co Inc', u'Shasun Pharmaceuticals Ltd', u'Omniactive Health Technologies Pvt Ltd', u'Food and Drug Administration', u'Pivotal Therapeutics Inc', u'Verenium Corp', u'ACGT Corp', u'Alvogen Inc', u'Medtronic plc', u\"River's Edge Pharmaceuticals LLC\", u'STYR Labs', u'Technology Acceleration Partners LLC', u'Laboratorios Casen-Fleet Sa', u'Novogen Ltd', u'Glanbia Nutritionals Inc', u'IntelGenx Technologies Corp', u'University of California Davis', u'Orphan Europe SARL', u'Perrigo Co plc', u'Wacker Biochem Corp', u'Valeant Pharmaceuticals International Inc', u'Upsher-Smith Laboratories Inc', u'Azur Pharma Ltd', u'Piramal Enterprises Ltd', u'Ceapro Inc', u'SemBioSys Genetics Inc', u'Teligent Inc', u'Cardax Inc', u'Capsugel Inc', u'rEVO Biologics Inc', u'Martek Biosciences Corp', u'Matrix Genetics LLC', u'Pfizer Inc', u'Immunotec Inc', u'Everstone Capital', u'Healthspan', u'University of Alberta', u'Probi AB', u'Cognis Inc', u'Orphan Medical Inc', u'Debiopharm SA', u'Proterro Inc', u'Kyowa Hakko Kirin Pharma Inc', u'Innovus Pharmaceuticals Inc']), u'IgAnephropathy': set([u'Vifor Pharma', u'BioMarin Pharmaceutical Inc', u'IGAN Biosciences Inc', u'Anthera Pharmaceuticals Inc', u'Zenyaku Kogyo Co Ltd', u'Pharmalink AB', u'Shire plc', u'National Institute of Diabetes, Digestive and Kidney Diseases', u'West Pharmaceutical Services Inc', u'ChemoCentryx Inc', u'Kissei Pharmaceutical Co Ltd']), u'Shigelladysenteriaeinfection': set([u'Program for Appropriate Technology in Health', u'EpiBiome Inc', u'Bill & Melinda Gates Foundation', u'University of California San Diego', u'National Institute of Allergy and Infectious Diseases', u'International Vaccine Institute']), u'Diverticulosis': set([u'Alfa Wassermann SpA', u'Merckle GmbH']), u'Metastaticlivercancer': set([u'Celsion Corp', u'Hebrew University of Jerusalem', u'Delcath Systems Inc', u'Galectin Therapeutics Inc', u'BioCancell Therapeutics Ltd', u'Novartis Institutes for BioMedical Research Inc', u'National Institute for Health Research (NIHR)', u'MD Anderson Cancer Center', u'National Institute of Allergy and Infectious Diseases', u'H Lee Moffitt Cancer Center and Research Institute', u'University of Oxford']), u'S': set([u'Novexel SA', u'Genta Inc', u'Aventis Pharma AG', u'National Cancer Institute']), u'Bacterialurinarytractinfection': set([u'Daiichi Seiyaku Co Ltd', u\"Dr Reddy's Laboratories Ltd\", u'Ciba-Geigy (Japan) Ltd', u'Johnson & Johnson', u'Chugai Pharmaceutical Co Ltd', u'Life Sciences Greenhouse of Central Pennsylvania', u'Karolinska Institutet', u'OM Pharma', u'Mylan Inc', u'Eli Lilly & Co', u'SmithKline Beecham Corp', u'Tetraphase Pharmaceuticals Inc', u'Daiichi Sankyo Co Ltd', u'Abbott Laboratories', u'LG Life Sciences Ltd', u'Dainippon Pharmaceutical Co Ltd', u'GlaxoSmithKline plc', u'Medison Pharma Ltd', u'Eddingpharm Inc', u'Chiron Corp', u'Undisclosed', u'TTY Biopharm Co Ltd', u'MerLion Pharmaceuticals Pte Ltd', u'MedImmune LLC', u'Sanofi', u'Melinta Therapeutics Inc', u'Chong Kun Dang Pharmaceutical Corp', u'Emisphere Technologies Inc', u'The Menarini Group', u'Kyowa Hakko Bio Co Ltd', u'Bayer AG', u'Sequoia Sciences Inc', u'US Army Medical Research Institute of Infectious Diseases', u'Astellas Pharma Inc', u'Chaperone Technologies Inc', u'Sunovion Pharmaceuticals Canada Inc', u'Ranbaxy Laboratories Ltd', u'Wistar Institute of Anatomy & Biology', u'JW Pharmaceutical Corp', u'Paratek Pharmaceuticals Inc', u'Rhone-Poulenc SA', u'Washington University in St Louis', u'Oscient Pharmaceuticals Corp', u'Genesoft Inc', u'LG Chem Ltd', u'Cubist Pharmaceuticals Inc', u'AstraZeneca plc', u'Pfizer Inc', u'Shionogi & Co Ltd', u'Patheon Inc', u'Lilly China Research & Development Co Ltd', u'Royalty Pharma', u'Dura Pharmaceuticals Inc']), u'Abnormalurinecomposition': set([u'Patheon Pharmaceuticals Inc', u'University of California San Diego School of Medicine', u'French Government', u'Cambrex Corp', u'Horizon Orphan LLC', u'Bennu Pharmaceuticals Inc']), u'Hemorrhoids': set([u'Intendis GmbH', u'Amer & Co', u'CSL Ltd', u'Adamis Pharmaceuticals Corp', u'National Institutes of Health', u'Norgine Ltd', u'CeNeS Pharmaceuticals plc', u'Kyowa Kirin', u'Neptune Pharmaceutical Corp', u'Tsumura & Co', u'Mitsubishi Pharma Corp', u'Rekio Pharma Ltd', u'Orexo AB', u'Assembly Biosciences Inc', u'Almac Group', u'inVentiv Clinical Solutions']), u'Coronarythrombosis': set([u'Eli Lilly & Co', u'Janssen Biotech Inc', u'Momenta Pharmaceuticals Inc', u'Chiesi USA Inc', u'Corimmun GmbH', u'Tanabe Seiyaku Co Ltd', u'The Medicines Company', u'Sandoz Inc', u'Trigen GmbH', u'Sanofi', u'Janssen Biologics BV']), u'Liverfailure': set([u'Ajou University', u'LifeLiver Co Ltd', u'US Government', u'Proven Process Medical Devices Inc', u'Ventria Bioscience', u'Rocky Mountain Poison and Drug Center', u'University of Colorado at Denver and Health Sciences Center', u'Alfama Inc', u'Giner Inc', u'Promethera Biosciences SA/NV', u'FCB-Pharmicell Co Ltd']), u'Organtransplantation': set([u'Deltagen Research Laboratories', u'Evotec AG', u'US Government', u'Icoria Inc', u'National Institutes of Health', u'Astellas Institute for Regenerative Medicine', u'Regenerex LLC', u'UK Government', u'Yissum Research Development Co', u'One Lambda', u'Genmab A/S', u'University of California San Francisco', u'Waters Medical Systems LLC', u'Thermo Fisher Scientific Inc', u'ProChon Biotech Ltd', u'Minapharm Pharmaceuticals', u'Globe Laboratories Inc', u'National Jewish Health', u'Humacyte', u'University of Mississippi', u'Geron Corp', u'Viron Therapeutics Inc', u'BTG plc', u'GMSbiotech Inc', u'Albumedix A/S', u'Znomics Inc', u'Servier', u'MBA Medical', u'National Pharmaceuticals Corp', u'EpiVax Inc', u'Ono Pharmaceutical Co Ltd', u'Bio-Ess Laboratories LLC', u'Burroughs Wellcome International Ltd', u'Xcellerex LLC', u'Vesta Therapeutics Inc', u'Musculoskeletal Transplant Foundation', u'Zydus-Cadila Group', u'Essential Pharmaceuticals, LLC', u'Isotechnika Pharma Inc', u'Monash University', u'Japan Tobacco Inc', u'Pharming Group NV', u'University of Wisconsin-Madison', u'FibroGen Inc', u'Roche Holding AG', u'Cadus Corp', u'Astellas Pharma Inc', u'Dendreon Corp', u'Alavita Pharmaceuticals Inc', u'Biocision Inc', u'Neovii Biotech GmbH', u'Cumberland Emerging Technologies Inc', u'Revivicor Inc', u'NuLife BioMed', u'Tioma Therapeutics Inc', u'Merck Serono SA', u'Lonza Group AG', u'Agouron Pharmaceuticals Inc', u'University of Auckland', u'Proteo Biotech AG', u'Therapure Biopharma Inc', u'Cubist Pharmaceuticals Inc', u'Paragonix Technologies Inc', u'National Research Council of Canada', u'Xeno Trans Ltd', u'Novartis AG', u'BioTransplant Inc', u'LXR Biotechnology Inc', u'Proteus Digital Health Inc', u'GandTex LLC', u'NovaThera Ltd', u'University of Utah', u'Transcriptome Sciences Inc', u'Proveca Ltd', u'Sankyo Co Ltd', u'XTL Biopharmaceuticals Ltd', u'CellTrend GmbH', u'Benitec Biopharma Ltd', u'Singapore Immunology Network']), u'Liverdisease': set([u'Daiichi Seiyaku Co Ltd', u'University of Medicine and Dentistry of New Jersey', u'US Government', u'Regeneron Pharmaceuticals Inc', u'University of Connecticut', u'Intercept Pharmaceuticals Inc', u'Guangdong Xianqiang Pharmaceutical Co Ltd', u'The Charles Stark Draper Laboratory Inc', u'InterMune Inc', u'Cellular Dynamics International Inc', u'NicOx SA', u'Aeolus Pharmaceuticals Inc', u'Amsterdam Molecular Therapeutics BV', u'GlaxoSmithKline plc', u'Biotecnol SA', u'Hadasit Medical Research Services and Development Ltd', u'MultiCell Technologies Inc', u'Chiron Corp', u'Ionis Pharmaceuticals Inc', u'Immuron Ltd', u'Novartis Pharma AG', u'Massachusetts Life Sciences Center', u'Albireo Ltd', u'Selcia Ltd', u'US Department of Veterans Affairs', u'Astex Pharmaceuticals Inc', u'Wyeth Pharmaceuticals', u'Microbot Medical Inc', u'uniQure BV', u'Leiden University Medical Center', u'The University Health Network', u'Roche Holding AG', u'Bracco SpA', u'University of North Carolina', u'Huons Co Ltd', u'Helena Biosciences', u'Phenex Pharmaceuticals AG', u'Cytori Therapeutics Inc', u'Universita Degli Studi Di Perugia', u'Molecular Biosystems Inc', u'Genethon', u'Shionogi & Co Ltd', u'Tanabe Seiyaku Co Ltd', u'Antwerp University Hospital', u'Norgine BV', u'Alnylam Pharmaceuticals Inc', u'BGN Technologies', u'Exelixis Inc', u'4D Molecular Therapeutics LLC', u'Conatus Pharmaceuticals Inc', u'Promethera Biosciences SA/NV', u'Amgen Inc', u'University of California San Francisco', u'Arrowhead Pharmaceuticals Inc', u'Royal College of Surgeons in Ireland', u'Daiichi Sankyo Co Ltd', u'Abbott Laboratories', u'Zeria Pharmaceutical Co Ltd', u'Endo Pharmaceuticals Solutions Inc', u'Eisai Co Ltd', u'Commonwealth Scientific and Industrial Research Organization', u'Alpha-1 Foundation', u'MediGene AG', u'University of California', u'Korea Research Institute of Bioscience and Biotechnology', u'Mallinckrodt Inc', u'Hanmi Pharmaceutical Co Ltd', u'Iconix Biosciences Inc', u'Massachusetts General Hospital', u'Medical Research Council', u'Reverx Pty Ltd', u'UCB Pharma GmbH', u'Cycle Pharmaceuticals Ltd', u'Chung-Ang University', u'Yecuris Corp', u'Universite Catholique de Louvain', u'Biomedical Translational Imaging Centre', u'EpiCept Corp', u'ENTEROME Bioscience SA', u'Merck Millipore', u'University of Navarra', u'Can-Fite BioPharma Ltd', u'Dong-A ST Co Ltd', u'Eiken Chemical Co Ltd', u'Grelan Pharmaceutical Co Ltd', u'Prasco Laboratories', u'Human Metabolome Technologies Inc', u'Organovo Holdings', u'The Alpha-1 Project', u'Ibn Cina Drug Stores', u'Boehringer Ingelheim Corp', u'Cardax Pharmaceuticals Inc', u'Tobira Therapeutics Inc', u'Genfit SA', u'Solstice Biologics LLC', u'Yeungnam University', u'Takara Shuzo Co Ltd', u'University of Antwerp', u'F Hoffmann-La Roche AG', u'F H Faulding & Co Ltd', u'VINNOVA', u'Chugai Pharmaceutical Co Ltd', u'Tufts University', u'Syngenta AG', u'Genentech Inc', u'University of California San Diego School of Medicine', u'Nippon Shinyaku Co Ltd', u'Connetics Corp', u'Hayashibara Biochemical Laboratories Inc', u'IDIS Ltd', u'Biogen Inc (FL)', u'National Institute of Diabetes, Digestive and Kidney Diseases', u'MegaPharm Ltd', u'Morningside Venture Investments Ltd', u'Lumena Pharmaceuticals', u'Minophagen Pharm Co', u'Yuhan Corp', u'Eden Biodesign Ltd', u'Maxygen Holdings Ltd', u'XOMA Corp', u'Todai TLO Ltd', u'Sumitomo Dainippon Pharma Co Ltd', u'Nippon Chemiphar Co Ltd', u'Daewoong Pharmaceutical Co Ltd', u'Merck & Co Inc', u'Ocera Therapeutics Inc', u'HepaVec AG fuer Gentherapie', u'Sanofi', u'StrideBio LLC', u'NGM Biopharmaceuticals Inc', u'University of Miami', u'Dr Falk Pharma GmbH', u'Numoda Corp', u'Swedish Orphan AB', u'Weizmann Institute of Science', u'University of Edinburgh', u'Central Drug Research Institute', u'Pacific Pharma Inc', u'Genovo Inc', u'Aptalis Pharma Inc', u'Pfizer Inc', u'Zyma GmbH', u'Duphar Interfran Ltd', u'Gilead Sciences Inc', u'Living Cell Technologies Ltd', u'Maxim Pharmaceuticals Inc', u'Cytonet LLC', u'International Stem Cell Corp', u'AMAG Pharmaceuticals Inc', u'University of Pittsburgh', u'Estero-Anstalt', u'Guerbet', u'EPIX Pharmaceuticals Inc', u'Nattermann & Cie GmbH', u'BioLineRx Ltd', u'Massachusetts Institute of Technology', u'Hoffmann-La Roche AG', u'Nitto Denko Corp', u'Peptor Ltd', u'Phynova Group Ltd', u'Kureha Corp', u'CRISPR Therapeutics', u'Inverni della Beffa SpA', u'Galmed Pharmaceuticals Ltd', u'Alfa Wassermann SpA', u'VistaGen Therapeutics Inc', u'Atlas Pharmaceuticals Inc', u'Nestle Health Science', u'National Institutes of Health', u'University of Tokyo', u'Geron Corp', u'Seventh Wave Laboratories', u'Mallinckrodt Medical Inc', u'Bristol-Myers Squibb Co', u'National Urea Cycle Disorders Foundation', u'Eagle Vision Pharmaceutical Corp', u'Cedars-Sinai Medical Center', u'Thomas Jefferson University', u'Wayne State University', u'Intellia Therapeutics Inc', u'Celgene Corp', u'National Institute on Alcohol Abuse and Alcoholism', u'Astellas Pharma Inc', u'Eurofarma', u'Sosei Group Corp', u'Proteonomix Inc', u'Vesta Therapeutics Inc', u'University of Ghent', u'Verva Pharmaceuticals Ltd', u'Quality Brands International Direct', u'NanoCarrier Co Ltd', u'Selecta Biosciences Inc', u'GE Healthcare', u'Janssen Pharmaceuticals Inc', u'Korea Pharma Co Ltd', u'Aventis Pharma SA', u'Digna Biotech SL', u'ValiGen Inc', u'UCL Business PLC', u'StemCell Technologies', u'ThromboGenics NV', u'German Federal Ministry of Education and Research', u'OncoGenex Pharmaceuticals Inc']), u'Chlamydiainfection': set([u'Okamoto Industries', u'SIGA Technologies Inc', u'BioVeris Corp', u'Umea University', u'Takeda GmbH', u'CEL-SCI Corp', u'Antigen Discovery Inc', u'Otsuka Pharmaceutical Co Ltd', u'University of Washington', u'National Institute of Allergy and Infectious Diseases', u'Polydex Pharmaceuticals Ltd', u'Cempra Inc', u'China Agricultural University', u'Univ Massachusetts', u'National Institutes of Health', u'Bill & Melinda Gates Foundation', u'Uppsala University', u'University of California', u'Aventis Pharma AG', u'Nidek Co Ltd', u'Agennix AG', u'GlaxoSmithKline plc', u'Rush University Medical Center', u'ValiRx plc', u'Biovei Inc', u'Undisclosed', u'TherapyX Inc', u'VINNOVA', u'Contraceptive Research and Development Organization', u'Creative Antibiotics Sweden AB', u'Starpharma Holdings Ltd', u'Dong-A ST Co Ltd', u'NanoBio Corp', u'Aquila Biopharmaceuticals Inc', u'BigDNA Ltd', u'Novexel SA', u'ActivBiotics Inc', u'University of California Irvine', u'Chiron PathoGenesis', u'Immune Solutions Ltd', u'Queensland University of Technology', u'Corixa Corp', u'Fujifilm Finechemicals Co Ltd', u'Oregon State University', u'Toyama Chemical Co Ltd', u'Kaneka Corp', u'University of Arkansas']), u'Lymphangioleiomyomatosis': set([u\"Cincinnati Children's Hospital Medical Center\", u'Baylor College of Medicine', u'Pfizer Inc', u'AstraZeneca plc', u'Opthea Ltd', u'Nobelpharma Co Ltd']), u'Autism': set([u'Rugen Therapeutics R & D (Shanghai) Co Ltd', u'US Government', u'BioMarin Pharmaceutical Inc', u\"Alzheimer's Drug Discovery Foundation\", u'Luc Therapeutics Inc', u'MSD OSS BV', u'4d pharma plc', u'The Unconventional Foundation for Autism', u'Mount Sinai School of Medicine', u'Neurobiological Technologies Inc', u'Forest Laboratories Inc', u'Univ Massachusetts', u'Cannabis Science Inc', u'Immuron Ltd', u'Marina Biotech Inc', u'University College Cork', u'Delivering Scientific Innovation for Autism LLC', u'University of Washington', u'Ramot at Tel Aviv University Ltd', u'Roche Holding AG', u'NantHealth Inc', u'The National Institute of Mental Health', u'Optinose US Inc', u'Virginia Commonwealth University', u'Simons Foundation', u'Catalent Inc', u\"Boston Children's Hospital\", u'Brain Canada', u'SmithKline Beecham Pharmaceuticals', u'Harvard University', u'The European Union', u'Intelligence Advanced Research Projects Activity', u'Cloud Pharmaceuticals Inc', u'Novartis AG', u'Eunice Kennedy Shriver National Institute of Child Health & Human Development', u'Vanderbilt University', u'Siegfried Holding Ltd', u'Massachusetts General Hospital', u'Ashvattha Therapeutics LLC', u'Orpheris Inc', u'Cochin Institute', u'Hager Biosciences LLC', u'Janssen Pharmaceutical KK', u'SINTEF Group', u'Janssen Pharmaceutica NV', u'The Research Council of Norway', u'Johns Hopkins University', u'Neurochlore', u'Oslo University Hospital', u'University of Melbourne', u'H Lundbeck A/S', u'University of North Carolina', u'National Institute of Neurological Disorders and Stroke', u'The Global Alliance for Innovation in Neuroscience Inc', u'Innovative Medicines Initiative', u'IntelliCell BioSciences Inc', u'Wyss Institute for Biologically Inspired Engineering', u'Intra-Cellular Therapies Inc', u'Allergan plc', u'CHU Sainte Justine', u'AgeneBio Inc', u'Undisclosed', u'Scripps Research Institute', u'MRIGlobal', u'Olfactory Biosciences Corp', u'Feinstein Institute for Medical Research', u'Pastorus Pharma Llc', u'IntelliSyn Pharma', u'Seaside Therapeutics Inc', u'Allergan Inc', u'Foundation for Mitochondrial Medicine', u'George Washington University', u'Smerud Medical Research International AS', u'Iliad Neurosciences Inc', u'Epigenetix Inc', u'University of California Los Angeles', u'Proteome Sciences plc', u'State University of New York', u'International Business Machines Corp', u'Childrens Medical Center Corp', u'Yale University', u'University of Utah', u'Egenix Inc', u'Illumina Inc', u'Autism Research Institute', u'Yale School of Medicine', u'University of California San Diego', u'Innovation Pharmaceuticals Inc', u'Servier', u'National Institutes of Health', u'OptiNose AS', u'Neuropharm Group plc', u'Scios Inc', u'Curemark LLC', u'Autism Science Foundation', u'University of Calgary', u'Janssen Pharmaceutica BV', u'Par Pharmaceutical Co Inc', u'Biovail Corp', u'Retrophin Inc', u'Coronis NeuroSciences', u'University of California Irvine', u'Repligen Corp', u'Cypress Bioscience Inc', u'SynapDx Corp', u'Shin Nippon Biomedical Laboratories Ltd', u'Merz & Co GmbH']), u'Pagetsbreastdisease': set([u'Emisphere Technologies Inc', u'Novartis AG']), u'Pterygium': set([u'MedInsight Research Institute', u'Ariel University']), u'Easternequineencephalitisvirusinfection': set([u'University of Texas Medical Branch at Galveston', u'Ichor Medical Systems Inc', u'University of Pittsburgh', u'National Center for Research Resources', u'Emory University', u'Profectus BioSciences Inc', u'US Department of Defense', u'Defyrus Inc', u'Battelle', u'AltraVax Inc', u'National Institute of Allergy and Infectious Diseases', u'US Government', u'Canadian Department of National Defence', u'Tulane University', u'Defense Threat Reduction Agency']), u'Esophagealhemorrhage': set([u'Medunik Canada', u'QOL Medical']), u'Thrombocytedisorder': set([u'HemaSure Denmark A/S', u'Genentech Inc', u'COR Therapeutics Inc', u'Merck & Co Inc', u'Novo Nordisk A/S']), u'Psoriaticarthritis': set([u'Biopasgroup', u'Janssen-Cilag Ltd', u'Valocor Therapeutics Ltd', u'LG Life Sciences Ltd', u'Novo Nordisk A/S', u'moksha8 Pharmaceuticals Inc', u'Baxter International Inc', u'Amgen Inc', u'Xian-Janssen Pharmaceutical Ltd', u'BioXpress Therapeutics SA', u'Daiichi Sankyo Co Ltd', u'Orion Corporation', u'Stiefel Laboratories (UK) Ltd', u'Biogen Inc', u'Nuevolution A/S', u'Celltrion Inc', u'UCB Celltech', u'Novartis AG', u'Immunex Corp', u'IMIDomics SL', u'Novelion Therapeutics Inc', u'Bristol-Myers Squibb Co', u'Nordic Group', u'Genentech Inc', u'Wyeth-Ayerst Pharmaceuticals Inc', u'Eli Lilly & Co', u'Coherus BioSciences Inc', u'Celgene Corp', u'Tanabe Seiyaku Co Ltd', u'OptiMed Specialty Pharmacy', u'AbbVie Inc', u'Mitsubishi Tanabe Pharma Corp', u'Galapagos NV', u'Alder Biopharmaceuticals Inc', u'AET BioTechnology Ltd', u'Janssen Biotech Inc', u'Almirall Prodesfarma SA', u'AstraZeneca plc', u'Caisson Biotech LLC', u'Gilead Sciences Inc', u'Cumberland Pharmaceuticals Inc', u'Vitaeris Inc', u'Kern Pharma SL', u'Wyeth', u'Biochemie GmbH', u'PDL BioPharma Inc', u'Boehringer Ingelheim Corp']), u'Campylobacterinfection': set([u'US Naval Medical Research Center', u'Antex Biologics Inc', u'US Army Medical Research Institute of Infectious Diseases', u'US Department of Defense', u'Acambis plc', u'GlaxoSmithKline plc']), u'Surgicalprocedure': set([u'US Government', u'Brainlab Ltd', u'Baxter International Inc', u'Medical Enterprises Distribution, LLC', u'Elekta AB', u'Ohio State University', u'Adhezion Biomedical', u'Enlyton Ltd', u'Acuna Fombona', u'Sinclair Pharma plc', u'PolyNovo Biomaterials Pty Ltd', u'AlloSource', u'Tel Aviv Sourasky Medical Center', u'Integra LifeSciences Holdings Corp', u'Ramot at Tel Aviv University Ltd', u'Pervasis Therapeutics Inc', u'OsteoRemedies LLC', u'Apifix Ltd', u'Refine LLC', u'Omnivision Technologies Inc', u'Induce Biologics Inc', u'Antibe Therapeutics Inc', u'Precision Optics Corp', u'DePuy Synthes Companies', u'Thermigen Llc', u'Biomet Inc']), u'Leukemia': set([u'Biovest International Inc', u'Quest Diagnostics Inc', u'Targa Therapeutics Corp', u'Damon Runyon-Walter Winchell Foundation', u'Koebenhavns Universitet', u'Wellstat Biologics Corp', u'US Health and Human Services Department', u'Il Dong Pharmaceutical Co Ltd', u\"Cincinnati Children's Hospital Medical Center\", u'AAIPharma Services Corp', u'MethylGene Inc', u'Seattle Genetics Inc', u'Coherus BioSciences Inc', u'University of Florida', u'MedPharm Ltd', u'Pharmaceutical Product Development LLC', u'University of Sao Paulo', u'Cancer Council New South Wales', u'BPH Energy Ltd', u'University of Arizona', u'Milstein Medical Asian American Partnership Foundation', u'University of Rochester', u'PBL Therapeutics', u'Bio-Path Holdings Inc', u'Cellectis SA', u'Aviragen Therapeutics Inc', u'Kuhnil Pharmaceutical Co Ltd', u'Universita Degli Studi Di Perugia', u'ElsaLys Biotech', u'Glasgow University', u'Zhejiang Huahai Pharmaceutical Group Co Ltd', u'Sigma-Tau Ind Farm Riunite SpA', u'Academic Medical Center, University of Amsterdam', u'National Health and Medical Research Council', u'Israeli Government', u'Cambridge Antibody Technology Group plc', u'Nippon Kayaku Co Ltd', u'Znomics Inc', u'Ministry of Health & Welfare, Korea', u'Tempus Inc', u'Poniard Pharmaceuticals Inc', u'Corixa Corp', u'Cantab Biopharmaceuticals Ltd', u'Medac GmbH', u'Ajinomoto Althea Inc', u'JCR Pharmaceuticals Co Ltd', u'Chinese Government', u'Synergy Pharmaceuticals Inc', u'Kyorin Pharmaceutical Co Ltd', u'ImmunoGen Inc', u'Navigate BioPharma Services Inc', u'Tioma Therapeutics Inc', u'EvoGenix Pty Ltd', u'PolaRx Biopharmaceuticals Inc', u'The Cancer Council Victoria', u'SIOGEN Biotech', u'Oncobiologics Inc', u'Swedish Orphan Biovitrum AB', u'Talon Therapeutics Inc', u'TKsignal Ltd', u'Deciphera Pharmaceuticals LLC', u'Pacira Pharmaceuticals Inc', u'Bioindustry Initiative of the US State Department', u'Areva Med LLC', u'AnorMED Inc', u'Oregon Health Sciences University', u'Chroma Therapeutics Ltd', u'Daewoong Pharmaceutical Co Ltd', u'JSC F-Synthesis', u'Cure Cancer Australia', u'LEO Pharma A/S', u'Vion Pharmaceuticals Inc', u'CTI BioPharma Corp', u'CSL Ltd', u'VU University Medical Center', u'Actinium Pharmaceuticals Inc', u'Erasmus University Medical Center Rotterdam', u'Invent Biotecnologia Ltda', u'KRS Global Biotechnology Inc', u'Cancer Research Technology Ltd', u'Pharmion Corp', u'Johnson & Johnson', u'SHAL Technologies Inc', u'Peter MacCallum Cancer Centre', u'Horizon Discovery Group plc', u'Centauri Therapeutics Ltd', u'SmithKline Beecham plc', u'Bavarian Nordic A/S', u'AltaRex Medical Corp', u'Northwestern University', u'Actium Research Inc', u'Servier', u'Bristol-Myers Squibb Co', u'CEAMED SA', u'Victorian Cancer Agency', u'Seoul National University', u'Astellas Pharma Inc', u'Live Like Bella Childhood Cancer Foundation', u'Institute of Cancer Research UK', u'Coulter Pharmaceutical Inc', u'Arriani Pharmaceuticals SA', u'Aurigene Discovery Technologies Ltd', u'University of Oxford', u'European Institute of Oncology', u\"PX'Therapeutics SA\", u'Karolinska Institutet', u'Barbara Ann Karmanos Cancer Institute', u'IDEC Pharmaceuticals Corp', u'Orion Corporation', u'Chiron Corp', u'Genesis Technology Group Inc', u'University Of Southampton', u'MLL Munich Leukemia Laboratory', u'OJSC Farmak', u'Astex Pharmaceuticals Inc', u'Vernalis plc', u'HemoGenyx', u'Aventis SA', u'Dutch-Belgian Cooperative Trial Group for Hematology Oncology', u'Murdoch Childrens Research Institute', u'Garvan Institute of Medical Research', u'Roche Holding AG', u'Touchstone Innovations Plc', u'Shire plc', u'University of British Columbia', u'Apollo Life Sciences Pty Ltd', u'ANI Pharmaceuticals Inc', u'Genecor International Inc', u'TG Therapeutics Inc', u'Korea Drug Development Fund', u'Statens Serum Institut', u'Gen Ilac', u'Dana-Farber Cancer Institute Inc', u'Evotec AG', u'Exelixis Inc', u'McMaster University', u'Amgen Inc', u'EUSA Pharma USA', u'Biotech Australia', u'The University of Birmingham', u'Eunice Kennedy Shriver National Institute of Child Health & Human Development', u'ZIOPHARM Oncology Inc', u'Georgetown University', u'Jiangsu Hengrui Medicine Co Ltd', u'Inflazyme Pharmaceuticals', u'Enzon Pharmaceuticals Inc', u'Goodwin Biotechnology Inc', u'Immunomedics Inc', u'Pennsylvania State University', u'Merck Millipore', u'Dong-A ST Co Ltd', u'AllCells LLC', u'Allergan Inc', u'The Research Council of Norway', u'Fight Against Cancer Innovation Trust', u'CerRx Inc', u'Roche GlycArt Ag', u'Rockefeller University', u'Cancer Research UK', u'Genentech Inc', u'Mayo Clinic Foundation', u'Harbin Gloria Pharmaceuticals Co Ltd', u'Weill Medical College of Cornell University', u'American Cancer Society', u'Laureate Biopharmaceutical Services Inc', u'Sumitomo Dainippon Pharma Co Ltd', u'PDL BioPharma Inc', u'Cell and Gene Therapy Catapult', u'The University of Kansas Cancer Center', u'GE Ventures', u'Medison Pharma Ltd', u'Sagami Chemical Research Center', u'Deutsches Rote Kreuze', u'Deutsches Krebsforschungszentrum', u'Ottawa Regional Cancer Foundation', u'MolMed SpA', u'R-Pharm', u'Jeil-Kirin Pharmaceutical Inc', u'AstraZeneca plc', u'University of Utah', u'Boehringer Ingelheim Vetmedica GmbH', u'University of Texas Southwestern Medical Center', u'Metdem Healthcare Ltd', u'Genta Inc', u'Beijing Pason Pharmaceuticals Inc', u'Nippon Shinyaku Co Ltd', u'Tolero Pharmaceuticals Inc', u'Australian Government', u'University of London School of Pharmacy', u'Genmab A/S', u'Qualiber Inc', u'ASTA Medica AG', u'Nerviano Medical Sciences Srl', u'Ligand Pharmaceuticals Inc', u'Innovation Pharmaceuticals Inc', u'Abiogen Pharma SpA', u'MacroGenics Inc', u'Aqualis ASA', u'Trellis Bioscience Inc', u'Fujifilm Diosynth Biotechnologies', u'Cornell University', u'Accelera Srl', u'Walter and Eliza Hall Institute of Medical Research', u'Indiana University', u'PiSA Farmaceutica', u'Dyax Corp', u'Igenica Inc', u'Nextera AS', u'Jackson Laboratory', u'German Federal Ministry of Education and Research', u'Veeda Clinical Research', u'Barrier Therapeutics Inc', u'Advaxis Inc', u'Koken Co Ltd', u'EMD Serono Inc', u'Il-Yang Pharmaceutical Co', u'Cosmo Pharmaceuticals SpA', u'Australian Nuclear Science & Technology Organization', u'SGX Pharmaceuticals Inc', u'Medipost Co Ltd', u'Rasna Therapeutics Inc', u'LegoChem Bioscience Inc', u'MedImmune LLC', u'Samaritan Pharmaceuticals Inc', u'Fred Hutchinson Cancer Research Center', u'University of London', u'ARIAD Pharmaceuticals Inc', u'Pharmacia & Upjohn Co', u'Kite Pharma Inc', u'Peplin Inc', u'Kiadis Pharma Netherlands BV', u'Ottawa Hospital Research Institute', u'Inex Pharmaceuticals Corp', u'Kanebo KK', u'Mylan Inc', u'Harvard University', u'Hyundai Hope on Wheels Foundation', u'NeoPharm Inc', u'EuroGen Pharmaceuticals Ltd', u'Teva Pharmaceutical Industries Ltd', u'University of California San Francisco', u'CryoPort Inc', u'Cell Medica Ltd', u'Mundipharma EDO GmbH', u'Threshold Pharmaceuticals Inc', u'Skolkovo', u'Northwestern University Feinberg School of Medicine', u'Invivoscribe Technologies Inc', u'Micromet Inc', u'Nottingham Trent University', u'Medigene Immunotherapies GmbH', u'Complete Genomics Inc', u'Oncology Therapeutic Development', u'Debiopharm SA', u'MiNeueT Therapeutics Ltd', u'Autolus LLC', u'IDIS Ltd', u'Stemline Therapeutics Inc', u'Universita di Bologna', u'Oxford BioMedica plc', u'Epizyme Inc', u'ViaCell Inc', u'The Knut and Alice Wallenberg Foundation', u'Baxter Healthcare Corp', u'OncoTartis Inc', u'Panther Biotechnology Inc', u'XOMA Corp', u'Merck & Co Inc', u'Zenyaku Kogyo Co Ltd', u'BioChem Pharma (International ) Inc', u'Sanofi', u'Vertex Pharmaceuticals Inc', u'Columbia University', u'Novogen Ltd', u'University of California Davis', u\"Riley Children's Foundation\", u'MacroChem Corp', u'Ascalon International Inc', u'InNexus Biotechnology Inc', u'New York State Stem Cell Science', u'Case Western Reserve University', u'Hannover Medical School', u'Sellas Life Sciences Group', u'Caladrius Biosciences Inc', u'Kura Oncology Inc', u'Massachusetts Institute of Technology', u'Imclone LLC', u'University of Jena', u'Cancer Research Ventures Ltd', u'Elanco Animal Health', u'PRISM Pharma Co Ltd', u'Lonza Group AG', u'Elan Corp plc', u'City of Hope', u'Sanofi Genzyme', u'CJ Corp', u'Celgene Corp', u'Imperial College London', u'Max Delbruck Centrum Fur Molekulare Medizin', u'T.J. Martell Foundation', u'Duke University', u'Bioniche Teoranta', u'IATROS Bio/Pharma Inc', u'University of Alberta', u'ProMIS Neurosciences Inc', u'UCL Business PLC', u'University of Newcastle', u'US Government', u'The Leukemia & Lymphoma Society', u'Netherlands Government', u'DiNonA Inc', u'Ambit Biosciences Corp', u'GlaxoSmithKline plc', u'QIMR Berghofer Medical Research Institute', u'Rafarma Pharmaceuticals Inc', u'The Leukaemia Foundation', u'University of Michigan', u'Ontario Institute for Cancer Research', u'Consejeria de Industria', u'ERYtech Pharma', u'Nordic Nanovector ASA', u'Biomas Inc', u'Oxis Biotech Inc', u\"Boston Children's Hospital\", u'Sanquin Blood Supply Foundation', u'MD Anderson Cancer Center', u'Research Center For Toxicology And Hygenic Regulation Of Biopreparations', u'Daiichi Sankyo Co Ltd', u'Abbott Laboratories', u'Eisai Co Ltd', u'National Cancer Institute', u'Sidney Kimmel Comprehensive Cancer Center', u'Cyteir Therapeutics Inc', u'Korea Research Institute of Bioscience and Biotechnology', u'Karolinska Development AB', u'Fresenius Medical Care AG', u'Osiris Therapeutics Inc', u'University of Minnesota', u'Monash University', u'SymBio Pharmaceuticals Ltd', u'Applied Immune Technologies Ltd', u'Kosan Biosciences Inc', u'The First Hospital Of China Medical University', u'Lundbeck Inc', u'CytRx Corp', u'Ferrer Internacional SA', u'Pluristem Therapeutics Inc', u'Royalty Pharma', u'Orphan Australia', u'Chugai Pharmaceutical Co Ltd', u'Undisclosed', u'Hayashibara Biochemical Laboratories Inc', u'Otsuka Pharmaceutical Co Ltd', u'Hanwha Corp', u'Herrick Foundation', u'Compliment Corp', u'Southern Research Institute', u'Callisto Pharmaceuticals Inc', u'Pharmachemie BV', u'Republic of Korea Government', u'Heidelberg Pharma Holding Ltd', u'National Institute on Drug Abuse', u'Nohla Therapeutics Inc', u'University College London', u'Orekhovich Institute of Biomedical Chemistry', u\"Children's Hospital of Los Angeles\", u'University of Virginia', u'Kyowa Hakko Kirin Co Ltd', u'Immune Therapeutics Inc', u'Cyclacel Pharmaceuticals Inc', u'Pfizer Inc', u'Sandoz Inc', u'Memorial Sloan-Kettering Cancer Center', u'Mount Sinai Medical Center', u'Illumina Inc', u'Baylor College of Medicine', u'Mabion SA', u'UK Government', u'Paul Scherrer Institut', u'MEI Pharma Inc', u'Zevacor Molecular', u'Eureka Therapeutics Inc', u'Viragen Inc', u'Ohio State University', u'NuView Life Sciences', u'National Institutes of Health', u'Axxiom Inc', u'MI Bioresearch', u'OncoVista Innovative Therapies Inc', u'Childrens Hospital of Philadelphia', u'Takara Bio Inc', u'Novartis AG', u'University of New Mexico', u'Alize Pharma SAS', u'Immunovative Therapies Ltd', u'Sojo University']), u'Complexregionalpainsyndrome': set([u'NovaPharm Therapeutics', u\"Lee's Pharmaceutical Holdings Limited\", u'Mallinckrodt plc', u'Abiogen Pharma SpA', u'Grunenthal GmbH', u'Piramal Critical Care Inc']), u'Proteinmetabolismdisorder': set([u'Malin Corp plc', u'Wren Therapeutics Limited']), u'Babesiainfection': set([u'US Government', u'Diatherix Laboratories Inc']), u'Alpha-1antitrypsindeficiency': set([u'AgResearch Ltd', u'Weill Medical College of Cornell University', u'Undisclosed', u'Baxter International Inc', u'CSL Behring LLC', u'AGTC', u'Arrowhead Pharmaceuticals Inc', u'National Institute of Diabetes, Digestive and Kidney Diseases', u'GlaxoSmithKline plc', u'LFB SA', u'geneRx+ Inc', u'Chiesi Farmaceutici SpA', u'Albert Einstein College of Medicine', u'Aradigm Corp', u'National Institutes of Health', u'Food and Drug Administration', u'OncBioMune Mexico SA de CV', u'Ionis Pharmaceuticals Inc', u'Arcturus Therapeutics Inc', u'Annapurna Therapeutics SAS', u'University of Florida', u'Lovelace Respiratory Research Institute', u'Alpha-1 Foundation', u'University of Pittsburgh', u'Sangamo Therapeutics Inc', u'Bayer AG', u'Univ Massachusetts', u'Amunix Inc', u'Nektar Therapeutics', u'Grifols Inc', u'INHIBRx LLC', u'The Alpha-1 Project', u'Activaero GmbH', u'BioRx', u'rEVO Biologics Inc', u'Profile Therapeutics Inc', u'InterMune Inc', u'PPL Therapeutics plc', u'Alnylam Pharmaceuticals Inc', u'Alpha Therapeutic Corp', u'PARI Pharma GmbH', u'University of Massachusetts Medical School', u'Kamada Ltd']), u'Fungalinfection': set([u'Marrone Organic Innovations', u'Lumara Health Inc', u'Axxess Pharma Inc', u'Divergence Inc', u'US Health and Human Services Department', u'Pharmagenesis Inc', u'Universitat Rovira I Virgili', u'Aparna Biosciences Corp', u'Questcor Pharmaceuticals Inc', u'Novartis Consumer Health SA', u'PolyMedix Inc', u'Hawker Resources Inc', u'Ramot at Tel Aviv University Ltd', u'Sumitomo Pharmaceuticals Co Ltd', u'Unigen Pharmaceuticals Inc', u'Hospira Inc', u'Polyphor Ltd', u'Sandoz Ltd', u'Foamix Pharmaceuticals Ltd', u'Sankyo Pharmaceutical', u'National Research Council of Canada', u'Torrex Pharma Ges mbH', u'Sigma-Tau Ind Farm Riunite SpA', u'LifePharms Inc', u'Centre National de la Recherche Scientifique (CNRS)', u'The European Union', u'Nippon Kayaku Co Ltd', u'Glenmark Pharmaceuticals Ltd', u'University Of North Dakota', u'Trine Pharmaceuticals Inc', u'Promiliad Biopharma Inc', u'Aparts BV', u'Barrier Therapeutics Inc', u'Brandeis University', u'Altan Pharma Ltd', u'Agennix AG', u'Siegfried Holding Ltd', u'University of Otago', u'Wellcome Trust', u'Janssen Korea Ltd', u'Cilag AG', u'Amplyx Pharmaceuticals Inc', u'Biofrontera Discovery GmbH', u'Janssen Pharmaceutica NV', u'Maryland Technology Development Corp', u'Janus Pharmaceuticals Inc', u'Race Pharmaceuticals Inc', u'Trana Discovery Inc', u'Palacky University', u'Biothera Pharmaceuticals Inc', u'Pharmacelsus', u'Dong-A ST Co Ltd', u'Coley Pharmaceutical Group Inc', u'IASO Pharma Inc', u'Bayer Yakuhin Ltd', u'Undisclosed', u'Napa Biosciences Inc', u'Institute of Organic Chemistry And Biochemistry of The Academy of Sciences of The Czech Republic', u'Eli Lilly & Co', u'Cumberland Emerging Technologies Inc', u'Seren Pharmaceuticals Inc', u'REVOLUTION Medicines Inc', u'Centrose LLC', u'Stiefel', u'Michigan State University', u'Novartis Vaccines & Diagnostics', u'Nanjing Forestry University', u'Toyama Chemical Co Ltd', u'Ferrer Internacional SA', u'Johnson & Johnson', u'Hexima Ltd', u'The Liposome Company Inc', u'Blueberry Therapeutics Ltd', u'Immtech Pharmaceuticals Inc', u'SmithKline Beecham plc', u'Vicuron Pharmaceuticals Inc', u'UCB Celltech', u'Walter Reed Army Institute of Research', u'Arrow Therapeutics Ltd', u'Bristol-Myers Squibb Co', u'NeXstar Pharmaceuticals Inc', u'Takata Seiyaku', u'Astellas Pharma Inc', u'BioDelivery Sciences International Inc', u'Discovery Partners LLC', u'Novexel SA', u'Enamine Ltd', u'Hoechst Marion Roussel Inc', u'Zengen Inc', u'FARMA-APS', u'Ardea Biosciences Inc', u'Bayer (Canada) Inc', u'BTG plc', u'OOO VagaPharm', u'Y B Chavan College of Pharmacy', u'Chinese Government', u'ArQule Inc', u'Veristat, Inc.', u'Dynamic Microbials Ltd', u'Acrux Ltd', u'Second Military Medical University PLA', u'University of British Columbia', u'Microcide Pharmaceuticals Inc', u'Handok Inc', u'Biosearch Italia SpA', u'UCB Pharma SA', u'Santee Biosciences Inc', u'l\\u2019Universite Paris Descartes', u'Biotica Technology Ltd', u'NPO Petrovax Pharm LLC', u'Institute of Plant Protection CAAS', u'Nosopharm SAS', u'Hainan Hailing Chemipharma Corporation Limitd', u'Karo Pharma AB', u'Virtual Drug Development Inc', u'Coelacanth Corp', u'Endo Pharmaceuticals Solutions Inc', u'Laboratorios Effik SA', u'University of Aberdeen', u'Zeneus Pharma Ltd', u'Palau Pharma SA', u'University of Alabama at Birmingham', u'Shaanxi Synthetic Pharmaceutical Co Ltd', u'Samyang Corp', u'Enzon Pharmaceuticals Inc', u'Basilea Pharmaceutica International Ltd', u'Albany Molecular Research Inc', u'OnTarget Chemistry AB', u'Prasco Laboratories', u'LG Chem Ltd', u'Viamet Pharmaceuticals Holdings LLC', u'Highnoon Laboratories Ltd', u'Aventis Pharma Ltd', u'F Hoffmann-La Roche AG', u'King Faisal Specialized Hospital & Research Center', u'SICOR Inc', u'Dr Babasaheb Ambedkar Marathwada University', u'Genentech Inc', u'Mitsubishi Pharma Corp', u'Mayo Clinic Foundation', u'Actavis Inc', u'Sequella Inc', u'Genzyme General', u'French Government', u'Ironwood Pharmaceuticals Inc', u'Research Corporation Technologies', u'Mycoses Study Group Education and Research Consortium', u'LION bioscience Inc', u'R-Pharm', u'China Medical System Holdings Ltd', u'Cubist Pharmaceuticals Inc', u'AstraZeneca plc', u'Technology Strategy Board', u'Synvax Pharmaceuticals Inc', u'Horizon Pharma plc', u'Scotia Holdings plc', u'Sheffield Hallam University', u'University of London School of Pharmacy', u'Zydus Healthcare USA LLC', u'Mochida Pharmaceutical Co Ltd', u'University of Mississippi', u'China Agricultural University', u'Abiogen Pharma SpA', u'Korea Rural Development Administration', u'Summit Pharmaceuticals International Corp', u'Icoria Inc', u'Aronex Pharmaceuticals Inc', u'Sichuan Kelun Pharmaceutical Co Ltd', u'Bristol-Myers Squibb Pharma Co', u'Dong Wha Pharmaceutical Co Ltd', u'Alpha-Beta Technology Inc', u'Pcovery ApS', u'Cyclenium Pharma Inc', u'BioDiem Ltd', u'Yung-Shin Pharmaceutical Industry Co Ltd', u'Ocean Pharmaceuticals Inc', u'Walter and Eliza Hall Institute of Medical Research', u'Dyax Corp', u'3M Co', u'University of Illinois at Urbana-Champaign', u'Triad Therapeutics Inc', u'Teligent Inc', u'Aventis Pharma SA', u'SPA Societa Prodotti Antibiotici SpA', u'Oscient Pharmaceuticals Corp', u'Aquaartis', u'University of Connecticut', u'CPBS', u'University of Brasilia', u'Onxeo SA', u'ASKA Pharmaceutical Co Ltd', u'Global Clean Energy Holdings Inc', u'Merck Centre of Fungal Genetics', u'Vical Inc', u'King Saud University', u'Kunming Institute of Zoology The Chinese Academy of Sciences', u'Nissan Chemical Industries Ltd', u'Sun Pharmaceutical Industries Ltd', u'Dong Kook Pharmaceutical Co Ltd', u'F2G Ltd', u'National Center for Research Resources', u'Pfizer Inc', u'Cetek Corp', u'Hikma Pharmaceuticals plc', u'Main Life Corporation Ltd', u'Incyte Corp', u'SCYNEXIS Inc', u'Mylan Inc', u'Alberta Peptide Institute', u'SEQUUS Pharmaceuticals Inc', u'Zeneca Group plc', u'ISAGRO USA InC', u'Boehringer Ingelheim International GmbH', u'GlobeImmune Inc', u'Angelini Pharmaceuticals SpA', u'MycoLogics Inc', u'Fundaci\\xf3n MEDINA', u'Resolution Pharmaceuticals Inc', u'Carrus Capital Corp', u'AnGes MG Inc', u'Boehringer Ingelheim Corp', u'Argenta Discovery Inc', u'Cidara Therapeutics Inc', u'Institute of Dental Research', u'University of Sheffield', u'Connetics Corp', u'Unimedic AB', u'University of California', u'Merck & Co Inc', u'Sanofi', u'Groundwork BioAg Ltd', u'Bayer AG', u'Pharmacia Corp', u'Phytera Inc', u'Ancora Pharmaceuticals Inc', u'Almirall Prodesfarma SA', u'Seachaid Pharmaceuticals Inc', u'Gilead Sciences Inc', u'Kaken Pharmaceutical Co Ltd', u'Wyeth', u'Spero Therapeutics LLC', u'Anhui Jiren Pharmaceutical Co Ltd', u'Evolva Holding SA', u'Tularik Inc', u'Griffith University', u'Laboratorios Dr Esteve SA', u'Smith & Nephew Biotherapeutics', u'Aurigene Discovery Technologies Ltd', u'Elan Corp plc', u'Aventis SA', u'Trimble Ab', u'Whitehead Institute for Biomedical Research', u'Topica Pharmaceuticals', u'Ranbaxy Laboratories Ltd', u'Omnia Molecular', u'Tufts University', u'Therabel Pharma NV', u'University of Texas Health Science Center San Antonio', u'National Institute of Dental and Craniofacial Research', u'Boehringer Ingelheim Austria GmbH', u'Connetics Australia Pty Ltd', u'XTL Biopharmaceuticals Ltd', u'Daiichi Seiyaku Co Ltd', u'US Government', u'Orchid Pharma Ltd', u'iCo Therapeutics Inc', u'NAEJA Pharmaceuticals Inc', u'SamChunDang Pharm Co Ltd', u'InterMune Inc', u'Grupo Uriach', u'Breckenridge Pharmaceutical Inc', u'GlaxoSmithKline plc', u'AureoGen Biosciences Inc', u'Biotoscana International', u'Immunex Corp', u'Schering-Plough Research Institute', u'Myongji University (MJU)', u'Clinigen Group plc', u'Takeda Oncology', u'St Petersburg Institute of Experimental Medicine', u'Sankyo Co Ltd', u'Shionogi & Co Ltd', u'Inpharmatica Ltd', u'US Department of Defense', u'Taiwan Liposome Co', u'Specs', u'SS Pharmaceutical - ethical drug division', u'MD Anderson Cancer Center', u'Abbott Laboratories', u'Eisai Co Ltd', u'AlerGenetica SL', u'OrthoNeutrogena', u'National Cancer Institute', u'Novartis AG', u'University of Pune', u'DreamPharma Corp', u'Fujisawa Pharmaceutical Co Ltd', u'University of Minnesota', u'Guild Associates Inc', u'Penederm Inc', u'University of Manchester', u'Taiho Pharmaceutical Co Ltd', u'University of Colorado System', u'University of Barcelona', u'Gdansk University of Technology', u'Kyowa Hakko Kogyo Co Ltd', u'Recordati SpA', u'Farmades SpA', u'York Pharma plc', u'Mayne Pharma Group Ltd', u'University of North Carolina', u'Syngenta AG', u'Medicis Pharmaceutical Corp', u'Drugs for Neglected Diseases Initiative', u'Maxygen Holdings Ltd', u'National Institute on Drug Abuse', u'CytoSorbents Corp', u'Indian Institute of Chemical Technology', u'Nanjing University', u'Galderma SA', u'Stockton Group', u'PLIVA dd', u'Federal University of Ceara', u'US Department of Agriculture', u'NovaBay Pharmaceuticals Inc', u'Genaera Corp', u'Shaman Pharmaceuticals Inc', u'Visterra Inc', u'Peregrine Renovations LLC', u'Shenyang Pharmaceutical University', u'Tsumura & Co', u'Central Drug Research Institute', u'Inhibitex Inc', u'University of Arizona', u'Elitra Pharmaceuticals Inc', u'Duke University', u'Arietis Corp', u'Avir Pharma Inc', u'Luqa Pharmaceuticals', u'National Institute of Allergy and Infectious Diseases', u'Nihon Nohyaku Co Ltd', u'Arena Pharmaceuticals Inc', u'Organon International Inc', u'Phylogica Ltd', u'Aarhus University', u'National Institutes of Health', u'Verenium Corp', u'Asahi Kasei Pharma Corp', u'National Institutes of Standards and Technology', u'Anadys Pharmaceuticals Inc', u'Chemo Group', u'Takara Bio Inc', u'Ciba-Geigy Corp', u'Deinove', u'California Institute for Medical Research']), u'Yellowfevervirusinfection': set([u'Themis Bioscience GmbH', u'University of Texas Medical Branch at Galveston', u'Isotechnika Pharma Inc', u'Fraunhofer USA Inc', u'Baxter International Inc', u'Ministry of Health, Brazil', u'Sanofi Pasteur', u'National Institute of Allergy and Infectious Diseases', u'iBio Inc', u'Bavarian Nordic A/S', u'PowderJect Pharmaceuticals plc', u'Oregon Health Sciences University', u'Scripps Research Institute', u'Robert Koch Institute', u'Centers for Disease Control and Prevention', u'University of Washington', u'AvidBiotics Corp', u'CSL Ltd', u'Pnuvax Inc', u'Evolva SA', u'Medigen Inc', u'Institut Pasteur', u'Crucell Switzerland AG', u'GE Healthcare', u'National Center for Research Resources', u'Najit Technologies Inc', u'Kineta Inc', u'Acambis plc']), u'Alexanderdisease': set([u'Ionis Pharmaceuticals Inc', u'University of Wisconsin-Madison', u'University of Iowa', u'National Institute of Neurological Disorders and Stroke']), u'Craniofacialdevelopmentdisorder': set([u'Nexus CMF', u'ReNovo Biotech Inc']), u'Amblyopia': set([u'Finnish Funding Agency for Technology and Innovation', u'Hermo Pharma Oy Ltd']), u'Cervicaldystonia': set([u'Hannover Medical School', u'Solstice Neurosciences Inc', u'Addex Therapeutics Ltd', u'Revance Therapeutics Inc', u'DRAXIS Health Inc', u'Emory University', u'Medicis Pharmaceutical Corp', u'Ipsen', u'Elan Corp plc', u'Axogen Ltd', u'Eisai Co Ltd', u'Ajinomoto Althea Inc']), u'Irritablebowelsyndrome': set([u'ViThera Pharmaceuticals Inc', u'Symphony Capital LLC', u'CellAct Pharma GmbH', u'OnSite Diagnostic Labs India Pvt Ltd', u'Bill & Melinda Gates Foundation', u'US Government', u'Forest Laboratories Inc', u'GlaxoSmithKline plc', u'BTG plc', u'Synergy Pharmaceuticals Inc', u'Hyseq Inc', u'Ipsen', u'Albireo Ltd', u'Arch Biopartners Inc', u'Assembly Biosciences Inc', u'Mitsubishi-Tokyo Pharmaceuticals Inc', u'Ono Pharmaceutical Co Ltd', u'Rose Pharma A/S', u'Shire plc', u'Mitsubishi Tanabe Pharma Corp', u'Ajinomoto Co Inc', u'R&R Inc', u'Bio-Medisinsk Innovasjon AS', u'Arachnova Ltd', u'Direct Relief International', u'TG Therapeutics Inc', u'Probi AB', u'Meiji Seika Pharma Co Ltd', u'AltheRx Pharmaceuticals Inc', u'The Procter & Gamble Co', u'Biohit OYJ', u'Commonwealth Laboratories Inc', u'Daiichi Sankyo Co Ltd', u'Abbott Laboratories', u'Trine Pharmaceuticals Inc', u'Novartis AG', u'Johns Hopkins University School of Medicine', u'RedHill Biopharma Ltd', u'PsiOxus Therapeutics Ltd', u'Massachusetts General Hospital', u'University of California San Francisco', u'Rottapharm Madaus', u'Celtis Pharm Co Ltd', u'Adolor Corp', u'ENTEROME Bioscience SA', u'Dong-A ST Co Ltd', u'Alvogen Inc', u'Numoda Corp', u'EndoLogic LLC', u'Janssen Pharmaceutica NV', u'National Institute of Biomedical Innovation', u'Boehringer Ingelheim Corp', u'DuPont Pharmaceuticals Ltd', u'Recordati SpA', u'H Lundbeck A/S', u'Lexicon Pharmaceuticals Inc', u'Prometheus Laboratories Inc', u'Centre for Digestive Diseases', u'PBM Pharmaceuticals Inc', u'Neurogen Corp', u'Mitsubishi Pharma Corp', u'Xian-Janssen Pharmaceutical Ltd', u'IDIS Ltd', u'Albany Molecular Research Inc', u'MicroDose Therapeutx Inc', u'Astellas Pharma Inc', u'Allergan plc', u'The Lieber Institute For Brain Development', u'BMP Sunstone Corp', u'Undisclosed', u'Altus Formulation', u'Glaxo Group Ltd', u'Sanofi', u'Tioga Pharmaceuticals Inc', u'Eli Lilly & Co', u'Bayer AG', u'CSL Ltd', u'Dynogen Pharmaceuticals Inc', u'University of Barcelona', u'Kyowa Hakko Kirin Co Ltd', u'Soligenix Inc', u'Celentyx Ltd', u'BioSeek Plc', u'Argenta Discovery Ltd', u'Biomerica Inc', u'Ironwood Pharmaceuticals Inc', u'Almirall Prodesfarma SA', u'Aptalis Pharma Inc', u'Pfizer Inc', u'Universitat Autonoma de Barcelona', u'Synthetic Biologics Inc', u'Sungkyunkwan University', u'Institut National de la Recherche Agronomique', u'Edusa Pharmaceuticals Inc', u'Giaconda Ltd', u'EPIX Pharmaceuticals Inc', u'Nippon Shinyaku Co Ltd', u'Daejeon University', u'Zcube SRL', u'Intrexon Corp', u'Alimentary Pharmabiotic Centre', u'Kureha Corp', u'Alfa Wassermann SpA', u'BL&H Co Ltd', u'Alizyme plc', u'University of Tokyo', u'Xention Ltd', u'Bristol-Myers Squibb Co', u'Furiex Pharmaceuticals Inc', u'INSERM', u'Cedars-Sinai Medical Center', u'PN Gerolymatos SA', u'Thornton & Ross Ltd', u'Salix Pharmaceuticals Ltd', u'Concordia International Corp', u'Napo Pharmaceuticals Inc', u'Takeda Pharmaceutical Co Ltd', u'University of Alberta', u'AGI Therapeutics plc']), u'Renalfibrosis': set([u'Pharmaxis Ltd', u'InterMune Inc', u'National Institute of Diabetes, Digestive and Kidney Diseases', u'US Government', u'University of Wurzburg', u\"Seattle Children's Hospital\", u'ProMetic Life Sciences Inc', u'Bristol-Myers Squibb Co', u'Marnac Inc', u'Australian Research Council', u'Medikine Inc', u'Regulus Therapeutics Inc', u'University of Washington', u'FibroGen Inc', u'Shenzhen Royal Asset Management Co Ltd', u'Medical University of South Carolina', u'Epigen Biosciences Inc', u'Horizon Orphan LLC', u'Sankyo Co Ltd', u'Allosterix Ltd', u'Glasgow University', u'University of Sydney']), u'Fasciolahepaticainfection': set([u'World Health Organization', u'Novartis AG']), u'DiffuselargeB-celllymphoma': set([u'Weill Medical College of Cornell University', u'US Government', u'The Leukemia & Lymphoma Society', u'Louisiana State University Health Sciences Center New Orleans', u'Genentech Inc', u'Incyte Corp', u'Amgen Inc', u'Mylan Inc', u'Genmab A/S', u'Sierra Oncology Inc', u'Cancer Genetics Inc', u'Veristat, Inc.', u'Pharsight Corp', u'Daiichi Sankyo Co Ltd', u'Abbott Laboratories', u'H Lee Moffitt Cancer Center and Research Institute', u'Biogen Inc', u'Apogee Biotechnology Corp', u'Pharmacyclics Inc', u'GlaxoSmithKline plc', u'Oxford BioMedica plc', u'Seattle Genetics Inc', u'Epizyme Inc', u'Kite Pharma Inc', u'LifeArc', u'National Cancer Institute', u'Augusta University Research Institute Inc', u'Cancer Prevention and Research Institute of Texas', u'Australian Nuclear Science & Technology Organization', u'MethylGene Inc', u'First Affiliated Hospital of Anhui Medical University', u'Hackensack University Medical Center', u'ImmunoCellular Therapeutics Ltd', u'Bristol-Myers Squibb Co', u'Merck & Co Inc', u'Hanmi Pharmaceutical Co Ltd', u'University of Leicester', u'Domainex Ltd', u'University of Southern California', u'Stanford University', u'The Chemotherapy Foundation', u'Sinobioway Cell Therapy Co Ltd', u'CryoPort Inc', u'Mabion SA', u'Celgene Corp', u'Takeda Oncology', u'Memgen LLC', u'Cornell University', u'Roche Holding AG', u'Novartis AG', u'Janssen Pharmaceutical KK', u'HUYA Bioscience International LLC', u'Sevion Therapeutics Inc', u'Seattle Cancer Care Alliance', u'ImmunoGen Inc', u'Pretoria East Hospital', u'Oxford University Hospitals NHS Trust', u'SmithKline Beecham plc', u'Coulter Pharmaceutical Inc', u'Quintiles Transnational Corp', u'Janssen Biotech Inc', u'Janssen Pharmaceutica NV', u'NanoString Technologies Inc', u'AstraZeneca plc', u'Burroughs Wellcome Foundation', u'Gilead Sciences Inc', u'Groote Schuur Hospital', u'US Oncology Inc', u'Idun Pharmaceuticals Inc', u'Corixa Corp', u'Beth Israel Deaconess Medical Center', u'DRI Capital', u'Karyopharm Therapeutics Inc', u'Debiopharm SA', u'Lymphoma Study Association', u'Medarex Inc', u'Cell>Point LLC']), u'Dysphonia': set([u'National Institute on Deafness and Other Communication Disorders', u'Purdue University']), u'Chronicsinusitis': set([u'Regeneron Pharmaceuticals Inc', u'Genentech Inc', u'Entellus Medical Inc', u'Intrexon Corp', u'Fiagon Gmbh', u'Amgen Inc', u'CRS Bio Inc', u'University of Ghent']), u'Cannabisdependence': set([u'Omni Health Inc', u'Bethesda Biomedical', u'Vapomins Vertriebsgesellschaft mbH', u'National Institute on Drug Abuse', u'Zynerba Pharmaceuticals Inc', u'Mary\\u2019s Medicinals Llc']), u'Otitismedia': set([u'Alcon Inc', u'LG Life Sciences Ltd', u'MiddleBrook Pharmaceuticals Inc', u'Green Cross Corp', u'Australian Government', u'Laboratorios Farmaceuticos Rovi SA', u'Nventa Biopharmaceuticals Corp', u'Pediapharm Inc', u'Tufts University', u'Clonmel Healthcare', u'Sanofi Pasteur', u'Nippon Soda Co Ltd', u'Abbott Laboratories', u'Sanofi Pasteur MSD', u'Takeda Pharmaceutical Co Ltd', u'SmithKline Beecham plc', u'Dainabot KK', u'GlaxoSmithKline plc', u'Otic Pharma Ltd', u'National Institutes of Health', u'US Government', u'Provalis plc', u'Emergent BioSolutions Inc', u'Shanghai Pharmaceuticals Holding Co Ltd', u'Hanmi Pharmaceutical Co Ltd', u'Taisho Pharmaceutical Co Ltd', u'BioChem Pharma (International ) Inc', u'Victory Pharma Inc', u'Ribi ImmunoChem Research Inc', u\"Lee's Pharmaceutical Holdings Limited\", u'Biocontrol Ltd', u'Auris Medical Holding AG', u'Bayer AG', u'Murdoch Childrens Research Institute', u'Otifex Therapeutics Pty Ltd', u'SK Chemicals Life Science', u'Global Alliance for Vaccines and Immunization', u'North American Vaccine Inc', u'Pfizer Vaccines', u'DoctorDirectory', u'Biological Mimetics Inc', u'Par Pharmaceutical Inc', u'Genesoft Inc', u'Almirall Prodesfarma SA', u'Leiden University Medical Center', u'Pavmed Inc', u'Pfizer Inc', u'Cardiovascular Systems Inc', u'Boehringer Ingelheim Corp', u'Ilsung Pharmaceutical Co Ltd', u'13Therapeutics Inc', u'Laboratorios SALVAT SA', u'Otodyne Inc', u'Undisclosed', u'Arbor Pharmaceuticals Inc', u'National Research Council of Canada', u'Dr Reddy\\u2019s Research and Development BV', u'Cortecs International Ltd']), u'Renaltum': set([u'Biocompatibles International plc', u'Bayer HealthCare Pharmaceuticals Inc']), u'Fever': set([u'Johnson & Johnson', u'US Government', u'Undisclosed', u'UK Government', u'Cumberland Pharmaceuticals Inc', u'Tulane University', u'Ligand Pharmaceuticals Inc', u'Cadence Pharmaceuticals Inc', u'Lawrence Laboratories Ltd', u'Foundation for Innovative New Diagnostics', u'Autoimmune Technologies', u'National Institutes of Health', u'Moberg Pharma AB', u'Corgenix Medical Corp', u'Japan Tobacco Inc', u'Prokarium', u'bioCSL PTY Ltd', u'Seelos Therapeutics Inc', u'Navigen Inc', u'Federal government of Mexico', u'Kindred Biosciences Inc', u'Piramal Enterprises Ltd', u'Prestige Brands Holdings Inc', u'Chembio Diagnostic Systems Inc', u'Integrated BioTherapeutics Inc', u'CordenPharma International GmbH', u'Custopharm Inc', u'Alveda Pharmaceuticals Inc', u'University of Utah', u'US Department of Defense', u'Perrigo Co plc']), u'Renaldisease': set([u'Daiichi Seiyaku Co Ltd', u'Karolinska Institutet', u'US Government', u'BioMarin Pharmaceutical Inc', u'Asahi Kasei Corp', u'BioLink Life Sciences Inc', u'Galenica AG', u'Baxter International Inc', u'AxCell Biosciences Corp', u'Life-Tech. Inc.', u'Capricor Therapeutics Inc', u'Biogen Inc', u'GlaxoSmithKline plc', u'Vifor Pharma', u'InMed Pharmaceuticals Inc', u'NephroGenex Inc', u'Mountain View Pharmaceuticals Inc', u'Novelion Therapeutics Inc', u'Savient Pharmaceuticals Inc', u'Clinipace', u'Uppsala University', u'Millar Instruments Inc', u'DSM Chemie Linz GmbH', u'Radikal Therapeutics Inc', u'DRAXIMAGE', u'Acologix Inc', u'Renovar Inc', u'Hydra Biosciences Inc', u'Synvista Therapeutics Inc', u'Ranbaxy Pharmaceuticals Inc', u'Regenerex LLC', u'IGAN Biosciences Inc', u'Nektar Therapeutics', u'Murdoch Childrens Research Institute', u'Shire-Movetis NV', u'National Institute of Advanced Industrial Science and Technology', u'Hospira Inc', u'Nissan Chemical Industries Ltd', u'Shire plc', u'Gamida Cell Ltd', u'Emcure Pharmaceuticals Ltd', u'Medline Industries Inc', u'Cytori Therapeutics Inc', u'Spectrum Pharmaceuticals Inc', u'Toray Industries Inc', u'Organovo Inc', u'ModeRNA Therapeutics', u'Eukarion Inc', u'Merckle GmbH', u'Reata Pharmaceuticals Inc', u'Mayo Clinic Foundation', u'Teijin Pharma Ltd', u'Pharmaniaga Bhd', u'Repligen Corp', u'Sequenom Inc', u'Evotec AG', u'Exelixis Inc', u'Stryker Corp', u'Valencian Biomedical Research Foundation', u'ZymoGenetics Inc', u'Amgen Inc', u'Cambridge Antibody Technology Group plc', u'Harvard University', u'Daiichi Sankyo Co Ltd', u'Abbott Laboratories', u'UniQuest Pty Ltd', u'Mount Sinai School of Medicine', u'Speedel Pharma AG', u'Boryung Biopharma Co Ltd', u'GelTex Pharmaceuticals Inc', u'Solana Therapeutics Inc', u'Dynamis Therapeutics Inc', u'Novartis AG', u'Gambro AB', u'Modern Healthcare Solutions Co Ltd', u'Keryx Biopharmaceuticals Inc', u'Vanderbilt University', u'DaVita Clinical Research', u'Fresenius Medical Care AG', u'Sumitomo Pharmaceuticals Co Ltd', u'Natureplex LLC', u'SensiGen LLC', u'Fourth Military Medical University PLA', u'Mallinckrodt Inc', u'Revive Therapeutics Ltd', u'ViveBio LLC', u'Cholestech Corp', u'Sunshine Heart Inc.', u'ALZA Corp', u'Achillion Pharmaceuticals Inc', u'Shiva Biomedical LLC', u'Windtree Therapeutics Inc', u'Olympus Corp', u'Japan Tobacco Inc', u'CorMedix Inc', u'Alvogen Inc', u'Human Metabolome Technologies Inc', u'Thrasos Therapeutics', u'The Knut and Alice Wallenberg Foundation', u'Exponential Biotherapies Inc', u'Fresenius Medical Care North America (FMCNA)', u'Boehringer Ingelheim Corp', u'EA Pharma Co Ltd', u'Action Pharma A/S', u'Baker Norton Pharmaceuticals Inc', u'Relypsa Inc', u'Debiopharm SA', u'H Lundbeck A/S', u'Patheon Pharmaceuticals Inc', u'Kinetek Pharmaceuticals Inc', u'Chugai Pharmaceutical Co Ltd', u'Warren Pharmaceuticals Inc', u'Active Pass Pharmaceuticals Inc', u'Genentech Inc', u'Institut de Recherches Cliniques de Montreal', u'Panion & BF Biotech Inc', u'Mitsubishi Pharma Corp', u'Evolva Holding SA', u'National Institute of Diabetes, Digestive and Kidney Diseases', u'Benesis Corp', u'Symphony Evolution Inc', u'Ore Pharmaceuticals Inc', u'University of California San Diego', u'Advanced Renal Technologies', u'Gambro UF Solutions, Inc', u'Ionis Pharmaceuticals Inc', u'Osaka University', u'Inspira Health Network', u'University of California', u'Organovo Holdings', u'Dragon Pharmaceutical Inc', u'Medikine Inc', u'ChemoCentryx Inc', u'Sanofi', u'Nippon Zoki Pharmaceutical Co Ltd', u'Eli Lilly & Co', u'La Jolla Pharmaceutical Co', u'Ardelyx Inc', u'DaVita Inc', u'Altair Nanotechnologies Inc', u'Development Center for Biotechnology', u'US Department of Veterans Affairs', u'Yoshindo Inc', u'Kyowa Hakko Kirin Co Ltd', u'Sarfez Pharmaceuticals Inc', u'George Washington University', u'Gene Vector Technologies Ltd', u'Kissei Pharmaceutical Co Ltd', u'Cyclacel Pharmaceuticals Inc', u'Hyundai Pharmaceutical', u'Hannover Medical School', u'IVAX Corp', u'AstraZeneca plc', u'G1 Therapeutics Inc', u'Seattle Life Sciences', u'Cumberland Pharmaceuticals Inc', u'Idera Pharmaceuticals Inc', u'Lorem Vascular Co Ltd', u'Deltanoid Pharmaceuticals', u'Institute for the Promotion of Innovation by Science and Technology in Flanders', u'University of Pittsburgh', u'InVasc Therapeutics Inc', u'Guerbet', u'Sanwa Kagaku Kenkyusho Co Ltd', u'Serodus ASA', u'BioLineRx Ltd', u'Par Pharmaceutical Co Inc', u'Baylor College of Medicine', u'Advanced Neuroscience Allies Pvt Ltd', u'University of Washington', u'Kureha Corp', u'Zeria Pharmaceutical Co Ltd', u'National Institute of Allergy and Infectious Diseases', u'Impedimed Pty Ltd', u'Nephrogen LLC', u'Quintiles IMS Holdings', u'Taisho Pharmaceutical Co Ltd', u'Alfa Wassermann SpA', u'IMPAX Laboratories Inc', u'Atlas Pharmaceuticals Inc', u'Discovery BioMed Inc', u'Bayer AG', u'National Institutes of Health', u'Fresenius SE & Co KGaA', u'Ono Pharmaceutical Co Ltd', u'Bristol-Myers Squibb Co', u'Elanex Pharmaceuticals Inc', u'Curis Inc', u'Yuyu Inc', u'Sanofi Genzyme', u'KAI Pharmaceuticals Inc', u'Quark Pharmaceuticals Inc', u'Stealth BioTherapeutics Inc', u'NU Trust', u'Bioceuticals Arzneimittel AG', u'ERCell LLC', u'Imperial College London', u'Astellas Pharma Inc', u'Phenos GmbH', u'Valeant Pharmaceuticals International Inc', u'Duke University', u'Phosphate Therapeutics', u'Ferring Research Ltd', u'The Green Cross Corp', u'GE Healthcare', u'IPCA Laboratories Ltd', u'National Cancer Institute', u\"Brigham & Women's Hospital\", u'Hoechst Marion Roussel Inc', u'Mitsubishi Tanabe Pharma Corp', u'North Shore Long Island Jewish Health System', u'Kyowa Kirin', u'Medistem Inc', u'CoNCERT Pharmaceuticals Inc', u'Biostar Pharmaceuticals Inc', u'OncoGenex Pharmaceuticals Inc']), u'Cryptosporidiuminfection': set([u'ImmuCell Corp', u'Laboratorios Columbia SA de CV', u'US Government', u'University of North Carolina', u'Sirenas Marine Discovery LLC', u'Phylogica Ltd', u'ioGenetics Inc', u'University of Connecticut', u'Bill & Melinda Gates Foundation', u'Immtech Pharmaceuticals Inc', u'Mobidiag Oy', u'University of Virginia', u'Promiliad Biopharma Inc', u'Murdoch University', u'Romark Laboratories LC', u'Virginia Polytechnic Institute and State University', u'National Institute of Allergy and Infectious Diseases', u'Aviragen Therapeutics Inc', u'AB ANALITICA', u'Precision Antibody Inc']), u'Otitisexterna': set([u'Alcon Inc', u'BL&H Co Ltd', u'Bayer AG', u'Guangzhou Boji Medical & Biotechnological Co Ltd', u'Undisclosed', u'Laboratorios SALVAT SA', u'Fera Pharmaceuticals LLC', u'Zhaoke Pharmaceutical (Hefei) Co Ltd', u'Arbor Pharmaceuticals Inc']), u'Dermatologicalsymptom': set([u'Ranbaxy Laboratories Ltd', u'Medy-Tox Inc']), u'Borderlinepersonalitydisorder': set([u'Eurand America Inc', u'AstraZeneca plc']), u'Genitaltractinflammation': set([u'ProMetic Life Sciences Inc', u'Arriva Pharmaceuticals Inc']), u'GauchersdiseasetypeIII': set([u'Oxford GlycoSciences plc', u'UCB SA', u'Teva Pharmaceutical Industries Ltd', u'Actelion Ltd']), u'Laborcomplication': set([u'UCB Celltech', u'HCB Happy Child Birth Holding AG', u'Corthera Inc', u'Plethora Solutions Holdings plc', u'Connetics Corp', u'Paladin Labs Inc', u'Dilafor AB', u'F H Faulding & Co Ltd', u'Opocrin SpA']), u'Coronavirusinfection': set([u'Ludwig-Maximilians University of Munich', u'New York Blood Center', u'The Jenner Institute', u'University of Maryland Baltimore County', u'Regeneron Pharmaceuticals Inc', u'Baylor College of Medicine', u'Australian Government', u'National Institutes of Health', u'The University of Hong Kong', u'Fudan University', u'Phelix Therapeutics Llc', u'Rega Institute for Medical Research', u'National Institute of Allergy and Infectious Diseases', u'US Government', u'Walter Reed Army Institute of Research', u'US Health and Human Services Department', u'Southern Research Institute', u'Greffex Inc', u'Inovio Pharmaceuticals Inc', u'Vaccitech Ltd', u'University of Maryland', u'Aphios Corp', u'Interferon Sciences Inc', u'Texas A&M University System', u'Biotron Ltd', u'University of Queensland', u'Lovelace Respiratory Research Institute', u'GeneOne Life Science Inc', u'Chinese Academy of Sciences', u'Isotechnika Pharma Inc', u'Leiden University Medical Center', u'University of Maryland School of Medicine', u'Autoimmune Technologies', u'UK Government', u'NanoViricides Inc', u'SAB Biotherapeutics Inc', u'University of Minnesota', u'The National Institute of Mental Health', u'Brighton Biotech Inc', u'Thomas Jefferson University', u'Erasmus University Medical Center Rotterdam', u'Scientific Products Pharmaceutical Co LTD', u'Hemispherx Biopharma Inc', u'American Red Cross', u'Planet Biotechnology Inc', u'Viroclinics BV', u'University of Illinois', u'International Vaccine Institute']), u'Endometrioidcarcinoma': set([u'Exelixis Inc', u\"Hospital Vall D'Hebron\", u'National Comprehensive Cancer Network', u'Clarient', u'MD Anderson Cancer Center', u'PJSC Pharmsynthez', u'Translational Genomics Research Institute', u'Rafa Laboratories Ltd', u'Incyte Corp', u'US Government', u'Takeda Pharmaceutical Co Ltd', u'Oryzon Genomics SA', u'Sinopharma A-Think Pharmaceutical Co Ltd', u'Arno Therapeutics Inc', u'US Health and Human Services Department', u'CMC Biologics Inc', u'Critical Outcome Technologies Inc', u'Reig Jofre Group', u'PharmaMar SA', u'PapGene Inc', u'Medivation Inc', u'Ability Pharmaceuticals SL', u'PDL BioPharma Inc', u'Merck & Co Inc', u'City of Hope', u'Heat Biologics Inc', u'Ewha Womans University', u'SciClone Pharmaceuticals Inc', u'Washington University in St Louis', u'University of Texas Southwestern Medical Center', u'Columbia University', u'Zentaris GmbH', u'Oncoceutics Inc', u'MolecularMD Corp', u'Imperial College London', u'Astellas Pharma Inc', u'ARIAD Pharmaceuticals Inc', u'Alvogen Korea', u'Astrazeneca Korea', u'The Mary Kay Foundation', u'Viventia Bio Inc', u'Novacell Technology Inc', u'AEterna Zentaris Inc', u'Ministry of Health, Welfare and Family Affairs', u'Ohio State University Comprehensive Cancer Center', u'National Cancer Institute', u'Ergomed PLC', u'Pfizer Inc', u'Population Council', u'Danco Laboratories LLC', u'Cyntec Co Ltd', u'Merrimack Pharmaceuticals Inc', u'Radius Health Inc', u'RuiYi Inc', u'Swedish Orphan Biovitrum AB', u'Tulane University', u'Xenetic Biosciences Inc', u'University of Arizona']), u'Diabeticcomplication': set([u'Eli Lilly & Co', u'Biorex Research and Development Co', u'Exelixis Inc', u'Beiersdorf AG', u'GT Biopharma Inc', u'American Diabetes Association', u'Genentech Inc', u'CSC Pharmaceuticals Handels GmbH', u'National Institute of Diabetes, Digestive and Kidney Diseases', u'Abbott Laboratories', u'Chugai Pharmaceutical Co Ltd', u'Symphony Evolution Inc', u'Takeda Pharmaceutical Co Ltd', u'Peplin Inc', u'University of California San Diego', u'Juvenile Diabetes Research Foundation', u'New Jersey Medical School', u'University of Ottawa', u'Dynamis Therapeutics Inc', u'Jeil Pharmaceutical Co Ltd', u'Womens & Childrens Hospital', u'ASTA Medica Inc', u'Barrier Therapeutics Inc', u'Taisho Pharmaceutical Co Ltd', u'Sumitomo Dainippon Pharma Co Ltd', u'Senju Pharmaceutical Co Ltd', u'Crinos SpA', u'Synvista Therapeutics Inc', u'City of Hope', u'Smith & Nephew plc', u'Panorama Research Inc', u'Ahn-Gook Pharmaceuticals Co Ltd', u'GenKyoTex SA', u'ICOS Corp', u'Advanced Tissue Sciences Inc', u'Vericel Corp', u'Development Center for Biotechnology', u'GlycoMimetics Inc', u'Bayer AG', u'Vasix Corp', u'ALS Association', u'Lilly Deutschland GmbH', u'Kyorin Pharmaceutical Co Ltd', u'Gamida Cell Ltd', u'NicOx SA', u'Biomedical Frontiers Inc', u'Metaphore Pharmaceuticals Inc', u'Glaxo Group Ltd', u'FDA Office of Orphan Products Development', u'Questcor Pharmaceuticals Inc', u'Handok Inc', u'Neuralstem Inc', u'Inotek Pharmaceuticals Corp', u'Daegu Hanny University', u'National Institutes of Health', u'CytRx Corp', u'Ferrer Internacional SA', u'Recordati SpA', u'Laboratorios Silesia SA', u'Emory University', u'National Heart Lung and Blood Institute', u'Pfizer Inc', u'Hemosol Inc', u'Biomedical Research Models Inc', u'Scotia Holdings plc', u'German Federal Ministry of Education and Research', u'NOXXON Pharma AG']), u'Santavuori-Haltiadisease': set([u'US Government', u'Microbot Medical Inc', u'Abeona Therapeutics Inc', u'University of North Carolina']), u'Chromosomedisorder': set([u'National Health and Medical Research Council', u'Albert Einstein College of Medicine', u'Garvan Institute of Medical Research', u'National Institutes of Health', u'BioReference Laboratories', u'Natera Inc']), u'Largeintestinetumor': set([u'University Hospitals of Leicester - Leicester Royal Infirmary', u'CRUK/MRC Oxford Institute for Radiation Oncology', u'Nova Laboratories Ltd', u'AstraZeneca plc']), u'Ischemicstroke': set([u'Ministry of Health & Welfare, Korea', u'Chugai Pharmaceutical Co Ltd', u'Acticor Biotech', u'China Pharmaceutical University', u'STATegics Inc', u'Elan Corp plc', u'Acorda Therapeutics Inc', u'Chinese Academy of Medical Sciences', u'National Institute of Neurological Disorders and Stroke', u'Fudan University', u'University of South Alabama', u'University of Nebraska Medical Center', u'California Institute of Regenerative Medicine', u'US Government', u'NeuroVive Pharmaceutical AB', u'Institute of Materia Medica Chinese Academy of Medical Sciences & Peking Union Medical College', u'Phoenix Biotechnology Inc', u'University of Gottingen', u'Avilex Pharma', u'Korea University', u'Zocere Inc', u'Seoul National University', u'Healios KK', u'China Medical University (Taiwan)', u'Allosteros Therapeutics Inc', u'BioPharmaceuticals Australia', u'State Foundation Institute of Pharmacology RAMS', u'Anaconda Biomed Sl', u'SunTen Phytotech Co Ltd', u'SanBio Co Ltd', u'DiaMedica Inc', u'Chinese Government', u'Shanghai Shyndec Pharmaceutical Co Ltd', u'Shanghai Institute of Pharmaceutical Industry', u'QPS Holdings, LLC', u'Exscien Corp', u'Cedars-Sinai Medical Center', u'ZZ Biotech LLC', u'Isomerase Therapeutics Ltd', u'Aurum Biosciences Ltd', u'Creganna Medical Devices Ltd', u'Thrombolytic Science International LLC', u'Hillhurst Biopharmaceuticals Inc', u'Aptus Biotech Sl', u'VINNOVA', u'Shin Poong Pharmaceutical Co Ltd', u'Second Military Medical University PLA', u'Wellcome Trust', u'Southeast University', u'Merck Millipore', u'Epigen Biosciences Inc', u'Duke University', u'Beijing Collab Pharma Co Ltd', u'CSPC Zhongqi Pharmaceutical Technology (Shijiazhuang) Co Ltd', u'Science & Technology Corporation @ UNM', u'Universidad Complutense de Madrid', u'Athersys Inc', u'Mediolanum Farmaceutici SpA', u'biOasis Technologies Inc', u'Randox Laboratories Ltd', u'Nanjing Medical University', u'Guangdong 8Plus1 Medicine Co Ltd', u'National Center for Research Resources', u'KAT General Hospital', u'Glasgow University', u'Universiteit Maastricht', u'Undisclosed', u'FCB-Pharmicell Co Ltd', u'Glucox Biotech AB', u'H Lundbeck A/S', u'National Research Council of Canada', u'International Biotechnology Center Generium LLC']), u'Phlebothrombosis': set([u'Rex Medical LP', u\"Brigham & Women's Hospital\", u'Argon Medical Devices Inc', u'Patient Centered Outcome Research Institute', u'Merck & Co Inc', u'Daiichi Sankyo Co Ltd']), u'Streptococcusinfection': set([u'Rockefeller University', u'Tzamal Medical Group Ltd', u'Vilnius University', u'European Commission', u'The European Union', u'University of Lund', u'GeneArrest Ltd', u'Polydex Pharmaceuticals Ltd', u'The Danish National Advanced Technology Foundation', u'Cardiome Pharma Corp', u\"Guy's & St Thomas' Hospital NHS Trust\", u'Sinclair Pharma plc', u'Breathtec Biomedical Inc', u'UAB Bioseka', u'Technion Research & Development Foundation Ltd', u'Biovail Corp', u'Actinova Ltd', u'North American Vaccine Inc', u'Minervax ApS', u'Cook Pharmaceutical Solutions', u\"Brigham & Women's Hospital\", u'BCY LifeSciences Inc', u'CoTherix Inc', u\"King's College London\"]), u'Opticnervedisorder': set([u'Novoron Bioscience Inc', u'National Eye Institute', u'BioAxone Biosciences Inc', u'US Government']), u'Plasmodiumvivaxinfection': set([u'National Health and Medical Research Council', u'Medecins Sans Frontieres', u'Instituto de Tecnologia em Farmacos (Brazil)', u'Institute For Medical Research (Inc In Malaysia)', u'Kenya Medical Research Institute', u'Novartis Research Foundation', u'The European Union', u'The Macfarlane Burnet Institute For Medical Research & Public Health Ltd', u'Ellipse Pharmaceuticals', u'National Center for Research Resources', u'GenVec Inc', u'Drugs for Neglected Diseases Initiative', u'National Institute of Allergy and Infectious Diseases', u'NYU Langone Medical Center', u'Ehime University', u'University of Mississippi', u'Mahidol University', u'Cempra Inc', u'Indian Council of Medical Research', u'Quintiles Transnational Corp', u'Armed Forces Research Institute of Medical Sciences', u'Vical Inc', u'Walter Reed Army Institute of Research', u'Bill & Melinda Gates Foundation', u'Merck & Co Inc', u'Cardinal systems', u'Protein Potential LLC', u'GlaxoSmithKline plc', u'Molplex Pharmaceuticals', u'Swiss Agency for Development and Cooperation', u'La Agencia Espa\\xf1ola de Cooperaci\\xf3n Internacional para el Desarrollo', u'Imaxio', u'Department for International Development', u'French Development Agency', u'Tottori University', u'World Health Organization', u'ICGEB New Delhi', u'Nagasaki University', u'Komfo Anokye Teaching Hospital', u'Institut de Recherche pour le Developpement (IRD)', u'Medicines for Malaria Venture', u'Cellfree Sciences Co Ltd', u'Walter and Eliza Hall Institute of Medical Research', u'Global Health Innovative Technology Fund', u'Catalent Inc', u'Swiss Tropical & Public Health Institute', u'Emory University', u'US Department of Defense', u'Universite de Bordeaux', u'The PATH Malaria Vaccine Initiative', u'University of Oxford', u'Universiti Sains Malaysia', u'Ferrer Internacional SA']), u'Hairdisease': set([u'OSI Pharmaceuticals Inc', u'University of Pennsylvania', u\"L'Oreal SA\", u'New York University', u'ICTV Brands', u'Pfizer Inc', u'ECI Inc', u'PhotoMedex Inc', u'Genentech Inc', u'Medicis Pharmaceutical Corp', u'XOMA Corp', u'Cosmo Pharmaceuticals SpA', u'Johnson & Johnson Consumer Products Inc']), u'Essentialhypertension': set([u'China Medical System Holdings Ltd', u'Sanofi KK', u'Actavis Inc', u'AstraZeneca plc', u'Shenzhen Ausa Pharmed Co Ltd', u'Quantum Genomics Corp', u'Roche Holding AG', u'Mitsubishi Tanabe Pharma Corp', u'Anhui Biological Medical Research Institute', u'Elan Corp plc', u'PCAS Pharma Synthesis', u'Recro Pharma Inc', u'Chong Kun Dang Pharmaceutical Corp', u'Alkermes plc']), u'Vibrio': set([u'Direct Relief International', u'Bill & Melinda Gates Foundation', u'Napo Pharmaceuticals Inc']), u'Cardiopulmonarybypasssurgery': set([u'Talent Biotechs Ltd', u'Clalit Health Services']), u'Lysosomestoragedisease': set([u'Lysosomal Therapeutics Inc', u'US Government', u'BioMarin Pharmaceutical Inc', u'AngioChem Inc', u'Sangamo Therapeutics Inc', u'Stanford University', u'Telethon Institute of Genetics and Medicine', u'Vtesse Inc', u'Mayo Clinic Foundation', u'Shire Human Genetic Therapies Inc', u'Harvard University', u'Neuraltus Pharmaceuticals Inc', u'Mount Sinai School of Medicine', u'Reino de Espana', u'Sagetis Biotech', u'GlaxoSmithKline plc', u'Neurotrope BioScience Inc', u'Calporta Therapeutics Inc', u'Nimbus Therapeutics', u'Minoryx Therapeutics sl', u\"St Jude Children's Research Hospital\", u'Undisclosed', u'REGiMMUNE Corp', u'Zacharon Pharmaceuticals Inc', u'Massachusetts Eye & Ear Infirmary', u'Genzyme General', u'Sanofi Genzyme', u'Synageva BioPharma Corp', u'Microbot Medical Inc', u'Proteostasis Therapeutics Inc', u'Neurotrope Inc', u'University of Pennsylvania', u'Amicus Therapeutics Inc', u'Hospira Inc', u'Shire plc', u'Kyowa Hakko Kirin Co Ltd', u'BBB Therapeutics BV', u'Childrens Hospital of Philadelphia', u'Selecta Biosciences Inc', u'University of California Los Angeles', u'ReNeuron Group plc', u'biOasis Technologies Inc', u'Fondazione Brains for Brain ONLUS', u'National Human Genome Research Institute', u'Transkaryotic Therapies', u'University of Michigan', u'Ultragenyx Pharmaceutical Inc', u'AmpliPhi Biosciences Corp']), u'Renalfailure': set([u'US Government', u'Solvay SA', u'Orphan Therapeutics LLC', u'PanGen Biotech Inc', u'Netherlands Government', u'GlaxoSmithKline plc', u'BTG plc', u'Vernalis Group plc', u'BioStratum Inc', u'Ipsen', u'European Community', u'Opsona Therapeutics Ltd', u'OSI Pharmaceuticals Inc', u'Mitsubishi-Tokyo Pharmaceuticals Inc', u'Janssen Biotech Inc', u'Sumitomo Pharmaceuticals Co Ltd', u'Biotempt BV', u'Roche Holding AG', u'Almac Diagnostics', u'Euram Ltd', u'INEOS Group', u'Sankyo Co Ltd', u'Dompe SpA', u'Toray Industries Inc', u'Elan Pharmaceuticals Inc', u'Catalent Inc', u'North Carolina Biotechnology Center', u'NitroMed Inc', u'Universiteit Maastricht', u'Angion Biomedica Corp', u'Stryker Corp', u'Abbott Laboratories', u'Endacea Inc', u'Michigan Economic Development Corp', u'3SBio Inc', u'Wuxi AppTec Inc', u'A1M Pharma AB', u'Gambro AB', u'Irix Pharmaceuticals Inc', u'Institut Klinick\\xe9 a Experiment\\xe1ln\\xed Medicin', u'Vanderbilt University', u'Catholic University of Leuven', u'Tanabe Seiyaku Co Ltd', u'Plexxikon Inc', u'FibroGen Inc', u'Theragnostic Technologies Inc', u'BASF Pharma', u'Institut Investigaci\\xf3 Biom\\xe8dica Bellvitge', u'University of Edinburgh', u'CCM Duopharma Biotech Bhd', u'Haemopep Pharma GmbH', u'Joslin Diabetes Center Inc', u'F Hoffmann-La Roche AG', u'Ortho Biotech Products LP', u'Genentech Inc', u'Gangnam Severance Hospital', u'National Institute of Diabetes, Digestive and Kidney Diseases', u'St Andrews University', u'Shanghai Institute of Materia Medica of the Chinese Academy of Sciences', u'University of California', u'Merck & Co Inc', u'Sanofi', u'Daewon Pharm Co Ltd', u'Eli Lilly & Co', u'University of Miami', u'CardioPep Pharma GmbH', u'Kyowa Hakko Kirin Co Ltd', u'The University of Newcastle Upon Tyne', u'NephroGenex Inc', u'University Medical Center Groningen', u'Gilead Colorado Inc', u'Hannover Medical School', u'Erasmus University Medical Center Rotterdam', u'Exponential Biotherapies Inc', u'Pfizer Inc', u'Kaken Pharmaceutical Co Ltd', u'Wyeth BioPharma', u'Purdue University', u'EpiStem Ltd', u'Silence Therapeutics AG', u'AM-Pharma Holding BV', u'National Institute of Allergy and Infectious Diseases', u'Nephrogen LLC', u'NeuroVive Pharmaceutical AB', u'Top Institute Pharma', u'Actelion Ltd', u'Albert Einstein College of Medicine', u'Servier', u'Taisho Pharmaceutical Co Ltd', u'Hopital Maisonneuve-Rosemont', u'Scios Inc', u'Synvista Therapeutics Inc', u'Curis Inc', u'Quark Pharmaceuticals Inc', u'Cephalon Inc', u'ESP Pharma Inc', u'Astellas Pharma Inc', u'Phenos GmbH', u'Sosei Group Corp', u'Global Blood Therapeutics Inc', u'NephRx Corp', u'ChronTech Pharma AB', u'PharmaNet Canada Inc', u'Vectura Group plc', u'Takeda Pharmaceutical Co Ltd', u'Linkoping University', u'Axovan AG', u'United Therapeutics Corp', u\"King's College London\"]), u'Multiplesclerosis': set([u\"Hospital Vall D'Hebron\", u'Unimed Pharmaceuticals Inc', u'Sareum Holdings plc', u'Lectus Therapeutics Ltd', u'European Commission', u'US Health and Human Services Department', u'Transparency Life Sciences LLC', u\"Cincinnati Children's Hospital Medical Center\", u'Questcor Pharmaceuticals Inc', u'Forward Pharma A/S', u'Ionis Pharmaceuticals Inc', u'Novartis Pharma AG', u'Fannin Innovation', u'VU University Medical Center', u'Celldex Therapeutics Inc', u'GDI Integrated Facility Services Inc', u'Walter Reed Army Institute of Research', u'UC Davis InnovationAccess', u'Hangzhou Tongming Science and Technology Development Limited Company', u'Ambrx Inc', u'Orphagen Pharmaceuticals Inc', u'Zhejiang Xianju Pharmaceutical Corp Ltd', u'Fondazione IRCCS Istituto Neurologico Carlo Besta', u'PharmaSeed Ltd', u'Toray Industries Inc', u'Op-T-Mune Inc', u'AutoImmune Inc', u'Formatech Inc', u'Agence nationale de la recherche (ANR)', u'Alseres Pharmaceuticals Inc', u'Perrigo Co plc', u'Universite De Montreal', u'Scienion AG', u'MGI GP Inc', u'New York University', u'Yale School of Medicine', u'Israeli Government', u'Centre National de la Recherche Scientifique (CNRS)', u'Cambridge Antibody Technology Group plc', u'The European Union', u'Nippon Kayaku Co Ltd', u'Glenmark Pharmaceuticals Ltd', u'Drogsan Ilaclari San. ve Tic. A.S.', u'Protagen AG', u'The Multiple Sclerosis Society of Canada', u'Amplimmune Inc', u'MedDay Pharmaceuticals', u'Rhenovia Pharma SAS', u'National Multiple Sclerosis Society', u'Antisense Therapeutics Ltd', u'Phytomedics Inc', u'Myelin Repair Foundation Inc', u'Istituto Scientifico H San Raffaele', u'Neuren Pharmaceuticals Ltd', u'Merrimack Pharmaceuticals Inc', u'University of Gottingen', u'Santen Pharmaceutical Co Ltd', u'Ogeda SA', u'Universidad De Cordoba', u'University of Rochester Medical Center', u'Gladstone Institute of Neurological Disease', u'University of Adelaide', u'Pharmacopeia Inc', u'Inovio Pharmaceuticals Inc', u'Wellcome Trust', u'Kyorin Pharmaceutical Co Ltd', u'Celera Group', u'Probiodrug AG', u'Karo Pharma AB', u'East Carolina University', u'ImmuNext Inc', u'Tianjin International Joint Academy of Biotechnology and Medicine', u'4SC AG', u'DSM Nutritional Products AG', u'RPI Finance Trust', u'MD Biosciences GmbH', u'AERES Biomedical Ltd', u'UCB-Bioproducts SA', u'BaroFold Inc', u'Minapharm Pharmaceuticals', u'EpiVax Inc', u'Flamel Technologies SA', u'SoyMeds Inc', u'Advanced Viral Research Corp', u'Oregon Health Sciences University', u'Centro para el Desarrollo Tecnologico Industrial', u'Trophos SA', u'AmorChem LP', u'Sunnybrook Health Sciences Centre', u'Xalud Therapeutics Inc', u'CTI BioPharma Corp', u'Eli Lilly & Co', u'Synt:em', u'Tikvah Therapeutics Inc', u'CSL Ltd', u'Weizmann Institute of Science', u'Pivot-IndUS', u'BioMena SA', u'GroupMed (Holding)', u'CenTRion Therapeutics Ltd', u'University of California Los Angeles', u'Erasmus University Medical Center Rotterdam', u'CeNeS Pharmaceuticals Inc', u'Synthon BV', u'Cell Signals Inc', u'AppTec Laboratory Services', u'Families of Spinal Muscular Atrophy', u'Regenesance BV', u'Artielle ImmunoTherapeutics Inc', u'Quay Pharmaceuticals Ltd', u'AbbVie Inc', u'Dalton Pharma Services', u'Northwestern University', u'Chronos Therapeutics', u'Anavex Life Sciences Corp', u'Medical Need Europe AB', u'Bristol-Myers Squibb Co', u'Evotec (UK) Ltd', u'Accentia BioPharmaceuticals Inc', u'Rush University Medical Center', u'Pontificia Universidad Catolica De Chile', u'Chinese Academy of Sciences', u'Dr Rentschler Biotechnologie GmbH', u'VINNOVA', u'Advanced Biotherapy Inc', u'University of Auckland', u'Antisoma plc', u'Meda AB', u'Hebrew University of Jerusalem', u'Athersys Inc', u'MS Therapeutics Ltd', u'Nerveda Inc', u'Hemispherx Biopharma Inc', u'Galapagos NV', u'Enceladus Pharmaceuticals', u'DRI Capital', u'University of Cambridge', u'Karolinska Institutet', u'Merck Sharp & Dohme BV', u'GenPat77 Pharmacogenetics AG', u'Ipsen Biopharmaceuticals Inc', u'Angiotech Pharmaceuticals Inc', u'Phase 2 Discovery Inc', u'IDEC Pharmaceuticals Corp', u'KineMed Inc', u'BTG plc', u'Giddi Pharma Co Ltd', u'Fudan University Shanghai Medical College', u'GeNeuro SA', u'Selexis SA', u'Stanford University', u'Microbot Medical Inc', u'Vernalis plc', u'Numares Gmbh', u'Ono Pharmaceutical Co Ltd', u'Omnia Biologics Inc', u'Shire plc', u'Mitsubishi Tanabe Pharma Corp', u'Vaccinex Inc', u'Roche Madison Inc', u'ANI Pharmaceuticals Inc', u'Cour Pharmaceutical Development Co Inc', u'Neurotec Pharma SL', u'ImmuLogic Pharmaceutical Corp', u'Eukarion Inc', u'Accenture', u'Diplomat Pharmacy Inc', u'Charite Universitaetsmedizin Berlin', u'Evotec AG', u'Meiji Seika Pharma Co Ltd', u'Charles River Laboratories International Inc', u'Cell Pharm GmbH', u'Amgen Inc', u'CuroNZ Ltd', u'Catholic University of Korea', u'Endo Pharmaceuticals Solutions Inc', u'Cajal Institute', u'Consejo Superior De Investigaciones Cientificas', u'Airmid Inc', u'Johns Hopkins University School of Medicine', u'University of Bristol', u'ACADIA Pharmaceuticals Inc', u'BioPartners GmbH', u'Italfarmaco SpA', u'Medical Research Council', u'Transgene SA', u'Lonza Group AG', u'Goodwin Biotechnology Inc', u'Cleveland Clinic Foundation', u\"M's Science Corp\", u'Uni Pharma Co Ltd', u'LineaGen', u'Acelerox LLC', u'Novoron Bioscience Inc', u'Transition Therapeutics Inc', u'University of Edinburgh', u'Vicore Pharma AB', u'Canbex Therapeutics Ltd', u'Inception Sciences Inc', u'University of Oxford', u'Symbiotix Biotherapies Inc', u'Nuon Therapeutics Inc', u'Ohio State University', u'Umea University', u'Tularik Inc', u'Genentech Inc', u'University of Milan', u'PJSC Pharmsynthez', u'Mitsubishi Pharma Corp', u'Multiple Sclerosis International Federation', u'Korea Drug Development Fund', u'Aegis Therapeutics LLC', u'Reino de Espana', u'ARC Ventures', u'Oklahoma Medical Research Foundation', u'Alpha Cancer Technologies Inc', u'Cyxone AB', u'Pharmaron Inc', u'Xenetic Biosciences Inc', u'PDL BioPharma Inc', u'Henry M Jackson Foundation for the Advancement of Military Medicine', u'Samus Therapeutics Inc', u'Atara Biotherapeutics Inc', u'Genzyme General', u'Scripps Research Institute', u'Advancell', u'University of Southern California', u'M et P Pharma AG', u'University of Texas Southwestern Medical Center', u'Consiglio Nazionale delle Ricerche', u'Deutsches Rote Kreuze', u'BRAINCo Biopharma S.L', u'Granules India Ltd', u'VivaCell Biotechnology Espana SL', u'Harvard NeuroDiscovery Center', u'CinnaGen Co', u'Pharmaceutical Research Associates Inc', u'Janssen Biotech Inc', u'Lycera Corp', u'SuppreMol GmbH', u'Fast Forward LLC', u'AstraZeneca plc', u'BTB Pharma', u'University of Utah', u'Tolerion Inc', u'Lacer SA', u'CanniMed Ltd', u'PolyTherics Ltd', u'Pharmstandard OJSC', u'University of Turku', u'Janssen-Cilag Ltd', u'Australian Government', u'Santhera Pharmaceuticals AG', u'Genmab A/S', u'Universidad Complutense de Madrid', u'Bioject Medical Technologies Inc', u'Axogen Ltd', u'Mochida Pharmaceutical Co Ltd', u'Pharmos Corp', u'myTomorrows', u'Nerviano Medical Sciences Srl', u'Critical Outcome Technologies Inc', u'University of Alberta', u'Guangdong Medicine Group Corp', u'Synthetic Biologics Inc', u'ProMetic Life Sciences Inc', u'Hadassah University Hospital', u'Pepgen Corp', u'Kyoto University', u'Fujifilm Diosynth Biotechnologies', u'VG Life Sciences Inc', u'IXICO Plc', u'Hospira Adelaide Pty Ltd', u'Karyopharm Therapeutics Inc', u'Undisclosed', u'Nexpep Pty Ltd', u'Mithra Pharmaceuticals', u'University Hospital Basel', u'Zhejiang University', u'GE Healthcare', u'Walter and Eliza Hall Institute of Medical Research', u\"Brigham & Women's Hospital\", u'Biologix FZ Co', u'Serono Inc', u'German Federal Ministry of Education and Research', u\"Royal Brisbane & Women's Hospital\", u'Max Planck Institut fur Experimentelle Medizin', u'MENTRIK Biotech LLC', u'Sociedade Beneficente Israelita Brasileira Hospital Albert Einsten', u'Cardinal Health Inc', u'Abdi Ibrahim Ilac Sanayi Ve Ticaret Anonim Sirketi', u'EMD Serono Inc', u'Centre for Drug Research and Development', u'Q Therapeutics Inc', u'RegeneRx Biopharmaceuticals Inc', u'Mount Sinai School of Medicine', u'Maxygen Inc', u'Forest Laboratories Inc', u'Global Clean Energy Holdings Inc', u'Novo Nordisk A/S', u'Kadimastem Ltd', u'Rice University', u'University of Queensland', u'Uppsala University', u'Aventis Pharma AG', u'Universite Pierre et Marie Curie', u'MedImmune LLC', u'OSI Pharmaceuticals Inc', u'Molecumetics Ltd', u'GW Pharmaceuticals plc', u'Five Prime Therapeutics Inc', u'Yonsei University', u'University of Science and Technology, Korea', u'University of Manitoba', u'IMTM GmbH', u'ARIUS Research Inc', u'Adhaere Pharmaceuticals Inc', u'New Zealand Foundation for Research, Science and Technology', u'Navinta LLC', u'ReNeuron Group plc', u'Siemens Healthineers Inc', u'Innate Immunotherapeutics Ltd', u'Signal Research Division', u'Prothena Corp plc', u'Tego BioSciences Corp', u'Asembia', u'Ottawa Hospital Research Institute', u'National Center For Advancing Translational Sciences', u'Universidad del Pais Vasco', u'Active Biotech AB', u'Mylan Inc', u'Japan Science and Technology Agency', u'Califia Bio Inc', u'Boehringer Mannheim GmbH', u'Aphios Corp', u'XOMA Corp', u'Bolder BioTechnology Inc', u'Teva Pharmaceutical Industries Ltd', u'Marnac Inc', u'Biogen Idec Hemophilia Inc', u'Bionomics Ltd', u'Maryland Stem Cell Research Fund', u'University of California San Francisco', u'CryoPort Inc', u'Affymetrix Inc', u'Therapeutic Human Polyclonals Inc', u'Fraunhofer-Institute fur Zelltherapy und Immunologie', u'QIMR Berghofer Medical Research Institute', u'OPKO Health Inc', u'Glasgow Caledonian University', u'Nuraging Biotech Srl', u'Yissum Research Development Co', u'Millennium Pharmaceuticals Ltd', u'Glaxo Group Ltd', u'CFR Pharmaceuticals SA', u'Encysive Pharmaceuticals Inc', u'Neuro Bioscience Inc', u'Proteorex Therapeutics Inc', u'Patient Centered Outcome Research Institute', u'Neopharm Ltd', u'University of Sydney', u'ILEX Oncology Inc', u'French Muscular Dystrophy Association', u'Harvard Medical School', u'Iluten', u'Cangene Corp', u'Schering-Plough Corp', u'Revalesio Corp', u'CMC Biologics Inc', u'Abion Inc', u'Provid Pharmaceuticals Inc', u'Merck & Co Inc', u'Zenyaku Kogyo Co Ltd', u'ChemoCentryx Inc', u'National Eye Institute', u'rEVO Biologics Inc', u'Sanofi', u'Delmar Chemicals Inc', u'Radikal Therapeutics Inc', u'Auspex Pharmaceuticals Inc', u'Bayer AG', u'Ovamed GmbH', u'CBio Ltd', u'Case Western Reserve University', u'Canadian Department of National Defence', u'Nektar Therapeutics', u'Almirall Prodesfarma SA', u'Neurocrine Biosciences Inc', u'Zhejiang Jiuzhou Pharmaceutical Co Ltd', u'University of Greenwich', u'Medicines Patent Pool', u'Endece Neural', u'Briana Bio-Tech Inc', u'Kineta Inc', u'Wyeth', u'Aix-Marseille Universit\\xe9', u'Acambis plc', u'University of Iowa', u'Ichor Medical Systems Inc', u'Asphelia Pharmaceuticals Inc', u'The University of Massachussetts', u'National Institute of Allergy and Infectious Diseases', u'University of Regensburg', u'Swiss National Science Foundation', u'University of Kansas', u'Amarin Corp plc', u'Peptimmune Inc', u'Juvenile Diabetes Research Foundation', u'Aurigene Discovery Technologies Ltd', u'Max-Planck-Gesellschaft', u'Ablynx NV', u'Elan Corp plc', u'MorphoSys AG', u'Sanofi Genzyme', u'Regulus Therapeutics Inc', u'Stendhal International', u'Centaur Pharmaceuticals Inc', u'Proteostasis Therapeutics Inc', u'University of Calgary', u'MGI Pharma Inc', u'bioCSL PTY Ltd', u'Roche Holding AG', u'Therapix Biosciences Ltd', u'PanGenetics BV', u'Ranbaxy Laboratories Ltd', u'Apollo Endosurgery Inc', u'Queensland Institute of Medical Research', u'MediciNova Inc', u'Digna Biotech SL', u'American Red Cross', u'MicroConstants China', u'The Bronx Project Inc', u'Io Therapeutics Inc', u'nEUROinflammation consortium', u'Tiziana Life Sciences PLC', u'Berlex Laboratories Inc', u\"Dr Reddy's Laboratories Ltd\", u'State of Ohio', u'US Government', u'BioMarin Pharmaceutical Inc', u'Korea Institute of Science and Technology', u'Ludwig-Maximilians University of Munich', u'Medisyn Technologies Inc', u'Acorda Therapeutics Inc', u'Netherlands Government', u'Chromos Molecular Systems Inc', u'California Institute of Regenerative Medicine', u'United States Army Medical Research Institute of Chemical Defense', u'Biogen Inc', u'UMeWorld Ltd', u'GlaxoSmithKline plc', u'Celltrion Inc', u'Bayer Schering Pharma AG', u'MultiCell Technologies Inc', u'Interferon Sciences Inc', u'Ipsen', u'I N C Research Ltd', u'Renovis Inc', u'Novimmune SA', u'MakScientific LLC', u'Takeda Oncology', u'Nortis Inc', u'BrainStorm Cell Therapeutics Inc', u'Paratek Pharmaceuticals Inc', u'Cognosci Inc', u'Anergen Inc', u'Emory University', u'National Heart Lung and Blood Institute', u'US Department of Defense', u'Gencia Corp', u'Murdoch University', u'Biomedical Primate Research Centre', u'Nutra Pharma Corp', u'Blood Group Alliance Inc', u'Salus Therapeutics Inc', u'Corbin Therapeutics Inc', u'Medarex Inc', u'Abbott Laboratories', u'KAEL-GemVax Co Ltd', u'Sten K Johnson\\u2019s Foundation', u'Ganymed Pharmaceuticals AG', u'Novartis AG', u'Merck KGaA', u'Korea Research Institute of Bioscience and Biotechnology', u'University of Maryland', u'GeneOne Life Science Inc', u'Monash University', u'DioGenix Inc', u'CHU De Nantes', u'Ohr Pharmaceutical Inc', u'UCB SA', u'Piramal Enterprises Ltd', u'Immune Response BioPharma Inc', u'University of Colorado System', u'Memorial University', u'McGill University', u'Effimune SA', u'Johns Hopkins University', u'Glialogix Inc', u'Pluristem Therapeutics Inc', u'H Lundbeck A/S', u'PROLOR Biotech Inc', u'University of North Carolina', u'National Institute of Neurological Disorders and Stroke', u'Aptar Pharma SAS', u'Ortho Biotech Products LP', u'University of California San Diego School of Medicine', u'Acyte Biotec Pty Ltd', u'Quimatryx', u'Atlantic Technology Ventures Inc', u'Transdermal Research Pharm Laboratories LLC', u'Vakzine Projekt Management GmbH', u'ProBioGen AG', u'Opexa Therapeutics Inc', u'Tohoku University Graduate School Of Medicine', u'SRI International', u'Howard Florey Institute of Experimental Physiology and Medicine', u'SangStat Medical Corp', u'Ben Franklin Technology Partners of Southeastern Pennsylvania', u'Western Maryland Health System (WMHS)', u'National Institute on Drug Abuse', u'Endece LLC', u'MIVAC Development', u'Galderma SA', u'USpharma Windlas LLC', u'OncoImmune Inc', u'Cellmid Ltd', u'Maruho Co Ltd', u'BioRap Technologies Ltd', u'Axim Biotechnologies Inc', u'Kissei Pharmaceutical Co Ltd', u'Valentis Inc', u'Servier', u'Ikano Therapeutics Inc', u'Pfizer Inc', u'Peregrine Renovations LLC', u'Peak Harvest Health', u'Curadim Pharma', u'Human Genome Sciences Inc', u'Suntory Pharmaceutical Research Laboratories LLC', u'Vertex Pharmaceuticals Inc', u'Biogenesys Inc', u'SEPPIC SA', u'Memorial Sloan-Kettering Cancer Center', u'Mount Sinai Medical Center', u'Wyss Institute for Biologically Inspired Engineering', u'Baylor College of Medicine', u'Croda International plc', u'DevCo Pharmaceuticals Ltd', u'Takeda Pharmaceutical Co Ltd', u'Viragen Inc', u'EUSA Pharma USA', u'ReWalk Robotics Ltd', u'National Institutes of Health', u'Natco Pharma Ltd', u'German Primate Center', u'Menarini Asia-Pacific', u'Sarepta Therapeutics Inc', u'Curis Inc', u'Aequus Pharmaceuticals Inc', u'Apitope Technology (Bristol) Ltd', u'Zenyth Therapeutics Ltd', u'Renovo Neural Inc', u'Applied Research using OMIC Sciences SL', u'Nordic Group', u'University of Chicago', u'Mitochon Pharmaceuticals', u'Axxam SpA', u'Kingston Scientific Partnership', u\"Seattle Children's Hospital\", u'Cambrex Corp', u'Merck Serono SA', u'XenoPort Inc', u'Nuron Biotech Inc', u'Ezose Sciences Inc', u'biOasis Technologies Inc', u'Rafa Laboratories Ltd', u'Trillium Therapeutics Inc', u'Independent Pharmaceutica AB', u'University at Buffalo', u'Bionure Inc']), u'Streptococcuspneumoniaeinfection': set([u'Biovac Institute', u\"St Jude Children's Research Hospital\", u'Biovector Therapeutics SA', u'Genocea Biosciences Inc', u'Sanofi Pasteur', u'US Health and Human Services Department', u'Serum Institute of India Ltd', u'GlaxoSmithKline plc', u'Arizona State University', u'European Eurostars Programme', u'MedImmune LLC', u'Sanofi Pasteur MSD', u'Shire plc', u'Paratek Pharmaceuticals Inc', u'Intercell AG', u'Chengdu Institute of Biological Products', u'Shionogi & Co Ltd', u'Statens Serum Institut', u\"Boston Children's Hospital\", u'ID Biomedical Corp', u'National Research Council of Canada', u'Shire BioChem Inc', u'Wockhardt Ltd', u'Israeli Government', u'Virometix AG', u'Nventa Biopharmaceuticals Corp', u'Abera Bioscience AB', u'Novartis AG', u'Indian Government Department of Biotechnology', u'Fujifilm Finechemicals Co Ltd', u'University of Havana', u'Basilea Pharmaceutica International Ltd', u'Arsanis Biosciences GmbH', u'Windtree Therapeutics Inc', u'CanSino Biologics Inc', u'Boehringer Ingelheim Corp', u'Swiss Tropical & Public Health Institute', u'Fina Biosolutions Llc', u'Protea Vaccine Technologies Ltd', u'University Hospitals Case Medical Center', u'Liquidia Technologies Inc', u'Rockefeller University', u'Finlay Institute', u'Unimedic AB', u'Xenetic Biosciences Inc', u'Undisclosed', u'Affinivax Inc', u'Merck & Co Inc', u'Xcellerex LLC', u'BioChem Pharma (International ) Inc', u'Sanofi', u'Walvax Biotechnology Co Ltd', u'Shanghai Pharmaceuticals Holding Co Ltd', u'Eli Lilly & Co', u'Centers for Disease Control and Prevention', u'GlaxoSmithKline Biologicals', u'Radboud University', u'Mucosis BV', u'Sinovac Biotech Ltd', u'CSL Ltd', u'US Army Medical Research Institute of Infectious Diseases', u'Global Alliance for Vaccines and Immunization', u'Kyowa Hakko Kirin Co Ltd', u'Adimab LLC', u'Pfizer Inc', u'Swiss Federal Office of the Commission for Technology and Innovation', u'Childrens Medical Center Corp', u'Human Genome Sciences Inc', u'Provalis plc', u'Alcon Inc', u'Immunobiology Ltd', u'Laboratorios Farmaceuticos Rovi SA', u'UK Government', u'Avir Pharma Inc', u'National Institute of Allergy and Infectious Diseases', u'Cempra Inc', u'GigaGen Inc', u'Program for Appropriate Technology in Health', u'Bayer AG', u'Bill & Melinda Gates Foundation', u'Food and Drug Administration', u'Chinese Government', u'JSC Binnopharm', u'ACE BioSciences A/S', u'Astellas Pharma Inc', u'Tergene Biotech Pvt Ltd', u'North American Vaccine Inc', u'Netherlands Vaccine Institute', u'Crucell NV', u'Isconova AB', u'ContraFect Corp', u'SK Chemicals Co Ltd']), u'Plasmodiuminfection': set([u'Sanofi-Aventis US LLC', u'iThemba Pharmaceuticals Pty Ltd', u'Koebenhavns Universitet', u'University of Lille', u'Cooperative Research Centre for Vaccine Technology', u'European Commission', u'Ehime University', u'Inovio Pharmaceuticals Inc', u'University of Connecticut', u'VGX Pharmaceuticals LLC', u'European Community', u'University of South Florida', u'Cyvax Inc', u'Colthurst Ltd', u'United States Agency for International Development', u'Walter Reed Army Institute of Research', u'Panasonic Corp', u'S Kant HEALTHCARE Ltd', u'Virion Systems Inc', u'Medicines for Malaria Venture', u'Catalent Inc', u'Research Councils UK', u'Sichuan BoXin LaiTe Biotechnology Inc', u'National Health and Medical Research Council', u'Tokyo Institute of Technology', u'New York University', u'Guilin Pharmaceutical Co Ltd', u'Centre National de la Recherche Scientifique (CNRS)', u'CEL-SCI Corp', u'Monash University', u'Upstream Biosciences Inc', u'The European Union', u'LICA Pharmaceuticals A/S', u'Center for Infectious Disease Research', u'MV Lomonosov Moscow State University', u'London School of Hygiene and Tropical Medicine', u'Panacela Labs Inc', u'Pharmacopeia Inc', u'Wellcome Trust', u'Titan Pharmaceuticals Inc', u'University of Lausanne', u'Ministry of Science and Technology of the People\\xb4s Republic of China', u'Kitasato University', u'Acceptys Inc', u'Pharmexa A/S', u'Instituto de Tecnologia em Farmacos (Brazil)', u'Fraunhofer USA Inc', u'Novartis Research Foundation', u'The University of Hong Kong', u'International Center for Genetic Engineering and Biotechnology (ICGEB)', u'Neopharma', u'Undisclosed', u'Telormedix SA', u'Centers for Disease Control and Prevention', u'GlaxoSmithKline Biologicals', u'Pen Pharmaceutical Services Ltd', u'University of Wisconsin-Madison', u'CSL Ltd', u'BIO Ventures for Global Health', u'Weizmann Institute of Science', u'BD Technologies', u'Horizon Orphan LLC', u'Michigan State University', u'Anza Therapeutics Inc', u'Crystec Pharma', u'Johns Hopkins University', u'Zalicus Inc', u'Hong Kong University of Science & Technology', u'Harbor Therapeutics Inc', u'ETH Zurich', u'GeoVax Labs Inc', u'University of Washington', u'The PATH Malaria Vaccine Initiative', u'Program for Appropriate Technology in Health', u'IMPAX Laboratories Inc', u'Actelion Ltd', u'Yamanouchi Pharmaceutical Co Ltd', u'Provepep', u'The Center for World Health & Medicine at Saint Louis University', u'Israel Institute for Biological Research', u'Auburn University', u'Chinese Academy of Sciences', u'60\\xb0 Pharmaceuticals LLC', u'James Cook University of North Queensland', u'MediSynergics LLC', u'NanoPass Technologies Ltd', u'Artificial Cell Technologies Inc', u'Army Malaria Institute', u'Oncovir Inc', u'Howard Hughes Medical Institute', u'BTG plc', u'Sabin Vaccine Institute', u'CASS Foundation', u'Chinese Government', u'Lipotek Pty Ltd', u'University of Pennsylvania', u'National Natural Science Foundation of China', u'Roche Holding AG', u'University of British Columbia', u'Mitsubishi Tanabe Pharma Corp', u'Suda Ltd', u'ANI Pharmaceuticals Inc', u'Liverpool School of Tropical Medicine', u'Sanofi Genzyme', u'Intercell AG', u'Atreca Inc', u'Faulding & Co Ltd', u'University of Bamako', u'The Jenner Institute', u'Shreya Life Sciences Pvt Ltd', u'Ministry of Health of Uganda', u'University of Buenos Aires', u'Artes Biotechnology', u'Ohio State University', u'Shanghai Wanxing Bio-Pharmaceutical Co Ltd', u'Leidos Inc', u'University of Bristol', u'Johns Hopkins Bloomberg School of Public Health', u'Georgetown University', u'CleveXel Pharma', u'Medical Research Council', u'Pevion Biotech Ltd', u'SBI Pharmaceuticals', u'Science Applications International Corp', u'National Institute of Oceanography', u'Institute of Microbiology and Epidemiology Academy of Military Medical Sciences PLA', u'Oxford Drug Design', u'VLP Therapeutics LLC', u'University of Edinburgh', u'Instituto De Medicina Molecular', u'Swiss Tropical & Public Health Institute', u'Star Medical (Botswana) Ltd', u'UNITAID', u'F Hoffmann-La Roche AG', u'University of Oxford', u'Bharat Biotech International Ltd', u'TBG Diagnostics Ltd', u'The Macfarlane Burnet Institute For Medical Research & Public Health Ltd', u'Ramaciotti Foundation', u'Xenetic Biosciences Inc', u'Microbiotix Inc', u'Australian Research Council', u'National Institute of Digestive Disorders and Kidney Disease', u'BioFocus DPI', u'CASI Pharmaceuticals Inc', u'iQur Ltd', u'Institut de Recherche pour le Developpement (IRD)', u'AstraZeneca plc', u'Technology Strategy Board', u'Novozymes GroPep Ltd', u'VLP Biotech Inc', u'Nattermann & Cie GmbH', u'Sirenas Marine Discovery LLC', u'Australian Government', u'US Naval Medical Research Center', u'The Institute for OneWorld Health', u'NYU Langone Medical Center', u'Top Institute Pharma', u'Tulane University', u'Immunovaccine Inc', u'VG Life Sciences Inc', u'Engineering and Physical Sciences Research Council', u'Functional Technologies Corp', u'Covis Pharma Sarl', u'Mycosynthetix Inc', u'GVK Biosciences Pvt Ltd', u'St James Associates Llc/Faber Research Series', u'Portland State University', u'Institut Pasteur', u'Selecta Biosciences Inc', u'Walter and Eliza Hall Institute of Medical Research', u'Isconova AB', u'Takeda Pharmaceutical Co Ltd', u'University of Toronto', u'LeukoSite Inc', u'Etubics Corp', u'Royal DSM NV', u'Turing Pharmaceuticals LLC', u'Vaccibody AS', u'Pola Chemical Ind Inc', u'Sanofi Pasteur', u'The Technology Innovation Agency', u'Latvian Institute of Organic Synthesis', u'Onxeo SA', u'The Danish National Advanced Technology Foundation', u'World Health Organization', u'FIT Biotech Oyj Plc', u'Chongqing Holley Holding', u'Vical Inc', u'DesignMedix Inc', u'Magellan BioScience Group Inc', u'University of Bonn', u'Leiden University Medical Center', u'University of the Western Cape', u'Foundation for Innovative New Diagnostics', u'Aquila Biopharmaceuticals Inc', u'Global Health Innovative Technology Fund', u'ReiThera Srl', u'National Center for Research Resources', u'Chimerix Inc', u'Microbial Chemistry Research Foundation', u'Loyola University of Chicago', u'National Center For Advancing Translational Sciences', u'Active Biotech AB', u'AstraZeneca UK Ltd', u'SCYNEXIS Inc', u'Chinese Academy of Medical Military Sciences', u'Pfenex Inc', u'International AIDS Vaccine Initiative', u'Genomics Institute of the Novartis Research Foundation', u'Sanaria Inc', u'University of Heidelberg', u'Kancera AB', u'Celtaxsys Inc', u'Kwang Dong Pharmaceutical Co Ltd', u'University of California San Francisco', u'Affymetrix Inc', u'Glaxo Group Ltd', u'Artepharm Global Corp', u'University of Melbourne', u'University of Ghent', u'Biotechnology and Biological Sciences Research Council (BBSRC)', u'Guangzhou Institutes of Biomedicine and Health', u\"Universit\\xe9 d'Abomey-Calavi\", u'Advanced Life Sciences Holdings Inc', u'SinoBiomed Inc', u'US Military Malaria Vaccine Program', u'Cipla Ltd', u'CMC Biologics Inc', u'University of Basel', u'University of California', u'Merck & Co Inc', u'Biomes Inc', u'Perlegen Sciences Inc', u'Sanofi', u'Wyeth-Ayerst Pharmaceuticals Inc', u'Columbia University', u'University of Oslo', u'Bayer AG', u'African Malaria Network Trust', u'United States Army', u'FUJIFILM Holdings Corp', u'Ancora Pharmaceuticals Inc', u'University of Geneva', u'Gilead Sciences Inc', u'Human Frontier Science Program', u'Ministry Of Industry & Trade Of The Russian Federation', u'Mymetics Corp', u'Copernicus Therapeutics Inc', u'Yunnan Institute of Parasitic Diseases', u'US Department of Defense', u'Merck Sharp & Dohme Ltd', u'4SC AG', u'Broad Institute Inc', u'Makerere University', u'Sinochem Corp', u'Ichor Medical Systems Inc', u'Massachusetts Institute of Technology', u'Cancer Vaccine Acceleration Fund', u'University of Cape Town', u'Eberhard Karls Universit\\xe4t T\\xfcbingen', u'Akshaya Bio Inc', u'Dendreon San Diego LLC', u'Protherics plc', u'The Australian National University', u'Global Vaccines Inc', u'Kuros Biosciences Ltd', u'Spirogen Ltd', u'European Vaccine Initiative', u'Centre National de Recherche et de Formation sur le Paludisme', u'Celgene Corp', u'Imperial College London', u'Sosei Group Corp', u'Whitehead Institute for Biomedical Research', u'Ranbaxy Laboratories Ltd', u'Chembio Diagnostic Systems Inc', u'University of Leeds', u'The Paul G. Allen Family Foundation', u'Queensland Institute of Medical Research', u'Janssen Pharmaceuticals Inc', u'IPCA Laboratories Ltd', u'Crucell NV', u'Adjuvantys Inc', u'Universita degli Studi di Sassari', u'California Institute for Biomedical Research', u'Daiichi Seiyaku Co Ltd', u'US Government', u'Palumed SA', u'Parasight Ltd', u'GenVec Inc', u'4SC Discovery GmbH', u'GlaxoSmithKline plc', u'QIMR Berghofer Medical Research Institute', u'Tetragenetics Inc', u'Chulalongkorn University', u'European Eurostars Programme', u'Fundacao Oswaldo Cruz (Fiocruz)', u'Vaccine Research Institute of San Diego', u'Cenix BioScience GmbH', u'Aduro BioTech Inc', u'AusBiotech', u'St Petersburg Institute of Experimental Medicine', u'Paratek Pharmaceuticals Inc', u'SEDAC Therapeutics SA', u'Emory University', u'Aeras Global TB Vaccine Foundation', u'RMF Dictagene SA', u'Biomedical Primate Research Centre', u'Alnylam Pharmaceuticals Inc', u'Profectus BioSciences Inc', u'Advinus Therapeutics Ltd', u'Alliance Pharma plc', u'Daiichi Sankyo Co Ltd', u'Eisai Co Ltd', u'Cloud Pharmaceuticals Inc', u'ExpreS2ion Biotechnologies', u'La Trobe University', u'pSivida Corp', u'Jacobus Pharmaceutical Co Inc', u'Vaccine Solutions Pty Ltd', u'Infectious Disease Research Institute', u'Gates Malaria Partnership', u'Piramal Enterprises Ltd', u'University of Colorado System', u'McGill University', u'Provincial Laboratory for Public Health', u'NeED Pharmaceuticals Srl', u'Ferrer Internacional SA', u'Immtech Pharmaceuticals Inc', u'University of North Carolina', u'Industrial Research Ltd', u'Drugs for Neglected Diseases Initiative', u'BioDiem Ltd', u'Cellfree Sciences Co Ltd', u'Actelion Pharmaceuticals Ltd', u'Kymab Ltd', u'Treague Ltd', u'Indian Institute of Chemical Technology', u'The Francis Crick Institute', u'Radboud University', u'Eisai Inc', u'Mucosis BV', u'Epimmune Inc', u'University of Bradford', u'The University of Liverpool', u'Central Drug Research Institute', u'Northeastern University', u'Kitasato Institute', u'Wyeth BioPharma', u'Oxxon Therapeutics Ltd', u'University of California at Berkeley', u'National Institute of Allergy and Infectious Diseases', u'iBio Inc', u'Institut Pasteur de Lille', u'SEEK', u'CITIC Technology Inc China', u'AdAlta Pty Ltd', u'Albert Einstein College of Medicine', u'National Institutes of Health', u'Bill & Melinda Gates Foundation', u'GlobalAcorn', u'Jilin University', u'Apovia AG', u'Chiron Viagene Inc', u'Merck Serono SA', u'Strides Shasun Ltd', u'Novartis AG', u'Qatar Foundation', u'Guo Kang Pharmaceutical & Medical Supplies Ltd']), u'T-celllargegranularlymphocyteleukemia': set([u'University of Chicago', u'Penn State Hershey Medical Center', u'The Leukemia & Lymphoma Society', u'National Cancer Institute', u'Cleveland Clinic Foundation']), u'Neuropathicpain': set([u'Karolinska Institutet', u'OliPass Corp', u'Medical University of South Carolina', u'Novo Nordisk A/S', u'Korea Institute of Science and Technology', u'Hunter-Fleming Ltd', u'Reperio Pharmaceuticals Ltd', u'NeuroSolutions Ltd', u'YD Life Science Inc', u'Medisyn Technologies Inc', u'Acorda Therapeutics Inc', u'Isogenica Ltd', u'NeuroMax Ltd', u'Valeant Pharmaceuticals International Inc', u'WiSys Technology Foundation Inc', u'Dalhousie University', u'US Government', u'Biogen Inc', u'Araim Pharmaceuticals Inc', u'Neurobiological Technologies Inc', u'Forest Laboratories Inc', u'GlaxoSmithKline plc', u'Quintiles Transnational Corp', u'NsGene A/S', u'Ministry of Health, Welfare and Family Affairs', u'Chiesi Farmaceutici SpA', u'Inven2', u'Healthcare Royalty Partners', u'DURECT Corp', u'University of Queensland', u'DRAXIS Health Inc', u'Novartis Pharma AG', u'Renovis Inc', u'US Department of Veterans Affairs', u'University of Saskatchewan', u'Hydra Biosciences Inc', u'University of Pittsburgh', u'NeuroFix Therapeutics Inc', u'Aestus Therapeutics Inc', u'University of Bonn', u'C4T SCarl', u'Pedipharm Oy', u'IMPAX Laboratories Inc', u'Shionogi & Co Ltd', u\"People's Government of Jiangsu Province\", u'Roche Holding AG', u'CeNeS Pharmaceuticals plc', u'IriSys LLC', u'ARIAD Pharmaceuticals Inc', u'Relevare Pharmaceuticals Ltd', u'Solvay Pharmaceuticals Inc', u'Soin Neuroscience', u'Neuromics Inc', u'UCB Pharma SA', u'Handok Inc', u'Taiho Pharmaceutical Co Ltd', u'Teikoku Seiyaku KK', u'Ergomed PLC', u'St Marianna University School of Medicine', u'Purdue Pharma LP', u'Stiefel', u'JT Pharmaceuticals Inc', u'WEX Pharmaceuticals Inc', u'Pfizer Inc', u'Pharmaleads', u'Cascade Therapeutics Inc', u\"Boston Children's Hospital\", u'Alnylam Pharmaceuticals Inc', u'St Louis University', u'Rinat-Pfizer Inc', u'National Research Council of Canada', u'National Institute of General Medical Sciences', u'CrystalGenomics Inc', u'Evotec AG', u'MGI GP Inc', u'Nagasaki University', u'The Wolfson Institute for Biomedical Research', u'Netherlands Institute for Regenerative Medicine', u'Cynapsus Therapeutics Inc', u'Amgen Inc', u'Universitat Autonoma de Barcelona', u'Japan Science and Technology Agency', u'Solace Pharmaceuticals', u'Astellas Pharma Europe Ltd', u'University of Michigan', u'Sunovion Pharmaceuticals Inc', u'Abbott Laboratories', u'Catalyst Pharmaceutical Partners Inc', u'Catena Pharmaceuticals Inc', u'Eisai Co Ltd', u'University of Virginia', u'Yonsei University', u'Lipopharma Therapeutics SL', u'XTL Biopharmaceuticals Ltd', u'XenoPort Inc', u'Hallym University', u'Harris FRC Corp', u'National Cancer Institute', u'H Lundbeck A/S', u'Merck KGaA', u'Janssen Pharmaceutica BV', u'Syngene International Ltd', u'ACADIA Pharmaceuticals Inc', u'Kyushu University', u'TTY Biopharm Co Ltd', u'University of Maryland', u'AfaSci Inc', u'Brane Discovery Srl', u'Eicosis LLC', u'St Vincents Hospital (Melbourne) Ltd', u'Bionomics Ltd', u'Massachusetts General Hospital', u'Spinifex Pharmaceuticals Pty Ltd', u'Nemus Bioscience Inc', u'UCB Pharma GmbH', u'Astellas Pharma Inc', u'WuXi PharmaTech (Cayman) Inc', u'Kiadis Pharma Netherlands BV', u'Daeyang E&C', u'Newron Pharmaceuticals SpA', u'Mundipharma EDO GmbH', u'Neurosciences Victoria Ltd', u'Cleveland Clinic Foundation', u'Wellcome Trust', u'Kyorin Pharmaceutical Co Ltd', u'CERSCI Therapeutics', u'National Institute Of Environmental Health Sciences', u'Can-Fite BioPharma Ltd', u'University of Athens', u'Dong-A ST Co Ltd', u'NeuroTargets Ltd', u'University of Colorado System', u'LifeArc', u'Midatech Pharma US Inc', u'Jiangsu Nhwa Pharmaceutical Group Co Ltd', u'Biofrontera Bioscience GmbH', u'Imprimis Pharmaceuticals Inc', u'Helsinn Healthcare SA', u'NeurOp Inc', u'University of Massachusetts Medical School', u'Boehringer Ingelheim Corp', u'PolyNovo Ltd', u'University of California San Diego', u'Johns Hopkins University', u'Infinity Pharmaceuticals Inc', u'Halimed Pharmaceuticals Inc', u'University of Melbourne', u'Diamyd Inc', u'SK Biopharmaceuticals', u'Neopharm Ltd', u'Debiopharm SA', u'CIMA Labs Inc', u'Benitec Biopharma Ltd', u'Lexicon Pharmaceuticals Inc', u'Synthia Dermatech LLC', u'MD Biosciences GmbH', u'FAAH Pharma Inc', u'University of North Carolina', u'National Institute of Neurological Disorders and Stroke', u'NPS Pharmaceuticals Inc', u'Neurotune AG', u'Genentech Inc', u'Saniona ApS', u'Grunenthal GmbH', u'Argolyn Bioscience Inc', u'Korea Drug Development Fund', u'St Vincents Hospital Sydney Ltd', u'National Institute of Diabetes, Digestive and Kidney Diseases', u'Huazhong University of Science and Technology', u'AnaBios Corp', u'Ultrafine Chemicals Ltd', u'Relieve Genetics Inc', u'Howard Florey Institute of Experimental Physiology and Medicine', u'EMPA Healthcare LLC', u'H:S Rigshospitalet', u'Republic of Korea Government', u'Aquilus Pharmaceuticals Inc', u'Aptinyx Inc', u'National Institute on Drug Abuse', u'Sumitomo Dainippon Pharma Co Ltd', u'Nippon Chemiphar Co Ltd', u'Daewoong Pharmaceutical Co Ltd', u'Merck & Co Inc', u'Australian Research Council', u'Lundbeck Canada Inc', u'MediciNova Inc', u'Sanofi', u'Daewon Pharm Co Ltd', u'Medison Pharma Ltd', u'Columbia University', u'Eli Lilly & Co', u\"Universita' Degli Studi Di Teramo\", u'Immune Pharmaceuticals Inc', u'Bayer AG', u'University of California Davis', u'SATT Paca Corse', u'Allergan Inc', u'Maruho Co Ltd', u'GL PharmTech Corp', u'Institute for the Study of Aging (ISOA), Ltd', u'Supernus Pharmaceuticals Inc', u'Kyowa Hakko Kirin Co Ltd', u'Novel Pain Therapeutics LLC', u'University of Rome Tor Vergata', u'Kissei Pharmaceutical Co Ltd', u'University of California Irvine', u'GW Pharmaceuticals plc', u'University of California Los Angeles', u'Cameleon Ltd', u'CeNeS Pharmaceuticals Inc', u'ReNeuron Group plc', u'AstraZeneca plc', u'Esteve', u'Neurocrine Biosciences Inc', u'Childrens Medical Center Corp', u'Kaken Pharmaceutical Co Ltd', u'Xalud Therapeutics Inc', u'NeurogesX Inc', u'Allelix Neuroscience Inc', u'University of Adelaide', u'Northeastern University', u'Undisclosed', u'Wyeth', u'Aix-Marseille Universit\\xe9', u'Yissum Research Development Co', u'CanniMed Ltd', u'University of Arizona', u'Desitin Arzneimittel GmbH', u'LamdaGen Llc', u'BioLineRx Ltd', u'University of Manitoba', u'Massachusetts Institute of Technology', u'Icagen Inc', u'Intrexon Corp', u'Cambridge Biotechnology Ltd', u'Universidad Complutense de Madrid', u'Euthymics Bioscience Inc', u'Cita NeuroPharmaceuticals Inc', u'Xdynia LLC', u'Glenmark Pharmaceuticals Ltd', u'Pharmos Corp', u'University of Mississippi', u'Addiction Therapeutix Inc', u'Vernalis Research Ltd', u'VistaGen Therapeutics Inc', u'Regeneus Pty Ltd', u'UniQuest Pty Ltd', u'Ceptaris Therapeutics Inc', u'Par Pharmaceutical Co Inc', u'Crinetics Pharmaceuticals Inc', u'National Institutes of Health', u'Anavex Life Sciences Corp', u'Knight Therapeutics Inc', u'University of Wisconsin-Milwaukee', u'Bristol-Myers Squibb Co', u'Elan Corp plc', u'OSEO', u'Sphaera Pharma', u'Zenyth Therapeutics Ltd', u'Alpharma Ireland Ltd', u'TransMolecular Inc', u'Centaur Pharmaceuticals Inc', u'IntelGenx Technologies Corp', u'Cephalon Inc', u'bioCSL PTY Ltd', u'MD Anderson Cancer Center', u'Cornell University', u'Zalicus Inc', u'BioDelivery Sciences International Inc', u'Sosei Group Corp', u'Alion Pharmaceuticals Inc', u'Professional Compounding Centers Of America Ltd', u'Avanir Pharmaceuticals Inc', u'RTI International', u'Apollo Endosurgery Inc', u'Adamas Pharmaceuticals Inc', u'Meda AB', u'University of Bristol', u'Janssen Pharmaceuticals Inc', u'Hebrew University of Jerusalem', u'Depomed Inc', u'Avigen Inc', u'Indiana University', u'Patheon Pharmaceuticals Inc', u'Novartis AG', u'Oncodesign Biotechnology SA', u'Gedeon Richter Ltd', u'Epitome Pharmaceuticals Ltd', u'Calmare Therapeutics Inc', u'Merz & Co GmbH', u'PNA Center for Neurological Research', u'Traxion Therapeutics Inc', u'Centrexion Therapeutics Corp']), u'Urinarydysfunction': set([u'Afferent Pharmaceuticals', u'Matrix Pharma (Pvt) Ltd', u'Yamanouchi Pharmaceutical Co Ltd', u'Pahang Pharmacy Sdn Bhd', u'Q-Med AB', u'Synthelabo', u'Macropharma Corp', u'Celgene Corp', u'Nippon Shinyaku Co Ltd', u'Mitsubishi Pharma Corp', u'Orion Corporation', u'ASTA Medica AG', u'Abbott Laboratories', u'Jouveinal Laboratories Inc', u'GlaxoSmithKline plc', u'Boehringer Mannheim GmbH', u'Hormos Medical Corp', u'Laborat\\xf3rio Qu\\xedmico Farmac\\xeautico Bergamo Ltda', u'University of Queensland', u'Undisclosed', u'Novartis Pharma AG', u'Sanofi-Synthelabo', u'Schering SpA', u'UCB Pharma GmbH', u'Toyama Chemical Co Ltd', u'Apogepha Arzneimittel GmbH', u'Astellas Pharma Inc', u'Roche Holding AG', u'Eurofarma', u'Oceana Therapeutics Inc', u'KeyNeurotek Pharmaceuticals AG', u'Dong-A ST Co Ltd', u'The Green Cross Corp', u'Prasco Laboratories', u'Icagen Inc (pre-merger)', u'Nycomed Christiaens BV', u'Shionogi & Co Ltd', u'Boehringer Ingelheim Corp', u'Xenome Ltd', u'Boryung Pharm Co Ltd', u'Leiras Oy', u'Procaps SA', u'Apricus Biosciences Inc']), u'Parathyroiddisease': set([u'Giner Inc', u'Proven Process Medical Devices Inc']), u'Autoimmunehemolyticanemia': set([u'Johns Hopkins University', u'Accentia BioPharmaceuticals Inc']), u'Neurodegenerativedisease': set([u'Prosetta Biosciences Inc', u'Neurobiological Technologies Inc', u'Buck Institute', u'University of Maryland', u'BioHaven Pharmaceutical Holding Co Ltd', u'Tiantan Puhua Neurological Hospital', u'MethylGene Inc', u'Ionis Pharmaceuticals Inc', u'University of South Florida', u'Sigma-Aldrich Corp', u'MGI GP Inc', u'University of Arizona', u'Carna Biosciences Inc', u'Daito Chemix Corp', u'Galapagos NV', u'Dompe SpA', u'Banner Sun Health Research Institute', u'NeuroSpheres Ltd', u'North Carolina Biotechnology Center', u'Medical Research Council', u'eemagine GmbH', u'Perrigo Co plc', u'Sigma-Tau Ind Farm Riunite SpA', u'National Health and Medical Research Council', u'AngioChem Inc', u'Centre National de la Recherche Scientifique (CNRS)', u'Universitat Autonoma de Barcelona', u'University of California San Francisco', u'Xtrexa Bio Inc', u'Tel Aviv University', u'The European Union', u'Tulane University', u'Essex Bio-Technology Ltd', u\"Universite d'Angers\", u'KinoPharma Inc', u'Life Technologies Corp', u'Istituto Scientifico H San Raffaele', u'Neuren Pharmaceuticals Ltd', u'Families of Spinal Muscular Atrophy', u'Siegfried Holding Ltd', u'Metafold Therapeutics Inc', u'Ogeda SA', u'Universidad De Cordoba', u'Ashvattha Therapeutics LLC', u'Gladstone Institute of Neurological Disease', u'Neurosciences Victoria Ltd', u'BioVex Inc', u'Wellcome Trust', u'Errant Gene Therapeutics LLC', u'German center for neurodegenerative diseases', u'Lumos Labs', u'Gliatech Inc', u'Austin Health', u'VistaGen Therapeutics Inc', u'RayBiotech Inc', u'Janssen Pharmaceutica NV', u'Taiho Pharmaceutical Co Ltd', u'Neuro-Hitech Inc', u'German Federal Ministry of Education and Research', u'PolyNovo Ltd', u'Genfit SA', u'Medtronic Inc', u'Patheon Pharmaceuticals Inc', u'The Bronx Project Inc', u'M3 Biotechnology Inc', u'Pharmexa A/S', u'AnC Bio Group', u'Galenea Corp', u'Progenra Inc', u'CBD solutions', u'Blaze Bioscience Inc', u'AlzeCure Foundation', u'Massachusetts Institute of Technology', u'Undisclosed', u'Encore Pharmaceuticals Inc', u'LEO Pharma A/S', u'Eli Lilly & Co', u'Amydis Diagnostics', u'DNage BV', u'Tikvah Therapeutics Inc', u'Weizmann Institute of Science', u'Naprogenix Inc', u'AC Immune SA', u'NsGene A/S', u'Horizon Orphan LLC', u'Sunesis Pharmaceuticals Inc', u'CeNeS Pharmaceuticals Inc', u'National Institute on Aging', u'Synaging', u'National Taiwan University', u'SIBIA Neurosciences Inc', u'Medicon A/S', u'Johnson & Johnson', u'KU Leuven R&D', u'AbbVie Inc', u'RhinoCyte Inc', u'Nymirum', u'GRI Bio Inc', u'Pharnext SAS', u'Ramot at Tel Aviv University Ltd', u'Taisho Pharmaceutical Co Ltd', u'Bristol-Myers Squibb Co', u'OSEO', u'Seoul National University', u'Astellas Pharma Inc', u'University of Auckland', u'Rhone-Poulenc SA', u'Hebrew University of Jerusalem', u'VivaCell Biotechnology Espana SL', u'Life Sciences Discovery Fund', u'Incro Pharmaceuticals Corp', u'Oncodesign Biotechnology SA', u'Power3 Medical Products Inc', u'J David Gladstone Institutes', u'ImaginAb Inc', u\"King's College London\", u'Chronos Therapeutics', u'University of Texas Medical Branch at Galveston', u'Novo Nordisk A/S', u'Regeneron Pharmaceuticals Inc', u'Herantis Pharma Plc', u\"Alzheimer's Drug Discovery Foundation\", u'Boehringer Ingelheim GmbH', u'Orion Corporation', u'Ataxion Inc', u'Pharmacyclics Inc', u'KineMed Inc', u'BTG plc', u'University of Bonn', u'Dementia Consortium', u'University of Oregon', u'Chiron Corp', u'DRAXIS Health Inc', u'Texas A&M University System', u'ArQule Inc', u'Stanford University', u'Microbot Medical Inc', u'Vernalis plc', u'Accera Inc', u'University of Montpellier', u'Mitsubishi-Tokyo Pharmaceuticals Inc', u'Roche Holding AG', u'The National Institute of Mental Health', u'Cerveau Technologies Inc', u'VIB', u'UCB Pharma SA', u'Selvita SA', u'Stony Brook Medicine', u'Avid Radiopharmaceuticals Inc', u'University of Massachusetts Medical School', u'National Institute of General Medical Sciences', u'Evotec AG', u'Meiji Seika Pharma Co Ltd', u'Diaxonhit', u'Amgen Inc', u'CuroNZ Ltd', u'NPS Allelix Corp', u'Endo Pharmaceuticals Solutions Inc', u'Cajal Institute', u'Tanabe Seiyaku Co Ltd', u'CircaGen Pharmaceutical', u'Consejo Superior De Investigaciones Cientificas', u'University of Bristol', u'Georgetown University', u'Aurum Ventures MKI', u'Imago Pharmaceuticals Inc', u'Actelion Pharmaceuticals Ltd', u'Hager Biosciences LLC', u'Medeia Therapeutics Ltd', u'Cypralis Ltd', u'Cleveland Clinic Foundation', u'Allon Therapeutics Inc', u'Azur Pharma Ltd', u'Jiangsu Nhwa Pharmaceutical Group Co Ltd', u'Allergan Inc', u'University of Edinburgh', u'Daegu Hanny University', u'Xencor Inc', u'University of California San Diego', u'Vicore Pharma AB', u'Roche Palo Alto', u'Stemedica Cell Technologies Inc', u'Denali Therapeutics Inc', u'Carthera', u'Jefferson Corner Group', u'SICOR Inc', u'Genentech Inc', u'Saniona ApS', u'INSTITUTO BIODONOSTIA', u'ALviva Biopharmaceuticals Inc', u'Aelan Cell Technologies Inc', u'Intra-Cellular Therapies Inc', u'Neuroallianz Consortium', u'Oklahoma Medical Research Foundation', u'New York University', u'Lakehead University', u'Eden Biodesign Ltd', u'DuChemBio Co Ltd', u'DiamiR LLC', u'Sumitomo Dainippon Pharma Co Ltd', u'Rosalind Franklin University of Medicine & Science', u'Henry M Jackson Foundation for the Advancement of Military Medicine', u'Inbiomed', u'Scripps Research Institute', u'University of Texas Southwestern Medical Center', u'Consiglio Nazionale delle Ricerche', u'The Michael J. Fox Foundation', u'Shirley Ryan AbilityLab', u'Yeda Research and Development Co Ltd', u'Harvard NeuroDiscovery Center', u'AEterna Zentaris Inc', u'NuvIAR', u'Proteome Sciences plc', u'ReNeuron Group plc', u'AstraZeneca plc', u'Technology Strategy Board', u'SUGEN Inc', u'University of Utah', u'Takara Bio Europe Ab', u'Memory Pharmaceuticals Corp', u'New York University School of Medicine, US', u'QRxPharma Ltd', u'Academia Sinica', u'Translational Genomics Research Institute', u'University of Tasmania', u'Pharmos Corp', u'NYU Langone Medical Center', u'Dainippon Pharmaceutical Co Ltd', u'Thera Neuropharma Inc', u'Molecular Neuroimaging LLC', u'Ceptaris Therapeutics Inc', u'Osaka Prefecture University', u'Senju Pharmaceutical Co Ltd', u'Proclara Biosciences', u'PharmatrophiX', u'National Science Foundation', u'The New York Stem Cell Foundation', u'Kyoto University', u'Cedars-Sinai Medical Center', u'AGY Therapeutics Inc', u'Ovid Therapeutics Inc', u'Medical University of South Carolina', u'Siemens Medical Systems Inc', u'Yung-Shin Pharmaceutical Industry Co Ltd', u'Coronis NeuroSciences', u'Rhenovia Pharma SAS', u'GE Healthcare', u'Walloon Region of Belgium Government', u'Albert-Ludwigs-Universit\\xe4t Freiburg', u'Avigen Inc', u\"Brigham & Women's Hospital\", u'Antitope Ltd', u'Takeda Pharmaceutical Co Ltd', u'University of Cambridge', u'Institut Henri Beaufour', u'RXi Pharmaceuticals Corp', u'University of Florida', u'Cardinal Health Inc', u'EMD Serono Inc', u'University of Barcelona', u'Mount Sinai School of Medicine', u'Oryzon Genomics SA', u'Korea Research Institute of Chemical Technology', u'Kadimastem Ltd', u'Idun Pharmaceuticals Inc', u'FORUM Pharmaceuticals Inc', u'Universitaire Ziekenhuizen Leuven', u'InteRNA Technologies BV', u'MedImmune LLC', u'Exiqon A/S', u'OSI Pharmaceuticals Inc', u'University of Washington', u'Boston University School of Medicine', u'University of London', u'ARIAD Pharmaceuticals Inc', u'Navinta LLC', u'Annexon Biosciences', u'Ground Fluor Pharmaceuticals Inc', u'Sanford-Burnham Medical Research Institute', u'Signal Research Division', u\"Wisconsin Alzheimer's Disease Research Center\", u'International Biotechnology Center Generium LLC', u'Tufts University', u'The University of Geneva Medical Center (CMU)', u'SCYNEXIS Inc', u'Harvard University', u'Orpheris Inc', u'Repligen Corp', u'Yumanity Therapeutics', u'University of Heidelberg', u'Teva Pharmaceutical Industries Ltd', u'Catholic University of Leuven', u'State Foundation Institute of Pharmacology RAMS', u'Axonyx Inc', u'UCB Pharma GmbH', u'University of Louisville', u'Ministerio de Economia y Competitividad', u'Kyorin Pharmaceutical Co Ltd', u'Samyang Optics Co Ltd', u'Parke-Davis & Co', u'University of Sydney', u'Carmot Therapeutics Inc', u'Weston Brain Institute', u'National Biomanufacturing Centre', u'Zedira GmbH', u'Duke University Medical Center', u'Wyeth Pharmaceuticals', u'French Muscular Dystrophy Association', u'Harvard Medical School', u'IDIS Ltd', u'Sirtris Pharmaceuticals Inc', u'Aventis Pharma SA', u'Kaleidos Pharma Inc', u'NeoCytex Biopharma Inc', u'Expression Drug Designs LLC', u'University of California', u'Merck & Co Inc', u'Sanofi', u'The Salk Institute for Biological Studies', u'Vertex Pharmaceuticals Inc', u'Columbia University', u'Clinical Imaging Research Centre', u'Novogen Ltd', u'Bayer AG', u'Renovis Inc', u'Laboratoire de Chimie de Coordination du CNRS', u'BBB Therapeutics BV', u'Klogene Therapeutics Inc', u'University Medical Center Groningen', u'Bennu Pharmaceuticals Inc', u'Imanova Ltd', u'Neurocrine Biosciences Inc', u'Swiss Federal Office of the Commission for Technology and Innovation', u'Institute for the Promotion of Innovation by Science and Technology in Flanders', u'Aptuit Inc', u'University of Iowa', u'Purdue University', u'NeuroNascent Inc', u'RaNeDis Pharmaceuticals', u'Vect-Horus', u'Eberhard Karls Universit\\xe4t T\\xfcbingen', u'Walter Reed Army Institute of Research', u'Wyss Institute for Biologically Inspired Engineering', u'Pharm-Eco Laboratories Inc', u'Calporta Therapeutics Inc', u'CANTABio Pharmaceuticals Inc', u'RxMD Inc', u'Elan Corp plc', u'Renishaw plc', u'INSERM', u'Sanofi Genzyme', u'Centaur Pharmaceuticals Inc', u'Proteostasis Therapeutics Inc', u'Cephalon Inc', u'Celgene Corp', u'Array BioPharma Inc', u'National Institute on Alcohol Abuse and Alcoholism', u'PN Gerolymatos SA', u'Ciba-Geigy AG', u'GeneGo Inc', u'Duke University', u'Innovative NeuroTechnologies Inc', u'Sanofi GmbH', u'CoPlex Therapeutics LLC', u'Senexis Ltd', u'Samus Therapeutics Inc', u'Janssen Pharmaceuticals Inc', u'RNL Bio Co Ltd', u'Rhone-Poulenc Rorer Inc', u'Io Therapeutics Inc', u'C2N Diagnostics', u'US Government', u'Ecole Polytechnique Federale de Lausanne', u'Vaccinex Inc', u'Palumed SA', u'GenVec Inc', u'California Institute of Regenerative Medicine', u'Biogen Inc', u'GlaxoSmithKline plc', u\"Ataxia Telangiectasia Children's Project Inc\", u'Axxam SpA', u'Bayer Schering Pharma AG', u'Mc10 Inc', u'Ipsen', u'European Eurostars Programme', u'Enigma Biomedical Group Inc', u'Nodthera Ltd', u'University of Michigan', u'MakScientific LLC', u'MitoKor', u'Abbott Healthcare Products BV', u'Claria Bioscience LLC', u'Technische Universitat Darmsdadt', u'University of Alabama in Huntsville', u'Boston University', u'PhoreMost Ltd', u'Emory University', u\"Boston Children's Hospital\", u'Alnylam Pharmaceuticals Inc', u'UCB SA', u'Sequenom Inc', u'Link Medicine Corp', u'IXICO Plc', u'RespireRx Pharmaceuticals Inc', u'Ekam Imaging Inc', u'Daiichi Sankyo Co Ltd', u'Neuraltus Pharmaceuticals Inc', u'Eisai Co Ltd', u'Proneuron Biotechnologies Inc', u'IntelliHep', u'National Cancer Institute', u'Novartis AG', u'Trillium Therapeutics Inc', u'Corvus Pharmaceuticals Inc', u'ALSP Inc', u'Eli Lilly & Co Ltd', u'Fujisawa Pharmaceutical Co Ltd', u'University of Pennsylvania', u'Universidade Estadual De Maringa', u'Panorama Research Inc', u'Chaperone Therapeutics Inc', u'TyrNovo Ltd', u'National Institute Of Radiological Sciences', u'Metabolic Solutions Development Co', u'Summit Therapeutics plc', u'Hawthorn Pharmaceuticals Inc', u'Bicoll GmbH', u'Neurimmune Holding AG', u'Varinel Inc', u'York Instruments', u'McGill University', u'Universitair Medisch Centrum Utrecht', u'Neurome Inc', u'Washington University in St Louis', u'AMO Pharma Ltd', u'Johns Hopkins University', u'Myriad Genetics Inc', u'Kyowa Hakko Kogyo Co Ltd', u'H Lundbeck A/S', u'Genea Ltd', u'Sens Foundation Inc', u'National Institute of Neurological Disorders and Stroke', u'University of California San Diego School of Medicine', u'GeneData AG', u'Neuropore Therapies Inc', u'Amarantus BioScience Holdings Inc', u'Phoenix Biotechnology Inc', u'Southern Research Institute', u'Calico Life Sciences LLC', u'Boots Hoechst Celanese', u'Rijksuniversiteit te Groningen', u'Nuclea Biotechnologies LLC', u'AgeneBio Inc', u'Jeil Pharmaceutical Co Ltd', u'Merck Serono SA', u'ImmunoCellular Therapeutics Ltd', u'French Government', u'Hanyang University', u'Tosk Inc', u'University College London', u'Addex Therapeutics Ltd', u'Cureon A/S', u'Servier', u'Sharp Edge Labs', u'Sunovion Pharmaceuticals Inc', u'Pfizer Inc', u'Tego BioSciences Corp', u'Living Cell Technologies Ltd', u'Allelix Neuroscience Inc', u'Spark Therapeutics LLC', u'Yissum Research Development Co', u'University of Illinois', u'Memorial Sloan-Kettering Cancer Center', u'Mount Sinai Medical Center', u'LamdaGen Llc', u'BioLineRx Ltd', u'NeoGenesis Pharmaceuticals Inc', u'Baylor College of Medicine', u'Synthelabo', u'Nihon Nohyaku Co Ltd', u'Arena Pharmaceuticals Inc', u'Ohio State University', u'National Institutes of Health', u'Aquinnah Pharmaceuticals Inc', u'South Texas Accelerated Research Therapeutics', u'Curis Inc', u'Cardiff University', u'American Cyanamid Co', u'Siena Biotech SpA', u'Kentucky Science and Technology Corp', u'Yungjin Pharmaceutical Co Ltd', u'Alion Pharmaceuticals Inc', u'Cambrex Corp', u'Howard Florey Institute of Experimental Physiology and Medicine', u'Purdue Neuroscience Corp', u'XenoPort Inc', u'University of California Irvine', u'biOasis Technologies Inc', u'Lascco SA', u'Biologics Inc', u'Gedeon Richter Ltd', u'Poli Industria Chimica SpA']), u'Blastomycesinfection': set([u'Johnson & Johnson', u'Barrier Therapeutics Inc']), u'Abdominalsurgery': set([u'Undisclosed', u'Florida Hospital Nicholson Center', u'Titan Medical Inc', u'Neosurgical Ltd']), u'Femalesexualdysfunction': set([u'Amerinet Inc', u'VIVUS Inc', u'Chugai Pharmaceutical Co Ltd', u'King Pharmaceuticals Inc', u'National Institutes of Health', u'Endoceutics Inc', u'Paladin Labs Inc', u'Oz Biogenics Ltd', u'Novation', u'US Government', u'Harvard Scientific Corp', u'Kyowa Kirin', u'Lantheus Medical Imaging Inc', u'GlaxoSmithKline plc', u'L.B. RESOURCES LTD', u'J&H Co. LTD', u'PDI Research Laboratories Inc', u'Bayer Schering Pharma AG', u'Medivir AB', u'Khandelwal Laboratories Ltd', u'Androsolutions Inc', u'Michael James Enterprises', u'Pfizer Inc', u'Pharma MAEHLE GmbH', u'Marina Biotech Inc', u'Innovus Pharmaceuticals Inc', u'Camargo Pharmaceutical Services', u'Solvay Pharmaceuticals Inc', u'Glaxo Group Ltd', u'ICOS Corp', u'Eli Lilly & Co', u'The Procter & Gamble Co', u'Bio-Sphere Technology Inc', u'Endorecherche Inc', u'CSL Ltd', u'Acrux Ltd', u'PT Kalbe Farma Tbk', u'Biovail Corp', u'New Life Scientific Inc', u'XION Corp', u'Watson Laboratories Inc', u'Senetek plc', u'Ramot at Tel Aviv University Ltd', u'M Pharmaceutical Inc', u'Palatin Technologies Inc', u'ANI Pharmaceuticals Inc', u'Handok Inc', u'Inotek Pharmaceuticals Corp', u'Globe Medical Tech Inc', u'Adamis Pharmaceuticals Corp', u'FUJIFILM RI Pharma Co', u'biotask', u'Gedeon Richter Ltd', u'Orexo AB', u'Calmare Therapeutics Inc', u'University of Arizona', u'Rutgers University', u'Undisclosed', u'AMAG Pharmaceuticals Inc', u'Laboratoire Densmore', u'Apricus Biosciences Inc', u'Luminarie Pty Ltd', u'Catalent Inc', u'EPIX Pharmaceuticals Inc', u'Antares Pharma Inc']), u'Congenitalhemophilia': set([u'Swedish Orphan Biovitrum AB', u'LFB SA']), u'Gallbladderdisease': set([u'Gilead Sciences Inc', u'GlaxoSmithKline plc']), u'Encephalomyelitis': set([u'PsiOxus Therapeutics Ltd', u'Defense Threat Reduction Agency']), u'Wiskott-Aldrichsyndrome': set([u'Fondazione Telethon', u'Genethon', u'Istituto Scientifico H San Raffaele', u'bluebird bio Inc', u'Food and Drug Administration', u'MolMed SpA', u\"Boston Children's Hospital\", u'Childrens Hospital of Philadelphia', u'GlaxoSmithKline plc']), u'Hyperactivity': set([u'Shangxi RFL Pharmaceutical Co Ltd', u'Beijing Kangbeide Pharmaceutical Technology Development Co Ltd']), u'Cervixdisease': set([u'AnGes MG Inc', u'GenoLac BL Corp', u'Bioleaders Corp']), u'Hypothyroidism': set([u'Eli Lilly & Co', u'T3 Therapeutics LLC', u'Karo Pharma AB', u'Archimedes Pharma Ltd', u'Bristol-Myers Squibb Co', u'Therapeutics for Rare and Neglected Diseases']), u'Analdysplasia': set([u'CEL-SCI Corp', u'Nventa Biopharmaceuticals Corp', u'US Naval Medical Research Center', u'Roche Holding AG']), u'Lambert-Eatonsyndrome': set([u'Biocept Inc', u'EUSA Pharma USA', u'BioMarin Pharmaceutical Inc', u'Assistance Publique Hopitaux de Paris', u'Catalyst Pharmaceutical Partners Inc']), u'Obsessivecompulsivedisorder': set([u'Rugen Therapeutics R & D (Shanghai) Co Ltd', u'Meiji Seika Pharma Co Ltd', u'US Government', u'NPS Pharmaceuticals Inc', u'Mitsubishi Pharma Corp', u'Abbott Laboratories', u'Solvay Meiji Yakuhin KK', u'Savant HWP Inc', u'Catalyst Pharmaceutical Partners Inc', u'Intra-Cellular Therapies Inc', u'Mochida Pharmaceutical Co Ltd', u'Onxeo SA', u'Forest Laboratories Inc', u'GlaxoSmithKline plc', u'Allergan plc', u'Quintiles Transnational Corp', u'Targacept Inc', u'Tikvah Therapeutics Inc', u'National Institute on Drug Abuse', u'Bristol-Myers Squibb Co', u'Scios Inc', u'Myungin Pharm Co Ltd', u'Brookhaven National Laboratory', u'Organix Inc', u'University of South Florida', u'Therapade Technologies LLC', u'Eli Lilly & Co', u'Recordati SpA', u'FAES Farma SA', u'Therapix Biosciences Ltd', u'Roche Holding AG', u'Mitsubishi Tanabe Pharma Corp', u'Hannover Medical School', u'Layton Bioscience Inc', u'POZEN Inc', u'Xian-Janssen Pharmaceutical Ltd', u'Asubio Pharma Co Ltd', u'Cascade Therapeutics Inc', u'Omeros Corp', u'H Lundbeck A/S']), u'CrimeanCongofevervirusinfection': set([u'INSERM', u'National Institute of Allergy and Infectious Diseases', u'Hawaii Biotech Inc', u'Sanofi Pasteur', u'Fabentech']), u'Meningioma': set([u'National Cancer Institute', u'PharmaMar SA', u'European Organisation for Research and Treatment of Cancer (EORTC)', u'Dana-Farber Cancer Institute Inc', u'Massachusetts General Hospital', u'American Brain Tumor Association']), u'Cryptococcusneoformansmeningitis': set([u'Johnson & Johnson', u'MD Anderson Cancer Center', u'Genentech Inc', u'Connetics Corp', u'InterMune Inc', u'National Institute of Allergy and Infectious Diseases', u'Maxygen Holdings Ltd', u'National Institutes of Health', u'University of Minnesota - Clinical and Translational Science Institute', u'NeXstar Pharmaceuticals Inc', u'Boehringer Ingelheim International GmbH', u'Aronex Pharmaceuticals Inc', u'Sumitomo Pharmaceuticals Co Ltd', u'Mycoses Study Group Education and Research Consortium', u'Matinas BioPharma Inc', u'Amplyx Pharmaceuticals Inc', u'Boehringer Ingelheim Austria GmbH', u'Viamet Pharmaceuticals Holdings LLC', u'Ferrer Internacional SA', u'Horizon Pharma plc', u'Barrier Therapeutics Inc', u'Boehringer Ingelheim Corp']), u'Thrombocytopenicpurpura': set([u'Symphogen A/S', u'Sanofi Genzyme', u'Medexus Inc', u'Ohio State University', u'Ligand Pharmaceuticals Inc', u'MacroGenics Inc', u'Baxter Healthcare Corp', u'Astellas Pharma Inc', u'CSL Behring LLC', u'Cypress Bioscience Inc', u'ProMetic Life Sciences Inc', u'AkaRx Inc', u'Vermillion Inc', u'Chinese Government', u'Cambridge Antibody Technology Group plc', u'SmithKline Beecham Corp', u'GENERIUM Pharmaceuticals', u'Cangene Corp', u'Medarex Inc', u'3SBio Inc', u'Coral Therapeutics, Inc']), u'Castlemansdisease': set([u\"Castleman's Awareness & Research Effort and Castleman Disease Collaborative Network\", u'Janssen Research & Development LLC']), u'Chronicobstructiveairwaydisease': set([u'Sunovion Pharmaceuticals Inc', u'Encysive Pharmaceuticals Inc', u'Vectura Group plc', u'Arrow International Ltd', u'GlaxoSmithKline plc', u'ICOS Corp']), u'Neuroblastoma': set([u'Leiden/Amsterdam Center for Drug Research', u'Apricity Therapeutics Inc', u'Exelixis Inc', u'National Health and Medical Research Council', u'Ascalon International Inc', u'Novogen Ltd', u'Apeiron Biologics GmbH', u'Genentech Inc', u'The Northwestern Mutual Life Insurance Company', u'HaRo Pharmaceutical Inc', u'BioMarin Nederland BV', u'Paladin Labs Inc', u'Syndivia SAS', u'CellProtect Nordic Pharmaceuticals AB', u'Cancer Prevention Pharmaceuticals Inc', u'Healx Ltd', u'Solving Kids\\u2019 Cancer', u'VIRTTU Biologics', u'Helmholtz Association', u\"Children's Cancer Institute Australia for Medical Research\", u'University of New South Wales', u'European Neuroblastoma Association', u'Lead Discovery Center GmbH', u'European Neuroblastoma Research Network', u\"Cincinnati Children's Hospital Medical Center\", u'MabVax Therapeutics Inc', u'National Cancer Institute', u'Advanced Accelerator Applications SA', u'EUSA Pharma', u'Calando Pharmaceuticals Inc', u\"Nemours Children's Hospital\", u'Food and Drug Administration', u'Southern Medical University Zhujing Hospital', u\"Neuroblastoma Children's Cancer Alliance UK\", u'NanoProteagen Inc', u'Karolinska Institutet', u'Cleveland BioLabs Inc', u'Y-mAbs Therapeutics Inc', u'MabVax Therapeutics Holdings Inc', u'Shenzhen Genoimmune Medical Institute', u'Medison Pharma Ltd', u'aPODD Foundation', u'Leiden University Medical Center', u'Clinigen Group plc', u'Bellicum Pharmaceuticals Inc', u'US Government', u'Pediatric Oncology Experimental Therapeutics Investigation Consortium', u'Van Andel Institute', u'University of Vermont', u\"Children's Hospital of Los Angeles\", u\"Oncology Children's Foundation\", u'United Therapeutics Corp', u'Biotec Pharmacon ASA', u'NSW Government', u'Villa Joep', u'CorMedix Inc', u'Childrens Hospital of Philadelphia', u\"Children's Cancer Research Institute\", u'University of Iowa', u'FDA Office of Orphan Products Development', u\"Nationwide Children's Hospital\", u'Patheon Pharmaceuticals Inc', u'OGD2 Pharma SAS', u'Zenobia Therapeutics Inc', u'CerRx Inc', u'Emory University', u'University of Toronto', u'Sutro Biopharma Inc', u'Gen Ilac', u'University of Central Florida', u'Scripps Research Institute', u'Charite Universitaetsmedizin Berlin', u'Ospedale Pediatrico Bambino Ges\\xf9 (IRCCS)', u'Kolltan Pharmaceuticals Inc', u'Memorial Sloan-Kettering Cancer Center']), u'Enterobacterinfection': set([u\"Dr Reddy's Laboratories Ltd\", u'GlaxoSmithKline plc', u'Kyowa Hakko Bio Co Ltd', u'Daiichi Sankyo Co Ltd']), u'Adrenomyeloneuropathy': set([u'Centers for Disease Control and Prevention', u'ReceptoPharm Inc']), u'Collagendisease': set([u'Cipla Ltd', u'Merck Sharp & Dohme BV', u'LTT Bio-Pharma Co Ltd', u'Jikei University', u'ANI Pharmaceuticals Inc']), u'Amoebainfection': set([u'University of Vermont', u'National Institute of Infectious Diseases Japan', u'aRigen Pharmaceuticals Inc', u'Mycosynthetix Inc', u'National Institute of Allergy and Infectious Diseases', u'University of South Florida']), u'Leukopenia': set([u'Wyeth', u'Chugai Pharmaceutical Co Ltd', u'AMRAD Pharmaceuticals Pty Ltd', u'Pharmagenesis Inc', u'Kirin Brewery Co Ltd', u'ASTA Medica AG', u'Zhejiang Chinagene Biopharmaceutical Co Ltd', u'PhytoHealth Corp', u'Cangene Corp', u'Novartis AG', u'US Government', u'Bolder BioTechnology Inc', u'Immunex Corp', u'MabVax Therapeutics Holdings Inc', u'Dragon Pharmaceutical Inc', u'Shanghai Institute of Biochemistry and Cell Biology, SIBS, CAS', u'Pharmaceutical Product Development LLC', u'CJ Corp', u'Apotex Inc', u'University of British Columbia', u'Scotia Pharmaceuticals', u'HealthCare Asia Pharmaceuticals Inc', u'Sankyo Co Ltd', u'Teijin Ltd', u'Pfizer Inc', u'Astex Pharmaceuticals Inc', u'Rhone-Poulenc Rorer Ltd', u'Chemokine Therapeutics Corp', u'Rhone-Poulenc Rorer Inc', u'Suzhou Zhongkai Bio-Pharmaceuticals Co Ltd', u'Wyeth BioPharma']), u'Sezarysyndrome': set([u'Innate Pharma SA', u'Vivalis', u'OSEO', u'Universita Degli Studi di Genova']), u'Ocularpain': set([u'University of Cologne', u'Novaliq GmbH', u'Sarentis Therapeutics Inc', u'Catalyst LLC', u'Incept LLC', u'AbbVie Inc', u'Reata Pharmaceuticals Inc', u'SiteOne Therapeutics Inc', u'Senju Pharmaceutical Co Ltd', u'Scripps Research Institute', u'Ocular Therapeutix Inc', u'Genomics Institute of the Novartis Research Foundation', u'National Eye Institute', u'Omeros Corp', u'ITROM', u'ISTA Pharmaceuticals Inc']), u'Scleroderma': set([u'LG Life Sciences Ltd', u'BioMarin Pharmaceutical Inc', u'National Institute of Arthritis and Musculoskeletal and Skin Diseases', u'Genentech Inc', u'Collgard Biopharmaceuticals Ltd', u'Intrexon Corp', u'Connetics Corp', u'Paladin Labs Inc', u'Medicis Pharmaceutical Corp', u'IDIS Ltd', u'Cambridge Antibody Technology Group plc', u'myTomorrows', u'iBio Inc', u'Biogen Inc', u'Protagen AG', u'University of Pittsburgh', u'Celltrion Inc', u'UCB Celltech', u'Bayer Schering Pharma AG', u'Novici Biotech LLC', u'Michigan Translational Research and Commercialization', u'National Institutes of Health', u'ISDIN SA', u'US Government', u'LifeCyte Inc', u'Intervet International BV', u'Bristol-Myers Squibb Co', u'Marnac Inc', u'IBEX Technologies Inc', u'Zenyaku Kogyo Co Ltd', u'Panorama Research Inc', u'Accentia BioPharmaceuticals Inc', u'Stanford University', u'BioFocus DPI', u'University of Michigan', u'Fibrocell Science Inc', u'Medical University of South Carolina', u'United Therapeutics Corp', u'Cureveda LLC', u'arGentis Pharmaceuticals LLC', u'Silence Therapeutics plc', u'University of Tennessee', u'Cytori Therapeutics Inc', u'Sanofi Genzyme', u'Scleroderma Research Foundation', u'Digna Biotech SL', u'National Heart Lung and Blood Institute', u'EUCRO GmbH & Co KG', u'Corixa Corp', u'INOVA Diagnostics Inc', u'Suntory Pharmaceutical Inc', u'F H Faulding & Co Ltd', u'Johns Hopkins University', u'Genesis Research and Development Corp Ltd']), u'Hemiplegia': set([u'Hikma Pharmaceuticals plc', u'Jazz Pharmaceuticals plc']), u'Hydrocephalus': set([u'Millar Inc', u'Endotronix Inc']), u'Radiotherapyinducedemesis': set([u'Galena Biopharma Inc', u'R-Pharm US LLC', u'SciClone Pharmaceuticals Inc', u'Midatech Pharma PLC', u'MonoSol Rx Inc', u'APR Applied Pharma Research SA']), u'Skinrash': set([u'Albert Einstein College of Medicine', u'Talon Therapeutics Inc']), u'Viralpneumonia': set([u'Hedral Therapeutics Inc', u'Oregon Health Sciences University', u'Gilead Sciences Inc', u'Pharmacia & Upjohn Co', u'Rega Institute for Medical Research', u'National Institute of Allergy and Infectious Diseases', u'Virion Systems Inc']), u'Aorticvalvedisease': set([u\"Cincinnati Children's Hospital Medical Center\", u'Thubrikar Aortic Valve Inc', u'Admedus Ltd', u'National Center for Research Resources', u'Lantheus Medical Imaging Inc', u'Northwestern University Feinberg School of Medicine', u'Bristol-Myers Squibb Co', u'Coroneo Inc', u'The Gladstone Institute of Cardiovascular Disease', u'iPierian Inc', u'Kyoto University', u'Labcor Laboratories', u'Wide Line Limited', u'National Heart Lung and Blood Institute']), u'Tinea': set([u'UCB Pharma SA', u'OrthoNeutrogena', u'Green Cross Corp', u'Penederm Inc', u'Ferrer Internacional SA', u'Novartis AG', u'Maruho Co Ltd', u'Kaken Pharmaceutical Co Ltd', u'Dong Wha Pharmaceutical Co Ltd', u'Pola Chemical Ind Inc', u'Kyorin Pharmaceutical Co Ltd', u'Samil Pharmaceutical Co Ltd', u'Mylan Inc', u'Shiseido Co Ltd', u'Nihon Nohyaku Co Ltd']), u'Osteonecrosis': set([u'Vericel Corp', u'Osteologix Holdings PLC', u'Servier', u'National Institutes of Health']), u'Erythematosquamousskindisease': set([u'Ferrer Internacional SA', u'Barrier Therapeutics Inc', u'Intendis GmbH', u'Valeant Pharmaceuticals International Inc']), u'CreutzfeldtJakobdisease': set([u'Ludwig-Maximilians University of Munich', u'CPL BCX Pharma AB', u'Merck Serono SA', u'NeuroScios GmbH', u'University of California San Francisco', u'Medical Research Council', u'Synthetic Biologics Inc', u'ASTA Medica AG', u'Daiichi Sankyo Co Ltd', u'Max-Planck-Institut f\\xfcr Biophysikalische Chemie', u'Axonyx Inc', u'GlaxoSmithKline plc']), u'Dravetsyndrome': set([u'Epygenix Therapeutics Inc', u'University of California San Francisco', u'National Institute of Neurological Disorders and Stroke']), u'Severecombinedimmunodeficiencysyndrome': set([u'University of Minnesota', u'Hannover Medical School', u'University of California Los Angeles', u'CRISPR Therapeutics', u'Genethon', u'Sangamo Therapeutics Inc', u'Orphan Technologies Ltd', u'Orchard Therapeutics', u\"St Jude Children's Research Hospital\", u'National Institutes of Health', u'University of London', u'PCT, a Caladrius company', u'MaxCyte Inc', u'St Georges University of London', u\"Boston Children's Hospital\", u'National Institute of Allergy and Infectious Diseases', u\"Seattle Children's Hospital\", u'Hopital Necker Enfants Malades', u'University College London']), u'Duchennedystrophy': set([u'Brown University', u'Acceleron Pharma Inc', u'Catabasis Pharmaceuticals Inc', u'Netherlands Government', u'European Commission', u'Carolinas Medical Center', u'California Institute of Regenerative Medicine', u'Capricor Therapeutics Inc', u'Amsterdam Molecular Therapeutics BV', u'BioMarin Pharmaceutical Inc', u'Takeda Pharmaceutical Co Ltd', u'Fight DMD', u'Sarepta Therapeutics Inc', u'Marina Biotech Inc', u'TREAT-NMD', u'The European Union', u'Leiden University Medical Center', u'DMD Therapeutics Inc', u'University of London', u'Roche Holding AG', u'Solid Biosciences LLC', u'Shire plc', u'Ercole Biotech Inc', u'Galapagos NV', u'University of North Carolina', u'Cellectis SA', u'Duchenne Now', u'ReveraGen BioPharma Inc', u'Muscular Dystrophy Association', u'Genethon', u'Ksilink', u'StrykaGen', u'National Heart Lung and Blood Institute', u'Technology Strategy Board', u'Murdoch University', u\"Boston Children's Hospital\", u'National Center For Advancing Translational Sciences', u'Rosetta Genomics Ltd', u'University of Minnesota', u'National Institute of Arthritis and Musculoskeletal and Skin Diseases', u'University of Oxford', u\"Children's National Medical Center\", u'Bamboo Therapeutics Inc', u'Daiichi Sankyo Co Ltd', u'Ohio State University', u'Duchenne UK', u'Mitochon Pharmaceuticals', u\"Ryan's Quest\", u'University of Washington', u'The Foundation to Eradicate Duchenne', u'Eunice Kennedy Shriver National Institute of Child Health & Human Development', u'Istituto Scientifico H San Raffaele', u'Biovista Inc', u'GlaxoSmithKline plc', u'Massachusetts General Hospital', u'Medical Research Council', u'Action Duchenne', u'United Parent Projects Muscular Dystrophy', u'Universita degli Studi di Roma La Sapienza', u'JCR Pharmaceuticals Co Ltd', u'FibroGen Inc', u'CHU De Nantes', u\"Nationwide Children's Hospital\", u'Duchenne Alliance', u'Myomics Inc', u'EspeRare Foundation', u'Armgo Pharma Inc', u'Tonus Therapeutics', u'Boehringer Ingelheim Corp', u'University of Texas Southwestern Medical Center', u'PTC Therapeutics Inc', u'Universite Laval', u'Debiopharm SA', u'Sigma-Tau Ind Farm Riunite SpA', u'Phrixus Pharmaceuticals Inc', u'Lexicon Pharmaceuticals Inc', u'Atlantic Gene Therapies', u'Akashi Therapeutics', u'RTI International', u'National Institute of Neurological Disorders and Stroke', u'BioMarin Nederland BV', u'University of Nevada', u'Grunenthal GmbH', u'IDIS Ltd', u'SynCo BioPartners', u'CellGene Inc', u'MediTip Co Ltd', u'Houston Methodist Research Institute', u'SRI International', u'Asklepios Biopharmaceutical Inc', u'Japan National Institute of Neuroscience', u'Ben Franklin Technology Partners of Southeastern Pennsylvania', u'RASRx', u'US Government', u'Senter', u'University of Southern California', u'Giddi Pharma Co Ltd', u'Nippon Medical School Foundation', u'National Center Of Neurology & Psychiatry', u'La Jolla Pharmaceutical Co', u'University of Miami', u'Indiana University Research and Technology Corp Inc', u'The University of Newcastle Upon Tyne', u'NicOx SA', u'University of Geneva', u'Orphan Disease Treatment Institute Co Ltd', u'University of California Los Angeles', u'Association Institut De Myologie', u'Sanford-Burnham Medical Research Institute', u'CureDuchenne', u'Milo Biotechnology', u'University College London', u'US Department of Defense', u'Zalicus Inc', u'Nippon Shinyaku Co Ltd', u'GenEdit Inc', u'Nash Avery Foundation', u'Santhera Pharmaceuticals AG', u'Marathon Pharmaceuticals LLC', u'University of Western Australia', u'University of Missouri', u\"Charley's Fund Inc\", u'University of California at Berkeley', u'CRISPR Therapeutics', u'Collgard Biopharmaceuticals Inc', u'Northwestern University', u'Actelion Ltd', u'Servier', u'National Institutes of Health', u'Food and Drug Administration', u'Parent Project Muscular Dystrophy', u'Duchenne Parent Project', u'Bristol-Myers Squibb Co', u'Joining Jack', u'Sanofi Genzyme', u'American Cyanamid Co', u'Cedars-Sinai Medical Center', u'Ethicor Pharma Ltd', u'Summit Therapeutics plc', u'Save Our Sons', u'Anagenesis Biotechnologies', u'Centre Hospitalier Universitaire De Quebec', u'ActiGraph', u\"Children's National Health System\", u'Merck Serono SA', u'Halo Therapeutics LLC', u'FDA Office of Orphan Products Development', u'Synthena AG', u'Idera Pharmaceuticals Inc', u'University of Bern', u'Phylogica Ltd', u'Prothelia Inc', u'Tivorsan Pharmaceuticals Inc']), u'RossRivervirusinfection': set([u'Nanotherapeutics Inc', u'Baxter International Inc']), u'Nervoussysteminflammation': set([u'Clinical Data Inc', u'CrystalGenomics Inc', u'AC Immune SA', u'DevCo Pharmaceuticals Ltd', u'Eisai Co Ltd', u'University of Dundee', u'Ultrafine Chemicals Ltd', u'Essex Bio-Technology Ltd', u'Undisclosed', u'PAION AG', u'Tonghua Dongbao Pharmaceutical Co Ltd', u'University College London', u'Vernalis plc', u'Corbin Therapeutics Inc', u'Takeda Oncology', u'Louisiana State University', u'University of Virginia', u'MegaPharm Ltd', u'Boehringer Ingelheim Corp', u'Exelgen Ltd', u'Swedish Orphan Biovitrum AB', u'St Charles Pharmaceuticals Inc']), u'Lactationdisorder': set([u'Wyeth-Ayerst Pharmaceuticals Inc', u'Farmitalia Carlo Erba Srl']), u'Mentaldeficiency': set([u'Orexo AB', u'Argolyn Bioscience Inc', u'Inflazyme Pharmaceuticals', u'Greenwood Genetic Center Inc']), u'Enterococc': set([u'Kyowa Hakko Bio Co Ltd', u'Daiichi Sankyo Co Ltd']), u'Hypoalbuminemia': set([u'Benesis Corp', u'Mitsubishi Tanabe Pharma Corp', u'The Green Cross Corp', u'Asahi Kasei Corp']), u'Leukoplakia': set([u'Stiefel', u'DUSA Pharmaceuticals Inc', u'National Institutes of Health', u'National Cancer Institute', u'Bayer Schering Pharma AG']), u'Zygomyceteinfection': set([u'F Hoffmann-La Roche AG', u'Unimedic AB', u'Basilea Pharmaceutica International Ltd']), u'Lecithincholesterolacetyltransferasedeficiency': set([u'National Heart Lung and Blood Institute', u'Advanced BioScience Laboratories Inc', u'National Center For Advancing Translational Sciences', u'AlphaCore Pharma LLC']), u'Peanuthypersensitivity': set([u'Alfacyte Ltd', u'Monash University', u'National Health and Medical Research Council', u'National Center for Complementary and Alternative Medicine', u'Allertein Therapeutics Llc', u'Tunitas Therapeutics Inc', u'Nestle Health Science', u'Stanford University', u'Astellas Pharma Inc', u'US Government', u'AnaptysBio Inc', u'Alfred Health', u'Aimmune Therapeutics Inc', u'Duke University', u'Benaroya Research Center at Virginia Mason', u'Immunomic Therapeutics Inc', u'National Institute of Allergy and Infectious Diseases', u'Northwestern University', u'Mount Sinai School of Medicine', u'Scottish Enterprise', u'Stallergenes Greer plc']), u'Lacrimalglanddisease': set([u'Alcon Inc', u'University of North Carolina', u'Evolutec Group plc', u'NPS Pharmaceuticals Inc', u'Croma Pharma GmbH', u'Senju Pharmaceutical Co Ltd', u'Samil Pharmaceutical Co Ltd', u'Merck & Co Inc', u'Santen Pharmaceutical Co Ltd', u'Tanabe Seiyaku Co Ltd', u'MGI Pharma Inc', u'Astellas Pharma Inc', u'Taejoon Pharm Co Ltd', u'Sirion Therapeutics Inc', u'Fovea Pharmaceuticals SA', u'MegaPharm Ltd', u'Cambrex Corp', u'Kissei Pharmaceutical Co Ltd', u'Kuhnil Pharmaceutical Co Ltd', u'Sankyo Co Ltd', u'Allergan Inc', u'Inspire Pharmaceuticals Inc', u'Laboratorios Sophia', u'CIBA Vision Corp', u'Zalicus Inc']), u'HepatitisDvirusinfection': set([u'Hepatera LLC', u'Janssen Pharmaceutica NV', u'MYR GmbH', u'SomaGenics Inc', u'The Australian National University', u'Bristol-Myers Squibb Co', u'University of Heidelberg', u'Eiger BioPharmaceuticals Inc', u'CN Bio Innovations Ltd', u'Merck Sharp & Dohme Corp', u'National Institute of Allergy and Infectious Diseases', u'BioDiem Ltd', u'University of Canberra']), u'Portwinestain': set([u'University of California Irvine', u'National Center for Research Resources']), u'Herpetickeratitis': set([u'Alcon Inc', u'Editas Medicine Inc', u'RPS Diagnostics', u'University of Wisconsin-Madison', u'OPKO Health Inc', u'Acuity Pharmaceuticals', u'Fox Chase Chemical Diversity Center Inc', u'Calmune Corp', u'Sirion Therapeutics Inc', u'Redox Pharmaceutical Corp', u'VIRAZE', u'National Institute of Allergy and Infectious Diseases', u'NicOx SA', u'Pathogenics Inc', u'Bausch & Lomb Inc', u'NanoViricides Inc', u'RiboVax Biotechnologies SA']), u'Liverinjury': set([u'Unitech Pharmaceuticals Inc', u'InSphero AG', u'National Cancer Institute', u'Ventria Bioscience', u\"Brigham & Women's Hospital\", u'Undisclosed', u'University of Colorado at Denver and Health Sciences Center', u'Gentris Corp', u'Pfizer Inc', u'Rocky Mountain Poison and Drug Center', u'National Science Foundation', u'Yale University', u'Hepregen Corp', u'Syntimmune Inc', u'Mallinckrodt plc', u'Dong-A ST Co Ltd', u'Shanghai Institutes of Preventative Medicine', u'Tobira Therapeutics Inc']), u'Uterinecervix': set([u'Mateon Therapeutics Inc', u'Bristol-Myers Squibb Co']), u'Toxicity': set([u'US Government', u'Molecular Targeting Technologies Inc', u'Cytopathfinder Inc', u'SpePharm Holding BV', u'Institute of Pharmacology and Toxicology Academy of Military Medical Sciences PLA', u'European Commission', u'Lynx Therapeutics GmbH', u'Applied Biosystems', u'Asuragen Inc', u'BTG plc', u'Zhejiang Hisun Pharmaceutical Co Ltd', u'Cleveland BioLabs Inc', u'University of Washington', u'Clinigen Group plc', u'Walter Reed Army Institute of Research', u'National Science Foundation', u'The National Institute of Mental Health', u'Paladin Labs Inc', u'University of Arkansas', u'US Department of Defense', u'National Center For Advancing Translational Sciences', u'Thomas Jefferson University', u'Advinus Therapeutics Ltd', u'Large Scale Biology Corp', u'Baxter Oncology GmbH', u'Abbott Laboratories', u'US Army Research Office', u'Cumberland Pharmaceuticals Inc', u'US Environmental Protection Agency', u'Original BioMedicals Co Ltd', u'National Cancer Institute', u'Clinuvel Pharmaceuticals Ltd', u'Teva Pharmaceutical Industries Ltd', u'University of Alabama at Birmingham', u'MicroPharm Ltd', u'Iconix Biosciences Inc', u'GlaxoSmithKline plc', u'Southern Illinois University School Of Medicine', u'ALZA Corp', u'Cleveland Clinic Foundation', u'Adolor Corp', u'Ohr Pharmaceutical Inc', u'Amplyx Pharmaceuticals Inc', u'UAB Research Foundation', u'Gem Pharmaceuticals LLC', u'Medesis Pharma SA', u'University of California San Diego', u'Compugen Ltd', u'Terapio Corp', u'Dura Pharmaceuticals Inc', u'Xenon Pharmaceuticals Inc', u'Biobide SL', u'Institute For Hepatitis & Virus Research', u'Biocodex USA', u'National Institute of Neurological Disorders and Stroke', u'Visikol', u'Ministry of Economic Affairs, ROC', u'Yissum Research Development Co', u'Medimmune Oncology Inc', u'Andrx Corp', u'InterveXion Therapeutics LLC', u'Gilead Pharmasset LLC', u'CLL Pharma', u'Callisto Pharmaceuticals Inc', u'Ebewe Pharma Gesmbh Nfg KG', u'Smartox Biotechnology', u'SurModics Pharmaceuticals', u'Advanced Viral Research Corp', u'Undisclosed', u'National Institute on Drug Abuse', u'Vivalis', u'Medical College of Wisconsin', u'Medison Pharma Ltd', u'Eli Lilly & Co', u'Altimmune Inc', u'Synt:em', u'Beijing Institute of Pharmacology and Toxicology', u'Commissariat a l`Energie Atomique', u'LION bioscience Inc', u'BioFactura Inc', u'Inotek Pharmaceuticals Corp', u'National Institute Of Environmental Health Sciences', u'HD Biosciences', u'Pfizer Inc', u'Tego BioSciences Corp', u'Intarcia Therapeutics Inc', u'Symberix LLC', u'Human Genome Sciences Inc', u'University of Utah', u'Critical Path Institute', u'University of Illinois', u'Atox Bio Inc', u'BioSeek LLC', u'BioResearch Ireland', u'Cytodesign Inc', u'UK Government', u'Rubicon Biotechnology Inc', u'Luxcel Biosciences Ltd', u'ASTA Medica AG', u'National Institute of Allergy and Infectious Diseases', u'BL&H Co Ltd', u'Protherics plc', u'Albert Einstein College of Medicine', u'National Institutes of Health', u'Wellstat Therapeutics Corp', u'Medicago Inc', u'BioImagene Inc', u'Quark Pharmaceuticals Inc', u'The New Energy and Industrial Technology Development Organization', u'Neurion Pharmaceuticals Inc', u'Merck Serono SA', u'Phylogix Inc', u'21st Century Therapeutics Inc', u'Biologics Inc', u'Cyprotex Plc', u'Takeda Pharmaceutical Co Ltd', u'TopoTarget A/S', u'BioNumerik Pharmaceuticals Inc', u'BASF AG', u'Sichuan New Phiaring Bio-medical Science', u'Defense Threat Reduction Agency']), u'Uveitis': set([u'Alcon Inc', u'Ludwig-Maximilians University of Munich', u'Janssen-Cilag Ltd', u'Servier', u'US Government', u'Apexigen Inc', u'Artielle ImmunoTherapeutics Inc', u'PDL BioPharma Inc', u'Merrimack Pharmaceuticals Inc', u'Sociedade Beneficente Israelita Brasileira Hospital Albert Einsten', u'University of Oxford', u'Xian-Janssen Pharmaceutical Ltd', u'Aciont Inc', u'European Commission', u'Pharmos Corp', u'McGill University', u'4SC Discovery GmbH', u'Atrium Medical Corp', u'iVeena LLC', u'Allergan plc', u'Juvenile Diabetes Research Foundation', u'Novartis AG', u'Milstein Medical Asian American Partnership Foundation', u'National Institutes of Health', u'XOMA Corp', u'Isotechnika Pharma Inc', u'MacuSight Inc', u'Fujisawa Pharmaceutical Co Ltd', u'pSivida Corp', u'French Government', u'Merck & Co Inc', u'Apitope Technology (Bristol) Ltd', u'rEVO Biologics Inc', u'Laboratorios Sophia', u'Tanabe Seiyaku Co Ltd', u'Chong Kun Dang Pharmaceutical Corp', u'Biomedical Primate Research Centre', u'Bonac Corp', u'Virogenomics Inc', u'Celltrion Inc', u'TxCell SA', u'CHU De Nantes', u'Eyegate Pharmaceuticals Inc', u'Roche Holding AG', u'Oregon Health Sciences University', u'Sirion Therapeutics Inc', u'Santen Pharmaceutical Co Ltd', u'Panoptes Pharma Ges.m.b.H', u'Tianjin Medical University Eye Hospital', u'Can-Fite BioPharma Ltd', u'Hokkaido University Graduate School of Medicine', u'Cambrex Corp', u'RespiVert Ltd', u'National Eye Institute', u'Janssen Biotech Inc', u'Enzo Biochem Inc', u'Sucampo Pharmaceuticals Inc', u'Inotek Pharmaceuticals Corp', u'Effimune SA', u'pSivida Inc', u'Boehringer Ingelheim Corp', u'Anvil Biosciences LLC', u'AutoImmune Inc', u'Oculex Pharmaceuticals Inc', u'Valeant Pharmaceuticals International Inc', u'Senju Pharmaceutical Co Ltd', u'University of Utah', u'Beth Israel Deaconess Medical Center', u'E and B Technologies Llc', u'Kern Pharma SL', u'Glasgow Caledonian University', u'Eleven Biotherapeutics Inc', u'Institute for the Promotion of Innovation by Science and Technology in Flanders', u'F Hoffmann-La Roche AG', u'Bausch & Lomb Inc', u'University of Aberdeen', u'13Therapeutics Inc', u'Topivert Pharma Ltd']), u'GM1gangliosidosis': set([u'University of Massachusetts Medical School', u'Brammer Biopharmaceuticals LLC', u'LYSOGENE', u'Auburn University']), u'Contraception': set([u'Agile Therapeutics Inc', u'Lumara Health Inc', u'TTK Healthcare Ltd', u'Instituto Biochimico Ltda', u'MSD OSS BV', u'Mylan Inc', u'Grunenthal GmbH', u'Corium International Inc', u'National Institute of Allergy and Infectious Diseases', u'Glenmark Pharmaceuticals Ltd', u'ASKA Pharmaceutical Co Ltd', u'Famy Care Ltd', u'Biotech Australia', u'Actavis Inc', u'Chiesi Farmaceutici SpA', u'Organon (Ireland) Ltd', u'National Institutes of Health', u'SRI International', u'Bayer Inc', u'Ligand Pharmaceuticals Inc', u'HRA Pharma', u'Futura Medical plc', u'Cedars-Sinai Medical Center', u'Okamoto Industries', u'SSL International Plc', u'Shenyang Sky and Land Latex', u'Monash University', u'Buckman Laboratories International, Inc', u'FAES Farma SA', u'Uteron Pharma S.A.', u'Evestra Inc', u'Acrux Ltd', u'Sosei Group Corp', u'Virginia Polytechnic Institute and State University', u'Barr Pharmaceuticals Inc', u'Starpharma Holdings Ltd', u'Donesta Bioscience Bv', u'Mithra Pharmaceuticals', u'Warner Chilcott plc', u'Zhejiang Xianju Pharmaceutical Corp Ltd', u'ANI Pharmaceuticals Inc', u'Prasco Laboratories', u'Janssen Pharmaceuticals Inc', u'Amneal Pharmaceutical LLC', u'Pfizer Inc', u'Koushan Pharmed', u'Lupin Ltd', u'Gedeon Richter Ltd', u'Watson Laboratories Inc', u'Wake Forest University', u'Fuji Pharma Co Ltd', u'Pantarhei Bioscience BV']), u'Pepticulcer': set([u'Byk-Gulden SA (Pty) Ltd', u'Takeda GmbH', u'Marathon Pharmaceuticals LLC', u'Andrx Corp', u'Valeant Pharmaceuticals North America LLC', u'Daiichi Sankyo Co Ltd', u'Abbott Laboratories', u'Eisai Co Ltd', u'Hokuriku Seiyaku KK', u'Il-Yang Pharmaceutical Co', u'Takeda Pharmaceutical Co Ltd', u'Merck KGaA', u'Salix Pharmaceuticals Ltd', u'Shionogi USA Inc', u'Nippon Chemiphar Co Ltd', u'Daewoong Pharmaceutical Co Ltd', u'Merck & Co Inc', u'bioMerieux Vitek Inc', u'Sanofi', u'Eli Lilly & Co', u'Salix Pharmaceuticals Inc', u'The Procter & Gamble Co', u'Mitsubishi-Tokyo Pharmaceuticals Inc', u'Teva Takeda Yakuhin Ltd', u'Astellas Pharma Inc', u'PLIVA dd', u'Kyorin Pharmaceutical Co Ltd', u'Mitsubishi Tanabe Pharma Corp', u'JW Pharmaceutical Corp', u'Acambis Inc', u'Pharmacia & Upjohn Inc', u'Glaxo Group Ltd', u'GE Healthcare', u'Biomerica Inc', u'Janssen Pharmaceutica NV', u'AstraZeneca plc', u'Pfizer Inc', u'Boehringer Ingelheim Corp', u'Aptalis Pharma Inc', u'Cumberland Pharmaceuticals Inc', u'Pernix Therapeutics Holdings Inc', u'Sandoz Inc', u'University of Zagreb', u'Casper Pharma LLC', u'Sigma-Tau Ind Farm Riunite SpA']), u'Verrucavulgaris': set([u'Texas Emerging Technology Fund', u'Henderson Morley plc', u'Polypeptide Laboratories AB (SWEDEN)', u'DUSA Pharmaceuticals Inc', u'University of Aberdeen', u'Bayer Schering Pharma AG', u'Cure Medical Manufacturing', u'National Institutes of Health', u'Cirrus Pharmaceutical Co', u'Helix BioPharma Corp', u'MedPharm Ltd', u'The Althea Foundation', u'Burke Pharmaceuticals LLC', u'Cutanea Life Sciences Inc', u'Hamlet Pharma AB', u'Allergan Inc', u'Peplin Inc', u'Stiefel', u'Santalis Healthcare Corporation', u'Kyowa Kirin', u'Biomas Inc', u'Aclaris Therapeutics Inc', u'Hapten Pharmaceuticals Llc', u'Peroxychem Llc', u'Berlex Laboratories Inc', u'RXi Pharmaceuticals Corp']), u'Adrenalcorticalcarcinoma': set([u'US Government', u'National Cancer Institute', u'Pfizer Inc', u'MD Anderson Cancer Center', u'Millendo Therapeutics Inc', u'Uppsala University', u'Bristol-Myers Squibb Co', u'Orphagen Pharmaceuticals Inc', u'OnTarget Chemistry AB', u'HRA Pharma', u'Abgenix Inc', u'University of Michigan Comprehensive Cancer Center']), u'Brainhypoxia-ischemia': set([u'Cato Research Ltd', u'ProThera Biologics LLC', u'National Institute of Neurological Disorders and Stroke', u'Chiesi Farmaceutici SpA', u'NeuroproteXeon', u'Theraptosis']), u'Posttraumaticstressdisorder': set([u'kDAC Therapeutics', u'University of Houston', u'Biotie Therapies AG', u'Turing Pharmaceuticals LLC', u'Azevan Pharmaceuticals Inc', u'Mitsubishi Pharma Corp', u'US Army Medical Materiel Development Activity', u'Marinus Pharmaceuticals Inc', u'Harvard University', u'Intra-Cellular Therapies Inc', u'Allegiance Equity Corp', u'GlaxoSmithKline plc', u'Tikvah Therapeutics Inc', u'Vanda Pharmaceuticals Inc', u'Cohen Veterans Bioscience', u'Premier Biomedical Inc', u'US Department of Veterans Affairs', u'PsychoGenics Inc', u'Chronos Therapeutics', u'Cannabis Science Inc', u'Western Maryland Health System (WMHS)', u'Scripps Research Institute', u'Myungin Pharm Co Ltd', u'Marina Biotech Inc', u'Blanchette Rockefeller Neurosciences Institute (BRNI)', u'Resilience Therapeutics Inc', u'Siegfried Holding Ltd', u'Medtronic plc', u'Therapade Technologies LLC', u'Eli Lilly & Co', u'University of Miami', u'Apotex Inc', u'Quintiles Transnational Corp', u'Shire plc', u'NeurOp Inc', u'University of California Irvine', u'Panaxia Pharmaceutical Industries Ltd', u'The National Institute of Mental Health', u'The Unconventional Foundation for Autism', u'William Beaumont Army Medical Center', u'University of Western Ontario', u'Tonix Pharmaceuticals Holding Corp', u'Algae Dynamics Corp', u'Peak Harvest Health', u'Emory University', u'US Department of Defense', u'Intrust, Post-traumatic Stress Disorder and Traumatic Brain Injury Clinical Consortium', u'Stanford University School of Medicine', u'Nobilis Therapeutics LLC', u'Broad Institute Inc']), u'Gestationaldiabetes': set([u'DiabetOmics Llc', u'Johnson & Johnson', u'Agency For Science Technology & Research', u'MaRS Innovation', u'TBG Diagnostics Ltd', u'MiRXES Pte Ltd', u'Janssen Human Microbiome Institute', u'BD Technologies', u'Beta Therapeutics Pty Ltd', u'DayTwo Ltd', u'Disease Interception Accelerator']), u'Acutelymphoblasticleukemia': set([u'University of Medicine and Dentistry of New Jersey', u'Servier', u'US Government', u'National Comprehensive Cancer Network', u'The Leukemia & Lymphoma Society', u'Transcept Pharmaceuticals Inc', u'Baxter International Inc', u'Orphan Europe SARL', u'Alize Pharma II SAS', u'Adaptive Biotechnologies Corp', u'Bellicum Pharmaceuticals Inc', u'GlaxoSmithKline plc', u'BTG plc', u'Universit\\xe9 De Rennes 1', u'LINK Healthcare Pte Ltd', u'MedImmune LLC', u'Astex Pharmaceuticals Inc', u'Fred Hutchinson Cancer Research Center', u'Center for Biomarker Research in Medicine', u'Olon SpA', u'Theradex Systems Inc', u'University of British Columbia', u'ARIAD Pharmaceuticals Inc', u'Kite Pharma Inc', u'Specialised Therapeutics Australia Pty Ltd', u'KuDOS Pharmaceuticals Ltd', u'ERYtech Pharma', u'Rare Disease Therapeutics Inc', u'Dana-Farber Cancer Institute Inc', u'AnnaMed Inc', u'National Institute of General Medical Sciences', u'International Biotechnology Center Generium LLC', u'Inex Pharmaceuticals Corp', u'PDL BioPharma Inc', u'MD Anderson Cancer Center', u'Incyte Corp', u'Amgen Inc', u'Pfenex Inc', u'Daiichi Sankyo Co Ltd', u'Amarna Therapeutics BV', u'Dermin Spzoo', u'National Cancer Institute', u'Novartis AG', u\"Children's Oncology Group\", u'Medac GmbH', u'CryoPort Inc', u'Angelini Pharmaceuticals SpA', u'Enzon Pharmaceuticals Inc', u'University of Wurzburg', u'Goodwin Biotechnology Inc', u'Therapeutic Advances in Childhood Leukemia Consortium', u'Jazz Pharmaceuticals plc', u'Peking University Institute of Hematology', u'Robert H Lurie Cancer Center', u'Micromet Inc', u'University of Southern California', u'CytRx Corp', u'Johns Hopkins University', u'University of California San Diego', u'Juno Therapeutics Inc', u'Wacker Biotech GmbH', u'Sigma-Tau Ind Farm Riunite SpA', u'Ospedale Pediatrico Bambino Ges\\xf9 (IRCCS)', u'Talon Therapeutics Inc', u'ILEX Oncology Inc', u'Health Protection Agency', u'Cancer Research UK', u'Stanford University', u'Paladin Labs Inc', u'Otsuka Pharmaceutical Co Ltd', u'Universita di Bologna', u'Apexian Pharmaceuticals Inc', u'Oxford BioMedica plc', u'Callisto Pharmaceuticals Inc', u'Epizyme Inc', u'william lawrence and blanche hughes foundation', u'Oregon Health Sciences University', u'University of California', u'Merck & Co Inc', u'Regenacy Pharmaceuticals LLC', u'Sanofi', u'International BFM Study Group', u'Eli Lilly & Co', u'MolecularMD Corp', u'Spectrum Pharmaceuticals Inc', u'Only For Children Pharmaceuticals', u'AAIPharma Services Corp', u'Princeton University', u'Syntrix Biosystems Inc', u'Pfizer Inc', u'Rhizen Pharmaceuticals SA', u'Triangle Pharmaceuticals Inc', u'Vertex Pharmaceuticals Inc', u\"St Jude Children's Research Hospital\", u'Ohara Pharmaceutical Co Ltd', u'AbbVie Inc', u'Genmab A/S', u'myTomorrows', u'Takeda Pharmaceutical Co Ltd', u'Pfanstiehl Laboratories Inc', u'EUSA Pharma USA', u'Lonza Group AG', u'Milstein Medical Asian American Partnership Foundation', u'National Institutes of Health', u'Mateon Therapeutics Inc', u'Bristol-Myers Squibb Co', u'Elan Corp plc', u'Opus Bio Inc', u'Moleculin Biotech Inc', u'Ohio State University', u'Aronex Pharmaceuticals Inc', u'Celgene Corp', u'OncoVista Innovative Therapies Inc', u'Karyopharm Therapeutics Inc', u'Incozen Therapeutics Pvt Ltd', u'Huntsman Cancer Institute', u\"Brigham & Women's Hospital\", u'Aventis Pharma SA', u'XL-Protein GmbH', u'MannKind Corp', u'Biologix FZ Co', u'OPi SA', u'Bioenvision Inc', u'ORBONA Pharma Ltd', u'Rhone-Poulenc Rorer Inc', u'Pint Pharma', u'Tragen Pharmaceuticals', u'Nova Laboratories Ltd']), u'Vertigo': set([u'Castle Creek Pharmaceuticals LLC', u'Hennig Arzneimittel GmbH', u'Sensorion Pharmaceuticals', u'Palau Pharma SA', u'Chelsea Therapeutics International Ltd', u'French Government', u'Synergia Pharma Inc']), u'Hormonerefractoryprostatecancer': set([u'Providence Portland Medical Center', u'US Government', u'Prostate Cancer Foundation', u'Kirin Brewery Co Ltd', u'Selexel', u'China State Institute of Pharmaceutical Industry', u'Essa Pharma Inc', u'Onxeo SA', u'GlaxoSmithKline plc', u'VolitionRX Ltd', u'Bayer Schering Pharma AG', u'Biotoscana International', u'Medivation Inc', u'Ipsen', u'University of Tennessee', u'Vanderbilt University', u'Veristat, Inc.', u'Bellicum Pharmaceuticals Inc', u'University of Texas Health Science Center Houston', u'Ontario Institute for Cancer Research', u'ARIAD Pharmaceuticals Inc', u'Aranda Pharma Ltd', u'Attogen Inc', u'TESARO Inc', u'Orion Corporation', u'Bayer HealthCare AG', u'Technology Strategy Board', u'University of Central Florida', u'Fortis Therapeutics Inc', u'Novus Therapeutics Inc', u'Active Biotech AB', u'MD Anderson Cancer Center', u'Tarrex Biopharma', u'Innocrin Pharmaceuticals Inc', u'Endo Health Solutions Inc', u'Ohio State University', u'Tallikut Pharmaceuticals Inc', u'TransGenex Nanobiotech Inc', u'Drexel University', u'DNA Chip Research', u'GTx Inc', u'National Cancer Institute', u'Clovis Oncology Inc', u'Tempus Inc', u'NeoPharm Inc', u'Fujisawa Pharmaceutical Co Ltd', u'Poniard Pharmaceuticals Inc', u'Georgetown University Medical Center', u'Ewopharma AG', u'University of California San Francisco', u'Astellas Pharma Inc', u'WuXi PharmaTech (Cayman) Inc', u'Dendreon Corp', u'Morehouse School Of Medicine', u'Wellcome Trust', u'Scripps Research Institute', u'Immune Response BioPharma Inc', u'Genomic Health Inc', u'Millennium Pharmaceuticals Ltd', u'Prostate Cancer Clinical Trials Consortium', u'CytRx Corp', u'US Health and Human Services Department', u'Gloucester Pharmaceuticals Inc', u'Mayo Clinic Foundation', u'Strata Oncology', u'Algeta ASA', u'Integrated Oncology Solutions Inc', u'Emergent BioSolutions Inc', u'Veru Inc', u'Merck & Co Inc', u'French Government', u'Ascentage Pharma Group Corporation Ltd', u'The Salk Institute for Biological Studies', u'CTI BioPharma Corp', u'Eli Lilly & Co', u'National Institute on Minority Health and Health Disparities', u'University of Wisconsin-Madison', u'Pierre Fabre SA', u'Janssen Inc', u'HemaCare Corp', u'Kyowa Hakko Kirin Co Ltd', u'Madrigal Pharmaceuticals Inc', u'AEterna Zentaris Inc', u'Princeton University', u'Madison Vaccines Inc', u'AstraZeneca plc', u'Akzo Nobel NV', u'Cadila Pharmaceuticals Ltd', u'University of Maryland', u'Context Therapeutics LLC', u'Memorial Sloan-Kettering Cancer Center', u'Harbor Therapeutics Inc', u'H Lee Moffitt Cancer Center and Research Institute', u'BZL Biologics Inc', u'Eisai Co Ltd', u'Northwestern University', u'Lantern Pharma', u'California Institute for Biomedical Research', u'National Institutes of Health', u'Epic Sciences Inc', u'Oncolys BioPharma Inc', u'Novavax Inc', u'Bristol-Myers Squibb Co', u'MorphoSys AG', u'Aduro BioTech Inc', u'Cedars-Sinai Medical Center', u'Fujifilm Diosynth Biotechnologies', u'JYANT Technologies Inc', u'Cornell University', u'Valeant Pharmaceuticals International Inc', u'National Institute of Biomedical Imaging and Bioengineering', u'Ascenta Therapeutics Inc', u'Sanpower Group Co Ltd', u'Jubilant Life Sciences Ltd', u'Ferring Research Ltd', u'Biologics Inc', u'Takeda Pharmaceutical Co Ltd', u'Cancer Prevention and Research Institute of Texas', u'CellCentric Ltd', u'Norris Comprehensive Cancer Center']), u'Lymphoidleukemia': set([u'BC Cancer Foundation', u'Canadian Institutes of Health Research', u'Lin Bioscience Inc', u'Genome Canada', u'University of California Davis', u'National Cancer Institute', u'BC Cancer Agency', u'Sirion Gmbh', u'Helmholtz Zentrum M\\xfcnchen', u'Columbia University']), u'Geneticdisorder': set([u'Regeneron Pharmaceuticals Inc', u'X4 Pharmaceuticals Inc', u'Baxter International Inc', u'Orchard Therapeutics', u'Aevi Genomic Medicine Inc', u'Human Longevity Inc', u'Biogen Inc', u'Life Technologies Corp', u'GlaxoSmithKline plc', u'Asuragen Inc', u'Congenica Ltd', u'Astex Pharmaceuticals Inc', u'University of Washington', u'nLife Therapeutics SL', u'Imaxio', u'Genomeon LLC', u'Shire plc', u'NantHealth Inc', u'Center for iPS Cells Research and Application', u'Cellectis SA', u'Solvay Pharmaceuticals Inc', u'WaVe Life Sciences Ltd', u'Sage Bionetworks', u'Canadian Institutes of Health Research', u'Scotia Pharmaceuticals', u'National Heart Lung and Blood Institute', u'REGENXBIO Inc', u'Alnylam Pharmaceuticals Inc', u'UCB SA', u'Ultragenyx Pharmaceutical Inc', u'University of Massachusetts Medical School', u'Repligen Corp', u'National Center For Advancing Translational Sciences', u'Recursion Pharmaceuticals LLC', u'Weill Medical College of Cornell University', u'Regenacy Pharmaceuticals LLC', u'Good Start Genetics Inc', u'ValiGen Inc', u'Mount Sinai School of Medicine', u'Somatix Therapy Corp', u'Cloud Pharmaceuticals Inc', u'Acetylon Pharmaceuticals Inc', u'National Cancer Institute', u'Novartis AG', u'X-Chem Inc', u'Darui Biotechnology Co Ltd', u'University of California San Diego', u'PharmaCell', u'Teva Pharmaceutical Industries Ltd', u'Agence Nationale de Valorisation de la Recherche', u'Catholic University of Leuven', u'Massachusetts General Hospital', u'Medical Research Council', u'RIKEN', u'Transgene SA', u'Ethris GmbH', u'OPKO Health Inc', u'Agena Bioscience Inc', u'Counsyl Inc', u'Roche Diagnostics', u'AllCells LLC', u'McGill University', u'2bPrecise LLC', u'AMO Pharma Ltd', u'Sema4', u'PTC Therapeutics Inc', u'Childrens Hospital of Eastern Ontario (CHEO)', u'University of Oxford', u'Continuum Analytics', u'National Center for Accelerating Translational Sciences', u'National Institute of Neurological Disorders and Stroke', u'French Muscular Dystrophy Association', u'Agilent Technologies Inc', u'Mayo Clinic Foundation', u'Alexion Pharmaceuticals Inc', u'arGEN-X NV', u'Yale University', u'Fulcrum Therapeutics', u'Oxford BioMedica plc', u'Laureate Biopharmaceutical Services Inc', u'Dysautonomia Foundation Inc', u'Onconova Therapeutics Inc', u'Undisclosed', u'University of Texas Southwestern Medical Center', u\"Rady Children's Hospital\", u'Dr Falk Pharma GmbH', u'bluebird bio Inc', u'BD Technologies', u'MolMed SpA', u'NSW Government', u'New York State Stem Cell Science', u'Sharp Edge Labs', u'AstraZeneca plc', u'Pfizer Inc', u'ORIG3N Inc', u'Caladrius Biosciences Inc', u'Spark Therapeutics LLC', u'National Taiwan University', u'Vertex Pharmaceuticals Inc', u'Daan Gene Co Ltd of Sun Yat-Sen University', u'Edico Genome Corp', u'Mount Sinai Medical Center', u'Fondazione Telethon', u'LG Life Sciences Ltd', u'RaNeDis Pharmaceuticals', u'Enobia Pharma Inc', u'Whitehead Institute for Biomedical Research', u'Sydney Childrens Hospital', u'Clal Biotechnology Industries Ltd', u'Horizon Discovery Group plc', u'CRISPR Therapeutics', u'T-Top Clinical Research Co Ltd', u'Editas Medicine Inc', u'Lonza Group AG', u'Blueprint Medicines Corp', u'National Institutes of Health', u'Massachusetts Eye & Ear Infirmary', u'Agilis Biotherapeutics LLC', u'University of Utah', u'Sanofi Genzyme', u'Proteostasis Therapeutics Inc', u'Thomas Jefferson University', u'University of London', u'Catholic Medical Center', u'Imperial College London', u'Astellas Pharma Inc', u'BioAxone Biosciences Inc', u'Synlab Services Gmbh', u'Fabric Genomics', u'Axxam SpA', u'Warren Pharmaceuticals Inc', u'Childrens Hospital of Philadelphia', u'Selecta Biosciences Inc', u'Leadiant Biosciences Inc', u'Edico Genome Inc', u'Quadrant Technologies Ltd', u'North Shore Long Island Jewish Health System', u'Takeda Pharmaceutical Co Ltd', u'Genome Medical Inc', u'Sentieon Inc', u'Centre Ren\\xe9 Huguenin', u'University of Cambridge']), u'Kidneytransplantrejection': set([u'Janssen-Cilag Ltd', u'LG Life Sciences Ltd', u'Genentech Inc', u'The University of Newcastle Upon Tyne', u'Rabin Medical Center', u'Medarex Inc', u'Astellas Pharma Global Development Inc', u'University of California San Francisco', u'National Institute of Diabetes, Digestive and Kidney Diseases', u'Biogen Inc', u'Taiba Pharma LLC', u'Universiteit Utrecht', u'Hillhurst Biopharmaceuticals Inc', u'Santarus Inc', u'Astellas Pharma Canada Inc', u'Lonza Group AG', u'Chiesi Farmaceutici SpA', u'Renovar Inc', u'Fujisawa Pharmaceutical Co Ltd', u'Institut Klinick\\xe9 a Experiment\\xe1ln\\xed Medicin', u'Veloxis Pharmaceuticals A/S', u'Bristol-Myers Squibb Co', u'European Community', u'Diosynth BV', u'Novimmune SA', u'Opsona Therapeutics Ltd', u'University of Alberta', u'Stanford University', u'Astellas Pharma Inc', u'Almac Diagnostics', u'Medeor Therapeutics Inc', u'Life Science and Health \\u2013 Topconsortium for Knowledge and Innovation Foundation', u'Euram Ltd', u'ViveBio LLC', u'Silence Therapeutics plc', u'Catholic University of Leuven', u'University Medical Center Groningen', u'Natera Inc', u'Institut Investigaci\\xf3 Biom\\xe8dica Bellvitge', u'Novartis AG', u'Quark Pharmaceuticals Inc', u'Transplant Genomics', u'Human Genome Sciences Inc', u'Alnylam Pharmaceuticals Inc', u'Hikma Pharmaceuticals plc', u'Rosetta Genomics Ltd', u'Pharming Group NV', u'Sanofi Chimie SA', u\"King's College London\"]), u'Carbohydratemetabolismdisorder': set([u'Guangdong Zhongsheng Pharmaceutical Co Ltd', u'Orphan Medical Inc', u'Sichuan University', u'QOL Medical']), u'Polycythemia': set([u'ChronTech Pharma AB', u'Swedish Orphan AB']), u'HumanTcellleukemiavirus1infection': set([u'National Institutes of Health', u'Bioniz Therapeutics Inc', u'Merck & Co Inc', u'Medicines Patent Pool']), u'Hantavirusinfection': set([u'Inovio Pharmaceuticals Inc', u'US Department of Defense', u'Albert Einstein College of Medicine', u'US Army Medical Research Institute of Infectious Diseases', u'SAB Biotherapeutics Inc', u'Navigen Inc', u'Pierre Fabre SA', u'Orexo AB', u'The Geneva Foundation', u'European Commission', u'Rega Institute for Medical Research', u'National Institute of Allergy and Infectious Diseases', u'Eurocine Vaccines AB']), u'GuillainBarresyndrome': set([u'Weizmann Institute of Science', u'Neurorecovery Inc', u'Merck Serono SA', u'Food and Drug Administration']), u'Fatigue': set([u'Roussel Uclaf Corp', u'PhytoHealth Corp', u'Pharmagenesis Inc', u'MD Anderson Cancer Center', u'Hoffmann-La Roche AG', u'Prodotti Formenti Srl', u'SmithKline Beecham Corp', u'Abbott Laboratories', u'US Government', u'Eisai Co Ltd', u'Bago', u'Amarin Corp plc', u'Targacept Inc', u'Lundbeck Italia SpA', u'Merck KGaA', u'MultiCell Technologies Inc', u'Undisclosed', u'Dartmouth College', u'Perelman School of Medicine', u'University of South Florida', u'Tanabe Seiyaku Co Ltd', u'Crescendo Pharmaceuticals Corp', u'ALZA Corp', u'Glaxo Group Ltd', u'Layton Bioscience Inc', u'Helsinn Healthcare SA', u'Clinical Development & Support Services Ltd', u'National Institute on Aging', u'University of California San Francisco', u'Laboratoires Houde SA', u'Patient Centered Outcome Research Institute', u'Parke-Davis & Co', u'Bentley Pharmaceuticals Inc', u'Sigma-Tau Ind Farm Riunite SpA']), u'Lipodystrophy': set([u'University of California San Diego School of Medicine', u'US Government', u'Ionis Pharmaceuticals Inc', u'Shionogi & Co Ltd', u'Hybrigenics SA', u'Bolder BioTechnology Inc', u'Bioject Medical Technologies Inc', u'Emmaus Medical Inc', u'Amylin Pharmaceuticals Inc', u'National Institute of Diabetes, Digestive and Kidney Diseases', u'EMD Serono Inc', u'Lynx Therapeutics GmbH', u'TRC Capital Corporation', u'Merck Serono SA', u'Galmed Pharmaceuticals Ltd']), u'Uremia': set([u'Swedish Orphan Biovitrum AB', u'Hyperion Therapeutics Inc', u'Horizon Pharma plc', u'Valeant Pharmaceuticals International Inc']), u'Infertility': set([u\"Dr Reddy's Laboratories Ltd\", u'Karolinska Institutet', u'Wyeth-Ayerst International Inc', u'Serono Japan Co Ltd', u'The University of Hong Kong', u'Connetics Corp', u'Paladin Labs Inc', u'ASTA Medica AG', u'Biogen Inc (FL)', u'University of Michigan', u'Nippon Kayaku Co Ltd', u'Eisai Co Ltd', u'ASKA Pharmaceutical Co Ltd', u'Boehringer Mannheim GmbH', u'Cell Genesys Inc', u'Wayne State University School of Medicine', u'Universita\\' Degli Studi \"Magna Graecia\" Di Catanzaro', u'The Knut and Alice Wallenberg Foundation', u'Novartis AG', u'Johns Hopkins University School of Medicine', u'OvaScience Inc', u'University College Dublin', u'Michigan Translational Research and Commercialization', u'National Institutes of Health', u'Vitro Diagnostics Inc', u'Ipsen', u'Daewoong Pharmaceutical Co Ltd', u'Translational Technologies, Inc', u'Curis Inc', u'Massachusetts General Hospital', u'Wyeth-Ayerst Pharmaceuticals Inc', u'Alkermes plc', u'Novartis Pharma AG', u'Philochem AG', u'Biogen Idec Hemophilia Inc', u'UCB Celltech', u'CeNeS Pharmaceuticals plc', u'Genzyme Molecular Oncology', u'Iverson Genetic Diagnostics Inc', u'Alvogen Korea', u'Astrazeneca Korea', u'Celmatix Inc', u'AEterna Zentaris Inc', u'Merck Serono SA', u'University of Siena', u'Columbia Laboratories (Bermuda) Ltd', u'Reprogen Inc', u'Handok Inc', u'AstraZeneca plc', u'Akzo Nobel NV', u'Neurocrine Biosciences Inc', u'Corthera Inc', u'Torrent Pharmaceuticals Ltd', u'Zenyth Therapeutics Ltd', u'Trophogen Inc', u'Ferring Pharmaceuticals SA', u'Shionogi & Co Ltd', u'The First Affiliated Hospital of Zhengzhou University', u'EMD Serono Inc', u'Debiopharm SA', u'F H Faulding & Co Ltd', u'23andMe Inc']), u'Tissueadhesions': set([u'Nanotheta Co Ltd', u'Toray Industries Inc', u'Taiho Pharmaceutical Co Ltd', u'Promore Pharma', u'BioActive Polymers AB', u'PharmaResearch Products Co Ltd', u'Grunenthal GmbH', u'Moerae Matrix Inc', u'Technomark Life Sciences', u'Adhesys Medical GmbH', u'Sk\\xe5ne University Hospital', u'Lipopeptide AB', u'National Institute of General Medical Sciences']), u'Vasculardiseasebylocation': set([u'Undisclosed', u'Ace Laboratories Inc']), u'RNAvirusinfection': set([u'ViroPharma Inc', u'Chiroscience R&D Ltd', u'Fox Chase Chemical Diversity Center Inc', u'3-Dimensional Pharmaceuticals Inc', u'Sarepta Therapeutics Inc', u'National Institute of Allergy and Infectious Diseases', u'ArQule Inc', u'Oregon State University']), u'U': set([u'Celltrion Inc', u'Bristol-Myers Squibb Co']), u'UshersyndromeIII': set([u'Usher III Initiative Inc', u'BioFocus DPI']), u'Diabeticangiopathy': set([u'Glycadia Inc', u'National Institutes of Health']), u'Intracranialvasospasm': set([u'AzERx Inc', u'Purdue University', u'Vernalis Group plc', u'Capstone Therapeutics Corp', u'Roche Holding AG', u'DarPharma Inc']), u'Hematologicaldisease': set([u'Medical University of South Carolina', u'Novo Nordisk A/S', u'Asahi Kasei Corp', u'Baxter International Inc', u'Angiotech Pharmaceuticals Inc', u'Cerus Corp', u'OPi SA', u'Incyte Corp', u'Medline Industries Inc', u'Biogen Inc', u'University of Alabama', u'T2 Biosystems Inc', u'Soleno Therapeutics Inc', u'Hyseq Inc', u'Interferon Sciences Inc', u'Osaka International Cancer Institute', u'Seattle Genetics Inc', u'Ionis Pharmaceuticals Inc', u'HemoBioTech Inc', u'Calithera Biosciences', u'Merck Sharp & Dohme (Australia) Pty Ltd', u'University of Pittsburgh', u'University of Michigan', u'Lenetix Medical Screening Laboratory Inc', u'BPH Energy Ltd', u'NuvOx Pharma LLC', u'Apotex Inc', u'Aurelium BioPharma Inc', u'Stanford University', u'Kaketsuken', u'Vaccinex Inc', u'Orphagen Pharmaceuticals Inc', u'CryoLife Inc', u'Archerdx Inc', u'Celera South San Francisco', u'Daiichi Sankyo Europe GmbH', u'Asahi Kasei Pharma America Corp', u'Shionogi & Co Ltd', u'HanAll Biopharma Co Ltd', u'Alliance Pharma plc', u'National Heart Lung and Blood Institute', u'Schein Pharmaceutical Inc', u'Texas Tech University', u'Zymeworks Inc', u'Alnylam Pharmaceuticals Inc', u'Ribomic Inc', u'National Research Council of Canada', u'Sysmex Corp', u'Sequenom Inc', u'R-Health LLC', u'University of Minnesota', u'National Health and Medical Research Council', u'Charles River Laboratories International Inc', u'Ludwig Boltzmann Institute', u'PDL BioPharma Inc', u'Childrens Hospital Oakland Research Institute', u'Tufts University School of Medicine', u'Amgen Inc', u'Symbiosis Corp', u'Affibody AB', u'Catalyst Biosciences Inc', u'San Raffaele Telethon Institute for Gene Therapy', u'Portola Pharmaceuticals Inc', u'Oxiquant Inc', u'Geron Corp', u'Grifols SA', u'National Cancer Institute', u'Novartis AG', u'Anthera Pharmaceuticals Inc', u'SRI International', u'Hadassah Medical Organization', u'Haemacure Corp', u'Cantab Biopharmaceuticals Ltd', u'Progenitor Inc', u'Symphogen A/S', u'Vericel Corp', u'Inflazyme Pharmaceuticals', u'SmithKline Beecham Corp', u'St Louis University', u'Merck Millipore', u'Jazz Pharmaceuticals plc', u'Innovative Medical Management', u'Pharmacia & Upjohn Inc', u'University of Colorado System', u'Midatech Pharma US Inc', u'Jiangsu Nhwa Pharmaceutical Group Co Ltd', u'Actinium Pharmaceuticals Inc', u'Regen BioPharma Inc', u'Pharmion Corp', u'Johns Hopkins University', u'Xencor Inc', u'Memorial Sloan-Kettering Cancer Center', u'Pluristem Therapeutics Inc', u'Swedish Orphan Biovitrum AB', u'Link Pharmaceuticals Ltd', u'Chugai Pharmaceutical Co Ltd', u'AMRAD Pharmaceuticals Pty Ltd', u'Tartis Inc', u'Genentech Inc', u'Regenerex LLC', u'Otsuka Holdings Co Ltd', u'KBI Biopharma Inc', u'Quintiles Ltd', u'National Institute of Diabetes, Digestive and Kidney Diseases', u'Alexion Pharmaceuticals Inc', u'Weill Medical College of Cornell University', u'Cangene Corp', u'Oklahoma Medical Research Foundation', u'Proteos SRL', u'PCT, a Caladrius company', u'CMC Biologics Inc', u'BMP Sunstone Corp', u'Oregon Health Sciences University', u'Emergent BioSolutions Inc', u'Rockefeller University', u'Bryant Expert Medical Equipment Service Inc', u'Orphan Canada Inc', u'Chugai Biopharmaceuticals Inc', u'BioChem Pharma (International ) Inc', u'Stada Arzneimittel AG', u'Medison Pharma Ltd', u'SQI Diagnostics Systems Inc', u'Serenex Inc', u'Cascade Lifesciences Inc', u'Bayer AG', u'CSL Ltd', u'bluebird bio Inc', u'LION bioscience Inc', u'Be The Match BioTherapies', u'Kyowa Hakko Kirin Co Ltd', u'DNAPrint genomics Inc', u'Cellerant Therapeutics Inc', u'University of California Los Angeles', u'Pharma Bio', u'Pfizer Inc', u'Aptevo Therapeutics Inc', u'A-Bio Pharma Pte Ltd', u'SUGEN Inc', u'PharmaSwiss SA', u'HUYA Bioscience International LLC', u'Cancer Research Technology Ltd', u'Aviragen Therapeutics Inc', u'Undisclosed', u'Broad Institute Inc', u'Wyeth BioPharma', u'Nippon Shinyaku Co Ltd', u'Massachusetts Institute of Technology', u'Takeda Pharmaceuticals International GmbH', u'Magenta Therapeutics Inc', u'Phebra Pty Ltd', u'ASTA Medica AG', u'INOXIA Lifesciences GmbH', u'Takeda Oncology', u'Immunotech Developments Inc', u'CRISPR Therapeutics', u'Knight Therapeutics Inc', u'Ligand Pharmaceuticals Inc', u'PPC', u'BL&H Co Ltd', u'Institute of Materia Medica Chinese Academy of Medical Sciences & Peking Union Medical College', u'Sysmex America Inc', u'Sophia Genetics Sa', u'Albert Einstein College of Medicine', u'Abeona Therapeutics Inc', u'Bristol-Myers Squibb Co', u'Elan Corp plc', u'The Medicines Company', u'Bioverativ Inc', u'MorphoSys AG', u'Sanofi Genzyme', u'Kyoto University', u'Aronex Pharmaceuticals Inc', u'Celgene Corp', u'Anadys Pharmaceuticals Inc', u'Array BioPharma Inc', u'VINNOVA', u'KS Biomedix Holdings plc', u'Editas Medicine Inc', u'Global Blood Therapeutics Inc', u'ImageIQ Inc', u'Gentium SpA', u'Alifax Holding Spa', u'Peptos Pharma Llc', u'Rhone-Poulenc Rorer Ltd', u'Antitope Ltd', u'Etablissement Francais du Sang', u'Cesca Therapeutics Inc', u'American Red Cross', u'Hemostemix Ltd', u'PAREXEL International', u'Taligen Therapeutics Inc', u'Rhone-Poulenc Rorer Inc', u'BioCryst Pharmaceuticals Inc', u'Mera Pharmaceuticals Inc']), u'Retinoschisis': set([u'National Neurovision Research Institute', u'University of Florida', u'Oregon Health Sciences University', u'AGTC', u'Biogen Inc', u'Foundation Fighting Blindness']), u'Craniosynostosis': set([u'Academic Medical Center, University of Amsterdam', u'Complete Genomics Inc', u'Erasmus University Medical Center Rotterdam', u'Sanquin Blood Supply Foundation']), u'Ushersyndrome': set([u'ProQR Therapeutics BV', u'Rare Partners Srl', u'Johns Hopkins University School of Medicine', u'National Institute on Deafness and Other Communication Disorders', u'Radboud University Medical Center Nijmegen', u'Universita Cattolica del Sacro Cuore']), u'Frontotemporaldementia': set([u'Ludwig-Maximilians University of Munich', u'US Government', u'National Institute of Neurological Disorders and Stroke', u\"Alzheimer's Drug Discovery Foundation\", u'Axon Neuroscience SE', u'Weston Brain Institute', u'FTLD Consortium', u'Mayo Clinic Foundation', u'Daiichi Sankyo Co Ltd', u'Mayo Clinic FLORIDA', u'CRISPR Therapeutics', u'P2D Biosciences', u'Howard Florey Institute of Experimental Physiology and Medicine', u'Cloud Pharmaceuticals Inc', u'Essex Bio-Technology Ltd', u'Hospital for Sick Children', u'National Institutes of Health', u'A&G Pharmaceutical Inc', u'Scripps Research Institute', u'Scripps Florida', u'Sunnybrook Health Sciences Centre', u'Medical Research Council', u'University College London', u'Columbia University', u'Target ALS Foundation', u'The University Health Network', u'University of Manchester', u'Procypra Therapeutics LLC', u'University of British Columbia', u'Washington University in St Louis', u'International Center for Genetic Engineering and Biotechnology (ICGEB)', u'Alector LLC', u'LifeArc', u'University of Western Ontario', u'University of California Los Angeles', u'Relief Therapeutics Holding AG', u'Molecular Neuroimaging LLC', u'National Institute on Aging', u'University of California San Francisco', u'University of Cambridge', u\"Boston Children's Hospital\", u'Avid Radiopharmaceuticals Inc', u'The Association for Frontotemporal Degeneration', u'AC Immune SA']), u'Blepharitis': set([u'Quintiles Transnational Corp', u'Biem Pharmaceuticals', u'Inspire Pharmaceuticals Inc', u'InSite Vision Inc', u'Undisclosed', u'Bioceutica SA', u'University of Missouri', u'Cardinal Health Inc', u'Lux Biosciences Inc', u'Clinipace']), u'Proteindeficiency': set([u'QSV Biologics', u'Critical Biologics Corp']), u'Achondroplasia': set([u'Chugai Pharmaceutical Co Ltd', u'BioMarin Pharmaceutical Inc', u'Masaryk University', u'Osaka University', u'Catalent Inc', u'ProChon Biotech Ltd', u'SUGEN Inc', u'Ribomic Inc', u'MorphoSys AG', u'TherAchon SAS']), u'Dysplasia': set([u'Edimer Pharmaceuticals Inc', u'NanoMed Pharmaceuticals Inc', u'Light Sciences Corp', u'CMC Biologics Inc', u'National Cancer Institute', u'University of Kentucky', u'Henderson Morley plc', u'Nventa Biopharmaceuticals Corp', u'Roche Holding AG', u'DUSA Pharmaceuticals Inc', u'Amistad Pharma SAS', u'Ohio State University', u'Roswell Park Cancer Institute']), u'Chlamydiaeinfection': set([u'Quretech Bio Ab', u'Umea Biotech Incubator']), u'Lymphedema': set([u'The New Energy and Industrial Technology Development Organization', u'AnGes MG Inc', u'National Cancer Institute', u'Ark Therapeutics Group plc', u'Stanford University', u'Eiger BioPharmaceuticals Inc', u'Laurantis Pharma Oy', u'Adepthera LLC']), u'Inflammatorydisease': set([u'Deltagen Research Laboratories', u'Takeda Vaccines Inc', u'TMRC Co Ltd', u'LeukoSight Inc', u'NEOMED Institute', u'Wilex AG', u'ANANDA Scientific Inc', u'Nautilus Neurosciences Inc', u'Archemix Corp', u'AxCell Biosciences Corp', u'European Commission', u'Laboratoire L Lafon SA', u'Turgut \\u0130laclari As', u'Life Technologies Corp', u'Suntory Ltd', u'Verily Life Sciences LLC', u'Univ Massachusetts', u'Hadasit Medical Research Services and Development Ltd', u'PLx Pharma Inc (pre-merger)', u'Centre for Cancer Biology', u'Cortical Pty Ltd', u'Proximagen Group plc', u'Universita degli Studi di Napoli Federico II', u'Ionis Pharmaceuticals Inc', u'Interprotein Corp', u'Coherus BioSciences Inc', u'Tolerys SA', u'Anesiva Inc', u'University of Prince Edward Island', u'MabVax Therapeutics Holdings Inc', u'Strekin AG', u'Locus Pharmaceuticals Inc', u'University of South Florida', u'Zydus-Cadila Group', u'ISTA Pharmaceuticals Inc', u'Janssen Pharmaceutical KK', u'Exodos Life Science Partners', u'Creabilis Therapeutics Srl', u'Tel Aviv Sourasky Medical Center', u'Walter Reed Army Institute of Research', u'SnowBrand Pharmaceuticals Inc', u'Chiesi USA Inc', u'Glycosynnovations Pty Ltd', u'CeNeS Pharmaceuticals plc', u'UCB Celltech', u'Echelon Biosciences Inc', u'Cellix Bio Pvt Ltd', u'Galapagos NV', u'Hansa Medical AB', u'R&R Inc', u'Vernalis plc', u'Xian-Janssen Pharmaceutical Ltd', u'Phenex Pharmaceuticals AG', u'Kuhnil Pharmaceutical Co Ltd', u'Celera South San Francisco', u'Botulinum Toxin Research Associates Inc', u'Polyphor Ltd', u'Dompe SpA', u'Handok Inc', u'Toray Industries Inc', u'Catalent Inc', u'Merckle GmbH', u'North Carolina Biotechnology Center', u'Biophage Pharma Inc', u'Graffinity Pharmaceuticals AG', u'Cengent Therapeutics Inc', u'Senju Pharmaceutical Co Ltd', u'WuXi PharmaTech (Cayman) Inc', u'RIKEN', u'Rhizen Pharmaceuticals SA', u'Aquapharm Biodiscovery Ltd', u'Biomeks Ilac', u'Curative Health Services', u'National Research Council of Canada', u'Transcription Factor Therapeutics', u'Innovus Pharmaceuticals Inc', u'CrystalGenomics Inc', u'NiKem Research Srl', u'GeneDesign Inc', u'National Health and Medical Research Council', u'Oxagen Ltd', u'Julphar Gulf Pharmaceutical Industries', u'Israeli Government', u'Centre National de la Recherche Scientifique (CNRS)', u'Nventa Biopharmaceuticals Corp', u'Pohang University of Science & Technology', u'Glycan Pharmaceuticals Inc', u'ZymoGenetics Inc', u'Cambridge Antibody Technology Group plc', u'Rega Institute for Medical Research', u'The European Union', u'Nippon Kayaku Co Ltd', u'Glenmark Pharmaceuticals Ltd', u'Cytoguide ApS', u'Ability Biomedical Corp', u'Bioceros BV', u'Abmaxis Inc', u'University of Cambridge', u'Acetylon Pharmaceuticals Inc', u'National Multiple Sclerosis Society', u'Antisense Therapeutics Ltd', u'Znomics Inc', u'Maxygen Inc', u'Plexxikon Inc', u'Phillips University', u'Covella Pharmaceuticals Inc', u'University of Maryland Biotechnology Institute', u'Yeda Research and Development Co Ltd', u'Poniard Pharmaceuticals Inc', u'Cerep SA', u'Cantab Biopharmaceuticals Ltd', u'Istituto Scientifico H San Raffaele', u'Imaginative Research Associates Inc', u'University of Gottingen', u'Lipomed AG', u'ISDIN SA', u'Juvaris BioTherapeutics Inc', u'National Jewish Health', u'Japan Science and Technology Agency', u'University of Florence', u'Pharmacopeia Inc', u'Toyama Chemical Co Ltd', u'Botanisol LLC', u'Kyung Hee University', u'Cytokine PharmaSciences Inc', u'ImmunoGen Inc', u'Cleveland Clinic Foundation', u'Celera Group', u'Innovative Medical Management', u'Colby Pharmaceutical Co', u'Zengen Inc', u'Avexegen Therapeutics Inc', u'Grelan Pharmaceutical Co Ltd', u'ImmuRx Inc', u'Janssen Pharmaceutica NV', u'EvoGenix Pty Ltd', u'Helsinn Healthcare SA', u'ImmuNext Inc', u'Boston University', u'Express Scripts Inc', u'PreveCeutical Medical Inc', u'Diamyd Medical AB', u'Genfit SA', u'Infinity Pharmaceuticals Inc', u'Macrophage Pharma Limited', u'Rutgers University', u'Swedish Orphan Biovitrum AB', u'Biochemie GmbH', u'Cigalah', u'NovaSAID AB', u'Henry Ford Health Science Center', u'MD Biosciences GmbH', u'Can-Fite BioPharma Ltd', u'InflaRx GmbH', u'Questcor Pharmaceuticals Inc', u'Piramed Pharma', u'Otsuka Holdings Co Ltd', u'Selventa', u'Grunenthal GmbH', u'Wellstat ImmunoTherapeutics LLC', u'AMRIF BV', u'PeptiDream Inc', u'Alexion Pharmaceuticals Inc', u'arGEN-X NV', u'California Institute of Technology', u'Flamel Technologies SA', u'PPD Discovery Inc', u'European Research Council (ERC)', u'Finnish Funding Agency for Technology and Innovation', u'Revance Therapeutics Inc', u'University of Texas System', u'Advanced Viral Research Corp', u'Marine Biological Laboratory', u'Emergent BioSolutions Inc', u'Queen Mary University of London', u'Chroma Therapeutics Ltd', u'Daewoong Pharmaceutical Co Ltd', u'biolitec AG', u'AmorChem LP', u'Immunetrics Inc', u'Logical Therapeutics Inc', u'APR Applied Pharma Research SA', u'Mirrx Therapeutics', u'Eli Lilly & Co', u'Proteros Biostructures GmbH', u'Chiroscience R&D Ltd', u'Synt:em', u'McGill University', u'Eyegate Pharmaceuticals Inc', u'Louisiana State University', u'Seikagaku Corp', u'Cook Pharmica', u'F-star Biotechnologische Forschungs-und Entwicklungs GmbH', u'ComGenex Inc', u'University of Pennsylvania', u'Progenitor Inc', u'Alder Biopharmaceuticals Inc', u'Carolus Therapeutics Inc', u'University of Maryland College Park', u'Madrigal Pharmaceuticals Inc', u'Conaris Research Institute AG', u'PXBioVision GmbH', u'Trillium Therapeutics', u'NextCell Pharma AB', u'Argenta Discovery Ltd', u'Metabasis Therapeutics Inc', u'University of California Los Angeles', u'MedImmune LLC', u'BioDuro LLC', u'Stiefel', u'Schein Pharmaceutical Inc', u'National Institute on Aging', u'The Leukemia & Lymphoma Society', u'Keio University', u'AppTec Laboratory Services', u'Universitat Autonoma de Barcelona', u'VivaCell Biotechnology Espana SL', u'Laboratoires Thea', u'X-Chem Inc', u'KRS Global Biotechnology Inc', u'RuiYi Inc', u'Selcia Ltd', u'University of Maryland', u'Tripos Inc', u'InVasc Therapeutics Inc', u'Johns Hopkins University', u'Sanwa Kagaku Kenkyusho Co Ltd', u'University of Regensburg', u'Beactica AB', u'Harbor Therapeutics Inc', u'Helicon Therapeutics Inc', u'Momenta Pharmaceuticals Inc', u'China Pharmaceutical University', u'GlycoMar Ltd', u'Innate Pharma SA', u'West-Ward Pharmaceutical Corp', u'AbbVie Inc', u'Amphora Discovery Corp', u'Smart Assays', u'University of Kansas', u'Kyowa Hakko Kogyo Co Ltd', u'East of England Development Agency', u'Metabolon Inc', u'Advirna LLC', u'Tiziana Life Sciences PLC', u'SmithKline Beecham plc', u'Taisho Pharmaceutical Co Ltd', u'Korea Advanced Institute of Science and Technology', u'Dong-A University', u'Glycomed Inc', u'Karus Therapeutics Ltd', u'Glycores 2000 Srl', u'Pharnext SAS', u'Hyland Immuno', u'Helsinn Group', u'Nestle Health Science', u'Biographics Laboratory', u'Mercian Corp', u'Knight Therapeutics Inc', u'SoLogic Pty Limited', u'Bristol-Myers Squibb Co', u'Roche Palo Alto', u'Evotec (UK) Ltd', u'Chinese Academy of Sciences', u'Hybrigenics SA', u'Dr Rentschler Biotechnologie GmbH', u'Pharming Group NV', u'Cambridge Drug Discovery Ltd', u'VINNOVA', u'Astellas Pharma Inc', u'University of Toronto', u'PowderJect Pharmaceuticals plc', u'ProtoKinetix Inc', u'Institute of Cancer Research UK', u'New Haven Pharmaceuticals Inc', u'Northwestern University', u'Todai TLO Ltd', u'Metaphore Pharmaceuticals Inc', u'Lonza Group AG', u'Oscient Pharmaceuticals Corp', u'GC-Rise Pharmaceutical Co Ltd', u'Athersys Inc', u'Protherics plc', u'Molecular Partners AG', u'Selective Genetics Inc', u'Synovo GmbH', u'Oncodesign Biotechnology SA', u'Arresto BioSciences', u'Sareum Holdings plc', u'Ikaria Inc', u'University of Michigan', u'Mitsubishi Chemical Corp', u'Bio-Quant Inc', u'Crimson Pharmaceutical (Hong Kong) Ltd', u'BioAegis Therapeutics Inc', u'Intellikine Inc', u'Genesis Research and Development Corp Ltd', u'Karolinska Institutet', u'Sumitomo Dainippon Pharma Co Ltd', u'MaimoniDex RA', u'Pharmaxis Ltd', u'Novo Nordisk A/S', u'Regeneron Pharmaceuticals Inc', u'Mera Pharmaceuticals Inc', u'CMIC Holdings Co Ltd', u'Phenomix Corp', u'Arachos Pharma Ltd', u'Aevi Genomic Medicine Inc', u'Proteo Biotech AG', u'University of Tokyo', u'IDEC Pharmaceuticals Corp', u'Translate Bio', u'Thios Pharmaceuticals Inc', u'Pharmacyclics Inc', u'Pathogenex GmbH', u'Guangdong Zhongke Drug Research & Development Co Ltd', u'BTG plc', u'RespiVert Ltd', u'Cambridge Scientific Pty Ltd', u'Icogenex Corp', u'Chiesi Farmaceutici SpA', u'Sun Pharmaceutical Industries Ltd', u'Chiron Corp', u'Toulouse White Biotechnology', u'Dharmacon Inc', u'ReveraGen BioPharma Inc', u'DSM Chemie Linz GmbH', u'TaiGen Biotechnology Co Ltd', u'LeukoSite Inc', u'Selexis SA', u'Elan Corp plc', u'Congenica Ltd', u'Panacea Biotec Ltd', u'ArQule Inc', u'Shijiazhuang Yiling Pharmaceutical Co Ltd', u'The Austrian Research Promotion Agency FFG', u'IBEX Technologies Inc', u'Opsona Therapeutics Ltd', u'Matrix Therapeutics Ltd', u'Lorantis Ltd', u'Beijing Tide Pharmaceutical Co Ltd', u'The University Health Network', u'Enteris BioPharma Inc', u'Mitsubishi-Tokyo Pharmaceuticals Inc', u'Mateon Therapeutics Inc', u'Roche Holding AG', u'Chiroscience Group plc', u'University of British Columbia', u'MorphoSys AG', u'Ercole Biotech Inc', u'GeneData AG', u'University of Munster', u'Vaccinex Inc', u'Guangzhou Institute of Biomedicine and Health, Chinese Academy of Sciences', u'Hain Diagnostika GmbH', u'University of Bonn', u'Nodthera Ltd', u'URIST Regenerative Med Inc', u'UCB Pharma SA', u'Sanofi Genzyme', u'Selvita SA', u'Hisamitsu Pharmaceutical Co Inc', u'Samsung BioLogics Co Ltd', u'Biocon Ltd', u'Agios Pharmaceuticals Inc', u'Alliance Pharma plc', u'Encore Pharmaceuticals Inc', u'Biotica Technology Ltd', u'NitroMed Inc', u'Mayo Clinic Foundation', u'Royal College of Surgeons of England', u'Dana-Farber Cancer Institute Inc', u'Ribomic Inc', u'Charite Universitaetsmedizin Berlin', u'Biokine Therapeutics Ltd', u'Istituto Clinico Humanitas', u'National Institute of General Medical Sciences', u'Evotec AG', u'Trubion Pharmaceuticals Inc', u'Exelixis Inc', u'Charles River Laboratories International Inc', u'Aspyrian Therapeutics Inc', u'Xencor Inc', u'XOMA Corp', u'Amgen Inc', u'TumorEnd LLC', u'Karo Pharma AB', u'BioTrove Inc', u'CytoMed Inc', u'Tetra Bio-Pharma Inc', u'Saudi-Arabian Japanese Pharmaceutical Co', u'Artes Biotechnology', u'Endo Health Solutions Inc', u'Endo Pharmaceuticals Solutions Inc', u'Cajal Institute', u'University of Aberdeen', u'Consejo Superior De Investigaciones Cientificas', u'Diosynth Inc', u'National Institute of Biomedical Imaging and Bioengineering', u'Akari Therapeutics Plc', u'Shanghai Institute of Materia Medica of the Chinese Academy of Sciences', u'University of Bristol', u'A*STAR Institute of Molecular and Cell Biology', u'Gemini Genomics plc', u'Palau Pharma SA', u'Georgetown University', u'SkyePharma plc', u'Jiangsu Hengrui Medicine Co Ltd', u'Imperial College London', u'Zymeworks Inc', u'Massachusetts General Hospital', u'Confluence Life Sciences Inc', u'BioXell SpA', u'Lev Pharmaceuticals Inc', u'Inflazyme Pharmaceuticals', u'Phycosource', u'Numerate Inc', u'Enzon Pharmaceuticals Inc', u'Biovation Ltd', u'GRI Bio Inc', u'Takeda Pharmaceutical Co Ltd', u'TBG Diagnostics Ltd', u'Laboratoires Mayoly Spindler', u'Atlantic Canada Opportunities Agency', u'Avexxin AS', u'Pennsylvania State University', u'Baxalta Inc', u'Sosei Group Corp', u'AtheroGenics Inc', u'Phenicia Group', u'Albany Molecular Research Inc', u'Oxford Drug Design', u'Cytovance Biologics LLC', u'Gliatech Inc', u'Prasco Laboratories', u'Allergan Inc', u'HealthLinx Ltd', u'Eiger BioPharmaceuticals Inc', u'Medgel Corp', u'Actinobac Biomed Inc', u'The Research Council of Norway', u'Osaka University', u'Fibrex Medical R&D GmbH', u'Yuhan Corp', u'Interleukin Genetics Inc', u'GNT Pharma Co Ltd', u'Vicore Pharma AB', u'Ichor Therapeutics', u'Patheon Pharmaceuticals Inc', u'Wakunaga Pharmaceutical Co Ltd', u'Jeil Pharmaceutical Co Ltd', u'Highnoon Laboratories Ltd', u'Duke University', u'F Hoffmann-La Roche AG', u'Medical University of Vienna', u'Euclises Pharmaceuticals Inc', u'Estrellita Pharmaceuticals', u'Rockefeller University', u'Viron Therapeutics Inc', u'Domantis Ltd', u'Tularik Inc', u'Shanghai Genomics Inc', u'Genentech Inc', u'Dicerna Pharmaceuticals Inc', u'Yissum Research Development Co', u'Mitsubishi Pharma Corp', u'Wellcome Trust Sanger Institute', u'DCPrime BV', u'Korea Drug Development Fund', u'SFJ Pharmaceuticals Inc', u'Rigel Pharmaceuticals Inc', u'Tabuk Pharmaceutical Manufacturing Co', u'Lead Chemical Co Ltd', u'Baylor Research Institute', u'Oklahoma Medical Research Foundation', u'Ramaciotti Foundation', u'LifeArc', u'Medial Ltd', u'Eden Biodesign Ltd', u'PAZ Arzneimittelentwicklungsgesellschaft GmbH', u'Microbiotix Inc', u'Eastern Virginia Medical School', u'Sinclair Pharma plc', u'PDL BioPharma Inc', u'Biolipox AB', u'Scripps Research Institute', u'Australian Research Council', u'Avila Therapeutics Inc', u'Diosynth Biotechnology', u'Meda AB', u'Topas Therapeutics GmbH', u'BioFocus DPI', u'CASI Pharmaceuticals Inc', u'Hutchison Medipharma Enterprises Ltd', u'Dompe Farmaceutici SpA', u'CoNCERT Pharmaceuticals Inc', u'Pafogen Inc', u'Phytomedics Inc', u'Hebrew University of Jerusalem', u'Pierre Fabre SA', u'Department of Science & Technology', u'Genzyme General', u'Vitaeris Inc', u'Teva Pharmaceutical Industries Ltd', u'INHIBRx LLC', u'Caprion Pharmaceuticals Inc', u'Seres Therapeutics Inc', u'Institut de Recherche pour le Developpement (IRD)', u'BioSenex', u'IVAX Corp', u'Cubist Pharmaceuticals Inc', u'AstraZeneca plc', u'Technology Strategy Board', u'OncoArendi Therapeutics Sp Z Oo', u'Tanabe Research Labs USA Inc', u'Knoll AG', u'X-BODY BioSciences', u'Antibe Therapeutics Inc', u'ChemomAb Ltd', u'University of Utah', u'Van Andel Institute', u'Lacer SA', u'Melacure Therapeutics AB', u'Draconis Pharma SL', u'Terumo Corp', u'Janssen-Cilag Ltd', u'Vectura Group plc', u'Zebra Biologics Inc', u'Reprixys Pharmaceuticals Corp', u'Radius Pharmaceuticals', u'Tolero Pharmaceuticals Inc', u'Australian Government', u'Gilead Palo Alto Inc', u'La Jolla Pharmaceutical Co', u'Genmab A/S', u'Portola Pharmaceuticals Inc', u'ASTA Medica AG', u'Amylin Pharmaceuticals Inc', u'Patheon Inc', u'Pharmos Corp', u'Japan Tobacco Inc', u'BioChem Therapeutic Inc', u'Knoll Pharmaceuticals Ltd', u'Biocopea Ltd', u'Ben-Gurion University Of The Negev', u'Alfa Wassermann SpA', u'Top Institute Pharma', u'Abiogen Pharma SpA', u'National Center for Complementary and Alternative Medicine', u'Proteomika SL', u'Discovery BioMed Inc', u'Numab AG', u'Oncolys BioPharma Inc', u'ProMetic Life Sciences Inc', u'ProtAffin Biotechnologie AG', u'NOXXON Pharma AG', u'Xcovery Inc', u'UNIZYME Laboratories A/S', u'Piramal Enterprises Ltd', u'Zealand Pharma A/S', u'Pepgen Corp', u'BioPontis Alliance LLC', u'Horizon Pharma GmbH', u'ICOS Corp', u'Novascreen Biosciences Corp', u'Corbin Therapeutics Inc', u'Unilife', u'Capsugel France SA', u'Critical Therapeutics Inc', u'ThromboGenics NV', u'InDex Pharmaceuticals AB', u'Dong Wha Pharmaceutical Co Ltd', u'Valeant Pharmaceuticals International Inc', u'Aptahem AB', u'Medical University of South Carolina', u'Zhejiang CONBA Pharmaceutical Co Ltd', u'Alpha-Beta Technology Inc', u'Kennedy Institute of Rheumatology', u'GVK Biosciences Pvt Ltd', u'Undisclosed', u'Helion Biotech ApS', u'NanoCarrier Co Ltd', u'Holland Food Ventures', u'Institut Pasteur', u'University of Padova', u'Zaiya Inc', u'NeoPharm Co Ltd', u'LION bioscience Inc', u\"Brigham & Women's Hospital\", u'Dyax Corp', u'Antitope Ltd', u'13Therapeutics Inc', u'Xenome Ltd', u'Atlantic Healthcare plc', u'OptiMed Specialty Pharmacy', u'Singapore Immunology Network', u'Axovan AG', u'Telormedix SA', u'Triad Therapeutics Inc', u'CuraGen Corp', u'Laboratories Acbel SA', u'German Federal Ministry of Education and Research', u'Dr Lo Zambeletti SpA', u'Immune Therapeutics Inc', u'Clinical Data Inc', u'Daiichi Seiyaku Co Ltd', u'La Jolla Institute of Allergy & Immunology', u'Royal DSM NV', u'CellAct Pharma GmbH', u'Pepscan Systems BV', u'Inflamalps SA', u'Nattermann & Cie GmbH', u'GLYCODesign Inc', u'Arana Therapeutics Ltd', u'EMD Serono Inc', u'Amura Therapeutics Ltd', u'Pharmagenesis Inc', u'Aeolus Pharmaceuticals Inc', u'Forest Laboratories Inc', u'ASKA Pharmaceutical Co Ltd', u'Commonwealth Government', u'Kowa Co Ltd', u'Ortho Pharmaceutical Corp', u'Kissei Pharmaceutical Co Ltd', u'Ministry of Health, Welfare and Family Affairs', u'Vernalis Group plc', u'Orexo AB', u'University of Queensland', u'Kirin Holdings Co Ltd', u'Verona Pharma plc', u'MGI Pharma Inc', u'Schepens Eye Research Institute', u'Mount Sinai Hospital', u'Aventis Pharma AG', u'AvantGen Inc', u'LegoChem Bioscience Inc', u'Hunan University of Traditional Chinese Medicine', u'Mercachem Holding BV', u'BioVascular Inc', u'Cell Biologics Inc', u'OSI Pharmaceuticals Inc', u'ICM Pharma Pte Ltd', u'Molecumetics Ltd', u'PAION AG', u'Cortech Inc', u'INRIA Institut National de Recherche en Informatique et en Automatique', u'SMG Pharmaceuticals Inc', u'Five Prime Therapeutics Inc', u'Rosa & Co LLC', u'ARIAD Pharmaceuticals Inc', u'SARomics AB', u'Abpro Inc', u'Immune Network Ltd', u'NanoBio Corp', u'Ludwig Institute for Cancer Research', u'Nippon Shinyaku Co Ltd', u'Faron Pharmaceuticals Ltd', u'C10 Pharma', u'Meditrade Ltd', u'Xenova Group plc', u'ReNeuron Group plc', u'University of Colorado, Boulder', u'The Babraham Institute', u'Teijin Ltd', u'Receptor Life Sciences', u'Defense Advanced Research Projects Agency', u'Pfizer Inc', u'Netherlands Government', u'Signal Research Division', u'Ogeda SA', u'Omeros Corp', u'Hikma Pharmaceuticals plc', u'Universidad De Cordoba', u'X-Rx Discovery Inc', u'TxCell SA', u'Vifor Pharma', u'Inex Pharmaceuticals Corp', u'Active Biotech AB', u'SCYNEXIS Inc', u'Mylan Inc', u'Affitech A/S', u'Harvard University', u'Laboratorios Elmor SA', u'Wichita State University', u'MEDRx Co Ltd', u'Boehringer Mannheim GmbH', u'Oxford University Innovation', u'Repligen Corp', u'Aphios Corp', u'University of Ghent', u'Hadassah Medical Organization', u'IMIDomics SL', u'Celtaxsys Inc', u'Qurient Therapeutics', u'CytoCore Inc', u'Biogen Idec Hemophilia Inc', u'Allakos Inc', u'Catholic University of Leuven', u'Amira Pharmaceuticals Inc', u'Torrey Pines Institute for Molecular Studies', u'Diosynth BV', u'Cetek Corp', u'UCB Pharma GmbH', u'Angelini Pharmaceuticals SpA', u'Clarity Pharmaceuticals Pty Ltd', u'OPKO Health Inc', u'Mundipharma EDO GmbH', u'German Government', u'Mathilda and Terrence Kennedy Institute of Rheumatology Trust', u'Peakdale Molecular', u'Axikin Pharmaceuticals Inc', u'Affilogic Laboratories', u'Khepri Pharmaceuticals', u'Hooke Laboratories Inc', u'Quorex Pharmaceuticals Inc', u'Glaxo Group Ltd', u'Biotechnology Cluster Rhine Neckar (BioRN)', u'AnGes MG Inc', u'Micromet Inc', u'Encysive Pharmaceuticals Inc', u'University of Illinois', u'Boehringer Ingelheim Corp', u'EPI Health LLC', u'The University of Massachussetts', u'Tokuhon Co Ltd', u'Tobira Therapeutics Inc', u'Avalon Pharmaceuticals Inc', u'Oryzon Genomics SA', u'Beta Therapeutics Pty Ltd', u'Ciblex Corp', u'Neopharm Ltd', u'University of Sydney', u'Carmot Therapeutics Inc', u'CIMA Labs Inc', u'Dura Pharmaceuticals Inc', u'Sirona Biochem Corp', u'ILEX Oncology Inc', u'Fujifilm Diosynth Biotechnologies', u'Good Doctor Pharmaceutical Group Co Ltd', u'Guangzhou Institutes of Biomedicine and Health', u'Pharma Med Inc', u'JARI Pharmaceuticals BV', u'Dong-A ST Co Ltd', u'BioSeek LLC', u'Tsinghua University', u'Probiodrug AG', u'Revotar Biopharmaceuticals AG', u'National Institute of Diabetes, Digestive and Kidney Diseases', u'SARcode Bioscience Inc', u'Savient Pharmaceuticals Inc', u'Schering-Plough Corp', u'Roche Innovation Center Copenhagen A/S', u'Oxford BioMedica plc', u'Sorrento Therapeutics Inc', u'CMC Biologics Inc', u'Hospital for Sick Children', u'Baxter Healthcare Corp', u'Institut National de la Recherche Agronomique', u'Pathway Therapeutics Ltd', u'University of Edinburgh', u'Nidus Laboratories Inc', u'Ception Therapeutics Inc', u'Provid Pharmaceuticals Inc', u'Funxional Therapeutics Ltd', u'Merck & Co Inc', u'Zenyaku Kogyo Co Ltd', u'ChemoCentryx Inc', u'National Eye Institute', u'rEVO Biologics Inc', u'Ace Laboratories Inc', u'Daewon Pharm Co Ltd', u'Chong Kun Dang Pharmaceutical Corp', u'Columbia University', u'Tanabe Seiyaku Co Ltd', u'Ensemble Therapeutics Corp', u'Bayer AG', u'University of York', u'Yutoku Pharmaceutical Ind Co Ltd', u'Enlivex Therapeutics Ltd', u'Pulmatrix Inc', u'Alligator Bioscience AB', u'Gilead Sciences Inc', u'Case Western Reserve University', u'BioSeek Plc', u'Medical Biology Institute', u'Jagotec AG', u'Almirall Prodesfarma SA', u'Therapure Biopharma Inc', u'Astex Pharmaceuticals Inc', u'Strathclyde Institute for Drug Research', u'BioProjet, Societe Civile de Recherche', u'Science Foundation Ireland', u'Kaken Pharmaceutical Co Ltd', u'Intarcia Therapeutics Inc', u'Symberix LLC', u'POZEN Inc', u'Hadasit Bio-Holdings Ltd', u'Copernicus Therapeutics Inc', u'Tragara Pharmaceuticals Inc', u'Wyeth', u'Institute for the Promotion of Innovation by Science and Technology in Flanders', u'Aptuit Inc', u'Ziarco Pharma Ltd', u'Medosan Industrie Biochimiche Riunite SpA', u'CollaGenex Pharmaceuticals Inc', u'University Medical Center Groningen', u'Nuo Therapeutics Inc', u'Massachusetts Institute of Technology', u'Intrexon Corp', u'Takeda Pharmaceuticals International GmbH', u'Apogenix GmbH', u'US Department of Defense', u'LTT Bio-Pharma Co Ltd', u'PharmaGap Inc', u'InnVentis', u'Sunol Molecular Corp', u'Griffith University', u'Curacyte AG', u'20/20 HealthCare Partners LLC', u'Dojin Iyaku-Kako Co Ltd', u'Lead Discovery Center GmbH', u'Novartis Pharma KK', u'Juvenile Diabetes Research Foundation', u'Fuzhou University', u'Dendreon San Diego LLC', u'Aurigene Discovery Technologies Ltd', u'North Coast Biologics LLC', u'The Australian National University', u'Anteana Therapeutics Inc', u'Pfizer Central Research', u'Picower Institute for Medical Research', u'AnaptysBio Inc', u'Ablynx NV', u'Ono Pharmaceutical Co Ltd', u'Oscotec Inc', u'Chinese Government', u'FFF Enterprises', u'Aventis SA', u'INSERM', u'Hamamatsu Photonics', u'Ligand Pharmaceuticals Inc', u'Regulus Therapeutics Inc', u'MSD Japan', u'BioInvent International AB', u'Panag Pharma Inc', u'Kalypsys Inc', u'Celgene Corp', u'Takeda Cambridge Ltd', u'Dekel Pharmaceuticals Ltd', u'Array BioPharma Inc', u'Therapix Biosciences Ltd', u'Eurofarma', u'Biovail Corp', u'Universit\\xe4tsklinikum Hamburg-Eppendorf', u'Genelabs Technologies Inc', u'BioTie Therapies Corp', u'Avanir Pharmaceuticals Inc', u'Tufts University', u'Apollo Endosurgery Inc', u'Shire plc', u'Therabel Pharma NV', u'Debiopharm SA', u'University of Georgia', u'IOTA Pharmaceuticals Ltd', u'Janssen Pharmaceuticals Inc', u'Biotherapix SLU', u'Flexion Therapeutics Inc', u'Laboratoire Chauvin SA', u'Nestle SA', u'Digna Biotech SL', u'XL-Protein GmbH', u'Ambiotis SAS', u'University of Alberta', u'Applied Immunotherapeutics Inc', u'Asana BioSciences LLC', u'The Collaborative Group', u'GD Searle & Co', u'Cyathus Exquirere Pharmaforschungs GmbH', u'Berlex Laboratories Inc', u\"Dr Reddy's Laboratories Ltd\", u'US Government', u'BioMarin Pharmaceutical Inc', u'Cooper Maroc Pharmaceuticals', u'Hunter-Fleming Ltd', u'Galenica AG', u'JSS University', u'Medisyn Technologies Inc', u'BioAtla Llc', u'MSD OSS BV', u'Biotechnology Development Corp', u'Feinstein Institute for Medical Research', u'InterMune Inc', u'National Biomanufacturing Centre', u'Kowa Pharmaceuticals America Inc', u'China State Institute of Pharmaceutical Industry', u'Union Life Sciences Limited', u'Alliance for Lupus Research', u'United States Army Medical Research Institute of Chemical Defense', u'Biogen Inc', u'Unigene Laboratories Inc', u'UMeWorld Ltd', u'GlaxoSmithKline plc', u'Covance Inc', u'Bayer Schering Pharma AG', u'Hyseq Inc', u'Makoto Life Sciences Inc', u'ZAI Laboratory Inc', u'Janssen Biotech Inc', u'moksha8 Pharmaceuticals Inc', u'Ipsen', u'Immunex Corp', u'Toyota Tsusho Corp', u'Marina Biotech Inc', u'Myungmoon Pharm Co Ltd', u'RxMD Inc', u'Wyeth Pharmaceuticals', u'Novimmune SA', u'INSERM Transfert', u'ITH Immune Therapy Holdings AB', u'Fibrocell Science Inc', u'Cenix BioScience GmbH', u'Virginia Commonwealth University', u'Takeda Oncology', u'Stanford University', u'Sunesis Pharmaceuticals Inc', u'Halozyme Therapeutics Inc', u'Abbott Healthcare Products BV', u'Innovative Genomics Initiative', u'Oneday - Biotech & Pharma Ltd', u'Source MDx', u'Novis Pharmaceuticals Llc', u'Siamab Therapeutics', u'Neurogen Corp', u'Sankyo Co Ltd', u'Universitat Innsbruck', u'Fox Chase Cancer Center', u'Taro International Ltd', u'BioWa Inc', u'3M Pharmaceuticals', u'Shionogi & Co Ltd', u'ECI Inc', u'Endo International plc', u'South China Sea Institute of Oceanology Chinese Academy of Sciences', u'Reata Pharmaceuticals Inc', u'National Heart Lung and Blood Institute', u'ANUTECH Pty Ltd', u'BioMotiv LLC', u'Gencia Corp', u'Alnylam Pharmaceuticals Inc', u'UCB SA', u'Ontogen Corp', u'SS Pharmaceutical - ethical drug division', u'GNI Group Ltd', u'Sujana Biotech LLC', u'Wockhardt Ltd', u'Johnson & Johnson Pharmaceutical Research & Development LLC', u'Beckman Coulter Inc', u'Aronex Pharmaceuticals Inc', u'Advinus Therapeutics Ltd', u'Sigma-Tau Ind Farm Riunite SpA', u'Medarex Inc', u'MIKA Pharma GmbH', u'Cystic Fibrosis Foundation Therapeutics Inc', u'Accelerate Brain Cancer Cure', u'Catalyst Biosciences Inc', u'Daiichi Sankyo Co Ltd', u'Abbott Laboratories', u'Sparta Pharmaceuticals Inc', u'Eisai Co Ltd', u'Commonwealth Scientific and Industrial Research Organization', u'American Heart Association', u'G2 Therapies Ltd', u'Tanox Inc', u'IntelliHep', u'Wuxi AppTec Inc', u'National Cancer Institute', u'Novartis AG', u'Merck KGaA', u'Almac Discovery Ltd', u'Johnson & Johnson', u'Ministerio de Economia y Competitividad', u'Korea Research Institute of Bioscience and Biotechnology', u'VLST Corp', u'Fujisawa Pharmaceutical Co Ltd', u'Novelion Therapeutics Inc', u'ipal GmbH', u'Ewopharma AG', u'Nuevolution A/S', u'Rheinisch-Westfaelische Technische Hochschule Aachen', u'Krish Biotech Research Pvt Ltd', u'Promics Pty Ltd', u'University of Minnesota', u'Vernalis Research Ltd', u'Yale University', u'The Procter & Gamble Co', u'Galectin Therapeutics Inc', u'Cadus Corp', u'University of Manchester', u'TechnoPhage SA', u'Ohr Pharmaceutical Inc', u'Seoul Pharma Co Ltd', u'Taiho Pharmaceutical Co Ltd', u'Apoplogic Pharmaceuticals Inc', u'Italian Research Ministry', u'Taligen Therapeutics Inc', u'Takara Bio USA Inc', u'Alfresa Pharma Corp', u'University of Colorado System', u'Dermira Inc', u'3-Dimensional Pharmaceuticals Inc', u'University of Barcelona', u'Ethypharm SA', u'Zambon Co SpA', u'Medical Research Council', u'CytRx Corp', u'University of Massachusetts Medical School', u'Ferrer Internacional SA', u'Pharmix Corp', u'AcSentient Inc', u'Hospira Adelaide Pty Ltd', u'Immtech Pharmaceuticals Inc', u'Nordic Bioscience A/S', u'MakScientific LLC', u'RXi Pharmaceuticals Corp', u'Compugen Ltd', u'Pluristem Therapeutics Inc', u'Karyopharm Therapeutics Inc', u'US Public Health Service', u'H Lundbeck A/S', u'Orphan Australia', u'Abgenix Inc', u'CVS Caremark', u'Aileron Therapeutics Inc', u'University of North Carolina', u'NITTO DENKO Avecia', u'National Institute of Neurological Disorders and Stroke', u'Oregon Health Sciences University', u'ITR Laboratories Canada Inc', u'GeneCare Research Institute Co Ltd', u'Hayashibara Biochemical Laboratories Inc', u'Atlantic Technology Ventures Inc', u'Meiji Seika Pharma Co Ltd', u'Rijksuniversiteit te Leiden', u'Clinquest Group', u'Lehigh University', u'Universiteit Utrecht', u'SRI International', u'Ultrafine Chemicals Ltd', u'Sanofi Chimie SA', u'Allergan plc', u'Cellzome', u'iTherX Pharmaceuticals Inc', u'IOmet Pharma Ltd', u'SangStat Medical Corp', u'CollaGenex International Ltd', u'Karr Dental AG', u'Wellcome Trust - Burroughs Wellcome Fund', u'Nurix Inc', u'Arris Pharmaceutical Corp', u'Syncom BV', u'University of California', u'CytoSorbents Corp', u'MD Anderson Cancer Center', u'Novo A/S', u'Servier', u'Molecular Pharmacology (USA) Ltd', u'Biotoxtech Co Ltd', u'Alloksys Life Sciences BV', u'Alter SA', u'Bloom Burton & Co', u'Epimmune Inc', u'Cellmid Ltd', u'Commissariat a l`Energie Atomique', u'Zhejiang University', u'TNO', u\"Children's Hospital of Los Angeles\", u'University of Virginia', u'Kyowa Hakko Kirin Co Ltd', u'Hosokawa Powder Technology Research Institute', u'Greenwall Foundation', u'NicOx SA', u'Liaoning Normal University', u'BD Biosciences', u'Cyclacel Pharmaceuticals Inc', u'Quintiles Transnational Corp', u'Walter and Eliza Hall Institute of Medical Research', u'Genaera Corp', u'UCB Pharma Ltd', u'Center for Blood Research Inc', u'Medinox Inc', u'Sunovion Pharmaceuticals Inc', u'Esteve', u'Sanofi', u'Seattle Life Sciences', u'The Salk Institute for Biological Studies', u'University of Leicester', u'Human Genome Sciences Inc', u'Vertex Pharmaceuticals Inc', u'Northeastern University', u'Cadila Pharmaceuticals Ltd', u'Affibody AB', u'AFFiRiS AG', u'Apricus Biosciences Inc', u'Genor Biopharma Co Ltd', u'Institute of Advanced Chemistry of Catalonia', u'University of Arizona', u'Topivert Pharma Ltd', u'AusIndustry', u'Block Drug Co Inc', u'BioLineRx Ltd', u'NeoGenesis Pharmaceuticals Inc', u'Valentis Inc', u'Virdante Pharmaceuticals Inc', u'Sawai Pharmaceutical Co Ltd', u'Cara Therapeutics Inc', u'MEI Pharma Inc', u'Beryllium Discovery Corp', u'RW Johnson Pharmaceutical Research Institute', u'UniQuest Pty Ltd', u'National Institute of Allergy and Infectious Diseases', u'Gedeon Richter Ltd', u'Yamanouchi Pharmaceutical Co Ltd', u'ILTOO Pharma', u'Octamer Inc', u'Galena Biopharma Inc', u'Targacept Inc', u'Phylogica Ltd', u'Heptares Therapeutics Ltd', u'National Institutes of Health', u'TopoTarget A/S', u'Chromos Molecular Systems Inc', u'Xiamen University', u'Grannus BioSciences Ltd', u'OncoNOx ApS', u'Verenium Corp', u'Jilin University', u'Rohto Pharmaceutical Co Ltd', u'Zenyth Therapeutics Ltd', u'Synvolux IP BV', u'AmbioPharm Inc', u'National Institutes of Standards and Technology', u'Onyx Pharmaceuticals Inc', u'JYANT Technologies Inc', u'ChemDiv Inc', u'Phytera Inc', u'Ranbaxy Laboratories Ltd', u'BioMed X GmbH', u'Fagron Group Bv', u'Trinity College Dublin', u'Axxam SpA', u'Inflammatorx Inc', u'AlfaGene Biosciences Inc', u'JW Pharmaceutical Corp', u'LPB Istituto Farmaceutico SpA', u'Sanford-Burnham Medical Research Institute', u'Centenary Institute Cancer Medicine & Cell Biology', u'Childrens Hospital of Philadelphia', u'Merck Serono SA', u'AyoxxA Biosystems GmbH', u'DecImmune Therapeutics', u'Willvonseder & Marchesani GmbH & Co KG', u'The Menarini Group', u'Eurodrug Laboratories', u'Cytopia Ltd', u'Royalty Pharma', u'MannKind Corp', u'Cancer Therapy & Research Center', u'Bri Biopharmaceuticals Research Inc', u'AcurePharma AB', u'Keryx Biopharmaceuticals Inc', u'University Of Western Sydney', u'Navigo Proteins GmbH', u'Affymax Inc', u'Technion - Israel Institute of Technology', u'BioCryst Pharmaceuticals Inc', u'BASF AG'])}\n"
     ]
    }
   ],
   "source": [
    "adj_list = {}\n",
    "for s in wb.sheets():\n",
    "    values = []\n",
    "    for row in range(s.nrows):\n",
    "        \n",
    "        for col in range(0,s.ncols,2):\n",
    "            value  = (s.cell(row,col).value)\n",
    "            try : value = str(int(value))\n",
    "            except : pass\n",
    "            if col == 0:\n",
    "                firm = value\n",
    "              \n",
    "            else:\n",
    "                diseases = value.split(';')\n",
    "                for d in diseases:\n",
    "                    if d in adj_list:\n",
    "                        if firm not in adj_list[d]:   \n",
    "                            adj_list.setdefault(d, set()).add(firm)\n",
    "                    else:\n",
    "                        adj_list.setdefault(d, set()).add(firm)\n",
    "                \n",
    "adj_list.pop('TOPICS', None)\n",
    "print (adj_list)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 4,
   "metadata": {},
   "outputs": [],
   "source": [
    "import pandas as pd"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 8,
   "metadata": {},
   "outputs": [],
   "source": [
    "# clean up the example\n",
    "adj_list = {k: [v.strip() for v in vs] for k, vs in adj_list.items()}"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 20,
   "metadata": {},
   "outputs": [],
   "source": [
    "\n",
    "\n",
    "\n",
    "edges = [(b, a) for a, bs in adj_list.items() for b in bs]\n",
    "\n",
    "df = pd.DataFrame(edges)\n",
    "\n",
    "m = pd.read_csv(\"firm_by_illnes_2.csv\")\n",
    "\n",
    "adj_matrix = pd.crosstab(m[\"to\"], m[\"from\"])"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 21,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th>from</th>\n",
       "      <th>Acutemyelogenousleukemia</th>\n",
       "      <th>Alzheimersdisease</th>\n",
       "      <th>Arthritis</th>\n",
       "      <th>Asthma</th>\n",
       "      <th>Braintumor</th>\n",
       "      <th>Breasttum</th>\n",
       "      <th>Breasttumor</th>\n",
       "      <th>Chronicthromboembolicpulmonaryhypertension</th>\n",
       "      <th>Colorectaltumor</th>\n",
       "      <th>Diabetesmellitus</th>\n",
       "      <th>...</th>\n",
       "      <th>Parkinsonsdisease</th>\n",
       "      <th>Prostatectomy</th>\n",
       "      <th>Prostatetu</th>\n",
       "      <th>Prostatetumor</th>\n",
       "      <th>Psoriasis</th>\n",
       "      <th>Renaltumor</th>\n",
       "      <th>Rheumatoidarthritis</th>\n",
       "      <th>StageIIImelanoma</th>\n",
       "      <th>StageIVmelanoma</th>\n",
       "      <th>Uvealmelanoma</th>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>to</th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>600002</th>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>...</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>600007</th>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>...</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>600008</th>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>...</td>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>600009</th>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "      <td>...</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>600014</th>\n",
       "      <td>0</td>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>...</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>600016</th>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>...</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>600017</th>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>...</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>600018</th>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>...</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>600019</th>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>1</td>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>...</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>600021</th>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "      <td>1</td>\n",
       "      <td>1</td>\n",
       "      <td>...</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>600026</th>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>1</td>\n",
       "      <td>...</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>600029</th>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>1</td>\n",
       "      <td>...</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>600030</th>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>...</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>600033</th>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>...</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>600035</th>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>...</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>600036</th>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>...</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>600037</th>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>...</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>600040</th>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>...</td>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>600043</th>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>...</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>600044</th>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>...</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>600050</th>\n",
       "      <td>0</td>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>...</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>600051</th>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>...</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>600053</th>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>...</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>600058</th>\n",
       "      <td>0</td>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>...</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>600061</th>\n",
       "      <td>0</td>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>...</td>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>600062</th>\n",
       "      <td>1</td>\n",
       "      <td>1</td>\n",
       "      <td>1</td>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "      <td>1</td>\n",
       "      <td>1</td>\n",
       "      <td>...</td>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>1</td>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>600064</th>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>...</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>600065</th>\n",
       "      <td>1</td>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "      <td>...</td>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>1</td>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>600069</th>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>...</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>600074</th>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>1</td>\n",
       "      <td>...</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>...</th>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>805849</th>\n",
       "      <td>0</td>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>...</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>805854</th>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>...</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>805866</th>\n",
       "      <td>0</td>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>...</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>805873</th>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>...</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>805880</th>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>...</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>805881</th>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>...</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>805884</th>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>...</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>805889</th>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>...</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>805890</th>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>...</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>805904</th>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>...</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>805907</th>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>...</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>805913</th>\n",
       "      <td>0</td>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>...</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>805916</th>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>...</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>805917</th>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "      <td>...</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>805918</th>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>...</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>805920</th>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>...</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>805926</th>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>...</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>805928</th>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>...</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>805935</th>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>...</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>805936</th>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>...</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>805939</th>\n",
       "      <td>0</td>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>...</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>805940</th>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>...</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>805942</th>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "      <td>...</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>805950</th>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>...</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>805951</th>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>...</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>805959</th>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>...</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>805960</th>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>...</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>805966</th>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>...</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>805974</th>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>...</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>805980</th>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>...</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>6416 rows × 61 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "from    Acutemyelogenousleukemia  Alzheimersdisease  Arthritis  Asthma  \\\n",
       "to                                                                       \n",
       "600002                         0                  0          0       0   \n",
       "600007                         0                  0          0       0   \n",
       "600008                         0                  0          0       0   \n",
       "600009                         0                  0          0       0   \n",
       "600014                         0                  1          0       0   \n",
       "600016                         0                  0          0       1   \n",
       "600017                         0                  0          0       1   \n",
       "600018                         0                  0          0       1   \n",
       "600019                         0                  0          1       1   \n",
       "600021                         0                  0          0       0   \n",
       "600026                         0                  0          0       0   \n",
       "600029                         1                  0          0       0   \n",
       "600030                         0                  0          0       0   \n",
       "600033                         0                  0          0       1   \n",
       "600035                         0                  0          0       0   \n",
       "600036                         0                  0          0       0   \n",
       "600037                         0                  0          0       0   \n",
       "600040                         0                  0          0       0   \n",
       "600043                         0                  0          0       0   \n",
       "600044                         0                  0          0       0   \n",
       "600050                         0                  1          0       0   \n",
       "600051                         0                  0          0       0   \n",
       "600053                         0                  0          0       0   \n",
       "600058                         0                  1          0       0   \n",
       "600061                         0                  1          0       0   \n",
       "600062                         1                  1          1       1   \n",
       "600064                         0                  0          0       0   \n",
       "600065                         1                  1          0       1   \n",
       "600069                         0                  0          0       0   \n",
       "600074                         0                  0          0       0   \n",
       "...                          ...                ...        ...     ...   \n",
       "805849                         0                  1          0       0   \n",
       "805854                         0                  0          0       0   \n",
       "805866                         0                  1          0       0   \n",
       "805873                         1                  0          0       0   \n",
       "805880                         0                  0          0       0   \n",
       "805881                         0                  0          0       0   \n",
       "805884                         0                  0          0       0   \n",
       "805889                         0                  0          0       0   \n",
       "805890                         0                  0          0       1   \n",
       "805904                         0                  0          0       0   \n",
       "805907                         0                  0          0       0   \n",
       "805913                         0                  1          0       0   \n",
       "805916                         0                  0          1       0   \n",
       "805917                         0                  0          0       0   \n",
       "805918                         0                  0          0       0   \n",
       "805920                         0                  0          0       0   \n",
       "805926                         0                  0          0       0   \n",
       "805928                         0                  0          0       0   \n",
       "805935                         0                  0          0       0   \n",
       "805936                         0                  0          0       0   \n",
       "805939                         0                  1          0       0   \n",
       "805940                         0                  0          0       0   \n",
       "805942                         0                  0          0       1   \n",
       "805950                         0                  0          0       0   \n",
       "805951                         0                  0          0       1   \n",
       "805959                         0                  0          0       0   \n",
       "805960                         0                  0          0       0   \n",
       "805966                         0                  0          0       0   \n",
       "805974                         1                  0          0       0   \n",
       "805980                         0                  0          0       1   \n",
       "\n",
       "from    Braintumor  Breasttum  Breasttumor  \\\n",
       "to                                           \n",
       "600002           0          0            0   \n",
       "600007           0          0            1   \n",
       "600008           0          0            0   \n",
       "600009           0          0            0   \n",
       "600014           0          0            0   \n",
       "600016           0          0            0   \n",
       "600017           0          0            1   \n",
       "600018           0          0            0   \n",
       "600019           0          0            1   \n",
       "600021           0          0            1   \n",
       "600026           0          0            0   \n",
       "600029           0          0            0   \n",
       "600030           0          0            0   \n",
       "600033           0          0            0   \n",
       "600035           0          0            0   \n",
       "600036           0          0            0   \n",
       "600037           0          0            1   \n",
       "600040           0          0            0   \n",
       "600043           0          0            0   \n",
       "600044           0          0            1   \n",
       "600050           0          0            1   \n",
       "600051           1          0            0   \n",
       "600053           0          0            0   \n",
       "600058           0          0            0   \n",
       "600061           0          0            1   \n",
       "600062           0          0            1   \n",
       "600064           0          0            0   \n",
       "600065           0          0            1   \n",
       "600069           0          0            1   \n",
       "600074           0          0            0   \n",
       "...            ...        ...          ...   \n",
       "805849           0          0            0   \n",
       "805854           0          0            0   \n",
       "805866           0          0            0   \n",
       "805873           0          0            0   \n",
       "805880           0          0            0   \n",
       "805881           0          0            0   \n",
       "805884           1          0            1   \n",
       "805889           0          0            0   \n",
       "805890           0          0            0   \n",
       "805904           0          0            0   \n",
       "805907           0          0            1   \n",
       "805913           0          0            0   \n",
       "805916           0          0            0   \n",
       "805917           0          0            1   \n",
       "805918           0          0            0   \n",
       "805920           0          0            0   \n",
       "805926           0          0            0   \n",
       "805928           0          0            0   \n",
       "805935           0          0            0   \n",
       "805936           0          0            0   \n",
       "805939           0          0            0   \n",
       "805940           0          0            0   \n",
       "805942           0          0            0   \n",
       "805950           0          0            0   \n",
       "805951           0          0            0   \n",
       "805959           0          0            0   \n",
       "805960           0          0            0   \n",
       "805966           0          0            0   \n",
       "805974           0          0            0   \n",
       "805980           0          0            0   \n",
       "\n",
       "from    Chronicthromboembolicpulmonaryhypertension  Colorectaltumor  \\\n",
       "to                                                                    \n",
       "600002                                           0                0   \n",
       "600007                                           0                0   \n",
       "600008                                           0                0   \n",
       "600009                                           0                1   \n",
       "600014                                           0                0   \n",
       "600016                                           0                0   \n",
       "600017                                           0                0   \n",
       "600018                                           0                0   \n",
       "600019                                           0                0   \n",
       "600021                                           0                1   \n",
       "600026                                           0                0   \n",
       "600029                                           0                0   \n",
       "600030                                           0                0   \n",
       "600033                                           0                0   \n",
       "600035                                           0                0   \n",
       "600036                                           0                0   \n",
       "600037                                           0                0   \n",
       "600040                                           0                0   \n",
       "600043                                           0                0   \n",
       "600044                                           0                0   \n",
       "600050                                           0                0   \n",
       "600051                                           0                0   \n",
       "600053                                           0                0   \n",
       "600058                                           0                0   \n",
       "600061                                           0                0   \n",
       "600062                                           0                1   \n",
       "600064                                           0                0   \n",
       "600065                                           0                1   \n",
       "600069                                           0                0   \n",
       "600074                                           0                0   \n",
       "...                                            ...              ...   \n",
       "805849                                           0                0   \n",
       "805854                                           0                0   \n",
       "805866                                           0                0   \n",
       "805873                                           0                0   \n",
       "805880                                           0                0   \n",
       "805881                                           0                0   \n",
       "805884                                           0                0   \n",
       "805889                                           0                0   \n",
       "805890                                           0                0   \n",
       "805904                                           0                0   \n",
       "805907                                           0                0   \n",
       "805913                                           0                0   \n",
       "805916                                           0                0   \n",
       "805917                                           0                1   \n",
       "805918                                           0                0   \n",
       "805920                                           0                0   \n",
       "805926                                           0                0   \n",
       "805928                                           0                0   \n",
       "805935                                           0                0   \n",
       "805936                                           0                0   \n",
       "805939                                           0                0   \n",
       "805940                                           0                0   \n",
       "805942                                           0                1   \n",
       "805950                                           0                0   \n",
       "805951                                           0                0   \n",
       "805959                                           0                0   \n",
       "805960                                           0                0   \n",
       "805966                                           0                0   \n",
       "805974                                           0                0   \n",
       "805980                                           0                0   \n",
       "\n",
       "from    Diabetesmellitus      ...        Parkinsonsdisease  Prostatectomy  \\\n",
       "to                            ...                                           \n",
       "600002                 0      ...                        0              0   \n",
       "600007                 0      ...                        0              0   \n",
       "600008                 0      ...                        1              0   \n",
       "600009                 0      ...                        0              0   \n",
       "600014                 0      ...                        0              0   \n",
       "600016                 0      ...                        0              0   \n",
       "600017                 0      ...                        0              0   \n",
       "600018                 0      ...                        0              0   \n",
       "600019                 0      ...                        0              0   \n",
       "600021                 1      ...                        0              0   \n",
       "600026                 1      ...                        0              0   \n",
       "600029                 1      ...                        0              0   \n",
       "600030                 0      ...                        0              0   \n",
       "600033                 0      ...                        0              0   \n",
       "600035                 0      ...                        0              0   \n",
       "600036                 0      ...                        0              0   \n",
       "600037                 0      ...                        0              0   \n",
       "600040                 0      ...                        1              0   \n",
       "600043                 0      ...                        0              0   \n",
       "600044                 0      ...                        0              0   \n",
       "600050                 0      ...                        0              0   \n",
       "600051                 0      ...                        0              0   \n",
       "600053                 0      ...                        0              0   \n",
       "600058                 0      ...                        0              0   \n",
       "600061                 0      ...                        1              0   \n",
       "600062                 1      ...                        1              0   \n",
       "600064                 0      ...                        0              0   \n",
       "600065                 0      ...                        1              0   \n",
       "600069                 0      ...                        0              0   \n",
       "600074                 1      ...                        0              0   \n",
       "...                  ...      ...                      ...            ...   \n",
       "805849                 0      ...                        0              0   \n",
       "805854                 0      ...                        0              0   \n",
       "805866                 0      ...                        0              0   \n",
       "805873                 0      ...                        0              0   \n",
       "805880                 0      ...                        0              0   \n",
       "805881                 0      ...                        0              0   \n",
       "805884                 0      ...                        0              0   \n",
       "805889                 0      ...                        0              0   \n",
       "805890                 0      ...                        0              0   \n",
       "805904                 0      ...                        0              0   \n",
       "805907                 0      ...                        0              0   \n",
       "805913                 0      ...                        0              0   \n",
       "805916                 0      ...                        0              0   \n",
       "805917                 0      ...                        0              0   \n",
       "805918                 0      ...                        0              0   \n",
       "805920                 0      ...                        0              0   \n",
       "805926                 0      ...                        0              0   \n",
       "805928                 0      ...                        0              0   \n",
       "805935                 0      ...                        0              0   \n",
       "805936                 0      ...                        0              0   \n",
       "805939                 0      ...                        0              0   \n",
       "805940                 0      ...                        0              0   \n",
       "805942                 0      ...                        0              0   \n",
       "805950                 0      ...                        0              0   \n",
       "805951                 0      ...                        0              0   \n",
       "805959                 0      ...                        0              0   \n",
       "805960                 0      ...                        0              0   \n",
       "805966                 0      ...                        0              0   \n",
       "805974                 0      ...                        0              0   \n",
       "805980                 0      ...                        0              0   \n",
       "\n",
       "from    Prostatetu  Prostatetumor  Psoriasis  Renaltumor  Rheumatoidarthritis  \\\n",
       "to                                                                              \n",
       "600002           0              0          0           0                    1   \n",
       "600007           0              1          0           0                    1   \n",
       "600008           0              0          0           0                    0   \n",
       "600009           0              0          0           0                    0   \n",
       "600014           0              0          0           0                    0   \n",
       "600016           0              0          0           0                    0   \n",
       "600017           0              0          0           0                    0   \n",
       "600018           0              0          0           0                    0   \n",
       "600019           0              0          0           0                    0   \n",
       "600021           0              0          0           0                    1   \n",
       "600026           0              0          0           0                    0   \n",
       "600029           0              0          1           0                    1   \n",
       "600030           0              0          1           0                    0   \n",
       "600033           0              0          0           0                    0   \n",
       "600035           0              0          0           0                    0   \n",
       "600036           0              0          0           0                    0   \n",
       "600037           0              0          0           0                    1   \n",
       "600040           0              0          0           0                    0   \n",
       "600043           0              0          0           0                    0   \n",
       "600044           0              0          0           0                    0   \n",
       "600050           0              0          0           0                    0   \n",
       "600051           0              0          0           0                    0   \n",
       "600053           0              0          0           0                    0   \n",
       "600058           0              0          0           0                    0   \n",
       "600061           0              1          0           0                    0   \n",
       "600062           0              1          1           0                    1   \n",
       "600064           0              0          0           0                    0   \n",
       "600065           0              1          1           0                    1   \n",
       "600069           0              0          0           0                    0   \n",
       "600074           0              0          0           0                    0   \n",
       "...            ...            ...        ...         ...                  ...   \n",
       "805849           0              0          0           0                    0   \n",
       "805854           0              0          0           0                    0   \n",
       "805866           0              0          0           0                    0   \n",
       "805873           0              0          0           0                    0   \n",
       "805880           0              0          0           0                    0   \n",
       "805881           0              0          0           0                    0   \n",
       "805884           0              0          0           0                    0   \n",
       "805889           0              0          0           0                    0   \n",
       "805890           0              0          0           0                    1   \n",
       "805904           0              0          0           0                    0   \n",
       "805907           0              0          0           0                    0   \n",
       "805913           0              0          0           0                    0   \n",
       "805916           0              0          0           0                    0   \n",
       "805917           0              0          0           0                    0   \n",
       "805918           0              0          0           0                    0   \n",
       "805920           0              0          0           0                    0   \n",
       "805926           0              1          0           0                    0   \n",
       "805928           0              0          1           0                    1   \n",
       "805935           0              0          0           0                    0   \n",
       "805936           0              0          0           0                    0   \n",
       "805939           0              0          0           0                    0   \n",
       "805940           0              0          0           0                    0   \n",
       "805942           0              0          0           0                    0   \n",
       "805950           0              1          0           0                    0   \n",
       "805951           0              0          0           0                    0   \n",
       "805959           0              1          0           0                    0   \n",
       "805960           0              0          1           0                    0   \n",
       "805966           0              0          0           0                    1   \n",
       "805974           0              0          0           0                    0   \n",
       "805980           0              0          0           0                    1   \n",
       "\n",
       "from    StageIIImelanoma  StageIVmelanoma  Uvealmelanoma  \n",
       "to                                                        \n",
       "600002                 0                0              0  \n",
       "600007                 0                0              0  \n",
       "600008                 0                0              0  \n",
       "600009                 0                0              0  \n",
       "600014                 0                0              0  \n",
       "600016                 0                0              0  \n",
       "600017                 0                0              0  \n",
       "600018                 0                0              0  \n",
       "600019                 0                0              0  \n",
       "600021                 0                0              0  \n",
       "600026                 0                0              0  \n",
       "600029                 0                0              0  \n",
       "600030                 0                0              0  \n",
       "600033                 0                0              0  \n",
       "600035                 0                0              0  \n",
       "600036                 0                0              0  \n",
       "600037                 0                0              0  \n",
       "600040                 0                0              0  \n",
       "600043                 0                0              0  \n",
       "600044                 0                0              0  \n",
       "600050                 0                0              0  \n",
       "600051                 0                0              0  \n",
       "600053                 0                0              0  \n",
       "600058                 0                0              0  \n",
       "600061                 0                0              0  \n",
       "600062                 0                0              0  \n",
       "600064                 0                0              0  \n",
       "600065                 0                0              0  \n",
       "600069                 0                0              0  \n",
       "600074                 0                0              0  \n",
       "...                  ...              ...            ...  \n",
       "805849                 0                0              0  \n",
       "805854                 0                0              0  \n",
       "805866                 0                0              0  \n",
       "805873                 0                0              0  \n",
       "805880                 0                0              0  \n",
       "805881                 0                0              0  \n",
       "805884                 0                0              0  \n",
       "805889                 0                0              0  \n",
       "805890                 0                0              0  \n",
       "805904                 0                0              0  \n",
       "805907                 0                0              0  \n",
       "805913                 0                0              0  \n",
       "805916                 0                0              0  \n",
       "805917                 0                0              0  \n",
       "805918                 0                0              0  \n",
       "805920                 0                0              0  \n",
       "805926                 0                0              0  \n",
       "805928                 0                0              0  \n",
       "805935                 0                0              0  \n",
       "805936                 0                0              0  \n",
       "805939                 0                0              0  \n",
       "805940                 0                0              0  \n",
       "805942                 0                0              0  \n",
       "805950                 0                0              0  \n",
       "805951                 0                0              0  \n",
       "805959                 0                0              0  \n",
       "805960                 0                0              0  \n",
       "805966                 0                0              0  \n",
       "805974                 0                0              0  \n",
       "805980                 0                0              0  \n",
       "\n",
       "[6416 rows x 61 columns]"
      ]
     },
     "execution_count": 21,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "adj_matrix\n",
    "\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 22,
   "metadata": {},
   "outputs": [],
   "source": [
    "adj_matrix.to_csv('topicByfirm25.cvs')"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {
    "collapsed": true
   },
   "outputs": [],
   "source": [
    "# company by company 15030 rows × 1797 columns\n",
    "edges = []\n",
    "for it in adj_list.values():\n",
    "    for it2 in range(len(it)):\n",
    "        for it3 in range(it2,len(it)):\n",
    "            edges.append((it[it2], it[it3]))\n",
    "    \n",
    "edges"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": [
    "\n",
    "import pandas as pd\n",
    "df_f_by_f = pd.read_csv(\"firm_by_firm.csv\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {
    "collapsed": true
   },
   "outputs": [],
   "source": []
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "Python 2",
   "language": "python",
   "name": "python2"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 2
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython2",
   "version": "2.7.12"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 2
}
